{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "znlt8jyJKg-5"
   },
   "source": [
    "##### INF8460 – Traitement automatique de la langue naturelle - Automne 2024\n",
    "### TP1 - Recherche de documents avec une métrique de similarité\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Identification de l'équipe:\n",
    "\n",
    "### Groupe de laboratoire:\n",
    "\n",
    "### Equipe numéro :\n",
    "\n",
    "### Membres:\n",
    "\n",
    "- membre 1 (% de contribution, nature de la contribution)\n",
    "- membre 2 (% de contribution, nature de la contribution)\n",
    "- membre 3 (% de contribution, nature de la contribution)\n",
    "\n",
    "* nature de la contribution: Décrivez brièvement ce qui a été fait par chaque membre de l’équipe. Tous les membres sont censés contribuer au développement. Bien que chaque membre puisse effectuer différentes tâches, vous devez vous efforcer d’obtenir une répartition égale du travail. Soyez précis ! N'indiquez pas seulement : travail réparti équitablement"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Mise en place"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Objectif du TP\n",
    "\n",
    "La recherche d'information est le processus d'accès aux données, généralement des documents ou d'autres données non structurées, à partir d'une requête. Dans ce TP, vous aurez en entrée une requête textuelle sous forme d'affirmation. Il faudra retrouver dans un corpus de littérature scientifique les documents pertinents qui justifient ou infirment la véracité de cette affirmation. Vous utiliserez des modèles vectoriels et des métriques de similarité pour cette tâche."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Jeux de données\n",
    "\n",
    "Dans ce TP, vous utiliserez le jeu de données dans le répertoire _data_. Il s'agit d'un ensemble de données comprenant 809 affirmations rédigées par des experts et 5183 documents de références pour ces affirmations. Ces documents contiennent des phrases qui confirment ou infirment (contredisent) les affirmations. L'objectif est donc de trouver un document pertinent, c'est-à-dire contenant la ou les phrases qui permettent d'évaluer une affirmation donnée en entrée en utilisant une similarité sémantique. \n",
    "\n",
    "Le jeu de données comprend :\n",
    "\n",
    "1. Un corpus (_corpus.jsonl_) qui contient des documents décrits avec les informations suivantes :\n",
    "    - 'doc_id' : permet d'identifier le document en entrée\n",
    "    - 'title' : donne le titre du document\n",
    "    - 'abstract': est le résumé du document\n",
    "    - 'structured': indique si le document est structuré ou pas\n",
    "\n",
    "2. Un ensemble d'affirmations (_claims.jsonl_) qui contient des documents décrits avec les informations suivantes :\n",
    "    - 'id' : identifie l'affirmation.\n",
    "    - 'claim' : est l'affirmation en tant que telle.\n",
    "    - 'evidence' : précise quelles phrases du document sont pertinentes pour l'affirmation. Chaque phrase est accompagnée d'une étiquette de véracité (confirm/contradict) pour indiquer si la phrase confirme ou contredit l'affirmation.  \n",
    "    - 'cited_doc_ids' : indique les identifiants des documents cités.\n",
    "\n",
    "\n",
    "\n",
    "Dans _claims.jsonl_, seuls les identifiants des documents sont renseignés. Pour avoir les détails d'un document tel que le titre (\"title\") et le résumé (\"abstract\"), il faudra consulter le fichier _corpus.jsonl_. \n",
    "\n",
    "Voici un exemple :\n",
    "\n",
    "- **Affirmation (claim)** : Consumption of whole fruits increases the risk of type 2 diabetes.\n",
    "- **Cited document(s) ID(s)** : 1974176\n",
    "- **Evidence (sentence in the document containing the proof)** : [{'sentences': [11], 'label': 'CONTRADICT'}]\n",
    "\n",
    "  Ici [11] constitue le numéro de la phrase qui contredit l'affirmation.\n",
    "\n",
    "- **Cited document(s) title(s)** : Fruit consumption and risk of type 2 diabetes: results from three prospective longitudinal cohort studies\n",
    "- **Cited document(s) abstract(s) (list of sentences)** : \n",
    "    - [0] 'OBJECTIVE To determine whether individual fruits are differentially associated with risk of type 2 diabetes.\\n'\n",
    "    - [1] 'DESIGN Prospective longitudinal cohort study.'\n",
    "    - ...\n",
    "    - [10] 'CONCLUSION Our findings suggest the presence of heterogeneity in the associations between individual fruit consumption and risk of type 2 diabetes.'\n",
    "    - [11] 'Greater consumption of specific whole fruits, particularly blueberries, grapes, and apples, is significantly associated with a lower risk of type 2 diabetes, whereas greater consumption of fruit juice is associated with a higher risk.'\n",
    "\n",
    "Le champ \"evidence\" indique la phrase au niveau du résumé du document qui confirme ou infirme l'affirmation, d'où le numéro de la phrase et le label qui y sont renseignés. Dans le cas particulier de l'exemple ci-dessus, on voit bien que la onzième phrase du résumé du document est la plus pertinente pour l'affirmation et qu'elle la contredit, ce qui explique le label \"CONTRADICT\" dans \"evidence\". Cependant, dans le cadre de ce TP, on ne s'intéresse qu'à la présence de cette phrase pertinente dans le document, donc on ne considérera pas cette colonne \"evidence\" dans la suite du TP."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "26Qe_-7z25EE"
   },
   "source": [
    "### Librairies permises\n",
    "- Jupyter notebook\n",
    "- NLTK\n",
    "- Numpy \n",
    "- Pandas\n",
    "- Sklearn\n",
    "- PowerLaw\n",
    "- Matplotlib\n",
    "- TQDM\n",
    "- BM25\n",
    "- Pour toute autre librairie, demandez à votre chargé de laboratoire"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "zupXN9tr3oEa"
   },
   "source": [
    "## Étapes du TP\n",
    "A partir du notebook _INF8460_A24_TP1_ qui est distribué, vous devez réaliser les étapes suivantes. (Notez que les cellules dans le squelette sont là à titre informatif - il est fort probable que vous rajoutiez des sections au fur et à mesure de votre TP)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Lien vers les fichiers à utiliser\n",
    "# Ne pas modifier\n",
    "\n",
    "PATH = 'data/ai2_data/'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "#!pip install rank_bm25 \n",
    "#!pip install powerlaw"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Import des librairies\n",
    "\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "import powerlaw\n",
    "from collections import defaultdict, Counter\n",
    "from tqdm import tqdm\n",
    "import matplotlib.pyplot as plt\n",
    "from typing import List, Dict\n",
    "\n",
    "import nltk\n",
    "from nltk.tokenize import word_tokenize\n",
    "from nltk.stem.porter import PorterStemmer\n",
    "from nltk.corpus import stopwords\n",
    "from string import punctuation\n",
    "\n",
    "import sklearn\n",
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "from sklearn.metrics.pairwise import cosine_similarity\n",
    "\n",
    "from rank_bm25 import BM25Okapi"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package punkt to\n",
      "[nltk_data]     C:\\Users\\K-1\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package punkt is already up-to-date!\n",
      "[nltk_data] Downloading package stopwords to\n",
      "[nltk_data]     C:\\Users\\K-1\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package stopwords is already up-to-date!\n"
     ]
    }
   ],
   "source": [
    "nltk.download('punkt')\n",
    "nltk.download('stopwords')\n",
    "stop_words = stopwords.words('english')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 1. Traitement des données (15 points)\n",
    "Vous allez effectuer une analyse afin d'avoir une idée claire des données que vous aurez à manipuler."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### 1.1 Chargement des données (2 points)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 1.1.1 Chargement et affichage des données (1 point)\n",
    "\n",
    "Chargez les données '_claims.jsonl_' et '_corpus.jsonl_' puis affichez-les dans des dataframes en utilisant panda."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>claim</th>\n",
       "      <th>evidence</th>\n",
       "      <th>cited_doc_ids</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>0-dimensional biomaterials lack inductive prop...</td>\n",
       "      <td>{}</td>\n",
       "      <td>[31715818]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>1 in 5 million in UK have abnormal PrP positiv...</td>\n",
       "      <td>{'13734012': [{'sentences': [4], 'label': 'CON...</td>\n",
       "      <td>[13734012]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>4</td>\n",
       "      <td>1-1% of colorectal cancer patients are diagnos...</td>\n",
       "      <td>{}</td>\n",
       "      <td>[22942787]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>6</td>\n",
       "      <td>10% of sudden infant death syndrome (SIDS) dea...</td>\n",
       "      <td>{}</td>\n",
       "      <td>[2613775]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>9</td>\n",
       "      <td>32% of liver transplantation programs required...</td>\n",
       "      <td>{'44265107': [{'sentences': [15], 'label': 'SU...</td>\n",
       "      <td>[44265107]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>804</th>\n",
       "      <td>1403</td>\n",
       "      <td>siRNA knockdown of A20 accelerates tumor progr...</td>\n",
       "      <td>{'33370': [{'sentences': [6], 'label': 'CONTRA...</td>\n",
       "      <td>[33370, 38355793]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805</th>\n",
       "      <td>1404</td>\n",
       "      <td>siRNA knockdown of A20 slows tumor progression...</td>\n",
       "      <td>{'33370': [{'sentences': [6], 'label': 'SUPPOR...</td>\n",
       "      <td>[33370, 38355793]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>806</th>\n",
       "      <td>1405</td>\n",
       "      <td>taa1 tar1 tar2 triple mutants in Arabidopsis d...</td>\n",
       "      <td>{}</td>\n",
       "      <td>[10504681]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>807</th>\n",
       "      <td>1406</td>\n",
       "      <td>β-sheet opening occurs during pleurotolysin po...</td>\n",
       "      <td>{'2617858': [{'sentences': [4], 'label': 'SUPP...</td>\n",
       "      <td>[2617858]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>808</th>\n",
       "      <td>1407</td>\n",
       "      <td>β1/Ketel is able to bind microtubules.</td>\n",
       "      <td>{}</td>\n",
       "      <td>[8087082, 29863668]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>809 rows × 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       id                                              claim  \\\n",
       "0       0  0-dimensional biomaterials lack inductive prop...   \n",
       "1       2  1 in 5 million in UK have abnormal PrP positiv...   \n",
       "2       4  1-1% of colorectal cancer patients are diagnos...   \n",
       "3       6  10% of sudden infant death syndrome (SIDS) dea...   \n",
       "4       9  32% of liver transplantation programs required...   \n",
       "..    ...                                                ...   \n",
       "804  1403  siRNA knockdown of A20 accelerates tumor progr...   \n",
       "805  1404  siRNA knockdown of A20 slows tumor progression...   \n",
       "806  1405  taa1 tar1 tar2 triple mutants in Arabidopsis d...   \n",
       "807  1406  β-sheet opening occurs during pleurotolysin po...   \n",
       "808  1407             β1/Ketel is able to bind microtubules.   \n",
       "\n",
       "                                              evidence        cited_doc_ids  \n",
       "0                                                   {}           [31715818]  \n",
       "1    {'13734012': [{'sentences': [4], 'label': 'CON...           [13734012]  \n",
       "2                                                   {}           [22942787]  \n",
       "3                                                   {}            [2613775]  \n",
       "4    {'44265107': [{'sentences': [15], 'label': 'SU...           [44265107]  \n",
       "..                                                 ...                  ...  \n",
       "804  {'33370': [{'sentences': [6], 'label': 'CONTRA...    [33370, 38355793]  \n",
       "805  {'33370': [{'sentences': [6], 'label': 'SUPPOR...    [33370, 38355793]  \n",
       "806                                                 {}           [10504681]  \n",
       "807  {'2617858': [{'sentences': [4], 'label': 'SUPP...            [2617858]  \n",
       "808                                                 {}  [8087082, 29863668]  \n",
       "\n",
       "[809 rows x 4 columns]"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# TODO\n",
    "df_claims = pd.read_json(f'{PATH}/claims.jsonl', lines = True)\n",
    "df_corpus = pd.read_json(f'{PATH}/corpus.jsonl', lines = True)\n",
    "df_claims\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>doc_id</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "      <th>structured</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>4983</td>\n",
       "      <td>Microstructural development of human newborn c...</td>\n",
       "      <td>[Alterations of the architecture of cerebral w...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>5836</td>\n",
       "      <td>Induction of myelodysplasia by myeloid-derived...</td>\n",
       "      <td>[Myelodysplastic syndromes (MDS) are age-depen...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>7912</td>\n",
       "      <td>BC1 RNA, the transcript from a master gene for...</td>\n",
       "      <td>[ID elements are short interspersed elements (...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>18670</td>\n",
       "      <td>The DNA Methylome of Human Peripheral Blood Mo...</td>\n",
       "      <td>[DNA methylation plays an important role in bi...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>19238</td>\n",
       "      <td>The human myelin basic protein gene is include...</td>\n",
       "      <td>[Two human Golli (for gene expressed in the ol...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5178</th>\n",
       "      <td>195689316</td>\n",
       "      <td>Body-mass index and cause-specific mortality i...</td>\n",
       "      <td>[BACKGROUND The main associations of body-mass...</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5179</th>\n",
       "      <td>195689757</td>\n",
       "      <td>Targeting metabolic remodeling in glioblastoma...</td>\n",
       "      <td>[A key aberrant biological difference between ...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5180</th>\n",
       "      <td>196664003</td>\n",
       "      <td>Signaling architectures that transmit unidirec...</td>\n",
       "      <td>[A signaling pathway transmits information fro...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5181</th>\n",
       "      <td>198133135</td>\n",
       "      <td>Association between pre-diabetes, type 2 diabe...</td>\n",
       "      <td>[AIMS Trabecular bone score (TBS) is a surroga...</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5182</th>\n",
       "      <td>198309074</td>\n",
       "      <td>Adhesion molecules and chemokines: relation to...</td>\n",
       "      <td>[Introduction: Among the inflammatory mediator...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5183 rows × 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "         doc_id                                              title  \\\n",
       "0          4983  Microstructural development of human newborn c...   \n",
       "1          5836  Induction of myelodysplasia by myeloid-derived...   \n",
       "2          7912  BC1 RNA, the transcript from a master gene for...   \n",
       "3         18670  The DNA Methylome of Human Peripheral Blood Mo...   \n",
       "4         19238  The human myelin basic protein gene is include...   \n",
       "...         ...                                                ...   \n",
       "5178  195689316  Body-mass index and cause-specific mortality i...   \n",
       "5179  195689757  Targeting metabolic remodeling in glioblastoma...   \n",
       "5180  196664003  Signaling architectures that transmit unidirec...   \n",
       "5181  198133135  Association between pre-diabetes, type 2 diabe...   \n",
       "5182  198309074  Adhesion molecules and chemokines: relation to...   \n",
       "\n",
       "                                               abstract  structured  \n",
       "0     [Alterations of the architecture of cerebral w...       False  \n",
       "1     [Myelodysplastic syndromes (MDS) are age-depen...       False  \n",
       "2     [ID elements are short interspersed elements (...       False  \n",
       "3     [DNA methylation plays an important role in bi...       False  \n",
       "4     [Two human Golli (for gene expressed in the ol...       False  \n",
       "...                                                 ...         ...  \n",
       "5178  [BACKGROUND The main associations of body-mass...        True  \n",
       "5179  [A key aberrant biological difference between ...       False  \n",
       "5180  [A signaling pathway transmits information fro...       False  \n",
       "5181  [AIMS Trabecular bone score (TBS) is a surroga...        True  \n",
       "5182  [Introduction: Among the inflammatory mediator...       False  \n",
       "\n",
       "[5183 rows x 4 columns]"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_corpus"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 1.1.2 Statistique sur les évidences (1 point)\n",
    "\n",
    "Calculez les pourcentages d'apparition de chaque label des évidences dans \"_df_claims_\" (CONTRADICT ou SUPPORT). Pour rappel les évidences sont les extraits pertinents des résumés qui supportent ou contredisent les affirmations. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(34.39716312056738, 65.60283687943263)"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# On calcule les pourcentages des labels present dans evidence\n",
    "# TODO\n",
    "\n",
    "sum_contradict = 0\n",
    "sum_support = 0\n",
    "total = 0\n",
    "for index, row in df_claims.iterrows():\n",
    "    #print(row['evidence'].keys())\n",
    "    #print('-----------------------')\n",
    "    cite_doc_id = row['cited_doc_ids']\n",
    "    if row['evidence']:\n",
    "        for doc_id in cite_doc_id:\n",
    "            #print(doc_id)\n",
    "            if str(doc_id) in row['evidence'].keys():\n",
    "                label = row['evidence'][f'{doc_id}'][0]['label']\n",
    "                #print(label)\n",
    "                total += 1\n",
    "                if label == 'CONTRADICT':\n",
    "                    sum_contradict += 1\n",
    "                else:\n",
    "                    sum_support += 1\n",
    "                \n",
    "\n",
    "\n",
    "prob_contradict = (sum_contradict/total)*100\n",
    "prob_support = (sum_support/total)*100\n",
    "\n",
    "prob_contradict, prob_support\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "> Réponse attendue:\n",
    "> \n",
    "> CONTRADICT: 35.63%\n",
    "> \n",
    "> SUPPORT: 64.37%"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### 1.2 Analyse statistique des données (7 points)\n",
    "\n",
    "Nous allons faire une suite de transformations sur les données pour les rendre plus faciles à manipuler."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 1.2.1 Implémentation de la fonction \"_list_to_string_\" \n",
    "\n",
    "Nous mettons à votre disposition la fonction \"_list_to_string_\" qui transforme une liste de phrases en un texte en les concaténant et enlèvant tous les caractères de nouvelle ligne (`\\n`) pour s'assurer que nous avons un texte complet. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "# On transforme la liste de phrases en un texte\n",
    "def list_to_string(x):\n",
    "    if isinstance(x, list):\n",
    "        return ' '.join(str(i).replace(\"\\n\",\"\").replace(\"  \",\" \") for i in x)  # Enlève les caractère de retour à la ligne et convertit les éléments de la liste en chaînes et les joint\n",
    "    return str(x)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 1.2.2 Utilisation de la fonction \"_list_to_string_\" \n",
    "\n",
    "Appliquons cette fonction \"_list_to_string_\" aux colonnes \"_title_\" et \"abstract\" du dataframe \"_df_corpus_\"."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "# On applique la fonction aux colonnes \"title\" et \"abstract\"\n",
    "df_corpus['title']    = df_corpus['title'].apply(list_to_string)\n",
    "df_corpus['abstract'] = df_corpus['abstract'].apply(list_to_string)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0       Microstructural development of human newborn c...\n",
       "1       Induction of myelodysplasia by myeloid-derived...\n",
       "2       BC1 RNA, the transcript from a master gene for...\n",
       "3       The DNA Methylome of Human Peripheral Blood Mo...\n",
       "4       The human myelin basic protein gene is include...\n",
       "                              ...                        \n",
       "5178    Body-mass index and cause-specific mortality i...\n",
       "5179    Targeting metabolic remodeling in glioblastoma...\n",
       "5180    Signaling architectures that transmit unidirec...\n",
       "5181    Association between pre-diabetes, type 2 diabe...\n",
       "5182    Adhesion molecules and chemokines: relation to...\n",
       "Name: title, Length: 5183, dtype: object"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_corpus['title']"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 1.2.3 Ajout de la colonne \"_text_\" dans \"df_corpus\"\n",
    "\n",
    "\n",
    "Ajoutons maintenant une colonne \"_text_\" qui est la concaténation du titre (\"_title_\") et du résumé (\"_abstract_\") au niveau du dataframe \"df_corpus\"."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0       Microstructural development of human newborn c...\n",
       "1       Induction of myelodysplasia by myeloid-derived...\n",
       "2       BC1 RNA, the transcript from a master gene for...\n",
       "3       The DNA Methylome of Human Peripheral Blood Mo...\n",
       "4       The human myelin basic protein gene is include...\n",
       "                              ...                        \n",
       "5178    Body-mass index and cause-specific mortality i...\n",
       "5179    Targeting metabolic remodeling in glioblastoma...\n",
       "5180    Signaling architectures that transmit unidirec...\n",
       "5181    Association between pre-diabetes, type 2 diabe...\n",
       "5182    Adhesion molecules and chemokines: relation to...\n",
       "Name: text, Length: 5183, dtype: object"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# On concatene les textes dans \"title\" et \"abstract\"\n",
    "df_corpus['text'] = df_corpus['title'] + \" \" + df_corpus['abstract']\n",
    "df_corpus['text']"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 1.2.4 Ajout de colonnes dans \"_df_claims_\" (1 point)\n",
    "\n",
    "Ajoutez les colonnes \"_claim_length_\" et \"_num_cited_doc_\" qui donnent, pour chaque affirmation, le nombre de mots dans la colonne \"_claim_\" et le nombre de documents cités au niveau de la colonne \"_cited_doc_ids_\" pour le dataframe \"_df_claims_\". Vous pouvez considérer que des mots sont simplement une séquence de caractères séparés par un espace."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>claim</th>\n",
       "      <th>evidence</th>\n",
       "      <th>cited_doc_ids</th>\n",
       "      <th>num_cited_doc</th>\n",
       "      <th>claim_length</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>0-dimensional biomaterials lack inductive prop...</td>\n",
       "      <td>{}</td>\n",
       "      <td>[31715818]</td>\n",
       "      <td>1</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>1 in 5 million in UK have abnormal PrP positiv...</td>\n",
       "      <td>{'13734012': [{'sentences': [4], 'label': 'CON...</td>\n",
       "      <td>[13734012]</td>\n",
       "      <td>1</td>\n",
       "      <td>10</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>4</td>\n",
       "      <td>1-1% of colorectal cancer patients are diagnos...</td>\n",
       "      <td>{}</td>\n",
       "      <td>[22942787]</td>\n",
       "      <td>1</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>6</td>\n",
       "      <td>10% of sudden infant death syndrome (SIDS) dea...</td>\n",
       "      <td>{}</td>\n",
       "      <td>[2613775]</td>\n",
       "      <td>1</td>\n",
       "      <td>16</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>9</td>\n",
       "      <td>32% of liver transplantation programs required...</td>\n",
       "      <td>{'44265107': [{'sentences': [15], 'label': 'SU...</td>\n",
       "      <td>[44265107]</td>\n",
       "      <td>1</td>\n",
       "      <td>13</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>804</th>\n",
       "      <td>1403</td>\n",
       "      <td>siRNA knockdown of A20 accelerates tumor progr...</td>\n",
       "      <td>{'33370': [{'sentences': [6], 'label': 'CONTRA...</td>\n",
       "      <td>[33370, 38355793]</td>\n",
       "      <td>2</td>\n",
       "      <td>14</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805</th>\n",
       "      <td>1404</td>\n",
       "      <td>siRNA knockdown of A20 slows tumor progression...</td>\n",
       "      <td>{'33370': [{'sentences': [6], 'label': 'SUPPOR...</td>\n",
       "      <td>[33370, 38355793]</td>\n",
       "      <td>2</td>\n",
       "      <td>14</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>806</th>\n",
       "      <td>1405</td>\n",
       "      <td>taa1 tar1 tar2 triple mutants in Arabidopsis d...</td>\n",
       "      <td>{}</td>\n",
       "      <td>[10504681]</td>\n",
       "      <td>1</td>\n",
       "      <td>14</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>807</th>\n",
       "      <td>1406</td>\n",
       "      <td>β-sheet opening occurs during pleurotolysin po...</td>\n",
       "      <td>{'2617858': [{'sentences': [4], 'label': 'SUPP...</td>\n",
       "      <td>[2617858]</td>\n",
       "      <td>1</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>808</th>\n",
       "      <td>1407</td>\n",
       "      <td>β1/Ketel is able to bind microtubules.</td>\n",
       "      <td>{}</td>\n",
       "      <td>[8087082, 29863668]</td>\n",
       "      <td>2</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>809 rows × 6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       id                                              claim  \\\n",
       "0       0  0-dimensional biomaterials lack inductive prop...   \n",
       "1       2  1 in 5 million in UK have abnormal PrP positiv...   \n",
       "2       4  1-1% of colorectal cancer patients are diagnos...   \n",
       "3       6  10% of sudden infant death syndrome (SIDS) dea...   \n",
       "4       9  32% of liver transplantation programs required...   \n",
       "..    ...                                                ...   \n",
       "804  1403  siRNA knockdown of A20 accelerates tumor progr...   \n",
       "805  1404  siRNA knockdown of A20 slows tumor progression...   \n",
       "806  1405  taa1 tar1 tar2 triple mutants in Arabidopsis d...   \n",
       "807  1406  β-sheet opening occurs during pleurotolysin po...   \n",
       "808  1407             β1/Ketel is able to bind microtubules.   \n",
       "\n",
       "                                              evidence        cited_doc_ids  \\\n",
       "0                                                   {}           [31715818]   \n",
       "1    {'13734012': [{'sentences': [4], 'label': 'CON...           [13734012]   \n",
       "2                                                   {}           [22942787]   \n",
       "3                                                   {}            [2613775]   \n",
       "4    {'44265107': [{'sentences': [15], 'label': 'SU...           [44265107]   \n",
       "..                                                 ...                  ...   \n",
       "804  {'33370': [{'sentences': [6], 'label': 'CONTRA...    [33370, 38355793]   \n",
       "805  {'33370': [{'sentences': [6], 'label': 'SUPPOR...    [33370, 38355793]   \n",
       "806                                                 {}           [10504681]   \n",
       "807  {'2617858': [{'sentences': [4], 'label': 'SUPP...            [2617858]   \n",
       "808                                                 {}  [8087082, 29863668]   \n",
       "\n",
       "     num_cited_doc  claim_length  \n",
       "0                1             5  \n",
       "1                1            10  \n",
       "2                1            12  \n",
       "3                1            16  \n",
       "4                1            13  \n",
       "..             ...           ...  \n",
       "804              2            14  \n",
       "805              2            14  \n",
       "806              1            14  \n",
       "807              1             7  \n",
       "808              2             6  \n",
       "\n",
       "[809 rows x 6 columns]"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# TODO\n",
    "def total_ref(x):\n",
    "    return len(x)\n",
    "\n",
    "def total_words(x):\n",
    "    return len(x.split())\n",
    "    \n",
    "df_claims['num_cited_doc'] = df_claims['cited_doc_ids'].apply(total_ref)\n",
    "df_claims['claim_length'] = df_claims['claim'].apply(total_words)\n",
    "df_claims\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 1.2.5 Ajout des colonnes de mesures de longeurs de textes (documents) (1 point)\n",
    "\n",
    "Ajoutez les colonnes \"_title_length_\", \"_abstract_length_\" et \"_text_length_\" qui donnent le nombre de mots dans les colonnes \"_title_\", \"_abstract_\" et \"_text_\" du dataframe \"_df_corpus_\". Pour le reste du TP, nous définirons la longueur du \"_title_\", \"_abstract_\" et du \"_text_\" comme étant le nombre de mots dans les chaînes de caractères respectives. Encore une fois, vous pouvez considérer que des mots sont simplement une séquence de caractères séparés par un espace."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>doc_id</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "      <th>structured</th>\n",
       "      <th>text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>4983</td>\n",
       "      <td>Microstructural development of human newborn c...</td>\n",
       "      <td>Alterations of the architecture of cerebral wh...</td>\n",
       "      <td>False</td>\n",
       "      <td>Microstructural development of human newborn c...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>5836</td>\n",
       "      <td>Induction of myelodysplasia by myeloid-derived...</td>\n",
       "      <td>Myelodysplastic syndromes (MDS) are age-depend...</td>\n",
       "      <td>False</td>\n",
       "      <td>Induction of myelodysplasia by myeloid-derived...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>7912</td>\n",
       "      <td>BC1 RNA, the transcript from a master gene for...</td>\n",
       "      <td>ID elements are short interspersed elements (S...</td>\n",
       "      <td>False</td>\n",
       "      <td>BC1 RNA, the transcript from a master gene for...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>18670</td>\n",
       "      <td>The DNA Methylome of Human Peripheral Blood Mo...</td>\n",
       "      <td>DNA methylation plays an important role in bio...</td>\n",
       "      <td>False</td>\n",
       "      <td>The DNA Methylome of Human Peripheral Blood Mo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>19238</td>\n",
       "      <td>The human myelin basic protein gene is include...</td>\n",
       "      <td>Two human Golli (for gene expressed in the oli...</td>\n",
       "      <td>False</td>\n",
       "      <td>The human myelin basic protein gene is include...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5178</th>\n",
       "      <td>195689316</td>\n",
       "      <td>Body-mass index and cause-specific mortality i...</td>\n",
       "      <td>BACKGROUND The main associations of body-mass ...</td>\n",
       "      <td>True</td>\n",
       "      <td>Body-mass index and cause-specific mortality i...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5179</th>\n",
       "      <td>195689757</td>\n",
       "      <td>Targeting metabolic remodeling in glioblastoma...</td>\n",
       "      <td>A key aberrant biological difference between t...</td>\n",
       "      <td>False</td>\n",
       "      <td>Targeting metabolic remodeling in glioblastoma...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5180</th>\n",
       "      <td>196664003</td>\n",
       "      <td>Signaling architectures that transmit unidirec...</td>\n",
       "      <td>A signaling pathway transmits information from...</td>\n",
       "      <td>False</td>\n",
       "      <td>Signaling architectures that transmit unidirec...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5181</th>\n",
       "      <td>198133135</td>\n",
       "      <td>Association between pre-diabetes, type 2 diabe...</td>\n",
       "      <td>AIMS Trabecular bone score (TBS) is a surrogat...</td>\n",
       "      <td>True</td>\n",
       "      <td>Association between pre-diabetes, type 2 diabe...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5182</th>\n",
       "      <td>198309074</td>\n",
       "      <td>Adhesion molecules and chemokines: relation to...</td>\n",
       "      <td>Introduction: Among the inflammatory mediators...</td>\n",
       "      <td>False</td>\n",
       "      <td>Adhesion molecules and chemokines: relation to...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5183 rows × 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "         doc_id                                              title  \\\n",
       "0          4983  Microstructural development of human newborn c...   \n",
       "1          5836  Induction of myelodysplasia by myeloid-derived...   \n",
       "2          7912  BC1 RNA, the transcript from a master gene for...   \n",
       "3         18670  The DNA Methylome of Human Peripheral Blood Mo...   \n",
       "4         19238  The human myelin basic protein gene is include...   \n",
       "...         ...                                                ...   \n",
       "5178  195689316  Body-mass index and cause-specific mortality i...   \n",
       "5179  195689757  Targeting metabolic remodeling in glioblastoma...   \n",
       "5180  196664003  Signaling architectures that transmit unidirec...   \n",
       "5181  198133135  Association between pre-diabetes, type 2 diabe...   \n",
       "5182  198309074  Adhesion molecules and chemokines: relation to...   \n",
       "\n",
       "                                               abstract  structured  \\\n",
       "0     Alterations of the architecture of cerebral wh...       False   \n",
       "1     Myelodysplastic syndromes (MDS) are age-depend...       False   \n",
       "2     ID elements are short interspersed elements (S...       False   \n",
       "3     DNA methylation plays an important role in bio...       False   \n",
       "4     Two human Golli (for gene expressed in the oli...       False   \n",
       "...                                                 ...         ...   \n",
       "5178  BACKGROUND The main associations of body-mass ...        True   \n",
       "5179  A key aberrant biological difference between t...       False   \n",
       "5180  A signaling pathway transmits information from...       False   \n",
       "5181  AIMS Trabecular bone score (TBS) is a surrogat...        True   \n",
       "5182  Introduction: Among the inflammatory mediators...       False   \n",
       "\n",
       "                                                   text  \n",
       "0     Microstructural development of human newborn c...  \n",
       "1     Induction of myelodysplasia by myeloid-derived...  \n",
       "2     BC1 RNA, the transcript from a master gene for...  \n",
       "3     The DNA Methylome of Human Peripheral Blood Mo...  \n",
       "4     The human myelin basic protein gene is include...  \n",
       "...                                                 ...  \n",
       "5178  Body-mass index and cause-specific mortality i...  \n",
       "5179  Targeting metabolic remodeling in glioblastoma...  \n",
       "5180  Signaling architectures that transmit unidirec...  \n",
       "5181  Association between pre-diabetes, type 2 diabe...  \n",
       "5182  Adhesion molecules and chemokines: relation to...  \n",
       "\n",
       "[5183 rows x 5 columns]"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_corpus"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>doc_id</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "      <th>structured</th>\n",
       "      <th>text</th>\n",
       "      <th>title_length</th>\n",
       "      <th>abstract_length</th>\n",
       "      <th>text_length</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>4983</td>\n",
       "      <td>Microstructural development of human newborn c...</td>\n",
       "      <td>Alterations of the architecture of cerebral wh...</td>\n",
       "      <td>False</td>\n",
       "      <td>Microstructural development of human newborn c...</td>\n",
       "      <td>17</td>\n",
       "      <td>278</td>\n",
       "      <td>295</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>5836</td>\n",
       "      <td>Induction of myelodysplasia by myeloid-derived...</td>\n",
       "      <td>Myelodysplastic syndromes (MDS) are age-depend...</td>\n",
       "      <td>False</td>\n",
       "      <td>Induction of myelodysplasia by myeloid-derived...</td>\n",
       "      <td>7</td>\n",
       "      <td>201</td>\n",
       "      <td>208</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>7912</td>\n",
       "      <td>BC1 RNA, the transcript from a master gene for...</td>\n",
       "      <td>ID elements are short interspersed elements (S...</td>\n",
       "      <td>False</td>\n",
       "      <td>BC1 RNA, the transcript from a master gene for...</td>\n",
       "      <td>20</td>\n",
       "      <td>180</td>\n",
       "      <td>200</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>18670</td>\n",
       "      <td>The DNA Methylome of Human Peripheral Blood Mo...</td>\n",
       "      <td>DNA methylation plays an important role in bio...</td>\n",
       "      <td>False</td>\n",
       "      <td>The DNA Methylome of Human Peripheral Blood Mo...</td>\n",
       "      <td>9</td>\n",
       "      <td>238</td>\n",
       "      <td>247</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>19238</td>\n",
       "      <td>The human myelin basic protein gene is include...</td>\n",
       "      <td>Two human Golli (for gene expressed in the oli...</td>\n",
       "      <td>False</td>\n",
       "      <td>The human myelin basic protein gene is include...</td>\n",
       "      <td>21</td>\n",
       "      <td>241</td>\n",
       "      <td>262</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5178</th>\n",
       "      <td>195689316</td>\n",
       "      <td>Body-mass index and cause-specific mortality i...</td>\n",
       "      <td>BACKGROUND The main associations of body-mass ...</td>\n",
       "      <td>True</td>\n",
       "      <td>Body-mass index and cause-specific mortality i...</td>\n",
       "      <td>15</td>\n",
       "      <td>413</td>\n",
       "      <td>428</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5179</th>\n",
       "      <td>195689757</td>\n",
       "      <td>Targeting metabolic remodeling in glioblastoma...</td>\n",
       "      <td>A key aberrant biological difference between t...</td>\n",
       "      <td>False</td>\n",
       "      <td>Targeting metabolic remodeling in glioblastoma...</td>\n",
       "      <td>6</td>\n",
       "      <td>159</td>\n",
       "      <td>165</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5180</th>\n",
       "      <td>196664003</td>\n",
       "      <td>Signaling architectures that transmit unidirec...</td>\n",
       "      <td>A signaling pathway transmits information from...</td>\n",
       "      <td>False</td>\n",
       "      <td>Signaling architectures that transmit unidirec...</td>\n",
       "      <td>8</td>\n",
       "      <td>246</td>\n",
       "      <td>254</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5181</th>\n",
       "      <td>198133135</td>\n",
       "      <td>Association between pre-diabetes, type 2 diabe...</td>\n",
       "      <td>AIMS Trabecular bone score (TBS) is a surrogat...</td>\n",
       "      <td>True</td>\n",
       "      <td>Association between pre-diabetes, type 2 diabe...</td>\n",
       "      <td>14</td>\n",
       "      <td>233</td>\n",
       "      <td>247</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5182</th>\n",
       "      <td>198309074</td>\n",
       "      <td>Adhesion molecules and chemokines: relation to...</td>\n",
       "      <td>Introduction: Among the inflammatory mediators...</td>\n",
       "      <td>False</td>\n",
       "      <td>Adhesion molecules and chemokines: relation to...</td>\n",
       "      <td>13</td>\n",
       "      <td>233</td>\n",
       "      <td>246</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5183 rows × 8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "         doc_id                                              title  \\\n",
       "0          4983  Microstructural development of human newborn c...   \n",
       "1          5836  Induction of myelodysplasia by myeloid-derived...   \n",
       "2          7912  BC1 RNA, the transcript from a master gene for...   \n",
       "3         18670  The DNA Methylome of Human Peripheral Blood Mo...   \n",
       "4         19238  The human myelin basic protein gene is include...   \n",
       "...         ...                                                ...   \n",
       "5178  195689316  Body-mass index and cause-specific mortality i...   \n",
       "5179  195689757  Targeting metabolic remodeling in glioblastoma...   \n",
       "5180  196664003  Signaling architectures that transmit unidirec...   \n",
       "5181  198133135  Association between pre-diabetes, type 2 diabe...   \n",
       "5182  198309074  Adhesion molecules and chemokines: relation to...   \n",
       "\n",
       "                                               abstract  structured  \\\n",
       "0     Alterations of the architecture of cerebral wh...       False   \n",
       "1     Myelodysplastic syndromes (MDS) are age-depend...       False   \n",
       "2     ID elements are short interspersed elements (S...       False   \n",
       "3     DNA methylation plays an important role in bio...       False   \n",
       "4     Two human Golli (for gene expressed in the oli...       False   \n",
       "...                                                 ...         ...   \n",
       "5178  BACKGROUND The main associations of body-mass ...        True   \n",
       "5179  A key aberrant biological difference between t...       False   \n",
       "5180  A signaling pathway transmits information from...       False   \n",
       "5181  AIMS Trabecular bone score (TBS) is a surrogat...        True   \n",
       "5182  Introduction: Among the inflammatory mediators...       False   \n",
       "\n",
       "                                                   text  title_length  \\\n",
       "0     Microstructural development of human newborn c...            17   \n",
       "1     Induction of myelodysplasia by myeloid-derived...             7   \n",
       "2     BC1 RNA, the transcript from a master gene for...            20   \n",
       "3     The DNA Methylome of Human Peripheral Blood Mo...             9   \n",
       "4     The human myelin basic protein gene is include...            21   \n",
       "...                                                 ...           ...   \n",
       "5178  Body-mass index and cause-specific mortality i...            15   \n",
       "5179  Targeting metabolic remodeling in glioblastoma...             6   \n",
       "5180  Signaling architectures that transmit unidirec...             8   \n",
       "5181  Association between pre-diabetes, type 2 diabe...            14   \n",
       "5182  Adhesion molecules and chemokines: relation to...            13   \n",
       "\n",
       "      abstract_length  text_length  \n",
       "0                 278          295  \n",
       "1                 201          208  \n",
       "2                 180          200  \n",
       "3                 238          247  \n",
       "4                 241          262  \n",
       "...               ...          ...  \n",
       "5178              413          428  \n",
       "5179              159          165  \n",
       "5180              246          254  \n",
       "5181              233          247  \n",
       "5182              233          246  \n",
       "\n",
       "[5183 rows x 8 columns]"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# TODO\n",
    "\n",
    "df_corpus['title_length'] = df_corpus['title'].apply(total_words)\n",
    "df_corpus['abstract_length'] = df_corpus['abstract'].apply(total_words)\n",
    "df_corpus['text_length'] = df_corpus['text'].apply(total_words)\n",
    "df_corpus\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 1.2.6 Analyse statistique (1.5 point)\n",
    "\n",
    "Faites l'analyse statistique des données en affichant le \"_min_\", le \"_max_\" et la \"_moyenne_\" pour les deux colonnes \"_claim_length_\" et \"_num_cited_doc_\" que vous venez de créer."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Analyse Statisque de claims_length : \n",
      "Min :  3\n",
      "Max :  39\n",
      "Avergage :  12.332509270704573\n",
      "--------------------\n",
      "Analyse Statisque de num_cited_doc : \n",
      "Min :  1\n",
      "Max :  5\n",
      "Avergage :  1.1359703337453646\n"
     ]
    }
   ],
   "source": [
    "# TODO\n",
    "claims_min = df_claims['claim_length'].min()\n",
    "claims_max = df_claims['claim_length'].max()\n",
    "claims_avg = df_claims['claim_length'].mean()\n",
    "\n",
    "num_doc_min = df_claims['num_cited_doc'].min()\n",
    "num_doc_max = df_claims['num_cited_doc'].max()\n",
    "num_doc_avg = df_claims['num_cited_doc'].mean()\n",
    "\n",
    "print('Analyse Statisque de claims_length : ')\n",
    "print('Min : ', claims_min)\n",
    "print('Max : ', claims_max)\n",
    "print('Avergage : ', claims_avg)\n",
    "print('--------------------')\n",
    "print('Analyse Statisque de num_cited_doc : ')\n",
    "print('Min : ', num_doc_min)\n",
    "print('Max : ', num_doc_max)\n",
    "print('Avergage : ', num_doc_avg)\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 1.2.7 Histogrammes (2 points)\n",
    "\n",
    "En considérant le dataframe du corpus de résumés (\"_df_corpus_\"), affichez dans 3 histogrammes les distributions suivantes:\n",
    "\n",
    "- Fréquence des titres ('_title_') en fonction de leur longueur\n",
    "- Fréquence des résumés ('_abstract_') en fonction de leur longueur\n",
    "- Fréquence des textes ('_text_') en fonction de leur longueur\n",
    "\n",
    "Utilisez la valeur de 30 pour le paramètre \"_bins_\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(array([[<Axes: title={'center': 'title_length'}>]], dtype=object),\n",
       " array([[<Axes: title={'center': 'abstract_length'}>]], dtype=object),\n",
       " array([[<Axes: title={'center': 'text_length'}>]], dtype=object))"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAigAAAGxCAYAAABIjE2TAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjcuMiwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy8pXeV/AAAACXBIWXMAAA9hAAAPYQGoP6dpAAA3zUlEQVR4nO3dfVhU953//9cA4yAGiGLCMJUYkmLaBExdTIzarbTAGKvRrG1NQ9qaxDZ0TWxYtDbUTR1ygylpkC40JnatuvGitHs1bm9yI7iNpC7Nr0hiq6abZq8gxhRCGwmgkGEC5/dHvkw7ciOHm8yZ4fm4rrnMOed9znze8xnglTNzZmyGYRgCAACwkIhgDwAAAOB8BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQgzNXV1cnj8ejdd98NWJ+ZmanMzEz/cldXlzwejw4dOjTgGHv27JHNZtPJkycnZIw2m00ej2dCjm3WcI+Dx+ORzWbTX//61w9/YMAkExXsAQCYWHV1dSoqKtLtt9+uiy++2L/+8ccfD6jr6upSUVGRJAUEl8mGxwGwBgIKMEldffXVwR4CAAyJl3iAMObxePTNb35TkpSSkiKbzSabzaZDhw4FvMRz8uRJXXLJJZKkoqIif93tt98+7PEPHjyorKwsxcXFKSYmRosXL9Z///d/j8vYW1palJeXp1mzZmnKlClKSUlRUVGR3n//fX/NyZMnZbPZ9L3vfU+lpaVKSUnRRRddpIULF+qll14acMwf/vCHmjNnjhwOh66++mpVVlbq9ttv1+WXX27qcXj77bd16623Kj4+XomJibrzzjvV3t4+Ln0D+ABnUIAw9tWvflVnzpxReXm5nn76aSUlJUkaePYkKSlJzz//vG688UatW7dOX/3qVyXJ/8d6MPv27dNXvvIVrVq1Snv37pXdbteTTz6ppUuX6sCBA8rKyhr1uFtaWnT99dcrIiJC3/nOd3TllVfqt7/9rR566CGdPHlSu3fvDqj/wQ9+oI997GMqKyuTJN1///367Gc/q8bGRsXHx0uSdu7cqby8PH3uc5/T9u3b1d7erqKiInm9XtOPw+c+9zndcsstWrdunY4dO6bCwkJJ0o9+9KNR9wzgPAaAsPboo48akozGxsaA9UuWLDGWLFniX/7LX/5iSDK2bt064Bi7d+8OOMa5c+eMGTNmGDfddFNAXW9vr3Httdca119/vakxnn+/eXl5xkUXXWQ0NTUF1H3ve98zJBknTpwwDMMwGhsbDUlGenq68f777/vrfve73xmSjB//+Mf+cTmdTmPBggUBx2tqajLsdrsxe/bsET0OW7duNSQZJSUlAevXr19vREdHG319fab6BjA0XuIBYFpdXZ3OnDmjtWvX6v333/ff+vr6dOONN6q+vl7nzp0b9fF/9atf6dOf/rRcLlfA8ZctWyZJqq2tDahfvny5IiMj/ctz586VJDU1NUmSXnvtNbW0tGjNmjUB+1122WVavHix6fGtXLkyYHnu3Ll677331NraavpYAAbHSzwATHv77bclSZ///OeHrDlz5oymTZs26uP/8pe/lN1uH3T7+Zf5JiQkBCw7HA5JUnd3tyTpnXfekSQlJiYOOFZiYqIaGxtNje9C9wdg7AgoAEybOXOmJKm8vFw33HDDoDWDhQEzx587d64efvjhQbe7XC5Tx+sPFP3B6u+1tLSYHyCACUdAAcLcSP/v3sxZgMWLF+viiy/Wq6++qnvuuWfsgzzPihUr9Oyzz+rKK6/U9OnTx3y8q666Sk6nUz/96U9VUFDgX3/q1CnV1dUFBB7OhgDWQEABwlx6erok6fvf/77Wrl0ru92uq666akBdbGysZs+erZ///OfKysrSjBkzNHPmTP8luH/voosuUnl5udauXaszZ87o85//vC699FL95S9/0e9//3v95S9/0Y4dO0Y95gceeEA1NTVatGiRvvGNb+iqq67Se++9p5MnT+rZZ5/VE088oVmzZo34eBERESoqKlJeXp4+//nP684779S7776roqIiJSUlKSLib2/HM/M4AJg4vEkWCHOZmZkqLCzUL3/5S33yk5/Uddddp4aGhkFrd+3apZiYGK1cuVLXXXfdsB8//6UvfUkvvPCCzp49q7y8PGVnZ+vee+/Vyy+/PKZLjKUPLvc9cuSI3G63Hn30Ud1444368pe/rB/96Ef6xCc+MaqzKnfddZd27typ3//+9/qnf/onFRUV6b777tO8efMCPmFXMvc4AJgYNsMwjGAPAgCC4d1339WcOXN08803a+fOncEeDoC/w0s8ACaFlpYWPfzww/r0pz+thIQENTU1afv27ers7NS9994b7OEBOA8BBcCE+fuPpR9MREREwPs/JpLD4dDJkye1fv16nTlzRjExMbrhhhv0xBNP6JprrvlQxgBg5HiJB8CEOHnypFJSUoat2bp1K+/vADAozqAAmBAul0v19fUXrAGAwXAGBQAAWA6XGQMAAMsJyZd4+vr69Oc//1mxsbGy2WzBHg4AABgBwzDU2dkpl8t1wTfIh2RA+fOf/6zk5ORgDwMAAIzCm2++ecFPgw7JgBIbGyvpgwbj4uKGrfX5fKqurpbb7R7ym1HDAX2GF/oMH5OhR4k+w81E9dnR0aHk5GT/3/HhhGRA6X9ZJy4ubkQBJSYmRnFxcWH/ZKLP8EGf4WMy9CjRZ7iZ6D5H8vYM3iQLAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsJyrYA8Dkdfl9z5jexxFpqOT6CRgMAMBSOIMCAAAsh4ACAAAsx1RAef/99/Wv//qvSklJ0dSpU3XFFVfogQceUF9fn7/GMAx5PB65XC5NnTpVmZmZOnHiRMBxvF6vNmzYoJkzZ2ratGlauXKlTp8+PT4dAQCAkGcqoHz3u9/VE088oYqKCv3xj39USUmJHn30UZWXl/trSkpKVFpaqoqKCtXX18vpdConJ0ednZ3+mvz8fO3fv19VVVU6fPiwzp49qxUrVqi3t3f8OgMAACHL1Jtkf/vb32rVqlVavny5JOnyyy/Xj3/8Yx05ckTSB2dPysrKtGXLFq1evVqStHfvXiUmJqqyslJ5eXlqb2/Xrl279NRTTyk7O1uStG/fPiUnJ+vgwYNaunTpePYHAABCkKmA8slPflJPPPGE/vSnP2nOnDn6/e9/r8OHD6usrEyS1NjYqJaWFrndbv8+DodDS5YsUV1dnfLy8tTQ0CCfzxdQ43K5lJaWprq6ukEDitfrldfr9S93dHRIknw+n3w+37Bj7t9+obpQF4p9OiIN8/tEfLBPKPU5GqE4n6MxGfqcDD1K9BluJqpPM8czFVC+9a1vqb29XR/72McUGRmp3t5ePfzww7r11lslSS0tLZKkxMTEgP0SExPV1NTkr5kyZYqmT58+oKZ///Nt27ZNRUVFA9ZXV1crJiZmRGOvqakZUV2oC6U+x3K5cCj1ORb0GT4mQ48SfYab8e6zq6trxLWmAspPfvIT7du3T5WVlbrmmmt09OhR5efny+Vyae3atf46m80WsJ9hGAPWnW+4msLCQhUUFPiXOzo6lJycLLfbrbi4uGGP6/P5VFNTo5ycHNnt9gu1GLJCsc80zwHT+zgiDD04vy+k+hyNUJzP0ZgMfU6GHiX6DDcT1Wf/KyAjYSqgfPOb39R9992nL37xi5Kk9PR0NTU1adu2bVq7dq2cTqekD86SJCUl+fdrbW31n1VxOp3q6elRW1tbwFmU1tZWLVq0aND7dTgccjgcA9bb7fYRP3BmakNZKPXp7R0+tA4nlPocC/oMH5OhR4k+w81492nmWKau4unq6lJEROAukZGR/suMU1JS5HQ6A04J9fT0qLa21h8+MjIyZLfbA2qam5t1/PjxIQMKAACYXEydQbnpppv08MMP67LLLtM111yjV155RaWlpbrzzjslffDSTn5+voqLi5WamqrU1FQVFxcrJiZGubm5kqT4+HitW7dOGzduVEJCgmbMmKFNmzYpPT3df1UPAACY3EwFlPLyct1///1av369Wltb5XK5lJeXp+985zv+ms2bN6u7u1vr169XW1ubFixYoOrqasXGxvprtm/frqioKK1Zs0bd3d3KysrSnj17FBkZOX6dAQCAkGUqoMTGxqqsrMx/WfFgbDabPB6PPB7PkDXR0dEqLy8P+IA3AACAfnwXDwAAsBwCCgAAsBwCCgAAsBwCCgAAsBwCCgAAsBxTV/EAGL3L73tmxLWOSEMl13/wdQDeXptOPrJ8AkcGANbDGRQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5BBQAAGA5pgLK5ZdfLpvNNuB29913S5IMw5DH45HL5dLUqVOVmZmpEydOBBzD6/Vqw4YNmjlzpqZNm6aVK1fq9OnT49cRAAAIeaYCSn19vZqbm/23mpoaSdIXvvAFSVJJSYlKS0tVUVGh+vp6OZ1O5eTkqLOz03+M/Px87d+/X1VVVTp8+LDOnj2rFStWqLe3dxzbAgAAocxUQLnkkkvkdDr9t1/96le68sortWTJEhmGobKyMm3ZskWrV69WWlqa9u7dq66uLlVWVkqS2tvbtWvXLj322GPKzs7WvHnztG/fPh07dkwHDx6ckAYBAEDoiRrtjj09Pdq3b58KCgpks9n0xhtvqKWlRW6321/jcDi0ZMkS1dXVKS8vTw0NDfL5fAE1LpdLaWlpqqur09KlSwe9L6/XK6/X61/u6OiQJPl8Pvl8vmHH2b/9QnWhLhT7dEQa5veJ+GCfUOqzn5l++/sM5X5HIhSft2ZNhh4l+gw3E9WnmePZDMMw/1dC0k9/+lPl5ubq1KlTcrlcqqur0+LFi/XWW2/J5XL56+666y41NTXpwIEDqqys1B133BEQNiTJ7XYrJSVFTz755KD35fF4VFRUNGB9ZWWlYmJiRjN8AADwIevq6lJubq7a29sVFxc3bO2oz6Ds2rVLy5YtCwgjkmSz2QKWDcMYsO58F6opLCxUQUGBf7mjo0PJyclyu90XbNDn86mmpkY5OTmy2+3D1oayUOwzzXPA9D6OCEMPzu8LqT77mem3v8/7j0TI22fTcc/gZxdDXSg+b82aDD1K9BluJqrP/ldARmJUAaWpqUkHDx7U008/7V/ndDolSS0tLUpKSvKvb21tVWJior+mp6dHbW1tmj59ekDNokWLhrw/h8Mhh8MxYL3dbh/xA2emNpSFUp/e3uGD63BCqc9+o+nX22eTt9cWcr2aFYrzadZk6FGiz3Az3n2aOdaoPgdl9+7duvTSS7V8+XL/upSUFDmdTv+VPdIH71Opra31h4+MjAzZ7faAmubmZh0/fnzYgAIAACYX02dQ+vr6tHv3bq1du1ZRUX/b3WazKT8/X8XFxUpNTVVqaqqKi4sVExOj3NxcSVJ8fLzWrVunjRs3KiEhQTNmzNCmTZuUnp6u7Ozs8esKAACENNMB5eDBgzp16pTuvPPOAds2b96s7u5urV+/Xm1tbVqwYIGqq6sVGxvrr9m+fbuioqK0Zs0adXd3KysrS3v27FFkZOTYOgEAAGHDdEBxu90a6sIfm80mj8cjj8cz5P7R0dEqLy9XeXm52bsGAACTBN/FAwAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALMd0QHnrrbf0pS99SQkJCYqJidEnPvEJNTQ0+LcbhiGPxyOXy6WpU6cqMzNTJ06cCDiG1+vVhg0bNHPmTE2bNk0rV67U6dOnx94NAAAIC6YCSltbmxYvXiy73a7nnntOr776qh577DFdfPHF/pqSkhKVlpaqoqJC9fX1cjqdysnJUWdnp78mPz9f+/fvV1VVlQ4fPqyzZ89qxYoV6u3tHbfGAABA6IoyU/zd735XycnJ2r17t3/d5Zdf7v9vwzBUVlamLVu2aPXq1ZKkvXv3KjExUZWVlcrLy1N7e7t27dqlp556StnZ2ZKkffv2KTk5WQcPHtTSpUsH3K/X65XX6/Uvd3R0SJJ8Pp98Pt+wY+7ffqG6UBeKfToiDfP7RHywTyj12c9Mv/19hnK/IxGKz1uzJkOPEn2Gm4nq08zxbIZhjPi35tVXX62lS5fq9OnTqq2t1Uc+8hGtX79eX/va1yRJb7zxhq688kq9/PLLmjdvnn+/VatW6eKLL9bevXv161//WllZWTpz5oymT5/ur7n22mt18803q6ioaMD9ejyeQddXVlYqJiZmxM0CAIDg6erqUm5urtrb2xUXFzdsrakzKG+88YZ27NihgoICffvb39bvfvc7feMb35DD4dBXvvIVtbS0SJISExMD9ktMTFRTU5MkqaWlRVOmTAkIJ/01/fufr7CwUAUFBf7ljo4OJScny+12X7BBn8+nmpoa5eTkyG63m2k3pIRin2meA6b3cUQYenB+X0j12c9Mv/193n8kQt4+m457Bp5ZDAeh+Lw1azL0KNFnuJmoPvtfARkJUwGlr69P8+fPV3FxsSRp3rx5OnHihHbs2KGvfOUr/jqbzRawn2EYA9adb7gah8Mhh8MxYL3dbh/xA2emNpSFUp/e3uGfE8MJpT77jaZfb59N3l5byPVqVijOp1mToUeJPsPNePdp5lim3iSblJSkq6++OmDdxz/+cZ06dUqS5HQ6JWnAmZDW1lb/WRWn06menh61tbUNWQMAACY3UwFl8eLFeu211wLW/elPf9Ls2bMlSSkpKXI6naqpqfFv7+npUW1trRYtWiRJysjIkN1uD6hpbm7W8ePH/TUAAGByM/USz7/8y79o0aJFKi4u1po1a/S73/1OO3fu1M6dOyV98NJOfn6+iouLlZqaqtTUVBUXFysmJka5ubmSpPj4eK1bt04bN25UQkKCZsyYoU2bNik9Pd1/VQ8AAJjcTAWU6667Tvv371dhYaEeeOABpaSkqKysTLfddpu/ZvPmzeru7tb69evV1tamBQsWqLq6WrGxsf6a7du3KyoqSmvWrFF3d7eysrK0Z88eRUZGjl9nAAAgZJkKKJK0YsUKrVixYsjtNptNHo9HHo9nyJro6GiVl5ervLzc7N0DAIBJgO/iAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlkNAAQAAlmMqoHg8HtlstoCb0+n0bzcMQx6PRy6XS1OnTlVmZqZOnDgRcAyv16sNGzZo5syZmjZtmlauXKnTp0+PTzcAACAsmD6Dcs0116i5udl/O3bsmH9bSUmJSktLVVFRofr6ejmdTuXk5Kizs9Nfk5+fr/3796uqqkqHDx/W2bNntWLFCvX29o5PRwAAIORFmd4hKirgrEk/wzBUVlamLVu2aPXq1ZKkvXv3KjExUZWVlcrLy1N7e7t27dqlp556StnZ2ZKkffv2KTk5WQcPHtTSpUvH2A4AAAgHpgPK66+/LpfLJYfDoQULFqi4uFhXXHGFGhsb1dLSIrfb7a91OBxasmSJ6urqlJeXp4aGBvl8voAal8ultLQ01dXVDRlQvF6vvF6vf7mjo0OS5PP55PP5hh1v//YL1YW6UOzTEWmY3yfig31Cqc9+Zvrt7zOU+x2JUHzemjUZepToM9xMVJ9mjmczDGPEvzWfe+45dXV1ac6cOXr77bf10EMP6X//93914sQJvfbaa1q8eLHeeustuVwu/z533XWXmpqadODAAVVWVuqOO+4ICBuS5Ha7lZKSoieffHLQ+/V4PCoqKhqwvrKyUjExMSMdPgAACKKuri7l5uaqvb1dcXFxw9aaOoOybNky/3+np6dr4cKFuvLKK7V3717dcMMNkiSbzRawj2EYA9ad70I1hYWFKigo8C93dHQoOTlZbrf7gg36fD7V1NQoJydHdrt92NpQFop9pnkOmN7HEWHowfl9IdVnPzP99vd5/5EIeftsOu4Jz5c/Q/F5a9Zk6FGiz3AzUX32vwIyEqZf4vl706ZNU3p6ul5//XXdfPPNkqSWlhYlJSX5a1pbW5WYmChJcjqd6unpUVtbm6ZPnx5Qs2jRoiHvx+FwyOFwDFhvt9tH/MCZqQ1lodSnt3f44DqcUOqz32j69fbZ5O21hVyvZoXifJo1GXqU6DPcjHefZo41ps9B8Xq9+uMf/6ikpCSlpKTI6XSqpqbGv72np0e1tbX+8JGRkSG73R5Q09zcrOPHjw8bUAAAwORi6gzKpk2bdNNNN+myyy5Ta2urHnroIXV0dGjt2rWy2WzKz89XcXGxUlNTlZqaquLiYsXExCg3N1eSFB8fr3Xr1mnjxo1KSEjQjBkztGnTJqWnp/uv6gEAADAVUE6fPq1bb71Vf/3rX3XJJZfohhtu0EsvvaTZs2dLkjZv3qzu7m6tX79ebW1tWrBggaqrqxUbG+s/xvbt2xUVFaU1a9aou7tbWVlZ2rNnjyIjI8e3MwAAELJMBZSqqqpht9tsNnk8Hnk8niFroqOjVV5ervLycjN3DQAAJhG+iwcAAFgOAQUAAFgOAQUAAFgOAQUAAFgOAQUAAFgOAQUAAFjOmD7qHghFl9/3zKj3PfnI8nEcCQBgKJxBAQAAlkNAAQAAlkNAAQAAlkNAAQAAlsObZBGS0jwH5O21BXsYAIAJwhkUAABgOQQUAABgOQQUAABgOQQUAABgOQQUAABgOQQUAABgOVxmDJgwlu/xAQCMHGdQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5YwpoGzbtk02m035+fn+dYZhyOPxyOVyaerUqcrMzNSJEycC9vN6vdqwYYNmzpypadOmaeXKlTp9+vRYhgIAAMLIqANKfX29du7cqblz5wasLykpUWlpqSoqKlRfXy+n06mcnBx1dnb6a/Lz87V//35VVVXp8OHDOnv2rFasWKHe3t7RdwIAAMLGqALK2bNnddttt+mHP/yhpk+f7l9vGIbKysq0ZcsWrV69Wmlpadq7d6+6urpUWVkpSWpvb9euXbv02GOPKTs7W/PmzdO+fft07NgxHTx4cHy6AgAAIS1qNDvdfffdWr58ubKzs/XQQw/51zc2NqqlpUVut9u/zuFwaMmSJaqrq1NeXp4aGhrk8/kCalwul9LS0lRXV6elS5cOuD+v1yuv1+tf7ujokCT5fD75fL5hx9q//UJ1oS4U+3REGub3iTAC/g1X5/cZSvNqRig+b82aDD1K9BluJqpPM8czHVCqqqr08ssvq76+fsC2lpYWSVJiYmLA+sTERDU1NflrpkyZEnDmpb+mf//zbdu2TUVFRQPWV1dXKyYmZkTjrqmpGVFdqAulPkuuH/2+D87vG7+BWFh/n88++2yQRzKxQul5O1qToUeJPsPNePfZ1dU14lpTAeXNN9/Uvffeq+rqakVHRw9ZZ7PZApYNwxiw7nzD1RQWFqqgoMC/3NHRoeTkZLndbsXFxQ17XJ/Pp5qaGuXk5Mhutw9bG8pCsc80zwHT+zgiDD04v0/3H4mQt2/451QoO7/P456BZxbDQSg+b82aDD1K9BluJqrP/ldARsJUQGloaFBra6syMjL863p7e/Xiiy+qoqJCr732mqQPzpIkJSX5a1pbW/1nVZxOp3p6etTW1hZwFqW1tVWLFi0a9H4dDoccDseA9Xa7fcQPnJnaUBZKfXp7Rx8wvH22Me0fKvr7DJU5Ha1Qet6O1mToUaLPcDPefZo5lqk3yWZlZenYsWM6evSo/zZ//nzddtttOnr0qK644go5nc6AU0I9PT2qra31h4+MjAzZ7faAmubmZh0/fnzIgAIAACYXU2dQYmNjlZaWFrBu2rRpSkhI8K/Pz89XcXGxUlNTlZqaquLiYsXExCg3N1eSFB8fr3Xr1mnjxo1KSEjQjBkztGnTJqWnpys7O3uc2gIAAKFsVFfxDGfz5s3q7u7W+vXr1dbWpgULFqi6ulqxsbH+mu3btysqKkpr1qxRd3e3srKytGfPHkVGRo73cAAAQAgac0A5dOhQwLLNZpPH45HH4xlyn+joaJWXl6u8vHysdw8AAMIQ38UDAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsh4ACAAAsJyrYAwBgXZff98yo9z35yPJxHAmAyYYzKAAAwHIIKAAAwHIIKAAAwHIIKAAAwHIIKAAAwHIIKAAAwHIIKAAAwHIIKAAAwHL4oDaMyVg+yAsAgKFwBgUAAFgOAQUAAFgOAQUAAFiOqYCyY8cOzZ07V3FxcYqLi9PChQv13HPP+bcbhiGPxyOXy6WpU6cqMzNTJ06cCDiG1+vVhg0bNHPmTE2bNk0rV67U6dOnx6cbAAAQFkwFlFmzZumRRx7RkSNHdOTIEX3mM5/RqlWr/CGkpKREpaWlqqioUH19vZxOp3JyctTZ2ek/Rn5+vvbv36+qqiodPnxYZ8+e1YoVK9Tb2zu+nQEAgJBlKqDcdNNN+uxnP6s5c+Zozpw5evjhh3XRRRfppZdekmEYKisr05YtW7R69WqlpaVp79696urqUmVlpSSpvb1du3bt0mOPPabs7GzNmzdP+/bt07Fjx3Tw4MEJaRAAAISeUV9m3Nvbq//8z//UuXPntHDhQjU2NqqlpUVut9tf43A4tGTJEtXV1SkvL08NDQ3y+XwBNS6XS2lpaaqrq9PSpUsHvS+v1yuv1+tf7ujokCT5fD75fL5hx9m//UJ1oS5YfToijQ/3/iKMgH/D1fl9Buv5O5b5HcmYJ8PP52ToUaLPcDNRfZo5ns0wDFO/gY4dO6aFCxfqvffe00UXXaTKykp99rOfVV1dnRYvXqy33npLLpfLX3/XXXepqalJBw4cUGVlpe64446AsCFJbrdbKSkpevLJJwe9T4/Ho6KiogHrKysrFRMTY2b4AAAgSLq6upSbm6v29nbFxcUNW2v6DMpVV12lo0eP6t1339XPfvYzrV27VrW1tf7tNpstoN4wjAHrznehmsLCQhUUFPiXOzo6lJycLLfbfcEGfT6fampqlJOTI7vdPmxtKAtWn2meAx/afUkfnFF4cH6f7j8SIW/f8M+rUHZ+n8c9g59dnGhjmd+RjHky/HxOhh4l+gw3E9Vn/ysgI2E6oEyZMkUf/ehHJUnz589XfX29vv/97+tb3/qWJKmlpUVJSUn++tbWViUmJkqSnE6nenp61NbWpunTpwfULFq0aMj7dDgccjgcA9bb7fYRP3BmakPZh92ntzc4IcHbZwvafX+Y+vsM1nN3LI+xmTFPhp/PydCjRJ/hZrz7NHOsMX/UvWEY8nq9SklJkdPpVE1NjebNmydJ6unpUW1trb773e9KkjIyMmS321VTU6M1a9ZIkpqbm3X8+HGVlJSMdShA2BrLVwqcfGT5OI4EAD4cpgLKt7/9bS1btkzJycnq7OxUVVWVDh06pOeff142m035+fkqLi5WamqqUlNTVVxcrJiYGOXm5kqS4uPjtW7dOm3cuFEJCQmaMWOGNm3apPT0dGVnZ09IgwAAIPSYCihvv/22vvzlL6u5uVnx8fGaO3eunn/+eeXk5EiSNm/erO7ubq1fv15tbW1asGCBqqurFRsb6z/G9u3bFRUVpTVr1qi7u1tZWVnas2ePIiMjx7czAAAQskwFlF27dg273WazyePxyOPxDFkTHR2t8vJylZeXm7lrAAAwifBdPAAAwHIIKAAAwHIIKAAAwHIIKAAAwHIIKAAAwHLG/EFtsIY0zwGVXP/Bv2Y//ZMP8gIAWA1nUAAAgOUQUAAAgOUQUAAAgOUQUAAAgOUQUAAAgOUQUAAAgOUQUAAAgOUQUAAAgOUQUAAAgOUQUAAAgOUQUAAAgOUQUAAAgOUQUAAAgOUQUAAAgOUQUAAAgOVEBXsAACbW5fc9E+whAIBpnEEBAACWQ0ABAACWQ0ABAACWQ0ABAACWQ0ABAACWQ0ABAACWw2XG4DJUAIDlcAYFAABYDgEFAABYDgEFAABYjqmAsm3bNl133XWKjY3VpZdeqptvvlmvvfZaQI1hGPJ4PHK5XJo6daoyMzN14sSJgBqv16sNGzZo5syZmjZtmlauXKnTp0+PvRsAABAWTAWU2tpa3X333XrppZdUU1Oj999/X263W+fOnfPXlJSUqLS0VBUVFaqvr5fT6VROTo46Ozv9Nfn5+dq/f7+qqqp0+PBhnT17VitWrFBvb+/4dQYAAEKWqat4nn/++YDl3bt369JLL1VDQ4M+9alPyTAMlZWVacuWLVq9erUkae/evUpMTFRlZaXy8vLU3t6uXbt26amnnlJ2drYkad++fUpOTtbBgwe1dOnScWoNAACEqjFdZtze3i5JmjFjhiSpsbFRLS0tcrvd/hqHw6ElS5aorq5OeXl5amhokM/nC6hxuVxKS0tTXV3doAHF6/XK6/X6lzs6OiRJPp9PPp9v2DH2b79QXahzRBgB/4Yr+gwdI/mZmww/n5OhR4k+w81E9WnmeDbDMEb1G9AwDK1atUptbW36zW9+I0mqq6vT4sWL9dZbb8nlcvlr77rrLjU1NenAgQOqrKzUHXfcERA4JMntdislJUVPPvnkgPvyeDwqKioasL6yslIxMTGjGT4AAPiQdXV1KTc3V+3t7YqLixu2dtRnUO655x794Q9/0OHDhwdss9lsAcuGYQxYd77hagoLC1VQUOBf7ujoUHJystxu9wUb9Pl8qqmpUU5Ojux2+7C1oSzjgef14Pw+3X8kQt6+4R/rUOaIMOgzRBz3XPjl2snw8zkZepToM9xMVJ/9r4CMxKgCyoYNG/SLX/xCL774ombNmuVf73Q6JUktLS1KSkryr29tbVViYqK/pqenR21tbZo+fXpAzaJFiwa9P4fDIYfDMWC93W4f8QNnpjYU9f8R8/bZ5O0NzT9oZtCn9Zn5eQv3n09pcvQo0We4Ge8+zRzL1FU8hmHonnvu0dNPP61f//rXSklJCdiekpIip9Opmpoa/7qenh7V1tb6w0dGRobsdntATXNzs44fPz5kQAEAAJOLqTMod999tyorK/Xzn/9csbGxamlpkSTFx8dr6tSpstlsys/PV3FxsVJTU5Wamqri4mLFxMQoNzfXX7tu3Tpt3LhRCQkJmjFjhjZt2qT09HT/VT0AAGByMxVQduzYIUnKzMwMWL97927dfvvtkqTNmzeru7tb69evV1tbmxYsWKDq6mrFxsb667dv366oqCitWbNG3d3dysrK0p49exQZGTm2bgAAQFgwFVBGcsGPzWaTx+ORx+MZsiY6Olrl5eUqLy83c/cAAGCS4Lt4AACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5RBQAACA5UQFewAAwtPl9z1zwRpHpKGS66U0zwF5e23+9ScfWT6RQwMQAjiDAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALIeAAgAALMf056C8+OKLevTRR9XQ0KDm5mbt379fN998s3+7YRgqKirSzp071dbWpgULFugHP/iBrrnmGn+N1+vVpk2b9OMf/1jd3d3KysrS448/rlmzZo1LUwAmr5F8/spQ+PwVwDpMn0E5d+6crr32WlVUVAy6vaSkRKWlpaqoqFB9fb2cTqdycnLU2dnpr8nPz9f+/ftVVVWlw4cP6+zZs1qxYoV6e3tH3wkAAAgbps+gLFu2TMuWLRt0m2EYKisr05YtW7R69WpJ0t69e5WYmKjKykrl5eWpvb1du3bt0lNPPaXs7GxJ0r59+5ScnKyDBw9q6dKlY2gHAACEg3H9qPvGxka1tLTI7Xb71zkcDi1ZskR1dXXKy8tTQ0ODfD5fQI3L5VJaWprq6uoGDSher1der9e/3NHRIUny+Xzy+XzDjql/+4XqQp0jwgj4N1zRZ3gZqs+x/Lw6Ikf/mE3E74nJ8juIPsPLRPVp5njjGlBaWlokSYmJiQHrExMT1dTU5K+ZMmWKpk+fPqCmf//zbdu2TUVFRQPWV1dXKyYmZkRjq6mpGVFdqHpwfv+/fcEdyIeEPsPL+X0+++yzoz5WyfWjH8dY7vdCwv13UD/6DC/j3WdXV9eIayfkywJtNlvAsmEYA9adb7iawsJCFRQU+Jc7OjqUnJwst9utuLi4YY/r8/lUU1OjnJwc2e32EXYQejIeeF4Pzu/T/Uci5O0b/rEOZY4Igz7DyFB9HveM/qXeNM+BUe87lvsdymT5HUSf4WWi+ux/BWQkxjWgOJ1OSR+cJUlKSvKvb21t9Z9VcTqd6unpUVtbW8BZlNbWVi1atGjQ4zocDjkcjgHr7Xb7iB84M7WhqP+Xu7fPFvCtsOGKPsPL+X2m3l89hqON/vGayN8R4f47qB99hpfx7tPMscb1c1BSUlLkdDoDTgn19PSotrbWHz4yMjJkt9sDapqbm3X8+PEhAwoAAJhcTJ9BOXv2rP7v//7Pv9zY2KijR49qxowZuuyyy5Sfn6/i4mKlpqYqNTVVxcXFiomJUW5uriQpPj5e69at08aNG5WQkKAZM2Zo06ZNSk9P91/VAwAAJjfTAeXIkSP69Kc/7V/uf2/I2rVrtWfPHm3evFnd3d1av369/4PaqqurFRsb699n+/btioqK0po1a/wf1LZnzx5FRkaOQ0sAACDUmQ4omZmZMoyhL+Oz2WzyeDzyeDxD1kRHR6u8vFzl5eVm7x4AAEwCfBcPAACwHAIKAACwHAIKAACwHAIKAACwHAIKAACwHAIKAACwHAIKAACwHAIKAACwHAIKAACwHAIKAACwHAIKAACwHAIKAACwHAIKAACwHAIKAACwHAIKAACwnKhgDwB/c/l9z4x6X0fkOA4EAIAg4wwKAACwHAIKAACwHAIKAACwHAIKAACwHAIKAACwHK7iAYBxMNRVeI5IQyXXS2meA/L22gatOfnI8okcGhCSOIMCAAAsh4ACAAAsh5d4AOD/GcuHJQIYXwSUccYvOAAAxo6AMghCBgAAwcV7UAAAgOVwBgUAgmwsZ225RBnhioACACFsrC9JE3BgVbzEAwAALIeAAgAALCeoAeXxxx9XSkqKoqOjlZGRod/85jfBHA4AALCIoL0H5Sc/+Yny8/P1+OOPa/HixXryySe1bNkyvfrqq7rsssuCNSwAmFSC9QZd3hiMCwnaGZTS0lKtW7dOX/3qV/Xxj39cZWVlSk5O1o4dO4I1JAAAYBFBOYPS09OjhoYG3XfffQHr3W636urqBtR7vV55vV7/cnt7uyTpzJkz8vl8w96Xz+dTV1eX3nnnHdnt9hGNL+r9cyOqs5KoPkNdXX2K8kWot2/wb0wNB/QZXiZDn+Hc4zvvvOP/b7O/a8fye/bv7/fDtGDbf8sRYehf5/XpE1ueltfEfP5/hVkTOLLxN5q/nSPR2dkpSTIM48LFRhC89dZbhiTjf/7nfwLWP/zww8acOXMG1G/dutWQxI0bN27cuHELg9ubb755wawQ1M9BsdkC06dhGAPWSVJhYaEKCgr8y319fTpz5owSEhIGrf97HR0dSk5O1ptvvqm4uLjxGbgF0Wd4oc/wMRl6lOgz3ExUn4ZhqLOzUy6X64K1QQkoM2fOVGRkpFpaWgLWt7a2KjExcUC9w+GQw+EIWHfxxRebus+4uLiwfjL1o8/wQp/hYzL0KNFnuJmIPuPj40dUF5Q3yU6ZMkUZGRmqqakJWF9TU6NFixYFY0gAAMBCgvYST0FBgb785S9r/vz5WrhwoXbu3KlTp07p61//erCGBAAALCJoAeWWW27RO++8owceeEDNzc1KS0vTs88+q9mzZ4/r/TgcDm3dunXAS0Thhj7DC32Gj8nQo0Sf4cYKfdoMYyTX+gAAAHx4+C4eAABgOQQUAABgOQQUAABgOQQUAABgOQQUAABgOWEfUB5//HGlpKQoOjpaGRkZ+s1vfhPsIY0rj8cjm80WcHM6ncEe1pi9+OKLuummm+RyuWSz2fRf//VfAdsNw5DH45HL5dLUqVOVmZmpEydOBGewo3ShHm+//fYBc3vDDTcEZ7BjsG3bNl133XWKjY3VpZdeqptvvlmvvfZaQE04zOdI+gz1Od2xY4fmzp3r/3TRhQsX6rnnnvNvD4d5lC7cZ6jP41C2bdsmm82m/Px8/7pgzmlYB5Sf/OQnys/P15YtW/TKK6/oH//xH7Vs2TKdOnUq2EMbV9dcc42am5v9t2PHjgV7SGN27tw5XXvttaqoqBh0e0lJiUpLS1VRUaH6+no5nU7l5OT4vykzFFyoR0m68cYbA+b22Wef/RBHOD5qa2t1991366WXXlJNTY3ef/99ud1unTv3t2+zDYf5HEmfUmjP6axZs/TII4/oyJEjOnLkiD7zmc9o1apV/j9Y4TCP0oX7lEJ7HgdTX1+vnTt3au7cuQHrgzqnY/5qYgu7/vrrja9//esB6z72sY8Z9913X5BGNP62bt1qXHvttcEexoSSZOzfv9+/3NfXZzidTuORRx7xr3vvvfeM+Ph444knngjCCMfu/B4NwzDWrl1rrFq1KijjmUitra2GJKO2ttYwjPCcT8MY2KdhhOecTp8+3fj3f//3sJ3Hfv19Gkb4zWNnZ6eRmppq1NTUGEuWLDHuvfdewzCC/7MZtmdQenp61NDQILfbHbDe7Xarrq4uSKOaGK+//rpcLpdSUlL0xS9+UW+88UawhzShGhsb1dLSEjC3DodDS5YsCbu5PXTokC699FLNmTNHX/va19Ta2hrsIY1Ze3u7JGnGjBmSwnc+z++zX7jMaW9vr6qqqnTu3DktXLgwbOfx/D77hcs8StLdd9+t5cuXKzs7O2B9sOc0aB91P9H++te/qre3d8C3IycmJg74FuVQtmDBAv3Hf/yH5syZo7ffflsPPfSQFi1apBMnTighISHYw5sQ/fM32Nw2NTUFY0gTYtmyZfrCF76g2bNnq7GxUffff78+85nPqKGhIWQ/ZtswDBUUFOiTn/yk0tLSJIXnfA7WpxQec3rs2DEtXLhQ7733ni666CLt379fV199tf8PVrjM41B9SuExj/2qqqr08ssvq76+fsC2YP9shm1A6Wez2QKWDcMYsC6ULVu2zP/f6enpWrhwoa688krt3btXBQUFQRzZxAv3ub3lllv8/52Wlqb58+dr9uzZeuaZZ7R69eogjmz07rnnHv3hD3/Q4cOHB2wLp/kcqs9wmNOrrrpKR48e1bvvvquf/exnWrt2rWpra/3bw2Ueh+rz6quvDot5lKQ333xT9957r6qrqxUdHT1kXbDmNGxf4pk5c6YiIyMHnC1pbW0dkAbDybRp05Senq7XX3892EOZMP1XKU22uU1KStLs2bNDdm43bNigX/ziF3rhhRc0a9Ys//pwm8+h+hxMKM7plClT9NGPflTz58/Xtm3bdO211+r73/9+2M3jUH0OJhTnUZIaGhrU2tqqjIwMRUVFKSoqSrW1tfq3f/s3RUVF+ectWHMatgFlypQpysjIUE1NTcD6mpoaLVq0KEijmnher1d//OMflZSUFOyhTJiUlBQ5nc6Aue3p6VFtbW1Yz+0777yjN998M+Tm1jAM3XPPPXr66af161//WikpKQHbw2U+L9TnYEJ1Tv+eYRjyer1hM49D6e9zMKE6j1lZWTp27JiOHj3qv82fP1+33Xabjh49qiuuuCK4czrhb8MNoqqqKsNutxu7du0yXn31VSM/P9+YNm2acfLkyWAPbdxs3LjROHTokPHGG28YL730krFixQojNjY25Hvs7Ow0XnnlFeOVV14xJBmlpaXGK6+8YjQ1NRmGYRiPPPKIER8fbzz99NPGsWPHjFtvvdVISkoyOjo6gjzykRuux87OTmPjxo1GXV2d0djYaLzwwgvGwoULjY985CMh1aNhGMY///M/G/Hx8cahQ4eM5uZm/62rq8tfEw7zeaE+w2FOCwsLjRdffNFobGw0/vCHPxjf/va3jYiICKO6utowjPCYR8MYvs9wmMfh/P1VPIYR3DkN64BiGIbxgx/8wJg9e7YxZcoU4x/+4R8CLvkLB7fccouRlJRk2O12w+VyGatXrzZOnDgR7GGN2QsvvGBIGnBbu3atYRgfXP62detWw+l0Gg6Hw/jUpz5lHDt2LLiDNmm4Hru6ugy3221ccsklht1uNy677DJj7dq1xqlTp4I9bNMG61GSsXv3bn9NOMznhfoMhzm98847/b9PL7nkEiMrK8sfTgwjPObRMIbvMxzmcTjnB5RgzqnNMAxj4s/TAAAAjFzYvgcFAACELgIKAACwHAIKAACwHAIKAACwHAIKAACwHAIKAACwHAIKAACwHAIKAACwHAIKAACwHAIKAACwHAIKAACwnP8fn/fGylthSRoAAAAASUVORK5CYII=",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# TODO\n",
    "title_hist = df_corpus.hist(column='title_length', bins=30)\n",
    "abstract_hist = df_corpus.hist(column='abstract_length', bins=30)\n",
    "text_hist = df_corpus.hist(column='text_length', bins=30)\n",
    "title_hist, abstract_hist, text_hist\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 1.2.8 Quelles remarques faites-vous sur les affirmations (claims) et les documents ? (1.5 points) \n",
    "\n",
    "En observant les maximums, les minimums et les moyennes, que remarquez-vous à propos des affirmations ('_claims_') ? À l'aide des graphiques générés, comparez également les documents."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "# TODO\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### 1.3 Pré-traitement (6 points)\n",
    "Les affirmations et résumés de texte de votre ensemble de données doivent d’abord être représentés et indexés pour ensuite pouvoir effectuer une recherche de document (pouvant être \"_title_\", \"_abstract_\" ou la fusion des deux représentée par \"_text_\") qui justifie/contredit une affirmation. Vous devez donc implémenter une étape de pré-traitement des données."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 1.3.1 Implémentation de la fonction \"_tokenize_sentence_\" (1 point)\n",
    "\n",
    "Implémentez la fonction \"_tokenize_sentence_\" pour la segmentation d'une phrase en une liste de jetons. Utilisez la librarie `nltk`."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['this', 'is', 'a', 'test', 'to', 'tokenkenize', 'the', 'sentence', '.']\n"
     ]
    }
   ],
   "source": [
    "#from nltk.tokenize import RegexpTokenizer\n",
    "# TODO\n",
    "def tokenize_sentence(sentence):\n",
    "    #tokenizer = RegexpTokenizer(r'\\w+')\n",
    "    #return tokenizer.tokenize(sentence.lower())\n",
    "    return nltk.tokenize.word_tokenize(sentence.lower())\n",
    "# END TODO\n",
    "test_sentence = \"This is a test to tokenkenize the sentence.\"\n",
    "print(tokenize_sentence(test_sentence))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 1.3.2 Implémentation de la fonction \"_tokenize_text_\" (1 point)\n",
    "Implémentez la fonction \"_tokenize_text_\" qui utilise \"_tokenize_sentence_\" pour faire la segmentation d'un texte (liste de phrases)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[['it', \"'s\", 'my', 'first', 'test', 'tokens', 'sentence', '.'], ['for', 'the', 'second', 'sentence', ',', 'this', 'is', 'a', 'new', 'sentence', '.']]\n"
     ]
    }
   ],
   "source": [
    "# TODO\n",
    "def tokenize_text(text):\n",
    "    tokens = []\n",
    "    for sentence in text:\n",
    "        #temp_tokens = tokenize_sentence(sentence)\n",
    "        #tokens.extend(temp_tokens)\n",
    "        #if we want [['First', 'test', 'tokens'], ['second', 'test, 'tokens]] instead\n",
    "        tokens.append(tokenize_sentence(sentence)) \n",
    "    return tokens\n",
    "\n",
    "text = [\"It's my first test tokens sentence.\", \"For the second sentence, this is a new sentence.\"]\n",
    "tokens = tokenize_text(text)\n",
    "print(tokens)\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\"It's my first test tokens sentence.\""
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text[0]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 1.3.3 Implémentation de la fonction \"_stem_tokens_\" (1 point)\n",
    "\n",
    "Implémentez la fonction \"_stem_tokens_\" qui prend une liste de jetons (tokens) en entrée et retourne une liste contenant leur forme racinisée (stems) en utilisant l'algorithme de racinisation PorterStemmer de la bibliothèque nltk."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[['it', \"'s\", 'my', 'first', 'test', 'token', 'sentenc', '.'], ['for', 'the', 'second', 'sentenc', ',', 'thi', 'is', 'a', 'new', 'sentenc', '.']]\n"
     ]
    }
   ],
   "source": [
    "# TODO\n",
    "def stem_tokens(tokens):\n",
    "    stemmer = PorterStemmer()\n",
    "    stem_tokens = []\n",
    "    \n",
    "    for sentence in tokens:\n",
    "        temp_stem_tokens = []\n",
    "        for token in sentence:\n",
    "            temp_stem_tokens.append(stemmer.stem(token))\n",
    "        stem_tokens.append(temp_stem_tokens)\n",
    "    \n",
    "    return stem_tokens\n",
    "\n",
    "stemmmer_tokens = stem_tokens(tokens)\n",
    "print(stemmmer_tokens)\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 1.3.4 Pré-traitement (2 points)\n",
    "\n",
    "En utilisant vos précédentes fonctions, faites maintenant le pré-traitement des champs \"_text_\", \"_title_\" et \"_abstract_\" du dataframe \"_df_corpus_\" et \"_claim_\" du dataframe \"_df_claims_\" en suivant les étapes suivantes:\n",
    "- conversion en minuscules\n",
    "- segmentation (tokenization) des passages\n",
    "- suppression des stop-words et ponctuation\n",
    "- racinisation (stemming) des jetons\n",
    "\n",
    "Nommez la liste des affirmations pré-traitées par \"_claims_preprocessed_\". Pour le corpus de documents considérez les ensembles de titres \"_title_\", de résumés \"abstract\" et la fusion des deux \"_text_\" et nommez les listes correspondantes par \"_titles_preprocessed_\", \"_abstracts_preprocessed_\" et \"_texts_preprocessed_\" respectivement."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [],
   "source": [
    "# TODO\n",
    "\n",
    "def remove_punctuation_from_tokens(tokens):\n",
    "    return [token for token in tokens if token not in punctuation]\n",
    "\n",
    "def preprocess(text, stop_words):\n",
    "    tokens_list = tokenize_text(text)\n",
    "    preprocessed_tokens = []\n",
    "    \n",
    "    for tokens in tokens_list:\n",
    "        temp_tokens = []\n",
    "        tokens = remove_punctuation_from_tokens(tokens)\n",
    "        for token in tokens:\n",
    "            if token not in stop_words:\n",
    "                temp_tokens.append(token)\n",
    "                \n",
    "        preprocessed_tokens.append(temp_tokens)\n",
    "    \n",
    "    \n",
    "    stemmed_tokens = stem_tokens(preprocessed_tokens)\n",
    "    \n",
    "    return stemmed_tokens\n",
    "        \n",
    "\n",
    "titles_preprocessed = preprocess(df_corpus['title'].tolist(), stop_words)\n",
    "\n",
    "texts_preprocessed = preprocess(df_corpus['text'].tolist(), stop_words)\n",
    "\n",
    "abstracts_preprocessed = preprocess(df_corpus['abstract'].tolist(), stop_words)\n",
    "\n",
    "claims_preprocessed = preprocess(df_claims['claim'].tolist(), stop_words)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>doc_id</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "      <th>structured</th>\n",
       "      <th>text</th>\n",
       "      <th>title_length</th>\n",
       "      <th>abstract_length</th>\n",
       "      <th>text_length</th>\n",
       "      <th>titles_preprocessed</th>\n",
       "      <th>abstracts_preprocessed</th>\n",
       "      <th>texts_preprocessed</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>4983</td>\n",
       "      <td>Microstructural development of human newborn c...</td>\n",
       "      <td>Alterations of the architecture of cerebral wh...</td>\n",
       "      <td>False</td>\n",
       "      <td>Microstructural development of human newborn c...</td>\n",
       "      <td>17</td>\n",
       "      <td>278</td>\n",
       "      <td>295</td>\n",
       "      <td>[microstructur, develop, human, newborn, cereb...</td>\n",
       "      <td>[alter, architectur, cerebr, white, matter, de...</td>\n",
       "      <td>[microstructur, develop, human, newborn, cereb...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>5836</td>\n",
       "      <td>Induction of myelodysplasia by myeloid-derived...</td>\n",
       "      <td>Myelodysplastic syndromes (MDS) are age-depend...</td>\n",
       "      <td>False</td>\n",
       "      <td>Induction of myelodysplasia by myeloid-derived...</td>\n",
       "      <td>7</td>\n",
       "      <td>201</td>\n",
       "      <td>208</td>\n",
       "      <td>[induct, myelodysplasia, myeloid-deriv, suppre...</td>\n",
       "      <td>[myelodysplast, syndrom, md, age-depend, stem,...</td>\n",
       "      <td>[induct, myelodysplasia, myeloid-deriv, suppre...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>7912</td>\n",
       "      <td>BC1 RNA, the transcript from a master gene for...</td>\n",
       "      <td>ID elements are short interspersed elements (S...</td>\n",
       "      <td>False</td>\n",
       "      <td>BC1 RNA, the transcript from a master gene for...</td>\n",
       "      <td>20</td>\n",
       "      <td>180</td>\n",
       "      <td>200</td>\n",
       "      <td>[bc1, rna, transcript, master, gene, id, eleme...</td>\n",
       "      <td>[id, element, short, interspers, element, sine...</td>\n",
       "      <td>[bc1, rna, transcript, master, gene, id, eleme...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>18670</td>\n",
       "      <td>The DNA Methylome of Human Peripheral Blood Mo...</td>\n",
       "      <td>DNA methylation plays an important role in bio...</td>\n",
       "      <td>False</td>\n",
       "      <td>The DNA Methylome of Human Peripheral Blood Mo...</td>\n",
       "      <td>9</td>\n",
       "      <td>238</td>\n",
       "      <td>247</td>\n",
       "      <td>[dna, methylom, human, peripher, blood, mononu...</td>\n",
       "      <td>[dna, methyl, play, import, role, biolog, proc...</td>\n",
       "      <td>[dna, methylom, human, peripher, blood, mononu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>19238</td>\n",
       "      <td>The human myelin basic protein gene is include...</td>\n",
       "      <td>Two human Golli (for gene expressed in the oli...</td>\n",
       "      <td>False</td>\n",
       "      <td>The human myelin basic protein gene is include...</td>\n",
       "      <td>21</td>\n",
       "      <td>241</td>\n",
       "      <td>262</td>\n",
       "      <td>[human, myelin, basic, protein, gene, includ, ...</td>\n",
       "      <td>[two, human, golli, gene, express, oligodendro...</td>\n",
       "      <td>[human, myelin, basic, protein, gene, includ, ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   doc_id                                              title  \\\n",
       "0    4983  Microstructural development of human newborn c...   \n",
       "1    5836  Induction of myelodysplasia by myeloid-derived...   \n",
       "2    7912  BC1 RNA, the transcript from a master gene for...   \n",
       "3   18670  The DNA Methylome of Human Peripheral Blood Mo...   \n",
       "4   19238  The human myelin basic protein gene is include...   \n",
       "\n",
       "                                            abstract  structured  \\\n",
       "0  Alterations of the architecture of cerebral wh...       False   \n",
       "1  Myelodysplastic syndromes (MDS) are age-depend...       False   \n",
       "2  ID elements are short interspersed elements (S...       False   \n",
       "3  DNA methylation plays an important role in bio...       False   \n",
       "4  Two human Golli (for gene expressed in the oli...       False   \n",
       "\n",
       "                                                text  title_length  \\\n",
       "0  Microstructural development of human newborn c...            17   \n",
       "1  Induction of myelodysplasia by myeloid-derived...             7   \n",
       "2  BC1 RNA, the transcript from a master gene for...            20   \n",
       "3  The DNA Methylome of Human Peripheral Blood Mo...             9   \n",
       "4  The human myelin basic protein gene is include...            21   \n",
       "\n",
       "   abstract_length  text_length  \\\n",
       "0              278          295   \n",
       "1              201          208   \n",
       "2              180          200   \n",
       "3              238          247   \n",
       "4              241          262   \n",
       "\n",
       "                                 titles_preprocessed  \\\n",
       "0  [microstructur, develop, human, newborn, cereb...   \n",
       "1  [induct, myelodysplasia, myeloid-deriv, suppre...   \n",
       "2  [bc1, rna, transcript, master, gene, id, eleme...   \n",
       "3  [dna, methylom, human, peripher, blood, mononu...   \n",
       "4  [human, myelin, basic, protein, gene, includ, ...   \n",
       "\n",
       "                              abstracts_preprocessed  \\\n",
       "0  [alter, architectur, cerebr, white, matter, de...   \n",
       "1  [myelodysplast, syndrom, md, age-depend, stem,...   \n",
       "2  [id, element, short, interspers, element, sine...   \n",
       "3  [dna, methyl, play, import, role, biolog, proc...   \n",
       "4  [two, human, golli, gene, express, oligodendro...   \n",
       "\n",
       "                                  texts_preprocessed  \n",
       "0  [microstructur, develop, human, newborn, cereb...  \n",
       "1  [induct, myelodysplasia, myeloid-deriv, suppre...  \n",
       "2  [bc1, rna, transcript, master, gene, id, eleme...  \n",
       "3  [dna, methylom, human, peripher, blood, mononu...  \n",
       "4  [human, myelin, basic, protein, gene, includ, ...  "
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_corpus['titles_preprocessed'] = titles_preprocessed\n",
    "df_corpus['abstracts_preprocessed'] = abstracts_preprocessed\n",
    "df_corpus['texts_preprocessed'] = texts_preprocessed\n",
    "\n",
    "df_claims['claims_preprocessed'] = claims_preprocessed\n",
    "\n",
    "df_corpus.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>claim</th>\n",
       "      <th>evidence</th>\n",
       "      <th>cited_doc_ids</th>\n",
       "      <th>num_cited_doc</th>\n",
       "      <th>claim_length</th>\n",
       "      <th>claims_preprocessed</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>0-dimensional biomaterials lack inductive prop...</td>\n",
       "      <td>{}</td>\n",
       "      <td>[31715818]</td>\n",
       "      <td>1</td>\n",
       "      <td>5</td>\n",
       "      <td>[0-dimension, biomateri, lack, induct, properti]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>1 in 5 million in UK have abnormal PrP positiv...</td>\n",
       "      <td>{'13734012': [{'sentences': [4], 'label': 'CON...</td>\n",
       "      <td>[13734012]</td>\n",
       "      <td>1</td>\n",
       "      <td>10</td>\n",
       "      <td>[1, 5, million, uk, abnorm, prp, posit]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>4</td>\n",
       "      <td>1-1% of colorectal cancer patients are diagnos...</td>\n",
       "      <td>{}</td>\n",
       "      <td>[22942787]</td>\n",
       "      <td>1</td>\n",
       "      <td>12</td>\n",
       "      <td>[1-1, colorect, cancer, patient, diagnos, regi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>6</td>\n",
       "      <td>10% of sudden infant death syndrome (SIDS) dea...</td>\n",
       "      <td>{}</td>\n",
       "      <td>[2613775]</td>\n",
       "      <td>1</td>\n",
       "      <td>16</td>\n",
       "      <td>[10, sudden, infant, death, syndrom, sid, deat...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>9</td>\n",
       "      <td>32% of liver transplantation programs required...</td>\n",
       "      <td>{'44265107': [{'sentences': [15], 'label': 'SU...</td>\n",
       "      <td>[44265107]</td>\n",
       "      <td>1</td>\n",
       "      <td>13</td>\n",
       "      <td>[32, liver, transplant, program, requir, patie...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   id                                              claim  \\\n",
       "0   0  0-dimensional biomaterials lack inductive prop...   \n",
       "1   2  1 in 5 million in UK have abnormal PrP positiv...   \n",
       "2   4  1-1% of colorectal cancer patients are diagnos...   \n",
       "3   6  10% of sudden infant death syndrome (SIDS) dea...   \n",
       "4   9  32% of liver transplantation programs required...   \n",
       "\n",
       "                                            evidence cited_doc_ids  \\\n",
       "0                                                 {}    [31715818]   \n",
       "1  {'13734012': [{'sentences': [4], 'label': 'CON...    [13734012]   \n",
       "2                                                 {}    [22942787]   \n",
       "3                                                 {}     [2613775]   \n",
       "4  {'44265107': [{'sentences': [15], 'label': 'SU...    [44265107]   \n",
       "\n",
       "   num_cited_doc  claim_length  \\\n",
       "0              1             5   \n",
       "1              1            10   \n",
       "2              1            12   \n",
       "3              1            16   \n",
       "4              1            13   \n",
       "\n",
       "                                 claims_preprocessed  \n",
       "0   [0-dimension, biomateri, lack, induct, properti]  \n",
       "1            [1, 5, million, uk, abnorm, prp, posit]  \n",
       "2  [1-1, colorect, cancer, patient, diagnos, regi...  \n",
       "3  [10, sudden, infant, death, syndrom, sid, deat...  \n",
       "4  [32, liver, transplant, program, requir, patie...  "
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_claims.head(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "doc_id                                                            195689316\n",
       "title                     Body-mass index and cause-specific mortality i...\n",
       "abstract                  BACKGROUND The main associations of body-mass ...\n",
       "structured                                                             True\n",
       "text                      Body-mass index and cause-specific mortality i...\n",
       "title_length                                                             15\n",
       "abstract_length                                                         413\n",
       "text_length                                                             428\n",
       "titles_preprocessed       [body-mass, index, cause-specif, mortal, 900, ...\n",
       "abstracts_preprocessed    [background, main, associ, body-mass, index, b...\n",
       "texts_preprocessed        [body-mass, index, cause-specif, mortal, 900, ...\n",
       "Name: 5178, dtype: object"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_corpus.iloc[5178]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 1.3.5 Jetons uniques (types) (1 point)\n",
    "\n",
    "Affichez maintenant le nombre total de jetons dans tous les textes (_text_) et affirmations (_claim_) (en les considérant comme un seul corpus) après le pré-traitement. Puis, affichez le nombre de jetons uniques (types) dans les textes (_text_) et les affirmations (_claim_). "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "7150\n"
     ]
    }
   ],
   "source": [
    "# TODO\n",
    "def count_total_tokens(tokens):\n",
    "    total_tokens = 0\n",
    "    for token in tokens:\n",
    "        if isinstance(token, list):\n",
    "            total_tokens += count_total_tokens(token)\n",
    "        else:\n",
    "            total_tokens += 1\n",
    "            \n",
    "    return total_tokens\n",
    "\n",
    "\n",
    "#Question incomplete\n",
    "total_text_tokens = count_total_tokens(df_corpus['texts_preprocessed'].tolist())\n",
    "total_claim_tokens = count_total_tokens(df_claims['claims_preprocessed'].tolist())\n",
    "\n",
    "print(total_claim_tokens)\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "3qH8-QAw8BEV"
   },
   "source": [
    "### 2. Représentation des affirmations et des documents  (45 points)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### 2.1  Vocabulaire (15 points)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 2.1.1 Implémentation de la fonction \"_get_vocab_\" (3 points)\n",
    "\n",
    "Implémentez la fonction \"_get_vocab_\" qui prend une liste de textes composés chacun d'une liste de jetons et retourne un dictionnaire dont les clés sont les jetons uniques et les valeurs sont leur fréquence dans l'ensemble des textes."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'world': 4, 'the': 2, 'is': 2, 'sports': 2, 'cup': 2, 'football': 1, 'a': 1, 'nhl': 1, 'games': 1, 'school': 1, 'work': 1, 'activities': 1, 'club': 1}\n"
     ]
    }
   ],
   "source": [
    "# TODO\n",
    "def get_vocab(text_list):\n",
    "    text_dict = {}\n",
    "    for text in text_list:\n",
    "        for token in text:\n",
    "            if token not in text_dict:\n",
    "                text_dict[token] = 1\n",
    "            else:\n",
    "                text_dict[token] += 1\n",
    "    text_dict = dict(sorted(text_dict.items(), key = lambda item: item[1], reverse=True))\n",
    "    return text_dict\n",
    "\n",
    "\n",
    "example_list = [['the', 'football', 'is', 'sports', 'a', 'world', 'cup'], ['the', 'cup', 'nhl', 'games', 'is'],\n",
    "               ['school', 'work', 'activities', 'club', 'sports', 'world', 'world', 'world']]\n",
    "\n",
    "example_dict = get_vocab(example_list)\n",
    "print(example_dict)\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 2.1.2 Implémentez la fonction \"_show_top_N_types_\" (3 points)\n",
    "\n",
    "Implémentez la fonction \"show_top_N_types\" qui affiche les N jetons les plus fréquents à partir d'un dictionnaire comme celui retourné par la fonction \"_get_vocab_\".\n",
    "\n",
    "La fonction prend deux arguments: le dictionnaire \"_dictionary_\" et le paramètre \"_N_\". "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'world': 4, 'the': 2}"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# TODO\n",
    "def show_top_N_types(text_dict, N):\n",
    "    \n",
    "    n_dict = dict(list(text_dict.items())[0:N]) \n",
    "    return n_dict\n",
    "\n",
    "n_example = show_top_N_types(example_dict, 2)\n",
    "n_example\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 2.1.3 Construction du vocabulaire (1 point)\n",
    "\n",
    "Construisez maintenant le vocabulaire pour les affirmations et le corpus de documents à partir des listes \"texts_preprocessed\" et \"claims_preprocessed\". \n",
    "\n",
    "Ensuite affichez les 15 jetons les plus fréquents ainsi que leur fréquence."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'cell': 10464, 'patient': 4175, 'activ': 4145, 'studi': 4014, 'use': 3799, 'express': 3626, 'result': 3213, 'protein': 3083, 'gene': 3004, 'cancer': 2945, 'increas': 2794, 'associ': 2659, 'effect': 2567, 'function': 2515, 'human': 2464}\n"
     ]
    }
   ],
   "source": [
    "# TODO\n",
    "texts_preprocessed = df_corpus['texts_preprocessed'].tolist()\n",
    "claims_preprocessed = df_claims['claims_preprocessed'].tolist()\n",
    "\n",
    "corpus_vocab = texts_preprocessed + claims_preprocessed\n",
    "vocab_dict = get_vocab(corpus_vocab)\n",
    "vocab_15 = show_top_N_types(vocab_dict, 15)\n",
    "print(vocab_15)\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Sortie attendue:\n",
    "\n",
    "```Nombre de types composant le vocabulaire: 45195\n",
    "Les 15 types les plus fréquents:\n",
    "('cell', 10464)\n",
    "('patient', 4175)\n",
    "('activ', 4145)\n",
    "('studi', 4014)\n",
    "('use', 3799)\n",
    "('express', 3626)\n",
    "('result', 3213)\n",
    "('protein', 3083)\n",
    "('gene', 3004)\n",
    "('cancer', 2945)\n",
    "('increas', 2794)\n",
    "('associ', 2659)\n",
    "('effect', 2567)\n",
    "('function', 2515)\n",
    "('human', 2464)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 2.1.4 Implémentation de la fonction \"_show_distribution_\" (4 points)\n",
    "\n",
    "Implémentez la fonction \"__show_distribution__\" qui permet de visualiser la distribution des fréquences des jetons à partir d'un dictionnaire comme celui retourné par la fonction \"_get_vocab_\", en utilisant un graphique où l'axe des abscisses représente le rang d'un type (après un tri par ordre de fréquence décroissante) et l'axe des ordonnées représente sa fréquence sur une échelle logarithmique.  \n",
    "\n",
    "Par exemple, le point (10000, 10) voudrait dire que le 10000ème mot le plus fréquent a une fréquence à peu prés egale à 10 dans le vocabulaire."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{1: 10464, 2: 4175, 3: 4145, 4: 4014, 5: 3799, 6: 3626, 7: 3213, 8: 3083, 9: 3004, 10: 2945, 11: 2794, 12: 2659, 13: 2567, 14: 2515, 15: 2464, 16: 2391, 17: 2233, 18: 2098, 19: 2084, 20: 2073, 21: 2055, 22: 2049, 23: 2000, 24: 1951, 25: 1857, 26: 1846, 27: 1831, 28: 1755, 29: 1694, 30: 1691, 31: 1682, 32: 1665, 33: 1652, 34: 1649, 35: 1633, 36: 1626, 37: 1625, 38: 1613, 39: 1536, 40: 1533, 41: 1521, 42: 1513, 43: 1499, 44: 1447, 45: 1438, 46: 1383, 47: 1378, 48: 1359, 49: 1343, 50: 1331, 51: 1316, 52: 1312, 53: 1282, 54: 1269, 55: 1258, 56: 1230, 57: 1226, 58: 1225, 59: 1223, 60: 1218, 61: 1206, 62: 1203, 63: 1175, 64: 1174, 65: 1173, 66: 1147, 67: 1144, 68: 1136, 69: 1135, 70: 1117, 71: 1113, 72: 1111, 73: 1100, 74: 1099, 75: 1087, 76: 1080, 77: 1078, 78: 1076, 79: 1075, 80: 1064, 81: 1056, 82: 1036, 83: 1031, 84: 1029, 85: 1028, 86: 1024, 87: 1020, 88: 1000, 89: 998, 90: 993, 91: 991, 92: 973, 93: 972, 94: 967, 95: 952, 96: 945, 97: 935, 98: 933, 99: 928, 100: 922, 101: 920, 102: 917, 103: 914, 104: 897, 105: 880, 106: 863, 107: 855, 108: 854, 109: 850, 110: 847, 111: 845, 112: 843, 113: 833, 114: 825, 115: 822, 116: 819, 117: 817, 118: 815, 119: 813, 120: 802, 121: 801, 122: 796, 123: 791, 124: 790, 125: 785, 126: 783, 127: 776, 128: 772, 129: 767, 130: 766, 131: 764, 132: 763, 133: 758, 134: 756, 135: 755, 136: 747, 137: 743, 138: 742, 139: 739, 140: 735, 141: 732, 142: 729, 143: 716, 144: 713, 145: 708, 146: 704, 147: 699, 148: 697, 149: 696, 150: 695, 151: 693, 152: 690, 153: 685, 154: 683, 155: 679, 156: 671, 157: 666, 158: 664, 159: 663, 160: 658, 161: 657, 162: 656, 163: 650, 164: 645, 165: 643, 166: 641, 167: 630, 168: 629, 169: 627, 170: 626, 171: 621, 172: 619, 173: 618, 174: 615, 175: 613, 176: 609, 177: 606, 178: 605, 179: 603, 180: 602, 181: 599, 182: 598, 183: 597, 184: 594, 185: 590, 186: 589, 187: 586, 188: 582, 189: 581, 190: 575, 191: 574, 192: 570, 193: 568, 194: 567, 195: 564, 196: 563, 197: 561, 198: 559, 199: 554, 200: 553, 201: 552, 202: 550, 203: 548, 204: 546, 205: 543, 206: 542, 207: 541, 208: 540, 209: 539, 210: 537, 211: 535, 212: 531, 213: 530, 214: 527, 215: 526, 216: 524, 217: 518, 218: 517, 219: 515, 220: 514, 221: 511, 222: 510, 223: 509, 224: 508, 225: 507, 226: 504, 227: 503, 228: 502, 229: 500, 230: 499, 231: 497, 232: 496, 233: 495, 234: 494, 235: 492, 236: 488, 237: 486, 238: 485, 239: 480, 240: 477, 241: 476, 242: 475, 243: 474, 244: 471, 245: 470, 246: 469, 247: 467, 248: 466, 249: 465, 250: 464, 251: 463, 252: 461, 253: 459, 254: 457, 255: 456, 256: 452, 257: 451, 258: 450, 259: 449, 260: 448, 261: 447, 262: 445, 263: 444, 264: 443, 265: 442, 266: 441, 267: 438, 268: 437, 269: 436, 270: 435, 271: 433, 272: 432, 273: 423, 274: 422, 275: 421, 276: 420, 277: 418, 278: 417, 279: 416, 280: 413, 281: 411, 282: 410, 283: 409, 284: 408, 285: 406, 286: 405, 287: 403, 288: 402, 289: 401, 290: 397, 291: 396, 292: 393, 293: 392, 294: 390, 295: 388, 296: 387, 297: 386, 298: 384, 299: 381, 300: 377, 301: 376, 302: 375, 303: 372, 304: 369, 305: 368, 306: 366, 307: 364, 308: 363, 309: 360, 310: 359, 311: 358, 312: 357, 313: 356, 314: 354, 315: 353, 316: 352, 317: 351, 318: 350, 319: 349, 320: 348, 321: 347, 322: 346, 323: 345, 324: 343, 325: 342, 326: 341, 327: 340, 328: 338, 329: 336, 330: 335, 331: 333, 332: 331, 333: 330, 334: 329, 335: 328, 336: 327, 337: 326, 338: 324, 339: 323, 340: 322, 341: 321, 342: 319, 343: 318, 344: 317, 345: 316, 346: 315, 347: 313, 348: 312, 349: 311, 350: 309, 351: 308, 352: 307, 353: 306, 354: 305, 355: 304, 356: 303, 357: 302, 358: 301, 359: 300, 360: 299, 361: 296, 362: 294, 363: 291, 364: 290, 365: 289, 366: 288, 367: 287, 368: 284, 369: 283, 370: 282, 371: 281, 372: 280, 373: 279, 374: 278, 375: 277, 376: 276, 377: 274, 378: 272, 379: 271, 380: 270, 381: 269, 382: 268, 383: 267, 384: 266, 385: 265, 386: 264, 387: 263, 388: 262, 389: 261, 390: 260, 391: 259, 392: 258, 393: 256, 394: 255, 395: 254, 396: 253, 397: 252, 398: 251, 399: 250, 400: 249, 401: 248, 402: 247, 403: 246, 404: 245, 405: 244, 406: 243, 407: 242, 408: 241, 409: 240, 410: 239, 411: 238, 412: 237, 413: 236, 414: 235, 415: 234, 416: 233, 417: 232, 418: 230, 419: 229, 420: 228, 421: 227, 422: 226, 423: 225, 424: 224, 425: 223, 426: 222, 427: 220, 428: 219, 429: 218, 430: 217, 431: 216, 432: 215, 433: 214, 434: 213, 435: 212, 436: 211, 437: 210, 438: 209, 439: 208, 440: 207, 441: 206, 442: 205, 443: 204, 444: 203, 445: 202, 446: 201, 447: 200, 448: 199, 449: 198, 450: 197, 451: 196, 452: 195, 453: 194, 454: 193, 455: 192, 456: 191, 457: 190, 458: 189, 459: 188, 460: 187, 461: 186, 462: 185, 463: 184, 464: 183, 465: 182, 466: 181, 467: 179, 468: 178, 469: 177, 470: 176, 471: 175, 472: 174, 473: 173, 474: 172, 475: 171, 476: 170, 477: 169, 478: 168, 479: 167, 480: 166, 481: 165, 482: 164, 483: 163, 484: 162, 485: 161, 486: 160, 487: 159, 488: 158, 489: 157, 490: 156, 491: 155, 492: 154, 493: 153, 494: 152, 495: 151, 496: 150, 497: 149, 498: 148, 499: 147, 500: 146, 501: 145, 502: 144, 503: 143, 504: 142, 505: 141, 506: 140, 507: 139, 508: 138, 509: 137, 510: 136, 511: 135, 512: 134, 513: 133, 514: 132, 515: 131, 516: 130, 517: 129, 518: 128, 519: 127, 520: 126, 521: 125, 522: 124, 523: 123, 524: 122, 525: 121, 526: 120, 527: 119, 528: 118, 529: 117, 530: 116, 531: 115, 532: 114, 533: 113, 534: 112, 535: 111, 536: 110, 537: 109, 538: 108, 539: 107, 540: 106, 541: 105, 542: 104, 543: 103, 544: 102, 545: 101, 546: 100, 547: 99, 548: 98, 549: 97, 550: 96, 551: 95, 552: 94, 553: 93, 554: 92, 555: 91, 556: 90, 557: 89, 558: 88, 559: 87, 560: 86, 561: 85, 562: 84, 563: 83, 564: 82, 565: 81, 566: 80, 567: 79, 568: 78, 569: 77, 570: 76, 571: 75, 572: 74, 573: 73, 574: 72, 575: 71, 576: 70, 577: 69, 578: 68, 579: 67, 580: 66, 581: 65, 582: 64, 583: 63, 584: 62, 585: 61, 586: 60, 587: 59, 588: 58, 589: 57, 590: 56, 591: 55, 592: 54, 593: 53, 594: 52, 595: 51, 596: 50, 597: 49, 598: 48, 599: 47, 600: 46, 601: 45, 602: 44, 603: 43, 604: 42, 605: 41, 606: 40, 607: 39, 608: 38, 609: 37, 610: 36, 611: 35, 612: 34, 613: 33, 614: 32, 615: 31, 616: 30, 617: 29, 618: 28, 619: 27, 620: 26, 621: 25, 622: 24, 623: 23, 624: 22, 625: 21, 626: 20, 627: 19, 628: 18, 629: 17, 630: 16, 631: 15, 632: 14, 633: 13, 634: 12, 635: 11, 636: 10, 637: 9, 638: 8, 639: 7, 640: 6, 641: 5, 642: 4, 643: 3, 644: 2, 645: 1}\n"
     ]
    }
   ],
   "source": [
    "# TODO\n",
    "def show_distribution(vocab_dict):\n",
    "    \n",
    "    rank_dict = {key: rank for rank, key in enumerate(sorted(set(vocab_dict.values()),reverse=True), 1)}\n",
    "    rank_dict = {v: k for k, v in rank_dict.items()}\n",
    "    \n",
    "    plt.bar(list(rank_dict.keys()), np.log10(list(rank_dict.values())), color='maroon', width=0.4)\n",
    "    plt.show()\n",
    "    \n",
    "    return rank_dict\n",
    "    \n",
    "rank_dict = show_distribution(vocab_dict)\n",
    "print(rank_dict)\n",
    "\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 2.1.5 Vérification de la loi de Zipf (4 points)\n",
    "\n",
    "Afin de vérifier la loi de Zipf, donnez une estimation de la valeur de la constante k de cette loi définie comme suit: \n",
    "\n",
    "$$ f \\approx \\frac{k}{r^\\alpha} $$ \n",
    "\n",
    "où $ f $ est la fréquence d'un mot, $ r $ est le rang de ce mot dans la liste triée par fréquence décroissante, et $ k $ est une constante. Etant données les fluctuations sur les valeurs de fréquence, vous pouvez utiliser la librairie ['powerlaw'](https://pypi.org/project/powerlaw/) conçue pour analyser et ajuster des distributions de loi de puissance aux données et qui peut être utile dans l'estimation de $ \\alpha $.\n",
    "\n",
    "Affichez la constante $ k $ trouvée, les fréquences réelles des mots avec celles qui sont prédites par la loi de Zipf."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Calculating best minimal value for power law fit\n",
      "xmin progress: 00%\r",
      "xmin progress: 00%\r",
      "xmin progress: 00%\r",
      "xmin progress: 00%\r",
      "xmin progress: 00%\r",
      "xmin progress: 00%\r",
      "xmin progress: 00%\r",
      "xmin progress: 01%\r",
      "xmin progress: 01%\r",
      "xmin progress: 01%\r",
      "xmin progress: 01%\r",
      "xmin progress: 01%\r",
      "xmin progress: 01%\r",
      "xmin progress: 02%\r",
      "xmin progress: 02%\r",
      "xmin progress: 02%\r",
      "xmin progress: 02%\r",
      "xmin progress: 02%\r",
      "xmin progress: 02%\r",
      "xmin progress: 02%\r",
      "xmin progress: 03%\r",
      "xmin progress: 03%\r",
      "xmin progress: 03%\r",
      "xmin progress: 03%\r",
      "xmin progress: 03%\r",
      "xmin progress: 03%\r",
      "xmin progress: 04%\r",
      "xmin progress: 04%\r",
      "xmin progress: 04%\r",
      "xmin progress: 04%\r",
      "xmin progress: 04%\r",
      "xmin progress: 04%\r",
      "xmin progress: 04%\r",
      "xmin progress: 05%\r",
      "xmin progress: 05%\r",
      "xmin progress: 05%\r",
      "xmin progress: 05%\r",
      "xmin progress: 05%\r",
      "xmin progress: 05%\r",
      "xmin progress: 06%\r",
      "xmin progress: 06%\r",
      "xmin progress: 06%\r",
      "xmin progress: 06%\r",
      "xmin progress: 06%\r",
      "xmin progress: 06%\r",
      "xmin progress: 06%\r",
      "xmin progress: 07%\r",
      "xmin progress: 07%\r",
      "xmin progress: 07%\r",
      "xmin progress: 07%\r",
      "xmin progress: 07%\r",
      "xmin progress: 07%\r",
      "xmin progress: 08%\r",
      "xmin progress: 08%\r",
      "xmin progress: 08%\r",
      "xmin progress: 08%\r",
      "xmin progress: 08%\r",
      "xmin progress: 08%\r",
      "xmin progress: 09%\r",
      "xmin progress: 09%\r",
      "xmin progress: 09%\r",
      "xmin progress: 09%\r",
      "xmin progress: 09%\r",
      "xmin progress: 09%\r",
      "xmin progress: 09%\r",
      "xmin progress: 10%\r",
      "xmin progress: 10%\r",
      "xmin progress: 10%\r",
      "xmin progress: 10%\r",
      "xmin progress: 10%\r",
      "xmin progress: 10%\r",
      "xmin progress: 11%\r",
      "xmin progress: 11%\r",
      "xmin progress: 11%\r",
      "xmin progress: 11%\r",
      "xmin progress: 11%\r",
      "xmin progress: 11%\r",
      "xmin progress: 11%\r",
      "xmin progress: 12%\r",
      "xmin progress: 12%\r",
      "xmin progress: 12%\r",
      "xmin progress: 12%\r",
      "xmin progress: 12%\r",
      "xmin progress: 12%\r",
      "xmin progress: 13%\r",
      "xmin progress: 13%\r",
      "xmin progress: 13%\r",
      "xmin progress: 13%\r",
      "xmin progress: 13%\r",
      "xmin progress: 13%\r",
      "xmin progress: 13%\r",
      "xmin progress: 14%\r",
      "xmin progress: 14%\r",
      "xmin progress: 14%\r",
      "xmin progress: 14%\r",
      "xmin progress: 14%\r",
      "xmin progress: 14%\r",
      "xmin progress: 15%\r",
      "xmin progress: 15%\r",
      "xmin progress: 15%\r",
      "xmin progress: 15%\r",
      "xmin progress: 15%\r",
      "xmin progress: 15%\r",
      "xmin progress: 15%\r",
      "xmin progress: 16%\r",
      "xmin progress: 16%\r",
      "xmin progress: 16%\r",
      "xmin progress: 16%\r",
      "xmin progress: 16%\r",
      "xmin progress: 16%\r",
      "xmin progress: 17%\r",
      "xmin progress: 17%\r",
      "xmin progress: 17%\r",
      "xmin progress: 17%\r",
      "xmin progress: 17%\r",
      "xmin progress: 17%\r",
      "xmin progress: 18%\r",
      "xmin progress: 18%\r",
      "xmin progress: 18%\r",
      "xmin progress: 18%\r",
      "xmin progress: 18%\r",
      "xmin progress: 18%\r",
      "xmin progress: 18%\r",
      "xmin progress: 19%\r",
      "xmin progress: 19%\r",
      "xmin progress: 19%\r",
      "xmin progress: 19%\r",
      "xmin progress: 19%\r",
      "xmin progress: 19%\r",
      "xmin progress: 20%\r",
      "xmin progress: 20%\r",
      "xmin progress: 20%\r",
      "xmin progress: 20%\r",
      "xmin progress: 20%\r",
      "xmin progress: 20%\r",
      "xmin progress: 20%\r",
      "xmin progress: 21%\r",
      "xmin progress: 21%\r",
      "xmin progress: 21%\r",
      "xmin progress: 21%\r",
      "xmin progress: 21%\r",
      "xmin progress: 21%\r",
      "xmin progress: 22%\r",
      "xmin progress: 22%\r",
      "xmin progress: 22%\r",
      "xmin progress: 22%\r",
      "xmin progress: 22%\r",
      "xmin progress: 22%\r",
      "xmin progress: 22%\r",
      "xmin progress: 23%\r",
      "xmin progress: 23%\r",
      "xmin progress: 23%\r",
      "xmin progress: 23%\r",
      "xmin progress: 23%\r",
      "xmin progress: 23%\r",
      "xmin progress: 24%\r",
      "xmin progress: 24%\r",
      "xmin progress: 24%\r",
      "xmin progress: 24%\r",
      "xmin progress: 24%\r",
      "xmin progress: 24%\r",
      "xmin progress: 25%\r",
      "xmin progress: 25%\r",
      "xmin progress: 25%\r",
      "xmin progress: 25%\r",
      "xmin progress: 25%\r",
      "xmin progress: 25%\r",
      "xmin progress: 25%\r",
      "xmin progress: 26%\r",
      "xmin progress: 26%\r",
      "xmin progress: 26%\r",
      "xmin progress: 26%\r",
      "xmin progress: 26%\r",
      "xmin progress: 26%\r",
      "xmin progress: 27%\r",
      "xmin progress: 27%\r",
      "xmin progress: 27%\r",
      "xmin progress: 27%\r",
      "xmin progress: 27%\r",
      "xmin progress: 27%\r",
      "xmin progress: 27%\r",
      "xmin progress: 28%\r",
      "xmin progress: 28%\r",
      "xmin progress: 28%\r",
      "xmin progress: 28%\r",
      "xmin progress: 28%\r",
      "xmin progress: 28%\r",
      "xmin progress: 29%\r",
      "xmin progress: 29%\r",
      "xmin progress: 29%\r",
      "xmin progress: 29%\r",
      "xmin progress: 29%\r",
      "xmin progress: 29%\r",
      "xmin progress: 29%\r",
      "xmin progress: 30%\r",
      "xmin progress: 30%\r",
      "xmin progress: 30%\r",
      "xmin progress: 30%\r",
      "xmin progress: 30%\r",
      "xmin progress: 30%\r",
      "xmin progress: 31%\r",
      "xmin progress: 31%\r",
      "xmin progress: 31%\r",
      "xmin progress: 31%\r",
      "xmin progress: 31%\r",
      "xmin progress: 31%\r",
      "xmin progress: 31%\r",
      "xmin progress: 32%\r",
      "xmin progress: 32%\r",
      "xmin progress: 32%\r",
      "xmin progress: 32%\r",
      "xmin progress: 32%\r",
      "xmin progress: 32%\r",
      "xmin progress: 33%\r",
      "xmin progress: 33%\r",
      "xmin progress: 33%\r",
      "xmin progress: 33%\r",
      "xmin progress: 33%\r",
      "xmin progress: 33%\r",
      "xmin progress: 34%\r",
      "xmin progress: 34%\r",
      "xmin progress: 34%\r",
      "xmin progress: 34%\r",
      "xmin progress: 34%\r",
      "xmin progress: 34%\r",
      "xmin progress: 34%\r",
      "xmin progress: 35%\r",
      "xmin progress: 35%\r",
      "xmin progress: 35%\r",
      "xmin progress: 35%\r",
      "xmin progress: 35%\r",
      "xmin progress: 35%\r",
      "xmin progress: 36%\r",
      "xmin progress: 36%\r",
      "xmin progress: 36%\r",
      "xmin progress: 36%\r",
      "xmin progress: 36%\r",
      "xmin progress: 36%\r",
      "xmin progress: 36%\r",
      "xmin progress: 37%\r",
      "xmin progress: 37%\r",
      "xmin progress: 37%\r",
      "xmin progress: 37%\r",
      "xmin progress: 37%\r",
      "xmin progress: 37%\r",
      "xmin progress: 38%\r",
      "xmin progress: 38%\r",
      "xmin progress: 38%\r",
      "xmin progress: 38%\r",
      "xmin progress: 38%\r",
      "xmin progress: 38%\r",
      "xmin progress: 38%\r",
      "xmin progress: 39%\r",
      "xmin progress: 39%\r",
      "xmin progress: 39%\r",
      "xmin progress: 39%\r",
      "xmin progress: 39%\r",
      "xmin progress: 39%\r",
      "xmin progress: 40%\r",
      "xmin progress: 40%\r",
      "xmin progress: 40%\r",
      "xmin progress: 40%\r",
      "xmin progress: 40%\r",
      "xmin progress: 40%\r",
      "xmin progress: 40%\r",
      "xmin progress: 41%\r",
      "xmin progress: 41%\r",
      "xmin progress: 41%\r",
      "xmin progress: 41%\r",
      "xmin progress: 41%\r",
      "xmin progress: 41%\r",
      "xmin progress: 42%\r",
      "xmin progress: 42%\r",
      "xmin progress: 42%\r",
      "xmin progress: 42%\r",
      "xmin progress: 42%\r",
      "xmin progress: 42%\r",
      "xmin progress: 43%\r",
      "xmin progress: 43%\r",
      "xmin progress: 43%\r",
      "xmin progress: 43%\r",
      "xmin progress: 43%\r",
      "xmin progress: 43%\r",
      "xmin progress: 43%\r",
      "xmin progress: 44%\r",
      "xmin progress: 44%\r",
      "xmin progress: 44%\r",
      "xmin progress: 44%\r",
      "xmin progress: 44%\r",
      "xmin progress: 44%\r",
      "xmin progress: 45%\r",
      "xmin progress: 45%\r",
      "xmin progress: 45%\r",
      "xmin progress: 45%\r",
      "xmin progress: 45%\r",
      "xmin progress: 45%\r",
      "xmin progress: 45%\r",
      "xmin progress: 46%\r",
      "xmin progress: 46%\r",
      "xmin progress: 46%\r",
      "xmin progress: 46%\r",
      "xmin progress: 46%\r",
      "xmin progress: 46%\r",
      "xmin progress: 47%\r",
      "xmin progress: 47%\r",
      "xmin progress: 47%\r",
      "xmin progress: 47%\r",
      "xmin progress: 47%\r",
      "xmin progress: 47%\r",
      "xmin progress: 47%\r",
      "xmin progress: 48%\r",
      "xmin progress: 48%\r",
      "xmin progress: 48%\r",
      "xmin progress: 48%\r",
      "xmin progress: 48%\r",
      "xmin progress: 48%\r",
      "xmin progress: 49%\r",
      "xmin progress: 49%\r",
      "xmin progress: 49%\r",
      "xmin progress: 49%\r",
      "xmin progress: 49%\r",
      "xmin progress: 49%\r",
      "xmin progress: 50%\r",
      "xmin progress: 50%\r",
      "xmin progress: 50%\r",
      "xmin progress: 50%\r",
      "xmin progress: 50%\r",
      "xmin progress: 50%\r",
      "xmin progress: 50%\r",
      "xmin progress: 51%\r",
      "xmin progress: 51%\r",
      "xmin progress: 51%\r",
      "xmin progress: 51%\r",
      "xmin progress: 51%\r",
      "xmin progress: 51%\r",
      "xmin progress: 52%\r",
      "xmin progress: 52%\r",
      "xmin progress: 52%\r",
      "xmin progress: 52%\r",
      "xmin progress: 52%\r",
      "xmin progress: 52%\r",
      "xmin progress: 52%\r",
      "xmin progress: 53%\r",
      "xmin progress: 53%\r",
      "xmin progress: 53%\r",
      "xmin progress: 53%\r",
      "xmin progress: 53%\r",
      "xmin progress: 53%\r",
      "xmin progress: 54%\r",
      "xmin progress: 54%\r",
      "xmin progress: 54%\r",
      "xmin progress: 54%\r",
      "xmin progress: 54%\r",
      "xmin progress: 54%\r",
      "xmin progress: 54%\r",
      "xmin progress: 55%\r",
      "xmin progress: 55%\r",
      "xmin progress: 55%\r",
      "xmin progress: 55%\r",
      "xmin progress: 55%\r",
      "xmin progress: 55%\r",
      "xmin progress: 56%\r",
      "xmin progress: 56%\r",
      "xmin progress: 56%\r",
      "xmin progress: 56%\r",
      "xmin progress: 56%\r",
      "xmin progress: 56%\r",
      "xmin progress: 56%\r",
      "xmin progress: 57%\r",
      "xmin progress: 57%\r",
      "xmin progress: 57%\r",
      "xmin progress: 57%\r",
      "xmin progress: 57%\r",
      "xmin progress: 57%\r",
      "xmin progress: 58%\r",
      "xmin progress: 58%\r",
      "xmin progress: 58%\r",
      "xmin progress: 58%\r",
      "xmin progress: 58%\r",
      "xmin progress: 58%\r",
      "xmin progress: 59%\r",
      "xmin progress: 59%\r",
      "xmin progress: 59%\r",
      "xmin progress: 59%\r",
      "xmin progress: 59%\r",
      "xmin progress: 59%\r",
      "xmin progress: 59%\r",
      "xmin progress: 60%\r",
      "xmin progress: 60%\r",
      "xmin progress: 60%\r",
      "xmin progress: 60%\r",
      "xmin progress: 60%\r",
      "xmin progress: 60%\r",
      "xmin progress: 61%\r",
      "xmin progress: 61%\r",
      "xmin progress: 61%\r",
      "xmin progress: 61%\r",
      "xmin progress: 61%\r",
      "xmin progress: 61%\r",
      "xmin progress: 61%\r",
      "xmin progress: 62%\r",
      "xmin progress: 62%\r",
      "xmin progress: 62%\r",
      "xmin progress: 62%\r",
      "xmin progress: 62%\r",
      "xmin progress: 62%\r",
      "xmin progress: 63%\r",
      "xmin progress: 63%\r",
      "xmin progress: 63%\r",
      "xmin progress: 63%\r",
      "xmin progress: 63%\r",
      "xmin progress: 63%\r",
      "xmin progress: 63%\r",
      "xmin progress: 64%\r",
      "xmin progress: 64%\r",
      "xmin progress: 64%\r",
      "xmin progress: 64%\r",
      "xmin progress: 64%\r",
      "xmin progress: 64%\r",
      "xmin progress: 65%\r",
      "xmin progress: 65%\r",
      "xmin progress: 65%\r",
      "xmin progress: 65%\r",
      "xmin progress: 65%\r",
      "xmin progress: 65%\r",
      "xmin progress: 65%\r",
      "xmin progress: 66%\r",
      "xmin progress: 66%\r",
      "xmin progress: 66%\r",
      "xmin progress: 66%\r",
      "xmin progress: 66%\r",
      "xmin progress: 66%\r",
      "xmin progress: 67%\r",
      "xmin progress: 67%\r",
      "xmin progress: 67%\r",
      "xmin progress: 67%\r",
      "xmin progress: 67%\r",
      "xmin progress: 67%\r",
      "xmin progress: 68%\r",
      "xmin progress: 68%\r",
      "xmin progress: 68%\r",
      "xmin progress: 68%\r",
      "xmin progress: 68%\r",
      "xmin progress: 68%\r",
      "xmin progress: 68%\r",
      "xmin progress: 69%\r",
      "xmin progress: 69%\r",
      "xmin progress: 69%\r",
      "xmin progress: 69%\r",
      "xmin progress: 69%\r",
      "xmin progress: 69%\r",
      "xmin progress: 70%\r",
      "xmin progress: 70%\r",
      "xmin progress: 70%\r",
      "xmin progress: 70%\r",
      "xmin progress: 70%\r",
      "xmin progress: 70%\r",
      "xmin progress: 70%\r",
      "xmin progress: 71%\r",
      "xmin progress: 71%\r",
      "xmin progress: 71%\r",
      "xmin progress: 71%\r",
      "xmin progress: 71%\r",
      "xmin progress: 71%\r",
      "xmin progress: 72%\r",
      "xmin progress: 72%\r",
      "xmin progress: 72%\r",
      "xmin progress: 72%\r",
      "xmin progress: 72%\r",
      "xmin progress: 72%\r",
      "xmin progress: 72%\r",
      "xmin progress: 73%\r",
      "xmin progress: 73%\r",
      "xmin progress: 73%\r",
      "xmin progress: 73%\r",
      "xmin progress: 73%\r",
      "xmin progress: 73%\r",
      "xmin progress: 74%\r",
      "xmin progress: 74%\r",
      "xmin progress: 74%\r",
      "xmin progress: 74%\r",
      "xmin progress: 74%\r",
      "xmin progress: 74%\r",
      "xmin progress: 75%\r",
      "xmin progress: 75%\r",
      "xmin progress: 75%\r",
      "xmin progress: 75%\r",
      "xmin progress: 75%\r",
      "xmin progress: 75%\r",
      "xmin progress: 75%\r",
      "xmin progress: 76%\r",
      "xmin progress: 76%\r",
      "xmin progress: 76%\r",
      "xmin progress: 76%\r",
      "xmin progress: 76%\r",
      "xmin progress: 76%\r",
      "xmin progress: 77%\r",
      "xmin progress: 77%\r",
      "xmin progress: 77%\r",
      "xmin progress: 77%\r",
      "xmin progress: 77%\r",
      "xmin progress: 77%\r",
      "xmin progress: 77%\r",
      "xmin progress: 78%\r",
      "xmin progress: 78%\r",
      "xmin progress: 78%\r",
      "xmin progress: 78%\r",
      "xmin progress: 78%\r",
      "xmin progress: 78%\r",
      "xmin progress: 79%\r",
      "xmin progress: 79%\r",
      "xmin progress: 79%\r",
      "xmin progress: 79%\r",
      "xmin progress: 79%\r",
      "xmin progress: 79%\r",
      "xmin progress: 79%\r",
      "xmin progress: 80%\r",
      "xmin progress: 80%\r",
      "xmin progress: 80%\r",
      "xmin progress: 80%\r",
      "xmin progress: 80%\r",
      "xmin progress: 80%\r",
      "xmin progress: 81%\r",
      "xmin progress: 81%\r",
      "xmin progress: 81%\r",
      "xmin progress: 81%\r",
      "xmin progress: 81%\r",
      "xmin progress: 81%\r",
      "xmin progress: 81%\r",
      "xmin progress: 82%\r",
      "xmin progress: 82%\r",
      "xmin progress: 82%\r",
      "xmin progress: 82%\r",
      "xmin progress: 82%\r",
      "xmin progress: 82%\r",
      "xmin progress: 83%\r",
      "xmin progress: 83%\r",
      "xmin progress: 83%\r",
      "xmin progress: 83%\r",
      "xmin progress: 83%\r",
      "xmin progress: 83%\r",
      "xmin progress: 84%\r",
      "xmin progress: 84%\r",
      "xmin progress: 84%\r",
      "xmin progress: 84%\r",
      "xmin progress: 84%\r",
      "xmin progress: 84%\r",
      "xmin progress: 84%\r",
      "xmin progress: 85%\r",
      "xmin progress: 85%\r",
      "xmin progress: 85%\r",
      "xmin progress: 85%\r",
      "xmin progress: 85%\r",
      "xmin progress: 85%\r",
      "xmin progress: 86%\r",
      "xmin progress: 86%\r",
      "xmin progress: 86%\r",
      "xmin progress: 86%\r",
      "xmin progress: 86%\r",
      "xmin progress: 86%\r",
      "xmin progress: 86%\r",
      "xmin progress: 87%\r",
      "xmin progress: 87%\r",
      "xmin progress: 87%\r",
      "xmin progress: 87%\r",
      "xmin progress: 87%\r",
      "xmin progress: 87%\r",
      "xmin progress: 88%\r",
      "xmin progress: 88%\r",
      "xmin progress: 88%\r",
      "xmin progress: 88%\r",
      "xmin progress: 88%\r",
      "xmin progress: 88%\r",
      "xmin progress: 88%\r",
      "xmin progress: 89%\r",
      "xmin progress: 89%\r",
      "xmin progress: 89%\r",
      "xmin progress: 89%\r",
      "xmin progress: 89%\r",
      "xmin progress: 89%\r",
      "xmin progress: 90%\r",
      "xmin progress: 90%\r",
      "xmin progress: 90%\r",
      "xmin progress: 90%\r",
      "xmin progress: 90%\r",
      "xmin progress: 90%\r",
      "xmin progress: 90%\r",
      "xmin progress: 91%\r",
      "xmin progress: 91%\r",
      "xmin progress: 91%\r",
      "xmin progress: 91%\r",
      "xmin progress: 91%\r",
      "xmin progress: 91%\r",
      "xmin progress: 92%\r",
      "xmin progress: 92%\r",
      "xmin progress: 92%\r",
      "xmin progress: 92%\r",
      "xmin progress: 92%\r",
      "xmin progress: 92%\r",
      "xmin progress: 93%\r",
      "xmin progress: 93%\r",
      "xmin progress: 93%\r",
      "xmin progress: 93%\r",
      "xmin progress: 93%\r",
      "xmin progress: 93%\r",
      "xmin progress: 93%\r",
      "xmin progress: 94%\r",
      "xmin progress: 94%\r",
      "xmin progress: 94%\r",
      "xmin progress: 94%\r",
      "xmin progress: 94%\r",
      "xmin progress: 94%\r",
      "xmin progress: 95%\r",
      "xmin progress: 95%\r",
      "xmin progress: 95%\r",
      "xmin progress: 95%\r",
      "xmin progress: 95%\r",
      "xmin progress: 95%\r",
      "xmin progress: 95%\r",
      "xmin progress: 96%\r",
      "xmin progress: 96%\r",
      "xmin progress: 96%\r",
      "xmin progress: 96%\r",
      "xmin progress: 96%\r",
      "xmin progress: 96%\r",
      "xmin progress: 97%\r",
      "xmin progress: 97%\r",
      "xmin progress: 97%\r",
      "xmin progress: 97%\r",
      "xmin progress: 97%\r",
      "xmin progress: 97%\r",
      "xmin progress: 97%\r",
      "xmin progress: 98%\r",
      "xmin progress: 98%\r",
      "xmin progress: 98%\r",
      "xmin progress: 98%\r",
      "xmin progress: 98%\r",
      "xmin progress: 98%\r",
      "xmin progress: 99%\r",
      "xmin progress: 99%\r",
      "xmin progress: 99%\r",
      "xmin progress: 99%\r",
      "xmin progress: 99%\r",
      "xmin progress: 99%\r"
     ]
    },
    {
     "data": {
      "text/plain": [
       "3.0499370131037176"
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# TODO\n",
    "fit = powerlaw.Fit(list(rank_dict.values()))\n",
    "alpha = fit.power_law.alpha\n",
    "alpha\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "pdxcQdRJ818T"
   },
   "source": [
    "#### 2.2  Création d’un modèle sac de mots (10 points)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 2.2.1 Répresentation de texte (5 points)\n",
    "\n",
    "En utilisant sklearn et à partir de vos données pré-traitées (\"_claims_preprocessed_\", \"_titles_preprocessed_\", \"_abstracts_preprocessed_\" et \"_texts_preprocessed_\"), représentez chaque affirmation (_claim_) et document avec le vocabulaire créé 'précédemment dans la variables \"_claims_preprocessed_joined\", \"_titles_preprocessed_joined_\", \"_abstract_preprocessed_joined_\" et \"_texts_preprocessed_joined_\". Cela veut dire que tout jeton qui n'est pas dans le vocabulaire doit être enlevé dans le document et l'affirmation. Faites cela pour les trois possibilités de représentation de document: \"_title_\", \"_abstract_\" et \"_text_\"."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {
    "id": "NKJxoJSwBovJ"
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(['0-dimension biomateri lack induct properti',\n",
       "  '1 5 million uk abnorm prp posit',\n",
       "  '1-1 colorect cancer patient diagnos region distant metastas',\n",
       "  '10 sudden infant death syndrom sid death happen newborn age less 6 month',\n",
       "  '32 liver transplant program requir patient discontinu methadon treatment 2001',\n",
       "  '4-pba treatment decreas endoplasm reticulum stress respons gener endoplasm reticulum stress marker',\n",
       "  '4-pba treatment rais endoplasm reticulum stress respons gener endoplasm reticulum stress marker',\n",
       "  '40mg/day dosag folic acid 2mg/day dosag vitamin b12 affect chronic kidney diseas ckd progress',\n",
       "  \"5'-nucleotidas metabol 6mp\",\n",
       "  '50 patient expos radiat activ marker mesenchym stem cell',\n",
       "  '53 perinat mortal due low birth weight',\n",
       "  '61 colorect cancer patient diagnos region distant metastas',\n",
       "  '7-day-old adult caenorhabd elegan exhibit approxim 5 learn capac seen 1-day old adult',\n",
       "  '7-day-old adult caenorhabd elegan exhibit approxim 75 learn capac seen 1-day old adult',\n",
       "  '70 burn patient admit hospit treatment appear hospit emerg ward outpati clinic',\n",
       "  '76-85 peopl sever mental disord receiv treatment low middl incom countri',\n",
       "  '90 patient melanoma object respons pd-1 blockad experi progress melanoma',\n",
       "  '90 sudden infant death syndrom sid death happen newborn age less 6 month',\n",
       "  '100g dose chloroquin chemoprophylact regimen result retin toxic 1 year weekli intak',\n",
       "  '100g dose chloroquin chemoprophylact regimen result retin toxic 5-6 year weekli intak',\n",
       "  'helper 2 cell th2 environ imped diseas develop patient system lupu erythematosu sle',\n",
       "  \"breast cancer patient 's capac metabol tamoxifen influenc treatment outcom\",\n",
       "  \"countri 's vaccin allianc gavi elig indictiv acceler adopt hub vaccin\",\n",
       "  'defici folat increas blood level homocystein',\n",
       "  'defici vitamin b12 decreas blood level homocystein',\n",
       "  'defici vitamin b6 decreas blood level homocystein',\n",
       "  'diminish ovarian reserv sole indic infertil priori non-infertil popul',\n",
       "  'diminish ovarian reserv strong indic infertil even priori non-infertil popul',\n",
       "  'high microerythrocyt count protect sever anemia homozyg alpha thalassemia trait subject',\n",
       "  'low percentag hematopoiet progenitor cell suscept hiv-1 infect ex vivo',\n",
       "  'mutat hnf4a lead increas risk develop diabet age 14 year',\n",
       "  'mutat hnf4a lead increas risk diabet age 14 year',\n",
       "  'singl nucleotid variant gene dgkk strongli associ increas risk hypospadia',\n",
       "  'strong bia phage genom locat spacer deriv observ mani crispr subtyp confer immun phage',\n",
       "  'aldh1 express associ poorer prognosi breast cancer primari tumor',\n",
       "  'amp-activ protein kinas ampk activ reduc inflammation-rel fibrosi lung',\n",
       "  'apoe4 express ipsc-deriv neuron result decreas tau phosphoryl',\n",
       "  'art effect infect hiv-posit peopl',\n",
       "  'art substanti reduc infect hiv-posit peopl',\n",
       "  'atf4 gener endoplasm reticulum stress marker',\n",
       "  'atm rad3 relat protein critic sens dna damag',\n",
       "  'atm rad3 relat protein role sens dna damag',\n",
       "  'azt given ribavirin increas anemia',\n",
       "  'activ cdk5 phosphoryl atm protein respons dna damag',\n",
       "  'activ cdk5 regul dna damage-induc neuron death',\n",
       "  'activ ppm1d enhanc p53 function',\n",
       "  'activ rac1 homolog ced-10 kill viabl cell srgp-1 mutant caenorhabd elegan',\n",
       "  'activator-inhibitor pair provid ventral xrl-sizzl',\n",
       "  'activ h. pylori ureas polymer structur consist five distinct subunit',\n",
       "  'activ ly49q induc neutrophil polar',\n",
       "  'activ ly49q prevent neutrophil polar',\n",
       "  'activ caspase-11 particip regul phagosome-lysosom fusion',\n",
       "  'activ caspase-11 protein promot pyroptosi',\n",
       "  'acut ablat kra caus sever growth impair',\n",
       "  'acut ablat snail embryon cortex affect prolifer number embryon cortic precursor',\n",
       "  'addit bmp4 activin chir99021 su504 reprogram fibroblast gener expand maintain cardiovascular progenitor cell cpc',\n",
       "  'adult tissue-resid macrophag seed birth',\n",
       "  'adult tissue-resid macrophag seed birth',\n",
       "  'adult tissue-resid macrophag possess self-renew capac',\n",
       "  'adult tissue-resid macrophag stem embryon yolk sac fetal liver',\n",
       "  'adult tissue-resid macrophag stem embryon yolk sac fetal liver',\n",
       "  'age patient less suscept ischaemia/reperfus injuri',\n",
       "  'age patient suscept ischaemia/reperfus injuri',\n",
       "  'aggrav inflamm depend nlrp3 inflammasom activ',\n",
       "  'albendazol use treat soil-transmit helminth',\n",
       "  'algerian physician constitu largest compon sub-saharan africa-train physician unit state',\n",
       "  'alirocumab treatment reduc apo fraction clearanc rate',\n",
       "  'allogen mechan circulatori support effect autolog mechan circulatori support treat acut myocardi infarct',\n",
       "  'alter origin fire caus chang termin zone okazaki fragment',\n",
       "  'ambulatori blood pressur monitor inaccur diagnos hypertens',\n",
       "  'amitriptylin effect treatment chronic tension-typ headach',\n",
       "  'm2-like phenotyp brown adipos tissu macrophag quickli induc cold exposur',\n",
       "  'androgenet haploid mous embryon stem cell esc deriv genet manipul vitro',\n",
       "  'angiotensin convert enzym inhibitor associ decreas risk function renal insuffici',\n",
       "  'anthrax spore difficult dispos dispers',\n",
       "  'anthrax spore remain deadli affect area decontamin',\n",
       "  'antidepress increas sever migrain',\n",
       "  'antidepress reduc sever migrain',\n",
       "  'antimicrobi agent less effect due pressur antimicrobi usag',\n",
       "  'antimicrobi agent effect due pressur antimicrobi usag',\n",
       "  'antiretrovir therapi increas rate tuberculosi across broad rang cd4 strata',\n",
       "  'approxim 250,000 peopl infect human t-cell lymphotrop viru type 1 unit kingdom',\n",
       "  'assess treatment adher benefici clinic practic measur routin outcom',\n",
       "  'asymptomat visual impair screen elderli popul lead improv vision',\n",
       "  'least 85 patient expos radiat activ marker myofibroblast',\n",
       "  'autolog transplant mesenchym stem cell better graft function induct therapi anti-interleukin-2 receptor antibodi',\n",
       "  'autophagi defici liver increas vulner insulin resist',\n",
       "  'b cell go though plasmablast differenti antibodi product continu express ebi2',\n",
       "  'b3-galectin decreas cell resist tyrosin kinas inhibitor tki engag altern kras-ralb signal complex downstream egfr',\n",
       "  'b3-galectin increas cell resist tyrosin kinas inhibitor tki engag altern kras-ralb signal complex downstream egfr',\n",
       "  'bcl-2 activ antagon apoptot effect c-myc',\n",
       "  'bcl-2 promot apoptot effect c-myc',\n",
       "  'blm gene encod recq-class dna helicas',\n",
       "  'brca 1 mutat carrier risk breast ovarian cancer depend mutat locat',\n",
       "  'bacteri mening diagnos basi posit cerebrospin fluid csf cultur',\n",
       "  'bacteriophaga ms2 qβ member levivirida',\n",
       "  'bariatr surgeri increas rate colorect cancer',\n",
       "  'bariatr surgeri increas rate postmenopaus breast cancer',\n",
       "  'bariatr surgeri lead neg outcom mental health',\n",
       "  'bariatr surgeri lead posit outcom mental health',\n",
       "  'bariatr surgeri reduc colorect cancer',\n",
       "  'bariatr surgeri reduc postmenopaus breast cancer',\n",
       "  'basophil promot diseas develop patient system lupu erythematosu sle',\n",
       "  'bcp1 chaperon rpl23',\n",
       "  'beta-band coher diminish visibl stimuli invis stimuli',\n",
       "  'beta-band coher enhanc visibl stimuli invis stimuli',\n",
       "  'bip gener endoplasm reticulum stress marker',\n",
       "  'bind p53 enhanc region p53ber regul activ p53 transcript cell cycl arrest product p53-depend erna',\n",
       "  'birth-weight neg associ breast cancer',\n",
       "  'block interact tdp-43 respiratori complex protein nd3 nd6 prevent tdp-43-induc neuron loss',\n",
       "  'bone marrow bm transplant use treat acut myeloid leukemia aml',\n",
       "  \"bone marrow cell n't contribut adult macrophag compart\",\n",
       "  'british femal student bulli british male student',\n",
       "  'british male student bulli british femal student',\n",
       "  'broadli hiv-1 neutral antibodi bnab 10eb affin phospholipid',\n",
       "  'c2 work synergist a-769662 activ dephosphoryl ampk',\n",
       "  'ccl19 ligand ccr7',\n",
       "  'ccl19 predominantli present within dln',\n",
       "  'cd28 initi tonic signal convent cell caus exhaust phenotyp limit effici',\n",
       "  'cd28 signal regul traffick murin auto-react cell target tissu',\n",
       "  'cd44v6 associ constitut reprogram cancer stem cell drive cancer metastasi',\n",
       "  'cdk6 show impair bind loss-of-funct variant p18 ink4c',\n",
       "  'cdk6 show improv bind loss-of-funct variant p18 ink4c',\n",
       "  'chop gener endoplasm reticulum stress marker',\n",
       "  'copi coatmer involv lipid homeostasi',\n",
       "  'copi coatmer involv viral replic',\n",
       "  'crp posit correl postop mortal follow coronari arteri bypass graft cabg surgeri',\n",
       "  'ca2+ cycl control whole-bodi energi homeostasi beig fat',\n",
       "  'ca2+ cycl ucp1-depend thermogen mechan',\n",
       "  'ca2+ cycl ucp1-independ thermogen mechan',\n",
       "  'cancer cell stimul accumul intra-tumour myeloid-deriv suppressor cell promot granulocyt coloni stimul factor product',\n",
       "  'cancer-associ fibroblast caf constitu tumor microenviron',\n",
       "  'cancer-associ fibroblast caf known interact cancer cell format activ caf',\n",
       "  'cancer-associ fibroblast caf interact cancer cell mediat format activ caf',\n",
       "  'cancer initi benefit epiderm growth factor receptor target therapi later becom refractori sever mechan',\n",
       "  'cardiac tissue-resid macrophag directli contribut electr activ',\n",
       "  'carrier hnf4a mutat reduc risk diabet',\n",
       "  'cell autonom sex determin somat cell occur galliform',\n",
       "  'cellular clock associ mitosi time nih 3t3 cell',\n",
       "  'cellular clock predict mitosi time nih 3t3 cell',\n",
       "  'cellular differenti embryon stem cell accompani chang replic time transcript nuclear local',\n",
       "  'certain immunomodulator-human dialyz leukocyt extract hdle peptid recogn toll-lik receptor tlr macrophag dendrit cell',\n",
       "  'charcoal effect treatment acut paraquat poison',\n",
       "  'charcoal show benefit acut paraquat poison',\n",
       "  'chemic injuri repress transglutaminas 2 activ',\n",
       "  'chenodeoxychol acid treatment decreas brown adipos tissu activ',\n",
       "  'chenodeoxychol acid treatment increas brown adipos tissu activ',\n",
       "  'chines individu tt homozygos mthfr gene less vulner stroke caus low level folat intak',\n",
       "  'chines individu tt homozygos mthfr gene vulner stroke caus low level folat intak',\n",
       "  'chlamydia trachomati preval uk among individu 50 60',\n",
       "  'chlamydia trachomati preval uk among sexually-experienc individu age 16 24',\n",
       "  'cholesterol load induc klf4 express vsmc result express pro-inflammatori cytokin',\n",
       "  'chronic hiv stimul b cell lead prematur exhaust b cell',\n",
       "  'cis-act lncrna control express gene posit vicin transcript site',\n",
       "  'citrullin protein extern neutrophil extracellular trap act indirectli disrupt inflammatori cycl',\n",
       "  'citrullin protein extern neutrophil extracellular trap act indirectli perpetu inflammatori cycl via induct autoantibodi',\n",
       "  'clathrin stabil spindl fiber apparatu mitosi',\n",
       "  'cnn1 recruit vari cell cycl time',\n",
       "  'cognit behavior therapi ineffect treatment insomnia',\n",
       "  'combin nicotin replac therapi vareniclin bupropion effect 12 week reatment compar vareniclin monotherapi',\n",
       "  'commelina yellow mottl viru comymv three typic badnaviru orf capabl encod protein 23 15 216 kd',\n",
       "  'commelina yellow mottl viru comymv genom consist 2140 bais pair',\n",
       "  'compar transcriptom analysi identifi new platelet protein structur featur suggest role platelet function',\n",
       "  'concentr snv cnv stem-cel regulatori element bind site transcript factor ipsc-lin distinct found cell',\n",
       "  'consumpt whole fruit increas risk type 2 diabet',\n",
       "  'continu hhv-8 transmiss among msm san francisco may explain urogenit contact',\n",
       "  'convert apoe4 apoe3 gene edit prevent patholog associ apoe4 human ipscderiv neuron',\n",
       "  'convert apoe4 apoe3 gene edit worsen patholog associ apoe4 human ipscderiv neuron',\n",
       "  'cost effect evalu base crct data accur reflect price patient actual clinic practic',\n",
       "  'cost effect evalu base crct data lack extern valid',\n",
       "  'crossov hot spot found within gene promot saccharomyc cerevisia',\n",
       "  'cyclin a2 destruct necessari switch unstabl stabl kt-mt attach mitosi',\n",
       "  'cytochrom c transfer cytosol mitochondri intermembran space apoptosi',\n",
       "  'cytosol protein bind iron-respons element mrna code tfrc1',\n",
       "  'dms3 protein enabl pol v transcript vivo',\n",
       "  'drd1 protein enabl pol v transcript vivo',\n",
       "  'dusp4 decreas apoptosi',\n",
       "  'dusp4 downregul deactiv ras-erk pathway',\n",
       "  'dusp4 increas apoptosi',\n",
       "  'de novo assembl sequenc data fewer specif contig unassembl sequenc data',\n",
       "  'de novo assembl sequenc data shorter contig unassembl sequenc data',\n",
       "  'decreas p62 prostat tumor stroma result defect autophagi',\n",
       "  'decreas convers pge 2 ppari ligand 15-ket-pg 2 caus accumul pge',\n",
       "  'decreas diastol blood pressur dbp associ abdomin aortic aneurysm',\n",
       "  'delet raptor increas g-csf level',\n",
       "  'delet atm rad3 relat protein predict acut tissu loss',\n",
       "  'delet atm rad3 relat protein lead acut tissu loss',\n",
       "  'deltex known interact eif3f',\n",
       "  'deltex interact eif3 known interact deltex elf3',\n",
       "  'deplet t-helper 17 th17 cell simian immunodefici viru siv infect decreas dissemin salmonella typhimurium gut',\n",
       "  'deplet t-helper 17 th17 cell simian immunodefici viru siv infect increas dissemin salmonella typhimurium gut',\n",
       "  'deplet nitric oxid respons vasospasm',\n",
       "  'deregul hand2 crucial step endometri carcinogenesi mice',\n",
       "  'destin contain port throughput cpt neg relat dengu viru denv-1 diffus air traffic shipment',\n",
       "  'destin contain port throughput cpt posit relat dengu viru denv-1 diffus air traffic shipment',\n",
       "  'dexamethason increas risk postop bleed',\n",
       "  'diabet remiss occur less peopl treat convent therapi peopl treat laparoscop adjust gastric band surgeri',\n",
       "  'diabet remiss occur peopl treat convent therapi peopl treat laparoscop adjust gastric band surgeri',\n",
       "  'diabet patient acut coronari syndrom experi decreas short-term long-term risk bleed event',\n",
       "  'differenti e2f-1 -2 -3 tko cell intestin exhibit apoptosi',\n",
       "  'differenti progenitor cell myeloid cell skew upon activ insulin signal',\n",
       "  'differenti progenitor cell myeloid cell skew insulin signal suppress',\n",
       "  'diminish ovarian reserv reliabl indic infertil non-infertil popul',\n",
       "  'distant cre import transcript regul',\n",
       "  'distant cre less conserv among speci',\n",
       "  'drosophila supracellular actomyosin structur found boundari wing imagin disc',\n",
       "  'dscam1 act hypervari pattern-recognit receptor immun system',\n",
       "  'non-homolog end join ligat step toler disrepair distort join 3 strand break compar 5 strand break',\n",
       "  'non-homolog end join ligat step toler disrepair distort join 5 strand break compar 3 strand break',\n",
       "  'primari earli antibodi respons activ b cell migrat toward inner-and outer follicular area oxysterol accumul gener stromal cell',\n",
       "  'eg7 tumor kill system oxaliplatin prime cd8+ cell tumor-drain lymph node cell',\n",
       "  'egr2 import myelin peripher nervou system',\n",
       "  'er-loc phosphatas sac1 process pi4p coordin osbp endosome-loc protein sort nexin 2',\n",
       "  'erap1 snp epistat hla allel ankylos spondyl',\n",
       "  'earli patent ductu ateriosu pda screen decreas in-hospit mortal',\n",
       "  'earli patent ductu ateriosu pda screen increas in-hospit mortal',\n",
       "  'ectop express sall4 nanog esrrb lin28 gener induc pluripot stem cell mous embryon fibroblast effici factor combin',\n",
       "  'egr2 regul homeostasi b cell',\n",
       "  'egr3 regul homeostasi b cell',\n",
       "  'eilat viru eilv produc mosquito elicit rapid long-last neutral antibodi nonhuman primat',\n",
       "  'elev cell-fre mitochondri dna level associ mortal',\n",
       "  'elimin last sporad case malaria requir consider fund',\n",
       "  'emodin form hydrogen bond residu involv pgam1 substrat bind',\n",
       "  'energi balanc requir hypothalam glutam neurotransmiss',\n",
       "  'enhanc earli product inflammatori chemokin damag viral control lung',\n",
       "  'environment factor influenc develop breast cancer',\n",
       "  'environmentally-induc senesc mimick diseas model ad specif molecul cultur system',\n",
       "  'epidemiolog diseas burden noncommunic diseas preval high econom set',\n",
       "  'ethanol stress increas express ibp bacteria',\n",
       "  'ethanol stress increas express psp bacteria',\n",
       "  'ethanol stress increas express srl bacteria',\n",
       "  'ethanol stress lower express psp bacteria',\n",
       "  'ethanol stress reduc express srl bacteria',\n",
       "  'excess gestat weight gain associ obesity-rel pregnanc outcom',\n",
       "  'exercis increas cancer mortal rate among chines citizen',\n",
       "  'exercis reduc cancer mortal rate among chines citizen',\n",
       "  'exhaust b cell contribut poor ab respons hiv-infect individu',\n",
       "  'exposur fine particul air pollut unrel anxieti preval',\n",
       "  'express msx2 induc 3 hour addit bmp4 earlier cdx2',\n",
       "  'express oncolyt viru antigen peptid make relaps like',\n",
       "  'express oncolyt viru antigen peptid permit addit protect relaps',\n",
       "  'f4/80+ macrophag regul matur osteoblast mainten',\n",
       "  'fact histon chaperon compens histon 2a h2a -histon 2b h2b dimer evict histon exchang process',\n",
       "  'femal carrier apolipoprotein e4 apoe4 allel decreas risk dementia',\n",
       "  \"femal carrier apolipoprotein e4 apoe4 allel increas risk alzheim 's diseas\",\n",
       "  'femal carrier apolipoprotein e4 apoe4 allel longer lifetim exposur estrogen due increas reproduct period',\n",
       "  'femal carrier apolipoprotein e4 apoe4 allel shorter lifetim exposur estrogen due decreas reproduct period',\n",
       "  'fibroblast growth factor ligand signal receptor tyrosin kinas',\n",
       "  'fibroblast growth factor 21 protect atherosclerosi modul adiponectin srebp2 level',\n",
       "  'flexibl molecul experi less steric hindranc tumor microenviro rigid molecul',\n",
       "  'folat vitamin b12 level influenc associ homocystein preeclampsia',\n",
       "  'everi 1,000 children cerebr palsi 300 prematur underweight birth',\n",
       "  'forkhead 0 fox0 transcript factor involv apoptosi',\n",
       "  'forkhead 0 fox0 transcript factor involv cellular differenti',\n",
       "  'format n-termin pyroglutam glutamin cyclas gc compet ntaq1 nt-gln substrat',\n",
       "  'foxo3a activ neuron death inhibit reactiv oxygen speci ro',\n",
       "  'foxk2 regul autophagi gene muscl cell fibroblast cell',\n",
       "  'foxp3 enabl express transcript regul implic memori cell develop',\n",
       "  'foxp3 repress express transcript regul implic memori cell develop',\n",
       "  'g-csf increas expans infiltr mdsc tumor',\n",
       "  'gata3 regul cell cycl progress bone marrow hematopoiet stem cell',\n",
       "  'gata3 regul self-renew capac bone marrow hematopoiet stem cell',\n",
       "  'gastric infect helicobact pylori decreas risk gastric cancer human',\n",
       "  'gastric infect helicobact pylori increas risk gastric cancer human',\n",
       "  'gastric lavag effect treatment acut paraquat poison',\n",
       "  'gener exercis therapi effect rotat cuff exercis reduc pain improv function shoulder',\n",
       "  'gener exercis therapi effect scapular stabil exercis reduc pain improv function shoulder',\n",
       "  'gene involv pre-mrna splice signific impact genom stabil',\n",
       "  'gene regul esrrb transcript factor sensit mbd3 function',\n",
       "  'genet defici mast cell lead decreas weight gain mous model diet-induc obes',\n",
       "  'genet delet jam-a increas gut permeabl',\n",
       "  'genom aberr metastas provid inform target therapi',\n",
       "  \"genom sequenc involv altern splice respons hutchinson-gilford progeria syndrom hgp abund `` progerinonli '' allel lmna knock-in model\",\n",
       "  'glial calcium wave influenc seizur',\n",
       "  'glioblastoma multiform gbm character extens invas rapid growth necrosi angiogenesi',\n",
       "  'glucos restrict 0.05 reduc rl replic life span 20-40 s. cerevisia',\n",
       "  'glycan adapt involv insertion-delet event',\n",
       "  'glycan adapt rare observ b-cell repertoir',\n",
       "  'gpr124 increas bbb breakdown mous model ischem stroke',\n",
       "  'gpr124 suppress bbb breakdown mous model ischem stroke',\n",
       "  'guanin nucleotid dissoci inhibitor rho-gdi interact p75 ntr death domain',\n",
       "  'guanin nucleotid exchang factor gef mediat rhoa activ respons tension forc fibronectin-bind integrin',\n",
       "  'h.pylori-medi gastric cancer occur due accumul mutat host epitheli cell',\n",
       "  'h4 g94p protein induc chromatin assembl increas free histon',\n",
       "  'h4 g94p protein induc degrad free histon via rad53-depend mechan',\n",
       "  'h4 g94p protein inhibit chromatin assembl decreas free histon',\n",
       "  'h4 g94p protein suppress degrad free histon via rad53-depend mechan',\n",
       "  'hand2 methyl key step earli endometri carcinogenesi',\n",
       "  'hiv trans-activ protein tat effect transport larg small molecul across cellular membran larger popul neuron',\n",
       "  'hnf4a mutat associ macrosomia infanc',\n",
       "  'hoxb4 facilit hsc expans co-cultur hsc',\n",
       "  'hoxb4 highli express compon cellular secretom fetal liver cell popul',\n",
       "  'hsct-t dosag may diagnost onset symptom occur less 3 hour ami',\n",
       "  'main partner improv hiv outcom',\n",
       "  'main partner worsen hiv outcom',\n",
       "  'hba1c consist overestim glycem control black individu sickl cell trait sct',\n",
       "  'headach correl cognit impair',\n",
       "  'healthi volunt exhibit rapid transient increas cellular atp bolus-inject fructos',\n",
       "  'helicobact pylori-induc aberr nf-kb-depend express activation-induc cytidin deaminas contribut mutagenesi host dna',\n",
       "  'helminth interfer immun system control coinfect microbi pathogen 16',\n",
       "  'hematopoiet stem cell purif reach puriti rate 90',\n",
       "  'high level crp lead higher risk exacerb chronic obstruct pulmonari diseas copd',\n",
       "  'higher plasma level i-carnitin associ trimethylamin n-oxid neg correl cardiovascular event human',\n",
       "  'higher plasma level i-carnitin associ trimethylamin n-oxid posit correl cardiovascular event human',\n",
       "  'homozyg delet murin sbd gene osterix-express mesenchym stem progenitor cell mpc induc oxid stress',\n",
       "  'human embryon stem cell give rise cell type three embryon germ layer',\n",
       "  'human embryon stem cell give rise cell type outer embryon germ layer two layer',\n",
       "  'human embryon stem cell capac give rise differenti progeni repres three embryon germ layer',\n",
       "  'hypocretin neuron suppress panicpron state rat',\n",
       "  'hypothalam glutam neurotransmiss unrel energi balanc',\n",
       "  'ifi16 imped sting phosphoryl transloc result reduc activ sting',\n",
       "  'ifit1 speed viral replic allow prolifer mis-cap viral rna',\n",
       "  'il-10 product monocyt inhibit cd4 cell respons',\n",
       "  'il-6 signal play major role atherosclerot cardiovascular diseas',\n",
       "  'itam phosphoryl allow transfer cell receptor tcr signal echo-domain cytoplasm tail cell receptor tcr',\n",
       "  'iga plasma cell specif transglutaminas 2 scarc duoden mucosa celiac diseas patient diseas activ',\n",
       "  'immun complex trigger cell death lead extracellular releas nuclear dna',\n",
       "  'immun complex trigger cell death lead sequestr oxid mitochondri dna',\n",
       "  'immun respons immun cell geograph segreg',\n",
       "  'improv oer catalyst show stabl activ sever hundr hour',\n",
       "  'british men haplogroup decreas risk cardiovascular diseas',\n",
       "  'british men haplogroup increas risk cardiovascular diseas 50',\n",
       "  's. cerevisia absenc rna surveil pathway caus sensit high iron condit',\n",
       "  's. cerevisia absenc rna surveil pathway reduc sensit high iron condit',\n",
       "  'naiv state block wingless-int-1 secret mous embryon stem cell inhibit self-renew mous embryon stem cell',\n",
       "  'breast cancer loss myoepitheli cell promot transit ductal carcinoma situ invas carcinoma',\n",
       "  'breast cancer loss myoepitheli cell slow transit ductal carcinoma situ invas carcinoma',\n",
       "  'chronic viral infect tumor peptid select inhibit ptpr util boost insuffici activ pdc',\n",
       "  'domest popul saccharomyc cerevisia segment aneuploidi common',\n",
       "  'domest popul saccharomyc cerevisia segment aneuploidi occur infrequ',\n",
       "  'melanoma anti-ctla-4 treatment reinvigor exhaust pd-1+eomes+cd8 cell',\n",
       "  'patient congenit heart defect β-blocker significantli improv clinic heart failur outcom',\n",
       "  'pediatr tissu cell naiv cell emigr thymu',\n",
       "  'rhesu macaqu daili subcutan inject emtricitabin ineffect protect rectal transmit simian-human immunodefici viru',\n",
       "  'rhesu macaqu daili subcutan inject tenofovir protect rectal transmit simian-human immunodefici viru',\n",
       "  'uk drown affect boy girl equal',\n",
       "  'transgen mice harbor green floresc protein control sox2 promot 50 percent cell green floresc coloc cell prolifer marker',\n",
       "  'young middle-ag adult current remot use adhd medic increas risk seriou cardiovascular event',\n",
       "  'incid 10/66 dementia higher incid dsm-iv dementia',\n",
       "  'incid 10/66 dementia lower incid dsm-iv dementia',\n",
       "  'incid heart failur increas 10 women sinc 1979',\n",
       "  'incid sepsi fallen substanti 2009 2014',\n",
       "  'includ pharmacist round team alter incid advers drug event ade',\n",
       "  'includ pharmacist round team reduc incid advers drug event ade',\n",
       "  'increas p62 prostat tumor stroma result defect autophagi',\n",
       "  'increas ldl receptor play role reduct plasma lp',\n",
       "  'increas convers pge 2 ppari ligand 15-ket-pg 2 caus accumul pge',\n",
       "  'increas diastol blood pressur dbp associ abdomin aortic aneurysm',\n",
       "  'increas flux microbi product provok immun respons',\n",
       "  'increas flux microbi product suppress immun respons',\n",
       "  'increas lipolysi lead higher p38 phosphoryl adipos tissu',\n",
       "  'increas microtubul acetyl exacerb lrrk2 roc-cor domain mutat induc locomotor deficit',\n",
       "  'increas microtubul acetyl repair interfer axon transport caus lrrk2 roc-cor domain mutat',\n",
       "  'increas microtubul acetyl worsen interfer axon transport caus lrrk2 roc-cor domain mutat',\n",
       "  'increas mobil retrotransposon lead mutat higher tumorigenesi rate',\n",
       "  'increas mobil retrotransposon assosci mutat higher tumorigenesi rate',\n",
       "  'increas puriti cytoplasm membran isol overexpressor indic stronger spot ompf 2d bn-page gel',\n",
       "  'increas vessel densiti along reduct fibrosi improv efficaci chemotherapi treatment',\n",
       "  'individu alzheim particip six month physic activ improv cognit function 18 month',\n",
       "  'individu low serum vitamin concentr decreas risk multipl sclerosi',\n",
       "  'induc hepat stem cell possess potenti differenti cholangiocyt cell',\n",
       "  'induc hepat stem cell possess potenti differenti hepatocyt cell',\n",
       "  'induct urokinas receptor signal podocyt caus foot process effac proteinuria',\n",
       "  'inhibit hdac6 increas surviv mice arid1a mutat tumor',\n",
       "  'inhibit focal adhes format enabl cell convert mechan strain eventu scar',\n",
       "  'inhibit focal adhes format increas rate cell convert mechan strain inflamm fibrosi',\n",
       "  'inhibit glucose-6-phosp dehydrogenas improv lipogenesi deactiv lkb1-ampk signal',\n",
       "  'input mental physic health care profession effect decreas homeless',\n",
       "  'insid bodi falciparum parasit reproduc asexu',\n",
       "  'insulin decreas risk sever kidney failur',\n",
       "  'insulin effect appetit via ventral tegment neuron',\n",
       "  'intak folic acid fa vitamin b6 vb6 increas level homocystein',\n",
       "  'intak folic acid fa vitamin b6 vb6 reduc level homocystein',\n",
       "  'integr care ineffect tackl multipl comorbid',\n",
       "  'integr care success tackl multipl comorbid',\n",
       "  'integr classroom-bas collabor learn web-bas collabor learn offer best class perform',\n",
       "  'interferon stimul gene isg irf1 irg1 ifi27 rsad2 encourag west nile viru replic cortic neuron',\n",
       "  'interferon stimul gene isg irf1 irg1 ifi27 rsad2 inhibit west nile viru replic cortic neuron',\n",
       "  'interleukin-18 play import role pathogenesi atherosclerosi',\n",
       "  'intra-cerebroventricular infus amyloid-β oligom increas express fibronectin type-iii domain-contain protein 5 mrna mice hippocampi',\n",
       "  'intra-cerebroventricular infus amyloid-β oligom reduc express fibronectin type-iii domain-contain protein 5 mrna mice hippocampi',\n",
       "  'intramembran cleavag signal peptid peptidas aid degrad protein complex membran orient',\n",
       "  'proven moder consumpt candi chocol reduc risk cardiovascular diseas cvd specif',\n",
       "  'jmjd6 catalyz hydroxyl c-termin lysin supress transcript activ',\n",
       "  'jmjd6 slow hydroxyl c-termin lysin',\n",
       "  'klf4 necessari vsmc gain genet characterist cell type within atherosclerot lesion',\n",
       "  'krt17 modul express transcript regul air diseas epithelia',\n",
       "  'kir7.1 modul channel activ g protein-coupl melanocortin-4 receptor mc4r paraventricular nucleu hypothalamu',\n",
       "  'klf2 import proper myeloid cell function',\n",
       "  'klf4 import proper myeloid cell differenti',\n",
       "  'klf4 requir proper myeloid cell differenti',\n",
       "  'knockout proxim tubule-specif delet bmp receptor alk3 caus epitheli damag',\n",
       "  'knockout proxim tubule-specif delet bmp receptor alk3 caus fibrosi',\n",
       "  'l3mbtl2 bind h2ak119ub mark chromatin form prc1 complex',\n",
       "  'ldl cholesterol causal role develop cardiovascular diseas',\n",
       "  'lrba prevent ctla 4 recycl',\n",
       "  'lrba promot ctla 4 recycl',\n",
       "  'lsd1-posit promot associ rna polymeras ii',\n",
       "  'lack fgf21 mice increas life expect',\n",
       "  'lack fgf21 mice lead atherosclerot plaqu format',\n",
       "  'lack fgf21 mice lead reduc lifespan',\n",
       "  'lack fgf21 mice slow rate atherosclerot plaqu format',\n",
       "  'lamin associ nuclear membran structur mainten',\n",
       "  'lamin found within inner layer mitochondri membran cell',\n",
       "  'lamin found within inner layer nuclear membran cell',\n",
       "  'lamin effect nuclear membran structur mainten',\n",
       "  'less 10 patient expos radiat activ marker mesenchym stem cell',\n",
       "  'lice attenu siv vaccin induc stronger antigen-specif cell respons lymph node cell',\n",
       "  'lipopolysaccharid inflamm independ effect kidney barrier function',\n",
       "  'lmna knock-in model appropri test therapeut approach hutchinson-gilford progeria syndrom hgp',\n",
       "  'local pin1 root arabidopsi requir vps9a',\n",
       "  'long rang chromatin interact regul transcript',\n",
       "  'long chain polyunsatur fatti acid supplement signific effect wheez asthma 3 6 year',\n",
       "  'long chain polyunsatur fatti acid supplement associ lower rate atop eczema 1 year',\n",
       "  'long chain polyunsatur fatti acid supplement reduc wheez asthma',\n",
       "  'low express mir7a repress target gene exert biolog function ovari',\n",
       "  'low express mir7a repress target gene exert biolog function testi',\n",
       "  'low nucleosom occup correl high methyl level across speci',\n",
       "  'ly49q direct organ neutrophil polar regul membran raft function',\n",
       "  'ly6c hi monocyt higher inflammatori capac ly6c lo monocyt',\n",
       "  'lysin histon demethylas inhibitor jib 04 inact kdm5a',\n",
       "  'm. stadtmana induc asc speck format blaer1 monocyt',\n",
       "  'm. stadtmana induc asc speck format blaer1 monocyt',\n",
       "  'mek inhibitor effect treatment ras-driven mous model cancer',\n",
       "  'mfge8 regul fat absorpt bind av-beta3 av-beta5 integrin',\n",
       "  'mical redox enzym regul actin dynam mani cell type',\n",
       "  'mical redox enzym regul actin dynam',\n",
       "  'mt bind domain drive amyloid structur format',\n",
       "  'muc1-c activ nf-κb p65 signal pathway interact iκb kinas ß',\n",
       "  'mafa phosphoryl decreas ubiquitin',\n",
       "  'mafa phosphoryl enhanc ubiquitin',\n",
       "  'mafa ubiquitin decreas recruit coavtiv p/caf mafa',\n",
       "  'mafa ubiquitin increas recruit coavtiv p/caf mafa',\n",
       "  'major antigen-induc signal cell receptor secondari signal costimulatori receptor requir cell activ',\n",
       "  'major vault protein mvp lead aggress tumor regul sort tumor suppress mir-193a extracellular vesicl ev',\n",
       "  'major vault protein regul sort tumor suppress mir-193a ev',\n",
       "  'malaria high vectori capac',\n",
       "  'mani cytokin produc cancer cell also contribut carcinogenesi',\n",
       "  'mani transmembran receptor transmit signal long-rang conform chang associ alpha-helic across plasma membran',\n",
       "  \"marmoset brain region homolog broca 's area\",\n",
       "  'mathemat model predict use artemisinin-bas combin therapi nongametocytocid drug modest impact reduc malaria transmiss',\n",
       "  'mecp2 influenc synapt matur neuron',\n",
       "  'measur routin outcom benefici clinic practic assess treatment adher',\n",
       "  'medic treat obes highli effect',\n",
       "  'medic treat obes side effect',\n",
       "  'medic treat obes unwant side effect',\n",
       "  'men suscept death due pneumonia compar women',\n",
       "  'metastat colorect cancer treat singl agent fluoropyrimidin result similar efficaci better qualiti life compar oxaliplatin-bas chemotherapi elderli patient',\n",
       "  'mice incap produc neutral antibodi repons chikungunya viru chikv produc mosquito',\n",
       "  'mice defect deoxyribonucl acid dna polymeras poli fail reveal increas sensit ioniz radiat ir',\n",
       "  'mice defect deoxyribonucl acid dna polymeras polm fail reveal increas sensit ioniz radiat ir',\n",
       "  'mice defect deoxyribonucl acid dna polymeras polm reveal increas sensit ioniz radiat ir',\n",
       "  'mice lack sirt1 sf1-express neuron immun diet-induc obes insulin resist',\n",
       "  'mice lack sirt1 sf1-express neuron increas suscept diet-induc obes insulin resist',\n",
       "  'mice lack interferon-γ receptor highli suscept experiment autoimmun myocard',\n",
       "  'mice without ifn-γ receptor highli suscept eam induc α-myhc/cfa',\n",
       "  'microcin j25 encourag nucleosid triphosph ntp bind',\n",
       "  'microcin j25 inhibit nucleosid triphosph ntp bind',\n",
       "  'microglia innat immun cell type central nervou system',\n",
       "  'microglia innat immun cell type peripher nervou system',\n",
       "  'migrain aura associ ischem stroke',\n",
       "  'misunderstand doctor patient lead non-adher',\n",
       "  'mitochondria play major role apoptosi',\n",
       "  'mitochondria play major role energi product',\n",
       "  'mitochondria play trivial role calcium homeostasi',\n",
       "  'moder consumpt candi chocol reduc risk cardiovascular diseas cvd',\n",
       "  'monoclon antibodi target n-cadherin encourag castrat resist',\n",
       "  'monoclon antibodi target n-cadherin encourag metastasi',\n",
       "  'monoclon antibodi target n-cadherin inhibit castrat resist',\n",
       "  'monoclon antibodi target n-cadherin inhibit growth',\n",
       "  'termin event okazaki fragment dictat initi pattern',\n",
       "  \"mous model gener use `` artifici spermatid ''\",\n",
       "  'mutant mice lack svct2 sever reduc ascorb acid level brain adren',\n",
       "  'mutat g-beta protein gnb1 present mani cancer result loss interact g-alpha subunit concomit activ akt pathway',\n",
       "  'mutat rim1 decreas level ime1 rna',\n",
       "  'mutat rim1 rais level ime1 rna',\n",
       "  'myelin sheath lipid-rich cellular structur',\n",
       "  'myelin sheath play role action potenti propag',\n",
       "  'n348i mutat caus resist nevirapin',\n",
       "  'n348i mutat reduc resist nevirapin',\n",
       "  'nac destabil increas effect contrast agent renal function',\n",
       "  'nac inhibit gener angiotensin-convert enzym',\n",
       "  'nr5a2 play role develop endometri tissu',\n",
       "  'nr5a2 import revers cholesterol transport human',\n",
       "  'natriuret peptid increas suscept diabet',\n",
       "  'natriuret peptid protect diabet',\n",
       "  'neutrophil extracellular trap net antigen may contain target autoantigen pr3 mpo',\n",
       "  'neutrophil produc il-1β respons larg particl',\n",
       "  'nigerian physician constitu largest compon sub-saharan africa-train physician unit state',\n",
       "  'nonhuman primat incap produc neutral antibodi repons eilat viru eilv produc mosquito',\n",
       "  'nonhypertens peopl 55 year old 90 chanc develop hypertens lifetim',\n",
       "  'noninvas posit pressur ventil predict acut respiratori failur solid organ transplant',\n",
       "  'nonsteroid antinflammatori drug ineffect cancer treatment',\n",
       "  'nonsteroid antinflammatori drug show potenti anticanc indic',\n",
       "  'normal express runx1 caus tumorsupress effect',\n",
       "  'normal granuloma form absenc tnf zebrafish',\n",
       "  'normal granuloma form presenc tnf zebrafish',\n",
       "  'notch signal occur tumor cell stromal cell',\n",
       "  'nuclear transfer adult human fibroblast human oocyt give rise blastocyst contain expand pluripot cell',\n",
       "  'oat toler coeliac patient may oat specif inflammatori cell small bowel mucosa',\n",
       "  'obes decreas life qualiti',\n",
       "  'obes rais life qualiti',\n",
       "  'occipit activ level associ auditori spatial perform pariet region brain',\n",
       "  'omnivor produc less trimethylamin n-oxid dietari i-carnitin vegan',\n",
       "  'omnivor produc trimethylamin n-oxid dietari i-carnitin vegan',\n",
       "  'omnivor produc trimethylamin n-oxid dietari i-carnitin vegetarian',\n",
       "  'one five surgic random control trial discontinu earli',\n",
       "  'one two surgic random control trial discontinu earli',\n",
       "  'origin gross domest product gdp neg relat dengu viru denv-1 diffus air traffic shipment',\n",
       "  'origin gross domest product gdp posit relat dengu viru denv-1 diffus air traffic shipment',\n",
       "  'osteocyt essenti role g-csf induc hspc mobil',\n",
       "  'osteoparthr oa character degener articular cartilag joint edg subchondr bone hyperplasia',\n",
       "  'half gabones children schimmelpenning-feuerstein-mim syndrom sfm plasma lactat 5mmol/l',\n",
       "  'overexpress cnp1 n-tail variant exacerb temperature-sensit growth defect scm3-139',\n",
       "  'overexpress cnp1 n-tail variant rescu temperature-sensit growth defect scm3-139',\n",
       "  'oxid dna damag activ sting signal',\n",
       "  'oxid dna damag inhibit sting signal',\n",
       "  'oxid phosphoryl one primari glycometabol pathway cell',\n",
       "  'pcsk9 inhibitor decreas plasma lp level',\n",
       "  'pd-1 trigger monocyt enhanc il-10 product monocyt',\n",
       "  'pge 2 suppresss intestin tumor growth alter express tumor suppress dna repair gene',\n",
       "  'pkg-la larg impact express pain hypersensit pgk-la knockout mice',\n",
       "  'pkg-la larg impact express spinal long term potenti pgk-la knockout mice',\n",
       "  'pkg-la play essenti role express spinal long term potenti pgk-la knockout mice',\n",
       "  'prc1-bound plasmid sediment slower rate unbound plasmid sucros gradient',\n",
       "  'pten regul transcript activ srf',\n",
       "  'particip quit smoke reduc lung cancer risk approxim 50',\n",
       "  'patient stabl partnership slower progress hiv aid',\n",
       "  'patient stabl partnership progress hiv death rate patient partnership',\n",
       "  'patient common epitheli cancer like emerg event first hospit admiss live resource-depriv area',\n",
       "  'patient common epitheli cancer less like emerg event first hospit admiss live resource-depriv area',\n",
       "  'patient microcytosi higher erythrocyt count vulner sever malari anaemia infect plasmodium falciparum',\n",
       "  'patient microcytosi higher erythrocyt count resist sever malari anaemia infect plasmodium falciparum',\n",
       "  'patient panic anxieti show decreas csf level hypocretin',\n",
       "  'pediatr scd patient vaso-occlus crisi show increas morphin use breath 80 ppm ino 4 hour',\n",
       "  'perigenit skin primari site hiv acquisit',\n",
       "  'peroxynitrit requir induct cell toler',\n",
       "  'persist cell provid relaps resist cancer patient',\n",
       "  'persistor cell one reason incomplet respons tyrosin kinas inhibitor tki therapi cancer patient',\n",
       "  'pharmacist attend ward round increas advers event ward',\n",
       "  'pharmacist attend ward round reduc advers event ward',\n",
       "  'phase inform use predict donor-recipi match organ transplant',\n",
       "  'physic activ improv cognit function individu alzheim',\n",
       "  'physic activ level associ differ maxim oxygen consumpt black white youth',\n",
       "  'physic activ level associ differ maxim oxygen consumpt black white youth',\n",
       "  'physic injuri repress transgultaminas activ',\n",
       "  'piezo1 channel sensor cell migrat epitheli cell',\n",
       "  'pioglitazon use associ increas risk prostat cancer',\n",
       "  'pioglitazon use significantli associ increas risk pancreat cancer',\n",
       "  'pioglitazon use significantli associ increas risk prostat cancer',\n",
       "  'pioneer factor oct3/4 interact major chromatin remodel factor',\n",
       "  'polym nutrit increas cardiovascular mortal',\n",
       "  'post-transcript handl mitochondri transcript occur mitochondri rna granul',\n",
       "  'pre-mrna associ spliceosom compon less stabl unassoci splice substrat',\n",
       "  'pre-mrna associ spliceosom compon stabl unassoci splice substrat',\n",
       "  'prescrib exercis train improv qualiti life',\n",
       "  'primpol degrad short dna replic intermedi lead strand dna replic',\n",
       "  'primpol gener short dna replic intermedi lead strand dna replic',\n",
       "  'primari cervic cancer screen hpv detect lower longitudin sensit convent cytolog detect cervic intraepitheli neoplasia grade 2',\n",
       "  'primari cervic cytolog screen hpv detect higher longitudin sensit detect sever cervic intraepitheli neoplasia convent cytolog',\n",
       "  'primari pro-inflammatori cytokin suppress secondari pro- anti-inflammatori mediat',\n",
       "  'pro-inflammatori cytokin regul tumor develop',\n",
       "  'pro-inflammatori cytokin repress tumor develop',\n",
       "  'progerin induc prematur age stem cell',\n",
       "  'propriospin interneuron play role plastic reorgan spinal circuit integr recoveri spinal cord injuri',\n",
       "  'pseudogen ptenp1 encod transcript regul pten express',\n",
       "  'pseudoknot evolutionarili conserv eukaryot',\n",
       "  'pure neural progenitor cell npc popul obtain cell cultur undergo passag filtrat isol cell sort method',\n",
       "  'pyridostatin decreas telomer fragil brca2-defici cell',\n",
       "  'pyridostatin deregul g2/m progress',\n",
       "  'pyridostatin encourag prolifer homolog recombin defect cell',\n",
       "  'pyridostatin induc checkpoint activ',\n",
       "  'pyridostatin induc double-strand break accumul',\n",
       "  'pyridostatin prevent double-strand break accumul',\n",
       "  'pyridostatin reduc prolifer homolog recombin defect cell',\n",
       "  'pyridostatin stabil g quadruplex telomer region',\n",
       "  'r2d2 stop mirna product increas select dcr2 long dsrna',\n",
       "  'ra activ dif2 nb4 cell induc hallmark transcript activ promot',\n",
       "  'rad52 involv break-induc dna replic bir',\n",
       "  'rank-rankl pathway signal known associ develop aire-express medullari thymic epitheli cell',\n",
       "  'rank-rankl pathway signal link develop aire-express medullari thymic epitheli cell',\n",
       "  'rtel1 interact trf2 c4c4 motif',\n",
       "  'runx express skin tissu',\n",
       "  'runx1 downregul mutat tlx1 t-all',\n",
       "  'radioiodin treatment non-tox multinodular goitr increas thyroid volum',\n",
       "  'rapamycin delay age fruit fli',\n",
       "  'rapamycin increas concentr triacylglycerol fruit fli',\n",
       "  'rapid phosphotransf rate correl histidin kinas regul specif',\n",
       "  'recognit start codon depend translat initi factor if3',\n",
       "  'reduc level lipolysi lead higher p38 phosphoryl adipos tissu',\n",
       "  'reduc phosphoryl pp2a increas hdac4 dephosphoryl enhanc pp2a-hdac4 interact',\n",
       "  'reduc phosphoryl pp2a suppress hdac4 dephosphoryl',\n",
       "  'reduc respons interleukin-2 regulatori cell associ autoimmun diseas type 1 diabet',\n",
       "  'reduc h3k4me3 methyl induc mous epiblast stem cell naiv pluripot effici',\n",
       "  'reduct rpl38 alter composit hox gene mrna translat mice without lower overal protein synthesi',\n",
       "  'reduct puriti cytoplasm membran isol overexpressor indic stronger spot ompa 2d bn-page gel',\n",
       "  'reduct puriti cytoplasm membran isol overexpressor indic stronger spot ompf 2d bn-page gel',\n",
       "  'remov h3k9me3 ectop express h3k9 demethylas decreas reprogram effici scnt experi',\n",
       "  'remov h3k9me3 ectop express h3k9 demethylas improv reprogram effici scnt experi',\n",
       "  'remov h3k9me3 improv reprogram effici human somat cell nuclear transfer experi',\n",
       "  'replac oct4 sox2 gene gata3 abil reprogram human cell',\n",
       "  'replac oct4 sox2 gene gata3 capabl reprogram human cell',\n",
       "  'replac histon h2a h2a.z acceler gene activ yeast destabil +1 nucleosom',\n",
       "  'repress il-18 neg effect atherosclerot lesion composit progress',\n",
       "  'retino acid receptor-rel orphan receptor gamma rorγ therapeut target castration-resist prostat cancer crpc',\n",
       "  'rhythmic express cry1 translat directli circadian regul camp signal gluconeogenesi',\n",
       "  'rhythmic express cry1 translat directli circadian regul camp signal hepat glucos metabol',\n",
       "  'ribosom protein rp express control part stress-activ regul',\n",
       "  'ribosome-inactiv protein-2 rip-2 interact p75 ntr death domain',\n",
       "  'ribosomopathi high degre cell tissu specif patholog',\n",
       "  'risedron increas risk vertebr non-vertebr fractur',\n",
       "  'rise temperatur caus global warm increas risk dengu fever transmiss',\n",
       "  'rise temperatur caus global warm lower risk dengu fever transmiss',\n",
       "  'risk cardiovascular event cut third use antihypertens drug therapi among hemodialysi patient',\n",
       "  'risk-adjust mortal rate similar teach non-teach hospit',\n",
       "  'rotat cuff exercis effect gener exercis therapi reduc pain improv function shoulder',\n",
       "  'roughli 55 women chronic pelvic pain underli patholog',\n",
       "  'satellit cell dysfunct key factor sarcopenia develop',\n",
       "  'scpif1p higher bind abil g-rich ssdna non-g-rich ssdna',\n",
       "  'scpif1p reduc bind abil g-rich ssdna compar non-g-rich ssdna',\n",
       "  'scapular stabil exercis effect gener exercis therapi reduc pain improv function shoulder',\n",
       "  'self-advocaci train effect decreas homeless',\n",
       "  'sepsi relat mortal remain stabl 2009-2014',\n",
       "  'sepsi relat mortal risen 2009 2014',\n",
       "  'sequenc conserv gene regulatori region speci high-accuraci predictor conserv function',\n",
       "  'sequenc conserv gene regulatori region speci poor predictor conserv function',\n",
       "  'side effect associ antidepress repres mortal risk postmenopaus women',\n",
       "  'side effect associ antidepress increas risk stroke',\n",
       "  'side effect associ antidepress lower risk myocardi infarct',\n",
       "  'sildenafil worsen erectil function men experi sexual dysfunct result use ssri antidepress',\n",
       "  'smc5/6 engag halt activ sumo e3 ligas mms21 atp-depend remold',\n",
       "  'sn present matur dc inflamm vivo',\n",
       "  'special function cell type deriv human pluripot stem cell',\n",
       "  'splenomegali observ knockin mous lack shp-2 mapk pathway',\n",
       "  'stack stabl purin present +5 posit c1698',\n",
       "  'stiff substrat encourag mesoderm differenti degrad beta-catenin integrin-depend manner',\n",
       "  'stiff substrat inhibit mesoderm differenti degrad beta-catenin integrin-depend manner',\n",
       "  'stroke patient prior use direct oral anticoagul higher risk in-hospit mortal stroke patient prior use warfarin',\n",
       "  'student perform poorli earli year medic school increas risk profession misconduct later career',\n",
       "  'student perform poorli earli year medic school less like commit profession misconduct later career',\n",
       "  'suboptim nutrit lead caus prematur death',\n",
       "  'sudden death occur patient complex ventricular arrhythmia',\n",
       "  'sudden death occur patient orthostat hypertens without cardiac conduct abnorm',\n",
       "  \"surfactin produc cell exopolym produc cell cooper gener `` van gogh '' bundl slide abil special media\",\n",
       "  'surgic treatment superior non-surg treat adult displac fractur proxim humeru',\n",
       "  'sweet tast receptor tongu deactiv 1 10 mm glucos',\n",
       "  'sympathet nerv activ elev throughout normal pregnanc',\n",
       "  'sympathet nerv activ reduc throughout normal pregnanc',\n",
       "  'system immunosuppress therapi enhanc chanc cancer mortal patient inflammatori eye diseas i',\n",
       "  'system immunosuppress therapi increas chanc cancer mortal patient inflammatori eye diseas i',\n",
       "  'system lupu erythematosu risk factor cardiovascular diseas',\n",
       "  'cell receptor /cd3 microdomain requir induc immunolog synaps',\n",
       "  'tmem27 marker beta cell',\n",
       "  'tnfaip3 glioblastoma tumor enhanc',\n",
       "  'tnfaip3 glioblastoma tumor suppressor',\n",
       "  'tnfaip3 tumor enhanc glioblastoma',\n",
       "  'trap+ osteoclast regul matur osteoblast mainten',\n",
       "  'take 400mg α-tocopheryl acet prevent prostat cancer',\n",
       "  'take 400mg α-tocopheryl acet combin vitamin c reduc risk prostat cancer',\n",
       "  'take anti-depres associ decreas aβ level brain experiment anim',\n",
       "  'taxat sugar-sweeten beverag reduc incid rate type ii diabet india',\n",
       "  'ten percent 10 kidney cancer uk attribut excess weight',\n",
       "  'c-type lectin receptor clec-2 rearrang actin cytoskeleton dendrit cell promot effici motil along stromal surfac',\n",
       "  'desmond program caus substanti weight loss particip',\n",
       "  'desmond program demonstr signific impact biochem outcom',\n",
       "  'desmond program demonstr signific impact lifestyl outcom',\n",
       "  'desmond program demonstr signific impact weight loss',\n",
       "  'dexi promot region bound multipl transcript factor murin haematopoiet progenitor cell line',\n",
       "  'ddrb protein deinococcu radioduran function pentam',\n",
       "  'g34r/v mutat creat hypomethyl phenotyp h3k36 histon',\n",
       "  'g34r/v mutat creat hypomethyl phenotyp h3k36 histon',\n",
       "  'h2a-h2b evict defect compens histon chaperon',\n",
       "  'hsv-2 infect typic asymptomat',\n",
       "  'm2-phenotyp brown adipos tissu macrophag increas brown adipos tissu thermogen activ',\n",
       "  'nf-κb essenti modul gene induc intestin inflamm promot receptor-interact protein rip kinas 1 kinas activity-medi epitheli cell death',\n",
       "  'nf-κb essenti modul gene prevent intestin inflamm inhibit receptor-interact protein rip kinas 1 kinas activity-medi epitheli cell death',\n",
       "  'pdpn gene deactiv c-type lectin receptor clec-2',\n",
       "  'ppr mda5 twenti n-termin card domain',\n",
       "  'prdm1 gene key determin primordi germ cell',\n",
       "  'prdm1 gene combin prdm14 gene play import role primordi germ cell specif',\n",
       "  'prr mda5 c-termin domain',\n",
       "  'rank-rank-ligand rankl pathway involv develop aire-express medullari thymic epitheli cell mtec',\n",
       "  \"snf1 complex regul carbon energi metabol baker 's yeast saccharomyc cerevisia\",\n",
       "  'traf1/c5 rs10818488 allel polymorph regul neighbor c5 gene',\n",
       "  'us health care system save 5 billion 7 patient wait kidney transplant particip optim nation kidney pair donat program',\n",
       "  \"world health organ 's data collect process bias downward unequ select larger outbreak\",\n",
       "  'abil activ e2f prevent cell death limit termin differenti cell',\n",
       "  'amount publicli avail dna data doubl everi 10 month',\n",
       "  'appear brown-lik beig cell primarili occur viscer fat subcutan fat',\n",
       "  'artifactu c-termin helix swap start domain observ ups1-mdm35 heterodim starkin superfamili',\n",
       "  'combin physic examin c-reactiv protein valu improv accuraci radiograph verifi pneumonia predict',\n",
       "  'composit myosin-ii isoform switch isoform b isoform hematopoiet differenti',\n",
       "  'cytokin receptor regul chemotaxi format lymph node involv product myeloperoxidas left atrium',\n",
       "  'deamin cytidin uridin minu strand viral dna inactiv viral genom induc g-to-a mutat',\n",
       "  'densiti cytokin receptor bear cell affect distanc cytokin act',\n",
       "  'densiti cytokin receptor bear cell effect distanc cytokin act',\n",
       "  'deregul prolong activ monocyt deleteri effect chronic infecti condit',\n",
       "  'deregul prolong activ monocyt improv inflammatori diseas outcom',\n",
       "  'effect lipopolysaccharid kidney barrier function depend inflamm level',\n",
       "  \"first mbt repeat four malign brain tumor 4mbt domain drosophila 's sfmbt ortholog mammalian l3mbtl2 requir interact spacer region drosophila 's pleiohomeot pho human ortholog yy1\",\n",
       "  'gene daf-16 encod forkhead box foxo requir phenotyp associ reduc insulin/insulin-lik growth factor igf signal',\n",
       "  'gener reactiv oxygen speci activ oncogen contribut increas genom instabl leukaemia cell',\n",
       "  'innat immun respons struggl remov small number parasit',\n",
       "  'latent infect myeloid cell human cytomegaloviru induc number chang gene express',\n",
       "  'mean suicid rate women higher miscarriag live birth',\n",
       "  'mean suicid rate women lower miscarriag live birth',\n",
       "  'microtubule-depend deliveri secret matrix metalloproteas mmp partial respons disassembl adhes site',\n",
       "  'minor g allel foxo3 downregul pro-inflammatori cytokin',\n",
       "  \"minor g allel foxo3 relat less sever symptom crohn 's diseas\",\n",
       "  'minor g allel foxo3 up-regul il-10',\n",
       "  'morpholog chang larg white adipocyt small brown adipocyt sign decreas energi expenditur potenti white adipos tissu',\n",
       "  'morpholog chang larg white adipocyt small brown adipocyt sign increas energi expenditur potenti white adipos tissu',\n",
       "  'preval advers event semaglutid cardiovascular',\n",
       "  'preval advers event semaglutid gastrointestin',\n",
       "  'myocardi cell lineag origin develop cardiac progenitor exclus endoderm origin',\n",
       "  'number unfertil oocyt mate hermaphrodit increas age',\n",
       "  'one-child polici creat hospit environ femal infant',\n",
       "  'origin crf01_1b2k protein occur 1923 1956',\n",
       "  'peak incid fractur occur pubert growth spurt earli adolesc',\n",
       "  'peak incid fractur occur toddler',\n",
       "  'predomin local linc00173 mononuclear macrophag nuclei',\n",
       "  'prolif capac neural progenitor differ across speci',\n",
       "  'prolif capac progenitor regul cell-autonom',\n",
       "  'proport peopl visual difficulti two time higher low-incom countri high-incom countri',\n",
       "  'recruit wdr5 target loci depend kat8',\n",
       "  \"relationship breast cancer patient 's capac metabol tamoxifen treatment outcom independ patient 's genet make-up\",\n",
       "  'remov reactiv oxygen speci activ oncogen contribut increas genom instabl leukaemia cell',\n",
       "  'repeat-vari diresidu rvd loop transcription-activ like tal effector specifi nucleotides-amino acid contact target promot element',\n",
       "  'risk breast cancer among parou women decreas placent weight pregnanc',\n",
       "  'risk cancer rise level alcohol consumpt',\n",
       "  'risk femal prison harm ten time male prison',\n",
       "  'tip inner tube toxic type vi secret system t6ss antibacteri effector escherichia coli e. coli decor vgrg paar protein',\n",
       "  'tissu surround granuloma immun cell induc anti-inflammatori immun respons',\n",
       "  'therapeut receiv acceler approv encount lower frequenc post-market safeti event',\n",
       "  'posit correl hip fractur statin use',\n",
       "  'relat erythromycin use hypertroph pylor stenosi',\n",
       "  'associ hnf4a mutat diabet risk',\n",
       "  'increas risk hypospadia clomiphen',\n",
       "  'known interact pioneer factor oct3/4 major chromatin remodel factor',\n",
       "  'relat erythromycin use hypertroph pylor stenosi',\n",
       "  'estim 30 million case pneumonia young children worldwid 2010',\n",
       "  'thiopurin activ metabolit catabol dephosphoryl thioguanin nucleotid',\n",
       "  'tirasemtiv effect cardiac muscl',\n",
       "  'tirasemtiv target cardiac muscl',\n",
       "  'tirasemtiv target fast-twitch muscl',\n",
       "  'toll-lik receptor tlr signal involv pathogenesi human md',\n",
       "  'tonic signal scfv induc constitut stimul',\n",
       "  'tonic signal scfv amplifi myd88/cd40',\n",
       "  'tonic signal scfv prevent constitut stimul',\n",
       "  'tradit review bias interpret',\n",
       "  'trans-act factor lncrna influenc mrna translat',\n",
       "  'transcript factor eb induc transcript pro-inflammatori cytokin macrophag infect staphylococcu aureu',\n",
       "  'transcript rate s. cerevisia rang 0.7 2 kb/min',\n",
       "  'transcript rate s. cerevisia rang 7 12 kb/min',\n",
       "  'transplant human glial progenitor cell matur host anim',\n",
       "  'treatment protein name fn impair regen abil age muscl',\n",
       "  'treatment protein name fn restor regen abil age muscl',\n",
       "  'treatment ec uptak inhibitor am404 result dose-depend decreas express immobl',\n",
       "  'tuberculosi incid occur higher rate spars popul area uk',\n",
       "  'tuberculosis-induc granuloma express differ immun system protein signatur surround tissu',\n",
       "  'tumor develop occur conjunct suppress pro-inflammatori cytokin',\n",
       "  'tumor develop occur conjunct upregul pro-inflammatori cytokin',\n",
       "  'two variant chromosom 6q21 associ radiat therapy-induc second malign pediatr hodgkin lymphoma patient',\n",
       "  'type 1 diabet associ subtl perturb reg develop',\n",
       "  'ultrasound guidanc significantli reduc number needl insert attempt necessari given procedur',\n",
       "  'ultrasound guidanc significantli reduc number traumat procedur attempt needl insert',\n",
       "  'understand epigenet regul replic essenti reation design episom replic vector',\n",
       "  'up-regul p53 pathway relat molecular event speed cancer progress',\n",
       "  'upon develop tyrosine-kinas inhibitor resist new mutat epiderm growth factor receptor emerg caus treatment failur',\n",
       "  'upon viral challeng influenza-specif memori cd4+ cell greatli diminish earli product inflammatori chemokin lung',\n",
       "  'upon viral challeng influenza-specif memori cd4+ cell greatli enhanc earli product inflammatori chemokin lung',\n",
       "  'upregul pd1 caus downmodul satb1',\n",
       "  'upregul pd1 caus upregul satb1',\n",
       "  'upregul dynein drosophila neuron increas number microtubul plus-end grow toward cell bodi neuron',\n",
       "  'urban import risk factor relat transmiss dengu fever',\n",
       "  'v-9302 inhibit antitumor respons decreas cell death oxid stress',\n",
       "  'vaccin gastrointestin tract induc protect rectal vagin mucosa',\n",
       "  'vareniclin monotherapi effect 26 week treatment compar combin nicotin replac therapi vareniclin bupropion',\n",
       "  'vari express level ebi2 affect posit migrat b cell',\n",
       "  'venul less signific tunica adventitia arteriol',\n",
       "  'vgrg tssl protein punctur membran form spike tip tube apparatu',\n",
       "  'vitamin defici effect birth weight',\n",
       "  'vitamin import factor relationship calcium parathyroid hormon',\n",
       "  'walk traffic area london improv lung function elderli adult',\n",
       "  'walk traffic area london improv lung function elderli adult',\n",
       "  \"weigh food record wfr result high complet sinc 're cheap run impos low particip burden\",\n",
       "  \"weigh food record wfr result poor complet sinc 're costli run impos high particip burden\",\n",
       "  'whole brain radiotherapi increas occurr new brain metastas',\n",
       "  'women suscept death due pneumonia compar men',\n",
       "  'women lower birth weight like develop breast cancer later life',\n",
       "  'yap/taz requir intestin regener mous model ulcer coliti',\n",
       "  'apkcz caus tumour suppress affect glutamin metabol',\n",
       "  'csmac format repress weak ligand signal',\n",
       "  'erna influenc link senesc age carcinogenesi',\n",
       "  'mcm 5 2 u requir proper decod nnr codon eukaryot',\n",
       "  'mir-142-5p known regul rais bodi temperatur',\n",
       "  'mir-142-5p temperature-sensit microrna mirna',\n",
       "  \"mirna enforc homeostasi suppress low-level `` leaki '' transcript\",\n",
       "  'mirna regul uniqu suit mrna maintain homeostasi cell',\n",
       "  'p16ink4a degrad link abnorm wound respons caus microinvas step advanc oral potenti malign lesion opml',\n",
       "  'p16ink4a degrad encod cdkn2a',\n",
       "  'p75 ntr associ cell death executor nade interact p75 ntr death domain',\n",
       "  'qsofa score associ length stay emerg depart patient',\n",
       "  'r-protein chaperon found complex r-protein bind partner',\n",
       "  'sirna knockdown a20 acceler tumor progress vivo murin xenograft model',\n",
       "  'sirna knockdown a20 slow tumor progress vivo murin xenograft model',\n",
       "  'taa1 tar1 tar2 tripl mutant arabidopsi make root meristem embryogenesi',\n",
       "  'β-sheet open occur pleurotolysin pore format',\n",
       "  'β1/ketel abl bind microtubul'],\n",
       " ['microstructur develop human newborn cerebr white matter assess vivo diffus tensor magnet reson imag',\n",
       "  'induct myelodysplasia myeloid-deriv suppressor cell',\n",
       "  'bc1 rna transcript master gene id element amplif abl prime revers transcript',\n",
       "  'dna methylom human peripher blood mononuclear cell',\n",
       "  'human myelin basic protein gene includ within 179-kilobas transcript unit express immun central nervou system',\n",
       "  'target a20 decreas glioma stem cell surviv tumor growth',\n",
       "  'effici target express silent gene human esc ipsc use zinc-fing nucleas',\n",
       "  'empir bayesian model analys molecular serotyp microarray',\n",
       "  'bayesian measur model complex fit',\n",
       "  'simplifi likelihood ratio',\n",
       "  'induct earli ifn-induc gene absenc type',\n",
       "  'arteriolar function viscer adipos tissu impair human obes',\n",
       "  'common carotid intima media thick ankle-brachi pressur index correl local global atheroma burden cross section studi use whole bodi magnet reson angiographi',\n",
       "  'loss immun escap mutat persist hcv infect pregnanc enhanc replic vertic transmit virus',\n",
       "  'journey develop hematopoiet stem cell',\n",
       "  'sacroiliac joint spondyloarthropathi',\n",
       "  'rapid method extract cotton gossypium spp genom dna suitabl rflp pcr analysi',\n",
       "  'cross section statur weight refer curv uk 1990',\n",
       "  'sutur provid nich mesenchym stem cell craniofaci bone',\n",
       "  'cardiac neural crest cell contribut dormant multipot stem cell mammalian heart',\n",
       "  'mammalian target rapamycin signal pathway mediat epileptogenesi model tempor lobe epilepsi',\n",
       "  'acut administr recombin angiopoietin-1 amelior multiple-organ dysfunct syndrom improv surviv murin sepsi',\n",
       "  'mechan link obes insulin resist type 2 diabet',\n",
       "  'track fate glomerular epitheli cell vivo use serial multiphoton imag novel mous model fluoresc lineag tag',\n",
       "  'ctcf bind h19 imprint control region mediat matern inherit higher-ord chromatin conform restrict enhanc access igf2',\n",
       "  'de novo assembl pml nuclear subcompart occur multipl pathway induc telomer elong',\n",
       "  \"effect opal termin codon preced nsp4 gene sequenc o'nyong-nyong viru genom anophel gambia infect\",\n",
       "  'down-regul host microrna herpesviru saimiri noncod rna',\n",
       "  'htrf technolog tailor drug discoveri –a review theoret aspect recent applic',\n",
       "  'chk1 inhibit replic factori activ allow dormant origin fire exist factori',\n",
       "  'fra-1 protooncogen regul il-6 express macrophag promot gener m2d macrophag',\n",
       "  'analysi sio2 nanoparticl bind protein rat blood brain homogen',\n",
       "  'infer nucleosom posit histon mark annot chip data',\n",
       "  'gener larg number dendrit cell mous bone marrow cultur supplement granulocyte/macrophag colony-stimul factor',\n",
       "  'insulin action resist obes type 2 diabet',\n",
       "  'effect lower blood pressur cardiovascular event mortal patient dialysi systemat review meta-analysi randomis control trial',\n",
       "  'interact adenoviru e3 14.7-kilodalton protein novel tumor necrosi factor alpha-induc cellular protein contain leucin zipper domain',\n",
       "  'pml induc compact trf2 deplet dna damag signal telomer promot altern lengthen',\n",
       "  'gr-1+cd11b+ myeloid cell tip balanc immun protect tumor promot premetastat lung',\n",
       "  'activin/nod signal stem cell',\n",
       "  'distinct rna-depend rna polymeras requir rnai trigger double-strand rna versu truncat transgen paramecium tetraurelia',\n",
       "  'mechan renal cell apoptosi induc cyclosporin systemat review vitro studi',\n",
       "  'blood stem cell emerg aortic endothelium novel type cell transit',\n",
       "  'probabl person person transmiss novel avian influenza h7n9 viru eastern china 2013 epidemiolog investig',\n",
       "  'genet variat interleukin-28b gene associ spontan clearanc progress hepat c viru moroccan patient',\n",
       "  'cd127 express invers correl foxp3 suppress function human cd4+ reg cell',\n",
       "  'environment factor influenc cutan product vitamin',\n",
       "  'genom imprint develop growth behavior stem cell',\n",
       "  'quantit detect hepat c viru rna light cycler pcr comparison two differ pcr assay',\n",
       "  'target arginin metabol pathway treat arginine-depend cancer',\n",
       "  'rank signal link develop invari γδ cell progenitor aire+ medullari epithelium',\n",
       "  'long-term immun defici allogen stem cell transplant b-cell defici associ late infect',\n",
       "  'stimulatori potenc cell antigen influenc format immunolog synaps',\n",
       "  'control glutam clearanc synapt efficaci glial coverag neuron',\n",
       "  'durat androgen suppress treatment prostat cancer',\n",
       "  'function neuroimag studi sound local visual cortex activ predict perform early-blind individu',\n",
       "  'high-infiltr tumor-associ macrophag predict unfavor clinic outcom node-neg breast cancer',\n",
       "  'murin dishevel 3 function redund pathway dishevel 1 2 normal cardiac outflow tract cochlea neural tube develop',\n",
       "  'dynam adheren junction epitheli establish mainten remodel',\n",
       "  'long-term outcom patient asystol induc head-up tilt test',\n",
       "  'zinc 15 – ligand discoveri everyon',\n",
       "  'condensin-medi remodel mitot chromatin landscap fission yeast',\n",
       "  'efficaci 6-month thrice-weekli regimen treatment new sputum smear-posit pulmonari tuberculosi clinic trial condit',\n",
       "  'curcumin attenu inflammatori respons il-1beta-induc human synovi fibroblast collagen-induc arthriti mous model',\n",
       "  'loss igf-iea igf-ieb impair myogen differenti',\n",
       "  'antimicrobi peptid pleurocidin synerg antibiot hydroxyl radic format membran damag exert antibiofilm activ',\n",
       "  'outcom pregnanc women moder sever renal insuffici',\n",
       "  'high-mobl group box-1 protein induc osteogen phenotyp chang aortic valv interstiti cell',\n",
       "  \"ribosi high-resolut quantit approach measur vivo kinet pre-mrna splice 3'-end process saccharomyc cerevisia\",\n",
       "  'gener mice condit allel p75 ntr neurotrophin receptor gene',\n",
       "  'triple-stain flow cytometr method assess plasma- acrosome-membran integr cryopreserv bovin sperm immedi thaw presenc egg-yolk particles1',\n",
       "  'univers voluntari hiv test immedi antiretrovir therapi strategi elimin hiv transmiss mathemat model',\n",
       "  'common variant dgkk strongli associ risk hypospadia',\n",
       "  'neutrophil suppress intralumin nk cell-medi tumor cell clearanc enhanc extravas dissemin carcinoma cell',\n",
       "  \"high km solubl 5'-nucleotidas human placenta properti alloster regul imp atp\",\n",
       "  'histon incorpor tran reassembl yeast pho5 promot',\n",
       "  'nation studi physician awar adher cardiovascular diseas prevent guidelin',\n",
       "  'technic advanc floral dip simplifi method agrobacterium-medi',\n",
       "  'pathway connect signal coordin yeast stress-activ signal network',\n",
       "  'premigratori migratori neural crest cell multipot vivo',\n",
       "  \"implement eshr 'poor respond criteria research studi methodolog implic\",\n",
       "  'gener gene-edit rat deliveri crispr/cas9 protein donor dna intact zygot use electropor',\n",
       "  'uridyl mirna hen1 suppressor1 arabidopsi',\n",
       "  'pre-exposur prophylaxi prevent hiv infect current statu futur opportun challeng',\n",
       "  'prepregn bmi risk gestat diabet systemat review literatur meta-analysi',\n",
       "  'multipl risk behaviour increas socio-econom gap time',\n",
       "  'variat trend health burden visual impair due cataract global analysi',\n",
       "  'multiplex genom engin use crispr/ca system',\n",
       "  'transform intact yeast cell treat alkali cation',\n",
       "  'health-rel qualiti life measur eq-5d among popul without specif chronic condit population-bas survey shaanxi provinc china',\n",
       "  'memori modular cell-fat decis make',\n",
       "  'lpd deplet reveal srf specifi radial versu tangenti migrat pyramid neuron',\n",
       "  'identif p18 ink4c tumor suppressor gene glioblastoma multiform',\n",
       "  'two-stag control oxid stress regulon escherichia coli soxr protein trigger redox-induc express sox regulatori gene',\n",
       "  'air pollut cardiovascular diseas statement healthcar profession expert panel popul prevent scienc american heart associ',\n",
       "  'non-invas ventil chronic obstruct pulmonari diseas patient helmet versu facial mask',\n",
       "  'case manag client access health social servic outpati substanc abus treatment',\n",
       "  'evid ipl1-sli15 aurora kinase-incenp complex promot chromosom bi-orient alter kinetochore-spindl pole connect',\n",
       "  'critic review cutan vascul updat diagnost criteria',\n",
       "  'e2f-depend histon acetyl recruit tip60 acetyltransferas complex chromatin late g1',\n",
       "  'chemic approach stem cell biolog therapeut',\n",
       "  'genome-wid map chromatin state pluripot lineage-commit cell',\n",
       "  'oncofet long noncod rna pvt1 promot prolifer stem cell-lik properti hepatocellular carcinoma cell stabil nop2',\n",
       "  'candida albican distinct fungal model cellular age studi',\n",
       "  'anktm1 trp-like channel express nocicept neuron activ cold temperatur',\n",
       "  'plasma vitamin metabolit risk colorect cancer women',\n",
       "  'dna deamin mediat innat immun retrovir infect',\n",
       "  'global region nation disability-adjust life-year dali 315 diseas injuri healthi life expect hale 1990–2015 systemat analysi global burden diseas studi 2015',\n",
       "  'advers drug event databas construct silico predict',\n",
       "  'genet test ecolog allopatr speciat anol island archipelago',\n",
       "  'defici pharmacolog stabil mast cell reduc diet-induc obes diabet mice',\n",
       "  'famili aphas episod anoth variant partial epilepsi simpl inherit',\n",
       "  'endosome- contact control actin nucleat retrom function vap-depend regul pi4p',\n",
       "  'anaphase-promot complex/cyclosome–depend proteolysi human cyclin start begin mitosi subject spindl assembl checkpoint',\n",
       "  'human cell leukemia viru reactiv progress adult t-cell leukemia-lymphoma',\n",
       "  'montelukast fluticason compar salmeterol fluticason protect asthma exacerb adult one year doubl blind randomis compar trial',\n",
       "  'control assembl function glutam receptor amino-termin domain',\n",
       "  'fission yeast yeast emerg model unravel cellular age eukaryot',\n",
       "  'centrifug elutri method isol larg number function intact human peripher blood monocyt',\n",
       "  'asthma unit state olymp athlet particip 1996 summer game',\n",
       "  'relaps specif mutat nt5c2 childhood acut lymphoblast leukemia',\n",
       "  'relationship sloan-kett viru express mous follicular develop',\n",
       "  'involv cb1 cannabinoid receptor emot behaviour',\n",
       "  'exosom level mirna-21 cerebrospin fluid associ poor prognosi tumor recurr glioma patient',\n",
       "  'age‐associ microrna express human peripher blood associ all‐caus mortal age‐rel trait',\n",
       "  'histon deacetylas hdac frontotempor lobar degener',\n",
       "  'evolut impact subclon mutat chronic lymphocyt leukemia',\n",
       "  'transcript program sporul bud yeast',\n",
       "  'grass plant bind retain uptak transport infecti prion',\n",
       "  'innat lymphoid cell mediat influenza-induc airway hyper-react independ adapt immun',\n",
       "  'behaviour chang wheel new method characteris design behaviour chang intervent',\n",
       "  'intermitt prophylaxi oral truvada protect macaqu rectal shiv infect',\n",
       "  'rna favour analys egfr mutat malign pleural effus lung cancer',\n",
       "  'pharmacolog correct defect pparγ signal amelior diseas sever cftr-defici mice',\n",
       "  'visual volatil substanc differ organel atmospheric-pressur mass microscop',\n",
       "  'code sweet bitter umami tast differ receptor cell share similar signal pathway',\n",
       "  'green synthesi silver nanoparticl character inhibitori effect age format use biophys techniqu',\n",
       "  'myosin light chain–activ phosphoryl site requir oogenesi drosophila',\n",
       "  'stage patholog process alzheim diseas age categori 1 100 year',\n",
       "  'coronari bypass graft patenc patient diabet bypass angioplasti revascular investig bari',\n",
       "  'novel atac-seq approach reveal lineage-specif reinforc open chromatin landscap via cooper baf p63',\n",
       "  'age habitu exercis dynam arteri complianc',\n",
       "  'comparison cancer screen practic cancer survivor gener popul korean nation health nutrit examin survey knhane 2001–2007',\n",
       "  'neg effect transcript activ gal4',\n",
       "  'bayh–dol act univers research develop',\n",
       "  'relat past exposur fine particul air pollut preval anxieti observ cohort studi',\n",
       "  'mitochondri target compound delay age yeast mechan link mitochondri membran lipid metabol mitochondri redox biology☆',\n",
       "  'isol african syke monkey cercopithecu miti lentiviru relat human simian immunodefici virus',\n",
       "  'role single-strand dna–bind protein ssbb pneumococc transform mainten reservoir genet plastic',\n",
       "  'cerebr organoid model human brain develop microcephali',\n",
       "  'local gene partial epilepsi chromosom 10q',\n",
       "  'metastat colon requir repress epithelial-mesenchym transit induc prrx1',\n",
       "  'cohort studi risk cervic intraepitheli neoplasia grade 2 3 relat papillomaviru infect',\n",
       "  'investig surviv prognosi glioblastoma use evolut properti gene network',\n",
       "  'compound heterozyg zmpste24 mutat reduc prelamin process result sever progeroid phenotyp',\n",
       "  'reliabl patient respons pay perform scheme analysi nation gener practition patient survey data england',\n",
       "  'impact low alcohol verbal descriptor perceiv strength experiment studi',\n",
       "  'transgen interleukin 10 prevent induct experiment autoimmun encephalomyel',\n",
       "  'autosom domin immun dysregul syndrom human ctla4 mutat',\n",
       "  'specif inhibit cyclin-depend kinas 4/6 pd 0332991 associ antitumor activ human tumor xenograft',\n",
       "  'neutrophil support lung colon metastasis-initi breast cancer cell',\n",
       "  'effect previou miscarriag depress symptom subsequ pregnanc postpartum first babi studi',\n",
       "  'il-1β il-4 il-12 control fate group 2 innat lymphoid cell human airway inflamm lung',\n",
       "  'summari',\n",
       "  'naringenin inhibit allergen-induc airway inflamm airway respons inhibit nf-kappab activ murin model asthma',\n",
       "  'evolut fox gene role develop diseas',\n",
       "  'emerg structur dynam cell coloni contact inhibit locomot',\n",
       "  'failur cell cleavag induc senesc tetraploid primari cell',\n",
       "  'cell death signific apoptosi',\n",
       "  'mitochondri rna-bind protein grsf1 local rna granul requir posttranscript mitochondri gene express',\n",
       "  'identif purif 62,000-dalton protein bind specif polypyrimidin tract intron',\n",
       "  'capsul endoscopi acut upper gastrointestin hemorrhag prospect cohort studi',\n",
       "  'electropor cas9 protein/sgrna earli pronuclear zygot gener non-mosa mutant mous',\n",
       "  'molecular basi target rna recognit cleavag human risc',\n",
       "  'cancer associ fibroblast caf tumor microenviron',\n",
       "  'cold exposur promot atherosclerot plaqu growth instabl via ucp1-depend lipolysi',\n",
       "  'mild overexpress mecp2 caus progress neurolog disord mice',\n",
       "  'alcohol sale risk seriou assault',\n",
       "  'mir-375 inhibit autophagi reduc viabil hepatocellular carcinoma cell hypox condit',\n",
       "  'pseudouridin profil reveal regul mrna pseudouridyl yeast human cell',\n",
       "  'descent memori t-cell subset',\n",
       "  'differenti distribut il28b.rs12979860 single-nucleotid polymorph among egyptian healthcar worker without hepat c virus-specif cellular immun respons',\n",
       "  'tcr ligand densiti affin determin peripher induct foxp3 vivo',\n",
       "  'electromagnet interfer radio frequenc identif induc potenti hazard incid critic care medic equip',\n",
       "  'potent rnai short rna trigger',\n",
       "  'il-23–respons innat lymphoid cell increas inflammatori bowel diseas',\n",
       "  'scale dorsal-ventr pattern embryo size-depend degrad spemann ’ organ signal',\n",
       "  'augment antitumor immun respons epigenet modifi agent',\n",
       "  'activ proteinase-activ receptor 2 human osteoarthrit cartilag upregul catabol proinflammatori pathway capabl induc cartilag degrad basic scienc studi',\n",
       "  'neutrophil extracellular trap enrich oxid mitochondri dna interferogen contribut lupus-lik diseas',\n",
       "  'microenviron rigid modul respons her2 receptor tyrosin kinas inhibitor lapatinib via yap taz transcript factor',\n",
       "  'effect popul size pattern molecular evolut variat',\n",
       "  'emot dysregul part psychopatholog adhd adult',\n",
       "  'neural basi melanocortin-4 receptor regul appetit',\n",
       "  'lymph node cell respons predict efficaci live attenu siv vaccin',\n",
       "  'activ serotonin 2c receptor dopamin neuron inhibit binge-lik eat mice',\n",
       "  'restor chaperone-medi autophagi age liver improv cellular mainten hepat function',\n",
       "  \"incid repetit hospital-tr deliber self harm find world 's first nation registri\",\n",
       "  'common mechan cellular death induc bactericid antibiot',\n",
       "  'increas atherosclerosi mice reconstitut apolipoprotein e null macrophag',\n",
       "  'endothelium-medi relax porcin collateral-depend arteriol improv exercis train',\n",
       "  'loss rhogap srgp-1 promot clearanc dead injur cell caenorhabd elegan',\n",
       "  'abnorm myeloid progenitor compart syndrom fetal liver preced acquisit gata1 mutat',\n",
       "  'regulatori metabol rewir laboratori evolut ethanol toler e. coli',\n",
       "  'famili risk lymphoprolif tumor famili patient chronic lymphocyt leukemia result swedish family-canc databas',\n",
       "  'collagen/polypropylen composit mesh biocompat abdomin wall reconstruct',\n",
       "  'microvessel densiti statu p53 protein potenti prognost factor adjuv anthracyclin chemotherapi retrospect analysi earli breast cancer patient group',\n",
       "  'rank elimin feasibl malaria-endem countri',\n",
       "  'genet obes adult adopte biolog sibl',\n",
       "  '2010 rheumatoid arthriti classif criteria american colleg rheumatology/european leagu rheumat collabor initi',\n",
       "  'role fibroblast mediat effect tobacco-induc epitheli cell growth invas',\n",
       "  'immtac-redirect tumour cell kill induc potenti antigen cross-present dendrit cell',\n",
       "  'basal keratinocyt tetrasomi low-grad squamou intra-epitheli lesion cervix restrict high intermedi risk hpv infect type-specif',\n",
       "  \"“ rapid-impact intervent ” polici integr control africa 's neglect tropic diseas could benefit poor\",\n",
       "  'fty720 fingolimod neuroprotect disease-modifi agent cellular mous model huntington diseas',\n",
       "  'specif residu determin bind affin two-compon signal transduct system',\n",
       "  'hnrnp a1 associ telomer end stimul telomeras activ',\n",
       "  'rapamycin pass torch new gener mtor inhibitor',\n",
       "  'dynam capsul restructur main pneumococc autolysin lyta respons epithelium',\n",
       "  'mammalian scribbl polar protein regul epitheli cell adhes migrat e-cadherin',\n",
       "  'histon acetyl dna demethyl cell result anaplast larg cell lymphoma-lik phenotyp',\n",
       "  'yeastract provid programmat access curat transcript regulatori associ saccharomyc cerevisia web servic interfac',\n",
       "  'mechan specifi promot nucleosom locat ident',\n",
       "  'hiv seroposit tuberculosi larg gener hospit malawi',\n",
       "  'determin neonat mortal indonesia',\n",
       "  'high densiti map mhc identifi share role hla-drb1 01:03 inflammatori bowel diseas heterozyg advantag ulcer coliti',\n",
       "  'high-threshold mechanosensit ion channel block novel conopeptid mediat pressure-evok pain',\n",
       "  'hyperact neuroendocrin secret caus size feed metabol defect c. elegan bardet-biedl syndrom mutant',\n",
       "  'fiji open-sourc platform biological-imag analysi',\n",
       "  'pharmacolog character potent inhibitor class phosphatidylinositid 3-kinas',\n",
       "  'optim crispr/ca tool effici germlin somat genom engin drosophila',\n",
       "  'cost-effect 10-year risk threshold initi statin therapi primari prevent cardiovascular diseas',\n",
       "  'biochem properti highli neuroinvas prion strain',\n",
       "  'twin-arginin transloc tat protein export pathway',\n",
       "  'new develop atsa program packag small-angl scatter data analysi',\n",
       "  'first myriapod genom sequenc reveal conserv arthropod gene content genom organis centiped strigamia maritima',\n",
       "  'genet function diversif small rna pathway plant',\n",
       "  'immunosuppress fty720 inhibit thymocyt emigr',\n",
       "  'valid conceptu model inter-profession approach share decis make mix method studi',\n",
       "  'glutaminolysi activ rag-mtorc1 signal',\n",
       "  'microrna-31/factor-inhibit hypoxia-induc factor 1 nexu regul keratinocyt differenti',\n",
       "  'advantag larval control african malaria vector low mobil behaviour respons immatur mosquito stage allow high effect coverag',\n",
       "  'arabidopsi chromatin-modifi nuclear sirna pathway involv nucleolar rna process center',\n",
       "  'peripher arteri diseas elderli rotterdam studi',\n",
       "  'antioxid attenu plasma cytokin respons exercis human',\n",
       "  'relat colon proglucagon express metabol respons oligofructos high fat diet-f mice',\n",
       "  'aurora b phosphoryl spatial distinct target differenti regul kinetochore-microtubul interfac',\n",
       "  'prognost import 6-mercaptopurin dose intens acut lymphoblast leukemia',\n",
       "  'orai1 stim1 critic breast tumor cell migrat metastasi',\n",
       "  'mous spermatogen stem cell continu interconvert equipot singli isol syncyti state',\n",
       "  'pseudoknot rna structur divers function',\n",
       "  'essenti role interferon gamma resist mycobacterium tuberculosi infect',\n",
       "  'malign prothrombot mutat risk venou thrombosi',\n",
       "  'hippo signal pathway restrict oncogen potenti intestin regener program',\n",
       "  'essenc snp',\n",
       "  'combin inhibit pi3k mtorc1 yield durabl remiss orthotop patient-deriv xenograft her2-posit breast cancer brain metastas',\n",
       "  'activ frontal neocort area vocal product marmoset',\n",
       "  'famili hiatal hernia larg five gener famili confirm true autosom domin inherit',\n",
       "  'excitatori loop astrocyt contribut drive neuron seizur threshold',\n",
       "  'diminish perform neuropsycholog test late life depress correl microstructur white matter abnorm',\n",
       "  'atyp antipsychot olanzapin caus weight gain target serotonin receptor 2c',\n",
       "  'case-control studi endogen steroid hormon endometri cancer',\n",
       "  'foxo4 necessari neural differenti human embryon stem cell',\n",
       "  'gestat protein restrict affect trophoblast differenti',\n",
       "  'vitro character anti-pd-1 antibodi nivolumab bms-936558 vivo toxicolog non-human primat',\n",
       "  'combin impact lifestyle-rel factor total cause-specif mortal among chines women prospect cohort studi',\n",
       "  'aptamer-function lipid nanoparticl target osteoblast novel rna interference–bas bone anabol strategi',\n",
       "  'high abund plasma cell secret transglutaminas 2–specif iga autoantibodi limit somat hypermut celiac diseas intestin lesion',\n",
       "  'alter white matter integr adult major depress disord magnet reson imag studi',\n",
       "  'clinic studi therapeut effect acupunctur treatment post-strok depress',\n",
       "  '30 year nf-κb blossom relev human pathobiolog',\n",
       "  'increas gene express brown fat uncoupl protein ucp 1 skelet muscl ucp2 ucp3 mac16-induc cancer cachexia',\n",
       "  'vitro anti-tumor effect statin head neck squamou cell carcinoma systemat review',\n",
       "  'circul mitochondri dna patient icu marker mortal deriv valid',\n",
       "  'fructosamin use indic hyperglycaemia glucos control clinic epidemiolog studi – cross-sect longitudin experi amori cohort',\n",
       "  'lifeact versatil marker visual f-actin',\n",
       "  'robust random forest-bas gene select method',\n",
       "  'improv variant discoveri local re-align short-read next-gener sequenc data use srma',\n",
       "  'function element within dynein microtubule-bind domain',\n",
       "  'transcript factor egr2 egr3 essenti control inflamm antigen-induc prolifer b cell',\n",
       "  'effect hyperosmol alkalin phosphatas stress-respons protein 27 mcf-7 breast cancer cell',\n",
       "  'bile acid chenodeoxychol acid increas human brown adipos tissu activ',\n",
       "  'rnase h postrepl repair protect cell ribonucleotid incorpor dna',\n",
       "  'select elimin high constitut activ chemokin bind human herpesviru 8 encod seven transmembran oncogen orf74',\n",
       "  'insulin-lik signal pathway affect longev reproduct caenorhabd elegan',\n",
       "  'estim prion concentr fluid tissu quantit pmca',\n",
       "  'posit clone apec gene',\n",
       "  'amp-activ protein kinas ubiquit signal pathway key role cardiovascular system',\n",
       "  'differenti trophoblast stem cell giant cell trigger p57/kip2 inhibit cdk1 activ',\n",
       "  'atg5-independ autophagi regul mitochondri clearanc essenti ipsc reprogram',\n",
       "  'mutat orai1 caus immun defici abrog crac channel function',\n",
       "  'estim global preval childhood underweight 1990 2015',\n",
       "  'canon wnt signal regul organ-specif assembl differenti cn vasculatur',\n",
       "  'bone progenitor dysfunct induc myelodysplasia secondari leukemia',\n",
       "  'gener diploid embryo xenopu tropicali',\n",
       "  'oct4-induc pluripot adult neural stem cell',\n",
       "  'get start yeast',\n",
       "  'pcna function molecular platform trigger cdt1 destruct prevent re-repl',\n",
       "  'meiosi drosophila see believ',\n",
       "  'effect physic activ cognit function older adult risk alzheim diseas random trial',\n",
       "  \"variant 6q21 implic prdm1 etiolog therapy-induc second malign hodgkin 's lymphoma\",\n",
       "  'long non-cod rna profil human lymphoid progenitor cell reveal transcript diverg b cell cell lineag',\n",
       "  'vti famili snare protein necessari plant viabil mediat differ protein transport pathway',\n",
       "  'clasp link focal adhesion-associ microtubul captur local exocytosi adhes site turnov',\n",
       "  'chd4 rangtp-depend map stabil microtubul regul bipolar spindl format',\n",
       "  'myocardi muscarin receptor upregul normal respons isoproterenol denerv heart famili amyloid polyneuropathi',\n",
       "  '6-phosphoglucon dehydrogenas link oxid ppp lipogenesi tumor growth inhibit lkb1-ampk signal',\n",
       "  'plant nuclear rna polymeras iv mediat sirna dna methylation-depend heterochromatin format',\n",
       "  'sema3a regul bone-mass accrual sensori innerv',\n",
       "  'direct lineag reprogram strategi mechan applic',\n",
       "  'converg intracrani marker consciou access',\n",
       "  'hyperglycemia associ increas bone miner densiti decreas trabecular bone score elderli japanes men fujiwara-kyo osteoporosi risk men formen studi',\n",
       "  'matrix remodel promot pulmonari hypertens feedback mechanoactiv yap/taz-mir-130/301 circuit',\n",
       "  'exosom transfer stroma-deriv mir21 confer paclitaxel resist ovarian cancer cell target apaf1',\n",
       "  'age-rel chang kynuren acid product rat brain',\n",
       "  'polycomb group protein suz12 requir embryon stem cell differenti',\n",
       "  '1.9 structur proteasome-11 activ complex implic proteasome-pan/pa700 interact',\n",
       "  'innat immun chemic trigger oxid stress modifi translat fidel',\n",
       "  'yeast sirtuin regul age',\n",
       "  'effect combin treatment aliskiren blocker renin-angiotensin system hyperkalaemia acut kidney injuri systemat review meta-analysi',\n",
       "  'in out dna transfer bacteria',\n",
       "  'synapt island defin territori singl astrocyt',\n",
       "  'role dna methyl epigenet silenc hand2 endometri cancer develop',\n",
       "  'socioeconom factor materi inequ perceiv control self-rat health cross-sect data seven post-communist countri',\n",
       "  'integrin αvβ3/c-src “ oncogen unit ” promot anchorage-independ tumor progress',\n",
       "  'genomewid analysi prc1 prc2 occup identifi two class bival domain',\n",
       "  'spatiotempor regul epithelial-mesenchym transit essenti squamou cell carcinoma metastasi',\n",
       "  'control apoptosi asymmetr cell divis',\n",
       "  'cxcr2 mediat nadph oxidase–independ neutrophil extracellular trap format cystic fibrosi airway inflamm',\n",
       "  'model impact artemisinin combin therapi long-act treatment malaria transmiss intens',\n",
       "  'system metabol engin escherichia coli l-threonin product',\n",
       "  'associ adhd obes systemat review meta-analysi',\n",
       "  'amyloid-dna composit bacteri biofilm stimul autoimmun',\n",
       "  'comprehens genom character defin human glioblastoma gene core pathway',\n",
       "  'ly2405319 engin fgf21 variant improv metabol statu diabet monkey',\n",
       "  'epigenet control stem cell potenti homeostasi age diseas',\n",
       "  'host–parasit interact evolut gene express',\n",
       "  'crucial role interleukin il -1 induct il-17–produc cell mediat autoimmun encephalomyel',\n",
       "  'aberr lumin progenitor candid target popul basal tumor develop brca1 mutat carrier',\n",
       "  'get site inflamm leukocyt adhes cascad updat',\n",
       "  \"genome-wid loss 5-hmc novel epigenet featur huntington 's diseas\",\n",
       "  'plan postdisast resili',\n",
       "  'increas stress-induc inflammatori respons male patient major depress increas earli life stress',\n",
       "  'kif3a/b heterodimer kinesin superfamili protein work microtubul plu end-direct motor membran organel transport',\n",
       "  'genet screen identifi lkb1–mark signal axi control hippo–yap pathway',\n",
       "  'beyond melanoma inhibit pd-1/pd-l1 pathway solid tumor',\n",
       "  'partit symptom hypoglycaemia use multi-sampl confirmatori factor analysi',\n",
       "  'extracellular vesicl human cardiac progenitor cell inhibit cardiomyocyt apoptosi improv cardiac function myocardi infarct',\n",
       "  'increas adipocyt o2 consumpt trigger hif-1α caus inflamm insulin resist obes',\n",
       "  'lpcat3-depend product arachidonoyl phospholipid key determin triglycerid secret',\n",
       "  'character single-strand dna-bind protein pseudomona aeruginosa pao1',\n",
       "  'primari cilia coordin receptor tyrosin kinas rtk signal',\n",
       "  'detect target tumor relaps resist innat effector earli recurr',\n",
       "  'forc tissu morphogenesi pattern',\n",
       "  'cd169+ macrophag present lipid antigen mediat earli activ invari nkt cell lymph node',\n",
       "  'oxygen metabol caus chromosom break associ neuron apoptosi observ dna double-strand break repair mutant',\n",
       "  'insert mutagenesi gene therapi stem cell biolog',\n",
       "  'market voucher subsidi free net combin achiev high bed net coverag rural tanzania',\n",
       "  'human chorion gonadotropin level matern blood late pregnanc relat birthweight sex condit infant birth',\n",
       "  'brain-specif phosphoryl mecp2 regul activity-depend bdnf transcript dendrit growth spine matur',\n",
       "  'candid gene approach identifi traf1/c5 region risk factor rheumatoid arthriti',\n",
       "  'potenti use γ-secretas modul treatment alzheim diseas',\n",
       "  \"ration design flaviviru vaccin abolish viral rna 2'-o methyl\",\n",
       "  'fruit consumpt risk type 2 diabet result three prospect longitudin cohort studi',\n",
       "  'oncomir-196 promot invas phenotyp oral cancer nme4-jnk-timp1-mmp signal pathway',\n",
       "  'revers engin tlx oncogen transcript network identifi runx1 tumor suppressor t-all',\n",
       "  'impact new antiretrovir treatment guidelin hiv epidem dynam cost south africa',\n",
       "  'er-associ mitochondri divis link distribut mitochondria mitochondri dna yeast',\n",
       "  'bmi-1 autoantibodi new potenti biomark cervic carcinoma',\n",
       "  'microrna gener threshold target gene express',\n",
       "  'oncogen mtor signal recruit myeloid-deriv suppressor cell promot tumor initi',\n",
       "  'manag women genet predisposit breast cancer',\n",
       "  'astrocyt famili sporad al patient toxic motor neuron',\n",
       "  'high-intens function exercis program protein-enrich energi supplement older person depend activ daili live randomis control trial',\n",
       "  'inhibit fatti acid oxid modul immunosuppress function myeloid-deriv suppressor cell enhanc cancer therapi',\n",
       "  'predict mortal patient hospit acut exacerb chronic obstruct pulmonari diseas',\n",
       "  'clathrin requir function mitot spindl',\n",
       "  'origin neuron function vivo nonsynapt glutam',\n",
       "  'disease-associ function il-33 new kid il-1 famili',\n",
       "  'interferon alpha therapi hepat c treatment complet respons rate among patient substanc use disord',\n",
       "  'associ infect helicobact pylori risk gastric cancer evid prospect investig',\n",
       "  'oncostatin leukemia inhibitori factor use function receptor mice',\n",
       "  'multifunct vivo vascular imag use near-infrar ii fluoresc',\n",
       "  'colorect cancer surviv socioeconom group england variat mainli short term diagnosi',\n",
       "  'cardiac myocyt remodel mediat n-cadherin-depend mechanosens',\n",
       "  'neat1 novel cancer‐rel long non‐cod rna',\n",
       "  'function therapeut potenti long non-cod rna cardiovascular develop diseas',\n",
       "  'oct4 link multipl epigenet pathway pluripot network',\n",
       "  'tet1 dispens maintain pluripot loss compat embryon postnat develop',\n",
       "  'ldl-cholesterol concentr genome-wid associ studi',\n",
       "  'popul densiti water suppli risk dengu fever vietnam cohort studi spatial analysi',\n",
       "  'helicobact pylori induc ag cell motil elong via independ signal pathway',\n",
       "  'sequenc alignment/map format samtool',\n",
       "  'character two class small molecul inhibitor arp2/3 complex',\n",
       "  'stress cell-to-substr interfac locomot fibroblast',\n",
       "  'cancer-associ adipocyt exhibit activ phenotyp contribut breast cancer invas',\n",
       "  'preval cardiovascular diseas risk factor chines popul 2007-2008 china nation diabet metabol disord studi',\n",
       "  'microvascular macrovascular complic diabet',\n",
       "  'involv s-nitrosyl actin inhibit neurotransmitt releas nitric oxid',\n",
       "  'independ associ lobular involut mammograph breast densiti breast cancer risk',\n",
       "  'pleiotropi mechan stabil cooper',\n",
       "  'homeobox gene goosecoid control cell migrat xenopu embryo',\n",
       "  'epigenet switch involv activ pioneer factor foxa1-depend enhanc',\n",
       "  'leptin treatment amelior anxieti ob/ob obes mice',\n",
       "  'predict new molecular target known drug',\n",
       "  'bone loss vascular calcif bi-direct interplay',\n",
       "  'immobil chemokin field solubl chemokin gradient cooper shape migrat pattern dendrit cell',\n",
       "  'local prolifer domin lesion macrophag accumul atherosclerosi',\n",
       "  'enzymat activ lysosom proteas associ amyloid deposit alzheim brain',\n",
       "  'gastric juic mir-129 potenti biomark screen gastric cancer',\n",
       "  'epidemiolog expans structur studi clinic challeng new β-lactamas gram-neg bacteria',\n",
       "  'robust synchron coupl circadian cell cycl oscil singl mammalian cell',\n",
       "  'identif brainstem circuit control feed',\n",
       "  'infection-induc netosi dynam process involv neutrophil multitask vivo',\n",
       "  'swim train suppress tumor growth mice',\n",
       "  'lung dendrit cell imprint cell lung home promot lung immun chemokin receptor ccr4',\n",
       "  'microrna safeguard turmoil',\n",
       "  'vascular smooth muscl cell calcif mediat regul exosom secret',\n",
       "  'vaccin malaria',\n",
       "  'microrna-21 induc rapamycin model tuber sclerosi tsc lymphangioleiomyomatosi lam',\n",
       "  'reduc nf1 express confer resist egfr inhibit lung cancer',\n",
       "  'human irgm induc autophagi elimin intracellular mycobacteria',\n",
       "  'implement clinic pharmaci educ program teach hospit resid orient document intervent',\n",
       "  'surgic anatomi conduct tissu',\n",
       "  'agreement onlin dietari assess tool myfood24 interviewer-administ 24-h dietari recal british adolesc age 11-18 year',\n",
       "  'modul cancer chemotherapi green tea',\n",
       "  'histon deacetylas 5 interact krüppel-lik factor 2 inhibit transcript activ endothelium',\n",
       "  'n348i hiv-1 revers transcriptas counteract nevirapine-medi bia toward rnase h cleavag plus-strand initi',\n",
       "  'cancer survivorship research challeng recruit adult long term cancer survivor cooper clinic trial group',\n",
       "  'arylsulfatas b improv locomotor function mous spinal cord injuri',\n",
       "  'world health organ adult adhd self-report scale asr short screen scale use gener popul',\n",
       "  'human milk proresolv mediat stimul resolut acut inflamm',\n",
       "  'cerebr perfus stroke',\n",
       "  'epigenet regul mir-184 mbd1 govern neural stem cell prolifer differenti',\n",
       "  'landscap genet lesion 944 patient myelodysplast syndrom',\n",
       "  'integr molecular genet profil pediatr high-grad glioma reveal key differ adult diseas',\n",
       "  'gene set enrich analysi knowledge-bas approach interpret genome-wid express profil',\n",
       "  'evolut rna multipl function',\n",
       "  'vitro–expand antigen-specif regulatori cell suppress autoimmun diabet',\n",
       "  'stathmin overexpress identifi high-risk patient lymph node metastasi endometri cancer',\n",
       "  'statin prophylaxi inflammatori mediat follow cardiopulmonari bypass systemat review',\n",
       "  'array-bas compar genom hybrid genome-wid screen dna copi number bladder tumor',\n",
       "  'tet2 requir resolv inflamm recruit hdac2 specif repress il-6',\n",
       "  'control immun tnfr-relat molecul ox40 cd134',\n",
       "  'drosophila dhr96 nuclear receptor bind cholesterol regul cholesterol homeostasi',\n",
       "  'neuroimag investig associ aerob fit hippocamp volum memori perform preadolesc children',\n",
       "  'associ matern serum 25-hydroxyvitamin level pregnanc neonat outcom systemat review meta-analysi observ studi',\n",
       "  'β-adrenerg receptor antagon prevent anxiety-lik behavior microgli reactiv induc repeat social defeat',\n",
       "  'vitro differenti transplant neural precursor human embryon stem cell',\n",
       "  'character prostaglandin e2 product candida albican',\n",
       "  'global role klf1 erythropoiesi reveal chip-seq primari erythroid cell',\n",
       "  'koba 2.0 web server annot identif enrich pathway diseas',\n",
       "  'transloc sickl cell erythrocyt microrna plasmodium falciparum inhibit parasit translat contribut malaria resist',\n",
       "  'cd28 itk signal regul autoreact cell traffick',\n",
       "  'delay acceler age share common longev assur mechan',\n",
       "  'arginin deplet mechan immun privileg corneal allograft',\n",
       "  'once-a-day concerta methylphenid versu three-times-daili methylphenid laboratori natur set',\n",
       "  'leaderless gene bacteria clue evolut translat initi mechan prokaryot',\n",
       "  'neuron sirt1 defici increas insulin sensit brain peripher tissu',\n",
       "  'candid causal regulatori effect integr express qtl complex trait genet associ',\n",
       "  'gender-depend differ outcom treatment infect hospit patient',\n",
       "  'compar safeti target therapi metastat colorect cancer elderli younger patient studi use intern pharmacovigil databas',\n",
       "  'cpg island methyl premalign stage gastric carcinoma',\n",
       "  'famili amyloidot polyneuropathi current emerg treatment option transthyretin-medi amyloidosi',\n",
       "  'invari natur killer cell bridg innat adapt immun',\n",
       "  'olmesartan-bas therapi effect way improv blood pressur control cardiovascular protect',\n",
       "  'manslaught fake artesun asia—wil africa next',\n",
       "  'workshop endotheli cell dysfunct lead diabet nephropathi focu nitric oxid',\n",
       "  'nuclear argonaut promot multi-gener epigenet inherit germlin immort',\n",
       "  'autophag program cell death select catalas degrad',\n",
       "  'human epiderm stem cell function regul circadian oscil',\n",
       "  'engraft engin es cell–deriv cardiomyocyt bm cell restor contractil function infarct myocardium',\n",
       "  'hyaluronan impair vascular function drug deliveri mous model pancreat cancer',\n",
       "  'ribos 2′-o-methyl provid molecular signatur distinct self non-self mrna depend rna sensor mda5',\n",
       "  'relationship activ level aerob fit bodi fat 8- 10-yr-old children',\n",
       "  'junction actin assembl mediat formin-lik 2 downstream rac1',\n",
       "  'inhibit hdm2 activ p53 ribosom protein l23',\n",
       "  'associ blood monocyt platelet marker carotid arteri characterist atherosclerosi risk commun carotid mri studi',\n",
       "  'vascular endotheli cadherin control vegfr-2 intern signal intracellular compart',\n",
       "  'diversif hiv-1 envelop hyper-vari domain v2 v4 v5 higher probabl transmitted/found envelop glycosyl favor develop heterolog neutral breadth',\n",
       "  'glycolyt oligodendrocyt maintain myelin long-term axon integr',\n",
       "  'siglec-1 novel dendrit cell receptor mediat hiv-1 trans-infect recognit viral membran gangliosid',\n",
       "  'composit gut microbiota throughout life emphasi earli life',\n",
       "  'intrauterin protein restrict combin earli postnat overfeed associ adult-onset obes produc glucos intoler pancreat dysfunct',\n",
       "  'somat code mutat human induc pluripot stem cell',\n",
       "  'cell cycl cdk cancer chang paradigm',\n",
       "  'sudden infant death syndrom',\n",
       "  'regul heterochromat silenc histon h3 lysine-9 methyl rnai',\n",
       "  'conform chang pore format perforin-rel protein pleurotolysin',\n",
       "  'widespread regul microrna biogenesi function decay',\n",
       "  'cytidin deaminas cem15 induc hypermut newli synthes hiv-1 dna',\n",
       "  'variant toll-interact protein gene associ suscept sepsi chines han popul',\n",
       "  \"children 's estim food portion size develop evalu three portion size assess tool use children\",\n",
       "  '3d map yeast kinetochor reveal presenc core accessori centromere-specif histon',\n",
       "  'american societi clinic oncolog polici statement role oncologist cancer prevent risk assess',\n",
       "  'blm helicas contribut telomer mainten process late-repl intermedi structur',\n",
       "  'format thymu rat es cell xenogen nude mouse↔rat es chimera',\n",
       "  'wnt/beta-catenin signal requir cn non-cn angiogenesi',\n",
       "  'cyanidin-3-rutinosid natur polyphenol antioxid select kill leukem cell induct oxid stress',\n",
       "  'gout-associ uric acid crystal activ nalp3 inflammasom',\n",
       "  'hematopoiet stem cell quiescenc promot error-pron dna repair mutagenesi',\n",
       "  'recruit nck cd3ϵ reveal ligand-induc conform chang essenti cell receptor signal synaps format',\n",
       "  'pseudo-seq genome-wid detect pseudouridin modif rna',\n",
       "  'mammalian epigenom',\n",
       "  'microtubule-associ histon deacetylas 6 support calcium store sensor stim1 mediat malign cell behavior',\n",
       "  'tumor necrosi factor famili receptor rank cd40 cooper establish thymic medullari microenviron self-toler',\n",
       "  'rare common variant twenti argument',\n",
       "  'dna methyl statu predict cell type-specif enhanc activ',\n",
       "  'blm helicas facilit telomer replic lead strand synthesi telomer',\n",
       "  'reflect 25 year myc',\n",
       "  'protect effect exercis phosphoinositid 3-kinas p110alpha signal dilat hypertroph cardiomyopathi',\n",
       "  'effect cigarett smoke alcohol consumpt fruit veget consumpt ivf outcom review present origin data',\n",
       "  'effici mitochondri genom edit crispr/cas9',\n",
       "  'histon variant h2a.z mark 5′ end activ inact gene euchromatin',\n",
       "  'exercis respiratori train improv exercis capac qualiti life patient sever chronic pulmonari hypertens',\n",
       "  'hiv-1 regul latenc monocyte-macrophag lineag cd4+ lymphocyt',\n",
       "  'effect electro-acupunctur therapi post-strok depress patient differ degre motor function impair pilot studi',\n",
       "  'cell receptor ligat induc format dynam regul signal assembl',\n",
       "  'development heterogen cardiac fibroblast predict patholog prolifer activ',\n",
       "  'pre-eclampsia connect angiogen metabol pathway',\n",
       "  'protein lysin acetylated/deacetyl enzym metabolism-rel diseas',\n",
       "  'differenti specif endocrin fgf19 fgf21 fgfr1 fgfr4 complex klb',\n",
       "  'therapeut efficaci multi-epitop vaccin helicobact pylori infect balb/c mice model',\n",
       "  'dna fragment blood plasma cancer patient quantit evid origin apoptot necrot cell',\n",
       "  'pharmacodynam pharmacokinet eptifibatid patient acut coronari syndrom prospect analysi pursuit',\n",
       "  \"proinflammatori cytokin underli inflamm crohn 's diseas\",\n",
       "  'statist method assess agreement two method clinic measur',\n",
       "  'multidrug abc transport bmrc/bmrd bacillu subtili regul via ribosome-medi transcript attenu mechan',\n",
       "  'neural crest sourc mesenchym stem cell special hematopoiet stem cell nich function',\n",
       "  'hotspot aberr epigenom reprogram human induc pluripot stem cell',\n",
       "  'inherit coronari arteri diseas men analysi role chromosom',\n",
       "  'cytoscap 2.8 new featur data integr network visual',\n",
       "  'detect histon modif specif gene loci singl cell histolog section',\n",
       "  'mechanist character sulfur-relay system eukaryot 2-thiouridin biogenesi trna wobbl posit',\n",
       "  'high preval asthma cross countri skier',\n",
       "  'character biochem properti bacillu subtili recq helicas',\n",
       "  'sod1 integr signal oxygen glucos repress respir',\n",
       "  'prognost impact platelet distribut width-to-platelet count ratio patient breast cancer',\n",
       "  'persist lcmv infect control blockad type interferon signal',\n",
       "  'lam6 regul extent contact organel',\n",
       "  'endocrin regul human fetal growth role mother placenta fetu',\n",
       "  'endothelial-to-mesenchym transit contribut cardiac fibrosi',\n",
       "  'coupl local translat degrad regul growth cone collaps',\n",
       "  'cdk11 rangtp-depend microtubul stabil factor regul spindl assembl rate',\n",
       "  'popul dynam pathogen conundrum vivax malaria',\n",
       "  'identif analysi ribonucleas p mrp rna broad rang eukaryot',\n",
       "  'calcium absorpt vari within refer rang serum 25-hydroxyvitamin',\n",
       "  'evolut virul opportunist pathogen gener plastic control',\n",
       "  'genome-wid profil h3k56 acetyl transcript factor bind site human adipocyt',\n",
       "  'detect character circular rna',\n",
       "  'classif unstabl angina revisit',\n",
       "  'alcohol intak blood pressur systemat review implement mendelian random approach',\n",
       "  'rapid sensit rt-quic detect human creutzfeldt-jakob diseas use cerebrospin fluid',\n",
       "  'wortmannin phosphoinositid 3-kinas inhibitor select enhanc cytotox receptor-directed-toxin chimera vitro vivo',\n",
       "  'chronic stress glucocorticoid receptor resist inflamm diseas risk',\n",
       "  'pituitari adenyl cyclase-activ polypeptid pacap neuron-deriv peptid regul glial glutam transport metabol',\n",
       "  'factor influenc b lymphopoiesi allogen hematopoiet cell transplant',\n",
       "  'genet variant rs1994016 rs3825807 adamts7 affect mrna express atherosclerot occlus peripher arteri diseas',\n",
       "  \"distinct pariet tempor pathway homologu broca 's area monkey\",\n",
       "  'mira-seq dna methyl analysi cpg island',\n",
       "  'mani imag auditori scene',\n",
       "  'mobil intracellular copper store ctr2 vacuolar copper transport',\n",
       "  'peroxisom signal platform antivir innat immun',\n",
       "  'two-sid confid interv singl proport comparison seven method stat med',\n",
       "  'nuclear accumul hdac4 atm defici promot neurodegener ataxia-telangiectasia',\n",
       "  'regul function e-cadherin/catenin complex cell monocyte-macrophag lineag dc',\n",
       "  'polymorph ligand depend chang human glucagon-lik peptide-1 receptor glp-1r function alloster rescu loss function mutat',\n",
       "  'neuron circuitri mechan regul adult quiescent neural stem cell fate decis',\n",
       "  'global vitamin level relat age gender skin pigment latitud ecolog meta-regress analysi',\n",
       "  'identif character novel monocyte/macrophag differentiation-depend gene respons lipopolysaccharid ceramid lysophosphatidylcholin',\n",
       "  'novel 3-hydroxysteroid dehydrogenas regul reproduct develop longev',\n",
       "  'argonaut transport sirna cytoplasm nucleu',\n",
       "  'phosphatidylinositol 4,5-bisphosph function second messeng regul cytoskeleton–plasma membran adhes',\n",
       "  'tissue-resid memori cell local specialist immun defenc',\n",
       "  'defect replic stress respons inhibit lymphomagenesi impair lymphocyt reconstitut',\n",
       "  'human dna methylom base resolut show widespread epigenom differ',\n",
       "  'laparoscop adhesiolysi patient chronic abdomin pain blind randomis control multi-centr trial',\n",
       "  'insulin signal dietari restrict differenti influenc declin learn memori age',\n",
       "  'uniqu respons pathway establish alloster interact among nuclear hormon receptor',\n",
       "  'midlif late‐lif vascular risk factor white matter microstructur integr atherosclerosi risk commun neurocognit studi',\n",
       "  'kra gene amplif overexpress mutat associ aggress metastat endometri cancer',\n",
       "  'hyperhomocysteinemia atherosclerot vascular diseas pathophysiolog screen treatment',\n",
       "  'best -- worst scale health care research',\n",
       "  'genet variant non-genet factor predict circul vitamin level hispan non-hispan white women breast cancer health dispar studi',\n",
       "  'gener character methyl-lysin histon antibodi',\n",
       "  'hallmark age',\n",
       "  'sensit mass spectrometri platform identifi metabol chang life histori trait c. elegan',\n",
       "  'characteris antibiot prescript acut respiratori tract infect danish gener practic retrospect registri base cohort studi',\n",
       "  'lack skelet muscl il-6 affect pyruv dehydrogenas activ rest prolong exercis',\n",
       "  'clinic patholog characterist patient brca-posit brca-neg breast cancer',\n",
       "  'interferon success anti-vir immunotherapi',\n",
       "  'genet analysi human obes italian sampl',\n",
       "  'non-cod rna landscap human hematopoiesi leukemia',\n",
       "  'incid risk central nervou system metastas site first recurr patient her2-posit breast cancer treat adjuv trastuzumab',\n",
       "  'neutrophil activ regul innat adapt immun',\n",
       "  'function dna methyl island start site gene bodi beyond',\n",
       "  'metaplasia transdifferenti pure biolog clinic',\n",
       "  'pioglitazon use risk bladder cancer common cancer person diabet',\n",
       "  'embryon stem cell line human blastocyst somat differenti vitro',\n",
       "  'multipoint kra oncogen mutat potenti indic mucin carcinoma entir spectrum mucin ovarian neoplasm',\n",
       "  'identif distinct regul yeast tata box-contain gene',\n",
       "  'il6 deriv cancer-associ fibroblast promot chemoresist via cxcr7 esophag squamou cell carcinoma',\n",
       "  'myelodysplast syndrom revisit role bone marrow microenviron diseas pathogenesi',\n",
       "  'smc complex differenti compact mitot chromosom accord genom context',\n",
       "  'pattern chlamydia test differ set implic wider sti diagnosi care probabl sampl survey british popul',\n",
       "  'treatment nonalcohol fatti liver diseas role ampk',\n",
       "  'microenvironment-depend growth pre-neoplast malign plasma cell human mice',\n",
       "  'effect activ charcoal hemoperfus renal function patient paraquat poison',\n",
       "  'diabetes-induc effect cardiomyocyt chick embryon heart micromass mous embryon d3 differenti stem cell',\n",
       "  'motion magnif',\n",
       "  'human trpml1 channel structur open close conform',\n",
       "  'integr genom viewer igv high-perform genom data visual explor',\n",
       "  'genom engin use target cancer-associ enhanc',\n",
       "  'long‐term follow‐up cd19 car therapi acut lymphoblast leukemia',\n",
       "  'periosteum contain skelet stem cell high bone regen potenti control periostin',\n",
       "  'metabol strike back metabol flux regul cell signal',\n",
       "  'associ pembrolizumab tumor respons surviv among patient advanc melanoma',\n",
       "  'inflammatori signal human tuberculosi granuloma spatial organ',\n",
       "  'suppress interferon-medi anti-hbv respons singl cpg methyl 5′-utr trim22',\n",
       "  'development analysi bone marrow neutrophil reveal popul special expans traffick effector function',\n",
       "  'tak1-medi autophagi fatti acid oxid prevent hepatosteatosi tumorigenesi',\n",
       "  'formin junction',\n",
       "  'crispr adapt bias explain prefer acquisit foreign dna',\n",
       "  'high-resolut map open chromatin rice genom',\n",
       "  'prospect studi bodi fat distribut risk endometri cancer',\n",
       "  'breast cancer cluster northeast unit state geograph analysi',\n",
       "  'cd200r/cd200 inhibit osteoclastogenesi new mechan osteoclast control mesenchym stem cell human',\n",
       "  'tumor-specif th17-polar cell erad larg establish melanoma',\n",
       "  'defin commun acquir pneumonia sever present hospit intern deriv valid studi',\n",
       "  'mitochondri iron chelat amelior cigarette-smok induc bronchiti emphysema mice',\n",
       "  'cancer-associ fibroblast neutral anti-tumor effect csf1 receptor blockad induc pmn-mdsc infiltr tumor',\n",
       "  'phenotyp deficit hiv-1 envelop associ matur v2-direct broadli neutral antibodi lineag',\n",
       "  'high somat mutat neoantigen burden correl decreas progression-fre surviv multipl myeloma',\n",
       "  'postmarket safeti event among novel therapeut approv us food drug administr 2001 2010',\n",
       "  'risk chronic obstruct pulmonari diseas spatial epidemiolog analysi health insur claim copd northeastern germani',\n",
       "  'larg intergen non-cod rna-ror modul reprogram human induc pluripot stem cell',\n",
       "  'extracellular vesicl isol character toward clinic applic',\n",
       "  'up-regul nrip2 colorect cancer initi cell modul wnt pathway target rorβ',\n",
       "  'speed limit nonvesicular intracellular sterol transport',\n",
       "  'misunderstand prescrib decis gener practic qualit studi',\n",
       "  'phase-pl cryo-em structur bias agonist-bound human glp-1 receptor–g complex',\n",
       "  'therapeut equival alendron 70 mg once-weekli alendron 10 mg daili treatment osteoporosi alendron once-weekli studi group',\n",
       "  'associ toll-lik receptor 4 human monocyt subset vulner characterist coronari plaqu assess 64-slice multidetector comput tomographi',\n",
       "  'expand cardiovascular progenitor cell reprogram fibroblast',\n",
       "  'thyroid hormon inhibit lung fibrosi mice improv epitheli mitochondri function',\n",
       "  'tenomodulin promot human adipocyt differenti benefici viscer adipos tissu expans',\n",
       "  'evid limit human lifespan',\n",
       "  'effect oral semaglutid compar placebo subcutan semaglutid glycem control patient type 2 diabet random clinic trial',\n",
       "  'fast accur short read align burrows–wheel transform',\n",
       "  'financi cost doctor emigr sub-saharan africa human capit analysi',\n",
       "  'chromatin modifi enzym modul reprogram',\n",
       "  'natur variat paramet innat immun cell preferenti driven genet factor',\n",
       "  'transcript program function heterogen clinic target mast cell',\n",
       "  'lin28b enhanc tumorigenesi autochthon krasg12v-driven lung carcinoma mous model',\n",
       "  'cost-effect comparison topic silver sulfadiazin enclos silver dress partial-thick burn treatment',\n",
       "  'random clinic studi hydrofib dress silver silver sulfadiazin manag partial-thick burn',\n",
       "  'hepat c viru blood transfus past present risk',\n",
       "  'p62/sqstm1 bind vitamin receptor inhibit hepat stellat cell activ fibrosi liver cancer',\n",
       "  'develop criteria evalu geroprotector key stage toward translat clinic',\n",
       "  'β-catenin signal role liver homeostasi injuri tumorigenesi',\n",
       "  'global burden dengu analysi global burden diseas studi 2013',\n",
       "  'formin-medi actin polymer cell–cel junction stabil e-cadherin maintain monolay integr wound repair',\n",
       "  'mechan activ heterotyp e-cadherin/n-cadherin adhes enabl fibroblast drive cancer cell invas',\n",
       "  'long non-cod rna hottip promot bcl-2 express induc chemoresist small cell lung cancer spong mir-216a',\n",
       "  'gsd 2.0 upgrad gene featur visual server',\n",
       "  'slp-65 regul immunoglobulin light chain gene recombin pi 3 k-pkb-foxo pathway',\n",
       "  'case-mix classif system explain healthcar cost use administr data itali',\n",
       "  'epcam-regul intramembran proteolysi induc cancer stem cell-lik gene signatur hepat b virus-infect hepatocyt',\n",
       "  'parathyroid hormon direct bone marrow mesenchym cell fate',\n",
       "  'metformin attenu blood-brain barrier disrupt mice follow middl cerebr arteri occlus',\n",
       "  'epstein-barr viru nuclear antigen 1 ebna1 confer resist apoptosi ebv-posit b-lymphoma cell up-regul survivin',\n",
       "  'microfluid platform evalu migrat cell patient dyt1 dystonia',\n",
       "  'sugar-sweeten beverag weight gain children adult systemat review meta-analysi',\n",
       "  'tumorigen potenti pluripot stem cell minim',\n",
       "  'epidemiolog sepsi septic shock critic care unit comparison sepsis-2 sepsis-3 popul use nation critic care databas',\n",
       "  'thymic express golli-myelin basic protein gene sjl/j mous',\n",
       "  'urin microrna biomark bladder cancer diagnost meta-analysi',\n",
       "  'elev plasma transform growth factor bgr 1 level predict develop hypertens normotens 14-year follow-up studi',\n",
       "  'myc disrupt circadian clock metabol cancer cell',\n",
       "  'integr map quail coturnix japonica confirm high degre synteni conserv chicken gallu gallu despit 35 million year diverg',\n",
       "  'cadherin activ requir activity-induc spine remodel',\n",
       "  'aliskiren combin losartan type 2 diabet nephropathi',\n",
       "  'overweight celiac diseas preval clinic characterist effect gluten-fre diet',\n",
       "  'structur studi four-mbt repeat protein mbtd1',\n",
       "  'glutamin support pancreat cancer growth kras-regul metabol pathway',\n",
       "  'cd4+ cell help guid format cd103+ lung-resid memori cd8+ cell influenza viral infect',\n",
       "  'inhibit apoptosi overcom stage-rel compat barrier chimera format mous embryo',\n",
       "  'comput statist analys amino acid usag physico-chem properti twelv late embryogenesi abund protein class',\n",
       "  'direct reprogram hepat myofibroblast hepatocyt vivo attenu liver fibrosi',\n",
       "  'epitheli mesenchym transit tgfβ-1 induct increas stem characterist primari non small cell lung cancer cell line',\n",
       "  'dnmt3a dnmt3b associ enhanc regul human epiderm stem cell homeostasi',\n",
       "  'cdk inhibitor cancer therapi next',\n",
       "  'lipid desatur metabol marker therapeut target ovarian cancer stem cell',\n",
       "  'mesenchym inflamm drive genotox stress hematopoiet stem cell predict diseas evolut human pre-leukemia',\n",
       "  'novel function set lipid-deriv mediat antiinflammatori action gener omega-3 fatti acid via cyclooxygenas 2–nonsteroid antiinflammatori drug transcellular process',\n",
       "  'cholesteryl ester transfer protein cetp polymorph affect mrna splice hdl level sex-depend cardiovascular risk',\n",
       "  '6-sulphat chondroitin posit influenc axon regener',\n",
       "  'tissu mechan orchestr wnt-depend human embryon stem cell differenti',\n",
       "  'predict perform quick sequenti organ failur assess score screen tool sepsi mortal intens care unit admiss patient febril neutropenia',\n",
       "  'lin28 regul stem cell metabol convers prime pluripot',\n",
       "  'genet drift compromis mitochondri replac nuclear transfer human oocyt',\n",
       "  'tal effector remot control gene activ',\n",
       "  'vascular heterogen special develop diseas',\n",
       "  'associ intracerebr hemorrhag among patient take non–vitamin k antagonist vs vitamin k antagonist oral anticoagul in-hospit mortal',\n",
       "  'elev red blood cell distribut width contribut poor prognosi patient undergo resect nonmetastat rectal cancer',\n",
       "  'health worker cohort studi method studi design',\n",
       "  'aberr pro-atri natriuret peptide/corin/natriuret peptid receptor signal present matern vascular endothelium preeclampsia',\n",
       "  'optimis strategi plasmodium falciparum malaria elimin cambodia primaquin mass drug administr artemisinin resist',\n",
       "  'role parasite-deriv prostaglandin d2 inhibit epiderm langerhan cell migrat schistosomiasi infect',\n",
       "  'axicabtagen ciloleucel car t‐cell therapi refractori larg b‐cell lymphoma',\n",
       "  'beta adrenerg blockad decreas immunomodulatori effect social disrupt stress',\n",
       "  'stereotact radiosurgeri plu whole-brain radiat therapi vs stereotact radiosurgeri alon treatment brain metastas random control trial',\n",
       "  'rank signal cd4+3− induc cell regul develop aire-express epitheli cell thymic medulla',\n",
       "  'proteom approach character biochemistri meat qualiti defect',\n",
       "  'phosphoryl janu kinas 1 jak1 amp-activ protein kinas ampk link energi sens anti-inflammatori signal',\n",
       "  'iap antagonist induc anti-tumor immun multipl myeloma',\n",
       "  'psychobiolog protect factor modifi associ age sexual health men find men ’ health 40+ studi',\n",
       "  'patient-deriv induc pluripot stem cell cancer research precis oncolog',\n",
       "  'structur basi sequence-specif recognit dna tal effector',\n",
       "  'caveolin-1 delet exacerb cardiac interstiti fibrosi promot m2 macrophag activ mice myocardi infarct',\n",
       "  'lipid hydroperoxid measur oxid fe2+ presenc xylenol orang comparison tba assay iodometr method',\n",
       "  'role exosom cardioprotect',\n",
       "  'rate chang declin steroid hormon new paramet healthi age men',\n",
       "  'develop novel helper-depend adenovirus-epstein-barr viru hybrid system stabl transform mammalian cell',\n",
       "  'spliceosom assembl pathway differ type altern splice converg commit splice site pair complex',\n",
       "  'transcript mhm region chicken z chromosom accumul non-cod rna nucleu femal cell adjac dmrt1 locu',\n",
       "  'macropinocytosi protein amino acid suppli rout ras-transform cell',\n",
       "  'link splice pol ii transcript stabil pre-mrna influenc splice pattern',\n",
       "  'emerg role skelet muscl extracellular matrix remodel obes exercis',\n",
       "  'effect specif exercis strategi need surgeri patient subacromi imping syndrom randomis control studi',\n",
       "  'nucleotid sequenc avian sarcoma viru oncogen src propos amino acid sequenc gene product',\n",
       "  'issu design interpret mdr-tb clinic trial report first global mdr-tb clinic trial landscap meet',\n",
       "  'para-aort splanchnopleura earli mous embryo contain b1a cell progenitor',\n",
       "  'establish cultur pluripotenti cell mous embryo',\n",
       "  'mhc class ii interact cd4 mediat region analog mhc class bind site cd8',\n",
       "  'instabl decay primari structur dna',\n",
       "  'single-cel proteom analysi s. cerevisia reveal architectur biolog nois',\n",
       "  'direct convers fibroblast function neuron defin factor',\n",
       "  'inflammasome-medi dysbiosi regul progress nafld obes',\n",
       "  'chromatin remodel promot suppress antisens transcript',\n",
       "  'human mitochondri dead-box protein ddx28 resid rna granul function mitoribosom assembl',\n",
       "  'convers adult pancreat α-cell β-cell extrem β-cell loss',\n",
       "  'driver mutat histon h3.3 chromatin remodel gene paediatr glioblastoma',\n",
       "  'translat control intron splice eukaryot',\n",
       "  'altern activ macrophag produc catecholamin sustain adapt thermogenesi',\n",
       "  'altern lengthen telomer mediat mitot dna synthesi engag break-induc replic process',\n",
       "  'light act directli organ cell cultur set vertebr circadian clock',\n",
       "  'small molecul inhibit kras–pdeδ interact impair oncogen kra signal',\n",
       "  'evolut novel cooper swarm bacterium myxococcu xanthu',\n",
       "  'exon duplic diverg human preproglucagon gene',\n",
       "  'bh1 bh2 domain bcl-2 requir inhibit apoptosi heterodimer bax',\n",
       "  'kap1 control endogen retrovirus embryon stem cell',\n",
       "  'tor signal pathway control nuclear local nutrient-regul transcript factor',\n",
       "  'inhibit pluripotenti embryon stem cell differenti purifi polypeptid',\n",
       "  'pancreat cancer genom reveal aberr axon guidanc pathway gene',\n",
       "  'rejuven age progenitor cell exposur young system environ',\n",
       "  'continu single-cel imag blood gener haemogen endothelium',\n",
       "  'format germ-lin chimaera embryo-deriv teratocarcinoma cell line',\n",
       "  'chloroquin resist link mdr-like gene plasmodium falciparum cross',\n",
       "  'identif cold receptor reveal gener role trp channel thermosens',\n",
       "  'surfac mechan mediat pattern format develop retina',\n",
       "  'role inscut orient asymmetr cell divis drosophila',\n",
       "  'specif interfer ingest dsrna',\n",
       "  'bacteri rna small antivir compound activ caspase-1 cryopyrin/nalp3',\n",
       "  'control cortic gaba circuitri develop nrg1 erbb4 signal',\n",
       "  'obes medic problem',\n",
       "  'nonlinear elast biolog gel',\n",
       "  'live-cel delamin counterbal epitheli growth limit tissu overcrowd',\n",
       "  'broad antiretrovir defenc human apobec3g lethal edit nascent revers transcript',\n",
       "  'gener cell polar plant link endocytosi auxin distribut cell fate decis',\n",
       "  'congenit leptin defici associ sever early-onset obes human',\n",
       "  'target cell-surfac β-amyloid precursor protein lysosom altern process amyloid-bear fragment',\n",
       "  'keratin cytoskelet protein regul protein synthesi epitheli cell growth',\n",
       "  'co-cryst structur hnf-3/fork head dna-recognit motif resembl histon h5',\n",
       "  'mechan link extra centrosom chromosom instabl',\n",
       "  'haematopoiet stem cell earli lymphoid progenitor occupi distinct bone marrow nich',\n",
       "  'broad neutral coverag hiv multipl highli potent antibodi',\n",
       "  'coordin rho gtpase activ cell protrus',\n",
       "  'understand mechan underli human gene express variat rna sequenc',\n",
       "  'mesenchym haematopoiet stem cell form uniqu bone marrow nich',\n",
       "  'respons self antigen imprint regulatori memori tissu',\n",
       "  'reprogram human somat cell pluripot defin factor',\n",
       "  'haematopoiet stem cell asymmetr segreg chromosom retain brdu',\n",
       "  'circadian clock human red blood cell',\n",
       "  \"g-protein-coupl receptor kaposi 's sarcoma-associ herpesviru viral oncogen angiogenesi activ\",\n",
       "  'therapeut potenti gsk-j4 histon demethylas kdm6b/jmjd3 inhibitor acut myeloid leukemia',\n",
       "  'structur proton-g urea channel gastric pathogen helicobact pylori',\n",
       "  'drosophila oocyt local mediat differenti cadherin-bas adhes',\n",
       "  'somat sex ident cell-autonom chicken',\n",
       "  'centrosom polar deliv secretori granul immunolog synaps',\n",
       "  'deubiquitin p53 hausp import pathway p53 stabil',\n",
       "  'defect tryptophan catabol underli inflamm mous chronic granulomat diseas',\n",
       "  'experiment theoret studi mitot spindl orient',\n",
       "  'chromothripsi dna damag micronuclei',\n",
       "  'dna-bind factor shape mous methylom distal regulatori region',\n",
       "  'molecular basi rna-depend rna polymeras ii activ',\n",
       "  'bacteria activ sensori neuron modul pain inflamm',\n",
       "  'e2f1-3 switch activ progenitor cell repressor differenti cell',\n",
       "  'k-ra g12c inhibitor alloster control gtp affin effector interact',\n",
       "  'cyclin regul kinetochore-microtubul promot faith chromosom segreg',\n",
       "  'induc pluripot stem cell spinal muscular atrophi patient',\n",
       "  'role mitochondria nlrp3 inflammasom activ',\n",
       "  'break-induc telomer synthesi underli altern telomer mainten',\n",
       "  'innat immun induc composition-depend rig-i recognit hepat c viru rna',\n",
       "  'gener transgen non-human primat germlin transmiss',\n",
       "  'induct human neuron cell defin transcript factor',\n",
       "  'paar-repeat protein sharpen diversifi type vi secret system spike',\n",
       "  'replic stress activ dna repair synthesi mitosi',\n",
       "  'specif amyloid-β protein assembl brain impair memori',\n",
       "  'cleavag gsdmd inflammatori caspas determin pyroptot cell death',\n",
       "  'role corin trophoblast invas uterin spiral arteri remodel pregnanc',\n",
       "  'metabol rescu pluripot cell patient mtdna diseas',\n",
       "  'yeast pif1p helicas remov telomeras telomer dna',\n",
       "  'small regulatori rna inhibit rna polymeras ii elong phase transcript',\n",
       "  'cdk1 suffici drive mammalian cell cycl',\n",
       "  'calori restrict extend saccharomyc cerevisia lifespan increas respir',\n",
       "  'mosaic ppm1d mutat associ predisposit breast ovarian cancer',\n",
       "  'immunogen induc pluripot stem cell',\n",
       "  'direct convers human fibroblast multilineag blood progenitor',\n",
       "  'mical link semaphorin f-actin disassembl',\n",
       "  'novel foxo1-depend transcript program control treg cell function',\n",
       "  'function screen identifi mirna induc cardiac regener',\n",
       "  'specif sensory–motor connect encod sema3e–plxnd1 recognit',\n",
       "  'chromatin remodel complex involv transcript dna process',\n",
       "  'oncogen pathway signatur human cancer guid target therapi',\n",
       "  'ctcf mediat methylation-sensit enhancer-block activ h19/igf2 locu',\n",
       "  'broad potent neutral hiv-1 gp41-specif human antibodi',\n",
       "  'disrupt hepcidin/ferroportin regulatori system caus pulmonari iron overload restrict lung diseas',\n",
       "  'genome-wid genet analysi polyploidi yeast',\n",
       "  'divers herit lineag imprint earli haematopoiet progenitor',\n",
       "  'crowd induc live cell extrus maintain homeostat cell number epithelia',\n",
       "  'direct observ ligand recognit cell',\n",
       "  'crypt stem cell cells-of-origin intestin cancer',\n",
       "  'microbi engin product advanc biofuel',\n",
       "  'sperm chromatin proteom identifi evolutionarili conserv fertil factor',\n",
       "  'nanog safeguard pluripot mediat germlin develop',\n",
       "  'succin inflammatori signal induc il-1β hif-1α',\n",
       "  'planar cell polar signal coupl cell divis morphogenesi neurul',\n",
       "  'challeng new drug discoveri tuberculosi',\n",
       "  'subunit arrang phenylethanolamin bind glun1/glun2b nmda receptor',\n",
       "  \"associ nod2 leucine-rich repeat variant suscept crohn 's diseas\",\n",
       "  'human cardiovascular progenitor cell develop kdr+ embryonic-stem-cell-deriv popul',\n",
       "  'cancer-rel inflamm',\n",
       "  'escrt-iii recognit vps4 atpas',\n",
       "  'pif1 famili helicas suppress genom instabl g-quadruplex motif',\n",
       "  'lysyl oxidas essenti hypoxia-induc metastasi',\n",
       "  'identif human brain tumour initi cell',\n",
       "  'anthropometr refer data intern use recommend world health organ expert committe',\n",
       "  'divers intervent extend mous lifespan suppress share age-associ epigenet chang critic gene regulatori region',\n",
       "  'extracellular vesicl drug deliveri',\n",
       "  'effect soy isoflavon phytat homocystein c-reactiv protein iron statu postmenopaus women',\n",
       "  'replic fork stabil confer chemoresist brca-defici cell',\n",
       "  'plasma corin predictor cardiovascular event patient chronic heart failur',\n",
       "  'cryo-em structur tau filament alzheim ’ diseas brain',\n",
       "  'modul proteoglycan receptor ptpσ promot recoveri spinal cord injuri',\n",
       "  'gp130–src–yap modul link inflamm epitheli regener',\n",
       "  'hemoglobin concentr white black orient children need separ criteria screen anemia',\n",
       "  'diverg reprogram rout lead altern stem-cel state',\n",
       "  'autophagi mediat degrad nuclear lamina',\n",
       "  'pro-resolv lipid mediat lead resolut physiolog',\n",
       "  'zmynd11 link histon h3.3k36me3 transcript elong tumour suppress',\n",
       "  'autocrin bdnf–trkb signal within singl dendrit spine',\n",
       "  'whole genom redefin mutat landscap pancreat cancer',\n",
       "  'human oocyt reprogram adult somat nuclei type 1 diabet diploid pluripot stem cell',\n",
       "  'three-dimension human neural cell cultur model alzheim ’ diseas',\n",
       "  'mesenchymal-endothelial-transit contribut cardiac neovascular',\n",
       "  'estim optim serum concentr 25-hydroxyvitamin multipl health outcom',\n",
       "  'cohesin-depend globul heterochromatin shape 3d genom architectur s. pomb',\n",
       "  'tempor shift circuit mediat retriev fear memori',\n",
       "  'deriv novel human ground state naiv pluripot stem cell',\n",
       "  'predict immunogen tumour mutat combin mass spectrometri exom sequenc',\n",
       "  'vivo genom edit use staphylococcu aureu cas9',\n",
       "  'effect exercis intens cardiovascular fit total bodi composit viscer adipos obes adolesc',\n",
       "  'low methionin ingest rat extend life span',\n",
       "  'epicatechin cocoa polyphenol extract modul gene express human caco-2 cell',\n",
       "  'atla activ enhanc across human cell type tissu',\n",
       "  'precis microbiom reconstitut restor bile acid mediat resist clostridium difficil',\n",
       "  'transcript initi complex structur elucid dna open',\n",
       "  'multipl mechan disrupt let-7 microrna famili neuroblastoma',\n",
       "  'radiat dual checkpoint blockad activ non-redund immun mechan cancer',\n",
       "  'g-protein-independ coupl mc4r kir7.1 hypothalam neuron',\n",
       "  'role ghrelin relationship hyperphagia acceler gastric empti diabet mice',\n",
       "  'human serum 25-hydroxycholecalciferol respons extend oral dose cholecalciferol',\n",
       "  'intratumor heterogen branch evolut reveal multiregion sequenc',\n",
       "  'success microbi consortia develop infant gut microbiom',\n",
       "  'gamma-tocopherol major form vitamin e us diet deserv attent',\n",
       "  \"disclosur apo genotyp risk alzheim 's diseas\",\n",
       "  'blood pressur incid twelv cardiovascular diseas lifetim risk healthi life-year lost age-specif associ 1·25 million peopl',\n",
       "  'onlin consum contribut drug knowledg mixed-method comparison consumer-gener profession control psychotrop medic inform internet',\n",
       "  'effect supplement zinc growth serum zinc concentr prepubert children meta-analysi random control trial',\n",
       "  'mechan age-rel macular degener',\n",
       "  'n-end rule pathway regul pathogen respons plant',\n",
       "  'h3k9 demethylas kdm4e epigenet regul bovin embryon develop defect factor nuclear reprogram',\n",
       "  'risk gestat hypertens relat folic acid supplement pregnanc',\n",
       "  'air regul neg select organ-specif cell',\n",
       "  'extracellular acid ph activ sterol regulatori element-bind protein 2 promot tumor progress',\n",
       "  'mutat human circadian clock gene cry1 famili delay sleep phase disord',\n",
       "  'later hypothalam signal mechan underli feed stimul differenti contribut src famili tyrosin kinas feed trigger either nmda inject food depriv',\n",
       "  'relationship advanc glycat end‐product accumul low skelet muscl mass japanes men women',\n",
       "  'large-scal profil reveal influenc genet variat gene express human induc pluripot stem cell',\n",
       "  'ethanol extract allium fistulosum inhibit develop non-alcohol fatti liver diseas',\n",
       "  'cardiovascular risk factor childhood carotid arteri intima-media thick adulthood cardiovascular risk young finn studi',\n",
       "  'microrna-29 induc cellular senesc age muscl multipl signal pathway',\n",
       "  'rictor novel bind partner mtor defin rapamycin-insensit raptor-independ pathway regul cytoskeleton',\n",
       "  'activ estrogen receptor phosphoryl mitogen-activ protein kinas',\n",
       "  'regul antimicrobi respons nlr protein',\n",
       "  'acetylcystein prevent acut deterior renal function follow elect coronari angiographi intervent random control trial',\n",
       "  'dna methyl human cerebr cortex dynam regul throughout life span involv differenti neuron',\n",
       "  'mulberri leav moru alba l. amelior obesity-induc hepat lipogenesi fibrosi oxid stress high-fat diet-f mice',\n",
       "  'hmg-coa reductas inhibitor risk hip fractur elderli patient',\n",
       "  'qualiti modern cross-sect ecolog studi bibliometr review',\n",
       "  'efficaci beta1 integrin egfr target sphere-form human head neck cancer cell',\n",
       "  'anxieti',\n",
       "  'challeng overcom antibiot resist plant extract potenti sourc antimicrobi resist modifi agent',\n",
       "  'effect n-acetylcystein nucleu accumben neurotransmiss relaps cocain',\n",
       "  'phospholipid transfer function er-mitochondria encount structur reveal vitro',\n",
       "  'integrin β3–kras–ralb complex drive tumour stem resist egfr inhibit',\n",
       "  'gain toxic apolipoprotein e4 effect human ipsc-deriv neuron amelior small-molecul structur corrector',\n",
       "  'lncrna neat1/let-7a-5p axi regul cisplatin resist nasopharyng carcinoma target rsf-1 modul ras-mapk pathway',\n",
       "  'antibacteri peptid microcin j25 inhibit transcript bind within obstruct rna polymeras secondari channel',\n",
       "  'explor exploit system effect deregul replic licens',\n",
       "  'regulatori principl pluripot ground state',\n",
       "  'neonat mortal level 193 countri 2009 trend sinc 1990 systemat analysi progress project prioriti',\n",
       "  'neuroprotect effect four phenylethanoid glycosid h2o2-induc apoptosi pc12 cell via nrf2/are pathway',\n",
       "  'mortal risk attribut high low ambient temperatur multicountri observ studi',\n",
       "  'survivin requir endomitot cell cycl megakaryocyt',\n",
       "  'β1 integrin mediat altern surviv pathway breast cancer cell resist lapatinib',\n",
       "  'incid trend sepsi us hospit use clinic vs claim data 2009-2014',\n",
       "  'body-mass index risk 22 specif cancer population-bas cohort studi 5·24 million uk adult',\n",
       "  'cryo-em structur herpesviru capsid 3.1 å',\n",
       "  'asymptot resampl strategi assess compar indirect effect multipl mediat model',\n",
       "  'distinct metabolom signatur associ longev human',\n",
       "  'expand problem adipos depot remodel postnat adipocyt progenitor recruit',\n",
       "  'clonal competit bcrabl-driven leukemia transplant acceler clonal convers',\n",
       "  'open babel open chemic toolbox',\n",
       "  'young adolesc nutrit assess comput yana-c',\n",
       "  'antiretrovir therapi prevent tuberculosi adult hiv systemat review meta-analysi',\n",
       "  'diabet metabol syndrom breast cancer review current evid',\n",
       "  'loss tdp43 inhibit progress triple-neg breast cancer coordin srsf3',\n",
       "  'atherosclerot plaqu ruptur -- patholog basi plaqu stabil instabl',\n",
       "  'pioneer factor pax7 deploy stabl enhanc repertoir specif cell fate',\n",
       "  'human cancer cell util mitot dna synthesi resist replic stress telomer regardless telomer mainten mechan',\n",
       "  'low drug level thrombot complic high‐risk atrial fibril patient treat direct oral anticoagul',\n",
       "  'consensu guidelin detect immunogen cell death',\n",
       "  'long-term erk inhibit kras-mut pancreat cancer associ myc degrad senescence-lik growth suppress',\n",
       "  'trf2 recruit rtel1 telomer phase promot t-loop unwind',\n",
       "  'macrophag facilit electr conduct heart',\n",
       "  'tunabl diffusion‐consumpt mechan cytokin propag enabl plastic cell‐to‐cel commun immun system',\n",
       "  'cardiac neural crest contribut cardiomyogenesi zebrafish',\n",
       "  'sodium hydroxid product seawat desalin brine process design energi effici',\n",
       "  'high-throughput genet screen identifi larg divers collect new sporul gene bacillu subtili',\n",
       "  'psychobiolog mechan underli social buffer hypothalamic-pituitary-adrenocort axi review anim model human studi across develop',\n",
       "  'elev circul branched-chain amino acid earli event human pancreat adenocarcinoma develop',\n",
       "  'effect use pi3k mek inhibitor treat mutant k-ra g12d pik3ca h1047r murin lung cancer',\n",
       "  'transdifferenti glioblastoma cell vascular endotheli cell',\n",
       "  'ribosom dna copi loss repeat instabl atrx-mut cancer',\n",
       "  'combin indoor residu spray insecticide-tr net malaria control africa review possibl outcom outlin suggest futur',\n",
       "  'membran estrogen receptor-α level mcf-7 breast cancer cell predict camp prolifer respons',\n",
       "  'embryon cell lineag nematod caenorhabd elegan',\n",
       "  'self-react b cell germin center reaction',\n",
       "  'chronic inflamm inflammag potenti contribut age-associ diseas',\n",
       "  'cryptochrom enabl plant anim determin circadian time',\n",
       "  'neural crest-deriv stem cell migrat differenti cardiomyocyt myocardi infarct',\n",
       "  'mitochondria sensor regul calcium signal',\n",
       "  'caspase-11 promot fusion phagosom harbor pathogen bacteria lysosom modul actin polymer',\n",
       "  'adipocyt inflamm essenti healthi adipos tissu expans remodel',\n",
       "  'chronic variabl stress activ hematopoiet stem cell',\n",
       "  'cntf revers obesity-induc insulin resist activ skelet muscl ampk',\n",
       "  'global spread hepat c viru 1a 1b phylodynam phylogeograph analysi',\n",
       "  'pharmacolog intervent smoke cessat overview network meta-analysi',\n",
       "  'librari yeast transcript factor motif reveal widespread function rsc3 target nucleosom exclus promot',\n",
       "  'epha3 maintain tumorigen therapeut target glioblastoma multiform',\n",
       "  'chimer antigen receptor-modifi cell acut lymphoid leukemia',\n",
       "  'extended-connect fingerprint',\n",
       "  'suppressor cytokin signal 3 inhibit antivir ifn-beta signal enhanc hiv-1 replic macrophag',\n",
       "  'molecular model human 26 proteasom',\n",
       "  'urinari bisphenol concentr earli reproduct health outcom among women undergo ivf',\n",
       "  'cost-effect option diagnosi high blood pressur primari care model studi',\n",
       "  'folic acid improv endotheli function coronari arteri diseas via mechan larg independ homocystein lower',\n",
       "  'focal adhes kinas link mechan forc skin fibrosi via inflammatori signal',\n",
       "  'prognost accuraci sofa score sir criteria qsofa score in-hospit mortal among adult suspect infect admit intens care unit',\n",
       "  'predictor mammograph densiti insight gain novel regress analysi twin studi',\n",
       "  'shape landscap escherichia coli chromosom replication-transcript encount cell ectop replic origin',\n",
       "  'epithelial–mesenchym transit tumour progress',\n",
       "  'platelet interfac thrombosi inflamm cancer',\n",
       "  'cellular role dna topoisomeras molecular perspect',\n",
       "  'microrna spong progress possibl',\n",
       "  'wip1 phosphatas regul p53-depend apoptosi stem cell tumorigenesi mous intestin',\n",
       "  'shunt problem control function shunt normal tumour vasculatur',\n",
       "  'pharmacolog blockad asct2-depend glutamin transport lead anti-tumor efficaci preclin model',\n",
       "  'antidepress decreas csf aβ product healthi individu transgen ad mice',\n",
       "  'variat qualiti sustain long-term glycaem control continu subcutan insulin infus',\n",
       "  'histor review megakaryopoiesi thrombopoiesi',\n",
       "  'obes metabol complic role adipokin relationship obes inflamm insulin resist dyslipidemia nonalcohol fatti liver diseas',\n",
       "  'combat trastuzumab resist target src common node downstream multipl resist pathway',\n",
       "  'microrna new tool diagnosi prognosi therapi hepatocellular carcinoma',\n",
       "  'vertebr gene ticrr essenti checkpoint replic regul',\n",
       "  'matern methyl cpg island kvlqt1 associ antisens patern transcript loss imprint beckwith-wiedemann syndrom',\n",
       "  'alarm level drug-resist tuberculosi belaru result survey minsk',\n",
       "  'partit regulatori mechan within-host malaria dynam use effect propag number',\n",
       "  ...],\n",
       " ['alter architectur cerebr white matter develop human brain affect cortic develop result function disabl line scan diffusion-weight magnet reson imag mri sequenc diffus tensor analysi appli measur appar diffus coeffici calcul rel anisotropi delin three-dimension fiber architectur cerebr white matter preterm n 17 full-term infant n 7 assess effect prematur cerebr white matter develop earli gestat preterm infant n 10 studi second time term central white matter mean appar diffus coeffici 28 wk high 1.8 microm2/m decreas toward term 1.2 microm2/m posterior limb intern capsul mean appar diffus coeffici time similar 1.2 versu 1.1 microm2/m rel anisotropi higher closer birth term greater absolut valu intern capsul central white matter preterm infant term show higher mean diffus coeffici central white matter 1.4 +/- 0.24 versu 1.15 +/- 0.09 microm2/m p 0.016 lower rel anisotropi area compar full-term infant white matter 10.9 +/- 0.6 versu 22.9 +/- 3.0 p 0.001 intern capsul 24.0 +/- 4.44 versu 33.1 +/- 0.6 p 0.006 nonmyelin fiber corpu callosum visibl diffus tensor mri earli 28 wk full-term preterm infant term show mark differ white matter fiber organ data indic quantit assess water diffus diffus tensor mri provid insight microstructur develop cerebr white matter live infant',\n",
       "  'myelodysplast syndrom md age-depend stem cell malign share biolog featur activ adapt immun respons ineffect hematopoiesi report myeloid-deriv suppressor cell mdsc classic link immunosuppress inflamm cancer markedli expand bone marrow md patient play pathogenet role develop ineffect hematopoiesi clonal distinct mdsc overproduc hematopoiet suppress cytokin function potent apoptot effector target autolog hematopoiet progenitor use multipl transfect cell model found mdsc expans driven interact proinflammatori molecul s100a9 cd33 2 protein form function ligand/receptor pair recruit compon cd33 ’ immunoreceptor tyrosine-bas inhibit motif itim induc secret suppress cytokin il-10 tgf-β immatur myeloid cell s100a9 transgen mice display bone marrow accumul mdsc accompani develop progress multilineag cytopenia cytolog dysplasia importantli earli forc matur mdsc either all-trans-retino acid treatment activ immunoreceptor tyrosine-bas activ motif–bear itam-bear adapt protein dap12 interrupt cd33 signal rescu hematolog phenotyp find indic primari bone marrow expans mdsc driven s100a9/cd33 pathway perturb hematopoiesi contribut develop md',\n",
       "  \"id element short interspers element sine found high copi number mani rodent genom bc1 rna id-rel transcript deriv singl copi bc1 rna gene bc1 rna gene shown master gene id element amplif rodent genom id element dispers process term retroposit retroposit process involv number potenti regulatori step regulatori step may includ transcript appropri tissu transcript stabil prime rna transcript revers transcript integr studi focus prime rna transcript revers transcript bc1 rna gene transcript shown abl prime revers transcript effici intramolecular site-specif fashion self-prim abil consequ secondari structur 3'-uniqu region observ gene activ amplifi throughout rodent evolut make rna capabl effici self-prim revers transcript strongli suggest self-prim least one featur establish bc1 rna gene master gene amplif id element\",\n",
       "  'dna methyl play import role biolog process human health diseas recent technolog advanc allow unbias whole-genom dna methyl methylom analysi carri human cell use whole-genom bisulfit sequenc 24.7-fold coverag 12.3-fold per strand report comprehens 92.62 methylom analysi uniqu sequenc human peripher blood mononuclear cell pbmc asian individu whose genom deciph yh project pbmc constitut import sourc clinic blood test world-wid found 68.4 cpg site 0.2 non-cpg site methyl demonstr non-cpg cytosin methyl minor human pbmc analysi pbmc methylom reveal rich epigenom landscap 20 distinct genom featur includ regulatori protein-cod non-cod rna-cod repeat sequenc integr methylom data yh genom sequenc enabl first comprehens assess allele-specif methyl asm two haploid methylom individu allow identif 599 haploid differenti methyl region hdmr cover 287 gene 76 gene hdmr within 2 kb transcript start site 80 display allele-specif express ase data demonstr asm recurr phenomenon highli correl ase human pbmc togeth recent report similar studi studi provid comprehens resourc futur epigenom research confirm new sequenc technolog paradigm large-scal epigenom studi',\n",
       "  'two human golli gene express oligodendrocyt lineag -mbp myelin basic protein cdna isol human oligodendroglioma cell line analysi cdna enabl us determin entir structur human golli-mbp gene golli-mbp gene encompass mbp transcript unit approxim 179 kb length consist 10 exon seven constitut mbp gene human golli-mbp gene contain two transcript start site give rise famili altern splice transcript least two golli-mbp transcript contain first three exon gene one mbp exon produc first transcript start site second famili transcript contain mbp exon produc well-known mbp human rna blot analysi reveal golli-mbp transcript express fetal thymu spleen human b-cell macrophag cell line well fetal spinal cord find clearli link express exon encod autoimmunogen/encephalitogen mbp central nervou system cell tissu immun system normal express golli-mbp gene also establish genet locu includ mbp gene conserv among speci provid evid mbp transcript unit integr part golli transcript unit suggest structur arrang import genet function and/or regul gene',\n",
       "  'glioblastoma deadli cancer display function cellular hierarchi maintain self-renew glioblastoma stem cell gsc gsc regul molecular pathway distinct bulk tumor may use therapeut target determin a20 tnfaip3 regul cell surviv nf-kappab pathway overexpress gsc rel non-stem glioblastoma cell mrna protein level determin function signific a20 gsc target a20 express lentiviral-medi deliveri short hairpin rna shrna inhibit a20 express decreas gsc growth surviv mechan associ decreas cell-cycl progress decreas phosphoryl p65/rela elev level a20 gsc contribut apoptot resist gsc less suscept tnfalpha-induc cell death match non-stem glioma cell a20 knockdown sensit gsc tnfalpha-medi apoptosi decreas surviv gsc upon a20 knockdown contribut reduc abil cell self-renew primari secondari neurospher format assay tumorigen potenti gsc decreas a20 target result increas surviv mice bear human glioma xenograft silico analysi glioma patient genom databas indic a20 overexpress amplif invers correl surviv togeth data indic a20 contribut glioma mainten effect glioma stem cell subpopul although inactiv mutat a20 lymphoma suggest a20 act tumor suppressor similar point mutat identifi glioma genom sequenc fact data suggest a20 may function tumor enhanc glioma promot gsc surviv a20 anticanc therapi therefor view caution effect like differ depend tumor type',\n",
       "  'realiz full potenti human embryon stem cell hesc induc pluripot stem cell hipsc requir effici method genet modif howev techniqu gener cell type–specif lineag report well reliabl tool disrupt repair overexpress gene gene target ineffici best thu routin use report highli effici target three gene human pluripot cell use zinc-fing nucleas zfn –mediat genom edit first use zfn specif oct4 pou5f1 locu gener oct4-egfp report cell monitor pluripot state hesc second insert transgen aavs1 locu gener robust drug-induc overexpress system hesc final target pitx3 gene demonstr zfn use gener report cell target non-express gene hesc hipsc',\n",
       "  'background microarray offer great potenti platform molecular diagnost test clinic sampl presenc numer biomark highli multiplex assay studi appli infecti diseas data microarray design molecular serotyp streptococcu pneumonia use identifi presenc one 91 known pneumococc serotyp dna extract microarray incorpor oligonucleotid probe known capsular polysaccharid synthesi gene requir statist analysi microarray intens data determin serotyp combin serotyp present within sampl base combin gene detect result propos empir bayesian model calcul probabl combin serotyp microarray data model take consider depend serotyp induc gene common homolog gene although ident similar sequenc serotyp similar capsular gene composit extra probe includ microarray provid addit inform integr bayesian model serotyp combin high probabl second model bayesian random effect model appli determin rel abund serotyp conclus assess accuraci propos analysi appli method experiment data sampl contain individu serotyp sampl contain combin serotyp known level abund two known serotyp s. pneumonia test individu sampl could uniqu determin bayesian model model also enabl presenc combin serotyp within sampl determin serotyp low abund within combin serotyp detect 2 abund studi well detect presenc serotyp combin approxim measur percentag abund serotyp within combin obtain',\n",
       "  \"summari consid problem compar complex hierarch model number paramet clearli defin use inform theoret argument deriv measur pd effect number paramet model differ posterior mean devianc devianc posterior mean paramet interest gener pd approxim correspond trace product fisher 's inform posterior covari normal model trace ‘ hat ’ matrix project observ onto fit valu properti exponenti famili explor posterior mean devianc suggest bayesian measur fit adequaci contribut individu observ fit complex give rise diagnost plot devianc residu leverag ad pd posterior mean devianc give devianc inform criterion compar model relat inform criteria approxim decis theoret justif procedur illustr exampl comparison drawn altern bayesian classic propos throughout emphas quantiti requir trivial comput markov chain mont carlo analysi\",\n",
       "  'likelihood ratio one best measur diagnost accuraci although seldom use interpret requir calcul convert back forth “ probabl ” “ odd ” diseas articl describ simpler method interpret likelihood ratio one avoid calcul nomogram convers “ odd ” diseas sever exampl illustr clinician use method refin diagnost decis bedsid',\n",
       "  'recognit influenza viru flu tlr7 plasmacytoid dendrit cell pdc produc type ifn signific amount synthet tlr7 ligand induc matur pdc evidenc express costimulatori molecul product proinflammatori cytokin howev induc low-level product ifn-alpha dissect tlr7 signal pdc differ profil induc studi effect 2 tlr7 ligand flu cl097 activ blood-isol pdc human gen2.2 pdc cell line type ifn product pdc correl differenti interferon regulatori factor 7 irf7 transloc nucleu induc 2 tlr7 ligand surprisingli activ nevertheless observ rapid express ifn-induc gene mxa cxcl10 trail within 4 hour stimul express control stat1 phosphoryl independ type ifn stat1 activ found strictli depend pi3k-p38mapk pathway show new signal pathway lead rapid express ifn-induc gene tlr7 trigger thu pdc unusu tlr7 signal capac promptli respond viral infect earli phase innat immun respons',\n",
       "  'object purpos studi character relationship adipos tissu phenotyp depot-specif microvascular function fat method result 30 obes subject age 42±11 year bodi mass index 46±11 kg/m 2 undergo bariatr surgeri intraop collect viscer subcutan adipos tissu character depot-specif adipos phenotyp assess vasomotor function adipos microvasculatur use videomicroscopi small arteriol 75-250 μm isol differ fat compart endothelium-depend acetylcholine-medi vasodil sever impair viscer arteriol compar subcutan depot p 0.001 anova nonendothelium depend respons papaverin nitroprussid similar endotheli nitric oxid synthas inhibit n ω -nitro-l-arginin methyl ester reduc subcutan vasodil effect sever blunt viscer arteriolar respons viscer fat exhibit greater express proinflammatori oxid stress-rel hypoxia-induc proangiogen gene increas activ macrophag popul higher capac cytokin product ex vivo conclus find provid clinic evid viscer microenviron may intrins toxic arteri health provid potenti mechan viscer adipos burden link atherosclerot vascular diseas find also support evolv concept adipos tissu qualiti quantiti may play signific role shape cardiovascular phenotyp human obes',\n",
       "  'background common carotid intima media thick cimt ankl brachial pressur index abpi use surrog marker atherosclerosi shown correl arteri stiff howev correl global atherosclerot burden previous assess compar cimt abpi atheroma burden measur whole bodi magnet reson angiographi wb-mra method 50 patient symptomat peripher arteri diseas recruit cimt measur use ultrasound rest exercis abpi perform wb-mra perform 1.5t mri scanner use 4 volum acquisit divid dose intraven gadolinium gadoter meglumin dotarem guerbet fr wb-mra data divid 31 anatom arteri segment score accord degre lumin narrow 0 normal 1 50 2 50-70 3 70-99 4 vessel occlus segment score sum standard atheroma score calcul result atherosclerot burden high standardis atheroma score 39.5±11 common cimt show posit correl whole bodi atheroma score β 0.32 p 0.045 howev due strong correl neck thorac segment β 0.42 p 0.01 correl rest bodi abpi correl whole bodi atheroma score β -0.39 p 0.012 due strong correl ilio-femor vessel correl thorac neck vessel multipl linear regress correl cimt global atheroma burden present β 0.13 p 0.45 correl abpi atheroma burden persist β -0.45 p 0.005 conclus abpi cimt correl global atheroma burden measur whole bodi contrast enhanc magnet reson angiographi popul symptomat peripher arteri diseas howev primarili due strong correl ilio-femor atheroma burden',\n",
       "  'global 1 pregnant women persist infect hepat c viru hcv mother-to-child transmiss hcv occur 3-5 pregnanc account new childhood infect hcv-specif cd8 cytotox lymphocyt ctl vital clearanc acut hcv infect 60-80 infect persist cell becom function exhaust select mutant virus escap cell recognit increas hcv replic pregnanc suggest maternofet immun toler mechan may impair hcv-specif ctl limit select pressur persist virus assess possibl character circul viral quasispeci consecut pregnanc two women reveal loss escap mutat hla class epitop pregnanc associ emerg fit virus ctl select pressur reimpos childbirth point escap mutat epitop predomin quasispeci viral load drop sharpli importantli virus transmit perinat enhanc fit due revers escap mutat find indic immunoregulatori chang pregnanc reduc ctl select pressur hcv class epitop therebi facilit vertic transmiss virus optim replic fit',\n",
       "  'hematopoiet stem cell hsc develop embryogenesi complex process involv multipl anatom site hsc precursor specifi mesoderm matur function hsc undergo self-renew divis gener pool hsc process develop hsc migrat variou embryon nich provid signal establish conserv self-renew abil process recapitul gener hsc embryon stem cell elucid interact develop hsc nich facilit gener expans hsc vitro exploit clinic potenti',\n",
       "  'term spondyloarthropathi spa describ defin group relat inflammatori joint diseas share characterist clinic featur uniqu associ major histocompat complex class molecul hla-b27 five subgroup differenti ankylos spondyl reactiv arthriti psoriat arthriti arthriti associ inflammatori bowel diseas undifferenti spa sacroiliac joint central involv spa clearli pathognomon ankylos spondyl patient affect earli diseas overcom diagnost difficulti earli sacroili dynam magnet reson imag shown visual acut chronic chang sacroiliac joint inflamm sacroiliac joint patient spa recent examin detail use immunohistolog situ hybridr cell macrophag variou cytokin found infiltr biopsi specimen obtain guid comput tomographi studi intra-articular corticosteroid treatment success undertaken investig biopsi specimen show absenc dna reactiv arthritis-associ bacteria pathogenesi spa reason tropism sacroiliac joint still obscur natur relat genet background spa initi trigger bacteri infect remain establish chronic diseas autoimmun mechan might import',\n",
       "  'extract high-qual genom dna fromgossypium cotton speci difficult due high level polysaccharid oxidiz quinon interf substanc describ procedur consist permit isol cotton genom dna satisfactori size qualiti rflp pcr analysi well routin clone applic sever antioxid phenol-bind reagent phenol oxidas inhibitor use throughout procedur polysaccharid elimin earli procedur isol nuclei',\n",
       "  \"current refer curv statur weight uk first publish 1966 use ever sinc despit increas concern may adequ describ growth present day british children use current data seven sourc new refer curv estim birth 20 year children 1990. great major data nation repres analysi use cole 's lm method produc effici estim convent centil give good fit data curv differ current use curv key age statur weight view concern express current curv differ new curv propos curv present adopt new uk refer curv\",\n",
       "  'bone tissu undergo constant turnov support stem cell recent studi show perivascular mesenchym stem cell msc contribut turnov long bone craniofaci bone flat bone deriv differ embryon origin long bone ident regul nich craniofacial-bon msc remain unknown identifi gli1+ cell within sutur mesenchym main msc popul craniofaci bone associ vasculatur give rise craniofaci bone adult activ injuri repair gli1+ cell typic msc vitro ablat gli1+ cell lead craniosynostosi arrest skull growth indic cell indispens stem cell popul twist1 +/- mice craniosynostosi show reduc gli1+ msc sutur suggest craniosynostosi may result diminish sutur stem cell studi indic craniofaci sutur provid uniqu nich msc craniofaci bone homeostasi repair',\n",
       "  'arod cardiac side popul cell fraction form clonal spheroid serum-fre medium express nestin musashi-1 multi-drug resist transport gene 1 marker undifferenti neural precursor cell marker lost follow differenti replac express neuron- glial- smooth muscl cell– cardiomyocyte-specif protein cardiosphere-deriv cell transplant chick embryo migrat truncu arteriosu cardiac outflow tract contribut dorsal root ganglia spinal nerv aortic smooth muscl cell lineag studi use doubl transgen mice encod protein 0–cre/floxed-egfp reveal undifferenti differenti neural crest-deriv cell fetal myocardium undifferenti cell express gata-bind protein 4 nestin actinin wherea differenti cell identifi cardiomyocyt result suggest cardiac neural crest-deriv cell migrat heart remain dormant multipot stem cells—and right conditions—differenti cardiomyocyt typic neural crest-deriv cell includ neuron glia smooth muscl',\n",
       "  'understand molecular mechan mediat epileptogenesi critic develop effect therapi epilepsi recent found mammalian target rapamycin mtor signal pathway involv epileptogenesi mtor inhibitor prevent epilepsi mous model tuber sclerosi complex investig potenti role mtor rat model tempor lobe epilepsi initi statu epilepticu acut kainate-induc seizur result biphas activ mtor pathway evid increas phospho-s6 p-s6 express initi rise p-s6 express start approxim 1 h seizur onset peak 3-6 h return baselin 24 h hippocampu neocortex reflect widespread stimul mtor signal acut seizur activ resolut statu epilepticu second increas p-s6 observ hippocampu start 3 peak 5-10 persist sever week kainat inject correl develop chronic epileptogenesi within hippocampu mtor inhibitor rapamycin administ kainat block acut chronic phase seizure-induc mtor activ decreas kainate-induc neuron cell death neurogenesi mossi fiber sprout develop spontan epilepsi late rapamycin treatment termin statu epilepticu block chronic phase mtor activ reduc mossi fiber sprout epilepsi neurogenesi neuron death find indic mtor signal mediat mechan epileptogenesi kainat rat model mtor inhibitor potenti antiepileptogen effect model',\n",
       "  'introduct endotheli activ lead vascular barrier breakdown play essenti role pathophysiolog multiple-organ dysfunct syndrom mod sepsi increas evid suggest function vessel-protect factor angiopoietin-1 ang-1 ligand endothelial-specif tie2 receptor inhibit antagonist angiopoietin-2 ang-2 sepsi order revers effect sepsis-induc suppress ang-1 elev ang-2 aim investig whether intraven inject recombin human rh ang-1 protect mod murin sepsi method polymicrobiolog abdomin sepsi induc cecal ligat punctur clp mice treat either 1 μg intraven rhang-1 control buffer immedi clp induct everi 8h thereaft sham-oper anim serv time-match control result compar buffer-tr control rhang-1 treat septic mice show signific improv sever hematolog biochem indic mod moreov rhang-1 stabil endotheli barrier function evidenc inhibit protein leakag lung capillari alveolar compart histolog analysi reveal rhang-1 treatment attenu leukocyt infiltr lung kidney septic mice probabl due reduc endotheli adhes molecul express rhang-1 treat mice final protect effect rhang-1 treatment reflect improv surviv time lethal clp model conclus clinic relev murin sepsi model intraven rhang-1 treatment alon suffici significantli improv varieti sepsis-associ organ dysfunct surviv time like preserv endotheli barrier function studi need pave road clinic applic therapi concept',\n",
       "  'obes associ increas risk develop insulin resist type 2 diabet obes individu adipos tissu releas increas amount non-esterifi fatti acid glycerol hormon pro-inflammatori cytokin factor involv develop insulin resist insulin resist accompani dysfunct pancreat islet β-cell — cell releas insulin — failur control blood glucos level result abnorm β-cell function therefor critic defin risk develop type 2 diabet knowledg foster explor molecular genet basi diseas new approach treatment prevent',\n",
       "  \"podocyt critic mainten healthi glomerular filter howev difficult studi intact kidney technic limit report develop serial multiphoton microscopi mpm glomeruli sever day visual motil podocyt pariet epitheli cell pec vivo podocin-gfp mice podocyt form sporad multicellular cluster unilater ureter ligat migrat pariet bowman 's capsul track singl cell podocin-confetti mice featur cell-specif express cfp gfp yfp rfp reveal simultan migrat multipl podocyt phosphoenolpyruv carboxykinas pepck -gfp mice serial mpm found pec-to-podocyt migrat nanotubul connect data support highli dynam rather static natur glomerular environ cellular composit futur applic new approach advanc understand mechan glomerular injuri regener\",\n",
       "  'thought h19 imprint control region icr direct silenc matern inherit igf2 allel ctcf-depend chromatin insul icr shown interact physic silenc region igf2 differenti methyl region dmr 1 role ctcf chromatin loop whether restrict physic access distal enhanc igf2 known perform systemat chromosom conform captur analys igf2/h19 region 160 kb identifi sequenc interact physic distal enhanc icr found patern chromosom enhanc interact igf2 promot matern allel prevent ctcf bind within h19 icr ctcf bind matern icr regul interact matrix attach region mar 3 dmr1 igf2 thu form tight loop around matern igf2 locu may contribut silenc mutat ctcf bind site h19 icr lead loss ctcf bind de novo methyl ctcf target site within igf2 dmr1 show ctcf coordin region epigenet mark systemat chromosom conform captur analysi imprint cluster reveal ctcf critic role epigenet regul higher-ord chromatin structur gene silenc consider distanc genom',\n",
       "  'telomerase-neg tumor cell use altern lengthen telomer alt pathway involv dna recombin repair maintain prolif potenti cytolog hallmark process accumul promyelocyt leukemia pml nuclear protein telomer dna form alt-associ pml bodi apb de novo format telomer pml nuclear subcompart investig recruit apb protein compon show function distinct protein abl initi format bona fide apb high effici self-organ self-propag manner includ 1 pml sp100 constitut compon pml nuclear bodi 2 telomer repeat bind factor 1 2 trf1 trf2 respect 3 dna repair protein nbs1 4 sumo e3 ligas mms21 well isol sumo1 domain interact domain anoth protein factor contrast repair factor rad9 rad17 rad51 less effici apb nucleat recruit preassembl apb artifici creat apb induc telomer extens dna repair mechan infer coloc site non-repl dna synthesi histon h2a.x phosphoryl increas telomer repeat length activ absent recruit apb factor pericentr locu establish apb function intermedi alt pathway',\n",
       "  \"genom rna alphaviru encod four differ nonstructur protein nsp1 nsp2 nsp3 nsp4 polyprotein p123 produc translat termin opal termin codon nsp3 nsp4 polyprotein p1234 produc translat readthrough occur opal termin codon replac sens codon alphaviru genom evolutionari pressur appear maintain genom sequenc encod stop codon opal open read frame arginin gener featur o'nyong-nyong viru onnv genom indic requir point altern replic onnv vertebr invertebr host may determin predomin particular codon locu viral quasispeci howev systemat studi previous test hypothesi whole anim report result first studi investig natur mosquito host function signific opal stop codon alphaviru genom use full-length cdna clone onnv construct seri mutant arginin nsp3 nsp4 replac opal ochr amber stop codon presenc opal stop codon upstream nsp4 nearli doubl 75.5 infect onnv viru possess codon amino acid arginin correspond posit 39.8 although frequenc opal viru dissemin mosquito midgut differ significantli arginin viru day 8 10 dissemin began earlier mosquito infect opal viru although clear fit advantag provid onnv presenc opal codon nsp3 nsp4 anophel gambia sequenc analysi onnv rna extract mosquito bodi head indic codon usag posit correspond viru administ blood meal result suggest select onnv variant occur de novo mutat posit nsp3 nsp4 readili occur mosquito taken togeth result suggest primari fit advantag provid onnv presenc opal codon nsp3 nsp4 relat mosquito infect\",\n",
       "  'cell transform herpesviru saimiri express seven viral u-rich noncod rna unknown function call hsur note conserv sequenc hsur 1 2 constitut potenti bind site three host-cel microrna mirna coimmunoprecipit experi confirm hsur 1 2 interact predict mirna viral transform cell abund one mirna mir-27 dramat lower transform cell consequ effect express mir-27 target gene transient knockdown ectop express hsur 1 demonstr direct degrad matur mir-27 sequence-specif binding-depend manner viral strategi illustr use ncrna manipul host-cel gene express via mirna pathway',\n",
       "  'htrf homogen time resolv fluoresc frequent use gener assay technolog measur analyt homogen format ideal platform use drug target studi high-throughput screen ht technolog combin fluoresc reson energi transfer technolog fret time-resolv measur tr tr-fret assay signal gener fluoresc reson energi transfer donor acceptor molecul close proxim buffer media interfer dramat reduc dual-wavelength detect final signal proport extent product format htrf assay usual sensit robust miniatur 384 1536-well plate format assay technolog appli mani antibody-bas assay includ gpcr signal camp ip-on kinas cytokin biomark bioprocess antibodi protein product well assay protein-protein proteinpeptid protein-dna/rna interact sinc introduct drug-screen world ten year ago research use htrf expedit studi gpcr kinas new biomark protein-protein interact target interest htrf also util altern method bioprocess monitor first-gener htrf technolog use europium cryptat fluoresc donor monitor reaction biomolecul extend 2008 introduct second-gener donor terbium cryptat tb enhanc screen perform terbium cryptat possess differ photophys properti compar europium includ increas quantum yield higher molar extinct coeffici addit compat acceptor fluorophor use europium serv donor fluorophor green-emit fluor multipl emiss peak includ one 490 nm moreov terbium htrf assay read htrf-compat instrument europium htrf assay overal htrf highli sensit robust technolog detect molecular interact vitro wide use primari secondari screen phase drug develop review address gener principl htrf current applic drug discoveri',\n",
       "  'replic origin licens load mcm2-7 hexam entri phase howev ∼10 licens origin normal use phase other remain dormant fork progress inhibit dormant origin initi nearbi ensur dna eventu replic appar contrast replic stress activ ataxia telangiectasia rad-3-rel atr chk1 checkpoint kinas inhibit origin fire studi show low level replic stress atr/chk1 predominantli suppress origin initi inhibit activ new replic factori therebi reduc number activ factori time inhibit replic fork progress allow dormant origin initi within exist replic factori inhibit new factori activ atr/chk1 therefor redirect replic toward activ factori fork inhibit away region yet start replic minim deleteri consequ fork stall prevent similar problem aris unrepl region genom',\n",
       "  'tumor microenviron tme play promin role growth tumor cell major inflammatori compon tme m2d macrophag educ tme adopt immunosuppress role promot tumor metastasi progress fra-1 form activ protein-1 heterodim jun partner drive gene transcript fra-1 thought drastic induc tumorigenesi progress howev function role fra-1 gener m2d macrophag poorli understood date demonstr 4t1 mammari carcinoma cell co-cultur raw264.7 macrophag cell skew raw264.7 macrophag cell differenti m2d macrophag 4t1 cell stimul de novo overexpress fra-1 raw264.7 cell fra-1 bind interleukin 6 il-6 promot increas product cytokin il-6 raw264.7 cell il-6 act autocrin fashion skew raw264.7 macrophag cell differenti m2d macrophag find open new insight revers m2d macrophage-induc immun toler improv efficaci immunotherapeut approach',\n",
       "  'multitud nanoparticl titanium oxid tio2 zinc oxid aluminum oxid gold oxid silver oxid iron oxid silica oxid found mani chemic cosmet pharmaceut electron product recent sio2 nanoparticl shown inert toxic profil associ irrevers toxicolog chang anim model henc exposur sio2 nanoparticl increas sio2 nanoparticl routin use numer materi strengthen filler concret construct composit nontox platform biomed applic drug deliveri theragnost hand recent vitro experi indic sio2 nanoparticl cytotox therefor investig nanoparticl identifi potenti toxic pathway analyz adsorb protein corona surfac sio2 nanoparticl blood brain rat four type sio2 nanoparticl chosen investig protein corona type analyz use liquid chromatography-tandem mass spectrometri technolog total 115 48 plasma protein rat identifi bound neg charg 20 nm 100 nm sio2 nanoparticl respect 50 36 protein found 20 nm 100 nm arginine-co sio2 nanoparticl respect higher number protein adsorb onto 20 nm size sio2 nanoparticl onto 100 nm size nanoparticl regardless charg protein compar two charg higher number protein found arginine-co posit charg sio2 nanoparticl neg charg nanoparticl protein identifi bound corona sio2 nanoparticl analyz cluego cytoscap plugin use protein ontolog identifi biolog interact pathway protein bound surfac nanoparticl may affect function conform properti distribut complic biolog process',\n",
       "  'motiv nucleosom basic repeat unit chromatin contain two copi four core histon h2a h2b h3 h4 147 bp dna residu histon protein subject numer post-transl modif methyl acetyl chromatin immunoprecipiti follow sequenc chip-seq techniqu provid genome-wid occup data modifi histon protein requir appropri comput method result present nuchunt algorithm use data chip-seq experi direct mani histon modif infer posit nucleosom nuchunt annot nucleosom intens histon modif demonstr annot use infer nucleosom state distinct correl underli genom featur chromatin-rel process transcript start site enhanc elong rna polymeras ii chromatin-medi repress thu nuchunt versatil tool use predict posit nucleosom panel histon modif chip-seq experi infer distinct histon modif pattern associ differ chromatin state avail softwar avail http //epigen.molgen.mpg.de/nuchunter/',\n",
       "  'antigen-pres major histocompat complex mhc class ii-rich dendrit cell known aris bone marrow howev marrow lack matur dendrit cell substanti number prolifer less-matur cell yet identifi methodolog induc dendrit cell growth recent describ mous blood modifi mhc class ii-neg precursor marrow key step remov major nonadher newli form granulocyt gentl wash first 2-4 cultur leav behind prolifer cluster loos attach firmli adher `` stroma. `` day 4-6 cluster dislodg isol 1-g sediment upon recultur larg number dendrit cell releas latter readili identifi basi distinct cell shape ultrastructur repertoir antigen detect panel monoclon antibodi dendrit cell express high level mhc class ii product act power accessori cell initi mix leukocyt reaction neither cluster matur dendrit cell gener macrophag colony-stimul factor rather granulocyte/macrophag colony-stimul factor gm-csf appli therefor gm-csf gener three lineag myeloid cell granulocyt macrophag dendrit cell sinc 5 x 10 6 dendrit cell develop 1 wk precursor within larg hind limb bone singl anim marrow progenitor act major sourc dendrit cell featur prove use futur molecular clinic studi otherwis trace cell type',\n",
       "  \"nutrit excess major forerunn type 2 diabet enhanc secret insulin attenu insulin 's metabol action liver skelet muscl adipos tissu howev conflict evid indic lack knowledg time event develop obes diabet point key gap understand metabol diseas perspect review altern viewpoint recent result tempor mechanist connect hyperinsulinemia obes insulin resist although much attent address earli step insulin signal cascad insulin resist obes seem larg elicit downstream step new find also connect insulin resist extens metabol cross-talk liver adipos tissu pancrea skelet muscl advanc past 5 year offer excit opportun daunt challeng develop new therapeut strategi treatment type 2 diabet\",\n",
       "  'background patient undergo dialysi substanti increas risk cardiovascular mortal morbid although sever trial shown cardiovascular benefit lower blood pressur gener popul uncertainti efficaci toler reduc blood pressur patient dialysi systemat review meta-analysi assess effect blood pressur lower patient dialysi method systemat search medlin embas cochran librari databas trial report 1950 novemb 2008 without languag restrict extract standardis dataset randomis control trial blood pressur lower patient dialysi report cardiovascular outcom meta-analysi done random effect model find identifi eight relev trial provid data 1679 patient 495 cardiovascular event weight mean systol blood pressur 4.5 mm hg lower diastol blood pressur 2.3 mm hg lower activ treat patient control blood pressur lower treatment associ lower risk cardiovascular event rr 0.71 95 ci 0.55-0.92 p=0.009 all-caus mortal rr 0.80 0.66-0.96 p=0.014 cardiovascular mortal rr 0.71 0.50-0.99 p=0.044 control regimen effect seem consist across rang patient group includ studi interpret treatment agent lower blood pressur routin consid individu undergo dialysi reduc high cardiovascular morbid mortal rate popul',\n",
       "  'earli region 3 e3 group c human adenovirus ad encod sever inhibitor tumor necrosi factor alpha tnf-alpha cytolysi includ e3 14.7-kda protein e3-14.7k heterodim contain two polypeptid 10.4 14.5 kda understand mechan viral protein inhibit tnf-alpha function e3-14.7k protein use screen hela cell cdna librari search interact protein yeast two-hybrid system novel protein contain multipl leucin zipper domain without signific homolog known protein identifi name fip-2 14.7k-interact protein fip-2 interact e3-14.7k vitro vivo coloc ad e3-14.7k cytoplasm especi near nuclear membran caus redistribut viral protein fip-2 caus cell death howev revers protect effect e3-14.7k cell kill induc overexpress intracellular domain 55-kda tnf receptor rip death protein involv tnf-alpha fa apoptosi pathway delet analysi indic revers effect fip-2 depend interact e3-14.7k three major mrna form fip-2 detect multipl human tissu express transcript induc tnf-alpha treatment time-depend manner two differ cell line fip-2 consensu sequenc sever potenti posttransl modif data suggest fip-2 one cellular target ad e3-14.7k mechan affect cell death involv tnf receptor rip downstream molecul affect either two molecul',\n",
       "  'altern lengthen telomer alt mechan allow cancer cell escap senesc apoptosi absenc activ telomeras characterist featur pathway assembl alt-associ promyelocyt leukemia pml nuclear bodi apb telomer dissect role apb human alt cell line perform rna interfer screen use autom 3d fluoresc microscopi platform advanc 3d imag analysi identifi 29 protein affect apb format includ protein involv telomer chromatin organ protein sumoyl dna repair integr extend find found apb format induc cluster telomer repeat telomer compact concomit deplet shelterin protein trf2 also known terf2 apb-depend chang correl induct dna damag respons telomer apb evid strong enrich phosphoryl form ataxia telangiectasia mutat atm kinas accordingli propos apb promot telomer mainten induc dna damag respons alt-posit tumor cell chang telomer chromatin state trigger atm phosphoryl',\n",
       "  'mechan primari tumor affect select distant organ tumor cell arriv remain elucid report show gr-1+cd11b+ cell significantli increas lung mice bear mammari adenocarcinoma tumor cell arriv premetastat lung immatur myeloid cell significantli decreas ifn-gamma product increas proinflammatori cytokin addit produc larg quantiti matrix metalloproteinas 9 mmp9 promot vascular remodel delet mmp9 normal aberr vasculatur premetastat lung diminish lung metastasi product activ mmp9 select restrict lung organ larg number gr-1+cd11b+ cell work reveal novel protumor mechan gr-1+cd11b+ cell chang premetastat lung inflammatori prolif environ diminish immun protect promot metastasi aberr vasculatur format thu inhibit gr-1+cd11b+ cell could normal premetastat lung environ improv host immunosurveil inhibit tumor metastasi',\n",
       "  'activin/nod growth factor control broad rang biolog process includ earli cell fate decis organogenesi adult tissu homeostasi provid overview mechan activin/nod signal pathway govern stem cell function differ stage develop describ recent find associ activin/nod signal patholog condit focus cancer stem cell tumorigenesi potenti target therapi moreov discuss futur direct question current remain unansw role activin/nod signal stem cell self-renew differenti prolifer',\n",
       "  'mani eukaryot rna-depend rna polymeras rdrp play key role rnai pathway implic recognit process aberr transcript trigger process amplif silenc respons test function rdrp gene ciliat paramecium tetraurelia experiment induc endogen mechan gene silenc organ rnai trigger either high-copi truncat transgen directli feed cell double-strand rna dsrna surprisingli dsrna-induc silenc depend put function rdr1 rdr2 gene requir accumul primari sirna distinct class small rna suggest secondari sirna contrast third gene highli diverg catalyt domain rdr3 requir sirna accumul rnai trigger truncat transgen data implic rdr3 accumul previous describ endogen sirna regul surfac antigen gene famili one gene normal express clonal cell line knockdown rdr3 lead co-express multipl antigen result provid evid function special paramecium rdrp gene distinct rnai pathway oper veget growth',\n",
       "  'background chronic cyclosporin csa nephrotox ccn major caus chronic renal dysfunct effect clinic intervent yet object reveal mechan renal cell apoptosi ccn analyz vitro studi mechan method collect vitro studi mechan renal cell apoptosi induc csa medlin 1966 juli 2010 embas 1980 juli 2010 isi 1986 juli 2010 evalu qualiti accord vitro standard extract data follow pico principl synthes data result first csa could upregul fa fas-l express increas fadd apoptosi enzym caspase-2 -3 -4 -7 -8 -9 -10 downregul bcl-2 bcl-xl second csa could induc oxid stress damag antioxid defens system third csa could increas express herp grp78 chop fourth csa could induc renal cell apoptosi increas ino p53 express cultur cell conclus least four pathway involv renal cell apoptosi induc csa differ cell speci caspas might final common pathway vitro might provid potenti point intervent need confirm vivo',\n",
       "  'ontogeni haematopoiet stem cell hsc embryon develop still highli debat especi possibl lineag relationship vascular endotheli cell first anatom site cell long-term hsc potenti isol aorta-gonad-mesonephro agm specif vicin dorsal aortic floor although author present evid hsc may aris directli aortic floor dorsal aortic lumen other support notion hsc first emerg within underli mesenchym show non-invas high-resolut imag live zebrafish embryo hsc emerg directli aortic floor stereotyp process involv cell divis strong bend egress singl endotheli cell aortic ventral wall sub-aort space concomit transform haematopoiet cell process polar dorso-ventr also rostro-caud versu medio-later direct depend runx1 express runx1-defici embryo exit event initi similar much rarer abort violent death exit cell result demonstr aortic floor haemogen hsc emerg sub-aort space asymmetr cell divis new type cell behaviour call endotheli haematopoiet transit',\n",
       "  'object determin whether novel avian influenza h7n9 viru transmit person person effici design epidemiolog investig conduct famili cluster two patient avian h7n9 march 2013. set wuxi eastern china particip two patient close contact relev environ sampl patient environ collect test real time revers transcriptase-polymeras chain reaction rrt-pcr viral cultur haemagglutin inhibit assay contact becam ill sampl test avian h7n9 rrt-pcr pair serum sampl obtain contact serolog test haemagglutin inhibit assay main outcom measur clinic data histori exposur onset ill result laboratori test pathogen analysi sequenc phylogenet tree isol strain result index patient becam ill five six day last exposur poultri second patient daughter age 32 provid unprotect bedsid care hospit known exposur poultri develop symptom six day last contact father two strain isol success two patient genom sequenc analys phylogenet tree show virus almost genet ident forti three close contact patient identifi one mild ill neg result avian h7n9 rrt-pcr 43 close contact test neg haemagglutin inhibit antibodi specif avian h7n9 conclus infect daughter probabl result contact father index patient unprotect exposur suggest cluster viru abl transmit person person transmiss limit non-sustain',\n",
       "  'background genet variat il28b gene strongli associ treatment outcom spontan clearanc progress hepat c viru infect hcv aim present studi investig role polymorph locu progress outcom hcv infect moroccan popul method analyz cohort 438 individu among 232 patient persist hcv infect 115 patient mild chronic hepat 117 advanc liver diseas cirrhosi hepatocellular carcinoma 68 individu natur clear hcv 138 healthi subject il28b snp rs12979860 rs8099917 genotyp use taqman 5 allel discrimin assay result protect rs12979860-c rs8099917-t allel common subject spontan clearanc 77.9 vs 55.2 p 0.00001 95.6 vs 83.2 p 0.0025 respect individu clearanc 4.69 95 ci 1.99-11.07 time like c/c genotyp rs12979860 polymorph p 0.0017 3.55 95 ci 0.19-66.89 time like t/t genotyp rs8099917 patient advanc liver diseas carri rs12979860-t/t genotyp frequent patient mild chronic hepat c 1.89 95 ci 0.99-3.61 p 0.0532 risk even pronounc compar healthi control 4.27 95 ci 2.08-8.76 p 0.0005 rs8099917-g allel also associ advanc liver diseas 2.34 95 ci 1.40-3.93 p 0.0100 conclus moroccan popul polymorph near il28b gene play role spontan clearanc progress hcv infect',\n",
       "  'regulatori reg cell critic regul immun toler reg cell defin base express cd4 cd25 transcript factor foxp3 howev marker proven problemat uniqu defin special cell subset human found il-7 receptor cd127 down-regul subset cd4+ cell peripher blood demonstr major cell foxp3+ includ express low level cd25 combin cd4 cd25 cd127 result highli purifi popul reg cell account significantli cell previous identifi base cell surfac marker cell highli suppress function suppressor assay fact cell separ base sole cd4 cd127 express anerg although repres least three time number cell includ cd25+cd4+ cd25−cd4+ cell subset suppress “ classic ” cd4+cd25hi reg cell subset final show cd127 use quantit reg cell subset individu type 1 diabet support use cd127 biomark human reg cell',\n",
       "  \"vertebr includ human obtain daili vitamin requir casual exposur sunlight exposur sunlight solar ultraviolet b photon 290-315 nm penetr skin caus photolysi 7-dehydrocholesterol precholecalciferol form precholecalciferol undergo thermal induc rearrang doubl bond form cholecalciferol increas skin pigment age topic applic sunscreen diminish cutan product cholecalciferol latitud season time day well ozon pollut atmospher influenc number solar ultraviolet b photon reach earth 's surfac therebi alter cutan product cholecalciferol boston exposur sunlight month novemb februari produc signific amount cholecalciferol skin windowpan glass absorb ultraviolet b radiat exposur sunlight glass window result product cholecalciferol recogn vitamin insuffici vitamin defici common elderli peopl especi infirm expos sunlight live latitud provid sunlight-medi cholecalciferol winter month vitamin insuffici defici exacerb osteoporosi caus osteomalacia increas risk skelet fractur vitamin insuffici defici prevent encourag respons exposur sunlight and/or consumpt multivitamin tablet contain 10 microgram 400 iu vitamin\",\n",
       "  'gene subject genom imprint mammal preferenti express singl parent allel imprint express small number gene crucial normal develop gene often directli regul fetal growth recent work also demonstr intric role imprint gene brain import consequ behavior neuron function final new studi reveal import proper express specif imprint gene induc pluripot stem cell adult stem cell review find highlight complex natur development import imprint gene',\n",
       "  'new light cycler technolog adapt detect hepat c viru hcv rna clinic sampl sera 81 patient test light cycler pcr amplicor hcv monitor assay in-hous pcr data demonstr light cycler fast reliabl method detect quantit hcv rna',\n",
       "  'signific dispar metabol tumor normal cell inspir develop metabolism-bas anti-tumor therapeut arginin semi-essenti amino acid normal cell synthes arginin de novo also take extracellular arginin sever type tumor abnorm arginin metabol enzym complet reli extracellular arginin support necessari biolog process properti refer arginin auxotrophi take advantag characterist arginin auxotrophi tumor arginin depriv gener induc use arginin deiminas adi arginas investig novel strategi cancer therapi arginin depriv demonstr promis efficaci arginine-auxotroph tumor integr perspect clinic oncologist laboratori scientist articl review import aspect arginin depriv promis anticanc therapi',\n",
       "  'thymic medulla provid special microenviron neg select cell presenc autoimmun regul air -express medullari thymic epitheli cell mtec embryonic-neonat period necessari suffici establish long-last toler show emerg first cohort air mtec key development stage prior αβ cell repertoir select jointli direct rankl lymphoid tissu induc cell invari vγ5 dendrit epiderm cell detc progenitor first thymocyt express product gene rearrang turn gener air mtec foster skint-1-depend aire-independ detc progenitor matur emerg invari detc repertoir henc data attribut function import tempor develop vγ5 γδ cell thymu medulla format αβ cell toler induct demonstr rank-medi reciproc link detc air mtec matur',\n",
       "  \"immun reconstitut analyz 140 consecut patient 2-year disease-fre underw myeloabl allogen transplant cd4 cd8 defect observ involv naiv termin differenti memori compet cell limit valu activ subset natur killer cell normal six month observ expans cd19 /cd5 b cell three month persist defect memori b cell chronic graft-versus-host diseas influenc significantli paramet cd8 subset naïv compet cd4 subset strongli affect profound impact chronic graft-versus-host diseas b-cell subset especi memori b popul cumul incid late sever infect low 14 four year use cox 's model low b-cell count 12 p=0.02 24 p=0.001 month associ hazard develop late infect particular patient develop chronic graft-versus-host diseas\",\n",
       "  'cell activ predic interact cell receptor peptide-major histocompat pmhc ligand factor determin stimulatori potenc pmhc molecul remain unclear describ result show peptid exhibit mani hallmark weak agonist stimul cell prolifer wild-typ agonist ligand silico approach suggest inabl form central supramolecular activ cluster csmac could underli increas prolifer conclus support experi show enhanc csmac format reduc stimulatori capac weak peptid studi highlight fact complex interplay factor determin qualiti cell antigen',\n",
       "  'analysi excitatori synapt transmiss rat hypothalam supraopt nucleu reveal glutam clearanc consequ glutam concentr diffus extracellular space associ degre astrocyt coverag neuron reduct glutam clearanc whether induc pharmacolog associ rel decreas glial coverag vicin synaps affect transmitt releas modul presynapt metabotrop glutam receptor astrocyt wrap neuron therefor contribut regul synapt efficaci central nervou system',\n",
       "  'background combin radiotherapi plu long-term medic suppress androgen 2 year improv overal surviv patient local advanc prostat cancer compar use radiotherapi plu short-term androgen suppress use radiotherapi plu long-term androgen suppress treatment local advanc prostat cancer method randomli assign patient local advanc prostat cancer receiv external-beam radiotherapi plu 6 month androgen suppress two group one receiv treatment short-term suppress receiv 2.5 year treatment lutein hormone-releas hormon agonist long-term suppress outcom noninferior short-term androgen suppress compar long-term suppress requir hazard ratio 1.35 overal surviv one-sid alpha level 0.05. interim analysi show futil result present adjust one-sid alpha level 0.0429. result total 1113 men regist 970 randomli assign 483 short-term suppress 487 long-term suppress median follow-up 6.4 year 132 patient short-term group 98 long-term group die number death due prostat cancer 47 short-term group 29 long-term group 5-year overal mortal short-term long-term suppress 19.0 15.2 respect observ hazard ratio 1.42 upper 95.71 confid limit 1.79 p=0.65 noninferior advers event group includ fatigu diminish sexual function hot flush conclus combin radiotherapi plu 6 month androgen suppress provid inferior surviv compar radiotherapi plu 3 year androgen suppress treatment local advanc prostat cancer clinicaltrials.gov number nct00003026',\n",
       "  'blind individu often demonstr enhanc nonvisu perceptu abil howev neural substrat underli improv perform remain fulli understood earlier behavior studi demonstr early-blind peopl local sound accur sight control use monaur cue order investig neural basi behavior differ human carri function imag studi use positron emiss tomographi speaker array permit pseudo-free-field present within scanner binaur sound local sight control group show decreas cerebr blood flow occipit lobe seen early-blind individu monaur sound local one ear plug subgroup early-blind subject behavior superior sound local display two activ foci occipit cortex effect seen blind person superior monaur sound local abil sight individu degre activ one foci strongli correl sound local accuraci across entir group blind subject result show blind person perform better sight person recruit occipit area carri auditori local monaur condit therefor conclud comput carri occipit cortex specif underli enhanc capac use monaur cue find shed light intermod compensatori mechan also individu differ mechan inhibitori pattern differ sight individu depriv vision earli life',\n",
       "  'tumor microenviron compos tumor cell fibroblast endotheli cell infiltr immun cell may inhibit promot tumor growth progress object retrospect studi character densiti tumor-associ macrophag tam breast cancer correl densiti tam clinicopatholog paramet paraffin-embed specimen clinicopatholog data includ 5 year follow-up inform obtain 172 breast cancer patient immunohistochem stain cd68 marker macrophag perform evalu blind fashion found tam significantli frequent high histopatholog grade breast cancer patient breast cancer patient high densiti tam significantli lower rate disease-fre surviv 5-year overal surviv patient low densiti tam furthermor high-infiltr tam indic wors surviv rate patient node-neg breast cancer conclus number tam tumor stroma independ predictor surviv time breast cancer patient high-infiltr tam signific unfavor prognost factor patient invas breast cancer potenti use prognost marker breast cancer',\n",
       "  'dishevel dvl protein import signal compon canon beta-catenin/wnt pathway control cell prolifer pattern planar cell polar pcp pathway coordin cell polar within sheet cell also direct converg extens cell ce movement produc narrow elong tissu three mammalian dvl gene identifi development role dvl1 dvl2 previous determin identifi function dvl3 develop provid evid function redund among three murin dvl dvl3 -/- mice die perinat cardiac outflow tract abnorm includ doubl outlet right ventricl persist truncu arteriosi mutant also display misorient stereocilia organ corti phenotyp enhanc addit loss singl allel pcp compon vangl2/ltap ltaplp/+ although neurul appear normal dvl3 -/- ltaplp/+ mutant dvl3 +/- ltaplp/+ combin mutant display incomplet neural tube closur importantli show mani role dvl3 also share dvl1 dvl2 sever phenotyp observ dvl3 mutant defici anoth dvl increas dvl dosag genet dvl transgen demonstr abil dvl compens enabl normal develop interestingli global canon wnt signal appear larg unaffect doubl dvl mutant suggest low dvl level suffici function canon wnt signal summari demonstr dvl3 requir cardiac outflow tract develop describ import pcp pathway neurul cochlea develop final establish sever development process three dvl function redund',\n",
       "  \"epitheli cadherin e-cadherin -catenin complex bind cytoskelet compon regulatori signal molecul form matur adheren junction aj dynam structur physic connect neighbor epitheli cell coupl intercellular adhes contact cytoskeleton help defin cell 's apical-bas axi togeth activ coordin form polar function cell epithelium sever molecul regul aj format integr includ rho famili gtpase par polar protein howev recent develop live-cel imag extent e-cadherin activ turn junction begun appreci turnov contribut junction format mainten epitheli integr tissu homeostasi remodel\",\n",
       "  'aim analys long-term outcom largest report cohort patient present asystol head-up tilt test method result sinc 1990 1322 patient syncop unknown origin undergon tilt-tabl test 330 patient 24 x 9 present abnorm respons syncop pre-syncop furthermor 58 patient 17 x 5 suffer period asystol 3000 ms test asystol median interquartil rang last 10 4 19 x 2 rang 3-90 two differ protocol angl tilt westminst 60 degre n=1124 isoproterenol 80 degre n=198 influenc time syncop episod 13 6 x 5 20 x 5 vs 2 1 6 x 5 min p=0,0005 durat asystol period therapi asystol featur three differ stage first patient treat pacemak later drug therapi metoprolol and/or etilefrin recommend lastli 1995 specif treatment given cohort age- gender-match studi patient without compar asystol 2:1 basi 40 x 7 month follow-up 17 x 7 66 x 8 12 patient 20 x 6 asystol syncop recurr furthermor 34 patient 28 x 8 without asystol present syncop episod follow-up 51 x 6 month 29 x 3 73 x 1 p=n kaplan-mei analysi patient without asystol show mean time free recurr 92 x 6 +/- 6 month vs 82 x 6 +/- 4 x 7 month p=n previou number syncop signific relationship recurr p=0 x 002 therapi cardiac relat death conclus 1 asystol head-up tilt test impli malign outcom syncop recurr low 2 pacemak drug therapi significantli influenc outcom correl previou number syncop episod gender age asystol occurr asystol durat time asystol head-up tilt test 3 tilt protocol angl might influenc time incid asystol head-up tilt test',\n",
       "  \"mani question biolog activ avail small molecul remain inaccess investig could benefit answer narrow gap chemoinformat biolog develop suit ligand annot purchas target biolog associ tool incorpor zinc meant investig comput specialist new version contain 120 million purchas `` drug-lik '' compound -- effect organ molecul sale -- quarter avail immedi deliveri zinc connect purchas compound high-valu one metabolit drug natur product annot compound literatur compound may access gene annot well major minor target class gene belong offer new analysi tool easi nonspecialist yet limit expert zinc retain origin 3d root -- molecul avail biolog relev ready-to-dock format zinc freeli avail http //zinc15.docking.org\",\n",
       "  'eukaryot genom consist dna molecul far longer cell contain reach greatest compact chromosom condens mitosi process aid condensin structur mainten chromosom smc famili member spatial organ mitot chromosom condensin shape chromatin architectur yet fulli understood use chromosom conform captur hi-c studi mitot chromosom condens fission yeast schizosaccharomyc pomb show interphas landscap character small chromatin domain replac fewer larger domain mitosi condensin achiev set longer-rang intrachromosom dna interact compact individu chromosom time local chromatin contact constrain condensin profound implic local chromatin function mitosi result highlight condensin major determin chang chromatin landscap cell prepar genom cell divis',\n",
       "  'background revis nation tuberculosi control programm india patient new smear-posit pulmonari tuberculosi treat thrice-weekli regimen antitubercular drug 2h 3 r 3 z 3 e 3 /4h 3 r 3 h isoniazid r rifampicin z pyrazinamid e ethambutol 6 month conduct retrospect analysi efficaci andtoler regimen clinic trial condit hiv-neg patient newli diagnos smear-posit pulmonari tuberculosi method retrospect analys data patient assign control regimen 2h 3 r 3 z 3 e 3 /4h 3 r 3 two clinic trial 2001-06 nation institut research tuberculosi chennai india result 268 patient treat regimen data efficaci analysi avail 249. end treatment 249 patient 238 96 favour statu treatment failur occur remain 11 7 organ initi drug-suscept 4 initi drug resist 238 patient favour statu end treatment 14 6 recurr tuberculosi follow 24 month intention-to-treat analysi 245 94 262 patient favour statu end treatment 28 patient initi drug resist 24 86 favour outcom 4 24 patient found recurr tuberculosi 2 year follow-up among 221 patient initi infect drug-suscept organ drug resist develop 7 patient treatment fail 10 recurr tuberculosi 5 7 patient treatment fail continu excret drug-suscept bacilli 6 month advers drug reaction observ 38 14 262 patient 3 1.1 need modif treatment conclus thrice-weekli 6-month regimen antitubercular drug administ full supervis associ high rate favour treatment outcom hiv-neg patient newli diagnos sputum smearposit pulmonari tuberculosi advers drug reaction patient',\n",
       "  'curcumin major compon turmer shown exhibit anti-oxid anti-inflammatori activ present studi perform determin whether curcumin efficaci collagen-induc arthriti cia mice il-1beta-induc activ fibroblast-lik synoviocyt flss dba/1 mice immun bovin type ii collagen cii treat curcumin everi day 2week initi immun arthriti evalu incid diseas use arthriti index base paw thick vitro prolifer cii- concanavalin a-induc splenic cell examin use ifn-gamma product pro-inflammatori cytokin tnf-alpha il-1beta examin mous ankl joint serum igg1 igg2a isotyp analyz express level prostaglandin e 2 pge 2 cyclooxygenase-2 cox-2 matrix metalloproteinas mmp human flss also determin result show compar untreat cia mice curcumin-tr mice downregul clinic arthriti score prolifer splenic cell express level tnf-alpha il-1beta ankl joint express level igg2a serum addit alter nuclear factor nf -kappab transcript activ flss curcumin inhibit pge 2 product cox-2 express mmp secret result suggest curcumin effect suppress inflammatori respons inhibit pro-inflammatori mediat regul humor cellular immun respons',\n",
       "  'action protein product result altern splice igf1 gene receiv increas attent recent year howev signific function relev observ remain poorli defin address function igf-i splice variant examin impact loss igf-iea igf-ieb prolifer differenti cultur mous myoblast rna interference-medi reduct total igf-i igf-iea alon igf-ieb alon effect cell viabil growth medium howev cell defici total igf-i igf-iea alon prolifer significantli slower control cell cell defici igf-ieb serum-fre media simultan loss specif loss either splice variant significantli inhibit myosin heavi chain myhc immunoreact 70-80 p 0.01 differenti condit 48 h 2 hors serum determin western immunoblot loss protein associ reduc myhc isoform mrna reduct total igf-i igf-iea mrna significantli reduc myhc mrna approxim 50-75 p 0.05 loss igf-ieb also reduc myhc isoform mrna significantli except myh7 lesser degre ∼20-40 p 0.05 provis matur igf-i synthet e peptid restor myh3 express control level cell defici igf-iea igf-ieb collect data suggest igf-i splice variant may regul myoblast differenti action matur igf-i e peptid',\n",
       "  \"background pleurocidin 25-mer antimicrobi peptid amp known exert bactericid activ howev synergist activ mechan pleurocidin combin convent antibiot antibiofilm effect peptid poorli understood method interact pleurocidin antibiot evalu use checkerboard assay studi mechan involv synerg detect hydroxyl radic format use 3'- p-hydroxyphenyl fluorescein measur nad /nadh ratio nad cycl assay observ chang bacteri viabil hydroxyl radic scaveng thiourea investig cytoplasm membran damag use propidium iodid also antibiofilm effect pleurocidin examin tissu cultur plate method result combin pleurocidin antibiot show synergist interact bacteri strain fraction inhibitori concentr index fici ≤0.5 except enterococcu faecium treat combin peptid ampicillin fici=0.75 identifi pleurocidin alon combin antibiot induc format hydroxyl radic oxid stress caus transient nadh deplet addit thiourea prevent bacteri death especi case combin treatment pleurocidin ampicillin show synerg combin pleurocidin erythromycin increas permeabl bacteri cytoplasm membran addit pleurocidin exhibit potent inhibitori effect preform biofilm bacteri organ conclus pleurocidin synerg antibiot hydroxyl radic format membrane-act mechan exert antibiofilm activ gener signific synergist effect pleurocidin antibiot suggest amp potenti therapeut agent adjuv antimicrobi chemotherapi\",\n",
       "  'background pregnant women mild preexist renal diseas rel complic pregnanc risk matern obstetr complic women moder sever renal insuffici remain uncertain method determin frequenc type matern obstetr complic outcom pregnanc 67 women primari renal diseas 82 pregnanc women initi serum creatinin concentr least 1.4 mg per decilit 124 mumol per liter gestat continu beyond first trimest result mean +/- sd serum creatinin concentr increas 1.9 +/- 0.8 mg per decilit 168 +/- 71 mumol per liter earli pregnanc 2.5 +/- 1.3 mg per decilit 221 +/- 115 mumol per liter third trimest frequenc hypertens rose 28 percent base line 48 percent third trimest high-grad proteinuria urinari protein excret 3000 mg per liter 23 percent 41 percent 70 pregnanc 57 women data avail pregnanc immedi post partum pregnancy-rel loss matern renal function occur 43 percent eight pregnanc 10 percent total associ rapid acceler matern renal insuffici obstetr complic includ high rate preterm deliveri 59 percent growth retard 37 percent infant surviv rate 93 percent conclus among pregnant women moder sever renal insuffici rate complic due worsen renal function hypertens obstetr complic increas fetal surviv high',\n",
       "  'object calcif aortic valv av diseas known inflammation-rel process high-mobl group box-1 hmgb1 protein toll-lik receptor 4 tlr4 report particip sever inflammatori diseas purpos present studi determin whether hmgb1-tlr4 axi involv calcif av diseas evalu effect hmgb1 potenti mechan pro-osteogen phenotyp chang valvular interstiti cell vic method express hmgb1 tlr4 human calcif av evalu use immunohistochem stain immunoblot cultur vic use vitro model vic stimul hmgb1 analysi versu without tlr4 small interf ribonucl acid sirna c-jun n-termin kinas mitogen-activ protein kinas jnk mapk nuclear factor kappa-b nf-κb inhibitor result enhanc accumul hmgb1 tlr4 observ calcif valv moreov found hmgb1 induc high level pro-inflammatori cytokin product promot osteoblast differenti calcif vic addit hmgb1 induc phosphoryl jnk mapk nf-κb howev effect markedli suppress sirna silenc tlr4 addit blockad jnk mapk nf-κb phosphoryl prohibit hmgb1-induc product pro-osteogen factor miner vic conclus hmgb1 protein may promot osteoblast differenti calcif vic tlr4-jnk-nf-κb signal pathway',\n",
       "  \"describ method obtain quantit descript rna process high resolut bud yeast model gene express system construct teton induct studi tetoff repress derepress rna degrad studi yeast strain seri report gene integr genom control teto7 promot revers transcript quantit real-time-pcr rt-qpcr method adapt allow determin mrna abund averag number copi per cell popul fluoresc situ hybrid fish measur transcript number individu cell valid rt-qpcr approach averag copy-numb determin despit broad distribut transcript level within popul cell addit rt-qpcr use distinguish product differ step splice report transcript method develop map quantifi 3'-end cleavag polyadenyl system permit pre-mrna product splice 3'-end matur degrad quantit monitor unpreced kinet detail suitabl mathemat model use approach demonstr report transcript splice prior 3'-end cleavag polyadenyl cotranscript\",\n",
       "  'p75 ntr neurotrophin receptor implic multipl biolog patholog process signific advanc recent made understand physiolog role p75 ntr mani detail aspect remain determin part two exist knockout mous model exon 3 4 delet respect display featur defi definit conclus describ gener mice carri condit p75 ntr p75 ntr-fx allel made flank exon 4-6 encod transmembran cytoplasm domain loxp site valid novel condit allel neural crest-specif p75 ntr /wnt1-cre mutant convent p75 ntr null mutant gener mutant display abnorm hind limb reflex impli loss p75 ntr neural crest-deriv cell caus peripher neuropathi similar seen convent p75 ntr mutant novel condit p75 ntr allel offer new opportun investig role p75 ntr specif tissu cell',\n",
       "  'abstract simultan evalu postthaw viabil acrosom integr spermatozoa flow cytometri would provid valuabl test tool research routin work present studi new triple-stain combin develop simultan evalu viabil acrosom integr bovin sperm process egg yolk-bas extend flow cytomet sybr-14 propidium iodid pi enabl discrimin sperm cell egg yolk debri particl instrument flow cytometr analys frozen-thaw bovin sperm impli wash step remov egg yolk longer requir addit phycoerythrin-conjug peanut agglutinin pe-pna use discrimin acrosome-damaged/react sperm cell acrosome-intact cell repeat calcul use two process ejacul 10 bull three straw per batch analyz duplic measur method-agr analysi sybr-14/pe-pna/pi fluorescein isothiocyan fitc -conjug pna perform fitc-pna/pi stain carri 14 frozen-thaw semen sampl immedi thaw 3-h incub 37°c british standard institut repeat index sybr-14/pe-pna/pi combin 2.6 averag fitc-pna/pi method show 6.3 overestim live acrosome-intact sperm cell subpopul conclus new triple-stain combin highli repeat easi use routin applic provid precis estim rate sperm cell intact head membran acrosom compar gener use valid fitc-pna/pi stain',\n",
       "  'background roughli 3 million peopl worldwid receiv antiretrovir therapi art end 2007 estim 6.7 million still need treatment 2.7 million becam infect hiv 2007. prevent effort might reduc hiv incid unlik elimin diseas investig theoret strategi univers voluntari hiv test immedi treatment art examin condit hiv epidem could driven toward elimin method use mathemat model explor effect case reproduct number stochast model long-term dynam hiv epidem determinist transmiss model test peopl test-cas commun age 15 year older hiv everi year start peopl art immedi diagnos hiv posit use data south africa test case generalis epidem assum hiv transmiss heterosexu find studi strategi could greatli acceler transit present endem phase adult live hiv receiv art elimin phase art within 5 year could reduc hiv incid mortal less one case per 1000 peopl per year 2016 within 10 year full implement strategi reduc preval hiv less 1 within 50 year estim 2032 yearli cost present strategi theoret strategi would us 1.7 billion howev time cost present strategi would continu increas wherea theoret strategi would decreas interpret univers voluntari hiv test immedi art combin present prevent approach could major effect sever generalis hiv/aid epidem approach merit mathemat model research broad consult',\n",
       "  'hypospadia common congenit malform male extern genitalia perform genome-wid associ studi use pool dna 436 individu hypospadia case 494 control european descent select highest rank snp individu genotyp discoveri sampl addit dutch sampl 133 case parent swedish seri 266 case 402 control individu genotyp two snp rs1934179 rs7063116 dgkk encod diacylglycerol kinas κ produc compel evid associ hypospadia discoveri sampl allele-specif odd ratio 2.5 p 2.5 × 10−11 2.3 p 2.9 × 10−9 respect dutch 3.9 p 2.4 × 10−5 3.8 p 3.4 × 10−5 swedish 2.5 p 2.6 × 10−8 2.2 p 2.7 × 10−6 replic sampl express studi show express dgkk preputi tissu case control lower carrier risk allel rs1934179 p 0.047 propos dgkk major risk gene hypospadia',\n",
       "  'unlabel immun cell promot initi metastat dissemin carcinoma cell primari tumor contrast well-studi function initi stage metastasi specif role immunocyt facilit progress critic later step invasion-metastasi cascad remain poorli understood defin novel function neutrophil promot intralumin surviv extravas site metastat dissemin show cd11b /ly6g neutrophil enhanc metastasi format via two distinct mechan first neutrophil inhibit natur killer cell function lead signific increas intralumin surviv time tumor cell thereaft neutrophil oper facilit extravas tumor cell secret il1β matrix metalloproteinas result identifi neutrophil key regul intralumin surviv extravas cross-talk host cell dissemin carcinoma cell signific studi provid import insight system contribut neutrophil cancer metastasi identifi neutrophil facilit intermedi step invasion-metastasi cascad demonstr neutrophil suppress natur killer cell activ increas extravas tumor cell cancer discov 6 6 630-49 ©2016 aacr.thi articl highlight issu featur p. 561',\n",
       "  \"human placent solubl `` high km '' 5'-nucleotidas separ `` low km '' 5'-nucleotidas nonspecif phosphatas amp-sepharos affin chromatographi enzym purifi 8000-fold specif activ 25.6 mumol/min/mg subunit molecular mass 53 kda nativ molecular mass 210 kda suggest tetramer structur solubl high km 5'-nucleotidas activ imp gmp deoxi deriv imp hydrolyz 15 time faster amp enzym virtual absolut requir magnesium ion regul purin nucleosid 5'-triphosph strongli activ enzym potenc order datp greater atp greater gtp 2,3-diphosphoglycer activ enzym potent atp three millimolar atp decreas km imp 0.33 0.09 mm increas vmax 12-fold atp activ modifi imp concentr 20 microm imp atp-depend activ curv sigmoid 2 mm imp hyperbol a0.5 valu atp 2.26 0.70 mm rel maxim veloc 32.9 126.0 nmol/min respect inorgan phosphat shift hyperbol substrat veloc relationship imp sigmoid one physiolog concentr cofactor 3 mm atp 1-4 mm pi 150 mm kcl ph 7.4 enzym 25-35 time activ toward 100 microm imp 100 microm amp data show solubl human placent high km 5'-nucleotidas coexist human placenta low km enzym b physiolog condit enzym favor hydrolysi imp critic regul imp atp pi level c kinet properti atp imp modifi compound suggest complex interact associ bind site\",\n",
       "  'yeast remodel pho5 promot chromatin upon activ accompani transient hyperacetyl subsequ evict histon promot tran cours rerepress nucleosom reassembl promot analyz histon reassembl inact promot chromatin come use strain two differ tag differ regul version histon h3 allow us discrimin histon origin chromatin fraction histon aris solubl histon pool way show incorpor histon origin sourc tran promot closur occur rapidli histon chaperon asf1 hir1 well swi/snf nucleosom remodel complex appear import rapid reassembl nucleosom pho5 promot',\n",
       "  'background data evalu physician adher cardiovascular diseas cvd prevent guidelin accord physician specialti patient characterist particularli gender method result onlin studi 500 randomli select physician 300 primari care physician 100 obstetricians/gynecologist 100 cardiologist use standard questionnair assess awar adopt barrier nation cvd prevent guidelin specialti experiment case studi design test physician accuraci determin cvd risk level assign applic guidelin among high- intermediate- low-risk patient intermediate-risk women assess framingham risk score significantli like assign lower-risk categori primari care physician men ident risk profil p 0.0001 trend similar obstetricians/gynecologist cardiologist assign risk level significantli predict recommend lifestyl prevent pharmacotherapi adjust risk assign impact patient gender prevent care signific except less aspirin p 0.01 weight manag recommend p 0.04 intermediate-risk women physician rate effect abil help patient prevent cvd fewer 1 5 physician knew women men die year cvd conclus percept risk primari factor associ cvd prevent recommend gender dispar recommend prevent therapi explain larg lower perceiv risk despit similar calcul risk women versu men educ intervent physician need improv qualiti cvd prevent care lower morbid mortal cvd men women',\n",
       "  'agrobacterium vacuum infiltr method made possibl transform arabidopsi thaliana without plant tissu cultur regener present studi method evalu substanti modifi transform method develop labor-intens vacuum infiltr process elimin favor simpl dip develop floral tissu solut contain agrobacterium tumefacien 5 sucros 500 microlit per litr surfact silwet l-77 sucros surfact critic success floral dip method plant inocul numer immatur floral bud siliqu present produc transform progeni highest rate plant tissu cultur media hormon benzylamino purin ph adjust unnecessari agrobacterium could appli plant rang cell densiti repeat applic agrobacterium improv transform rate overal yield transform approxim twofold cover plant 1 day retain humid inocul also rais transform rate twofold multipl ecotyp transform method modifi method facilit high-throughput transform arabidopsi effort t-dna gene tag posit clone attempt target gene replac',\n",
       "  \"stress cell coordin multi-facet respons span mani level physiolog yet knowledg complet stress-activ regulatori network well design principl signal integr remain incomplet develop experiment comput approach integr avail protein interact data gene fit contribut mutant transcriptom profil phospho-proteom chang cell respond salt stress infer salt-respons signal network yeast infer subnetwork present mani novel predict implic new regul uncov unrecogn crosstalk known pathway point previous unknown 'hub signal integr exploit predict show cdc14 phosphatas central hub network modif rna polymeras ii coordin induct stress-defens gene reduct growth-rel transcript find ortholog human network enrich cancer-caus gene underscor import subnetwork 's predict understand stress biolog\",\n",
       "  'neural crest nc embryon stem/progenitor cell popul gener divers array cell lineag includ peripher neuron myelin schwann cell melanocyt among other howev long-stand controversi whether broad development perspect reflect vivo multipot individu nc cell whether nc compris heterogen mixtur lineage-restrict progenitor resolv controversi perform vivo fate map singl trunk nc cell premigratori migratori stage use r26r-confetti mous model combin quantit clonal analys definit marker differenti demonstr vast major individu nc cell multipot clone contribut singl deriv intriguingli multipot maintain migratori nc cell thu find provid definit evid vivo multipot premigratori migrat nc cell mous',\n",
       "  'bologna criteria defin poor ovarian respons por ivf provid use templat new research field assist concept howev design studi around european societi human reproduct embryolog por criteria methodolog challeng new definit includ variou por subpopul divers baselin characterist unknown clinic prognosi design rct potenti result bia may introduc women subpopul evenli alloc intervent group case small moderate-s rct single-sequ random method may ensur balanc alloc group stratifi random method provid altern methodolog approach depend chosen methodolog patient characterist outcom within intervent group may better report accord relev subpopul',\n",
       "  'gener gene-edit anim use crisprs/cas9 system base microinject zygot ineffici time consum demand high technic skill report optim electropor method intact rat zygot use sgrna cas9 protein combin ssodn ~100 nt result high frequenc knockout 15 50 analyz anim importantli use ssodn donor templat result precis knock-in mutat 25-100 analyz anim compar microinject electropor long ssdna dsdna donor success use microinject past allow gener genome-edit anim despit dsdna visual within zygot thu simultan electropor larg number intact rat zygot rapid simpl effici method gener varieti genome-edit rat',\n",
       "  \"hen1-medi 2'-o-methyl shown key mechan protect plant microrna mirna small interf rna sirna well anim piwi-interact rna pirna degrad 3 termin uridyl 1-8 howev enzym uridyl unmethyl mirna sirna pirna hen1 unknown studi genet screen identifi second-sit mutat hen1 suppressor1-2 heso1-2 partial suppress morpholog phenotyp hypomorph hen1-2 allel null hen1-1 allel arabidopsi heso1 encod termin nucleotidyl transferas prefer add untempl uridin 3 end rna complet abolish 2'-o-methyl heso1-2 affect profil u-tail mirna sirna increas abund truncat and/or normal size one hen1 often result increas total amount mirna sirna hen1 contrast overexpress heso1 hen1-2 caus sever morpholog defect less accumul mirna result demonstr heso1 enzym uridyl unmethyl mirna sirna hen1 observ also suggest uridyl may destabil unmethyl mirna unknown mechan compet 3'-to-5 exoribonucleas activ hen1 studi shall implic pirna uridyl hen1 anim\",\n",
       "  'global incid hiv exce 2 million new infect annual effect intervent decreas hiv transmiss need random placebo-control studi demonstr daili oral antiretrovir pre-exposur prophylaxi prep fixed-dos combin tablet contain tenofovir disoproxil fumar emtricitabin significantli reduc hiv incid among divers at-risk popul studi efficaci prep correl level adher offici guidelin recommend provis prep peopl greatest risk hiv acquisit demonstr project suggest high level uptak adher possibl outsid control studi howev sever potenti barrier implement prep remain challeng includ low awar util prep at-risk individu uncertainti adher ‘ real-world ’ set major healthcar provid untrain prep provis limit data potenti advers effect long-term use tenofovir–emtricitabin high cost prep medic stigma associ prep use behavior would warrant prep innov pharmacolog chemoprophylact approach could provid solut challeng less-than-daili oral dose regimen long-act inject medic could reduc pill burden facilit adher local deliveri prep medic genit compart via gel ring film may limit system drug exposur potenti toxic portfolio chemoprophylact agent deliveri system expand meet divers sexual health need product prefer individu may benefit prep hope antiretrovir chemoprophylaxi could becom accept feasibl highli effect addit exist hiv prevent strategi',\n",
       "  'object studi assess quantifi risk gestat diabet mellitu gdm accord prepregn matern bodi mass index bmi design systemat review observ studi publish last 30 year four electron databas search public 1977-2007 bmi elect measur obes diagnost criteria gdm accept studi select screen gdm exclud languag restrict methodolog qualiti primari studi assess 1745 citat screen 70 studi two unpublish involv 671 945 women includ 59 cohort 11 case-control studi high medium qualiti compar women normal bmi unadjust pool odd ratio underweight woman develop gdm 0.75 95 confid interv ci 0.69 0.82 overweight moder obes morbidli obes women 1.97 95 ci 1.77 2.19 3.01 95 ci 2.34 3.87 5.55 95 ci 4.27 7.21 respect everi 1 kg -2 increas bmi preval gdm increas 0.92 95 ci 0.73 1.10 risk gdm posit associ prepregn bmi inform import counsel women plan pregnanc',\n",
       "  'background unhealthi behaviour often occur combin studi relationship educ lifestyl defin cluster risk behaviour analys purpos assess socio-econom chang multipl risk behaviour time method cross-sect data belgian health interview survey 1997 2001 2004 analys studi restrict person age ≥ 15 year inform health behaviour educ n 7431 n 8142 n 7459 respect lifestyl index creat base sum four unhealthi behaviour smoker vs. non-smok riski versu non-riski alcohol use sedentary vs. physic activ poor vs. healthi diet lifestyl index dichotom low 0-2 vs. high 3-4 assess socio-econom inequ multipl risk behaviour summari measur odd ratio rel index inequ rii calcul use logist regress stratifi sex result adult popul 7.5 combin three four unhealthi behaviour lower educ men risk besid among men significantli increas 1.6 2001 3.4 2004 p 0.029 increas among women less pronounc rii hand show gradient neither men women conclus multipl risk behaviour common among lower educ peopl increas polar socio-econom inequ assess 2001 2004 among men therefor health promot programm focu lower socio-econom class target risk behaviour simultan',\n",
       "  'purpos evalu global trend health burden peopl visual impair cataract term disability-adjust life year dali correl nation level socioeconom develop method global region nation dali number crude rate age-standard rate cataract vision loss age sex obtain databas global burden diseas studi 2015. human develop index per capita gross domest product country-level data deriv intern open databas regress analysi use assess correl age-standard dali rate socioeconom variabl result global dali number cataract vision loss increas 89.42 2048.18 95 ci confid interv 1457.60-2761.80 thousand 1990 3879.74 95 ci 2766.07-5232.43 thousand 2015 p 0.001 femal higher dali number 315.83 95 ci 237.17-394.4 crude rate 38.29 95 ci 35.35-41.23 adjust age countri p 0.001 age-standard dali rate higher countri low human develop index hdi 91.03 95 ci 73.04-108.75 low hdi 81.67 95 ci 53.24-108.82 medium hdi 55.89 95 ci 36.87-69.63 high hdi 17.10 95 ci 13.91-26.84 high hdi countri p 0.01 respect nation age-standard dali rate 2015 neg associ hdi r2 0.489 p 0.001 per capita gross domest product r2 0.331 p 0.001 stepwis multipl regress show hdi significantli correl nation age-standard dali rate 2015 adjust confound factor p 0.001 conclus global health burden vision loss due cataract increas 1990 2015 despit consider effort world health organ vision 2020 initi',\n",
       "  'function elucid causal genet variant element requir precis genom edit technolog type ii prokaryot crispr cluster regularli interspac short palindrom repeat /ca adapt immun system shown facilit rna-guid site-specif dna cleavag engin two differ type ii crispr/ca system demonstr cas9 nucleas direct short rna induc precis cleavag endogen genom loci human mous cell cas9 also convert nick enzym facilit homology-direct repair minim mutagen activ lastli multipl guid sequenc encod singl crispr array enabl simultan edit sever site within mammalian genom demonstr easi programm wide applic rna-guid nucleas technolog',\n",
       "  'intact yeast cell treat alkali cation took plasmid dna li+ cs+ rb+ k+ na+ effect induc compet condit transform saccharomyc cerevisia d13-1a plasmid yrp7 studi detail cscl optimum incub time 1 h optimum cell concentr 5 x 10 7 cell per ml optimum concentr cs+ 1.0 m. transform effici increas increas concentr plasmid dna polyethylen glycol absolut requir heat puls variou polyamin basic protein stimul uptak plasmid dna besid circular dna linear plasmid dna also taken cs+-treat yeast cell although uptak effici consider reduc transform effici cs+ li+ compar convent protoplast method plasmid contain ars1 although plasmid contain 2 micron origin replic',\n",
       "  'introduct aim studi examin health-rel qualiti life hrqol measur eq-5d investig influenc chronic condit risk factor hrqol base distribut sampl locat shaanxi provinc china method multi-stag stratifi cluster sampl method perform select subject eq-5d employ measur hrqol likelihood individu select chronic diseas would report problem eq-5d dimens calcul test rel two refer group multivari linear regress model use investig factor associ eq va result frequent report problem involv pain/discomfort 8.8 anxiety/depress 7.6 nearli half respond report problem five dimens chronic patient higher eq va score associ male gender higher level educ employ younger age urban area resid access free medic servic higher level physic activ except anemia select chronic diseas indic neg eq va score three lead risk factor cerebrovascular diseas cancer mental diseas increas age number chronic condit frequenc physic activ found gradient effect conclus result present work add volum knowledg regard popul health statu area apart known health statu use mortal morbid data medic polici social individu attent given manag chronic diseas improv hrqol longitudin studi must perform monitor chang hrqol permit evalu outcom chronic diseas intervent program',\n",
       "  \"genet ident cell share environ display markedli differ phenotyp often unclear much variat deriv chanc extern signal attempt individu cell exert autonom phenotyp program observ thousand cell hundr consecut gener constant condit dissect stochast decis solitari motil state chain sessil state bacillu subtili show motil state 'memoryless exhibit autonom control time spent state contrast time spent connect chain cell tightli control enforc coordin among relat cell multicellular state show three-protein regulatori circuit govern decis modular initi mainten chain genet separ function stimul initi pathway trigger biofilm format argu autonom time allow trial commit multicellular extern signal could extend\",\n",
       "  'corticogenesi pyramid neuron ∼80 cortic neuron aris ventricular zone pass multipolar stage becom bipolar attach radial glia migrat proper posit within cortex pyramid neuron migrat radial remain attach glial substrat pass subventricular intermedi zone region rich tangenti migrat interneuron axon fibr tract examin role lamellipodin lpd homologu key regul neuron migrat polar caenorhabd elegan corticogenesi lpd deplet caus bipolar pyramid neuron adopt tangenti rather radial-gli migrat mode without affect cell fate mechanist lpd deplet reduc activ srf transcript factor regul chang ratio polymer unpolymer actin therefor lpd deplet expos role srf direct pyramid neuron select radial migrat pathway along glia rather tangenti migrat mode',\n",
       "  'genom alter lead aberr activ cyclin/cyclin-depend kinas cdk complex drive pathogenesi mani common human tumor type case glioblastoma multiform gbm alter commonli due homozyg delet p16 ink4a less commonli due genom amplif individu gene encod cyclin cdk describ delet p18 ink4c cdk inhibitor novel genet alter drive pathogenesi gbm delet p18 ink4c often occur tumor also harbor homozyg delet p16 ink4a express p18 ink4c complet absent 43 gbm primari tumor studi immunohistochemistri lentivir reconstitut p18 ink4c express physiolog level p18 ink4c -defici p18 ink4c -profici gbm cell led senescence-lik g 1 cell cycl arrest studi identifi p18 ink4c gbm tumor suppressor gene reveal addit mechan lead aberr activ cyclin/cdk complex terribl malign',\n",
       "  'escherichia coli respond redox stress impos superoxide-gener agent paraquat activ synthesi mani 80 polypeptid express key group induc protein control transcript level soxr locu soxr regulon two-stag control system hypothes soxr intracellular redox signal would trigger soxr protein transcript activ sox gene result increas level sox protein would activ transcript variou soxr regulon gene b. dempl c.f amábil cueva cell 67:837-839 1990 construct operon fusion e. coli lac gene sox promot monitor sox transcript express sox promot strongli induc paraquat manner strictli depend function soxr gene sever superoxide-gener agent also trigger soxr -depend sox express induct paraquat phenazin methosulf depend presenc oxygen numer oxid stress agent h2o2 gamma ray heat shock etc fail induc sox aerob growth superoxid dismutase-defici bacteria trigger soxr-depend sox express result indic specif redox signal sox induct direct role soxr protein activ sox gene indic band-shift dnase footprint experi demonstr specif bind soxr protein cell extract sox promot mode soxr bind dna appear similar homolog merr soxr footprint span -10 -35 region sox promot',\n",
       "  'air pollut heterogen complex mixtur gase liquid particul matter epidemiolog studi demonstr consist increas risk cardiovascular event relat short- long-term exposur present-day concentr ambient particul matter sever plausibl mechanist pathway describ includ enhanc coagulation/thrombosi propens arrhythmia acut arteri vasoconstrict system inflammatori respons chronic promot atherosclerosi purpos statement provid healthcar profession regulatori agenc comprehens review literatur air pollut cardiovascular diseas addit implic find relat public health regulatori polici address practic recommend healthcar provid patient outlin final section suggest futur research made address number remain scientif question',\n",
       "  'helmet new interfac potenti increas success rate non-invas ventil improv toler perform physiolog comparison helmet convent facial mask deliv non-invas ventil hypercapn patient chronic obstruct pulmonari diseas prospect control random studi cross-ov design 10 patient evalu ga exchang inspiratori effort patient–ventil synchroni patient toler 30 min non-invas ventil deliv either helmet facial mask trial preced period spontan unassist breath arteri blood gase inspiratori effort durat diaphragm contract ventil assist effort-to-support delay begin end inspir number ineffect effort patient comfort non-invas ventil improv ga exchang p 0.05 inspiratori effort p 0.01 interfac helmet howev less effici mask reduc inspiratori effort p 0.05 worsen patient–ventil synchroni indic longer delay trigger p 0.05 cycl p 0.05 mechan assist number ineffect effort p 0.005 patient comfort differ two interfac helmet facial mask equal toler effect amelior ga exchang decreas inspiratori effort helmet howev less effici decreas inspiratori effort worsen patient–ventil interact',\n",
       "  'primari goal case manag coordin servic across treatment set integr substanc abus servic type servic offer commun includ hous mental health medic social servic howev case manag global construct consist sever key dimens includ extent case manag coverag degre manag referr process locat case manag activ on-sit off-sit studi examin relationship specif dimens case manag util health ancillari social servic outpati substanc abus treatment gener result suggest activ case manag referr process provid case manag on-sit off-sit consist predict greater use health ancillari social servic substanc abus client howev effect specif gener health care mental health servic case manag appear littl effect use social servic aftercar plan',\n",
       "  'sister kinetochor attach microtubul opposit spindl pole mitosi bi-orient remain poorli understood yeast ortholog aurora b-incenp protein kinas complex ipl1-sli15 may role crucial process necessari prevent attach sister kinetochor microtubul spindl pole investig ipl1 function cell replic chromosom nevertheless duplic spindl pole bodi spb kinetochor detach old spb reattach old new spb equal frequenc ipl1+ cell remain attach old spb ipl1 mutant rais possibl ipl1-sli15 facilit bi-orient promot turnov kinetochore-spb connect traction sister kinetochor toward opposit spindl pole creat tension surround chromatin',\n",
       "  'vascul inflamm vessel wall result mural destruct hemorrhag aneurysm format infarct intimal-medi hyperplasia subsequ stenosi lead tissu ischemia skin part due larg vascular bed exposur cold temperatur frequent presenc stasi involv mani distinct well un-nam vasculit syndrom vari local self-limit gener life-threaten multi-organ diseas exclud mimic vascul diagnosi cutan vascul requir biopsi confirm acut sign fibrinoid necrosi chronic sign endarter obliteran past sign acellular scar heal arter must recogn presenc extravascular find pattern fibrosi collagenolyt granuloma note although vascul classifi etiolog mani case identifi caus singl etiolog agent elicit sever distinct clinicopatholog express vascul therefor classif cutan vascul best approach morpholog determin vessel size princip inflammatori respons histolog pattern roughli correl pathogen mechan coupl direct immunofluoresc examin anti-neutrophil cytoplasm antibodi anca statu find work-up system diseas allow specif diagnosi ultim effect therapi herein review cutan vascul focus diagnost criteria classif epidemiolog etiolog pathogenesi evalu cutan vascul patient',\n",
       "  'e2f protein either activ repress transcript follow mitogen stimul repress e2f4-p130-histon deacetylas complex dissoci activ speci e2f1 -2 -3 associ target promot histon h3 h4 simultan becom hyperacetyl remain unclear whether prerequisit consequ e2f bind show activ e2f speci requir hyperacetyl target chromatin human cell overexpress dominant-neg dn e2f1 mutant serum-stimul t98g cell block e2f bind h4 acetyl albeit partial h3 acetyl target gene activ s-phase entri also block dn e2f1 convers ectop activ e2f1 rapidli induc h3 h4 acetyl demonstr direct role e2f event e2f1 previous shown bind histon acetyltransferas hat p300/cbp pcaf/gcn5 hand ectop express e2f1 also bound unrel hat tip60 induc recruit five subunit tip60 complex tip60 trrap p400 tip48 tip49 target promot vivo moreov e2f-depend recruit tip60 chromatin occur late g 1 follow serum stimul specul activ multipl hat complex account e2f-depend acetyl transcript s-phase entri',\n",
       "  'small molecul modul stem cell fate function offer signific opportun allow full realiz therapeut potenti stem cell ration design screen small molecul identifi use compound probe fundament mechan stem cell self-renew differenti reprogram facilit develop cell-bas therapi therapeut drug target endogen stem progenitor cell repair regener discuss recent scientif therapeut progress well new perspect futur challeng use chemic approach stem cell biolog regen medicin',\n",
       "  'report applic single-molecule-bas sequenc technolog high-throughput profil histon modif mammalian cell obtain four billion base sequenc chromatin immunoprecipit dna gener genome-wid chromatin-st map mous embryon stem cell neural progenitor cell embryon fibroblast find lysin 4 lysin 27 trimethyl effect discrimin gene express pois express stabli repress therefor reflect cell state lineag potenti lysin 36 trimethyl mark primari code non-cod transcript facilit gene annot trimethyl lysin 9 lysin 20 detect satellit telomer activ long-termin repeat spread proxim uniqu sequenc lysin 4 lysin 9 trimethyl mark imprint control region final show chromatin state read allele-specif manner use singl nucleotid polymorph studi provid framework applic comprehens chromatin profil toward character divers mammalian cell popul',\n",
       "  'unlabel mani protein-cod oncofet gene highli express murin human fetal liver silenc adult liver protein product hepat oncofet gene use clinic marker recurr hepatocellular carcinoma hcc therapeut target hcc herein examin express profil long noncod rna lncrna found fetal adult liver mice mani fetal hepat lncrna identifi one lncrna-mpvt1 oncofet rna found promot cell prolifer cell cycl express stem cell-lik properti murin cell interestingli found human lncrna-hpvt1 up-regul hcc tissu patient higher lncrna-hpvt1 express poor clinic prognosi protumorigen effect lncrna-hpvt1 cell prolifer cell cycl stem cell-lik properti hcc cell confirm vitro vivo gain-of-funct loss-of-funct experi moreov mrna express profil data show lncrna-hpvt1 up-regul seri cell cycl gene smmc-7721 cell rna pulldown mass spectrum experi identifi nop2 rna-bind protein bind lncrna-hpvt1 confirm lncrna-hpvt1 up-regul nop2 enhanc stabil nop2 protein lncrna-hpvt1 function depend presenc nop2 conclus studi demonstr express mani lncrna up-regul earli liver develop fetal liver use search new diagnost marker hcc lncrna-hpvt1 promot cell prolifer cell cycl acquisit stem cell-lik properti hcc cell stabil nop2 protein regul lncrna-hpvt1/nop2 pathway may benefici effect treatment hcc',\n",
       "  'unicellular eukaryot organ repres popular model system understand age eukaryot candida albican polymorph fungu appear anoth distinct unicellular age model addit bud yeast saccharomyc cerevisia fission yeast schizosaccharomyc pomb two type candida cell yeast blastospor form hyphal filament form similar replic lifespan take advantag morpholog chang abl obtain cell differ age old candida cell tend accumul glycogen oxid damag protein delet sir2 gene caus decreas lifespan insert extra copi sir2 extend lifespan indic like s. cerevisia sir2 regul cellular age c. albican interestingli sir2 delet result accumul extra-chromosom rdna molecul influenc retent oxid protein mother cell suggest extra-chromosom rdna molecul may associ cellular age c. albican novel age model allow effici large-scal isol old cell may facilit biochem character genomics/proteom studi cellular age help verifi age pathway observ organ includ s. cerevisia',\n",
       "  'mammal detect temperatur special neuron peripher nervou system four trpv-class channel implic sens heat one trpm-class channel sens cold combin rang temperatur activ channel cover major relev physiolog spectrum sens mammal signific gap noxiou cold rang describ character anktm1 cold-activ channel lower activ temperatur compar cold menthol receptor trpm8 anktm1 distant famili member trp channel littl amino acid similar trpm8 found subset nocicept sensori neuron coexpress trpv1/vr1 capsaicin/heat receptor trpm8 consist express anktm1 identifi noxiou cold-sensit sensori neuron also respond capsaicin menthol',\n",
       "  'object experiment evid suggest 1,25-dihydroxyvitamin precursor 25-hydroxyvitamin 25 oh may aid prevent colorect cancer therefor examin risk relat plasma concentr vitamin metabolit method nest case-control studi among women nurs health studi identifi 193 colorect cancer case age 46 78 year diagnos 11 year blood collect two control match per case year birth month blood draw odd ratio risk colorect cancer calcul use condit logist regress adjust bodi mass index physic activ smoke famili histori use hormon replac therapi aspirin use dietari intak result found signific invers linear associ plasma 25 oh risk colorect cancer p 0.02 among women highest quintil 95 confid interv 0.53 0.27-1.04 invers associ remain strong limit women =60 year blood collect p 0.006 appar among younger women p 0.70 benefit higher 25 oh concentr observ cancer distal colon rectum p 0.02 evid proxim colon p 0.81 contrast 25 oh observ associ 1,25-dihydroxyvitamin colorect cancer although risk elev among women highest quintil also lower half 25 oh distribut 2.52 95 confid interv 1.04-6.11 conclus result support evid previou studi conclud higher plasma level 25 oh associ lower risk colorect cancer older women particularli cancer distal colon rectum',\n",
       "  'cem15/apobec3g cellular protein requir resist infect virion infect factor vif -defici human immunodefici viru hiv use murin leukemia viru mlv -base system provid evid cem15/apobec3g dna deaminas incorpor virion viral product subsequ trigger massiv deamin deoxycytidin deoxyuridin within retrovir minu first -strand cdna thu provid probabl trigger viral destruct furthermor hiv vif protect mlv cem15/apobec3g-depend restrict find impli target dna deamin major strategi innat immun retrovirus like also contribut sequenc variat observ mani virus includ hiv',\n",
       "  'background healthi life expect hale disability-adjust life-year dali provid summari measur health across geographi time inform assess epidemiolog pattern health system perform help prioritis invest research develop monitor progress toward sustain develop goal sdg aim provid updat hale dali geographi worldwid evalu diseas burden chang develop method use result global burden diseas injuri risk factor studi 2015 gbd 2015 all-caus mortal cause-specif mortal non-fat diseas burden deriv hale dali sex 195 countri territori 1990 2015. calcul dali sum year life lost yll year life live disabl yld geographi age group sex year estim hale use sullivan method draw age-specif death rate yld per capita assess observ level dali hale differ expect trend calcul socio-demograph index sdi composit indic construct measur incom per capita averag year school total fertil rate find total global dali remain larg unchang 1990 2015 decreas communic neonat matern nutrit group 1 diseas dali offset increas dali due non-communic diseas ncd much epidemiolog transit caus chang popul growth age acceler widespread improv sdi also correl strongli increas import ncd total dali age-standardis dali rate due group 1 caus significantli decreas 2015 although total burden climb major ncd age-standardis dali rate due ncd declin nonetheless age-standardis dali rate due sever high-burden ncd includ osteoarthr drug use disord depress diabet congenit birth defect skin oral sens organ diseas either increas remain unchang lead increas rel rank mani geographi 2005 2015 hale birth increas averag 2·9 year 95 uncertainti interv 2·9-3·0 men 3·5 year 3·4-3·7 women hale age 65 year improv 0·85 year 0·78-0·92 1·2 year 1·1-1·3 respect rise sdi associ consist higher hale somewhat smaller proport life spent function health loss howev rise sdi relat increas total disabl mani countri territori central america eastern sub-saharan africa increasingli lower rate diseas burden expect given sdi time subset geographi record grow gap observ expect level dali trend driven mainli rise burden due war interperson violenc variou ncd interpret health improv global mean popul spend time function health loss absolut expans morbid proport life spent ill health decreas somewhat increas sdi rel compress morbid support continu effort elev person incom improv educ limit fertil analysi dali hale relationship sdi repres robust framework benchmark geography-specif health perform sdg progress country-specif driver diseas burden particularli caus higher-than-expect dali inform financi research invest prevent effort health polici health system improv initi countri along develop continuum fund bill melinda gate foundat',\n",
       "  'advers drug event ade harm associ use given medic normal dosag crucial drug approv clinic use continu stay market mani ade identifi trial drug approv clinic use result advers morbid mortal date million ade report around world method avoid reduc ade import issu drug discoveri develop report comprehens databas advers drug event name metaadedb includ 520,000 drug-ad associ among 3059 uniqu compound includ 1330 drug 13,200 ade item data integr text mine compound ade annot commonli use concept defin medic subject head mesh meanwhil comput method name phenotyp network infer model pnim develop predict potenti ade base databas area receiv oper characterist curv auc 0.9 10-fold cross valid auc valu 0.912 extern valid set extract us-fda advers event report system indic predict capabl method reliabl metaadedb access free charg http //www.lmmd.org/online_services/metaadedb/ databas method provid us use tool search known side effect predict potenti side effect given drug compound',\n",
       "  \"darwin 's studi galapago wallac 's studi indonesia island play import role evolutionari investig radiat within archipelago readili interpret support convent view allopatr speciat even ongo paradigm shift toward mode speciat island radiat lesser antillean anol thought exemplifi process geolog molecular phylogenet evid show archipelago martiniqu anol provid sever exampl secondari contact island speci four precursor island speci 8 mybp diverg met island coalesc form current island martiniqu moreov adjac anol popul also show mark adapt distinct habitat zonat allow allopatr ecolog speciat test system take advantag opportun replic island coalesc independ ecolog adapt carri extens popul genet studi hypervari neutral nuclear marker show even substanti period spatial isol put allospeci show less reproduct isol conspecif popul adjac habitat three case subsequ island coalesc degre genet interchang show alway signific genet signatur past allopatri may quit strong select regim allow case complet allopatr speciat spite strong prima faci case importantli greater genet isol across xeric/rainforest ecoton associ secondari contact reject develop reproduct isol allopatr diverg support potenti ecolog speciat even though full speciat achiev case also explain pauciti anol speci lesser antil compar greater antil\",\n",
       "  'although mast cell function classic relat allerg respons recent studi indic cell contribut common diseas multipl sclerosi rheumatoid arthriti atherosclerosi aortic aneurysm cancer studi present evid mast cell also contribut diet-induc obes diabet exampl white adipos tissu wat obes human mice contain mast cell wat lean counterpart furthermor context mice western diet genet induc defici mast cell pharmacolog stabil reduc bodi weight gain level inflammatori cytokin chemokin proteas serum wat concert improv glucos homeostasi energi expenditur mechanist studi reveal mast cell contribut wat muscl angiogenesi associ cell apoptosi cathepsin activ adopt transfer experi cytokine-defici mast cell show cell produc interleukin-6 il-6 interferon-gamma ifn-gamma contribut mous adipos tissu cystein proteas cathepsin express apoptosi angiogenesi therebi promot diet-induc obes glucos intoler result show reduc obes diabet mice treat clinic avail mast cell-stabil agent suggest potenti develop new therapi common human metabol disord',\n",
       "  'report famili partial epilepsi simpl inherit affect member commonli aphas episod secondari gener onset occur either adolesc adulthood patient respons medic vari greatli neurolog defect declin intellig found case repres anoth varieti rare famili partial epilepsi neocort epilepsi featur',\n",
       "  'vap vapa vapb evolutionarili conserv endoplasm reticulum er -anchor protein help gener tether er membran lipid exchang across adjac bilay report regul pi4p level endosom vap affect wash-depend actin nucleat organel function retrom protein coat respons endosome-to-golgi traffic vap recruit retrom bud site endosom via interact retrom snx2 subunit cell lack vap accumul high level pi4p actin comet trans-golgi protein endosom defect mimick downregul osbp vap interactor pi4p transport particip vap-depend er-endosom tether result reveal role pi4p retromer-/wash-depend bud endosom collect data show er control bud dynam associ cytoskeleton anoth membran direct contact lead bilay lipid modif',\n",
       "  'cyclin stabl protein g2 phase destabil cell enter mitosi almost complet degrad metaphas anaphas transit microinject antibodi subunit anaphase-promot complex/cyclosom apc/c human cdc20 fizzi arrest cell metaphas stabil cyclin b1 cyclin effici polyubiquityl cdc20 cdh1-activ apc/c vitro contrast cyclin b1 proteolysi cyclin delay spindl assembl checkpoint degrad cyclin b1 acceler inhibit spindl assembl checkpoint data suggest apc/c activ cell enter mitosi immedi target cyclin degrad wherea spindl assembl checkpoint delay degrad cyclin b1 metaphas anaphas transit “ destruct box ” d-box cyclin 10–20 residu longer cyclin b. overexpress wild-typ cyclin delay metaphas anaphas transit wherea express cyclin mutant lack d-box arrest cell anaphas',\n",
       "  'background human t-cell leukemia virus-associ adult t-cell leukemia-lymphoma atll poor prognosi despit trial varieti differ treatment regimen viru express report limit absent atll diagnos suggest secondari genet epigenet chang import diseas pathogenesi method find prospect investig combin chemotherapi follow antiretrovir therapi disord nineteen patient prospect enrol 2002 2006 five medic center phase ii clinic trial infusion chemotherapi etoposid doxorubicin vincristin daili prednison bolu cyclophosphamid epoch given two six cycl maxim clinic respons follow antivir therapi daili zidovudin lamivudin alpha interferon-2a one year seven patient studi less one month due progress diseas chemotherapi toxic eleven patient achiev object respons median durat respons thirteen month two complet remiss chemotherapi induct viral rna express increas median 190-fold viru replic occur coincid develop diseas progress conclus epoch chemotherapi follow antiretrovir therapi activ therapeut regimen adult t-cell leukemia-lymphoma viral reactiv induct chemotherapi may contribut treatment failur altern therapi sore need diseas simultan prevent viru express cytocid malign cell',\n",
       "  'object assess effect montelukast versu salmeterol ad inhal fluticason propion asthma exacerb patient whose symptom inadequ control fluticason alon design set 52 week two period doubl blind multicentr trial patient whose symptom remain uncontrol inhal corticosteroid randomis add montelukast salmeterol particip patient 15-72 year n 1490 clinic histori chronic asthma 1 year baselin forc expiratori volum one second fev1 valu 50-90 predict beta agonist improv 12 fev1 main outcom measur primari end point percentag patient least one asthma exacerb result 20.1 patient group receiv montelukast fluticason asthma exacerb compar 19.1 group receiv salmeterol fluticason differ 1 95 confid interv -3.1 5.0 risk ratio montelukast-fluticasone/salmeterol-fluticason 1.05 0.86 1.29 treatment montelukast fluticason shown non-inferior treatment salmeterol fluticason salmeterol fluticason significantli increas fev1 beta agonist use morn peak expiratori flow compar montelukast fluticason p 0.001 wherea fev1 beta agonist use improv asthma specif qualiti life nocturn awaken similar group montelukast fluticason significantli p 0.011 reduc peripher blood eosinophil count compar salmeterol fluticason treatment gener well toler conclus addit montelukast patient whose symptom remain uncontrol inhal fluticason could provid equival clinic control salmeterol',\n",
       "  \"extracellular amino-termin domain atd ionotrop glutam receptor subunit form semiautonom compon glutam receptor resid distal membran control surprisingli divers set receptor function function includ subunit assembl receptor traffick channel gate agonist potenc alloster modul mani diverg featur differ ionotrop glutam receptor class differ subunit within class may stem differenti regul amino-termin domain emerg knowledg structur function amino-termin domain review may enabl target region therapeut modul glutamaterg signal toward end nmda receptor antagonist interact glun2b atd show promis anim model ischemia neuropath pain parkinson 's diseas\",\n",
       "  'past year simpl organ yeast worm contribut great deal age research studi pioneer saccharomyc cerevisia use elucid signific number molecular mechan underli cellular age discov novel longev gene importantli gene prove mani time conserv multicellular eukaryot consequ discoveri approach extend yeast model schizosaccharomyc pomb candida albican kluyveromyc lacti cryptococcu neoforman fission yeast research found link asymmetr cell divis nutrient signal pathway age review discuss state knowledg mechan control replic chronolog age pomb emerg yeast model',\n",
       "  'centrifug elutri use isol human peripher blood monocyt hpbm mononuclear-enrich cell harvest secondari compon follow platelet concentr collect sampl hpbm recov either one two popul consist either total hpbm small sm larg monocyt lm elutri carri 3,500 +/- 5 rpm separ lymphocyt hpbm ca++- mg++-free pb without edta averag 5.05 +/- 1.50 x 10 8 hpbm recov total hpbm puriti 95 +/- 3 sm lm obtain split total hpbm two equal popul hpbm puriti 92 +/- 3 93 +/- 3 respect nonspecif esteras stain elutri media shown effect viabil trypan blue exclus three hpbm popul shown histochem lack reactiv leu-1 leu-7 function deplet nk cell activ purifi lymphocyt popul hpbm popul enrich hla-dr okm-1 okm-5 my-8 leu m-3 monoclon antibodi marker stain differ percent posit cell sm lm popul monocyte-specif monoclon antibodi three monocyt popul mediat antibody-depend cell-medi cytotox human red blood cell lm mediat lysi 27.0 +/- 5 sm 7 +/- 3 abstract truncat 250 word',\n",
       "  'background asthma preval appear increas gener popul sought determin whether asthma preval also increas highli competit athlet object aim determin mani unit state olymp athlet chosen particip 1996 summer olymp game past histori asthma symptom suggest asthma took asthma medic method analyz respons question ask allerg respiratori diseas unit state olymp committe usoc medic histori questionnair complet athlet chosen repres us 1996 summer olymp game atlanta result 699 athlet complet questionnair 107 15.3 previou diagnosi asthma 97 13.9 record use asthma medic time past one hundr seventeen 16.7 report use asthma medic diagnosi asthma basi diagnosi asthma seventy-thre 10 4 athlet current take asthma medic time process atlanta note took asthma medic perman semiperman basi consid activ asthma athlet particip cycl mountain bike highest preval told asthma taken asthma medic past 50 frequenc activ asthma vari 45 cyclist emountain biker none diver weight lifter 11 athlet particip 1984 summer olymp game report exercise-induc asthma basi criteria may less restrict basi less restrict criteria 20 athlet particip 1996 olymp game might consid asthma conclus asthma appear preval athlet particip 1996 summer game gener popul particip 1984 summer game studi also suggest asthma may influenc sport athlet choos',\n",
       "  \"relaps childhood acut lymphoblast leukemia carri poor prognosi despit intens retreat owe intrins drug resist biolog pathway mediat resist unknown report transcriptom profil match diagnosi relaps bone marrow specimen ten individu pediatr b-lymphoblast leukemia use rna sequenc transcriptom sequenc identifi 20 newli acquir novel nonsynonym mutat present initi diagnosi 2 individu harbor relapse-specif mutat gene nt5c2 encod 5'-nucleotidas full-exon sequenc nt5c2 complet 61 relaps specimen identifi addit mutat 5 case enzymat analysi mutant protein show base substitut confer increas enzymat activ resist treatment nucleosid analog therapi clinic individu harbor nt5c2 mutat relaps earli within 36 month initi diagnosi p 0.03 result suggest mutat nt5c2 associ outgrowth drug-resist clone\",\n",
       "  'sloan-kett viru gene product ski uniqu nuclear pro-oncoprotein belong ski/sno proto-oncogen famili ski play multipl role varieti cell type induc oncogen transform termin muscl differenti express high level ski/snon import transcript regul transform growth factor-β tgf-β superfamili function mainli heterodim sinc tgf-β superfamili key regul follicl develop previous shown snon also vital follicl develop research conduct clarifi relationship ski express mous follicular develop ovari neonat gonadotropin-induc immatur mice immunohistochem real-tim pcr techniqu postnat mice posit stain ski highli detect oocyt nuclei postnat day 1. follicular develop local move gradual oocyt nuclei perinuclear space total level decreas estrou cycl ski express appar proestru estru faint metestru highest diestru inject gonadotropin ski found perinuclear space weak oocyt nuclei follow initi lutein express ski found corpu luteum real-tim pcr result also show ski mrna express opposit ovulation-rel gene cumulu expans develop follicl express level decreas ski express specif manner follicl develop ovul lutein ski might play essenti role process especi earli follicular develop',\n",
       "  'rational endogen exogen cannabinoid act cb1 cannabinoid receptor implic control varieti behaviour neuroendocrin function includ emot respons learn memori process recent knockout mice defici cb1 cannabinoid receptor gener anim result excel tool evalu neurophysiolog endogen cannabinoid system object establish role cb1 cannabinoid receptor sever emotional-rel behaviour respons includ aggress anxieti depress learn model use cb1 knockout mice method evalu spontan respons cb1 knockout mice wild-typ control differ behaviour paradigm includ light/dark box chronic unpredict mild stress resident–intrud test activ avoid paradigm result find show cb1 knockout mice present increas aggress respons measur resident–intrud test anxiogenic-lik respons light/dark box furthermor higher sensit exhibit depressive-lik respons chronic unpredict mild stress procedur observ cb1 knockout mice suggest increas suscept develop anhedon state anim final cb1 knockout mice show signific increas condit respons produc activ avoid model suggest improv learn memori process conclus taken togeth find demonstr endogen cannabinoid activ cb1 receptor implic control emot behaviour particip physiolog process learn memori',\n",
       "  'glioma common type primari brain tumor extracellular vesicl form exosom known mediat cell-cel commun transport cell-deriv protein nucleic acid includ variou microrna mirna examin cerebrospin fluid csf patient recurr glioma level cancer-rel mirna evalu valu prognosi compar measur csf- serum- exosome-contain mir-21 level sampl seventi glioma patient follow surgeri compar brain trauma patient non-tumor control group exosom mir-21 level csf glioma patient found significantli higher control wherea differ detect serum-deriv exosom mir-21 express csf-deriv exosom mir-21 level correl tumor spinal/ventricl metastasi recurr anatom site prefer addit 198 glioma tissu sampl verifi mir-21 level associ tumor grade diagnosi neg correl median valu patient overal surviv time use lentivir inhibitor suppress mir-21 express u251 cell result show level mir-21 target gene pten reck pdcd4 up-regul protein level therefor conclud exosom mir-21 level could demonstr promis indic glioma diagnosi prognosi particularli valu predict tumor recurr metastasi',\n",
       "  \"recent studi provid evid correl dna methyl express protein-cod gene human age relat microrna express age age-rel clinic outcom character thoroughli explor associ age whole-blood microrna express 5221 adult identifi 127 microrna differenti express age p 3.3 × 10-4 bonferroni-correct microrna underexpress older individu integr analysi microrna mrna express reveal chang age-associ mrna express possibl driven age-associ microrna pathway involv rna process translat immun function fit linear model predict 'microrna age incorpor express level 80 microrna microrna age correl modestli predict age dna methyl r 0.3 mrna express r 0.2 suggest microrna age may complement mrna epigenet age predict model use differ microrna age chronolog age biomark acceler age δage found δage associ all-caus mortal hazard ratio 1.1 per year differ p 4.2 × 10-5 adjust sex chronolog age addit δage associ coronari heart diseas hypertens blood pressur glucos level conclus construct microrna age predict model base whole-blood microrna express profil age-associ microrna target potenti util detect acceler age predict risk age-rel diseas\",\n",
       "  'aim frontotempor lobar degener ftld clinic patholog heterogen although associ variat mapt grn c9orf72 pathogenesi nongenet form ftld remain unknown epigenet factor histon regul histon deacetylas hdac may play role dysregul transcript activ thought underpin neurodegen process method distribut intens hdac 4 5 6 assess semi-quantit immunostain section tempor cortex hippocampu cerebellum 33 patholog confirm case ftld 27 control result found significantli greater intens cytoplasm immunostain hdac4 hdac6 granul cell dentat gyru case ftld overal compar control specif case ftld tau-pick compar ftld tau-mapt control differ note ftld-tdp subtyp differ genet nongenet form ftld chang seen hdac5 ftld control case conclus dysregul hdac4 and/or hdac6 could play role pathogenesi ftld-tau associ pick bodi although lack immunostain impli chang contribut directli format pick bodi',\n",
       "  'clonal evolut key featur cancer progress relaps studi intratumor heterogen 149 chronic lymphocyt leukemia cll case integr whole-exom sequenc copi number measur fraction cancer cell harbor somat mutat identifi driver mutat predominantli clonal e.g. myd88 trisomi 12 del 13q subclon e.g. sf3b1 tp53 correspond earlier later event cll evolut sampl leukemia cell 18 patient two time point ten twelv cll case treat chemotherapi one six without treatment underw clonal evolut predominantli involv subclon driver mutat e.g. sf3b1 tp53 expand time furthermor presenc subclon driver mutat independ risk factor rapid diseas progress studi thu uncov pattern clonal evolut cll provid insight stepwis transform link presenc subclon advers clinic outcom',\n",
       "  'diploid cell bud yeast produc haploid cell development program sporul consist meiosi spore morphogenesi dna microarray contain nearli everi yeast gene use assay chang gene express sporul least seven distinct tempor pattern induct observ transcript factor ndt80 appear import induct larg group gene end meiotic prophas consensu sequenc known propos respons tempor regul could identifi sole analysi sequenc coordin express gene tempor express pattern provid clue potenti function hundr previous uncharacter gene vertebr homolog may function gametogenesi',\n",
       "  'prion protein-bas infecti agent respons prion diseas environment prion contamin implic diseas transmiss analyz bind retent infecti prion protein prp sc plant small quantiti prp sc contain dilut brain homogen excretori materi urin fece bind wheat grass root leav wild-typ hamster effici infect ingest prion-contamin plant prion-plant interact occur prion divers origin includ chronic wast diseas furthermor leav contamin spray prion-contain prepar retain prp sc sever week live plant final plant uptak prion contamin soil transport aerial part plant stem leav find demonstr plant effici bind infecti prion act carrier infect suggest possibl role environment prion contamin horizont transmiss diseas',\n",
       "  \"patient asthma major public health problem high risk seriou diseas influenza viru infect pathogen mechan influenza caus airway diseas asthma fulli known show mous model influenza infect acut induc airway hyper-react ahr cardin featur asthma independ helper type 2 th2 cell adapt immun instead influenza infect induc ahr previous unknown pathway requir interleukin 13 il-13 –il-33 axi cell non-t cell non-b cell innat lymphoid type call 'natur helper cell infect influenza viru activ nlrp3 inflammasom result much product il-33 alveolar macrophag turn activ natur helper cell produc substanti il-13\",\n",
       "  \"background improv design implement evidence-bas practic depend success behaviour chang intervent requir appropri method characteris intervent link analysi target behaviour exist plethora framework behaviour chang intervent clear well serv purpos paper evalu framework develop evalu new framework aim overcom limit method systemat search electron databas consult behaviour chang expert use identifi framework behaviour chang intervent evalu accord three criteria comprehens coher clear link overarch model behaviour new framework develop meet criteria reliabl could appli examin two domain behaviour chang tobacco control obes result nineteen framework identifi cover nine intervent function seven polici categori could enabl intervent none framework review cover full rang intervent function polici minor met criteria coher linkag model behaviour centr propos new framework 'behaviour system involv three essenti condit capabl opportun motiv term 'com-b system form hub 'behaviour chang wheel bcw around posit nine intervent function aim address deficit one condit around place seven categori polici could enabl intervent occur bcw use reliabl characteris intervent within english depart health 's 2010 tobacco control strategi nation institut health clinic excel 's guidanc reduc obes conclus intervent polici chang behaviour use characteris mean bcw compris 'behaviour system hub encircl intervent function polici categori research need establish far bcw lead effici design effect intervent\",\n",
       "  'hiv continu spread global mainli sexual contact despit advanc treatment care prevent transmiss vaccin microbicid proven difficult promis strategi avoid transmiss prophylact treatment antiretrovir drug exposur hiv clinic trial evalu efficaci daili treatment revers transcriptas inhibitor tenofovir disoproxil fumar tdf truvada tdf plu emtricitabin way hypothes intermitt prophylact treatment long-act antivir drug would effect daili dose block earliest stage viral replic prevent mucos transmiss test hypothesi intermitt give prophylact truvada macaqu monkey expos rectal simian-human immunodefici viru shiv week 14 week simpl regimen oral dose truvada given 1 3 7 day exposur follow second dose 2 hour exposur protect daili drug administr possibl long intracellular persist drug addit two-dos regimen initi 2 hour viru exposur effect full protect obtain doubl truvada concentr dose saw protect first dose delay 24 hour exposur underscor import block initi replic mucosa result show intermitt prophylact treatment antivir drug highli effect prevent shiv infect wide window protect strengthen possibl develop feasibl cost-effect strategi prevent hiv transmiss human',\n",
       "  'malign pleural effus mpe use specimen allow evalu egfr statu nonsmal cell lung cancer nsclc howev direct sequenc genom dna mpe sampl found sensit egfr mutat detect test whether egfr analysi rna less prone interfer nontumour cell lower egfr express compar three method sequenc cell-deriv rna versu sequenc mass-spectrometr analysi genom dna parallel egfr mutat detect mpe sampl 150 lung adenocarcinoma patient receiv first-lin tyrosin kinas inhibitor tki among mpe sampl egfr mutat much frequent identifi sequenc use rna sequenc mass-spectrometr analysi genom dna mutat 67.3 versu 44.7 46.7 l858r exon 19 delet 61.3 versu 41.3 46.7 respect better mutat detect yield sequenc rna coupl superior predict clinic efficaci first-lin tki patient acquir resist egfr sequenc rna provid satisfactori detect t790m 54.2 result demonstr egfr sequenc use rna templat greatli improv sensit egfr mutat detect sampl mpe highlight rna favour sourc analys egfr mutat heterogen mpe specimen nsclc',\n",
       "  'cystic fibrosi caus mutat cystic fibrosi transmembran conduct regul encod cftr impair role apic chlorid channel support bicarbon transport individu cystic fibrosi show retain thicken mucu plug airway obstruct lumin organ well numer abnorm includ inflamm affect organ alter lipid metabol insulin resist show colon epitheli cell whole lung tissu cftr-defici mice show defect peroxisom proliferator-activ receptor-gamma ppar-gamma encod pparg function contribut patholog program gene express lipidom analysi colon epitheli cell suggest defect result part reduc amount endogen ppar-gamma ligand 15-keto-prostaglandin e 2 15-keto-pg 2 treatment cftr-defici mice synthet ppar-gamma ligand rosiglitazon partial normal alter gene express pattern associ cftr defici reduc diseas sever rosiglitazon effect chlorid secret colon increas express gene encod carbon anhydras 4 2 car4 car2 increas bicarbon secret reduc mucu retent studi reveal revers defect ppar-gamma signal cftr-defici cell pharmacolog correct amelior sever cystic fibrosi phenotyp mice',\n",
       "  'develop mass microscop mass spectrometri imag spatial resolut higher nake eye equip atmospher pressur ion-sourc chamber laser desorption/ion ap-ldi quadrupol ion trap time-of-flight qit-tof analyz optic microscop combin mass spectromet permit us precis determin relev tissu region prior perform imag mass spectrometri im ultraviolet laser tightli focus triplet len use achiev high spatial resolut atmospher pressur ion-sourc chamber enabl us analyz fresh sampl minim loss intrins water volatil compound mass-microscop ap-ldi imag freshli cut ginger rhizom section reveal 6-gingerol k m/z 333.15 posit mode h m/z 293.17 neg mode monoterpen k m/z 191.09 compound relat pungenc flavor respect local oil drop-contain organel ap-ldi-tandem ms/m analys appli compar authent signal freshli cut ginger directli standard reagent thu atmosphere-imag mass spectromet enabl us monitor qualiti plant organel level',\n",
       "  'mammal tast wide repertoir chemosensori stimuli two unrel famili receptor t1r t2r mediat respons sweet amino acid bitter compound demonstr knockout trpm5 tast trp ion channel plcbeta2 phospholipas c select express tast tissu abolish sweet amino acid bitter tast recept impact sour salti tast therefor despit reli differ receptor sweet amino acid bitter transduct converg common signal molecul use plcbeta2 taste-blind anim examin fundament question tast percept tast modal encod cellular level mice engin rescu plcbeta2 function exclus bitter-receptor express cell respond normal bitter tastant tast sweet amino acid stimuli thu bitter encod independ sweet amino acid tast receptor cell broadli tune across modal',\n",
       "  'advanc glycat end-product age result non-enzymat glycat one major factor implic secondari complic diabet scientist focus discov new compound may use potenti age inhibitor without affect normal structur function biomolecul number natur synthet compound propos age inhibitor studi investig inhibitori effect agnp silver nanoparticl age format agnp ~30.5 nm synthes alo vera leaf extract character use uv-vi spectroscopi energy-dispers x-ray spectroscopi edx high resolution-transmiss electron microscopi x-ray diffract dynam light scatter dl techniqu inhibitori effect agnp age format evalu investig degre reactiv free amino group lysin arginin residu protein-bound carbonyl carboxymethyl lysin cml content effect protein structur use variou physicochem techniqu result show agnp significantli inhibit age format concentr depend manner agnp posit effect protein structur find strongli suggest agnp may play therapeut role diabetes-rel complic',\n",
       "  'drosophila spaghetti squash sqh gene encod regulatori myosin light chain rmlc nonmuscl myosin ii biochem analysi vertebr nonmuscl smooth muscl myosin ii establish phosphoryl certain amino acid rmlc greatli increas actin-depend myosin atpas motor activ myosin vitro assess vivo import site drosophila correspond serine-21 threonine-20 creat seri transgen specif amino acid alter phenotyp transgen examin otherwis null mutant background oocyt develop drosophila femal germ line cystoblast entir lack function sqh gene show sever defect prolifer cytokinesi ring canal cytoplasm bridg link oocyt nurs cell egg chamber abnorm suggest role myosin ii establish mainten addit numer aggreg myosin heavi chain accumul sqh null cell mutant sqh transgen sqh -a20 a21 serine-21 threonine-20 replac alanin behav respect ident null allel system except heavi chain aggreg found contrast express sqh -a21 primari phosphoryl target serine-21 site alter partial restor function germ line myosin ii allow cystoblast divis oocyt develop albeit cytokinesi failur defect rapid cytoplasm transport nurs cell cytoplasm characterist late stage oogenesi damag ring canal substitut glutam serine-21 mutant sqh -e21 allow oogenesi complet minim defect produc egg develop normal produc fertil adult fli express sqh -a20 secondari phosphoryl site absent appear entir wild type taken togeth genet evid argu phosphoryl serine-21 critic rmlc function activ myosin ii vivo function partial provid phosphoryl threonine-20',\n",
       "  'two thousand three hundr thirti two nonselect brain 1- 100-year-old individu examin use immunocytochemistri at8 gallya silver stain abnorm tau immunocytochemistri 4g8 campbell-switz stain use detect ofβ-amyloid total 342 case neg gallya stain restag at8 10 immunoneg fifty-eight case subcort tau predominantli locu coeruleu abnorm cortic tau subcort stage a-c cortic involv abnorm tau neurit identifi first transentorhin region stage 1a 38 case transentorhin pyramid cell display pretangl materi stage 1b 236 case pretangl gradual becam argyrophil neurofibrillari tangl nft progress parallel nft stage vi pretangl restrict subcort site seen chiefli younger age total case 1,031 44.2 β-amyloid plaqu first plaqu occur neocortex onset tauopathi brainstem plaqu gener develop 40 4 case culmin tenth decad 75 β-amyloid plaqu nft significantli correl p 0.0001 data suggest tauopathi associ sporad alzheim diseas may begin earlier previous thought possibl lower brainstem rather transentorhin region',\n",
       "  'background studi compar long-term statu bypass graft patient without diabet uncertainti exist whether diabet independ predict poor clinic outcom cabg method result among 1526 patient bari underw cabg initi revascular 99 292 34 treat diabet mellitu tdm insulin oral hypoglycem agent 469 1234 38 without tdm follow-up angiographi angiogram longest interv initi surgeri percutan graft intervent mean 3.9 year review averag 3.0 graft place initi cabg patient tdm n=297 intern mammari arteri ima 33 2.9 graft patient without tdm n=1347 ima 34 patient tdm like without small 1.5 mm graft distal vessel 29 versu 22 vessel poor qualiti 9 versu 6 follow-up angiographi 89 ima graft free stenos =50 among patient tdm versu 85 among patient without tdm p=0.23 vein graft correspond percentag 71 versu 75 p=0.40 statist adjust tdm unrel graft stenosi =50 adjust odd ratio 0.87 95 ci 0.58 1.32 conclus despit diabet patient smaller distal vessel vessel judg poorer qualiti diabet appear advers affect patenc ima vein graft averag 4-year follow-up previous observ differ surviv cabg-treat patient without diabet may larg result differenti risk mortal noncardiac caus',\n",
       "  \"background open chromatin region correl activ regulatori element develop dysregul diseas baf swi/snf complex essenti develop demonstr remodel reconstitut chromatin vitro control access individu region vivo howev remain unclear baf control open chromatin landscap regul development process human epiderm differenti result use novel `` on-plat '' atac-sequenc approach profil open chromatin landscap low number adher cell demonstr baf complex essenti maintain 11.6 open chromatin region epiderm differenti baf-depend open chromatin region highli cell-type-specif strongli enrich bind site p63 master epiderm transcript factor dna sequenc p63 bind site intrins favor nucleosom format inaccess cell type without p63 prevent ectop activ epiderm cell baf p63 mutual recruit maintain 14,853 open chromatin region demonstr baf p63 cooper posit nucleosom away p63 bind site recruit transcript machineri control tissu differenti conclus baf display high specif control open chromatin landscap epiderm differenti cooper master transcript factor p63 maintain lineage-specif open chromatin region\",\n",
       "  'background reduct complianc large-s cardiothorac central arteri independ risk factor develop cardiovascular diseas advanc age method result determin role habitu exercis age-rel decreas central arteri complianc use cross-sect intervent approach first studi 151 healthi men age 18 77 year 54 sedentari 45 recreat activ 53 endur exercise-train central arteri complianc simultan b-mode ultrasound arteri applan tonometri common carotid arteri lower p 0.05 middle-ag older men young men 3 group signific differ sedentari recreat activ men age howev arteri complianc endurance-train middle-ag older men 20 35 higher 2 less activ group p 0.01 age-rel differ central arteri complianc smaller endurance-train men sedentari recreat activ men second studi 20 middle-ag older 53+/-2 year sedentari healthi men 3-month aerob exercis intervent primarili walk regular exercis increas central arteri complianc p 0.01 level similar middle-ag older endurance-train men effect independ chang bodi mass adipos arteri blood pressur maxim oxygen consumpt conclus regular aerobic-endur exercis attenu age-rel reduct central arteri complianc restor level previous sedentari healthi middle-ag older men may one mechan habitu exercis lower risk cardiovascular diseas popul',\n",
       "  'studi aim describ cancer screen rate second primari cancer among cancer survivor korea compar rate two control group individu without histori cancer chronic diseas individu without histori cancer without chronic diseas studi cross-sect analysi 15,556 adult ≥30 year old particip 2001 2005 2007 korean nation health nutrit examin survey knhane preval breast cervic gastric colorect cancer screen examin accord nation guidelin assess compar two control group screen rate among cancer survivor 48.5 54.7 34.7 28.6 breast cervic gastric colorect cancer screen respect cancer survivor show higher screen rate four cancer site compar control group breast cancer screen statist signific adjust gender age marit statu educ incom work statu health insur smoke drink statu self-report health statu cancer survivor like individu without cancer histori obtain screen examin accord recommend guidelin still screen rate even among survivor suboptim emphas need systemat approach second primari cancer screen prevent',\n",
       "  'yeast transcript activ gal4 bind specif site dna activ transcript adjac genes1–5 distinct activ region gal4 rich acid residu suggest region interact anoth protein compon transcript machineri tata-bind protein rna polymeras ii dna-bind region serv posit activ region near gene6,7,8 show variou gal4 deriv express high level yeast inhibit transcript certain gene lack gal4 bind site effici activ inhibit strongli inhibit depend dna-bind domain suggest inhibit call squelch reflect titrat transcript factor activ region gal4',\n",
       "  'paper examin relationship univers research develop r activ bayh-dol act act made much easier univers obtain patent research fund feder govern may provid univers incent alter r activ act may provid incent reduc basic research gener licens fee increas appli research gener patent licens fee addit industri might will fund univers r project sinc result would easier patent paper differ exist literatur use patent data measur research output use research develop data measur invent input examin effect act',\n",
       "  'object determin whether higher past exposur particul air pollut associ preval high symptom anxieti design observ cohort studi set nurs health studi particip 71,271 women enrol nurs health studi resid throughout contigu unit state valid estim exposur particul matter least one exposur period interest data anxieti symptom main outcom measur meaning high symptom anxieti defin score 6 point greater phobic anxieti subscal crown-crisp index administ 2004. result 71,271 elig women age 57 85 year mean 70 year time assess anxieti symptom preval high anxieti symptom 15 exposur particul matter character use estim averag exposur particul matter 2.5 μm diamet pm2.5 2.5 10 μm diamet pm2.5-10 one month three month six month one year 15 year prior assess anxieti symptom residenti distanc nearest major road two year prior assess significantli increas odd high anxieti symptom observ higher exposur pm2.5 multipl averag period exampl odd ratio per 10 µg/m 3 increas prior one month averag pm2.5 1.12 95 confid interv 1.06 1.19 prior 12 month averag pm2.5 1.15 1.06 1.26 model includ multipl exposur window suggest short term averag period relev long term averag period associ anxieti exposur pm2.5-10 residenti proxim major road relat anxieti symptom dose depend manner conclus exposur fine particul matter pm2.5 associ high symptom anxieti recent exposur potenti relev distant exposur research evalu whether reduct exposur ambient pm2.5 would reduc popul level burden clinic relev symptom anxieti warrant',\n",
       "  'recent studi reveal mechan delay age yeast natur compound specif impact mitochondri redox process mechan exogen ad lithochol bile acid enter yeast cell accumul mainli inner mitochondri membran elicit age-rel remodel phospholipid synthesi movement within mitochondri membran remodel mitochondri phospholipid dynam progress chronolog age yeast cell ultim caus signific chang mitochondri membran lipidom chang composit membran phospholipid alter mitochondri abund morpholog therebi trigger chang age-rel chronolog longevity-defin redox process mitochondri respir mainten mitochondri membran potenti preserv cellular homeostasi mitochondri produc reactiv oxygen speci coupl electron transport atp synthesi',\n",
       "  'analysi serum sampl 100 wild-caught colony-born syke monkey cercopithecu miti kenya reveal 59 anim antibodi cross-react human immunodefici viru type 2 hiv-2 simian immunodefici virus siv lentiviru design sivsyk isol five six seroposit asymptomat syke monkey four case isol possibl deplet cd8+ lymphocyt cocultiv cd4 -enrich cell popul peripher blood mononuclear cell seroneg syke monkey sivsyk resembl siv hiv morpholog mg2 -depend revers transcriptas enzym replic cytopath cemx174 sup-t1 cell sivsyk differ substanti siv howev fail replic normal human mangabey macaqu peripher blood mononuclear cell serum seroposit syke monkey immunoprecipit env antigen hiv-1 well hiv-2 sivsmm sivagm data demonstr high preval natur infect syke monkey kenya lentiviru appear uniqu respect host rang antigen cross-react',\n",
       "  \"bacteria encod single-strand dna ssdna bind protein ssb crucial genom mainten bacillu subtili streptococcu pneumonia altern ssb ssbb express uniqu compet genet transform precis role disappointingli obscur report investig involv comparison null mutant ssbb c-ter truncat ssbbδ7 ssbb s. pneumonia latter construct ssb acid tail emerg key site interact partner protein provid evid ssbb directli protect intern ssdna show ssbb highli abund potenti allow bind ~1.15 mb ssdna half genom equival particip process ssdna recombin high dna concentr crucial import chromosom transform whilst antagon plasmid transform latter observ explain long-stand observ plasmid transform ineffici s. pneumonia compar chromosom transform former support previou suggest ssbb creat reservoir ssdna allow success recombin cycl ssbbδ7 fulfil reservoir function suggest ssbb c-ter necessari process protein access store ssdna propos evolutionari raison d'être ssbb abund mainten reservoir contribut genet plastic s. pneumonia increas likelihood multipl transform event cell\",\n",
       "  'complex human brain made difficult studi mani brain disord model organ highlight need vitro model human brain develop develop human pluripot stem cell-deriv three-dimension organoid cultur system term cerebr organoid develop variou discret although interdepend brain region includ cerebr cortex contain progenitor popul organ produc matur cortic neuron subtyp furthermor cerebr organoid shown recapitul featur human cortic develop name characterist progenitor zone organ abund outer radial glial stem cell final use rna interfer patient-specif induc pluripot stem cell model microcephali disord difficult recapitul mice demonstr prematur neuron differenti patient organoid defect could help explain diseas phenotyp togeth data show three-dimension organoid recapitul develop diseas even complex human tissu',\n",
       "  'strong evid genet contribut epilepsi commonli assum genet contribut limit ‘ gener ’ epilepsi form ‘ partial ’ epilepsi nongenet linkag analysi singl famili contain 11 affect individu obtain strong evid local gene partial epilepsi suscept gene map chromosom 10q maximum two–point lod score d10s192 3.99 θ=0.0 affect individu share singl haplotyp seven tightli link contigu marker maximum lod score haplotyp 4.83 θ=0.0 key recombin place suscept locu within 10 centimorgan interv',\n",
       "  'epithelial-mesenchym transit emt requir embryo format tissu cell origin far final destin carcinoma cell hijack program tumor dissemin relev emt cancer still debat unclear migratori cell colon distant tissu form macrometastas show homeobox factor prrx1 emt induc confer migratori invas properti loss prrx1 requir cancer cell metastas vivo revert epitheli phenotyp concomit acquisit stem cell properti thu unlik classic emt transcript factor prrx1 uncoupl emt stem biomark associ patient surviv lack metastasi',\n",
       "  'background human papillomaviru hpv associ cervic intraepitheli neoplasia tempor relat infect neoplasia remain unclear rel import specif type hpv sexual transmit diseas risk factor method studi prospect cohort 241 women present evalu sexual transmit diseas neg cervic cytolog test women follow everi four month cytolog colposcop examin uterin cervix test hpv dna sexual transmit diseas result cervic intraepitheli neoplasia grade 2 3 confirm biopsi 28 women basi surviv analysi cumul incid cervic intraepitheli neoplasia two year 28 percent among women posit test hpv 3 percent among without detect hpv dna risk highest among hpv type 16 18 infect adjust rel risk compar women without hpv infect 11 95 percent confid interv 4.6 26 attribut risk 52 percent 24 case cervic intraepitheli neoplasia grade 2 3 among hpv-posit women detect within 24 month first posit test hpv adjust presenc hpv infect develop cervic intraepitheli neoplasia also associ younger age first intercours presenc serum antibodi chlamydia trachomati presenc serum antibodi cytomegaloviru cervic infect neisseria gonorrhoea conclus cervic intraepitheli neoplasia common appar earli manifest cervic infect hpv particularli type 16 18',\n",
       "  'recent year widespread interest larg number public applic graph theori techniqu construct analyz biologically-inform gene network cancer cell line data set current research effort predominantli look overal static topolog represent network investig applic graph theoret techniqu evolutionari investig cancer number studi use graph theori metric degre between close central identifi import hub gene network howev fulli investig import gene across differ stage diseas previou human glioblastoma public identifi four subtyp glioblastoma adult base signatur gene one public verhaak et al found subtyp correspond narrow median surviv rang 11.3 month aggress subtyp 13.1 month least aggress one work present evolutionari graph theori studi glioblastoma base surviv data categor confirm gene associ differ surviv time identifi use establish graph theori metric work extend applic graph theori approach evolutionari studi cancer cell line data',\n",
       "  'hutchinson–gilford progeria syndrom hgp omim 176670 extrem rare devast disord mimic prematur aging.1–3 affect children appear normal birth typic develop failur thrive first two year featur includ alopecia micrognathia loss subcutan fat promin vein abnorm dentit sclerodermat skin chang osteolysi clavicl distal phalang mean age death age 13 year commonli due atherosclerosi hgp mainli sporad occurr genet caus implic follow identif de novo heterozyg mutat lmna gene major hgp patients.4,5 singl famili show autosom recess inherit homozyg lmna mutat also reported.6 lmna encod lamin c compon nuclear lamina meshwork underli nuclear envelop serv structur support also thought contribut chromatin organis regul gene expression.7,8 interestingli mutat lmna recent associ least eight inherit disord known laminopathi differenti dystroph effect varieti tissu includ muscl neuron skin bone adipos tissu review mounk et al 9 howev realis disord share common genet defect led clinic re-evalu emerg evid signific phenotyp overlap.10 henc laminopathi might reason consid spectrum relat diseas hgp phenotyp similar sever laminopathi particular atyp werner ’ syndrome11 mandibuloacr dysplasia mad omim 248370 608612 .12 diseas associ lipodystrophy,3,13 promin featur anoth laminopathi famili partial lipodystrophi dunnigan varieti omim 151660 .14 mad classifi two …',\n",
       "  'object assess robust patient respons new nation survey patient experi basi provid financi incent doctor design analysi repres respond gp patient survey compar sampl 5.5 million patient regist 8273 gener practic england januari 2009 gener popul analysi non-respons bia look relat practic respons rate score survey analysi reliabl survey estim proport varianc practic score attribut true differ practic result overal respons rate 38.2 2.2 million respons compar survey use similar methodolog uk men young adult peopl live depriv area under-repres among respond howev question relat pay perform systemat associ respons rate questionnair score two question trigger payment gener practition reliabl measur practic perform averag practice-level reliabl coeffici 93.2 95.0 less 3 0.5 practic fewer number respons requir achiev convent reliabl level 90 70 chang payment formula 2009 result increas averag impact random variat patient score payment gener practition compar payment made 2007 2008. conclus littl evid support concern gener practition low respons rate select non-respons bia led systemat unfair payment attach questionnair score studi rais issu relat valid reliabl payment base patient survey provid lesson uk countri consid use patient experi part pay perform scheme',\n",
       "  \"object low alcohol label set label carri descriptor 'low 'lighter denot alcohol content beverag grow interest policymak produc lower strength alcohol product howev lack evid gener popul perceiv verbal descriptor strength present research examin consum percept strength abv appeal alcohol product use low high alcohol verbal descriptor design within-subject experiment studi particip rate strength appeal 18 term denot low nine term high eight term regular one term strength either 1 wine 2 beer accord drink prefer method thousand six hundr adult 796 wine 804 beer drinker sampl nation repres uk panel result low lower light lighter reduc form cluster rate denot lower strength product regular higher strength cluster intensifi consist extra low super low extra light super light similar cluster perceiv strength observ amongst high verbal descriptor regular appeal strength descriptor low high verbal descriptor use intensifi rate least appeal conclus perceiv strength appeal alcohol product diminish verbal descriptor impli deviat regular implic find discuss term polici implic lower strength alcohol label associ public health outcom statement contribut alreadi known subject current uk eu legisl limit number low strength verbal descriptor associ alcohol volum abv 1.2 abv lower grow interest policymak produc extend rang lower strength alcohol product current cap 1.2 abv set nation legisl lack evid gener popul perceiv verbal descriptor alcohol product strength low high studi add verbal descriptor lower strength wine beer form two cluster effect commun reduc alcohol content low lower light lighter reduc consid lower strength regular averag abv descriptor use intensifi extra low super low extra light super light consid lowest strength similar cluster perceiv strength observ amongst high verbal descriptor appeal alcohol product reduc verbal descriptor impli deviat regular\",\n",
       "  'effect interleukin 10 il-10 treatment autoimmune-medi central nervou system inflamm controversi studi model system experiment autoimmun encephalomyel eae use variou rout regimen deliveri method il-10 suggest variabl may affect immunoregulatori function studi influenc factor il-10 regul eae pathogenesi analyz transgen mice express human il-10 hil-10 transgen control class ii major histocompat complex mhc promot hil-10 transgen mice highli resist eae induc activ immun resist appear mediat suppress autoreact cell function myelin-react helper 1 cell induc nonpathogen il-10 transgen mice antibodi deplet confirm eae resist depend presenc transgen il-10 mice express hil-10 transgen endogen murin il-10 gene demonstr transgen il-10 mhc class ii–express cell suffici block induct eae studi demonstr il-10 prevent eae complet present appropri level time diseas induct',\n",
       "  'protein cytotox lymphocyt antigen-4 ctla-4 essenti neg regul immun respons loss caus fatal autoimmun mice studi larg famili five individu present complex autosom domin immun dysregul syndrom character hypogammaglobulinemia recurr infect multipl autoimmun clinic featur identifi heterozyg nonsens mutat exon 1 ctla4 screen 71 unrel patient compar clinic phenotyp identifi five addit famili nine individu previous undescrib splice site missens mutat ctla4 clinic penetr incomplet eight adult total 19 genet proven ctla4 mutat carrier consid unaffect howev ctla-4 protein express decreas regulatori cell treg cell patient carrier ctla4 mutat wherea treg cell gener present elev number individu suppress function ctla-4 ligand bind transendocytosi cd80 impair mutat ctla4 also associ decreas circul b cell number taken togeth mutat ctla4 result ctla-4 haploinsuffici impair ligand bind result disrupt b cell homeostasi complex immun dysregul syndrom',\n",
       "  'pd 0332991 highli specif inhibitor cyclin-depend kinas 4 cdk4 ic50 0.011 micromol/l cdk6 ic50 0.016 micromol/l activ panel 36 addit protein kinas potent antiprolif agent retinoblastoma rb -posit tumor cell vitro induc exclus g1 arrest concomit reduct phospho-ser780/ser795 rb protein oral administr pd 0332991 mice bear colo-205 human colon carcinoma produc mark tumor regress therapeut dose pd 0332991 caus elimin phospho-rb prolif marker ki-67 tumor tissu down-regul gene transcript control e2f result indic inhibit cdk4/6 alon suffici caus tumor regress net reduct tumor burden tumor',\n",
       "  'despit progress develop drug effici target cancer cell treatment metastat tumour often ineffect well-establish depend cancer cell microenviron suggest target non-cancer-cel compon tumour might form basi develop novel therapeut approach howev as-yet poorli character contribut host respons tumour growth metastat progress repres limit exploit approach identifi neutrophil main compon driver metastat establish within pre- metastat lung microenviron mous breast cancer model neutrophil fundament role inflammatori respons contribut tumorigenesi still controversi use variou strategi block neutrophil recruit pre-metastat site demonstr neutrophil specif support metastat initi importantli find neutrophil-deriv leukotrien aid colon distant tissu select expand sub-pool cancer cell retain high tumorigen potenti genet pharmacolog inhibit leukotriene-gener enzym arachidon 5-lipoxygenas alox5 abrog neutrophil pro-metastat activ consequ reduc metastasi result reveal efficaci use target therapi specif tumour microenviron compon indic neutrophil alox5 inhibit may limit metastat progress',\n",
       "  'object test hypothesi nullipar women histori miscarriag increas risk depress late pregnanc 1 6 12 month postpartum compar women without histori miscarriag conduct secondari analysi longitudin cohort studi first babi studi compar 448 pregnant women histori miscarriag 2,343 pregnant women without histori miscarriag risk probabl depress score 12 edinburgh postnat depress scale logist regress model use estim odd ratio time point gener estim equat use obtain estim longitudin analysi women histori miscarriag like woman without histori miscarriag score probabl depress rang third trimest 6 12 month postpartum like 1 month postpartum adjust sociodemograph factor 1.66 95 ci 1.03–2.69 women histori miscarriag may vulner depress first month postpartum women without prior miscarriag effect appear persist beyond time period support promot awar surround issu recommend research plan identifi risk factor may posit woman histori miscarriag higher risk depress',\n",
       "  'group 2 innat lymphoid cell ilc2 secret type 2 cytokin protect parasit also contribut varieti inflammatori airway diseas report interleukin 1β il-1β directli activ human ilc2 il-12 induc convers activ ilc2 interferon-γ ifn-γ -produc ilc1 revers il-4 plastic ilc manifest diseas tissu patient sever chronic obstruct pulmonari diseas copd chronic rhinosinus nasal polyp crswnp display il-12 il-4 signatur accumul ilc1 ilc2 respect eosinophil major cellular sourc il-4 reveal cross-talk il-5-produc ilc2 il-4-produc eosinophil propos il-12 il-4 govern ilc2 function ident imbal result perpetu type 1 type 2 inflamm',\n",
       "  'steroid receptor rna activ sra known rna coactiv augment transactiv nuclear receptor nr identifi slirp sra stem-loop interact rna bind protein bind function substructur sra str7 slirp express normal tumor tissu contain rna recognit motif rrm repress nr transactiv sra- rrm-depend manner augment effect tamoxifen modul associ src-1 sra sharp rrm-contain corepressor also bind str7 augment repress slirp slirp coloc skip chr14q24.3 anoth nr coregul reduc skip-potenti nr signal slirp recruit endogen promot ps2 metallothionein latter sra-depend manner ncor promot recruit depend slirp major endogen slirp resid mitochondria data demonstr slirp modul nr transactiv suggest may regul mitochondri function provid mechanist insight interact sra slirp src-1 ncor',\n",
       "  'naringenin flavonoid antiinflammatori immunomodulatori properti investig whether naringenin could attenu allergen-induc airway inflamm possibl mechan murin model asthma mice sensit challeng ovalbumin mice administ naringenin ovalbumin challeng evalu develop airway inflamm airway reactiv interleukin il 4 il13 chemokin c-c motif ligand ccl 5 ccl11 bronchoalveolar lavag fluid serum total ige detect elisa ikappabalpha degrad induc nitric oxid synthas ino lung measur western blot also test nf-kappab bind activ electrophoret mobil shift assay mrna level ino ccl5 ccl11 detect real-tim pcr naringenin attenu ovalbumin-induc airway inflamm airway reactiv experiment mice naringenin-tr mice lower level il4 il13 bronchoalveolar lavag fluid lower serum total ige furthermor naringenin inhibit pulmonari ikappabalpha degrad nf-kappab dna-bind activ level ccl5 ccl11 ino also significantli reduc result indic naringenin may play protect role asthma process inhibit nf-kappab decreas express target gene may account phenomenon',\n",
       "  'forkhead box fox famili transcript factor origin unicellular eukaryot expand time multipl duplic event sometim gene loss 40 member mammal fox gene evolv acquir special function mani key biolog process mutat fox gene profound effect human diseas caus phenotyp vari cancer glaucoma languag disord summar salient featur evolut fox gene famili highlight divers contribut variou fox subfamili development process organogenesi speech acquisit',\n",
       "  'cell tissu organ broad spectrum structur accord function drastic chang organ epithelial-mesenchym transit format spheroid aggreg often associ either tissu morphogenesi cancer progress studi organ cell coloni mean simul self-propel particl gener cell-lik interact interplay cell soft cell-cel adhes contact inhibit locomot cil yield structur collect dynam observ sever exist tissu phenotyp includ regular distribut cell dynam cell cluster gel-lik network collect migrat monolay 3d aggreg give analyt predict transit noncohes cohes 3d cell arrang explicitli show cil yield effect repuls promot cell dispers therebi hinder format cohes tissu yet continu monolay cil lead collect cell motion ensur tensil intercellular stress oppos cell extrus thu work highlight promin role cil determin emerg structur dynam cell coloni',\n",
       "  'tetraploidi aris variou mitot cleavag defect mammalian cell inherit multipl centrosom induc aneuploidi tetraploid cell continu cycl arrest tetraploid cell cycl therefor potenti critic cellular control report primari rat embryo fibroblast ref52 human foreskin fibroblast becom senesc tetraploid g1 drug- small interf rna sirna -induc failur cell cleavag contrast t-antigen-transform ref52 p53+/+ hct116 tumor cell rapidli becom aneuploid continu cycl cleavag failur tetraploid primari cell quickli becom quiescent determin loss ki-67 prolifer marker fluoresc ubiquitination-bas cell cycl indicator/l cell cycl marker geminin arrest due dna damag γ-h2ax dna damag marker remain control level tetraploidi induct arrest tetraploid cell final becom senesc determin sa-β-galactosidas activ tetraploid arrest depend p16ink4a express sirna suppress p16ink4a bypass tetraploid arrest permit primari cell becom aneuploid conclud tetraploid primari cell becom senesc without dna damag induct senesc critic tetraploidi arrest',\n",
       "  'publish summari classif cell death base morpholog biochem criteria circumst occurr current irrevers structur alter provid unequivoc evid death biochem indic cell death univers applic precis defin studi cell function reproduct capac necessarili differenti death dormant state recoveri may possibl also prove feasibl categor die cell one two discret distinct pattern morpholog chang gener found occur dispar individu characterist circumst one pattern swell proceed ruptur plasma organel membran dissolut organ structure—term “ coagul necrosi ” result injuri agent toxin ischemia affect cell group rather singli evok exud inflamm develop vivo morpholog pattern character condens cell mainten organel integr format surfac protuber separ membrane-bound globul tissu phagocytos digest resid cell associ inflamm',\n",
       "  'rna-bind protein heart posttranscript gene regul coordin process storag handl cellular rna show grsf1 previous implic bind select translat influenza mrna target mitochondria form granul coloc foci newli synthes mtrna next mitochondri nucleoid grsf1 preferenti bind rna transcrib three contigu gene light strand mtdna nd6 mrna long noncod rna cytb nd5 contain multipl consensu bind sequenc rnai-medi knockdown grsf1 lead alter mitochondri rna stabil abnorm load mrna lncrna mitochondri ribosom impair ribosom assembl result specif protein synthesi defect failur assembl normal amount oxid phosphoryl complex data implic grsf1 key regul posttranscript mitochondri gene express',\n",
       "  'protein molecular size 62,000 dalton p62 detect hela cell nuclear extract uv cross-link mrna precursor p62 bind specif polypyrimidin tract 3 splice site region intron p62 purifi homogen bind polypyrimidin tract pre-mrna bind requir ag dinucleotid 3 splice site alter polypyrimidin tract reduc bind p62 yield correspond reduct effici format u2 snrnp/pre-mrna complex splice p62 protein retain spliceosom remain bound pre-mrna polypyrimidin tract bind protein pptb propos critic compon recognit 3 splice site splice',\n",
       "  'background studi aim capsul endoscopi may play role evalu patient present acut upper gastrointestin hemorrhag emerg depart patient method evalu adult acut upper gastrointestin hemorrhag present emerg depart two academ center patient ingest wireless video capsul follow immedi nasogastr tube aspir later esophagogastroduodenoscopi egd compar capsul endoscopi nasogastr tube aspir determin presenc blood egd discrimin sourc bleed identif peptic/inflammatori lesion safeti patient satisfact result studi enrol 49 patient 32 men 17 women mean age 58.3 ± 19 year three patient complet capsul endoscopi five intoler nasogastr tube blood detect upper gastrointestin tract significantli often capsul endoscopi 15 /18 83.3 nasogastr tube aspir 6 /18 33.3 p 0.035 signific differ identif peptic/inflammatori lesion capsul endoscopi 27 /40 67.5 egd 35 /40 87.5 p 0.10 0.39 95 ci 0.11 1.15 capsul endoscopi reach duodenum 45 /46 patient 98 one patient 2.2 self-limit short breath one 2.2 cough capsul ingest conclus emerg depart set capsul endoscopi appear feasibl safe peopl present acut upper gastrointestin hemorrhag capsul endoscopi identifi gross blood upper gastrointestin tract includ duodenum significantli often nasogastr tube aspir identifi inflammatori lesion well egd capsul endoscopi may facilit patient triag earlier endoscopi consid substitut egd',\n",
       "  'crispr/cas9 system power tool elucid role gene wide varieti organ includ mice obtain genet modifi embryo mice method cas9 mrna sgrna usual introduc zygot microinject electropor howev mutant gener method genet mosaic compos sever type cell carri differ mutat complic phenotyp analysi founder embryo mice simplifi analysi elucid role gene involv development process method produc non-mosa mutant need establish method gener non-mosa mous mutant embryo introduc cas9 protein sgrna vitro fertil ivf zygot electropor enabl genom edit occur first replic mous genom result cell mutant carri set mutat method solv problem mosaicism/allel complex founder mutant embryo mice gener cripsr/cas9 system',\n",
       "  'rna-induc silenc complex risc ribonucleoprotein particl compos single-strand short interf rna sirna endonucleolyt activ argonaut protein capabl cleav mrna complementari sirna mechan risc cleav target rna well understood howev remain enigmat risc find target rna show vitro vivo access target site correl directli effici cleavag demonstr risc unabl unfold structur rna cours target recognit risc transient contact single-strand rna nonspecif promot sirna-target rna anneal furthermor 5 part sirna within risc creat thermodynam threshold determin stabl associ risc target rna therefor provid mechanist insight reveal featur risc target rna crucial achiev effici specif rna interfer',\n",
       "  'cancer associ fibroblast caf one crucial compon tumor microenviron promot growth invas cancer cell variou mechan caf demonstr high degre heterogen due variou origin howev mani distinct morpholog featur physiolog function caf identifi becom clear crosstalk cancer cell caf play key role progress cancer understand mutual relationship would eventu enabl us treat cancer patient target caf review discuss latest find role caf tumorigenesi metastasi well potenti therapeut implic caf',\n",
       "  'molecular mechan underli cold-associ high cardiovascular risk remain unknown show cold-trigg food-intake-independ lipolysi significantli increas plasma level small low-dens lipoprotein ldl remnant lead acceler develop atherosclerot lesion mice two genet mous knockout model apolipoprotein e -/- apo -/- ldl receptor -/- ldlr -/- mice persist cold exposur stimul atherosclerot plaqu growth increas lipid deposit furthermor mark increas inflammatori cell plaque-associ microvessel detect cold-acclim apo -/- ldlr -/- mice lead plaqu instabl delet uncoupl protein 1 ucp1 key mitochondri protein involv thermogenesi brown adipos tissu bat apo -/- strain complet protect mice cold-induc atherosclerot lesion cold acclim markedli reduc plasma level adiponectin system deliveri adiponectin protect apo -/- mice plaqu develop find provid mechanist insight low-temperature-associ cardiovascular risk',\n",
       "  'mutat x-link methyl-cpg-bind protein 2 mecp2 encod transcript repressor caus rett syndrom varieti relat neurodevelopment disord vast major mutat associ human diseas loss-of-funct mutat precis aspect mecp2 function respons phenotyp remain unknown overexpress wild-typ human protein transgen mice use larg genom clone contain entir human mecp2 locu detail neurobehavior electrophysiolog studi transgen line mecp2 tg1 express mecp2 approxim 2-fold wild-typ level demonstr onset phenotyp around 10 week age surprisingli mice display enhanc motor contextu learn enhanc synapt plastic hippocampu 20 week age howev mice develop seizur becam hypoact approxim 30 die 1 year age data demonstr mecp2 level must tightli regul vivo even mild overexpress protein detriment furthermor result support possibl duplic gain-of-funct mutat mecp2 might underli case x-link delayed-onset neurobehavior disord',\n",
       "  \"background alcohol contribut caus unintent injuri motor vehicl crash prior research associ alcohol use violent injuri limit survey-bas data inclus case singl trauma centr without adequ control beyond limit inabl prior research comprehens captur alcohol sale ontario alcohol sold retail outlet run provinci govern hospit financ provinci health care system assess risk hospit due assault associ retail alcohol sale across ontario method find perform population-bas case-crossov analysi person age 13 year older hospit assault ontario 1 april 2002 1 decemb 2004. day prior assault case 's hospit volum alcohol sold store closest proxim victim 's home compar volum alcohol sold store 7 earlier condit logist regress analysi use determin associ rel risk rr assault per 1,000 l higher daili sale alcohol 3,212 person admit hospit assault nearli 25 age 13 20 83 male total 1,150 assault 36 involv use sharp blunt weapon 1,532 48 aros unarm brawl fight everi 1,000 l alcohol sold per store per day rel risk hospit assault 1.13 95 confid interv ci 1.02-1.26 risk accentu male 1.18 95 ci 1.05-1.33 youth age 13 20 1.21 95 ci 0.99-1.46 urban area 1.19 95 ci 1.06-1.35 conclus risk victim seriou assault increas alcohol sale especi among young urban men akin reduc risk drive impair consider given novel method prevent alcohol-rel violenc\",\n",
       "  \"background aim tumor cell surviv hypox condit induc autophagi investig role microrna mirna regul autophagi hepatocellular carcinoma hcc cell hypox condit method use gain- loss-of-funct method evalu effect mirna autophagi human hcc cell line huh7 hep3b hypox condit autophagi quantifi immunoblot immunofluores transmiss electron microscopi analys incub cell bafilomycin a1 use luciferas report assay confirm associ mirna target analyz growth hcc xenograft tumor nude mice result mir-375 down-regul hcc cell tissu inhibit autophagi hypox condit suppress convers lc3i lc3ii therebi autophag flux abil mir-375 inhibit autophagi independ abil regul 3'-phosphoinositide-depend protein kinase-1-akt-mammalian target rapamycin signal instead involv suppress atg7 autophagy-associ gene mir-375 bound directli predict site 3 untransl region atg7 up-regul mir-375 down-regul atg7 inhibit mitochondri autophagi hcc cell reduc elimin damag mitochondria hypoxia increas releas mitochondri apoptot protein reduc viabil hcc cell mice xenograft tumor express mir-375 fewer autophag cell larger area necrosi grew slowli tumor hcc cell express lower level mir-375 conclus mir-375 inhibit autophagi reduc express atg7 impair viabil hcc cell hypox condit cultur mice mirna inhibit autophagi cancer cell might develop therapeut\",\n",
       "  'post-transcript modif rna nucleosid occur live organ pseudouridin abund modifi nucleosid non-cod rna enhanc function transfer rna ribosom rna stabil rna structur messeng rna known contain pseudouridin artifici pseudouridyl dramat affect mrna function -- chang genet code facilit non-canon base pair ribosom decod centr howev without evid natur occur mrna pseudouridyl physiolog relev unclear present comprehens analysi pseudouridyl saccharomyc cerevisia human rna use pseudo-seq genome-wid single-nucleotide-resolut method pseudouridin identif pseudo-seq accur identifi known modif site well mani novel site non-cod rna reveal hundr pseudouridyl site mrna genet analysi allow us assign new modif site one seven conserv pseudouridin synthas pus1-4 6 7 9. notabl major pseudouridin mrna regul respons environment signal nutrient depriv yeast serum starvat human cell result suggest mechan rapid regul rewir genet code induc mrna modif find reveal unanticip role pseudouridyl provid resourc identifi target pseudouridin synthas implic human diseas',\n",
       "  'immun system evolv continu increas complex provid host advantag infecti agent develop immunolog memori engend long-last protect lengthen lifespan host gener subset memori cell distinct home function properti increas defens capabl howev development relationship memori t-cell subset matter debat opinion articl light recent develop suggest probabl two distinct lineag compris memori cd8+ t-cell popul gener respons infect',\n",
       "  'cc genotyp interleukin il -28b.rs12979860 gene associ spontan hepat c viru hcv clearanc treatment respons distribut correl il28b.rs12979860 single-nucleotid polymorph snp hcv-specif cell-medi immun cmi respons among egyptian healthcar worker hcw known determin relationship 402 hcw serv patient cohort ~85 hcv preval enrol 402 hcw four group group 1 n 258 seroneg avirem subject group 2 n 25 seroneg virem subject group 3 n 41 subject spontan resolv hcv infect group 4 n 78 chronic hcv patient subject test hcv-specif cmi respons use ex-vivo interferon-gamma ifnγ elispot assay nine hcv genotype-4a overlap 15-mer peptid pool correspond hcv protein subject test il28b.rs12979860 snp real-tim pcr hcv-specif cmi demonstr ~27 seroneg avirem hcw group 1 suggest clearanc infect low-level exposur hcv frequenc il28b.rs12979860 c allel homozygos four group 49 48 49 23 allel 14 16 12 19 respect suggest differenti distribut among subject differ hcv statu report il28b.rs12979860 predict outcom hcv infect p 0.05 find relationship il28b genotyp outcom hcv-specif cmi respons four group p 0.05 data show differenti il28b.rs12979860 genotyp distribut among egyptian hcw differ hcv statu could predict outcom hcv-specif cmi respons',\n",
       "  'cell receptor tcr ligat requir extrathym differenti forkhead box p3 foxp3 regulatori cell sever line evid indic weak tcr stimul favor induct foxp3 peripheri howev remain determin tcr ligand potenc influenc process character densiti affin tcr ligand favor foxp3 induct found low dose strong agonist result maxim induct foxp3 vivo initi foxp3 induct weak agonist peptid could enhanc disrupt tcr-peptid major histocompat complex pmhc interact alter peptid dose howev time cours experi reveal foxp3-posit cell induc weak agonist stimul delet along foxp3-neg counterpart wherea foxp3-posit cell induc low dose strong agonist persist result suggest togeth pmhc ligand potenc densiti durat tcr interact defin cumul quantiti tcr stimul determin initi peripher foxp3 induct howev persist induc foxp3 cell tcr ligand potenc densiti noninterchang factor influenc rout peripher toler',\n",
       "  'context health care applic autoidentif technolog radio frequenc identif rfid propos improv patient safeti also track trace medic equip howev electromagnet interfer emi rfid medic devic never report object assess classifi incid emi rfid critic care equip design set without patient connect emi 2 rfid system activ 125 khz passiv 868 mhz assess control condit may 2006 proxim 41 medic devic 17 categori 22 differ manufactur academ medic centr univers amsterdam amsterdam netherland assess took place accord intern test protocol incid emi classifi accord critic care advers event scale hazard signific light result 123 emi test 3 per medic devic rfid induc 34 emi incid 22 classifi hazard 2 signific 10 light passiv 868-mhz rfid signal induc higher number incid 26 incid 41 emi test 63 compar activ 125-khz rfid signal 8 incid 41 emi test 20 differ 44 95 confid interv 27 -53 p .001 passiv 868-mhz rfid signal induc emi 26 medic devic includ 8 also affect activ 125-khz rfid signal 26 41 devic 63 median distanc rfid reader medic devic emi incid 30 cm rang 0.1-600 cm conclus control nonclin set rfid induc potenti hazard incid medic devic implement rfid critic care environ requir on-sit emi test updat intern standard',\n",
       "  \"rna interfer rnai gene-silenc mechan ribonucleoprotein complex rna-induc silenc complex risc double-strand ds short-interf rna sirna target complementari mrna site-specif cleavag subsequ degrad longer dsrna endogen process 21- 24-nucleotid nt sirna mirna induc gene silenc rnai studi human cell typic use synthet 19- 20-nt sirna duplex 2-nt overhang 3'-end strand report systemat synthesi analysi sirna delet passeng and/or guid strand reveal short rnai trigger 16-nt sirna induc potent rnai human cell result indic minim requir dsrna trigger rnai approxim 42 a-form helix approxim 1.5 helic turn 16-nt sirna effect knock mrna protein level 19-nt sirna target endogen cdk9 gene suggest 16-nt sirna potent rnai trigger vitro kinet analysi rna-induc silenc complex risc program hela cell indic 16-nt sirna higher risc-load capac 19-nt sirna result suggest risc assembl activ rnai necessarili requir 19-nt duplex sirna 16-nt duplex design potent trigger induc rnai\",\n",
       "  \"result experiment genet studi highlight role il-23/il-17 axi pathogenesi inflammatori bowel diseas ibd il-23-driven inflamm primarili link th17 cell howev recent identifi novel popul innat lymphoid cell ilc mice produc il-17 il-22 ifn-γ respons il-23 mediat innat coliti relev ilc popul human health diseas current poorli understood studi analyz role il-23-respons ilc human intestin control ibd patient result show increas express th17-associ cytokin gene il17a il17f among intestin cd3⁻ cell ibd il17a il17f express restrict cd56⁻ ilc wherea il-23 induc il22 il26 cd56⁺ ilc compart furthermor observ signific select increas cd127⁺cd56⁻ ilc inflam intestin crohn 's diseas cd patient ulcer coliti patient result indic il-23-respons ilc present human intestin intestin inflamm cd associ select accumul phenotyp distinct ilc popul character inflammatori cytokin express ilc may contribut intestin inflamm cytokin product lymphocyt recruit organ inflammatori tissu may repres novel tissue-specif target subtyp ibd\",\n",
       "  \"spemann 's organ play key role dorsal-ventr dv pattern amphibian embryo secret diffus protein chordin antagonist ventral bone morphogenet protein bmp dv pattern robust amphibian embryo ventral half surgic remov develop smaller proport pattern larva show robust pattern depend facilit chordin degrad requir express chordin-proteinas inhibitor sizzl opposit side sizzl stabl diffus wide along dv axi stabil chordin expand distribut ventral direct expand chordin distribut turn limit bmp-depend sizzl product form axis-wid feedback loop shape chordin 's activ use bisect assay demonstr chordin degrad dynam control embryo-size-coupl sizzl accumul propos scale model enabl dv pattern adjust proport embryon axi size\",\n",
       "  'epigenet silenc immune-rel gene strike featur cancer genom occur process tumorigenesi phenomena impact antigen process antigen present tumor cell facilit evas immunosurveil modul tumor microenviron alter express immunosuppress cytokin impair antigen-pres cell cytolyt t-cell function potenti revers immunosuppress epigenet modul therefor promis versatil therapeut approach reinstat endogen immun recognit tumor lysi pre-clin studi identifi multipl element immun system modul epigenet mechan result improv antigen present effector t-cell function breakdown suppressor mechan recent clinic studi util epigenet therapi prior combin immun therapi improv clinic outcom',\n",
       "  'proteinase-activ receptor par belong famili g protein-coupl receptor par activ serine-depend cleavag gener tether activ ligand par-2 shown involv inflammatori pathway investig situ level modul par-2 human normal osteoarthr oa cartilage/chondrocyt furthermor evalu role par-2 synthesi major catabol factor oa cartilag includ metalloproteinas mmp -1 mmp-13 inflammatori mediat cyclooxygenas 2 cox-2 well par-2-activ signal pathway oa chondrocyt par-2 express determin use real-tim revers transcription-polymeras chain reaction protein level immunohistochemistri normal oa cartilag protein modul investig oa cartilag explant treat specif par-2-activ peptid par-2-ap sligkv-nh2 1 400 μm interleukin 1 beta il-1β 100 pg/ml tumor necrosi factor-alpha tnf-α 5 ng/ml transform growth factor-beta-1 tgf-β1 10 ng/ml signal pathway inhibitor p38 sb202190 mek1/2 mitogen-activ protein kinas kinas pd98059 nuclear factor-kappa b nf-κb sn50 par-2 level determin immunohistochemistri signal pathway analyz oa chondrocyt western blot use specif phospho-antibodi extracellular signal-regul kinas 1/2 erk1/2 p38 jnk c-jun n-termin kinas nf-κb presenc absenc par-2-ap and/or il-1β par-2-induc mmp cox-2 level cartilag determin immunohistochemistri par-2 produc human chondrocyt significantli upregul oa compar normal chondrocyt p 0.04 p 0.03 respect receptor level significantli upregul il-1β p 0.006 tnf-α p 0.002 well par-2-ap 10 100 400 μm p 0.02 downregul inhibit p38 48 hour incub par-2 activ significantli induc mmp-1 cox-2 start 10 μm p 0.005 mmp-13 100 μm p 0.02 well phosphoryl erk1/2 p38 within 5 minut incub p 0.03 though statist signific il-1β produc addit effect activ erk1/2 p38 studi document first time function consequ par-2 activ human oa cartilag identifi p38 major signal pathway regul synthesi demonstr specif par-2 activ induc erk1/2 p38 oa chondrocyt result suggest par-2 potenti new therapeut target treatment oa',\n",
       "  'neutrophil extracellular trap net implic autoimmun gener role steril inflamm remain unclear ribonucleoprotein immun complex rnp ic induc netosi requir mitochondri reactiv oxygen speci ro maxim net stimul rnp ic stimul neutrophil mitochondria becom hypopolar transloc cell surfac extracellular releas oxid mitochondri dna proinflammatori vitro dna inject mice stimul type interferon ifn signal pathway depend dna sensor sting mitochondri ro also necessari spontan netosi low-dens granulocyt individu system lupu erythematosu also observ individu chronic granulomat diseas lack nadph oxidas activ still develop autoimmun type ifn signatur mitochondri ro inhibit vivo reduc diseas sever type ifn respons mous model lupu togeth find highlight role mitochondria gener net also pro-inflammatori oxid mitochondri dna autoimmun diseas',\n",
       "  'stiff biophys properti extracellular matrix modul cellular function includ prolifer invas differenti also may affect therapeut respons therapeut durabl cancer treatment remain problem chemotherapi pathway-target drug reason well understood tumor progress accompani chang biophys properti tissu ask whether matrix rigid modul sensit versu resist state her2-amplifi breast cancer cell respons her2-target kinas inhibitor lapatinib antiprolif effect lapatinib invers proport elast modulu adhes substrata down-regul mechanosensit transcript coactiv yap taz either sirna small-molecul yap/tead inhibitor verteporfin elimin modulus-depend lapatinib resist reduct yap vivo mice also slow growth implant her2-amplifi tumor show trend increas sensit lapatinib yap decreas thu address role stiff resist efficaci her2 pathway-target therapeut via mechanotransduct arm hippo pathway',\n",
       "  'effect size popul ne determin rate chang composit popul caus genet drift random sampl genet variant finit popul ne crucial determin level variabl popul effect select rel drift articl review properti ne varieti differ situat biolog interest factor influenc particular action select mean ne vari across genom advanc genom techniqu give new insight select shape ne',\n",
       "  'attention-deficit hyperact disord common condit adulthood disord character symptom inattent hyperact impuls alongsid symptom discuss whether symptom emot dysregul could add addit better descript psychopatholog adhd neither current icd-10 dsm-iv upcom dsm-5 includ symptom emot dysregul core aspect adhd sever author e.g. wender 1995 describ adult adhd differenti way propos concept disord consid subject experi adult patient introduc symptomatolog emot symptom empir studi attest dimens suffici reliabl valid symptom emot dysregul defin seem distinct factor psychopatholog adult adhd pharmacolog psychotherapeut intervent help allevi type symptom review attest decis role emot symptom adhd symptomatolog taken seriou consider futur research',\n",
       "  'pro-opiomelanocortin pomc agouti-rel peptid agrp -express neuron arcuat nucleu hypothalamu arc opposit regul calor deplet coordin stimul inhibit homeostat satieti respect bimod princip underscor antagonist action ligand downstream melanocortin-4 receptor mc4r paraventricular nucleu hypothalamu pvh although popul critic energi balanc underli neural circuitri remain unknown use mice express cre recombinas mc4r neuron demonstr bidirect control feed follow real-tim activ inhibit pvh mc4r neuron identifi cell function expon arc agrp neuron-driven hunger moreov reveal function mediat pvh mc4r →later parabrachi nucleu lpbn pathway activ circuit encod posit valenc calor deplet mice thu satiat appetit natur pvh mc4r →lpbn neuron support principl drive reduct highlight circuit promis target antiobes drug develop',\n",
       "  'live attenu simian immunodefici viru siv vaccin lav remain efficaci vaccin nonhuman primat model hiv aid yet basi robust protect remain poorli understood show degre lav-medi protect intraven wild-typ sivmac239 challeng strongli correl magnitud function siv-specif effector-differenti cell lymph node respons cell blood cellular humor innat immun paramet found mainten protect cell respons associ persist lav replic lymph node occur almost exclus follicular helper cell thu effect lav maintain lymphoid tissue-bas effector-differenti siv-specif cell intercept suppress earli wild-typ siv amplif present suffici frequenc complet control perhap clear infect observ provid rational develop safe persist vector elicit maintain respons',\n",
       "  'background neural network regul bing eat remain identifi effect treatment bing eat limit method combin neuroanatom pharmacolog electrophysiolog cre-lox chemogenet approach investig function 5-hydroxytryptamin 5-ht 2c receptor 5-ht2cr express dopamin da neuron regul binge-lik eat behavior mice result show 5-ht stimul da neural activ 5-ht2cr-mediat mechan activ midbrain 5-ht→da neural circuit effect inhibit binge-lik eat behavior mice notabl 5-ht medic includ fluoxetin d-fenfluramin lorcaserin select 5-ht2cr agonist act 5-ht2cr express da neuron inhibit binge-lik eat mice conclus identifi 5-ht2cr popul da neuron one potenti target antibing therapi provid preclin evid 5-ht2cr agonist could use treat bing eat',\n",
       "  'chaperone-medi autophagi cma select mechan degrad cytosol protein lysosom contribut remov alter protein part cellular quality-control system previous found cma activ declin age organ propos failur cellular clearanc could contribut accumul alter protein abnorm cellular homeostasi eventu function loss characterist age organ determin whether neg featur age prevent maintain effici autophag activ late life work correct cma defect age rodent gener doubl transgen mous model amount lysosom receptor cma previous shown decreas abund age modul analyz model consequ prevent age-depend decreas receptor abund age rodent cellular organ level show cma activ maintain advanc age decreas receptor abund prevent preserv autophag activ associ lower intracellular accumul damag protein better abil handl protein damag improv organ function',\n",
       "  'background suicid signific public health issu almost one million peopl die suicid year worldwid deliber self harm dsh singl import risk factor suicid yet countri reliabl data dsh develop nation dsh registri republ ireland establish incid hospital-tr dsh nation level spectrum pattern present dsh repetit method find 2003 2009 irish nation registri deliber self harm collect data dsh present 40 hospit emerg depart countri data collect train data registr offic use standard method case ascertain definit registri record 75,119 dsh present involv 48,206 individu total incid rate fell 209 95 ci 205-213 per 100,000 2003 184 95 ci 180-189 per 100,000 2006 increas 209 95 ci 204-213 per 100,000 2009. notabl annual chang success 10 increas male rate 2008 2009. signific variat age peak rate women 15-19 year age group 620 95 ci 605-636 per 100,000 men 20-24 age group 427 95 ci 416-439 per 100,000 repetit rate vari significantli age method self harm number previou episod conclus population-bas data hospital-tr dsh repres import index burden mental ill suicid risk commun increas dsh rate irish men 2008 2009 coincid advent econom recess ireland find underlin need develop effect intervent reduc dsh repetit rate key prioriti health system',\n",
       "  'antibiot mode-of-act classif base upon drug-target interact whether result inhibit cellular function lethal bacteria show three major class bactericid antibiot regardless drug-target interact stimul product highli deleteri hydroxyl radic gram-neg gram-posit bacteria ultim contribut cell death also show contrast bacteriostat drug produc hydroxyl radic demonstr mechan hydroxyl radic format induc bactericid antibiot end product oxid damag cellular death pathway involv tricarboxyl acid cycl transient deplet nadh destabil iron-sulfur cluster stimul fenton reaction result suggest three major class bactericid drug potenti target bacteri system remedi hydroxyl radic damag includ protein involv trigger dna damag respons e.g. reca',\n",
       "  'macrophage-deriv foam cell express apolipoprotein e apo abundantli atherosclerot lesion examin physiolog role apo secret macrophag atherogenesi bone marrow transplant use reconstitut c57bl/6 mice macrophag either null wild type apo gene 13 week atherogen diet c57bl/6 mice reconstitut apo null marrow develop 10-fold atherosclerosi control absenc signific differ serum cholesterol level lipoprotein profil apo express absent macrophage-deriv foam cell c57bl/6 mice reconstitut apo null marrow thu lack apo express macrophag promot foam cell format data support protect role apo express macrophag earli atherogenesi',\n",
       "  'background endothelium-depend modul coronari tone impair collateral-depend coronari microcircul use porcin model chronic coronari occlus collater develop evalu hypothesi exercis train enhanc endothelium-medi relax increas endotheli nitric oxid synthas ecno mrna level collateral-depend microvasculatur method result adult femal miniatur swine subject chronic progress ameroid occlus proxim left circumflex coronari arteri lcx 2 month anim randomli expos 16-week exercise-train ex group treadmil run sedentari sed group cage confin protocol complet ex sed program coronari arteriol approxim 100 microm diamet isol collateral-depend lcx distal occlus nonocclud left anterior descend coronari arteri lad region heart arteriol studi vitro videomicroscopi frozen ecno mrna analysi rt-pcr techniqu relax endothelium-depend vasodil bradykinin decreas p 0.05 arteriol isol collateral-depend lcx versu nonocclud lad region sed anim bradykinin-medi relax howev differ lcx versu lad arteriol isol ex anim nitroprusside-induc relax unaffect either chronic occlus exercis importantli ecno mrna express significantli decreas arteriol isol lcx versu lad region sed anim train ecno mrna express differ lad lcx arteriol conclus data indic exercis train enhanc bradykinin-medi relax collateral-depend lcx arteriol isol chronic coronari occlus like effect ecno mrna express increas product',\n",
       "  'multicellular anim rapidli clear die cell bodi mani pathway mediat cell remov conserv evolut identifi srgp-1 neg regul cell clearanc caenorhabd elegan mammalian cell loss srgp-1 function result improv engulf apoptot cell wherea srgp-1 overexpress inhibit apoptot cell corps remov show srgp-1 function engulf cell function gtpase activ protein gap ced-10 rac1 interestingli loss srgp-1 function promot clearanc alreadi dead cell also remov cell brought verg death subleth apoptot necrot cytotox insult contrast impair engulf allow damag cell escap clearanc result increas long-term surviv propos c. elegan use engulf machineri part primit evolutionarili conserv survey mechan identifi remov unfit cell within tissu',\n",
       "  'syndrom ds children high frequenc acut megakaryoblast leukemia amkl earli childhood least 2 utero genet event requir although suffici ds-amkl trisomi 21 t21 n-terminal-trunc gata1 mutat investig role t21 ds-amkl compar second trimest hemopoiesi ds without gata1 mutat gestation-match normal control ds fetal liver fl marrow megakaryocyte-erythroid progenitor frequenc increas 55.9 +/- 4 vs 17.1 +/- 3 cd34 cd38 cell p .001 common myeloid progenitor 19.6 +/- 2 vs 44.0 +/- 7 granulocyte-monocyt gm progenitor 15.8 +/- 4 vs 34.5 +/- 9 commensur reduc clonogen ds-fl versu normal fl cd34 cell markedli increas 78 +/- 7 vs 15 +/- 3 affect megakaryocyte-erythroid approxim 7-fold higher gm colony-form unit-granulocyt erythrocyt macrophag megakaryocyt cfu-gemm progenitor replat effici cfu-gemm also markedli increas data indic t21 profoundli disturb fl hemopoiesi provid testabl hypothesi explain increas suscept gata1 mutat ds-amkl ds-associ transient myeloprolif disord',\n",
       "  'understand genet basi adapt central problem biolog howev reveal underli molecular mechan challeng chang fit may result perturb mani pathway may contribut rel littl develop combin experimental/comput framework address problem use understand genet basi ethanol toler escherichia coli use fit profil measur consequ single-locu perturb context ethanol exposur module-level comput analysi use reveal organ contribut loci cellular process regulatori pathway e.g osmoregul cell-wal biogenesi whose modif significantli affect ethanol toler strikingli discov domin compon adapt involv metabol rewir boost intracellular ethanol degrad assimil phenotyp metabolom analysi laboratory-evolv ethanol-toler strain investig natur access pathway ethanol toler remark laboratory-evolv strain larg follow adapt path infer coarse-grain search fit landscap',\n",
       "  \"import genet factor etiolog chronic lymphocyt leukemia cll suggest famili popul studi howev spectrum malign share common genet factor cll effect sex age famili risk unknown use swedish family-canc databas test increas famili risk cll lymphoprolif tumor cancer diagnos 1958 1998 assess 14 336 first-degre rel 5918 cll case 28 876 first-degre rel 11 778 control cancer risk rel case compar rel control use margin surviv model rel case significantli increas risk cll rel risk rr 7.52 95 confid interv ci 3.63-15.56 non-hodgkin lymphoma rr 1.45 95 ci 0.98-2.16 hodgkin lymphoma rr 2.35 95 ci 1.08-5.08 cll risk similar parent sibl offspr case male femal rel affect case 's age diagnosi anticip signific analyz use life tabl method conclud famili compon cll share lymphoprolif malign suggest common genet pathway howev clinic diagnos cll uncommon absolut excess risk rel small\",\n",
       "  'background intraperiton placement polypropylen mesh lead extens viscer adhes contraind differ coat use improv polypropylen mesh properti collagen protein uniqu biocompat cell ingrowth enhanc potenti novel acet acid extract collagen coat develop allow placement polypropylen mesh direct contact viscera author aim evalu long-term influenc acet acid extract collagen coat surgic aspect biomechan properti polypropylen mesh implant direct contact viscera includ complic adhes viscera strength incorpor microscop inflammatori reaction method forti adult wistar rat divid two group experiment polypropylen mesh/acet acid extract collagen coat control polypropylen mesh astandard procedur mesh implant perform anim kill 3 month surgeri analyz complic mesh area cover adhes type adhes strength incorpor intens inflammatori respons result mean adhes area lower polypropylen mesh/acet acid extract collagen coat 14.5 percent versu 69.9 percent p 0.001 adhes sever decreas experiment group grade 0 1 frequent p 0.04 p 0.002 respect grade 3 less frequent p 0.0001 associ adhes area sever found p 0.0001 complic strength incorpor intens inflammatori respons mesh similar conclus viscer adhes polypropylen mesh significantli reduc acet acid extract collagen coat collagen coat increas complic induc alter polypropylen mesh incorpor',\n",
       "  'consider subgroup patient earli breast cancer address benefit anthracyclin base chemotherapi aim retrospect studi investig effect microvessel densiti mvd statu p53 protein 5-year diseas free surviv df group breast cancer patient treat anthracyclin adjuv set correl mvd p53 statu clinicopatholog paramet also assess mvd p53 statu analyz immunohistochem group 172 women breast cancer clinic stage t1-2 n1-n2 m0 123 tumor 71.5 lower mvd ≤ 214.8 microvesells/mm 2 49 28.5 higher mvd 214.8 microvesells/mm 2 proport higher mvd tumor significantli increas n2 p 0.000 estrogen p 0.046 progesteron receptor p 0.029 neg tumor p53 posit indic 50 cancer 29.1 significantli associ higher grade p 0.000 steroid receptor neg p 0.000 cytokeratin5/6 posit p 0.026 topoisomeras iiα overexpress p 0.005 higher prolifer rate p 0.001 univari analysi higher mvd p 0.016 p53 neg p 0.023 significantli relat longer df median follow-up 36 month multivari cox regress analysi mvd independ associ df data suggest higher mvd favour prognost factor earli advanc breast cancer patient adjuv anthracyclin base chemotherapi',\n",
       "  'experi gain global malaria erad program 1955-72 identifi set share technic oper factor enabl countri success elimin malaria spatial data factor assembl malaria-endem countri combin provid object rel rank countri technic oper combin elimin feasibl analysi done separ plasmodium falciparum plasmodium vivax limit approach discuss rel rank suggest malaria elimin would feasibl countri america asia least feasibl countri central west africa result differ feasibl measur technic oper factor highlight differ type challeng face countri result intend prescript predict provid absolut assess feasibl show spatial inform avail facilit evidence-bas assess rel feasibl malaria elimin countri rapidli updat',\n",
       "  'adopt studi genet effect obes adulthood carri adopte separ natur parent earli life compar biolog full half sibl rear natur parent adopte repres four group sampl larger popul categoris either thin medium weight overweight obes weight height obtain 115 full sibl 57 adopte 850 half sibl 341 adopte full sibl bodi mass index kg/m2 significantli increas weight adopte bodi mass index half sibl show steadi weaker increas across four weight group adopte signific interact sex adopte sex sibl half sibl sex common parent contrast find half sibl previous natur parent strike signific increas bodi mass index full sibl overweight obes adopte degre fat adult live environ appear influenc genet factor independ sex may includ polygen well major gene effect obes',\n",
       "  \"object 1987 american colleg rheumatolog acr formerli american rheumat associ classif criteria rheumatoid arthriti ra criticis lack sensit earli diseas work undertaken develop new classif criteria ra method joint work group acr european leagu rheumat develop three phase new approach classifi ra work focus identifi among patient newli present undifferenti inflammatori synov factor best discrimin high risk persist and/or eros diseas -- appropri current paradigm underli diseas construct 'ra result new criteria set classif 'definit ra base confirm presenc synov least one joint absenc altern diagnosi better explain synov achiev total score 6 greater possibl 10 individu score four domain number site involv joint rang 0-5 serolog abnorm rang 0-3 elev acute-phas respons rang 0-1 symptom durat two level rang 0-1 conclus new classif system redefin current paradigm ra focus featur earlier stage diseas associ persist and/or eros diseas rather defin diseas late-stag featur refocu attent import need earlier diagnosi institut effect disease-suppress therapi prevent minimis occurr undesir sequela current compris paradigm underli diseas construct 'ra\",\n",
       "  'cigarett smoke smokeless tobacco extract contain multipl carcinogen compound littl known mechan tumor develop progress upon chronic exposur carcinogen present tobacco product examin effect smokeless tobacco extract human oral fibroblast show smokeless tobacco extract elev level intracellular reactiv oxygen oxid dna damag dna double-strand break dose-depend manner extend exposur extract induc fibroblast undergo senescence-lik growth arrest strike accompani chang secretori phenotyp use cocultur smokeless tobacco extracts-expos fibroblast immort nontumorigen keratinocyt show factor secret extracts-modifi fibroblast increas prolifer invas partial transform epitheli cell normal counterpart addit smokeless tobacco extracts-expos fibroblast caus partial transform keratinocyt lose express e-cadherin zo-1 well involucrin chang indic compromis epitheli function commonli associ malign progress togeth result suggest fibroblast may contribut tumorigenesi indirectli increas epitheli cell aggress thu tobacco may initi mutagen chang epitheli cell also promot growth invas mutant cell creat procarcinogen stromal environ',\n",
       "  'antigen cross-present dendrit cell dc thought play critic role drive polyclon durabl cell respons cancer follow therefor capac emerg immunotherapeut agent orchestr tumour erad may depend abil induc antigen cross-present immtac immune-mobilis monoclon tcr cell receptor cancer new class solubl bi-specif anti-canc agent combin pico-molar affin tcr-base antigen recognit cell activ via cd3-specif antibodi fragment immtac specif recognis human leucocyt antigen hla -restrict tumour-associ antigen present cancer cell lead cell redirect potent anti-tumour respons use immtac specif hla-a 02-restrict peptid deriv melanoma antigen gp100 term imcgp100 observ immtac-driven melanoma-cel death lead cross-present melanoma antigen dc turn activ melanoma-specif cell polyclon cell redirect imcgp100 moreov activ melanoma-specif cell cross-pres dc enhanc presenc imcgp100 featur serv increas prospect break toler tumour microenviron mechan dc cross-present occur via ‘ cross-dress ’ involv rapid direct captur dc membran fragment die tumour cell dc cross-present gp100-peptide-hla complex visualis quantifi use fluoresc label solubl tcr data demonstr immtac engag innat adapt compon immun system enhanc prospect mediat effect durabl anti-tumour respons patient',\n",
       "  'human papillomaviru hpv infect appear earli event cervic carcinogenesi addit abnorm requir biolog transform analys 179 low-grad cervic squamou intra-epitheli lesion sil 15 normal cervic presenc hpv use situ hybrid polymeras chain reaction pcr pcr perform gp5+/gp6+ primer follow hybrid use probe low hpv 6 11 40 42 43 44 intermedi hpv 31 33 35 39 51 52 58 59 66 68 high-risk hpv hpv 16 18 45 56 interphas cytogenet analysi use pericentromer probe chromosom 1 3 4 6 10 11 17 18 x also perform identifi numer chromosom abnorm tetrasomi nine chromosom identifi within basal keratinocyt restrict epithelia infect high risk 17 46 intermedi risk 23 83 hpv hpv type-specif tetrasomi identifi epithelia infect low risk hpv n 62 number includ multipl infect find indic induct tetrasomi properti restrict high intermediate-risk hpv type type-specif factor govern lesion develop abnorm yet unclear © 2000 cancer research campaign',\n",
       "  'past two decad signific achiev control hand import human tropic infect 1 achiev includ substant reduct preval incid so-cal neglect diseas lymphat filariasi onchocerciasi guinea worm leprosi trachoma box 1 2 neglect diseas poverty-promot often stigmat condit occur primarili rural area low-incom countri box 2 3 ancient afflict describ bibl ancient text burden human millennia 3 result aggress region vertic intervent possibl neglect tropic infect could eventu control point elimin area endem 2–8 case guinea worm infect diseas erad might also soon possibl 9 box 2. common featur neglect tropic diseas ancient afflict burden human centuri poverty-promot condit associ stigma rural area low-incom countri fragil state commerci market product target diseas intervent appli histori success',\n",
       "  'huntington diseas hd genet neurodegen disord current cure way stop even slow brain chang caus present studi aim investig whether fty720 first approv oral therapi multipl sclerosi may effect hd model eventu constitut altern therapeut approach treatment diseas util preclin target valid paradigm examin vivo efficaci chronic administr fty720 r6/2 hd mous model find indic fty720 improv motor function prolong surviv reduc brain atrophi r6/2 mice benefici effect fty720 administr associ signific strengthen neuron activ connect reduct mutant huntingtin aggreg also parallel increas phosphoryl mutant huntingtin serin 13/16 residu predict attenu protein toxic',\n",
       "  'unlabel two-compon system tc compris histidin kinas cognat respons regul allow bacteria sens respond wide varieti signal histidin kinas hk phosphoryl dephosphoryl cognat respons regul rr respons stimuli gener reaction appear highli specif requir appropri associ hk rr protein myxococcu xanthu genom encod one largest repertoir signal protein bacteria 685 open read frame orf includ least 127 hk least 143 rr 27 bona fide ntrc-famili respons regul 21 encod adjac predict cognat kinas use system-wid profil method determin hk-ntrc rr pair display kinet prefer phosphotransf phosphatas function therebi defin cognat signal system m. xanthu isotherm titrat calorimetri measur indic cognat hk-rr pair interact dissoci constant kd approxim 1 µm noncogn pair measur bind lastli chimera gener histidin kinas crd hk1190 reveal residu confer phosphotransf phosphatas specif dictat bind affin therebi establish discret protein-protein interact prevent cross talk data indic bind affin critic paramet govern system-wid signal fidel bacteri signal transduct protein import use vitro phosphotransf phosphatas profil assay isotherm titrat calorimetri taken system-wid approach demonstr specif famili two-compon signal protein myxococcu xanthu result demonstr previous identifi specif residu dictat bind affin phosphatas specif follow phosphotransf specif cognat hk-rr pair data indic preferenti bind affin basi signal fidel bacteri two-compon system',\n",
       "  \"telomeras ribonucleoprotein enzym complex reverse-transcrib integr rna templat add short dna repeat 3'-end telomer g-quadruplex structur dna substrat block extens telomeras found hnrnp a1 -- previous implic telomer length regul -- bind single-strand structur human telomer repeat latter case disrupt higher-ord structur use vitro telomeras assay observ deplet hnrnp a/b protein 293 human embryon kidney cell extract dramat reduc telomeras activ fulli recov upon addit purifi recombin hnrnp a1 find suggest hnrnp a1 function auxiliari essenti factor telomeras holoenzym show use chromatin immunoprecipit hnrnp a1 associ human telomer vivo propos hnrnp a1 stimul telomer elong unwind g-quadruplex g-g hairpin structur form transloc step\",\n",
       "  'mammalian target rapamycin mtor atyp protein kinas control growth metabol respons nutrient growth factor cellular energi level frequent dysregul cancer metabol disord rapamycin alloster inhibitor mtor approv immuno-suppress 1999. recent year interest focus potenti anticanc drug howev perform rapamycin analogu rapalogu undistinguish despit isol success subset cancer suggest full therapeut potenti target mtor yet exploit new gener atp-competit inhibitor directli target mtor catalyt site display potent comprehens mtor inhibit earli clinic trial',\n",
       "  'bacteri pathogen produc complex carbohydr capsul protect bactericid immun molecul paradox pneumococc capsul sensit bacterium antimicrobi peptid found epitheli surfac show upon interact antimicrobi peptid encapsul pneumococci surviv remov capsul cell surfac within minut process depend suicid amidas autolysin lyta contrast classic bacteri autolysi capsul shed lyta promot bacteri surviv dispers circumferenti around cell howev autolysi capsul shed depend cell wall hydrolyt activ lyta capsul shed drastic increas invas epitheli cell main pathway pneumococci reduc surfac bound capsul earli acut lung infect mice previous unrecogn role lyta remov capsul combat antimicrobi peptid may explain nearli clinic isol pneumococci conserv enzym despit lethal select pressur antibiot',\n",
       "  'scribbl scrib conserv polar protein requir drosophila melanogast synapt function neuroblast differenti epitheli polar also tumor suppressor rodent scrib implic receptor recycl planar polar apical/bas polar show knockdown scrib disrupt adhes madin–darbi canin kidney epitheli cell consequ cell acquir mesenchym appear migrat rapidli lose direction although tight junction assembl delay confluent monolay remain polar effect independ rac activ scrib bind βpix rather scrib deplet disrupt e-cadherin–medi cell–cel adhes chang morpholog migrat phenocopi e-cadherin knockdown adhes partial rescu express e-cadherin–α-catenin fusion protein e-cadherin–green fluoresc protein result suggest scrib stabil coupl e-cadherin catenin consist idea mammalian scrib could behav tumor suppressor regul epitheli cell adhes migrat',\n",
       "  'characterist featur anaplast larg cell lymphoma signific repress t-cell express program despit t-cell origin reason down-regul t-cell phenotyp still unknown elucid whether epigenet mechan respons loss t-cell phenotyp treat anaplast larg cell lymphoma t-cell lymphoma/leukemia cell line n=4 epigenet modifi evok dna demethyl histon acetyl global gene express data treat untreat cell line gener select differenti express gene evalu real-tim revers transcriptas polymeras chain reaction western blot analysi addit histon h3 lysin 27 trimethyl analyz chromatin immunoprecipit combin dna demethyl histon acetyl anaplast larg cell lymphoma cell abl reconstitut t-cell phenotyp instead treatment induc cell up-regul anaplast larg cell lymphoma-characterist gene e.g id2 lgals1 c-jun ii almost complet extinct t-cell phenotyp includ cd3 lck zap70 addit suppress trimethyl histon h3 lysin 27 import t-cell transcript factor gene gata3 lef1 tcf1 present anaplast larg cell lymphoma cell line absenc primari tumor specimen demonstr immunohistochemistri data suggest epigenet activ suppressor e.g id2 contribut down-regul t-cell express program anaplast larg cell lymphoma maintain trimethyl histon h3 lysin 27',\n",
       "  'yeast search transcript regul consensu track yeastract inform system http //www.yeastract.com develop support analysi transcript regulatori associ saccharomyc cerevisia last updat june 2010 databas contain 48,200 regulatori associ transcript factor tf target gene includ 298 specif dna-bind site 110 character tf regulatori associ store databas revisit detail inform experiment evid sustain associ ad classifi direct indirect evid inclus new data gather respons request yeastract user allow user restrict queri subset data base exist experiment evid direct action tf promot region target gene anoth new featur releas avail data machin readabl web-servic interfac user longer restrict set avail queri made avail exist web interfac use web servic interfac queri retriev exploit yeastract data use implement addit function yeastract inform system complement sever comput tool facilit use curat data answer number import biolog question sinc first releas 2006 yeastract extens use hundr research world expect make new data servic avail system continu instrument yeast biologist system biolog research',\n",
       "  'chromatin architectur eukaryot gene promot gener character nucleosome-fre region nfr flank least one h2a.z variant nucleosom comput predict nucleosom posit base thermodynam properti dna-histon interact met limit success show action essenti rsc remodel complex s. cerevisia help explain discrep theori experi rsc-deplet cell nfr shrink averag posit flank nucleosom move toward predict site nucleosom posit distinct subset promot addit requir essenti myb famili protein abf1 reb1 whose bind site enrich nfr contrast h2a.z deposit dispens nucleosom posit regul h2a.z deposit use steroid-induc protein splice strategi show nfr establish necessari h2a.z deposit studi suggest order pathway assembl promot chromatin architectur',\n",
       "  'incid acquir immunodefici syndrom aid malawi one highest central africa sinc tuberculosi import initi manifest diseas consecut patient admit tuberculosi tb ward zomba gener hospit malawi ask permiss undergo human immunodefici viru hiv -antibodi test addit two studi done septemb 1986 medic in-pati clinic suspect immun defici april 1988 blood donor test hiv seroposit seventy-f percent tb patient volunt 32 125 26 seroposit high-risk age group 20-40 year percentag rose 32. among medic in-pati suspect immun defici seroposit rose sharpli april 1987 octob 1988. among blood donor test 20 seroposit',\n",
       "  \"background neonat mortal account almost 40 per cent under-f child mortal global understand factor relat neonat mortal import guid develop focus evidence-bas health intervent prevent neonat death studi aim identifi determin neonat mortal indonesia nation repres sampl birth 1997 2002. method data sourc analysi 2002-2003 indonesia demograph health survey surviv inform 15,952 singleton live-born infant born 1997 2002 examin multilevel logist regress use hierarch approach perform analyz factor associ neonat death use commun socio-econom statu proxim determin result commun level odd neonat death significantli higher infant east java 5.01 p 0.00 north central southeast sulawesi gorontalo combin 3.17 p 0.03 compar lowest neonat mortal region bali south sulawesi jambi provinc progress reduct odd found percentag deliveri assist train deliveri attend cluster increas odd neonat death higher infant born mother father employ 1.84 p 0.00 infant born father unemploy 2.99 p 0.02 odd also higher higher rank infant short birth interv 2.82 p 0.00 male infant 1.49 p 0.01 smaller average-s infant 2.80 p 0.00 infant 's whose mother histori deliveri complic 1.81 p 0.00 infant receiv postnat care significantli protect neonat death 0.63 p 0.03 conclus public health intervent direct reduc neonat death address commun household individu level factor significantli influenc neonat mortal indonesia low birth weight short birth interv infant well perinat health servic factor avail skill birth attend postnat care util taken account plan intervent reduc neonat mortal indonesia\",\n",
       "  \"genome-wid associ studi relat chronic inflammatori bowel diseas ibd known crohn 's diseas ulcer coliti shown strong evid associ major histocompat complex mhc region encod larg number immunolog candid includ antigen-pres classic human leukocyt antigen hla molecul studi ibd indic multipl independ associ exist hla non-hla gene lack statist power defin architectur associ causal allel address perform high-dens snp type mhc 32,000 individu ibd implic multipl hla allel primari role hla-drb1 01:03 crohn 's diseas ulcer coliti noteworthi differ observ diseas includ predomin role class ii hla variant heterozyg advantag observ ulcer coliti suggest import role adapt immun respons colon environ pathogenesi ibd\",\n",
       "  'littl known molecular basi somatosensori mechanotransduct mammal screen librari peptid toxin effect mechan activ current cultur dorsal root ganglion neuron one conopeptid analogu term nmb-1 noxiou mechanosens blocker 1 select inhibit ic50 1 µm sustain mechan activ current subset sensori neuron biotinyl nmb-1 retain activ bind select peripherin-posit nocicept sensori neuron select nmb-1 confirm fact inhibitori effect voltage-g sodium calcium channel ligand-g channel acid-sens ion channel trpa1 channel convers tarantula toxin gsmtx-4 inhibit stretch-activ ion channel effect mechan activ current sensori neuron behavior assay nmb-1 inhibit respons high intens pain mechan stimul effect low intens mechan stimul thermosens unexpectedli nmb-1 found also inhibitor rapid fm1-43 load measur mechanotransduct cochlear hair cell data demonstr pharmacolog distinct channel respond distinct type mechan stimuli suggest mechan activ sustain current underli noxiou mechanosens nmb-1 thu provid novel diagnost tool molecular definit channel involv hear pressure-evok pain',\n",
       "  'bardet-biedl syndrom bb rare autosom recess disord clinic present includ polydactyli retinopathi hyperphagia obes short statur cognit impair development delay disrupt bb protein varieti organ impair cilia format function multi-organ defect bb attribut defici variou cilia-associ signal pathway c. elegan bb gene express exclus sixti ciliat sensori neuron anim bb mutant exhibit sensori defect well bodi size feed metabol abnorm show contrast mani cilia-defect mutant c. elegan bb mutant exhibit increas releas dense-cor vesicl organism-wid phenotyp associ enhanc activ insulin neuropeptid biogen amin signal pathway show alter bodi size feed metabol abnorm bb mutant correct wild-typ level abrog enhanc secret dense-cor vesicl without concomit correct ciliari defect find expand role bb protein regul dense-core-vesicl exocytosi suggest featur bardet-biedl syndrom may caus excess neuroendocrin secret',\n",
       "  'fiji distribut popular open-sourc softwar imagej focus biological-imag analysi fiji use modern softwar engin practic combin power softwar librari broad rang script languag enabl rapid prototyp image-process algorithm fiji facilit transform new algorithm imagej plugin share end user integr updat system propos fiji platform product collabor comput scienc biolog research commun',\n",
       "  'extens evid implic activ lipid phosphatidylinositid 3-kinas pi3k pathway genesi progress variou human cancer pi3k inhibitor thu consider potenti molecular cancer therapeut detail pharmacolog properti prototyp new seri inhibitor class pi3k pi103 potent inhibitor low ic50 valu recombin pi3k isoform p110alpha 2 nmol/l p110beta 3 nmol/l p110delta 3 nmol/l p110gamma 15 nmol/l pi103 also inhibit torc1 83.9 0.5 micromol/l exhibit ic50 14 nmol/l dna-pk high degre select pi3k famili shown lack activ pi103 panel 70 protein kinas pi103 potent inhibit prolifer invas wide varieti human cancer cell vitro show biomark modul consist inhibit pi3k signal pi103 extens metabol distribut rapidli tissu tumor result tumor growth delay eight differ human cancer xenograft model variou pi3k pathway abnorm decreas phosphoryl akt observ u87mg glioma consist drug level achiev also show inhibit invas orthotop breast ovarian cancer xenograft model obtain evid pi103 antiangiogen potenti despit rapid vivo metabol pi103 valuabl tool compound explor biolog function class pi3k importantli repres lead optim novel class target molecular cancer therapeut',\n",
       "  'type ii cluster regularli interspac short palindrom repeat crispr /crispr-associ ca system emerg recent power method manipul genom variou organ report toolbox high-effici genom engin drosophila melanogast consist transgen cas9 line versatil guid rna grna express plasmid systemat evalu reveal cas9 line ubiquit germ-line-restrict pattern activ also demonstr differenti activ grna express differ u6 snrna promot previous untest u6:3 promot give potent effect appropri combin cas9 grna allow target essenti nonessenti gene transmiss rate rang 25-100 also demonstr optim crispr/ca tool use offset nicking-bas mutagenesi furthermor combin oligonucleotid long double-strand donor templat reagent allow precis genom edit homology-direct repair rate make select marker unnecessari last demonstr novel applic crispr/cas-medi technolog reveal loss-of-funct phenotyp somat cell follow effici biallel target cas9 express ubiquit tissue-restrict manner crispr/ca tool facilit rapid evalu mutant phenotyp specif gene precis modif genom single-nucleotid precis result also pave way high-throughput genet screen crispr/ca',\n",
       "  'import american colleg cardiolog american heart associ acc/aha cholesterol treatment guidelin wide-scal implic treat adult without histori atherosclerot cardiovascular diseas ascvd statin object estim cost-effect variou 10-year ascvd risk threshold could use acc/aha cholesterol treatment guidelin design set particip microsimul model includ lifetim time horizon us societ perspect 3 discount rate cost health outcom model hypothet individu repres us popul age 40 75 year receiv statin treatment experienc ascvd event die ascvd-rel non-ascvd-rel caus base ascvd natur histori statin treatment paramet data sourc model paramet includ nation health nutrit examin survey larg clinic trial meta-analys statin benefit treatment publish sourc main outcom measur estim ascvd event prevent increment cost per quality-adjust life-year qali gain result base-cas scenario current ascvd threshold 7.5 higher estim associ 48 adult treat statin increment cost-effect ratio icer 37,000/qali compar 10 higher threshold lenient ascvd threshold 4.0 higher 61 adult treat 3.0 higher 67 adult treat icer 81,000/qali 140,000/qali respect shift 7.5 higher ascvd risk threshold 3.0 higher ascvd risk threshold estim associ addit 161,560 cardiovascular diseas event avert cost-effect result sensit chang disutil associ take pill daili statin price risk statin-induc diabet probabilist sensit analysi higher 93 chanc optim ascvd threshold 5.0 lower use cost-effect threshold 100,000/qali conclus relev microsimul model us adult age 45 75 year correct current 10-year ascvd risk threshold ≥7.5 risk threshold use acc/aha cholesterol treatment guidelin accept cost-effect profil icer 37,000/qali lenient ascvd threshold would optim use cost-effect threshold 100,000/qali ≥4.0 risk threshold 150,000/qali ≥3.0 risk threshold optim ascvd threshold sensit patient prefer take pill daili chang statin price risk statin-induc diabet',\n",
       "  'infecti prion propag peripher entri site central nervou system cn caus progress neurodegener ultim lead death yet pathogenesi prion diseas vari dramat depend strain conform variant aberrantli fold aggreg protein prp sc although prion strain invad cn prion strain gain entri caus clinic sign diseas conform basi remark variat pathogenesi among strain unclear use mouse-adapt prion strain show highli neuroinvas prion strain primarili form diffus aggreg brain noncongophil conform unstabl denatur condit lead rapidli lethal diseas neuroinvas strain effici gener prp sc short incub period contrast weakli neuroinvas prion strain form larg fibrillari plaqu stabl congophil ineffici gener prp sc long incub period overal result indic neuroinvas prion strain also least stabl support concept effici replic unstabl natur rapidli convert prion may featur link effici spread cn',\n",
       "  'twin-arginin transloc tat protein export system present cytoplasm membran bacteria archaea highli unusu properti transport fulli fold protein system must therefor provid transmembran pathway larg enough allow passag structur macromolecular substrat differ size maintain imperm membran ion gram-neg bacterium escherichia coli complex task achiev use three small membran protein tata tatb tatc review summar recent advanc understand remark machin oper',\n",
       "  'new develop program packag atsa version 2.4 process analysi isotrop small-angl x-ray neutron scatter data describ includ multiplatform data manipul display tool ii program autom data process calcul overal paramet iii improv usag high- low-resolut model structur method iv new algorithm build three-dimension model weakli interact oligomer system complex v enhanc tool analys data mixtur flexibl system new atsa releas includ instal current major platform window linux mac osx provid improv index user document web-rel develop includ user discuss forum widen onlin access run atsa program also present',\n",
       "  'myriapod e.g. centiped milliped display simpl homonom bodi plan rel arthropod member class terrestri attain terrestri independ insect myriapoda arthropod class repres sequenc genom present analysi genom centiped strigamia maritima retain compact genom undergon less gene loss shuffl previous sequenc arthropod mani orthologu gene conserv bilaterian ancestor lost insect analysi locat mani gene conserv macro-synteni context mani small-scal exampl gene cluster describ sever exampl s. maritima show differ solut insect similar problem insect olfactori receptor gene famili absent s. maritima olfact air like effect expans receptor gene famili gene s. maritima evolv paralogu gener code sequenc divers insect use altern splice strike dscam gene drosophila gener 100,000 altern splice form s. maritima encod 100 paralogu see intrigu linkag absenc known photosensori protein blind organ addit absenc canon circadian clock gene phylogenet posit myriapod allow us identifi arthropod phylogeni sever particular molecular mechan trait emerg exampl conclud juvenil hormon signal evolv emerg exoskeleton arthropod rr-1 contain cuticl protein evolv lineag lead mandibulata also identifi variou gene expans loss occur genom s. maritima offer us uniqu glimps ancestr arthropod genom also display mani adapt specif life histori',\n",
       "  'multicellular eukaryot produc small rna molecul approxim 21–24 nucleotid two gener type microrna mirna short interf rna sirna collect function sequence-specif guid silenc regul gene transposon virus modifi chromatin genom structur format activ small rna requir factor belong gene famili encod dicer dicer-lik dcl argonaut protein case sirna rna-depend rna polymeras rdr protein unlik mani anim plant encod multipl dcl rdr protein use seri insert mutant arabidopsi thaliana uniqu function three dcl protein mirna dcl1 endogen sirna dcl3 viral sirna dcl2 biogenesi identifi one rdr protein rdr2 requir endogen sirna analyz loss endogen sirna dcl3 rdr2 mutant associ loss heterochromat mark increas transcript accumul loci defect sirna-gener activ respons turnip crinkl viru dcl2 mutant plant correl increas viru suscept conclud prolifer diversif dcl rdr gene evolut plant contribut special small rna-direct pathway develop chromatin structur defens',\n",
       "  'one major role thymu provid peripher immun system matur cell mechan involv cellular export fulli understood studi examin abil novel immunosuppress reagent fty720 inhibit cell export thymu daili administr fty720 dose 1 mg kg result mark decreas number peripher blood lymphocyt thymu long-term daili administr fty720 caus three- fourfold increas proport matur medullari thymocyt cd4 cd8 cd4 cd8 well slight decreas double-posit cell cd4 cd8 ratio phenotyp analysi tcralpha beta h-2k cd44 cd69 cd24 reveal increas subset repres possibl peripher recent thymic emigr high level express l-selectin subset suggest prevent leav thymu intrathym label fluorescein isothiocyan one fourth label cell could detect lymph node spleen fty720-treat mice compar saline-tr control mice taken togeth result suggest immunosuppress action fty720 least part could due inhibitori effect cell emigr thymu peripheri',\n",
       "  \"rational aim object follow increas interest inter-profession ip health care team engag patient decis make develop conceptu model ip approach share decis make sdm primari care assess valid model stakehold canada method 15 individu interview 7 group interview 79 stakehold ask 1 propos chang ip-sdm model 2 identifi barrier facilit model 's implement clinic practic 3 assess model use theori apprais questionnair perform themat analysi transcript descript analysi questionnair result stakehold suggest place patient centr extend concept famili includ signific other clarifi outcom highlight concept time merg micro meso macro level one figur recogn influenc environ emot common barrier identifi time constraint insuffici resourc imbal power among health profession common facilit educ train inter-profession sdm motiv achiev ip approach sdm mutual knowledg understand disciplinari role stakehold consid concept relationship concept clear rate model logic testabl clear schemat represent relev inter-profession collabor sdm primari care conclus stakehold valid new ip-sdm model primari care set propos modif futur research assess model help implement sdm ip clinic practic\",\n",
       "  'amino acid control cell growth via activ highli conserv kinas torc1 glutamin particularli import amino acid cell growth control metabol howev role glutamin torc1 activ remain poorli defin glutamin metabol glutaminolysi produc α-ketoglutar demonstr glutamin combin leucin activ mammalian torc1 mtorc1 enhanc glutaminolysi α-ketoglutar product inhibit glutaminolysi prevent gtp load ragb lysosom transloc subsequ activ mtorc1 constitut activ rag heterodim activ mtorc1 absenc glutaminolysi convers enhanc glutaminolysi cell-perm α-ketoglutar analog stimul lysosom transloc activ mtorc1 final cell growth autophagi two process control mtorc1 regul glutaminolysi thu mtorc1 sens activ glutamin leucin via glutaminolysi α-ketoglutar product upstream rag may provid explan glutamin addict cancer cell',\n",
       "  \"notch play critic role transit prolifer differenti epidermi corneal epithelium furthermor aberr notch signal featur diseas like psoriasi eczema nonmelanoma skin cancer melanoma differenti prolifer impair wherea much known downstream event follow notch signal factor respons neg regul notch receptor signal ligand activ incomplet understood notch undergo hydroxyl factor-inhibit hypoxia-induc factor 1 fih-1 howev biolog signific phenomenon unclear show fih-1 express up-regul diseas epidermi corneal epithelium elev fih-1 level primari human epiderm keratinocyt hek human corneal epitheli keratinocyt hcek impair differenti submerg cultur `` three-dimension '' organotyp raft model human epidermi part via coordin decreas notch signal knockdown fih-1 enhanc keratinocyt differenti loss fih-1 vivo increas notch activ limbal epithelium result differenti phenotyp microrna-31 mir-31 endogen neg regul fih-1 express result keratinocyt differenti mediat notch activ ectop express mir-31 undifferenti corneal epitheli cell line promot differenti recapitul corneal epithelium three-dimension raft cultur model result defin previous unknown mechan keratinocyt fate decis notch signal potenti part control mir-31/fih-1 nexu\",\n",
       "  'base sensit analysi macdonald-ross model long argu best way reduc malaria transmiss target adult femal mosquito insecticid reduc longev human-feed frequenc vector howev analys ignor fundament biolog differ mosquito adult immatur stage preced adult highli mobil fli insect readili detect avoid mani intervent measur wherea mosquito egg larva pupa confin within rel small aquat habitat readili escap control measur hypothes control adult immatur mosquito compromis abil avoid intervent excito-repel insecticid appli simpl model intervent avoid mosquito demonstr substanti reduc effect coverag term proport vector popul cover overal impact malaria transmiss review histor evid larval control african malaria vector effect conclud limit effect coverag larval control practic rather fundament larval control strategi vector malaria sub-saharan africa could highli effect complementari adult control intervent priorit develop evalu implement integr part roll back malaria',\n",
       "  'arabidopsi thaliana small interf rna sirna direct cytosin methyl endogen dna repeat pathway involv two form nuclear rna polymeras iv pol iva pol ivb rna-depend rna polymeras 2 rdr2 dicer-lik 3 dcl3 argonaute4 ago4 chromatin remodel drd1 de novo cytosin methyltransferas drm2 show rdr2 dcl3 ago4 nrpd1b largest subunit pol ivb coloc sirna within nucleolu contrast pol iva drd1 extern nucleolu coloc endogen repeat loci mutation-induc loss pathway protein caus downstream protein misloc reveal order action pol iva act first local rna depend suggest rna templat hypothes mainten heterochromat state involv locus-specif pol iva transcript follow sirna product assembl ago4- nrpd1b-contain silenc complex within nucleolar process center',\n",
       "  'assess age- sex-specif preval peripher arteri diseas pad intermitt claudic ic elderli popul perform population-bas studi 7715 subject 40 men 60 women age 55 year presenc pad ic determin measur ankle-arm systol blood pressur index aai mean world health organization/ros questionnair respect pad consid present aai 0.90 either leg preval pad 19.1 95 confid interv 18.1 20.0 16.9 men 20.5 women symptom ic report 1.6 95 confid interv 1.3 1.9 studi popul 2.2 men 1.2 women pad 6.3 report symptom ic 8.7 men 4.9 women wherea 68.9 ic aai 0.90 found subject aai 0.90 like smoker hypertens symptomat asymptomat cardiovascular diseas compar subject aai 0.90 higher author conclud preval pad elderli high wherea preval ic rather low although preval clearli increas advanc age vast major pad patient report symptom ic',\n",
       "  'exercis increas plasma tnf-alpha il-1beta il-6 yet stimuli sourc tnf-alpha il-1beta remain larg unknown test role oxid stress potenti contribut monocyt cytokin especi il-1beta respons previous untrain individu six healthi nonathlet perform two 45-min bicycl exercis session 70 vo 2 max combin antioxid vitamin e c 60 day allopurinol 15 day n-acetylcystein 3 day blood drawn baselin end-exercis 30 120 min postexercis plasma cytokin determin elisa monocyt intracellular cytokin level flow cytometri antioxid tnf-alpha increas 60 il-1beta threefold il-6 sixfold secondari exercis p 0.05 antioxid plasma il-1beta becam undetect tnf-alpha respons exercis abolish il-6 respons significantli blunt p 0.05 exercis increas percentag monocyt produc cytokin mean fluoresc intens conclud untrain human oxid stress major stimulu exercise-induc cytokin product monocyt play role process',\n",
       "  'sever data suggest ferment dietari fiber could play role control obes associ metabol disord aim studi investig put role short chain fructo-oligosaccharid of non-digest oligosaccharid mice fed standard diet mice fed two distinct high fat diet induc metabol disord associ obes confirm mice sever effect previous shown rat fed standard diet enrich of name increas total empti caecum weight signific decreas epididym fat mass increas colon portal plasma glucagon-lik peptide-1 glp-1 phenomenon posit correl higher colon proglucagon mrna level curious 4-week treatment of ad dose induc differ effect ad two differ high fat diet of decreas energi intak bodi weight gain glycemia epididym fat mass ad togeth high fat-carbohydr free diet of promot colon proglucagon express insulin secret result support associ increas proglucagon express proxim colon of effect glycemia fat mass develop and/or bodi weight gain conclus dietari oligosaccharid would constitut interest class dietari fiber promot certain condit endogen glp-1 product benefici physiolog consequ remain proven human studi',\n",
       "  'accur chromosom segreg requir care regul interact kinetochor microtubul plastic achiev correct divers attach defect remain unclear demonstr aurora b kinas phosphoryl three spatial distinct target within conserv outer kinetochor knl1/mis12 complex/ndc80 complex kmn network key player kinetochore-microtubul attach combinatori phosphoryl kmn network gener grade level microtubule-bind activ full phosphoryl sever compromis microtubul bind alter phosphoryl state protein caus correspond chromosom segreg defect importantli spatial distribut target along kinetochor axi lead differenti phosphoryl respons chang tension attach state total rather gener exclus binari chang microtubul bind result suggest mechan tension-depend fine-tun kinetochore-microtubul interact',\n",
       "  '6-mercaptopurin 6mp methotrex backbon continu therapi childhood acut lymphoblast leukemia studi oral 6mp methotrex indic chronic system exposur activ metabolit agent name red blood cell rbc concentr methotrex polyglutam mtxpg thioguanin nucleotid tgn posit correl event-fre surviv ef object evalu whether mtxpg tgn dose intens administ methotrex 6mp prognost set treatment protocol treatment coordin singl center weekli dose methotrex given parenter protocol total xii 182 children achiev remiss receiv weekli methotrex 40 mg/m2 parenter daili oral 6mp interrupt everi 6 week first year puls chemotherapi total 709 tgn 418 mtx-pg 267 thiopurin methyltransferas tpmt measur along complet dose intens inform dose receiv divid protocol dose per week 19,046 week 6mp methotrex analyz univari analys higher dose intens 6mp weekli methotrex signific predictor overal ef p =.006 039 respect occurr neutropenia associ wors outcom p =.040 multivari analysi higher dose intens 6mp p =.020 signific predictor ef lower tpmt activ p =.096 tend associ better outcom 6mp dose intens also associ p =.007 ef among patient homozyg wild-typ tpmt phenotyp lower 6mp dose intens primarili due miss week therapi reduct daili dose conclud increas dose-intens oral 6mp import determin ef particularli among children homozyg wild-typ tpmt phenotyp howev increas intens therapi neutropenia preclud chemotherapi administr may counterproduct',\n",
       "  'tumor metastasi primari caus death cancer patient understand molecular mechan underli tumor metastasi provid potenti drug target report orai1 stim1 involv store-oper calcium entri essenti breast tumor cell migrat vitro tumor metastasi mice reduct orai1 stim1 rna interfer highli metastat human breast cancer cell treatment pharmacolog inhibitor store-oper calcium channel decreas tumor metastasi anim model data demonstr role orai1 stim1 tumor metastasi suggest store-oper calcium entri channel potenti cancer therapeut target',\n",
       "  \"ident behavior mous spermatogen stem cell long-stand focu interest prevail `` model '' stem cell function restrict singli isol spermatogonia examin single-cel dynam gfrα1+ stem cell vivo evalu altern hypothesi fragment syncyti spermatogonia also contribut stem cell function homeostasi use live imag puls label quantit determin fate individu gfrα1+ cell find steady-st spermatogenesi entir gfrα1+ popul compris singl stem cell pool cell continu interconvert syncyti state minim biophys model reli rate incomplet cell divis syncyti fragment precis predict stochast fate gfrα1+ cell steadi state postinsult regener thu result defin altern dynam model spermatogen stem cell function mous testi\",\n",
       "  'rna molecul fulfil divers set biolog function within cell transfer genet inform dna protein enzymat catalysi reflect rang role simpl linear string rna—mad uracil guanin cytosin adenine—form varieti complex three-dimension structur protein form distinct structur motif zinc finger beta barrel certain structur also commonli adopt rna molecul among preval rna structur motif known pseudoknot first recogn turnip yellow mosaic viru 1 pseudoknot rna structur minim compos two helic segment connect single-strand region loop figur 1 although sever distinct fold topolog pseudoknot exist best character h type h-type fold base loop hairpin form intramolecular pair base outsid stem figur 1a \\u200band1b .1b caus format second stem loop result pseudoknot two stem two loop figur 1c two stem abl stack top form quasi-continu helix one continu one discontinu strand single-strand loop region often interact adjac stem loop 1–stem 2 loop 2–stem 1 form hydrogen bond particip overal structur molecul henc rel simpl fold yield complex stabl rna structur due variat length loop stem well type interact pseudoknot repres structur divers group fit play varieti divers role biolog role includ form catalyt core variou ribozym 2,3 self-splic intron 4 telomeras 5 addit pseudoknot play critic role alter gene express induc ribosom frameshift mani virus 6–9',\n",
       "  'tuberculosi major health problem develop countri reemerg recent year mani industri countri increas suscept immunocompromis individu tuberculosi mani experiment studi indic cell-medi immun play import role resist lymphokin interferon gamma ifn-gamma thought princip mediat macrophag activ resist intracellular pathogen mice develop fail produc ifn-gamma gko target disrupt gene ifn-gamma upon infect mycobacterium tuberculosi although develop granuloma gko mice fail produc reactiv nitrogen intermedi unabl restrict growth bacilli contrast control mice gko mice exhibit heighten tissu necrosi succumb rapid fatal cours tuberculosi could delay prevent treatment exogen recombin ifn-gamma',\n",
       "  'context venou thrombosi common complic patient cancer lead addit morbid compromis qualiti life object identifi individu cancer increas thrombot risk evalu differ tumor site presenc distant metastas carrier statu prothrombot mutat design set patient larg population-bas case-control multipl environment genet assess mega risk factor venou thrombosi studi 3220 consecut patient age 18 70 year first deep venou thrombosi leg pulmonari embol march 1 1999 may 31 2002 6 anticoagul clinic netherland separ 2131 control particip partner patient report via questionnair acquir risk factor venou thrombosi three month discontinu anticoagul therapi patient control interview blood sampl taken dna isol ascertain factor v leiden prothrombin 20210a mutat main outcom measur risk venou thrombosi result overal risk venou thrombosi increas 7-fold patient malign odd ratio 6.7 95 confid interv ci 5.2-8.6 vs person without malign patient hematolog malign highest risk venou thrombosi adjust age sex adjust 28.0 95 ci 4.0-199.7 follow lung cancer gastrointestin cancer risk venou thrombosi highest first month diagnosi malign adjust 53.5 95 ci 8.6-334.3 patient cancer distant metastas higher risk vs patient without distant metastas adjust 19.8 95 ci 2.6-149.1 carrier factor v leiden mutat also cancer 12-fold increas risk vs individu without cancer factor v leiden adjust 12.1 95 ci 1.6-88.1 similar result indirectli calcul prothrombin 20210a mutat patient cancer conclus patient cancer highli increas risk venou thrombosi especi first month diagnosi presenc distant metastas carrier factor v leiden prothrombin 20210a mutat appear even higher risk',\n",
       "  'although development role hippo signal organ size control well appreci pathway function tissu regener larg unknown address issu use dextran sodium sulfat dss -induc colon regener model find regener crypt express elev yes-associ protein yap level inactiv yap caus obviou intestin defect normal homeostasi sever impair dss-induc intestin regener convers hyperactiv yap result widespread early-onset polyp format follow dss treatment thu yap oncoprotein must exquisit control tissu regener allow compensatori prolifer prevent intrins oncogen potenti tissu regener program',\n",
       "  'singl nucleotid polymorph snp abund form genom variat distinguish rare variat requir least abund allel frequenc 1 wide rang genet disciplin stand benefit greatli studi use snp recent surg interest snp stem continu depend upon merg coincid matur sever research area i.e large-scal genom analysi relat technolog ii bio-informat comput iii genet analysi simpl complex diseas state iv global human popul genet field propel forward often unchart territori ongo discoveri effort promis yield hundr thousand human snp next year major question ask experiment theoret ethic effect way unlock full potenti upcom snp revolut',\n",
       "  'brain metastas repres greatest clinic challeng treat her2-posit breast cancer report develop orthotop patient-deriv xenograft pdx her2-express breast cancer brain metastas bcbm use identif target combin therapi combin inhibit pi3k mtor result durabl tumor regress three five pdx therapeut respons correl reduct phosphoryl 4ebp1 mtorc1 effector two nonrespond pdx show hypermut genom enrich mutat dna-repair gene suggest associ genom instabl therapeut resist find suggest biomarker-driven clinic trial pi3k inhibitor combin mtor inhibitor conduct patient her2-posit bcbm',\n",
       "  \"primat often reli vocal commun mediat social interact although much known acoust structur primat vocal social context usual utter knowledg neocort control audio-voc interact primat still incipi mostli deriv lesion studi squirrel monkey macaqu map neocort area relat vocal control new world primat speci common marmoset employ method previous use success vertebr speci analysi express immedi earli gene egr-1 freeli behav anim neocort distribut egr-1 immunoreact cell three marmoset expos playback conspecif vocal vocal spontan h/v group compar data three marmoset also heard playback vocal h/n group anterior cingul cortex dorsomedi prefront cortex ventrolater prefront cortex present higher number egr-1 immunoreact cell h/v group h/n anim result provid direct evid ventrolater prefront cortex region compris broca 's area human associ auditori process species-specif vocal orofaci control macaqu engag vocal output marmoset altogeth result support notion network neocort area relat vocal commun marmoset quit similar old world primat vocal product role play area import evolut speech primat discuss\",\n",
       "  'background famili hiatal hernia rare document aim describ pattern inherit famili hiatal hernia within affect famili subject thirti eight member famili pedigre across five gener method famili member interview investig barium meal evid hiatal hernia result twenti three 38 famili member radiolog evid hiatal hernia individu hiatal hernia born unaffect parent one case direct male male transmiss shown conclus famili inherit hiatal hernia occur evid direct male male transmiss point autosom domin mode inherit',\n",
       "  'seizur focal epilepsi sustain highli synchron neuron discharg aris restrict brain site subsequ spread larg portion brain despit intens experiment research field earlier cellular event initi sustain focal seizur still well defin identif central understand pathophysiolog focal epilepsi develop new pharmacolog therapi drug-resist form epilepsi promin involv astrocyt ictogenesi recent propos test whether cooper astrocyt neuron prerequisit support ictal seizure-lik interict epileptiform event simultan patch-clamp record ca2+ imag techniqu perform new vitro model focal seizur induc local applic n-methyl-d-aspart acid nmda rat entorhin cortex slice found ca2+ elev astrocyt correl initi develop mainten focal seizure-lik discharg delay astrocyt activ ictal discharg also observ model includ whole vitro isol guinea pig brain site gener seizur activ precis monitor contrast interict discharg associ ca2+ chang astrocyt select inhibit stimul astrocyt ca2+ signal block enhanc respect ictal discharg affect interict discharg gener data reveal neuron engag astrocyt recurr excitatori loop possibl involv gliotransmiss promot seizur ignit sustain ictal discharg neuron-astrocyt interact may repres novel target develop effect therapeut strategi control seizur',\n",
       "  'background tradit t2 weight mr imag result non-specif extent underli white matter structur abnorm present late life depress lld diffus tensor imag provid uniqu opportun investig extent natur structur injuri limit examin subset region interest roi confound common studi elderli popul includ comorbid vascular patholog furthermor comprehens correl diffus tensor imag dti measur includ axial radial diffus measur demonstr late life depress popul method 51 depress 16 non-depress age- cerebrovascular risk factor-match elderli subject underw tradit anatom t1 t2 weight imag well dti dti data skeleton use tract base spatial statist tbss region global analys perform result widespread structur abnorm within white matter detect lld group account age gender educ match cerebrovascular risk factor global t2 white matter hyperintens t2wmh region differ promin uncin cingul white matter gener character increas radial diffus age-rel chang particularli cingul bundl advanc individu lld rel control regress analysi demonstr signific correl region fraction anisotropi radial diffus five differ neuropsycholog factor score tbss analysi demonstr greater extent white matter abnorm lld respons treatment compar control conclus white matter integr compromis late life depress larg manifest increas radial diffus specif region suggest underli myelin injuri possibl mechan underli myelin injuri chronic white matter ischemia relat intrins cerebrovascular diseas region cingul bundl white matter injuri relat late life depress appear independ compound age-rel chang correl neuropsycholog test indic essenti effect white matter injuri function statu lastli respons treatment may depend extent white matter injuri suggest need intact function network',\n",
       "  'atyp antipsychot olanzapin often induc excess weight gain type 2 diabet howev mechan underli drug-induc metabol perturb remain poorli understood use experiment model reproduc olanzapine-induc hyperphagia obes femal c57bl/6 mice found olanzapin treatment acut increas food intak impair glucos toler alter physic activ energi expenditur mice furthermor olanzapine-induc hyperphagia weight gain blunt mice lack serotonin 2c receptor htr2c final show treatment htr2c-specif agonist lorcaserin suppress olanzapine-induc hyperphagia weight gain lorcaserin treatment also improv glucos toler olanzapine-f mice collect studi suggest olanzapin exert untoward metabol effect via antagon htr2c',\n",
       "  'background suggest identifi risk factor endometri cancer oper singl etiolog pathway i.e. exposur rel high level unoppos estrogen estrogen absenc progestin studi howev address issu directli purpos assess risk develop endometri cancer among premenopaus postmenopaus women relat circul level steroid hormon sex hormone-bind globulin shbg independ effect hormon assess adjust known risk factor method data use analysi case-control studi conduct five geograph region unit state incid case newli diagnos period june 1 1987 may 15 1990. case patient age 20-74 year match control subject age race geograph region commun control subject obtain random-digit-di procedur subject 20-64 year old file health care financ administr subject 65 year old addit control subject hysterectomi perform benign condit obtain particip center women report use exogen estrogen oral contracept within 6 month interview exclud result 68 case patient 107 control subject among premenopaus women 208 case patient 209 control subject among postmenopaus women hormon analys perform blood sampl obtain case patient hysterectomi control subject surgeri odd ratio or 95 confid interv ci estim use uncondit logist regress analysi control match variabl potenti confound p valu two-sid result high circul level androstenedion associ 3.6-fold 2.8-fold increas risk among premenopaus postmenopaus women respect adjust factor p trend .01 .001 respect risk relat hormon fraction vari menopaus statu among postmenopaus women reduc risk associ high shbg level persist adjust made obes factor 0.51 95 ci 0.27-0.95 high estron level associ increas risk 3.8 95 ci 2.2-6.6 although adjust risk factor particularli bodi mass index diminish effect 2.2 95 ci 1.2-4.4 albumin-bound estradiol e2 marker bioavail fraction also remain import risk factor adjust made factor 2.0 95 ci 1.0-3.9 contrast high concentr total free albumin-bound e2 unrel increas risk premenopaus women premenopaus postmenopaus group risk associ obes fat distribut affect adjust hormon conclus high endogen level unoppos estrogen relat increas risk endometri cancer independ risk factor inconsist common underli biolog pathway risk factor endometri cancer oper implic research focu altern endocrinolog mechan risk associ obes bodi fat distribut biolog relev increas risk associ androstenedion premenopaus postmenopaus diseas',\n",
       "  'proteostasi critic maintain cell function proteom stabil may play import role human embryon stem cell hesc immort notabl hesc popul exhibit high assembl activ proteasom key node proteostasi network foxo4 insulin/igf-1 respons transcript factor regul proteasom activ hesc find loss foxo4 reduc potenti hesc differenti neural lineag therefor foxo4 cross evolutionari boundari link hesc function invertebr longev modul',\n",
       "  'whether gestat protein restrict pr affect placent develop function remain unknown test hypothesi pr affect trophoblast differenti mid-and late pregnanc rat fed 20 isocalor 6 protein diet day 1 14 18 pregnanc effect pr trophoblast differenti determin chang express marker gene trophoblast lineag day 18 pregnanc pr increas express esrrb id1 andid2 trophoblast stem cell marker decreas express ascl2 spongiotrophblast cell marker prl2c1 trophoblast giant cell marker alter express gjb3 pcdh12 glycogen cell marker junction zone jz labyrinth zone lz pr chang express prl2b1 trophoblast giant cell marker gcm1 syna syncytiotrophoblast cell marker decreas express ctsq sinusoid trophoblast giant cell marker result indic pr impair differenti trophoblast stem cell spongiotrophoblast trophoblast giant cell jz format sinusoid trophoblast giant cell lz',\n",
       "  'program death-1 pd-1 receptor serv immunolog checkpoint limit bystand tissu damag prevent develop autoimmun inflammatori respons pd-1 express activ cell downmodul t-cell effector function upon bind ligand pd-l1 pd-l2 antigen-pres cell patient cancer express pd-1 tumor-infiltr lymphocyt interact ligand tumor immun cell tumor microenviron undermin antitumor immun support rational pd-1 blockad cancer immunotherapi report detail develop character nivolumab fulli human igg4 s228p anti-pd-1 receptor-block monoclon antibodi nivolumab bind pd-1 high affin specif effect inhibit interact pd-1 ligand vitro assay demonstr abil nivolumab potent enhanc t-cell respons cytokin product mix lymphocyt reaction superantigen cytomegaloviru stimul assay vitro antibody-depend cell-medi complement-depend cytotox observ use nivolumab activ cell target nivolumab treatment induc advers immune-rel event given cynomolgu macaqu high concentr independ circul anti-nivolumab antibodi observ data provid comprehens preclin character nivolumab antitumor activ safeti demonstr human clinic trial variou solid tumor',\n",
       "  \"background although cigarett smoke excess alcohol drink obes sever well-studi unhealthi lifestyle-rel factor link risk multipl chronic diseas prematur death littl known combin impact mortal outcom particular among chines non-western popul object studi quantifi overal impact lifestyle-rel factor beyond activ cigarett smoke alcohol consumpt all-caus cause-specif mortal chines women method find use data shanghai women 's health studi ongo population-bas prospect cohort studi china particip includ 71,243 women age 40 70 year enrol 1996-2000 never smoke drank alcohol regularli healthi lifestyl score creat basi five lifestyle-rel factor shown independ associ mortal outcom normal weight lower waist-hip ratio daili exercis never expos spous 's smoke higher daili fruit veget intak score rang zero least healthi five healthi point averag follow-up 9 year 2,860 death occur includ 775 cardiovascular diseas cvd 1,351 cancer adjust hazard ratio mortal decreas progress increas number healthi lifestyl factor compar women score zero hazard ratio 95 confid interv women four five factor 0.57 0.44-0.74 total mortal 0.29 0.16-0.54 cvd mortal 0.76 0.54-1.06 cancer mortal invers associ healthi lifestyl score mortal seen consist regardless chronic diseas statu baselin popul attribut risk 4-5 healthi lifestyl factor 33 total death 59 cvd death 19 cancer death conclus first studi knowledg quantifi combin impact lifestyle-rel factor mortal outcom chines women healthier lifestyl pattern-includ normal weight lower central adipos particip physic activ nonexposur spousal smoke higher fruit veget intake-wa associ reduct total cause-specif mortal among lifetim nonsmok nondrink women support import overal lifestyl modif diseas prevent pleas see later articl editor summari\",\n",
       "  'current major concern safeti efficaci rna interfer rnai -base bone anabol strategi still exist lack direct osteoblast-specif deliveri system osteogen sirna screen aptam ch6 cell-selex specif target rat human osteoblast develop ch6 aptamer–function lipid nanoparticl lnp encapsul osteogen pleckstrin homolog domain-contain famili member 1 plekho1 sirna ch6-lnps-sirna result show ch6 facilit vitro osteoblast-select uptak plekho1 sirna mainli via macropinocytosi boost vivo osteoblast-specif plekho1 gene silenc promot bone format improv bone microarchitectur increas bone mass enhanc mechan properti osteopen healthi rodent result indic osteoblast-specif aptamer-function lnp could act new rnai-bas bone anabol strategi advanc target deliveri select osteogen sirna tissu level cellular level',\n",
       "  'celiac diseas immune-medi disord mucos autoantibodi enzym transglutaminas 2 tg2 gener respons exogen antigen gluten individu express human leukocyt antigen hla-dq2 hla-dq8 ref 3 assess comprehens nonbias manner iga anti-tg2 respons express clone antibodi repertoir ex vivo–isol intestin antibody-secret cell asc found tg2-specif plasma cell markedli expand within duoden mucosa individu activ celiac diseas tg2-specif antibodi high affin yet show littl adapt somat mutat unlik infection-induc peripher blood plasmablast tg2-specif asc recent prolifer short-liv ex vivo altogeth observ demonstr germlin repertoir high affin tg2 may favor massiv gener autoreact b cell tg2-specif antibodi block enzymat activ serv substrat tg2-mediat crosslink express igd igm iga1 igg1 could result preferenti recruit plasma cell naiv igd- igm-express b cell thu possibl explain antibodi respons tg2 bear sign primari immun respons despit diseas chronic',\n",
       "  'object purpos studi investig alter white matter integr adult major depress disord mdd use magnet reson imag mri method perform diffus tensor imag 3t mri scanner 45 patient major depress 45 healthi control match age sex educ use voxel-bas analysi measur fraction anisotropi fa investig differ patient control group examin correl microstructur abnorm white matter symptom sever age ill onset cumul ill durat respect result found signific decreas fa left hemispher includ anterior limb intern capsul inferior pariet portion superior longitudin fasciculu patient mdd compar healthi control diffus tensor imag measur left anterior limb intern capsul neg relat sever depress symptom even control age sex conclus find provid new evid microstructur chang white matter non-late-onset adult depress result complement observ late-lif depress support hypothesi disrupt cortical- subcort circuit integr may involv etiolog major depress disord',\n",
       "  \"object observ therapeut effect `` xingnao kaiqiao zhenfa '' acupunctur techniqu restor conscious treatment post-strok depress method total 256 stroke patient divid acupunctur group n 180 male 138 femal 42 medic group n 76 male 57 femal 19 accord visit sequenc hospit acupoint use neiguan pc 6 renzhong gv 26 baihui gv 20 yintang ex-hn 3 sanyinjiao sp 6 affect side needl retain 20 min everi time patient medic group ask take amitriptylin 50 mg/d first 200 mg/d acupunctur treatment conduct twice daili one month 's treatment therapeut effect evalu self-rat depress scale sd hamilton rate scale depress hrsd use assess patient 's state depress result treatment 180 76 case acupunctur medic group 31 17.2 13 17.1 cure 73 40.6 18 23.7 mark improv depress state 27 15.0 12 15.8 improv 49 27.2 33 43.4 fail effect rate 72.8 56.6 respect markedli effect rate total effect rate acupunctur group significantli higher medic group p 0.05 treatment total score sd hrsd sever index two group decreas pronouncedli comparison individu pre-treat therapeut effect acupunctur group significantli better medic group reduc sd hrsd sever index p 0 .05 addit decreas valu depress pessimist mood irrit acupunctur group bigger medic group p 0.05 signific differ found two group decreas valu insomnia p 0.05 conclus `` acupunctur techniqu restor conscious '' effect improv depress patient symptom therapeut effect acupunctur markedli superior medic post-strok patient\",\n",
       "  'nf-κb discov 30 year ago rapidli induc transcript factor sinc time found broad role gene induct divers cellular respons particularli throughout immun system summar elabor regulatori pathway involv transcript factor use recent discoveri human genet diseas place specif protein within relev medic biolog context',\n",
       "  'weight loss cancer cachexia attribut decreas food intak and/or enhanc energi expenditur investig role uncoupl protein ucp ucpi -2 -3 murin model cachexia mac16 adenocarcinoma weight fell 24 non-tumor-bear control p 0.01 18 day mac16 inocul signific reduct fat-pad mass -67 p 0.01 muscl mass -20 p 0.01 food intak 26-60 lower p 0.01 control day 17-18. non-tumor-bear mice pair-f match mac16-induc hypophagia show less weight loss 10 control p 0.01 16 mac-16 p 0.01 smaller decreas fat-pad mass 21 control p 0.01 core temperatur mac16 mice significantli lower -2.4 degre c p 0.01 control pair-feed effect mac16 mice show significantli higher ucp1 mrna level brown adipos tissu bat control +63 p 0.01 pair-feed effect ucp2 -3 express bat differ significantli group contrast ucp2 mrna level skelet muscl compar increas mac16 pair-f group respect 183 163 control p 0.05 signific differ two group similarli ucp3 mrna significantli higher control mac16 +163 p 0.05 pair-f +253 p 0.01 group signific differ two experiment group overexpress ucp1 bat mac16-bear mice may adapt respons hypothermia appar induc tumor product increas thermogenesi bat could increas total energi expenditur thu contribut tissu wast increas ucp2 -3 express muscl attribut reduc food intak may involv lipid util lipolysi mac16-induc cachexia',\n",
       "  'background statin commonli use arteriosclerot diseas recent retrospect analys suggest statin also prevent cancer aim systemat review verifi vitro anti-tumor effect statin head neck squamou cell carcinoma method studi gather search cochran medlin embas lilac pubm may 9 2015 time languag restrict vitro studi discuss effect statin head neck carcinoma select result 153 identifi paper 14 studi met inclus criteria studi demonstr statin signific effect head neck squamou cell carcinoma cell line influenc cell viabil cell cycl cell death protein express level involv pathway carcinogenesi corrobor potenti vitro anti-tumor effect provid highlight biolog mechan statin use alon associ tradit therapi cancer conclus though studi topic current avail evid suggest statin show preclin experi support potenti statin adjuv agent chemotherapi and/or radiotherapi approach routin use manag hnscc undergo clinic assess',\n",
       "  \"background mitochondri dna mtdna critic activ inflamm innat immun system howev mtdna level test role biomark intens care unit icu hypothes circul cell-fre mtdna level would associ mortal improv risk predict icu patient method find analys mtdna level perform blood sampl obtain two prospect observ cohort studi icu patient brigham women 's hospit registri critic ill bwh roci n 200 molecular epidemiolog acut respiratori distress syndrom ard n 243 mtdna level plasma assess measur copi number nadh dehydrogenas 1 gene use quantit real-tim pcr medic icu patient elev mtdna level ≥3,200 copies/µl plasma increas odd die within 28 icu admiss bwh roci odd ratio 7.5 95 ci 3.6-15.8 p 1×10 -7 ard 8.4 95 ci 2.9-24.2 p 9×10 -5 cohort evid associ note non-med icu patient addit elev mtdna level improv net reclassif index nri 28-d mortal among medic icu patient ad clinic model bwh roci nri 79 standard error 14 p 1×10 -4 ard nri 55 standard error 20 p 0.007 cohort bwh roci cohort elev mtdna level increas risk death even analys limit patient sepsi acut respiratori distress syndrom studi limit includ lack data elucid concis patholog role mtdna patient limit number measur biomark conclus increas mtdna level associ icu mortal inclus mtdna level improv risk predict medic icu patient data suggest mtdna could serv viabl plasma biomark medic icu patient\",\n",
       "  'context fructosamin glycem biomark may use indic control diabet respect object object studi evalu fructosamin indic hyperglycaemia glucos control subject diabet design set patient amori cohort subject serum glucos fructosamin hba1c examin studi cross-sect longitudin n 10,987 5,590 overnight-fast guidelin american diabet associ follow classif prediabet diabet separ analys perform patient newli detect known diagnosi type 1 type 2 diabet respect result three biomark strongli correl regard associ fructosamin hba1c pearson linear correl coeffici rang 0.67-0.75 observ fast non-fast subject type 1 type 2 diabet analys glucos control fast patient type 2 diabet three biomark measur three separ occas within averag 290 day index examin show similar trend time glucos fructosamin hba1c discrimin subject without diabet across rang fructosamin level good area curv auc 0.91-0.95 fructosamin level 2.5 mmol/l classifi subject diabet sensit 61 specif 97 conclus fructosamin close associ hba1c glucos respect may use biomark hyperglycaemia glucos control clinic epidemiolog studi',\n",
       "  'live imag actin cytoskeleton crucial studi mani fundament biolog process current approach visual actin sever limit describ lifeact 17-amino-acid peptid stain filament actin f-actin structur eukaryot cell tissu lifeact interfer actin dynam vitro vivo chemic modifi peptid form allow visual actin dynam nontransfect cell',\n",
       "  \"gene select import part microarray data analysi provid inform lead better mechanist understand investig phenomenon time gene select difficult noisi natur microarray data consequ gene select often perform machin learn method random forest method particularli well suit purpos work four state-of-the-art random forest-bas featur select method compar gene select context analysi focus stabil select although necessari determin signific result often ignor similar studi comparison post-select accuraci valid random forest classifi reveal investig method equival context howev method substanti differ respect number select gene stabil select analys method boruta algorithm predict gene potenti import post-select classifi error rate frequent use measur found potenti decept measur gene select qualiti number consist select gene consid boruta algorithm clearli best although also comput intens method boruta algorithm 's comput demand could reduc level compar algorithm replac random forest import compar measur random fern similar simplifi classifi despit design assumpt minim optim select method found select high fraction fals posit\",\n",
       "  'primari compon next-gener sequenc analysi align short read refer genom read align independ howev read observ non-refer dna sequenc highli correl use better model true variat target genom novel short-read micro realign srma leverag correl better resolv consensu underli dna sequenc target genom describ',\n",
       "  'dynein interact microtubul atp-sensit linkag map structur complex region heavi chain follow fourth p-loop motif virtual noth known regard bind affin achiev modul atp hydrolysi perform detail dissect microtubul contact site use fragment express alanin substitut peptid competit work identifi three cluster amino acid import physic contact microtubul two fall within region share sequenc homolog map1b third region downstream amino acid substitut within one region elimin weaken microtubul bind kk3379 80 e3385 k3387 k3397 kk3410,11 w3414 rkk3418-20 f3426 r3464 s3466 k3467 suggest activ highli coordin peptid activ displac map1b microtubul perturb dynein bind support previou evid similar site interact also identifi four amino acid whose substitut affect releas motor microtubul e3413 r3444 e3460 c3469 suggest nucleotide-sensit affin may local control site contact work first detail descript dynein-tubulin interact provid framework understand affin achiev modul',\n",
       "  'lymphocyt provid optim respons pathogen minim inflammatori patholog howev intrins mechan regul respons unknown report delet transcript factor egr2 egr3 lymphocyt result lethal autoimmun syndrom excess serum proinflammatori cytokin also impair antigen receptor-induc prolifer b cell egr2- egr3-defect b cell hyperact signal transduc activ transcription-1 stat1 stat3 antigen receptor-induc activ transcript factor ap-1 sever impair discov egr2 and/or egr3 directli induc express suppressor cytokin signaling-1 socs1 socs3 inhibitor stat1 stat3 also block function batf ap-1 inhibitor b cell thu egr2 egr3 regul b cell function adapt immun respons homeostasi promot antigen receptor signal control inflamm',\n",
       "  'mcf-7 continu cell line deriv human breast carcinoma exhibit low alkalin phosphatas alp activ enzym heat-stabl inhibit l-phenylalanin l-phenylalanylgly-cylglycin l-homoarginin 1-bromotetramisol levamisol data indic mcf-7 produc term-placent alp oncodevelopment enzym form inappropri express varieti human tumor contrast human cancer cell produc enzym monophenotyp alp activ mcf-7 cell significantli increas glucocorticoid sodium butyr comparison exposur hyperosmol caus strike increas enzym activ cycloheximid block effect result obtain cell-fre assay confirm cytochem immunocytochem assay whole cell agent test enzym modul experi affect cell prolifer possibl effect two stress-respons protein srp 27 srp 72 also examin specif immunocytochem assay use test reveal neither protein affect glucocorticoid sodium butyr effect srp 27 alter intracellular distribut srp 72 hyperosmol significantli affect srp 72 caus increas srp 27',\n",
       "  'interest brown adipos tissu bat target combat metabol diseas recent renew discoveri function bat human rodent bat activ bile acid activ type 2 iodothyronin deiodinas d2 bat via g-coupl protein receptor tgr5 result increas oxygen consumpt energi expenditur examin effect oral supplement bile acid chenodeoxychol acid cdca human bat activ treatment 12 healthi femal subject cdca 2 day result increas bat activ whole-bodi energi expenditur also increas upon cdca treatment vitro treatment primari human brown adipocyt deriv cdca specif tgr5 agonist increas mitochondri uncoupl d2 express effect absent human primari white adipocyt find identifi bile acid target activ bat human',\n",
       "  'chemic ident integr genom challeng incorpor ribonucleosid triphosph rntp place deoxyribonucleosid triphosph dntp replic misincorpor limit select dna replicas show accumul ribonucleosid monophosph rnmp genom caus replic stress toxic consequ particularli absenc rnase h1 rnase h2 remov rnmp demonstr postrepl repair prr pathways-mms2-depend templat switch pol ζ-depend bypass-ar crucial toler presenc rnmp chromosom inde show pol ζ effici replic 1-4 rnmp moreov cell lack rnase h accumul mono- polyubiquityl pcna constitut activ prr find describ crucial function rnase h1 rnase h2 templat switch transles dna synthesi overcom rntp misincorpor dna replic may relev pathogenesi aicardi-goutièr syndrom',\n",
       "  \"open read frame 74 orf74 encod human herpesviru 8 highli constitut activ seven transmembran 7tm receptor stimul angiogen chemokin e.g growth-rel oncogene-alpha inhibit angiostat chemokin e.g interferon-gamma-induc protein transgen mice express orf74 control cd2 promot develop highli vascular kaposi 's sarcoma-lik tumor target mutagenesi creat three distinct phenotyp orf74 receptor normal high constitut signal phospholipas c pathway depriv bind action chemokin obtain delet 22 amino acid n-termin extens orf74 high constitut activ select elimin stimulatori regul angiogen chemokin obtain substitut basic residu extracellular end tm-v tm-vi orf74 lack constitut activ preserv abil stimul agonist chemokin obtain introduct asp residu hydrophob presum membrane-expos face tm-ii conclud care molecular dissect select elimin either agonist invers agonist modul well high constitut activ viral encod oncogen orf74 mutant form presum use transgen anim identifi molecular mechan transform activ\",\n",
       "  'mutat daf-2 age-1 caus dramat increas longev well development arrest dauer diapaus stage caenorhabd elegan daf-2 age-1 encod compon insulin-lik signal pathway daf-2 age-1 act similar point genet epistasi pathway dauer arrest longev regul activ daf-16 gene mutat daf-16 caus dauer-defect phenotyp epistat diapaus arrest life span extens phenotyp daf-2 age-1 mutant show mutat pathway also affect fertil embryon develop weak daf-2 allel matern rescu age-1 allel caus life span extens arrest dauer stage also reduc fertil viabil find age-1 hx546 reduc matern zygot age-1 activ daf-16 mutat suppress daf-2 age-1 phenotyp includ dauer arrest life span extens reduc fertil viabil defect data show insulin signal mediat daf-2 age-1 phosphatidylinositol-3-oh kinas regul reproduct embryon develop well dauer diapaus life span daf-16 transduc signal regul fertil life span metabol insulin-lik signal pathway similar endocrin regul metabol fertil mammalian insulin signal',\n",
       "  'prion proteinac infecti agent respons prion diseas detect high sensit protein misfold cyclic amplif pmca technolog describ quantit pmca procedur calcul concentr low level prion biolog sampl use procedur determin quantiti misfold prion protein prpsc brain spleen blood urin scrapie-affect hamster',\n",
       "  'autoimmun polyglandular syndrom type ap 1 also call apec autosomal-recess disord map human chromosom 21q22.3 marker d21s49 d21s171 linkag studi isol novel gene region air autoimmun regul encod protein contain motif suggest transcript factor includ two zinc-fing phd-finger motif proline-rich region three lxxll motif two mutat c→t substitut chang arg 257 cga stop codon tga a→g substitut chang ly 83 aag glu codon gag found novel gene swiss finnish apec patient arg257stop r257x predomin mutat finnish apec patient account 10/12 allel studi result indic gene respons pathogenesi apec identif gene defect apec facilit genet diagnosi potenti treatment diseas enhanc gener understand mechan underli autoimmun diseas',\n",
       "  'amp-activ protein kinas ampk key regul cellular whole-bodi energi homeostasi act restor energi homoeostasi whenev cellular energi charg deplet last 2 decad becom appar ampk regul sever cellular function specif role cardiovascular tissu act regul cardiac metabol contractil function well promot anticontractil anti-inflammatori antiatherogen action blood vessel review discuss role ampk cardiovascular system includ molecular basi mutat ampk alter cardiac physiolog propos mechan ampk regul vascular function physiolog pathophysiolog condit',\n",
       "  'genom endoredupl mammalian develop rare event mechan unknown first appear fibroblast growth factor 4 fgf4 depriv induc differenti trophoblast stem ts cell nonprolifer trophoblast giant tg cell requir embryo implant show ro3306 inhibit cyclin-depend protein kinas 1 cdk1 enzym requir enter mitosi induc differenti ts cell tg cell contrast ro3306 induc abort endoredupl apoptosi embryon stem cell reveal inactiv cdk1 trigger endoredupl cell program differenti polyploid cell similarli fgf4 depriv result cdk1 inhibit overexpress two cdk-specif inhibitor p57/kip2 p21/cip1 ts cell mutant reveal p57 requir trigger endoredupl inhibit cdk1 p21 suppress express checkpoint protein kinas chk1 therebi prevent induct apoptosi furthermor cdk2 -/- ts cell reveal cdk2 requir endoredupl cdk1 inhibit express p57 tg cell restrict g-phase nuclei allow cdk activ phase thu endoredupl ts cell trigger p57 inhibit cdk1 concomit suppress dna damag respons p21',\n",
       "  'success gener induc pluripot stem cell entail major metabol switch mitochondri oxid phosphoryl glycolysi reprogram process mechan metabol reprogram howev remain elus result suggest atg5-independ autophag process mediat mitochondri clearanc characterist event involv metabol switch found block autophagi canon autophagi inhibit mitochondri clearanc turn prevent ipsc induct furthermor ampk seem upstream autophag pathway target small molecul modul mitochondri clearanc metabol reprogram work reveal atg5-independ autophagi crucial establish pluripot also suggest ipsc gener tumorigenesi share similar metabol switch',\n",
       "  'antigen stimul immun cell trigger ca2+ entri ca2+ release-activ ca2+ crac channel promot immun respons pathogen activ transcript factor nfat previous shown cell patient one form hereditari sever combin immun defici scid syndrom defect store-oper ca2+ entri crac channel function identifi genet defect patient use combin two unbias genome-wid approach modifi linkag analysi single-nucleotid polymorph array drosophila rna interfer screen design identifi regul store-oper ca2+ entri nfat nuclear import approach converg novel protein call orai1 contain four put transmembran segment scid patient homozyg singl missens mutat orai1 express wild-typ orai1 scid cell restor store-oper ca2+ influx crac current icrac propos orai1 essenti compon regul crac channel complex',\n",
       "  'context one key target unit nation millennium develop goal reduc preval underweight among children younger 5 year half 1990 2015. object estim trend childhood underweight geograph region world design set particip time seri studi preval underweight defin weight 2 sd mean weight age nation center health statist world health organ refer popul nation preval rate deriv global databas child growth malnutrit includ data approxim 31 million children younger 5 year particip 419 nation nutrit survey 139 countri 1965 2002. main outcom measur linear mixed-effect model use estim preval rate number underweight children region 1990 2015 calcul chang ie increas decreas valu 1990 2015. result worldwid underweight preval project declin 26.5 1990 17.6 2015 chang -34 95 confid interv ci -43 -23 develop countri preval estim decreas 1.6 0.9 chang -41 95 ci -92 343 develop region preval forecast declin 30.2 19.3 chang -36 95 ci -45 -26 africa preval underweight forecast increas 24.0 26.8 chang 12 95 ci 8 -16 asia preval estim decreas 35.1 18.5 chang -47 95 ci -58 -34 worldwid number underweight children project declin 163.8 million 1990 113.4 million 2015 chang -31 95 ci -40 -20 number project decreas subregion except subregion sub-saharan eastern middl western africa expect experi substanti increas number underweight children conclus overal improv global situat anticip howev neither world whole develop region expect achiev millennium develop goal larg due deterior situat africa subregion except northern africa expect fail meet goal',\n",
       "  \"everi organ depend blood vessel oxygen nutrient vasculatur associ individu organ structur molecularli divers central nervou system cn vasculatur consist tightli seal endothelium form blood-brain barrier wherea blood vessel organ porou wnt7a wnt7b encod two wnt ligand produc neuroepithelium develop cn coincid vascular invas use genet mous model found ligand directli target vascular endothelium cn use canon wnt signal pathway promot format cns-specif differenti organ 's vasculatur\",\n",
       "  \"mesenchym cell contribut 'stroma normal malign tissu specif mesenchym cell particip regulatori nich stem cell examin mesenchym osteolineag cell modul haematopoiesi show delet dicer1 specif mous osteoprogenitor matur osteoblast disrupt integr haematopoiesi myelodysplasia result acut myelogen leukaemia emerg acquir sever genet abnorm intact dicer1 examin gene express alter osteoprogenitor result dicer1 delet show reduc express sbd gene mutat schwachman-bodian-diamond syndrome-a human bone marrow failur leukaemia pre-disposit condit delet sbd mous osteoprogenitor induc bone marrow dysfunct myelodysplasia therefor perturb specif mesenchym subset stromal cell disord differenti prolifer apoptosi heterolog cell disrupt tissu homeostasi furthermor primari stromal dysfunct result secondari neoplast diseas support concept niche-induc oncogenesi\",\n",
       "  'spectacular advantag xenopu tropicali eas diploid embryo gener year round simpl administr human chorion gonadotropin investig gener mani hundr synchron embryo vitro fertil thousand embryo mate pair abil induc ovul desir facilit mani differ experi experiment embryolog molecular manipul gene product genet',\n",
       "  'four transcript factor oct4 sox2 klf4 c-myc induc pluripot mous human fibroblast previous describ direct reprogram adult mous neural stem cell nsc oct4 either klf4 c-myc nsc endogen express sox2 c-myc klf4 well sever intermedi reprogram marker report exogen express germline-specif transcript factor oct4 suffici gener pluripot stem cell adult mous nsc one-factor induc pluripot stem cell 1f ip similar embryon stem cell vitro vivo cell effici differenti nsc cardiomyocyt germ cell vitro also capabl teratoma format germlin transmiss vivo result demonstr oct4 requir suffici directli reprogram nsc pluripot',\n",
       "  \"publish summari yeast saccharomyc cerevisia recogn model system repres simpl eukaryot whose genom easili manipul yeast slightli greater genet complex bacteria share mani technic advantag permit rapid progress molecular genet prokaryot virus properti make yeast particularli suitabl biolog studi includ rapid growth dispers cell eas replica plate mutant isol well-defin genet system import highli versatil dna transform system nonpathogen yeast handl littl precaut larg quantiti normal baker 's yeast commerci avail provid cheap sourc biochem studi develop dna transform made yeast particularli access gene clone genet engin techniqu structur gene correspond virtual genet trait identifi complement plasmid librari plasmid introduc yeast cell either replic molecul integr genom contrast organ integr recombin transform dna yeast proce exclus via homolog recombin clone yeast sequenc accompani foreign sequenc plasmid therefor direct specif locat genom\",\n",
       "  'ubiquitin-medi proteolysi replic licens factor cdt1 cdc10-depend transcript 1 phase key mechan limit dna replic singl round per cell cycl metazoan xenopu egg extract cdt1 destroy chromatin dna replic report replication-depend proteolysi cdt1 requir interact prolifer cell nuclear antigen pcna homotrimer process factor dna polymeras cdt1 bind pcna consensu pcna-interact motif conserv cdt1 metazoan remov pcna egg extract inhibit replication-depend cdt1 destruct mutat pcna-interact motif yield stabil cdt1 protein induc re-repl ddb1 compon cul4 e3 ubiquitin ligas mediat human cdt1 proteolysi respons dna damag also requir replication-depend cdt1 destruct cdt1 ddb1 interact extract ddb1 chromatin load depend bind cdt1 pcna indic pcna dock activ pre-form cdt1–cul4ddb1 ligas complex thu pcna function platform cdt1 destruct ensur effici tempor restrict inactiv key cell-cycl regul',\n",
       "  'recent mani excit advanc achiev understand drosophila meiosi due combin cytolog genet approach new techniqu permit character chromosom posit spindl format femal meiosi i. protein encod nod ncd gene two gene known need proper partit chromosom lack exchang event identifi found kinesin-lik motor effect mutat gene spindl chromosom togeth local protein yield model mechan femal meiosi i. male meiosi chromosom region respons homolog pair resolv level specif dna sequenc provid foundat elucid molecular basi meiotic pair cytolog techniqu avail drosophila also permit inroad regul sister-chromatid segreg product two gene mei-s332 ord essenti sister-chromatid cohes identifi recent addit advanc understand drosophila meiosi delin function centromer use minichromosom deriv identif sever regulatori gene meiotic cell cycl',\n",
       "  'context mani observ studi shown physic activ reduc risk cognit declin howev evid random trial lack object determin whether physic activ reduc rate cognit declin among older adult risk design set random control trial 24-week physic activ intervent conduct 2004 2007 metropolitan perth western australia assessor cognit function blind group membership particip recruit volunt report memori problem meet criteria dementia three hundr eleven individu age 50 year older screen elig 89 elig 52 refus particip total 170 particip random 138 particip complet 18-month assess intervent particip randomli alloc educ usual care group 24-week home-bas program physic activ main outcom measur chang alzheim diseas assess scale-cognit subscal adas-cog score possibl rang 0-70 18 month result intent-to-treat analysi particip intervent group improv 0.26 point 95 confid interv -0.89 0.54 usual care group deterior 1.04 point 95 confid interv 0.32 1.82 adas-cog end intervent absolut differ outcom measur intervent control group -1.3 point 95 confid interv -2.38 -0.22 end intervent 18 month particip intervent group improv 0.73 point 95 confid interv -1.27 0.03 adas-cog usual care group improv 0.04 point 95 confid interv -0.46 0.88 word list delay recal clinic dementia rate sum box improv modestli well wherea word list total immedi recal digit symbol code verbal fluenci beck depress score medic outcom 36-item short-form physic mental compon summari chang significantli conclus studi adult subject memori impair 6-month program physic activ provid modest improv cognit 18-month follow-up period trial registr anzctr.org.au identifi actrn12605000136606',\n",
       "  \"survivor pediatr hodgkin 's lymphoma risk radiat therapy–induc second malign neoplasm smn identifi two variant chromosom 6q21 associ smn survivor hodgkin 's lymphoma treat radiat therapi children adult variant compris risk locu associ decreas basal express prdm1 encod pr domain contain 1 znf domain impair induct prdm1 protein radiat exposur data suggest new gene-exposur interact may implic prdm1 etiolog radiat therapy-induc smn\",\n",
       "  \"elucid transcript 'landscap regul human lymphoid commit postnat life use rna sequenc assembl long non-cod transcriptom across human bone marrow thymic progenitor cell span earliest stage b lymphoid lymphoid specif 3,000 gene encod previous unknown long non-cod rna lncrna reveal analysi rare popul lymphoid commit character lncrna express pattern highli stage specif lineag specif protein-cod gene protein-cod gene co-express neighbor lncrna gene show enrich ontolog relat lymphoid differenti exquisit cell-typ specif global lncrna express pattern independ reveal new development relationship among earliest progenitor cell human bone marrow thymu\",\n",
       "  'arabidopsi genom contain famili v-snare vti11 vti12 vti13 vti11 vti12 express appreci level although two protein 60 ident complement differ transport pathway express yeast vti1 mutant vti11 identifi recent mutat gene shoot gravitrop mutant zig show vti11 zig mutant defect vascular pattern auxin transport arabidopsi t-dna insert mutant vti12 normal phenotyp nutrient-rich growth condit howev nutrient-poor condit vti12 show acceler senesc phenotyp suggest vti12 may play role plant autophagi pathway vti11 vti12 also abl substitut respect snare complex double-mut cross zig vti12 embryo lethal result suggest vti1 protein necessari plant viabil two protein partial function redund',\n",
       "  'turnov integrin-bas focal adhes fa extracellular matrix ecm essenti coordin cell movement collect migrat human keratinocyt fa assembl near lead edg grow matur result contractil forc disassembl underneath advanc cell bodi report cluster microtubule-associ clasp1 clasp2 protein around fa tempor correl fa turnov clasp ll5β also known phldb2 recruit clasp fa facilit fa disassembl clasp requir fa-associ ecm degrad matrix metalloproteas inhibit slow fa disassembl similarli clasp phldb2 ll5β deplet final clasp-medi microtubul tether fa establish fa-direct transport pathway deliveri dock local fusion exocyt vesicl near fa propos clasp coupl microtubul organ vesicl transport cell interact ecm establish local secret pathway facilit fa turnov sever cell-matrix connect',\n",
       "  'background product gtp-bound form ran gtpase rangtp around chromosom induc spindl assembl activ nuclear local signal nl -contain protein sever nl protein identifi spindl assembl factor complex process led us search addit protein distinct role spindl assembl result identifi chromatin-remodel atpas chd4 rangtp-depend microtubul mt -associ protein map mt bind occur via region contain nl chromatin-bind domain xenopu egg extract cultur cell chd4 larg dissoci mitot chromosom partial local spindl immunodeplet chd4 egg extract significantli reduc quantiti mt produc around chromatin prevent spindl assembl chd4 rnai hela drosophila s2 cell induc defect spindl assembl chromosom align earli mitosi lead chromosom missegreg analysi egg extract hela cell reveal chd4 rangtp-depend mt stabil moreov chd4-contain nurd complex promot organ mt bipolar spindl egg extract importantli function chd4 independ chromatin remodel conclus result uncov new role chd4 map requir mt stabil involv gener spindl bipolar',\n",
       "  'background patient famili amyloid polyneuropathi rare hereditari form amyloidosi progress autonom neuropathi diseas usual induc heart failur associ sudden death conduct disturb increas risk complic anesthesia although cardiac sympathet denerv clearli demonstr postsynapt statu cardiac autonom nervou system remain unelucid method result twenty-on patient studi age 39+/-11 year normal coronari arteri left ventricular eject fraction 68+/-9 evalu densiti affin constant myocardi muscarin receptor pet 11 c-mqnb methylquinuclidinyl benzil specif hydrophil antagonist use cardiac beta-receptor function effici studi heart rate hr respons intraven infus isoproterenol 5 minut 2 mg atropin 5 10 15 ng/kg per minut 5 minut per step mean muscarin receptor densiti higher patient control subject b max 35.5+/-8.9 versu 26.1+/-6.7 pmol/ml p=0.003 without chang receptor affin increas hr inject atropin well mqnb lower patient compar control subject despit similar basal hr deltahr atropin 11+/-21 versu 62+/-17 p 0.001 consist parasympathet denerv increment infus isoproterenol induc similar increas hr patient control subject conclus cardiac autonom denerv famili amyloid polyneuropathi result upregul myocardi muscarin receptor without chang cardiac beta-receptor respons catecholamin',\n",
       "  'oxid pentos phosphat pathway ppp contribut tumour growth precis contribut 6-phosphoglucon dehydrogenas 6pgd third enzym pathway tumorigenesi remain unclear found suppress 6pgd decreas lipogenesi rna biosynthesi elev ro level cancer cell attenu cell prolifer tumour growth 6pgd-mediat product ribulose-5-phosph ru-5-p inhibit ampk activ disrupt activ lkb1 complex therebi activ acetyl-coa carboxylas 1 lipogenesi ru-5-p nadph thought precursor rna biosynthesi lipogenesi respect thu find provid addit link oxid ppp lipogenesi ru-5-p-depend inhibit lkb1-ampk signal moreov identifi develop 6pgd inhibitor physcion deriv s3 effect inhibit 6pgd cancer cell prolifer tumour growth nude mice xenograft without obviou toxic suggest 6pgd could anticanc target',\n",
       "  'eukaryot three nuclear dna-depend rna polymeras name pol ii iii interestingli plant catalyt subunit fourth nuclear polymeras pol iv genet biochem evid indic pol iv function overlap pol ii iii nonessenti viabil howev disrupt pol iv catalyt subunit gene nrpd1 nrpd2 inhibit heterochromatin associ chromocent coincid loss cytosin methyl pericentromer 5s gene cluster atsn1 retroel loss cg cng cnn methyl pol iv mutant implic partnership pol iv methyltransferas respons rna-direct de novo methyl consist hypothesi 5s gene atsn1 sirna essenti elimin pol iv mutant data suggest pol iv help produc sirna target de novo cytosin methyl event requir facult heterochromatin format higher-ord heterochromatin associ',\n",
       "  'semaphorin 3a sema3a diffus axon chemorepel import role axon guidanc previou studi demonstr sema3a−/− mice multipl development defect due abnorm neuron innerv show mice sema3a abundantli express bone cell-bas assay show sema3a affect osteoblast differenti cell-autonom fashion accordingli sema3a−/− mice low bone mass due decreas bone format howev osteoblast-specif sema3a-defici mice sema3acol1−/− sema3aosx−/− mice normal bone mass even though express sema3a bone substanti decreas contrast mice lack sema3a neuron sema3asynapsin−/− sema3anestin−/− mice low bone mass similar sema3a−/− mice indic neuron-deriv sema3a respons observ bone abnorm independ local effect sema3a bone inde number sensori innerv trabecular bone significantli decreas sema3asynapsin−/− mice wherea sympathet innerv trabecular bone unchang moreov ablat sensori nerv decreas bone mass wild-typ mice wherea reduc low bone mass sema3anestin−/− mice support essenti role sensori nervou system normal bone homeostasi final neuron abnorm sema3a−/− mice olfactori develop identifi sema3asynasin−/− mice demonstr neuron-deriv sema3a contribut abnorm neural develop seen sema3a−/− mice indic sema3a produc neuron regul neural develop autocrin manner studi demonstr sema3a regul bone remodel indirectli modul sensori nerv develop directli act osteoblast',\n",
       "  'direct lineag reprogram one special cell type anoth use defin factor fundament re-shap tradit concept regard epigenet stabil differenti cell rapid increas cell type gener direct convers recent year strategi becom promis approach produc function cell review recent advanc lineag reprogram includ identif novel reprogram factor underli molecular mechan strategi gener function matur cell assay character induc cell also discuss progress toward applic lineag reprogram major futur challeng strategi',\n",
       "  'compar consciou nonconsci process briefli flash word use visual mask procedur record intracrani electroencephalogram ieeg ten patient nonconsci process mask word observ multipl cortic area mostli within earli time window 300 ms accompani induc gamma-band activ without coher long-dist neural activ suggest quickli dissip feedforward wave contrast consciou process unmask word character converg four distinct neurophysiolog marker sustain voltag chang particularli prefront cortex larg increas spectral power gamma band increas long-dist phase synchroni beta rang increas long-rang granger causal argu measur provid distinct window distribut state consciou process result direct impact current theoret discuss concern neural correl consciou access',\n",
       "  'purpos patient type 2 diabet mellitu t2dm increas fractur risk despit higher areal bone miner densiti abmd studi aim clarifi associ glycem insulin resist statu bone microarchitectur whether pentosidin bone turnov marker play role associ method total 2012 community-dwel men age ≥65year complet baselin measur spine abmd fast plasma glucos fpg serum insulin hemoglobin a1c hba1c osteocalcin type procollagen n-termin propeptid type collagen c-termin crosslink telopeptid tartrate-resist acid phosphatas isoenzym 5b pentosidin height weight interview regard past diseas histori homeostasi model assessment-insulin resist homa-ir also calcul t2dm defin physician-diagnos middl age elderly-onset diabet mellitu accord biochem test result evalu bone microarchitectur trabecular bone score tb calcul vertebra use abmd measur result exclud particip diseas histori and/or take medic affect bone metabol 1683 men age 72.9±5.2year analyz men t2dm significantli higher abmd compar without t2dm signific differ tb howev fpg hba1c homa-ir level significantli invers correl tb adjust age bmi abmd multivari linear regress analys reveal glycem indic fpg hba1c significantli associ increas abmd decreas tb homa-ir associ tb associ chang adjust bone turnov maker pentosidin level conclus hyperglycemia elev insulin-resist associ low tb independ bone turnov pentosidin level',\n",
       "  'pulmonari hypertens ph deadli vascular diseas enigmat molecular origin found vascular extracellular matrix ecm remodel stiffen earli pervas process promot ph multipl pulmonari vascular cell type ecm stiffen induc microrna-130/301 famili via activ co-transcript factor yap taz microrna-130/301 control ppar -apoe-lrp8 axi promot collagen deposit lox-depend remodel upregul yap/taz via mechanoact feedback loop turn ecm remodel control pulmonari vascular cell crosstalk via mechanotransduct modul secret vasoact effector regul associ microrna pathway vivo pharmacolog inhibit microrna-130/301 apo lox activ amelior ecm remodel ph thu ecm remodel control yap/taz-mir-130/301 feedback circuit earli ph trigger offer combinatori therapeut target devast diseas',\n",
       "  'advanc ovarian cancer usual spread viscer adipos tissu omentum howev oment stromal cell-deriv molecular determin modul ovarian cancer growth character use next-gener sequenc technolog identifi significantli higher level microrna-21 mir21 isomirna exosom tissu lysat isol cancer-associ adipocyt caa fibroblast caf ovarian cancer cell function studi reveal mir21 transfer caa caf cancer cell suppress ovarian cancer apoptosi confer chemoresist bind direct novel target apaf1 data suggest malign phenotyp metastat ovarian cancer cell alter mir21 deliv exosom deriv neighbour stromal cell oment tumour microenviron inhibit transfer stromal-deriv mir21 altern modal treatment metastat recurr ovarian cancer',\n",
       "  \"two separ vitro assay use examin biosynthesi broad spectrum excitatori amino acid receptor antagonist kynuren acid kyna life span adult rat assess kyna 's anabol enzym kynurenin aminotransferas reveal steadi increas 3 24 month age five brain region examin chang observ liver chang particularli pronounc cortex striatum enzym activ increas three-fold period studi kyna product bioprecursor l-kynurenin also investig tissu slice found significantli enhanc cortex hippocampu old anim effect depolar agent sodium replac virtual ident tissu young old rat data excel agreement report age-depend increas kyna concentr brain tissu suggest enhanc kyna tone age brain togeth report declin cerebr excitatori amino acid receptor densiti age increas product kyna may play role cognit memori dysfunct old anim\",\n",
       "  'polycomb group pcg protein form multiprotein complex call polycomb repress complex prc prc2 contain pcg protein ezh2 suz12 eed repress transcript methyl lysin k 27 histon h3 h3 suz12 essenti prc2 activ inactiv result earli lethal mous embryo demonstr suz12 -/- mous embryon stem es cell establish expand tissu cultur suz12 -/- es cell character global loss h3k27 trimethyl h3k27me3 higher express level differentiation-specif gene moreov suz12 -/- es cell impair proper differenti result lack repress es cell marker well activ differentiation-specif gene final demonstr pcg activ recruit sever gene es cell differenti despit increas h3k27me3 level alway suffici prevent transcript activ summari demonstr suz12 requir establish specif express program requir es cell differenti furthermor provid evid pcg differ mechan regul transcript cellular differenti',\n",
       "  'proteasom cylindr structur function multipl cellular process degrad wide varieti cytosol nuclear protein substrat access product releas enclos catalyt chamber occur axial pore open activ complex report high-resolut structur wild-typ mutant archaeal proteasom bound activ pa26 structur support propos order open conform requir proteolysi format trigger outward displac surround residu structur associ biochem assay reveal mechan bind involv interact pa26 c terminu conserv lysin surprisingli biochem observ implic equival interact unrel atp-depend activ pan pa700',\n",
       "  'translat fidel essenti protein cell function requir accur transfer rna trna aminoacyl purifi aminoacyl-trna synthetas exhibit fidel one error per 10,000 100,000 coupl accuraci trna aminoacyl vivo uncertain howev might consider lower show mammalian cell approxim 1 methionin met residu use protein synthesi aminoacyl non-methionyl-trna remark met-misacyl increas tenfold upon expos cell live non-infecti virus toll-lik receptor ligand chemic induc oxid stress met misacyl specif non-methionyl-trna famili met-misacyl trna use translat met-misacyl block inhibitor cellular oxidas implic reactiv oxygen speci ro misacyl trigger among six amino acid test trna misacyl occur exclus met met residu known protect protein ros-medi damag propos met-misacyl function adapt increas met incorpor protein protect cell oxid stress demonstr unexpect condit aspect decod mrna find illustr import consid altern iter genet code',\n",
       "  'sirtuin phylogenet conserv famili nad -depend protein deacetylas consum one molecul nad everi deacetyl lysin side chain requir nad potenti make prone regul fluctuat nad biosynthesi intermedi thu link cellular metabol sir2 protein saccharomyc cerevisia found sirtuin famili member well character histon deacetylas function transcript silenc heterochromatin domain pro-longev factor replic life span rl defin number time mother cell divid bud senesc delet sir2 shorten rl increas gene dosag caus extens furthermor sir2 implic mediat benefici effect calor restrict cr life span yeast also higher eukaryot paradigm share disagr debat also help rapidli drive age research field forward s. cerevisia four addit sirtuin hst1 hst2 hst3 hst4 review discuss function sir2 hst homolog replic age chronolog age also address sirtuin regul respons environment stress cr',\n",
       "  'object examin safeti use aliskiren combin agent use block renin-angiotensin system design systemat review meta-analysi randomis control trial data sourc medlin embas cochran librari two trial registri publish 7 may 2011. studi select publish unpublish randomis control trial compar combin treatment use aliskiren angiotensin convert enzym inhibitor angiotensin receptor blocker monotherapi use agent least four week provid numer data advers event outcom hyperkalaemia acut kidney injuri random effect model use calcul pool risk ratio 95 confid interv outcom result 10 randomis control studi 4814 particip includ analysi combin therapi aliskiren angiotensin convert enzym inhibitor angiotensin receptor blocker significantli increas risk hyperkalaemia compar monotherapi use angiotensin convert enzym angiotensin receptor blocker rel risk 1.58 95 confid interv 1.24 2.02 aliskiren alon 1.67 1.01 2.79 risk acut kidney injuri differ significantli combin therapi monotherapi group 1.14 0.68 1.89 conclus use aliskerin combin angiotensin convert enzym inhibitor angiotensin receptor blocker associ increas risk hyperkalaemia combin use agent warrant care monitor serum potassium level',\n",
       "  'transform conjug permit passag dna bacteri membran repres domin mode transfer genet inform bacteri cell bacteri eukaryot cell respons spread fitness-enhanc trait includ antibiot resist process usual involv recognit double-strand dna follow transfer singl strand elabor molecular machin respons negoti passag macromolecular dna layer cell surfac nearli machin compon involv transform conjug identifi present model role dna transport',\n",
       "  'mammalian brain astrocyt modul neuron function part synchron neuron fire coordin synapt network littl howev known accomplish structur standpoint investig structur basi astrocyte-medi neuron synchroni synapt coordin three-dimension relationship cortic astrocyt neuron investig use transgen viral approach label astrocyt enhanc green fluoresc protein perform three-dimension reconstruct astrocyt tissu section live anim vivo found cortic astrocyt occupi nonoverlap territori similar describ hippocampu use immunofluoresc label neuron somata singl astrocyt enwrap averag four neuron somata upper limit eight single-neuron dye-fil allow us estim one astrocyt contact 300-600 neuron dendrit togeth recent find show glial ca2+ signal restrict individu astrocyt vivo ca2+ signal lead gliotransmiss propos concept function island synaps group synaps confin within boundari individu astrocyt modul gliotransmitt environ control astrocyt descript offer new structur base conceptu framework evalu function data involv interact neuron astrocyt mammalian brain',\n",
       "  'background endometri cancer incid continu rise wake current age obes epidem much risk endometri cancer develop influenc environ lifestyl accumul evid suggest epigenom serv interfac genom environ hypermethyl stem cell polycomb group target gene epigenet hallmark cancer object studi determin function role epigenet factor endometri cancer develop method find epigenome-wid methyl analysi 27,000 cpg site endometri cancer tissu sampl n 64 control sampl n 23 reveal hand2 gene encod transcript factor express endometri stroma one commonli hypermethyl silenc gene endometri cancer novel integr epigenome-transcriptome-interactom analysi reveal hand2 hub highli rank differenti methyl hotspot endometri cancer find valid use candid gene methyl analysi multipl clinic sampl set tissu sampl total 272 addit women increas hand2 methyl featur premalign endometri lesion seen parallel decreas rna protein level furthermor women high endometri hand2 methyl premalign lesion less like respond progesteron treatment hand2 methyl analysi endometri secret collect use high vagin swab taken women postmenopaus bleed specif identifi patient earli stage endometri cancer high sensit high specif receiv oper characterist area curv 0.91 stage 1a 0.97 higher stage 1a final mice harbour hand2 knock-out specif endometrium shown develop precancer endometri lesion increas age lesion also demonstr lack pten express conclus hand2 methyl common crucial molecular alter endometri cancer could potenti employ biomark earli detect endometri cancer predictor treatment respons true clinic util hand2 dna methyl howev requir valid prospect studi pleas see later articl editor summari',\n",
       "  'studi examin associ perceiv control sever socioeconom variabl self-rat health seven post-communist countri russia estonia lithuania latvia hungari poland czech republ questionnair interview use collect data self-rat health last 12 month educ marit statu perceiv control base nine question materi depriv base avail food cloth heat popul two ecolog measur materi inequ avail inequ score estim survey data distanc 90th 10th percentil materi depriv gini coeffici publish sourc data 5330 men women age 20-60 analys preval poor health wors averag vari 8 czech 19 hungarian age-sex-adjust odd ratio univers vs primari educ 0.36 0.26-0.49 odd ratio per 1 standard deviat increas perceiv control materi depriv 0.58 95 ci 0.48-0.69 1.51 1.40-1.63 respect odd ratio increas inequ equival differ least unequ popul 1.49 0.88-2.52 use materi inequ score 1.41 0.91-2.20 use gini coeffici indic effect either inequ measur seen adjust individu depriv perceiv control result suggest western popul educ materi depriv strongli relat self-rat health perceiv control appear statist mediat effect materi depriv non-signific effect ecolog measur inequ elimin control individu characterist',\n",
       "  'integrin regul adhesion-depend growth surviv invas tumor cell particular express integrin alpha v beta 3 associ progress varieti human tumor reveal previous undescrib adhesion-independ role integrin alpha v beta 3 pancreat cancer carcinoma specif alpha v beta 3 express carcinoma cell enhanc anchorage-independ tumor growth vitro increas lymph node metastas vivo effect requir recruit c-src beta 3 integrin cytoplasm tail lead c-src activ crk-associ substrat ca phosphoryl tumor cell surviv unexpectedli independ cell adhes focal adhes kinas fak activ pharmacolog blockad c-src kinas activ decreas express endogen alpha v beta 3 integrin c-src inhibit anchorage-independ growth also suppress metastasi vivo yet manipul affect tumor cell migrat invas data defin unexpect role integrin mediat anchorag independ suggest alpha v beta 3 -c-src signal modul may account aggress behavior integrin alpha v beta 3 -express tumor human',\n",
       "  'embryon stem es cell bival chromatin domain overlap repress h3 lysin 27 tri-methyl activ h3 lysin 4 tri-methyl histon modif mark promot 2,000 gene gain insight structur function bival domain map key histon modif subunit polycomb-repress complex 1 2 prc1 prc2 genomewid human mous es cell chromatin immunoprecipit follow ultra high-throughput sequenc find bival domain segreg two class -- first occupi prc2 prc1 prc1-posit second specif bound prc2 prc2-onli prc1-posit bival domain appear function distinct effici retain lysin 27 tri-methyl upon differenti show stringent conserv chromatin state associ overwhelm number development regul gene promot also use comput genom search sequenc determin polycomb bind analysi reveal genomewid locat prc2 prc1 larg predict locat size underli motif content cpg island propos larg cpg island deplet activ motif confer epigenet memori recruit full repertoir polycomb complex pluripot cell',\n",
       "  \"epithelial-mesenchym transit emt implic convert stationari epitheli tumor cell motil mesenchym cell metastasi howev involv emt metastasi still controversi due lack mesenchym phenotyp human carcinoma metastas use spontan squamou cell carcinoma mous model show activ emt-induc transcript factor twist1 suffici promot carcinoma cell undergo emt dissemin blood circul importantli distant site turn twist1 allow revers emt essenti dissemin tumor cell prolifer form metastas studi demonstr vivo requir `` revers emt '' tumor metastasi may resolv controversi import emt carcinoma metastasi\",\n",
       "  'asymmetr cell divis apoptosi program cell death two fundament process import develop function multicellular organ found process asymmetr cell divis apoptosi function link specif show asymmetr cell divis nematod caenorhabd elegan mediat pathway involv three gene dnj-11 mida1 ces-2 hlf ces-1 snail directli control enzymat machineri respons apoptosi interestingli mida1-lik protein glsa alga volvox carteri well snail-rel protein snail escargot worniu drosophila melanogast previous implic asymmetr cell divis therefor c. elegan dnj-11 mida1 ces-2 hlf ces-1 snail may compon pathway involv asymmetr cell divis conserv throughout plant anim kingdom furthermor base result propos pathway directli control apoptot fate c. elegan possibl anim well',\n",
       "  'upon activ neutrophil releas dna fiber decor antimicrobi protein form neutrophil extracellular trap net although net bactericid contribut innat host defens excess net format link pathogenesi autoinflammatori diseas howev mechan regul net format particularli chronic inflamm poorli understood show g protein–coupl receptor gpcr cxcr2 mediat net format downstream analys show cxcr2-mediat net format independ nadph oxidas involv src famili kinas show pathophysiolog relev mechan cystic fibrosi lung diseas character chronic neutrophil inflamm found abund net airway fluid individu cystic fibrosi mous cystic fibrosi lung diseas net amount correl impair obstruct lung function pulmonari blockad cxcr2 intra-airway deliveri small-molecul antagonist inhibit net format improv lung function vivo without affect neutrophil recruit proteolyt activ antibacteri host defens studi establish cxcr2 receptor mediat nadph oxidase–independ net format provid evid gpcr pathway oper druggabl cystic fibrosi lung diseas',\n",
       "  'background artemisinin deriv use recent introduc combin therapi act plasmodium falciparum malaria significantli lower patient infecti potenti reduc population-level transmiss parasit increas interest malaria elimin understand impact transmiss act antimalari drug differ pharmacodynam becom key issu studi estim reduct transmiss may achiev introduc differ type treatment symptomat p. falciparum malaria endem area method find develop mathemat model predict potenti impact transmiss outcom introduc act first-lin treatment uncompl malaria six area vari transmiss intens tanzania also estim impact could achiev antimalari differ efficaci prophylact time gametocytocid effect rate treatment asymptomat infect symptomat infect six studi area estim use model togeth data cross-sect survey 5,667 individu conduct prior polici chang sulfadoxine-pyrimethamin act effect act drug type gametocytaemia infecti mosquito independ estim clinic trial data predict percentag reduct preval infect incid clinic episod achiev act highest area low initi transmiss 53 reduct preval infect seen 100 current treatment switch act area baselin slide-preval parasitaemia lowest 3.7 compar 11 reduct highest-transmiss set baselin slide preval 57.1 estim percentag reduct incid clinic episod similar absolut size public health impact howev greater highest-transmiss area 54 clinic episod per 100 person per year avert compar five per 100 person per year lowest-transmiss area high coverag import reduc presumpt treatment improv diagnosi substanti reduc number treatment cours requir per clinic episod avert lower-transmiss set although loss overal impact transmiss efficaci antimalari regimen specif gametocytocid properti long prophylact time estim effect reduc transmiss short-act act highest-transmiss set conclus result suggest act potenti transmiss reduct approach achiev insecticide-tr net lower-transmiss set act partner drug nonartemisinin regimen longer prophylact time could result larger impact higher-transmiss set although long term benefit must evalu relat risk develop parasit resist',\n",
       "  'amino-acid produc tradit develop repeat random mutagenesi owe difficulti ration engin complex highli regul metabol network report develop genet defin l-threonin overproduc escherichia coli strain system metabol engin feedback inhibit aspartokinas iii encod thra lysc respect transcript attenu regul locat thrl remov pathway thr degrad remov delet tdh mutat ilva meta lysa gene delet make precursor avail thr biosynthesi target gene engin identifi transcriptom profil combin silico flux respons analysi express level manipul accordingli final engin e. coli strain abl produc thr high yield 0.393 g per gram glucos 82.4 g/l thr fed-batch cultur system metabol engin strategi report may broadli employ develop genet defin organ effici product variou bioproduct',\n",
       "  'object impuls inattent relat attent deficit hyperact disord adhd may increas food intak consequ weight gain howev find associ obesity/overweight adhd mix author conduct meta-analysi estim associ method broad rang databas search aug. 31 2014. unpublish studi also obtain studi qualiti rate newcastle-ottawa scale random-effect model use result forty-two studi includ total 728,136 individu 48,161 adhd subject 679,975 comparison subject retain signific associ obes adhd found children odd ratio=1.20 95 ci=1.05-1.37 adult odd ratio=1.55 95 ci=1.32-1.81 pool preval obes increas 70 adult adhd 28.2 95 ci=22.8-34.4 compar without adhd 16.4 95 ci=13.4-19.9 40 children adhd 10.3 95 ci=7.9-13.3 compar without adhd 7.4 95 ci=5.4-10.1 signific associ adhd obes remain limit studi 1 report odd ratio adjust possibl confound factor 2 diagnos adhd direct interview 3 use directli measur height weight gender studi set studi countri studi qualiti moder associ obes adhd adhd also significantli associ overweight individu medic adhd higher risk obes conclus studi provid meta-analyt evid signific associ adhd obesity/overweight research address possibl underli mechan long-term effect adhd treatment weight individu adhd obes',\n",
       "  'research human microbiom establish commens pathogen bacteria influenc obes cancer autoimmun mechan mostli unknown found compon bacteri biofilm amyloid protein curli irrevers form fiber bacteri dna biofilm format interact acceler amyloid polymer creat potent immunogen complex activ immun cell includ dendrit cell produc cytokin type interferon pathogen system lupu erythematosu sle given system curli-dna composit trigger immun activ product autoantibodi lupus-pron wild-typ mice also found infect lupus-pron mice curli-produc bacteria trigger higher autoantibodi titer compar curli-defici bacteria data provid mechan microbiom biofilm-produc enter infect may contribut progress sle point potenti molecular target treatment autoimmun',\n",
       "  'human cancer cell typic harbour multipl chromosom aberr nucleotid substitut epigenet modif drive malign transform cancer genom atla tcga pilot project aim assess valu large- scale multi- dimension analysi molecular characterist human cancer provid data rapidli research commun report interim integr analysi dna copi number gene express dna methyl aberr 206 glioblastoma common type primari adult brain cancer nucleotid sequenc aberr 91 206 glioblastoma analysi provid new insight role erbb2 nf1 tp53 uncov frequent mutat phosphatidylinositol- 3- oh kinas regulatori subunit gene pik3r1 provid network view pathway alter develop glioblastoma furthermor integr mutat dna methyl clinic treatment data reveal link mgmt promot methyl hypermut phenotyp consequ mismatch repair defici treat glioblastoma observ potenti clinic implic togeth find establish feasibl power tcga demonstr rapidli expand knowledg molecular basi cancer',\n",
       "  'fibroblast growth factor 21 fgf21 novel metabol regul repres promis target treatment sever metabol diseas administr recombin wild type fgf21 diabet anim lead dramat improv glycaemia amelior system measur metabol health report pharmacolog outcom observ non-human primat upon administr recent describ fgf21 analogu ly2405319 ly diabet rhesu monkey treat subcutan ly daili period seven week dose ly use 3 9 50 mg/kg deliv escal fashion washout measur taken 2 4 6 8 week follow final ly dose ly therapi led dramat rapid lower sever import metabol paramet includ glucos bodi weight insulin cholesterol triglycerid level dose test addit observ favor chang circul profil adipokin increas adiponectin reduc leptin indic direct fgf21 action adipos tissu importantli first time show fgf21 base therapi metabol efficaci anim late stage diabet glycem efficaci ly anim partial attenu lipid lower effect fulli preserv suggest fgf21 may viabl treatment option even patient advanc diseas progress find support continu explor fgf21 pathway treatment metabol diseas',\n",
       "  'stem cell declin import cellular driver aging-associ pathophysiolog multipl tissu epigenet regul central establish maintain stem cell function emerg evid indic epigenet dysregul contribut alter potenti stem cell age unlik termin differenti cell impact epigenet dysregul stem cell propag beyond self alter herit transmit differenti progeni addit perpetu amplifi within stem cell pool self-renew divis review focus recent studi examin epigenet regul tissue-specif stem cell homeostasi age aging-rel diseas',\n",
       "  'interact host parasit provid ongo sourc select promot evolut varieti featur interact speci use genet explicit mathemat model explor pattern gene express evolv genet loci respons host resist parasit infect result reveal strike yet intuit conclus gene express evolv along differ trajectori two interact speci specif host resist loci frequent evolv co-express allel wherea parasit infect loci evolv express singl allel result aris host co-express resist allel abl recogn clear greater divers parasit genotyp token parasit co-express antigen elicitor allel like recogn clear host favour express singl allel model provid testabl predict help interpret accumul data express level gene relev host−parasit interact',\n",
       "  'recent demonstr interleukin il -23–driven il-17–produc thil-17 cell mediat inflammatori patholog certain autoimmun diseas show induct antigen-specif thil-17 cell helper th 1 th2 cell immun antigen adjuv abrog il-1 receptor type i–defici il-1ri−/− mice furthermor incid experiment autoimmun encephalomyel eae significantli lower il-1ri−/− compar wild-typ mice correl failur induc autoantigen-specif thil-17 cell wherea induct th1 th2 respons substanti differ howev eae induc il-1ri−/− mice adopt transfer autoantigen-specif cell wild-typ mice eae il-23 alon induc il-17 product cell il-1ri−/− mice il-23–induc il-17 product substanti enhanc il-1α il-1β even absenc cell receptor stimul demonstr essenti role phosphatidylinositol 3-kinas nuclear factor κb novel protein kinas c isoform il-1– il-23–medi il-17 product tumor necrosi factor α also synerg il-23 enhanc il-17 product il-1 depend find demonstr il-1 function upstream il-17 promot pathogen thil-17 cell eae',\n",
       "  'basal-lik breast cancer aris women carri mutat brca1 gene encod tumor suppressor protein brca1 thought develop mammari stem cell explor earli cellular chang occur brca1 mutat carrier prospect isol distinct epitheli subpopul normal mammari tissu preneoplast specimen individu heterozyg brca1 mutat describ three epitheli subset includ basal stem/progenitor lumin progenitor matur lumin cell unexpectedli found breast tissu brca1 mutat carrier harbor expand lumin progenitor popul show factor-independ growth vitro moreov gene express profil reveal breast tissu heterozyg brca1 mutat basal breast tumor similar normal lumin progenitor cell subset includ stem cell–enrich popul c-kit tyrosin kinas receptor encod kit emerg key marker lumin progenitor cell highli express brca1-associ preneoplast tissu tumor find suggest aberr lumin progenitor popul target transform brca1-associ basal tumor',\n",
       "  'neutrophil recruit lymphocyt recircul monocyt traffick requir adhes transmigr blood-vessel wall tradit three step roll activ firm adhes recent augment refin slow roll adhes strengthen intralumin crawl paracellular transcellular migrat recogn separ addit step neutrophil second activ pathway discov requir signal g-protein-coupl receptor signal step lead integrin activ begin emerg review focus new aspect one central paradigm inflamm immun — leukocyt adhes cascad',\n",
       "  \"5-hydroxymethylcytosin 5-hmc may repres new epigenet modif cytosin dynam 5-hmc neurodevelop recent report littl known genom distribut function neurodegen diseas huntington 's diseas hd observ mark reduct 5-hmc signal yac128 yeast artifici chromosom transgen 128 cag repeat hd mous brain tissu compar age-match wild-typ wt mice suggest defici 5-hmc reconstruct hd brain postnat develop genome-wid distribut analysi 5-hmc confirm diminish 5-hmc signal striatum cortex yac128 hd mice gener genom featur 5-hmc highli conserv affect either diseas brain region intriguingli identiﬁ disease-specif yac128 versu wt differenti hydroxymethyl region dhmr found acquisit dhmr gene bodi posit epigenet regul gene express ingenu pathway analysi ipa genotype-specif dhmr-annot gene reveal altern number canon pathway involv neuron development/differenti wnt/β-catenin/sox pathway axon guidanc signal pathway neuron function/surviv glutam receptor/calcium/creb gaba receptor signal dopamine-darpp32 feedback pathway etc could import onset hd result indic loss 5-hmc marker novel epigenet featur hd aberr epigenet regul may impair neurogenesi neuron function surviv hd brain studi also open new avenu hd treatment re-establish nativ 5-hmc landscap may potenti slow/halt progress hd\",\n",
       "  'focu articl plan resili aftermath catastroph first author offer concept plan resili goal recov commun benefit plan effort creat resili place next discuss major issu associ plan postdisast recoveri includ barrier pose feder state govern plan resili promis risk compact urban form model guid rebuild failur involv citizen plan disast final discuss lesson prior research address issu polici recommend foster predisast recoveri plan resili commun',\n",
       "  'object author sought determin innat immun system activ follow psychosoci stress patient major depress increas earli life stress method plasma interleukin il -6 lymphocyt subset dna bind nuclear factor nf -kb peripher blood mononuclear cell compar medic healthi male subject current major depress increas earli life stress n=14 versu nondepress male comparison subject n=14 complet trier social stress test result trier social stress test-induc increas il-6 nf-kappab dna-bind greater major depress patient increas earli life stress independ correl depress sever earli life stress natur killer nk cell percentag also increas follow stress howev differ group correl nk cell percentag stress-induc nf-kappab dna-bind il-6 conclus male major depress patient increas earli life stress exhibit enhanc inflammatori respons psychosoci stress provid preliminari indic link major depress earli life stress advers health outcom diseas associ inflamm',\n",
       "  'clone new member murin brain kinesin superfamili kif3b found amino acid sequenc highli homolog ident kif3a previous clone name kif3 47 ident kif3b local variou organ tissu develop neuron mice accumul anterograd move membran organel ligat nerv axon immunoprecipit assay brain reveal kif3b form complex kif3a three high molecular weight approxim 100 kd -associ polypeptid call kinesin superfamily-associ protein 3 kap3 vitro reconstruct use baculoviru express system show kif3a kif3b directli bind absenc kap3 recombin kif3a/b complex approxim 50-nm rod two globular head singl globular tail demonstr plu end-direct microtubul slide activ vitro addit show kif3b motor activ vitro make complex wild-typ kif3b chimer motor protein kif3b head kif3a rod tail subcellular fraction mous brain homogen show consider amount nativ kif3 complex associ membran fraction synapt vesicl immunoprecipit anti-kif3b antibody-conjug bead electron microscop studi also reveal kif3 associ membran organel moreov found composit kap3 differ brain testi find suggest kif3b form heterodim kif3a function new microtubule-bas anterograd transloc membran organel kap3 may determin function divers kif3 complex variou kind cell vivo',\n",
       "  'hippo–yap pathway emerg signal cascad involv regul stem cell activ organ size identifi compon pathway perform rnai-bas kinom screen human cell screen identifi sever kinas previous associ hippo signal control multipl cellular process one hit lkb1 common tumour suppressor whose mechan action partial understood demonstr lkb1 act substrat microtubul affinity-regul kinas famili regul local polar determin scribbl activ core hippo kinas data also indic yap function import tumour suppress effect lkb1 result identifi signal axi link yap activ lkb1 mutat implic treatment lkb1-mutant human malign addit find provid insight upstream signal hippo–yap signal cascad',\n",
       "  'immun checkpoint inhibitor identifi breakthrough treatment melanoma given dramat respons pd-1/pd-l1 blockad like extend mani cancer hundr clinic trial conduct propos use excit modal therapi varieti malign immun checkpoint inhibitor extens studi melanoma recent lung cancer littl known regard immun checkpoint blockad cancer review focu tumor immun microenviron express pd-1/pd-l1 effect immun modul use pd-1 pd-l1 inhibitor patient head neck prostat urotheli renal breast gastrointestin lung cancer',\n",
       "  'alloc hypoglycaem symptom autonomi neuroglycopen group tend occur priori basi view practic need clear symptom marker hypoglycaemia scientif approach must pursu substanti evid present two larg scale studi perform support three factor model hypoglycaem symptomatolog base statist associ discov among symptom report diabet patient studi 1 involv 295 insulin-tr outpati found 11 key hypoglycaem symptom segreg three clear factor autonomi sweat palpit shake hunger neuroglycopen confus drowsi odd behaviour speech difficulti incoordin malais nausea headach three factor valid separ group 303 insulin-tr diabet out-pati confirmatori factor analys show three factor model optim model explain symptom covari group multi-sampl confirmatori factor analysi test rigor assumpt rel load symptom factor across group equal residu varianc symptom ident across group assumpt success indic three factor model replic detail across two larg sampl suggest result indic valid group symptom may use futur research clinic practic',\n",
       "  'aim recent evid suggest cardiac progenitor cell cpc may improv cardiac function injuri underli mechan indirect mediat remain unidentifi exosom secret membran vesicl hereaft collect refer extracellular vesicl ev act paracrin signal mediat report ev secret human cpc crucial cardioprotect agent method result cpc deriv atrial appendag explant patient underw heart valv surgeri cpc-condit medium cm inhibit apoptosi mous hl-1 cardiomyocyt cell enhanc tube format human umbil vein endotheli cell effect abrog deplet cm ev reproduc ev secret cpc secret human dermal fibroblast transmiss electron microscopi nanoparticl track analysi show ev 30-90 nm diamet size exosom although smaller larger vesicl also present microrna highli enrich ev secret cpc compar fibroblast includ mir-210 mir-132 mir-146a-3p mir-210 down-regul known target ephrin a3 ptp1b inhibit apoptosi cardiomyocyt cell mir-132 down-regul target rasgap-p120 enhanc tube format endotheli cell infarct heart inject ev cpc fibroblast exhibit less cardiomyocyt apoptosi enhanc angiogenesi improv lv eject fraction 0.8 ± 6.8 vs. -21.3 ± 4.5 p 0.05 compar inject control medium conclus ev activ compon paracrin secret human cpc cell-fre approach ev could circumv mani limit cell transplant',\n",
       "  'adipos tissu hypoxia inflamm causal implic obesity-induc insulin resist report earli cours high-fat diet hfd feed obes adipocyt respir becom uncoupl lead increas oxygen consumpt state rel adipocyt hypoxia event suffici trigger hif-1α induct set chronic adipos tissu inflammatori respons characterist obes molecular level event involv satur fatti acid stimul adenin nucleotid translocas 2 ant2 inner mitochondri membran protein lead uncoupl respiratori state genet pharmacolog inhibit either ant2 hif-1α prevent revers pathophysiolog event restor state insulin sensit glucos toler result reveal sequenti seri event obesity-induc inflamm insulin resist',\n",
       "  'role specif phospholipid pl lipid transport difficult assess due inabl select manipul membran composit vivo show phospholipid remodel enzym lysophosphatidylcholin acyltransferas 3 lpcat3 critic determin triglycerid tg secret due uniqu abil catalyz incorpor arachidon membran mice lack lpcat3 intestin fail thrive wean exhibit enterocyt lipid accumul reduc plasma tg mice lack lpcat3 liver show reduc plasma tg hepatosteatosi secret lipid-poor low-dens lipoprotein vldl lack arachidonoyl pl mechanist studi indic lpcat3 activ impact membran lipid mobil live cell suggest biophys basi requir arachidonoyl pl lipid lipoprotein particl data identifi lpcat3 key factor lipoprotein product illustr manipul membran composit use regulatori mechan control metabol pathway',\n",
       "  'single-strand dna-bind protein ssb play import role dna metabol dna replic repair recombin essenti cell surviv character single-strand dna ssdna -bind properti pseudomona aeruginosa pao1 ssb passb use fluoresc quench measur electrophoret mobil shift analysi emsa analysi purifi passb gel filtrat chromatographi reveal stabl tetram solut fluoresc titrat passb bound 22-32 nucleotid nt per tetram depend salt concentr use emsa character stoichiometri passb complex seri ssdna homopolym size bind site determin 29 ± 1 nt furthermor emsa result indic dissoci constant passb first tetram less second tetram basi biophys analys ssdna bind mode passb expect noncoop',\n",
       "  'primari cilia microtubule-bas sensori organel coordin signal pathway cell-cycl control migrat differenti cellular process critic develop tissu homeostasi accordingli defect assembl function primari cilia lead plethora development disord patholog condit known ciliopathi review summar current statu role primari cilia coordin receptor tyrosin kinas rtk signal pathway present potenti mechan signal crosstalk network primari cilium discuss defect ciliari rtk signal link human diseas disord',\n",
       "  'tumor recurr repres major clinic challeng data show emerg recurr tumor acquir phenotyp radic differ origin primari tumor phenotyp allow evad host-deriv innat immun respons elicit progress minim residu diseas mrd activ grow recurr screen innat respons predict accur mice recurr would occur prematur induct recurr resensit mrd primari therapi suggest possibl paradigm shift clinic treatment dormant diseas current expect approach replac activ attempt uncov mrd evolut escap phenotyp complet combin screen second-lin treatment target innat insensit 100 mice would otherwis relaps cure data may open new avenu earli detect appropri time highli target treatment tumor recurr irrespect tumor type frontlin treatment',\n",
       "  'develop mechan forc caus chang size shape number posit gene express cell therefor integr morphogenet process forc gener actin-myosin network forc transmiss adhes complex two self-organ phenomena drive tissu morphogenesi coordin integr forc long-rang forc transmiss mechanosens cell within tissu produc large-scal tissu shape chang extrins mechan forc also control tissu pattern modul cell fate specif differenti thu interplay tissu mechan biochem signal orchestr tissu morphogenesi pattern develop',\n",
       "  'invari natur killer cell inkt cell involv host defens microbi infect although known inkt cell recogn glycolipid present cd1d encount antigen vivo remain unclear use multiphoton microscopi visual dynam activ inkt cell lymph node antigen administr inkt cell becam confin cd1d-depend manner close proxim subcapsular sinu cd169 macrophag macrophag retain intern present lipid antigen requir inkt cell activ cytokin product popul expans thu cd169 macrophag act true antigen-pres cell control earli inkt cell activ favor fast initi immun respons',\n",
       "  'cell defici major dna double-strand break repair pathway nonhomolog dna end join nhej increas spontan chromosom break howev sourc chromosom break remain undefin show observ spontan chromosom break partial suppress reduc cellular oxygen tension convers elev level reactiv oxygen speci overexpress antioxid enzym superoxid dismutas 1 sod1 transgen mous increas chromosom breakag effect sod1 also modul cellular oxygen tension elev chromosom breakag correl histolog signific increas amount neuron cell death ku86 -/- sod1 transgen embryo seen ku86 -/- embryo therefor oxygen metabol major sourc genom instabl observ nhej-defici cell presum cell',\n",
       "  'purpos review recent preclin clinic studi reveal semirandom insert transgen chromosom dna hematopoiet cell may induc clonal competit potenti may even trigger leukemia sarcoma insert mutagenesi caus gene vector thu led major uncertainti among develop advanc hematopoiet cell therapi review summar novel studi underli mechan studi demonstr possibl improv gene vector biosafeti gener new insight stem cell biolog recent find characterist insert pattern variou retrovir gene vector system may explain properti viral integras associ cellular cofactor cell cultur assay anim model includ disease-specif cancer-pron mous model emerg reveal contribut vector featur system factor induct clonal imbal databas summar vector insert site domin hematopoiet clone evolv new tool identifi gene regul clonal homeostasi summari mechanist studi insert mutagenesi random gene vector insert lead improv tool advanc hematopoiet cell therapi simultan fascin insight gene network regul cell fit gener import consequ field hematolog oncolog regen medicin',\n",
       "  'background tanzania well-develop network commerci itn retail 2004 govern introduc voucher subsidi pregnant women mid 2005 help distribut free net under-f small number district includ rufiji southern coast child health campaign contribut multipl insecticide-tr net deliveri strategi exist time place coverag poor rural commun assess method cross-sect household survey 6,331 member randomli select 1,752 household 31 rural villag demograph surveil system rufiji district southern tanzania conduct 2006. questionnair administ everi consent respond net use treatment statu deliveri mechan find net use 62.7 overal 87.2 amongst infant 0 1 year 81.8 amongst young children 1 5 year 54.5 amongst older children 6 15 year 59.6 amongst adult 15 year 30.2 net treat six month prior interview biggest sourc net use infant purchas privat sector voucher subsidi 41.8 half net use young children 50.0 third use older children 37.2 obtain free charg vaccin campaign largest sourc net amongst popul overal commerci purchas 45.1 use primari mean protect adult 60.2 use deliveri mechan especi sale net full market price under-serv poorest differ equiti observ voucher-subsid freeli distribut net conclus three deliveri strategi enabl poor rural commun achiev net coverag high enough yield person commun level protect entir popul reach relev target group free net temporarili suppress net market illustr set complementari rather mutual exclus approach',\n",
       "  'total 527 blood sampl obtain unselect popul women 36 40 week gestat serum human chorion gonadotropin hcg level measur use specif radioimmunoassay beta 1-subunit hcg serum hcg level higher primigravida women carri femal fetus also relat birthweight child occurr fetal distress',\n",
       "  'mutat duplic mecp2 caus rett rett-lik syndrom neurodevelopment disord character mental retard motor dysfunct autist behavior mecp2 express mani mammalian tissu function global repressor transcript howev molecular mechan mecp2 dysfunct lead neural-specif phenotyp rtt remain poorli understood show neuron activ subsequ calcium influx trigger de novo phosphoryl mecp2 serin 421 s421 camkii-depend mechan mecp2 s421 phosphoryl induc select brain respons physiolog stimuli significantli find s421 phosphoryl control abil mecp2 regul dendrit pattern spine morphogenesi activity-depend induct bdnf transcript find suggest trigger mecp2 phosphoryl neuron activ regul program gene express mediat nervou system matur disrupt process individu mutat mecp2 may underli neural-specif patholog rtt',\n",
       "  'correct kurreeman fa padyukov l marqu rb schrodi sj seddighzadeh et al 2007 candid gene approach identifi traf1/c5 region risk factor rheumatoid arthriti plo med 4 9 e278 doi:10.1371/journal.pmed.0040278 tabl 1 allel ratio column eight allel ratiosb case control refer allel allel b allele1 allele2 describ footnot b allel suscept allel denot column seven footnot read bnumber allel compar case versu control allel allel b case allel allel b control allel refer suscept allel given column seven',\n",
       "  'although signific progress occur past 20 year regard understand alzheim diseas pathogenesi yet identifi disease-modifi therapeut capabl substanti alter clinic cours preval neurodegen diseas short review discuss 2 approach current test clinic γ-secretas inhibit γ-secretas modul emphas signific differ 2 therapeut approach also discuss certain genetic- biomarker-bas translat clinic trial paradigm may assist develop use therapeut agent',\n",
       "  \"virus replic cytoplasm access host nuclear cap machineri virus evolv viral methyltransferas methyl n-7 2'-o cap rna altern `` snatch '' host mrna cap form 5 end viral rna function 2'-o methyl viral rna cap mimic cellular mrna evad host innat immun restrict cytoplasm viru defect 2'-o methyl replic viral rna lack 2'-o methyl recogn elimin host immun respons mutant viru could ration design live attenu vaccin use japanes enceph viru jev import mosquito-born flaviviru prove novel vaccin concept show jev methyltransferas respons n-7 2'-o cap methyl well evas host innat immun respons recombin viru complet defect 2'-o methyl stabl cell cultur passag 30 day mutant viru attenu mice elicit robust humor cellular immun respons retain engin mutat vivo singl dose immun induc full protect lethal challeng jev strain mice mechanist attenu phenotyp attribut enhanc sensit mutant viru antivir effect interferon ifit protein collect result demonstr feasibl use 2'-o methylation-defect viru vaccin approach vaccin approach applic flavivirus nonflavivirus encod viral 2'-o methyltransferas\",\n",
       "  'object determin whether individu fruit differenti associ risk type 2 diabet design prospect longitudin cohort studi set health profession unit state particip 66,105 women nurs health studi 1984-2008 85,104 women nurs health studi ii 1991-2009 36,173 men health profession follow-up studi 1986-2008 free major chronic diseas baselin studi main outcom measur incid case type 2 diabet identifi self report confirm supplementari questionnair result 3,464,641 person year follow-up 12,198 particip develop type 2 diabet adjust person lifestyl dietari risk factor diabet pool hazard ratio type 2 diabet everi three servings/week total whole fruit consumpt 0.98 95 confid interv 0.97 correct 0.99 mutual adjust individu fruit pool hazard ratio type 2 diabet everi three servings/week 0.74 0.66 0.83 blueberri 0.88 0.83 0.93 grape raisin 0.89 0.79 1.01 prune 0.93 0.90 0.96 appl pear 0.95 0.91 0.98 banana 0.95 0.91 0.99 grapefruit 0.97 0.92 1.02 peach plum apricot 0.99 0.95 1.03 orang 1.03 0.96 1.10 strawberri 1.10 1.02 1.18 cantaloup pool hazard ratio increment fruit juic consumpt 1.08 1.05 1.11 associ risk type 2 diabet differ significantli among individu fruit p 0.001 cohort conclus find suggest presenc heterogen associ individu fruit consumpt risk type 2 diabet greater consumpt specif whole fruit particularli blueberri grape appl significantli associ lower risk type 2 diabet wherea greater consumpt fruit juic associ higher risk',\n",
       "  \"background microrna-196 mir-196 highli up-regul oral cancer cell report aberrantli express sever cancer howev signific mir-196 oral cancer yet address method cellular function respons mir-196 modul examin includ cell growth migrat invas radio/chemosensit algorithm-bas studi use identifi regulatori target mir-196 mir-196 target gene downstream molecular mechan confirm rt-qpcr western blot luciferas report confoc microscopi analys mir-196 express determin pair cancer adjac normal tissu oral cancer patient result mir-196a mir-196b highli over-express cancer tissu correl lymph node metastasi p 0.001 p 0.006 respect function mir-196 activ promot cell migrat invas without affect cell growth mechanist mir-196 perform 's function inhibit nme4 express activ p-jnk suppress timp1 augment mmp1/9 conclus mir-196 contribut oral cancer promot cell migrat invas clinic mir-196a/b significantli over-express cancer tissu correl lymph node metastasi thu find provid new knowledg underli mechan cancer metastasi mir-196 may serv promis marker better oral cancer manag\",\n",
       "  'tlx1 tlx3 transcript factor oncogen key role pathogenesi cell acut lymphoblast leukemia t-all use revers engin global transcript network deciph oncogen regulatori circuit control tlx1 tlx3 system biolog analysi defin cell leukemia homeobox 1 tlx1 tlx3 master regul oncogen transcript circuit govern t-all notabl network structur analysi hierarch network identifi runx1 key mediat t-all induc tlx1 tlx3 predict tumor-suppressor role runx1 cell transform consist result identifi recurr somat loss-of-funct mutat runx1 human t-all overal result place tlx1 tlx3 top oncogen transcript network control leukemia develop show power network analys identifi key element regulatori circuit govern human cancer identifi runx1 tumor-suppressor gene t-all',\n",
       "  'background sinc novemb 2009 recommend adult infect hiv initi antiretrovir therapi art cd4+ cell count ≤350 cells/µl rather ≤200 cells/µl south africa decid adopt strategi pregnant tb co-infect patient estim impact fulli adopt new guidelin hiv epidem dynam associ cost method find use establish model transmiss control hiv specifi sexual network healthcar set quantifi model repres hlabisa subdistrict kwazulu-nat south africa predict hiv epidem dynam number art program cost new guidelin rel treat patient ≤200 cells/µl next 30 year first five year new treatment guidelin requir 7 extra annual invest wherea 28 patient receiv treatment furthermor profound impact hiv incid lead rel less annual cost seven year result cumul net cost reach break-even point averag 16 year conclus studi strengthen recommend start art ≤350 cells/µl hiv-infect patient apart benefit associ mani life-year save modest frontload appear lead net save within limit time-horizon find robust altern assumpt forese chang art price effect therefor south africa aim rapidli expand healthcar infrastructur fulli embrac new guidelin',\n",
       "  'mitochondri divis import mitochondri distribut function recent data demonstr er-mitochondria contact mark mitochondri divis site molecular basi function contact understood show yeast er-mitochondria tether complex erm highli conserv miro gtpase gem1 spatial function link er-associ mitochondri divis gem1 act neg regul er-mitochondria contact activ requir spatial resolut distribut newli gener mitochondri tip follow divis previou data demonstr erm local subset activ replic mitochondri nucleoid show mitochondri divis spatial link nucleoid major nucleoid segreg prior divis result distribut newli gener tip mitochondri network thu postul er-associ divis serv link distribut mitochondria mitochondri nucleoid cell doi http //dx.doi.org/10.7554/elife.00422.001',\n",
       "  \"bmi-1 overexpress varieti cancer elicit immun respons lead induct autoantibodi howev bmi-1 autoantibodi biomark seldom studi except nasopharyng carcinoma whether bmi-1 autoantibodi use biomark cervic carcinoma unclear studi bmi-1 protein isol screen t7 phage cdna librari mix cervic carcinoma tissu analyz bmi-1 autoantibodi level serum sampl 67 patient cervic carcinoma 65 control use elisa immunoblot bmi-1 mrna protein level over-express cervic carcinoma cell line immunoblot result exhibit increas bmi-1 autoantibodi level patient sera compar normal sera addit result antibodi affin assay show differ cervic polyp normal sera bmi-1 autoantibodi level significantli greater patient sera normal control patient 0.827±0.043 normal 0.445±0.023 p 0.001 's level bmi-1 autoantibodi increas significantli stage 0.672±0.019 compar normal sera p 0.001 level bmi-1 autoantibodi increas gradual tumor progress stage 0.672±0.019 stage ii 0.775 ±0.019 stage iii 0.890 ±0.027 stage iv 1.043±0.041 significantli correl diseas progress cervic cancer p 0.001 statist analys use logist regress receiv oper characterist roc curv indic bmi-1 autoantibodi level use biomark cervic carcinoma sensit 0.78 specif 0.76 auc 0.922 conclus measur bmi-1 autoantibodi level patient cervic cancer could clinic prognost valu well non-tissu specif biomark neoplasm express bmi-1\",\n",
       "  \"microrna mirna short highli conserv noncod rna molecul repress gene express sequence-depend manner perform single-cel measur use quantit fluoresc microscopi flow cytometri monitor target gene 's protein express presenc absenc regul mirna find although averag level repress modest agreement previou population-bas measur repress among individu cell vari dramat particular show regul mirna establish threshold level target mrna protein product highli repress near threshold protein express respond sensit target mrna input consist mathemat model molecular titrat result show mirna act switch fine-tun gene express\",\n",
       "  \"myeloid-deriv suppressor cell mdsc play critic role primari metastat cancer progress mdsc regul wide variabl even among patient harbour type malign mechan govern heterogen larg unknown integr human tumour genom syngen mammari tumour model demonstr mtor signal cancer cell dictat mammari tumour 's abil stimul mdsc accumul regul g-csf inhibit pathway activ exampl fgfr impair tumour progress partial rescu restor mdsc g-csf tumour-initi cell tic exhibit elev g-csf mdsc reciproc increas tic frequenc activ notch tumour cell form feedforward loop analys primari breast cancer patient-deriv xenograft corrobor mechan patient find establish non-canon oncogen role mtor signal recruit pro-tumorigen mdsc show defin cancer subset may evolv promot depend distinct immun microenviron\",\n",
       "  'manag women genet predisposit breast cancer requir care plan women brca 1 brca 2 mutat increas risk breast cancer cancer well particularli ovarian cancer screen prophlyact surgeri chemoprevent commonli util strategi manag patient women may choos one strategi random prospect trial assess impact strategi specif mutat carrier patient inform screen prophylact surgeri chemoprevent potenti harm well benefit',\n",
       "  'amyotroph later sclerosi al fatal motor neuron diseas astrocyt implic contribut substanti motor neuron death famili f al howev propos role astrocyt patholog al deriv part rodent model fal base upon domin mutat within superoxid dismutas 1 sod1 gene account 2 al case role sporad al affect 90 al patient remain establish use astrocyt gener postmortem tissu fal sal patient show astrocyt deriv patient group similarli toxic motor neuron also demonstr sod1 viabl target sal knockdown significantli attenu astrocyte-medi toxic toward motor neuron data highlight astrocyt non-cel autonom compon sal provid vitro model system investig common diseas mechan evalu potenti therapi sal fal',\n",
       "  'aim randomis control trial determin high-intens function exercis program improv balanc gait abil lower-limb strength older person depend activ daili live intak protein-enrich energi supplement immedi exercis increas effect train one hundr ninety-on older person depend activ daili live live residenti care facil mini-ment state examin mmse score 10 particip randomis high-intens function exercis program control activ includ 29 session 3 month well protein-enrich energi supplement placebo berg balanc scale self-pac maximum gait speed one-repetit maximum lower-limb strength followed-up three six month analys 2 x 2 factori ancova use intention-to-treat principl three month exercis group improv significantli self-pac gait speed compar control group mean differ 0.04 m/ p 0.02 six month signific improv favour exercis group berg balanc scale 1.9 point p 0.05 self-pac gait speed 0.05 m/ p 0.009 lower-limb strength 10.8 kg p 0.03 interact effect seen exercis nutrit intervent conclus high-intens function exercis program posit long-term effect balanc gait abil lower-limb strength older person depend activ daili live intak protein-enrich energi supplement immedi exercis appear increas effect train',\n",
       "  'myeloid-deriv suppressor cell mdsc promot tumor growth inhibit t-cell immun promot malign cell prolifer migrat therapeut potenti block mdsc tumor limit heterogen plastic resist variou chemotherapi agent recent studi highlight role energi metabol pathway differenti function immun cell howev metabol characterist regul mdsc remain unclear aim determin energi metabol pathway use mdsc establish impact immunosuppress function test whether inhibit block mdsc enhanc antitumor therapi use sever murin tumor model found tumor-infiltr mdsc t-mdsc increas fatti acid uptak activ fatti acid oxid fao accompani increas mitochondri mass upregul key fao enzym increas oxygen consumpt rate pharmacolog inhibit fao block immun inhibitori pathway function t-mdsc decreas product inhibitori cytokin fao inhibit alon significantli delay tumor growth t-cell-depend manner enhanc antitumor effect adopt t-cell therapi furthermor fao inhibit combin low-dos chemotherapi complet inhibit t-mdsc immunosuppress effect induc signific antitumor effect interestingli similar increas fatti acid uptak express fao-rel enzym found human mdsc peripher blood tumor result support possibl test fao inhibit novel approach block mdsc enhanc variou cancer therapi',\n",
       "  \"purpos identifi factor affect short-term prognosi patient acut exacerb chronic obstruct pulmonari diseas copd patient method 590 patient copd primari diseas hospit pneumolog unit univers hospit 1981 1990 studi standard protocol treatment acut exacerb copd adopt patient patient record retrospect analyz two observ 23 clinic laboratori variabl defin patient statu admiss collect age arteri ga data also taken account outcom mortal record interobserv reproduc test comput kappa coeffici spearman 's rho dichotom continu variabl respect relationship clinic laboratori factor outcom assess first univari analysi logist regress analysi assess independ predict role variabl previous shown univari correl mortal result mortal rate 14.4 logist regress analysi identifi four independ predictor death age odd ratio 1.07 95 confid interv ci 1.04 1.11 alveolar-arteri oxygen gradient greater 41 mm hg 2.33 95 ci 1.39 3.90 ventricular arrhythmia 1.91 95 ci 1.10 3.31 atrial fibril 2.27 95 ci 1.14 4.51 conclus patient acut exacerb copd high risk death identifi time admiss variabl reflect heart dysfunct import determin risk among pulmonari function data alveolar-arteri oxygen gradient contribut predict model\",\n",
       "  'clathrin establish function gener vesicl transfer membran protein around cell format clathrin-co vesicl occur continu non-divid cell shut mitosi clathrin concentr spindl apparatu show clathrin stabil fibr mitot spindl aid congress chromosom clathrin bound spindl directli amino-termin domain clathrin heavi chain deplet clathrin heavi chain use rna interfer prolong mitosi kinetochor fibr destabil lead defect congress chromosom metaphas plate persist activ spindl checkpoint normal mitosi rescu clathrin triskelia n-termin domain clathrin heavi chain indic stabil kinetochor fibr depend uniqu structur clathrin import clathrin normal mitosi may relev understand human cancer involv gene fusion clathrin heavi chain',\n",
       "  'basal extracellular glutam sampl vivo present micromolar concentr extracellular space outsid synapt cleft neither origin function glutam known report reveal blockad glutam releas cystine-glutam antiport produc signific decreas 60 extrasynapt glutam level rat striatum wherea blockad voltage-depend na+ ca2+ channel produc rel minim chang 0-30 indic primari origin vivo extrasynapt glutam striatum aris nonvesicular glutam releas cystine-glutam antiport measur 35 cystin uptak shown similar vesicular releas activ cystine-glutam antiport neg regul group ii metabotrop glutam receptor mglur2/3 via camp-depend protein kinas mechan extracellular glutam deriv antiport shown regul extracellular level glutam dopamin infus mglur2/3 antagonist rs -1-amino-5-phosphonoindan-1-carboxyl acid apica increas extracellular glutam level previou blockad antiport prevent apica-induc rise extracellular glutam suggest glutam releas antiport sourc endogen tone mglur2/3 blockad antiport also produc increas extracellular dopamin revers infus mglur2/3 agonist 2r,4r -4-aminopyrrolidine-2,4-dicarboxlyl indic antiporter-deriv glutam modul dopamin transmiss via mglur2/3 heteroreceptor result suggest nonvesicular releas cystine-glutam antiport primari sourc vivo extracellular glutam glutam modul glutam dopamin transmiss',\n",
       "  'interleukin-33 il-33 newli describ member il-1 famili express mani cell type follow pro-inflammatori stimul thought releas cell lysi il-33 receptor consist st2 il-1 receptor accessori protein also wide express particularli helper 2 th2 cell mast cell il-33 host-protect helminth infect reduc atherosclerosi promot th2-type immun respons howev il-33 also promot pathogenesi asthma expand th2 cell mediat joint inflamm atop dermat anaphylaxi mast cell activ thu il-33 could new target therapeut intervent across rang diseas',\n",
       "  'backgroundindividu substanc use disord sud increas risk hepat c viral infect hcv studi explor treatment respons empir object studi assess interferon alpha therapi ifn complet respons rate among patient hcv histori comorbid sud data need inform treatment strategi guidelin patient use medic record databas inform retrospect collect 307,437 veteran seen veteran integr servic network 20 visn 20 veteran healthcar administr vha 1998 2003. patient treat type ifn includ regular pegyl ifn combin therapi ifn ribavirin known hcv genotyp ifn complet respons rate compar among patient histori sud sud+ group patient without histori sud sud- group .resultsodd ratio analys reveal compar sud- group sud+ group equal like complet ifn therapi genotyp 2 3 73.1 vs. 68.0 genotyp 1 4 39.5 vs. 39.9 within sampl patient began ifn therapi sud- sud+ group similarli like achiev end treatment respons genotyp 2 3 52.8 vs. 54.3 genotyp 1 4 24.5 vs. 24.8 sustain viral respons genotyp 2 3 42.6 vs. 41.1 genotyp 1 4 16.0 vs. 22.3 .conclusionindividu without histori sud respond antivir therapi hcv similar rate collect find suggest patient co-morbid sud hcv diagnos success complet cours antivir therapi',\n",
       "  'object investig associ gastric cancer prior infect helicobact pylori design case-control comparison preval igg antibodi h pylori blood sampl collect prospect diagnosi gastric cancer case presenc h pylori antibodi greater 10 microgram igg/ml determin enzym link immunosorb assay elisa subject 29 men subsequ diagnosi gastric cancer 116 age match control select 22,000 middl age men particip two ongo cohort studi british unit provid associ studi caerphilli collabor heart diseas studi provid blood sampl 1975-1982. result 20 29 case 69 54 116 control 47 posit h pylori specif antibodi median specif igg concentr significantli higher case control 90 micrograms/ml v 3.6 micrograms/ml p less 0.01 estim odd ratio risk gastric cancer histori infect h pylori 2.77 95 confid interv 1.04 7.97 2p 0.039 conclus h pylori infect may import caus gastric cancer 35 55 case may associ infect',\n",
       "  'oncostatin osm leukemia inhibitori factor lif member interleukin-6 il-6 subfamili cytokin use common signal transduc gp130 human osm hosm lif share function high-affin receptor compos gp130 lif receptor beta subunit lifrbeta second high-affin receptor hosm recent found form gp130 hosm receptor beta subunit howev natur murin osm mosm receptor remain unknown use recent clone mosm cdna produc recombin mosm studi biolog activ receptor structur murin hematopoiet cell line m1 da1.a embryon stem cell line cce ba/f3 transfect express gp130 lifrbeta respond murin lif mlif hosm equal well cell respond mosm 30-fold 100-fold higher concentr mlif hosm contrast nih3t3 cell respond mosm mlif hosm scatchard plot analys show mosm bound gp130 low-affin kd 2.8 4.2 nmol/l bind affin increas presenc lifrbeta howev mosm bound nih3t3 cell high-affin kd 660 pmol/l wherea mlif bind nih3t3 cell result indic unlik hosm mosm mlif share function receptor mosm deliv signal specif receptor complex studi mice defin physiolog role osm',\n",
       "  'vivo real-tim epifluoresc imag mous hind limb vasculatur second near-infrar region nir-ii perform use single-wal carbon nanotub fluorophor high spatial ∼30 μm tempor 200 ms per frame resolut small-vessel imag achiev 1–3 mm deep hind limb owe benefici nir-ii optic window afford deep anatom penetr low scatter spatial resolut unattain tradit nir imag nir-i microscop comput tomographi tempor resolut far exce scan microscop imag techniqu arteri venou vessel unambigu differenti use dynam contrast-enhanc nir-ii imag techniqu basi distinct hemodynam deep tissu penetr high spatial tempor resolut nir-ii imag allow precis quantif blood veloc normal ischem femor arteri beyond capabl ultrasonographi lower blood veloc',\n",
       "  'unlabel object studi examin differ cancer surviv socioeconom group england particular attent surviv short term follow-up patient method individu diagnos colorect cancer 1996 2004 england identifi cancer registri record five-year cumul rel surviv excess death rate comput result colon cancer high excess death rate first month follow-up excess death rate highest socioeconom depriv group subsequ period excess mortal rate much lower less socioeconom variat pattern variat excess death rate gener similar rectal cancer socioeconom differ death rate persist sever year longer excess death rate entir colorect cancer patient popul observ affluent socioeconom quintil annual reduct would 360 death colon cancer 336 death rectal cancer patient death occur almost entir first month first year diagnosi conclus recent develop nation cancer control agenda includ increas emphasi outcom measur short-term cancer surviv oper measur variat progress cancer control provid clue natur surviv differ socioeconom group result present give strong support strategi',\n",
       "  'cell-to-cel adhes crucial maintain structur function integr cardiac cell littl known mechanosensit mechanotransduct cell-to-cel interact studi cardiac mechanotransduct myofibrillogenesi focus cell-extracellular matrix ecm -specif interact studi assess direct role intercellular adhes specif n-cadherin-medi mechanotransduct morpholog intern organ neonat ventricular cardiac myocyt result show cadherin-medi cell attach capabl elicit cytoskelet network respons similar integrin-medi forc respons transmiss affect myofibrillar organ myocyt shape cortic stiff traction forc mediat n-cadherin shown compar sustain ecm direct chang predict traction forc function impos load gel stiff provid ad evid n-cadherin mechanorespons adhes receptor strikingli mechan sensit respons gain term measur cell-spread area function impos load adhes substrat rigid consist higher n-cadherin-co surfac compar ecm protein-co surfac addit cytoskelet architectur myocyt n-cadherin adhes microenviron characterist differ ecm environ suggest two mechanotransduct cell adhes system may play independ complementari role myocyt cytoskelet spatial organ result indic cell-to-cell-medi forc percept transmiss involv organ develop cardiac structur function',\n",
       "  'aberr overexpress long non-cod rna neat1 nuclear paraspeckl assembl transcript 1 document differ type solid tumour lung cancer oesophag cancer colorect cancer hepatocellular carcinoma high level associ poor prognosi contrast neat1 downregul acut promyelocyt leukaemia promot leucocyt differenti review provid overview current evid concern oncogen role potenti clinic util neat1 investig warrant elucid upstream downstream mechan neat1 overexpress',\n",
       "  'popular genome-wid analys rna sequenc led discoveri larg part human genom effect transcrib encod protein long non-cod rna emerg critic regul gene express normal diseas state studi long non-cod rna express heart combin gene associ studi reveal molecul regul cardiovascular develop diseas long non-cod rna function implic cardiac pathophysiolog constitut potenti therapeut target review current knowledg function long non-cod rna cardiovascular system emphasi cardiovascular develop biolog focus hypertens coronari arteri diseas myocardi infarct ischemia heart failur discuss potenti therapeut implic challeng long non-cod rna research direct futur research translat focu',\n",
       "  \"oct4 well-known transcript factor play fundament role stem cell self-renew pluripot somat cell reprogram howev limit inform avail oct4-associ protein complex intrins protein-protein interact dictat oct4 's critic regulatori activ employ improv affin purif approach combin mass spectrometri purifi oct4 protein complex mous embryon stem cell mesc discov mani novel oct4 partner import self-renew pluripot mesc notabl found oct4 associ multipl chromatin-modifi complex document well newli prove function signific stem cell mainten somat cell reprogram studi establish solid biochem basi genet epigenet regul stem cell pluripot provid framework explor altern factor-bas reprogram strategi\",\n",
       "  'tet famili enzym tet1/2/3 convert 5-methylcytosin 5mc 5-hydroxymethylcytosin 5hmc mous embryon stem cell mesc highli express tet1 elev level 5hmc tet1 implic esc mainten lineag specif vitro precis function develop well defin establish role tet1 pluripot develop gener tet1 mutant mesc mice tet1 -/- esc reduc level 5hmc subtl chang global gene express pluripot support develop live-born mice tetraploid complement assay display skew differenti toward trophectoderm vitro tet1 mutant mice viabl fertil grossli normal though mutant mice slightli smaller bodi size birth data suggest tet1 loss lead partial reduct 5hmc level affect pluripot esc compat embryon postnat develop',\n",
       "  'background ldl cholesterol causal role develop cardiovascular diseas improv understand biolog mechan underli metabol regul ldl cholesterol might help identifi novel therapeut target therefor genome-wid associ studi ldl-cholesterol concentr method use genome-wid associ data 11,685 particip measur circul ldl-cholesterol concentr across five studi includ data 293 461 autosom singl nucleotid polymorph snp minor allel frequenc 5 pass qualiti control criteria also use data second genome-wid array 4337 particip three five studi data 290,140 snp replic studi two independ popul consist 4979 particip statist approach includ meta-analysi linkag disequilibrium plot use refin associ signal analys pool data seven popul determin effect snp variat circul ldl-cholesterol concentr find initi scan found two snp rs599839 p=1.7x10 -15 rs4970834 p=3.0x10 -11 show genome-wid statist associ ldl cholesterol chromosom locu 1p13.3 second genom screen found third statist associ snp locu rs646776 p=4.3x10 -9 meta-analysi data studi show associ snp rs599839 combin p=1.2x10 -33 rs646776 p=4.8x10 -20 ldl-cholesterol concentr snp rs599839 rs646776 explain around 1 variat circul ldl-cholesterol concentr associ 15 sd chang ldl cholesterol per allel assum sd 1 mmol/l interpret found evid novel locu ldl cholesterol chromosom 1p13.3 result potenti provid insight biolog mechan underli regul ldl cholesterol might help discoveri novel therapeut target cardiovascular diseas',\n",
       "  'background aed aegypti major vector dengu virus often breed water storag contain use household without tap water suppli occur high number even dens urban area analys interact human popul densiti lack tap water caus dengu fever outbreak aim identifi geograph area highest risk method find conduct individual-level cohort studi popul 75,000 geo-referenc household vietnam cours two epidem basi dengu hospit admiss n 3,013 appli space-tim scan statist mathemat model confirm find identifi surprisingli narrow rang critic human popul densiti around 3,000 7,000 people/km² prone dengu outbreak studi area popul densiti typic villag peri-urban area scan statist show area high popul densiti adequ water suppli experi sever outbreak risk dengu higher rural urban area larg explain lack pipe water suppli human popul densiti often fall within critic rang mathemat model suggest simpl assumpt regard area-level vector/host ratio may explain occurr outbreak conclus rural area may contribut least much dissemin dengu fever citi improv water suppli vector control area human popul densiti critic dengu transmiss could increas effici control effort pleas see later articl editor summari',\n",
       "  'helicobact pylori induc motogen cytoskelet respons gastric epitheli cell demonstr respons induc via independ signal pathway often occur parallel cag pathogen island appear nonessenti induct motil wherea elong phenotyp depend transloc phosphoryl caga',\n",
       "  'summari sequenc alignment/map sam format gener align format store read align refer sequenc support short long read 128 mbp produc differ sequenc platform flexibl style compact size effici random access format align 1000 genom project releas samtool implement variou util post-process align sam format index variant caller align viewer thu provid univers tool process read align avail http //samtools.sourceforge.net',\n",
       "  'polymer actin filament direct actin-rel protein arp 2/3 complex support mani type cellular movement howev question remain regard rel contribut arp2/3 complex versu mechan actin filament nucleat process path find neuron growth cone lack simpl method inhibit arp2/3 complex revers live cell describ two class small molecul bind differ site arp2/3 complex inhibit abil nucleat actin filament ck-0944636 bind arp2 arp3 appear block movement arp2 arp3 activ conform ck-0993548 insert hydrophob core arp3 alter conform class compound inhibit format actin filament comet tail listeria podosom monocyt two inhibitor differ mechan action provid power approach studi arp2/3 complex live cell',\n",
       "  'recent technolog improv elast substrat method make possibl produc spatial resolv measur traction exert singl motil cell studi appli develop produc map traction exert 3t3 fibroblast steadi locomot result imag spatial resolut approxim 5 micromet maximum intens approxim 10 2 kdyn/cm2 10 4 pn/micrometers2 find propuls thrust fibroblast locomot approxim 0.2 dyn impart substratum within 15 micromet lead edg observ demonstr lamellipodium fibroblast abl gener intens traction stress cell bodi posterior seem mechan passiv structur pull forward entir action',\n",
       "  'earli local tumor invas breast cancer result like encount cancer cell matur adipocyt role fat cell tumor progress remain unclear show murin human tumor cell cocultiv matur adipocyt exhibit increas invas capac vitro vivo use origin two-dimension cocultur system likewis adipocyt cultiv cancer cell also exhibit alter phenotyp term delipid decreas adipocyt marker associ occurr activ state character overexpress proteas includ matrix metalloproteinase-11 proinflammatori cytokin interleukin il -6 il-1β case il-6 show play key role acquir proinvas effect tumor cell equal import confirm presenc modifi adipocyt human breast tumor immunohistochemistri quantit pcr interestingli tumor larger size and/or lymph node involv exhibit higher level il-6 tumor surround adipocyt collect data provid vitro vivo evid invas cancer cell dramat impact surround adipocyt ii peritumor adipocyt exhibit modifi phenotyp specif biolog featur suffici name cancer-associ adipocyt caa iii caa modifi cancer cell characteristics/phenotyp lead aggress behavior result strongli support innov concept adipocyt particip highli complex viciou cycl orchestr cancer cell promot tumor progress might amplifi obes patient',\n",
       "  'aim cardiovascular diseas cvd preval debilit diseas affect chines popul goal present manuscript analys cardiovascular risk factor preval non-fat cvd data gather 2007-2008 china nation diabet metabol disord studi method result nation repres sampl 46 239 adult 20 year age older randomli recruit use multistag stratifi design method lifestyl factor diagnosi cvd stroke diabet famili histori subject collect oral glucos toler test standard meal test perform variou non-fat cvd report subject sudaan softwar use perform weight statist analys p 0.05 consid statist signific preval coronari heart diseas stroke cvd 0.74 1.07 1.78 male 0.51 0.60 1.10 femal respect presenc cvd increas age male femal preval overweight obes hypertens dyslipidaemia hyperglycaemia 36.67 30.09 67.43 26.69 male 29.77 24.79 63.98 23.62 femal respect total sampl 46 239 patient preval one subject 1 2 3 ≥4 5 defin risk factor i.e smoke overweight obes hypertens dyslipidaemia hyperglycaemia 31.17 27.38 17.76 10.19 respect follow adjust gender age odd ratio cvd 1 2 3 ≥4 risk factor 2.36 4.24 4.88 7.22 respect compar patient risk factor conclus morbid attribut five defin cardiovascular risk factor high chines popul multipl risk factor present individu therefor reason prevent strategi design attenu rapid rise cardiovascular morbid',\n",
       "  'diabet group chronic diseas character hyperglycemia modern medic care use vast array lifestyl pharmaceut intervent aim prevent control hyperglycemia addit ensur adequ deliveri glucos tissu bodi treatment diabet attempt decreas likelihood tissu bodi harm hyperglycemia import protect bodi hyperglycemia overst direct indirect effect human vascular tree major sourc morbid mortal type 1 type 2 diabet gener injuri effect hyperglycemia separ macrovascular complic coronari arteri diseas peripher arteri diseas stroke microvascular complic diabet nephropathi neuropathi retinopathi import physician understand relationship diabet vascular diseas preval diabet continu increas unit state clinic armamentarium primari secondari prevent complic also expand diabet retinopathi diabet retinopathi may common microvascular complic diabet respons ∼ 10,000 new case blind everi year unit state alone.1 risk develop diabet retinopathi microvascular complic diabet depend durat sever hyperglycemia develop diabet retinopathi patient type 2 diabet found relat sever hyperglycemia presenc hypertens u.k. prospect diabet studi ukpd patient type 1 diabet develop evid retinopathi within 20 year diagnosis.2,3 retinopathi may begin develop earli 7 year diagnosi diabet patient type 2 diabetes.1 sever propos patholog mechan diabet may lead …',\n",
       "  \"background role diffus messeng nitric oxid regul pain transmiss still debat matter pro-nocicept and/or anti-nocicept s-nitrosyl revers post-transl modif select cystein residu protein emerg import mechan act signal molecul occurr s-nitrosyl spinal cord target may modul pain transmiss remain unclarifi `` biotin-switch '' method matrix-assist laser desorption/ion time-of-flight mass spectrometri employ identifi s-nitrosyl protein result show actin major protein s-nitrosyl spinal cord donor s-nitroso-n-acetyl-dl-penicillamin snap interestingli actin s-nitrosyl s2 fraction p2 fraction spinal homogen treatment pc12 cell snap caus rapid s-nitrosyl actin inhibit dopamin releas cell like cytochalasin b depolymer actin snap decreas amount filament actin cytoskeleton beneath membran inhibit dopamin releas attenu inhibitor solubl guanylyl cyclas cgmp-depend protein kinas conclus present studi demonstr actin major s-nitrosyl protein spinal cord suggest directli regul neurotransmitt releas s-nitrosyl addit well-known phosphoryl cgmp-depend protein kinas\",\n",
       "  'background lobular involut age-rel atrophi breast lobul invers associ breast cancer risk mammograph breast densiti mbd posit associ breast cancer risk method evalu whether lobular involut mbd independ associ breast cancer risk women benign breast diseas perform nest cohort studi among women n 2666 benign breast diseas diagnos mayo clinic januari 1 1985 decemb 31 1991 mammogram avail within 6 month diagnosi women follow averag 13.3 year document breast cancer incid lobular involut categor none partial complet parenchym pattern classifi use wolf classif n1 nondens p1 p2 ductal promin occupi 25 25 breast respect dy extrem dens hazard ratio hr 95 confid interv ci assess associ lobular involut mbd breast cancer risk estim use adjust cox proport hazard model test statist signific two-sid result adjust mbd partial lobular involut associ higher risk breast cancer complet involut none hr breast cancer incid 2.62 95 ci 1.39 4.94 partial hr breast cancer incid 1.61 95 ci 1.03 2.53 p trend .002 similarli adjust involut dens breast associ higher risk breast cancer nondens breast dy hr breast cancer incid 1.67 95 ci 1.03 2.73 p2 hr breast cancer incid 1.96 95 ci 1.20 3.21 p1 hr breast cancer incid 1.23 95 ci 0.67 2.26 p trend .02 combin involut dens breast associ higher risk breast cancer complet involut nondens breast hr breast cancer incid 4.08 95 ci 1.72 9.68 p .006 conclus lobular involut mbd independ associ breast cancer incid combin associ even greater risk breast cancer',\n",
       "  'gene affect mani trait phenomenon known pleiotropi major constraint evolut adapt chang one trait may prevent would compromis trait affect gene show pleiotropi unexpect effect benefit one enigmat adaptations—cooper spectacular act cooper occur social amoeba dictyostelium discoideum cell die form stalk hold cell aloft reproduct spore identifi gene dima d. discoideum two contrast effect requir receiv signal molecul dif-1 caus differenti prestalk cell ignor dif-1 becom prestalk allow cell cheat avoid stalk howev find aggreg contain wild-typ cell lack dima gene result exclus spore pleiotrop linkag stalk spore format limit potenti cheat d. discoideum defect prestalk cell product result even greater reduct spore propos evolut pleiotrop link cheat person cost stabil cooper adapt',\n",
       "  \"goosecoid gsc homeobox gene express specif dorsal blastopor lip xenopu gastrula consid play import role spemann 's organ phenomenon lineag trace time-laps microscopi use follow fate embryon cell microinject gsc mrna microinject gsc non-cel autonom effect recruit neighbor uninject cell twin dorsal axi ectop express gsc mrna ventral blastomer well overexpress gsc dorsal blastomer lead cell movement toward anterior embryo result suggest function gsc control gastrul movement group cell dissoci cell demonstr vertebr homeobox gene regul region-specif cell migrat\",\n",
       "  'transcript factor tf bind specif discret region mammalian genom call cis-regulatori element among enhanc play key role regul gene express develop differenti despit recogn central regulatori role exert chromatin control tf function much remain learn regard chromatin structur enhanc establish analyz genomic-scal enhanc recruit foxa1 pioneer transcript factor trigger transcript compet cis-regulatori site importantli found foxa1 bind genom region show local dna hypomethyl cell-type-specif recruit chromatin link differenti dna methyl level bind site use neural differenti model show induct foxa1 express subsequ recruit enhanc associ dna demethyl concomitantli histon h3 lysin 4 methyl induc enhanc epigenet chang may stabil foxa1 bind allow subsequ recruit transcript regulatori effector interestingli clone report construct foxa1-depend enhanc abl recapitul cell type specif howev activ inhibit dna methyl henc enhanc intrins cell-type-specif regulatori region activ potenti foxa1 induct epigenet switch includ notabl dna demethyl',\n",
       "  'investig whether administ leptin influenc anxiety-lik behavior ob/ob mice repeat intraperiton administr leptin continu 5 day anxieti assess standard elev plu maze bodi weight measur daili repeat administr leptin significantli increas percentag total number entri open arm number total entri bodi weight significantli reduc 13.2 treatment leptin treatment amelior obes also anxieti ob/ob mice result indic treatment obes may lead solut psycholog problem',\n",
       "  'although drug intend select least bind sever physiolog target explain side effect efficaci mani drug-target combin exist would use explor possibl interact comput compar 3,665 us food drug administr fda -approv investig drug hundr target defin target ligand chemic similar drug ligand set predict thousand unanticip associ thirti test experiment includ antagon beta 1 receptor transport inhibitor prozac inhibit 5-hydroxytryptamin 5-ht transport ion channel drug vadilex antagon histamin h 4 receptor enzym inhibitor rescriptor overal 23 new drug-target associ confirm five potent 100 nm physiolog relev one drug n n-dimethyltryptamin dmt serotonerg receptor confirm knockout mous chemic similar approach systemat comprehens may suggest side-effect new indic mani drug',\n",
       "  'vascular calcif vc repres recogn advers predictor cardiovascular morbid mortal previous consid passiv degen vc recogn activ process resembl bone format share number histopatholog featur miner composit initi mechan bone develop metabol oxid stress inflamm key factor vc osteoporosi op biochem factor known primarili involv healthi bone metabol also regul vc biomark includ vitamin osteoprotegerin osteopontin matrix gla protein cathepsin k fibroblast growth factor-23 fetuin-a better understand highli control regulatori network multipl nest feedback loop cross talk organ may help decreas grow preval calcif vasculopathi well op age popul advanc common prevent therapeut intervent target condit',\n",
       "  'chemokin orchestr immun cell traffick elicit either direct random migrat activ integrin order induc cell adhes analyz dendrit cell dc migrat show distinct cellular respons depend mode chemokin present within tissu surface-immobil form chemokin ccl21 heparan sulfate-anchor ligand cc-chemokin receptor 7 ccr7 caus random movement dc confin chemokine-pres surfac trigger integrin-medi adhes upon direct contact ccl21 dc truncat anchor residu ccl21 therebi releas solid phase solubl ccl21 function resembl second ccr7 ligand ccl19 lack anchor residu form solubl gradient solubl ccr7 ligand trigger chemotact movement surfac adhes adhes random migrat direct steer cooper produc dynam spatial restrict locomot pattern close resembl cellular dynam observ secondari lymphoid organ',\n",
       "  'inflammatori respons drive atherogenesi macrophag accumul progress expand arteri wall observ circul monocyt give rise lesion macrophag reinforc concept monocyt infiltr dictat macrophag buildup recent work indic howev macrophag accumul depend monocyt recruit inflammatori context therefor revisit mechan underli macrophag accumul atherosclerosi murin atherosclerot lesion found macrophag turn rapidli 4 week replenish macrophag experiment atheromata depend predominantli local macrophag prolifer rather monocyt influx microenviron orchestr macrophag prolifer involv scaveng receptor sr-a studi reveal macrophag prolifer key event atherosclerosi identifi macrophag self-renew therapeut target cardiovascular diseas',\n",
       "  'format beta-amyloid brain individu alzheim diseas requir proteolyt cleavag membrane-associ precursor protein proteas may involv process yet identifi cathepsin normal intracellular proteolyt enzym associ lysosom howev section alzheim brain stain antisera cathepsin cathepsin b high level immunoreact also detect senil plaqu extracellular site cathepsin immunoreact seen control brain age-match individu without neurolog diseas patient huntington diseas parkinson diseas situ enzym histochemistri cathepsin cathepsin b section neocortex use synthet peptid protein substrat show senil plaqu contain highest level enzymat activ cathepsin ultrastructur level cathepsin immunoreact senil plaqu local princip lysosom dens bodi lipofuscin granul extracellular similar structur abund degener neuron alzheim neocortex cathepsin-laden neuron perikarya variou stage disintegr could seen within senil plaqu high level enzymat compet lysosom proteas abnorm local senil plaqu repres evid candid enzym may mediat proteolyt format amyloid propos amyloid precursor protein within senil plaqu process lysosom proteas princip deriv degener neuron escap cathepsin stringent regul intracellular milieu provid basi abnorm sequenc proteolyt cleavag accumul amyloid precursor protein',\n",
       "  'microrna mirna play crucial role occurr develop gastric cancer convent serolog test screen gastric cancer limit sensit specif sever mirna peripher blood use biomark gastric cancer howev mirna share sever type cancer thank tissu specif gastric juic examin feasibl use gastric juic mir-129-1/2 aberrantli express gastric cancer screen gastric cancer total 141 gastric juic sampl gastric cancer gastric ulcer atroph gastriti minim gastriti patient subject normal mucosa collect gastroscopi gastric juic mir-129-1/2 level detect quantit revers transcription-polymeras chain reaction receiv oper characterist roc curv construct differenti patient gastric cancer patient benign gastric diseas show compar patient benign gastric diseas patient gastric cancer significantli lower level gastric juic mir-129-1-3p mir-129-2-3p area roc curv auc 0.639 0.651 mir-129-1-3p mir-129-2-3p respect use parallel combin test auc 0.656. summari result suggest gastric juic mir-129-1-3p mir-129-2-3p potenti biomark screen gastric cancer detect gastric juic mirna conveni non-invas method diagnosi gastric cancer',\n",
       "  'β-lactamas evolut present infecti diseas commun major challeng treatment infect caus multidrug-resist gram-neg bacteria 1,000 natur occur β-lactamas exist attempt correl structur function becom daunt although new enzym extended-spectrum β-lactamas esbl famili frequent identifi older ctx-m-14 ctx-m-15 enzym becom preval esbl global surveil carbapenemas either serine-bas zinc-facilit hydrolysi mechan pose critic problem geograph region report kpc serin carbapenemas metallo-β-lactamas vim imp ndm-1 even though ndm-1 recent identifi rapid emerg newer enzym multipl β-lactamas appear singl organ make design new β-lactamas inactiv β-lactamase-st β-lactam difficult combin therapi like requir counteract continu evolut insidi enzym multidrug-resist pathogen',\n",
       "  'circadian cycl cell cycl two fundament period process period rang 1 day consequ coupl cycl lead synchron estim mutual interact two oscil time-laps imag singl mammalian nih3t3 fibroblast sever day analysi thousand circadian cycl divid cell clearli indic oscil tick 1:1 mode-lock state cell divis occur tightli 5 h peak circadian rev-erbα-yfp report express principl synchroni may caus either unidirect bidirect coupl gate cell divis circadian cycl studi data combin stochast model unambigu show revers coupl predomin nih3t3 cell moreov temperatur genet pharmacolog perturb show two interact cellular oscil adopt synchron state highli robust wide rang paramet find implic circadian function prolif tissu includ epidermi immun cell cancer',\n",
       "  'hunger driven neg energi balanc elicit search consumpt food respons part mediat neuron hypothalamu role specif cell type brain region less well defin show neuron dorsal raph nucleu express vesicular transport gaba glutam hereaft drnvgat drnvglut3 neuron reciproc activ chang energi balanc modul activ opposit effect feeding-drnvgat neuron increas wherea drnvglut3 neuron suppress food intak furthermor modul neuron obes ob/ob mice suppress food intak bodi weight normal locomotor activ final use molecular profil identifi druggabl target neuron show local infus agonist specif receptor neuron potent effect feed data establish drn import node control energi balanc paperclip',\n",
       "  'neutrophil extracellular trap net releas neutrophil die vitro process requir hour leav tempor gap invas microb may exploit neutrophil capabl migrat phagocytosi undergo netosi document gram-posit skin infect directli visual live polymorphonuclear cell pmn vivo rapidli releas net prevent system bacteri dissemin netosi occur crawl therebi cast larg area net net-releas pmn develop diffus decondens nuclei ultim becom devoid dna cell abnorm nuclei show unusu crawl behavior highlight errat pseudopod hyperpolar consist nucleu fulcrum crawl requir toll-lik receptor 2 complement-medi opson tightli regul net releas addit live human pmn inject mous skin develop decondens nuclei form net vivo intact anuclear neutrophil abund gram-posit human abscess therefor earli infect netosi involv neutrophil undergo lysi retain abil multitask',\n",
       "  'present studi design determin effect physic train develop cancer induc inject ehrlich tumor cell mice male swiss mice subject swim train protocol 5 days/wk 6 wk 1 h 50 maxim capacity-train group remain sedentari cage sedentari group inocul ehrlich tumor cell perform end fourth week anim kill 6 wk train heart solid tumor weight record tumor volum calcul portion tumor use evalu macrophag neutrophil accumul fix neutral 10 buffer formalin histolog analysi tumor volum weight respect approxim 270 280 greater sedentari mice train mice macrophag infiltr tumor tissu significantli lower train mice 0.65 +/- 0.16 vs. 1.78 +/- 0.43 macrophag x 10 3 sedentari group moreov neutrophil accumul tumor slightli reduc exercis train amount tumor cell reduc train mice exercis capac substanti increas train mice determin 440 increas exercis time 50 maxim capac summari swim train retard develop ehrlich tumor mice accompani reduct macrophag infiltr neutrophil accumul find provid conceptu support clinic observ control physic activ may therapeut import approach prevent cancer progress may improv outcom cancer treatment',\n",
       "  'cell traffick lung critic lung immun mechan mediat cell lung home well understood show lung dendrit cell dc imprint cell lung home lung dc-activ cell traffic effici lung respons inhal antigen homeostasi compar cell activ dc tissu consequ lung dc-imprint cell protect influenza effect gut skin dc-imprint cell lung dc imprint express ccr4 cell ccr4 contribut cell lung imprint lung dc-activ ccr4-defici cell fail traffic lung effici protect influenza effect lung dc-activ ccr4-suffici cell thu lung dc imprint cell lung home promot lung immun part ccr4',\n",
       "  'emerg data suggest microrna mirna instrument varieti stress respons addit recogn role develop surprisingli mirna normal suppress express target transcript may becom activ express stress might partial explain new interact mirna/argonaut complex rna-bind protein reloc differ subcellular compart stress',\n",
       "  'rational matrix vesicl mv secret vascular smooth muscl cell vsmc form first nidu miner fetuin-a potent circul inhibitor calcif specif load mv howev process fetuin-a intracellular traffick mv biogenesi poorli understood object object studi investig regul role mv biogenesi vsmc calcif method result alexa488-label fetuin-a intern human vsmc traffick via endosom system exocytos multivesicular bodi via exosom releas vsmc-deriv exosom enrich tetraspanin cd9 cd63 cd81 releas regul sphingomyelin phosphodiesteras 3. compar proteom show vsmc-deriv exosom composit similar exosom cell sourc also share compon osteoblast-deriv mv includ calcium-bind extracellular matrix protein elev extracellular calcium found induc sphingomyelin phosphodiesteras 3 express secret calcifi exosom vsmc vitro chemic inhibit sphingomyelin phosphodiesteras 3 prevent vsmc calcif vivo multivesicular bodi contain exosom observ vessel chronic kidney diseas patient dialysi cd63 found coloc calcif importantli factor tumor necrosi factor-α platelet deriv growth factor-bb also found increas exosom product lead increas calcif vsmc respons calcifi condit conclus studi identifi mv exosom show factor increas exosom releas promot vascular calcif respons environment calcium stress modul exosom releas pathway may novel therapeut target prevent',\n",
       "  \"licenc vaccin human parasit diseas plasmodium falciparum malaria major caus infecti mortal present great challeng vaccin develop led assess wide varieti approach malaria vaccin design develop assist avail safe challeng model small-scal efficaci test vaccin candid malaria vaccin develop forefront assess mani new vaccin technolog includ novel adjuv vector prime-boost regim concept commun vaccin block malaria transmiss current vaccin candid target singl stage parasit 's life cycl vaccin earli pre-erythrocyt stage shown success protein adjuv vaccin work antibodi sporozoit viral vector vaccin target intracellular liver-stag parasit cellular immun show partial efficaci human anti-sporozoit vaccin current phase iii trial howev effect malaria vaccin suitabl widespread cost-effect deploy like requir multi-compon vaccin target one life cycl stage attract near-term approach develop product combin exist partial effect pre-erythrocyt vaccin candid\",\n",
       "  'lymphangioleiomyomatosi lam multisystem diseas women manifest prolifer smooth muscle-lik cell lung result cystic lung destruct women lam also develop renal angiomyolipoma lam caus mutat tuber sclerosi complex gene tsc1 tsc2 result hyperact mammalian target rapamycin mtor signal mtor inhibitor rapamycin stabil lung function lam decreas volum renal angiomyolipoma lung function declin angiomyolipoma regrow treatment discontinu suggest factor induc mtorc1 inhibit may promot surviv tsc2-defici cell whether microrna mirna mir signal involv respons lam mtorc1 inhibit unknown identifi rapamycin-depend mirna lam patient angiomyolipoma-deriv cell use two separ screen first assay 132 mirna known signific tumor biolog use cut-off 1.5-fold chang 48 microrna rapamycin-induc 4 mir downregul second screen encompass 946 mirna 18 mir upregul rapamycin eight downregul dysregul mir 29b 21 24 221 106a 199a common platform classifi candid `` rapamirs. `` valid qrt-pcr confirm microrna increas mir-21 pro-surviv mir significantli increas mtor-inhibit p 0.01 regul mir-21 rapamycin cell type independ mtor inhibit promot process mir-21 transcript pri-mir-21 prematur form pre-mir-21 conclus find demonstr rapamycin upregul multipl mir includ pro-surviv mir tsc2-defici patient-deriv cell induct mir may contribut respons lam tsc patient rapamycin therapi',\n",
       "  'activ mutat egf receptor egfr associ clinic respons egfr tyrosin kinas inhibitor tki erlotinib gefitinib howev resist eventu aris often due second egfr mutat commonli t790m genome-wid sirna screen human lung cancer cell line analys murin mutant egfr-driven lung adenocarcinoma found erlotinib resist associ reduc express neurofibromin ra gtpase-activ protein encod nf1 gene erlotinib fail fulli inhibit ras-erk signal neurofibromin level reduc treatment neurofibromin-defici lung cancer map-erk kinas mek inhibitor restor sensit erlotinib low level nf1 express associ primari acquir resist lung adenocarcinoma egfr tki patient find identifi subgroup patient egfr-mut lung adenocarcinoma might benefit combin therapi egfr mek inhibitor',\n",
       "  'immunity-rel p47 guanosin triphosphatas irg play role defens intracellular pathogen found murin irgm1 lrg-47 guanosin triphosphatas induc autophagi gener larg autolysosom organel mechan elimin intracellular mycobacterium tuberculosi also identifi function human irg protein control intracellular pathogen report human irgm1 ortholog irgm play role autophagi reduct intracellular bacillari load',\n",
       "  'aim studi provid clinic pharmaci educ program masih daneshvari hospit univers affili hospit locat tehran iran purpos common pharmacist involv intervent aspect potenti field pharmaci student resid educ firstli identifi clinic pharmaci intervent drug inform form fill studi period januari 2006 till januari 2007. base result studi total number 772 intervent conduct studi year drug inform highest rate 22.30 among intervent follow dose adjust therapeut reduct addit mean number medic per patient 8.62 ± 7.54. conclus could said although countri challeng pharmaci profess initi stage compar develop countri result studi reveal high demand servic among health care provid',\n",
       "  'basi collect experi review disposit cardiac conduct tissu might observ surgeon normal abnorm heart sinu node lie subepicardi termin sulcu variabl blood suppli entir superior cavoatri junction potenti danger area morpholog discret tract extend atrial tissu sinu atrioventricular node atrioventricular node atrial extent atrioventricular conduct axi contain exclus within triangl koch axi penetr central fibrou bodi branch muscular ventricular septum immedi beneath interventricular compon membran septum landmark structur describ might seen right atrium left atrium aorta consider given surgic anatomi abnorm muscular atrioventricular connect underscor ventricular pre-excit syndrom final rule develop wherebi disposit conduct tissu predict accuraci congenit malform heart set normal abnorm chamber connect import variabl respect align atrial ventricular septal structur pattern ventricular architectur present',\n",
       "  'myfood24 onlin 24-h dietari assess tool develop use among british adolesc adult limit inform avail regard valid use new technolog assess nutrit intak among adolesc thu rel valid myfood24 face-to-fac interviewer-administ 24-h multiple-pass recal mpr conduct among seventy-f british adolesc age 11-18 year particip ask complet myfood24 interviewer-administ mpr day 2 non-consecut day school total energi intak ei nutrient record two method compar use intraclass correl coeffici icc bland-altman plot use within-individu inform weight κ assess agreement energi macronutri report nutrient myfood24 demonstr strong agreement interview mpr data icc rang 0·46 na 0·88 ei signific bia two method ei macronutri report nutrient mean differ myfood24 interviewer-administ mpr ei -230 kj -55 kcal 95 ci -490 30 kj -117 7 kcal p=0·4 limit agreement rang 39 3336 kj -797 kcal lower 34 2874 kj 687 kcal higher interviewer-administ mpr good agreement term classifi adolesc tertil ei κ w =0·64 agreement day 1 day 2 good myfood24 interviewer-administ mpr reflect reliabl myfood24 myfood24 potenti collect dietari data compar qualiti interviewer-administ mpr',\n",
       "  'biochem modul play import role develop cancer chemotherapi direct attent intak common beverag investig effect green tea tea compon antitumor activ doxorubicin carri combin treatment toxorubicin green tea ehrlich ascit carcinoma tumor-bear mice oral administr green tea enhanc 2.5-fold inhibitori effect doxorubicin tumor growth doxorubicin concentr tumor increas combin green tea doxorubicin contrast increas doxorubicin concentr observ normal tissu green tea combin furthermor enhanc antitumor activ doxorubicin induc green tea observ m5076 ovarian sarcoma low sensit doxorubicin result suggest drink green tea encourag cancer chemotherapi may improv qualiti life clinic patient',\n",
       "  'aim vascular endotheli dysfunct inflamm hallmark atherosclerosi krüppel-lik factor 2 klf2 key mediat anti-inflammatori anti-atherosclerot properti endothelium howev littl known molecular mechan regul klf2 transcript activ method result found histon deacetylas 5 hdac5 associ klf2 repress klf2 transcript activ hdac5 resid klf2 nuclei human umbil cord vein endotheli cell huvec steadi laminar flow attenu associ hdac5 klf2 via stimul hdac5 phosphorylation-depend nuclear export huvec also map klf2-hdac5-interact domain found n-termin region hdac5 interact c-termin domain klf2 chromatin immunoprecipit luciferas report assay show hdac5 direct associ klf2 suppress klf2 transcript activ hdac5 overexpress inhibit klf2-depend endotheli nitric oxid synthesi eno promot activ cos7 cell gene express huvec bovin aortic endotheli cell baec convers hdac5 silenc enhanc klf2 transcript henc eno express huvec moreov observ level eno protein thorac aorta isol hdac5 knockout mice higher wherea express pro-inflammatori vascular cell adhes molecul 1 lower compar hdac5 wild-typ mice conclus reveal novel role hdac5 modul klf2 transcript activ eno express find suggest hdac5 bind partner modul klf2 could new therapeut target prevent vascular endotheli dysfunct associ cardiovascular diseas',\n",
       "  'drug resistance-associ mutat hiv-1 revers transcriptas rt affect balanc polymeras ribonucleas h rnase h activ enzym recent demonstr n348i mutat connect domain caus select dissoci rnase h-compet complex wherea function integr polymerase-compet complex remain larg unaffect n348i associ resist non-nucleosid rt inhibitor nnrti nevirapin howev possibl mechan link chang rnase h activ chang nnrti suscept remain establish address problem consid recent find suggest nnrti may affect orient rt nucleic acid substrat increas rnase h activ demonstr rnase h-mediat primer remov inde effici presenc nnrti howev n348i mutant enzym abl counteract effect efavirenz tight bind inhibitor restrict influenc mutat find provid strong evid suggest n348i thwart inhibitori effect nevirapin initi -strand dna synthesi provid novel mechan resist data agreement clinic data demonstr stronger effect n348i suscept nevirapin compar efavirenz',\n",
       "  'introduct grow number adult cancer survivor increas need inform link potenti late long term effect specif treatment regimen adult cancer patient treat clinic trial howev patient previous enrol trial import sourc inform treatment-rel late effect method focus colorect cancer survivor use databas five phase iii random clinic trial nation surgic adjuv breast bowel project nsabp recruit enrol long term survivor studi late health outcom qualiti life describ challeng recruit patient 5 -20 year treatment result sixty-f nsabp treatment site invit enrol patient studi sixti particip potenti recruit 2,408 patient receiv registr form 976 patient 41 744 76 express interest particip 708 complet interview 95 express interest 29 total potenti sampl multipl barrier recruit difficulti locat patient lack institut commit lack patient interest conclus patient treat clinic trial import potenti sourc examin late effect cancer treatment retrospect recruit substanti limit futur mechan establish prospect long-term follow-up identifi understand frequenc type late effect associ cancer treatment implic cancer survivor cancer patient live longer import learn particip clinic trial whether specif treatment regimen associ seriou late effect',\n",
       "  'bacteri chondroitinas abc chaseabc use remov inhibitori chondroitin sulfat chain chondroitin sulfat proteoglycan improv regener rodent spinal cord injuri hypothes mammalian enzym arylsulfatas b arsb would also enhanc recoveri mous spinal cord injuri applic mammalian enzym would attract altern chaseabc robust chemic stabil reduc immunogen one-tim inject human arsb injur mous spinal cord elimin immunoreact chondroitin sulfat within five day 9 week injuri moder spinal cord injuri observ improv locomotor recoveri assess basso mous scale bm arsb treat mice compar buffer-tr control group 6 week inject sever spinal cord injuri mice inject equival unit arsb chaseabc improv similarli group achiev significantli locomotor recoveri buffer-tr control mice serotonin tyrosin hydroxylas immunoreact axon extens present mous spinal cord treat arsb chaseabc immunoreact axon penetr beyond injuri site arsb chaseabc treat mice control mice result indic mammalian arsb improv function recoveri cn injuri structural/molecular mechan underli observ function improv remain elucid',\n",
       "  \"background self-report screen scale adult attention-deficit/hyperact disord adhd world health organ adult adhd self-report scale asr develop conjunct revis composit intern diagnost interview cidi current report present data concord asr short-form asr screener blind clinic diagnos commun sampl method asr includ 18 question frequenc recent dsm-iv criterion symptom adult adhd asr screener consist six 18 question select base stepwis logist regress optim concord clinic classif asr respons compar blind clinic rate dsm-iv adult adhd sampl 154 respond previous particip us nation comorbid survey replic ncs-r oversampl report childhood adhd adult persist result asr symptom measur significantli relat compar clinic symptom rate vari substanti concord cohen 's kappa rang 0.16-0.81 optim score predict clinic syndrom classif sum unweight dichotom respons across 18 asr question howev wide variat symptom-level concord unweight six-quest asr screener outperform unweight 18-question asr sensit 68.7 v. 56.3 specif 99.5 v. 98.3 total classif accuraci 97.9 v. 96.2 kappa 0.76 v. 0.58 conclus clinic calibr larger sampl might show weight version 18-question asr outperform six-quest asr screener time howev unweight screener prefer full asr commun survey clinic outreach case-find initi\",\n",
       "  'human milk contain nutrient bioactiv product relev infant develop immunolog protect investig proresolv properti milk use human milk lipid mediat isol hlmi determin impact resolut program vivo human macrophag hlmi reduc maximum neutrophil number 14.6±1.2 × 106–11.0±1.0 × 106 cell per exud shorten resolut interv ri 50 neutrophil reduct 54 compar periton use rigor liquid-chromatographi tandem-mass spectrometri lc-ms-m -base lipid mediat lm metabololipidom demonstr human milk possess proresolv lm-special proresolv mediat lm-spm signatur profil contain spm e.g resolvin rv protectin pd maresin mar lipoxin lx bioactiv level pico-nanomolar concentr enhanc human macrophag efferocytosi bacteri contain spm identifi human milk includ d-seri rv e.g. rvd1 rvd2 rvd3 at-rvd3 rvd4 pd1 mar1 e-seri rv e.g rve1 rve2 rve3 lx lxa4 lxb4 spm identifi human milk rvd2 mar1 50 ng per mous individu shorten ri ∼75 milk mastiti gave higher leukotrien b4 prostanoid lower spm level taken togeth find provid evid human milk proresolv action via comprehens lm-spm profil describ potenti novel mechan maternal–inf biochem imprint',\n",
       "  'stroke heterogen syndrom caus multipl diseas mechan result disrupt cerebr blood flow subsequ tissu damag review cover mechan respons regul normal cerebr circul disrupt diseas state central concept treat patient acut ischaem stroke exist ischaem penumbra potenti salvag tissu evid exist human review',\n",
       "  \"methyl-cpg bind protein 1 mbd1 regul gene express via dna methylation-medi epigenet mechan previous demonstr mbd1 defici impair adult neural stem/progenitor cell ansc differenti neurogenesi underli mechan unclear show mbd1 regul express sever microrna ansc specif mir-184 directli repress mbd1 high level mir-184 promot prolifer inhibit differenti ansc wherea inhibit mir-184 rescu phenotyp associ mbd1 defici found mir-184 regul express numblik numbl known regul brain develop bind 3'-utr numbl mrna affect translat express exogen numbl could rescu ansc defect result either mir-184 overexpress mbd1 defici therefor mbd1 mir-184 numbl form regulatori network help control balanc prolifer differenti ansc\",\n",
       "  \"high-throughput dna sequenc significantli contribut diagnosi prognost patient myelodysplast syndrom md determin biolog prognost signific genet aberr md total 944 patient variou md subtyp screen known/put mutations/delet 104 gene use target deep sequenc array-bas genom hybrid total 845/944 patient 89.5 harbor least one mutat median 3 per patient rang 0-12 forty-seven gene significantli mutat tet2 sf3b1 asxl1 srsf2 dnmt3a runx1 mutat 10 case mani mutat associ higher risk group and/or blast elev surviv investig 875 patient univari analysi 25/48 gene result 47 gene test significantli plu prpf8 affect surviv p 0.05 statu 14 gene combin convent factor reveal novel prognost model 'model-1 separ patient four risk group 'low 'intermedi 'high 'veri high risk 3-year surviv 95.2 69.3 32.8 5.3 p 0.001 subsequ 'gene-onli model 'model-2 construct base 14 gene also yield four signific risk group p 0.001 model reproduc valid cohort n=175 patient p 0.001 thu large-scal genet molecular profil multipl target gene invalu subclassif prognost md patient\",\n",
       "  'purpos defin copi number alter gene express signatur underli pediatr high-grad glioma hgg patient method conduct high-resolut analysi genom imbal 78 de novo pediatr hgg includ seven diffus intrins pontin glioma 10 hgg aris children receiv cranial irradi previou cancer use singl nucleotid polymorph microarray analysi gene express analyz gene express microarray 53 tumor result compar publicli avail data adult tumor result signific differ copi number alter distinguish childhood adult glioblastoma pdgfra predomin target focal amplif childhood hgg includ diffus intrins pontin glioma gene express analys support import role deregul pdgfralpha signal pediatr hgg idh1 hotspot mutat found pediatr tumor highlight molecular differ adult secondari glioblastoma pediatr adult glioblastoma clearli distinguish frequent gain chromosom 1q 30 v 9 respect lower frequenc chromosom 7 gain 13 v 74 respect 10q loss 35 v 80 respect pdgfra amplif 1q gain occur significantli higher frequenc irradiation-induc tumor suggest initi event childhood gliomagenesi subset pediatr hgg show minim copi number chang conclus integr molecular profil show substanti differ molecular featur underli pediatr adult hgg indic find adult tumor simpli extrapol younger patient pdgfralpha may use target pediatr hgg includ diffus pontin glioma',\n",
       "  'although genomewid rna express analysi becom routin tool biomed research extract biolog insight inform remain major challeng describ power analyt method call gene set enrich analysi gsea interpret gene express data method deriv power focus gene set group gene share common biolog function chromosom locat regul demonstr gsea yield insight sever cancer-rel data set includ leukemia lung cancer notabl single-gen analysi find littl similar two independ studi patient surviv lung cancer gsea reveal mani biolog pathway common gsea method embodi freeli avail softwar packag togeth initi databas 1,325 biolog defin gene set',\n",
       "  'increas number transcript report transmit protein-cod regulatori inform apart challeng concept gene observ rais question extent phenomenon occur across genom dual encod function evolv eukaryot genom address question consid evolutionari path gene earliest form life earth gener regard protein evolv cellular machineri base entir within rna led domin protein-cod gene genom microorgan although like rna never lost capac function evidenc cis-act riboswitch utr basi subsequ evolut sophist regulatori architectur provid higher level epigenet control accur spatiotempor express development complex organ complic task hypothes mrna remain subject secondari select provid trans-act regulatori capabl parallel protein-cod function ii perhap mani protein-cod loci possibl consequ gene duplic lost protein-cod function en rout acquir sophist trans-regulatori function iii mani transcript becom subject secondari process releas differ product iv novel protein emerg within loci previous evolv function regulatori rna support idea dynam flux differ type inform rna evolutionari real time review recent observ arisen transcriptom survey complex eukaryot reconsid observ impact notion appar discret loci may express transcript one function conclus posit mani eukaryot loci evolv capac transact multitud overlap potenti independ function regulatori protein-cod rna',\n",
       "  'low number cd4+ cd25+ regulatori cell treg anerg phenotyp divers antigen specif present major challeng har potent tolerogen popul treat autoimmun transplant reject studi describ robust method expand antigen-specif treg autoimmune-pron nonobes diabet mice purifi cd4+ cd25+ treg expand 200-fold less 2 wk vitro use combin anti-cd3 anti-cd28 interleukin 2. expand treg express classic cell surfac phenotyp function vitro vivo suppress effector cell function significantli small number antigen-specif treg revers diabet diseas onset suggest novel approach cellular immunotherapi autoimmun',\n",
       "  'purpos overexpress oncogen stathmin link aggress endometri carcinoma potenti pi3kinas inhibitor diseas want valid prognost valu stathmin express larg prospect multicent set lymph node sampl part current surgic stage also aim test stathmin express endometri curettag specimen could predict lymph node metastasi experiment design total 1,076 endometri cancer patient recruit 10 center investig biolog tumor marker stathmin relat clinicopatholog variabl includ lymph node statu surviv stathmin immunohistochem stain carri 477 hysterectomi 818 curettag specimen result seventy-on percent patient n 763 subject lymph node sampl 12 metastat node n 94 overexpress stathmin detect 37 302 818 curettag 18 84 477 hysterectomi specimen investig stathmin overexpress curettag hysterectomi specimen highli correl significantli associ nonendometrioid histolog high grade aneuploidi stathmin analysi preoper curettag sampl significantli correl independ predictor lymph node metastas high stathmin express associ poor disease-specif surviv p ≤ 0.002 curettag hysterectomi specimen conclus stathmin immunohistochem stain identifi endometri carcinoma lymph node metastas poor surviv valu predict marker respons pi3kinas inhibit tool stratifi patient lymph node sampl endometri carcinoma remain determin',\n",
       "  'introduct induct inflammatori respons thought signific role complic follow cardiopulmonari bypass cpb statin drug increasingli recogn potent anti-inflammatori effect henc potenti influenc import mechan injuri cpb although current confirm inde case object systemat review pre-op prophylact statin therapi compar placebo standard care decreas inflammatori respons peopl undergo heart surgeri cpb method perform systemat comprehens literatur search random control trial rct open heart surgeri cpb adult children receiv prophylact statin treatment prior cpb report outcom includ marker inflamm two author independ identifi elig studi extract data assess studi qualiti use standard instrument weight mean differ wmd primari summari statist data pool use random effect model descript analysi use data could pool result eight rct includ review number trial inflammatori outcom even limit pool data demonstr benefit use statin attenu post-cpb increas interleukin 6 8 il-6 il-8 peak high sensit c-reactiv protein hscrp tumor necrosi factor-alpha tnf-alpha post-cpb wmd 95 confid interv ci -23.5 pg/ml -36.6 -10.5 -23.4 pg/ml -35.8 -11.0 -15.3 mg/l ci -26.9 -3.7 -2.10 pg/ml -3.83 -0.37 respect limit rct evid suggest prophylact statin therapi may also decreas adhes molecul follow cpb includ neutrophil cd11b solubl p sp -selectin conclus although rct evid may suggest reduct post-cpb inflamm statin therapi evid definit due signific limit sever trial methodolog rigor statin intervent highli variabl small number studi systemat review demonstr signific gap exist current literatur regard potenti anti-inflammatori effect statin therapi prior cpb',\n",
       "  'genome-wid copi number profil character 41 primari bladder tumor use array-bas compar genom hybrid array cgh addit previous identifi alter larg chromosom region alter identifi mani small genom region high-level amplif homozyg delet high-level amplif detect 192 genom clone frequent 6p22.3 e2f3 8p12 fgfr1 8q22.2 cmyc 11q13 ccnd1 ems1 int2 19q13.1 ccne homozyg delet detect 51 genom clone four show delet one case two clone map 9p21.3 cdkn2a/p16 nine case one 8p23.1 three case one 11p13 two case signific correl observ copi number gain clone contain ccne1 gain erbb2 gain ccnd1 delet tp53 addit signific complementari associ gain ccnd1 gain e2f3 although signific relationship copi number chang tumor stage grade link behavior among genom loci suggest array cgh increasingli import understand pathway critic bladder tumor biolog',\n",
       "  'epigenet modifi fundament role defin uniqu cellular ident establish mainten lineage-specif chromatin methyl statu sever dna modif 5-hydroxymethylcytosin 5hmc catalys ten eleven transloc tet methylcytosin dioxygenas famili member role tet protein regul chromatin architectur gene transcript independ dna methyl gradual uncov howev regul immun inflamm tet protein independ role modul dna methyl remain larg unknown show tet2 select mediat activ repress interleukin-6 il-6 transcript inflamm resolut innat myeloid cell includ dendrit cell macrophag loss tet2 result upregul sever inflammatori mediat includ il-6 late phase respons lipopolysaccharid challeng tet2-defici mice suscept endotoxin shock dextran-sulfate-sodium-induc coliti display sever inflammatori phenotyp increas il-6 product compar wild-typ mice iκbζ il-6-specif transcript factor mediat specif target tet2 il6 promot indic opposit regulatori role iκbζ initi resolut phase inflamm repress mechan independ dna methyl hydroxymethyl tet2 recruit hdac2 repress transcript il6 via histon deacetyl provid mechanist evid gene-specif transcript repress activ tet2 via histon deacetyl prevent constant transcript activ chromatin level resolv inflamm',\n",
       "  'tnfr/tnf superfamili member control divers aspect immun function research past 10 year shown one import promin interact famili ox40 cd134 partner ox40l cd252 molecul strongli regul convent cd4 cd8 cell recent data highlight abil modul nkt cell nk cell function well mediat cross-talk profession antigen-pres cell divers cell type mast cell smooth muscl cell endotheli cell addit ox40-ox40l interact alter differenti activ regulatori cell block ox40l produc strong therapeut effect multipl anim model autoimmun inflammatori diseas line prospect clinic futur reagent stimul ox40 signal show promis adjuv vaccin well treatment cancer',\n",
       "  'cholesterol homeostasi requir maintain normal cellular function avoid deleteri effect hypercholesterolemia show drosophila dhr96 nuclear receptor bind cholesterol requir coordin transcript respons gene regul cholesterol involv cholesterol uptak traffick storag dhr96 mutant die grown low level cholesterol accumul excess cholesterol maintain high-cholesterol diet cholesterol accumul phenotyp attribut misregul npc1b ortholog mammalian niemann-pick c1-like 1 gene npc1l1 essenti dietari cholesterol uptak studi defin dhr96 central regul cholesterol homeostasi',\n",
       "  'children becom overweight unhealthi unfit understand neurocognit benefit activ lifestyl childhood import public health educ implic anim research indic aerob exercis relat increas cell prolifer surviv hippocampu well enhanc hippocampal-depend learn memori recent evid extend relationship elderli human suggest high aerob fit level older adult associ increas hippocamp volum superior memori perform present studi aim extend link fit hippocamp volum memori sampl preadolesc children end magnet reson imag employ investig whether higher- lower-fit 9- 10-year-old children show differ hippocamp volum differ relat perform item relat memori task relat item memori primarili support hippocampu consist predict higher-fit children show greater bilater hippocamp volum superior relat memori task perform compar lower-fit children hippocamp volum also posit associ perform relat item memori task furthermor bilater hippocamp volum found mediat relationship fit level vo 2 max relat memori relationship aerob fit nucleu accumben volum memori report strengthen hypothes specif effect fit hippocampu find first indic aerob fit may relat structur function preadolesc human brain',\n",
       "  'object assess effect 25-hydroxyvitamin 25-ohd level pregnanc outcom birth variabl design systemat review meta-analysi data sourc medlin 1966 august 2012 pubm 2008 august 2012 embas 1980 august 2012 cinahl 1981 august 2012 cochran databas systemat review cochran databas regist clinic trial studi select studi report associ serum 25-ohd level pregnanc outcom interest pre-eclampsia gestat diabet bacteri vaginosi caesarean section small gestat age infant birth weight birth length head circumfer data extract two author independ extract data origin research articl includ key indic studi qualiti pool adjust odd ratio weight mean differ associ test subgroup repres differ patient characterist studi qualiti result 3357 studi identifi review elig 31 elig studi includ final analysi insuffici serum level 25-ohd associ gestat diabet pool odd ratio 1.49 95 confid interv 1.18 1.89 pre-eclampsia 1.79 1.25 2.58 small gestat age infant 1.85 1.52 2.26 pregnant women low serum 25-ohd level increas risk bacteri vaginosi low birthweight infant deliveri caesarean section conclus vitamin insuffici associ increas risk gestat diabet pre-eclampsia small gestat age infant pregnant women low 25-ohd level increas risk bacteri vaginosi lower birth weight infant deliveri caesarean section',\n",
       "  'psychosoci stress associ alter immun function develop psycholog disord includ anxieti depress show repeat social defeat mice increas c-fo stain brain region associ fear threat apprais promot anxiety-lik behavior β-adrenerg receptor-depend manner repeat social defeat also significantli increas number cd11b /cd45 high /ly6c high macrophag traffick brain addit sever inflammatori marker increas surfac microglia cd14 cd86 tlr4 macrophag cd14 cd86 social defeat repeat social defeat also increas presenc deramifi microglia medial amygdala prefront cortex hippocampu moreov mrna analysi microglia indic repeat social defeat increas level interleukin il -1β reduc level glucocorticoid respons gene glucocorticoid-induc leucin zipper gilz fk506 bind protein-51 fkbp51 stress-depend chang microglia macrophag prevent propranolol β-adrenerg receptor antagonist microglia isol social defeat mice cultur ex vivo produc markedli higher level il-6 tumor necrosi factor-α monocyt chemoattract protein-1 stimul lipopolysaccharid compar microglia control mice last repeat social defeat increas c-fo activ il-1 receptor type-1-defici mice promot anxiety-lik behavior microglia activ absenc function il-1 receptor type-1 find indic repeat social defeat-induc anxiety-lik behavior enhanc reactiv microglia depend activ β-adrenerg il-1 receptor',\n",
       "  'remark development potenti replic capac human embryon stem es cell promis almost unlimit suppli specif cell type transplant therapi describ vitro differenti enrich transplant neural precursor cell human es cell upon aggreg embryoid bodi differenti es cell form larg number neural tube–lik structur presenc fibroblast growth factor 2 fgf-2 neural precursor within format isol select enzymat digest purifi basi differenti adhes follow withdraw fgf-2 differenti neuron astrocyt oligodendrocyt transplant neonat mous brain human es cell–deriv neural precursor incorpor varieti brain region differenti neuron astrocyt teratoma format observ transplant recipi result depict human es cell sourc transplant neural precursor possibl nervou system repair',\n",
       "  'candida albican produc lipid metabolit function similar host prostaglandin studi use mass spectrometri demonstr c. albican produc authent prostaglandin e 2 pge 2 arachidon acid maxim pge 2 product achiev 37 degre c stationary-phas cultur supernat cell-fre lysat gener stationary-phas cell interestingli pge 2 product inhibit nonspecif cyclooxygenas lipoxygenas inhibitor inhibitor specif cyclooxygenas 2 isoenzym c. albican genom possess cyclooxygenas homolog howev sever gene may play role prostaglandin product c. albican investig found c. albican fatti acid desaturas homolog ole2 multicopp oxidas homolog fet3 play role prostaglandin product ole2/ole2 fet3/fet3 mutant strain exhibit reduc pge 2 level compar parent strain work demonstr synthesi pge 2 c. albican proce via novel pathway',\n",
       "  'klf1 regul divers suit gene direct erythroid cell differenti bipot progenitor determin local cis-regulatori context transcript factor network klf1 oper perform klf1 chip-seq mous found least 945 site genom e14.5 fetal liver erythroid cell occupi endogen klf1 mani recov site resid erythroid gene promot hbb-b1 major distant known gene data suggest klf1 directli regul aspect termin erythroid differenti includ product alpha- beta-globin protein chain heme biosynthesi coordin prolifer anti-apoptot pathway construct red cell membran cytoskeleton function primarili transcript activ addit suggest new mechan klf1 cooper transcript factor particular erythroid transcript factor gata1 maintain homeostasi erythroid compart',\n",
       "  'high-throughput experiment technolog often identifi dozen hundr gene relat chang biolog patholog process gene one want identifi biolog pathway may involv diseas may implic report web server koba 2.0 annot input set gene put pathway diseas relationship base map gene known annot allow id map cross-speci sequenc similar map perform statist test identifi statist significantli enrich pathway diseas koba 2.0 incorpor knowledg across 1327 speci 5 pathway databas kegg pathway pid biocyc reactom panther 5 human diseas databas omim kegg diseas fundo gad nhgri gwa catalog koba 2.0 access http //kobas.cbi.pku.edu.cn',\n",
       "  'erythrocyt carri variant hemoglobin allel hb caus sickl cell diseas resist infect malaria parasit plasmodium falciparum molecular basi resist long recogn multifactori remain incomplet understood show dysregul microrna mirna composit either heterozyg hba homozyg hbss erythrocyt contribut resist p. falciparum intraerythrocyt life cycl p. falciparum subset erythrocyt mirna transloc parasit two mirna mir-451 let-7i highli enrich hba hbss erythrocyt mirna along mir-223 neg regul parasit growth surprisingli found mir-451 let-7i integr essenti parasit messeng rna via impair ribosom load result translat inhibit henc sickl cell erythrocyt exhibit cell-intrins resist malaria part atyp mirna activ may repres uniqu host defens strategi complex eukaryot pathogen',\n",
       "  'activ self-react cell traffick target tissu lead autoimmun organ destruct mice lack co-inhibitori receptor cytotox lymphocyt antigen-4 ctla-4 develop fatal autoimmun character lymphocyt infiltr nonlymphoid tissu demonstr cd28 co-stimulatori pathway regul traffick self-react ctla4 -/- cell tissu concurr ablat cd28-activ tec famili kinas itk block spontan cell activ instead caus self-react ctla4 -/- cell accumul secondari lymphoid organ despit excess spontan cell activ prolifer lymphoid organ itk -/- ctla4 -/- mice otherwis healthi mount antivir immun respons exhibit long lifespan propos itk specif licens autoreact cell enter tissu mount destruct immun respons notabl itk inhibitor mimic null mutant phenotyp also prevent pancreat islet infiltr diabetogen cell mous model type 1 diabet highlight potenti util treatment human autoimmun disord',\n",
       "  \"mutant dwarf calorie-restrict mice benefit healthi age unusu long lifespan contrast mous model dna repair-defici progeroid syndrom age die prematur identifi mechan regul mammalian longev quantifi parallel genome-wid liver express profil mice two extrem lifespan contrari expect find signific genome-wid express associ progeroid long-liv mice subsequ analysi significantli over-repres biolog process reveal suppress endocrin energi pathway increas stress respons delay prematur age test relev process natur age compar transcriptom liver lung kidney spleen entir murin adult lifespan subsequ confirm find independ age cohort major gene show similar express chang four organ indic system transcript respons age system respons includ biolog process trigger progeroid long-liv mice howev genome-wid scale transcriptom natur age mice show strong associ progeroid long-liv mice thu endocrin metabol chang indic `` surviv '' respons genotox stress starvat wherea genome-wid associ gene express natur age indic biolog age may thu delin pro- anti-ag effect treatment aim health-span extens\",\n",
       "  'cornea immun privileg tissu sinc arginas found modul t-cell function deplet arginin investig express arginas cornea possibl role immun privileg use murin transplant model found endothelium epithelium murin cornea express function arginas capabl down-regul t-cell prolifer vitro cultur system administr specif arginas inhibitor n-hydroxy-nor-l-arg recipi mice result acceler reject allogen c57bl/6 b6 corneal graft contrast vivo blockad arginas activ effect alter cours reject primari skin graft express littl arginas addit inhibit arginas alter system t-cell prolifer data show arginas function cornea contribut immun privileg eye modul arginas contribut graft surviv',\n",
       "  \"object methylphenid mph commonli prescrib drug attention-deficit/hyperact disord adhd short half-lif necessit multipl daili dose need multipl dose produc problem medic administr school after-school hour therefor complianc previou long-act stimul prepar shown effect equival twice-daili dose mph studi test efficaci durat action natur laboratori set extended-releas mph prepar design last 12 hour therefor equival 3-times-daili dose method sixty-eight children adhd 6 12 year old particip within-subject double-blind comparison placebo immediate-releas ir mph 3 time day tid concerta once-daili mph formul three dose level medic use 5 mg ir mph tid/18 mg concerta day qd 10 mg ir mph tid/36 mg concerta qd 15 mg ir mph tid/54 mg concerta qd children current medic mph enrol child 's dose level base child 's mph dose studi dose concerta select compar daili dose mph child receiv achiev ascend rate mph deliveri determin initi investig provid necessari continu coverag concerta dose 20 higher daili basi compar tid regimen ir mph children receiv medic condit 7 day investig conduct context background clinic behavior intervent natur environ laboratori set parent receiv behavior parent train teacher taught establish school-hom daili report card drc drc list individu target behavior repres child 's salient area impair teacher set daili goal child 's impair target parent provid reward home goal attain weekday teacher complet drc use depend measur individu medic respons teacher parent also complet weekli standard rate behavior treatment effect evalu time cours medic effect children spent 12 hour laboratori set saturday medic effect measur use procedur method adapt summer treatment program measur classroom behavior academ productivity/accuraci taken laboratori classroom set children complet independ math read worksheet measur social behavior taken structur small-group board game set unstructur recess set measur includ behavior frequenc count academ problem complet accuraci independ observ teacher counselor rate individu behavior target goal report advers event sleep qualiti appetit collect result virtual measur set drug condit significantli differ placebo 2 drug differ children 's regular school set medic improv behavior measur teacher rate individu target behavior drc effect seen even measur parent rate laboratori set effect concerta equival tid mph last least 12 hour dose concerta significantli superior tid mph 2 parent rate score ask parent prefer concerta prefer tid ir mph placebo side effect children 's sleep appetit similar 2 prepar lab set medic improv product accuraci arithmet seatwork assign disrupt on-task behavior classroom rule follow medic improv children 's rule follow neg behavior small group board game well unstructur recess set individu target behavior also show signific improv medic across domain laboratori set children 's behavior across set deterior across laboratori day primari effect medic prevent deterior day wore result support use background behavior treatment clinic trial stimul medic illustr util measur individu daili target goal ie drc object measur medic respons laboratori natur school set conclus investig clearli support efficaci concerta long-act formul mph parent desir medic benefit child throughout day earli even abstract truncat\",\n",
       "  \"background shine-dalgarno sd signal long view domin translat initi signal prokaryot recent leaderless gene lack 5'-untransl region 5'-utr mrna shown abund archaea howev current large-scal silico analys initi mechan bacteria mainli base sd-led initi way leaderless one studi leaderless gene bacteria remain open caus uncertain understand translat initi mechan prokaryot result studi signal translat initi region gene 953 bacteri 72 archaeal genom make effort construct evolutionari scenario view leaderless gene bacteria algorithm design identifi multi-sign upstream region gene genom classifi gene sd-led ta-l atyp gene accord categori probabl signal upstream sequenc particularli occurr ta-lik signal 10 bp upstream translat initi site ti bacteria probabl mean leaderless gene conclus analysi reveal leaderless gene total widespread although domin varieti bacteria especi actinobacteria deinococcus-thermu twenti percent gene leaderless analyz close relat bacteri genom result impli chang translat initi mechan happen gene deriv common ancestor linearli depend phylogenet relationship analysi macroevolut leaderless gene show proport leaderless gene bacteria decreas trend evolut\",\n",
       "  'sirt1 nad -depend class iii deacetylas function cellular energi sensor addit well-character effect peripher tissu emerg evid suggest neuron sirt1 activ play role central regul energi balanc glucos metabol assess idea gener sirt1 neuron-specif knockout sinko mice standard chow hfd sinko mice insulin sensit sirt1 f/f mice thu sinko mice lower fast insulin level improv glucos toler insulin toler enhanc system insulin sensit hyperinsulinem euglycem clamp studi hypothalam insulin sensit sinko mice also increas control assess hypothalam activ pi3k phosphoryl akt foxo1 follow system insulin inject intracerebroventricular inject insulin led greater system effect improv glucos toler insulin sensit sinko mice compar control line vivo result insulin-induc akt foxo1 phosphoryl potenti inhibit sirt1 cultur hypothalam cell line mechanist effect trace reduc effect sirt1 directli deacetyl repress irs-1 function enhanc central insulin signal sinko mice accompani increas insulin receptor signal transduct liver muscl adipos tissu summari conclud neuron sirt1 neg regul hypothalam insulin signal lead system insulin resist intervent reduc neuron sirt1 activ potenti improv system insulin action limit weight gain obesigen diet',\n",
       "  'recent success genome-wid associ studi gwa follow challeng determin report suscept variant mediat complex trait diseas express quantit trait loci eqtl implic diseas associ overlap eqtl gwa signal howev abund eqtl strong correl structur ld genom make like overlap coincident driven function variant present studi propos empir methodolog call regulatori trait concord rtc account local ld structur integr eqtl gwa result order reveal subset associ signal due ci eqtl simul genom region variou ld pattern singl two causal variant show score outperform snp correl metric statist r 2 histor follow observ signific abund regulatori signal among current publish gwa loci appli method goal priorit relev gene respect complex trait detect sever potenti disease-caus regulatori effect strong enrich immunity-rel condit consist natur cell line test lcl furthermor present extens method tran interrog whole genom downstream effect diseas variant inform regard unknown primari biolog effect conclud integr cellular phenotyp associ organism complex trait facilit biolog interpret genet effect trait',\n",
       "  'context establish manag strategi outcom differ gender mani diseas effect infect adequ studi object investig role gender among hospit patient treat infect design observ cohort studi conduct 26-month period decemb 1996 januari 1999. set university-affili hospit particip total 892 patient surgic unit hospit 1470 consecut infecti episod 782 men 688 women main outcom measur mortal hospit gender infect episod overal specif infecti site includ lung peritoneum bloodstream cathet urin surgic site skin/soft tissu result among infect signific differ mortal base gender men 11.1 vs women 14.2 p .07 logist regress analysi factor independ associ mortal includ higher apach acut physiolog chronic health evalu ii score older age malign blood transfus diagnosi infect 7 day admiss gender femal odd ratio death 1.32 95 confid interv ci 0.90-1.94 p .16 mortal higher women lung men 18 vs women 34 p .002 soft tissu men 2 vs women 10 p .05 infect infecti site mortal differ gender factor associ mortal due pneumonia logist regress includ higher apach ii score malign diabet mellitu diagnosi infect 7 day admiss older age transplant femal gender death 2.25 95 ci 1.17-4.32 p .02 conclus although gender may predict mortal among infect women appear increas risk death hospital-acquir pneumonia even control comorbid',\n",
       "  'metastat colorect cancer mcrc increasingli treat use target therapi post-market safeti agent understudi especi elderli studi aim compar accord age advers drug reaction adr target therapi use mcrc real life extract vigibas contain world health organ individu case safeti report icsr perform adr report aflibercept bevacizumab cetuximab panitumumab regorafenib use crc consid drug chi-squar test use compar frequenc seriou adr patient age ≥75 75 year select adr drug drug-adr associ compar anticanc drug estim proport report ratio prr age group 21,565 icsr includ among 74 seriou 11 fatal median age 64 year inter quartil rang 56–71 15 patient age ≥75 57 male seriou icsr account 47,292 adr neutropenia report elderli drug diarrhea report elderli panitumumab cardiac disord report elderli patient particular heart failur especi bevacizumab cetuximab regorafenib respiratori thorac mediastin disord prr differ two group except encephalopathi significantli associ bevacizumab elderli adr relat target therapi use mcrc treatment differ across age group yet systemat report wors elderli patient select elderli patient could therefor treat target therapi',\n",
       "  'limit report methyl analysi premalign lesion gastric carcinoma thu far despit fact gastric carcinoma one tumor high frequenc cpg island hypermethyl determin frequenc time hypermethyl multistep gastric carcinogenesi non-neoplast gastric mucosa n 118 adenoma n 61 carcinoma n 64 analyz p16 human mut l homologu 1 hmlh1 death-associ protein dap -kinas thromobospondin-1 thbs1 tissu inhibitor metalloproteinas 3 timp-3 methyl statu use methylation-specif pcr three differ class methyl behavior found five test gene dap-kinas methyl similar frequenc four stage wherea hmlh1 p16 methyl cancer sampl 20.3 42.2 respect frequent intestin metaplasia 6.3 2.1 respect adenoma 9.8 11.5 respect howev hmlh1 p16 methyl chronic gastriti thbs-1 timp-3 methyl stage show mark increas hypermethyl frequenc chronic gastriti 10.1 14.5 respect intestin metaplasia 34.7 36.7 respect p 0.05 adenoma 28.3 26.7 respect carcinoma 48.4 57.4 respect p 0.05 hmlh1 thbs1 timp-3 hypermethyl frequenc similar intestin metaplasia adenoma p16 hypermethyl frequenc tend higher adenoma 11.5 intestin metaplasia 2.1 p 0.073 averag number methyl gene 0.6 1.1 1.1 2.0 per five gene per sampl chronic gastriti intestin metaplasia adenoma carcinoma respect show mark increas methyl gene non-metaplast mucosa intestin metaplasia p 0.001 well premalign lesion carcinoma p 0.002 result suggest cpg island hypermethyl occur earli multistep gastric carcinogenesi tend accumul along multistep carcinogenesi',\n",
       "  'transthyretin famili amyloid polyneuropathi ttr-fap fatal clinic disord character extracellular deposit abnorm fibril deriv misfold normal solubl transthyretin ttr molecul diseas commonli caus point mutat within ttr gene inherit autosom domin fashion 100 mutat identifi lead destabil physiolog ttr tetram result mani monom origin tendenc spontan conform chang self-aggreg main clinic featur ttr-fap progress sensorimotor autonom neuropathi begin polyneuropathi predominantli involv small unmyelin nerv fiber result dissoci sensori loss disproportion affect sensat pain temperatur autonom neuropathi typic accompani sensori deficit earli diseas cours symptom includ orthostat hypotens constip altern diarrhea erectil dysfunct anhydrosi urinari retent incontin later involv motor fiber caus rapidli progress weak gait disturb addit peripher nervou system heart gut frequent affect onset symptom bimod one peak age 33 year earli onset anoth distinct peak sixth decad life late onset cours ttr-fap uniformli progress fatal death occur averag 10.8 year onset symptom portugues patient 7.3 year late-onset japanes patient common caus includ cachexia cardiac failur arrhythmia secondari infect liver transplant standard therapi patient clinic condit good enough toler intervent stop progress neuropathi remov main sourc mutant ttr recent oral administ tafamidi meglumin approv european author treatment fap substanc shown stabil ttr tetram therebi improv outcom patient ttr-fap variou strategi studi vitro prevent ttr amyloidosi includ gene therapi immun dissolut ttr aggreg free radic scaveng none readi clinic use far',\n",
       "  'cell innat immun system interact pathogen via conserv pattern-recognit receptor wherea cell adapt immun system recogn pathogen divers antigen-specif receptor gener somat dna rearrang invari natur killer inkt cell subset lymphocyt bridg innat adapt immun system although inkt cell express cell receptor gener somat dna rearrang receptor semi-invari interact limit set lipid glycolipid antigen thu resembl pattern-recognit receptor innat immun system function inkt cell close resembl cell innat immun system rapidli elicit effector function follow activ fail develop immunolog memori inkt cell becom activ respons varieti stimuli particip regul variou immun respons activ inkt cell produc sever cytokin capac jump-start modul adapt immun respons varieti glycolipid antigen differenti elicit distinct effector function inkt cell identifi reagent employ test hypothesi inkt cell har therapeut purpos human diseas review innate-lik properti function inkt cell discuss interact cell type immun system',\n",
       "  'main purpos hypertens treatment reduct cardiovascular diseas burden among differ first-lin antihypertens drug class angiotensin-receptor blocker character good effect toler furthermor interrupt renin-angiotensin cascad relat sever benefit target organ protect cardiovascular prevent among differ angiotensin-receptor blocker olmesartan examin sever trial organ protect show improv sever diseas marker microinflamm regress plaqu volum vascular hypertrophi well microalbuminuria prevent olmesartan also wide examin combin either hydrochlorothiazid amlodipin well drug single-pil tripl combin show improv antihypertens efficaci without signific effect toler treatment strategi base drug characterist avail differ type combin first-lin drug class may repres effect way achiev blood pressur control major hypertens patient could also relat better cardiovascular diseas prevent',\n",
       "  'falciparum malaria kill particularli kill rural poor artemisinin deriv artesun vital compon plasmodium falciparum malaria treatment control face global increas antimalari drug resist sinc 1998 worsen epidem sophist counterfeit “ artesun ” tablet contain artesun plagu mainland southeast asia see figur s1 countri avail artesun fake 1–5 artemisinin deriv remark rapid antimalari effect well toler medicin avail sought rel expens demand creat cheaper version amongst poorest vulner peopl upon counterfeit preyed–with fatal result',\n",
       "  'clinic manifest diabet nephropathi express diabet microangiopathi review revisit previous propos steno hypothesi advanc hypothesi develop endotheli cell dysfunct repres common pathophysiolog pathway diabet complic specif abil glucos scaveng nitric oxid propos initi phase endotheli dysfunct gradual accumul advanc glycat end product induct plasminogen activ inhibitor-1 result decreas express endotheli nitric oxid synthas reduc gener nitric oxid propos pathophysiolog critic mainten phase endotheli dysfunct propos conceptu shift toward role endotheli dysfunct diabet complic may provid new strategi prevent',\n",
       "  'epigenet inform frequent eras near start new gener case howev epigenet inform transmit parent progeni multigener epigenet inherit particularli notabl exampl type epigenet inherit double-strand rna-medi gene silenc caenorhabd elegan rna-medi interfer rnai inherit five gener understand process conduct genet screen nematod defect transmit rnai silenc signal futur gener screen identifi herit rnai defect 1 hrde-1 gene hrde-1 encod argonaut protein associ small interf rna germ cell progeni anim expos double-strand rna nuclei germ cell hrde-1 engag nuclear rnai defect pathway direct trimethyl histon h3 ly 9 h3k9me3 rnai-target genom loci promot rnai inherit normal growth condit hrde-1 associ endogen express short interf rna direct nuclear gene silenc germ cell hrde-1- nuclear rnai-defici anim germlin silenc lost gener time concurr anim exhibit steadili worsen defect gamet format function ultim lead steril result establish argonaut protein hrde-1 direct gene-silenc event germ-cel nuclei drive multigener rnai inherit promot immort germ-cel lineag propos c. elegan use rnai inherit machineri transmit epigenet inform accru past gener futur gener regul import biolog process',\n",
       "  'autophagi play central role regul import cellular function cell surviv starvat control infecti pathogen recent shown autophagi induc cell die howev mechan autophag cell death program unclear show caspas inhibit lead cell death mean autophagi involv reactiv oxygen speci ro accumul membran lipid oxid loss plasma membran integr inhibit autophagi chemic compound knock express key autophagi protein atg7 atg8 receptor interact protein rip block ro accumul cell death caus abnorm ro accumul select autophag degrad major enzymat ro scaveng catalas caspas inhibit directli induc catalas degrad ro accumul block autophagi inhibitor find unveil molecular mechan role autophagi cell death provid insight complex relationship ro nonapoptot program cell death',\n",
       "  'human skin cope harm environment factor circadian natur yet circadian rhythm modul function human epiderm stem cell mostli unknown show human epiderm stem cell differenti counterpart core clock gene peak success phase manner establish distinct tempor interv 24 hr day period success clock wave associ peak express subset transcript tempor segreg predisposit epiderm stem cell respond cue regul prolifer differenti tgfβ calcium accordingli circadian arrhythmia profoundli affect stem cell function cultur vivo hypothes intric mechan ensur homeostasi provid epiderm stem cell environment relev tempor function cue cours day perturb may contribut age carcinogenesi',\n",
       "  'cellular cardiomyoplasti attract option treatment sever heart failur howev still unclear controversi promis cell sourc therefor investig examin fate function impact bone marrow bm cell embryon stem cell es cell –deriv cardiomyocyt transplant infarct mous heart prove particularli challeng es cell enrich cardiomyocyt long-term engraft tumorigen still poorli understood gener transgen es cell express puromycin resist enhanc green fluoresc protein cassett control cardiac-specif promot puromycin select result highli purifi 99 cardiomyocyt popul yield cardiomyocyt increas 6–10-fold induct prolifer purif long-term engraft 4–5 month observ co-transpl select es cell–deriv cardiomyocyt fibroblast injur heart syngen mice teratoma format found n 60 although transplant es cell–deriv cardiomyocyt improv heart function bm cell posit effect furthermor contribut bm cell cardiac endotheli smooth muscl neogenesi detect henc result demonstr es-bas cell therapi promis approach treatment impair myocardi function provid better result bm-deriv cell',\n",
       "  'object pancreat ductal adenocarcinoma pda characteris stromal desmoplasia vascular dysfunct critic impair drug deliveri studi examin role abund extracellular matrix compon megadalton glycosaminoglycan hyaluronan ha novel therapeut target pda method use genet engin mous model pda author enzymat deplet ha clinic formul pegyl human recombin ph20 hyaluronidas pegph20 examin tumour perfus vascular permeabl drug deliveri preclin util pegph20 combin gemcitabin assess short-term surviv studi result pegph20 rapidli sustain deplet ha induc re-expans pda blood vessel increas intratumor deliveri two chemotherapeut agent doxorubicin gemcitabin moreov pegph20 trigger fenestr interendotheli junction gap pda tumour endothelia promot tumour-specif increas macromolecular permeabl final combin therapi pegph20 gemcitabin led inhibit pda tumour growth prolong surviv gemcitabin monotherapi suggest immedi clinic util conclus author demonstr ha imped intratumor vasculatur pda propos enzymat deplet explor mean improv drug deliveri respons patient pancreat cancer',\n",
       "  '5′ cap structur higher eukaryot mrna ribos 2′-o-methyl likewis mani virus replic cytoplasm eukaryot evolv 2′-o-methyltransferas autonom modifi mrna howev defin biolog role 2′-o-methyl mrna remain elus show 2′-o-methyl viral mrna critic involv subvert induct type interferon demonstr human mous coronaviru mutant lack 2′-o-methyltransferas activ induc higher express type interferon highli sensit type interferon notabl induct type interferon virus defici 2′-o-methyltransferas depend cytoplasm rna sensor mda5 link mda5-medi sens viral rna 2′-o-methyl mrna suggest rna modif 2′-o-methyl provid molecular signatur discrimin self non-self mrna',\n",
       "  \"relationship children 's activ aerob fit fat unclear indirect estim activ e.g. heart rate hr recal may mask associ purpos studi assess relationship use tritrac-r3d pedomet heart rate thirty-four children age 8-10 yr particip studi tritrac pedomet worn 6 day hr measur 1 day activ measur tritrac pedomet correl posit fit whole group tritrac r 0.66 pedomet r 0.59 p 0.01 boy girl separ p 0.05 correl neg fat whole group r -0.42 p 0.05 contrast hr correl significantli fit hr 139 beats/min correl posit fat girl r 0.64 p 0.05 suggest hr mislead measur activ studi support posit relationship activ fit suggest neg relationship fat activ\",\n",
       "  'epitheli integr vital import deregul caus earli stage cancer de novo format adheren junction aj singl epitheli cell requir coordin spatial actin dynam mechan steer nascent actin polymer cell-cel adhes initi well understood investig real-tim actin assembl daughter cell-cel adhes format human breast epitheli cell 3d environ identifi formin-lik 2 fmnl2 specif requir actin assembl turnov newli form cell-cel contact well human epitheli lumen format fmnl2 associ compon aj complex involv rac1 activ fmnl2 c terminu optogenet control rac1 live cell rapidli drove fmnl2 epitheli cell-cel contact zone furthermor rac1-induc actin assembl subsequ aj format critic depend fmnl2 data uncov fmnl2 driver human epitheli aj format downstream rac1',\n",
       "  'import coordin cell growth prolifer recogn long time molecular basi relationship howev poorli understood show ribosom protein l23 interact hdm2 interact involv central acid domain hdm2 n-termin domain l23 l23 l11 anoth hdm2-interact ribosom protein simultan yet distinctli interact hdm2 togeth form ternari complex show overexpress l23 inhibit hdm2-induc p53 polyubiquitin degrad caus p53-depend cell cycl arrest hand knock l23 caus nucleolar stress trigger transloc b23 nucleolu nucleoplasm lead stabil activ p53 data suggest cell may maintain steady-st level l23 normal growth altern level l23 respons chang growth condit could imping hdm2-p53 pathway interrupt integr nucleolu',\n",
       "  'background atherosclerosi character infiltr inflammatori cell circul blood blood cell activ could play import role plaqu format method analyz relationship blood cellular marker quantit measur carotid wall compon 1,546 particip aric atherosclerosi risk commun carotid mri studi carotid imag perform use gadolinium contrast-enhanc mri cellular phenotyp flow cytometri result monocyt toll-lik receptor tlr -2 associ larger plaqu cd14 myeloperoxidas tlr-4 associ smaller platelet cd40l associ smaller plaqu thinner cap p-selectin associ smaller core size conclus blood cell activ significantli associ atherosclerot chang carotid wall',\n",
       "  'receptor endocytosi fundament step control magnitud durat natur cell signal event confluent endotheli cell contact inhibit growth respond poorli prolif signal vascular endotheli growth factor vegf previou studi found associ vascular endotheli cadherin vec vegf receptor vegfr type 2 contribut density-depend growth inhibit lampugnani g.m. a. zanetti m. corada t. takahashi g. balconi f. breviario f. orsenigo a. cattelino r. kemler t.o daniel e. dejana 2003. j. cell biol 161:793–804 present studi describ mechan vec reduc vegfr-2 signal found vegf induc clathrin-depend intern vegfr-2 vec absent engag junction vegfr-2 intern rapidli remain endosom compart longer time intern termin signal instead intern receptor phosphoryl codistribut activ phospholipas c–γ activ p44/42 mitogen-activ protein kinas phosphoryl cell prolifer inhibit vegfr-2 intern reestablish contact inhibit cell growth wherea silenc junction-associ density-enhanc phosphatase-1/cd148 phosphatas restor vegfr-2 intern signal thu vec limit cell prolifer retain vegfr-2 membran prevent intern signal compart',\n",
       "  'recent studi plasma neutral breadth hiv-1 infect individu nine intern aid vaccin initi iavi site report viral load hla-a 03 genotyp subtyp c infect strongli associ develop neutral breadth refin find studi analyz impact transmitted/found t/f envelop env earli env diversif autolog neutral develop plasma neutral breadth 21 particip identifi recent infect two site kigali rwanda n 9 lusaka zambia n 12 single-genom analysi full-length t/f env sequenc reveal 21 individu infect highli homogen popul viral variant categor subtyp c n 12 a1 n 7 recombin ac n 2 extens amino acid sequence-bas analysi variabl loop length glycosyl pattern t/f env reveal lower ratio nx nxt-encod glycan motif correl neutral breadth analysi compar amino acid sequenc chang insertions/delet glycan motif alter t/f env autolog earli env variant reveal extens diversif focus v2 v4 v5 region gp120 accompani contemporan viral escap significantli favor develop breadth result suggest effici glycosyl subtyp c t/f env fewer nxs-encod glycan site like elicit antibodi transit autolog heterolog neutral activ follow exposur gp120 diversif initi env-antibodi co-evolut cycl increas neutral breadth augment time addit viral host factor find suggest understand variat effici site-specif glycosyl influenc neutral antibodi elicit target could advanc design immunogen aim induc antibodi transit autolog heterolog neutral activ',\n",
       "  'oligodendrocyt myelin-form glial cell central nervou system maintain long-term axon integr howev underli support mechan understood identifi metabol compon axon–glia interact gener condit cox10 protohem ix farnesyltransferas mutant mice oligodendrocyt schwann cell fail assembl stabl mitochondri cytochrom c oxidas cox also known mitochondri complex iv peripher nervou system cox10 condit mutant exhibit sever neuropathi dysmyelin abnorm remak bundl muscl atrophi paralysi notabl perturb mitochondri respir caus glial cell death adult central nervou system found sign demyelin axon degener secondari inflamm unlik cultur oligodendrocyt sensit cox inhibitor post-myelin oligodendrocyt surviv well absenc cox activ importantli vivo magnet reson spectroscopi brain lactat concentr mutant increas compar control detect mice expos volatil anaesthet indic aerob glycolysi product deriv oligodendrocyt rapidli metabol within white matter tract myelin axon use lactat energy-depriv find suggest model axon–glia metabol coupl serv physiolog function',\n",
       "  'dendrit cell dc essenti antigen-pres cell induct immun pathogen howev hiv-1 spread strongli enhanc cluster dc cd4 cell uninfect dc captur hiv-1 mediat viral transfer bystand cd4 cell process term trans-infect initi studi identifi c-type lectin dc-sign hiv-1 bind factor dc interact viral envelop glycoprotein upon dc matur howev dc-sign down-regul hiv-1 captur trans-infect strongli enhanc via glycoprotein-independ captur pathway recogn sialyllactose-contain membran gangliosid show sialic acid-bind ig-lik lectin 1 siglec-1 cd169 highli express matur dc specif bind hiv-1 vesicl carri sialyllactos furthermor siglec-1 essenti trans-infect matur dc find identifi siglec-1 key factor hiv-1 spread via infecti dc/t-cell synaps highlight novel mechan mediat hiv-1 dissemin activ tissu',\n",
       "  'intestin microbiota becom relev aspect human health microbi colon run parallel immun system matur play role intestin physiolog regul increas evid earli microbi contact suggest human intestin microbiota seed birth matern microbiota form first microbi inoculum birth microbi divers increas converg toward adult-lik microbiota end first 3-5 year life perinat factor mode deliveri diet genet intestin mucin glycosyl contribut influenc microbi colon establish composit gut microbiota rel stabl throughout adult life alter result bacteri infect antibiot treatment lifestyl surgic long-term chang diet shift complex microbi system report increas risk diseas therefor adequ establish microbiota mainten throughout life would reduc risk diseas earli late life review discuss recent studi earli colon factor influenc process impact health',\n",
       "  'investig whether intrauterin protein restrict combin overfeed lactat would caus adult-onset obes metabol disord birth litter dam fed control 17 protein low protein 6 protein diet adjust size four co lo group respect eight cc lc group respect pup offspr fed diet contain 12 protein time wean 90 old compar cc lc group co lo group higher rel absolut food intak oxygen consumpt carbon dioxid product lower brown adipos tissu weight lipid content greater weight gain absolut rel white adipos tissu weight absolut lipid content compar co cc rat lc lo rat exhibit higher rel food intak brown adipos tissu weight lipid content reduc oxygen consumpt carbon dioxid product spontan activ increas rel retroperiton adipos tissu weight unalt absolut white adipos tissu weight lipid content fast serum glucos similar among group area glucos curv higher lo co rat lc cc rat basal insulinemia homeostasi model assess insulin resist homa-ir lower lo group group total area insulin curv lo rat similar cc rat lower co lc rat kitt higher lo lc co group cc group thu intrauterin protein restrict follow overfeed lactat induc obes produc glucos intoler impair pancreat function adulthood',\n",
       "  'defin transcript factor induc epigenet reprogram adult mammalian cell induc pluripot stem cell although dna factor integr reprogram method unknown whether genom remain unchang singl nucleotid level show 22 human induc pluripot stem hip cell line reprogram use five differ method contain averag five protein-cod point mutat region sampl estim six protein-cod point mutat per exom major mutat non-synonym nonsens splice variant enrich gene mutat caus effect cancer least half reprogramming-associ mutat pre-exist fibroblast progenitor low frequenc wherea rest occur reprogram thu hip cell acquir genet modif addit epigenet modif extens genet screen becom standard procedur ensur hip cell safeti clinic use',\n",
       "  'tumour-associ cell cycl defect often mediat alter cyclin-depend kinas cdk activ misregul cdk induc unschedul prolifer well genom chromosom instabl accord current model mammalian cdk essenti drive cell cycl phase therapeut strategi block cdk activ unlik select target tumour cell howev recent genet evid reveal wherea cdk1 requir cell cycl interphas cdk essenti prolifer special cell emerg evid suggest tumour cell may also requir specif interphas cdk prolifer thu select cdk inhibit may provid therapeut benefit certain human neoplasia',\n",
       "  'despit declin preval past two decad sudden infant death syndrom sid continu lead caus death infant age 1 month 1 year develop countri behaviour risk factor identifi epidemiolog studi includ prone side posit infant sleep smoke exposur soft bed sleep surfac overh evid also suggest pacifi use sleep time room share without bed share associ decreas risk sid although caus sid unknown immatur cardiorespiratori autonom control failur arous respons sleep import factor gene polymorph relat serotonin transport autonom nervou system develop might make affect infant vulner sid campaign risk reduct help reduc sid incid 50-90 howev reduc incid even greater stride must made reduc prenat smoke exposur implement recommend infant care practic continu research need identifi pathophysiolog basi sid',\n",
       "  'eukaryot heterochromatin character high densiti repeat transposon well modifi histon influenc gene express chromosom segreg fission yeast schizosaccharomyc pomb delet argonaut dicer rna-depend rna polymeras gene homolog encod part machineri respons rna interfer rnai delet result aberr accumul complementari transcript centromer heterochromat repeat accompani transcript de-repress transgen integr centromer loss histon h3 lysine-9 methyl impair centromer function propos double-strand rna aris centromer repeat target format mainten heterochromatin rnai',\n",
       "  'membran attack complex/perforin-lik macpf protein compris largest superfamili pore-form protein play crucial role immun pathogenesi solubl monom assembl larg transmembran pore via conform transit remain structur mechanist characteris present 11 å resolut cryo-electron microscopi cryo-em structur two-part fungal toxin pleurotolysin pli togeth crystal structur compon lipid bind plya protein pore-form macpf compon plyb data reveal 13-fold pore 80 å diamet 100 å height subunit compris plyb molecul atop membran bound dimer plya resolut em map togeth biophys comput experi allow confid assign subdomain macpf pore assembl major conform chang plyb ∼70° open bent distort central β-sheet macpf domain accompani extrus refold two α-helic region transmembran β-hairpin tmh1 tmh2 determin structur three differ disulphid bond-trap prepor intermedi analysi data molecular model flexibl fit allow us gener potenti trajectori β-sheet unbend result suggest macpf conform chang trigger disrupt interfac conserv helix-turn-helix motif top tmh2 follow releas propos transmembran region assembl β-hairpin via top zipper backbon hydrogen bond form membrane-insert β-barrel intermedi structur macpf domain refold β-barrel pore establish structur paradigm transit solubl monom pore may conserv across whole superfamili tmh2 region critic releas tmh cluster suggest region target endogen inhibitor macpf function',\n",
       "  'microrna mirna larg famili post-transcript regul gene express ∼21 nucleotid length control mani development cellular process eukaryot organ research past decad identifi major factor particip mirna biogenesi establish basic principl mirna function recent becom appar mirna regul subject sophist control mani report past year report regul mirna metabol function rang mechan involv numer protein–protein protein–rna interact regul import role context-specif function mirna',\n",
       "  'high mutat frequenc revers transcript princip role genet variat primat lentivir popul main drive forc gener drug resist escap immun surveil g hypermut one characterist primat lentivirus well retrovirus replic vivo cell cultur molecular mechan process howev remain clarifi demonstr cem15 also known apolipoprotein b mrna edit enzym catalyt polypeptide-lik 3g apobec3g endogen inhibitor human immunodefici viru type 1 hiv-1 replic cytidin deaminas abl induc g hypermut newli synthes viral dna effect counteract hiv-1 virion infect factor vif seem viral dna mutat viral defenc mechan host cell may induc either lethal hypermut instabl incom nascent viral revers transcript could account vif-defect phenotyp importantli accumul cem15-medi non-leth hypermut replic viral genom could potent contribut genet variat primat lentivir popul',\n",
       "  'introduct deregul excess host immun respons contribut pathogenesi sepsi toll-lik receptor tlr signal pathway neg regul play pivot role modul host immun respons develop sepsi object studi investig associ variant tlr signal pathway gene neg regul gene suscept sepsi chines han popul method patient sever sepsi n 378 healthi control subject n 390 enrol five gene name tlr2 tlr4 tlr9 myd88 tollip investig associ sepsi suscept tag singl nucleotid polymorph snp strategi twelv tag snp select base data chines han beij hapmap project genotyp direct sequenc mrna express level tollip determin use real-tim quantit polymeras chain reaction pcr assay concentr tumor necrosi factor alpha tnf-α interleukin-6 il-6 measur enzyme-link immunosorb assay elisa result result show minor c-allel rs5743867 tollip significantli associ decreas risk sepsi padj 0.00062 odd ratio adj 0.71 95 confid interv ci 0.59 0.86 adjust covari multipl logist regress analysi 3-snp haplotyp block harbor associ snp rs5743867 also display strong associ omnibu test p valu 0.00049. haplotyp gtc show protect role sepsi padj 0.0012 haplotyp gct show increas risk sepsi padj 0.00092 exposur lipopolysaccharid lp tollip mrna express level peripher blood mononuclear cell pbmc homozygot rs5743867c allel significantli higher heterozygot homozygot rs5743867t allel p 0.013 p 0.01 respect moreov concentr tnf-α il-6 cultur supernat significantli lower subject rs5743867cc genotyp ct tt genotyp subject p 0.016 p 0.003 tnf-α p 0.01 p 0.002 il-6 respect conclus find indic variant tollip significantli associ sepsi suscept chines han popul',\n",
       "  \"number method develop assist subject provid estim portion size applic improv portion size estim children investig systemat aim develop portion size assess tool use children assess accuraci children 's estim portion size use tool tool food photograph food model interact portion size assess system ipsa children n 201 age 4-16 year suppli known quantiti food eat school food leftov weigh children estim amount food use tool 24 h consum food age-specif portion size repres base portion size consum children nation survey signific differ found accuraci estim use three tool children age perform well use ipsa food photograph accuraci precis estim made use food model poor tool estim amount food serv accur estim amount consum issu relat report food left impact estim amount food actual consum requir studi ipsa shown potenti assess dietari intak children practic applic assess dietari intak children tool would need expand cover wider rang food valid 'real-lif situat\",\n",
       "  'bud yeast kinetochor ~68 nm length diamet slightli larger 25 nm microtubul kinetochor 16 chromosom organ stereotyp cluster encircl central spindl microtubul quantit analysi inner kinetochor cluster cse4 coma reveal structur featur appar singli attach kinetochor cluster cse4-contain kinetochor physic larger perpendicular spindl axi rel cluster ndc80 molecul singl cse4 molecul nucleosom kinetochor attach microtubul plu end cluster cse4 would appear geometr ident ndc80 thu structur inner kinetochor surfac chromosom remain unsolv use point fluoresc microscopi statist probabl map deduc two-dimension mean posit repres compon yeast kinetochor rel mitot spindl metaphas comparison experiment imag three-dimension architectur convolut mathemat model reveal pool cse4 radial displac cse4 kinetochor kinetochor microtubul plu end pool displac cse4 experiment deplet mrna process pat1δ xrn1δ mutant peripher cse4 molecul templat outer kinetochor compon studi suggest inner kinetochor plate centromere-microtubul interfac bud yeast yield inform number ndc80 molecul microtubul attach site',\n",
       "  \"oncologist critic opportun util risk assess cancer prevent strategi interrupt initi progress cancer cancer survivor individu high risk develop cancer expand knowledg natur histori prognosi cancer posit oncologist advis patient regard risk second malign treatment-rel cancer addit recogn expert full spectrum cancer care oncologist afford opportun involv community-bas cancer prevent activ although oncologist current provid mani cancer prevent risk assess servic patient econom barrier exist includ inadequ lack insur may compromis uniform patient access servic addit insuffici reimburs exist develop intervent may discourag patient access servic american societi clinic oncolog asco medic societi repres cancer specialist involv patient care clinic research commit support oncologist wide-rang involv cancer prevent statement risk assess prevent counsel although intend comprehens overview cancer prevent describ current role oncologist risk assess prevent provid exampl risk assess prevent activ offer oncologist identifi potenti opportun coordin oncologist primari care physician prevent educ coordin care cancer survivor describ asco 's involv educ train oncologist regard prevent propos improv payment environ encourag patient access servic\",\n",
       "  \"werner 's syndrom ws bloom 's syndrom bs cancer predisposit disord caus loss function recq helicas wrn blm respect bs ws character replic defect hyperrecombin event chromosom aberr hallmark cancer ineffici replic g-rich telomer strand contribut chromosom aberr ws cell demonstr link wrn telomer genom stabil herein provid evid blm also contribut chromosome-end mainten telomer defect td observ blm-defici cell elev frequenc similar cell lack function wrn helicas loss helicas exacerb td chromosom aberr indic blm wrn function independ telomer mainten blm local particularli recruit telomer chang respons replic dysfunct wrn-defici cell aphidicolin treatment exposur replic challeng caus increas decaten deoxyribonucl acid dna structur late-repl intermedi lri visibl blm-cover ultra-fin bridg ufb anaphas subset ufb origin telomer dna frequenc correl telomer replic defect propos blm complex contribut telomer mainten activ resolv lri\",\n",
       "  'variou condit differenti embryon stem es cell induc pluripot stem ip cell specif kind cell line intens investig howev product function organ three-dimension structur es ip cell difficult achiev vitro present paper describ establish green fluoresc protein-express rat es cell line product mouse↔rat es chimera inject rat es cell mous blastocyst rat es cell contribut variou organ chimera includ germ cell inject es cell blastocyst nu/nu mice lack thymu result chimera produc thymu deriv rat es cell bodi chimer anim may provid method deriv variou organ es ip cell',\n",
       "  'despit import cn blood vessel molecular mechan regul cn angiogenesi blood-brain barrier bbb format larg unknown analyz role wnt/beta-catenin signal regul format cn blood vessel first analysi top-gal wnt report mice identifi canon wnt/beta-catenin signal specif activ cn non-cn blood vessel develop activ correl express differ wnt ligand neural progenitor cell distinct locat throughout cn includ wnt7a wnt7b ventral region wnt1 wnt3 wnt3a wnt4 dorsal region blockad wnt/beta-catenin signal vivo specif disrupt cn non-cn angiogenesi defect includ reduct vessel number loss capillari bed format hemorrhag vascular malform remain adher mening furthermor demonstr wnt/beta-catenin signal regul express bbb-specif glucos transport glut-1 taken togeth experi reveal essenti role wnt/beta-catenin signal drive cns-specif angiogenesi provid molecular evid angiogenesi bbb format part link',\n",
       "  'anthocyanin group natur occur phenol compound wide avail fruit veget human diet broad biolog activ includ anti-mutagenesi anticarcinogenesi gener attribut antioxid activ studi effect mechan common type anthocyanin cyanidin-3-rutinosid sever leukemia lymphoma cell line found cyanidin-3-rutinosid extract purifi black raspberri cultivar jewel induc apoptosi hl-60 cell dose- time-depend manner paradox compound induc accumul peroxid involv induct apoptosi hl-60 cell addit cyanidin-3-rutinosid treatment result reactiv oxygen speci ro -depend activ p38 mapk jnk contribut cell death activ mitochondri pathway mediat bim down-regul bim overexpress bcl-2 bcl-x l consider block apoptosi notabl cyanidin-3-rutinosid treatment lead increas ro accumul normal human peripher blood mononuclear cell cytotox effect cell result indic cyanidin-3-rutinosid potenti use leukemia therapi advantag wide avail select tumor',\n",
       "  'develop acut chronic inflammatori respons known gout pseudogout associ deposit monosodium urat msu calcium pyrophosph dihydr cppd crystal respect joint periarticular tissu although msu crystal first identifi aetiolog agent gout eighteenth centuri recent ‘ danger signal ’ releas die cell littl known molecular mechan underli msu- cppd-induc inflamm show msu cppd engag caspase-1-activ nalp3 also call cryopyrin inflammasom result product activ interleukin il -1β il-18 macrophag mice defici variou compon inflammasom caspase-1 asc nalp3 defect crystal-induc il-1β activ moreov impair neutrophil influx found vivo model crystal-induc periton inflammasome-defici mice mice defici il-1β receptor il-1r find provid insight molecular process underli inflammatori condit gout pseudogout support pivot role inflammasom sever autoinflammatori diseas',\n",
       "  'adult stem cell includ hematopoiet stem cell hsc maintain quiescent rest state vivo quiescenc wide consid essenti protect mechan stem cell minim endogen stress caus cellular respir dna replic demonstr hsc quiescenc also detriment effect found hsc uniqu cell-intrins mechan ensur surviv respons ioniz irradi ir includ enhanc prosurviv gene express strong activ p53-mediat dna damag respons show quiescent prolifer hsc equal radioprotect use differ type dna repair mechan describ nonhomolog end join nhej -mediat dna repair quiescent hsc associ acquisit genom rearrang persist vivo contribut hematopoiet abnorm result demonstr quiescenc double-edg sword render hsc intrins vulner mutagenesi follow dna damag',\n",
       "  'membran receptor initi signal transduct upon ligand bind matter intens scrutini cell receptor complex tcr-cd3 compos tcr alpha/beta ligand bind subunit bound cd3 subunit respons signal transduct although long specul tcr-cd3 may undergo conform chang confirm still lack present strong evid ligand engag tcr-cd3 induc conform chang expos proline-rich sequenc cd3 epsilon result recruit adaptor protein nck occur earlier independ tyrosin kinas activ final interf nck-cd3 epsilon associ vivo demonstr tcr-cd3 recruit nck critic matur immun synaps cell activ',\n",
       "  'rna molecul contain varieti chemic divers posttranscript modifi base abund modifi base found cellular rna pseudouridin ψ recent map hundr site mrna mani dynam regul though pseudouridin landscap determin cell type growth condit enzym respons mrna pseudouridyl univers conserv suggest mani novel pseudouridyl site remain discov present pseudo-seq techniqu allow identif site pseudouridyl genome-wid single-nucleotid resolut chapter provid detail descript pseudo-seq includ protocol rna isol saccharomyc cerevisia pseudo-seq librari prepar data analysi includ descript process map sequenc read comput identif site pseudouridyl assign site specif pseudouridin synthas approach present readili adapt cell tissu type high-qual mrna isol identif novel pseudouridyl site import first step elucid regul function modif',\n",
       "  'chemic modif dna histon protein form complex regulatori network modul chromatin structur genom function epigenom refer complet descript potenti herit chang across genom composit epigenom within given cell function genet determin lineag environ sequenc human genom complet investig seek comprehens view epigenet chang determin genet inform made manifest across incred vari background development stage tissu type diseas state review current research effort emphasi large-scal studi emerg technolog challeng ahead',\n",
       "  'stromal-interact molecul 1 stim1 endoplasm reticulum ca 2+ storag sensor promot cell growth migrat angiogenesi breast cervic cancer report microtubule-associ histon deacetylas 6 hdac6 differenti regul activ stim1-medi store-oper ca 2+ entri soce cervic cancer cell normal cervic epitheli cell confoc microscopi live cell indic microtubul integr necessari stim1 traffick plasma membran interact orai1 essenti pore subunit soce cancer cell overexpress stim1 orai1 compar normal cervic epitheli cell hdac6 upregul cancer cell accompani hypoacetyl α-tubulin tubastatin-a specif hdac6 inhibitor inhibit stim1 transloc plasma membran block soce activ cancer cell normal epitheli cell genet pharmacolog inhibit hdac6 block stim1 membran traffick downstream ca 2+ influx evidenc total intern reflect fluoresc imag intracellular ca 2+ determin contrast hdac6 inhibit affect interact stim1 microtubul plu end-bind protein eb1 analysi surgic specimen confirm cervic cancer tissu overexpress stim1 orai1 accompani hypoacetyl α-tubulin togeth result identifi hdac6 candid target disrupt stim1-medi soce gener strategi block malign cell behavior',\n",
       "  'medullari thymic epitheli cell mtec establish cell self-toler express autoimmun regul air peripher tissue-specif self-antigen howev signal underli mtec develop remain larg unclear demonstr crucial regul mtec develop receptor activ nf-kappab rank cd40 signal wherea rank signal essenti mtec develop embryogenesi postnat mice cooper cd40 rank signal requir mtec develop success establish medullari microenviron ligat rank cd40 fetal thymic stroma vitro induc mtec develop tumor necrosi factor-associ factor 6 traf6 nf-kappab induc kinas nik ikappab kinas beta ikkbeta -depend manner result show developmental-stage-depend cooper rank cd40 promot mtec develop therebi establish self-toler',\n",
       "  'genome-wid associ studi greatli improv understand genet basi diseas risk fact tend identifi fraction specif causal loci led diverg opinion whether varianc hidden numer rare variant larg effect common variant small effect review 20 argument model genet basi complex trait conclud class effect readili reconcil',\n",
       "  'cell-select glucocorticoid receptor gr bind distal regulatori element associ cell type-specif region local access chromatin region either pre-exist chromatin pre-program induc receptor de novo mechan creat maintain site well understood observ global enrich cpg densiti pre-program element implic demethyl state mainten open chromatin tissue-specif manner contrast site activ open gr de novo character low cpg densiti form uniqu class enhanc devoid suppress effect agglomer methyl-cytosin furthermor treatment glucocorticoid induc rapid chang methyl level select cpg within de novo site final identifi gr-bind element cpg critic posit show methyl affect gr-dna interact vitro find present uniqu link tissue-specif chromatin access dna methyl transcript factor bind show dna methyl integr compon gene regul nuclear receptor',\n",
       "  'base vitro unwind activ g-quadruplex g4 dna bloom syndrome-associ helicas blm propos particip telomer replic aid fork progress g-rich telomer dna singl molecul analysi replic dna smard use determin contribut blm helicas telomer replic blm-defici cell replic fork initi origin within telomer copi g-rich strand lead strand synthesi move slower telomer compar adjac subtelomer fork progress telomer slow presenc g4 stabil use g4-specif antibodi found defici blm anoth g4-unwind helicas werner syndrome-associ helicas wrn result increas g4 structur cell importantli defici either helicas led greater increas g4 dna detect telomer compar g4 seen genome-wid collect find consist blm helicas facilit telomer replic resolv g4 structur form copi g-rich strand lead strand synthesi',\n",
       "  '25 year ago myc human homologu retrovir oncogen identifi sinc time myc research intens advanc impress reflect astonish increment insight myc regul function also impact numer biolog disciplin includ understand molecular oncogenesi gener chronicl major advanc understand myc biolog peer futur myc research',\n",
       "  \"physic activ protect cardiovascular diseas physiolog cardiac hypertrophi associ regular exercis usual benefici mark contrast patholog hypertrophi associ diseas p110alpha isoform phosphoinositid 3-kinas pi3k play critic role induct exercise-induc hypertrophi whether gene activ athlet 's heart might impact cardiac function surviv set heart failur unknown examin whether progress exercis train pi3k p110alpha activ affect surviv and/or cardiac function two model heart diseas subject transgen mous model dilat cardiomyopathi dcm swim train genet cross cardiac-specif transgen mice increas decreas pi3k p110alpha activ dcm model subject pi3k p110alpha transgen acut pressur overload ascend aortic constrict life-span cardiac function molecular marker patholog hypertrophi examin exercis train increas cardiac pi3k p110alpha activ prolong surviv dcm model 15-20 contrast reduc pi3k p110alpha activ drastic shorten lifespan approxim 50 increas pi3k p110alpha activ favor effect cardiac function fibrosi pressure-overload model attenu patholog growth pi3k p110alpha signal neg regul g protein-coupl receptor stimul extracellular respons kinas akt via pi3k p110gamma activ isol cardiomyocyt find suggest exercis enhanc pi3k p110alpha activ delay prevent progress heart diseas supraphysiolog activ benefici identif gene import hypertrophi athlet 's heart could offer new strategi treat heart failur\",\n",
       "  'background lifestyl factor includ cigarett smoke alcohol consumpt nutrit habit impact health well risk chronic diseas area in-vitro fertil ivf pregnanc lifestyl factor influenc oocyt product fertil rate pregnanc pregnanc loss chronic low-grad oxid stress may underli poor outcom ivf case method review current literatur present origin previous unpublish data obtain coupl attend pivet medic centr western australia result studi 80 femal 70 male partner complet 1-week diari document smoke alcohol fruit veget intak subsequ clinic outcom ivf treatment quantiti oocyt collect fertil rate pregnanc pregnanc loss submit multipl regress analysi order investig relationship patient treatment record lifestyl factor signific found male smoke caus increas risk pregnanc loss p 0.029 femal smoke caus advers effect ovarian reserv alcohol consumpt β 0.074 p 0.001 fruit veget consumpt β 0.034 p 0.001 posit effect fertil conclus base result current literatur import impact lifestyl factor ivf clinic outcom current conflict result regard lifestyl factor nutrit habit alcohol consumpt appar chronic oxid stress induc lifestyl factor poor nutrit habit associ lower rate ivf success',\n",
       "  'cluster regularli interspac short palindrom repeat crispr /cas9 system wide use nuclear dna edit gener mutat correct specif diseas allel despit flexibl applic determin crispr/cas9 origin identifi bacteri defens system viru target mitochondria mtdna edit show regular flag-cas9 local mitochondria edit mitochondri dna sgrna target specif loci mitochondri genom express flag-cas9 togeth grna target cox1 cox3 lead cleavag specif mtdna loci addit observ disrupt mitochondri protein homeostasi follow mtdna truncat cleavag crispr/cas9 overcom nonspecif distribut flag-cas9 also creat mitochondria-target cas9 mitocas9 new version cas9 local mitochondria togeth express grna target mtdna specif cleavag mtdna mitocas9-induc reduct mtdna transcript lead mitochondri membran potenti disrupt cell growth inhibit mitocas9 could appli edit mtdna togeth grna express vector without affect genom dna brief studi demonstr mtdna edit possibl use crispr/cas9 moreov develop mitocas9 specif local mitochondria facilit applic mitochondri genom edit',\n",
       "  's. cerevisia histon variant h2a.z deposit euchromatin flank silent heterochromatin prevent ectop spread show h2a.z nucleosom found promot region nearli gene euchromatin gener occur two posit nucleosom flank nucleosome-fre region nfr contain transcript start site astonishingli enrich 5 end observ activ transcrib gene also inact loci mutagenesi typic promot reveal 22 bp segment dna suffici program format nfr flank two h2a.z nucleosom segment contain bind site myb-rel protein reb1 adjac dt da tract effici deposit h2a.z promot specif pattern histon h3 h4 tail acetyl bromodomain protein bdf1 compon swr1 remodel complex deposit h2a.z',\n",
       "  'background pulmonari hypertens ph associ restrict physic capac limit qualiti life poor prognosi right heart failur present studi first prospect random studi evalu effect exercis respiratori train patient sever symptomat ph method result thirti patient ph 21 women mean age 50+/-13 year mean pulmonari arteri pressur 50+/-15 mm hg mean world health organ class 2.9+/-0.5 pulmonari arteri hypertens n=23 chronic thromboembol ph n=7 stabl disease-target medic randomli assign control n=15 primari train n=15 group medic remain unchang studi period primari end point chang baselin week 15 distanc walk 6 minut score short form health survey quality-of-lif questionnair chang function class borg scale paramet echocardiographi ga exchang also assess week 15 patient primari secondari train group improv 6-minut walk distanc mean differ control primari train group 111 95 confid interv 65 139 p 0.001 exercis train well toler improv score qualiti life function class peak oxygen consumpt oxygen consumpt anaerob threshold achiev workload systol pulmonari arteri pressur valu rest chang significantli 15 week exercis respiratori train 61+/-18 54+/-18 mm hg within train group conclus studi indic respiratori physic train could promis adjunct medic treatment sever ph effect add benefici result modern medic treatment',\n",
       "  'introduct 1996 haart rais hope erad hiv-1 unfortun discoveri latent hiv-1 reservoir cd4+ cell monocyte-macrophag lineag prove optim prematur long-liv hiv-1 reservoir constitut major obstacl erad hiv-1 review focu establish mainten hiv-1 latenc two major target hiv-1 cd4+ cell monocyte-macrophag lineag understand cell-typ molecular mechan establish mainten reactiv hiv-1 latenc reservoir crucial effici therapeut intervent complet viral erad holi graal clinician might achiev strateg intervent target latent product infect cell suggest new approach combin differ kind provir activ may help reduc dramat size latent hiv-1 reservoir patient haart',\n",
       "  'purpos present studi examin whether electro-acupunctur therapi reduc post-strok depress psd whether motor function impair interact effect therapi subject twenty-eight psd patient assess assign either good poor motor function group depend motor grade method beck depress inventori bdi hamilton depress rate scale hdr manual muscl test mmt administ screen initi phase studi 4th 8th 12th 16th week daili electro-acupunctur treatment result electro-acupunctur treatment reduc psd assess bdi hdr patient particular depress good motor function group significantli reduc poor motor function group degre motor function impair chang throughout studi either group conclus result present studi demonstr electro-acupunctur therapi improv psd treatment effect vari depend degre motor function impair',\n",
       "  'tcell antigen receptor tcr ligat initi tyrosin kinas activ signal complex assembl immun synaps format studi kinet mechan signal complex format live jurkat leukem cell use signal protein fluoresc tag variant enhanc gfp egfp within second contact coverslip coat stimulatori antibodi cell develop small dynam regul cluster enrich tcr phosphotyrosin zap-70 lat grb2 gad slp-76 exclud lipid raft marker enhanc yellow fluoresc protein–gpi compet induc calcium elev lat grb2 gad transient associ tcr although zap-70–contain cluster persist 20 min photobleach studi reveal zap-70 continu dissoci return complex strikingli slp-76 transloc perinuclear structur cluster tcr result emphas dynam chang composit signal complex indic complex form within second tcr engag absenc either lipid raft aggreg format central tcr-rich cluster',\n",
       "  'rational fibrosi mediat partli extracellular matrix-deposit fibroblast heart although mesenchym cell report multipl embryon origin function consequ heterogen unknown object sought valid panel surfac marker prospect identifi cardiac fibroblast elucid development origin cardiac fibroblast character correspond phenotyp also determin prolifer rate development subset fibroblast pressur overload injuri method result show thy1 cd45 cd31 cd11b ter119 cell constitut major cardiac fibroblast character cell use flow cytometri epifluoresc confoc microscopi transcript profil use revers transcript polymeras chain reaction rna-seq use lineag trace transplant studi parabiosi show adult cardiac fibroblast deriv epicardium minor aris endotheli cell small fraction pax3-express cell detect gener cardiac fibroblast bone marrow circul cell interestingli prolifer rate fibroblast subset injuri ident rel abund lineag remain injuri anatom distribut fibroblast lineag also remain unchang pressur overload furthermor rna-seq analysi demonstr tie2-deriv tbx18-deriv fibroblast within oper group exhibit similar gene express profil conclus cellular expans cardiac fibroblast transaort constrict surgeri restrict singl development subset parallel prolifer activ heterogen popul fibroblast pressur overload could suggest common signal mechan stimul patholog respons',\n",
       "  \"pre-eclampsia hypertens diseas pregnanc worldwid incid 5-8 review focus recent develop pre-eclampsia research relat angiogenesi metabol first address 'angiogen imbal theori hypothes pre-eclampsia result imbal factor promot antagon angiogenesi solubl fms-like tyrosin kinas sflt1 2-methoxyestradiol 2-me catechol-o-methyltransferas comt next analyz associ pre-eclampsia dysfunct metabol homocystein placent glycogen hope illumin variou connect exist angiogenesi metabol pre-eclampsia facilit updat reconsider old model pathogenesi\",\n",
       "  'lysin acetyl revers posttransl modifc epigenet phenomenon refer transfer acetyl group acetyl coa lysin e- amino group target protein modul acetyltransferas histone/ lysin k acetyltransferas hats/kat deacetylas histone/lysin k deacetylas hdacs/kdac lysin acetyl regul variou metabol process fatti acid oxid kreb cycl oxid phosphoryl angiogenesi thu disord lysin acetyl may correl obes diabet cardiovascular diseas term metabol complic accumul studi proteom acetyl lysin acetyl also involv cell immun statu degen diseas exampl alzheim ’ diseas huntington ’ diseas review primarili summar current studi lysin acetyl metabol modul metabolism-rel diseas cardiovascular diseas fat metabol disord',\n",
       "  'background recent studi suggest betaklotho klb endocrin fgf19 fgf21 redirect fgfr signal regul metabol homeostasi suppress obes diabet howev ident predomin metabol tissu major fgfr-klb resid critic mediat differenti action metabol effect fgf19 fgf21 remain unclear methodology/princip find determin receptor tissu specif fgf21 comparison fgf19 use direct sensit quantit bind kinet downstream signal transduct express earli respons gene upon administr fgf19 fgf21 mice found fgf21 bind fgfr1 much higher affin fgfr4 presenc klb fgf19 bind fgfr1 fgfr4 presenc klb compar affin interact fgf21 fgfr4-klb weak even high concentr could neglig physiolog concentr fgf19 fgf21 fgf1 exhibit bind affin klb bind fgf1 depend fgfr present fgf19 fgf21 unabl displac fgf1 bind convers fgf1 displac fgf19 fgf21 bind result indic klb indispens mediat bind fgf19 fgf21 fgfr requir fgf1 although fgf19 predominantli activ respons liver less extent adipos tissu fgf21 significantli adipos tissu adipocyt among sever metabol endocrin tissu respons adipos tissu fgf21 predomin blunt ablat klb fgfr1 conclus result indic unlik fgf19 fgf21 unabl bind fgfr4-klb complex affin compar fgfr1-klb therefor physiolog concentr less like directli significantli target liver fgfr4-klb predominantli resid howev fgf21 fgf19 potenti activ respons primarili adipos tissu fgfr1-klb resid',\n",
       "  'epitop vaccin promis option therapeut vaccin helicobact pylori h. pylori infect studi construct multi-epitop vaccin five epitop mucos adjuv e. coli heat-labil enterotoxin b subunit ltb name huepi-ltb evalu therapeut effect h. pylori infect balb/c mice model huepi-ltb contain three th epitop ureb two b cell epitop ureb hpaa construct express e. coli oral therapeut immun huepi-ltb significantli decreas h. pylori colon compar oral immun pb protect correl antigen-specif cd4+ cell igg mucos iga antibodi respons multi-epitop vaccin may promis vaccin candid may help control h. pylori infect',\n",
       "  'increas level dna fragment frequent found blood plasma cancer patient publish data suggest fraction dna blood plasma deriv cancer cell howev known much circul dna cancer noncanc cell quantit methylation-specif pcr promot region cdkn2a tumor suppressor gene abl quantifi fraction plasma dna deriv tumor cell plasma sampl 30 unselect cancer patient detect quantiti tumor dna 3 much 93 total circul dna investig possibl origin nontumor dna plasma demonstr contribut t-cell dna case investig possibl plasma dna origin apoptot necrot cell perform studi apoptot staurosporin necrot staurosporin plu oligomycin cell vitro mice induct apoptot anti-cd95 necrot acetaminophen liver injuri increas amount dna found releas supernat cell blood plasma sampl treat anim clear discrimin apoptot necrot plasma dna possibl gel electrophoresi characterist pattern dna fragment could identifi plasma deriv differ cancer patient data consist possibl apoptot necrot cell major sourc plasma dna cancer patient',\n",
       "  'background platelet deposit aggreg central pathogenesi ischem complic acut coronari syndrom ac pharmacodynam effect platelet glycoprotein iib/iiia antagonist eptifibatid delin healthi subject patient ac assess effect eptifibatid ex vivo platelet aggreg patient enrol platelet glycoprotein iib/iiia unstabl angina receptor suppress use integrilin eptifibatid therapi pursuit trial ac method result patient randomli assign intraven bolu 180 microgram/kg 72-hour infus eptifibatid 2.0 microgram/kg per minut n=48 placebo n=50 assess correl plasma eptifibatid level receptor occup inhibit ex vivo platelet aggreg 5 minut 1 4 24 48 72 hour treatment 4 8 hour termin infus blood collect buffer citrat d-phenylalanyl-l-prolyl-l-arginin chloromethylketon anticoagul although eptifibatid produc profound prolong inhibit platelet aggreg therapi aggreg appear recov partial 4 hour bolu aggreg respons greater thrombin receptor agonist peptid versu adp stimul inhibit platelet aggreg greater blood sampl anticoagul citrat versu d-phenylalanyl-l-prolyl-l-arginin chloromethylketon ppack plasma eptifibatid level correl significantli receptor occup inhibit platelet aggreg conclus bolu infus eptifibatid inhibit platelet aggreg profoundli patient ac follow brief partial recoveri result enhanc understand relat pharmacodynam clinic effect eptifibatid patient may import implic use percutan intervent',\n",
       "  \"purpos review encapsul current understand proinflammatori cytokin respons inflamm underli crohn 's diseas prospect use inform devis therapi condit base inhibit cytokin recent find current research shed new light role helper cell th 1 th17 respons pathogenesi crohn 's diseas initi studi conduct decad ago highlight view crohn 's diseas inflamm caus interleukin-12-driven th1 respons result gener interferon-gamma serv main inflammatori mediat recent year howev view larg eclips studi conduct mainli murin model show th17 respons main caus crohn 's diseas inflamm product interleukin-17 somewhat balanc view emerg hold interferon-gamma still major proinflammatori cytokin crohn 's diseas although may aris th1 th17-mediat respons differ phase inflammatori process summari new find continu support idea anti-interleukin-12p40 antibodi inhibit th1 th17 respons logic potent anticytokin treatment crohn 's diseas\",\n",
       "  'clinic measur comparison new measur techniqu establish one often need see whether agre suffici new replac old investig often analys inappropri notabl use correl coeffici use correl mislead altern approach base graphic techniqu simpl calcul describ togeth relat analysi assess repeat',\n",
       "  'express particular drug transport respons antibiot pressur critic element develop bacteri multidrug resist repres seriou concern human health obtain better understand underli regulatori mechan dissect transcript activ atp-bind cassett abc transport bmrc/bmrd gram-posit model bacterium bacillu subtili use promoter-gfp fusion live cell array technolog demonstr tempor control transcript activ bmrcd gene respons antibiot target protein synthesi intriguingli bmrcd express occur late-exponenti stationari growth stage irrespect time antibiot challeng show due tight transcript control transit state regul abrb moreov result show bmrcd gene co-transcrib bmrb yhej small open read frame immedi upstream bmrc harbor three altern stem-loop structur stem-loop appar crucial antibiotic-induc bmrcd transcript importantli antibiotic-induc bmrcd express requir translat bmrb impli bmrb serv regulatori leader peptid altogeth demonstr first time ribosome-medi transcript attenu mechan control express multidrug abc transport',\n",
       "  'mesenchym stem cell msc osteolineag cell contribut hematopoiet stem cell hsc nich bone marrow long bone howev development relationship remain unclear studi demonstr differ msc popul develop marrow long bone distinct function prolif mesoderm-deriv nestin msc particip fetal skeletogenesi lose msc activ soon birth contrast quiescent neural crest-deriv nestin cell preserv msc activ gener fetal chondrocyt instead differenti hsc niche-form msc help establish hsc nich secret cxcl12 perineur migrat cell bone marrow requir erbb3 receptor neonat nestin-gfp pdgfrα cell popul also contain schwann cell precursor compris matur schwann cell thu develop bone marrow hsc niche-form msc share common origin sympathet peripher neuron glial cell ontogen distinct msc non-overlap function endochondrogenesi hsc nich format',\n",
       "  'induc pluripot stem cell ipsc offer immens potenti regen medicin studi diseas develop somat cell reprogram involv epigenom reconfigur confer ipsc characterist similar embryon stem es cell howev remain unknown complet reestablish es-cell-lik dna methyl pattern throughout genom report first whole-genom profil dna methyl single-bas resolut five human ipsc line along methylom es cell somat cell differenti ipsc es cell ipsc show signific reprogram variabl includ somat memori aberr reprogram dna methyl ipsc share megabase-scal differenti methyl region proxim centromer telomer display incomplet reprogram non-cg methyl differ cg methyl histon modif lastli differenti ipsc trophoblast cell reveal error reprogram cg methyl transmit high frequenc provid ipsc reprogram signatur maintain differenti',\n",
       "  'background sexual dimorph exist incid preval coronari arteri diseas -- men commonli affect age-match women explor role chromosom coronari arteri diseas context sexual inequ method genotyp 11 marker male-specif region chromosom 3233 biolog unrel british men three cohort british heart foundat famili heart studi bhf-fh west scotland coronari prevent studi woscop cardiogen studi basi inform chromosom track back one 13 ancient lineag defin haplogroup examin associ common chromosom haplogroup risk coronari arteri diseas cross-sect bhf-fh prospect woscop final undertook function analysi chromosom effect monocyt macrophag transcriptom british men cardiogen studi find nine haplogroup identifi two r1b1b2 account roughli 90 chromosom variant among british men carrier haplogroup 50 higher age-adjust risk coronari arteri diseas men chromosom lineag bhf-fh odd ratio 1·75 95 ci 1·20-2·54 p=0·004 woscop 1·45 1·08-1·95 p=0·012 joint analysi popul 1·56 1·24-1·97 p=0·0002 associ haplogroup increas risk coronari arteri diseas independ tradit cardiovascular socioeconom risk factor analysi macrophag transcriptom cardiogen studi reveal 19 molecular pathway show strong differenti express men haplogroup lineag chromosom interconnect common gene relat inflamm immun strong relev atherosclerosi interpret human chromosom associ risk coronari arteri diseas men european ancestri possibl interact immun inflamm fund british heart foundat uk nation institut health research lew carti charit fund nation health medic research council australia european union 6th framework programm wellcom trust',\n",
       "  \"unlabel cytoscap popular bioinformat packag biolog network visual data integr version 2.8 introduc two power new featur -- custom node graphic attribut equat -- use jointli greatli enhanc cytoscap 's data integr visual capabl custom node graphic allow imag project onto node includ imag gener dynam remot locat attribut equat provid cytoscap spreadsheet-lik function valu attribut comput dynam function attribut network properti avail implement cytoscap desktop java applic releas librari gnu public licens lgpl binari instal bundl sourc code cytoscap 2.8 avail download http //cytoscape.org\",\n",
       "  'chromatin immunoprecipit assay contribut greatli understand role histon modif gene regul howev permit analysi single-cel resolut thu confound analys heterogen cell popul present method permit visual histon modif singl genom loci single-cel resolut formaldehyde-fix paraffin-embed tissu section base combin use situ hybrid proxim ligat assay show dimethyl lysin 4 histon h3 h3k4me2 myh11 locu restrict smooth muscl cell smc lineag human mous tissu section mark persist even phenotyp modul smc atherosclerot lesion show detect express smc marker gene methodolog promis broad applic studi epigenet mechan complex multicellular tissu develop diseas',\n",
       "  \"wobbl modif trna 5-methoxycarbonylmethyl-2-thiouridin mcm 5 2 u requir proper decod nnr codon eukaryot 2-thio group confer conform rigid mcm 5 2 u larg fix c3'-endo ribos pucker ensur stabl accur codon-anticodon pair identifi five gene saccharomyc cerevisia yil008w urm1 yhr111w uba4 yor251c tum1 ynl119w ncs2 ygl211w ncs6 requir 2-thiolat mcm 5 2 u. vitro sulfur transfer experi reveal tum1p stimul cystein desulfuras nfs1p accept persulfid sulfur nfs1p urm1 ubiquitin-rel modifi uba4 e1-lik enzym involv protein urmyl carboxy-terminu urm1p activ acyl-adenyl -coamp thiocarboxyl -cosh uba4p activ thiocarboxyl util subsequ reaction 2-thiouridin format mediat ncs2p/ncs6p could success reconstitut 2-thiouridin format vitro use recombin protein studi reveal 2-thiouridin format share pathway chemic reaction protein urmyl sulfur-flow eukaryot 2-thiouridin format distinct mechan bacteri sulfur-relay system base persulfid chemistri\",\n",
       "  'object studi preval asthma asthma symptom bronchial hyperrespons swedish cross countri skier compar non-skier monitor chang symptom bronchial hyperrespons year design cross section studi winter ski season summer set six ski club élite skier total 47 two differ area sweden subject 42 élite cross countri skier 29 non-ski refer main outcom measur bronchial respons asthma symptom lung function result bronchial respons significantli greater asthma symptom preval skier refer differ bronchial respons within either group winter summer 15 42 skier use antiasthmat drug regularli 23 combin asthma symptom hyperrespons airway physician diagnos asthma altogeth 33 skier symptom asthma bronchial hyperrespons one refer symptom asthma bronchial hyperrespons none use antiasthmat drug regularli conclus asthma asthma-lik symptom bronchial hyperrespons much common cross countri skier gener popul non-skier strenuou exercis low temperatur entail breath larg volum cold air probabl explan persist asthma skier',\n",
       "  \"recq famili helicas function safeguard genom unlik escherichia coli gram-posit bacillu subtili bacterium possess two recq-lik homologu recq bs rec requir repair dna double-strand break recq bs also bind fork dna ensur smooth progress cell cycl present first biochem analysi recombin recq bs recq bs bind weakli single-strand dna ssdna blunt-end double-strand dna dsdna strongli fork dsdna protein exhibit dna-stimul atpas activ atp- mg 2+ -depend dna helicas activ 3 → 5 polar molecular model show recq bs share high sequenc structur similar e. coli recq surprisingli recq bs resembl truncat saccharomyc cerevisia sgs1 human recq helicas recq ec regard enzymat activ specif recq bs unwind fork dsdna dna duplex 3'-overhang inact blunt-end dsdna 5'-overhung duplex interestingli recq bs unwind blunt-end dna structur featur includ nick gap 5'-flap kappa joint synthet replic fork holliday junction discuss find context recq bs 's possibl function preserv genom stabil\",\n",
       "  'cu/zn superoxid dismutas sod1 abund enzym best studi regul antioxid defens use yeast saccharomyc cerevisia report sod1 transmit signal oxygen glucos repress respir mechan involv sod1-medi stabil two casein kinas 1-gamma ck1γ homolog yck1p yck2p requir respiratori repress sod1 bind c-termin degron identifi yck1p/yck2p promot kinas stabil catalyz superoxid convers peroxid effect sod1 ck1γ stabil also observ mammalian sod1 ck1γ human cell line therefor singl circuit oxygen glucos reactiv oxygen repress respir sod1/ck1γ signal data therefor may provid mechanist insight rapidli prolifer cell mani cancer accomplish glucose-medi repress respir favor aerob glycolysi',\n",
       "  'activ platelet promot tumor cell growth angiogenesi invas platelet activ infer platelet volum indic pvi includ platelet distribut width pdw mean platelet volum mpv platelet distribut width-to-platelet count ratio pdw/p mean platelet volume-to-platelet count ratio platelet platelet-rel marker platelet-to-lymphocyt ratio found signific prognost factor patient breast cancer howev role pvi predict surviv breast cancer remain unknown henc perform retrospect analysi 275 patient breast cancer pvi compar clinicopatholog variabl assess identifi independ indic associ disease-fre surviv df use cox proport hazard model elev pdw/p significantli correl age her2 statu univari analysi reveal elev pdw mpv pdw/p well tumor size nuclear grade lymph node involv significantli associ inferior df rate tumor size p 0.01 nuclear grade lymph node involv pdw mpv pdw/p p 0.05 multivari analysi larg tumor size elev pdw/p signific prognost factor df hazard ratio 3.24 95 confid interv ci 1.24-8.47 2.99 95 ci 1.18-7.57 respect p 0.05 studi first reveal elev pdw/p significantli reduc df patient breast carcinoma measur pdw/p simpl rel inexpens almost univers avail use routin blood count make attract biomark improv risk assess',\n",
       "  'persist viral infect chronic immun activ neg immun regul express elev interferon signatur lymphoid tissu destruct correl diseas progress demonstr blockad type interferon ifn-i signal use ifn-i receptor neutral antibodi reduc immun system activ decreas express neg immun regulatori molecul restor lymphoid architectur mice persist infect lymphocyt choriomening viru ifn-i blockad establish persist viru infect result enhanc viru clearanc cd4 cell-depend henc demonstr direct causal link ifn-i signal immun activ neg immun regul express lymphoid tissu disorgan viru persist result suggest therapi target ifn-i may help control persist viru infect',\n",
       "  'commun organel crucial eukaryot cell function one coher unit import mean commun membran contact site two organel come close proxim allow transport lipid small solut contact site dynam size chang respons environment cellular stimuli howev regul unclear show saccharomyc cerevisia lam6 resid sever central contact site erm er/mitochondria encount structur vclamp vacuol mitochondria patch nvj nuclear vacuolar junction show lam6 suffici expans contact site physiolog condit necessari coordin contact site size given lam6 part larg protein famili conserv vertebr work open avenu investig underli principl organel commun',\n",
       "  'environ fetu develop critic surviv long-term health regul normal human fetal growth involv mani multidirect interact mother placenta fetu mother suppli nutrient oxygen fetu via placenta fetu influenc provis matern nutrient via placent product hormon regul matern metabol placenta site exchang mother fetu regul fetal growth via product metabol growth-regul hormon igf glucocorticoid adequ trophoblast invas earli pregnanc increas uteroplacent blood flow ensur suffici growth uteru placenta fetu placenta may respond fetal endocrin signal increas transport matern nutrient growth placenta activ transport system product placent hormon influenc matern physiolog even behavior consequ poor fetal growth short term long term form increas mortal morbid endocrin regul fetal growth involv interact mother placenta fetu effect may program long-term physiolog',\n",
       "  'cardiac fibrosi associ decreas extent microvasculatur disrupt normal myocardi structur result excess deposit extracellular matrix mediat recruit fibroblast sourc fibroblast unclear specif anti-fibrot therapi current avail show cardiac fibrosi associ emerg fibroblast origin endotheli cell suggest endothelial-mesenchym transit endmt similar event occur format atrioventricular cushion embryon heart transform growth factor-β1 tgf-β1 induc endotheli cell undergo endmt wherea bone morphogen protein 7 bmp-7 preserv endotheli phenotyp system administr recombin human bmp-7 rhbmp-7 significantli inhibit endmt progress cardiac fibrosi mous model pressur overload chronic allograft reject find show endmt contribut progress cardiac fibrosi rhbmp-7 use inhibit endmt interven progress chronic heart diseas associ fibrosi',\n",
       "  'local translat mediat axon respons semaphorin3a sema3a guidanc cue howev subset axon proteom local synthes wherea protein traffick soma reason specif protein local synthes unknown show local protein synthesi degrad link event growth cone find growth cone exhibit high level ubiquitin local signal pathway trigger ubiquitin degrad rhoa mediat sema3a-induc growth cone collaps inhibit rhoa degrad suffici remov protein-synthesi requir sema3a-induc growth cone collaps addit rhoa find local translat protein main target ubiquitin-proteasom system growth cone thu local protein degrad major featur growth cone creat requir local translat replenish protein need maintain growth cone respons',\n",
       "  'product ran-guanosin triphosph gtp around chromosom induc local nucleat plu end stabil microtubul mt nuclear protein tpx2 requir rangtp-depend mt nucleat find mt stabil affin purifi nuclear local signal nl -contain protein xenopu laevi egg extract nl protein fraction contain mt stabil activ purif use mass spectrometri identifi protein activ fraction includ cyclin-depend kinas 11 cdk11 cdk11 local spindl pole mt xenopu cultur cell egg extract recombin cdk11 demonstr rangtp-depend mt stabil activ wherea kinase-dead mutant inactiv cdk11 egg extract block rangtp-depend mt stabil dramat decreas spindl assembl rate simultan deplet tpx2 complet inhibit centrosome-depend spindl assembl result indic cdk11 respons rangtp-depend mt stabil around chromosom local stabil essenti normal rate spindl assembl spindl function',\n",
       "  'build mathemat model popul dynam pathogen within host involv consider factor similar ecolog pathogen prey cell host within multicellular host attack cell type integr cellular system turn interven infect exampl immun respons attempt sens elimin contain pathogen homeostat mechan tri compens cell loss review focus model appli malaria diseas caus single-cel eukaryot parasit infect red blood cell special concern given vivax malaria diseas often thought benign sometim incapacit parasit attack small proport red blood cell youngest one howev use mathemat model argu deplet pool red blood cell disastr host growth parasit vigor check host immun respons also model elucid aspect new field observ indic vivax malaria danger previous thought electron supplementari materi onlin version articl doi:10.1007/s12551-010-0034-3 contain supplementari materi avail author user',\n",
       "  'rnase p mrp ribonucleoprotein complex involv trna rrna process respect rna subunit two enzym structur relat play essenti role enzymat reaction rna highli conserv helic region p4 import catalyt reaction use bioinformat approach base conserv element comput analyz avail genom sequenc eukaryot organ identifi larg number novel nuclear rnase p mrp rna gene mrp rna instanc investig increas number known sequenc factor three present secondari structur model mani predict rna although sequenc abl fold consensu secondari structur p mrp rna strike variat size observ rang nosema locusta mrp rna 160 nt much larger rna e.g plasmodium knowlesi p rna 696 nt p mrp rna gene appear tandem protist emphas close evolutionari relationship rna',\n",
       "  'background calcium absorpt gener consid impair condit vitamin defici vitamin statu fulli normal absorpt known human object quantifi calcium absorpt two level vitamin replet use pharmacokinet method commerci market calcium supplement design two experi perform spring year one year apart first particip pretreat 25-hydroxyvitamin 25ohd mean serum 25ohd concentr 86.5 nmol/l pretreat mean serum concentr 50.2 nmol/l particip receiv 500 mg oral calcium load part standard low calcium breakfast low calcium lunch provid mid-day blood obtain fast frequent interv 10 12 hour thereaft method rel calcium absorpt two 25ohd concentr estim area curv auc load-induc increment serum total calcium result auc 9 +/- sem 3.63 mg hr/dl +/- 0.234 particip pretreat 25ohd 2.20 +/- 0.240 pretreat p 0.001 brief absorpt 65 higher serum 25ohd level averag 86.5 nmol/l level averag 50 nmol/l valu within nomin refer rang analyt conclus despit fact mean serum 25ohd level experi without supplement within current refer rang calcium absorpt perform 50 nmol/l significantli reduc rel mean 25ohd level 86 nmol/l thu individu serum 25-hydroxyvitamin level low end current refer rang may get full benefit calcium intak conclud lower end current refer rang set low',\n",
       "  'standard virul evolut theori assum virul factor maintain aid parasit exploit increas growth within and/or transmiss host increas number studi demonstr mani opportunist pathogen op conform assumpt virul factor maintain instead advantag non-parasit context review virul evolut theori context op highlight import incorpor environ outsid focal virul site illustr virul select constrain correl extern focal set pinpoint driver key environment correl focu generalist strategi phenotyp plastic end summari key theoret empir challeng met fuller understand op',\n",
       "  'grow epidem obes metabol diseas call better understand adipocyt biolog regul transcript adipocyt particularli import target sever therapeut approach transcript outcom influenc histon modif transcript factor bind although epigenet state bind site sever import transcript factor profil mous 3t3-l1 cell line data lack human adipocyt studi identifi h3k56 acetyl site human adipocyt deriv mesenchym stem cell h3k56 acetyl cbp p300 deacetyl sirt1 protein import role diabet insulin signal found almost half genom show sign h3k56 acetyl highest level h3k56 acetyl associ transcript factor protein adipokin signal type ii diabet pathway order discov transcript factor recruit acetyltransferas deacetylas site h3k56 acetyl analyz dna sequenc near h3k56 acetyl region found e2f recognit sequenc enrich use chromatin immunoprecipit follow high-throughput sequenc confirm gene bound e2f4 well hsf-1 c/ebpα higher expect level h3k56 acetyl transcript factor bind site acetyl site often adjac rare overlap also discov signific differ bound target c/ebpα 3t3-l1 human adipocyt highlight need construct species-specif epigenet transcript factor bind site map first genome-wid profil h3k56 acetyl e2f4 c/ebpα hsf-1 bind human adipocyt serv import resourc better understand adipocyt transcript regul',\n",
       "  'circular rna transcript first identifi earli 1990 knowledg speci remain limit studi tradit method rna analysi difficult novel bioinformat approach coupl biochem enrich strategi deep sequenc allow comprehens studi circular rna speci recent studi reveal thousand endogen circular rna mammalian cell highli abund evolutionarili conserv evid emerg circrna might regul microrna mirna function role transcript control also suggest therefor studi class noncod rna potenti implic therapeut research applic believ key futur challeng field understand regul function unusu molecul',\n",
       "  'unstabl angina critic phase coronari heart diseas wide variabl symptom prognosi decad ago classif unstabl angina base clinic symptom introduc system valid prospect clinic studi correl prognosi link angiograph histolog find use categor patient mani larg clinic trial recent year pathophysiolog role platelet activ inflamm unstabl angina elucid subsequ improv marker myocardi injuri acute-phas protein hemostat marker may associ clinic outcom identifi particularli cardiac-specif troponin troponin shown repres best predictor earli risk patient angina rest accordingli suggest origin classif extend subclassifi one larg group unstabl angina patient ie angina rest within past 48 hour class iiib troponin-posit po troponin-neg neg patient 30-day risk death myocardi infarct consid 20 class iiib-t po 2 class iiib-t neg patient initi result suggest troponin may function surrog marker thrombu format effect guid therapi glycoprotein iib/iiia antagonist low-molecular-weight heparin observ provid addit impetu ad measur marker clinic classif repres novel concept treat high-risk patient',\n",
       "  'background alcohol report common modifi risk factor hypertens howev observ studi subject confound behaviour sociodemograph factor clinic trial difficult implement limit follow-up time mendelian random provid robust evid natur associ use common polymorph aldehyd dehydrogenas 2 aldh2 surrog measur alcohol consumpt aldh2 encod major enzym involv alcohol metabol individu homozyg null variant 2 2 experi advers symptom drink alcohol consequ drink consider less alcohol wild-typ homozygot 1 1 heterozygot hypothesis polymorph may influenc risk hypertens affect alcohol drink behaviour method find carri fix effect meta-analys aldh2 genotyp blood pressur five studi n 7,658 hypertens three studi n 4,219 use studi identifi via systemat review male obtain overal odd ratio 2.42 95 confid interv ci 1.66-3.55 p 4.8 x 10 -6 hypertens compar 1 1 2 2 homozygot odd ratio 1.72 95 ci 1.17-2.52 p 0.006 compar heterozygot surrog moder drinker 2 2 homozygot systol blood pressur 7.44 mmhg 95 ci 5.39-9.49 p 1.1 x 10 -12 greater among 1 1 among 2 2 homozygot 4.24 mmhg 95 ci 2.18-6.31 p 0.00005 greater among heterozygot among 2 2 homozygot conclus find support hypothesi alcohol intak mark effect blood pressur risk hypertens',\n",
       "  \"unlabel fast definit diagnosi creutzfeldt-jakob diseas cjd import assess patient care option transmiss risk real-tim quaking-induc convers rt-quic assay cerebrospin fluid csf nasal-brush specimen valuabl distinguish cjd non-cjd condit requir 2.5 5 day improv rt-quic assay describ identifi posit csf sampl within 4 14 h better analyt sensit moreov analysi 11 cjd patient demonstr 7 rt-quic posit use previou condit 10 posit use new assay analys total 46 48 csf sampl sporad cjd patient posit 39 non-cjd patient neg give 95.8 diagnost sensit 100 specif second-gener rt-quic assay markedli improv speed sensit detect prion seed csf specimen cjd patient enhanc prospect rapid accur ant mortem cjd diagnosi import long-stand problem deal variou neurodegen protein misfold diseas earli accur diagnosi issu particularli import human prion diseas cjd prion deadli transmiss unusu resist decontamin recent develop rt-quic test allow highli sensit specif detect cjd human cerebrospin fluid broadli implement key diagnost tool howev current appli rt-quic take 2.5 5 day miss 11 23 cjd case markedli improv rt-quic analysi human csf cjd non-cjd patient discrimin matter hour rather day enhanc sensit improv allow much faster accur practic test cjd broader term studi provid prototyp test misfold protein aggreg caus mani import amyloid diseas alzheim 's parkinson 's tauopathi\",\n",
       "  'background gener resist neoplast cell line treatment ligand-toxin chimera attribut increas rate lysosom uptak degrad follow endocytosi chimera-receptor complex phosphoinositid 3-kinas pl 3-kinas activ known play role intracellular traffick particularli endosom lysosom hypothes co-expos cell pl 3-kinas inhibitor wortmannin might enhanc cytotox ligand-toxin chimera method vitro cytotox five receptor directed-toxin chimera bfgf-sap bfgf-pe afgf-p hbegf-sap bfgf-gelonin immunotoxin 11a8-sap examin presenc absenc pl 3-kinas inhibitor panel human neoplast cell line sk-mel-5 melanoma pa-1 ovarian teratocarcinoma du145 prostat carcinoma mcf-7 breast carcinoma vivo antitumor activ treatment regimen combin wortmannin 1 2 mg/kg i.p bfgf-sap 10 micrograms/kg i.v week 4 week evalu compar administr agent alon c3h/hen mice implant fsallc murin fibrosarcoma result concentr greater report ki pl 3-kinas inhibit 1-10 microm wortmannin enhanc cytotox combin saporin gelonin chimera produc subaddit cytotox combin pseudomona exotoxin chimera low nanomolar concentr select pl 3-kinas inhibit 5-100 nm examin effect one receptor directed-toxin chimera wortmannin dramat enhanc bfgf-sap cytotox three four cell line differ pl 3-kinas inhibitor ly294002 ki approxim 1 microm howev fail potenti bfgf-sap administ mice wortmannin combin bfgf-sap result signific decreas tumor volum compar vehicle-tr control observ mice treat either agent alon conclus taken togeth result suggest although wortmannin increas cytotox efficaci receptor-direct chimera potenti may occur altern pathway involv pl 3-kinas inhibit',\n",
       "  'propos model wherein chronic stress result glucocorticoid receptor resist gcr turn result failur down-regul inflammatori respons test model two viral-challeng studi studi 1 assess stress life event gcr control variabl includ baselin antibodi challeng viru age bodi mass index bmi season race sex educ viru type 276 healthi adult volunt volunt subsequ quarantin expos one two rhinovirus follow 5 nasal wash viral isol assess signs/symptom common cold studi 2 assess control variabl gcr 79 subject subsequ expos rhinoviru monitor baselin 5 viral challeng product local nasal secret proinflammatori cytokin il-1β tnf-α il-6 studi 1 covari control variabl recent exposur long-term threaten stress experi demonstr gcr gcr higher risk subsequ develop cold studi 2 control use studi 1 greater gcr predict product local proinflammatori cytokin among infect subject data provid support model suggest prolong stressor result gcr turn interfer appropri regul inflamm inflamm play import role onset progress wide rang diseas model may broad implic understand role stress health',\n",
       "  'brain glutamaterg neurotransmiss termin predominantli rapid uptak synapt releas glutam astrocyt na -depend glutam transport glt-1 glast subsequ convers glutamin enzym glutamin synthetas gs date sever factor identifi rapidli alter glial glutam uptak post-transl modif glutam transport condit known affect express glial glutam transport gs cocultur glia neuron demonstr neuron regul glial glutam turnov via pituitari adenyl cyclase-activ polypeptid pacap cerebr cortex pacap synthes neuron act subpopul astroglia involv glutam turnov exposur astroglia pacap increas maxim veloc 3 h glutam uptak promot express glt-1 glast gs moreov stimulatori effect neuron-condit medium glial glutam transport express attenu presenc pacap-inactiv antibodi pacap receptor antagonist pacap 6-38. contrast pacap vasoact intestin peptid promot glutam transport express distinctli higher concentr suggest pacap exert effect glial glutam turnov via pac1 receptor although pac1 receptor-depend activ protein kinas pka suffici promot express glast activ pka protein kinas c pkc requir promot glt-1 express optim given exist variou pac1 receptor isoform activ pka pkc differ level find point complex mechan pacap regul glial glutam transport metabol disturb regulatori mechan could repres major caus glutamate-associ neurolog psychiatr disord',\n",
       "  '93 allograft recipi number marrow b-cell precursor day 80 365 correl count circul b cell suggest posttransplant b-cell defici least part due insuffici b lymphopoiesi factor could affect b lymphopoiesi evalu number marrow b-cell precursor day 30 80 least 4-fold lower patient grade 2 4 acut graft-versus-host diseas gvhd compar patient grade 0 1 acut gvhd number b-cell precursor day 365 18-fold lower patient extens chronic gvhd compar patient limit chronic gvhd number b-cell precursor relat cd34 cell dose type transplant marrow versu blood stem cell donor age patient age conclud posttransplant b-cell defici result part inhibit b lymphopoiesi gvhd and/or treatment',\n",
       "  'aim peripher arteri diseas pad vascular diseas affect peripher circul recent genome-wid associ studi reveal relationship singl nucleotid polymorph snp adamts7 disintegrin metalloproteas thrombospondin motif 7 atherosclerosi studi aim determin adamts7 express peripher blood mononuclear cell pbmc frequenc adamts7 rs1994016 rs3825807 polymorph sampl turkish patient pad evalu associ matrix metalloproteinas mmp level pad develop method case-control studi adamts7mrna protein express determin use revers transcript quantit real-tim polymeras chain reaction rt-qpcr western blot respect rs1994016 rs3825807 variant adamts7 determin real-tim pcr 115 pad patient 116 healthi control plasma level nine mmp determin use multiplex immunoassay system result adamts7mrna level significantli higher pad patient control t=-2.75 p=.007 signific differ frequenc rs1994016 rs3825807 pad patient control p .05 pad patient adamts7mrna level significantli increas cc genotyp rs1994016 t=-2.31 p=.026 tt genotyp rs3825807 t=-2.23 p=.032 furthermor plasma level mmp-1 mmp-3 mmp-7 mmp-10 mmp-12 mmp-13 significantli higher pad patient control p .05 conclus first report relationship pad adamts7 express effect rs1994016 rs3825807 variant pad develop adamts7 may associ pad develop',\n",
       "  \"homologu two distinct architecton area 44 45 constitut anterior languag zone broca 's region human ventrolater frontal lobe recent establish macaqu monkey although know inferior pariet lobul later tempor cortic region project ventrolater frontal cortex know sever cortic area found region project homologu broca 's region macaqu monkey mean white matter pathway use autoradiograph method permit establish cortic area axon origin i.e. site inject precis cours axon white matter termin within particular cortic area examin pariet tempor connect area 44 two subdivis area 45 i.e. area 45a 45b result demonstr ventral temporo-front stream fiber origin variou auditori multisensori visual associ cortic area intermedi superolater tempor region axon cours via extrem capsul target strongli area 45 modest termin area 44. contrast dorsal stream axon origin variou cortic area inferior pariet lobul adjac caudal superior tempor sulcu found target area 44 45. axon cours superior longitudin fasciculu axon origin ventral inferior pariet lobul adjac superior tempor sulcu arch form simpl arcuat fasciculu cortex rostral part inferior pariet lobul preferenti link ventral premotor cortex ventral area 6 control orofaci musculatur cortex intermedi part inferior pariet lobul link area 44 45. find demonstr posterior pariet tempor connect ventrolater frontal area left hemispher human brain adapt variou aspect languag product precursor circuit found nonlinguist nonhuman primat brain also exist human brain possibl reason area adapt languag use human brain discuss result throw new light prelinguist precursor circuitri broca 's region help understand function interact broca 's ventrolater frontal region posterior pariet tempor associ area\",\n",
       "  'aim develop reliabl method whole genom analysi dna methyl materi method genome-scal analysi dna methyl includ affinity-bas approach enrich use methyl-cpg-bind protein one method methylated-cpg island recoveri assay mira base high affin mbd2b-mbd3l1 complex cpg-methyl dna provid detail descript mira combin next gener sequenc platform mira-seq result assess perform mira-seq compar data whole genom bisulfit sequenc conclus mira-seq reliabl genome-scal dna methyl analysi platform score dna methyl differ cpg-rich genom region method limit primer probe design cost effect',\n",
       "  'auditori scene consist mani spatial separ sound sourc mani sound sourc process auditori system experi determin mani speech sourc could local simultan azimuth plane differ word play multipl loudspeak listen report total number sound sourc individu locat experi ii accuraci local one speech sourc mixtur multipl speech sourc determin extra sound sourc ad exist set sound sourc task local extra sourc experi iii setup task experi except sound tone result show maximum number sound sourc listen could perceiv limit approxim four spatial separ speech signal three tonal signal local error increas along increas total number sound sourc four speech sourc alreadi exist accuraci local addit sourc near chanc',\n",
       "  'copper play essenti role process includ signal transcript protein traffick machineri oxid phosphoryl iron mobil neuropeptid matur normal develop wherea much known intracellular mobil ion calcium littl inform avail eukaryot cell mobil intracellular copper store describ mechan saccharomyc cerevisia ctr2 protein provid bioavail copper via mobil intracellular copper store wherea ctr2 exhibit structur similar ctr1 plasma membran copper import microscop biochem fraction studi local ctr2 vacuol membran demonstr ctr2 mobil vacuolar copper store manner depend amino acid residu conserv ctr1 ctr2 copper transport famili ctr2 delta mutant hyper-accumul vacuolar copper furthermor ctr2 mutant misloc plasma membran stimul extracellular copper uptak support direct role ctr2 copper transport across membran studi identifi novel mechan copper mobil suggest organ cope copper depriv via use intracellular vesicular store',\n",
       "  'peroxisom long establish play central role regul variou metabol activ mammalian cell organel act concert mitochondria control metabol lipid reactiv oxygen speci howev mitochondria emerg import site antivir signal transduct role peroxisom immun defens unknown report rig-i-lik receptor rlr adaptor protein mav locat peroxisom mitochondria find peroxisom mitochondri mav act sequenti creat antivir cellular state upon viral infect peroxisom mav induc rapid interferon-independ express defens factor provid short-term protect wherea mitochondri mav activ interferon-depend signal pathway delay kinet amplifi stabil antivir respons interferon regulatori factor irf1 play crucial role regul mavs-depend signal peroxisom result establish peroxisom import site antivir signal transduct',\n",
       "  'simpl interv estim method proport exhibit poor coverag produc evid inappropri interv criteria appropri evalu variou propos method includ close achiev coverag probabl nomin valu whether interv locat close distant middl scale expect interv width avoid aberr limit outsid 0,1 zero width interv eas use whether tabl softwar formula seven method singl proport evalu 96,000 paramet space point interv base tail area simpler score method recommend use case method avail aim align either minimum mean coverag nomin 1 -alpha',\n",
       "  'ataxia telangiectasia neurodegen diseas caus mutat atm gene report ataxia telangiectasia mutat atm defici caus nuclear accumul histon deacetylas 4 hdac4 neuron promot neurodegener nuclear hdac4 bind chromatin well myocyt enhanc factor 2a mef2a camp-respons element bind protein creb lead histon deacetyl alter neuron gene express block either hdac4 activ nuclear accumul blunt neurodegen chang rescu sever behavior abnorm atm-defici mice full rescu neurodegener howev also requir presenc hdac4 cytoplasm suggest ataxia telangiectasia phenotyp result loss cytoplasm hdac4 well nuclear accumul remain cytoplasm hdac4 must phosphoryl activ hdac4 phosphatas protein phosphatas 2a pp2a downregul atm-medi phosphoryl atm defici enhanc pp2a activ lead hdac4 dephosphoryl nuclear accumul hdac4 result defin crucial role cellular local hdac4 event lead ataxia telangiectasia neurodegener',\n",
       "  'e-cadherin best character adheren junction protein homotyp interact contribut mainten epitheli barrier function epitheli cell cytoplasm tail e-cadherin form dynam complex catenin regul sever intracellular signal transduct pathway includ wnt/β-catenin pi3k/akt rho gtpase nf-κb signal recent progress uncov novel critic role adhes molecul mononuclear phagocyt function e-cadherin regul matur migrat langerhan cell ligat prevent induct tolerogen state bone marrow-deriv dendrit cell dc respect function β-catenin could instrument determin balanc immunogen tolerogen dc vitro vivo fusion altern activ macrophag osteoclast also e-cadherin-depend addit e-cadherin ligand cd103 klrg1 express dc- t- nk-cell subset contribut interact e-cadherin-express dc macrophag discuss regul function implic e-cadherin express central orchestr immun system',\n",
       "  'glucagon-lik peptide-1 receptor glp-1r key physiolog regul insulin secret major therapeut target treatment type ii diabet howev regul glp-1r function complex multipl endogen peptid interact receptor includ full-length 1-37 truncat 7-37 form glp-1 exist amid form glp-1 1-36 nh₂ glp-1 7-36 nh₂ relat peptid oxyntomodulin addit glp-1r possess exogen agonist includ exendin-4 alloster modul compound 2 6,7-dichloro-2-methylsulfonyl-3-tert-butylaminoquinoxalin complex ligand-receptor system increas presenc sever singl nucleotid polymorph snp distribut across receptor investig 10 glp-1r snp character three physiolog relev signal pathway camp accumul extracellular signal-regul kinas 1/2 phosphoryl intracellular ca²⁺ mobil ligand bind cell surfac receptor express also determin demonstr ligand- pathway-specif effect multipl snp dramat effect observ met¹⁴⁹ receptor variant met¹⁴⁹ variant select loss peptide-induc respons across pathway examin preserv respons small molecul compound 2. contrast cys³³³ variant peptid respons preserv attenu respons compound 2. strikingli loss peptid function met¹⁴⁹ receptor variant could alloster rescu compound 2 provid proof-of-principl evid alloster drug could use treat patient loss function variant',\n",
       "  'adult neurogenesi aris neural stem cell within special nich neuron activ experi presum act local nich regul multipl stage adult neurogenesi neural progenitor prolifer new neuron matur synapt integr surviv unknown whether local neuron circuitri direct impact adult neural stem cell show adult mous hippocampu nestin-express radial glia-lik quiescent neural stem cell rgl respond tonic neurotransmitt γ-aminobutyr acid gaba mean γ2-subunit-contain gabaa receptor clonal analysi individu rgl reveal rapid exit quiescenc enhanc symmetr self-renew condit delet γ2 rgl close proxim termin express 67-kda glutam acid decarboxylas gad67 parvalbumin-express pv+ interneuron respond tonic gaba releas neuron function optogenet control activ dentat pv+ interneuron somatostatin-express vasoact intestin polypeptid vip -express interneuron dictat rgl choic quiescenc activ furthermor pv+ interneuron activ restor rgl quiescenc social isol experi induc rgl activ symmetr divis studi identifi nich cell–signal–receptor trio local circuitri mechan control activ self-renew mode quiescent adult neural stem cell respons neuron activ experi',\n",
       "  'perform meta-analysi cross-sect studi serum 25 oh statu global serum 25 oh level averag 54 nmol/l higher women men higher caucasian non-caucasian trend serum 25 oh level latitud vitamin defici widespread studi vitamin statu express serum 25-hydroxy-vitamin 25 oh nativ subject worldwid meta-analysi meta-regress studi report 25 oh healthi subject retriev pubm embas web scienc use term “ serum ” “ 25-hydroxy-vitamin ” “ cholecalciferol ” “ human ” total 394 studi includ mean 25 oh level 54 nmol/l 95 ci 52–57 nmol/l women borderlin significantli higher 25 oh level men caucasian higher level non-caucasian 25 oh level higher subject age 15 year younger subject unadjust signific decreas 25 oh latitud slope curv −0.03 ± 0.12 nmol/l per degre latitud north south equat p 0.8 signific declin latitud caucasian −0.69 ± 0.30 nmol/l per degre p 0.02 non-caucasian 0.03 ± 0.39 nmol/l per degre p 0.14 adjust age gender ethnic overal correl present 25 oh latitud −0.29 ± 0.24 nmol/l per degre p 0.23 overal influenc latitud 25 oh d. howev separ analys 25 oh decreas latitud caucasian non-caucasian widespread global vitamin insuffici present compar propos threshold level',\n",
       "  'novel differentiation-depend cdna dif-2 isol human mononuclear phagocyt differenti display full-length cdna clone sequenc dif-2 consist 156 amino acid predict isoelectr point 8.84. mrna express freshli isol monocyt downregul significantli monocyt subject differenti similar differentiation-depend downregul observ normal hepatocyt compar undifferenti hepg2 cell mrna express monocyt sensit lipopolysaccharid ceramid strongli increas dif-2 transcript lysophosphatidylcholin result weaker upregul dif-2 express dif-2 homolog gene previous isol mous fibroblast shown serum growth factor-induc immedi earli gene result indic dif-2 repres gene regul differenti process strongli respons lipopolysaccharid ceramid lysophosphatidylcholin',\n",
       "  'endogen small molecul metabolit regul anim longev emerg novel mean influenc health life span c. elegan bile acid-lik steroid call dafachron acid da regul development time longev conserv nuclear hormon receptor daf-12 homolog mammalian sterol-regul receptor lxr fxr use metabol genet mass spectrometri biochem approach identifi new activ da biosynthesi character evolutionarili conserv short chain dehydrogenas dhs-16 novel 3-hydroxysteroid dehydrogenas regul da product dhs-16 control daf-12 activ govern longev respons signal gonad elucid c. elegan bile acid biosynthet pathway reveal possibl novel ligand well strike biochem conserv anim could illumin new target manipul longev metazoan',\n",
       "  'ribonucleoprotein complex consist argonaute-lik protein small regulatori rna function wide rang biolog process mani small regulatori rna predict act least part within nucleu conduct genet screen identifi factor essenti rna interfer rnai nuclei caenorhabd elegan identifi argonaut protein nrde-3 absenc small interf rna sirna nrde-3 resid cytoplasm nrde-3 bind sirna gener rna-depend rna polymeras act messeng rna templat cytoplasm redistribut nucleu nuclear redistribut nrde-3 requir function nuclear local signal requir nuclear rnai result nrde-3 associ nuclear-loc nascent transcript thu specif argonaut protein transport specif class small regulatori rna distinct cellular compart regul gene express',\n",
       "  \"bind interact plasma membran cytoskeleton defin cell function cell shape format cell process cell movement endocytosi use optic tweezer tether forc measur show plasma membran phosphatidylinositol 4,5-bisphosph pip2 act second messeng regul adhes energi cytoskeleton plasma membran receptor stimuli hydrolyz pip2 lower adhes energi process could mimick express ph domain sequest pip2 target 5'-pip2-phosphatas plasma membran select lower plasma membran pip2 concentr studi suggest plasma membran pip2 control dynam membran function cell shape local increas decreas adhes actin-bas cortic cytoskeleton plasma membran\",\n",
       "  'cell crucial role protect infect cancer although traffick memori cell around bodi integr capac provid immun protect studi shown special memori cell uniqu tissue-resid subset give host enhanc region immun recent year consider progress understand tissue-resid cell develop function reveal mechan enhanc protect immun potenti influenc ration vaccin design review discuss major advanc emerg concept field summar known differenti protect function tissue-resid memori cell differ tissu bodi highlight key unansw question',\n",
       "  'dna replic stress promot genom instabl cancer howev contribut replic stress respons develop malign remain unresolv dna replic stress respons protein smarcal1 stabil dna replic fork prevent replic fork collaps caus dna break apoptosi fork regression/remodel function smarcal1 investig vivo function replic stress cancer unclear use gamma radiat ir -induc replic stress t-cell lymphoma mous model observ signific inhibit lymphomagenesi mice lack one allel smarcal1 notabl quarter smarcal1-defici mice develop tumor moreov hematopoiet stem/progenitor cell hspc develop thymocyt smarcal1-defici mice show increas dna damag apoptosi prolifer burst follow ir impair abil repopul thymu ir addit mice lack smarcal1 show signific hspc defect challeng respond replic stress stimuli thu data reveal critic function dna replic stress respons specif smarcal1 hematopoiet cell surviv tumor develop result also provid import insight immunodefici observ individu mutat smarcal1 suggest hspc defect',\n",
       "  'dna cytosin methyl central epigenet modif essenti role cellular process includ genom regul develop diseas present first genome-wid single-base-resolut map methyl cytosin mammalian genom human embryon stem cell fetal fibroblast along compar analysi messeng rna small rna compon transcriptom sever histon modif site dna–protein interact sever key regulatori factor widespread differ identifi composit pattern cytosin methyl two genom nearli one-quart methyl identifi embryon stem cell non-cg context suggest embryon stem cell may use differ methyl mechan affect gene regul methyl non-cg context show enrich gene bodi deplet protein bind site enhanc non-cg methyl disappear upon induc differenti embryon stem cell restor induc pluripot stem cell identifi hundr differenti methyl region proxim gene involv pluripot differenti widespread reduc methyl level fibroblast associ lower transcript activ refer epigenom provid foundat futur studi explor key epigenet modif human diseas develop',\n",
       "  'background laparoscop adhesiolysi chronic abdomin pain controversi evid base aim test hypothesi laparoscop adhesiolysi lead substanti pain relief improv qualiti life patient adhes chronic abdomin pain method patient diagnost laparoscopi chronic abdomin pain attribut adhes caus pain exclud adhes confirm diagnost laparoscopi patient randomli assign either laparoscop adhesiolysi treatment treatment alloc conceal patient assessor unawar patient treatment outcom pain assess 1 year visual analogu score va score scale 0-100 pain chang score use analges qualiti life score analysi intent treat find 116 patient enrol diagnost laparoscopi 100 randomli alloc either laparoscop adhesiolysi 52 treatment 48 group report substanti pain relief significantli improv qualiti life differ group mean chang baselin va score 12 month differ 3 point p=0.53 95 ci -7 13 interpret although laparoscop adhesiolysi reliev chronic abdomin pain benefici diagnost laparoscopi alon therefor laparoscop adhesiolysi recommend treatment adhes patient chronic abdomin pain',\n",
       "  'age-rel declin memori loss one devast condit increas longev identifi effect longevity-promot factor learn memori unknown show c. elegan insulin/igf-1 receptor mutant daf-2 improv memori perform earli adulthood maintain learn abil better age surprisingli demonstr extens long-term memori age contrast eat-2 mutant model dietari restrict dr exhibit impair long-term memori young adulthood maintain level memori longer age find crh-1 c. elegan homolog creb transcript factor requir long-term associ memori learn short-term memori express crh-1 declin age differ longev mutant creb express activ correl memori perform result suggest specif longev treatment acut long-term effect cognit function declin age regul rate-limit gene requir learn memori',\n",
       "  'heterodimer common paradigm among eukaryot transcript factor 9-ci retino acid receptor rxr serv common heterodimer partner sever nuclear receptor includ thyroid hormon receptor t3r retino acid receptor rar rais question whether complex possess dual hormon respons devis strategi examin transcript properti receptor individu tether heterodimer partner find intrins bind properti rxr mask t3r-rxr rar-rxr heterodim contrast rxr activ non-dna-bind cofactor ngfi-b/nurr1 orphan receptor heterodimer rxr constitut activ ngfi-b/nurr1 creat novel hormone-depend complex find suggest alloster interact among heterodim creat complex uniqu properti suggest allosteri critic featur underli gener divers hormon respons network',\n",
       "  'background diffus tensor imag measur white matter wm microstructur integr appear provid earlier indic wm injuri wm hyperintens howev risk factor poor wm microstructur integr establish studi quantifi associ vascular risk factor midlif late life measur late-lif wm microstructur integr method result use data 1851 particip aric atherosclerosi risk commun studi complet 3-t magnet reson imag includ diffus tensor imag part aric neurocognit studi aric-nc quantifi associ among lipid glucos blood pressur baselin aric visit 1987-1989 age 44-65 midlif visit 5 aric 2011-2013 age 67-90 late life concurr aric-nc region overal wm mean diffus fraction anisotropi obtain aric visit 5 aric particip also consid whether associ independ modifi wm hyperintens volum found elev blood pressur midlif late life elev glucos midlif late life associ wors late-lif wm microstructur integr associ independ degre wm hyperintens associ glucos wm microstructur integr appear stronger least wm hyperintens littl support advers associ lipid wm microstructur integr conclus hypertens midlif late life elev glucos midlif relat wors wm microstructur integr late life',\n",
       "  'background three quarter endometri carcinoma treat earli stage still 15 20 patient experi recurr littl effect system therapi homo sapien v-ki-ras2 kirsten rat sarcoma viral oncogen homologu kra mutat report import role tumorigenesi human cancer limit knowledg regard clinic relev kra statu endometri carcinoma method perform comprehens integr characteris genome-wid express relat kra mutat copy-numb alter primary- metastat endometri carcinoma lesion relat clinic histopatholog data primari investig set clinic valid set appli consist 414 primari tumour 61 metastat lesion total result amplif gain kra present 3 primari lesion 18 metastat lesion correl significantli poor outcom high intern feder gynaecolog obstetr stage non-endometrioid subtyp high grade aneuploidi receptor loss high kra mrna level also found associ aggress phenotyp contrast kra mutat present 14.7 primari lesion increas metastat lesion influenc outcom significantli associ endometrioid subtyp low grade obes conclus result support kra amplif kra mrna express increas primari metastat lesion relev endometri carcinoma diseas progress',\n",
       "  'hyperhomocysteinemia recent identifi import risk factor atherosclerot vascular diseas articl review homocystein metabol caus hyperhomocysteinemia pathophysiolog find disord epidemiolog studi homocystein vascular diseas screen hyperhomocysteinemia consid patient high risk vascular diseas abnorm homocystein metabol primari prevent vascular diseas treatment patient homocystein level 14 micromol/l higher consid secondari prevent treatment patient homocystein level 11 micromol/l higher consid treatment conveni administ folic acid supplement 400-1000 microg high-pot multivitamin contain least 400 microg folat higher dose folic acid cyanocobalamin supplement may requir patient prospect clinic trial data becom avail conserv recommend provid safe effect evidence-bas approach diagnosi evalu manag patient hyperhomocysteinemia',\n",
       "  \"statement like `` qualiti care highli valu wait time '' neither support refut comparison util paramet tradit discret choic experi dce best -- worst scale overcom problem ask respond perform differ choic task howev whilst natur best -- worst task gener understood number issu relat design analysi best -- worst choic experi requir exposit paper illustr aggreg analys data use qualiti life pilot studi demonstr richer insight drawn use best -- worst task\",\n",
       "  'genome-wid associ studi gwa identifi common polymorph near gc cyp2r1 cyp24a1 nadsyn1/dhcr7 gene associ circul level 25-hydroxyvitamin 25 oh european popul replic gwa find examin six select polymorph region relat circul 25 oh level 1,605 hispan women 629 u.s. hispan 976 mexican 354 non-hispan white nhw women also assess potenti interact variant known non-genet predictor 25 oh level includ bodi mass index bmi sunlight exposur vitamin intak diet supplement minor allel two gc polymorph rs7041 rs2282679 significantli associ lower 25 oh level hispan nhw women cyp2r1 polymorph rs2060793 also significantli associ 25 oh level group found signific associ polymorph cyp24a1 hispan control 25 oh level significantli associ rs12785878t rs1790349g haplotyp nadsyn1/dhcr7 region signific interact gc rs2282679 bmi rs12785878 time spent outdoor activ observ result provid support contribut common genet variant individu variabl circul 25 oh level observ interact snp non-genet factor warrant confirm',\n",
       "  'publish summari chapter summar develop character rabbit polyclon antibodi name histon direct methyl h3-k9 posit provid protocol peptid design rabbit immun qualiti control methyl-lysin histon antibodi follow vivo character use indirect inter-and metaphas chromatin wild-typ wt mutant mous cell defici suv39h histon methyltransferas hmtase histon amino-termini tail protrud nucleosom core subject varieti post-transl modif includ acetyl lysin residu phosphoryl serin threonin residu methyl lysin arginin residu ubiquitin lysin residu adp-ribosyl glutam acid residu addit structur role histon play import function control gene express regul access underli nucleosom templat without doubt develop high-qual position-specif methyl-lysin histon antibodi provid import tool decod epigenet inform part index distinct methyl state select lysin residu histon amino-termini compar analysi indic signific discrep specif avid avail methyl-lysin histon antibodi highlight need extens qualiti control experiment data correctli interpret despit exquisit complex histon lysin methyl',\n",
       "  'age character progress loss physiolog integr lead impair function increas vulner death deterior primari risk factor major human patholog includ cancer diabet cardiovascular disord neurodegen diseas age research experienc unpreced advanc recent year particularli discoveri rate age control least extent genet pathway biochem process conserv evolut review enumer nine tent hallmark repres common denomin age differ organ special emphasi mammalian age hallmark genom instabl telomer attrit epigenet alter loss proteostasi deregul nutrient sens mitochondri dysfunct cellular senesc stem cell exhaust alter intercellular commun major challeng dissect interconnected candid hallmark rel contribut age final goal identifi pharmaceut target improv human health age minim side effect',\n",
       "  'abnorm nutrient metabol hallmark age underli genet nutrit framework rapidli uncov particularli use c. elegan model howev direct metabol consequ perturb life histori c. elegan remain clarifi base recent advanc metabolom field optim valid sensit mass spectrometri ms platform identif major metabolit class worm appli studi age diet relat chang use platform allow detect 600 metabolit sampl 2500 worm observ mark chang fatti acid amino acid phospholipid worm life histori independ germ-lin worm underw strike shift lipid metabol earli adulthood least partli control metabol regul aak-2/ampk amino acid peak develop except aspart acid glycin accumul age worm dietari intervent also influenc worm metabolit profil regul highli specif depend metabolit class altogeth ms-base method power tool perform worm metabolom age metabolism-ori studi',\n",
       "  \"inappropri use antibiot contribut increas rate antimicrobi resist sever danish guidelin antibiot prescrib acut respiratori tract infect gener practic issu promot ration prescrib antibiot howev unclear recommend follow aim characteris pattern antibiot prescript patient diagnos acut respiratori tract infect mean electron prescript label clinic indic danish gener practic acut respiratori tract infect account 456,532 antibiot prescript issu juli 2012 june 2013. pneumonia common indic 178,354 prescript 39 follow acut tonsil 21 acut otiti media 19 total penicillin v account 58 prescript follow macrolid 18 amoxicillin 15 use second-lin agent increas age indic compris 40 prescript patient age 75 year women often prescrib antibiot regardless clinic indic first danish studi characteris antibiot prescript pattern acut respiratori tract infect data linkag clinic indic find confirm penicillin v commonli prescrib antibiot agent treatment patient acut respiratori tract infect danish gener practic howev second-lin agent like macrolid amoxicillin without clavulan acid overus strategi improv qualiti antibiot prescrib especi pneumonia acut otiti media acut rhinosinus warrant respiratori tract infect track overus antibiot better adher guidelin prescrib antibiot differ respiratori tract infect warrant danish gener practic over-us antibiot particularli so-cal 'second-lin agent amoxicillin increas resist may lead potenti catastroph scenario antibiot longer effect exactli widespread over-us antibiot differ infect howev clear rune aabenhu univers copenhagen co-work analyz primari care data regard antibiot prescript acut respiratori tract infect includ pneumonia ear infect denmark found penicillin v-the current recommend first-lin drug scandinavian countries-account 58 per cent prescript figur improv amoxicillin macrolid over-prescrib particularli elderli patient team also call analysi prescript given out-of-hour clinic\",\n",
       "  'pyruv dehydrogenas pdh play key role regul skelet muscl substrat util il-6 produc skelet muscl exercis durat depend manner report increas whole bodi fatti acid oxid muscl glucos uptak decreas pdha activ skelet muscl fed mice aim present studi examin whether muscl il-6 contribut exercise-induc pdh regul skelet muscl skelet muscle-specif il-6 knockout il-6 mko mice flox litterm control control complet singl bout treadmil exercis 10 60 120 min rest mice genotyp serv basal control respiratori exchang ratio rer overal higher p 0.05 il-6 mko control mice 120 min treadmil exercis rer decreas exercis independ genotyp ampk acc phosphoryl also increas exercis independ genotyp pdha activ control mice higher p 0.05 10 60 min exercis rest remain unchang il-6 mko mice addit pdha activ higher p 0.05 il-6 mko control mice rest 60 min exercis neither pdh phosphoryl acetyl could explain genotyp differ pdha activ togeth provid evid skelet muscl il-6 contribut regul pdh rest prolong exercis suggest muscl il-6 normal dampen carbohydr util prolong exercis via effect pdh',\n",
       "  'purpos mutat brca1 brca2 gene confer greater risk develop breast cancer determin whether tumor patholog featur clinic featur differ patient without brca mutat patient method tumor patholog featur clinic characterist examin 491 women breast cancer underw genet test brca mutat 1997 2006. retrospect review medic record conduct determin clinic characterist includ ethnic age clinic stage diagnosi age pariti number full-term pregnanc use oral contracept hormon replac therapi brca mutat statu tumor patholog review determin histolog type tumor grade estrogen receptor progesteron receptor her-2/neu statu result 491 patient identifi breast cancer 391 patient brca neg 86 patient brca posit triple-neg breast cancer ie neg estrogen receptor progesteron receptor her-2/neu statu diagnos 57.1 brca1-posit patient 23.3 brca2-posit patient 13.8 brca-neg patient brca1 mutat carrier higher nuclear grade tumor two group p .001 triple-neg cancer patient brca2 mutat carrier older diagnos brca1 mutat carrier noncarri p .01 conclus result suggest tumor associ brca1 mutat may divid two distinct group triple-neg non-triple-neg group futur studi seek determin whether patient brca1 mutat triple-neg breast cancer respond treatment better brca-neg patient similar tumor patholog',\n",
       "  \"interferon ifn glycoprotein strong antivir activ repres one first line host defens invad pathogen protein classifi three group type ii iii ifn base structur receptor cell surfac due abil modul immun respons becom attract therapeut option control chronic viru infect combin drug type ifn consid `` standard care '' suppress hepat c hcv hepat b hbv infect type iii ifn gener encourag result treatment hcv infect phase iii clinic trial howev though effect use ifn treatment without need caution ifn power cytokin affect wide array cell type result patient usual experi unpleas symptom percentag patient suffer system wide effect thu constant monitor requir patient treat ifn order reach treatment goal suppress viru infect maintain qualiti life\",\n",
       "  'analysi genet factor obes carri sampl nuclear famili aosta n. itali famili consist parent sib elementari school children consid obes preliminari screen similar sampl non-obes children nuclear famili number famili 67 112 respect sever test appli order examin genet contribut obes particular investig presenc domin major gene conclus genet factor certainli present sever analys suggest presenc domin major gene weak effect',\n",
       "  'non-cod rna emerg crucial regul gene express cell fate decis howev express pattern regulatori function normal malign human hematopoiesi incomplet understood present comprehens resourc defin non-cod rna landscap human hematopoiet system base highli specif non-cod rna express portrait per blood cell popul identifi uniqu fingerprint non-cod rnas-such linc00173 granulocytes-and assign critic regulatori circuit involv blood homeostasi follow incorpor acut myeloid leukemia sampl landscap uncov prognost relev non-cod rna stem cell signatur share acut myeloid leukemia blast healthi hematopoiet stem cell find highlight import non-cod transcriptom format mainten human blood hierarchi micro-rna known regul haematopoiesi leukemogenesi role long non-cod rna less clear author provid non-cod rna express landscap human hematopoiet system highlight role format mainten human blood hierarchi',\n",
       "  'background central nervou system cn diseas site first relaps exposur adjuv trastuzumab report carri comprehens meta-analysi determin risk cn metastas first site recurr patient her2-posit breast cancer receiv adjuv trastuzumab method elig studi includ random trial adjuv trastuzumab administ 1 year patient her2-posit breast cancer report cn metastas first site diseas recurr statist analys conduct calcul incid rel risk rr 95 confid interv ci use fixed-effect invers varianc random-effect model result total 9020 patient includ incid cn metastas first site diseas recurr her2-posit patient receiv adjuv trastuzumab 2.56 95 ci 2.07 3.01 compar 1.94 95 ci 1.54 2.38 her2-posit patient receiv adjuv trastuzumab rr cn first site relaps trastuzumab-tr patient 1.35 95 ci 1.02-1.78 p 0.038 compar control arm without trastuzumab therapi ratio cn metastas total number recurr event 16.94 95 ci 10.85 24.07 8.33 95 ci 6.49 10.86 trastuzumab-tr control group respect statist signific differ found base trastuzumab schedul median follow-up time evid public bia observ conclus adjuv trastuzumab associ signific increas risk cn metastas site first recurr her2-posit breast cancer patient',\n",
       "  'neutrophil long view final effector cell acut inflammatori respons primari role clearanc extracellular pathogen howev recent evid extend function cell newli discov repertoir effector molecul neutrophil armamentarium includ broad array cytokin extracellular trap effector molecul humor arm innat immun system addit neutrophil involv activ regul effector function innat adapt immun cell accordingli neutrophil crucial role pathogenesi broad rang diseas includ infect caus intracellular pathogen autoimmun chronic inflamm cancer',\n",
       "  \"dna methyl frequent describ 'silenc epigenet mark inde function 5-methylcytosin origin propos 1970 thank improv genome-scal map methyl evalu dna methyl differ genom context transcript start site without cpg island gene bodi regulatori element repeat sequenc emerg pictur function dna methyl seem vari context relationship dna methyl transcript nuanc realiz first improv understand function dna methyl necessari interpret chang mark observ diseas cancer\",\n",
       "  'transform one tissu type anoth make well establish set phenomena explain principl development biolog although phenomena might rare natur imagin possibl deliber reprogram cell one tissu type anoth manipul express transcript factor approach could gener new therapi mani human diseas',\n",
       "  'import studi suggest pioglitazon use may increas risk cancer object examin whether pioglitazon use diabet associ risk bladder 10 addit cancer design set particip cohort nest case-control analys among person diabet bladder cancer cohort follow 193,099 person age 40 year older 1997-2002 decemb 2012 464 case patient 464 match control survey addit confound cohort analysi 10 addit cancer includ 236,507 person age 40 year older 1997-2005 follow june 2012. cohort kaiser permanent northern california exposur ever use durat cumul dose time sinc initi pioglitazon time depend main outcom measur incid cancer includ bladder prostat femal breast lung/bronchu endometri colon non-hodgkin lymphoma pancrea kidney/ren pelvi rectum melanoma result among 193,099 person bladder cancer cohort 34,181 18 receiv pioglitazon median durat 2.8 year rang 0.2-13.2 year 1261 incid bladder cancer crude incid bladder cancer pioglitazon user nonus 89.8 75.9 per 100,000 person-year respect ever use pioglitazon associ bladder cancer risk adjust hazard ratio hr 1.06 95 ci 0.89-1.26 result similar case-control analys pioglitazon use 19.6 among case patient 17.5 among control adjust odd ratio 1.18 95 ci 0.78-1.80 adjust analys associ 8 10 addit cancer ever use pioglitazon associ increas risk prostat cancer hr 1.13 95 ci 1.02-1.26 pancreat cancer hr 1.41 95 ci 1.16-1.71 crude incid prostat pancreat cancer pioglitazon user vs nonus 453.3 vs 449.3 81.1 vs 48.4 per 100,000 person-year respect clear pattern risk cancer observ time sinc initi durat dose conclus relev pioglitazon use associ statist signific increas risk bladder cancer although increas risk previous observ could exclud increas prostat pancreat cancer risk associ ever use pioglitazon merit investig assess whether causal due chanc residu confound revers causal',\n",
       "  'describ deriv pluripot embryon stem es cell human blastocyst two diploid es cell line cultiv vitro extend period maintain express marker characterist pluripot primat cell human es cell express transcript factor oct-4 essenti develop pluripotenti cell mous graft scid mice line give rise teratoma contain deriv three embryon germ layer cell line differenti vitro extraembryon somat cell lineag neural progenitor cell may isol differenti es cell cultur induc form matur neuron embryon stem cell provid model studi earli human embryolog investig tool discoveri novel growth factor medicin potenti sourc cell use transplant therapi',\n",
       "  'kra mutat common phenomenon mani human neoplasm aim assess kra mutat statu along histolog continuum normal ovari develop benign borderlin malign ovarian mucin neoplasm analyz 41 case malign 10 case borderlin 7 case benign mucin ovarian tumor 7 case normal ovarian tissu preval kra mutat normal ovari 0.00 n=0/7 preval benign borderlin malign mucin neoplasm 57.14 n=4/7 90.00 n=9/10 75.61 n=31/41 respect multipl kra mutat detect 6 case mucin carcinoma includ 5 doubl mutat g13d/v14i n=1 g12v/g13 n=1 g12d/g13 n=3 one tripl mutat a11v/g13n/v14i n=1 identifi six case 3 novel kra mutat previous describ cosmic databas includ a11v n=3 v14i n=2 mucin carcinoma a11t n=1 mucin borderlin tumor conclus kra mutat appear one imper event ovarian mucin adenoma-borderlin tumor-carcinoma sequenc increas number kra mutat shown strongest predictor unequivoc malign ovarian mucin neoplasm',\n",
       "  'despit one first eukaryot transcript regulatori element identifi sequenc nativ tata box signific remain elus appli criteria associ tata box queri sever saccharomyc genom arriv consensu tata a/t a/t a/g approxim 20 yeast gene contain tata box strikingli tata box-contain gene associ respons stress highli regul preferenti util saga rather tfiid compar tata-less promot transcript regul yeast appear mechanist bipolar possibl reflect need balanc induc stress-rel respons constitut housekeep function',\n",
       "  'variou factor cellular compon tumor microenviron key driver associ drug resist mani cancer analyz factor molecular mechan involv chemoresist patient esophag squamou cell carcinoma escc found interleukin 6 il6 deriv mainli cancer-associ fibroblast play import role chemoresist upregul c-x-c motif chemokin receptor 7 cxcr7 express signal transduc activ transcript 3/nuclear factor-κb pathway cxcr7 knockdown result inhibit il6-induc prolifer chemoresist addit cxcr7 silenc significantli decreas gene express associ stem chemoresist epithelial–mesenchym transit suppress prolifer abil escc cell three-dimension cultur system angiogenesi assay clinic sampl escc patient high express cxcr7 il6 present significantli wors overal surviv progression-fre surviv upon receiv cisplatin oper result suggest il6–cxcr7 axi may provid promis target treatment escc',\n",
       "  'myelodysplast syndrom heterogen group diseas character ineffect hematopoiesi propens leukem transform pathogenesi complex like depend interplay aberr hematopoiet cell microenviron nich cell play role diseas evolut poorli defin delin hematopoiet stem cell nich abil interrog role hematopoiet diseas anim model further insight recent year data support view microenviron play activ role evolut myelodysplasia myeloprolif disord thu provid rational explor therapeut target mesenchymal–hematopoiet interact diseas',\n",
       "  'structur mainten chromosom smc protein complex key determin chromosom conform use hi-c polym model studi cohesin condensin two deepli conserv smc complex organ chromosom bud yeast saccharomyc cerevisia canon role cohesin co-align sister chromatid condensin gener compact mitot chromosom find strikingli differ role two complex bud yeast mitosi first cohesin respons compact mitot chromosom arm independ sister chromatid cohes polym simul demonstr role fulli account cis-loop chromatin second condensin gener dispens compact along chromosom arm instead play target role compact rdna proxim region promot resolut peri-centromer region result argu conserv mechan smc complex form chromatin loop distinct smc-depend loop activ select deploy appropri compact chromosom',\n",
       "  \"background follow widespread rollout chlamydia test non-specialist commun set uk mani individu receiv chlamydia test without offer comprehens sti hiv test assess sexual behaviour among tester differ set view understand need sti diagnost servic method probabl sampl survey british popul undertaken 2010-2012 third nation survey sexual attitud lifestyl analys weight data chlamydia test past year includ locat recent test diagnos past 5 year individu age 16-44 year report least one sexual partner past year 4992 women 3406 men result 26.8 95 ci 25.4 28.2 women 16.7 15.5 18.1 men report chlamydia test past year 28.4 women 41.2 men test genitourinari medicin gum 41.1 20.7 women men respect test gener practic gp remaind test non-gum set women test outsid gum like older relationship live rural area individu test outsid gum report fewer risk behaviour nevertheless 11.0 8.6 14.1 women 6.8 3.9 11.6 men test gp 13.2 10.2 16.8 9.6 6.5 13.8 women men test non-gum set report 'unsaf sex defin two partner condom use partner past year individu treat chlamydia outsid gum past 5 year less like report hiv test time frame women 54.5 42.7 65.7 vs 74.1 65.9 80.9 gum men 23.9 12.7 40.5 vs 65.8 56.2 74.3 conclus chlamydia test occur non-gum set among popul report fewer risk behaviour howev need provid pathway comprehens sti care sizeabl minor higher risk\",\n",
       "  'nonalcohol fatti liver diseas nafld grow worldwid epidem import risk factor develop insulin resist type 2 diabet nonalcohol steatohepat nash hepat cellular carcinoma hcc despit preval nafld lifestyl intervent involv exercis weight loss accept treatment diseas last decad numer experiment compound shown improv nafld preclin anim model mani therapeut shown increas activ cellular energi sensor amp-activ protein kinas ampk ampk activ reduc inflamm obes diabet increas ampk activ view viabl therapeut strategi improv nafld review propos three primari mechan ampk activ may improv nafld addit examin mechan ampk activ final identifi 27 studi use ampk activ reduc nafld futur consider studi examin relationship ampk nafld highlight',\n",
       "  'human cancer includ myeloma preced precursor state unmet need vivo model studi interact human preneoplast cell bone marrow microenviron non-malign cell genet human mice permit growth primari human preneoplast malign plasma cell togeth non-malign cell vivo growth larg restrict bone marrow mirror pattern patient myeloma xenograft captur genom complex parent tumor reveal addit somat chang moreov xenograft patient preneoplast gammopathi show progress growth suggest clinic stabil lesion may part due growth control extrins tumor cell data demonstr new approach investig entir spectrum human plasma cell neoplasia illustr util human model understand function divers human tumor',\n",
       "  'present studi retrospect analyz 19 patient diagnos paraquat pq poison aim investig effect activ charcoal hemoperfus renal function pq elimin result indic 7 patient die 12 surviv non-oligur renal failur occur 7 patient die among 12 surviv patient 10 normal renal function 2 develop non-oligur renal failur linear correl plasma urin paraquat concentr prior activ charcoal hemoperfus equat paramet togeth correl coeffici admiss follow y=0.5820+1.7348x r2=0.678 f=35.768 p 0.0001 equat paramet togeth correl coeffici follow activ charcoal hemoperfus y=0.6827+1.2649x r2=0.626 f=50.308 p 0.0001 therefor conclud patient normal renal function elimin kinet pq kidney associ plasma pq concentr activ charcoal hemoperfus littl effect avoid acut kidney injuri patient sever pq poison',\n",
       "  'diabet mellitu pregnanc consider medic challeng sinc relat \\u200eaugment morbid mortal concern fetu \\u200eand pregnant woman record show etiolog diabet \\u200eembryopathi complic mani teratolog factor might involv \\u200ein mechan diabet mellitus-induc congenit malform \\u200ein studi potenti cardiotox effect hyperglycemia hyperketonemia investig use two vitro model primari chick embryon cardiomyocyt stem cell deriv cardiomyocyt advers effect record system cell evalu chang beat activ cell activ protein content ro product dna damag differenti stem cell migrat diabet formula use produc increas dna damag declin cell migrat mous embryon stem cell result provid addit insight advers effect gestat diabet mellitu recommend expect mother matern staff monitor glycaem level month ahead concept studi also support recommend use antioxid pregnanc prevent dna damag product ro might result heart defect well development anomali',\n",
       "  \"present motion magnif techniqu act like microscop visual motion amplifi subtl motion video sequenc allow visual deform would otherwis invis achiev motion magnif need accur measur visual motion group pixel modifi initi imag registr step measur motion robust analysi featur point trajectori segment pixel base similar posit color motion novel measur motion similar group even small motion accord correl time often relat physic caus outlier mask mark observ explain layer motion model pixel simpli reproduc output origin regist observ motion select layer may magnifi user-specifi amount textur synthesi fills-in unseen `` hole '' reveal amplifi motion result motion-magnifi imag reveal emphas small motion origin sequenc demonstr deform load-bear structur subtl motion balanc correct peopl `` rigid '' structur bend hand pressur\",\n",
       "  'transient receptor potenti mucolipin 1 trpml1 ca2+-releas cation channel mediat calcium signal homeostasi lysosom mutat trpml1 lead mucolipidosi type iv sever lysosom storag disord report two electron cryo-microscopi structur full-length human trpml1 3.72-å apo structur ph 7.0 close state 3.49-å agonist-bound structur ph 6.0 open state sever aromat hydrophob residu pore helix 1 helic s5 s6 helix s6 neighbour subunit form hydrophob caviti hous agonist suggest distinct agonist-bind site found trpv1 trp channel differ subfamili open trpml1 associ distinct dilat lower gate togeth slight structur movement pore helix 1. work reveal regulatori mechan trpml channel facilit better understand trp channel activ provid insight molecular basi mucolipidosi type iv pathogenesi',\n",
       "  \"data visual essenti compon genom data analysi howev size divers data set produc today 's sequenc array-bas profil method present major challeng visual tool integr genom viewer igv high-perform viewer effici handl larg heterogen data set provid smooth intuit user experi level genom resolut key characterist igv focu integr natur genom studi support array-bas next-gener sequenc data integr clinic phenotyp data although igv often use view genom data public sourc primari emphasi support research wish visual explor data set colleagu end igv support flexibl load local remot data set optim provid high-perform data visual explor standard desktop system igv freeli avail download http //www.broadinstitute.org/igv gnu lgpl open-sourc licens\",\n",
       "  'transcript misregul involv develop mani diseas especi neoplast transform distal regulatori element enhanc play major role specifi cell-specif transcript pattern normal diseas tissu suggest enhanc may prime target therapeut intervent focus modul gene regul mediat cell type-specif enhanc hope normal epigenet pattern affect tissu could restor fewer side effect observ treatment employ rel nonspecif inhibitor epigenet drug new method employ genom nucleas site-specif epigenet regul target specif genom region use either artifici dna-bind protein rna-dna interact may allow precis genom engin enhanc howev field still infanc refin increas specif effici clearli requir',\n",
       "  'background cd19‐specif chimer antigen receptor car cell induc high rate initi respons among patient relaps b‐cell acut lymphoblast leukemia long‐term remiss subgroup patient method conduct phase 1 trial involv adult relaps b‐cell receiv infus autolog cell express 19‐28z car memori sloan ketter cancer center mskcc safeti long‐term outcom assess associ demograph clinic diseas characterist result total 53 adult receiv 19‐28z car cell manufactur mskcc infus sever cytokin releas syndrom occur 14 53 patient 26 95 confid interv ci 15 40 1 patient die complet remiss observ 83 patient median follow‐up 29 month rang 1 65 median event‐fre surviv 6.1 month 95 ci 5.0 11.5 median overal surviv 12.9 month 95 ci 8.7 23.4 patient low diseas burden 5 bone marrow blast treatment markedli enhanc remiss durat surviv median event‐fre surviv 10.6 month 95 ci 5.9 reach median overal surviv 20.1 month 95 ci 8.7 reach patient higher burden diseas ≥5 bone marrow blast extramedullari diseas greater incid cytokin releas syndrom neurotox event shorter long‐term surviv patient low diseas burden conclus entir cohort median overal surviv 12.9 month among patient low diseas burden median overal surviv 20.1 month accompani markedli lower incid cytokin releas syndrom neurotox event 19‐28z car t‐cell infus observ among patient higher diseas burden fund commonwealth foundat cancer research other clinicaltrials.gov number nct01044069',\n",
       "  'bone regener reli activ skelet stem cell ssc still remain poorli character show periosteum contain ssc high bone regen potenti compar bone marrow stromal cells/skelet stem cell bmsc mice although periost cell pc bmsc deriv common embryon mesenchym lineag postnat pc exhibit greater clonogen growth differenti capac bmsc bone repair pc effici contribut cartilag bone integr long-term transplant molecular profil uncov gene encod periostin extracellular matrix molecul associ enhanc respons injuri pc periostin gene delet impair pc function fractur consolid periostin-defici periosteum reconstitut pool pc injuri demonstr presenc ssc within periosteum requir periostin maintain pool overal result highlight import analyz periosteum pc understand bone phenotyp',\n",
       "  'mammalian cell depend growth factor signal take nutrient howev coordin glucos glutamin uptak mysteri issu gene develop wellen colleagu pp 2784-2799 show glucos flux hexosamin biosynthesi pathway regul growth factor receptor glycosyl enabl glutamin consumpt mechan ensur cell engag anabol metabol nutrient limit highlight substrat avail protein modif modul cell signal',\n",
       "  'import program death 1 pd-1 pathway limit immun respons melanoma block human anti-pd-1 monoclon antibodi pembrolizumab object character associ pembrolizumab tumor respons overal surviv among patient advanc melanoma design set particip open-label multicohort phase 1b clinic trial enrol decemb 2011-septemb 2013 median durat follow-up 21 month studi perform academ medic center australia canada franc unit state elig patient age 18 year older advanc metastat melanoma data pool 655 enrol patient 135 nonrandom cohort n 87 ipilimumab naiv n 48 ipilimumab treat 520 random cohort n 226 ipilimumab naiv n 294 ipilimumab treat cutoff date april 18 2014 safeti analys octob 18 2014 efficaci analys exposur pembrolizumab 10 mg/kg everi 2 week 10 mg/kg everi 3 week 2 mg/kg everi 3 week continu diseas progress intoler toxic investig decis main outcom measur primari end point confirm object respons rate best overal respons complet respons partial respons patient measur diseas baselin per independ central review secondari end point includ toxic durat respons progression-fre surviv overal surviv result among 655 patient median rang age 61 18-94 year 405 62 men 581 measur diseas baselin object respons report 194 581 patient 33 95 ci 30 -37 60 133 treatment-na patient 45 95 ci 36 54 overal 74 152/205 respons ongo time data cutoff 44 90/205 patient respons durat least 1 year 79 162/205 respons durat least 6 month twelve-month progression-fre surviv rate 35 95 ci 31 -39 total popul 52 95 ci 43 -60 among treatment-na patient median overal surviv total popul 23 month 95 ci 20-29 12-month surviv rate 66 95 ci 62 -69 24-month surviv rate 49 95 ci 44 -53 treatment-na patient median overal surviv 31 month 95 ci 24 reach 12-month surviv rate 73 95 ci 65 -79 24-month surviv rate 60 95 ci 51 -68 ninety-two 655 patient 14 experienc least 1 treatment-rel grade 3 4 advers event ae 27 655 4 patient discontinu treatment treatment-rel ae treatment-rel seriou ae report 59 patient 9 drug-rel death conclus relev among patient advanc melanoma pembrolizumab administr associ overal object respons rate 33 12-month progression-fre surviv rate 35 median overal surviv 23 month grade 3 4 treatment-rel ae occur 14 trial registr clinicaltrials.gov identifi nct01295827',\n",
       "  'granuloma patholog hallmark tuberculosi tb howev function mechan format remain poorli understood understand role granuloma tb analyz proteom granuloma subject tuberculosi unbias manner use laser-captur microdissect mass spectrometri confoc microscopi gener detail molecular map human granuloma found center granuloma pro-inflammatori environ character presenc antimicrobi peptid reactiv oxygen speci pro-inflammatori eicosanoid convers tissu surround caseum compar anti-inflammatori signatur find consist across set six human subject rabbit although balanc system pro- anti-inflammatori signal crucial tb diseas outcom find signal physic segreg within granuloma protein lipid snapshot human rabbit lesion analyz hypothes patholog respons tb shape precis anatom local inflammatori pathway develop granuloma',\n",
       "  'object interferon ifn mediat direct antivir activ play crucial role earli host immun respons viral infect howev ifn therapi hbv infect less effect viral infect design explor cellular target hbv respons ifn use proteome-wid screen result use lc-ms/m identifi protein downregul upregul ifn treatment hbv x protein hbx -stabl control cell found sever ifn-stimul gene downregul hbx includ trim22 known antiretrovir protein demonstr hbx suppress transcript trim22 singl cpg methyl 5′-utr reduc ifn regulatori factor-1 bind affin therebi suppress ifn-stimul induct trim22 conclus verifi find use mous model primari human hepatocyt human liver tissu data elucid mechan hbv evad host innat immun system',\n",
       "  'summari neutrophil special innat cell requir constant replenish prolif bone marrow bm precursor result short half‐lif although establish neutrophil deriv granulocyte‐macrophag progenitor gmp differenti pathway gmp function matur neutrophil poorli defin use mass cytometri cytof cell‐cycle‐bas analysi identifi three neutrophil subset within bm commit prolif neutrophil precursor preneu differenti non‐prolifer immatur neutrophil matur neutrophil transcriptom profil function analysi reveal preneu requir c/ebp egr transcript factor gener gmp prolif program substitut gain migratori effector function matur preneu expand microbi tumor stress immatur neutrophil recruit peripheri tumor‐bear mice summari studi identifi special bm granulocyt popul ensur suppli homeostasi stress respons graphic abstract figur caption avail highlightsprolifer activ identifi commit neutrophil precursor mice humansneutrophil subset possess distinct transcriptom function signaturesdefect neutrophil develop lead impair neutrophil‐medi responsesincreas circul immatur neutrophil associ cancer progress na neutrophil differenti pathway poorli defin evrard et al demonstr workflow character bone marrow neutrophil subset basi prolif capac molecular signatur therebi defin development trajectori function properti neutrophil',\n",
       "  'map kinas kinas kinas tgfβ-activ kinas 1 tak1 activ tlr il-1 tnf tgfβ turn activ ikk-nf-κb jnk regul cell surviv growth tumorigenesi metabol tak1 signal also upregul ampk activ autophagi investig tak1-depend regul autophagi lipid metabol tumorigenesi liver fast mice hepatocyte-specif delet tak1 exhibit sever hepatosteatosi increas mtorc1 activ suppress autophagi compar wt counterpart tak1-defici hepatocyt exhibit suppress ampk activ autophagi respons starvat metformin treatment howev ectop activ ampk restor autophagi cell peroxisom proliferator-activ receptor α pparα target gene β-oxid regul hepat lipid degrad also suppress hepatocyt lack tak1 due suppress autophagi β-oxid high-fat diet challeng aggrav steatohepat mice hepatocyte-specif delet tak1 notabl inhibit mtorc1 restor autophagi pparα target gene express tak1-defici liver indic tak1 act upstream mtorc1 mtorc1 inhibit also suppress spontan liver fibrosi hepatocarcinogenesi anim hepatocyte-specif delet tak1 data indic tak1 regul hepat lipid metabol tumorigenesi via ampk/mtorc1 axi affect autophagi pparα activ',\n",
       "  'actin cytoskeleton adhes junction physic function coupl cell-cel interfac epitheli cell actin regulatori complex arp2/3 establish role turnov junction actin howev role formin largest group actin regul less clear formin dynam shape actin cytoskeleton variou function within cell review describ recent progress formin regul actin dynam cell-cel contact highlight formin function polar protein traffic necessari epitheli',\n",
       "  \"crispr-ca cluster regularli interspac short palindrom repeat coupl crispr-associ protein bacteri immun system protect invad phage plasmid process crispr adapt short piec dna 'spacer acquir foreign element integr crispr array far remain mysteri spacer preferenti acquir foreign dna self chromosom avoid show spacer acquisit replication-depend dna break form stall replic fork promot spacer acquisit chromosom hotspot spacer acquisit confin chi site sequenc octam highli enrich bacteri chromosom suggest site limit spacer acquisit self dna show avoid self mediat recbcd double-strand dna break repair complex result suggest escherichia coli acquisit new spacer larg depend recbcd-medi process double-strand dna break occur primarili replic fork prefer foreign dna achiev higher densiti chi site self chromosom combin higher number fork foreign dna model explain strong prefer acquir spacer high copi plasmid phage\",\n",
       "  'gene express control complex interact transcript factor bind promot regulatori dna element one common characterist genom region associ regulatori protein pronounc sensit dnase digest gener genome-wid high-resolut map dnase hypersensit dh site seedl callu tissu rice oryza sativa approxim 25 dh site tissu found put promot indic vast major gene regulatori element rice locat promot region found 58 dh site callu seedl dh site detect seedl callu 31 display significantli differ level dnase sensit within two tissu gene differenti express seedl callu frequent associ dh site tissu dna sequenc contain within dh site hypomethyl consist known activ gene regulatori element interestingli tissue-specif dh site locat promot show higher level dna methyl averag dna methyl level dh site locat promot distinct elev h3k27me3 associ intergen dh site result suggest epigenet modif play role dynam chang number dnase sensit dh site develop',\n",
       "  'background epidemiolog studi found overal obes posit relat endometri cancer ec risk howev data assess associ bodi fat distribut risk ec still limit method follow 51,948 women first report waist circumfer wc hip circumfer 1986 nurs health studi waist-to-hip ratio whr calcul result 24 year follow-up 449 incid invas ec case diagnos multivari analysi without adjust bodi mass index bmi rel risk rr ec compar extrem categori 2.44 95 confid interv ci 1.72-3.45 wc 1.69 95 ci=1.20-2.40 whr howev adjust bmi posit associ substanti attenu longer signific rr=1.08 95 ci=0.69-1.67 wc 1.15 95 ci=0.81-1.64 whr respect conclus prospect cohort studi found independ associ bodi fat distribut risk ec adjust bmi',\n",
       "  'high breast cancer mortal rate report northeastern part unit state recent attent focus long island new york studi author investig whether high breast cancer mortal evenli spread northeast sens observ cluster death explain chanc alon whether cluster statist signific demograph data age-specif breast cancer mortal rate women obtain 244 counti 11 northeastern state district columbia 1988-1992. recent develop spatial scan statist use search cluster case without specifi size locat ahead time test statist signific adjust multipl test inher procedur basic analysi adjust age analys examin result affect incorpor race urban pariti confound variabl statist signific geograph broad cluster breast cancer death new york city-philadelphia pennsylvania metropolitan area p 0.0001 7.4 higher mortal rate rest northeast cluster remain signific race urban and/or pariti includ confound variabl four smaller subclust within area also signific strength philadelphia suburb p 0.0001 long island p 0.0001 central new jersey p 0.0001 northeastern new jersey p 0.0001 elev breast cancer mortal long island might view less uniqu local phenomenon part gener situat involv larg part new york city-philadelphia metropolitan area sever known hypothes risk factor could adjust may explain detect cluster notabl age first birth age menarch age menopaus breastfeed genet mutat environment factor',\n",
       "  'bone homeostasi maintain balanc bone-form osteoblast bone-degrad osteoclast osteoblast mesenchym origin wherea osteoclast belong myeloid lineag osteoclast osteoblast commun occur solubl factor secret cell-bon interact cell-cel contact modul activ cd200 immunoglobulin superfamilli member express variou type cell includ mesenchym stem cell msc cd200 receptor cd200r express myeloid cell monocytes/macrophag assum cd200 could new molecul involv control osteoclastogenesi could play role msc-osteoclast commun human studi demonstr solubl cd200 inhibit differenti osteoclast precursor well matur bone-resorb cell vitro solubl cd200 modifi monocyt phenotyp inhibit receptor activ nuclear factor kappa-b ligand rankl signal pathway well gene express osteoclast marker osteoclast-associ receptor oscar nuclear factor activ cell cytoplasm 1 nfatc1 moreov msc inhibit osteoclast format depend cell-cel contact associ cd200 express msc surfac result clearli demonstr msc express cd200 play major role regul bone resorpt bone physiolog cd200-cd200r coupl could new target control bone diseas',\n",
       "  'cd4+ cell differenti multipl effector subset potenti role subset anti-tumor immun fulli explor seek studi impact cd4+ cell polar tumor reject model mimick human diseas gener new mhc class ii-restrict t-cell receptor tcr transgen mous model cd4+ cell recogn novel epitop tyrosinase-rel protein 1 trp-1 antigen express normal melanocyt b16 murin melanoma cell could robustli polar th0 th1 th17 subtyp vitro evidenc cytokin chemokin adhes molecul profil surfac marker suggest potenti differenti effector function vivo contrari current view th1 cell import tumor reject found th17-polar cell better mediat destruct advanc b16 melanoma therapeut effect critic depend interferon-gamma ifn-gamma product wherea deplet interleukin il -17a il-23 littl impact taken togeth data indic appropri vitro polar effector cd4+ cell decis success tumor erad principl consid design clinic trial involv adopt transfer-bas immunotherapi human malign',\n",
       "  'background assess sever commun acquir pneumonia cap modifi british thorac societi mbt rule identifi patient sever pneumonia patient might suitabl home manag multicentr studi conduct deriv valid practic sever assess model stratifi adult hospitalis cap differ manag group method data three prospect studi cap conduct uk new zealand netherland combin deriv cohort compris 80 data use develop model prognost variabl identifi use multipl logist regress 30 day mortal outcom measur final model test valid cohort result 1068 patient studi mean age 64 year 51.5 male 30 day mortal 9 age /=65 year 3.5 95 ci 1.6 8.0 albumin 30 g/dl 4.7 95 ci 2.5 8.7 independ associ mortal mbt rule 5.2 95 ci 2.7 10 six point score one point confus urea 7 mmol/l respiratori rate /=30/min low systol 90 mm hg diastol /=60 mm hg blood pressur age /=65 year curb-65 score base inform avail initi hospit assess enabl patient stratifi accord increas risk mortal score 0 0.7 score 1 3.2 score 2 3 score 3 17 score 4 41.5 score 5 57 valid cohort confirm similar pattern conclus simpl six point score base confus urea respiratori rate blood pressur age use stratifi patient cap differ manag group',\n",
       "  'chronic obstruct pulmonari diseas copd link cigarett smoke genet determin previous identifi iron-respons element-bind protein 2 irp2 import copd suscept gene shown irp2 protein increas lung individu copd demonstr mice defici irp2 protect cigarett smoke cs -induc experiment copd integr rna immunoprecipit follow sequenc rip-seq rna sequenc rna-seq gene express function enrich cluster analysi identifi irp2 regul mitochondri function lung mice irp2 increas mitochondri iron load level cytochrom c oxidas cox led mitochondri dysfunct subsequ experiment copd frataxin-defici mice higher mitochondri iron load show impair airway mucociliari clearanc mcc higher pulmonari inflamm baselin wherea mice defici synthesi cytochrom c oxidas reduc cox protect cs-induc pulmonari inflamm impair mcc mice treat mitochondri iron chelat mice fed low-iron diet protect cs-induc copd mitochondri iron chelat also allevi cs-induc impair mcc cs-induc pulmonari inflamm cs-associ lung injuri mice establish copd suggest critic function role potenti therapeut intervent mitochondrial-iron axi copd',\n",
       "  'tumor-associ macrophag tam contribut aspect tumor progress use csf1r inhibitor target tam therapeut appeal limit anti-tumor effect identifi mechan limit effect csf1r target therapi demonstr carcinoma-associ fibroblast caf major sourc chemokin recruit granulocyt tumor csf1 produc tumor cell caus hdac2-medi downregul granulocyte-specif chemokin express caf limit migrat cell tumor treatment csf1r inhibitor disrupt crosstalk trigger profound increas granulocyt recruit tumor combin csf1r inhibitor cxcr2 antagonist block granulocyt infiltr tumor show strong anti-tumor effect',\n",
       "  'broadli neutral antibodi bnab hiv-1 evolv year iter process viru escap antibodi adapt hiv-1 vaccin design seek mimic enabl properti render hiv-1 envelop env capabl elicit bnab respons need defin follow evolut v2 apex direct bnab lineag vrc26 hiv-1 subtyp c superinfect donor cap256 investig phenotyp chang viru popul circul earli phase bnab induct longitudin virus evolv vrc26-resist primari infect pi viru vrc26-sensit superinfect su viru ensu pi-su recombin reveal substanti phenotyp chang env switch env properti coincid earli resist vrc26 decreas sensit su-lik virus vrc26 link reduc infect alter entri kinet lower sensit neutral cd4 attach vrc26 maintain neutral activ cell-associ cap256 viru indic escap cell-cel transmiss rout domin escap pathway reduc fit earli escap variant sustain sensit cell-cel transmiss featur limit viru replic therebi imped rapid escap support scenario vrc26 allow partial viral escap prolong period possibl increas time window bnab matur collect data highlight phenotyp plastic hiv-1 env evad bnab pressur need consid phenotyp trait select design env immunogen combin env variant differenti phenotyp pattern bnab sensit describ cap256 may maxim potenti induc bnab respons vaccin',\n",
       "  'tumor-specif mutat result immunogen neoantigen correl respons immun checkpoint inhibitor highli mutagen cancer howev earli result single-ag checkpoint inhibitor multipl myeloma mm underwhelm therefor sought understand relationship mutat neoantigen landscap mm patient respons therapi somat mutat burden neoantigen load respons therapi determin use interim data mmrf commpass studi nct01454297 664 mm patient popul mean somat missens mutat load 405.84 s=608.55 63.90 s=95.88 mutat per patient respect posit linear relationship mutat neoantigen burden r2=0.862 averag predict neoantigen load 23.52 s=52.14 neoantigen averag 9.40 s=26.97 express neoantigen surviv analysi reveal significantli shorter progression-fre surviv pf patient greater averag somat missens mutat load n=163 0.493 vs 0.726 2-year pf p=0.0023 predict express neoantigen load n=214 0.555 vs 0.729 2-year pf p=0.0028 pattern maintain stratifi diseas stage cytogenet abnorm therefor high mutat neoantigen load clinic relev risk factor neg impact surviv mm patient current standard care',\n",
       "  'import postmarket safeti event novel pharmaceut biolog occur new safeti risk identifi initi regulatori approv therapeut safeti event chang novel therapeut use clinic practic inform patient clinician decis make object character frequenc postmarket safeti event among novel therapeut approv us food drug administr fda examin whether novel therapeut characterist known time fda approv associ increas risk design set cohort studi novel therapeut approv fda januari 1 2001 decemb 31 2010 follow februari 28 2017. exposur novel therapeut characterist known time fda approv includ drug class therapeut area prioriti review acceler approv orphan statu near–regulatori deadlin approv regulatori review time main outcom measur composit 1 withdraw due safeti concern 2 fda issuanc increment box warn ad postmarket period 3 fda issuanc safeti commun result 2001 2010 fda approv 222 novel therapeut 183 pharmaceut 39 biolog 123 new postmarket safeti event 3 withdraw 61 box warn 59 safeti commun median follow-up period 11.7 year interquartil rang iqr 8.7-13.8 year affect 71 32.0 novel therapeut median time approv first postmarket safeti event 4.2 year iqr 2.5-6.0 year proport novel therapeut affect postmarket safeti event 10 year 30.8 95 ci 25.1 -37.5 multivari analysi postmarket safeti event statist significantli frequent among biolog incid rate ratio irr 1.93 95 ci 1.06-3.52 p .03 therapeut indic treatment psychiatr diseas irr 3.78 95 ci 1.77-8.06 p .001 receiv acceler approv irr 2.20 95 ci 1.15-4.21 p .02 near–regulatori deadlin approv irr 1.90 95 ci 1.19-3.05 p .008 event statist significantli less frequent among regulatori review time less 200 day irr 0.46 95 ci 0.24-0.87 p .02 conclus relev among 222 novel therapeut approv fda 2001 2010 32 affect postmarket safeti event biolog psychiatr therapeut acceler near–regulatori deadlin approv statist significantli associ higher rate event highlight need continu monitor safeti novel therapeut throughout life cycl',\n",
       "  'background chronic obstruct pulmonari diseas copd high preval rate germani increas expect within next year although risk factor individu level wide understood littl known spatial heterogen population-bas risk factor copd background knowledg broader population-bas process could help plan futur provis healthcar prevent strategi align expect demand aim studi analyz preval copd vari across northeastern germani smallest spatial-scal possibl identifi location-specif population-bas risk factor use health insur claim aok nordost method visual spatial distribut copd preval level municip urban district use condit autoregress besag-york-mollié bym model geograph weight regress model gwr appli analyz location-specif ecolog risk factor copd result sex- age-adjust preval copd 6.5 2012 vari wide across northeastern germani population-bas risk factor consist proport insur age 65 older insur migrat background household size area depriv result gwr model reveal popul risk copd vari consider across northeastern germani conclus area depriv direct indirect influenc preval copd person age social disadvantag area higher chanc develop copd even necessarili directli affect depriv individu level underlin import consid impact area depriv health plan healthcar addit result reveal part studi area insur migrat background person live multi-person household elev risk copd',\n",
       "  'convers lineage-commit cell induc pluripot stem cell ipsc reprogram accompani global remodel epigenom result alter pattern gene express character transcript reorgan larg intergen non-cod rna lincrna occur upon deriv human ipsc identifi numer lincrna whose express link pluripot among defin ten lincrna whose express elev ipsc compar embryon stem cell suggest activ may promot emerg ipsc support result indic lincrna direct target key pluripot transcript factor use loss-of-funct gain-of-funct approach found one lincrna lincrna-ror modul reprogram thu provid first demonstr critic function lincrna deriv pluripot stem cell',\n",
       "  'two broad categori extracellular vesicl ev exosom shed microvesicl smv differ size distribut well protein rna profil describ ev known play key role cell-cel commun act proxim well system review discuss natur ev subtyp strategi isol ev cell-cultur media bodi fluid procedur quantifi ev also discuss protein select enrich exosom smv potenti use marker discrimin ev subtyp well variou applic ev clinic diagnosi',\n",
       "  'background colorect cancer remain one common malign tumor worldwid colorect cancer initi cell ccic small subpopul respons malign behavior colorect cancer aberr activ wnt pathway regul self-renew ccic howev underli mechan remain poorli understood method via retrovir librari screen identifi nuclear receptor-interact protein 2 nrip2 novel interactor wnt pathway enrich colorect cancer colospher cell express level nrip2 retino acid-rel orphan receptor β rorβ examin fish qrt-pcr ihc western blot nrip2 overexpress knockdown colorect cancer cell produc studi role nrip2 wnt pathway also verifi bind nrip2 rorβ investig effect rorβ ccic vitro vivo genechip-scan specul downstream target hbp1 western blot chip luciferas report carri investig interact nrip2 rorβ hbp1 result nrip2 significantli up-regul ccic cell line primari colorect cancer tissu reinforc express nrip2 increas wnt activ silenc nrip2 attenu wnt activ transcript factor rorβ key target nrip2 regul wnt pathway activ rorβ transcript enhanc inhibitor hbp1 wnt pathway nrip2 prevent rorβ bind downstream hbp1 promot region reduc transcript hbp1 turn attenu hbp1-depend inhibit tcf4-mediat transcript conclus nrip2 novel interactor wnt pathway colorect cancer initi cell interact nrip2 rorβ hbp1 mediat new mechan ccic self-renew via wnt activ',\n",
       "  'sterol transport endoplasm reticulum er plasma membran pm occur nonvesicular mechan requir sterol transport protein stp examin idea transport enhanc membran contact site er close appos pm conclud sterol desorpt membran rather stp-mediat diffus rate limit cellular context appar kinet benefit stp-mediat sterol transfer occur contact site contact site may instead compartment lipid synthesi transport machineri provid opportun regul',\n",
       "  \"object identifi describ misunderstand patient doctor associ prescrib decis gener practic design qualit studi set 20 gener practic west midland south east england particip 20 gener practition 35 consult patient main outcom measur misunderstand patient doctor potenti actual advers consequ take medicin result 14 categori misunderstand identifi relat patient inform unknown doctor doctor inform unknown patient conflict inform disagr attribut side effect failur commun doctor 's decis relationship factor misunderstand associ lack patient particip consult term voic expect prefer voic respons doctor decis action associ potenti actual advers outcom non-adher treatment mani base inaccur guess assumpt particular doctor seem unawar relev patient idea medicin success prescrib conclus patient particip consult advers consequ lack particip import author develop educ intervent build find\",\n",
       "  'class b glucagon-lik peptide-1 glp-1 g protein-coupl receptor major target treatment type 2 diabet obes endogen mimet glp-1 peptid exhibit bias agonism—a differ function selectivity—that may provid improv therapeut outcom describ structur human glp-1 receptor complex g protein-bias peptid exendin-p5 gα heterotrim determin global resolut 3.3 å. extracellular surfac organ extracellular loop 3 proxim transmembran segment differ exendin-p5-bound structur previou glp-1-bound glp-1 receptor structur intracellular face six-degre differ angl gαs–α5 helix engag structur propag across g protein heterotrim addit structur differ rate extent conform reorgan gα protein structur provid insight molecular basi bias agon',\n",
       "  'dose conveni key element effect manag chronic diseas particularli import long-term manag osteoporosi less frequent dose medic may enhanc complianc therebi maxim effect therapi anim data support rational once-weekli dose alendron 70 mg 7 time daili oral treatment dose could provid similar efficaci daili dose alendron 10 mg due long durat effect bone addit dog studi suggest potenti esophag irrit observ daili oral bisphosphon may substanti reduc once-weekli dose dose regimen would provid patient increas conveni would like enhanc patient complianc compar efficaci safeti treatment oral once-weekli alendron 70 mg n=519 twice-weekli alendron 35 mg n=369 daili alendron 10 mg n=370 one-year double-blind multicent studi postmenopaus women age 42 95 osteoporosi bone miner densiti bmd either lumbar spine femor neck least 2.5 sd peak premenopaus mean prior vertebr hip fractur primari efficaci endpoint compar increas lumbar spine bmd use strict pre-defin equival criteria secondari endpoint includ chang bmd hip total bodi rate bone turnov assess biochem marker new regimen fulli satisfi equival criteria rel daili therapi mean increas lumbar spine bmd 12 month 5.1 95 ci 4.8 5.4 70 mg once-weekli group 5.2 4.9 5.6 35 mg twice-weekli group 5.4 5.0 5.8 10 mg daili treatment group increas bmd total hip femor neck trochant total bodi similar three dose regimen three treatment group similarli reduc biochem marker bone resorpt urinari n-telopeptid type collagen bone format serum bone-specif alkalin phosphatas middl premenopaus refer rang treatment regimen well toler similar incid upper gi advers experi fewer seriou upper gi advers experi trend toward lower incid esophag event once-weekli dose group compar daili dose group data consist preclin anim model suggest once-weekli dose potenti improv upper gi toler clinic fractur captur advers experi similar among group conclud alendron 70 mg once-weekli dose regimen provid patient conveni therapeut equival altern daili dose may enhanc complianc long-term persist therapi',\n",
       "  'background although toll-lik receptor 4 tlr-4 involv monocyt activ patient acceler form atherosclerosi relationship express tlr-4 circul monocyt coronari plaqu vulner previous evalu investig relationship use 64-slice multidetector comput tomographi mdct patient stabl angina pectori sap .method result enrol 65 patient sap underw mdct three monocyt subset cd14++cd16- cd14++cd16+ cd14+cd16+ express tlr-4 measur flow cytometri intracoronari plaqu assess 64-slice mdct defin vulner intracoronari plaqu accord presenc posit remodel remodel index 1.05 and/or low ct attenu 35 hu circul cd14++cd16+monocyt frequent express tlr-4 cd14++cd16-and cd14+cd16+monocyt p 0.001 rel proport express tlr-4 cd14++cd16+monocyt significantli greater patient vulner plaqu compar without 10.4 4.1-14.5 vs. 4.5 2.8-7.8 p=0.012 addit rel proport tlr-4 express cd14++cd16+monocyt posit correl remodel index r=0.28 p=0.025 neg correl ct attenu valu r=-0.31 p=0.013 conclus upregul tlr-4 cd14++cd16+monocyt might associ coronari plaqu vulner patient sap',\n",
       "  'stem cell-bas approach cardiac regener increasingli viabl strategi treat heart failur gener abund function autolog cell transplant set howev remain signific challeng isol cell popul extens prolifer capac restrict cardiovascular differenti potenti cardiac transdifferenti mous fibroblast induc expand cardiovascular progenitor cell iecpc prolifer extens 18 passag chemic defin condit 10 5 start fibroblast robustli produc 10 16 iecpc iecpc express cardiac signatur gene readili differenti function cardiomyocyt cm endotheli cell ec smooth muscl cell smc vitro even long-term expans transplant mous heart follow myocardi infarct iecpc spontan differenti cm ec smc improv cardiac function 12 week transplant thu iecpc power system studi cardiovascular specif provid strategi regen medicin heart',\n",
       "  'thyroid hormon th critic mainten cellular homeostasi stress respons role lung fibrosi unknown found activ express iodothyronin deiodinas 2 dio2 enzym activ th higher lung patient idiopath pulmonari fibrosi control individu correl diseas sever also found dio2-knockout mice exhibit enhanc bleomycin-induc lung fibrosi aerosol th deliveri increas surviv resolv fibrosi two model pulmonari fibrosi mice intratrach bleomycin induc tgf-β1 sobetirom th mimet also blunt bleomycin-induc lung fibrosi bleomycin-induc injuri th promot mitochondri biogenesi improv mitochondri bioenerget attenu mitochondria-regul apoptosi alveolar epitheli cell vivo vitro th blunt fibrosi ppargc1a- pink1-knockout mice suggest depend pathway conclud antifibrot properti th associ protect alveolar epitheli cell restor mitochondri function th may thu repres potenti therapi pulmonari fibrosi',\n",
       "  'proper regul energi storag adipos tissu crucial maintain insulin sensit molecul contribut process fulli reveal show type ii transmembran protein tenomodulin tnmd upregul adipos tissu insulin-resist versu insulin-sensit individu match bodi mass index bmi tnmd express increas human preadipocyt differenti wherea silenc tnmd block adipogenesi upon high-fat diet feed transgen mice overexpress tnmd develop increas epididym white adipos tissu ewat mass preadipocyt deriv tnmd transgen mice display greater prolifer consist elev adipogenesi tnmd transgen mice lipogen gene upregul ewat ucp1 brown fat liver triglycerid accumul attenu despit expand ewat transgen anim display improv system insulin sensit decreas collagen deposit inflamm ewat increas insulin stimul akt phosphoryl data suggest tnmd act protect factor viscer adipos tissu allevi insulin resist obes',\n",
       "  'driven technolog progress human life expect increas greatli sinc nineteenth centuri demograph evid reveal ongo reduct old-ag mortal rise maximum age death may gradual extend human longev togeth observ lifespan variou anim speci flexibl increas genet pharmaceut intervent result led suggest longev may subject strict species-specif genet constraint analys global demograph data show improv surviv age tend declin age 100 age death world ’ oldest person increas sinc 1990 result strongli suggest maximum lifespan human fix subject natur constraint',\n",
       "  'import glucagon-lik peptide-1 glp-1 receptor agonist effect therapi treatment type 2 diabet current avail inject object compar effect oral semaglutid placebo primari open-label subcutan semaglutid secondari glycem control patient type 2 diabet design set patient phase 2 random parallel-group dosage-find 26-week trial 5-week follow-up 100 site hospit clinic gener practic clinic research center 14 countri conduct decemb 2013 decemb 2014. 1106 particip assess 632 type 2 diabet insuffici glycem control use diet exercis alon stabl dose metformin random random stratifi metformin use intervent once-daili oral semaglutid 2.5 mg n 70 5 mg n 70 10 mg n 70 20 mg n 70 40-mg 4-week dose escal standard escal n 71 40-mg 8-week dose escal slow escal n 70 40-mg 2-week dose escal fast escal n 70 oral placebo n 71 double-blind once-weekli subcutan semaglutid 1.0 mg n 70 26 week main outcom measur primari end point chang hemoglob a1c hba1c baselin week 26. secondari end point includ chang baselin bodi weight advers event result baselin characterist compar across treatment group 632 random patient mean age 57.1 year sd 10.6 men 395 62.7 diabet durat 6.3 year sd 5.2 bodi weight 92.3 kg sd 16.8 bmi 31.7 sd 4.3 583 92 complet trial mean chang hba1c level baselin week 26 decreas oral semaglutid dosage-depend rang −0.7 −1.9 subcutan semaglutid −1.9 placebo −0.3 oral semaglutid reduct signific vs placebo dosage-depend estim treatment differ etd rang oral semaglutid vs placebo –0.4 –1.6 p .01 2.5 mg .001 dosag reduct bodi weight greater oral semaglutid dosage-depend rang −2.1 kg −6.9 kg subcutan semaglutid −6.4 kg vs placebo −1.2 kg signific oral semaglutid dosag 10 mg vs placebo dosage-depend etd rang –0.9 –5.7 kg p .001 advers event report 63 86 371 490 patient oral semaglutid group 81 56 69 patient subcutan semaglutid group 68 48 71 patient placebo group mild moder gastrointestin event common conclus relev among patient type 2 diabet oral semaglutid result better glycem control placebo 26 week find support phase 3 studi assess longer-term clinic outcom well safeti trial registr clinicaltrials.gov identifi nct01923181',\n",
       "  'motiv enorm amount short read gener new dna sequenc technolog call develop fast accur read align program first gener hash table-bas method develop includ maq accur featur rich fast enough align short read singl individu howev maq support gap align single-end read make unsuit align longer read indel may occur frequent speed maq also concern align scale resequenc hundr individu result implement burrows-wheel align tool bwa new read align packag base backward search burrows-wheel transform bwt effici align short sequenc read larg refer sequenc human genom allow mismatch gap bwa support base space read e.g illumina sequenc machin color space read ab solid machin evalu simul real data suggest bwa approxim 10-20x faster maq achiev similar accuraci addit bwa output align new standard sam sequenc alignment/map format variant call downstream analys align achiev open sourc samtool softwar packag avail http //maq.sourceforge.net',\n",
       "  \"object estim lost invest domest educ doctor migrat sub-saharan african countri australia canada unit kingdom unit state design human capit cost analysi use publicli access data set sub-saharan african countri particip nine sub-saharan african countri hiv preval 5 greater one million peopl hiv/aid least one medic school ethiopia kenya malawi nigeria south africa tanzania uganda zambia zimbabw data avail number doctor practis destin countri main outcom measur financi cost educ doctor primari secondari medic school assum migrat occur graduat use current countri specif interest rate save convert us dollar cost accord number sourc countri doctor current work destin countri save destin countri receiv train doctor result nine sourc countri estim govern subsidis cost doctor 's educ rang 21,000 £13,000 €15,000 uganda 58,700 south africa overal estim loss return invest doctor current work destin countri 2.17bn 95 confid interv 2.13bn 2.21bn cost countri rang 2.16m 1.55m 2.78m malawi 1.41bn 1.38bn 1.44bn south africa ratio estim compound lost invest gross domest product show zimbabw south africa largest loss benefit destin countri recruit train doctor largest unit kingdom 2.7bn unit state 846m conclus among sub-saharan african countri affect hiv/aid lost invest emigr doctor consider destin countri consid invest measur train sourc countri strengthen health system\",\n",
       "  'gener induc pluripot stem cell ipsc somat cell reprogram involv global epigenet remodel wherea sever protein known regul chromatin mark associ distinct epigenet state cell reprogram role specif chromatin-modifi enzym reprogram remain determin address chromatin-modifi protein influenc reprogram use short hairpin rna shrna target gene dna histon methyl pathway identifi posit neg modul ipsc gener wherea inhibit core compon polycomb repress complex 1 2 includ histon 3 lysin 27 methyltransferas ezh2 reduc reprogram effici suppress suv39h1 yy1 dot1l enhanc reprogram specif inhibit h3k79 histon methyltransferas dot1l shrna small molecul acceler reprogram significantli increas yield ipsc coloni substitut klf4 c-myc also known myc inhibit dot1l earli reprogram process associ mark increas two altern factor nanog lin28 play essenti function role enhanc reprogram genome-wid analysi h3k79me2 distribut reveal fibroblast-specif gene associ epitheli mesenchym transit lose h3k79me2 initi phase reprogram dot1l inhibit facilit loss mark gene fate repress pluripot state find implic specif chromatin-modifi enzym barrier facilit reprogram demonstr modul chromatin-modifi enzym exploit effici gener ipsc fewer exogen transcript factor',\n",
       "  'quantif character circul immun cell provid key indic human health diseas identifi rel effect environment genet factor variat paramet innat adapt immun cell homeostat condit combin standard flow cytometri blood leukocyt genome-wid dna genotyp 1,000 healthi unrel peopl western european ancestri found smoke togeth age sex latent infect cytomegaloviru main non-genet factor affect variat paramet human immun cell genome-wid associ studi 166 immunophenotyp identifi 15 loci show enrich disease-associ variant final demonstr paramet innat cell strongli control genet variat adapt cell driven mainli environment exposur data establish resourc gener new hypothes immunolog highlight role innat immun suscept common autoimmun diseas environment factor genet factor influenc human immun albert colleagu leverag data milieu intérieur consortium comprehens describ effect lifestyl environ genet human innat adapt immun',\n",
       "  'mast cell uniqu tissue-resid immun cell express array receptor activ sever extracellular cue includ antigen-immunoglobulin e ige complex bacteria virus cytokin hormon peptid drug mast cell constitut small popul tissu extraordinari abil respond rapidli releas granule-stor newli made mediat underpin import health diseas review document biolog mast cell introduc new concept opinion regard role human diseas beyond ige-medi allerg respons antiparasit function bring light recent discoveri develop mast cell research includ regul mast cell function differenti surviv novel mous model final highlight current futur opportun therapeut intervent mast cell function inflammatori diseas',\n",
       "  'lin28b rna-bind protein regul predominantli let-7 microrna essenti function inflamm wound heal embryon stem cell cancer lin28b express associ tumor initi progress resist poor outcom sever solid cancer includ lung cancer howev function role lin28b especi non-smal cell lung adenocarcinoma remain elus investig effect lin28b express lung tumorigenesi use lin28b transgen overexpress autochthon krasg12v-driven mous model found lin28b overexpress significantli increas number cd44+/cd326+ tumor cell upregul vegf-a mir-21 promot tumor angiogenesi epithelial-to-mesenchym transit emt accompani enhanc akt phosphoryl nuclear transloc c-myc moreov lin28b acceler tumor initi enhanc prolifer led shorten overal surviv addit analyz lung adenocarcinoma cancer genom atla tcga found lin28b express 24 kras-mut case underscor relev model',\n",
       "  'standard treatment partial-thick burn includ topic silver product silver sulfadiazin ssd cream enclos dress includ silver-impregn foam mepilex ag molnlyck health care gothenburg sweden silver-laden sheet aquacel ag convatec skillman nj current state health care limit resourc emphasi evidence-bas outcom cost-effect treatment studi includ decis analysi increment cost-util ratio compar enclos silver dress ssd partial-thick burn patient tbsa less 20 comprehens literatur review conduct identifi clinic relev health state partial-thick burn patient health state includ success heal infect noninfect delay heal requir either surgeri conserv manag probabl health state combin medicar cpt reimburs code cost patient-deriv util fit decis model util obtain use visual analog scale patient interview expect cost quality-adjust life year qali calcul use roll-back method increment cost-util ratio enclos silver dress rel ssd 40,167.99/qali one-way sensit analysi complic rate confirm robust model assum maximum willing pay 50,000/qali complic rate ssd must 22 higher enclos silver dress cost effect vari complic rate ssd enclos silver dress two-way sensit analysi demonstr cost effect use enclos silver dress major complic rate treatment modal enclos silver dress cost-effect mean treat partial thick burn',\n",
       "  'prospect random studi compar protocol care use either aquacel ag hydrofib convatec bristol-my squibb compani skillman nj dress silver n 42 silver sulfadiazin n 42 21 day manag partial-thick burn cover 5 40 bodi surfac area bsa aquacel ag dress associ less pain anxieti dress chang less burn sting wear fewer dress chang less nurs time fewer procedur medic silver sulfadiazin associ greater flexibl eas movement advers event includ infect compar treatment group aquacel ag dress protocol tend lower total treatment cost dollar 1040 vs. dollar 1180 greater rate re-epitheli 73.8 vs 60.0 result cost-effect per burn heal dollar 1,409.06 aquacel ag dress dollar 1,967.95 silver sulfadiazin protocol care aquacel r ag provid clinic econom benefit compar silver sulfadiazin patient partial-thick burn',\n",
       "  \"risk hcv transmiss blood blood product greatli reduc sinc earli 1980 's select non-remuner donor donor select prevent hiv transmiss initi surrog test region introduct anti-hcv test contribut alt surrog test becom obsolet sinc introduct anti-hcv test residu risk hcv transmiss due donat anti-hcv window period present 1 100 000 transfus cellular product transmiss hcv plasma product treat modern inactiv method solvent-deterg treatment report hemovigil programm present instal provid data safeti blood transfus introduct hcv nucleic amplif technolog nat qualiti control manufactur pool plasma product form blood donor screen minipool anticip mani european countri come year given industri develop nat test individu blood donat may becom avail within next 2 year hcv nat test annihil residu risk cost-effect becom rel low comparison public health measur\",\n",
       "  'hepat stellat cell hsc play critic role liver fibrosi hepatocellular carcinoma hcc vitamin receptor vdr activ hsc inhibit liver inflamm fibrosi found p62/sqstm1 protein upregul liver parenchym cell downregul hcc-associ hsc neg control hsc activ total bodi hsc-specif p62 ablat potenti hsc enhanc inflamm fibrosi hcc progress p62 directli interact vdr rxr promot heterodimer critic vdr rxr target gene recruit loss p62 hsc impair repress fibrosi inflamm vdr agonist demonstr p62 neg regul liver inflamm fibrosi abil promot vdr signal hsc whose activ support hcc',\n",
       "  \"come decad massiv shift age segment popul major social econom consequ around world one way offset increas expedit develop geroprotector substanc slow age repair age-associ damag extend healthi lifespan healthspan 200 geroprotector report model organ human use specif diseas indic path toward determin whether affect age human remain obscur translat clinic hamper multipl issu includ absenc common set criteria defin select classifi substanc given complex age process enorm divers mechan action translat research effort would benefit format scientif consensu follow definit 'geroprotector select criteria geroprotector comprehens classif system analyt model review current approach select put forth suggest select criteria standard select geroprotector streamlin discoveri analysi new candid save time cost involv translat clinic\",\n",
       "  'β-catenin encod ctnnb1 subunit cell surfac cadherin protein complex act intracellular signal transduc wnt signal pathway alter activ associ develop hepatocellular carcinoma liver diseas wnt addit signal pathway also converg β-catenin β-catenin also interact transcript factor t-cell factor forkhead box protein hypoxia induc factor 1α regul express target gene discuss role β-catenin metabol zonat adult liver β-catenin also regul express gene control metabol glucos nutrient xenobiot alter activ may contribut pathogenesi nonalcohol steatohepat alter β-catenin signal may lead activ hepat stellat cell requir fibrosi mani hepat tumor hepatocellular adenoma hepatocellular cancer hepatoblastoma mutat ctnnb1 result constitut activ β-catenin molecul could therapeut target discuss alter β-catenin activ contribut liver diseas might use diagnosi prognosi well develop therapeut',\n",
       "  'background dengu common arboviru infect global burden poorli quantifi estim dengu mortal incid burden global burden diseas studi 2013. method model mortal vital registr verbal autopsi surveil data use caus death ensembl model tool model incid offici report case adjust raw estim under-report base publish estim expans factor total 1780 country-year mortal data 130 countri 1636 country-year dengu case report 76 countri expans factor estim 14 countri find estim averag 9221 dengu death per year 1990 2013 increas low 8277 95 uncertainti estim 5353-10 649 1992 peak 11 302 6790-13 722 2010. yield total 576 900 330 000-701 200 year life lost prematur mortal attribut dengu 2013. incid dengu increas greatli 1990 2013 number case doubl everi decad 8·3 million 3·3 million-17·2 million appar case 1990 58·4 million 23·6 million-121·9 million appar case 2013. account disabl moder sever acut dengu post-dengu chronic fatigu 566 000 186 000-1 415 000 year live disabl attribut dengu 2013. consid fatal non-fat outcom togeth dengu respons 1·14 million 0·73 million-1·98 million disability-adjust life-year 2013. interpret although lower estim result offer evid true symptomat incid dengu probabl fall within commonli cite rang 50 million 100 million case per year mortal estim lower present elsewher consid light total evid suggest dengu mortal might fact substanti higher fund bill melinda gate foundat',\n",
       "  'cadherin-medi cell-cel adhes requir epitheli tissu integr homeostasi develop tissu repair e-cadherin stabil depend f-actin mechan regul actin polymer cell-cel junction remain poorli understood investig role formin-medi actin polymer cell-cel junction identifi mdia1 fmnl3 major factor enhanc actin polymer stabil e-cadherin epitheli junction fmnl3 local adheren junction downstream src cdc42 deplet lead reduct f-actin e-cadherin junction weaken cell-cel adhes import fmnl3 express up-regul junction local increas collect cell migrat deplet fmnl3 mdia1 migrat monolay result dissoci leader cell impair wound repair summari result show formin activ epitheli cell-cel junction import adhes mainten epitheli cohes dynam process wound repair',\n",
       "  'cancer-associ fibroblast caf promot tumour invas metastasi show caf exert physic forc cancer cell enabl collect invas forc transmiss mediat heterophil adhes involv n-cadherin caf membran e-cadherin cancer cell membran adhes mechan activ subject forc trigger β-catenin recruit adhes reinforc depend α-catenin/vinculin interact impair e-cadherin/n-cadherin adhes abrog abil caf guid collect cell migrat block cancer cell invas n-cadherin also mediat repolar caf away cancer cell parallel nectin afadin recruit cancer cell/caf interfac caf repolar afadin depend heterotyp junction caf cancer cell observ patient-deriv materi togeth find show mechan activ heterophil adhes caf cancer cell enabl cooper tumour invas',\n",
       "  'despit progress treatment small cell lung cancer sclc multidrug chemoresist poor prognosi still remain recent global assess long non-cod rna lncrna contribut sclc chemoresist use microarray data vitro vivo assay report hottip encod lncrna frequent amplifi sclc associ sclc cell chemosensit prolifer poor prognosi sclc patient moreov mechanist investig show hottip function oncogen sclc progress bind mir-216a abrog tumor-suppress function set hand hottip increas express anti-apoptot factor bcl-2 anoth import target gene mir-216a jointli enhanc chemoresist sclc regul bcl-2 taken togeth studi establish role hottip sclc progress chemoresist suggest candidaci new diagnost prognost biomark clinic manag sclc',\n",
       "  'unlabel visual gene structur annot featur help biologist investig function evolut intuit gene structur display server gsd wide use 60 000 user sinc first public 2007. report upgrad gsd 2.0 newli design interfac support type annot featur format well integr visual editor edit gener figur moreov user-specifi phylogenet tree ad facilit evolutionari analysi full sourc code also avail download avail implement web server sourc code freeli avail http //gsds.cbi.pku.edu.cn contact gaog mail.cbi.pku.edu.cn gsd mail.cbi.pku.edu.cn supplementari inform supplementari data avail bioinformat onlin',\n",
       "  'although essenti role adaptor protein slp-65 pre-b cell differenti establish molecular mechan underli function poorli understood studi uncov link slp-65–depend signal phosphoinositide-3-oh kinas pi 3 k –protein kinas b pkb –foxo pathway show forkhead box transcript factor foxo3a promot light chain rearrang pre-b cell data suggest pkb suppress light chain recombin phosphoryl foxo protein wherea reconstitut slp-65 function counteract pkb activ promot foxo3a foxo1 activ pre-b cell togeth data illumin molecular function slp-65 identifi key role foxo protein regul light chain recombin receptor edit b cell select',\n",
       "  'background italian nation health servic nh provid univers coverag citizen grant primari hospit care copay system outpati drug servic financ local health trust lht base capit system adjust age gender area resid appli risk-adjust system john hopkin adjust clinic group system acg® system order explain health care cost use routin collect administr data veneto region north-eastern itali method resid veneto region includ studi acg system appli classifi region popul base follow inform sourc year 2015 hospit discharg emerg room visit chronic diseas registri copay exempt ambulatori visit medic home care databas drug prescript simpl linear regress use contrast age-gend model model incorpor comprehens risk measur aim predict health care cost result simpl age-gend model explain 8 varianc 2015 total cost ad diagnoses-rel variabl provid 23 increas pharmaci base variabl provid addit 17 increas explain varianc adjust r-squar comprehens model 6 time simpl age-gend model conclus acg system provid substanti improv predict health care cost compar simpl age-gend adjust age main determin increas health care cost better explain accumul chronic condit result multimorbid',\n",
       "  'background aim hepatocyt hepat b viru hbv replic exhibit loss chromatin modifi polycomb repress complex 2 prc2 result re-express specif cellular prc2-repress gene epitheli cell adhes molecul epcam prc2-repress gene normal express hepat progenitor re-express hepat cancer stem cell hcsc herein investig function signific epcam re-express hbv-mediat hepatocarcinogenesi method employ molecular approach transfect fluorescence-activ cell sort immunoblot qrt-pcr investig role epcam-regul intramembran proteolysi rip hbv replic cell vitro liver tumor hbv x/c-myc mice chronic hbv infect patient result epcam undergo rip hbv replic cell activ canon wnt signal transfect wnt-respons plasmid express green fluoresc protein gfp identifi gfp popul hbv replic cell gfp+/wnt+ cell exhibit cisplatin- sorafenib-resist growth resembl hcsc increas express pluripot gene nanog oct4 sox2 hcsc marker bambi cd44 cd133 gene refer epcam rip wnt-induc hcsc-like gene signatur interestingli gene signatur also overexpress liver tumor x/c-myc bitransgen mice clinic group hbv-associ hepatocellular carcinoma identifi exhibit elev express hcsc-like gene signatur associ reduc overal surviv post-surg resect conclus hcsc-like gene signatur offer promis prognost tool classifi subtyp hbv-induc hcc sinc epcam rip wnt signal drive express hcsc-like signatur inhibit pathway explor therapeut strategi subtyp hbv-associ hcc lay summari studi provid evid molecular mechan chronic infect hepat b viru result develop poor prognosi liver cancer base mechan result suggest possibl therapeut intervent',\n",
       "  \"intermitt pth administr build bone mass prevent fractur mechan action unclear genet delet pth/pthrp receptor pth1r mesenchym stem cell use prx1cre found low bone format increas bone resorpt high bone marrow adipos tissu bmat bone marrow adipocyt trace prx1 express classic adipogen marker high receptor activ nuclear factor kappa b ligand rankl express rankl level also elev bone marrow supernat serum undetect adipos depot cell sort pref1+rankl+ marrow progenitor twice great mutant versu control marrow intermitt pth administr control mice reduc bmat significantli similar find note male osteoporot patient thu marrow adipocyt exhibit osteogen adipogen characterist uniqu respons pth secret rankl studi reveal import mechan pth 's therapeut action abil direct mesenchym cell fate\",\n",
       "  'background metformin wide use hypoglycem drug reduc stroke incid allevi chronic inflamm clinic trial howev effect metformin ischem stroke unclear investig effect metformin ischem stroke mice explor possibl underli mechan method ninety-eight adult male cd-1 mice underw 90-minut transient middl cerebr arteri occlus tmcao metformin 200 mg/kg administr 14 day neurobehavior outcom brain infarct volum inflammatori factor blood-brain barrier bbb permeabl ampk signal pathway evalu follow tmcao oxygen glucos depriv perform bend.3 cell explor mechan metformin inhibit inflammatori signal pathway result infarct volum reduc metformin-tr mice compar control group follow tmcao p 0.05 neurobehavior outcom greatli improv metformin-tr mice p 0.05 mpo+ cell gr1+ cell mpo activ bbb permeabl decreas metformin administr p 0.05 addit metformin activ ampk phosphoryl inhibit nf-κb activ down-regul cytokin il-1β il-6 tnf-α icam-1 express follow tmcao p 0.05 furthermor metformin activ ampk signal pathway allevi oxygen-glucos deprivation-induc icam-1 express bend.3 cell p 0.05 compound c select ampk inhibitor elimin promot effect conclus metformin down-regul icam-1 ampk-depend manner could effect prevent ischemia-induc brain injuri allevi neutrophil infiltr suggest metformin promis therapeut agent stroke therapi',\n",
       "  'resist apoptosi import compon overal mechan drive tumorigen process ebv ubiquit human gamma-herpesviru preferenti establish latent infect viral infect b-lymphocyt ebna1 typic express form ebv-posit malign import replic latent episom concert replic host cell investig effect ebna1 survivin up-regul ebv-infect human b-lymphoma cell present evid demonstr ebna1 form complex sp1 sp1-like protein bound cis-el survivin promot enhanc activ complex up-regul survivin knockdown survivin ebna1 show enhanc apoptosi infect cell thu support role ebna1 suppress apoptosi ebv-infect cell suggest ebv encod ebna1 contribut oncogen process up-regul apoptosi suppressor protein survivin ebv-associ b-lymphoma cell',\n",
       "  \"background microfluid platform quantit evalu cell biolog process allow low cost time effici research studi biolog patholog event monitor cell migrat real-tim imag healthi diseas state cell migrat crucial develop wound heal well maintain bodi 's homeostasi new method microfluid chamber allow precis measur investig whether fibroblast carri mutat tor1a gene underli hereditari neurolog diseas -- dyt1 dystonia decreas migrat properti compar control cell result observ fibroblast dyt1 patient show abnorm basic featur cell migrat reduc veloc persist movement comparison exist method microfluid method enabl us demonstr reduc polar nucleu abnorm orient nuclei golgi insid move dyt1 patient cell compar control cell well vectori movement singl cell conclus report differ assay use determin variou paramet cell migrat dyt1 patient cell consequ tor1a gene mutat includ microfluid platform provid mean evalu real-tim vectori movement singl cell resolut three-dimension environ\",\n",
       "  'background relat sugar-sweeten beverag ssb bodi weight remain controversi object conduct systemat review meta-analysi summar evid children adult design search pubm embas cochran databas march 2013 prospect cohort studi random control trial rct evalu ssb-weight relat separ meta-analys conduct children adult cohort rct use random- fixed-effect model result thirty-two origin articl includ meta-analys 20 children 15 cohort studi n 25,745 5 trial n 2772 12 adult 7 cohort studi n 174,252 5 trial n 292 cohort studi one daili serv increment ssb associ 0.06 95 ci 0.02 0.10 0.05 95 ci 0.03 0.07 -unit increas bmi children 0.22 kg 95 ci 0.09 0.34 kg 0.12 kg 95 ci 0.10 0.14 kg weight gain adult 1 random- fixed-effect model respect rct children show reduct bmi gain ssb reduc random fix effect -0.17 95 ci -0.39 0.05 -0.12 95 ci -0.22 -0.2 wherea rct adult show increas bodi weight ssb ad random fix effect 0.85 kg 95 ci 0.50 1.20 kg sensit analys rct children show pronounc benefit prevent weight gain ssb substitut trial compar school-bas educ program among overweight children compar normal-weight children conclus systemat review meta-analysi prospect cohort studi rct provid evid ssb consumpt promot weight gain children adult',\n",
       "  'human pluripot stem cell hpsc potenti fundament chang way go treat understand human diseas despit extraordinari potenti cell also innat capabl form tumor immunocompromis individu introduc pluripot state although current therapeut strategi involv transplant differenti hpsc deriv still concern transplant cell popul could contain small percentag cell fulli differenti addit cell frequent report acquir genet alter case associ certain type human cancer tri separ panic realiti ration evalu true tumorigen potenti cell also discuss recent studi examin effect cultur condit genet integr hpsc final present set sensibl guidelin minim tumorigen potenti hpsc-deriv cell © 2016 author insid cell publish wiley period inc',\n",
       "  'background new sepsi septic shock definit could chang epidemiolog sepsi differ criteria therefor compar sepsi popul identifi old new definit method use high-qual nation intens care unit icu databas 654 918 consecut admiss 189 adult icu england januari 2011 decemb 2015. primari outcom acut hospit mortal compar old sepsis-2 new sepsis-3 incid outcom trend outcom predict valid sepsi septic shock popul result among 197 724 sepsis-2 sever sepsi 197 142 sepsis-3 sepsi case identifi 153 257 sepsis-2 septic shock 39 262 sepsis-3 septic shock case extrapol popul incid sepsis-3 sepsi sepsis-3 septic shock 101.8 19.3 per 100 000 person-year respect 2015. sepsis-2 sever sepsi sepsis-3 sepsi similar incid similar mortal show signific risk-adjust improv mortal time sepsis-3 septic shock much higher acut physiolog chronic health evalu ii apach ii score greater mortal risk-adjust trend mortal improv compar sepsis-2 septic shock icu admiss identifi either sepsis-3 sepsi septic shock sepsis-2 sever sepsi septic shock significantli greater risk-adjust odd death compar non-sepsi admiss p 0.001 predict valid greatest sepsis-3 septic shock conclus icu databas compar sepsis-2 sepsis-3 identifi similar sepsi popul 92 overlap much smaller septic shock popul improv predict valid',\n",
       "  'cell antigen-specif repertoir thought shape thymic express self molecul sinc myelin basic protein mbp -like gene golli-mbp report express cell immun system present studi undertaken determin whether golli-mbp gene express mous thymu character transcript gene organ use exon-specif primer mbp golli-mbp cdna thymu tissu amplifi amplifi product analyz southern blot exon-specif oligonucleotid probe amplifi product subclon insert character dna sequenc thymic transcript found contain golli-mbp exon 1 2 3 5a 5b 5c 6 7 8 11',\n",
       "  'background diagnost valu microrna mirna detect patient bladder cancer bca controversi perform diagnost meta-analysi evalu current evid use mirna assay diagnos bca method systemat search pubm embas web scienc studi publish march 31 2015. pool sensit specif posit neg likelihood ratio diagnost odd ratio area curv auc calcul evalu overal test perform subgroup analys use explor between-studi heterogen deek funnel plot asymmetri test use test public bia appli softwar revman 5.2 stata 11.0 meta-analysi result total 23 studi nine articl includ meta-analysi total 719 patient 494 control pool sensit specif 0.75 95 confid interv ci 0.68-0.80 0.75 95 ci 0.70-0.80 respect pool posit likelihood ratio 3.03 95 ci 2.50-3.67 neg likelihood ratio 0.33 95 ci 0.27-0.42 diagnost odd ratio 9.07 95 ci 6.35-12.95 pool auc 0.81 95 ci 0.78-0.85 subgroup analys indic multipl mirna assay urin supernat assay show high accuraci diagnos bca conclus mirna assay may serv potenti noninvas diagnost tool detect bca howev clinic applic mirna assay bca diagnosi still need valid larg prospect studi',\n",
       "  'background transform growth factor β1 tgf-β1 multifunct cytokin grow evid tgf-β1 involv pathogenesi hypertens develop target organ damag hypertens although sever studi shown tgf-β1 induc vascular hypertrophi remodel variou vascular diseas longitudin data hypertens epidemiolog studi present studi test hypothesi whether elev tgf-β1 level predict develop hypertens method 2002-2004 528 subject receiv health examin uku town southwestern japan examin blood pressur bp bodi mass index blood test data fast plasma tgf-β1 obtain 528 individu 149 normotens bp 140/90 mm hg without antihypertens medic baselin followed-up 14 year result receiver-oper characterist curv use calcul cutoff valu 8.9 ng/ml 149 normotens baselin 59 subject develop hypertens plasma tgf-β1 level significantli associ develop hypertens adjust confound factor examin associ perform logist regress analysi divid baselin plasma tgf-β1 level 2 group use cutoff valu signific high odd ratio 3.582 95 confid interv 1.025-12.525 develop hypertens found highest group tgf-β1 level vs. lowest group adjust confound conclus first report demonstr causal relationship elev plasma tgf-β1 level predict develop hypertens normotens popul community-dwel japanes',\n",
       "  \"myc oncogen encod myc transcript factor bind genom site term e-box 5'-cacgtg-3 ident bind site heterodimer clock-bmal1 master circadian transcript factor henc hypothes ectop myc express perturb clock deregul e-box-driven compon circadian network cancer cell report deregul express myc n-myc disrupt molecular clock vitro directli induc rev-erbα dampen express oscil bmal1 could rescu knockdown rev-erb rev-erbα express predict poor clinic outcom n-myc-driven human neuroblastoma diminish bmal1 express re-express ectop bmal1 neuroblastoma cell line suppress clonogen ectop myc profoundli alter oscil glucos metabol perturb glutaminolysi result demonstr unsuspect link oncogen transform circadian metabol dysrhythmia surmis advantag cancer\",\n",
       "  'backgroundbi compar quail genom chicken chromosom rearrang occur two galliform speci 35 million year evolut detect practic point view definit conserv synteni help predict posit gene quail base inform taken chicken sequenc thu enhanc util speci biolog studi better knowledg genom structur microsatellit amplifi fragment length polymorph aflp genet map previous publish quail well compar cytogenet data chicken macrochromosom quail genom benefit extens integr map resultsth integr linkag map present base segreg analysi anonym marker function gene loci 1,050 quail three independ f2 popul ninety-two loci resolv 14 autosom linkag group z chromosome-specif linkag group align quail aflp map size linkag group rang 7.8 cm 274.8 cm total map distanc cover 904.3 cm averag space 9.7 cm loci coverag complet macrochromosom cja08 gonosom cjaw 23 microchromosom marker assign yet signific sequenc ident quail marker chicken enabl align quail linkag group chicken genom sequenc assembl togeth interspecif fluoresc situ hybrid fish reveal high similar marker order two speci eight macrochromosom 14 microchromosom studi conclusionintegr two microsatellit aflp quail genet map greatli enhanc qualiti result inform thu facilit identif quantit trait loci qtl align chicken chromosom confirm high conserv gene order expect two speci macrochromosom extend compar studi microchromosom suggest wealth inform mine chicken use genom analys quail',\n",
       "  'neural activ induc remodel pre- postsynapt membran maintain apposit cell adhes molecul among n-cadherin redistribut undergo activity-depend conform chang requir synapt plastic show depolar induc enlarg width spine head cadherin activ essenti synapt rearrang dendrit spine visual green fluoresc protein hippocamp neuron show expans activ ampa receptor synapt apposit zone may expand n-cadherin-venu fusion protein later dispers along expand spine head overexpress dominant-neg form n-cadherin result abrog spine expans inhibit actin polymer cytochalasin abolish spine expans togeth data suggest cadherin-bas adhes machineri coupl actin-cytoskeleton critic remodel synapt apposit zone',\n",
       "  'background diabet nephropathi lead caus end-stag renal diseas develop countri evalu renoprotect effect dual blockad renin-angiotensin-aldosteron system ad treatment aliskiren oral direct renin inhibitor treatment maxim recommend dose losartan 100 mg daili optim antihypertens therapi patient hypertens type 2 diabet nephropathi method enrol 599 patient multin random double-blind studi 3-month open-label run-in period patient receiv 100 mg losartan daili patient randomli assign receiv 6 month treatment aliskiren 150 mg daili 3 month follow increas dosag 300 mg daili anoth 3 month placebo addit losartan primari outcom reduct ratio albumin creatinin measur early-morn urin sampl 6 month result baselin characterist two group similar treatment 300 mg aliskiren daili compar placebo reduc mean urinari albumin-to-creatinin ratio 20 95 confid interv 9 30 p 0.001 reduct 50 24.7 patient receiv aliskiren compar 12.5 receiv placebo p 0.001 small differ blood pressur seen treatment group end studi period systol 2 mm hg lower p=0.07 diastol 1 mm hg lower p=0.08 aliskiren group total number advers seriou advers event similar group conclus aliskiren may renoprotect effect independ blood-pressure-low effect patient hypertens type 2 diabet nephropathi receiv recommend renoprotect treatment clinicaltrials.gov number nct00097955 clinicaltrials.gov',\n",
       "  'background well establish minor celiac patient present “ classic ” symptom due malabsorpt howev studi focuss distribut bodi mass index bmi celiac popul relationship clinic characterist respons treatment method review bmi measur clinic patholog characterist databas 371 celiac patient diagnos 10-yr period seen singl gastroenterologist assess respons gluten exclus compar bmi diagnosi 2 yr treatment patient serolog support dietari complianc result mean bmi 24.6 kg/m2 rang 16.3–43.5 seventeen patient 5 underweight bmi 18.5 211 57 normal 143 39 overweight bmi ≥25 includ 48 13 patient obes rang bmi ≥30.0 signific associ low bmi femal gender histori diarrhea reduc hemoglobin concentr reduc bone miner densiti bmd osteoporosi higher grade subtotal/tot villou atrophi patient compliant gluten-fre diet 81 gain weight 2 yr includ 82 initi overweight patient conclus celiac patient underweight diagnosi larg minor overweight less like present classic featur diarrhea reduc hemoglobin fail delay diagnosi celiac diseas may reflect lack awar larg subgroup increas weight alreadi overweight patient dietari gluten exclus potenti caus morbid gluten-fre diet convent prescrib need modifi accordingli',\n",
       "  \"background polycomb group pcg protein famili import development regul respect member function larg protein complex involv establish mainten transcript repress development control gene mbtd1 malign brain tumor domain-contain protein 1 one pcg protein mbtd1 contain four mbt repeat methodology/princip find determin crystal structur mbtd1 residu 130-566aa cover 4 mbt repeat 2.5 resolut x-ray crystallographi crystal structur mbtd1 reveal similar anoth four-mbt-repeat protein l3mbtl2 bind lower methyl lysin histon fluoresc polar experi confirm mbtd1 preferenti bind mono- di-methyllysin histon peptid like l3mbtl1 l3mbtl2 known mbt-peptid complex structur character date exhibit strong histon peptid sequenc select use `` caviti insert recognit mode '' recogn methyl lysin deepli buri methyl-lysin form extens interact protein peptid residu flank methyl-lysin form contact 1 nevertheless mutagenesi data base l3mbtl1 suggest histon peptid could bind mbt repeat orient conclus four mbt repeat mbtd1 exhibit asymmetr rhomboid architectur like mbt repeat protein character far mbtd1 bind mono- dimethyl lysin histon one four mbt repeat util semi-aromat cage enhanc version articl also view enhanc version text articl integr interact 3d represent anim transit pleas note web plugin requir access enhanc function instruct instal use web plugin avail text s1\",\n",
       "  'cancer cell metabol depend distinguish normal counterpart among depend increas use amino acid glutamin fuel anabol process inde spectrum glutamine-depend tumour mechan wherebi glutamin support cancer metabol remain area activ investig report identif non-canon pathway glutamin use human pancreat ductal adenocarcinoma pdac cell requir tumour growth wherea cell use glutam dehydrogenas glud1 convert glutamine-deriv glutam α-ketoglutar mitochondria fuel tricarboxyl acid cycl pdac reli distinct pathway glutamine-deriv aspart transport cytoplasm convert oxaloacet aspart transaminas got1 subsequ oxaloacet convert malat pyruv ostens increas nadph/nadp ratio potenti maintain cellular redox state importantli pdac cell strongli depend seri reaction glutamin depriv genet inhibit enzym pathway lead increas reactiv oxygen speci reduct reduc glutathion moreov knockdown compon enzym seri reaction also result pronounc suppress pdac growth vitro vivo furthermor establish reprogram glutamin metabol mediat oncogen kra signatur genet alter pdac transcript upregul repress key metabol enzym pathway essenti pathway pdac fact dispens normal cell may provid novel therapeut approach treat refractori tumour',\n",
       "  \"tissue-resid memori trm cell provid enhanc protect infect mucos site found cd4 cell import format function lung-resid cd8 cell influenza viru infect absenc cd4 cell cd8 cell display reduc express cd103 itga misloc away airway epithelia demonstr impair abil recruit cd8 cell lung airway upon heterosubtyp challeng cd4 cell-deriv interferon-γ necessari gener lung-resid cd103 cd8 trm cell furthermor express transcript factor t-bet increas `` unhelp '' lung trm cell reduct t-bet rescu cd103 express absenc cd4 cell help thu cd4 cell-depend signal import limit express t-bet allow develop cd103 cd8 trm cell lung airway follow respiratori infect\",\n",
       "  'cell type advanc develop embryon stem cell episc fail contribut chimera inject pre-implantation-stag blastocyst appar inject cell undergo apoptosi show transient promot cell surviv express anti-apoptot gene bcl2 enabl episc sox17+ endoderm progenitor integr blastocyst contribut chimer embryo upon inject blastocyst bcl2-express episc contribut bodili tissu chimer anim sox17+ endoderm progenitor specif contribut region-specif fashion endoderm tissu addit bcl2 express enabl rat episc contribut mous embryon chimera therebi form interspeci chimera could surviv adulthood system therefor provid method overcom cellular compat issu typic restrict chimera format applic type approach could broaden use embryon chimera includ region-specif chimera basic development biolog research regen medicin',\n",
       "  'late embryogenesi abund protein leap ubiquit protein expect play major role desicc toler littl known structur function relationship scarciti 3-d structur leap previou build leapdb databas dedic leap plant organ led classif 710 leap 12 non-overlap class distinct properti use resourc numer physico-chem properti leap amino acid usag leap comput statist analyz reveal distinct featur class unpreced analysi allow rigor character 12 leap class differ also multipl structur physico-chem featur although leap predict intrins disord protein analysi indic leap class 7 pf03168 probabl leap class 11 pf04927 nativ fold protein studi thu provid detail descript structur properti protein famili open path toward leap structur function analysi final sinc leap class clearli character uniqu set physico-chem properti allow develop softwar predict protein leap',\n",
       "  'direct induct induc hepatocyt ihep fibroblast hold potenti strategi regen medicin shown cultur set describ vivo ihep format use transcript factor induct genet fate trace mous model chronic liver diseas show ectop express transcript factor foxa3 gata4 hnf1a hnf4a polycistron lentivir vector convert mous myofibroblast cell hepatocyt phenotyp vivo express set transcript factor p75 neurotrophin receptor peptid p75ntrp -tag adenoviru enabl gener hepatocyte-lik cell myofibroblast fibrot mous liver reduc liver fibrosi therefor abl convert pro-fibrogen myofibroblast liver hepatocyte-lik cell posit function benefit direct vivo reprogram approach may open new avenu treatment chronic liver diseas',\n",
       "  'background cancer stem cell csc hypothesi assert small subset cell within tumour capabl tumour initi sustain epithelial-mesenchym transit emt embryon development program often activ cancer invas metastasi aim studi shed light relationship emt csc use lc31 lung cancer primari cell line materi method a549 lc31 cell line treat 2 ng/ml tgfβ-1 30 day 80 day respect evalu emt morpholog chang assess light microscopi immunofluoresc cytometri follow marker cytokeratin e-cadherin cd326 epitheli marker cd90 vimentin mesenchym marker moreov rt-pcr slug twist β-catenin gene perform tgfβ-1 treat untreat lc31 cell line perform stem test pneumospher growth stem marker express oct4 nanog sox2 c-kit cd133 western blot cd133 tumorigen assay use nod/scid mice perform result tgfβ-1 treat lc31 cell line lost epitheli morpholog assum fibroblast-lik appear result obtain a549 cell line control immunofluoresc cytometri show up-regul vimentin cd90 down-regul cytocheratin e-cadherin cd326 tgfβ-1 treat lc31 a549 cell line slug twist β-catenin m-rna transcript up-regul tgfβ-1 treat lc31 cell line confirm emt cell line show also over-express oct4 nanog sox2 cd133 gene stem addit tgfβ-1 treat lc31 cell line increas pneumosphere-form capac tumours-form abil nod/scid mice detect conclus induct emt tgfβ-1 exposur primari lung cancer cell line result acquisit mesenchym profil express stem cell marker',\n",
       "  'genome-wid local function endogen dnmt3a dnmt3b adult stem cell unknown show human epiderm stem cell two protein bind histon h3k36me3-depend manner activ enhanc requir produc associ enhanc rna protein prefer super-enhanc associ gene either defin ectoderm lineag establish stem cell differenti state howev dnmt3a dnmt3b differ mechan enhanc regul dnmt3a associ p63 maintain high level dna hydroxymethyl center enhanc tet2-depend manner wherea dnmt3b promot dna methyl along bodi enhanc deplet either protein inactiv target enhanc profoundli affect epiderm stem cell function altogeth reveal novel function dnmt3a dnmt3b enhanc could contribut role diseas tumorigenesi',\n",
       "  'pursuit drug inhibit cyclin-depend kinas cdk intens area research 15 year first-gener inhibitor flavopiridol cy-202 late-stag clinic trial far demonstr modest activ sever second-gener inhibitor clinic trial futur approach determin clinic benefit need incorpor lesson learn earli compound inform recent obtain genet analysi cdk preclin model discuss key concept consid valid clinic util cdk inhibitor cancer therapi',\n",
       "  'lack sensit single-cel analysi tool limit character metabol activ cancer stem cell hyperspectral-stimul raman scatter imag singl live cell mass spectrometri analysi extract lipid report significantli increas level unsatur lipid ovarian cancer stem cell csc compar non-csc higher lipid unsatur level also detect csc-enrich spheroid compar monolay cultur ovarian cancer cell line primari cell inhibit lipid desaturas effect elimin csc suppress sphere format vitro block tumor initi capac vivo mechanist demonstr nuclear factor κb nf-κb directli regul express level lipid desaturas inhibit desaturas block nf-κb signal collect find reveal increas lipid unsatur metabol marker ovarian csc target csc-specif therapi',\n",
       "  'mesenchym nich cell may drive tissu failur malign transform hematopoiet system underli molecular mechan relev human diseas remain poorli defin show perturb mesenchym cell mous model pre-leukem disord shwachman-diamond syndrom sd induc mitochondri dysfunct oxid stress activ dna damag respons hematopoiet stem progenitor cell massiv parallel rna sequenc highli purifi mesenchym cell sd mous model rang human pre-leukem syndrom identifi p53-s100a8/9-tlr inflammatori signal common drive mechan genotox stress transcript activ signal axi mesenchym nich predict leukem evolut progression-fre surviv myelodysplast syndrom md princip leukemia predisposit syndrom collect find identifi mesenchym niche-induc genotox stress heterotyp stem progenitor cell inflammatori signal target determin diseas outcom human pre-leukemia',\n",
       "  'aspirin therapi inhibit prostaglandin biosynthesi without directli act lipoxygenas yet via acetyl cyclooxygenas 2 cox-2 lead bioactiv lipoxin lx epimer carbon 15 15-epi-lx also term aspirin-trigg lx atl report inflammatori exud mice treat ω-3 polyunsatur fatti acid aspirin asa gener novel array bioactiv lipid signal human endotheli cell upregul cox-2 treat asa convert c20:5 ω-3 18r-hydroxyeicosapentaeno acid hepe 15r-hepe use polymorphonuclear leukocyt gener separ class novel trihydroxy-contain mediat includ 5-seri 15r-lx5 5,12,18r-trihep new compound prove potent inhibitor human polymorphonuclear leukocyt transendotheli migrat infiltr vivo atl analogu 5,12,18r-trihep 18r-hepe acetaminophen indomethacin also permit 18r-hepe 15r-hepe gener recombin cox-2 well ω-5 ω-9 oxygen fatti acid act hematolog cell find establish new transcellular rout produc array bioactiv lipid mediat via cox-2–nonsteroid antiinflammatori drug–depend oxygen cell–cel interact impact microinflamm gener relat compound provid novel mechan therapeut benefit ω-3 dietari supplement may import inflamm neoplasia vascular diseas',\n",
       "  'polymorph around cholesteryl ester transfer protein cetp gene associ hdl level risk coronari arteri diseas cad respons therapi mechan action polymorph yet defin use mrna allel express splice isoform measur human liver tissu identifi genet variant affect cetp level allel cetp mrna express ratio 56 human liver strongli associ sever variant 2.5-7 kb upstream transcript start site e.g. rs247616 p 6.4 × 10 -5 allel frequenc 33 addit common altern splice cetp isoform lack exon 9 δ9 shown prevent cetp secret dominant-neg manner δ 9 express rang 10 48 total cetp mrna 94 liver increas format isoform exclus associ exon 9 polymorph rs5883-c p 6.8 × 10 -10 intron 8 polymorph rs9930761-t c 5.6 × 10 -8 high linkag disequilibrium allel frequenc 6-7 rs9930761 chang key splice branch point nucleotid intron 8 rs5883 alter exon splice enhanc sequenc exon 9.the effect polymorph evalu two clinic studi whitehal ii studi 4745 subject rs247616 rs5883t/rs9930761c independ associ increas hdl-c level male similar effect size rs247616 p 9.6 × 10 -28 rs5883 p 8.6 × 10 -10 adjust rs247616 independ multiethn us cohort hypertens subject cad invest-gen rs5883t/rs9930761c alon significantli associ increas incid mi stroke all-caus mortal male rs5883 2.36 ci 1.29-4.30 p 0.005 n 866 variant reach signific femal either studi similar earlier result link low cetp activ poor outcom male result suggest genet sex-depend cetp splice effect cardiovascular risk mechan independ circul hdl-c level',\n",
       "  'chondroitin sulphat proteoglycan cspg upregul glial scar inhibit axon regener via sulphat glycosaminoglycan gag chondroitin 6-sulphotransferase-1 c6st-1 upregul injuri lead increas 6-sulphat gag studi ask increas 6-sulphat gag respons increas inhibit within glial scar whether repres partial revers permiss embryon state domin 6-sulphat glycosaminoglycan gag use c6st-1 knockout mice ko studi post-injuri chang chondroitin sulphotransferas csst express effect chondroitin 6-sulphat central peripher axon regener cn injuri wild-typ anim wt show increas mrna c6st-1 c6st-2 c4st-1 ko upregul csst pn injuri wt upregul c6st-1 ko show upregul c6st-2 examin regener nigrostriat axon demonstr mild spontan axon regener wt ko show mani fewer regener axon axon retract wt howev pn repair median ulnar nerv led similar normal level axon regener wt ko function test plastic repair also show evid enhanc plastic ko result suggest upregul 6-sulphat gag injuri make extracellular matrix permiss axon regener balanc differ css microenviron around lesion site import factor determin outcom nervou system injuri',\n",
       "  'regen medicin predic understand mechan regul develop appli condit direct stem cell fate embryogenesi guid cell-cel cell-matrix interact unclear physic cue influenc stem cell cultur use human embryon stem cell hesc examin whether mechan featur extracellular microenviron could differenti modul mesoderm specif found hydrogel-bas compliant matrix hesc accumul β-catenin cell-cel adhes show enhanc wnt-depend mesoderm differenti mechanist src-driven ubiquitin e-cadherin cbl-like ubiquitin ligas releas p120-catenin facilit transcript activ β-catenin initi reinforc mesoderm differenti contrast stiff hydrogel matrix hesc show elev integrin-depend gsk3 src activ promot β-catenin degrad inhibit differenti thu found mechan featur microenvironment matrix influenc tissue-specif differenti hesc alter cellular respons morphogen',\n",
       "  'sepsis-3 quick sequenti organ failur assess qsofa score develop criteria use recogn patient may poor outcom studi perform evalu predict perform qsofa score screen tool sepsi mortal intens care unit icu admiss patient febril neutropenia fn also tri compar perform system inflammatori respons syndrom sir criteria multin associ support care cancer mascc score fn use prospect collect adult fn data registri qsofa sir score calcul retrospect use preexist data primari outcom develop sepsi secondari outcom icu admiss 28-day mortal 615 patient 100 develop sepsi 20 die 38 admit icu multivari analysi qsofa independ factor predict sepsi icu admiss howev compar mascc score area receiv oper curv qsofa lower qsofa show low sensit 0.14 0.2 0.23 high specif 0.98 0.97 0.97 predict sepsi 28-day mortal icu admiss perform qsofa score inferior mascc score preexist risk stratif tool use predict outcom patient fn',\n",
       "  'rna-bind protein lin28a lin28b play critic role embryon develop tumorigenesi pluripot exact function poorli understood show like lin28a lin28b function effect nanog oct4 sox2 reprogram pluripot reactiv endogen lin28a lin28b loci requir maxim reprogram effici human fibroblast lin28b activ earli reprogram lin28a activ later transit bona fide induc pluripot stem cell ipsc murin cell lin28a lin28b facilit convers naiv prime pluripot proteom metabolom analysi highlight role lin28 maintain low mitochondri function associ prime pluripot regul one-carbon metabol nucleotid metabol histon methyl lin28 bind mrna protein import oxid phosphoryl modul protein abund thu lin28a lin28b play cooper role regul reprogram naive/prim pluripot stem cell metabol',\n",
       "  'replac mitochondria nuclear transfer oocyt two differ women emerg recent strategi prevent inherit mtdna diseas although experi human oocyt shown effect replac consequ small amount mtdna carryov studi suffici use human mitochondri replac stem cell line show even though low level heteroplasmi introduc human oocyt mitochondri carryov nuclear transfer often vanish sometim instead result mtdna genotyp drift revers origin genotyp comparison cell ident oocyte-deriv nuclear dna differ mtdna show either mtdna genotyp compat nucleu drift independ mitochondri function thu although function replac mitochondri genom possibl even low level heteroplasmi affect stabil mtdna genotyp compromis efficaci mitochondri replac',\n",
       "  'tal transcript activator-lik effector constitut novel class dna-bind protein predict specif employ gram-neg plant-pathogen bacteria genu xanthomona transloc cocktail differ effector protein via type iii secret system t3ss plant cell serv virul determin insid plant cell tal local nucleu bind target promot induc express plant gene dna-bind specif tal determin central domain tandem repeat repeat confer recognit one base pair bp dna rearrang repeat modul allow design protein desir dna-bind specif summar tal specif encod first structur data first data site-specif tal nucleas',\n",
       "  'blood lymphat vessel pervad almost bodi tissu numer essenti role physiolog diseas inner line network form singl layer endotheli cell special accord need tissu suppli wherea gener mechan blood lymphat vessel develop defin increas molecular precis studi process endotheli special remain mostli descript recent insight genet anim model illumin endotheli cell interact tissu environ provid paradigm vessel type- organ-specif endotheli differenti delin govern principl crucial understand tissu develop maintain function becom abnorm diseas',\n",
       "  'import although non–vitamin k antagonist oral anticoagul noac increasingli use prevent thromboembol diseas limit data noac-rel intracerebr hemorrhag ich object assess associ preced oral anticoagul use warfarin noac oral anticoagul oac in-hospit mortal among patient ich design set particip retrospect cohort studi 141 311 patient ich admit octob 2013 decemb 2016 1662 get guidelines–strok hospit exposur anticoagul therapi ich defin use oac within 7 day prior hospit arriv main outcom measur in-hospit mortal result among 141 311 patient ich mean sd age 68.3 15.3 year 48.1 women 15 036 10.6 take warfarin 4918 3.5 take noac preced ich 39 585 28.0 5783 4.1 take concomit singl dual antiplatelet agent respect patient prior use warfarin noac older higher preval atrial fibril prior stroke acut ich stroke sever measur nation institut health stroke scale significantli differ across 3 group median 9 interquartil rang 2-21 warfarin 8 2-20 noac 8 2-19 oac unadjust in-hospit mortal rate 32.6 warfarin 26.5 noac 22.5 oac compar patient without prior use oac risk in-hospit mortal higher among patient prior use warfarin adjust risk differ ard 9.0 97.5 ci 7.9 10.1 adjust odd ratio aor 1.62 97.5 ci 1.53 1.71 higher among patient prior use noac ard 3.3 97.5 ci 1.7 4.8 aor 1.21 97.5 ci 1.11-1.32 compar patient prior use warfarin patient prior use noac lower risk in-hospit mortal ard −5.7 97.5 ci −7.3 −4.2 aor 0.75 97.5 ci 0.69 0.81 differ mortal noac-treat patient warfarin-tr patient numer greater among patient prior use dual antiplatelet agent 32.7 vs 47.1 ard −15.0 95.5 ci −26.3 −3.8 aor 0.50 97.5 ci 0.29 0.86 among take agent without prior antiplatelet therapi 26.4 vs 31.7 ard −5.0 97.5 ci −6.8 −3.2 aor 0.77 97.5 ci 0.70 0.85 although interact p valu .07 statist signific conclus relev among patient ich prior use noac warfarin associ higher in-hospit mortal compar oac prior use noac compar prior use warfarin associ lower risk in-hospit mortal',\n",
       "  'sever studi report elev red blood cell distribut width rdw associ poor prognosi differ kind cancer aim studi investig prognost role rdw patient undergo resect nonmetastat rectal cancer retrospect review databas 625 consecut patient underw cur resect nonmetastat rectal cancer institut januari 2009 decemb 2014. cutoff valu rdw calcul receiver-oper characterist curv result demonstr patient high rdw-cv group lower overal surviv os p .018 disease-fre surviv p .004 also observ patient high rdw-sd group associ significantli lower os p .033 wherea disease-fre surviv df significantli differ p .179 .in multivari analysi found elev rdw-cv associ poor df hazard ratio hr 1.56 p .010 rdw-sd predict wors os hr 1.70 p .009 .we confirm elev rdw independ prognost factor patient undergo resect nonmetastat rectal cancer intervent surveil might paid patient nonmetastat rectal cancer elev rdw valu futur',\n",
       "  'object examin differ health outcom associ specif lifestyl genet factor materi method march 2004 april 2006 sampl employe three differ health academ institut well famili member enrol studi provid inform consent baselin follow-up 2010-2013 particip complet self-administ questionnair physic examin provid blood sampl result total 10 729 particip age 6 94 year recruit baselin 70 femal 50 mexican social secur institut nearli 42 adult sampl overweight 20 obes conclus studi offer new insight diseas mechan prevent analysi risk factor inform larg sampl mexican',\n",
       "  'object corin serin proteas convert pro-atri natriuret peptid pro-anp atrial natriuret peptid anp cardiac hormon regul salt-wat balanc blood pressur anp degrad natriuret peptid receptor npr studi determin aberr pro-anp/corin/npr signal present matern vascular system preeclampsia studi design matern venou blood obtain 197 pregnant women 84 normotens 16 complic chronic hypertens cht 11 mild 86 sever preeclampsia plasma corin pro-anp concentr measur enzyme-link immunosorb assay matern subcutan fat tissu obtain 12 pregnant women cesarean section deliveri 6 normotens 6 preeclampsia vascular anp receptor npr-a npr-b npr-c express examin immunostain paraffin embed subcutan fat tissu section result corin concentr significantli higher mild 2.78 ± 0.67 ng/ml p .05 sever 2.53 ± 0.18 ng/ml p .01 preeclampsia normotens 1.58 ± 0.08 ng/ml cht 1.55 ± 0.20 ng/ml group pro-anp concentr significantli higher cht 1.59 ± 0.53 ng/ml p .05 sever preeclampsia 1.42 ± 0.24 ng/ml p .01 normotens 0.48 ± 0.06 ng/ml mild preeclampsia 0.52 ± 0.09 ng/ml group anp npr-b express undetect matern vessel normotens preeclampt pregnanc reduc npr-a express increas npr-c express found matern vessel endothelium preeclampsia conclus anp vasodil npr-c clearanc receptor anp find upregul npr-c express suggest circul anp clearanc degrad increas preeclampsia result also suggest pro-anp/corin/npr signal domin vascular system preeclampsia',\n",
       "  'background malaria elimin requir varieti approach individu optim differ transmiss set recent field studi area low season transmiss south west cambodia demonstr dramat reduct malaria parasit preval follow mass drug administr mda high treatment coverag symptomat patient artemisinin-piperaquin plu primaquin studi employ multipl combin strategi unclear contribut made reduct malaria method find mathemat model fit trial result use assess effect variou compon intervent design optim elimin strategi explor interact artemisinin resist recent discov western cambodia model indic initi reduct p. falciparum malaria result mda artemisinin-piperaquin subsequ continu declin near elimin result mainli high coverag artemisinin-piperaquin treatment strategi effect addit primaquin mda artemisinin combin therapi act increas proport artemisinin resist infect although much less treatment symptomat case act increas slow ad primaquin artemisinin resist reduc effect intervent use act preval resist high main result robust assumpt primaquin action immun conclus key messag model result polici maker high coverag act treatment produc long-term reduct malaria wherea impact mda gener short-term primaquin enhanc effect act elimin malaria reduc increas proport artemisinin resist infect parasit preval better surveil measur elimin programm number symptomat case combin intervent effect sustain effort crucial success elimin',\n",
       "  'epiderm langerhan cell lc play key role immun defens mechan numer immunolog disord report show percutan infect c57bl/6 mice helminth parasit schistosoma mansoni lead activ lc surprisingli retent epidermi moreov use experiment model lc migrat induc tumor necrosi factor tnf -α show parasit transient impair departur lc epidermi subsequ accumul dendrit cell drain lymph node inhibitori effect mediat solubl lipophil factor releas parasit host-deriv antiinflammatori cytokin interleukin-10 find prostaglandin pg d2 major eicosanoid produc parasit specif imped tnf-α–trigger migrat lc adenyl cyclase–coupl pgd2 receptor dp receptor moreov potent dp receptor antagonist bw a868c restor lc migrat infect mice final model contact allergen-induc lc migrat show activ dp receptor inhibit lc emigr also dramat reduc contact hypersensit respons challeng taken togeth propos inhibit lc migrat could repres addit stratagem schistosom escap host immun system pgd2 may play key role control cutan immun respons',\n",
       "  'background phase 1 trial axicabtagen ciloleucel axi‐cel autolog anti‐cd19 chimer antigen receptor car t‐cell therapi show efficaci patient refractori larg b‐cell lymphoma failur convent therapi method multicent phase 2 trial enrol 111 patient diffus larg b‐cell lymphoma primari mediastin b‐cell lymphoma transform follicular lymphoma refractori diseas despit undergo recommend prior therapi patient receiv target dose 2×106 anti‐cd19 car cell per kilogram bodi weight receiv condit regimen low‐dos cyclophosphamid fludarabin primari end point rate object respons calcul combin rate complet respons partial respons secondari end point includ overal surviv safeti biomark assess result among 111 patient enrol axi‐cel success manufactur 110 99 administ 101 91 object respons rate 82 complet respons rate 54 .with median follow‐up 15.4 month 42 patient continu respons 40 continu complet respons overal rate surviv 18 month 52 common advers event grade 3 higher treatment neutropenia 78 patient anemia 43 thrombocytopenia 38 grade 3 higher cytokin releas syndrom neurolog event occur 13 28 patient respect three patient die treatment higher car t‐cell level blood associ respons conclus multicent studi patient refractori larg b‐cell lymphoma receiv car t‐cell therapi axi‐cel high level durabl respons safeti profil includ myelosuppress cytokin releas syndrom neurolog event fund kite pharma leukemia lymphoma societi therapi acceler program zuma‐1 clinicaltrials.gov number nct02348216',\n",
       "  'physiolog psycholog stress catecholamin produc sympathet nervou system sn regul immun system previou studi report activ β-adrenerg receptor βar mediat action catecholamin increas pro-inflammatori cytokin product number differ cell type impact sn immun modul social defeat examin follow studi design determin whether sn activ social disrupt stress sdr influenc anxiety-lik behavior well activ prime glucocorticoid resist splenocyt social stress cd-1 mice expos one three six cycl sdr hplc analysi plasma spleen reveal increas catecholamin six cycl sdr open field test use measur behavior characterist anxieti indic social defeat induc increas anxiety-lik behavior block pre-treat β-adrenerg antagonist propranolol pre-treat β-adrenerg antagonist propranolol significantli alter corticosteron level indic differ activ hypothalamic-pituitary-adren axi addit anxiety-lik behavior sdr induc splenomegali increas plasma il-6 tnfα mcp-1 revers pre-treat propranolol furthermor flow cytometr analysi cell propranolol pretreat mice reduc sdr-induc increas percentag cd11b splenic macrophag significantli decreas express tlr2 tlr4 cd86 surfac cell addit supernat 18h lps-stimul ex vivo cultur splenocyt propranolol-tr sdr mice contain less il-6 likewis propranolol pre-treat abrog glucocorticoid insensit cd11b cell ex vivo compar splenocyt sdr vehicle-tr mice togeth studi demonstr immun activ prime effect sdr result part consequ sn activ',\n",
       "  'context patient brain metastas unclear whether ad up-front whole-brain radiat therapi wbrt stereotact radiosurgeri sr benefici effect mortal neurolog function compar sr alon object determin wbrt combin sr result improv surviv brain tumor control function preserv rate frequenc neurolog death design set patient random control trial 132 patient 1 4 brain metastas less 3 cm diamet enrol 11 hospit japan octob 1999 decemb 2003. intervent patient randomli assign receiv wbrt plu sr 65 patient sr alon 67 patient main outcom measur primari end point overal surviv secondari end point brain tumor recurr salvag brain treatment function preserv toxic effect radiat caus death result median surviv time 1-year actuari surviv rate 7.5 month 38.5 95 confid interv 26.7 -50.3 wbrt sr group 8.0 month 28.4 95 confid interv 17.6 -39.2 sr alon p .42 12-month brain tumor recurr rate 46.8 wbrt sr group 76.4 sr alon group p .001 salvag brain treatment less frequent requir wbrt sr group n 10 sr alon n 29 p .001 death attribut neurolog caus 22.8 patient wbrt sr group 19.3 treat sr alon p .64 signific differ system neurolog function preserv toxic effect radiat conclus compar sr alon use wbrt plu sr improv surviv patient 1 4 brain metastas intracrani relaps occur consider frequent receiv wbrt consequ salvag treatment frequent requir up-front wbrt use trial registr umin.ac.jp/ctr identifi c000000412',\n",
       "  'aire-express medullari thymic epitheli cell mtec play key role prevent autoimmun express tissue-restrict antigen help purg emerg cell receptor repertoir self-react specif demonstr novel role cd4+3− induc cell popul previous link develop organ secondari lymphoid structur mainten cell memori function regul aire-medi promiscu gene express thymu cd4+3− cell close associ mtec adult thymu fetal thymu appear tempor link appear aire+ mtec show rankl signal cell promot matur rank-express cd80−aire− mtec progenitor cd80+aire+ mtec transplant rank-defici thymic stroma immunodefici host induc autoimmun collect data reveal cellular molecular mechan lead gener aire+ mtec highlight previous unrecogn role cd4+3−rankl+ induc cell intrathym self-toler',\n",
       "  'proteom use character qualiti defect includ pale soft exud pse meat pork poultri woodi broiler breast meat reddish catfish fillet meat tough beef myoglobin oxid pse broiler meat character 15 protein differ abund comparison normal broiler breast meat eight protein differenti express woodi breast meat comparison normal breast meat hemoglobin protein differenti express red normal catfish fillet howev induc low oxygen and/or heat stress condit catfish fillet lead product red fillet proteom data provid inform pertain protein differ exist meat qualiti defect howev data need evalu conjunct inform pertain genet nutrit environ live anim muscl meat convers meat qualiti analys sensori attribut understand causal protein biomark ultim prevent qualiti defect',\n",
       "  'adenosin 5′-monophosphate–activ protein kinas ampk pivot regul metabol cellular organism level ampk also suppress inflamm found pharmacolog activ ampk rapidli inhibit janu kinas jak –signal transduc activ transcript stat pathway variou cell vitro kinas assay reveal ampk directli phosphoryl two residu ser515 ser518 within src homolog 2 domain jak1 activ ampk enhanc interact jak1 14-3-3 protein cultur vascular endotheli cell fibroblast effect requir presenc ser515 ser518 abolish cell lack ampk catalyt subunit mutat ser515 ser518 abolish ampk-medi inhibit jak-stat signal stimul either sil-6rα/il-6 complex express constitut activ v658f-mutant jak1 human fibrosarcoma cell clinic use ampk activ metformin salicyl enhanc inhibitori phosphoryl endogen jak1 inhibit stat3 phosphoryl primari vascular endotheli cell therefor find reveal mechan jak1 function inflammatori signal may suppress respons metabol stress provid mechanist rational investig ampk activ rang diseas associ enhanc activ jak-stat pathway',\n",
       "  'cellular inhibitor apoptosi ciap 1 2 amplifi 3 cancer identifi multipl malign potenti therapeut target result role evas apoptosi consequ small-molecul iap antagonist lcl161 enter clinic trial abil induc tumor necrosi factor tnf -mediat apoptosi cancer cell howev ciap1 ciap2 recurr homozyg delet multipl myeloma mm result constitut activ noncanon nuclear factor nf -κb pathway surpris observ robust vivo anti-myeloma activ lcl161 transgen myeloma mous model patient relapsed-refractori mm addit cyclophosphamid result median progression-free-surviv 10 month effect result direct induct tumor cell death rather upregul tumor-cell-autonom type interferon ifn signal strong inflammatori respons result activ macrophag dendrit cell lead phagocytosi tumor cell treatment mm mous model lcl161 establish long-term anti-tumor protect induc regress fraction mice notabl combin lcl161 immune-checkpoint inhibitor anti-pd1 cur treat mice',\n",
       "  'sexual health sever decreas age male older 40 year erectil dysfunct ed common sexual disord although physic psycholog risk factor ed identifi protect factor yet determin date studi examin endocrin psychosoci factor parallel regard modifi effect age-rel increas ed two hundr seventy-on self-report healthi men age 40 75 year provid psychometr data sexual function set potenti psychosoci protect factor saliva sampl analysi steroid hormon proinflammatori cytokin around 35 particip report least mild form ed direct associ ed identifi perceiv gener health emot support relationship qualiti intimaci motiv steroid hormon proinflammatori marker moder analys associ age ed reveal posit effect testosteron dehydroepiandrosteron dhea perceiv gener health emot support intimaci motiv neg effect interleukin-6 p .05 f2 .17 group differ older men without ed emerg dhea psychometr measur perceiv gener health emot support satisfact life intimaci motiv p .05 .3 psychosoci endocrin paramet moder associ age sexual health perceiv gener health emot support intimaci motiv relationship qualiti emerg psychosoci protect factor ed higher dhea lower interleukin-6 level also buffer age-rel increas ed',\n",
       "  'togeth recent advanc process cultur human tissu bioengin xenotransplant genom edit induc pluripot stem cell ipsc present rang new opportun studi human cancer discuss main advantag limit ipsc model method intersect patient-deriv model cancer organoid organs-on-chip patient-deriv xenograft pdx highlight opportun ipsc model provid beyond offer exist system anim model present current challeng crucial area futur improv toward wider adopt technolog',\n",
       "  'tal transcript activator-lik effector secret phytopathogen bacteria recogn host dna sequenc central domain tandem repeat repeat compris 33 35 conserv amino acid target specif base pair use two hypervari residu known repeat variabl diresidu rvd posit 12 13. report crystal structur 11.5-repeat tal effector dna-fre dna-bound state tal repeat compris two helic connect short rvd-contain loop 11.5 repeat form right-hand superhel structur track along sens strand dna duplex rvd contact major groov 12th residu stabil rvd loop wherea 13th residu make base-specif contact understand dna recognit tal effector may facilit ration design dna-bind protein biotechnolog applic',\n",
       "  'advers remodel follow myocardi infarct mi lead heart failur driven imbalanc resolut inflamm macrophag cell import control post-mi inflamm macrophag subtyp secret mediat either promot inflamm extend injuri m1 phenotyp suppress inflamm promot scar format m2 phenotyp previous shown absenc caveolin-1 cav1 membran scaffold protein associ advers cardiac remodel mice mechan respons remain elucid explor role cav1 activ macrophag use wild type c57bl6/j wt cav1 tm1mls/j cav1 -/- mice echocardiographi cardiac function compar wt cav1 -/- mice 3day post-mi absenc cav1 surprisingli higher percentag m2 macrophag arginase-1 posit detect infarct zone convers restor cav1 function mi wt mice ad back cav1 scaffold domain reduc m2 activ profil adopt transfer cav1 null macrophag wt mice d3 post-mi exacerb advers cardiac remodel d14 post-mi vitro studi reveal cav1 null macrophag pronounc m2 profil activ respons il-4 stimul conclus cav1 delet promot array maladapt repair process mi includ increas tgf-β signal increas m2 macrophag infiltr dysregul m1/m2 balanc data also suggest cardiac remodel improv therapeut intervent regul cav1 function inflammatori respons phase',\n",
       "  'studi role hydroperoxid lipid peroxid diseas requir simpl sensit method direct hydroperoxid measur report techniqu measur hydroperoxid reli upon rapid hydroperoxide-medi oxid fe2+ acid condit fe3+ form chromophor xylenol orang absorb strongli 560 nm yield appar e560 h2o2 butyl hydroperoxid cumen hydroperoxid 4.3×104 m−1 cm−1 assay valid studi liposom lipid peroxid shown give result compar obtain iodometr method measur conjug dien assay involv thiobarbitur acid comparison underestim lipid peroxid measur hydroperoxidep se',\n",
       "  'exosom extracellular vesicl endosom origin emerg key mediat intercellular commun major cardiac cell types-includ cardiomyocyt endotheli cell fibroblasts-releas exosom modul cellular function exosom releas human cardiac progenitor cell cpc cardioprotect improv cardiac function myocardi infarct extent compar achiev parent cell cardiac progenitor cell-deriv exosom enrich cardioprotect microrna particularli mir-146a-3p circul exosom mediat remot ischaem precondit moreov current investig diagnost marker discoveri cell-deriv extracellular signal organel mediat paracrin effect stem cell suggest cell-fre strategi could supplant cell transplant review discuss emerg role exosom cardiovascular physiolog focu cardioprotect activ cpc-deriv exosom',\n",
       "  'research healthi age men increasingli focus age-rel hormon chang testosteron declin primarili investig age-rel chang sex steroid dehydroepiandrosteron dhea estradiol e2 progesteron p mostli neglect integr hormon paramet reflect age process men yet identifi 271 self-report healthi men 40 75 provid psychometr data saliva sampl hormon analysi correl analysi age sex steroid reveal neg associ four sex steroid dhea e2 p princip compon analysi includ ten salivari analyt identifi princip compon mainli unifi varianc four sex steroid hormon subsequ princip compon analysi includ four sex steroid extract princip compon declin steroid hormon dsh moder analysi associ age dsh reveal signific moder effect psychosoci factor depress chronic stress perceiv gener health conclus result provid evid sex steroid declin age men integr hormon paramet dsh rate chang use biomark healthi age men furthermor neg associ age dsh moder psychosoci factor',\n",
       "  'epstein-barr viru ebv episom stabli maintain permiss prolifer cell line due ebv nuclear antigen 1 ebna-1 protein-medi replic segreg previou studi show abil ebv episom confer long-term transgen express correct genet defect defici cell achiev quantit deliveri ebv episom vitro vivo develop binari helper-depend adenoviru hda -ebv hybrid system consist one hda vector express cre recombinas second hda vector contain sequenc ebv episom flank loxp site upon coinfect cell cre express first vector recombin loxp site second vector result circular ebv episom express transgen contain ebv-deriv famili repeat ebna-1 express cassett 19 kb human dna function replic origin mammalian cell hda-ebv hybrid system transform 40 cultur cell transgen express prolifer cell observ 20 week condit select express transgen absenc select ebv episom lost rate 8 10 per cell divis success deliveri ebv episom vivo demonstr liver transgen mice express cre albumin promot novel gene transfer system potenti confer long-term episom transgen express therefor correct genet defect reduc vector-rel toxic without insert mutagenesi',\n",
       "  'differenti splice site pair establish altern splice pattern result gener multipl mrna isoform process carri spliceosom activ seri sequenti structur rearrang five core snrnp determin splice site becom function pair carri seri kinet trap experi use pre-mrna undergo altern 5 splice site select altern exon inclus show commit splice site pair case occur complex character atp-depend associ u2 snrnp branch point interestingli time splice site pair independ intron exon definit mode splice site recognit use atp analog atpgamma show atp hydrolysi requir splice site pair independ u2 snrnp bind pre-mrna result identifi complex spliceosom assembl step dedic splice site pair suggest atp hydrolysi lock splice site splice pattern stabl u2 snrnp associ branch point',\n",
       "  'male hypermethyl mhm region locat near middl short arm z chromosom chicken consist approxim 210 tandem repeat bamhi 2.2-kb sequenc unit cytosin cpg dinucleotid region extens methyl two z chromosom male much less methyl singl z chromosom femal state methyl mhm region establish fertil 1-day embryon stage mhm region transcrib femal particular strand heterogen high molecular-mass non-cod rna accumul site transcript adjac dmrt1 locu nucleu transcript silenc mhm region male like caus cpg methyl sinc treatment male embryon fibroblast 5-azacytidin result hypo-methyl activ transcript region zzw triploid chicken mhm region hypomethyl transcrib two z chromosom wherea mhm region hypermethyl transcript inact three z chromosom zzz triploid chicken suggest possibl role w chromosom state mhm region',\n",
       "  'macropinocytosi highli conserv endocyt process extracellular fluid content intern cell larg heterogen vesicl known macropinosom oncogen ra protein shown stimul macropinocytosi function contribut uptak mechan transform phenotyp remain unknown show ras-transform cell use macropinocytosi transport extracellular protein cell intern protein undergo proteolyt degrad yield amino acid includ glutamin enter central carbon metabol accordingli depend ras-transform cell free extracellular glutamin growth suppress macropinocyt uptak protein consist macropinocytosi repres import rout nutrient uptak tumour pharmacolog inhibit compromis growth ras-transform pancreat tumour xenograft result identifi macropinocytosi mechan cancer cell support uniqu metabol need point possibl exploit process design anticanc therapi',\n",
       "  'rna process carri close proxim site transcript suggest regulatori link transcript pre-mrna splice use vitro transcription/spl assay demonstr associ rna polymeras ii pol ii transcript pre-mrna splice requir effici gene express pol ii-synthes rna contain function splice site protect nuclear degrad presum local concentr splice machineri suffici high ensur associ interact nucleas furthermor process transcript influenc altern splice newli synthes pre-mrna rna polymeras provid similar protect nucleas rna product display alter splice pattern link transcript rna process rna pol ii-specif propos connect transcript pol ii pre-mrna splice guarante extend half-lif proper process nascent pre-mrna',\n",
       "  'skelet muscl extracellular matrix remodel propos new featur associ obes metabol dysfunct exercis train improv muscl function obes may mediat regulatori effect muscl extracellular matrix review examin avail literatur skelet muscl extracellular matrix remodel obes effect exercis non-systemat literatur review perform pubm public 1970 2015. total 37 studi human anim retain studi report overal increas gene protein express differ type collagen growth factor enzymat regul skelet muscl extracellular matrix obes two studi investig effect exercis skelet muscl extracellular matrix obes suggest regulatori effect exercis effect exercis muscl extracellular matrix seem influenc durat type exercis train variabl effect singl session compar longer durat exercis studi need elucid mechan behind skelet muscl extracellular matrix remodel obes effect exercis',\n",
       "  'object evalu specif exercis strategi target rotat cuff scapula stabilis improv shoulder function pain unspecif exercis patient subacromi imping syndrom therebi decreas need arthroscop subacromi decompress design randomis particip singl assessor blind control studi set depart orthopaed swedish univers hospit particip 102 patient long stand six month persist subacromi imping syndrom earlier conserv treatment fail recruit orthopaed specialist intervent specif exercis strategi consist strengthen eccentr exercis rotat cuff concentric/eccentr exercis scapula stabilis combin manual mobilis control exercis programm consist unspecif movement exercis neck shoulder patient group receiv five six individu guid treatment session 12 week supervis session particip perform home exercis twice day 12 week main outcom measur primari outcom constant-murley shoulder assess score evalu shoulder function pain secondari outcom patient global impress chang treatment decis regard surgeri result 97 95 particip complet 12 week studi significantli greater improv constant-murley score specif exercis group control exercis group 24 point 95 confid interv 19 28.0 v 9 point 5 13 mean differ group 15 point 8.5 20.6 significantli patient specif exercis group report success outcom defin larg improv recov patient global assess chang treatment 69 35/51 v 24 11/46 odd ratio 7.6 3.1 18.9 p 0.001 significantli lower proport patient specif exercis group subsequ chose undergo surgeri 20 10/51 v 63 29/46 odd ratio 7.7 3.1 19.4 p 0.001 conclus specif exercis strategi focus strengthen eccentr exercis rotat cuff concentric/eccentr exercis scapula stabilis effect reduc pain improv shoulder function patient persist subacromi imping syndrom extens exercis strategi reduc need arthroscop subacromi decompress within three month timefram use studi trial registr clinic trial nct01037673',\n",
       "  'transform gene src avian sarcoma viru asv adjac region viral genom isol molecular clone viral dna nucleotid sequenc encompass whole src portion gene env encod gp 37 one two glycoprotein found viral envelop src encod singl hydrophob protein structur featur conform previou descript gene product pp60src appear singl viral protein respons initi mainten neoplast transform avian sarcoma viru neither src product bear obviou structur relationship sever viral oncogen encod protein src flank repeat nucleotid sequenc may facilit frequent delet gene viral genom',\n",
       "  'recogn current mdr-tb regimen suboptim base low-qual evid global mdr-tb clinic trial landscap meet held decemb 2014 strateg coordin research develop new treatment regimen diseas affect million peopl worldwid everi year sixti intern expert multidrug-resist tuberculosi mdr-tb met washington d.c. cape town south africa consid key mdr-tb trial-rel issu includ standard definit clinic trial capac build regimen optim foster complianc avoid emerg resist clinic relev special popul includ children co-infect hiv underpin gener suffici evid base facilit regulatori approv improv norm guidanc particip discuss treatment combin current studi phase 2b phase 3 trial well promis new regimen combin may evalu near futur includ regimen design specif enabl shorter durat all-or treatment mean maxim treatment complet hope clear definit challeng facilit process identifi solut acceler progress toward effect non-tox treatment programmat implement',\n",
       "  'definit erythropoiesi bird origin stem cell emerg splanchnopleur mesoderm near embryon aorta1–4 yolk sac still gener held uniqu provid haematopoiet stem cell mammalian ontogeny5 although may altern intraembryon sourc stem cell mous fetus6,7 search possibl non-yolk-sac sourc stem cell graft intraembryon splanchnopleura 10- 18-somit mous embryo adult immunodefici scid mice find signific amount donor-deriv serum igm normal number igm-secret plasma cell bla igma brightb220dullcd5+ cell subset fulli reconstitut donor progenitor 3 6 month engraft haematogen capac reveal experi present previous unrecogn site earliest describ embryo 12 hour fetal liver colon',\n",
       "  'pluripotenti cell present mous embryo least earli post-implant stage shown abil take part hi format chimaer animals1 form teratocarcinomas2 possibl establish progress grow cultur cell vitro cell line obtain teratocarcinoma format vivo report establish tissu cultur pluripot cell line isol directli vitro cultur mous blastocyst cell abl differenti either vitro innocul mous tumour vivo normal karyotyp',\n",
       "  'interact major histocompat complex mhc molecul cd4 cd coreceptor major role intrathym t-cell selection1 matur cell two glycoprotein associ class-specif bia mhc molecul recognit t-cell receptor cd4+ cell respond antigen associ mhc class ii molecul cd8+ cell respond antigen associ mhc class molecul physic interact cd4/mhc class ii molecul cd8/mhc class molecul demonstr cell adhes assay2–5 bind site cd class identified6,7 demonstr region mhc class iiβ-chain β2 domain structur analog cds-bind loop mhc class α3 domain critic function mous human cd4',\n",
       "  'although dna carrier genet inform limit chemic stabil hydrolysi oxid nonenzymat methyl dna occur signific ratesin vivo counteract specif dna repair process spontan decay dna like major factor mutagenesi carcinogenesi age also set limit recoveri dna fragment fossil',\n",
       "  \"major goal biolog provid quantit descript cellular behaviour task howev hamper difficulti measur protein abund variat present strategi pair high-throughput flow cytometri librari gfp-tag yeast strain monitor rapidli precis protein level single-cel resolut bulk protein abund measur 2,500 protein rich minim media provid detail view cellular respons condit captur mani chang observ dna microarray analys single-cel data argu nois protein express domin stochast production/destruct messeng rna beyond global trend dramat protein-specif differ nois strongli correl protein 's mode transcript function exampl protein respond environment chang noisi wherea involv protein synthesi quiet thu studi reveal remark structur biolog nois suggest protein nois level select reflect cost potenti benefit variat\",\n",
       "  'cellular differenti lineag commit consid robust irrevers process develop recent work shown mous human fibroblast reprogram pluripot state combin four transcript factor rais question whether transcript factor could directli induc defin somat cell fate undifferenti state hypothes combinatori express neural-lineage-specif transcript factor could directli convert fibroblast neuron start pool nineteen candid gene identifi combin three factor ascl1 brn2 also call pou3f2 myt1l suffic rapidli effici convert mous embryon postnat fibroblast function neuron vitro induc neuron cell express multipl neuron-specif protein gener action potenti form function synaps gener cell non-neur lineag could import implic studi neural develop neurolog diseas model regen medicin',\n",
       "  'non-alcohol fatti liver diseas nafld hepat manifest metabol syndrom lead caus chronic liver diseas western world twenti per cent nafld individu develop chronic hepat inflamm non-alcohol steatohepat nash associ cirrhosi portal hypertens hepatocellular carcinoma yet caus progress nafld nash remain obscur show nlrp6 nlrp3 inflammasom effector protein il-18 neg regul nafld/nash progress well multipl aspect metabol syndrom via modul gut microbiota differ mous model reveal inflammasome-deficiency-associ chang configur gut microbiota associ exacerb hepat steatosi inflamm influx tlr4 tlr9 agonist portal circul lead enhanc hepat tumour-necrosi factor tnf -α express drive nash progress furthermor co-hous inflammasome-defici mice wild-typ mice result exacerb hepat steatosi obes thu alter interact gut microbiota host produc defect nlrp3 nlrp6 inflammasom sens may govern rate progress multipl metabol syndrome-associ abnorm highlight central role microbiota pathogenesi heretofor seemingli unrel system auto-inflammatori metabol disord',\n",
       "  'chromatin allow eukaryot cell packag dna effici understand chromatin structur control across saccharomyc cerevisia genom investig role atp-depend chromatin remodel complex isw2 posit nucleosom find isw2 function adjac promot region reposit nucleosom interfac genic intergen sequenc nucleosom reposit isw2 direct result increas nucleosom occup intergen region loss isw2 activ lead inappropri transcript result gener code noncod transcript show isw2 reposit nucleosom enforc direction transcript prevent transcript initi cryptic site analys reveal chromatin organ global scale advanc understand transcript regul',\n",
       "  'human mitochondri ribosom special synthesi 13 protein fundament compon oxid phosphoryl system pathway mitoribosom biogenesi compartment process factor involv remain larg unknown identifi dead-box protein ddx28 rna granul compon essenti biogenesi mitoribosom larg subunit mt-lsu ddx28 interact 16 rrna mt-lsu rnai-medi ddx28 silenc hek293t cell affect mitochondri mrna stabil 16 rrna process modif howev lead reduc level 16 rrna mt-lsu protein impair mt-lsu assembl deepli attenu mitochondri protein synthesi consequ failur assembl oxid phosphoryl complex find identifi ddx28 essenti earli stage mitoribosom mt-lsu biogenesi process take place mainli near mitochondri nucleoid compart defin rna granul',\n",
       "  'pancreat insulin-produc beta-cel long lifespan healthi condit replic littl lifetim nevertheless show increas self-dupl increas metabol demand injuri beta-cel loss known whether adult mammal differenti regener new beta-cel extrem total beta-cel loss diabet would indic differenti precursor anoth heterolog non-beta-cel sourc show beta-cel regener transgen model diphtheria-toxin-induc acut select near-tot beta-cel ablat given insulin mice surviv show beta-cel mass augment time lineage-trac label glucagon-produc alpha-cel beta-cel ablat track larg fraction regener beta-cel deriv alpha-cel reveal previous disregard degre pancreat cell plastic inter-endocrin spontan adult cell convers could har toward method produc beta-cel diabet therapi either differenti set vitro induc regener',\n",
       "  'glioblastoma multiform gbm lethal brain tumour adult children howev dna copi number gene express signatur indic differ adult paediatr case explor genet event underli distinct sequenc exom 48 paediatr gbm sampl somat mutat h3.3-atrx-daxx chromatin remodel pathway identifi 44 tumour 21/48 recurr mutat h3f3a encod replication-independ histon 3 variant h3.3 observ 31 tumour led amino acid substitut two critic posit within histon tail k27m g34r/g34v involv key regulatori post-transl modif mutat atrx α-thalassaemia/ment retard syndrom x-link daxx death-domain associ protein encod two subunit chromatin remodel complex requir h3.3 incorpor pericentr heterochromatin telomer identifi 31 sampl overal 100 tumour harbour g34r g34v h3.3 mutat somat tp53 mutat identifi 54 case 86 sampl h3f3a and/or atrx mutat screen larg cohort glioma variou grade histolog n 784 show h3f3a mutat specif gbm highli preval children young adult furthermor presenc h3f3a/atrx-daxx/tp53 mutat strongli associ altern lengthen telomer specif gene express profil knowledg first report highlight recurr mutat regulatori histon human data suggest defect chromatin architectur underli paediatr young adult gbm pathogenesi',\n",
       "  'eukaryot gene interrupt non-cod intron must accur remov pre-messeng rna produc translat mrna splice guid local short conserv sequenc gene typic contain mani potenti splice site mechan specifi correct site remain poorli understood organ short intron recogn intron definit mechan effici predict sole basi sequenc motif multicellular eukaryot long intron recogn exon definit gene produc multipl mrna variant altern splice nonsense-medi mrna decay nmd pathway may shape observ set variant select degrad contain prematur termin codon frequent produc mammal show tini intron ciliat paramecium tetraurelia strong select pressur caus prematur termin mrna translat event intron retent bia observ among short intron plant fungi anim knock two p. tetraurelia gene encod upf1 protein crucial nmd show intrins effici splice vari wide among intron nmd activ significantli reduc fraction unsplic mrna result suggest independ altern splice speci larg intron number univers reli nmd compens suboptim splice effici accuraci',\n",
       "  'homeotherm use thermogenesi maintain core bodi temperatur ensur cellular function physiolog process continu cold environ prevail model thermogenesi hypothalamu sens cold temperatur trigger sympathet discharg result releas noradrenalin brown adipos tissu white adipos tissu act via β 3 -adrenerg receptor noradrenalin induc lipolysi white adipocyt wherea stimul express thermogen gene ppar-γ coactiv 1a ppargc1a uncoupl protein 1 ucp1 acyl-coa synthetas long-chain famili member 1 acsl1 brown adipocyt howev precis natur cell type involv effer loop well establish report mice unexpect requir interleukin-4 il-4 -stimul program altern macrophag activ adapt thermogenesi exposur cold temperatur rapidli promot altern activ adipos tissu macrophag secret catecholamin induc thermogen gene express brown adipos tissu lipolysi white adipos tissu absenc altern activ macrophag impair metabol adapt cold wherea administr il-4 increas thermogen gene express fatti acid mobil energi expenditur macrophage-depend manner thu discov role altern activ macrophag orchestr import mammalian stress respons respons cold',\n",
       "  'altern lengthen telomer alt telomerase-independ telomer mainten mechan occur subset cancer analyz telomerase-posit cell human terc knockout-deriv alt human cell line show alt cell harbor fragil telomer repres telomer replic problem alt-associ replic defect trigger mitot dna synthesi mida telomer rad52-depend rad51-independ manner telomer mida conserv dna synthesi process potenti mediat break-induc replic similar type ii alt survivor saccharomyc cerevisia replic stress induc ectop oncogen express cyclin e g-quadruplex r-loop format facilit alt pathway lead telomer cluster hallmark alt cancer timeless/tipin complex suppress telomer cluster telomer mida wherea smc5/6 complex promot summari alt cell exhibit telomer replic defect result persist dna damag respons telomer lead engag telomer mida spontan mitot telomer synthesi trigger dna replic stress potenti driver genom duplic cancer',\n",
       "  'express clock gene vertebr widespread restrict classic clock structur express clock gene zebrafish show strong circadian oscil mani tissu vivo cultur show endogen oscil exist peripher organ defin featur circadian clock set entrain local time usual environment light-dark cycl import question whether peripher oscil entrain local time signal central pacemak eye directli light-respons show peripher organ clock zebrafish set light-dark cycl cultur also show zebrafish-deriv cell line contain circadian oscil also directli light entrain',\n",
       "  'kra oncogen product consid major target anticanc drug discoveri howev direct interfer kra signal yet led clinic use drug correct local signal farnesyl kra regul prenyl-bind protein pdeδ sustain spatial organ kra facilit diffus cytoplasm report interf bind mammalian pdeδ kra mean small molecul provid novel opportun suppress oncogen ra signal alter local endomembran biochem screen subsequ structure-bas hit optim yield inhibitor kras–pdeδ interact select bind prenyl-bind pocket pdeδ nanomolar affin inhibit oncogen ra signal suppress vitro vivo prolifer human pancreat ductal adenocarcinoma cell depend oncogen kra find may inspir novel drug discoveri effort aim develop drug target oncogen ra',\n",
       "  'cooper among individu necessari evolutionari transit higher level biolog organ transit group individu one level singl cell cooper form select unit higher level multicellular organ though evolut cooper difficult observ directli higher eukaryot microorgan offer opportun report evolut novel cooper behaviour experiment lineag bacterium myxococcu xanthu wild-typ strain m. xanthu exhibit social depend swarm across soft surfac mechan known ‘ s-motil ’ requir presenc extracellular type iv pili lineag m. xanthu unabl make pili new mechanist basi cooper swarm evolv evolv swarm mediat least part enhanc product extracellular fibril matrix bind cells—and evolutionari interests—togeth though costli individu fibril product greatli enhanc popul expans group interconnect cell result show fundament transit primit cooper readili occur bacteria',\n",
       "  'glucagon 29-amino acid pancreat hormon counteract blood glucose-low action insulin stimul hepat glycogenolysi gluconeogenesis1 structur hamster pancreat glucagon precursor recent determin sequenc clone cdna2 hamster preproglucagon 180-amino acid protein contain five function region signal pre-peptid nh2-termin peptid also call glicentin-rel pancreat peptid grpp glucagon two carboxy-termin glucagon-lik peptid glp-1 glp-2 sequenc two non-allel anglerfish pancreat glucagon precursors3–5 also determin organ similar ident hamster protein lack polypeptid segment correspond hamster glp-2 presenc three region possess intern homolog glucagon glp-1 glp-2 within proglucagon absenc glp-2 anglerfish precursor suggest structur preproglucagon gene might provid insight evolut polyprotein isol sequenc human preproglucagon gene report organ human precursor deduc sequenc ident hamster protein gene contain least three interven sequenc divid protein-cod portion gene four region correspond signal peptid part nh2-termin peptid remaind nh2-termin peptid glucagon glp-1 glp-2 data suggest triplic subsequ sequenc diverg exon encod glucagon glucagon-lik peptid produc polyprotein precursor',\n",
       "  \"bcl-2 isol 14 18 chromosom breakpoint follicular b-cell lymphoma1–3 bcl-2 uniqu oncogen role extend cell surviv inhibit varieti apoptot deaths4–13 emerg famili bcl-2 -relat protein share two highli conserv regions14–20 refer bcl-2 homolog 1 2 bh1 bh2 domain fig 1 includ bax heterodimer bcl-2 overexpress counteract bcl-214 report site-specif mutagenesi bcl-2 establish two domain novel dimer motif substitu-t gli 145 bhl domain trp 188 bh2 domain complet abrog bcl-2 's death-repressor activ inter-leukin-3 depriv γ-irradi glucocorticoid-induc apoptosi mutat affect bcl-2 's function also disrupt heterodimer bax yet still permit bcl-2 homo-dimer result establish function role bh1 bh2 domain suggest bcl-2 exert action heterodimer bax\",\n",
       "  'forti per cent mammalian genom deriv retroel one-quart endogen retrovirus erv still activ notabl mice highli polymorph earli transposon etn /musd intracistern a-typ particl iap erv transcript silenc earli embryogenesi histon dna methyl review ref 7 although initi process essenti protect genom integr remain larg unknown kap1 krab-associ protein 1 also known tripartit motif-contain protein 28 trim28 repress gene recruit histon methyltransferas setdb1 heterochromatin protein 1 hp1 nurd histon deacetylas complex physiolog target known two line evid suggest kap1-medi repress could contribut control erv first kap1 trigger perman gene silenc earli embryogenesi second kap1 complex silenc retroviru murin leukaemia viru embryon cell consist hypothesi show kap1 delet lead mark upregul rang erv particular iap element mous embryon stem es cell earli embryo demonstr kap1 act synergist dna methyl silenc iap element enrich 5′ untransl region 5′utr iap genom kap1 delet lead loss histon 3 lysin 9 trimethyl h3k9me3 hallmark kap1-medi repress correspondingli iap 5′utr sequenc impos ci kap1-depend repress heterolog promot es cell result establish kap1 control endogen retroel earli embryon develop',\n",
       "  'rapamycin-sensit tor signal pathway saccharomyc cerevisia activ cell-growth program respons nutrient nitrogen carbon tor1 tor2 kinas tor control cytoplasm protein synthesi degrad conserv tap42 protein upon phosphoryl tor tap42 bind possibl inhibit type 2a type-2a-rel phosphatas howev mechan tor control nuclear event global repress starvation-specif transcript unknown show tor prevent transcript gene express upon nitrogen limit promot associ gata transcript factor gln3 cytoplasm protein ure2 bind gln3 ure2 requir tor-depend phosphoryl gln3 phosphoryl cytoplasm retent gln3 also depend tor effector tap42 antagon type-2a-rel phosphatas sit4 tor inhibit express carbon-source-regul gene stimul bind transcript activ msn2 msn4 cytoplasm 14-3-3 protein bmh2 thu tor signal pathway broadli control nutrient metabol sequest sever transcript factor cytoplasm',\n",
       "  'murin embryon stem es cell pluripot cell line establish directli earli embryo1,2 contribut differenti progeni adult tissu includ germ-cel lineage3 re-incorpor normal embryo provid cellular vector gener transgen animals4 use system identif polypeptid factor control differenti process earli development5 particular medium condit buffalo rat liver cell contain polypeptid factor es cell differenti inhibitori activ dia specif suppress spontan differenti es cell vitro therebi permit growth homogen stem cell popul absenc heterolog feeder cells6 es cell pluripotenti includ abil give rise function gamet preserv prolong cultur buffalo rat liver media sourc dia7 report purifi dia relat structur function recent identifi haemopoet regulatori factor human interleukin da cells8,9 leukaemia inhibitori factor10 dia human interleukin da/leukaemia inhibitori factor thu identifi relat multifunct regulatori factor distinct biolog activ earli embryon haemopoet stem cell system',\n",
       "  'pancreat cancer highli lethal malign effect therapi perform exom sequenc copi number analysi defin genom aberr prospect accru clinic cohort n 142 earli stage ii sporad pancreat ductal adenocarcinoma detail analysi 99 inform tumour identifi substanti heterogen 2,016 non-sil mutat 1,628 copy-numb variat defin 16 significantli mutat gene reaffirm known mutat kra tp53 cdkn2a smad4 mll3 tgfbr2 arid1a sf3b1 uncov novel mutat gene includ addit gene involv chromatin modif epc1 arid2 dna damag repair atm mechan zim2 map2k4 nalcn slc16a4 magea6 integr analysi vitro function data anim model provid support evid potenti role genet aberr carcinogenesi pathway-bas analysi recurr mutat gene recapitul cluster core signal pathway pancreat ductal adenocarcinoma identifi new mutat gene pathway also identifi frequent divers somat aberr gene describ tradit embryon regul axon guidanc particularli slit/robo signal also evid murin sleep beauti transposon-medi somat mutagenesi model pancreat cancer provid support evid potenti involv axon guidanc gene pancreat carcinogenesi',\n",
       "  'declin tissu regen potenti hallmark age may due age-rel chang tissue-specif stem cell declin skelet muscl stem cell satellit cell activ due loss notch signal result impair regener age muscl declin hepat progenitor cell prolifer owe format complex involv cebp-α chromatin remodel factor brahma brm inhibit regen capac age liver examin influenc system factor age progenitor cell tissu establish parabiot pair share circulatori system young old mice heterochron parabios expos old mice factor present young serum notabl heterochron parabiosi restor activ notch signal well prolifer regen capac age satellit cell exposur satellit cell old mice young serum enhanc express notch ligand delta increas notch activ enhanc prolifer vitro furthermor heterochron parabiosi increas age hepatocyt prolifer restor cebp-α complex level seen young anim result suggest age-rel declin progenitor cell activ modul system factor chang age',\n",
       "  'despit decad research ident cell gener first haematopoiet cell mammalian embryo unknown inde whether blood cell aris mesoderm cell mesenchym progenitor bipot endothelial–haematopoiet precursor haemogen endotheli cell remain controversi proxim endotheli blood cell site embryon haematopoiesi well similar gene express led hypothesi endothelium gener blood howev owe lack technolog imposs observ blood cell emerg continu single-cel level postul exist haemogen endotheli cell remain disput use new imag cell-track method show embryon endotheli cell haemogen continu long-term single-cel observ mous mesoderm cell gener endotheli cell blood coloni possibl detect haemogen endotheli cell give rise blood cell live endotheli haematopoiet cell identifi simultan detect morpholog multipl molecular function marker detach nascent blood cell endothelium directli link asymmetr cell divis haemogen endotheli cell specifi cell alreadi express endotheli marker result improv understand development origin mammalian blood potenti gener haematopoiet stem cell embryon stem cell',\n",
       "  'recent avail cultur embryo-deriv pluripotenti cell exhibit normal karyotyp high differenti ability1–3 encourag us assess potenti cell form function germ cell follow incorpor chimaer mice report result blastocyst inject studi use three independ isol xy embryo-deriv cell line ek.cp1 ek.cc1.1 ekcc1.2 produc high proport 50 live-born anim overtli chimaer seven chimaer male mice deriv three line far prove function germ-lin chimaera',\n",
       "  'chloroquin thought act falciparum malaria accumul acid vesicl parasit interf function1\\x964 parasit resist chloroquin expel drug rapidli unalt form therebi reduc level accumul vesicles5 discoveri verapamil partial revers chloroquin resist vitro 6 led propos efflux may involv atp-driven p-glycoprotein pump similar mammalian multidrug-resist mdr tumor cell line inde plasmodium falciparum contain least two mdr-like genes7,8 one suggest confer chloroquin resist cqr phenotype7,9,10 determin either gene link chloroquin resist perform genet cross cqr chloroquine-suscept cq clone p. falciparum examin 16 independ recombin progeni indic rapid efflux phenotyp control singl gene close link group gene linkag rapid efflux cqr phenotyp either mdr-like p. falciparum gene amplif gene data indic genet locu govern chloroquin efflux resist independ known mdr-like gene',\n",
       "  'cellular molecular mechan enabl us sens cold well understood insight process come use pharmacolog agent menthol elicit cool sensat character clone menthol receptor trigemin sensori neuron also activ thermal stimuli cool cold rang cold- menthol-sensit receptor cmr1 member trp famili excitatori ion channel propos function transduc cold stimuli somatosensori system find togeth previou identif heat-sensit channel vr1 vrl-1 demonstr trp channel detect temperatur wide rang princip sensor thermal stimuli mammalian peripher nervou system',\n",
       "  'pattern format biolog structur involv organ differ type cell spatial configur studi investig physic basi biolog pattern drosophila retina vivo demonstr e- n-cadherin mediat apic adhes retina epitheli cell differenti express n-cadherin within sub-group retin cell cone cell caus form overal shape minim surfac contact surround cell cell within group normal experiment manipul condit pack togeth way soap bubbl shape cone cell group pack compon precis imit physic tendenc surfac minim thu simpl pattern express n-cadherin result complex spatial pattern cell owe cellular surfac mechan',\n",
       "  'drosophila neuroblast epitheli cell procephal neurogen region divid perpendicular surfac segreg protein numb prospero basal daughter cell demonstr orient mitot spindl correct local numb prospero cell requir inscut gene moreov ectop express inscut epitheli cell lead spindl reorient inscut protein local apic cell cortex mitosi suggest inscut function establish polar asymmetr cell divis',\n",
       "  'genet interfer phenomenon nematod caenorhabd elegan describ express individu gene specif reduc microinject correspond fragment double-strand ds rna one strike featur process spread effect interfer broad region anim observ follow inject dsrna extracellular bodi caviti show c. elegan respond gene-specif manner dsrna encount environ c. elegan normal feed bacteria ingest grind pharynx subsequ absorb bacteri content gut find escherichia coli bacteria express dsrna confer specif interfer effect nematod larva feed',\n",
       "  'missens mutat cias1 gene caus three autoinflammatori disord famili cold autoinflammatori syndrom muckle–wel syndrom neonatal-onset multiple-system inflammatori diseas cryopyrin also call nalp3 product cias1 member nod-lrr protein famili link activ intracellular host defenc signal pathway cryopyrin form multi-protein complex term ‘ inflammasom ’ contain apoptosis-associ speck-lik protein asc caspase-1 promot caspase-1 activ process pro-interleukin il -1β ref 4 show effect cryopyrin defici inflammasom function immun respons cryopyrin asc essenti caspase-1 activ il-1β il-18 product respons bacteri rna imidazoquinolin compound r837 r848 contrast secret tumour-necrosi factor-α il-6 well activ nf-κb mitogen-activ protein kinas mapk unaffect cryopyrin defici furthermor show toll-lik receptor cryopyrin control secret il-1β il-18 differ intracellular pathway result reveal critic role cryopyrin host defenc bacteri rna-medi activ caspase-1 provid insight regard pathogenesi autoinflammatori syndrom',\n",
       "  'schizophrenia complex disord interfer function sever brain system requir cognit normal social behaviour although notabl clinic aspect diseas becom appar late adolesc earli adulthood mani line evid suggest schizophrenia neurodevelopment disord strong genet compon sever independ studi identifi neuregulin 1 nrg1 receptor erbb4 import risk gene schizophrenia although precis role diseas process remain unknown show nrg1 erbb4 signal control develop inhibitori circuitri mammalian cerebr cortex cell-autonom regul connect specif gaba γ-aminobutyr acid -contain interneuron contrast preval view support role gene format function excitatori synaps pyramid cell found erbb4 express mous neocortex hippocampu larg confin certain class interneuron particular erbb4 express mani parvalbumin-express chandeli basket cell local axon termin postsynapt densiti receiv glutamaterg input gain- loss-of-funct experi vitro vivo demonstr erbb4 cell-autonom promot format axo-axon inhibitori synaps pyramid cell function probabl mediat nrg1 addit erbb4 express gaba-contain interneuron regul format excitatori synaps onto dendrit cell contrast erbb4 dispens excitatori transmiss pyramid neuron altogeth result indic nrg1 erbb4 signal requir wire gaba-medi circuit postnat cortex provid new perspect involv gene aetiolog schizophrenia',\n",
       "  \"obes common within world 's popul begin replac undernutrit infecti diseas signific contributor ill health particular obes associ diabet mellitu coronari heart diseas certain form cancer sleep-breath disord obes defin body-mass index weight divid squar height 30 kg -2 greater take account morbid mortal associ modest degre overweight detriment effect intra-abdomin fat global epidem obes result combin genet suscept increas avail high-energi food decreas requir physic activ modern societi obes longer regard simpli cosmet problem affect certain individu epidem threaten global well\",\n",
       "  'unlik synthet materi biolog materi often stiffen deform nonlinear elast respons critic physiolog function tissu document sinc least 19th centuri molecular structur design principl respons unknown current model respons requir geometr complex order structur uniqu materi articl show much simpler molecular theori account strain stiffen wide rang molecularli distinct biopolym gel form purifi cytoskelet extracellular protein theori show system semi-flex chain filament protein arrang open crosslink meshwork invari stiffen low strain without need specif architectur multipl element differ intrins stiff',\n",
       "  'develop mainten epithelium requir fine balanc rate growth cell death howev mechan biochem mechan ensur proper feedback control tissu growth deregul contribut tumorigenesi poorli understood use fli notum model system identifi novel process crowding-induc cell delamin balanc growth ensur develop well-ord cell pack crowd region tissu proport cell undergo serial loss cell–cel junction progress loss apic area squeez neighbour path delamin recapitul simpl comput model epitheli mechan stochast cell loss reliev overcrowd system tend toward equilibrium show process delamin mechanist distinct apoptosis-medi cell extrus preced first sign cell death overal analysi reveal simpl mechan buffer epithelia variat growth live-cel delamin constitut mechanist link epitheli hyperplasia cell invas like import implic understand earli stage cancer develop',\n",
       "  'viral replic usual requir innat intracellular line defenc overcom task usual accomplish special viral gene product virion infect factor vif protein human immunodefici viru hiv requir late stage viral product counter antivir activ apobec3g apolipoprotein b mrna-edit enzym catalyt polypeptide-lik 3g also known cem15 protein express notabl human lymphocyt produc presenc apobec3g vif-defect viru non-infecti apobec3g close relat apobec1 central compon rna-edit complex deamin cytosin residu apob messeng rna apobec famili member also potent dna mutat activ dc deamin howev whether edit potenti apobec3g relev hiv inhibit unknown demonstr apobec3g exert antivir effect revers transcript trigger g-to-a hypermut nascent retrovir dna also find apobec3g act broad rang retrovirus addit hiv suggest hypermut edit gener innat defenc mechan import group pathogen',\n",
       "  'dynam polar membran protein defin differ cell boundari import role intercellular communication—a vital featur multicellular develop efflux carrier signal molecul auxin pin famili landmark cell polar plant crucial involv auxin distribution-depend develop includ embryo pattern organogenesi tropism polar pin local determin direct intercellular auxin flow yet mechan gener pin polar remain unclear identifi endocytosis-depend mechan pin polar gener analys development implic real-tim pin track show synthesi pin initi deliv plasma membran non-polar manner polar establish subsequ endocyt recycl interfer pin endocytosi either auxin manipul arabidopsi rab5 gtpase pathway prevent pin polar failur pin polar transient alter asymmetr auxin distribut embryogenesi increas local auxin respons apic embryo region result ectop express auxin pathway-associ root-form master regul embryon leav promot homeot transform leav root result indic two-step mechan gener pin polar local essenti role endocytosi process also highlight link endocytosis-depend polar individu cell auxin distribution-depend cell fate establish multicellular pattern',\n",
       "  \"extrem obes obes ob/ob mous attribut mutat gene encod leptin adipocyte-specif secret protein profound effect appetit energi expenditur know equival evid regard leptin 's role control fat mass human examin two sever obes children member highli consanguin pedigre serum leptin level low despit markedli elev fat mass homozyg frame-shift mutat involv delet singl guanin nucleotid codon 133 gene leptin found sever obes found congenit leptin-defici subject provid first genet evid leptin import regul energi balanc human\",\n",
       "  \"progress cerebr deposit amyloid β-peptid earli invari featur alzheim 's diseas β-peptid releas proteolyt cleavag β-amyloid precursor protein βapp 1 membrane-span glycoprotein express mammalian cell normal secret βapp involv cleavag β-peptid region2-3 releas solubl extramembran portion4,5 retain 10k c-termin fragment membrane6 secretori pathway preclud β-amyloid format search altern proteolyt process pathway gener β-peptide-bear fragment full-length β app incub live human endotheli cell βapp antibodi reveal reintern matur βapp cell surfac target endosomes/lysosom cell-surfac biotinyl full-length biotinyl βapp recov insid cell purif lysosom directli demonstr presenc matur βapp extens array β-peptide-contain proteolyt product result defin second process pathway βapp suggest may respons gener amyloid-bear fragment alzheim 's diseas\",\n",
       "  'cell growth increas mass size highli regul cellular event akt/mtor mammalian target rapamycin signal pathway central role control protein synthesi thu growth cell tissu organ strike exampl physiolog context requir rapid cell growth tissu repair respons injuri show keratin 17 intermedi filament protein rapidli induc wound stratifi epithelia regul cell growth bind adaptor protein 14-3-3σ mous skin keratinocyt lack keratin 17 ref 4 show depress protein translat smaller size correl decreas akt/mtor signal activ signal kinas normal activ point specif defect two amino acid residu locat amino-termin head domain keratin 17 requir serum-depend reloc 14-3-3σ nucleu cytoplasm concomit stimul mtor activ cell growth find reveal new unexpect role intermedi filament cytoskeleton influenc cell growth size regul protein synthesi',\n",
       "  'three-dimension structur hnf-3/fork head dna-recognit motif complex dna determin x-ray crystallographi 2.5 å resolut α/β protein bind b-dna monom interact dna backbon direct water-medi major minor groov base contact induc 13° bend transcript factor fold similar structur histon h5 amino-termin half three α-helic adopt compact structur present third helix major groov remaind protein includ twist antiparallel β-structur random coil interact minor groov',\n",
       "  \"chromosom instabl cin hallmark mani tumour correl presenc extra centrosom howev direct mechanist link extra centrosom cin establish propos extra centrosom gener cin promot multipolar anaphas highli abnorm divis produc three aneuploid daughter cell use long-term live-cel imag demonstr cell multipl centrosom rare undergo multipolar cell divis progeni divis typic inviabl thu multipolar divis explain observ rate cin contrast observ cin cell extra centrosom routin undergo bipolar cell divis display significantli increas frequenc lag chromosom anaphas defin mechan underli mitot defect gener cell differ centrosom number demonstr extra centrosom alon suffici promot chromosom missegreg bipolar cell divis segreg error consequ cell pass transient 'multipolar spindl intermedi merotel kinetochore-microtubul attach error accumul centrosom cluster anaphas find provid direct mechanist link extra centrosom cin two common characterist solid tumour propos mechan may common underli caus cin human cancer\",\n",
       "  'although haematopoiet stem cell hsc commonli assum resid within special microenviron nich publish experiment manipul hsc nich affect function divers restrict progenitor rais fundament question whether hsc restrict progenitor resid within distinct special nich whether share common nich assess physiolog sourc chemokin cxcl12 hsc restrict progenitor mainten cxcl12 dsred knock-in mice dsred-express2 recombin cxcl12 locu show cxcl12 primarili express perivascular stromal cell lower level endotheli cell osteoblast haematopoiet cell condit delet cxcl12 haematopoiet cell nestin-cre-express cell littl effect hsc restrict progenitor delet cxcl12 endotheli cell deplet hsc myeloerythroid lymphoid progenitor delet cxcl12 perivascular stromal cell deplet hsc certain restrict progenitor mobil cell circul delet cxcl12 osteoblast deplet certain earli lymphoid progenitor hsc myeloerythroid progenitor mobil cell circul differ stem progenitor cell thu resid distinct cellular nich bone marrow hsc occupi perivascular nich earli lymphoid progenitor occupi endost nich',\n",
       "  'broadli neutral antibodi highli variabl viral pathogen much sought treat protect global circul virus probe neutral antibodi repertoir four human immunodefici viru hiv -infect donor remark broad potent neutral respons rescu 17 new monoclon antibodi neutral broadli across clade mani new monoclon antibodi almost tenfold potent recent describ pg9 pg16 vrc01 broadli neutral monoclon antibodi 100-fold potent origin prototyp hiv broadli neutral monoclon antibodi monoclon antibodi larg recapitul neutral breadth found correspond donor serum mani recogn novel epitop envelop env glycoprotein gp120 illumin new target vaccin design analysi neutral full complement anti-hiv broadli neutral monoclon antibodi avail reveal certain combin antibodi offer markedli favour coverag enorm divers global circul virus other combin might sought activ passiv immun regim overal isol multipl hiv broadli neutral monoclon antibodi sever donor aggreg provid broad coverag low concentr highli posit indic eventu design effect antibody-bas hiv vaccin',\n",
       "  \"gtpase rac1 rhoa cdc42 act togeth control cytoskeleton dynam recent biosensor studi shown three gtpase activ front migrat cell biochem evid suggest may regul one anoth cdc42 activ rac1 ref 8 rac1 rhoa mutual inhibitori howev spatiotempor coordin second single-micrometr dimens typic individu protrus event remain unknown examin gtpase coordin mous embryon fibroblast simultan visual two gtpase biosensor use 'comput multiplex approach capabl defin relationship multipl protein activ visual separ experi found rhoa activ cell edg synchron edg advanc wherea cdc42 rac1 activ 2 micro-m behind edg delay 40 s. indic rac1 rhoa oper antagonist spatial separ precis time rhoa role initi event protrus wherea rac1 cdc42 activ pathway implic reinforc stabil newli expand protrus\",\n",
       "  'understand genet mechan underli natur variat gene express central goal medic evolutionari genet studi express quantit trait loci eqtl becom import tool achiev goal although eqtl studi far assay messeng rna level use express microarray recent advanc rna sequenc enabl analysi transcript variat unpreced resolut sequenc rna 69 lymphoblastoid cell line deriv unrel nigerian individu extens genotyp intern hapmap project pool data individu gener map transcript landscap cell identifi extens use unannot untransl region 100 new put protein-cod exon use genotyp hapmap project identifi thousand gene genet variat influenc overal express level splice demonstr eqtl near gene gener act mechan involv allele-specif express variat influenc inclus exon enrich within near consensu splice site result illustr power high-throughput sequenc joint analysi variat transcript splice allele-specif express across individu',\n",
       "  'cellular constitu form haematopoiet stem cell hsc nich bone marrow unclear studi implic osteoblast endotheli perivascular cell demonstr mesenchym stem cell msc identifi use nestin express constitut essenti hsc nich compon nestin+ msc contain bone-marrow colony-forming-unit fibroblast activ propag non-adher ‘ mesenspher ’ self-renew expand serial transplant nestin+ msc spatial associ hsc adrenerg nerv fibr highli express hsc mainten gene gene other trigger osteoblast differenti select downregul enforc hsc mobil β3 adrenoreceptor activ wherea parathormon administr doubl number bone marrow nestin+ cell favour osteoblast differenti vivo nestin+ cell deplet rapidli reduc hsc content bone marrow purifi hsc home near nestin+ msc bone marrow lethal irradi mice wherea vivo nestin+ cell deplet significantli reduc bone marrow home haematopoiet progenitor result uncov unpreced partnership two distinct somat stem-cel type indic uniqu nich bone marrow made heterotyp stem-cel pair',\n",
       "  'immun homeostasi tissu achiev delic balanc pathogen t-cell respons direct tissue-specif antigen abil tissu inhibit respons mechan tissu immun system commun establish maintain immun homeostasi current unknown clinic evid suggest chronic repeat exposur self antigen within tissu lead attenu patholog autoimmun respons possibl mean mitig inflammatori damag preserv function mani human organ-specif autoimmun diseas character initi present diseas sever subsequ flare lesser sever durat fact diseas often spontan resolv despit persist tissu autoantigen express practic antigen-specif immunotherapi allergen self antigen repeatedli inject skin diminut inflammatori respons occur success exposur although find indic tissu acquir abil attenu autoimmun reaction upon repeat respons antigen mechan occur unknown show upon express self antigen peripher tissu thymus-deriv regulatori cell treg cell becom activ prolifer differenti potent suppressor mediat resolut organ-specif autoimmun mice resolut inflammatori respons activ treg cell maintain target tissu prime attenu subsequ autoimmun reaction antigen re-express thu treg cell function confer ‘ regulatori memori ’ target tissu find provid framework understand treg cell respond expos self antigen peripher tissu offer mechanist insight tissu regul autoimmun',\n",
       "  'pluripot pertain cell earli embryo gener tissu organ embryon stem cell embryo-deriv cell line retain pluripot repres invalu tool research mechan tissu format recent murin fibroblast reprogram directli pluripot ectop express four transcript factor oct4 sox2 klf4 myc yield induc pluripot stem ip cell use factor deriv ip cell fetal neonat adult human primari cell includ dermal fibroblast isol skin biopsi healthi research subject human ip cell resembl embryon stem cell morpholog gene express capac form teratoma immune-defici mice data demonstr defin factor reprogramm human cell pluripot establish method wherebi patient-specif cell might establish cultur',\n",
       "  'stem cell propos segreg chromosom asymmetr self-renew divis older ‘ immort ’ dna strand retain daughter stem cell wherea newli synthes strand segreg differenti cell stem cell also propos retain dna label 5-bromo-2-deoxyuridin brdu either segreg chromosom asymmetr divid slowli howev puriti stem cell among brdu-label-retain cell document tissu ‘ immort strand hypothesi ’ test system definit stem cell marker test hypothes haematopoiet stem cell hsc highli purifi use well character marker administ brdu newborn mice mice treat cyclophosphamid granulocyt colony-stimul factor normal adult mice 4 10 day follow 70 day without brdu case less 6 hsc retain brdu less 0.5 brdu-retain haematopoiet cell hsc reveal brdu poor specif poor sensit hsc marker sequenti administr 5-chloro-2-deoxyuridin 5-iodo-2-deoxyuridin indic hsc segreg chromosom randomli divis individu hsc cultur reveal asymmetr segreg label thu hsc identifi basi brdu-label retent retain older dna strand divis indic gener properti stem cell',\n",
       "  'circadian ∼24 hour clock fundament import coordin physiolog organ divers cyanobacteria human current model molecular circadian clockwork eukaryot cell base transcription-transl feedback loop non-transcript mechan clockwork difficult studi mammalian system circumv problem develop novel assay use human red blood cell nucleu dna therefor perform transcript result show transcript requir circadian oscil human non-transcript event seem suffici sustain cellular circadian rhythm use red blood cell found peroxiredoxin highli conserv antioxid protein undergo ∼24-hour redox cycl persist mani day constant condit absenc extern cue moreov rhythm entrain tunabl environment stimuli temperature-compens key featur circadian rhythm anticip find facilit sophist cellular clock model highlight interdepend transcript non-transcript oscil potenti eukaryot cell',\n",
       "  \"kaposi 's sarcoma-associ herpesviru kshv/hhv8 gamma-2 herpesviru implic pathogenesi kaposi 's sarcoma primari effus b-cell lymphoma pel kshv infect malign progenitor cell kaposi 's sarcoma pel encod put oncogen gene may caus kaposi 's sarcoma pathogenesi stimul angiogenesi g-protein-coupl receptor encod open read frame orf 74 kshv express kaposi 's sarcoma lesion pel stimul signal pathway link cell prolifer constitut agonist-independ way show signal kshv g-protein-coupl receptor lead cell transform tumorigen induc switch angiogen phenotyp mediat vascular endotheli growth factor angiogenesi kaposi's-spindle-cel growth factor find receptor activ two protein kinas jnk/sapk p38mapk trigger signal cascad like induc inflammatori cytokin angiogenesi activ mitogen kaposi 's sarcoma cell b cell conclud kshv g-protein-coupl receptor viral oncogen exploit cell signal pathway induc transform angiogenesi kshv-mediat oncogenesi\",\n",
       "  'purpos acut myeloid leukemia aml heterogen diseas poor outcom despit increas evid show dysregul histon modif contribut aml specif drug target key histon modul appli clinic treatment aml investig whether target kdm6b demethylas tri-methyl histon h3 lysin 27 h3k27me3 therapeut potenti aml method kdm6b-specif inhibitor gsk-j4 appli treat primari cell aml patient aml cell line vitro vivo rna-sequenc perform reveal underli mechan inhibit kdm6b treatment aml result observ mrna express kdm6b up-regul aml posit correl poor surviv treatment gsk-j4 increas global level h3k27me3 reduc prolifer colony-form abil primari aml cell aml cell line gsk-j4 treatment significantli induc cell apoptosi cell-cycl arrest kasumi-1 cell display synergist effect cytosin arabinosid notabl inject gsk-j4 attenu diseas progress human aml xenograft mous model vivo treatment gsk-j4 predominantli result down-regul dna replic cell-cycle-rel pathway well abrog express critic cancer-promot hox gene chip-qpcr valid increas enrich h3k27me3 transcript start site hox gene conclus summari find suggest target kdm6b gsk-j4 therapeut potenti treatment aml',\n",
       "  \"half world 's popul chronic infect helicobact pylori caus gastriti gastric ulcer increas incid gastric adenocarcinoma proton-g inner-membran urea channel hpurei essenti surviv acid environ stomach channel close neutral ph open acid ph allow rapid access urea cytoplasm ureas ureas produc nh 3 co 2 neutral enter proton thu buffer periplasm ph roughli 6.1 even gastric juic ph 2.0. report structur hpurei reveal six protom assembl hexamer ring surround central bilay plug order lipid protom enclos channel form twist bundl six transmembran helic bundl defin previous unobserv fold compris two-helix hairpin motif repeat three time around central axi channel without invert repeat mammalian-typ urea transport channel protom interfac contain residu conserv amis/urei superfamili suggest preserv channel architectur oligomer state superfamili predominantli aromat aliphat side chain line entir channel defin two consecut constrict site middl channel mutat trp 153 cytoplasm constrict site ala phe decreas select urea comparison thiourea suggest solut interact trp 153 contribut specif previous unobserv hexamer channel structur describ provid new model permeat urea small amid solut prokaryot archaea\",\n",
       "  'drosophila follicl oocyt alway occupi posterior posit among group sixteen germlin cell although import cell arrang subsequ format anterior-posterior axi embryo well document molecular mechan respons posterior local oocyt unknown show homophil adhes molecul de-cadherin mediat oocyt posit follicl biogenesi de-cadherin express germlin includ oocyt surround follicl cell highest concentr de-cadherin found interfac oocyt posterior follicl cell mosaic analysi show de-cadherin requir germlin follicl cell correct oocyt local indic germline-soma interact may involv process analys behaviour oocyt follicl chimaer follicular epithelium find posit oocyt determin posit de-cadherin-express follicl cell oocyt attach select among de-cadherin posit follicl cell oocyt preferenti contact cell express higher level de-cadherin basi data propos wild-typ follicl oocyt compet success sister germlin cell contact posterior follicl cell sort process driven differ concentr de-cadherin knowledg first vivo exampl cell-sort process depend differenti adhes mediat cadherin',\n",
       "  'mammalian model sex determin embryo consid sexual indiffer transient action sex-determin gene initi gonad differenti although model thought appli vertebr yet establish examin three later gynandromorph chicken rare natur occur phenomenon one side anim appear male femal investig sex-determin mechan bird studi demonstr gynandromorph bird genuin male femal chimaera indic male femal avian somat cell may inher sex ident test hypothesi transplant presumpt mesoderm embryo reciproc sex gener embryo contain male femal chimaer gonad contrast outcom mammalian mixed-sex chimaera chicken mixed-sex chimaera donor cell exclud function structur host gonad exampl femal tissu transplant male host donor cell contribut develop testi retain femal ident express marker femal function studi demonstr avian somat cell possess inher sex ident bird sexual differenti substant cell autonom',\n",
       "  'cytotox lymphocyt ctl destroy viral infect tumorigen cell releas content special secretori lysosomes—term ‘ lytic granul ’ —at immunolog synaps form ctl target contact target cell microtubul organ centr ctl polar toward target granul move along microtubul minus-end direct toward polar microtubul organ centr howev final step secret remain unclear show ctl requir actin plus-end microtubul motor secret instead centrosom move contact plasma membran central supramolecular activ cluster immunolog synaps actin iqgap1 clear away synaps granul deliv directli plasma membran data show ctl use previous unreport mechan deliv secretori granul immunolog synaps granul secret control centrosom deliveri plasma membran',\n",
       "  'p53 tumour suppressor short-liv protein maintain low level normal cell mdm2-mediat ubiquitin subsequ proteolysi stabil p53 crucial tumour suppressor function howev precis mechan ubiquitin p53 level regul vivo complet understood mass spectrometri affinity-purifi p53-associ factor identifi herpesvirus-associ ubiquitin-specif proteas hausp novel p53-interact protein hausp strongli stabil p53 even presenc excess mdm2 also induc p53-depend cell growth repress apoptosi significantli hausp intrins enzymat activ specif deubiquitin p53 vitro vivo contrast express catalyt inact point mutant hausp cell increas level p53 ubiquitin destabil p53 find reveal import mechan p53 stabil direct deubiquitin also impli hausp might function tumour suppressor vivo stabil p53',\n",
       "  'half centuri ago chronic granulomat diseas cgd first describ diseas fatal affect abil children surviv infect variou mileston discoveri sinc made insuffici abil patient ’ leucocyt kill microb underli genet abnorm inherit disord phagocyt lack nadph oxidas activ gener reactiv oxygen speci notabl superoxid anion caus recurr bacteri fungal infect patient cgd also suffer chronic inflammatori condit promin granuloma format hollow viscera precis mechan increas microbi pathogen unclear reason exagger inflammatori respons show superoxide-depend step tryptophan metabol along kynurenin pathway block cgd mice lethal pulmonari aspergillosi lead unrestrain vγ1+ γδ t-cell reactiv domin product interleukin il -17 defect regulatori t-cell activ acut inflammatori lung injuri although benefici effect induc il-17 neutral γδ t-cell contract complet cure revers hyperinflammatori phenotyp achiev replac therapi natur kynurenin distal blockad pathway effect therapi includ co-administr recombin interferon-γ ifn-γ restor product downstream immunoact metabolit enabl emerg regulatori vγ4+ γδ foxp3+ αβ cell therefor paradox lack reactiv oxygen speci contribut hyperinflammatori phenotyp associ nadph oxidas defici dysfunct kynurenin pathway tryptophan catabol yet condit revert reactiv pathway downstream superoxide-depend step',\n",
       "  'architectur adhes cell microenviron critic factor regul spindl orient vivo use combin theori experi investig spindl orient hela human cell show spindl orient understood result action cortic forc gener interact spindl microtubul activ cortic cue develop simpl physic descript spindl mechan allow us calcul angular profil torqu act spindl well angular distribut spindl orient model account prefer spindl orient shape full angular distribut spindl orient observ larg varieti differ cellular microenviron geometri also correctli describ asymmetr spindl orient observ certain distribut cortic cue conclud basi simpl assumpt provid quantit descript spindl orient adher cell',\n",
       "  'genom sequenc uncov new mutat phenomenon cancer congenit disord call chromothripsi chromothripsi character extens genom rearrang oscil pattern dna copi number level curious restrict one chromosom mechan chromothripsi unknown previous propos could occur physic isol chromosom aberr nuclear structur call micronuclei use combin live cell imag single-cel genom sequenc demonstr micronucleu format inde gener spectrum genom rearrang recapitul known featur chromothripsi event restrict mis-segreg chromosom occur within one cell divis demonstr mechan chromothripsi involv fragment subsequ reassembl singl chromatid micronucleu collect experi establish new mutat process chromothripsi one extrem outcom',\n",
       "  'methyl cytosin essenti epigenet modif mammalian genom yet rule govern methyl pattern remain larg elus gain insight process gener base-pair-resolut mous methylom stem cell neuron progenitor advanc quantit analysi identifi low-methyl region lmr averag methyl 30 repres cpg-poor distal regulatori region evidenc locat dnase hypersensit presenc enhanc chromatin mark enhanc activ report assay lmr occupi dna-bind factor bind necessari suffici creat lmr comparison neuron stem-cel methylom confirm depend cell-type-specif lmr occupi cell-type-specif transcript factor studi provid methylom refer mous show dna-bind factor local influenc dna methyl enabl identif activ regulatori region',\n",
       "  'rna polymeras pol ii catalys dna-depend rna synthesi gene transcript howev evid pol ii also possess rna-depend rna polymeras rdrp activ pol ii use homopolymer rna templat extend rna sever nucleotid absenc dna implic replic rna genom hepat delta viru hdv plant viroid show intrins rdrp activ pol ii pure polymeras rna template–product scaffold nucleosid triphosph ntp crystallographi reveal template–product duplex site occupi dna–rna hybrid transcript rdrp activ resid activ site use transcript slower less process dna-depend activ rdrp activ also obtain part hdv antigenom complex transcript factor ii tfii pol ii cleav one hdv strand creat reactiv stem-loop hybrid site extend new rna 3′ end short rna stem-loop 5′ extens suffic activ growth critic length appar impair process rdrp activ pol ii provid miss link molecular evolut suggest pol ii evolv ancient replicas duplic rna genom',\n",
       "  'nociceptor sensori neuron special detect potenti damag stimuli protect organ initi sensat pain elicit defens behaviour bacteri infect produc pain unknown molecular mechan although presum secondari immun activ demonstr bacteria directli activ nociceptor immun respons mediat tlr2 myd88 cell b cell neutrophil monocyt necessari staphylococcu aureus-induc pain mice mechan thermal hyperalgesia mice correl live bacteri load rather tissu swell immun activ bacteria induc calcium flux action potenti nociceptor neuron part via bacteri n-formyl peptid pore-form toxin α-haemolysin distinct mechan specif ablat nav1.8-lineag neuron includ nociceptor abrog pain bacteri infect concurr increas local immun infiltr lymphadenopathi drain lymph node thu bacteri pathogen produc pain directli activ sensori neuron modul inflamm unsuspect role nervou system host-pathogen interact',\n",
       "  'establish model mammalian cell cycl control retinoblastoma protein rb function restrict cell enter phase bind sequest e2f activ e2f1 e2f2 e2f3 invari portray ultim effector transcript program commit cell enter progress phase use panel tissue-specif cre-transgen mice condit e2f allel examin effect e2f1 e2f2 e2f3 tripl defici murin embryon stem cell embryo small intestin show normal divid progenitor cell e2f1-3 function transcript activ contrari current view dispens cell divis instead necessari cell surviv differenti cell e2f1-3 function complex rb repressor silenc e2f target facilit exit cell cycl inactiv rb differenti cell result switch e2f1-3 repressor activ lead superactiv e2f respons target ectop cell divis loss e2f1-3 complet suppress phenotyp caus rb defici work contextu activ versu repressor function e2f1-3 vivo reveal distinct role divid versu differenti cell normal versu cancer-lik cell cycl',\n",
       "  'somat mutat small gtpase k-ra common activ lesion found human cancer gener associ poor respons standard therapi effort target oncogen directli face difficulti owe picomolar affin gtp/gdp absenc known alloster regulatori site oncogen mutat result function activ ra famili protein impair gtp hydrolysi diminish regul gtpase activ nucleotid state ra becom depend rel nucleotid affin concentr give gtp advantag gdp increas proport activ gtp-bound ra report develop small molecul irrevers bind common oncogen mutant k-ra g12c compound reli mutant cystein bind therefor affect wild-typ protein crystallograph studi reveal format new pocket appar previou structur ra beneath effector bind switch-ii region bind inhibitor k-ra g12c disrupt switch-i switch-ii subvert nativ nucleotid prefer favour gdp gtp impair bind raf data provid structure-bas valid new alloster regulatori site ra target mutant-specif manner',\n",
       "  'conspicu event cell cycl align chromosom metaphas chromosom align foster faith segreg format bi-ori attach kinetochor spindl microtubul notabl numer kinetochore-microtubul k-mt attach error present earli mitosi prometaphas persist error lead caus chromosom mis-segreg aneuploid human tumour cell continu mis-segreg whole chromosom display chromosom instabl robust error correct achiev prometaphas ensur error-fre mitosi remain unknown show k-mt attach prometaphas cell consider less stabl metaphas cell switch stabl k-mt attach metaphas requir proteasome-depend destruct cyclin prometaphas persist cyclin express prevent k-mt stabil even cell align chromosom contrast k-mt prematur stabil cyclin-a-defici cell consequ cell lack cyclin display higher rate chromosom mis-segreg thu stabil k-mt attach increas decis coordin fashion among chromosom cell transit prometaphas metaphas cyclin creat cellular environ promot microtubul detach kinetochor prometaphas ensur effici error correct faith chromosom segreg',\n",
       "  'spinal muscular atrophi one common inherit form neurolog diseas lead infant mortal patient select loss lower motor neuron result muscl weak paralysi often death although patient fibroblast use extens studi spinal muscular atrophi motor neuron uniqu anatomi physiolog may underli vulner diseas process report gener induc pluripot stem cell skin fibroblast sampl taken child spinal muscular atrophi cell expand robustli cultur maintain diseas genotyp gener motor neuron show select deficit compar deriv child ’ unaffect mother first studi show human induc pluripot stem cell use model specif patholog seen genet inherit diseas repres promis resourc studi diseas mechan screen new drug compound develop new therapi',\n",
       "  'inflammatori respons initi nlrp3 inflammasom trigger varieti situat host ‘ danger ’ includ infect metabol dysregul previou studi suggest nlrp3 inflammasom activ neg regul autophagi posit regul reactiv oxygen speci ro deriv uncharacter organel show mitophagy/autophagi blockad lead accumul damag ros-gener mitochondria turn activ nlrp3 inflammasom rest nlrp3 local endoplasm reticulum structur wherea inflammasom activ nlrp3 adaptor asc redistribut perinuclear space co-loc endoplasm reticulum mitochondria organel cluster notabl ro gener inflammasom activ suppress mitochondri activ dysregul inhibit voltage-depend anion channel indic nlrp3 inflammasom sens mitochondri dysfunct may explain frequent associ mitochondri damag inflammatori diseas',\n",
       "  'homology-direct dna repair essenti genom mainten templat dna synthesi altern lengthen telomer alt necessit homology-direct dna repair maintain telomer 10–15 human cancer dna damag induc assembl execut dna replic complex break-induc replisom telomer elsewher mammalian genom poorli understood defin break-induc telomer synthesi demonstr util special replisom underli alt telomer mainten dna double-strand break enact nascent telomer synthesi long-tract unidirect replic prolifer cell nuclear antigen pcna load replic factor c rfc act initi sensor telomer damag establish predomin dna polymeras δ pol δ pold3 subunit break-induc telomer synthesi requir rfc–pcna–pol δ axi independ canon replisom compon atm atr homolog recombin protein rad51 thu incept telomer damag recognit break-induc replisom orchestr homology-direct telomer mainten',\n",
       "  'innat immun defenc essenti control viru infect trigger host recognit viral macromolecular motif known pathogen-associ molecular pattern pamp hepat c viru hcv rna viru replic liver infect 200 million peopl worldwid infect regul hepat immun defenc trigger cellular rig-i helicas rig-i bind pamp rna signal interferon regulatori factor 3 activ induc express interferon-α/β antiviral/interferon-stimul gene isg limit infect identifi polyuridin motif hcv genom 3′ non-transl region replic intermedi pamp substrat rig-i show similar homopolyuridin homopolyriboadenin motif present genom rna virus chief featur rig-i recognit immun trigger human murin cell 5′ termin triphosph pamp rna necessari suffici rig-i bind primarili depend homopolymer ribonucleotid composit linear structur length hcv pamp rna stimul rig-i-depend signal induc hepat innat immun respons vivo trigger interferon isg express suppress hcv infect vitro result provid conceptu advanc defin specif homopolymer rna motif within genom hcv rna virus pamp substrat rig-i demonstr immunogen featur pamp–rig-i interact could use immun adjuv vaccin immunotherapi approach',\n",
       "  'common marmoset callithrix jacchu increasingli attract use non-human primat anim model biomed research rel high reproduct rate primat make potenti suitabl transgen modif although sever attempt made produc non-human transgen primat transgen express somat tissu live infant demonstr object analys polymeras chain reaction revers transcript western blot show inject self-inactiv lentivir vector sucros solut marmoset embryo result transgen common marmoset express transgen sever organ notabl achiev germlin transmiss transgen transgen offspr develop normal success creation transgen marmoset provid new anim model human diseas great advantag close genet relationship human model valuabl mani field biomed research',\n",
       "  'somat cell nuclear transfer cell fusion express lineage-specif factor shown induc cell-fat chang divers somat cell type recent observ forc express combin three transcript factor brn2 also known pou3f2 ascl1 myt1l effici convert mous fibroblast function induc neuron cell show three factor gener function neuron human pluripot stem cell earli 6 day transgen activ combin basic helix-loop-helix transcript factor neurod1 factor could also convert fetal postnat human fibroblast cell show typic neuron morpholog express multipl neuron marker even downregul exogen transcript factor importantli vast major human cell abl gener action potenti mani matur receiv synapt contact co-cultur primari mous cortic neuron data demonstr non-neur human somat cell well pluripot stem cell convert directli neuron lineage-determin transcript factor method may facilit robust gener patient-specif human neuron vitro diseas model futur applic regen medicin',\n",
       "  'bacteri type vi secret system t6ss larg multicompon dynam macromolecular machin import role ecolog mani gram-neg bacteria t6ss respons transloc wide rang toxic effector molecul allow predatori cell kill prokaryot well eukaryot prey cell t6ss organel function analog contractil tail bacteriophag thought attack cell initi penetr trimer protein complex call vgrg spike neither exact protein composit t6ss organel mechan effector select deliveri known report protein paar proline-alanine-alanine-arginin repeat superfamili form sharp conic extens vgrg spike involv attach effector domain spike crystal structur two paar-repeat protein bound vgrg-like partner show protein sharpen tip t6ss spike complex demonstr paar protein essenti t6ss-mediat secret target cell kill vibrio cholera acinetobact baylyi result indic new model t6ss organel vgrg-paar spike complex decor multipl effector deliv simultan target cell singl contraction-driven transloc event',\n",
       "  'oncogene-induc dna replic stress implic driver tumorigenesi mani chromosom rearrang characterist human cancer origin specif region genom call common fragil site cfss cfss difficult-to-repl loci manifest gap break metaphas chromosom term cf ‘ express ’ particularli cell expos replic stress mus81–eme1 structure-specif endonucleas promot appear chromosom gap break cfss follow replic stress show entri cell mitot prophas trigger recruit mus81 cfss nucleas activ mus81 promot pold3-depend dna synthesi cfss serv minim chromosom mis-segreg non-disjunct propos attempt condens incomplet duplic loci earli mitosi serv trigger complet dna replic cf loci human cell given pold3-depend mitot dna synthesi enhanc aneuploid cancer cell exhibit intrins high level chromosom instabl cin+ replic stress suggest target pathway could repres new therapeut approach',\n",
       "  \"memori function often declin age believ deterior initi chang synapt function rather loss neuron individu go develop alzheim 's diseas neurodegener use tg2576 mice express human amyloid-β precursor protein app variant link alzheim 's diseas investig caus memori declin absenc neurodegener amyloid-β protein amyloidosi young tg2576 mice 6 month old normal memori lack neuropatholog middle-ag mice 6–14 month old develop memori deficit without neuron loss old mice 14 month old form abund neurit plaqu contain amyloid-β ref 3–6 found memori deficit middle-ag tg2576 mice caus extracellular accumul 56-kda solubl amyloid-β assembl term aβ 56 aβ star 56 aβ 56 purifi brain impair tg2576 mice disrupt memori administ young rat propos aβ 56 impair memori independ plaqu neuron loss may contribut cognit deficit associ alzheim 's diseas\",\n",
       "  'inflammatori caspas caspase-1 -4 -5 -11 critic innat defenc caspase-1 activ ligand variou canon inflammasom caspase-4 -5 -11 directli recogn bacteri lipopolysaccharid trigger pyroptosi despit crucial role immun endotox shock mechan pyroptosi induct inflammatori caspas unknown identifi gasdermin gsdmd genome-wid cluster regularli interspac palindrom repeat crispr -cas9 nucleas screen caspase-11- caspase-1-medi pyroptosi mous bone marrow macrophag gsdmd-defici cell resist induct pyroptosi cytosol lipopolysaccharid known canon inflammasom ligand interleukin-1β releas also diminish gsdmd−/− cell despit intact process caspase-1 caspase-1 caspase-4/5/11 specif cleav linker amino-termin gasdermin-n carboxy-termin gasdermin-c domain gsdmd requir suffici pyroptosi cleavag releas intramolecular inhibit gasdermin-n domain show intrins pyroptosis-induc activ gasdermin famili member cleav inflammatori caspas share autoinhibit gain-of-funct mutat gsdma3 caus alopecia skin defect disrupt autoinhibit allow gasdermin-n domain trigger pyroptosi find offer insight inflammasome-medi immunity/diseas also chang understand pyroptosi program necrosi',\n",
       "  'pregnanc trophoblast invas uterin spiral arteri remodel import lower matern vascular resist increas uteroplacent blood flow impair spiral arteri remodel implic pre-eclampsia major complic pregnanc long time underli mechan remain unclear corin also known atrial natriuret peptide-convert enzym cardiac proteas activ atrial natriuret peptid anp cardiac hormon import regul blood pressur unexpectedli corin express detect pregnant uteru identifi new function corin anp promot trophoblast invas spiral arteri remodel show pregnant corin- anp-defici mice develop high blood pressur proteinuria characterist pre-eclampsia mice trophoblast invas uterin spiral arteri remodel markedli impair consist anp potent stimul human trophoblast invad matrigel patient pre-eclampsia uterin corin messeng rna protein level significantli lower normal pregnanc moreov identifi corin gene mutat pre-eclampt patient decreas corin activ process pro-anp result indic corin anp essenti physiolog chang maternal–fet interfac suggest defect corin anp function may contribut pre-eclampsia',\n",
       "  'mitochondria major role energi product via oxid phosphoryl depend express critic gene encod mitochondri mt dna mutat mtdna caus fatal sever debilit disord limit treatment option clinic manifest vari base mutat type heteroplasmi rel level mutant wild-typ mtdna within cell gener genet correct pluripot stem cell psc patient mtdna diseas multipl induc pluripot stem ip cell line deriv patient common heteroplasm mutat includ 3243a g caus mitochondri encephalomyopathi stroke-lik episod mela 8993t g 13513g implic leigh syndrom isogen mela leigh syndrom ip cell line gener contain exclus wild-typ mutant mtdna spontan segreg heteroplasm mtdna prolifer fibroblast furthermor somat cell nuclear transfer scnt enabl replac mutant mtdna homoplasm 8993t g fibroblast gener correct leigh-nt1 psc although leigh-nt1 psc contain donor oocyt wild-typ mtdna human haplotyp d4a differ leigh syndrom patient haplotyp f1a total 47 nucleotid site leigh-nt1 cell display transcriptom profil similar embryo-deriv psc carri wild-typ mtdna indic normal nuclear-to-mitochondri interact moreov genet rescu patient psc display normal metabol function compar impair oxygen consumpt atp product observ mutant cell conclud reprogram approach offer complementari strategi deriv psc contain exclus wild-typ mtdna spontan segreg heteroplasm mtdna individu ip cell line mitochondri replac scnt homoplasm mtdna-bas diseas',\n",
       "  \"telomer physic end eukaryot chromosom genet studi establish baker 's yeast pif1p dna helicas neg regul telomeras special revers transcriptas maintain telomer dna biochem basi inhibit unknown show vitro pif1p reduc process telomeras releas telomeras telomer oligonucleotid releas telomeras enzymat activ abl lengthen challeng oligonucleotid vivo overexpress pif1p reduc telomeras associ telomer wherea deplet cell pif1p increas level telomere-bound est1p telomeras subunit present telomer telomeras activ propos pif1p helicas activ limit telomeras action vivo vitro displac activ telomeras dna end\",\n",
       "  'eukaryot cell express wide varieti endogen small regulatori rna regul heterochromatin format development time defenc parasit nucleic acid genom rearrang mani small regulatori rna thought function nuclei instanc plant fungi short interf rna sirna associ nascent transcript direct chromatin and/or dna modif understand biolog role small regulatori rna conduct genet screen identifi factor requir rna interfer rnai caenorhabd elegan nuclei show gene nuclear rnai defective-2 nrde-2 encod evolutionarili conserv protein requir sirna-medi silenc nuclei nrde-2 associ argonaut protein nrde-3 within nuclei recruit nrde-3/sirna complex nascent transcript target rnai find nuclear-loc sirna direct nrde-2-depend silenc pre-messeng rna pre-mrna 3 site rnai nrde-2-depend accumul rna polymeras rnap ii genom loci target rnai nrde-2-depend decreas rnap ii occup rnap ii transcript activ 3 site rnai result defin nrde-2 compon nuclear rnai machineri demonstr metazoan sirna silenc nuclear-loc rna co-transcript addit result establish novel mode rnap ii regul sirna-direct recruit nrde factor inhibit rnap ii elong phase transcript',\n",
       "  'unicellular organ yeast requir singl cyclin-depend kinas cdk1 drive cell divis contrast mammalian cell thought requir sequenti activ least four differ cyclin-depend kinas cdk2 cdk3 cdk4 cdk6 drive cell interphas well cdk1 proceed mitosi model challeng recent genet evid mice surviv absenc individu interphas cdk moreov mous cell type prolifer absenc two even three interphas cdk similar result obtain ablat activ subunit cdk d-type e-typ cyclin show mous embryo lack interphas cdk cdk2 cdk3 cdk4 cdk6 undergo organogenesi develop midgest embryo cdk1 bind cyclin result phosphoryl retinoblastoma protein prb express gene regul e2f transcript factor mous embryon fibroblast deriv embryo prolifer vitro albeit extend cell cycl due ineffici inactiv rb protein howev becom immort continu passag also report embryo fail develop morula blastocyst stage absenc cdk1 result indic cdk1 essenti cell cycl cdk moreov show absenc interphas cdk cdk1 execut event requir drive cell divis',\n",
       "  'calori restrict cr extend lifespan wide spectrum organ regimen known lengthen lifespan mammal establish model cr bud yeast saccharomyc cerevisia system lifespan extend limit glucos reduc activ glucose-sens cyclic-amp-depend kinas pka lifespan extens mutant reduc pka activ requir sir2 nad nicotinamid adenin dinucleotid studi explor cr activ sir2 extend lifespan show shunt carbon metabol toward mitochondri tricarboxyl acid cycl concomit increas respir play central part process discuss metabol strategi may appli cr anim',\n",
       "  'improv sequenc technolog offer unpreced opportun investig role rare genet variat common diseas howev consider challeng respect studi design data analysi replic use pool next-gener sequenc 507 gene implic repair dna 1,150 sampl analyt strategi focus protein-trunc variant ptv large-scal sequenc case–control replic experi 13,642 individu show rare ptv p53-induc protein phosphatas ppm1d associ predisposit breast cancer ovarian cancer ppm1d ptv mutat present 25 7,781 case versu 1 5,861 control p 1.12 × 10−5 includ 18 mutat 6,912 individu breast cancer p 2.42 × 10−4 12 mutat 1,121 individu ovarian cancer p 3.10 × 10−9 notabl identifi ppm1d ptv mosaic lymphocyt dna cluster within 370-base-pair region final exon gene carboxy-termin phosphatas catalyt domain function studi demonstr mutat result enhanc suppress p53 respons ioniz radiat exposur suggest mutant allel encod hyperact ppm1d isoform thu although mutat caus prematur protein truncat result simpl loss-of-funct effect typic associ class variant instead probabl gain-of-funct effect result implic detect manag breast ovarian cancer risk gener data provid new insight role rare mosaic genet variant common condit use sequenc identif',\n",
       "  'induc pluripot stem cell ipsc reprogram somat cell defin factor hold great promis regen medicin renew sourc autolog cell wherea gener assum autolog cell immune-toler recipi ipsc deriv immunogen vigor examin show wherea embryon stem cell esc deriv inbr c57bl/6 b6 mice effici form teratoma b6 mice without evid immun reject allogen esc 129/svj mice fail form teratoma b6 mice due rapid reject recipi b6 mous embryon fibroblast mef reprogram ipsc either retrovir approach vipsc novel episom approach eipsc caus genom integr contrast b6 esc teratoma form b6 vipsc mostli immune-reject b6 recipi addit major teratoma form b6 eipsc immunogen b6 mice cell infiltr appar tissu damag regress observ small fraction teratoma global gene express analysi teratoma form b6 esc eipsc reveal number gene frequent overexpress teratoma deriv eipsc sever gene product shown contribut directli immunogen b6 eipsc-deriv cell b6 mice find indic contrast deriv esc abnorm gene express cell differenti ipsc induc t-cell-depend immun respons syngen recipi therefor immunogen therapeut valuabl cell deriv patient-specif ipsc evalu clinic applic autolog cell patient',\n",
       "  'case embryo-deriv stem cell applic reprogram human induc pluripot stem cell limit understand lineag specif demonstr abil gener progenitor matur cell haematopoiet fate directli human dermal fibroblast without establish pluripot ectop express oct4 also call pou5f1 -activ haematopoiet transcript factor togeth specif cytokin treatment allow gener cell express pan-leukocyt marker cd45 uniqu fibroblast-deriv cell gave rise granulocyt monocyt megakaryocyt erythroid lineag demonstr vivo engraft capac note adult haematopoiet program activ consist bypass pluripot state gener blood fate distinct haematopoiesi involv pluripot stem cell embryon program activ find demonstr restor multipot human fibroblast suggest altern approach cellular reprogram autolog cell-replac therapi avoid complic associ use human pluripot stem cell',\n",
       "  'instruct cue present cell surfac precis effect actin cytoskeleton poorli understood semaphorin one largest famili instruct cue wide studi effect cell movement navig angiogenesi immunolog cancer semaphorins/collapsin character part basi abil drastic alter actin cytoskelet dynam neuron process despit consider progress identif semaphorin receptor signal pathway molecul link precis control cytoskelet element remain unknown recent highli unusu protein mical famili enzym found associ cytoplasm portion plexin larg cell-surfac semaphorin receptor mediat axon guidanc synaptogenesi dendrit prune cell morpholog chang mical enzym perform reduction–oxid redox enzymat reaction also contain domain found protein regul cell morpholog howev noth known role mical redox activ mediat morpholog chang report mical directli link semaphorin plexin receptor precis control actin filament f-actin dynam found mical necessari suffici semaphorin–plexin-medi f-actin reorgan vivo likewis purifi mical protein found directli bind f-actin disassembl individu bundl actin filament also found mical util redox activ alter f-actin dynam vivo vitro indic previous unknown role specif redox signal event actin cytoskelet regul mical therefor novel f-actin-disassembl factor provid molecular conduit actin reorganization—a hallmark cell morpholog chang includ axon navigation—can precis achiev spatiotempor respons semaphorin',\n",
       "  'regulatori treg cell character express transcript factor forkhead box p3 foxp3 maintain immun homeostasi suppress self-destruct immun respons foxp3 oper late-act differenti factor control treg cell homeostasi function wherea earli treg-cell-lineag commit regul akt kinas forkhead box foxo famili transcript factor howev whether foxo protein act beyond treg-cell-commit stage control treg cell homeostasi function remain larg unexplor show foxo1 pivot regul treg cell function treg cell express high amount foxo1 display reduc t-cell-receptor-induc akt activ foxo1 phosphoryl foxo1 nuclear exclus mice treg-cell-specif delet foxo1 develop fatal inflammatori disord similar sever seen foxp3-defici mice without loss treg cell genome-wid analysi foxo1 bind site reveal ∼300 foxo1-bound target gene includ pro-inflammatori cytokin ifng seem directli regul foxp3 find show evolutionarili ancient akt–foxo1 signal modul control novel genet program indispens treg cell function',\n",
       "  'mammal enlarg heart embryon develop primarili depend increas cardiomyocyt number shortli birth howev cardiomyocyt stop prolifer growth myocardium occur hypertroph enlarg exist myocyt consequ minim renew cardiomyocyt adult life repair cardiac damag myocardi regener limit show exogen administr select microrna mirna markedli stimul cardiomyocyt prolifer promot cardiac repair perform high-cont microscopi high-throughput function screen human mirna promot neonat cardiomyocyt prolifer use whole-genom mirna librari forti mirna strongli increas dna synthesi cytokinesi neonat mous rat cardiomyocyt two mirna hsa-mir-590 hsa-mir-199a select test shown promot cell cycl re-entri adult cardiomyocyt ex vivo promot cardiomyocyt prolifer neonat adult anim myocardi infarct mice mirna stimul mark cardiac regener almost complet recoveri cardiac function paramet mirna identifi hold great promis treatment cardiac patholog consequ cardiomyocyt loss',\n",
       "  'spinal reflex mediat synapt connect sensori affer motor neuron organ circuit show sever level specif certain class propriocept sensori neuron make direct monosynapt connect motor neuron bound rule motor pool specif form strong connect motor neuron suppli muscl avoid motor pool suppli antagonist muscl pattern connect initi accur maintain absenc activ impli wire specif reli match recognit molecul surfac sensori motor neuron howev determin fine synapt specif region central nervou system yet defin address origin synapt specif reflex circuit use molecular genet method manipul recognit protein express subset sensori motor neuron show recognit system involv express class 3 semaphorin sema3 select motor neuron pool high-affin receptor plexin d1 plxnd1 propriocept sensori neuron critic determin synapt specif sensory–motor circuit mice chang profil sema3e–plxnd1 signal sensori motor neuron result function anatom rewir monosynapt connect alter motor pool specif find indic pattern monosynapt connect prototyp central nervou system circuit construct recognit program base repel signal',\n",
       "  'packag eukaryot genom chromatin present barrier restrict access enzym process dna overcom barrier cell possess number multi-protein atp-depend chromatin remodel complex contain atpas subunit snf2/swi2 superfamili chromatin remodel complex function increas nucleosom mobil clearli implic transcript analys snf2/swi2- iswi-rel protein identifi remodel complex potenti assist dna transact purifi complex saccharomyc cerevisia contain ino80 atpas ino80 complex contain 12 polypeptid includ two protein relat bacteri ruvb dna helicas catalys branch migrat holliday junction purifi complex remodel chromatin facilit transcript vitro display 3 5 dna helicas activ mutant ino80 show hypersensit agent caus dna damag addit defect transcript result indic chromatin remodel driven ino80 atpas may connect transcript well dna damag repair',\n",
       "  'develop oncogen state complex process involv accumul multipl independ mutat lead deregul cell signal pathway central control cell growth cell fate abil defin cancer subtyp recurr diseas respons specif therapi use dna microarray-bas gene express signatur demonstr multipl studi variou studi also demonstr potenti use gene express profil analysi oncogen pathway show gene express signatur identifi reflect activ statu sever oncogen pathway evalu sever larg collect human cancer gene express signatur identifi pattern pathway deregul tumour clinic relev associ diseas outcom combin signature-bas predict across sever pathway identifi coordin pattern pathway deregul distinguish specif cancer tumour subtyp cluster tumour base pathway signatur defin prognosi respect patient subset demonstr pattern oncogen pathway deregul underli develop oncogen phenotyp reflect biolog outcom specif cancer predict pathway deregul cancer cell line also shown predict sensit therapeut agent target compon pathway link pathway deregul sensit therapeut target compon pathway provid opportun make use oncogen pathway signatur guid use target therapeut',\n",
       "  'insulin-lik growth factor 2 igf2 h19 gene imprint result silenc matern patern allel respect event depend upon imprinted-control region two kilobas upstream h19 ref 1 2 patern chromosom element methyl requir silenc h19 ref 2-4 matern chromosom region unmethyl requir silenc igf2 gene 90 kilobas upstream propos unmethyl imprinted-control region act chromatin boundari block interact igf2 enhanc lie 3 h19 ref 5 6 enhancer-block activ would lost region methyl therebi allow express igf2 patern show use transgen mice tissu cultur unmethyl imprinted-control region mous human h19 exhibit enhancer-block activ furthermor show ctcf zinc finger protein implic vertebr boundari function bind sever site unmethyl imprinted-control region essenti enhanc block consist model ctcf bind abolish dna methyl first exampl knowledg regul chromatin boundari vertebr',\n",
       "  'character human monoclon antibodi provid consider insight mechan broad hiv-1 neutral report hiv-1 gp41 membrane-proxim extern region mper -specif antibodi name 10e8 neutral ∼98 test virus analysi sera 78 healthi hiv-1-infect donor demonstr 27 contain mper-specif antibodi 8 contain 10e8-lik specif contrast neutral mper antibodi 10e8 bind phospholipid autoreact bound cell-surfac envelop structur 10e8 complex complet mper reveal site vulner compris narrow stretch highli conserv gp41-hydrophob residu critic arginin lysin transmembran region analysi resist hiv-1 variant confirm import residu neutral highli conserv mper target potent non-self-react neutral antibodi suggest hiv-1 vaccin aim induc antibodi region hiv-1 envelop glycoprotein',\n",
       "  'emerg evid suggest pulmonari iron accumul implic spectrum chronic lung diseas howev mechan involv pulmonari iron deposit role vivo pathogenesi lung diseas remain unknown show point mutat murin ferroportin gene caus hereditari hemochromatosi type 4 slc40a1c326 increas iron level alveolar macrophag epitheli cell line conduct airway lung parenchyma vascular smooth muscl cell pulmonari iron overload associ oxid stress restrict lung diseas decreas total lung capac reduc blood oxygen satur homozyg slc40a1c326s/c326 mice compar wild-typ control find implic iron lung patholog far consid classic iron-rel disord',\n",
       "  'polyploidi increas set chromosom occur develop cellular stress diseas evolut despit preval littl known physiolog alter accompani polyploidi previous describ ‘ ploidy-specif lethal ’ gene delet lethal haploid diploid bud yeast caus lethal triploid tetraploid report genome-wid screen identifi ploidy-specif lethal function 39 3,740 mutat screen exhibit ploidy-specif lethal almost mutat affect genom stabil impair homolog recombin sister chromatid cohes mitot spindl function uncov defect wild-typ tetraploid predict screen identifi mechan tetraploid affect genom stabil show tetraploid high incid syntelic/monopolar kinetochor attach spindl pole suggest defect explain mismatch abil scale size spindl pole bodi spindl kinetochor thu geometr constraint may profound effect genom stabil phenomenon describ may relev varieti biolog context includ diseas state cancer',\n",
       "  'haematopoiet stem cell hsc subsequ progenitor produc blood cell precis natur kinet product contenti issu one model lymphoid myeloid product branch lymphoid-prim multipot progenitor lmpp branch subsequ produc dendrit cell howev model base mainli vitro clonal assay population-bas track vivo could miss vivo single-cel complex avoid issu use new quantit version ‘ cellular barcod ’ trace vivo fate hundr lmpp hsc single-cel level data demonstr lmpp highli heterogen cell type produc separ combin lymphoid- myeloid- dendritic-cell-bias produc convers although observ known lineag bia hsc cellular output deriv small number hsc gener cell type crucial vivo analysi output sibl cell deriv singl lmpp show often share similar fate suggest fate progenitor imprint furthermor imprint also observ dendritic-cell-bias lmpp dendrit cell may consid distinct lineag basi separ ancestri data suggest ‘ grade commit ’ model haematopoiesi herit divers lineag imprint occur earlier previous thought',\n",
       "  'epithelium provid protect barrier must maintain homeostat cell number match number divid cell number die cell although compensatori cell divis trigger die cell unknown cell death might reliev overcrowd due prolifer trigger apoptosi epithelia die cell extrud preserv function barrier extrus occur cell destin die signal surround epitheli cell contract actomyosin ring squeez die cell howev clear drive cell death normal homeostasi show human canin zebrafish cell overcrowd due prolifer migrat induc extrus live cell control epitheli cell number extrus live cell occur site highest crowd occur vivo induc experiment overcrowd monolay vitro like apoptot cell extrus live cell extrus result overcrowd also requir sphingosin 1-phosphat signal rho-kinase-depend myosin contract distinguish signal stretch-activ channel moreov disrupt stretch-activ channel piezo1 zebrafish prevent extrus lead format epitheli cell mass find reveal homeostat turnov growth divis epitheli cell confin substratum caus overcrowd lead extrus consequ death owe loss surviv factor result suggest live cell extrus could tumour-suppress mechan prevent accumul excess epitheli cell',\n",
       "  'activ cell interact t-cell receptor antigen peptid bound major histocompat complex mhc surfac antigen present cell apc crucial step adapt immun use three-dimension fluoresc microscopi visual individu peptide–i-ek class ii mhc complex label phycobiliprotein phycoerythrin effort character t-cell sensit requir form immunolog synaps singl cell show cell express cd4 antigen respond transient calcium signal even singl agonist peptide–mhc ligand organ molecul contact zone cell apc take characterist immunolog synaps ten agonist present sensit highli depend cd4 block molecul antibodi render cell unabl detect less 30 ligand',\n",
       "  'intestin cancer initi wnt-pathway-activ mutat gene adenomat polyposi coli apc cancer cell origin remain elus previous establish lgr5 leucine-rich-repeat contain g-protein-coupl receptor 5 knockin mous model tamoxifen-induc cre recombinas express long-liv intestin stem cell show delet apc stem cell lead transform within day transform stem cell remain locat crypt bottom fuell grow microadenoma microadenoma show unimped growth develop macroscop adenoma within 3-5week distribut lgr5+ cell within stem-cell-deriv adenoma indic stem cell/progenitor cell hierarchi maintain earli neoplast lesion apc delet short-liv transit-amplifi cell use differ cre mous growth induc microadenoma rapidli stall even 30week larg adenoma rare mice conclud stem-cell-specif loss apc result progress grow neoplasia',\n",
       "  \"advanc biofuel produc microorgan similar properti petroleum-bas fuel 'drop exist transport infrastructur howev produc biofuel yield high enough use requir engin microorgan 's metabol engin base one specif feedstock host organ data-driven synthetic-biolog approach use optim host pathway maxim fuel product despit success challeng still need met move advanc biofuel toward commerci compet convent fuel\",\n",
       "  'male infertil long-stand enigma signific medic concern integr sperm chromatin clinic indic male fertil vitro fertil potenti chromosom aneuploidi dna decondens damag correl reproduct failur identifi conserv protein import sperm chromatin structur packag reveal univers caus infertil combin proteom cytolog function analysi caenorhabd elegan identifi spermatogen chromatin-associ protein import fertil strategi employ multipl step purif chromatin compar meiotic cell type name undergo spermatogenesi oogenesi proteom analysi multidimension protein identif technolog mudpit factor co-purifi chromatin priorit sperm protein base abund subtract common protein elimin gener chromatin meiotic factor approach reduc 1,099 protein co-purifi spermatogen chromatin current extens catalogu 132 protein function analysi reduct gene function rna interfer coupl protein local studi reveal conserv spermatogenesis-specif protein vital dna compact chromosom segreg fertil unexpect role spermatogenesi also detect factor involv process strategi find fertil factor conserv c. elegan mammal achiev goal mous gene knockout correspond nematod protein 37 7/19 caus male steril list therefor provid signific opportun identifi caus male infertil target male contracept',\n",
       "  'nanog diverg homeodomain protein found mammalian pluripot cell develop germ cell delet nanog caus earli embryon lethal wherea constitut express enabl autonom self-renew embryon stem cell nanog accordingli consid core element pluripot transcript network howev report nanog fluctuat mous embryon stem cell transient downregul nanog appear predispos cell toward differenti mark commit genet delet show although prone differenti embryon stem cell self-renew indefinit perman absenc nanog expand nanog null cell colon embryon germ layer exhibit multilineag differenti fetal adult chimaera although also recruit germ line primordi germ cell lack nanog fail matur reach genit ridg defect rescu repair mutant allel thu nanog dispens express somat pluripot specif requir format germ cell nanog therefor act primarili construct inner cell mass germ cell state rather housekeep machineri pluripot surmis nanog stabil embryon stem cell cultur resist revers altern gene express state',\n",
       "  'macrophag activ gram-neg bacteri product lipopolysaccharid switch core metabol oxid phosphoryl glycolysi show inhibit glycolysi 2-deoxyglucos suppress lipopolysaccharide-induc interleukin-1β tumour-necrosi factor-α mous macrophag comprehens metabol map lipopolysaccharide-activ macrophag show upregul glycolyt downregul mitochondri gene correl directli express profil alter metabolit lipopolysaccharid strongli increas level tricarboxylic-acid cycl intermedi succin glutamine-depend anerplerosi princip sourc succin although ‘ gaba γ-aminobutyr acid shunt ’ pathway also role lipopolysaccharide-induc succin stabil hypoxia-induc factor-1α effect inhibit 2-deoxyglucos interleukin-1β import target lipopolysaccharid also increas succinyl sever protein therefor identifi succin metabolit innat immun signal enhanc interleukin-1β product inflamm',\n",
       "  'environment genet aberr lead neural tube closur defect ntd 1 everi 1,000 birth mous frog model birth defect indic van gogh-lik 2 vangl2 also known strabismu compon planar cell polar pcp signal might control neurul promot converg neural progenitor midlin show novel role pcp signal neurul zebrafish demonstr non-canon wnt/pcp signal polar neural progenitor along anteroposterior axi polar transient lost cell divis neural keel re-establish daughter cell reintegr neuroepithelium loss zebrafish vangl2 trilobit mutant abolish polar neural keel cell disrupt re-intercal daughter cell neuroepithelium result ectop neural progenitor accumul ntd remark block cell divis lead rescu trilobit neural tube morphogenesi despit persist defect converg extens result reveal function pcp signal coupl cell divis morphogenesi neurul indic previous unrecogn mechan might underli ntd',\n",
       "  'tuberculosi tb preval world today time human histori mycobacterium tuberculosi pathogen respons tb use divers strategi surviv varieti host lesion evad immun surveil key question robust approach discov new tb drug measur could taken reduc long protract clinic develop new drug emerg multi-drug-resist strain m. tuberculosi make discoveri new molecular scaffold prioriti current situat even necessit re-engin reposit old drug famili achiev effect control whatev strategi use success depend larg proper understand complex interact pathogen human host review discuss innov tb drug discoveri evolv strategi bring newer agent quickli patient',\n",
       "  \"sinc discov anti-hypertens agent ifenprodil neuroprotect activ effect nmda n-methyl-d-aspart receptor determin effort made understand mechan action develop improv therapeut compound basi knowledg neurotransmiss mediat nmda receptor essenti basic brain develop function receptor form heteromer ion channel becom activ concurr bind glycin glutam glun1 glun2 subunit respect function hallmark nmda receptor ion-channel activ alloster regul bind small compound amino-termin domain atd subtype-specif manner ifenprodil relat phenylethanolamin compound specif inhibit glun1 glun2b nmda receptor intens studi potenti use treatment variou neurolog disord diseas includ depress alzheim 's diseas parkinson 's diseas despit consider enthusiasm mechan underli recognit phenylethanolamin atd-medi alloster inhibit remain limit owe lack structur inform report glun1 glun2b atd form heterodim phenylethanolamin bind interfac glun1 glun2b rather within glun2b cleft crystal structur heterodim form glun1b atd xenopu laevi glun2b atd rattu norvegicu show highli distinct pattern subunit arrang differ arrang observ homodimer non-nmda receptor reveal molecular determin phenylethanolamin bind restrict domain movement bi-lob structur glun2b atd engin inter-subunit disulphid bond markedli decreas sensit ifenprodil indic conform freedom glun2b atd essenti ifenprodil-medi alloster inhibit nmda receptor find pave way improv design subtype-specif compound therapeut valu neurolog disord diseas\",\n",
       "  \"crohn 's diseas ulcer coliti two main type chronic inflammatori bowel diseas multifactori condit unknown aetiolog suscept locu crohn 's diseas map chromosom 16. use positional-clon strategi base linkag analysi follow linkag disequilibrium map identifi three independ associ crohn 's diseas frameshift variant two missens variant nod2 encod member apaf-1/ced-4 superfamili apoptosi regul express monocyt nod2 variant alter structur either leucine-rich repeat domain protein adjac region nod2 activ nuclear factor nf-kb activ function regul carboxy-termin leucine-rich repeat domain inhibitori role also act intracellular receptor compon microbi pathogen observ suggest nod2 gene product confer suscept crohn 's diseas alter recognit compon and/or over-activ nf-kb monocyt thu document molecular model pathogen mechan crohn 's diseas investig\",\n",
       "  'function heart compris distinct mesoderm-deriv lineag includ cardiomyocyt endotheli cell vascular smooth muscl cell studi mous embryo mous embryon stem cell differenti model provid evid indic three lineag develop common flk-1+ kinas insert domain protein receptor also known kdr cardiovascular progenitor repres one earliest stage mesoderm specif cardiovascular lineag determin whether compar progenitor present human cardiogenesi analys develop cardiovascular lineag human embryon stem cell differenti cultur show induct combin activin bone morphogenet protein 4 bmp4 basic fibroblast growth factor bfgf also known fgf2 vascular endotheli growth factor vegf also known vegfa dickkopf homolog 1 dkk1 serum-fre media human embryonic-stem-cell-deriv embryoid bodi gener kdrlow/c-kit cd117 neg popul display cardiac endotheli vascular smooth muscl potenti vitro transplant vivo plate monolay cultur kdrlow/c-kitneg cell differenti gener popul consist greater 50 contract cardiomyocyt popul deriv kdrlow/c-kitneg fraction give rise coloni contain three lineag plate methylcellulos cultur result limit dilut studi cell-mix experi support interpret coloni clone indic develop cardiovascular colony-form cell togeth find identifi human cardiovascular progenitor defin one earliest stage human cardiac develop',\n",
       "  \"mediat cellular effector inflamm import constitu local environ tumour type cancer inflammatori condit present malign chang occur convers type cancer oncogen chang induc inflammatori microenviron promot develop tumour regardless origin 'smoulder inflamm tumour microenviron mani tumour-promot effect aid prolifer surviv malign cell promot angiogenesi metastasi subvert adapt immun respons alter respons hormon chemotherapeut agent molecular pathway cancer-rel inflamm unravel result identif new target molecul could lead improv diagnosi treatment\",\n",
       "  'escrt endosom sort complex requir transport pathway requir termin membran fission event sever import biolog process includ endosom intralumin vesicl format hiv bud cytokinesi vps4 atpas perform key function pathway recogn membrane-associ escrt-iii assembl catalys disassembl possibl conjunct membran fission show microtubul interact transport mit domain human vps4a vps4b bind conserv sequenc motif locat carboxi termini chmp1–3 class escrt-iii protein structur vps4a mit–chmp1a vps4b mit–chmp2b complex reveal c-termin chmp motif form amphipath helix bind groov last two helic tetratricopeptide-lik repeat tpr vps4 mit domain opposit orient canon tpr interact distinct pocket mit domain bind three conserv leucin residu chmp motif mutat inhibit interact block vps4 recruit impair endosom protein sort reliev dominant-neg vps4 inhibit hiv bud thu studi reveal vps4 atpas recogn chmp substrat facilit membran fission event requir releas virus endosom vesicl daughter cell',\n",
       "  'saccharomyc cerevisia pif1 helicas prototyp member pif1 dna helicas famili conserv bacteria human show except potent g-quadruplex unwind conserv among pif1 helicas moreov pif1 helicas organ separ 3 billion year evolut suppress dna damag g-quadruplex motif yeast g-quadruplex-induc damag gener absenc pif1 helicas led new genet epigenet chang furthermor express yeast human pif1 suppress g-quadruplex-associ dna damag telomer lengthen',\n",
       "  'metastasi multistep process respons cancer death influenc immedi microenviron cell–cel cell–matrix interact extend tumour microenviron exampl vascular hypoxia low oxygen clinic associ metastasi poor patient outcom although underli process remain unclear microarray studi shown express lysyl oxidas lox elev hypox human tumour cell paradox lox express associ tumour suppress tumour progress role tumorigenesi seem depend cellular locat cell type transform statu show lox express regul hypoxia-induc factor hif associ hypoxia human breast head neck tumour patient high lox-express tumour poor distant metastasis-fre overal surviv inhibit lox elimin metastasi mice orthotop grown breast cancer tumour mechanist secret lox respons invas properti hypox human cancer cell focal adhes kinas activ cell matrix adhes furthermor lox may requir creat nich permiss metastat growth find indic lox essenti hypoxia-induc metastasi good therapeut target prevent treat metastas',\n",
       "  \"cancer stem cell csc hypothesi suggest neoplast clone maintain exclus rare fraction cell stem cell properti although exist csc human leukaemia establish littl evid exist csc solid tumour except breast cancer recent prospect isol cd133+ cell subpopul human brain tumour exhibit stem cell properti vitro howev true measur csc capac self renew exact recapitul origin tumour report develop xenograft assay identifi human brain tumour initi cell initi tumour vivo cd133+ brain tumour fraction contain cell capabl tumour initi nod-scid non-obes diabet sever combin immunodefici mous brain inject 100 cd133+ cell produc tumour could serial transplant phenocopi patient 's origin tumour wherea inject 105 cd133- cell engraft caus tumour thu identif brain tumour initi cell provid insight human brain tumour pathogenesi give strong support csc hypothesi basi mani solid tumour establish previous unidentifi cellular target effect cancer therapi\",\n",
       "  \"world health organ conven expert committe reevalu use anthropometri differ age assess health nutrit social wellb committe 's task includ identifi refer data anthropometr index appropri provid guidelin data use fetal growth committe recommend exist sex-specif multiraci refer view signific technic drawback current nation center health statist nch /who refer inadequaci assess growth breast-f infant committe recommend develop new refer concern weight length/height infant children complex costli undertak proper interpret midupp arm circumfer preschool requir age-specif refer data evalu adolesc height-for-ag committe recommend current nchs/who refer use nch bodi mass index bmi data upper percentil elev skew undesir set health goal howev data provision recommend defin obes base combin elev bmi high subcutan fat nch valu provision recommend refer data subscapular tricep skinfold thick guidelin also provid adjust adolesc anthropometr comparison matur statu current need adult refer data bmi interpret base pragmat bmi cutoff final committe note norm anthropometr data exist elderli especi 80 age proper definit health statu function biolog age remain develop group\",\n",
       "  \"background age-associ epigenet chang implic age notabl age-associ dna methyl chang compris so-cal age `` clock '' robust biomark age howev genet dietari drug intervent extend lifespan impact epigenom uncharacteris fill knowledg gap defin age-associ dna methyl chang whole-genom single-nucleotid level mous liver test impact longevity-promot intervent specif ame dwarf prop1 df/df mutat calori restrict rapamycin result wild-typ mice fed unsuppl ad libitum diet age-associ hypomethyl enrich super-enhanc highli express gene critic liver function gene harbour hypomethyl enhanc enrich gene chang express age hypermethyl enrich cpg island mark bival activ repress histon modif resembl hypermethyl liver cancer age-associ methyl chang suppress ame dwarf calori restrict mice select less specif rapamycin treat mice conclus age-associ hypo- hypermethyl event occur distinct regulatori featur genom distinct longevity-promot intervent specif genet dietari drug intervent suppress age-associ methyl chang consist idea intervent exert benefici effect part modul epigenom studi foundat understand epigenet contribut healthi age longev molecular basi dna methyl clock\",\n",
       "  'extracellular vesicl ev cell-deriv membran vesicl repres endogen mechan intercellular commun sinc discoveri ev capabl function transfer biolog inform potenti use ev drug deliveri vehicl gain consider scientif interest ev may multipl advantag current avail drug deliveri vehicl abil overcom natur barrier intrins cell target properti stabil circul howev therapeut applic ev drug deliveri system limit due lack method scalabl ev isol effici drug load furthermor order achiev target drug deliveri intrins cell target properti tune ev engin review discuss recent progress remain challeng develop ev drug deliveri vehicl',\n",
       "  'background soy protein compon may protect atherosclerot cardiovascular diseas cvd risk factor total homocystein thci c-reactiv protein crp excess bodi iron gener increas menopaus object primari object studi determin independ effect soy protein compon isoflavon phytat cvd risk factor postmenopaus women secondari object identifi factor blood lipid oxid stress index serum ferritin plasma folat plasma vitamin b-12 bodi mass index bmi contribut thci crp concentr design double-blind 6-wk studi 55 postmenopaus women age 47-72 randomli assign 1 4 soy protein 40 g/d isol treatment nativ phytat nativ isoflavon n 14 nativ phytat low isoflavon n 13 low phytat nativ isoflavon n 14 low phytat low isoflavon n 14 measur iron index thci crp bmi result soy protein nativ phytat significantli reduc thci p 0.017 transferrin satur p 0.027 ferritin p 0.029 wherea soy protein nativ isoflavon effect variabl baselin bmi highli correl thci r 0.39 p 0.003 crp r 0.55 p 0.0001 wherea hdl cholesterol correl crp r -0.30 p 0.02 multipl regress analysi show ldl cholesterol bmi contribut significantli r2= 19.9 p 0.003 overal varianc thci conclus consum phytate-rich food maintain healthi weight may reduc atherosclerot cvd risk factor postmenopaus women',\n",
       "  'cell defici brca1 brca2 gene reduc capac repair dna double-strand break homolog recombin consequ hypersensit dna-damag agent includ cisplatin poli adp-ribos polymeras parp inhibitor show loss mll3/4 complex protein ptip protect brca1/2-defici cell dna damag rescu lethal brca2-defici embryon stem cell howev ptip defici restor homolog recombin activ double-strand break instead absenc inhibit recruit mre11 nucleas stall replic fork turn protect nascent dna strand extens degrad gener acquisit parp inhibitor cisplatin resist associ replic fork protect brca2-defici tumour cell develop brca2 revers mutat disrupt multipl protein includ parp1 chd4 lead end point replic fork protect highlight complex tumour cell evad chemotherapeut intervent acquir drug resist',\n",
       "  'object aim studi determin prognost valu plasma corin patient chronic heart failur chf background recent year accumul evid indic corin play critic role regul blood pressur cardiac function method enrol 1,148 consecut chf patient prospect cohort studi explor associ plasma corin level clinic prognosi use multivari cox regress analysi result patient low corin level 458 pg/ml like women hypertens low corin found associ increas new york heart associ nyha function class n-termin pro-b-typ natriuret peptid nt-probnp level decreas left ventricular eject fraction lvef estim glomerular filtrat rate egfr multivari cox regress analysi suggest log corin independ predictor major advers cardiac event mace hazard ratio 0.62 95 confid interv 0.39 0.95 togeth age diabet nyha function class lvef egfr log nt-probnp addit log corin also signific predictor cardiovascular death p 0.041 heart failur rehospit p 0.015 adjust clinic variabl establish biomark advers prognosi kaplan-mei surviv curv show low corin signific predictor mace patient nt-probnp level median conclus studi demonstr plasma corin valuabl prognost marker mace patient chf independ establish convent risk factor',\n",
       "  \"alzheim 's diseas common neurodegen diseas mechanism-bas therapi diseas defin presenc abund neurofibrillari lesion neurit plaqu cerebr cortex neurofibrillari lesion compris pair helic straight tau filament wherea tau filament differ morpholog character neurodegen diseas high-resolut structur tau filament avail present cryo-electron microscopi cryo-em map 3.4-3.5 å resolut correspond atom model pair helic straight filament brain individu alzheim 's diseas filament core made two ident protofila compris residu 306-378 tau protein adopt combin cross-β/β-helix structur defin seed tau aggreg pair helic straight filament differ inter-protofila pack show ultrastructur polymorph find demonstr cryo-em allow atom character amyloid filament patient-deriv materi pave way investig rang neurodegen diseas\",\n",
       "  'contus spinal cord injuri lead varieti disabl owe limit neuron regener function plastic well establish upregul glial-deriv chondroitin sulphat proteoglycan cspg within glial scar perineuron net creat barrier axon regrowth sprout protein tyrosin phosphatas σ ptpσ along sister phosphatas leukocyt common antigen-rel lar nogo receptor 1 3 ngr recent identifi receptor inhibitori glycosyl side chain cspg find rat ptpσ critic role convert growth cone dystroph state tightli stabil within cspg-rich substrat gener membrane-perm peptid mimet ptpσ wedg domain bind ptpσ reliev cspg-mediat inhibit system deliveri peptid week restor substanti serotonerg innerv spinal cord level injuri facilit function recoveri locomotor urinari system result add new layer understand critic role ptpσ mediat growth-inhibit state neuron due cspg within injur adult spinal cord',\n",
       "  'inflamm promot regener injur tissu poorli understood mechan involv interleukin il -6 famili member express elev mani diseas includ inflammatori bowel diseas colorect cancer show mice human cell gp130 co-receptor il-6 cytokin trigger activ yap notch transcript regul control tissu growth regener independ gp130 effector stat3 yap notch intestin gp130 signal stimul epitheli cell prolifer caus aberr differenti confer resist mucos eros gp130 associ relat tyrosin kinas src ye activ receptor engag phosphoryl yap induc stabil nuclear transloc signal modul strongli activ upon mucos injuri promot heal maintain barrier function',\n",
       "  'concentr hemoglobin black found 0.5 1.0 g/dl lower income-match white sever larg survey differ could racial characterist black might due higher frequenc genet trait thalassemia minor hemoglobinopathi environment factor iron defici help make distinct analyz data multiphas examin 1973 1975 1718 white 741 black 315 orient healthi nonindig children 5 14 year age entir popul median hemoglobin concentr averag 0.5 g/dl lower black white sex test p less 0.001 differ still averag 0.5 g/dl p less 0.001 exclus abnorm hemoglobin electrophoresi hgb c whose mean corpuscular volum 5 normal mean age exclud iron defici thalassemia minor data strengthen impress black normal concentr hemoglobin averag 0.5 g/dl less white case 10 normal black mistakenli design anem norm appli',\n",
       "  'pluripot defin abil cell differenti deriv three embryon germ layer ectoderm mesoderm endoderm pluripot cell captur via archetyp deriv embryon stem cell via somat cell reprogram somat cell induc acquir pluripot stem cell ipsc state forc express key transcript factor mous cell fulfil strictest development assay pluripot cell gener complet ipsc-deriv embryo mice howev known whether addit class pluripot cell spectrum reprogram phenotyp encompass explor altern outcom somat reprogram fulli character reprogram cell independ preconceiv definit ipsc state demonstr maintain elev reprogram factor express level mous embryon fibroblast go uniqu epigenet modif arriv stabl nanog-posit altern pluripot state prove pluripot spectrum encompass multipl uniqu cell state',\n",
       "  'macroautophagi hereaft refer autophagi catabol membran traffick process degrad varieti cellular constitu associ human diseas although extens studi focus autophag turnov cytoplasm materi littl known role autophagi degrad nuclear compon report autophagi machineri mediat degrad nuclear lamina compon mammal autophagi protein lc3/atg8 involv autophagi membran traffick substrat deliveri present nucleu directli interact nuclear lamina protein lamin b1 bind lamin-associ domain chromatin lc3-lamin b1 interact downregul lamin b1 starvat mediat degrad upon oncogen insult activ ra lamin b1 degrad achiev nucleus-to-cytoplasm transport deliv lamin b1 lysosom inhibit autophagi lc3-lamin b1 interact prevent activ ras-induc lamin b1 loss attenu oncogene-induc senesc primari human cell studi suggest new function autophagi act guard mechan protect cell tumorigenesi',\n",
       "  'advanc understand mechan bring resolut acut inflamm uncov new genu pro-resolv lipid mediat includ lipoxin resolvin protectin maresin famili collect call special pro-resolv mediat synthet version mediat potent bioaction administ vivo anim experi mediat evok anti-inflammatori novel pro-resolv mechan enhanc microbi clearanc although identifi inflamm resolut special pro-resolv mediat conserv structur also function host defenc pain organ protect tissu remodel review cover mechan special pro-resolv mediat omega-3 essenti fatti acid pathway could help us understand physiolog function',\n",
       "  'recognit modifi histon ‘ reader ’ protein play critic role regul chromatin h3k36 trimethyl h3k36me3 deposit onto nucleosom transcrib region rna polymeras ii elong yeast mark turn recruit epigenet regul reset chromatin rel repress state thu suppress cryptic transcript howev much less known role h3k36me3 transcript regul mammal complic transcription-coupl incorpor histon variant h3.3 gene bodi show candid tumour suppressor zmynd11 specif recogn h3k36me3 h3.3 h3.3k36me3 regul rna polymeras ii elong structur studi show addit trimethyl-lysin bind aromat cage within pwwp domain h3.3-depend recognit mediat encapsul h3.3-specif ‘ ser 31 ’ residu composit pocket form tandem bromo–pwwp domain zmynd11 chromatin immunoprecipit follow sequenc show genome-wid co-loc zmynd11 h3k36me3 h3.3 gene bodi occup requir pre-deposit h3.3k36me3 although zmynd11 associ highli express gene function unconvent transcript co-repressor modul rna polymeras ii elong stage zmynd11 critic repress transcript program essenti tumour cell growth low express level zmynd11 breast cancer patient correl wors prognosi consist overexpress zmynd11 suppress cancer cell growth vitro tumour format mice togeth studi identifi zmynd11 h3.3-specif reader h3k36me3 link histone-variant-medi transcript elong control tumour suppress',\n",
       "  'brain-deriv neurotroph factor bdnf receptor trkb crucial mani form neuron plastic includ structur long-term potenti sltp correl anim ’ learn howev unknown whether bdnf releas trkb activ occur sltp use fluoresc reson energi transfer-bas sensor trkb two-photon fluoresc lifetim imag microscopi monitor trkb activ singl dendrit spine ca1 pyramid neuron cultur murin hippocamp slice respons sltp induct find fast onset 1 min sustain 20 min activ trkb stimul spine depend nmdar n-methyl-d-aspart receptor camkii signal postsynapt synthes bdnf confirm presenc postsynapt bdnf use electron microscopi local endogen bdnf dendrit spine hippocamp ca1 pyramid neuron consist find also show rapid glutamate-uncaging-evok time-lock bdnf releas singl dendrit spine use bdnf fuse supereclipt phluorin demonstr postsynapt bdnf–trkb signal pathway necessari structur function ltp togeth find reveal spine-autonom autocrin signal mechan involv nmdar–camkii-depend bdnf releas stimul dendrit spine subsequ trkb activ spine crucial structur function plastic',\n",
       "  'pancreat cancer remain one lethal malign major health burden perform whole-genom sequenc copi number variat cnv analysi 100 pancreat ductal adenocarcinoma pdac chromosom rearrang lead gene disrupt preval affect gene known import pancreat cancer tp53 smad4 cdkn2a arid1a robo2 new candid driver pancreat carcinogenesi kdm6a prex2 pattern structur variat variat chromosom structur classifi pdac 4 subtyp potenti clinic util subtyp term stabl local rearrang scatter unstabl signific proport harbour focal amplif mani contain druggabl oncogen erbb2 met fgfr1 cdk6 pik3r3 pik3ca low individu patient preval genom instabl co-segreg inactiv dna mainten gene brca1 brca2 palb2 mutat signatur dna damag repair defici 8 patient receiv platinum therapi 4 5 individu measur defect dna mainten respond',\n",
       "  'transfer somat cell nuclei oocyt give rise pluripot stem cell consist equival embryon stem cell hold promis autolog cell replac therapi although method induc pluripot stem cell somat cell transcript factor wide use basic research numer differ induc pluripot stem cell embryon stem cell report potenti affect clinic use therapeut potenti diploid embryon stem-cel line deriv adult cell diseas human subject systemat investig paramet affect effici blastocyst develop stem-cel deriv show improv oocyt activ protocol includ use kinas translat inhibitor cell cultur presenc histon deacetylas inhibitor promot develop blastocyst stage development effici vari oocyt donor invers relat number day hormon stimul requir oocyt matur wherea daili dose gonadotropin total number metaphas ii oocyt retriev affect development outcom use concentr sendai viru cell fusion induc increas intracellular calcium concentr caus prematur oocyt activ use dilut sendai viru calcium-fre medium use modifi nuclear transfer protocol deriv diploid pluripot stem-cel line somat cell newborn first time adult femal type 1 diabet',\n",
       "  'alzheim ’ diseas common form dementia character two patholog hallmark amyloid-β plaqu neurofibrillari tangl amyloid hypothesi alzheim ’ diseas posit excess accumul amyloid-β peptid lead neurofibrillari tangl compos aggreg hyperphosphoryl tau howev date singl diseas model serial link two patholog event use human neuron cell mous model famili alzheim ’ diseas fad mutat exhibit amyloid-β-induc synapt memori deficit fulli recapitul key patholog event alzheim ’ diseas includ distinct neurofibrillari tangl patholog human neuron deriv alzheim ’ diseas patient shown elev level toxic amyloid-β speci phosphoryl tau demonstr amyloid-β plaqu neurofibrillari tangl report fad mutat β-amyloid precursor protein presenilin 1 abl induc robust extracellular deposit amyloid-β includ amyloid-β plaqu human neural stem-cell-deriv three-dimension 3d cultur system importantli 3d-differenti neuron cell express fad mutat exhibit high level detergent-resist silver-posit aggreg phosphoryl tau soma neurit well filament tau detect immunoelectron microscopi inhibit amyloid-β gener β- γ-secretas inhibitor decreas amyloid-β patholog also attenu tauopathi also found glycogen synthas kinas 3 gsk3 regul amyloid-β-medi tau phosphoryl success recapitul amyloid-β tau patholog singl 3d human neural cell cultur system uniqu strategi recapitul alzheim ’ diseas patholog 3d neural cell cultur model also serv facilit develop precis human neural cell model neurodegen disord',\n",
       "  'endotheli cell contribut subset cardiac fibroblast undergo endothelial-to-mesenchym transit whether cardiac fibroblast adopt endotheli cell fate directli contribut neovascular cardiac injuri known use genet fate map techniqu demonstr cardiac fibroblast rapidli adopt endothelial-cell-lik phenotyp acut ischaem cardiac injuri fibroblast-deriv endotheli cell exhibit anatom function characterist nativ endotheli cell show transcript factor p53 regul switch cardiac fibroblast fate loss p53 cardiac fibroblast sever decreas format fibroblast-deriv endotheli cell reduc post-infarct vascular densiti worsen cardiac function convers stimul p53 pathway cardiac fibroblast augment mesenchymal-to-endotheli transit enhanc vascular improv cardiac function observ demonstr mesenchymal-to-endotheli transit contribut neovascular injur heart repres potenti therapeut target enhanc cardiac repair',\n",
       "  'recent evid suggest vitamin intak current recommend may associ better health outcom howev optim serum concentr 25-hydroxyvitamin 25 oh defin review summar evid studi evalu threshold serum 25 oh concentr relat bone miner densiti bmd lower-extrem function dental health risk fall fractur colorect cancer endpoint advantag serum concentr 25 oh begin 75 nmol/l 30 ng/ml best 90 100 nmol/l 36-40 ng/ml person concentr could reach current recommend intak 200 600 iu vitamin d/d younger older adult respect comparison vitamin intak achiev serum concentr 25 oh purpos estim optim intak led us suggest bone health younger adult studi outcom older adult increas current recommend intak vitamin warrant intak adult =1000 iu 25 microg dosag error correct vitamin cholecalciferol /d need bring vitamin concentr less 50 popul 75 nmol/l implic higher dose entir adult popul address futur studi',\n",
       "  \"eukaryot genom fold three-dimension structur self-associ topolog domain border enrich cohesin ccctc-bind factor ctcf requir long-rang interact local chromatin interact govern higher-ord fold chromatin fibr function cohesin process remain poorli understood perform genome-wid chromatin conform captur hi-c analysi explor high-resolut organ schizosaccharomyc pomb genom despit small size exhibit fundament featur found eukaryot analys wild-typ mutant strain reveal key element chromosom architectur genom organ chromosom arm small region chromatin local interact form 'globul featur requir function cohesin distinct role sister chromatid cohes cohesin enrich globul boundari loss caus disrupt local globul structur global chromosom territori contrast heterochromatin load cohesin specif site includ pericentromer subtelomer domain dispens globul format nevertheless affect genom organ show heterochromatin mediat chromatin fibr compact centromer promot promin inter-arm interact within centromere-proxim region provid structur constraint crucial proper genom organ loss heterochromatin relax constraint chromosom caus increas intra- inter-chromosom interact togeth analys uncov fundament genom fold principl drive higher-ord chromosom organ crucial coordin nuclear function\",\n",
       "  'fear memori allow anim avoid danger therebi increas chanc surviv fear memori retriev long learn littl known retriev circuit chang time show dorsal midlin thalamu rat requir retriev auditori condit fear late 24 hour 7 day 28 day earli 0.5 hour 6 hour time point learn consist paraventricular nucleu thalamu pvt subregion dorsal midlin thalamu show increas c-fo express late time point indic pvt gradual recruit fear retriev accordingli condit tone respons pvt neuron increas time train prelimb pl prefront cortex necessari fear retriev send dens project pvt retriev late time point activ pl neuron project pvt optogenet silenc project impair retriev late earli time point contrast silenc pl input basolater amygdala impair retriev earli late time point indic time-depend shift retriev circuit retriev late time point also activ pvt neuron project central nucleu amygdala silenc project late earli time point induc persist attenu fear thu pvt may act crucial thalam node recruit cortico-amygdalar network retriev mainten long-term fear memori',\n",
       "  'mous embryon stem es cell isol inner cell mass blastocyst preserv vitro naiv inner-cell-mass-lik configur provid exogen stimul leukaemia inhibitori factor lif small molecul inhibit erk1/erk2 gsk3β signal term 2i/lif condit hallmark naiv pluripot includ drive oct4 also known pou5f1 transcript distal enhanc retain pre-inactiv x chromosom state global reduct dna methyl h3k27me3 repress chromatin mark deposit development regulatori gene promot upon withdraw 2i/lif naiv mous es cell drift toward prime pluripot state resembl post-implant epiblast although human es cell share sever molecular featur naiv mous es cell also share varieti epigenet properti prime murin epiblast stem cell episc includ predomin use proxim enhanc element maintain oct4 express pronounc tendenc x chromosom inactiv femal human es cell increas dna methyl promin deposit h3k27me3 bival domain acquisit lineag regulatori gene feasibl establish human ground state naiv pluripot vitro equival molecular function featur character mous es cell remain defin establish defin condit facilit deriv genet unmodifi human naiv pluripot stem cell alreadi establish prime human es cell somat cell induc pluripot stem ip cell reprogram directli blastocyst novel naiv pluripot cell valid herein retain molecular characterist function properti highli similar mous naiv es cell distinct convent prime human pluripot cell includ compet gener cross-speci chimaer mous embryo underw organogenesi follow microinject human naiv ip cell mous morula collect find establish new avenu regen medicin patient-specif ip cell diseas model studi earli human develop vitro vivo',\n",
       "  'human tumour typic harbour remark number somat mutat present major histocompat complex class molecul mhci peptid contain mutat could potenti immunogen recogn ‘ non-self ’ neo-antigen adapt immun system recent work confirm mutant peptid serv t-cell epitop howev mutant epitop describ discoveri requir labori screen patient tumour-infiltr lymphocyt abil recogn antigen librari construct follow tumour exom sequenc sought simplifi discoveri immunogen mutant peptid character gener properti develop approach combin whole-exom transcriptom sequenc analysi mass spectrometri identifi neo-epitop two wide use murin tumour model 1,300 amino acid chang identifi ∼13 predict bind mhci small fraction confirm mass spectrometri peptid structur model bound mhci mutat solvent-expos therefor access t-cell antigen receptor predict immunogen vaccin mice confirm approach predict immunogen peptid yield therapeut activ t-cell respons predict also enabl gener peptide–mhci dextram could use monitor kinet distribut anti-tumour t-cell respons vaccin find indic suitabl predict algorithm may provid approach pharmacodynam monitor t-cell respons well develop person vaccin cancer patient',\n",
       "  'rna-guid endonucleas cas9 emerg versatil genome-edit platform howev size commonli use cas9 streptococcu pyogen spcas9 limit util basic research therapeut applic use highli versatil adeno-associ viru aav deliveri vehicl character six smaller cas9 orthologu show cas9 staphylococcu aureu sacas9 edit genom effici similar spcas9 1 kilobas shorter packag sacas9 singl guid rna express cassett singl aav vector target cholesterol regulatori gene pcsk9 mous liver within one week inject observ 40 gene modif accompani signific reduct serum pcsk9 total cholesterol level assess genome-wid target specif sacas9 spcas9 use bless demonstr sacas9-medi vivo genom edit potenti effici specif',\n",
       "  'background littl known intens exercis influenc cardiovascular fit bodi composit especi obes adolesc object goal determin effect physic train intens cardiovascular fit percentag bodi fat bf viscer adipos tissu vat obes adolesc design obes 13-16-y-old n 80 assign 1 biweekli lifestyl educ lse 2 lse moderate-intens physic train 3 lse high-intens physic train intervent last 8 mo physic train offer 5 d/wk target energi expenditur subject physic train group 1047 kj 250 kcal /session cardiovascular fit measur multistag treadmil test bf dual-energi x-ray absorptiometri vat magnet reson imag result increas cardiovascular fit high-intens physic train group moderate-intens group significantli greater lse alon group p 0.009 comparison 3 group signific compar lse alon group group compos subject physic train group combin attend train session or=2 d/wk show favor chang cardiovascular fit p 0.001 bf p 0.001 vat p 0.029 found evid high-intens physic train effect moderate-intens physic train enhanc bodi composit conclus cardiovascular fit obes adolesc significantli improv physic train especi high-intens physic train physic train also reduc viscer total-bodi adipos clear effect intens physic train',\n",
       "  'dietari energi restrict wide use mean experiment extend mammalian life span report lifelong reduct concentr singl dietari compon essenti amino acid l-methionin 0.86 0.17 diet result 30 longer life span male fischer 344 rat methionin restrict complet abolish growth although food intak actual greater bodi weight basi studi energi consumpt earli life indic energi intak 0.17 methionine-f anim near normal anim size although consumpt per anim much larger 0.86 methionine-f rat increas energi intak rat fed 0.17 methionin fail increas rate growth wherea restrict 0.85 methionine-f rat food intak 0.17 methionine-f anim materi reduc growth indic food restrict factor life span extens experi biochem well-defin pathway methionin metabol util offer potenti uncov precis mechan underli specif dietari restriction-rel extens life span',\n",
       "  'perform function genom analysi studi effect epicatechin polyphenol cocoa extract human colon adenocarcinoma cell line caco-2 specif human hematology/immunolog cdna array clontech contain 406 gene duplic use differenti express gene classifi accord level express calcul ratio valu obtain treatment rel control cell statist signific p 0.05 upregul ratio 1.5 downregul ratio 0.6 treatment epicatechin decreas express 21 gene upregul 24 gene upon incub cocoa polyphenol extract 24 gene underexpress 28 overexpress chang express ferritin heavi polypeptid 1 fth1 mitogen-activ protein kinas kinas 1 mapkk1 signal transduc activ transcript 1 stat1 topoisomeras 1 upon incub epicatechin myeloid leukemia factor 2 mlf2 ccaat/enhanc bind protein gamma c/ebpg mapkk1 atp-bind cassett subfamili c member 1 mrp1 stat1 topoisomeras 1 x-ray repair complement defect repair 1 xrcc1 upon incub cocoa polyphenol extract valid rt-pcr chang messeng rna level mapkk1 stat1 mrp1 topoisomeras 1 upon incub either epicatechin cocoa extract confirm protein level western blot chang express stat1 mapkk1 mrp1 fth1 gene involv cellular respons oxid stress agreement antioxid properti cocoa flavonoid addit chang express c/ebpg topoisomeras 1 mlf2 xrcc1 suggest novel mechan action flavonoid molecular level',\n",
       "  'enhanc control correct tempor cell-type-specif activ gene express multicellular eukaryot know properti regulatori activ target crucial understand regul differenti homeostasi use fantom5 panel sampl cover major human tissu cell type produc atla activ vivo-transcrib enhanc show enhanc share properti cpg-poor messeng rna promot produc bidirect exosome-sensit rel short unsplic rna gener strongli relat enhanc activ atla use compar regulatori program differ cell unpreced depth identifi disease-associ regulatori singl nucleotid polymorph classifi cell-type-specif ubiquit enhanc explor util enhanc redund explain gene express strength rather express pattern onlin fantom5 enhanc atla repres uniqu resourc studi cell-type-specif enhanc gene regul',\n",
       "  'gastrointestin tract mammal colon hundr microbi speci contribut health includ colon resist intestin pathogen mani antibiot destroy intestin microbi commun increas suscept intestin pathogen among clostridium difficil major caus antibiotic-induc diarrhoea greatli increas morbid mortal hospit patient intestin bacteria provid resist c. difficil infect vivo inhibitori mechan remain unclear correl loss specif bacteri taxa develop infect treat mice differ antibiot result distinct microbiota chang lead vari suscept c. difficil mathemat model augment analys microbiota hospit patient identifi resistance-associ bacteria common mice human use platform determin clostridium scinden bile acid 7α-dehydroxyl intestin bacterium associ resist c. difficil infect upon administr enhanc resist infect secondari bile acid depend fashion use workflow involv mous model clinic studi metagenom analys mathemat model identifi probiot candid correct clinic relev microbiom defici find implic ration design target antimicrobi well microbiome-bas diagnost therapeut individu risk c. difficil infect',\n",
       "  'transcript eukaryot protein-cod gene begin assembl rna polymeras pol ii initi complex promot dna open report cryo-electron microscopi cryo-em structur yeast initi complex contain close open dna resolut 8.8 å 3.6 å respect dna posit retain pol ii cleft network interact tata-box-bind protein tbp transcript factor tfiia tfiib tfiie tfiif dna open occur around tip pol ii clamp tfiie ‘ extend wing helix ’ domain occur absenc tfiih load dna templat strand activ centr may facilit movement obstruct protein element trigger alloster bind tfiie ‘ e-ribbon ’ domain result suggest unifi model transcript initi key event trap open promot dna extend protein–protein protein–dna contact',\n",
       "  'poor prognosi neuroblastoma associ genet amplif mycn mycn target let-7 tumour suppressor famili microrna implic numer cancer lin28b inhibitor let-7 biogenesi overexpress neuroblastoma report regul mycn show howev lin28b dispens mycn-amplifi neuroblastoma cell line despit de-repress let-7 demonstr mycn messeng rna level amplifi diseas except high suffici spong let-7 reconcil dispens lin28b found genet loss let-7 common neuroblastoma invers associ mycn amplif independ associ poor outcom provid rational chromosom loss pattern neuroblastoma propos let-7 disrupt lin28b mycn spong genet loss unifi mechan neuroblastoma develop broad implic cancer pathogenesi',\n",
       "  'immun checkpoint inhibitor result impress clinic respons optim result requir combin therapi rais fundament question mechan non-redund resist report major tumour regress subset patient metastat melanoma treat anti-ctla4 antibodi anti-ctla4 radiat reproduc effect mous model although combin treatment improv respons irradi unirradi tumour resist common unbias analys mice reveal resist due upregul pd-l1 melanoma cell associ t-cell exhaust accordingli optim respons melanoma cancer type requir radiat anti-ctla4 anti-pd-l1/pd-1 anti-ctla4 predominantli inhibit t-regulatori cell treg cell therebi increas cd8 t-cell treg cd8/treg ratio radiat enhanc divers t-cell receptor tcr repertoir intratumor cell togeth anti-ctla4 promot expans cell radiat shape tcr repertoir expand peripher clone addit pd-l1 blockad revers t-cell exhaust mitig depress cd8/treg ratio encourag oligoclon t-cell expans similarli result mice patient clinic trial melanoma show high pd-l1 respond radiat plu anti-ctla4 demonstr persist t-cell exhaust rapidli progress thu pd-l1 melanoma cell allow tumour escap anti-ctla4-bas therapi combin radiat anti-ctla4 anti-pd-l1 promot respons immun distinct mechan',\n",
       "  'regul releas anorexigen α-melanocyt stimul hormon α-msh orexigen agouti-rel protein agrp discret hypothalam arcuat neuron onto common target site central nervou system fundament role regul energi homeostasi peptid bind high affin melanocortin-4 receptor mc4r exist data show α-msh agonist coupl receptor gα signal pathway agrp bind competit block α-msh bind block constitut activ mediat ligand-mimet amino-termin domain receptor show mice regul fire activ neuron paraventricular nucleu hypothalamu pvn α-msh agrp mediat independ gα signal ligand-induc coupl mc4r closur inwardli rectifi potassium channel kir7.1 furthermor agrp bias agonist hyperpolar neuron bind mc4r open kir7.1 independ inhibit α-msh bind consequ kir7.1 signal appear central melanocortin-medi regul energi homeostasi within pvn coupl mc4r kir7.1 may explain unusu aspect control energi homeostasi melanocortin signal includ gene dosag effect mc4r sustain effect agrp food intak',\n",
       "  'background aim ghrelin orexigen peptid gastroprokinet effect mice streptozotocin stz -induc diabet exhibit hyperphagia alter gastric empti increas plasma ghrelin level investig caus role ghrelin herein compar chang ghrelin receptor knockout growth hormon secretagogu receptor ghs-r -/- wild-typ ghs-r +/+ mice stz-induc diabet method gastric empti measur 13 c octano acid breath test messeng rna mrna express neuropeptid npi agouti-rel peptid agrp proopiomelanocortin quantifi real-tim reverse-transcript polymeras chain reaction neural contract elicit electr field stimul fundic smooth muscl strip result diabet increas plasma ghrelin level similar extent genotyp hyperphagia pronounc ghs-r +/+ ghs-r -/- mice day 12 21. increas npi agrp mrna express less pronounc diabet ghs-r -/- ghs-r +/+ mice day 15 wherea decreas proopiomelanocortin mrna level similar genotyp gastric empti acceler similar extent genotyp start day 16. fundic smooth muscl strip diabet ghs-r +/+ ghs-r -/- mice neuron relax reduc wherea contract increas increas relat increas affin muscarin tachykinerg receptor conclus diabet hyperphagia regul central mechan ghrelin-sign pathway affect express npi agrp hypothalamu acceler gastric empti affect ghrelin signal caus diabet hyperphagia probabl involv local contractil chang fundu',\n",
       "  'background cholecalciferol input requir achiev maintain given serum 25-hydroxycholecalciferol concentr known particularli within rang compar probabl physiolog suppli vitamin object object establish quantit relat steadi state cholecalciferol input result serum 25-hydroxycholecalciferol concentr estim proport daili requir winter met cholecalciferol reserv bodi tissu store design cholecalciferol administ daili control oral dose label 0 25 125 250 micro g cholecalciferol approxim 20 wk winter 67 men live omaha 41.2 degre n latitud time cours serum 25-hydroxycholecalciferol concentr measur interv cours treatment result mean baselin valu 70.3 nmol/l equilibrium concentr serum 25-hydroxycholecalciferol chang winter month direct proport dose slope approxim 0.70 nmol/l addit 1 micro g cholecalciferol input calcul oral input requir sustain serum 25-hydroxycholecalciferol concentr present studi ie autumn 12.5 micro g 500 iu /d wherea total amount sourc supplement food tissu store need sustain start 25-hydroxycholecalciferol concentr estim approxim 96 micro g approxim 3800 iu /d differ tissu store provid approxim 78-82 micro g/d conclus healthi men seem use 3000-5000 iu cholecalciferol/d appar meet 80 winter cholecalciferol need cutan synthes accumul solar sourc preced summer month current recommend vitamin input inadequ maintain serum 25-hydroxycholecalciferol concentr absenc substanti cutan product vitamin',\n",
       "  'background intratumor heterogen may foster tumor evolut adapt hinder personalized-medicin strategi depend result singl tumor-biopsi sampl method examin intratumor heterogen perform exom sequenc chromosom aberr analysi ploidi profil multipl spatial separ sampl obtain primari renal carcinoma associ metastat site character consequ intratumor heterogen use immunohistochem analysi mutat function analysi profil messeng rna express result phylogenet reconstruct reveal branch evolutionari tumor growth 63 69 somat mutat detect across everi tumor region intratumor heterogen observ mutat within autoinhibitori domain mammalian target rapamycin mtor kinas correl s6 4ebp phosphoryl vivo constitut activ mtor kinas activ vitro mutat intratumor heterogen seen multipl tumor-suppressor gene converg loss function setd2 pten kdm5c underw multipl distinct spatial separ inactiv mutat within singl tumor suggest converg phenotyp evolut gene-express signatur good poor prognosi detect differ region tumor allel composit ploidi profil analysi reveal extens intratumor heterogen 26 30 tumor sampl four tumor harbor diverg allelic-imbal profil ploidi heterogen two four tumor conclus intratumor heterogen lead underestim tumor genom landscap portray singl tumor-biopsi sampl may present major challeng personalized-medicin biomark develop intratumor heterogen associ heterogen protein function may foster tumor adapt therapeut failur darwinian select fund medic research council other',\n",
       "  'colon process infant gut microbiom call chaotic view could reflect insuffici document factor affect microbiom perform 2.5-i case studi assembl human infant gut microbiom relat life event microbiom composit function sixti fecal sampl collect healthi infant along diari diet health statu analysi 300,000 16 rrna gene indic phylogenet divers microbiom increas gradual time chang commun composit conform smooth tempor gradient contrast major taxonom group show abrupt shift abund correspond chang diet health commun assembl nonrandom observ discret step bacteri success punctuat life event furthermor analysi ≈ 500,000 dna metagenom read 12 fecal sampl reveal earliest microbiom enrich gene facilit lactat util function gene involv plant polysaccharid metabol present introduct solid food prime infant gut adult diet howev ingest tabl food caus sustain increas abund bacteroidet elev fecal short chain fatti acid level enrich gene associ carbohydr util vitamin biosynthesi xenobiot degrad stabl commun composit characterist adult microbiom studi reveal seemingli chaotic shift microbiom associ life event howev addit experi ought conduct assess differ infant respond similar life event',\n",
       "  'gamma-tocopherol major form vitamin e mani plant seed us diet drawn littl attent compar alpha-tocopherol predomin form vitamin e tissu primari form supplement howev recent studi indic gamma-tocopherol may import human health possess uniqu featur distinguish alpha-tocopherol gamma-tocopherol appear effect trap lipophil electrophil alpha-tocopherol gamma-tocopherol well absorb accumul signific degre human tissu metabol howev larg 2,7,8-trimethyl-2- beta-carboxyethyl -6-hydroxychroman gamma-cehc mainli excret urin gamma-cehc correspond metabolit deriv alpha-tocopherol natriuret activ may physiolog import gamma-tocopherol gamma-cehc alpha-tocopherol inhibit cyclooxygenas activ thu possess antiinflammatori properti human anim studi indic plasma concentr gamma-tocopherol invers associ incid cardiovascular diseas prostat cancer distinguish featur gamma-tocopherol metabolit suggest gamma-tocopherol may contribut significantli human health way recogn previous possibl evalu especi consid high dose alpha-tocopherol deplet plasma tissu gamma-tocopherol contrast supplement gamma-tocopherol increas review current inform bioavail metabol chemistri nonantioxid activ gamma-tocopherol epidemiolog data concern relat gamma-tocopherol cardiovascular diseas cancer',\n",
       "  \"background apolipoprotein e apo genotyp provid inform risk alzheim 's diseas genotyp patient famili member discourag examin effect genotyp disclosur prospect random control trial method randomli assign 162 asymptomat adult parent alzheim 's diseas receiv result apo genotyp disclosur group receiv result nondisclosur group measur symptom anxieti depress test-rel distress 6 week 6 month 1 year disclosur nondisclosur result signific differ two group chang time-averag measur anxieti 4.5 disclosur group 4.4 nondisclosur group p=0.84 depress 8.8 8.7 respect p=0.98 test-rel distress 6.9 7.5 respect p=0.61 secondari comparison nondisclosur group disclosur subgroup subject carri apo epsilon4 allel associ increas risk also reveal signific differ howev epsilon4-neg subgroup significantli lower level test-rel distress epsilon4-posit subgroup p=0.01 subject clinic meaning chang psycholog outcom distribut evenli among nondisclosur group epsilon4-posit epsilon4-neg subgroup baselin score anxieti depress strongli associ post-disclosur score measur p 0.001 comparison conclus disclosur apo genotyp result adult children patient alzheim 's diseas result signific short-term psycholog risk test-rel distress reduc among learn apo epsilon4-neg person high level emot distress undergo genet test like emot difficulti disclosur clinicaltrials.gov number nct00571025\",\n",
       "  'background associ blood pressur differ manifest incid cardiovascular diseas contemporari popul compar studi aim analys associ blood pressur 12 differ present cardiovascular diseas method use link electron health record 1997 2010 calib cardiovascular research use link bespok studi electron health record programm assembl cohort 1·25 million patient 30 year age older initi free cardiovascular diseas fifth receiv blood pressure-low treatment studi heterogen age-specif associ clinic measur blood pressur 12 acut chronic cardiovascular diseas estim lifetim risk 95 year age cardiovascular disease-fre life-year lost adjust risk factor index age 30 60 80 year studi regist clinicaltrials.gov number nct01164371 find 5·2 year median follow-up record 83,098 initi cardiovascular diseas present age group lowest risk cardiovascular diseas peopl systol blood pressur 90-114 mm hg diastol blood pressur 60-74 mm hg evid j-shape increas risk lower blood pressur effect high blood pressur vari cardiovascular diseas endpoint strongli posit effect associ high systol blood pressur strongest intracerebr haemorrhag hazard ratio 1·44 95 ci 1·32-1·58 subarachnoid haemorrhag 1·43 1·25-1·63 stabl angina 1·41 1·36-1·46 weakest abdomin aortic aneurysm 1·08 1·00-1·17 compar diastol blood pressur rais systol blood pressur greater effect angina myocardi infarct peripher arteri diseas wherea rais diastol blood pressur greater effect abdomin aortic aneurysm rais systol pressur puls pressur associ invers abdomin aortic aneurysm hr per 10 mm hg 0·91 95 ci 0·86-0·98 strongest peripher arteri diseas 1·23 1·20-1·27 peopl hypertens blood pressur ≥140/90 mm hg receiv blood pressure-low drug lifetim risk overal cardiovascular diseas 30 year age 63·3 95 ci 62·9-63·8 compar 46·1 45·5-46·8 normal blood pressur develop cardiovascular diseas 5·0 year earlier 95 ci 4·8-5·2 stabl unstabl angina account 43 cardiovascular disease-fre year life lost associ hypertens index age 30 year wherea heart failur stabl angina account largest proport 19 year life lost index age 80 year interpret wide held assumpt blood pressur strong associ occurr cardiovascular diseas across wide age rang diastol systol associ concord support find high-resolut studi despit modern treatment lifetim burden hypertens substanti find emphasis need new blood pressure-low strategi help inform design randomis trial assess fund medic research council nation institut health research wellcom trust',\n",
       "  'background ongo initi filter onlin health search exclud consumer-gener content search return though inferior compar profession control content demonstr antidepress escitalopram antipsychot quetiapin rank last 5 year top-sel agent respect drug class drug variou off-label mental health non-ment health use rang relief insomnia migrain treatment sever development disord object object describ frequent report effect escitalopram quetiapin onlin consum review compar effect describ profession control commerci health websit gaug usabl onlin consum medic review method stratifi simpl random sampl 960 consum review select 6998 consum review two drug 2 consumer-gener www.askapatient.com www.crazymeds.u 2 profession control www.webmd.com www.revolutionhealth.com health websit profession medic descript includ standard inform medic latter 2 websit textual data induct code medic effect intercod agreement assess chi-squar use test associ consumer-report effect websit origin result consum take either escitalopram n 480 quetiapin n 480 frequent report symptom improv 30.4 146/480 24.8 119/480 symptom worsen 15.8 76/480 10.2 49/480 chang sleep 36 173/480 60.6 291/480 chang weight appetit 22.5 108/480 30.8 148/480 consum post review consumer-gener rather profession control websit report symptom worsen quetiapin 17.3 38/220 versu 5 11/220 p .001 consum post profession control websit report symptom improv 32.7 72/220 versu 21.4 47/220 p .008 profession descript frequent list physic advers effect warn suicid ideat consum review emphas effect disrupt daili routin provid richer descript effect context recent 20 consum review drug websit n 80 compar full sampl review frequenc commonli report effect conclus consum review profession medic descript gener report similar effect two psychotrop medic differ descript frequenc report profession medic descript offer advantag concis yet comprehens list drug effect consum review offer greater context situat exampl effect may manifest variou combin vari degre dispers consum review across websit limit integr brief brows strategi two target medic nonetheless retriev repres consum content current strategi filter onlin health search return trust approv websit may inappropri address challeng identifi qualiti health sourc internet strategi unduli limit access entir complementari sourc health inform',\n",
       "  \"background multipl studi carri assess effect zinc supplement children 's growth result studi inconsist factor respons vari outcom unknown object meta-analys random control intervent trial therefor complet assess effect zinc supplement physic growth serum zinc concentr prepubert children design total 33 accept studi appropri data identifi medlin nation librari medicin bethesda md search method weight mean effect size express sd unit calcul chang height weight weight-for-height serum zinc concentr use random-effect model factor associ effect size explor meta-regress techniqu result zinc supplement produc highli signific posit respons height weight increment effect size 0.350 95 ci 0.189 0.511 0.309 0.178 0.439 respect signific effect zinc weight-for-height index weight mean effect size -0.018 -0.132 0.097 zinc supplement caus larg increas children 's serum zinc concentr effect size 0.820 0.499 1.14 growth respons greater children low initi weight-for-ag z score age 6 mo low initi height-for-ag z score conclus intervent improv children 's zinc nutritur consid popul risk zinc defici especi elev rate underweight stunt popul mean serum zinc concentr use indic success deliveri absorpt zinc supplement children\",\n",
       "  'age-rel macular degener amd progress condit untreat 90 patient lead caus blind elderli worldwid two form amd wet dri classifi base presenc absenc blood vessel disrupt invad retina respect detail understand molecular mechan underli wet amd led sever robust fda-approv therapi contrast approv treatment dri amd review provid insight critic effector pathway mediat form diseas recur theme span aspect amd pathogenesi defect immun modul classic immune-privileg ocular interestingli latest advanc amd research also highlight common molecular diseas pathway neurodegen disord final therapeut potenti interven known mechanist step amd pathogenesi discuss',\n",
       "  'effici counteract pathogen plant reli complex set immun respons tightli regul allow time activ appropri durat adequ amplitud defens program coordin plant immun respons known requir activ ubiquitin/proteasom system control stabil protein eukaryot demonstr n-end rule pathway subset ubiquitin/proteasom system regul defens wide rang bacteri fungal pathogen model plant arabidopsi thaliana show pathway posit regul biosynthesi plant-defens metabolit glucosinol well biosynthesi respons phytohormon jasmon acid play key role plant immun result also suggest arginyl branch n-end rule pathway regul time amplitud defens program model pathogen pseudomona syringa avrrpm1',\n",
       "  'aberr epigenet reprogram often result development defect somat cell nuclear transfer scnt embryo embryon genom activ ega bovin eight-cel scnt embryo exhibit global hypermethyl histon h3 lysin 9 tri- di-methyl h3k9me3/2 intrins reason remain elus provid evid two h3k9 demethylas gene lysine-specif demethylas 4d kdm4d 4e kdm4e relat activ h3k9me3/2 demethyl vitro fertil ivf embryo defici express clone embryo time ega moreov kdm4e play crucial role ivf scnt embryon develop overexpress kdm4e restor global transcriptom improv blastocyst format increas clone effici scnt embryo result therebi indic kdm4e function crucial epigenet regul ega intern defect factor respons persist h3k9me3/2 barrier scnt-mediat reprogram furthermor show interact rna kdm4e essenti h3k9 demethyl ega observ advanc understand incomplet nuclear reprogram great import transgen cattl procreat',\n",
       "  'author investig associ folic acid supplement gestat hypertens studi popul includ women nonmalform infant unit state canada particip slone epidemiolog center birth defect studi 1993 2000. women interview within 6 month deliveri sociodemograph medic factor occurr hypertens without preeclampsia multivitamin use pregnanc rel risk adjust weight pariti twin pregnanc diabet smoke educ famili incom estim use cox regress model 2,100 women 204 9.7 report gestat hypertens onset 20th week gestat multivariate-adjust rel risk develop gestat hypertens month folic acid supplement compar use folic acid month 0.55 95 confid interv 0.39 0.79 find suggest folic acid-contain multivitamin may reduc risk gestat hypertens',\n",
       "  'autoimmun polyendocrinopathi syndrom type 1 recess mendelian disord result mutat novel gene air character spectrum organ-specif autoimmun diseas known toler mechan defect result air mutat trace fate autoreact cd4+ cell high affin pancreat antigen transgen mice air mutat show air defici caus almost complet failur delet organ-specif cell thymu result indic autoimmun polyendocrinopathi syndrom 1 caus failur special mechan delet forbidden cell clone establish central role toler mechan',\n",
       "  'condit tumor microenviron hypoxia nutrient starvat play critic role cancer progress howev role acid extracellular ph cancer progress studi extens hypoxia show extracellular acid ph ph 6.8 trigger activ sterol regulatori element-bind protein 2 srebp2 stimul nuclear transloc promot bind target along intracellular acidif interestingli inhibit srebp2 srebp1 suppress upregul low ph-induc cholesterol biosynthesis-rel gene moreov acyl-coa synthetas short-chain famili member 2 acss2 direct srebp2 target provid growth advantag cancer cell acid ph furthermor acid ph-respons srebp2 target gene associ reduc overal surviv cancer patient thu find show srebp2 key transcript regul metabol gene progress cancer cell partli respons extracellular acidif',\n",
       "  'pattern daili human activ control intrins circadian clock promot ∼24 hr rhythm mani behavior physiolog process system alter delay sleep phase disord dspd common form insomnia sleep episod shift later time misalign societ norm report hereditari form dspd associ domin code variat core circadian clock gene cry1 creat transcript inhibitor enhanc affin circadian activ protein clock bmal1 gain-of-funct cry1 variant caus reduc express key transcript target lengthen period circadian molecular rhythm provid mechanist link dspd symptom allel frequenc 0.6 revers phenotyp unrel famili corrobor late and/or fragment sleep pattern carrier suggest affect sleep behavior sizeabl portion human popul',\n",
       "  'rat feed trigger experiment use mani approach includ among 1 food depriv 2 acut microinject neurotransmitt l-glutam glu receptor agonist nmda later hypothalam area lha paradigm nmda receptor nmda-r within lha appear critic involv transfer signal encod glu stimul feed howev intracellular mechan underli signal transfer unknown protein-tyrosin kinas ptk particip nmda-r signal mechan determin ptk involv lha mechan underli type feed stimul food intak biochem measur lha inject ptk inhibitor significantli suppress feed elicit lha nmda inject 69 mildli suppress depriv feed 24 suggest ptk may less critic signal underli feed behavior convers food depriv nmda inject produc mark increas appar activ src ptk express pyk2 src-activ ptk consid togeth behavior biochem result demonstr although easier suppress nmda-elicit feed ptk inhibitor food depriv readili drive ptk activ vivo latter result may reflect greater ptk recruit neurotransmitt receptor distinct nmda-r activ deprivation-elicit nmda-elicit feed result also demonstr use one feed stimul paradigm may fail reveal true contribut signal molecul pathway underli feed behavior vivo',\n",
       "  \"aim present studi aim investig relationship advanc glycat end-product accumul skelet muscl mass among middle-ag older japanes men women method total 132 particip enrol cross-sect studi skin autofluoresc assess measur advanc glycation-end product appendicular skelet muscl mass measur use dual-energi x-ray absorptiometri skelet muscl index calcul divid appendicular skelet muscl mass height squar particip divid two group low skelet muscl index normal skelet muscl index use asian work group sarcopenia 's skelet muscl index criteria diagnos sarcopenia multivari logist regress analysi area receiv oper characterist curv use determin signific factor associ low skelet muscl index result particip consist 70 men mean age 57 ± 10 year 62 women mean age 60 ± 11 year 31 101 particip low normal skelet muscl index group respect skin autofluoresc significantli higher low skelet muscl index group compar normal skelet muscl index group p 0.01 skin autofluoresc signific independ factor associ low skelet muscl index base multivari logist regress analysi odd ratio 15.7 95 confid interv 1.85-133.01 p 0.012 cut-off skin autofluoresc 2.45 arbitrari unit sensit 0.75 specif 0.91. conclus skin autofluoresc independ factor associ low skelet muscl index among middle-ag older japanes men women geriatr gerontol int 2017 17 785-790\",\n",
       "  'studi use whole-genom sequenc gene express profil 215 human induc pluripot stem cell ipsc line differ donor identifi genet variant associ rna express 5,746 gene abl predict causal variant express quantit trait loci eqtl disrupt transcript factor bind valid subset experiment also identifi copy-numb variant cnv eqtl includ appear affect gene express alter copi number intergen regulatori region addit abl identifi effect gene express rare genic cnv regulatori single-nucleotid variant found reactiv gene express x chromosom depend gene chromosom posit work highlight valu ipsc genet associ analys provid uniqu resourc investig genet regul gene express pluripot cell',\n",
       "  'background/object non-alcohol fatti liver diseas nafld lead caus chronic liver diseas close associ metabol syndrom present studi observ effect ethanol extract allium fistulosum eaf nafld suggest possibl use eaf natur product applic develop treatment nafld materials/method prevent effect hepat lipid accumul estim use oleic acid oa -induc nafld model vitro western diet high-fat high-sucros wd -induc obes mous model anim divid three group n 7 normal diet group nd wd group wd plu 1 eaf group result eaf reduc oa-stimul lipid accumul hepg2 cell absenc cellular cytotox significantli block transcript activ sterol regulatori element-bind protein 1 fatti acid synthas gene subsequ investig effect vivo mice fed either nd wd presenc absenc eaf supplement comparison nd control wd-fed mice exhibit increas bodi weight liver weight epididym fat weight accumul fat hepatocyt effect significantli attenu eaf supplement conclus allium fistulosum attenu develop nafld eaf elicit anti-lipogen activ liver therefor eaf repres promis candid use develop novel therapeut drug drug combin prevent treatment nafld',\n",
       "  'context exposur cardiovascular risk factor childhood adolesc may associ develop atherosclerosi later life object studi relationship cardiovascular risk factor measur childhood adolesc common carotid arteri intima-media thick imt marker preclin atherosclerosi measur adulthood design set particip population-bas prospect cohort studi conduct 5 center finland among 2229 white adult age 24 39 year examin childhood adolesc age 3 18 year 1980 reexamin 21 year later septemb 2001 januari 2002. main outcom measur associ cardiovascular risk variabl level low-dens lipoprotein cholesterol ldl-c high-dens lipoprotein cholesterol hdl-c triglycerid ldl-c/hdl-c ratio systol diastol blood pressur bodi mass index smoke measur childhood adulthood common carotid arteri imt measur adulthood result multivari model adjust age sex imt adulthood significantli associ childhood ldl-c level p =.001 systol blood pressur p .001 bodi mass index p =.007 smoke p =.02 adult systol blood pressur p .001 bodi mass index p .001 smoke p =.004 number risk factor measur 12- 18-year-old adolesc includ high level ie extrem age- sex-specif 80th percentil ldl-c systol blood pressur bodi mass index cigarett smoke directli relat carotid imt measur young adult age 33 39 year p .001 men women remain signific adjust contemporan risk variabl number risk factor measur age 3 9 year demonstr weak direct relationship carotid imt age 24 30 year men p =.02 women p =.63 conclus risk factor profil assess 12- 18-year-old adolesc predict adult common carotid arteri imt independ contemporan risk factor find suggest exposur cardiovascular risk factor earli life may induc chang arteri contribut develop atherosclerosi',\n",
       "  \"mechan underli develop aging-induc muscl atrophi unclear microrna array individu qpcr analys found signific up-regul mir-29 muscl age rodent vs. result young age p85α igf-1 b-myb muscl level lower express certain cell arrest protein p53 p16 prb increas mir-29 express muscl progenitor cell mpc prolifer impair sa-βgal express increas signifi develop senesc impair mpc prolifer result interact mir-29 3'-utr p85a igf-1 b-myb suppress translat mediat myoblast prolifer vivo electropor mir-29 muscl young mice suppress prolifer increas level cellular arrest protein recapitul aging-induc respons muscl potenti stimulu mir-29 express wnt-3a sinc found exogen wnt-3a stimul mir-29 express 2.7-fold primari cultur mpc thu aging-induc muscl senesc result activ mir-29 wnt-3a lead suppress express sever signal protein p85α igf-1 b-myb act coordin impair prolifer mpc contribut muscl atrophi increas mir-29 provid potenti mechan aging-induc sarcopenia\",\n",
       "  'mammalian tor mtor pathway integr nutrient- growth factor-deriv signal regul growth process wherebi cell accumul mass increas size mtor larg protein kinas target rapamycin immunosuppress also block vessel restenosi potenti anticanc applic mtor interact raptor gbetal protein form complex target rapamycin demonstr mtor also part distinct complex defin novel protein rictor rapamycin-insensit companion mtor rictor share homolog previous describ pianissimo d. discoidieum ste20p s. pomb avo3p s. cerevisia interestingli avo3p part rapamycin-insensit tor complex contain yeast homolog raptor signal actin cytoskeleton pkc1 consist find rictor-contain mtor complex contain gbetal raptor neither regul mtor effector s6k1 bound fkbp12-rapamycin find rictor-mtor complex modul phosphoryl protein kinas c alpha pkcalpha actin cytoskeleton suggest aspect tor signal conserv yeast mammal',\n",
       "  'phosphoryl human estrogen receptor er serin residu posit 118 requir full activ er activ function 1 af-1 ser118 phosphoryl mitogen-activ protein kinas mapk vitro cell treat epiderm growth factor egf insulin-lik growth factor igf vivo overexpress mapk kinas mapkk guanin nucleotid bind protein ra activ mapk enhanc estrogen-induc antiestrogen tamoxifen -induc transcript activ wild-typ er mutant er alanin place ser118 thu activ amino-termin af-1 er modul phosphoryl ser118 ras-mapk cascad growth factor signal pathway',\n",
       "  'nucleotide-bind oligomer domain nod -like receptor nlr protein famili innat immun receptor play pivot role microbi sens lead initi antimicrobi immun respons dysregul function multipl nlr famili member link mice human propens infect autoinflammatori diseas despit increas understand nlr function interact mani aspect relat mechan sens downstream signal vivo function remain elus review focu key member nlr famili describ activ divers microb downstream effector function interact innat sensor protein famili also discuss role microbi sens nlr receptor lead activ adapt immun arm collabor antimicrobi defens',\n",
       "  'context antioxid acetylcystein prevent acut contrast nephrotox patient impair renal function undergo comput tomographi scan howev role coronari angiographi unclear object determin whether oral acetylcystein prevent acut deterior renal function patient moder renal insuffici undergo elect coronari angiographi design set prospect random double-blind placebo-control trial conduct may 2000 decemb 2001 grantham hospit univers hong kong particip two hundr chines patient age mean sd 68 6.5 year stabl moder renal insuffici creatinin clearanc 60 ml/min 1.00 ml/ undergo elect coronari angiographi without intervent intervent particip randomli assign receiv oral acetylcystein 600 mg twice per day n 102 match placebo tablet n 98 day day angiographi patient receiv low-osmol contrast agent main outcom measur occurr 25 increas serum creatinin level within 48 hour contrast administr chang creatinin clearanc serum creatinin level result twelv control patient 12 4 acetylcystein patient 4 develop 25 increas serum creatinin level within 48 hour contrast administr rel risk 0.32 95 confid interv ci 0.10-0.96 p =.03 serum creatinin lower acetylcystein group 1.22 mg/dl 107.8 micromol/l 95 ci 1.11-1.33 mg/dl vs 1.38 mg/dl 122.9 micromol/l 95 ci 1.27-1.49 mg/dl p =.006 first 48 hour angiographi acetylcystein treatment significantli increas creatinin clearanc 44.8 ml/min 0.75 ml/ 95 ci 42.7-47.6 ml/min 58.9 ml/min 0.98 ml/ 95 ci 55.6-62.3 ml/min 2 day contrast administr p .001 increas signific control group 42.1 44.1 ml/min 0.70 0.74 ml/ p =.15 benefit acetylcystein consist among variou patient subgroup persist least 7 day major treatment-rel advers event conclus acetylcystein protect patient moder chronic renal insuffici contrast-induc deterior renal function coronari angiograph procedur minim advers effect low cost',\n",
       "  \"role dna cytosin methyl epigenet regul chromatin structur function normal patholog brain develop age remain unclear examin methylight pcr dna methyl statu 50 loci encompass primarili 5′ cpg island gene relat cn growth develop tempor neocortex 125 subject rang age 17 week gestat 104 year old two psychiatr diseas cohorts—defin chronic neurodegener alzheim 's lack thereof schizophrenia —were includ robust progress rise dna methyl level across lifespan observ 8/50 loci gabra2 gad1 hoxa1 neurod1 neurod2 pgr stk11 syk typic conjunct declin level correspond mrna anoth 16 loci defin sharp rise dna methyl level within first month year birth disease-associ chang limit 2/50 loci alzheim 's cohort appear reflect acceler age-rel chang normal brain addit methyl studi sort nuclei provid evid bidirect methyl event cortic neuron transit childhood advanc age reflect signific increas 3 decreas 1 10 loci furthermor dnmt3a de novo dna methyl-transferas express across age includ subset neuron resid layer iii v matur cortex therefor dna methyl dynam regul human cerebr cortex throughout lifespan involv differenti neuron affect substanti portion gene predominantli age-rel increas\",\n",
       "  'obes associ chronic diseas fatti liver type 2 diabet cardiovascular diseas sever metabol syndrom obes caus metabol impair includ excess lipid accumul fibrosi hepat tissu well increas oxid stress order investig effect mulberri leaf moru alba l. extract mle obesity-induc oxid stress lipogenesi fibrosi liver mle gavag 12 week high-fat diet hfd -induc obes mice mle treatment significantli amelior lxrα-mediat lipogenesi hepat fibrosi marker α-smooth muscl actin mle up-regul lipolysis-associ marker lipoprotein lipas hfd-fed mice moreov mle normal activ antioxid enzym includ heme oxygenase-1 glutathion peroxidas accord protein level 4-hydroxynonen hfd-fed mice mle benefici effect obesity-rel fatti liver diseas regul hepat lipid metabol fibrosi antioxid defens system mle supplement might potenti therapeut approach obesity-rel diseas includ non-alcohol fatti liver diseas',\n",
       "  'context recent anim studi found 3-hydroxy-3-methylglutaryl coenzym hmg-coa lipid-low drug statin substanti increas bone format whether statin use human result clinic meaning bone format reduct risk osteoporot fractur known object determin whether use statin associ reduc hip fractur risk design case-control studi set patient total 6110 new jersey resid age 65 year older enrol medicar either medicaid pharmaci assist age disabl program case patient n=1222 underw surgic repair hip fractur 1994. control patient n=4888 identifi ratio 4:1 frequency-match case patient age sex main outcom measur adjust odd ratio hip fractur statin use 180 day 3 year prior index date earliest date admiss surgeri adjust demograph clinic characterist health care util result use statin either prior 180 day adjust 0.50 95 confid interv ci 0.33-0.76 prior 3 year adjust 0.57 95 ci 0.40-0.82 associ signific reduct risk hip fractur even control variabl race insur statu psychoact medic estrogen thiazid use ischem heart diseas cancer diabet mellitu signific relationship observ use nonstatin lipid-low agent hip fractur risk clear relationship observ degre reduct hip fractur risk extent statin use evid relationship nonstatin lipid-low agent adjust extent statin use prior 3 year current use index date associ 71 reduct risk adjust 0.29 95 ci 0.10-0.81 relationship statin use hip fractur risk persist control variabl number medic charlson comorbid index score hospit nurs home stay last 180 day well exclud patient nurs home prior index date die year index date use nonstatin lipid-low agent observ associ reduct hip fractur risk altern model analys conclus find support associ statin use elderli patient reduct risk hip fractur control trial need exclud possibl unmeasur confound jama 2000 283:3211-3216',\n",
       "  'ecolog studi design routin use epidemiologist spite limit present unknown well challeng design dealt epidemiolog research purpos bibliometr review critic evalu characterist statist method report result modern cross-sect ecolog paper search 6 major epidemiolog journal identifi cross-sect ecolog studi publish sinc januari 1 2000. total 125 articl met inclus requir assess via common evalu criteria found consider number cross-sect ecolog studi use unreli method contain statist oversight investig adjust outcom age sex improperli 64 statist valid potenti issu 20 regress model simpl linear regress common analyt approach 31 mani author omit import inform discuss ecolog natur studi 31 choic studi design 58 suscept research ecolog fallaci 49 result suggest need intern set guidelin standard report ecolog studi addit greater attent given relev biostatist literatur',\n",
       "  'background resist radiotherapi continu limit factor treatment cancer includ head neck squamou cell carcinoma hnscc simultan target β1 integrin egfr shown higher radiosensit potenti mono-target major test hnscc cancer model tumor-initi cell tic thought play key role therapi resist recurr enrich sphere form condit studi investig efficaci β1 integrin/egfr target without combin x-ray irradi behavior sphere-form cell sfc method hnscc cell line utscc15 utscc5 cal33 sa inject subcutan nude mice tumor up-tak plate primari secondari sphere format non-adhes condit thought reflect enrich sfc self-renew capac respect treatment accomplish inhibitori antibodi β1 integrin aiib2 egfr cetuximab well x-ray irradi 2 6 gy singl dose flow cytometri tic marker express cell cycl well western blot dna repair protein express phosphoryl employ result found higher primari secondari sphere form capac sa cell rel hnscc cell line line tumor up-tak rate sa versu utscc15 cell aiib2 cetuximab administr minor cytotox radiosensit effect sfc intriguingli secondari sa sphere repres fraction surviv sfc upon passag show greatli enhanc radiosensit compar primari sphere intriguingli neither aiib2 cetuximab significantli alter basal sphere form capac radiosensit increas accumul g0/g1 phase cell observ secondari sa sphere dna doubl strand break repair indic differ basi significantli enhanc atm chk2 dephosphoryl upon irradi conclus hnscc model sphere-form condit select cell unsuscept anti-β1 integrin anti-egfr inhibitori antibodi regard primari secondari sphere format data suggest sfc fraction express distinct surviv strategi independ β1 integrin egfr futur work warrant better understand sfc surviv enrich treatment untangl underli mechan identifi novel druggabl cancer target sfc',\n",
       "  'object examin effect routin administ psychiatr questionnair recognit manag outcom psychiatr disord non-psychiatr set data sourc embas medlin psyclit cinahl cochran control trial regist hand search key journal method systemat review randomis control trial administr routin feedback psychiatr screen outcom questionnair clinician non-psychiatr set narr overview key design featur end point togeth random effect quantit synthesi compar studi main outcom measur recognit psychiatr disord feedback questionnair result intervent psychiatr disord outcom psychiatr disord result nine randomis studi identifi examin use common psychiatr instrument primari care gener hospit set studi compar effect administr instrument follow feedback result clinician administr feedback meta-analyt pool possibl four studi 2457 particip measur effect feedback recognit depress disord routin administr feedback score patient irrespect score increas overal rate recognit mental disord anxieti depress rel risk detect depress clinician feedback 0.95 95 confid interv 0.83 1.09 two studi show routin administr follow select feedback high scorer increas rate recognit depress rel risk detect depress feedback 2.64 1.62 4.31 increas recognit howev translat increas rate intervent overal studi routin administr psychiatr measur show effect patient outcom conclus routin measur outcom costli exercis littl evid show benefit improv psychosoci outcom psychiatr disord manag non-psychiatr set',\n",
       "  'problem antibiot resist limit use cheap old antibiot necessit need continu search new antimicrobi compound understand mechan resist import develop strategi solv problem activ efflux drug alter target site enzymat degrad strategi pathogen bacteria acquir develop intrins resist antibiot multi-drug resist mdr pump capabl recogn expel varieti structur unrel compound bacteri cell confer resist wide rang antibiot sinc character mani gram posit gram neg pathogen like staphylococcu aureu pseudomona aeruginosa escherichia coli recent mycobacteria abil chemic compound call mdr inhibitor resist modifi agent modifi resist phenotyp bacteria work synergist antibiot vitro sinc observ search compound combin antibiot treatment drug resist infect may altern overcom problem resist bacteria crude extract medicin plant stand verit sourc potenti resist modifi agent african biospher promis potenti sourc compound owe rich plant speci divers',\n",
       "  'background relaps cocain seek link low glutam nucleu accumben core nacor caus potenti synapt glutam transmiss prefront cortex pfc affer system n-acetylcystein nac shown restor glutam homeostasi reduc relaps cocain seek depotenti pfc-nacor synaps examin effect nac appli directli nacor relaps neurotransmiss pfc-nacor synaps well involv metabotrop glutam receptor 2/3 mglur2/3 5 mglur5 method rat train self-administ cocain 2 week follow extinct receiv either intra-accumben nac system nac 30 120 minut respect induc reinstat condit cue combin cue cocain inject also record postsynapt current use vitro whole cell record acut slice measur cystin glutam uptak primari glial cultur result nac microinject nacor inhibit reinstat cocain seek slice low concentr nac reduc amplitud evok glutamaterg synapt current nacor mglur2/3-depend manner high dose nac increas amplitud mglur5-depend manner effect depend nac uptak cystein transport activ cysteine/glutam exchang final show block mglur5 inhibit cocain seek nac potenti conclus effect nac relaps cocain seek depend balanc stimul mglur2/3 mglur5 nacor efficaci nac improv simultan inhibit mglur5',\n",
       "  'phospholipid synthes mainli endoplasm reticulum er mitochondri inner membran cell properli distribut specif phospholipid divers cellular membran crucial problem mainten organelle-specif phospholipid composit although er-mitochondria encount structur erm propos facilit phospholipid transfer er mitochondria role erm still controversi await experiment demonstr develop novel vitro assay system isol yeast membran fraction monitor phospholipid exchang er mitochondria system found phospholipid transport er mitochondria reli membran intact energi sourc atp gtp membran potenti across mitochondri inner membran found lack erm compon impair phosphatidylserin transport er mitochondria phosphatidylethanolamin transport mitochondria er vitro assay system thu offer power tool analyz non-vesicular phospholipid transport er mitochondria',\n",
       "  'tumour cell stem-lik properti highli aggress often show drug resist reveal integrin αvβ3 serv marker breast lung pancreat carcinoma stem-lik properti highli resist receptor tyrosin kinas inhibitor erlotinib observ vitro mice bear patient-deriv tumour xenograft clinic specimen lung cancer patient progress erlotinib mechanist αvβ3 unligand state recruit kra ralb tumour cell plasma membran lead activ tbk1 nf-κb fact αvβ3 express result kras–ralb–nf-κb pathway necessari suffici tumour initi anchorag independ self-renew erlotinib resist pharmacolog target pathway bortezomib revers tumour stem erlotinib resist find identifi αvβ3 marker/driv carcinoma stem also reveal therapeut strategi sensit tumour rtk inhibit',\n",
       "  \"effort develop drug alzheim 's diseas ad shown promis anim studi fail human trial suggest press need studi ad human model system use human neuron deriv induc pluripot stem cell express apolipoprotein e4 apoe4 variant apo gene product major genet risk factor ad demonstr apoe4-express neuron higher level tau phosphoryl unrel increas product amyloid-β aβ peptid display gabaerg neuron degener apoe4 increas aβ product human mous neuron convert apoe4 apoe3 gene edit rescu phenotyp indic specif effect apoe4 neuron lack apo behav similarli express apoe3 introduct apoe4 express recapitul patholog phenotyp suggest gain toxic effect apoe4 treatment apoe4-express neuron small-molecul structur corrector amelior detriment effect thu show correct pathogen conform apoe4 viabl therapeut approach apoe4-rel ad\",\n",
       "  'long non-cod rna nuclear paraspeckl assembl transcript 1 neat1 report upregul involv oncogen growth drug resist nasopharyng carcinoma npc howev exact role neat1 underli mechan drug resist npc remain larg unclear studi express neat1 let-72-5p rsf-1 mrna detect revers transcription-quantit polymeras chain reaction rt-qpcr effect neat1 let-72-5p cell prolifer cisplatin resist npc cell investig 3- 4,5-dimethylthiazol-2-yl -2,5-diphenyl tetrazolium bromid mtt assay 5-ethynyl-20-deoxyuridin edu assay western blot analysi perform detect protein level rsf-1 ra p-raf1 raf1 p-mek1 mek1 p-erk1/2 erk1/2 xenograft tumor assay done elucid role neat1 involv npc tumor growth vivo found neat1 upregul let-7a-5p downregul npc tissu well npc cell line inhibit neat1 markedli repress cisplatin resist npc cell neat1 demonstr interact let-7a-5p besid neg correl neat1 let-7a-5p express observ npc tissu rsf-1 confirm target let-7a-5p neat1 remark revers inhibitori effect let-7q-5p cisplatin resist npc cell vitro addit neat1 knockdown inhibit ras-mapk pathway npc cell neat1 knockdown suppress tumor growth presenc cisplatin vivo overal find suggest neat1/let-7a-5p axi regul cisplatin resist npc target rsf-1 modul ras-mapk signal pathway',\n",
       "  \"antibacteri peptid microcin j25 mccj25 inhibit transcript bacteri rna polymeras rnap biochem result indic inhibit transcript occur level ntp uptak ntp bind rnap genet result indic inhibit transcript requir extens determin compris 50 amino acid residu within rnap secondari channel also known `` ntp-uptak channel '' `` pore '' biophys result indic inhibit transcript involv bind mccj25 within rnap secondari channel molecular model indic bind mccj25 within rnap secondari channel obstruct rnap secondari channel conclud mccj25 inhibit transcript bind within obstruct rnap secondari channel -- act essenti `` cork bottle. `` obstruct rnap secondari channel repres attract target drug discoveri\",\n",
       "  'mainten accur propag genet materi key featur physiolog develop wellb replic licens machineri crucial replic precis ensur replic take place per cell cycl thu express statu compon compris replic licens apparatu tightli regul avoid re-repl form replic stress lead genom instabl hallmark cancer present review discuss mechanist basi replic licens deregul lead system effect exemplifi role carcinogenesi varieti genet syndrom addit new insight demonstr particular threshold replic licens factor cdc6 act global transcript regul outlin new line explor role put replic licens factor chlr1/ddx11 mutat warsaw breakag syndrom cancer also consid final futur perspect focus potenti therapeut advantag target replic licens factor particularli cdc6 discuss',\n",
       "  \"pluripot remark capac singl cell engend special cell type adult organ properti captur indefinit deriv self-renew embryon stem cell esc repres invalu platform investig cell fate decis diseas recent advanc reveal manipul distinct signal cue render esc uniform `` ground state '' pluripot close recapitul pluripot naiv epiblast discuss extrins intrins regulatori principl underpin natur pluripot consid emerg spectrum pluripot state\",\n",
       "  \"background histor main focu studi childhood mortal infant under-f mortal rate neonat mortal death 28 day age receiv limit attent although death account 41 child death better assess progress develop annual estim neonat mortal rate nmr neonat death 193 countri period 1990-2009 forecast futur method find compil databas mortal neonat children 5 year compris 3,551 country-year inform reliabl civil registr data 1990 2009 avail 38 countri statist model develop estim nmr remain 155 countri 17 nation data countri consult undertaken identifi data input review estim 2009 estim 3.3 million babi die first month life-compar 4.6 million neonat death 1990-and half neonat death occur five countri world 44 global livebirth india 27.8 19.6 global livebirth nigeria 7.2 4.5 pakistan 6.9 4.0 china 6.4 13.4 democrat republ congo 4.6 2.1 1990 2009 global nmr declin 28 33.2 death per 1,000 livebirth 23.9. proport child death neonat period increas region world global 41 nmr halv region world africa 's nmr drop 17.6 43.6 35.9 conclus neonat mortal declin world region progress slowest region high nmr global health program need address neonat death effect millennium develop goal 4 two-third reduct child mortal achiev\",\n",
       "  'nuclear factor erythroid 2-relat factor 2 nrf2 key transcript factor oxid stress neurodegen disord phenylethanoid glycosid phg salidrosid acteosid isoacteosid echinacosid exhibit antioxid neuroprotect bioactiv studi perform investig neuroprotect effect molecular mechan phg phg pretreat significantli suppress h₂o₂-induc cytotox pc12 cell trigger nuclear transloc nrf2 revers downregul protein express heme oxygenas 1 ho-1 nad p h quinon oxidoreductas 1 nqo1 glutam cystein ligase-catalyt subunit gclc glutamate-cystein ligas modifi subunit gclm nrf2 sirna ho-1 inhibitor zinc protoporphyrin znpp reduc neuroprotect effect phg show potenti interact nrf2 bind site kelch-lik ech-associ protein 1 keap1 result may support hypothesi phg activ nrf2 demonstr potenti bind phg keap1-activ nrf2/are pathway phg glycosid enhanc effect',\n",
       "  'background although studi provid estim prematur death attribut either heat cold select countri none far offer systemat assess across whole temperatur rang popul expos differ climat aim quantifi total mortal burden attribut non-optimum ambient temperatur rel contribut heat cold moder extrem temperatur method collect data 384 locat australia brazil canada china itali japan south korea spain sweden taiwan thailand uk usa fit standard time-seri poisson model locat control trend day week estim temperature-mort associ distribut lag non-linear model 21 day lag pool multivari metaregress includ countri indic temperatur averag rang calcul attribut death heat cold defin temperatur optimum temperatur correspond point minimum mortal moder extrem temperatur defin use cutoff 2·5th 97·5th temperatur percentil find analys 74,225,200 death variou period 1985 2012. total 7·71 95 empir ci 7·43-7·91 mortal attribut non-optimum temperatur select countri within studi period substanti differ countri rang 3·37 3·06 3·63 thailand 11·00 9·29 12·47 china temperatur percentil minimum mortal vari roughli 60th percentil tropic area 80-90th percentil temper region temperature-attribut death caus cold 7·29 7·02-7·49 heat 0·42 0·39-0·44 extrem cold hot temperatur respons 0·86 0·84-0·87 total mortal interpret temperature-rel mortal burden attribut contribut cold effect day extrem temperatur substanti less attribut milder non-optimum weather evid import implic plan public-health intervent minimis health consequ advers temperatur predict futur effect climate-chang scenario fund uk medic research council',\n",
       "  'survivin member chromosom passeng complex play import role chromosom align separ cytokinesi although survivin requir prolifer surviv hematopoiet stem progenitor cell extent necessari endomitosi megakaryocyt remain controversi determin whether survivin requir polyploid analyz mice megakaryocyte-specif delet pf4-cre/survivin fl/fl mice harbor normal platelet count megakaryocyt reach ploidi state compar control litterm cd41 cell within anim show littl excis increas annexin v stain impli survivin requir surviv megakaryocyt progenitor vivo contrast megakaryocyt survivin excis ex vivo show robust excis increas degre polyploid result demonstr survivin necessari surviv megakaryocyt progenitor requir polyploid commit megakaryocyt',\n",
       "  'introduct overexpress human epiderm growth factor receptor -2 20 human breast cancer associ aggress growth led widespread use her2-target therapi trastuzumab lapatinib l despit success drug efficaci limit patient whose tumor demonstr de novo acquir resist treatment β1 integrin resid membran breast cancer cell activ sever element breast tumor progress includ prolifer surviv method develop panel her2-overexpress cell line resist l potent lt combin long-term exposur valid model 3d cultur parent l/t/lt-resist cell subject her2 β1 integrin inhibitor 3d monitor 12 day follow quantif coloni number parallel experi conduct cell either stain ki-67 termin deoxynucleotidyl transferas dutp nick end label tunel harvest protein analyz immunoblot result subject statist test use analysi varianc linear contrast follow adjust sidak method result use multipl cell line includ bt474 hcc1954 reveal l lt resist phosphoryl egfr/her1 her2 her3 strongli inhibit kinas downstream β1 integrin -- includ focal adhes kinas fak src -- up-regul blockad β1 antibodi aiib2 abrog up-regul function achiev signific growth inhibit l lt resist cell 3d without dramat affect parent cell sirna β1 well pharmacolog inhibit fak achiev growth inhibitori effect contrast trastuzumab-resist cell retain high level phosphoryl egfr/her1 her2 her3 modestli growth-inhibit aiib2 conclus data suggest her2 activ suppress resist involv l alon dictat whether β1 mediat altern pathway drive resist find justifi clinic studi investig inhibit β1 downstream signal moieti strategi overcom acquir l lt resist',\n",
       "  'import estim claims-bas analys suggest incid sepsi increas mortal rate sepsi decreas howev estim claim data may lack clinic fidel affect chang diagnosi code practic time object estim us nation incid sepsi trend use detail clinic data electron health record ehr system divers hospit design set popul retrospect cohort studi adult patient admit 409 academ commun feder hospit 2009-2014. exposur sepsi identifi use clinic indic presum infect concurr acut organ dysfunct adapt third intern consensu definit sepsi septic shock sepsis-3 criteria object consist ehr-bas surveil main outcom measur sepsi incid outcom trend 2009-2014 calcul use regress model compar claims-bas estim use intern classif diseas ninth revis clinic modif code sever sepsi septic shock case-find criteria valid sepsis-3 criteria use medic record review result total 173 690 sepsi case mean age 66.5 sd 15.5 77 660 42.4 women identifi use clinic criteria among 2 901 019 adult admit studi hospit 2014 6.0 incid 26 061 15.0 die hospit 10 731 6.2 discharg hospic 2009-2014 sepsi incid use clinic criteria stabl +0.6 rel change/i 95 ci −2.3 3.5 p .67 wherea incid per claim increas +10.3 /y 95 ci 7.2 13.3 p .001 in-hospit mortal use clinic criteria declin −3.3 /y 95 ci −5.6 −1.0 p .004 signific chang combin outcom death discharg hospic −1.3 /y 95 ci −3.2 0.6 p .19 contrast mortal use claim declin significantli −7.0 /y 95 ci −8.8 −5.2 p .001 death discharg hospic −4.5 /y 95 ci −6.1 −2.8 p .001 clinic criteria sensit identifi sepsi claim 69.7 95 ci 52.9 92.0 vs 32.3 95 ci 24.4 43.0 p .001 compar posit predict valu 70.4 95 ci 64.0 76.8 vs 75.2 95 ci 69.8 80.6 p .23 conclus relev clinic data 409 hospit sepsi present 6 adult hospit contrast claims-bas analys neither incid sepsi combin outcom death discharg hospic chang significantli 2009-2014. find also suggest ehr-bas clinic data provid object estim claims-bas data sepsi surveil',\n",
       "  'background high body-mass index bmi predispos sever site-specif cancer large-scal systemat detail characteris pattern risk across common cancer adjust potenti confound previous undertaken aim investig link bmi common site-specif cancer method primari care data individu clinic practic research datalink bmi data fit cox model investig associ bmi 22 common cancer adjust potenti confound fit linear non-linear spline model investig effect modif sex menopaus statu smoke age calcul popul effect find 5·24 million individu includ 166,955 develop cancer interest bmi associ 17 22 cancer effect vari substanti site 5 kg/m 2 increas bmi roughli linearli associ cancer uteru hazard ratio hr 1·62 99 ci 1·56-1·69 p 0·0001 gallbladd 1·31 1·12-1·52 p 0·0001 kidney 1·25 1·17-1·33 p 0·0001 cervix 1·10 1·03-1·17 p=0·00035 thyroid 1·09 1·00-1·19 p=0·0088 leukaemia 1·09 1·05-1·13 p≤0·0001 bmi posit associ liver 1·19 1·12-1·27 colon 1·10 1·07-1·13 ovarian 1·09 1.04-1.14 postmenopaus breast cancer 1·05 1·03-1·07 overal p 0·0001 effect vari underli bmi individual-level characterist estim invers associ prostat premenopaus breast cancer risk overal prostat 0·98 0·95-1·00 premenopaus breast cancer 0·89 0·86-0·92 never-smok prostat 0·96 0·93-0·99 premenopaus breast cancer 0·89 0·85-0·94 contrast lung oral caviti cancer observ associ never smoker lung 0·99 0·93-1·05 oral caviti 1·07 0·91-1·26 invers associ overal driven current smoker ex-smok probabl residu confound smoke amount assum causal 41 uterin 10 gallbladd kidney liver colon cancer could attribut excess weight estim 1 kg/m 2 population-wid increas bmi would result 3790 addit annual uk patient develop one ten cancer posit associ bmi interpret bmi associ cancer risk substanti population-level effect heterogen effect suggest differ mechan associ differ cancer site differ patient subgroup fund nation institut health research wellcom trust medic research council',\n",
       "  'structur genet human herpesvirus among largest complex virus use cryo–electron microscopi cryo-em optim imag reconstruct strategi report herp simplex viru type 2 hsv-2 capsid structur 3.1 angstrom built 3000 protein organ three type hexon central peripenton edg penton triplex hexon penton contain major capsid protein vp5 hexon also contain small capsid protein vp26 triplex compris vp23 vp19c act core organ vp5 protein form extens intermolecular network involv multipl disulfid bond 1500 total noncoval interact vp26 protein triplex underpin capsid stabil assembl conform adapt protein induc microenviron lead 46 differ conform assembl massiv quasisymmetr shell exemplifi structur function complex hsv',\n",
       "  'hypothes involv mediat common behavior scienc mediat exist predictor affect depend variabl indirectli least one interven variabl mediat method assess mediat involv multipl simultan mediat receiv littl attent methodolog literatur despit clear need provid overview simpl multipl mediat explor three approach use investig indirect process well method contrast two mediat within singl model present illustr exampl assess contrast potenti mediat relationship help social agent job satisfact also provid sa spss macro well mplu lisrel syntax facilit use method applic',\n",
       "  'alter metabol influenc lifespan experiment model data human lack use liquid chromatography/mass spectrometri quantifi 217 plasma metabolit examin relat longev larg cohort men women follow 20 year find higher concentr citric acid cycl intermedi isocitr bile acid taurochol associ lower odd longev defin attain 80 year age higher concentr isocitr taurochol also associ wors cardiovascular health baselin well risk futur cardiovascular diseas death none metabolit identifi associ cancer risk find suggest metabol pathway relat human longev link risk common caus death',\n",
       "  'rise incid obes associ metabol diseas increas urgenc understand aspect adipos tissu biolog includ function adipocyt adipos tissu expand obes expand adipos tissu adult impact physiolog highlight grow appreci import de novo adipocyt differenti adipos tissu expans adult human anim detail recent effort identifi adipos precursor popul contribut physiolog postnat recruit white brown beig adipocyt mice summar new data reveal complex adipos tissu develop vivo',\n",
       "  'background clonal competit cancer describ process progeni cell clone supersed succumb compet clone due differ function characterist mostli base subsequ acquir mutat even though pattern mutat well explor mani tumor dynam process clonal select underexpos method studi dynam clonal competit bcrabl-induc leukemia use γ-retrovir vector librari encod oncogen conjunct genet barcod end studi growth dynam transduc cell clonal level vitro vivo transplant mice result detect moder chang clonal abund vitro observ monoclon leukemia 6/30 mice transplant intriguingli caus two differ bcrabl clone analyz success clone appli mathemat model hematopoiet tissu mainten indic differenti engraft capac two domin clone provid possibl explan observ find support addit transplant experi increas bcrabl transcript level clone conclus find show clonal competit absolut process base mutat highli depend select mechan given environment context',\n",
       "  'background frequent problem comput model interconvers chemic structur differ format standard interchang format exist exampl chemic markup languag de facto standard arisen exampl smile format need interconvert format continu problem due multitud differ applic area chemistri data differ data store differ format 0d versu 3d exampl competit softwar along lack vendor-neutr format result discuss first time open babel open-sourc chemic toolbox speak mani languag chemic data open babel version 2.3 interconvert 110 format need repres wide varieti chemic molecular data requir librari implement wide rang cheminformat algorithm partial charg assign aromat detect bond order percept canonic detail implement open babel describ key advanc 2.3 releas outlin varieti use term softwar product scientif research includ applic far beyond simpl format interconvers conclus open babel present solut prolifer multipl chemic file format addit provid varieti use util conform search 2d depict filter batch convers substructur similar search develop use program librari handl chemic data area organ chemistri drug design materi scienc comput chemistri freeli avail open-sourc licens http //openbabel.org',\n",
       "  \"object assess rel valid accept computeris 24-h recal ‘ young adolesc 's nutrit assess comput yana-c ’ .design food nutrient intak assess yana-c compar food record studi 1 24-h dietari recal interview studi 2 .main outcom measur intak food group fruit fruit juic veget potato bread cereal milk chees milk product soft drink diet soft drink sugar/sweet pastry/cooki savouri snack butter/sauc egg fish meat nutrient energi carbohydr protein fat fiber calcium vitamin c iron .subject set total 237 pupil 11–14 two primari four secondari school studi 1 n=136 studi 2 n=101 belgium-fland result yana-c prove agre well standard method categor subject consum nonconsum κstudi 1=0.48–0.92 κstudi 2=0.38–0.90 spearman 's correl energi nutrient intak rang 0.44 0.79 studi 1 0.44 0.86 studi 2. nutrient energi intak gener exclud calcium significantli higher yana-c comparison food record comparison interview fiber statist use investig whether yana-c agre method rank portions/amount consum fair moder food group weight κ studi 1=0.11–0.55 studi 2=0.04–0.73 amount consum significantli lower yana-c standard cereal amount significantli higher yana-c food record milk soft drink sugar/sweet savouri snack interview potato pupil evalu program neg conclus yana-c promis method collect detail dietari inform young adolesc rel low staff resourc use mani nutrit research applic\",\n",
       "  'background human immunodefici viru hiv infect strongest risk factor develop tuberculosi fuell resurg especi sub-saharan africa 2010 estim 1.1 million incid case tuberculosi among 34 million peopl live hiv worldwid antiretrovir therapi substanti potenti prevent hiv-associ tuberculosi conduct systemat review studi analys impact antiretrovir therapi incid tuberculosi adult hiv infect method find pubm embas african index medicu lilac clinic trial registri systemat search randomis control trial prospect cohort studi retrospect cohort studi includ compar tuberculosi incid antiretrovir therapi statu hiv-infect adult median 6 mo develop countri meta-analys four categori base cd4 count antiretrovir therapi initi 1 less 200 cells/µl 2 200 350 cells/µl 3 greater 350 cells/µl 4 cd4 count eleven studi met inclus criteria antiretrovir therapi strongli associ reduct incid tuberculosi baselin cd4 count categori 1 less 200 cells/µl hazard ratio hr 0.16 95 confid interv ci 0.07 0.36 2 200 350 cells/µl hr 0.34 95 ci 0.19 0.60 3 greater 350 cells/µl hr 0.43 95 ci 0.30 0.63 4 cd4 count hr 0.35 95 ci 0.28 0.44 evid hazard ratio modif respect baselin cd4 count categori p 0.20 conclus antiretrovir therapi strongli associ reduct incid tuberculosi across cd4 count strata earlier initi antiretrovir therapi may key compon global nation strategi control hiv-associ tuberculosi syndem review registr intern prospect regist systemat review crd42011001209 pleas see later articl editor summari',\n",
       "  'incid breast cancer type 2 diabet metabol syndrom increas past decad obes epidem especi industri countri insulin resist hyperinsulinemia chang signal growth hormon steroid hormon associ diabet may affect risk breast cancer review epidemiolog studi associ type 2 diabet risk breast cancer avail evid role hormon mediat associ diabet breast cancer combin evid support modest associ type 2 diabet risk breast cancer appear consist among postmenopaus among premenopaus women despit mani propos potenti pathway mechan underli associ diabet breast cancer risk remain unclear particularli 2 diseas share sever risk factor includ obes sedentari lifestyl possibl intak satur fat refin carbohydr may confound associ although metabol syndrom close relat diabet embrac addit compon might influenc breast cancer risk role metabol syndrom breast carcinogenesi studi thu remain unknown',\n",
       "  'aberr altern splice highlight potenti hallmark cancer identifi tdp43 tar dna-bind protein 43 import splice regul respons uniqu splice profil triple-neg breast cancer tnbc clinic data demonstr tdp43 highli express tnbc poor prognosi knockdown tdp43 inhibit tumor progress includ prolifer metastasi overexpress tdp43 promot prolifer malign mammari epitheli cell deep sequenc analysi function experi indic tdp43 alter splice event splice factor srsf3 serine/arginine-rich splice factor 3 regul tnbc progress tdp43/srsf3 complex control specif splice event includ downstream gene par3 numb effect reduc metastasi prolifer upon knockdown tdp43 srsf3 mediat splice regul par3 numb exon 12 respect tdp43/srsf3 complex downstream par3 isoform potenti therapeut target tnbc',\n",
       "  'time primari reveiw 27 day atherosclerosi continu one main subject patholog research intrigu complex pathogenesi well import clinic sequela provid rational 1 larg number diseas total differ clinic present basic atherosclerosi relat among myocardi infarct stroke abdomin aneurysm lower limb ischemia determin larg extent morbid mortal western style popul despit broad spectrum clinic diseas acut manifest atherosclerosi share common pathogenet featur ruptur atherosclerot plaqu 2–4 plaqu disrupt may vari greatli extent tini fissur eros plaqu surfac deep intim tear extend soft lipid core lesion instanc least degre thrombu format occur 5 6 abdomin aorta arteri site promin involv process plaqu format also plaqu complic larg diamet vessel process plaqu disrupt thrombosi end lumin occlus may lead extens surfac ulcer compris larg area aortic wall observ mani autopsi case older age apart undisput role atherosclerosi abdomin aneurysm format 7 mural thrombosi lead surprisingli low rate clinic signific complic patient although cholesterol emboli regularli found kidney skin autopsi still present unclear impact variou biolog activ mediat releas erod aortic surfac may human bodi contrast small diamet vessel coronari arteri occlus thrombosi frequent often fatal complic plaqu … correspond author tel +31-20-5665-633 fax +31-20-914-738 e-mail a.c.vanderw amc.uva.nl',\n",
       "  'pioneer transcript factor establish new cell-fat compet trigger chromatin remodel howev mani featur pioneer action kinet stabil remain poorli defin show pax7 open uniqu repertoir enhanc necessari suffici specif one pituitari lineag pax7 bind target enhanc rapidli chromatin remodel gene activ slower enhanc open pax7 show loss dna methyl acquir stabl epigenet memori evidenc bind nonpion factor pax7 withdraw work show transient pax7 express suffici stabl specif cell ident analysi pax7 dynam pituitari lineag specif show pax7 bind rapidli uniqu mark heterochromatin pioneer site initi chromatin open remain stabl pax7 withdraw loss dna hypermethyl pioneer enhanc',\n",
       "  'telomer resembl common fragil site cfss difficult-to-repl exhibit fragil mitosi respons dna replic stress cfss fragil associ delay complet dna replic earli mitosi whereupon cell propos switch rad52-depend form break-induc replic show mitot dna synthesi mida also featur human telomer telomer mida restrict telomer display overt fragil featur wide rang cell line irrespect whether telomer maintain telomeras altern lengthen telomer alt mechan mida telomer requir rad52 mechanist similar cfs-associ mida notabl except telomer mida requir mus81-eme1 endonucleas propos model wherebi replic stress initi rad52-depend form break-induc replic bypass requir mus81-eme1 complet dna synthesi mitosi',\n",
       "  'essenti direct oral anticoagul doac requir laboratori monitor current doac specif measur perform trough patient atrial fibril patient develop thromboembol event show lower doac plasma level studi support concept measur doac level steadi state summari background direct oral anticoagul doac administ fix dose without need dose adjust accord laboratori test high interindividu variabl drug blood level shown doac evalu possibl relationship doac c-trough anticoagul level thromboembol event 565 consecut naiv patient atrial fibril af enrol studi perform within start laboratori registri method doac-specif measur dilut thrombin time anti-activ factor ii calibr dabigatran anti-activ fx calibr rivaroxaban apixaban c-trough perform local steadi state within 15-25 day start treatment doac interv c-trough level limit quantif highest valu subdivid four equal class result attribut class median valu result also calcul thromboembol complic occur 1 year follow-up record result thromboembol event 1.8 occur 10 patient baselin c-trough level lowest class drug level incid thromboembol event among patient doac c-trough level lowest level class 2.4 remain group 0 patient thrombot complic also higher mean cha2 ds2 -vasc score total patient popul 5.3 95 confid interv ci 4.3-6.3 versu 3.0 95 ci 2.9-3.1 conclus studi cohort thrombot complic occur doac-treat af patient low c-trough level rel high cha2 ds2 -vasc score larger studi warrant confirm preliminari observ',\n",
       "  \"apoptot cell long consid intrins tolerogen unabl elicit immun respons specif dead cell-associ antigen howev multipl stimuli trigger function peculiar type apoptot demis go unnot adapt arm immun system name `` immunogen cell death '' icd icd preced accompani emiss seri immunostimulatori damage-associ molecular pattern damp precis spatiotempor configur sever anticanc agent success employ clinic decad includ variou chemotherapeut radiotherapi elicit icd moreov defect compon underli capac immun system perceiv cell death immunogen neg influenc diseas outcom among cancer patient treat icd induc thu icd profound clinic therapeut implic unfortun gold-standard approach detect icd reli vaccin experi involv immunocompet murin model syngen cancer cell approach incompat larg screen campaign outlin strategi conceiv detect surrog marker icd vitro screen larg chemic librari put icd induc base high-cont high-throughput platform recent develop platform allow detect multipl damp like cell surface-expos calreticulin extracellular atp high mobil group box 1 hmgb1 and/or process underli emiss endoplasm reticulum stress autophagi necrot plasma membran permeabil surmis technolog facilit develop next-gener anticanc regimen kill malign cell simultan convert cancer-specif therapeut vaccin\",\n",
       "  'induct compensatori mechan erk reactiv limit effect raf mek inhibitor ras-mut cancer determin direct pharmacolog inhibit erk suppress growth subset kras-mut pancreat cancer cell line concurr phosphatidylinositol 3-kinas pi3k inhibit caus synergist cell death addit combin enhanc erk inhibitor action also identifi unexpectedli long-term treatment sensit cell line caus senesc mediat part myc degrad p16 reactiv enhanc basal pi3k-akt-mtor signal associ de novo resist erk inhibitor protein kinas identifi kinome-wid sirna screen genet gain-of-funct screen find reveal distinct consequ inhibit kinas cascad level erk',\n",
       "  'helicas rtel1 promot t-loop unwind suppress telomer fragil maintain integr vertebr telomer interact rtel1 pcna import prevent telomer fragil rtel1 engag telomer promot t-loop unwind unclear establish shelterin protein trf2 recruit rtel1 telomer phase requir prevent catastroph t-loop process structure-specif nucleas show trf2-rtel1 interact mediat metal-coordin c4c4 motif rtel1 compromis hoyeraal-hreidarsson syndrom hh mutat rtel1 r1264h convers defin trf2 i124d substitut mutat within trfh domain trf2 elimin rtel1 bind phenocopi rtel1 r1264h mutat give rise aberr t-loop excis telomer length heterogen loss telomer circl result implic trf2 recruit rtel1 facilit t-loop disassembl telomer phase',\n",
       "  'organ-specif function tissue-resid macrophag steady-st heart unknown show cardiac macrophag facilit electr conduct distal atrioventricular node conduct cell dens interspers elong macrophag express connexin 43. coupl spontan beat cardiomyocyt via connexin-43-contain gap junction cardiac macrophag neg rest membran potenti depolar synchroni cardiomyocyt convers macrophag render rest membran potenti cardiomyocyt posit accord comput model acceler repolar photostimul channelrhodopsin-2-express macrophag improv atrioventricular conduct wherea condit delet connexin 43 macrophag congenit lack macrophag delay atrioventricular conduct cd11bdtr mous macrophag ablat induc progress atrioventricular block observ implic macrophag normal aberr cardiac conduct',\n",
       "  'na immun cell commun exchang cytokin achiev context‐appropri respons distanc commun happen known use theoret consider experiment model immun respons vitro vivo quantifi spatial extent cytokin commun dens tissu establish competit cytokin diffus consumpt gener spatial nich high cytokin concentr sharp boundari size self‐assembl nich scale densiti cytokine‐consum cell paramet get tune immun respons vivo measur interact length scale 80–120 mgr result high degre cell‐to‐cel varianc cytokin exposur heterogen distribut cytokin sourc non‐genet cell‐to‐cel variabl often overlook single‐cel studi find thu provid basi understand variabl pattern immun respons diffus factor graphic abstract figur caption avail highlightscytokin penetr tissu govern diffusion‐consumpt mechanismspher cytokin nich gener around cytokine‐produc cellsth characterist nich size depend densiti cytokin consumerscytokin nich sourc variabl otherwis ident cell na cytokine‐medi commun allow immun cell achiev context‐appropri respons distanc commun happen unclear oyler‐yaniv et al 2017 show simpl diffusion‐consumpt mechan quantit describ spatial spread cytokin vivo result local nich high cytokin concentr contribut cell‐to‐cel variabl',\n",
       "  'bird mammal cardiac neural crest essenti heart develop contribut conotrunc cushion format outflow tract septat zebrafish prototyp heart lack outflow tract septat rais question whether cardiac neural crest exist zebrafish result three distinct lineage-label approach identifi zebrafish cardiac neural crest cell indic cell abil gener mf20-posit muscl cell myocardium major chamber develop fate-map demonstr cardiac neural crest cell origin neural tube region analog found bird well novel region rostral otic vesicl contrast vertebr cardiac neural crest invad myocardium segment heart includ outflow tract atrium atrioventricular junction ventricl zebrafish three distinct group premigratori neural crest along rostrocaud axi differ propens contribut differ segment heart correspondingli mark uniqu combin gene express pattern zebrafish serv model understand interact cardiac neural crest cardiovascular develop',\n",
       "  'abil increas ph crucial need desalin pretreat especi revers osmosi industri process use rais ph often incur signific emiss nonrenew resourc use altern wast brine desalin use creat sodium hydroxid via appropri concentr purif pretreat step input chlor-alkali process work effici process train variat develop model sodium hydroxid product seawat desalin brine use membran chlor-alkali electrolysi integr system includ nanofiltr concentr via evapor mechan vapor compress chemic soften ion-exchang soften dechlorin membran electrolysi system product compon perform energi consumpt naoh product process highlight depend electrolyz outlet condit brine recircul investig analysi process also includ assess energi effici major compon estim system oper expens comparison similar process brine-to-caust process shown technic feasibl offer sever advantag reduc environment impact desalin lessen brine discharg increas overal water recoveri ratio revers osmosi facil addit best-us condit given produc caustic use within plant also excess amount potenti revenu',\n",
       "  'differenti bacterium bacillu subtili dormant spore among well-character development pathway biolog classic genet screen perform past half centuri identifi score factor involv everi step morpholog process recent transcript profil uncov addit sporulation-induc gene requir success spore develop use transposon-sequenc tn-seq assess whether sporul gene left discov screen identifi 133 148 gene known sporul defect surprisingli discov 24 addit gene previous implic spore format investig function use fluoresc microscopi survey earli middl late stage differenti null mutant b. subtili order knockout collect analysi identifi mutant delay initi sporul defect membran remodel impair spore matur sever mutant novel sporul phenotyp perform in-depth character two new factor particip cell-cel signal pathway sporul one spoiit function activ σe mother cell spoiiil requir σg activ forespor analysi also reveal mani 36 sporulation-induc gene previous report mutant phenotyp requir time spore matur final discov larg set transposon insert trigger prematur initi sporul result highlight power tn-seq discoveri new gene novel pathway sporul combin recent complet null mutant collect open door similar screen less well-character process',\n",
       "  'discov stress-buff effect social relationship one major find psychobiolog last centuri howev understand underli neurobiolog psycholog mechan buffer begin emerg import avenu research concern neurocircuitri regul activ hypothalamic-pituitary-adrenocort hpa axi present review translat effort aim integr anim model human studi social regul hpa axi infanc adulthood specif focus process name social buffer process note across speci consist dampen hpa axi stress respons threat challeng occur presenc assist conspecif describ aspect relev underli neurobiolog enough inform exist expos major gap understand across domain literatur aim integr provid work conceptu model focus role oxytocinerg system prefront neural network 2 put biolog mediat process propos role earli experi critic shape later social buffer effect synthesi point gener futur direct specif experi need conduct build comprehens model hpa social buffer effect across life span incorpor multipl level analysi neuroendocrin behavior social',\n",
       "  'patient pancreat ductal adenocarcinoma pdac diagnos advanc diseas surviv less 12 month pdac link obes glucos intoler whether chang circul metabolit associ earli cancer progress unknown better understand metabol derang associ earli diseas profil metabolit prediagnost plasma individu pancreat cancer case match control four prospect cohort studi find elev plasma level branched-chain amino acid bcaa associ greater twofold increas risk futur pancreat cancer diagnosi elev risk independ known predispos factor strongest associ observ among subject sampl collect 2 5 year diagnosi occult diseas probabl present show plasma bcaa also elev mice early-stag pancreat cancer driven mutant kra express mice kras-driven tumor tissu breakdown tissu protein account increas plasma bcaa accompani early-stag diseas togeth find suggest increas whole-bodi protein breakdown earli event develop pdac',\n",
       "  'somat mutat activ phosphoinositid 3-kinas pi3k identifi p110-alpha catalyt subunit encod pik3ca frequent observ two hotspot helic domain e545k e542k kinas domain h1047r although p110-alpha mutant transform vitro oncogen potenti assess genet engin mous model furthermor clinic trial pi3k inhibitor recent initi unknown efficaci restrict specif genet defin malign studi engin mous model lung adenocarcinoma initi maintain express p110-alpha h1047r treatment tumor nvp-bez235 dual pan-pi3k mammalian target rapamycin mtor inhibitor clinic develop led mark tumor regress shown positron emiss tomography-comput tomographi magnet reson imag microscop examin contrast mous lung cancer driven mutant kra substanti respond single-ag nvp-bez235 howev nvp-bez235 combin mitogen-activ protein kinas kinas mek inhibitor arry-142886 mark synergi shrink kras-mut cancer vivo studi suggest inhibitor pi3k-mtor pathway may activ cancer pik3ca mutat combin mek inhibitor may effect treat kra mutat lung cancer',\n",
       "  'glioblastoma gbm malign brain tumor highli resist intens combin therapi anti-vegf therapi assess resist mechan anti-vegf therapi examin vessel gbm tumor induc transduct p53 +/- heterozyg mice lentivir vector contain oncogen marker gfp hippocampu gfap-cr recombinas cre mice surpris observ gfp vascular endotheli cell ec transplant mous gbm cell reveal tumor-deriv endotheli cell tdec origin tumor-initi cell result cell fusion ec tumor cell vitro differenti assay suggest hypoxia import factor differenti tumor cell ec independ vegf tdec format resist anti-vegf receptor inhibitor mous gbm led increas frequenc xenograft model human gbm sphere clinic specimen direct clinic sampl patient gbm also show presenc tdec suggest tdec import player resist anti-vegf therapi henc potenti target gbm therapi',\n",
       "  'atrx alpha thalassemia/ment retard x-link complex daxx deposit histon variant h3.3 repetit heterochromatin recent genom sequenc studi cancer reveal mutat atrx associ alt altern lengthen telomer activ report deplet atrx mous es cell lead select loss ribosom rna gene rdna copi number support atrx-mut human alt-posit tumor also show substanti lower rdna copi alt-neg tumor investig show rdna copi loss repeat instabl caus disrupt h3.3 deposit thu failur heterochromatin format rdna repeat absenc atrx also find atrx-deplet cell reduc ribosom rna transcript output show increas sensit rna polymeras pol transcript inhibitor cx5461 addit human alt-posit cancer cell line also sensit cx5461 treatment studi provid insight contribut atrx loss function tumorigenesi loss rdna stabil suggest therapeut potenti target pol transcript alt cancer',\n",
       "  'insecticide-tr net itn indoor residu spray ir current prefer method malaria vector control mani case method use togeth household especi suppress transmiss holoendem hyperendem scenario though widespread limit evid suggest co-appl confer greater protect benefit either itn ir use alon sinc method insecticide-bas intradomicilliari articl hypothesis outcom combin would depend effect candid activ ingredi mosquito enter attempt enter hous suggest enhanc household level protect achiev itn ir diverg yet complementari properti e.g highli deterr ir compound coupl highli toxic itn ensur problem insecticid resist avoid itn ir product prefer differ insecticid class e.g pyrethroid-bas net combin organophosph carbam base ir overal commun benefit would howev depend also factor proport peopl cover intervent behaviour vector speci articl conclud emphas need basic oper research includ mathemat model evalu irs/itn combin comparison ir alon itn alon',\n",
       "  '17β-estradiol e2 rapidli induc camp product condit camp level best measur signal pathway respons consequ prolif effect breast cancer cell fulli understood help resolv issu compar camp mechanist respons mcf-7 cell line select low merlow high merhigh express membran form estrogen receptor mer -α thu address receptor subform involv camp signal mcf-7 cell immunopan subsequ separ fluoresc activ cell sort merhigh mer-α-enrich merlow mer-α-deplet popul uniqu compar previous report incub condit 4°c found optim demonstr e2-induc camp product time-depend dose-depend effect e2 camp product determin cell subpopul effect forskolin 8-cpt camp protein kinas inhibitor h-89 adenylyl cyclas inhibitor sq 22,536 e2-induc cell prolifer assess use crystal violet assay demonstr rapid transient camp increas 1 pmol/l e2 stimul merhigh cell 4°c respons much reliabl robust 37°c condit often use loss camp 37°c due export 3-isobutyl-1-methylxanthin ibmx 1 mmol/l partial preserv camp suggest multipl phosphodiesteras modul level accumul camp consist much higher merhigh cell merlow cell implic mer-α level process ici172,780 block e2-induc respons 17α-estradiol elicit respons also suggest activ estrogen receptor e2 dose-depend camp product although biphas cell type respons 50-fold higher e2 concentr merhigh cell prolifer merlow cell stimul whole rang e2concentr wherea number merhigh cell greatli decreas concentr 1 nmol/l suggest estrogen over-stimul lead cell death previous report mer-α particip e2-medi activ adenylyl cyclas downstream particip protein kinas shown involv respons rapid mer-α-medi nongenom signal cascad gener camp downstream signal event contribut regul breast cancer cell number',\n",
       "  'embryon cell lineag caenorhabd elegan trace zygot newli hatch larva result entir cell lineag organ known embryogenesi 671 cell gener hermaphrodit 113 male 111 undergo program death remaind either differenti termin becom postembryon blast cell embryon lineag highli invari fate cell give rise spite fix relationship cell ancestri cell fate correl lack much obviou pattern thu although neuron aris embryon ectoderm produc mesoderm sister muscl lineal boundari necessarili coincid function boundari nevertheless cell ablat experi well previou cell isol experi demonstr substanti cell autonomi least section embryogenesi conclud cell lineag complex play import role determin cell fate discuss origin repeat unit partial segment bodi wall gener variou order symmetri analysi lineag term sublineag evolutionari implic',\n",
       "  'mainten immunolog self-toler requir lymphocyt carri self-react antigen receptor select prevent mount destruct inflammatori effector respons classic self-toler view term remov edit silenc b cell form self-react antigen receptor earli develop howev b cell activ foreign antigen enter germin center gc modifi antigen receptor somat hypermut shm immunoglobulin gene inevit emerg activ self-react gc b cell present uniqu challeng mainten self-toler must rapidli counter avoid autoantibodi product discuss current knowledg mechan enforc b cell self-toler particular focu control self-react gc b cell also consid self-react gc b cell escap self-toler initi autoantibodi product instead redeem via shm use product antibodi respons',\n",
       "  'human age character chronic low-grad inflamm phenomenon term `` inflammaging. `` inflammag highli signific risk factor morbid mortal elderli peopl age-rel diseas share inflammatori pathogenesi nevertheless precis etiolog inflammag potenti causal role contribut advers health outcom remain larg unknown identif pathway control age-rel inflamm across multipl system therefor import order understand whether treatment modul inflammag may benefici old peopl session inflamm advanc gerosci meet held nation institut health/nat institut age bethesda octob 30 31 2013 aim defin import unansw question inflammag articl report main outcom session',\n",
       "  'cryptochrom flavin-contain blue light photoreceptor relat photolyases-they found plant anim recent describ bacteria plant cryptochrom perform varieti function includ entrain circadian rhythm serv similar role drosophila mammal cryptochrom also perform addit function essenti compon circadian clock',\n",
       "  'object recent demonstr primit neural crest-deriv nc cell migrat cardiac neural crest embryon develop remain heart dormant stem cell capac differenti variou cell type includ cardiomyocyt examin migrat differenti potenti cell myocardi infarct mi method result obtain double-transgen mice cross protein-0 promoter-cr mice floxed-enhanc green fluoresc protein mice nc cell express enhanc green fluoresc protein neonat heart nc stem cell ncsc local predominantli outflow tract also distribut gradient base apex throughout ventricular myocardium time-laps video analysi reveal ncsc migratori ncsc persist adult heart mi ncsc accumul ischem border zone area bza express monocyt chemoattract protein-1 mcp-1 ex vivo cell migrat assay demonstr mcp-1 induc ncsc migrat chemotact effect significantli depress anti-mcp-1 antibodi small nc cardiomyocyt first appear bza 2 week post-mi gradual increas number thereaft conclus result suggest ncsc migrat bza via mcp-1/ccr2 signal contribut provis cardiomyocyt cardiac regener mi',\n",
       "  'past two decad calcium ca2+ accumul energ mitochondria emerg biolog process utmost physiolog relev mitochondri ca2+ uptak shown control intracellular ca2+ signal cell metabol cell surviv cell-typ specif function buffer cytosol ca2+ level regul mitochondri effector recent ident mitochondri ca2+ transport reveal open new perspect investig molecular intervent',\n",
       "  'inflammasom multiprotein complex includ member nlr nucleotide-bind domain leucine-rich repeat contain famili caspase-1 bacteri molecul sens within macrophag inflammasom assembl mediat activ caspase-1 caspase-11 mediat caspase-1 activ respons lipopolysaccharid bacteri toxin yet role bacteri infect unknown demonstr caspase-11 dispens caspase-1 activ respons legionella salmonella francisella listeria also determin activ mous caspase-11 requir restrict l. pneumophila infect similarli human caspase-4 caspase-5 homolog mous caspase-11 cooper restrict l. pneumophila infect human macrophag caspase-11 promot fusion l. pneumophila vacuol lysosom modul actin polymer cofilin howev caspase-11 dispens fusion lysosom phagosom contain nonpathogen bacteria uncov fundament differ traffick phagosom accord cargo',\n",
       "  'chronic inflamm constitut import link obes pathophysiolog sequela contrast belief inflammatori signal exert fundament neg impact metabol show proinflammatori signal adipocyt fact requir proper adipos tissu remodel expans three mous model adipos tissue-specif reduct proinflammatori potenti gener display reduc capac adipogenesi vivo differenti potenti unalt vitro upon high-fat-diet exposur expans viscer adipos tissu promin affect associ decreas intestin barrier function increas hepat steatosi metabol dysfunct impair local proinflammatori respons adipocyt lead increas ectop lipid accumul glucos intoler system inflamm adipos tissu inflamm therefor adapt respons enabl safe storag excess nutrient contribut viscer depot barrier effect filter gut-deriv endotoxin',\n",
       "  'exposur psychosoci stress risk factor mani diseas includ atherosclerosi although incomplet understood interact psych immun system provid one potenti mechan link stress diseas incept progress known cross-talk brain immun system includ hypothalamic-pituitary-adren axi central drive glucocorticoid product adren cortex sympathetic-adrenal-medullari axi control stress-induc catecholamin releas support fight-or-flight reflex remain unknown howev whether chronic stress chang hematopoiet stem cell activ show stress increas prolifer primit hematopoiet progenitor give rise higher level disease-promot inflammatori leukocyt found chronic stress induc monocytosi neutrophilia human investig sourc leukocytosi mice discov stress activ upstream hematopoiet stem cell condit chronic variabl stress mice sympathet nerv fiber releas surplu noradrenalin signal bone marrow nich cell decreas cxcl12 level β3-adrenerg receptor consequ hematopoiet stem cell prolifer elev lead increas output neutrophil inflammatori monocyt atherosclerosis-pron apo -/- mice subject chronic stress acceler hematopoiesi promot plaqu featur associ vulner lesion caus myocardi infarct stroke human',\n",
       "  'ciliari neurotroph factor cntf induc weight loss improv glucos toler human rodent cntf thought act central induc hypothalam neurogenesi modul food intak peripher alter hepat gene express manner similar leptin show cntf signal cntfrα–il-6r–gp130β receptor complex increas fatty-acid oxid reduc insulin resist skelet muscl activ amp-activ protein kinas ampk independ signal brain thu find show antiobesogen effect cntf peripheri result direct effect skelet muscl peripher effect suppress diet-induc genet model obes essenti requir therapeut treatment obesity-rel diseas',\n",
       "  \"background hepat c viru hcv estim affect 130-180 million peopl worldwid although origin unknown pattern viral divers suggest hcv genotyp 1 probabl origin west africa previou attempt estim spatiotempor paramet viru global region suggest epidem hcv transmiss began 1900 grew steadili late 1980 howev epidemiolog data suggest expans hcv may occur second world war aim studi elucid timescal rout global spread hcv method find show rare sequenc hcv region e2p7ns2 inform molecular epidemiolog studi commonli use ns5b region appli phylodynam method substanti set new e2p7ns2 ns5b sequenc togeth avail global hcv sequenc inform genom region order estim timescal natur global expans preval hcv subtyp 1a 1b show transmiss subtyp 1a 1b `` explod '' 1940 1980 spread 1b preced 1a least 16 95 confid interv 15-17 phylogeograph analysi avail ns5b sequenc suggest hcv subtyp 1a 1b dissemin develop world develop countri conclus evolutionari rate hcv appear faster previous suggest global spread hcv coincid widespread use transfus blood blood product expans intraven drug use slow prior wide implement anti-hcv screen differ transmiss rout associ subtyp 1a 1b provid explan rel earlier expans 1b data show plausibl rout hcv dispers develop countri develop world pleas see later articl editor summari\",\n",
       "  \"background smoke lead prevent caus ill prematur death worldwid medic proven help peopl quit three licens purpos europ usa nicotin replac therapi nrt bupropion vareniclin cytisin treatment pharmacolog similar vareniclin also licens use russia former socialist economi countri therapi includ nortriptylin also test effect object nrt bupropion vareniclin compar placebo achiev long-term abstin six month longer remain treatment compar placebo achiev long-term abstin risk advers seriou advers event sae compar treatment instanc harm may outweigh benefit method overview restrict cochran review includ randomis trial particip usual adult smoker exclud review smoke cessat pregnant women particular diseas group specif set cover nicotin replac therapi nrt antidepress bupropion nortriptylin nicotin receptor partial agonist vareniclin cytisin anxiolyt select type 1 cannabinoid receptor antagonist rimonab clonidin lobelin dianiclin mecamylamin nicobrevin opioid antagonist nicotin vaccin silver acet outcom benefit continu prolong abstin least six month start treatment outcom harm incid seriou advers event associ treatment search cochran databas systemat review cdsr cochran librari review 'smoke titl abstract keyword field last search conduct novemb 2012. assess methodolog qualiti use revis version amstar scale nrt bupropion vareniclin conduct network meta-analys compar other placebo benefit vareniclin bupropion risk seriou advers event main result identifi 12 treatment-specif review analys cover 267 studi involv 101,804 particip nrt bupropion superior placebo odd ratio 1.84 95 credibl interv credi 1.71 1.99 1.82 95 credi 1.60 2.06 respect vareniclin increas odd quit compar placebo 2.88 95 credi 2.40 3.47 head-to-head comparison bupropion nrt show equal efficaci 0.99 95 credi 0.86 1.13 vareniclin superior singl form nrt 1.57 95 credi 1.29 1.91 bupropion 1.59 95 credi 1.29 1.96 vareniclin effect nicotin patch 1.51 95 credi 1.22 1.87 nicotin gum 1.72 95 credi 1.38 2.13 'other nrt inhal spray tablet lozeng 1.42 95 credi 1.12 1.79 effect combin nrt 1.06 95 credi 0.75 1.48 combin nrt also outperform singl formul four categori nrt perform similarli apart 'other nrt margin effect nrt gum 1.21 95 credi 1.01 1.46 cytisin nicotin receptor partial agonist return posit find risk ratio rr 3.98 95 ci 2.01 7.87 without signific advers event sae across 82 includ exclud bupropion trial estim six seizur bupropion arm versu none placebo arm lower expect rate 1:1000 1:1500. sae meta-analysi bupropion studi demonstr excess neuropsychiatr rr 0.88 95 ci 0.31 2.50 cardiovascular event rr 0.77 95 ci 0.37 1.59 sae meta-analysi 14 vareniclin trial found differ vareniclin placebo arm rr 1.06 95 ci 0.72 1.55 subgroup analys detect signific excess neuropsychiatr event rr 0.53 95 ci 0.17 1.67 cardiac event rr 1.26 95 ci 0.62 2.56 nortriptylin increas chanc quit rr 2.03 95 ci 1.48 2.78 neither nortriptylin bupropion shown enhanc effect nrt compar nrt alon clonidin increas chanc quit rr 1.63 95 ci 1.22 2.18 offset dose-depend rise advers event mecamylamin combin nrt may increas chanc quit current evid inconclus treatment fail demonstr benefit compar placebo nicotin vaccin yet licens use aid smoke cessat relaps prevent nicobrevin 's uk licens revok manufactur rimonab taranab dianiclin longer support develop test treatment author conclus nrt bupropion vareniclin cytisin shown improv chanc quit combin nrt vareniclin equal effect quit aid nortriptylin also improv chanc quit current evid none treatment appear incid advers event would mitig use research warrant safeti vareniclin cytisin 's potenti effect afford treatment efficaci safeti nrt\",\n",
       "  'sequenc specif dna-bind protein primari mechan cell recogn genom featur describ systemat determin yeast transcript factor dna-bind specif obtain bind specif 112 dna-bind protein repres 19 distinct structur class one-third bind specif previous report sever bind sequenc strike genom distribut rel transcript start site support biolog relev suggest role promot architectur among rsc3 bind sequenc contain core cgcg found preferenti approxim 100 bp upstream transcript start site mutat rsc3 result dramat increas nucleosom occup hundr proxim promot contain rsc3 bind element littl impact promot lack rsc3 bind sequenc indic rsc3 play broad role target nucleosom exclus yeast promot',\n",
       "  'signific endeavor appli identifi function therapeut target glioblastoma gbm halt growth aggress cancer show receptor tyrosin kinas epha3 frequent overexpress gbm particular aggress mesenchym subtyp importantli epha3 highli express tumor-initi cell popul glioma appear critic involv maintain tumor cell less differenti state modul mitogen-activ protein kinas signal epha3 knockdown deplet epha3-posit tumor cell reduc tumorigen potenti degre compar treatment therapeut radiolabel epha3-specif monoclon antibodi result identifi epha3 function target receptor gbm',\n",
       "  'chimer antigen receptor-modifi cell specif cd19 shown promis treatment chronic lymphocyt leukemia cll remain establish whether chimer antigen receptor cell clinic activ acut lymphoblast leukemia two children relaps refractori pre-b-cel receiv infus cell transduc anti-cd19 antibodi t-cell signal molecul ctl019 chimer antigen receptor cell dose 1.4×10 6 1.2×10 7 ctl019 cell per kilogram bodi weight patient ctl019 cell expand level 1000 time high initi engraft level cell identifi bone marrow addit chimer antigen receptor cell observ cerebrospin fluid csf persist high level least 6 month eight grade 3 4 advers event note cytokine-releas syndrom b-cell aplasia develop patient one child cytokine-releas syndrom sever cytokin blockad etanercept tocilizumab effect revers syndrom prevent expans chimer antigen receptor cell reduc antileukem efficaci complet remiss observ patient ongo one patient 11 month treatment patient relaps blast cell longer express cd19 approxim 2 month treatment chimer antigen receptor-modifi cell capabl kill even aggress treatment-refractori acut leukemia cell vivo emerg tumor cell longer express target indic need target molecul addit cd19 patient',\n",
       "  'extended-connect fingerprint ecfp novel class topolog fingerprint molecular character histor topolog fingerprint develop substructur similar search ecfp develop specif structure-act model ecfp circular fingerprint number use qualiti rapidli calcul predefin repres essenti infinit number differ molecular featur includ stereochem inform featur repres presenc particular substructur allow easier interpret analysi result ecfp algorithm tailor gener differ type circular fingerprint optim differ use use ecfp wide adopt valid descript implement previous present literatur',\n",
       "  'hiv-1 replic within macrophag cn often result cognit motor impair known hiv-associ dementia sever form ifn-beta suppress viral replic within cell earli cn infect effect transient hiv-1 eventu overcom protect innat immun respons resum replic unknown mechan initi progress toward articl show suppressor cytokin signal soc 3 molecular inhibitor ifn signal may allow hiv-1 evad innat immun within cn found socs3 elev vivo siv/macaqu model pattern express correl recurr viral replic onset cn diseas vitro hiv-1 regulatori protein transactiv transcript induc socs3 human murin macrophag nf-kappab-depend manner socs3 express attenu respons macrophag ifn-beta proxim level pathway activ downstream antivir gene express consequ overcom inhibitori effect ifn-beta hiv-1 replic studi indic socs3 express induc stimuli present hiv-1-infect brain transactiv transcript inhibit antivir ifn-beta signal enhanc hiv-1 replic macrophag consequ socs3 express vitro support correl increas viral load onset cn diseas vivo suggest socs3 may allow hiv-1 evad protect innat immun respons within cn allow recurr viral replic ultim promot progress toward',\n",
       "  '26 proteasom play fundament role eukaryot homeostasi undertak highli control degrad wide rang protein includ key cellular regul control cell-cycl progress apoptosi report structur human 26 proteasom determin cryo-electron microscopi single-particl analysi secondari structur element identifi 20 proteolyt core region 19 regulatori particl use inform togeth crystal structur homolog model biochem inform construct molecular model complet 26 proteasom model allow detail descript 20 core within 26 proteasom redefin overal assign subunit within 19 regulatori particl inform present provid strong basi mechanist understand 26 proteasom',\n",
       "  'studi question women undergo ivf urinari bisphenol bpa concentr associ ovarian respons earli reproduct outcom includ oocyt matur fertil day 3 embryo qualiti blastocyst format summari answer higher urinari bpa concentr found associ decreas ovarian respons number fertil oocyt decreas blastocyst format known alreadi experiment anim vitro studi report associ bpa exposur advers reproduct outcom previous report associ urinari bpa decreas ovarian respons peak serum estradiol e 2 oocyt count time retriev women undergo ivf howev limit human data reproduct health outcom fertil embryo develop studi design size durat prospect preconcept cohort studi one hundr seventy-four women age 18-45 year undergo 237 ivf cycl recruit massachusett gener hospit fertil center boston usa novemb 2004 august 2010. women follow either live birth discontinu treatment cryothaw donor egg cycl includ analysi participants/materi set method urinari bpa concentr measur onlin solid-phas extraction-high-perform liquid chromatography-isotop dilution-tandem mass spectrometri mix effect model poisson regress multivari logist regress model use wherev appropri evalu associ cycle-specif urinari bpa concentr measur ovarian respons oocyt matur metaphas ii fertil embryo qualiti cleavag rate account correl among multipl ivf cycl woman use gener estim equat main result role chanc geometr mean sd urinari bpa concentr 1.50 2.22 µg/l adjust age potenti confound day 3 serum fsh smoke bmi signific linear dose-respons associ increas urinari bpa concentr decreas number oocyt overal matur decreas number normal fertil oocyt decreas e 2 level mean decreas 40 253 471 pg/ml urinari bpa quartil 2 3 4 compar lowest quartil respect p-valu trend 0.001 mean number oocyt normal fertil oocyt decreas 24 27 respect highest versu lowest quartil urinari bpa trend test p 0.001 0.002 respect women urinari bpa lowest quartil decreas blastocyst format trend test p-valu 0.08 limit reason caution potenti limit includ exposur misclassif due short half-lif bpa high variabl time uncertainti generaliz result gener popul women conceiv natur limit sampl wider implic find result extend studi use ivf model studi earli reproduct health outcom human indic neg dose-respons associ urinari bpa concentr serum peak e 2 oocyt yield confirm previou find addit found significantli decreas metaphas ii oocyt count number normal fertil oocyt suggest associ bpa urinari concentr decreas blastocyst format thu indic bpa may alter reproduct function suscept women undergo ivf studi funding/compet interest work support grant es009718 es000002 nation institut environment health scienc grant oh008578 nation institut occup safeti health none author actual potenti compet financi interest disclaim find conclus report author necessarili repres view center diseas control prevent',\n",
       "  'background diagnosi hypertens tradit base blood-pressur measur clinic home ambulatori measur better correl cardiovascular outcom ambulatori monitor accur clinic home monitor diagnos hypertens aim compar cost-effect differ diagnost strategi hypertens method markov model-bas probabilist cost-effect analysi use hypothet primary-car popul age 40 year older screen blood-pressur measur greater 140/90 mm hg risk-factor preval equival gener popul compar three diagnost strategies-furth blood pressur measur clinic home ambulatori monitor-in term lifetim cost quality-adjust life year cost-effect find ambulatori monitor cost-effect strategi diagnosi hypertens men women age cost-sav group -£56 95 ci -105 -10 men age 75 year -£323 -389 -222 women age 40 year result quality-adjust life year men women older 50 year 0·006 0·000 0·015 women age 60 year 0·022 0·012 0·035 men age 70 year find robust assess wide rang determinist sensit analys around base case sensit home monitor judg equal test perform ambulatori monitor treatment judg effect irrespect whether individu hypertens interpret ambulatori monitor diagnost strategi hypertens initi rais read clinic would reduc misdiagnosi save cost addit cost ambulatori monitor counterbalanc cost save better target treatment ambulatori monitor recommend patient start antihypertens drug fund nation institut health research nation institut health clinic excel',\n",
       "  'background homocystein risk factor coronari arteri diseas cad although causal relat remain proven import determin direct causal rest fact plasma homocystein safe inexpens reduc 25 folic acid reduct maxim achiev dose 0.4 mg/d high-dos folic acid 5 mg/d improv endotheli function cad although mechan controversi propos improv occur reduct total thci free non-protein bound homocystein fhci investig effect folic acid endotheli function chang homocystein patient cad method result random placebo-control studi folic acid 5 mg/d 6 week undertaken 33 patient endotheli function assess flow-medi dilat fmd measur 2 4 hour first dose folic acid 6 week treatment plasma folat increas markedli 1 hour 200 compar 25.8 nmol/l p 0.001 fmd improv 2 hour 83 compar 47 microm p 0.001 larg complet 4 hour 101 compar 51 microm p 0.001 thci significantli differ acut 4-hour thci 9.56 compar 9.79 micromol/l p=n fhci differ 3 hour slightli reduc 4 hour 1.55 compar 1.78 micromol/l p=0.02 fmd improv correl reduct either fhci thci time conclus data suggest folic acid improv endotheli function cad acut mechan larg independ homocystein',\n",
       "  'exuber fibroprolifer common complic injuri reason well understood one key compon wound repair often overlook mechan forc regul cell-matrix interact intracellular focal adhes compon includ focal adhes kinas fak report fak activ cutan injuri process potenti mechan load fibroblast-specif fak knockout mice substanti less inflamm fibrosi control mice model hypertroph scar format show fak act extracellular-rel kinas erk mechan trigger secret monocyt chemoattract protein-1 mcp-1 also known ccl2 potent chemokin link human fibrot disord similarli mcp-1 knockout mice form minim scar indic inflammatori chemokin pathway major mechan fak mechanotransduct induc fibrosi small-molecul inhibit fak block effect human cell reduc scar format vivo attenu mcp-1 signal inflammatori cell recruit find collect indic physic forc regul fibrosi inflammatori fak–erk–mcp-1 pathway molecular strategi target fak effect uncoupl mechan forc patholog scar format',\n",
       "  'import sepsis-3 criteria emphas valu chang 2 point sequenti sepsis-rel organ failur assess sofa score introduc quick sofa qsofa remov system inflammatori respons syndrom sir criteria sepsi definit object extern valid assess discriminatori capac increas sofa score 2 point 2 sir criteria qsofa score 2 point outcom among patient critic ill suspect infect design set particip retrospect cohort analysi 184 875 patient infection-rel primari admiss diagnosi 182 australian new zealand intens care unit icu 2000 2015. exposur sofa qsofa sir criteria appli data collect within 24 hour icu admiss main outcom measur primari outcom in-hospit mortal in-hospit mortal icu length stay lo 3 day composit secondari outcom discrimin assess use area receiv oper characterist curv auroc adjust analys perform use model baselin risk determin use variabl independ score system result among 184 875 patient mean age 62.9 year sd 17.4 women 82 540 44.6 common diagnosi bacteri pneumonia 32 634 17.7 total 34 578 patient 18.7 die hospit 102 976 patient 55.7 die experienc icu lo 3 day sofa score increas 2 point 90.1 86.7 manifest 2 sir criteria 54.4 qsofa score 2 point sofa demonstr significantli greater discrimin in-hospit mortal crude auroc 0.753 99 ci 0.750-0.757 sir criteria crude auroc 0.589 99 ci 0.585-0.593 qsofa crude auroc 0.607 99 ci 0.603-0.611 increment improv 0.164 99 ci 0.159-0.169 sofa vs sir criteria 0.146 99 ci 0.142-0.151 sofa vs qsofa p .001 sofa auroc 0.736 99 ci 0.733-0.739 outperform score secondari end point sir criteria auroc 0.609 99 ci 0.606-0.612 qsofa auroc 0.606 99 ci 0.602-0.609 increment improv 0.127 99 ci 0.123-0.131 sofa vs sir criteria 0.131 99 ci 0.127-0.134 sofa vs qsofa p .001 find consist outcom multipl sensit analys conclus relev among adult suspect infect admit icu increas sofa score 2 greater prognost accuraci in-hospit mortal sir criteria qsofa score find suggest sir criteria qsofa may limit util predict mortal icu set',\n",
       "  \"understand factor influenc mammograph dens nondens area import percent mammograph densiti adjust age strong continu distribut risk factor breast cancer especi adjust weight bodi mass index use computer-assist method measur mammograph dens area 571 monozygot 380 dizygot australian north american twin pair age 40 70 year use novel regress model approach twin 's measur dens nondens area regress one twin 's co-twin 's covari natur chang regress estim inclus twin and/or co-twin 's covari evalu consist causal and/or model causal mean possibl vari covari experiment expect valu outcom measur would chang adjust individu 's weight co-twin associ weight attenu consist causal effect weight mammograph measur absolut log cm 2 /kg thrice stronger nondens dens area adjust weight later age menarch greater height associ greater dens lesser nondens area manner inconsist causal associ dens nondens area pariti consist causal effect and/or within-person confound associ mammograph densiti measur height consist share earli life environment factor predispos height percent mammograph densiti possibl breast cancer risk\",\n",
       "  'cell divis requir unwind million dna base pair allow chromosom duplic gene transcript dna replic transcript share templat conflict process unavoid head-on collis thought particularli problemat surprisingli recent studi report unperturb cell cycl progress escherichia coli cell ectop replic origin highli transcrib rrn operon forc replic opposit normal studi re-gener similar strain found doubl time twice normal cell replic profil background reveal signific deviat comparison wild-typ profil particularli highli transcrib region termin area deviat allevi mutat either inactiv termin area destabilis rna polymeras complex allow easier displac replic fork data demonstr head-on replication-transcript conflict highli problemat inde analysi replic profil previous publish e. coli construct reveal chromosom rearrang allevi replication-transcript conflict intriguingli simpl way data support idea avoid head-on collis significantli contribut shape distinct architectur bacteri chromosom',\n",
       "  'without epithelial–mesenchym transit polar epitheli cell convert motil cell multicellular organ would incap get past blastula stage embryon develop howev import development programm sinist role tumour progress epithelial–mesenchym transit provid new basi understand progress carcinoma toward dedifferenti malign state',\n",
       "  \"although primarili recogn role hemostasi thrombosi platelet increasingli recogn multipurpos cell inde circul platelet abil influenc wide rang seemingli unrel pathophysiolog event highlight notabl observ link platelet inflamm reinforc platelet 's origin lower vertebr cell type hemostat immunolog role addit consid relev platelet cancer biolog focus hallmark cancer way platelet influenc multistep develop tumor beyond tradit role hemostasi thrombosi platelet 's involv interplay hemostasi thrombosi inflamm cancer like complex yet extrem import diseas process exist anim model platelet dysfunct current use antiplatelet therapi provid framework understand mechanist insight wide rang pathophysiolog event thu basic scientist studi platelet function think beyond tradit hemostasi thrombosi paradigm practic hematologist must appreci platelet relev wide rang diseas process\",\n",
       "  'dna topoisomeras magician dna world — allow dna strand doubl helic pass solv topolog problem dna replic transcript cellular transact extens biochem structur studi past three decad provid molecular model variou subfamili dna topoisomeras manipul dna review cellular role enzym examin molecular point view',\n",
       "  \"microrna mirna `` spong '' method introduc three year ago mean creat continu mirna loss function cell line transgen organ spong rna contain complementari bind site mirna interest produc transgen within cell mirna target gene spong 's bind site specif mirna seed region allow block whole famili relat mirna transgen approach proven use tool probe mirna function varieti experiment system discuss way spong relat construct optim review recent applic method particular emphasi stabl express cancer studi transgen anim\",\n",
       "  'colorect cancer one major caus cancer-rel death gain insight mechan underli develop investig role wip1 phosphatas highli express intestin stem cell mous model apc min -driven polyposi found wip1 remov increas life span apc min mice signific suppress polyp format protect depend p53 tumor suppressor play put role regul apoptosi intestin stem cell activ apoptosi stem cell wip1-defici mice wild-typ apc min mice increas wnt pathway constitut activ propos therefor wip1 phosphatas regul homeostasi intestin stem cell turn wip1 loss suppress apc min -driven polyposi lower threshold p53-depend apoptosi stem cell thu prevent convers tumor-initi stem cell',\n",
       "  'network blood vessel normal tumour tissu heterogen structur wide vari blood flow pathway length achiev effici blood flow distribut mechan structur adapt vessel diamet must abl inhibit format function shunt wherebi short pathway becom enlarg flow bypass long pathway adapt requir inform tissu metabol statu commun upstream feed vessel conduct respons propos impair vascular commun tumour microvascular network lead function shunt primari caus dysfunct microcircul local hypoxia cancer suggest anti-angiogen treatment tumour may restor vascular commun therebi improv normal flow distribut tumour vasculatur',\n",
       "  'uniqu metabol demand cancer cell underscor potenti fruit opportun drug discoveri era precis medicin howev therapeut target cancer metabol led surprisingli new drug date neutral amino acid glutamin serv key intermedi numer metabol process leverag cancer cell includ biosynthesi cell signal oxid protect herein report preclin develop v-9302 competit small molecul antagonist transmembran glutamin flux select potent target amino acid transport asct2 pharmacolog blockad asct2 v-9302 result attenu cancer cell growth prolifer increas cell death increas oxid stress collect contribut antitumor respons vitro vivo first studi knowledg demonstr util pharmacolog inhibitor glutamin transport oncolog repres new class target therapi lay framework paradigm-shift therapi target cancer cell metabol',\n",
       "  'serotonin signal suppress gener amyloid-β aβ vitro anim model alzheim ’ diseas ad show age transgen ad mous model app/ps1 plaque-bear mice antidepress citalopram select serotonin reuptak inhibitor decreas aβ brain interstiti fluid dose-depend manner growth individu amyloid plaqu assess plaque-bear mice chronic administ citalopram citalopram arrest growth preexist plaqu reduc appear new plaqu 78 healthi human volunt citalopram ’ effect aβ product aβ concentr cerebrospin fluid csf measur prospect use stabl isotop label kinet csf sampl acut dose citalopram aβ product csf slow 37 citalopram group compar placebo chang associ 38 decreas total csf aβ concentr drug-treat group abil safe decreas aβ concentr potenti import prevent strategi ad studi demonstr key target engag futur ad prevent trial',\n",
       "  \"aim investig pattern chang hba1c peopl type 1 diabet manag long-term continu subcutan insulin infus method studi hba1c chang use computer clinic record 35 adult peopl type 1 diabet elev hba1c ≥ 64 mmol/mol 8.0 multipl daili insulin inject switch continu subcutan insulin infus least 5 year result identifi three subgroup similar baselin hba1c differ long-term respons pump therapi group -- improv follow deterior 57 group b -- improv sustain throughout 5 year 31 group c-those hba1c chang significantli baselin 12 patient group c higher bmi 31.0 ± 5.2 vs. 25.9 ± 3.3 vs. 25.2 ± 3.1 kg/m² group c vs. group group b p 0.02 conclus improv glycaem control continu subcutan insulin infus maintain 5 year 88 peopl type 1 diabet studi variat long-term efficaci peopl improv worsen other maintain strict control subcutan insulin infus 'non-respond\",\n",
       "  \"studi thrombopoiesi evolv greatli sinc era platelet term `` dust blood '' 100 year ago time megakaryocyt identifi origin blood platelet marrow-deriv megakaryocyt progenitor cell function defin purifi primari regul process thrombopoietin clone character therapeut thrombopoiet agent develop journey continu learn physiolog mechan drive proplatelet format recapitul cell-fre system biochemistri evalu molecular underpin endomitosi increasingli understood intracellular signal sent engag larg number megakaryocyt surfac receptor defin mani transcript factor drive megakaryocyt fate determin identifi experiment manipul biolog process mimic seen cell type megakaryocyt platelet possess enough uniqu development featur virtual assur continu studi thrombopoiesi yield innumer clinic scientif insight mani decad come\",\n",
       "  'accumul evid indic obes close associ increas risk metabol diseas insulin resist type 2 diabet dyslipidemia nonalcohol fatti liver diseas obes result imbal food intak energi expenditur lead excess accumul adipos tissu adipos tissu recogn main site storag excess energi deriv food intak also endocrin organ expans adipos tissu produc number bioactiv substanc known adipocytokin adipokin trigger chronic low-grad inflamm interact rang process mani differ organ although precis mechan still unclear dysregul product secret adipokin caus excess adipos tissu adipos tissu dysfunct contribut develop obesity-rel metabol diseas review focu role sever adipokin associ obes potenti impact obesity-rel metabol diseas multipl line evid provid valuabl insight role adipokin develop obes metabol complic research still requir fulli understand mechan underli metabol action newli identifi adipokin',\n",
       "  'trastuzumab success ration design erbb2-target therapi howev half individu erbb2-overexpress breast cancer respond trastuzumab-bas therapi owe variou resist mechan clinic applic regimen overcom trastuzumab resist differ mechan yet avail show nonreceptor tyrosin kinas c-src src key modul trastuzumab respons common node downstream multipl trastuzumab resist pathway find src activ acquir de novo trastuzumab-resist cell uncov novel mechan src regul involv dephosphoryl pten increas src activ confer consider trastuzumab resist breast cancer cell correl trastuzumab resist patient target src combin trastuzumab sensit multipl line trastuzumab-resist cell trastuzumab elimin trastuzumab-resist tumor vivo suggest potenti clinic applic strategi overcom trastuzumab resist',\n",
       "  'microrna mirna evolutionarili conserv small noncod rna involv regul gene express protein translat mani studi shown play crucial role drive organ tissu differenti embryogenesi fine-tun fundament biolog process prolifer apoptosi grow evid indic deregul play import role cancer onset progress well act oncogen oncosuppressor review highlight recent find regard role mirna hepatocellular carcinoma hcc analyz possibl mechan contribut neoplasm moreov discuss possibl role circul mirna biomark field need urgent improv clinic surveil hcc fascin possibl use therapeut target drug',\n",
       "  \"eukaryot numer checkpoint pathway protect genom fidel normal cell divis respons dna damag screen g2/m checkpoint regul zebrafish identifi ticrr topbp1-interact checkpoint replic regul previous uncharacter gene requir prevent mitot entri treatment ioniz radiat ticrr defici embryonic-leth absenc exogen dna damag essenti normal cell cycl progress specif loss ticrr impair dna replic disrupt s/m checkpoint lead prematur mitot entri mitot catastroph show human ticrr ortholog associ topbp1 known checkpoint protein core compon dna replic preiniti complex pre-ic ticrr-topbp1 interact stabl without chromatin requir brct motif essenti topbp1 's replic checkpoint function importantli find ticrr defici disrupt chromatin bind pre-ic prerepl complex compon taken togeth data show ticrr act associ topbp1 play essenti role pre-ic format remain determin whether ticrr repres vertebr ortholog yeast pre-ic compon sld3 hitherto unknown metazoan replic checkpoint regul\",\n",
       "  'loss imprint igf2 gener h19-independ mechan associ larg percentag patient overgrowth cancer predisposit condit beckwith-wiedemann syndrom bw imprint control element propos exist within kvlqt1 locu multipl bws-associ chromosom rearrang disrupt gene identifi evolutionarili conserv matern methyl cpg island kvdmr1 intron kvlqt1 gene among 12 case bw normal h19 methyl 5 show demethyl kvdmr1 fibroblast lymphocyt dna wherea 4 case bw h19 hypermethyl methyl kvdmrl normal thu inactiv h19 hypomethyl kvdmr1 associ phenomenon repres distinct epigenet anomali associ biallel express igf2 revers transcription-pcr analysi human synten mous loci identifi presenc kvdmr1-associ rna transcrib exclus patern allel opposit orient respect matern express kvlqt1 gene propos kvdmr1 and/or associ antisens rna kvlqt1-a repres addit imprint control element center human 11p15.5 mous distal 7 imprint domain',\n",
       "  'resist anti-tuberculosi tb medicin major public health threat countri former soviet union repres quality-assur inform magnitud problem exist belaru survey conduct capit citi minsk novemb 2009 decemb 2010 156 consecut diagnos new 68 previous treat culture-posit tb patient resid minsk enrol survey mycobacterium tuberculosi isol obtain patient test suscept first- second-lin anti-tb drug multidrug-resist mdr -tb found 35.3 95 ci 27.7-42.8 new patient 76.5 95 ci 66.1-86.8 previous treat overal nearli one two patient enrol mdr-tb extens drug-resist tb report 15 107 mdr-tb patient 14.0 95 ci 7.3-20.7 patient 35 yr age shown two time higher odd ratio multidrug-resist tb age 35 yr find survey minsk citi alarm repres highest proport mdr-tb ever record world studi greatli contribut understand burden drug-resist tb urban area belaru',\n",
       "  'immun clearanc resourc limit via red blood cell deplet shape peak trough malaria parasitemia turn affect diseas sever transmiss quantit partit rel role effect time challeng use data rodent malaria estim effect propag number reflect rel import contrast within-host control mechan time sensit inocul parasit dose analysi show capac innat respons restrict initi parasit growth satur parasit dose experiment enhanc innat immun affect parasit densiti indirectli via resourc deplet statist approach offer tool improv target drug vaccin human therapi reveal dynam interact within-host regulatori mechan',\n",
       "  ...],\n",
       " ['microstructur develop human newborn cerebr white matter assess vivo diffus tensor magnet reson imag alter architectur cerebr white matter develop human brain affect cortic develop result function disabl line scan diffusion-weight magnet reson imag mri sequenc diffus tensor analysi appli measur appar diffus coeffici calcul rel anisotropi delin three-dimension fiber architectur cerebr white matter preterm n 17 full-term infant n 7 assess effect prematur cerebr white matter develop earli gestat preterm infant n 10 studi second time term central white matter mean appar diffus coeffici 28 wk high 1.8 microm2/m decreas toward term 1.2 microm2/m posterior limb intern capsul mean appar diffus coeffici time similar 1.2 versu 1.1 microm2/m rel anisotropi higher closer birth term greater absolut valu intern capsul central white matter preterm infant term show higher mean diffus coeffici central white matter 1.4 +/- 0.24 versu 1.15 +/- 0.09 microm2/m p 0.016 lower rel anisotropi area compar full-term infant white matter 10.9 +/- 0.6 versu 22.9 +/- 3.0 p 0.001 intern capsul 24.0 +/- 4.44 versu 33.1 +/- 0.6 p 0.006 nonmyelin fiber corpu callosum visibl diffus tensor mri earli 28 wk full-term preterm infant term show mark differ white matter fiber organ data indic quantit assess water diffus diffus tensor mri provid insight microstructur develop cerebr white matter live infant',\n",
       "  'induct myelodysplasia myeloid-deriv suppressor cell myelodysplast syndrom md age-depend stem cell malign share biolog featur activ adapt immun respons ineffect hematopoiesi report myeloid-deriv suppressor cell mdsc classic link immunosuppress inflamm cancer markedli expand bone marrow md patient play pathogenet role develop ineffect hematopoiesi clonal distinct mdsc overproduc hematopoiet suppress cytokin function potent apoptot effector target autolog hematopoiet progenitor use multipl transfect cell model found mdsc expans driven interact proinflammatori molecul s100a9 cd33 2 protein form function ligand/receptor pair recruit compon cd33 ’ immunoreceptor tyrosine-bas inhibit motif itim induc secret suppress cytokin il-10 tgf-β immatur myeloid cell s100a9 transgen mice display bone marrow accumul mdsc accompani develop progress multilineag cytopenia cytolog dysplasia importantli earli forc matur mdsc either all-trans-retino acid treatment activ immunoreceptor tyrosine-bas activ motif–bear itam-bear adapt protein dap12 interrupt cd33 signal rescu hematolog phenotyp find indic primari bone marrow expans mdsc driven s100a9/cd33 pathway perturb hematopoiesi contribut develop md',\n",
       "  \"bc1 rna transcript master gene id element amplif abl prime revers transcript id element short interspers element sine found high copi number mani rodent genom bc1 rna id-rel transcript deriv singl copi bc1 rna gene bc1 rna gene shown master gene id element amplif rodent genom id element dispers process term retroposit retroposit process involv number potenti regulatori step regulatori step may includ transcript appropri tissu transcript stabil prime rna transcript revers transcript integr studi focus prime rna transcript revers transcript bc1 rna gene transcript shown abl prime revers transcript effici intramolecular site-specif fashion self-prim abil consequ secondari structur 3'-uniqu region observ gene activ amplifi throughout rodent evolut make rna capabl effici self-prim revers transcript strongli suggest self-prim least one featur establish bc1 rna gene master gene amplif id element\",\n",
       "  'dna methylom human peripher blood mononuclear cell dna methyl play import role biolog process human health diseas recent technolog advanc allow unbias whole-genom dna methyl methylom analysi carri human cell use whole-genom bisulfit sequenc 24.7-fold coverag 12.3-fold per strand report comprehens 92.62 methylom analysi uniqu sequenc human peripher blood mononuclear cell pbmc asian individu whose genom deciph yh project pbmc constitut import sourc clinic blood test world-wid found 68.4 cpg site 0.2 non-cpg site methyl demonstr non-cpg cytosin methyl minor human pbmc analysi pbmc methylom reveal rich epigenom landscap 20 distinct genom featur includ regulatori protein-cod non-cod rna-cod repeat sequenc integr methylom data yh genom sequenc enabl first comprehens assess allele-specif methyl asm two haploid methylom individu allow identif 599 haploid differenti methyl region hdmr cover 287 gene 76 gene hdmr within 2 kb transcript start site 80 display allele-specif express ase data demonstr asm recurr phenomenon highli correl ase human pbmc togeth recent report similar studi studi provid comprehens resourc futur epigenom research confirm new sequenc technolog paradigm large-scal epigenom studi',\n",
       "  'human myelin basic protein gene includ within 179-kilobas transcript unit express immun central nervou system two human golli gene express oligodendrocyt lineag -mbp myelin basic protein cdna isol human oligodendroglioma cell line analysi cdna enabl us determin entir structur human golli-mbp gene golli-mbp gene encompass mbp transcript unit approxim 179 kb length consist 10 exon seven constitut mbp gene human golli-mbp gene contain two transcript start site give rise famili altern splice transcript least two golli-mbp transcript contain first three exon gene one mbp exon produc first transcript start site second famili transcript contain mbp exon produc well-known mbp human rna blot analysi reveal golli-mbp transcript express fetal thymu spleen human b-cell macrophag cell line well fetal spinal cord find clearli link express exon encod autoimmunogen/encephalitogen mbp central nervou system cell tissu immun system normal express golli-mbp gene also establish genet locu includ mbp gene conserv among speci provid evid mbp transcript unit integr part golli transcript unit suggest structur arrang import genet function and/or regul gene',\n",
       "  'target a20 decreas glioma stem cell surviv tumor growth glioblastoma deadli cancer display function cellular hierarchi maintain self-renew glioblastoma stem cell gsc gsc regul molecular pathway distinct bulk tumor may use therapeut target determin a20 tnfaip3 regul cell surviv nf-kappab pathway overexpress gsc rel non-stem glioblastoma cell mrna protein level determin function signific a20 gsc target a20 express lentiviral-medi deliveri short hairpin rna shrna inhibit a20 express decreas gsc growth surviv mechan associ decreas cell-cycl progress decreas phosphoryl p65/rela elev level a20 gsc contribut apoptot resist gsc less suscept tnfalpha-induc cell death match non-stem glioma cell a20 knockdown sensit gsc tnfalpha-medi apoptosi decreas surviv gsc upon a20 knockdown contribut reduc abil cell self-renew primari secondari neurospher format assay tumorigen potenti gsc decreas a20 target result increas surviv mice bear human glioma xenograft silico analysi glioma patient genom databas indic a20 overexpress amplif invers correl surviv togeth data indic a20 contribut glioma mainten effect glioma stem cell subpopul although inactiv mutat a20 lymphoma suggest a20 act tumor suppressor similar point mutat identifi glioma genom sequenc fact data suggest a20 may function tumor enhanc glioma promot gsc surviv a20 anticanc therapi therefor view caution effect like differ depend tumor type',\n",
       "  'effici target express silent gene human esc ipsc use zinc-fing nucleas realiz full potenti human embryon stem cell hesc induc pluripot stem cell hipsc requir effici method genet modif howev techniqu gener cell type–specif lineag report well reliabl tool disrupt repair overexpress gene gene target ineffici best thu routin use report highli effici target three gene human pluripot cell use zinc-fing nucleas zfn –mediat genom edit first use zfn specif oct4 pou5f1 locu gener oct4-egfp report cell monitor pluripot state hesc second insert transgen aavs1 locu gener robust drug-induc overexpress system hesc final target pitx3 gene demonstr zfn use gener report cell target non-express gene hesc hipsc',\n",
       "  'empir bayesian model analys molecular serotyp microarray background microarray offer great potenti platform molecular diagnost test clinic sampl presenc numer biomark highli multiplex assay studi appli infecti diseas data microarray design molecular serotyp streptococcu pneumonia use identifi presenc one 91 known pneumococc serotyp dna extract microarray incorpor oligonucleotid probe known capsular polysaccharid synthesi gene requir statist analysi microarray intens data determin serotyp combin serotyp present within sampl base combin gene detect result propos empir bayesian model calcul probabl combin serotyp microarray data model take consider depend serotyp induc gene common homolog gene although ident similar sequenc serotyp similar capsular gene composit extra probe includ microarray provid addit inform integr bayesian model serotyp combin high probabl second model bayesian random effect model appli determin rel abund serotyp conclus assess accuraci propos analysi appli method experiment data sampl contain individu serotyp sampl contain combin serotyp known level abund two known serotyp s. pneumonia test individu sampl could uniqu determin bayesian model model also enabl presenc combin serotyp within sampl determin serotyp low abund within combin serotyp detect 2 abund studi well detect presenc serotyp combin approxim measur percentag abund serotyp within combin obtain',\n",
       "  \"bayesian measur model complex fit summari consid problem compar complex hierarch model number paramet clearli defin use inform theoret argument deriv measur pd effect number paramet model differ posterior mean devianc devianc posterior mean paramet interest gener pd approxim correspond trace product fisher 's inform posterior covari normal model trace ‘ hat ’ matrix project observ onto fit valu properti exponenti famili explor posterior mean devianc suggest bayesian measur fit adequaci contribut individu observ fit complex give rise diagnost plot devianc residu leverag ad pd posterior mean devianc give devianc inform criterion compar model relat inform criteria approxim decis theoret justif procedur illustr exampl comparison drawn altern bayesian classic propos throughout emphas quantiti requir trivial comput markov chain mont carlo analysi\",\n",
       "  'simplifi likelihood ratio likelihood ratio one best measur diagnost accuraci although seldom use interpret requir calcul convert back forth “ probabl ” “ odd ” diseas articl describ simpler method interpret likelihood ratio one avoid calcul nomogram convers “ odd ” diseas sever exampl illustr clinician use method refin diagnost decis bedsid',\n",
       "  'induct earli ifn-induc gene absenc type recognit influenza viru flu tlr7 plasmacytoid dendrit cell pdc produc type ifn signific amount synthet tlr7 ligand induc matur pdc evidenc express costimulatori molecul product proinflammatori cytokin howev induc low-level product ifn-alpha dissect tlr7 signal pdc differ profil induc studi effect 2 tlr7 ligand flu cl097 activ blood-isol pdc human gen2.2 pdc cell line type ifn product pdc correl differenti interferon regulatori factor 7 irf7 transloc nucleu induc 2 tlr7 ligand surprisingli activ nevertheless observ rapid express ifn-induc gene mxa cxcl10 trail within 4 hour stimul express control stat1 phosphoryl independ type ifn stat1 activ found strictli depend pi3k-p38mapk pathway show new signal pathway lead rapid express ifn-induc gene tlr7 trigger thu pdc unusu tlr7 signal capac promptli respond viral infect earli phase innat immun respons',\n",
       "  'arteriolar function viscer adipos tissu impair human obes object purpos studi character relationship adipos tissu phenotyp depot-specif microvascular function fat method result 30 obes subject age 42±11 year bodi mass index 46±11 kg/m 2 undergo bariatr surgeri intraop collect viscer subcutan adipos tissu character depot-specif adipos phenotyp assess vasomotor function adipos microvasculatur use videomicroscopi small arteriol 75-250 μm isol differ fat compart endothelium-depend acetylcholine-medi vasodil sever impair viscer arteriol compar subcutan depot p 0.001 anova nonendothelium depend respons papaverin nitroprussid similar endotheli nitric oxid synthas inhibit n ω -nitro-l-arginin methyl ester reduc subcutan vasodil effect sever blunt viscer arteriolar respons viscer fat exhibit greater express proinflammatori oxid stress-rel hypoxia-induc proangiogen gene increas activ macrophag popul higher capac cytokin product ex vivo conclus find provid clinic evid viscer microenviron may intrins toxic arteri health provid potenti mechan viscer adipos burden link atherosclerot vascular diseas find also support evolv concept adipos tissu qualiti quantiti may play signific role shape cardiovascular phenotyp human obes',\n",
       "  'common carotid intima media thick ankle-brachi pressur index correl local global atheroma burden cross section studi use whole bodi magnet reson angiographi background common carotid intima media thick cimt ankl brachial pressur index abpi use surrog marker atherosclerosi shown correl arteri stiff howev correl global atherosclerot burden previous assess compar cimt abpi atheroma burden measur whole bodi magnet reson angiographi wb-mra method 50 patient symptomat peripher arteri diseas recruit cimt measur use ultrasound rest exercis abpi perform wb-mra perform 1.5t mri scanner use 4 volum acquisit divid dose intraven gadolinium gadoter meglumin dotarem guerbet fr wb-mra data divid 31 anatom arteri segment score accord degre lumin narrow 0 normal 1 50 2 50-70 3 70-99 4 vessel occlus segment score sum standard atheroma score calcul result atherosclerot burden high standardis atheroma score 39.5±11 common cimt show posit correl whole bodi atheroma score β 0.32 p 0.045 howev due strong correl neck thorac segment β 0.42 p 0.01 correl rest bodi abpi correl whole bodi atheroma score β -0.39 p 0.012 due strong correl ilio-femor vessel correl thorac neck vessel multipl linear regress correl cimt global atheroma burden present β 0.13 p 0.45 correl abpi atheroma burden persist β -0.45 p 0.005 conclus abpi cimt correl global atheroma burden measur whole bodi contrast enhanc magnet reson angiographi popul symptomat peripher arteri diseas howev primarili due strong correl ilio-femor atheroma burden',\n",
       "  'loss immun escap mutat persist hcv infect pregnanc enhanc replic vertic transmit virus global 1 pregnant women persist infect hepat c viru hcv mother-to-child transmiss hcv occur 3-5 pregnanc account new childhood infect hcv-specif cd8 cytotox lymphocyt ctl vital clearanc acut hcv infect 60-80 infect persist cell becom function exhaust select mutant virus escap cell recognit increas hcv replic pregnanc suggest maternofet immun toler mechan may impair hcv-specif ctl limit select pressur persist virus assess possibl character circul viral quasispeci consecut pregnanc two women reveal loss escap mutat hla class epitop pregnanc associ emerg fit virus ctl select pressur reimpos childbirth point escap mutat epitop predomin quasispeci viral load drop sharpli importantli virus transmit perinat enhanc fit due revers escap mutat find indic immunoregulatori chang pregnanc reduc ctl select pressur hcv class epitop therebi facilit vertic transmiss virus optim replic fit',\n",
       "  'journey develop hematopoiet stem cell hematopoiet stem cell hsc develop embryogenesi complex process involv multipl anatom site hsc precursor specifi mesoderm matur function hsc undergo self-renew divis gener pool hsc process develop hsc migrat variou embryon nich provid signal establish conserv self-renew abil process recapitul gener hsc embryon stem cell elucid interact develop hsc nich facilit gener expans hsc vitro exploit clinic potenti',\n",
       "  'sacroiliac joint spondyloarthropathi term spondyloarthropathi spa describ defin group relat inflammatori joint diseas share characterist clinic featur uniqu associ major histocompat complex class molecul hla-b27 five subgroup differenti ankylos spondyl reactiv arthriti psoriat arthriti arthriti associ inflammatori bowel diseas undifferenti spa sacroiliac joint central involv spa clearli pathognomon ankylos spondyl patient affect earli diseas overcom diagnost difficulti earli sacroili dynam magnet reson imag shown visual acut chronic chang sacroiliac joint inflamm sacroiliac joint patient spa recent examin detail use immunohistolog situ hybridr cell macrophag variou cytokin found infiltr biopsi specimen obtain guid comput tomographi studi intra-articular corticosteroid treatment success undertaken investig biopsi specimen show absenc dna reactiv arthritis-associ bacteria pathogenesi spa reason tropism sacroiliac joint still obscur natur relat genet background spa initi trigger bacteri infect remain establish chronic diseas autoimmun mechan might import',\n",
       "  'rapid method extract cotton gossypium spp genom dna suitabl rflp pcr analysi extract high-qual genom dna fromgossypium cotton speci difficult due high level polysaccharid oxidiz quinon interf substanc describ procedur consist permit isol cotton genom dna satisfactori size qualiti rflp pcr analysi well routin clone applic sever antioxid phenol-bind reagent phenol oxidas inhibitor use throughout procedur polysaccharid elimin earli procedur isol nuclei',\n",
       "  \"cross section statur weight refer curv uk 1990. current refer curv statur weight uk first publish 1966 use ever sinc despit increas concern may adequ describ growth present day british children use current data seven sourc new refer curv estim birth 20 year children 1990. great major data nation repres analysi use cole 's lm method produc effici estim convent centil give good fit data curv differ current use curv key age statur weight view concern express current curv differ new curv propos curv present adopt new uk refer curv\",\n",
       "  'sutur provid nich mesenchym stem cell craniofaci bone bone tissu undergo constant turnov support stem cell recent studi show perivascular mesenchym stem cell msc contribut turnov long bone craniofaci bone flat bone deriv differ embryon origin long bone ident regul nich craniofacial-bon msc remain unknown identifi gli1+ cell within sutur mesenchym main msc popul craniofaci bone associ vasculatur give rise craniofaci bone adult activ injuri repair gli1+ cell typic msc vitro ablat gli1+ cell lead craniosynostosi arrest skull growth indic cell indispens stem cell popul twist1 +/- mice craniosynostosi show reduc gli1+ msc sutur suggest craniosynostosi may result diminish sutur stem cell studi indic craniofaci sutur provid uniqu nich msc craniofaci bone homeostasi repair',\n",
       "  'cardiac neural crest cell contribut dormant multipot stem cell mammalian heart arod cardiac side popul cell fraction form clonal spheroid serum-fre medium express nestin musashi-1 multi-drug resist transport gene 1 marker undifferenti neural precursor cell marker lost follow differenti replac express neuron- glial- smooth muscl cell– cardiomyocyte-specif protein cardiosphere-deriv cell transplant chick embryo migrat truncu arteriosu cardiac outflow tract contribut dorsal root ganglia spinal nerv aortic smooth muscl cell lineag studi use doubl transgen mice encod protein 0–cre/floxed-egfp reveal undifferenti differenti neural crest-deriv cell fetal myocardium undifferenti cell express gata-bind protein 4 nestin actinin wherea differenti cell identifi cardiomyocyt result suggest cardiac neural crest-deriv cell migrat heart remain dormant multipot stem cells—and right conditions—differenti cardiomyocyt typic neural crest-deriv cell includ neuron glia smooth muscl',\n",
       "  'mammalian target rapamycin signal pathway mediat epileptogenesi model tempor lobe epilepsi understand molecular mechan mediat epileptogenesi critic develop effect therapi epilepsi recent found mammalian target rapamycin mtor signal pathway involv epileptogenesi mtor inhibitor prevent epilepsi mous model tuber sclerosi complex investig potenti role mtor rat model tempor lobe epilepsi initi statu epilepticu acut kainate-induc seizur result biphas activ mtor pathway evid increas phospho-s6 p-s6 express initi rise p-s6 express start approxim 1 h seizur onset peak 3-6 h return baselin 24 h hippocampu neocortex reflect widespread stimul mtor signal acut seizur activ resolut statu epilepticu second increas p-s6 observ hippocampu start 3 peak 5-10 persist sever week kainat inject correl develop chronic epileptogenesi within hippocampu mtor inhibitor rapamycin administ kainat block acut chronic phase seizure-induc mtor activ decreas kainate-induc neuron cell death neurogenesi mossi fiber sprout develop spontan epilepsi late rapamycin treatment termin statu epilepticu block chronic phase mtor activ reduc mossi fiber sprout epilepsi neurogenesi neuron death find indic mtor signal mediat mechan epileptogenesi kainat rat model mtor inhibitor potenti antiepileptogen effect model',\n",
       "  'acut administr recombin angiopoietin-1 amelior multiple-organ dysfunct syndrom improv surviv murin sepsi introduct endotheli activ lead vascular barrier breakdown play essenti role pathophysiolog multiple-organ dysfunct syndrom mod sepsi increas evid suggest function vessel-protect factor angiopoietin-1 ang-1 ligand endothelial-specif tie2 receptor inhibit antagonist angiopoietin-2 ang-2 sepsi order revers effect sepsis-induc suppress ang-1 elev ang-2 aim investig whether intraven inject recombin human rh ang-1 protect mod murin sepsi method polymicrobiolog abdomin sepsi induc cecal ligat punctur clp mice treat either 1 μg intraven rhang-1 control buffer immedi clp induct everi 8h thereaft sham-oper anim serv time-match control result compar buffer-tr control rhang-1 treat septic mice show signific improv sever hematolog biochem indic mod moreov rhang-1 stabil endotheli barrier function evidenc inhibit protein leakag lung capillari alveolar compart histolog analysi reveal rhang-1 treatment attenu leukocyt infiltr lung kidney septic mice probabl due reduc endotheli adhes molecul express rhang-1 treat mice final protect effect rhang-1 treatment reflect improv surviv time lethal clp model conclus clinic relev murin sepsi model intraven rhang-1 treatment alon suffici significantli improv varieti sepsis-associ organ dysfunct surviv time like preserv endotheli barrier function studi need pave road clinic applic therapi concept',\n",
       "  'mechan link obes insulin resist type 2 diabet obes associ increas risk develop insulin resist type 2 diabet obes individu adipos tissu releas increas amount non-esterifi fatti acid glycerol hormon pro-inflammatori cytokin factor involv develop insulin resist insulin resist accompani dysfunct pancreat islet β-cell — cell releas insulin — failur control blood glucos level result abnorm β-cell function therefor critic defin risk develop type 2 diabet knowledg foster explor molecular genet basi diseas new approach treatment prevent',\n",
       "  \"track fate glomerular epitheli cell vivo use serial multiphoton imag novel mous model fluoresc lineag tag podocyt critic mainten healthi glomerular filter howev difficult studi intact kidney technic limit report develop serial multiphoton microscopi mpm glomeruli sever day visual motil podocyt pariet epitheli cell pec vivo podocin-gfp mice podocyt form sporad multicellular cluster unilater ureter ligat migrat pariet bowman 's capsul track singl cell podocin-confetti mice featur cell-specif express cfp gfp yfp rfp reveal simultan migrat multipl podocyt phosphoenolpyruv carboxykinas pepck -gfp mice serial mpm found pec-to-podocyt migrat nanotubul connect data support highli dynam rather static natur glomerular environ cellular composit futur applic new approach advanc understand mechan glomerular injuri regener\",\n",
       "  'ctcf bind h19 imprint control region mediat matern inherit higher-ord chromatin conform restrict enhanc access igf2 thought h19 imprint control region icr direct silenc matern inherit igf2 allel ctcf-depend chromatin insul icr shown interact physic silenc region igf2 differenti methyl region dmr 1 role ctcf chromatin loop whether restrict physic access distal enhanc igf2 known perform systemat chromosom conform captur analys igf2/h19 region 160 kb identifi sequenc interact physic distal enhanc icr found patern chromosom enhanc interact igf2 promot matern allel prevent ctcf bind within h19 icr ctcf bind matern icr regul interact matrix attach region mar 3 dmr1 igf2 thu form tight loop around matern igf2 locu may contribut silenc mutat ctcf bind site h19 icr lead loss ctcf bind de novo methyl ctcf target site within igf2 dmr1 show ctcf coordin region epigenet mark systemat chromosom conform captur analysi imprint cluster reveal ctcf critic role epigenet regul higher-ord chromatin structur gene silenc consider distanc genom',\n",
       "  'de novo assembl pml nuclear subcompart occur multipl pathway induc telomer elong telomerase-neg tumor cell use altern lengthen telomer alt pathway involv dna recombin repair maintain prolif potenti cytolog hallmark process accumul promyelocyt leukemia pml nuclear protein telomer dna form alt-associ pml bodi apb de novo format telomer pml nuclear subcompart investig recruit apb protein compon show function distinct protein abl initi format bona fide apb high effici self-organ self-propag manner includ 1 pml sp100 constitut compon pml nuclear bodi 2 telomer repeat bind factor 1 2 trf1 trf2 respect 3 dna repair protein nbs1 4 sumo e3 ligas mms21 well isol sumo1 domain interact domain anoth protein factor contrast repair factor rad9 rad17 rad51 less effici apb nucleat recruit preassembl apb artifici creat apb induc telomer extens dna repair mechan infer coloc site non-repl dna synthesi histon h2a.x phosphoryl increas telomer repeat length activ absent recruit apb factor pericentr locu establish apb function intermedi alt pathway',\n",
       "  \"effect opal termin codon preced nsp4 gene sequenc o'nyong-nyong viru genom anophel gambia infect genom rna alphaviru encod four differ nonstructur protein nsp1 nsp2 nsp3 nsp4 polyprotein p123 produc translat termin opal termin codon nsp3 nsp4 polyprotein p1234 produc translat readthrough occur opal termin codon replac sens codon alphaviru genom evolutionari pressur appear maintain genom sequenc encod stop codon opal open read frame arginin gener featur o'nyong-nyong viru onnv genom indic requir point altern replic onnv vertebr invertebr host may determin predomin particular codon locu viral quasispeci howev systemat studi previous test hypothesi whole anim report result first studi investig natur mosquito host function signific opal stop codon alphaviru genom use full-length cdna clone onnv construct seri mutant arginin nsp3 nsp4 replac opal ochr amber stop codon presenc opal stop codon upstream nsp4 nearli doubl 75.5 infect onnv viru possess codon amino acid arginin correspond posit 39.8 although frequenc opal viru dissemin mosquito midgut differ significantli arginin viru day 8 10 dissemin began earlier mosquito infect opal viru although clear fit advantag provid onnv presenc opal codon nsp3 nsp4 anophel gambia sequenc analysi onnv rna extract mosquito bodi head indic codon usag posit correspond viru administ blood meal result suggest select onnv variant occur de novo mutat posit nsp3 nsp4 readili occur mosquito taken togeth result suggest primari fit advantag provid onnv presenc opal codon nsp3 nsp4 relat mosquito infect\",\n",
       "  'down-regul host microrna herpesviru saimiri noncod rna cell transform herpesviru saimiri express seven viral u-rich noncod rna unknown function call hsur note conserv sequenc hsur 1 2 constitut potenti bind site three host-cel microrna mirna coimmunoprecipit experi confirm hsur 1 2 interact predict mirna viral transform cell abund one mirna mir-27 dramat lower transform cell consequ effect express mir-27 target gene transient knockdown ectop express hsur 1 demonstr direct degrad matur mir-27 sequence-specif binding-depend manner viral strategi illustr use ncrna manipul host-cel gene express via mirna pathway',\n",
       "  'htrf technolog tailor drug discoveri –a review theoret aspect recent applic htrf homogen time resolv fluoresc frequent use gener assay technolog measur analyt homogen format ideal platform use drug target studi high-throughput screen ht technolog combin fluoresc reson energi transfer technolog fret time-resolv measur tr tr-fret assay signal gener fluoresc reson energi transfer donor acceptor molecul close proxim buffer media interfer dramat reduc dual-wavelength detect final signal proport extent product format htrf assay usual sensit robust miniatur 384 1536-well plate format assay technolog appli mani antibody-bas assay includ gpcr signal camp ip-on kinas cytokin biomark bioprocess antibodi protein product well assay protein-protein proteinpeptid protein-dna/rna interact sinc introduct drug-screen world ten year ago research use htrf expedit studi gpcr kinas new biomark protein-protein interact target interest htrf also util altern method bioprocess monitor first-gener htrf technolog use europium cryptat fluoresc donor monitor reaction biomolecul extend 2008 introduct second-gener donor terbium cryptat tb enhanc screen perform terbium cryptat possess differ photophys properti compar europium includ increas quantum yield higher molar extinct coeffici addit compat acceptor fluorophor use europium serv donor fluorophor green-emit fluor multipl emiss peak includ one 490 nm moreov terbium htrf assay read htrf-compat instrument europium htrf assay overal htrf highli sensit robust technolog detect molecular interact vitro wide use primari secondari screen phase drug develop review address gener principl htrf current applic drug discoveri',\n",
       "  'chk1 inhibit replic factori activ allow dormant origin fire exist factori replic origin licens load mcm2-7 hexam entri phase howev ∼10 licens origin normal use phase other remain dormant fork progress inhibit dormant origin initi nearbi ensur dna eventu replic appar contrast replic stress activ ataxia telangiectasia rad-3-rel atr chk1 checkpoint kinas inhibit origin fire studi show low level replic stress atr/chk1 predominantli suppress origin initi inhibit activ new replic factori therebi reduc number activ factori time inhibit replic fork progress allow dormant origin initi within exist replic factori inhibit new factori activ atr/chk1 therefor redirect replic toward activ factori fork inhibit away region yet start replic minim deleteri consequ fork stall prevent similar problem aris unrepl region genom',\n",
       "  'fra-1 protooncogen regul il-6 express macrophag promot gener m2d macrophag tumor microenviron tme play promin role growth tumor cell major inflammatori compon tme m2d macrophag educ tme adopt immunosuppress role promot tumor metastasi progress fra-1 form activ protein-1 heterodim jun partner drive gene transcript fra-1 thought drastic induc tumorigenesi progress howev function role fra-1 gener m2d macrophag poorli understood date demonstr 4t1 mammari carcinoma cell co-cultur raw264.7 macrophag cell skew raw264.7 macrophag cell differenti m2d macrophag 4t1 cell stimul de novo overexpress fra-1 raw264.7 cell fra-1 bind interleukin 6 il-6 promot increas product cytokin il-6 raw264.7 cell il-6 act autocrin fashion skew raw264.7 macrophag cell differenti m2d macrophag find open new insight revers m2d macrophage-induc immun toler improv efficaci immunotherapeut approach',\n",
       "  'analysi sio2 nanoparticl bind protein rat blood brain homogen multitud nanoparticl titanium oxid tio2 zinc oxid aluminum oxid gold oxid silver oxid iron oxid silica oxid found mani chemic cosmet pharmaceut electron product recent sio2 nanoparticl shown inert toxic profil associ irrevers toxicolog chang anim model henc exposur sio2 nanoparticl increas sio2 nanoparticl routin use numer materi strengthen filler concret construct composit nontox platform biomed applic drug deliveri theragnost hand recent vitro experi indic sio2 nanoparticl cytotox therefor investig nanoparticl identifi potenti toxic pathway analyz adsorb protein corona surfac sio2 nanoparticl blood brain rat four type sio2 nanoparticl chosen investig protein corona type analyz use liquid chromatography-tandem mass spectrometri technolog total 115 48 plasma protein rat identifi bound neg charg 20 nm 100 nm sio2 nanoparticl respect 50 36 protein found 20 nm 100 nm arginine-co sio2 nanoparticl respect higher number protein adsorb onto 20 nm size sio2 nanoparticl onto 100 nm size nanoparticl regardless charg protein compar two charg higher number protein found arginine-co posit charg sio2 nanoparticl neg charg nanoparticl protein identifi bound corona sio2 nanoparticl analyz cluego cytoscap plugin use protein ontolog identifi biolog interact pathway protein bound surfac nanoparticl may affect function conform properti distribut complic biolog process',\n",
       "  'infer nucleosom posit histon mark annot chip data motiv nucleosom basic repeat unit chromatin contain two copi four core histon h2a h2b h3 h4 147 bp dna residu histon protein subject numer post-transl modif methyl acetyl chromatin immunoprecipiti follow sequenc chip-seq techniqu provid genome-wid occup data modifi histon protein requir appropri comput method result present nuchunt algorithm use data chip-seq experi direct mani histon modif infer posit nucleosom nuchunt annot nucleosom intens histon modif demonstr annot use infer nucleosom state distinct correl underli genom featur chromatin-rel process transcript start site enhanc elong rna polymeras ii chromatin-medi repress thu nuchunt versatil tool use predict posit nucleosom panel histon modif chip-seq experi infer distinct histon modif pattern associ differ chromatin state avail softwar avail http //epigen.molgen.mpg.de/nuchunter/',\n",
       "  'gener larg number dendrit cell mous bone marrow cultur supplement granulocyte/macrophag colony-stimul factor antigen-pres major histocompat complex mhc class ii-rich dendrit cell known aris bone marrow howev marrow lack matur dendrit cell substanti number prolifer less-matur cell yet identifi methodolog induc dendrit cell growth recent describ mous blood modifi mhc class ii-neg precursor marrow key step remov major nonadher newli form granulocyt gentl wash first 2-4 cultur leav behind prolifer cluster loos attach firmli adher `` stroma. `` day 4-6 cluster dislodg isol 1-g sediment upon recultur larg number dendrit cell releas latter readili identifi basi distinct cell shape ultrastructur repertoir antigen detect panel monoclon antibodi dendrit cell express high level mhc class ii product act power accessori cell initi mix leukocyt reaction neither cluster matur dendrit cell gener macrophag colony-stimul factor rather granulocyte/macrophag colony-stimul factor gm-csf appli therefor gm-csf gener three lineag myeloid cell granulocyt macrophag dendrit cell sinc 5 x 10 6 dendrit cell develop 1 wk precursor within larg hind limb bone singl anim marrow progenitor act major sourc dendrit cell featur prove use futur molecular clinic studi otherwis trace cell type',\n",
       "  \"insulin action resist obes type 2 diabet nutrit excess major forerunn type 2 diabet enhanc secret insulin attenu insulin 's metabol action liver skelet muscl adipos tissu howev conflict evid indic lack knowledg time event develop obes diabet point key gap understand metabol diseas perspect review altern viewpoint recent result tempor mechanist connect hyperinsulinemia obes insulin resist although much attent address earli step insulin signal cascad insulin resist obes seem larg elicit downstream step new find also connect insulin resist extens metabol cross-talk liver adipos tissu pancrea skelet muscl advanc past 5 year offer excit opportun daunt challeng develop new therapeut strategi treatment type 2 diabet\",\n",
       "  'effect lower blood pressur cardiovascular event mortal patient dialysi systemat review meta-analysi randomis control trial background patient undergo dialysi substanti increas risk cardiovascular mortal morbid although sever trial shown cardiovascular benefit lower blood pressur gener popul uncertainti efficaci toler reduc blood pressur patient dialysi systemat review meta-analysi assess effect blood pressur lower patient dialysi method systemat search medlin embas cochran librari databas trial report 1950 novemb 2008 without languag restrict extract standardis dataset randomis control trial blood pressur lower patient dialysi report cardiovascular outcom meta-analysi done random effect model find identifi eight relev trial provid data 1679 patient 495 cardiovascular event weight mean systol blood pressur 4.5 mm hg lower diastol blood pressur 2.3 mm hg lower activ treat patient control blood pressur lower treatment associ lower risk cardiovascular event rr 0.71 95 ci 0.55-0.92 p=0.009 all-caus mortal rr 0.80 0.66-0.96 p=0.014 cardiovascular mortal rr 0.71 0.50-0.99 p=0.044 control regimen effect seem consist across rang patient group includ studi interpret treatment agent lower blood pressur routin consid individu undergo dialysi reduc high cardiovascular morbid mortal rate popul',\n",
       "  'interact adenoviru e3 14.7-kilodalton protein novel tumor necrosi factor alpha-induc cellular protein contain leucin zipper domain earli region 3 e3 group c human adenovirus ad encod sever inhibitor tumor necrosi factor alpha tnf-alpha cytolysi includ e3 14.7-kda protein e3-14.7k heterodim contain two polypeptid 10.4 14.5 kda understand mechan viral protein inhibit tnf-alpha function e3-14.7k protein use screen hela cell cdna librari search interact protein yeast two-hybrid system novel protein contain multipl leucin zipper domain without signific homolog known protein identifi name fip-2 14.7k-interact protein fip-2 interact e3-14.7k vitro vivo coloc ad e3-14.7k cytoplasm especi near nuclear membran caus redistribut viral protein fip-2 caus cell death howev revers protect effect e3-14.7k cell kill induc overexpress intracellular domain 55-kda tnf receptor rip death protein involv tnf-alpha fa apoptosi pathway delet analysi indic revers effect fip-2 depend interact e3-14.7k three major mrna form fip-2 detect multipl human tissu express transcript induc tnf-alpha treatment time-depend manner two differ cell line fip-2 consensu sequenc sever potenti posttransl modif data suggest fip-2 one cellular target ad e3-14.7k mechan affect cell death involv tnf receptor rip downstream molecul affect either two molecul',\n",
       "  'pml induc compact trf2 deplet dna damag signal telomer promot altern lengthen altern lengthen telomer alt mechan allow cancer cell escap senesc apoptosi absenc activ telomeras characterist featur pathway assembl alt-associ promyelocyt leukemia pml nuclear bodi apb telomer dissect role apb human alt cell line perform rna interfer screen use autom 3d fluoresc microscopi platform advanc 3d imag analysi identifi 29 protein affect apb format includ protein involv telomer chromatin organ protein sumoyl dna repair integr extend find found apb format induc cluster telomer repeat telomer compact concomit deplet shelterin protein trf2 also known terf2 apb-depend chang correl induct dna damag respons telomer apb evid strong enrich phosphoryl form ataxia telangiectasia mutat atm kinas accordingli propos apb promot telomer mainten induc dna damag respons alt-posit tumor cell chang telomer chromatin state trigger atm phosphoryl',\n",
       "  'gr-1+cd11b+ myeloid cell tip balanc immun protect tumor promot premetastat lung mechan primari tumor affect select distant organ tumor cell arriv remain elucid report show gr-1+cd11b+ cell significantli increas lung mice bear mammari adenocarcinoma tumor cell arriv premetastat lung immatur myeloid cell significantli decreas ifn-gamma product increas proinflammatori cytokin addit produc larg quantiti matrix metalloproteinas 9 mmp9 promot vascular remodel delet mmp9 normal aberr vasculatur premetastat lung diminish lung metastasi product activ mmp9 select restrict lung organ larg number gr-1+cd11b+ cell work reveal novel protumor mechan gr-1+cd11b+ cell chang premetastat lung inflammatori prolif environ diminish immun protect promot metastasi aberr vasculatur format thu inhibit gr-1+cd11b+ cell could normal premetastat lung environ improv host immunosurveil inhibit tumor metastasi',\n",
       "  'activin/nod signal stem cell activin/nod growth factor control broad rang biolog process includ earli cell fate decis organogenesi adult tissu homeostasi provid overview mechan activin/nod signal pathway govern stem cell function differ stage develop describ recent find associ activin/nod signal patholog condit focus cancer stem cell tumorigenesi potenti target therapi moreov discuss futur direct question current remain unansw role activin/nod signal stem cell self-renew differenti prolifer',\n",
       "  'distinct rna-depend rna polymeras requir rnai trigger double-strand rna versu truncat transgen paramecium tetraurelia mani eukaryot rna-depend rna polymeras rdrp play key role rnai pathway implic recognit process aberr transcript trigger process amplif silenc respons test function rdrp gene ciliat paramecium tetraurelia experiment induc endogen mechan gene silenc organ rnai trigger either high-copi truncat transgen directli feed cell double-strand rna dsrna surprisingli dsrna-induc silenc depend put function rdr1 rdr2 gene requir accumul primari sirna distinct class small rna suggest secondari sirna contrast third gene highli diverg catalyt domain rdr3 requir sirna accumul rnai trigger truncat transgen data implic rdr3 accumul previous describ endogen sirna regul surfac antigen gene famili one gene normal express clonal cell line knockdown rdr3 lead co-express multipl antigen result provid evid function special paramecium rdrp gene distinct rnai pathway oper veget growth',\n",
       "  'mechan renal cell apoptosi induc cyclosporin systemat review vitro studi background chronic cyclosporin csa nephrotox ccn major caus chronic renal dysfunct effect clinic intervent yet object reveal mechan renal cell apoptosi ccn analyz vitro studi mechan method collect vitro studi mechan renal cell apoptosi induc csa medlin 1966 juli 2010 embas 1980 juli 2010 isi 1986 juli 2010 evalu qualiti accord vitro standard extract data follow pico principl synthes data result first csa could upregul fa fas-l express increas fadd apoptosi enzym caspase-2 -3 -4 -7 -8 -9 -10 downregul bcl-2 bcl-xl second csa could induc oxid stress damag antioxid defens system third csa could increas express herp grp78 chop fourth csa could induc renal cell apoptosi increas ino p53 express cultur cell conclus least four pathway involv renal cell apoptosi induc csa differ cell speci caspas might final common pathway vitro might provid potenti point intervent need confirm vivo',\n",
       "  'blood stem cell emerg aortic endothelium novel type cell transit ontogeni haematopoiet stem cell hsc embryon develop still highli debat especi possibl lineag relationship vascular endotheli cell first anatom site cell long-term hsc potenti isol aorta-gonad-mesonephro agm specif vicin dorsal aortic floor although author present evid hsc may aris directli aortic floor dorsal aortic lumen other support notion hsc first emerg within underli mesenchym show non-invas high-resolut imag live zebrafish embryo hsc emerg directli aortic floor stereotyp process involv cell divis strong bend egress singl endotheli cell aortic ventral wall sub-aort space concomit transform haematopoiet cell process polar dorso-ventr also rostro-caud versu medio-later direct depend runx1 express runx1-defici embryo exit event initi similar much rarer abort violent death exit cell result demonstr aortic floor haemogen hsc emerg sub-aort space asymmetr cell divis new type cell behaviour call endotheli haematopoiet transit',\n",
       "  'probabl person person transmiss novel avian influenza h7n9 viru eastern china 2013 epidemiolog investig object determin whether novel avian influenza h7n9 viru transmit person person effici design epidemiolog investig conduct famili cluster two patient avian h7n9 march 2013. set wuxi eastern china particip two patient close contact relev environ sampl patient environ collect test real time revers transcriptase-polymeras chain reaction rrt-pcr viral cultur haemagglutin inhibit assay contact becam ill sampl test avian h7n9 rrt-pcr pair serum sampl obtain contact serolog test haemagglutin inhibit assay main outcom measur clinic data histori exposur onset ill result laboratori test pathogen analysi sequenc phylogenet tree isol strain result index patient becam ill five six day last exposur poultri second patient daughter age 32 provid unprotect bedsid care hospit known exposur poultri develop symptom six day last contact father two strain isol success two patient genom sequenc analys phylogenet tree show virus almost genet ident forti three close contact patient identifi one mild ill neg result avian h7n9 rrt-pcr 43 close contact test neg haemagglutin inhibit antibodi specif avian h7n9 conclus infect daughter probabl result contact father index patient unprotect exposur suggest cluster viru abl transmit person person transmiss limit non-sustain',\n",
       "  'genet variat interleukin-28b gene associ spontan clearanc progress hepat c viru moroccan patient background genet variat il28b gene strongli associ treatment outcom spontan clearanc progress hepat c viru infect hcv aim present studi investig role polymorph locu progress outcom hcv infect moroccan popul method analyz cohort 438 individu among 232 patient persist hcv infect 115 patient mild chronic hepat 117 advanc liver diseas cirrhosi hepatocellular carcinoma 68 individu natur clear hcv 138 healthi subject il28b snp rs12979860 rs8099917 genotyp use taqman 5 allel discrimin assay result protect rs12979860-c rs8099917-t allel common subject spontan clearanc 77.9 vs 55.2 p 0.00001 95.6 vs 83.2 p 0.0025 respect individu clearanc 4.69 95 ci 1.99-11.07 time like c/c genotyp rs12979860 polymorph p 0.0017 3.55 95 ci 0.19-66.89 time like t/t genotyp rs8099917 patient advanc liver diseas carri rs12979860-t/t genotyp frequent patient mild chronic hepat c 1.89 95 ci 0.99-3.61 p 0.0532 risk even pronounc compar healthi control 4.27 95 ci 2.08-8.76 p 0.0005 rs8099917-g allel also associ advanc liver diseas 2.34 95 ci 1.40-3.93 p 0.0100 conclus moroccan popul polymorph near il28b gene play role spontan clearanc progress hcv infect',\n",
       "  'cd127 express invers correl foxp3 suppress function human cd4+ reg cell regulatori reg cell critic regul immun toler reg cell defin base express cd4 cd25 transcript factor foxp3 howev marker proven problemat uniqu defin special cell subset human found il-7 receptor cd127 down-regul subset cd4+ cell peripher blood demonstr major cell foxp3+ includ express low level cd25 combin cd4 cd25 cd127 result highli purifi popul reg cell account significantli cell previous identifi base cell surfac marker cell highli suppress function suppressor assay fact cell separ base sole cd4 cd127 express anerg although repres least three time number cell includ cd25+cd4+ cd25−cd4+ cell subset suppress “ classic ” cd4+cd25hi reg cell subset final show cd127 use quantit reg cell subset individu type 1 diabet support use cd127 biomark human reg cell',\n",
       "  \"environment factor influenc cutan product vitamin vertebr includ human obtain daili vitamin requir casual exposur sunlight exposur sunlight solar ultraviolet b photon 290-315 nm penetr skin caus photolysi 7-dehydrocholesterol precholecalciferol form precholecalciferol undergo thermal induc rearrang doubl bond form cholecalciferol increas skin pigment age topic applic sunscreen diminish cutan product cholecalciferol latitud season time day well ozon pollut atmospher influenc number solar ultraviolet b photon reach earth 's surfac therebi alter cutan product cholecalciferol boston exposur sunlight month novemb februari produc signific amount cholecalciferol skin windowpan glass absorb ultraviolet b radiat exposur sunlight glass window result product cholecalciferol recogn vitamin insuffici vitamin defici common elderli peopl especi infirm expos sunlight live latitud provid sunlight-medi cholecalciferol winter month vitamin insuffici defici exacerb osteoporosi caus osteomalacia increas risk skelet fractur vitamin insuffici defici prevent encourag respons exposur sunlight and/or consumpt multivitamin tablet contain 10 microgram 400 iu vitamin\",\n",
       "  'genom imprint develop growth behavior stem cell gene subject genom imprint mammal preferenti express singl parent allel imprint express small number gene crucial normal develop gene often directli regul fetal growth recent work also demonstr intric role imprint gene brain import consequ behavior neuron function final new studi reveal import proper express specif imprint gene induc pluripot stem cell adult stem cell review find highlight complex natur development import imprint gene',\n",
       "  'quantit detect hepat c viru rna light cycler pcr comparison two differ pcr assay new light cycler technolog adapt detect hepat c viru hcv rna clinic sampl sera 81 patient test light cycler pcr amplicor hcv monitor assay in-hous pcr data demonstr light cycler fast reliabl method detect quantit hcv rna',\n",
       "  'target arginin metabol pathway treat arginine-depend cancer signific dispar metabol tumor normal cell inspir develop metabolism-bas anti-tumor therapeut arginin semi-essenti amino acid normal cell synthes arginin de novo also take extracellular arginin sever type tumor abnorm arginin metabol enzym complet reli extracellular arginin support necessari biolog process properti refer arginin auxotrophi take advantag characterist arginin auxotrophi tumor arginin depriv gener induc use arginin deiminas adi arginas investig novel strategi cancer therapi arginin depriv demonstr promis efficaci arginine-auxotroph tumor integr perspect clinic oncologist laboratori scientist articl review import aspect arginin depriv promis anticanc therapi',\n",
       "  'rank signal link develop invari γδ cell progenitor aire+ medullari epithelium thymic medulla provid special microenviron neg select cell presenc autoimmun regul air -express medullari thymic epitheli cell mtec embryonic-neonat period necessari suffici establish long-last toler show emerg first cohort air mtec key development stage prior αβ cell repertoir select jointli direct rankl lymphoid tissu induc cell invari vγ5 dendrit epiderm cell detc progenitor first thymocyt express product gene rearrang turn gener air mtec foster skint-1-depend aire-independ detc progenitor matur emerg invari detc repertoir henc data attribut function import tempor develop vγ5 γδ cell thymu medulla format αβ cell toler induct demonstr rank-medi reciproc link detc air mtec matur',\n",
       "  \"long-term immun defici allogen stem cell transplant b-cell defici associ late infect immun reconstitut analyz 140 consecut patient 2-year disease-fre underw myeloabl allogen transplant cd4 cd8 defect observ involv naiv termin differenti memori compet cell limit valu activ subset natur killer cell normal six month observ expans cd19 /cd5 b cell three month persist defect memori b cell chronic graft-versus-host diseas influenc significantli paramet cd8 subset naïv compet cd4 subset strongli affect profound impact chronic graft-versus-host diseas b-cell subset especi memori b popul cumul incid late sever infect low 14 four year use cox 's model low b-cell count 12 p=0.02 24 p=0.001 month associ hazard develop late infect particular patient develop chronic graft-versus-host diseas\",\n",
       "  'stimulatori potenc cell antigen influenc format immunolog synaps cell activ predic interact cell receptor peptide-major histocompat pmhc ligand factor determin stimulatori potenc pmhc molecul remain unclear describ result show peptid exhibit mani hallmark weak agonist stimul cell prolifer wild-typ agonist ligand silico approach suggest inabl form central supramolecular activ cluster csmac could underli increas prolifer conclus support experi show enhanc csmac format reduc stimulatori capac weak peptid studi highlight fact complex interplay factor determin qualiti cell antigen',\n",
       "  'control glutam clearanc synapt efficaci glial coverag neuron analysi excitatori synapt transmiss rat hypothalam supraopt nucleu reveal glutam clearanc consequ glutam concentr diffus extracellular space associ degre astrocyt coverag neuron reduct glutam clearanc whether induc pharmacolog associ rel decreas glial coverag vicin synaps affect transmitt releas modul presynapt metabotrop glutam receptor astrocyt wrap neuron therefor contribut regul synapt efficaci central nervou system',\n",
       "  'durat androgen suppress treatment prostat cancer background combin radiotherapi plu long-term medic suppress androgen 2 year improv overal surviv patient local advanc prostat cancer compar use radiotherapi plu short-term androgen suppress use radiotherapi plu long-term androgen suppress treatment local advanc prostat cancer method randomli assign patient local advanc prostat cancer receiv external-beam radiotherapi plu 6 month androgen suppress two group one receiv treatment short-term suppress receiv 2.5 year treatment lutein hormone-releas hormon agonist long-term suppress outcom noninferior short-term androgen suppress compar long-term suppress requir hazard ratio 1.35 overal surviv one-sid alpha level 0.05. interim analysi show futil result present adjust one-sid alpha level 0.0429. result total 1113 men regist 970 randomli assign 483 short-term suppress 487 long-term suppress median follow-up 6.4 year 132 patient short-term group 98 long-term group die number death due prostat cancer 47 short-term group 29 long-term group 5-year overal mortal short-term long-term suppress 19.0 15.2 respect observ hazard ratio 1.42 upper 95.71 confid limit 1.79 p=0.65 noninferior advers event group includ fatigu diminish sexual function hot flush conclus combin radiotherapi plu 6 month androgen suppress provid inferior surviv compar radiotherapi plu 3 year androgen suppress treatment local advanc prostat cancer clinicaltrials.gov number nct00003026',\n",
       "  'function neuroimag studi sound local visual cortex activ predict perform early-blind individu blind individu often demonstr enhanc nonvisu perceptu abil howev neural substrat underli improv perform remain fulli understood earlier behavior studi demonstr early-blind peopl local sound accur sight control use monaur cue order investig neural basi behavior differ human carri function imag studi use positron emiss tomographi speaker array permit pseudo-free-field present within scanner binaur sound local sight control group show decreas cerebr blood flow occipit lobe seen early-blind individu monaur sound local one ear plug subgroup early-blind subject behavior superior sound local display two activ foci occipit cortex effect seen blind person superior monaur sound local abil sight individu degre activ one foci strongli correl sound local accuraci across entir group blind subject result show blind person perform better sight person recruit occipit area carri auditori local monaur condit therefor conclud comput carri occipit cortex specif underli enhanc capac use monaur cue find shed light intermod compensatori mechan also individu differ mechan inhibitori pattern differ sight individu depriv vision earli life',\n",
       "  'high-infiltr tumor-associ macrophag predict unfavor clinic outcom node-neg breast cancer tumor microenviron compos tumor cell fibroblast endotheli cell infiltr immun cell may inhibit promot tumor growth progress object retrospect studi character densiti tumor-associ macrophag tam breast cancer correl densiti tam clinicopatholog paramet paraffin-embed specimen clinicopatholog data includ 5 year follow-up inform obtain 172 breast cancer patient immunohistochem stain cd68 marker macrophag perform evalu blind fashion found tam significantli frequent high histopatholog grade breast cancer patient breast cancer patient high densiti tam significantli lower rate disease-fre surviv 5-year overal surviv patient low densiti tam furthermor high-infiltr tam indic wors surviv rate patient node-neg breast cancer conclus number tam tumor stroma independ predictor surviv time breast cancer patient high-infiltr tam signific unfavor prognost factor patient invas breast cancer potenti use prognost marker breast cancer',\n",
       "  'murin dishevel 3 function redund pathway dishevel 1 2 normal cardiac outflow tract cochlea neural tube develop dishevel dvl protein import signal compon canon beta-catenin/wnt pathway control cell prolifer pattern planar cell polar pcp pathway coordin cell polar within sheet cell also direct converg extens cell ce movement produc narrow elong tissu three mammalian dvl gene identifi development role dvl1 dvl2 previous determin identifi function dvl3 develop provid evid function redund among three murin dvl dvl3 -/- mice die perinat cardiac outflow tract abnorm includ doubl outlet right ventricl persist truncu arteriosi mutant also display misorient stereocilia organ corti phenotyp enhanc addit loss singl allel pcp compon vangl2/ltap ltaplp/+ although neurul appear normal dvl3 -/- ltaplp/+ mutant dvl3 +/- ltaplp/+ combin mutant display incomplet neural tube closur importantli show mani role dvl3 also share dvl1 dvl2 sever phenotyp observ dvl3 mutant defici anoth dvl increas dvl dosag genet dvl transgen demonstr abil dvl compens enabl normal develop interestingli global canon wnt signal appear larg unaffect doubl dvl mutant suggest low dvl level suffici function canon wnt signal summari demonstr dvl3 requir cardiac outflow tract develop describ import pcp pathway neurul cochlea develop final establish sever development process three dvl function redund',\n",
       "  \"dynam adheren junction epitheli establish mainten remodel epitheli cadherin e-cadherin -catenin complex bind cytoskelet compon regulatori signal molecul form matur adheren junction aj dynam structur physic connect neighbor epitheli cell coupl intercellular adhes contact cytoskeleton help defin cell 's apical-bas axi togeth activ coordin form polar function cell epithelium sever molecul regul aj format integr includ rho famili gtpase par polar protein howev recent develop live-cel imag extent e-cadherin activ turn junction begun appreci turnov contribut junction format mainten epitheli integr tissu homeostasi remodel\",\n",
       "  'long-term outcom patient asystol induc head-up tilt test aim analys long-term outcom largest report cohort patient present asystol head-up tilt test method result sinc 1990 1322 patient syncop unknown origin undergon tilt-tabl test 330 patient 24 x 9 present abnorm respons syncop pre-syncop furthermor 58 patient 17 x 5 suffer period asystol 3000 ms test asystol median interquartil rang last 10 4 19 x 2 rang 3-90 two differ protocol angl tilt westminst 60 degre n=1124 isoproterenol 80 degre n=198 influenc time syncop episod 13 6 x 5 20 x 5 vs 2 1 6 x 5 min p=0,0005 durat asystol period therapi asystol featur three differ stage first patient treat pacemak later drug therapi metoprolol and/or etilefrin recommend lastli 1995 specif treatment given cohort age- gender-match studi patient without compar asystol 2:1 basi 40 x 7 month follow-up 17 x 7 66 x 8 12 patient 20 x 6 asystol syncop recurr furthermor 34 patient 28 x 8 without asystol present syncop episod follow-up 51 x 6 month 29 x 3 73 x 1 p=n kaplan-mei analysi patient without asystol show mean time free recurr 92 x 6 +/- 6 month vs 82 x 6 +/- 4 x 7 month p=n previou number syncop signific relationship recurr p=0 x 002 therapi cardiac relat death conclus 1 asystol head-up tilt test impli malign outcom syncop recurr low 2 pacemak drug therapi significantli influenc outcom correl previou number syncop episod gender age asystol occurr asystol durat time asystol head-up tilt test 3 tilt protocol angl might influenc time incid asystol head-up tilt test',\n",
       "  \"zinc 15 – ligand discoveri everyon mani question biolog activ avail small molecul remain inaccess investig could benefit answer narrow gap chemoinformat biolog develop suit ligand annot purchas target biolog associ tool incorpor zinc meant investig comput specialist new version contain 120 million purchas `` drug-lik '' compound -- effect organ molecul sale -- quarter avail immedi deliveri zinc connect purchas compound high-valu one metabolit drug natur product annot compound literatur compound may access gene annot well major minor target class gene belong offer new analysi tool easi nonspecialist yet limit expert zinc retain origin 3d root -- molecul avail biolog relev ready-to-dock format zinc freeli avail http //zinc15.docking.org\",\n",
       "  'condensin-medi remodel mitot chromatin landscap fission yeast eukaryot genom consist dna molecul far longer cell contain reach greatest compact chromosom condens mitosi process aid condensin structur mainten chromosom smc famili member spatial organ mitot chromosom condensin shape chromatin architectur yet fulli understood use chromosom conform captur hi-c studi mitot chromosom condens fission yeast schizosaccharomyc pomb show interphas landscap character small chromatin domain replac fewer larger domain mitosi condensin achiev set longer-rang intrachromosom dna interact compact individu chromosom time local chromatin contact constrain condensin profound implic local chromatin function mitosi result highlight condensin major determin chang chromatin landscap cell prepar genom cell divis',\n",
       "  'efficaci 6-month thrice-weekli regimen treatment new sputum smear-posit pulmonari tuberculosi clinic trial condit background revis nation tuberculosi control programm india patient new smear-posit pulmonari tuberculosi treat thrice-weekli regimen antitubercular drug 2h 3 r 3 z 3 e 3 /4h 3 r 3 h isoniazid r rifampicin z pyrazinamid e ethambutol 6 month conduct retrospect analysi efficaci andtoler regimen clinic trial condit hiv-neg patient newli diagnos smear-posit pulmonari tuberculosi method retrospect analys data patient assign control regimen 2h 3 r 3 z 3 e 3 /4h 3 r 3 two clinic trial 2001-06 nation institut research tuberculosi chennai india result 268 patient treat regimen data efficaci analysi avail 249. end treatment 249 patient 238 96 favour statu treatment failur occur remain 11 7 organ initi drug-suscept 4 initi drug resist 238 patient favour statu end treatment 14 6 recurr tuberculosi follow 24 month intention-to-treat analysi 245 94 262 patient favour statu end treatment 28 patient initi drug resist 24 86 favour outcom 4 24 patient found recurr tuberculosi 2 year follow-up among 221 patient initi infect drug-suscept organ drug resist develop 7 patient treatment fail 10 recurr tuberculosi 5 7 patient treatment fail continu excret drug-suscept bacilli 6 month advers drug reaction observ 38 14 262 patient 3 1.1 need modif treatment conclus thrice-weekli 6-month regimen antitubercular drug administ full supervis associ high rate favour treatment outcom hiv-neg patient newli diagnos sputum smearposit pulmonari tuberculosi advers drug reaction patient',\n",
       "  'curcumin attenu inflammatori respons il-1beta-induc human synovi fibroblast collagen-induc arthriti mous model curcumin major compon turmer shown exhibit anti-oxid anti-inflammatori activ present studi perform determin whether curcumin efficaci collagen-induc arthriti cia mice il-1beta-induc activ fibroblast-lik synoviocyt flss dba/1 mice immun bovin type ii collagen cii treat curcumin everi day 2week initi immun arthriti evalu incid diseas use arthriti index base paw thick vitro prolifer cii- concanavalin a-induc splenic cell examin use ifn-gamma product pro-inflammatori cytokin tnf-alpha il-1beta examin mous ankl joint serum igg1 igg2a isotyp analyz express level prostaglandin e 2 pge 2 cyclooxygenase-2 cox-2 matrix metalloproteinas mmp human flss also determin result show compar untreat cia mice curcumin-tr mice downregul clinic arthriti score prolifer splenic cell express level tnf-alpha il-1beta ankl joint express level igg2a serum addit alter nuclear factor nf -kappab transcript activ flss curcumin inhibit pge 2 product cox-2 express mmp secret result suggest curcumin effect suppress inflammatori respons inhibit pro-inflammatori mediat regul humor cellular immun respons',\n",
       "  'loss igf-iea igf-ieb impair myogen differenti action protein product result altern splice igf1 gene receiv increas attent recent year howev signific function relev observ remain poorli defin address function igf-i splice variant examin impact loss igf-iea igf-ieb prolifer differenti cultur mous myoblast rna interference-medi reduct total igf-i igf-iea alon igf-ieb alon effect cell viabil growth medium howev cell defici total igf-i igf-iea alon prolifer significantli slower control cell cell defici igf-ieb serum-fre media simultan loss specif loss either splice variant significantli inhibit myosin heavi chain myhc immunoreact 70-80 p 0.01 differenti condit 48 h 2 hors serum determin western immunoblot loss protein associ reduc myhc isoform mrna reduct total igf-i igf-iea mrna significantli reduc myhc mrna approxim 50-75 p 0.05 loss igf-ieb also reduc myhc isoform mrna significantli except myh7 lesser degre ∼20-40 p 0.05 provis matur igf-i synthet e peptid restor myh3 express control level cell defici igf-iea igf-ieb collect data suggest igf-i splice variant may regul myoblast differenti action matur igf-i e peptid',\n",
       "  \"antimicrobi peptid pleurocidin synerg antibiot hydroxyl radic format membran damag exert antibiofilm activ background pleurocidin 25-mer antimicrobi peptid amp known exert bactericid activ howev synergist activ mechan pleurocidin combin convent antibiot antibiofilm effect peptid poorli understood method interact pleurocidin antibiot evalu use checkerboard assay studi mechan involv synerg detect hydroxyl radic format use 3'- p-hydroxyphenyl fluorescein measur nad /nadh ratio nad cycl assay observ chang bacteri viabil hydroxyl radic scaveng thiourea investig cytoplasm membran damag use propidium iodid also antibiofilm effect pleurocidin examin tissu cultur plate method result combin pleurocidin antibiot show synergist interact bacteri strain fraction inhibitori concentr index fici ≤0.5 except enterococcu faecium treat combin peptid ampicillin fici=0.75 identifi pleurocidin alon combin antibiot induc format hydroxyl radic oxid stress caus transient nadh deplet addit thiourea prevent bacteri death especi case combin treatment pleurocidin ampicillin show synerg combin pleurocidin erythromycin increas permeabl bacteri cytoplasm membran addit pleurocidin exhibit potent inhibitori effect preform biofilm bacteri organ conclus pleurocidin synerg antibiot hydroxyl radic format membrane-act mechan exert antibiofilm activ gener signific synergist effect pleurocidin antibiot suggest amp potenti therapeut agent adjuv antimicrobi chemotherapi\",\n",
       "  'outcom pregnanc women moder sever renal insuffici background pregnant women mild preexist renal diseas rel complic pregnanc risk matern obstetr complic women moder sever renal insuffici remain uncertain method determin frequenc type matern obstetr complic outcom pregnanc 67 women primari renal diseas 82 pregnanc women initi serum creatinin concentr least 1.4 mg per decilit 124 mumol per liter gestat continu beyond first trimest result mean +/- sd serum creatinin concentr increas 1.9 +/- 0.8 mg per decilit 168 +/- 71 mumol per liter earli pregnanc 2.5 +/- 1.3 mg per decilit 221 +/- 115 mumol per liter third trimest frequenc hypertens rose 28 percent base line 48 percent third trimest high-grad proteinuria urinari protein excret 3000 mg per liter 23 percent 41 percent 70 pregnanc 57 women data avail pregnanc immedi post partum pregnancy-rel loss matern renal function occur 43 percent eight pregnanc 10 percent total associ rapid acceler matern renal insuffici obstetr complic includ high rate preterm deliveri 59 percent growth retard 37 percent infant surviv rate 93 percent conclus among pregnant women moder sever renal insuffici rate complic due worsen renal function hypertens obstetr complic increas fetal surviv high',\n",
       "  'high-mobl group box-1 protein induc osteogen phenotyp chang aortic valv interstiti cell object calcif aortic valv av diseas known inflammation-rel process high-mobl group box-1 hmgb1 protein toll-lik receptor 4 tlr4 report particip sever inflammatori diseas purpos present studi determin whether hmgb1-tlr4 axi involv calcif av diseas evalu effect hmgb1 potenti mechan pro-osteogen phenotyp chang valvular interstiti cell vic method express hmgb1 tlr4 human calcif av evalu use immunohistochem stain immunoblot cultur vic use vitro model vic stimul hmgb1 analysi versu without tlr4 small interf ribonucl acid sirna c-jun n-termin kinas mitogen-activ protein kinas jnk mapk nuclear factor kappa-b nf-κb inhibitor result enhanc accumul hmgb1 tlr4 observ calcif valv moreov found hmgb1 induc high level pro-inflammatori cytokin product promot osteoblast differenti calcif vic addit hmgb1 induc phosphoryl jnk mapk nf-κb howev effect markedli suppress sirna silenc tlr4 addit blockad jnk mapk nf-κb phosphoryl prohibit hmgb1-induc product pro-osteogen factor miner vic conclus hmgb1 protein may promot osteoblast differenti calcif vic tlr4-jnk-nf-κb signal pathway',\n",
       "  \"ribosi high-resolut quantit approach measur vivo kinet pre-mrna splice 3'-end process saccharomyc cerevisia describ method obtain quantit descript rna process high resolut bud yeast model gene express system construct teton induct studi tetoff repress derepress rna degrad studi yeast strain seri report gene integr genom control teto7 promot revers transcript quantit real-time-pcr rt-qpcr method adapt allow determin mrna abund averag number copi per cell popul fluoresc situ hybrid fish measur transcript number individu cell valid rt-qpcr approach averag copy-numb determin despit broad distribut transcript level within popul cell addit rt-qpcr use distinguish product differ step splice report transcript method develop map quantifi 3'-end cleavag polyadenyl system permit pre-mrna product splice 3'-end matur degrad quantit monitor unpreced kinet detail suitabl mathemat model use approach demonstr report transcript splice prior 3'-end cleavag polyadenyl cotranscript\",\n",
       "  'gener mice condit allel p75 ntr neurotrophin receptor gene p75 ntr neurotrophin receptor implic multipl biolog patholog process signific advanc recent made understand physiolog role p75 ntr mani detail aspect remain determin part two exist knockout mous model exon 3 4 delet respect display featur defi definit conclus describ gener mice carri condit p75 ntr p75 ntr-fx allel made flank exon 4-6 encod transmembran cytoplasm domain loxp site valid novel condit allel neural crest-specif p75 ntr /wnt1-cre mutant convent p75 ntr null mutant gener mutant display abnorm hind limb reflex impli loss p75 ntr neural crest-deriv cell caus peripher neuropathi similar seen convent p75 ntr mutant novel condit p75 ntr allel offer new opportun investig role p75 ntr specif tissu cell',\n",
       "  'triple-stain flow cytometr method assess plasma- acrosome-membran integr cryopreserv bovin sperm immedi thaw presenc egg-yolk particles1 abstract simultan evalu postthaw viabil acrosom integr spermatozoa flow cytometri would provid valuabl test tool research routin work present studi new triple-stain combin develop simultan evalu viabil acrosom integr bovin sperm process egg yolk-bas extend flow cytomet sybr-14 propidium iodid pi enabl discrimin sperm cell egg yolk debri particl instrument flow cytometr analys frozen-thaw bovin sperm impli wash step remov egg yolk longer requir addit phycoerythrin-conjug peanut agglutinin pe-pna use discrimin acrosome-damaged/react sperm cell acrosome-intact cell repeat calcul use two process ejacul 10 bull three straw per batch analyz duplic measur method-agr analysi sybr-14/pe-pna/pi fluorescein isothiocyan fitc -conjug pna perform fitc-pna/pi stain carri 14 frozen-thaw semen sampl immedi thaw 3-h incub 37°c british standard institut repeat index sybr-14/pe-pna/pi combin 2.6 averag fitc-pna/pi method show 6.3 overestim live acrosome-intact sperm cell subpopul conclus new triple-stain combin highli repeat easi use routin applic provid precis estim rate sperm cell intact head membran acrosom compar gener use valid fitc-pna/pi stain',\n",
       "  'univers voluntari hiv test immedi antiretrovir therapi strategi elimin hiv transmiss mathemat model background roughli 3 million peopl worldwid receiv antiretrovir therapi art end 2007 estim 6.7 million still need treatment 2.7 million becam infect hiv 2007. prevent effort might reduc hiv incid unlik elimin diseas investig theoret strategi univers voluntari hiv test immedi treatment art examin condit hiv epidem could driven toward elimin method use mathemat model explor effect case reproduct number stochast model long-term dynam hiv epidem determinist transmiss model test peopl test-cas commun age 15 year older hiv everi year start peopl art immedi diagnos hiv posit use data south africa test case generalis epidem assum hiv transmiss heterosexu find studi strategi could greatli acceler transit present endem phase adult live hiv receiv art elimin phase art within 5 year could reduc hiv incid mortal less one case per 1000 peopl per year 2016 within 10 year full implement strategi reduc preval hiv less 1 within 50 year estim 2032 yearli cost present strategi theoret strategi would us 1.7 billion howev time cost present strategi would continu increas wherea theoret strategi would decreas interpret univers voluntari hiv test immedi art combin present prevent approach could major effect sever generalis hiv/aid epidem approach merit mathemat model research broad consult',\n",
       "  'common variant dgkk strongli associ risk hypospadia hypospadia common congenit malform male extern genitalia perform genome-wid associ studi use pool dna 436 individu hypospadia case 494 control european descent select highest rank snp individu genotyp discoveri sampl addit dutch sampl 133 case parent swedish seri 266 case 402 control individu genotyp two snp rs1934179 rs7063116 dgkk encod diacylglycerol kinas κ produc compel evid associ hypospadia discoveri sampl allele-specif odd ratio 2.5 p 2.5 × 10−11 2.3 p 2.9 × 10−9 respect dutch 3.9 p 2.4 × 10−5 3.8 p 3.4 × 10−5 swedish 2.5 p 2.6 × 10−8 2.2 p 2.7 × 10−6 replic sampl express studi show express dgkk preputi tissu case control lower carrier risk allel rs1934179 p 0.047 propos dgkk major risk gene hypospadia',\n",
       "  'neutrophil suppress intralumin nk cell-medi tumor cell clearanc enhanc extravas dissemin carcinoma cell unlabel immun cell promot initi metastat dissemin carcinoma cell primari tumor contrast well-studi function initi stage metastasi specif role immunocyt facilit progress critic later step invasion-metastasi cascad remain poorli understood defin novel function neutrophil promot intralumin surviv extravas site metastat dissemin show cd11b /ly6g neutrophil enhanc metastasi format via two distinct mechan first neutrophil inhibit natur killer cell function lead signific increas intralumin surviv time tumor cell thereaft neutrophil oper facilit extravas tumor cell secret il1β matrix metalloproteinas result identifi neutrophil key regul intralumin surviv extravas cross-talk host cell dissemin carcinoma cell signific studi provid import insight system contribut neutrophil cancer metastasi identifi neutrophil facilit intermedi step invasion-metastasi cascad demonstr neutrophil suppress natur killer cell activ increas extravas tumor cell cancer discov 6 6 630-49 ©2016 aacr.thi articl highlight issu featur p. 561',\n",
       "  \"high km solubl 5'-nucleotidas human placenta properti alloster regul imp atp human placent solubl `` high km '' 5'-nucleotidas separ `` low km '' 5'-nucleotidas nonspecif phosphatas amp-sepharos affin chromatographi enzym purifi 8000-fold specif activ 25.6 mumol/min/mg subunit molecular mass 53 kda nativ molecular mass 210 kda suggest tetramer structur solubl high km 5'-nucleotidas activ imp gmp deoxi deriv imp hydrolyz 15 time faster amp enzym virtual absolut requir magnesium ion regul purin nucleosid 5'-triphosph strongli activ enzym potenc order datp greater atp greater gtp 2,3-diphosphoglycer activ enzym potent atp three millimolar atp decreas km imp 0.33 0.09 mm increas vmax 12-fold atp activ modifi imp concentr 20 microm imp atp-depend activ curv sigmoid 2 mm imp hyperbol a0.5 valu atp 2.26 0.70 mm rel maxim veloc 32.9 126.0 nmol/min respect inorgan phosphat shift hyperbol substrat veloc relationship imp sigmoid one physiolog concentr cofactor 3 mm atp 1-4 mm pi 150 mm kcl ph 7.4 enzym 25-35 time activ toward 100 microm imp 100 microm amp data show solubl human placent high km 5'-nucleotidas coexist human placenta low km enzym b physiolog condit enzym favor hydrolysi imp critic regul imp atp pi level c kinet properti atp imp modifi compound suggest complex interact associ bind site\",\n",
       "  'histon incorpor tran reassembl yeast pho5 promot yeast remodel pho5 promot chromatin upon activ accompani transient hyperacetyl subsequ evict histon promot tran cours rerepress nucleosom reassembl promot analyz histon reassembl inact promot chromatin come use strain two differ tag differ regul version histon h3 allow us discrimin histon origin chromatin fraction histon aris solubl histon pool way show incorpor histon origin sourc tran promot closur occur rapidli histon chaperon asf1 hir1 well swi/snf nucleosom remodel complex appear import rapid reassembl nucleosom pho5 promot',\n",
       "  'nation studi physician awar adher cardiovascular diseas prevent guidelin background data evalu physician adher cardiovascular diseas cvd prevent guidelin accord physician specialti patient characterist particularli gender method result onlin studi 500 randomli select physician 300 primari care physician 100 obstetricians/gynecologist 100 cardiologist use standard questionnair assess awar adopt barrier nation cvd prevent guidelin specialti experiment case studi design test physician accuraci determin cvd risk level assign applic guidelin among high- intermediate- low-risk patient intermediate-risk women assess framingham risk score significantli like assign lower-risk categori primari care physician men ident risk profil p 0.0001 trend similar obstetricians/gynecologist cardiologist assign risk level significantli predict recommend lifestyl prevent pharmacotherapi adjust risk assign impact patient gender prevent care signific except less aspirin p 0.01 weight manag recommend p 0.04 intermediate-risk women physician rate effect abil help patient prevent cvd fewer 1 5 physician knew women men die year cvd conclus percept risk primari factor associ cvd prevent recommend gender dispar recommend prevent therapi explain larg lower perceiv risk despit similar calcul risk women versu men educ intervent physician need improv qualiti cvd prevent care lower morbid mortal cvd men women',\n",
       "  'technic advanc floral dip simplifi method agrobacterium-medi agrobacterium vacuum infiltr method made possibl transform arabidopsi thaliana without plant tissu cultur regener present studi method evalu substanti modifi transform method develop labor-intens vacuum infiltr process elimin favor simpl dip develop floral tissu solut contain agrobacterium tumefacien 5 sucros 500 microlit per litr surfact silwet l-77 sucros surfact critic success floral dip method plant inocul numer immatur floral bud siliqu present produc transform progeni highest rate plant tissu cultur media hormon benzylamino purin ph adjust unnecessari agrobacterium could appli plant rang cell densiti repeat applic agrobacterium improv transform rate overal yield transform approxim twofold cover plant 1 day retain humid inocul also rais transform rate twofold multipl ecotyp transform method modifi method facilit high-throughput transform arabidopsi effort t-dna gene tag posit clone attempt target gene replac',\n",
       "  \"pathway connect signal coordin yeast stress-activ signal network stress cell coordin multi-facet respons span mani level physiolog yet knowledg complet stress-activ regulatori network well design principl signal integr remain incomplet develop experiment comput approach integr avail protein interact data gene fit contribut mutant transcriptom profil phospho-proteom chang cell respond salt stress infer salt-respons signal network yeast infer subnetwork present mani novel predict implic new regul uncov unrecogn crosstalk known pathway point previous unknown 'hub signal integr exploit predict show cdc14 phosphatas central hub network modif rna polymeras ii coordin induct stress-defens gene reduct growth-rel transcript find ortholog human network enrich cancer-caus gene underscor import subnetwork 's predict understand stress biolog\",\n",
       "  'premigratori migratori neural crest cell multipot vivo neural crest nc embryon stem/progenitor cell popul gener divers array cell lineag includ peripher neuron myelin schwann cell melanocyt among other howev long-stand controversi whether broad development perspect reflect vivo multipot individu nc cell whether nc compris heterogen mixtur lineage-restrict progenitor resolv controversi perform vivo fate map singl trunk nc cell premigratori migratori stage use r26r-confetti mous model combin quantit clonal analys definit marker differenti demonstr vast major individu nc cell multipot clone contribut singl deriv intriguingli multipot maintain migratori nc cell thu find provid definit evid vivo multipot premigratori migrat nc cell mous',\n",
       "  \"implement eshr 'poor respond criteria research studi methodolog implic bologna criteria defin poor ovarian respons por ivf provid use templat new research field assist concept howev design studi around european societi human reproduct embryolog por criteria methodolog challeng new definit includ variou por subpopul divers baselin characterist unknown clinic prognosi design rct potenti result bia may introduc women subpopul evenli alloc intervent group case small moderate-s rct single-sequ random method may ensur balanc alloc group stratifi random method provid altern methodolog approach depend chosen methodolog patient characterist outcom within intervent group may better report accord relev subpopul\",\n",
       "  'gener gene-edit rat deliveri crispr/cas9 protein donor dna intact zygot use electropor gener gene-edit anim use crisprs/cas9 system base microinject zygot ineffici time consum demand high technic skill report optim electropor method intact rat zygot use sgrna cas9 protein combin ssodn ~100 nt result high frequenc knockout 15 50 analyz anim importantli use ssodn donor templat result precis knock-in mutat 25-100 analyz anim compar microinject electropor long ssdna dsdna donor success use microinject past allow gener genome-edit anim despit dsdna visual within zygot thu simultan electropor larg number intact rat zygot rapid simpl effici method gener varieti genome-edit rat',\n",
       "  \"uridyl mirna hen1 suppressor1 arabidopsi hen1-medi 2'-o-methyl shown key mechan protect plant microrna mirna small interf rna sirna well anim piwi-interact rna pirna degrad 3 termin uridyl 1-8 howev enzym uridyl unmethyl mirna sirna pirna hen1 unknown studi genet screen identifi second-sit mutat hen1 suppressor1-2 heso1-2 partial suppress morpholog phenotyp hypomorph hen1-2 allel null hen1-1 allel arabidopsi heso1 encod termin nucleotidyl transferas prefer add untempl uridin 3 end rna complet abolish 2'-o-methyl heso1-2 affect profil u-tail mirna sirna increas abund truncat and/or normal size one hen1 often result increas total amount mirna sirna hen1 contrast overexpress heso1 hen1-2 caus sever morpholog defect less accumul mirna result demonstr heso1 enzym uridyl unmethyl mirna sirna hen1 observ also suggest uridyl may destabil unmethyl mirna unknown mechan compet 3'-to-5 exoribonucleas activ hen1 studi shall implic pirna uridyl hen1 anim\",\n",
       "  'pre-exposur prophylaxi prevent hiv infect current statu futur opportun challeng global incid hiv exce 2 million new infect annual effect intervent decreas hiv transmiss need random placebo-control studi demonstr daili oral antiretrovir pre-exposur prophylaxi prep fixed-dos combin tablet contain tenofovir disoproxil fumar emtricitabin significantli reduc hiv incid among divers at-risk popul studi efficaci prep correl level adher offici guidelin recommend provis prep peopl greatest risk hiv acquisit demonstr project suggest high level uptak adher possibl outsid control studi howev sever potenti barrier implement prep remain challeng includ low awar util prep at-risk individu uncertainti adher ‘ real-world ’ set major healthcar provid untrain prep provis limit data potenti advers effect long-term use tenofovir–emtricitabin high cost prep medic stigma associ prep use behavior would warrant prep innov pharmacolog chemoprophylact approach could provid solut challeng less-than-daili oral dose regimen long-act inject medic could reduc pill burden facilit adher local deliveri prep medic genit compart via gel ring film may limit system drug exposur potenti toxic portfolio chemoprophylact agent deliveri system expand meet divers sexual health need product prefer individu may benefit prep hope antiretrovir chemoprophylaxi could becom accept feasibl highli effect addit exist hiv prevent strategi',\n",
       "  'prepregn bmi risk gestat diabet systemat review literatur meta-analysi object studi assess quantifi risk gestat diabet mellitu gdm accord prepregn matern bodi mass index bmi design systemat review observ studi publish last 30 year four electron databas search public 1977-2007 bmi elect measur obes diagnost criteria gdm accept studi select screen gdm exclud languag restrict methodolog qualiti primari studi assess 1745 citat screen 70 studi two unpublish involv 671 945 women includ 59 cohort 11 case-control studi high medium qualiti compar women normal bmi unadjust pool odd ratio underweight woman develop gdm 0.75 95 confid interv ci 0.69 0.82 overweight moder obes morbidli obes women 1.97 95 ci 1.77 2.19 3.01 95 ci 2.34 3.87 5.55 95 ci 4.27 7.21 respect everi 1 kg -2 increas bmi preval gdm increas 0.92 95 ci 0.73 1.10 risk gdm posit associ prepregn bmi inform import counsel women plan pregnanc',\n",
       "  'multipl risk behaviour increas socio-econom gap time background unhealthi behaviour often occur combin studi relationship educ lifestyl defin cluster risk behaviour analys purpos assess socio-econom chang multipl risk behaviour time method cross-sect data belgian health interview survey 1997 2001 2004 analys studi restrict person age ≥ 15 year inform health behaviour educ n 7431 n 8142 n 7459 respect lifestyl index creat base sum four unhealthi behaviour smoker vs. non-smok riski versu non-riski alcohol use sedentary vs. physic activ poor vs. healthi diet lifestyl index dichotom low 0-2 vs. high 3-4 assess socio-econom inequ multipl risk behaviour summari measur odd ratio rel index inequ rii calcul use logist regress stratifi sex result adult popul 7.5 combin three four unhealthi behaviour lower educ men risk besid among men significantli increas 1.6 2001 3.4 2004 p 0.029 increas among women less pronounc rii hand show gradient neither men women conclus multipl risk behaviour common among lower educ peopl increas polar socio-econom inequ assess 2001 2004 among men therefor health promot programm focu lower socio-econom class target risk behaviour simultan',\n",
       "  'variat trend health burden visual impair due cataract global analysi purpos evalu global trend health burden peopl visual impair cataract term disability-adjust life year dali correl nation level socioeconom develop method global region nation dali number crude rate age-standard rate cataract vision loss age sex obtain databas global burden diseas studi 2015. human develop index per capita gross domest product country-level data deriv intern open databas regress analysi use assess correl age-standard dali rate socioeconom variabl result global dali number cataract vision loss increas 89.42 2048.18 95 ci confid interv 1457.60-2761.80 thousand 1990 3879.74 95 ci 2766.07-5232.43 thousand 2015 p 0.001 femal higher dali number 315.83 95 ci 237.17-394.4 crude rate 38.29 95 ci 35.35-41.23 adjust age countri p 0.001 age-standard dali rate higher countri low human develop index hdi 91.03 95 ci 73.04-108.75 low hdi 81.67 95 ci 53.24-108.82 medium hdi 55.89 95 ci 36.87-69.63 high hdi 17.10 95 ci 13.91-26.84 high hdi countri p 0.01 respect nation age-standard dali rate 2015 neg associ hdi r2 0.489 p 0.001 per capita gross domest product r2 0.331 p 0.001 stepwis multipl regress show hdi significantli correl nation age-standard dali rate 2015 adjust confound factor p 0.001 conclus global health burden vision loss due cataract increas 1990 2015 despit consider effort world health organ vision 2020 initi',\n",
       "  'multiplex genom engin use crispr/ca system function elucid causal genet variant element requir precis genom edit technolog type ii prokaryot crispr cluster regularli interspac short palindrom repeat /ca adapt immun system shown facilit rna-guid site-specif dna cleavag engin two differ type ii crispr/ca system demonstr cas9 nucleas direct short rna induc precis cleavag endogen genom loci human mous cell cas9 also convert nick enzym facilit homology-direct repair minim mutagen activ lastli multipl guid sequenc encod singl crispr array enabl simultan edit sever site within mammalian genom demonstr easi programm wide applic rna-guid nucleas technolog',\n",
       "  'transform intact yeast cell treat alkali cation intact yeast cell treat alkali cation took plasmid dna li+ cs+ rb+ k+ na+ effect induc compet condit transform saccharomyc cerevisia d13-1a plasmid yrp7 studi detail cscl optimum incub time 1 h optimum cell concentr 5 x 10 7 cell per ml optimum concentr cs+ 1.0 m. transform effici increas increas concentr plasmid dna polyethylen glycol absolut requir heat puls variou polyamin basic protein stimul uptak plasmid dna besid circular dna linear plasmid dna also taken cs+-treat yeast cell although uptak effici consider reduc transform effici cs+ li+ compar convent protoplast method plasmid contain ars1 although plasmid contain 2 micron origin replic',\n",
       "  'health-rel qualiti life measur eq-5d among popul without specif chronic condit population-bas survey shaanxi provinc china introduct aim studi examin health-rel qualiti life hrqol measur eq-5d investig influenc chronic condit risk factor hrqol base distribut sampl locat shaanxi provinc china method multi-stag stratifi cluster sampl method perform select subject eq-5d employ measur hrqol likelihood individu select chronic diseas would report problem eq-5d dimens calcul test rel two refer group multivari linear regress model use investig factor associ eq va result frequent report problem involv pain/discomfort 8.8 anxiety/depress 7.6 nearli half respond report problem five dimens chronic patient higher eq va score associ male gender higher level educ employ younger age urban area resid access free medic servic higher level physic activ except anemia select chronic diseas indic neg eq va score three lead risk factor cerebrovascular diseas cancer mental diseas increas age number chronic condit frequenc physic activ found gradient effect conclus result present work add volum knowledg regard popul health statu area apart known health statu use mortal morbid data medic polici social individu attent given manag chronic diseas improv hrqol longitudin studi must perform monitor chang hrqol permit evalu outcom chronic diseas intervent program',\n",
       "  \"memori modular cell-fat decis make genet ident cell share environ display markedli differ phenotyp often unclear much variat deriv chanc extern signal attempt individu cell exert autonom phenotyp program observ thousand cell hundr consecut gener constant condit dissect stochast decis solitari motil state chain sessil state bacillu subtili show motil state 'memoryless exhibit autonom control time spent state contrast time spent connect chain cell tightli control enforc coordin among relat cell multicellular state show three-protein regulatori circuit govern decis modular initi mainten chain genet separ function stimul initi pathway trigger biofilm format argu autonom time allow trial commit multicellular extern signal could extend\",\n",
       "  'lpd deplet reveal srf specifi radial versu tangenti migrat pyramid neuron corticogenesi pyramid neuron ∼80 cortic neuron aris ventricular zone pass multipolar stage becom bipolar attach radial glia migrat proper posit within cortex pyramid neuron migrat radial remain attach glial substrat pass subventricular intermedi zone region rich tangenti migrat interneuron axon fibr tract examin role lamellipodin lpd homologu key regul neuron migrat polar caenorhabd elegan corticogenesi lpd deplet caus bipolar pyramid neuron adopt tangenti rather radial-gli migrat mode without affect cell fate mechanist lpd deplet reduc activ srf transcript factor regul chang ratio polymer unpolymer actin therefor lpd deplet expos role srf direct pyramid neuron select radial migrat pathway along glia rather tangenti migrat mode',\n",
       "  'identif p18 ink4c tumor suppressor gene glioblastoma multiform genom alter lead aberr activ cyclin/cyclin-depend kinas cdk complex drive pathogenesi mani common human tumor type case glioblastoma multiform gbm alter commonli due homozyg delet p16 ink4a less commonli due genom amplif individu gene encod cyclin cdk describ delet p18 ink4c cdk inhibitor novel genet alter drive pathogenesi gbm delet p18 ink4c often occur tumor also harbor homozyg delet p16 ink4a express p18 ink4c complet absent 43 gbm primari tumor studi immunohistochemistri lentivir reconstitut p18 ink4c express physiolog level p18 ink4c -defici p18 ink4c -profici gbm cell led senescence-lik g 1 cell cycl arrest studi identifi p18 ink4c gbm tumor suppressor gene reveal addit mechan lead aberr activ cyclin/cdk complex terribl malign',\n",
       "  'two-stag control oxid stress regulon escherichia coli soxr protein trigger redox-induc express sox regulatori gene escherichia coli respond redox stress impos superoxide-gener agent paraquat activ synthesi mani 80 polypeptid express key group induc protein control transcript level soxr locu soxr regulon two-stag control system hypothes soxr intracellular redox signal would trigger soxr protein transcript activ sox gene result increas level sox protein would activ transcript variou soxr regulon gene b. dempl c.f amábil cueva cell 67:837-839 1990 construct operon fusion e. coli lac gene sox promot monitor sox transcript express sox promot strongli induc paraquat manner strictli depend function soxr gene sever superoxide-gener agent also trigger soxr -depend sox express induct paraquat phenazin methosulf depend presenc oxygen numer oxid stress agent h2o2 gamma ray heat shock etc fail induc sox aerob growth superoxid dismutase-defici bacteria trigger soxr-depend sox express result indic specif redox signal sox induct direct role soxr protein activ sox gene indic band-shift dnase footprint experi demonstr specif bind soxr protein cell extract sox promot mode soxr bind dna appear similar homolog merr soxr footprint span -10 -35 region sox promot',\n",
       "  'air pollut cardiovascular diseas statement healthcar profession expert panel popul prevent scienc american heart associ air pollut heterogen complex mixtur gase liquid particul matter epidemiolog studi demonstr consist increas risk cardiovascular event relat short- long-term exposur present-day concentr ambient particul matter sever plausibl mechanist pathway describ includ enhanc coagulation/thrombosi propens arrhythmia acut arteri vasoconstrict system inflammatori respons chronic promot atherosclerosi purpos statement provid healthcar profession regulatori agenc comprehens review literatur air pollut cardiovascular diseas addit implic find relat public health regulatori polici address practic recommend healthcar provid patient outlin final section suggest futur research made address number remain scientif question',\n",
       "  'non-invas ventil chronic obstruct pulmonari diseas patient helmet versu facial mask helmet new interfac potenti increas success rate non-invas ventil improv toler perform physiolog comparison helmet convent facial mask deliv non-invas ventil hypercapn patient chronic obstruct pulmonari diseas prospect control random studi cross-ov design 10 patient evalu ga exchang inspiratori effort patient–ventil synchroni patient toler 30 min non-invas ventil deliv either helmet facial mask trial preced period spontan unassist breath arteri blood gase inspiratori effort durat diaphragm contract ventil assist effort-to-support delay begin end inspir number ineffect effort patient comfort non-invas ventil improv ga exchang p 0.05 inspiratori effort p 0.01 interfac helmet howev less effici mask reduc inspiratori effort p 0.05 worsen patient–ventil synchroni indic longer delay trigger p 0.05 cycl p 0.05 mechan assist number ineffect effort p 0.005 patient comfort differ two interfac helmet facial mask equal toler effect amelior ga exchang decreas inspiratori effort helmet howev less effici decreas inspiratori effort worsen patient–ventil interact',\n",
       "  'case manag client access health social servic outpati substanc abus treatment primari goal case manag coordin servic across treatment set integr substanc abus servic type servic offer commun includ hous mental health medic social servic howev case manag global construct consist sever key dimens includ extent case manag coverag degre manag referr process locat case manag activ on-sit off-sit studi examin relationship specif dimens case manag util health ancillari social servic outpati substanc abus treatment gener result suggest activ case manag referr process provid case manag on-sit off-sit consist predict greater use health ancillari social servic substanc abus client howev effect specif gener health care mental health servic case manag appear littl effect use social servic aftercar plan',\n",
       "  'evid ipl1-sli15 aurora kinase-incenp complex promot chromosom bi-orient alter kinetochore-spindl pole connect sister kinetochor attach microtubul opposit spindl pole mitosi bi-orient remain poorli understood yeast ortholog aurora b-incenp protein kinas complex ipl1-sli15 may role crucial process necessari prevent attach sister kinetochor microtubul spindl pole investig ipl1 function cell replic chromosom nevertheless duplic spindl pole bodi spb kinetochor detach old spb reattach old new spb equal frequenc ipl1+ cell remain attach old spb ipl1 mutant rais possibl ipl1-sli15 facilit bi-orient promot turnov kinetochore-spb connect traction sister kinetochor toward opposit spindl pole creat tension surround chromatin',\n",
       "  'critic review cutan vascul updat diagnost criteria vascul inflamm vessel wall result mural destruct hemorrhag aneurysm format infarct intimal-medi hyperplasia subsequ stenosi lead tissu ischemia skin part due larg vascular bed exposur cold temperatur frequent presenc stasi involv mani distinct well un-nam vasculit syndrom vari local self-limit gener life-threaten multi-organ diseas exclud mimic vascul diagnosi cutan vascul requir biopsi confirm acut sign fibrinoid necrosi chronic sign endarter obliteran past sign acellular scar heal arter must recogn presenc extravascular find pattern fibrosi collagenolyt granuloma note although vascul classifi etiolog mani case identifi caus singl etiolog agent elicit sever distinct clinicopatholog express vascul therefor classif cutan vascul best approach morpholog determin vessel size princip inflammatori respons histolog pattern roughli correl pathogen mechan coupl direct immunofluoresc examin anti-neutrophil cytoplasm antibodi anca statu find work-up system diseas allow specif diagnosi ultim effect therapi herein review cutan vascul focus diagnost criteria classif epidemiolog etiolog pathogenesi evalu cutan vascul patient',\n",
       "  'e2f-depend histon acetyl recruit tip60 acetyltransferas complex chromatin late g1 e2f protein either activ repress transcript follow mitogen stimul repress e2f4-p130-histon deacetylas complex dissoci activ speci e2f1 -2 -3 associ target promot histon h3 h4 simultan becom hyperacetyl remain unclear whether prerequisit consequ e2f bind show activ e2f speci requir hyperacetyl target chromatin human cell overexpress dominant-neg dn e2f1 mutant serum-stimul t98g cell block e2f bind h4 acetyl albeit partial h3 acetyl target gene activ s-phase entri also block dn e2f1 convers ectop activ e2f1 rapidli induc h3 h4 acetyl demonstr direct role e2f event e2f1 previous shown bind histon acetyltransferas hat p300/cbp pcaf/gcn5 hand ectop express e2f1 also bound unrel hat tip60 induc recruit five subunit tip60 complex tip60 trrap p400 tip48 tip49 target promot vivo moreov e2f-depend recruit tip60 chromatin occur late g 1 follow serum stimul specul activ multipl hat complex account e2f-depend acetyl transcript s-phase entri',\n",
       "  'chemic approach stem cell biolog therapeut small molecul modul stem cell fate function offer signific opportun allow full realiz therapeut potenti stem cell ration design screen small molecul identifi use compound probe fundament mechan stem cell self-renew differenti reprogram facilit develop cell-bas therapi therapeut drug target endogen stem progenitor cell repair regener discuss recent scientif therapeut progress well new perspect futur challeng use chemic approach stem cell biolog regen medicin',\n",
       "  'genome-wid map chromatin state pluripot lineage-commit cell report applic single-molecule-bas sequenc technolog high-throughput profil histon modif mammalian cell obtain four billion base sequenc chromatin immunoprecipit dna gener genome-wid chromatin-st map mous embryon stem cell neural progenitor cell embryon fibroblast find lysin 4 lysin 27 trimethyl effect discrimin gene express pois express stabli repress therefor reflect cell state lineag potenti lysin 36 trimethyl mark primari code non-cod transcript facilit gene annot trimethyl lysin 9 lysin 20 detect satellit telomer activ long-termin repeat spread proxim uniqu sequenc lysin 4 lysin 9 trimethyl mark imprint control region final show chromatin state read allele-specif manner use singl nucleotid polymorph studi provid framework applic comprehens chromatin profil toward character divers mammalian cell popul',\n",
       "  'oncofet long noncod rna pvt1 promot prolifer stem cell-lik properti hepatocellular carcinoma cell stabil nop2 unlabel mani protein-cod oncofet gene highli express murin human fetal liver silenc adult liver protein product hepat oncofet gene use clinic marker recurr hepatocellular carcinoma hcc therapeut target hcc herein examin express profil long noncod rna lncrna found fetal adult liver mice mani fetal hepat lncrna identifi one lncrna-mpvt1 oncofet rna found promot cell prolifer cell cycl express stem cell-lik properti murin cell interestingli found human lncrna-hpvt1 up-regul hcc tissu patient higher lncrna-hpvt1 express poor clinic prognosi protumorigen effect lncrna-hpvt1 cell prolifer cell cycl stem cell-lik properti hcc cell confirm vitro vivo gain-of-funct loss-of-funct experi moreov mrna express profil data show lncrna-hpvt1 up-regul seri cell cycl gene smmc-7721 cell rna pulldown mass spectrum experi identifi nop2 rna-bind protein bind lncrna-hpvt1 confirm lncrna-hpvt1 up-regul nop2 enhanc stabil nop2 protein lncrna-hpvt1 function depend presenc nop2 conclus studi demonstr express mani lncrna up-regul earli liver develop fetal liver use search new diagnost marker hcc lncrna-hpvt1 promot cell prolifer cell cycl acquisit stem cell-lik properti hcc cell stabil nop2 protein regul lncrna-hpvt1/nop2 pathway may benefici effect treatment hcc',\n",
       "  'candida albican distinct fungal model cellular age studi unicellular eukaryot organ repres popular model system understand age eukaryot candida albican polymorph fungu appear anoth distinct unicellular age model addit bud yeast saccharomyc cerevisia fission yeast schizosaccharomyc pomb two type candida cell yeast blastospor form hyphal filament form similar replic lifespan take advantag morpholog chang abl obtain cell differ age old candida cell tend accumul glycogen oxid damag protein delet sir2 gene caus decreas lifespan insert extra copi sir2 extend lifespan indic like s. cerevisia sir2 regul cellular age c. albican interestingli sir2 delet result accumul extra-chromosom rdna molecul influenc retent oxid protein mother cell suggest extra-chromosom rdna molecul may associ cellular age c. albican novel age model allow effici large-scal isol old cell may facilit biochem character genomics/proteom studi cellular age help verifi age pathway observ organ includ s. cerevisia',\n",
       "  'anktm1 trp-like channel express nocicept neuron activ cold temperatur mammal detect temperatur special neuron peripher nervou system four trpv-class channel implic sens heat one trpm-class channel sens cold combin rang temperatur activ channel cover major relev physiolog spectrum sens mammal signific gap noxiou cold rang describ character anktm1 cold-activ channel lower activ temperatur compar cold menthol receptor trpm8 anktm1 distant famili member trp channel littl amino acid similar trpm8 found subset nocicept sensori neuron coexpress trpv1/vr1 capsaicin/heat receptor trpm8 consist express anktm1 identifi noxiou cold-sensit sensori neuron also respond capsaicin menthol',\n",
       "  'plasma vitamin metabolit risk colorect cancer women object experiment evid suggest 1,25-dihydroxyvitamin precursor 25-hydroxyvitamin 25 oh may aid prevent colorect cancer therefor examin risk relat plasma concentr vitamin metabolit method nest case-control studi among women nurs health studi identifi 193 colorect cancer case age 46 78 year diagnos 11 year blood collect two control match per case year birth month blood draw odd ratio risk colorect cancer calcul use condit logist regress adjust bodi mass index physic activ smoke famili histori use hormon replac therapi aspirin use dietari intak result found signific invers linear associ plasma 25 oh risk colorect cancer p 0.02 among women highest quintil 95 confid interv 0.53 0.27-1.04 invers associ remain strong limit women =60 year blood collect p 0.006 appar among younger women p 0.70 benefit higher 25 oh concentr observ cancer distal colon rectum p 0.02 evid proxim colon p 0.81 contrast 25 oh observ associ 1,25-dihydroxyvitamin colorect cancer although risk elev among women highest quintil also lower half 25 oh distribut 2.52 95 confid interv 1.04-6.11 conclus result support evid previou studi conclud higher plasma level 25 oh associ lower risk colorect cancer older women particularli cancer distal colon rectum',\n",
       "  'dna deamin mediat innat immun retrovir infect cem15/apobec3g cellular protein requir resist infect virion infect factor vif -defici human immunodefici viru hiv use murin leukemia viru mlv -base system provid evid cem15/apobec3g dna deaminas incorpor virion viral product subsequ trigger massiv deamin deoxycytidin deoxyuridin within retrovir minu first -strand cdna thu provid probabl trigger viral destruct furthermor hiv vif protect mlv cem15/apobec3g-depend restrict find impli target dna deamin major strategi innat immun retrovirus like also contribut sequenc variat observ mani virus includ hiv',\n",
       "  'global region nation disability-adjust life-year dali 315 diseas injuri healthi life expect hale 1990–2015 systemat analysi global burden diseas studi 2015 background healthi life expect hale disability-adjust life-year dali provid summari measur health across geographi time inform assess epidemiolog pattern health system perform help prioritis invest research develop monitor progress toward sustain develop goal sdg aim provid updat hale dali geographi worldwid evalu diseas burden chang develop method use result global burden diseas injuri risk factor studi 2015 gbd 2015 all-caus mortal cause-specif mortal non-fat diseas burden deriv hale dali sex 195 countri territori 1990 2015. calcul dali sum year life lost yll year life live disabl yld geographi age group sex year estim hale use sullivan method draw age-specif death rate yld per capita assess observ level dali hale differ expect trend calcul socio-demograph index sdi composit indic construct measur incom per capita averag year school total fertil rate find total global dali remain larg unchang 1990 2015 decreas communic neonat matern nutrit group 1 diseas dali offset increas dali due non-communic diseas ncd much epidemiolog transit caus chang popul growth age acceler widespread improv sdi also correl strongli increas import ncd total dali age-standardis dali rate due group 1 caus significantli decreas 2015 although total burden climb major ncd age-standardis dali rate due ncd declin nonetheless age-standardis dali rate due sever high-burden ncd includ osteoarthr drug use disord depress diabet congenit birth defect skin oral sens organ diseas either increas remain unchang lead increas rel rank mani geographi 2005 2015 hale birth increas averag 2·9 year 95 uncertainti interv 2·9-3·0 men 3·5 year 3·4-3·7 women hale age 65 year improv 0·85 year 0·78-0·92 1·2 year 1·1-1·3 respect rise sdi associ consist higher hale somewhat smaller proport life spent function health loss howev rise sdi relat increas total disabl mani countri territori central america eastern sub-saharan africa increasingli lower rate diseas burden expect given sdi time subset geographi record grow gap observ expect level dali trend driven mainli rise burden due war interperson violenc variou ncd interpret health improv global mean popul spend time function health loss absolut expans morbid proport life spent ill health decreas somewhat increas sdi rel compress morbid support continu effort elev person incom improv educ limit fertil analysi dali hale relationship sdi repres robust framework benchmark geography-specif health perform sdg progress country-specif driver diseas burden particularli caus higher-than-expect dali inform financi research invest prevent effort health polici health system improv initi countri along develop continuum fund bill melinda gate foundat',\n",
       "  'advers drug event databas construct silico predict advers drug event ade harm associ use given medic normal dosag crucial drug approv clinic use continu stay market mani ade identifi trial drug approv clinic use result advers morbid mortal date million ade report around world method avoid reduc ade import issu drug discoveri develop report comprehens databas advers drug event name metaadedb includ 520,000 drug-ad associ among 3059 uniqu compound includ 1330 drug 13,200 ade item data integr text mine compound ade annot commonli use concept defin medic subject head mesh meanwhil comput method name phenotyp network infer model pnim develop predict potenti ade base databas area receiv oper characterist curv auc 0.9 10-fold cross valid auc valu 0.912 extern valid set extract us-fda advers event report system indic predict capabl method reliabl metaadedb access free charg http //www.lmmd.org/online_services/metaadedb/ databas method provid us use tool search known side effect predict potenti side effect given drug compound',\n",
       "  \"genet test ecolog allopatr speciat anol island archipelago darwin 's studi galapago wallac 's studi indonesia island play import role evolutionari investig radiat within archipelago readili interpret support convent view allopatr speciat even ongo paradigm shift toward mode speciat island radiat lesser antillean anol thought exemplifi process geolog molecular phylogenet evid show archipelago martiniqu anol provid sever exampl secondari contact island speci four precursor island speci 8 mybp diverg met island coalesc form current island martiniqu moreov adjac anol popul also show mark adapt distinct habitat zonat allow allopatr ecolog speciat test system take advantag opportun replic island coalesc independ ecolog adapt carri extens popul genet studi hypervari neutral nuclear marker show even substanti period spatial isol put allospeci show less reproduct isol conspecif popul adjac habitat three case subsequ island coalesc degre genet interchang show alway signific genet signatur past allopatri may quit strong select regim allow case complet allopatr speciat spite strong prima faci case importantli greater genet isol across xeric/rainforest ecoton associ secondari contact reject develop reproduct isol allopatr diverg support potenti ecolog speciat even though full speciat achiev case also explain pauciti anol speci lesser antil compar greater antil\",\n",
       "  'defici pharmacolog stabil mast cell reduc diet-induc obes diabet mice although mast cell function classic relat allerg respons recent studi indic cell contribut common diseas multipl sclerosi rheumatoid arthriti atherosclerosi aortic aneurysm cancer studi present evid mast cell also contribut diet-induc obes diabet exampl white adipos tissu wat obes human mice contain mast cell wat lean counterpart furthermor context mice western diet genet induc defici mast cell pharmacolog stabil reduc bodi weight gain level inflammatori cytokin chemokin proteas serum wat concert improv glucos homeostasi energi expenditur mechanist studi reveal mast cell contribut wat muscl angiogenesi associ cell apoptosi cathepsin activ adopt transfer experi cytokine-defici mast cell show cell produc interleukin-6 il-6 interferon-gamma ifn-gamma contribut mous adipos tissu cystein proteas cathepsin express apoptosi angiogenesi therebi promot diet-induc obes glucos intoler result show reduc obes diabet mice treat clinic avail mast cell-stabil agent suggest potenti develop new therapi common human metabol disord',\n",
       "  'famili aphas episod anoth variant partial epilepsi simpl inherit report famili partial epilepsi simpl inherit affect member commonli aphas episod secondari gener onset occur either adolesc adulthood patient respons medic vari greatli neurolog defect declin intellig found case repres anoth varieti rare famili partial epilepsi neocort epilepsi featur',\n",
       "  'endosome- contact control actin nucleat retrom function vap-depend regul pi4p vap vapa vapb evolutionarili conserv endoplasm reticulum er -anchor protein help gener tether er membran lipid exchang across adjac bilay report regul pi4p level endosom vap affect wash-depend actin nucleat organel function retrom protein coat respons endosome-to-golgi traffic vap recruit retrom bud site endosom via interact retrom snx2 subunit cell lack vap accumul high level pi4p actin comet trans-golgi protein endosom defect mimick downregul osbp vap interactor pi4p transport particip vap-depend er-endosom tether result reveal role pi4p retromer-/wash-depend bud endosom collect data show er control bud dynam associ cytoskeleton anoth membran direct contact lead bilay lipid modif',\n",
       "  'anaphase-promot complex/cyclosome–depend proteolysi human cyclin start begin mitosi subject spindl assembl checkpoint cyclin stabl protein g2 phase destabil cell enter mitosi almost complet degrad metaphas anaphas transit microinject antibodi subunit anaphase-promot complex/cyclosom apc/c human cdc20 fizzi arrest cell metaphas stabil cyclin b1 cyclin effici polyubiquityl cdc20 cdh1-activ apc/c vitro contrast cyclin b1 proteolysi cyclin delay spindl assembl checkpoint degrad cyclin b1 acceler inhibit spindl assembl checkpoint data suggest apc/c activ cell enter mitosi immedi target cyclin degrad wherea spindl assembl checkpoint delay degrad cyclin b1 metaphas anaphas transit “ destruct box ” d-box cyclin 10–20 residu longer cyclin b. overexpress wild-typ cyclin delay metaphas anaphas transit wherea express cyclin mutant lack d-box arrest cell anaphas',\n",
       "  'human cell leukemia viru reactiv progress adult t-cell leukemia-lymphoma background human t-cell leukemia virus-associ adult t-cell leukemia-lymphoma atll poor prognosi despit trial varieti differ treatment regimen viru express report limit absent atll diagnos suggest secondari genet epigenet chang import diseas pathogenesi method find prospect investig combin chemotherapi follow antiretrovir therapi disord nineteen patient prospect enrol 2002 2006 five medic center phase ii clinic trial infusion chemotherapi etoposid doxorubicin vincristin daili prednison bolu cyclophosphamid epoch given two six cycl maxim clinic respons follow antivir therapi daili zidovudin lamivudin alpha interferon-2a one year seven patient studi less one month due progress diseas chemotherapi toxic eleven patient achiev object respons median durat respons thirteen month two complet remiss chemotherapi induct viral rna express increas median 190-fold viru replic occur coincid develop diseas progress conclus epoch chemotherapi follow antiretrovir therapi activ therapeut regimen adult t-cell leukemia-lymphoma viral reactiv induct chemotherapi may contribut treatment failur altern therapi sore need diseas simultan prevent viru express cytocid malign cell',\n",
       "  'montelukast fluticason compar salmeterol fluticason protect asthma exacerb adult one year doubl blind randomis compar trial object assess effect montelukast versu salmeterol ad inhal fluticason propion asthma exacerb patient whose symptom inadequ control fluticason alon design set 52 week two period doubl blind multicentr trial patient whose symptom remain uncontrol inhal corticosteroid randomis add montelukast salmeterol particip patient 15-72 year n 1490 clinic histori chronic asthma 1 year baselin forc expiratori volum one second fev1 valu 50-90 predict beta agonist improv 12 fev1 main outcom measur primari end point percentag patient least one asthma exacerb result 20.1 patient group receiv montelukast fluticason asthma exacerb compar 19.1 group receiv salmeterol fluticason differ 1 95 confid interv -3.1 5.0 risk ratio montelukast-fluticasone/salmeterol-fluticason 1.05 0.86 1.29 treatment montelukast fluticason shown non-inferior treatment salmeterol fluticason salmeterol fluticason significantli increas fev1 beta agonist use morn peak expiratori flow compar montelukast fluticason p 0.001 wherea fev1 beta agonist use improv asthma specif qualiti life nocturn awaken similar group montelukast fluticason significantli p 0.011 reduc peripher blood eosinophil count compar salmeterol fluticason treatment gener well toler conclus addit montelukast patient whose symptom remain uncontrol inhal fluticason could provid equival clinic control salmeterol',\n",
       "  \"control assembl function glutam receptor amino-termin domain extracellular amino-termin domain atd ionotrop glutam receptor subunit form semiautonom compon glutam receptor resid distal membran control surprisingli divers set receptor function function includ subunit assembl receptor traffick channel gate agonist potenc alloster modul mani diverg featur differ ionotrop glutam receptor class differ subunit within class may stem differenti regul amino-termin domain emerg knowledg structur function amino-termin domain review may enabl target region therapeut modul glutamaterg signal toward end nmda receptor antagonist interact glun2b atd show promis anim model ischemia neuropath pain parkinson 's diseas\",\n",
       "  'fission yeast yeast emerg model unravel cellular age eukaryot past year simpl organ yeast worm contribut great deal age research studi pioneer saccharomyc cerevisia use elucid signific number molecular mechan underli cellular age discov novel longev gene importantli gene prove mani time conserv multicellular eukaryot consequ discoveri approach extend yeast model schizosaccharomyc pomb candida albican kluyveromyc lacti cryptococcu neoforman fission yeast research found link asymmetr cell divis nutrient signal pathway age review discuss state knowledg mechan control replic chronolog age pomb emerg yeast model',\n",
       "  'centrifug elutri method isol larg number function intact human peripher blood monocyt centrifug elutri use isol human peripher blood monocyt hpbm mononuclear-enrich cell harvest secondari compon follow platelet concentr collect sampl hpbm recov either one two popul consist either total hpbm small sm larg monocyt lm elutri carri 3,500 +/- 5 rpm separ lymphocyt hpbm ca++- mg++-free pb without edta averag 5.05 +/- 1.50 x 10 8 hpbm recov total hpbm puriti 95 +/- 3 sm lm obtain split total hpbm two equal popul hpbm puriti 92 +/- 3 93 +/- 3 respect nonspecif esteras stain elutri media shown effect viabil trypan blue exclus three hpbm popul shown histochem lack reactiv leu-1 leu-7 function deplet nk cell activ purifi lymphocyt popul hpbm popul enrich hla-dr okm-1 okm-5 my-8 leu m-3 monoclon antibodi marker stain differ percent posit cell sm lm popul monocyte-specif monoclon antibodi three monocyt popul mediat antibody-depend cell-medi cytotox human red blood cell lm mediat lysi 27.0 +/- 5 sm 7 +/- 3 abstract truncat 250 word',\n",
       "  'asthma unit state olymp athlet particip 1996 summer game background asthma preval appear increas gener popul sought determin whether asthma preval also increas highli competit athlet object aim determin mani unit state olymp athlet chosen particip 1996 summer olymp game past histori asthma symptom suggest asthma took asthma medic method analyz respons question ask allerg respiratori diseas unit state olymp committe usoc medic histori questionnair complet athlet chosen repres us 1996 summer olymp game atlanta result 699 athlet complet questionnair 107 15.3 previou diagnosi asthma 97 13.9 record use asthma medic time past one hundr seventeen 16.7 report use asthma medic diagnosi asthma basi diagnosi asthma seventy-thre 10 4 athlet current take asthma medic time process atlanta note took asthma medic perman semiperman basi consid activ asthma athlet particip cycl mountain bike highest preval told asthma taken asthma medic past 50 frequenc activ asthma vari 45 cyclist emountain biker none diver weight lifter 11 athlet particip 1984 summer olymp game report exercise-induc asthma basi criteria may less restrict basi less restrict criteria 20 athlet particip 1996 olymp game might consid asthma conclus asthma appear preval athlet particip 1996 summer game gener popul particip 1984 summer game studi also suggest asthma may influenc sport athlet choos',\n",
       "  \"relaps specif mutat nt5c2 childhood acut lymphoblast leukemia relaps childhood acut lymphoblast leukemia carri poor prognosi despit intens retreat owe intrins drug resist biolog pathway mediat resist unknown report transcriptom profil match diagnosi relaps bone marrow specimen ten individu pediatr b-lymphoblast leukemia use rna sequenc transcriptom sequenc identifi 20 newli acquir novel nonsynonym mutat present initi diagnosi 2 individu harbor relapse-specif mutat gene nt5c2 encod 5'-nucleotidas full-exon sequenc nt5c2 complet 61 relaps specimen identifi addit mutat 5 case enzymat analysi mutant protein show base substitut confer increas enzymat activ resist treatment nucleosid analog therapi clinic individu harbor nt5c2 mutat relaps earli within 36 month initi diagnosi p 0.03 result suggest mutat nt5c2 associ outgrowth drug-resist clone\",\n",
       "  'relationship sloan-kett viru express mous follicular develop sloan-kett viru gene product ski uniqu nuclear pro-oncoprotein belong ski/sno proto-oncogen famili ski play multipl role varieti cell type induc oncogen transform termin muscl differenti express high level ski/snon import transcript regul transform growth factor-β tgf-β superfamili function mainli heterodim sinc tgf-β superfamili key regul follicl develop previous shown snon also vital follicl develop research conduct clarifi relationship ski express mous follicular develop ovari neonat gonadotropin-induc immatur mice immunohistochem real-tim pcr techniqu postnat mice posit stain ski highli detect oocyt nuclei postnat day 1. follicular develop local move gradual oocyt nuclei perinuclear space total level decreas estrou cycl ski express appar proestru estru faint metestru highest diestru inject gonadotropin ski found perinuclear space weak oocyt nuclei follow initi lutein express ski found corpu luteum real-tim pcr result also show ski mrna express opposit ovulation-rel gene cumulu expans develop follicl express level decreas ski express specif manner follicl develop ovul lutein ski might play essenti role process especi earli follicular develop',\n",
       "  'involv cb1 cannabinoid receptor emot behaviour rational endogen exogen cannabinoid act cb1 cannabinoid receptor implic control varieti behaviour neuroendocrin function includ emot respons learn memori process recent knockout mice defici cb1 cannabinoid receptor gener anim result excel tool evalu neurophysiolog endogen cannabinoid system object establish role cb1 cannabinoid receptor sever emotional-rel behaviour respons includ aggress anxieti depress learn model use cb1 knockout mice method evalu spontan respons cb1 knockout mice wild-typ control differ behaviour paradigm includ light/dark box chronic unpredict mild stress resident–intrud test activ avoid paradigm result find show cb1 knockout mice present increas aggress respons measur resident–intrud test anxiogenic-lik respons light/dark box furthermor higher sensit exhibit depressive-lik respons chronic unpredict mild stress procedur observ cb1 knockout mice suggest increas suscept develop anhedon state anim final cb1 knockout mice show signific increas condit respons produc activ avoid model suggest improv learn memori process conclus taken togeth find demonstr endogen cannabinoid activ cb1 receptor implic control emot behaviour particip physiolog process learn memori',\n",
       "  'exosom level mirna-21 cerebrospin fluid associ poor prognosi tumor recurr glioma patient glioma common type primari brain tumor extracellular vesicl form exosom known mediat cell-cel commun transport cell-deriv protein nucleic acid includ variou microrna mirna examin cerebrospin fluid csf patient recurr glioma level cancer-rel mirna evalu valu prognosi compar measur csf- serum- exosome-contain mir-21 level sampl seventi glioma patient follow surgeri compar brain trauma patient non-tumor control group exosom mir-21 level csf glioma patient found significantli higher control wherea differ detect serum-deriv exosom mir-21 express csf-deriv exosom mir-21 level correl tumor spinal/ventricl metastasi recurr anatom site prefer addit 198 glioma tissu sampl verifi mir-21 level associ tumor grade diagnosi neg correl median valu patient overal surviv time use lentivir inhibitor suppress mir-21 express u251 cell result show level mir-21 target gene pten reck pdcd4 up-regul protein level therefor conclud exosom mir-21 level could demonstr promis indic glioma diagnosi prognosi particularli valu predict tumor recurr metastasi',\n",
       "  \"age‐associ microrna express human peripher blood associ all‐caus mortal age‐rel trait recent studi provid evid correl dna methyl express protein-cod gene human age relat microrna express age age-rel clinic outcom character thoroughli explor associ age whole-blood microrna express 5221 adult identifi 127 microrna differenti express age p 3.3 × 10-4 bonferroni-correct microrna underexpress older individu integr analysi microrna mrna express reveal chang age-associ mrna express possibl driven age-associ microrna pathway involv rna process translat immun function fit linear model predict 'microrna age incorpor express level 80 microrna microrna age correl modestli predict age dna methyl r 0.3 mrna express r 0.2 suggest microrna age may complement mrna epigenet age predict model use differ microrna age chronolog age biomark acceler age δage found δage associ all-caus mortal hazard ratio 1.1 per year differ p 4.2 × 10-5 adjust sex chronolog age addit δage associ coronari heart diseas hypertens blood pressur glucos level conclus construct microrna age predict model base whole-blood microrna express profil age-associ microrna target potenti util detect acceler age predict risk age-rel diseas\",\n",
       "  'histon deacetylas hdac frontotempor lobar degener aim frontotempor lobar degener ftld clinic patholog heterogen although associ variat mapt grn c9orf72 pathogenesi nongenet form ftld remain unknown epigenet factor histon regul histon deacetylas hdac may play role dysregul transcript activ thought underpin neurodegen process method distribut intens hdac 4 5 6 assess semi-quantit immunostain section tempor cortex hippocampu cerebellum 33 patholog confirm case ftld 27 control result found significantli greater intens cytoplasm immunostain hdac4 hdac6 granul cell dentat gyru case ftld overal compar control specif case ftld tau-pick compar ftld tau-mapt control differ note ftld-tdp subtyp differ genet nongenet form ftld chang seen hdac5 ftld control case conclus dysregul hdac4 and/or hdac6 could play role pathogenesi ftld-tau associ pick bodi although lack immunostain impli chang contribut directli format pick bodi',\n",
       "  'evolut impact subclon mutat chronic lymphocyt leukemia clonal evolut key featur cancer progress relaps studi intratumor heterogen 149 chronic lymphocyt leukemia cll case integr whole-exom sequenc copi number measur fraction cancer cell harbor somat mutat identifi driver mutat predominantli clonal e.g. myd88 trisomi 12 del 13q subclon e.g. sf3b1 tp53 correspond earlier later event cll evolut sampl leukemia cell 18 patient two time point ten twelv cll case treat chemotherapi one six without treatment underw clonal evolut predominantli involv subclon driver mutat e.g. sf3b1 tp53 expand time furthermor presenc subclon driver mutat independ risk factor rapid diseas progress studi thu uncov pattern clonal evolut cll provid insight stepwis transform link presenc subclon advers clinic outcom',\n",
       "  'transcript program sporul bud yeast diploid cell bud yeast produc haploid cell development program sporul consist meiosi spore morphogenesi dna microarray contain nearli everi yeast gene use assay chang gene express sporul least seven distinct tempor pattern induct observ transcript factor ndt80 appear import induct larg group gene end meiotic prophas consensu sequenc known propos respons tempor regul could identifi sole analysi sequenc coordin express gene tempor express pattern provid clue potenti function hundr previous uncharacter gene vertebr homolog may function gametogenesi',\n",
       "  'grass plant bind retain uptak transport infecti prion prion protein-bas infecti agent respons prion diseas environment prion contamin implic diseas transmiss analyz bind retent infecti prion protein prp sc plant small quantiti prp sc contain dilut brain homogen excretori materi urin fece bind wheat grass root leav wild-typ hamster effici infect ingest prion-contamin plant prion-plant interact occur prion divers origin includ chronic wast diseas furthermor leav contamin spray prion-contain prepar retain prp sc sever week live plant final plant uptak prion contamin soil transport aerial part plant stem leav find demonstr plant effici bind infecti prion act carrier infect suggest possibl role environment prion contamin horizont transmiss diseas',\n",
       "  \"innat lymphoid cell mediat influenza-induc airway hyper-react independ adapt immun patient asthma major public health problem high risk seriou diseas influenza viru infect pathogen mechan influenza caus airway diseas asthma fulli known show mous model influenza infect acut induc airway hyper-react ahr cardin featur asthma independ helper type 2 th2 cell adapt immun instead influenza infect induc ahr previous unknown pathway requir interleukin 13 il-13 –il-33 axi cell non-t cell non-b cell innat lymphoid type call 'natur helper cell infect influenza viru activ nlrp3 inflammasom result much product il-33 alveolar macrophag turn activ natur helper cell produc substanti il-13\",\n",
       "  \"behaviour chang wheel new method characteris design behaviour chang intervent background improv design implement evidence-bas practic depend success behaviour chang intervent requir appropri method characteris intervent link analysi target behaviour exist plethora framework behaviour chang intervent clear well serv purpos paper evalu framework develop evalu new framework aim overcom limit method systemat search electron databas consult behaviour chang expert use identifi framework behaviour chang intervent evalu accord three criteria comprehens coher clear link overarch model behaviour new framework develop meet criteria reliabl could appli examin two domain behaviour chang tobacco control obes result nineteen framework identifi cover nine intervent function seven polici categori could enabl intervent none framework review cover full rang intervent function polici minor met criteria coher linkag model behaviour centr propos new framework 'behaviour system involv three essenti condit capabl opportun motiv term 'com-b system form hub 'behaviour chang wheel bcw around posit nine intervent function aim address deficit one condit around place seven categori polici could enabl intervent occur bcw use reliabl characteris intervent within english depart health 's 2010 tobacco control strategi nation institut health clinic excel 's guidanc reduc obes conclus intervent polici chang behaviour use characteris mean bcw compris 'behaviour system hub encircl intervent function polici categori research need establish far bcw lead effici design effect intervent\",\n",
       "  'intermitt prophylaxi oral truvada protect macaqu rectal shiv infect hiv continu spread global mainli sexual contact despit advanc treatment care prevent transmiss vaccin microbicid proven difficult promis strategi avoid transmiss prophylact treatment antiretrovir drug exposur hiv clinic trial evalu efficaci daili treatment revers transcriptas inhibitor tenofovir disoproxil fumar tdf truvada tdf plu emtricitabin way hypothes intermitt prophylact treatment long-act antivir drug would effect daili dose block earliest stage viral replic prevent mucos transmiss test hypothesi intermitt give prophylact truvada macaqu monkey expos rectal simian-human immunodefici viru shiv week 14 week simpl regimen oral dose truvada given 1 3 7 day exposur follow second dose 2 hour exposur protect daili drug administr possibl long intracellular persist drug addit two-dos regimen initi 2 hour viru exposur effect full protect obtain doubl truvada concentr dose saw protect first dose delay 24 hour exposur underscor import block initi replic mucosa result show intermitt prophylact treatment antivir drug highli effect prevent shiv infect wide window protect strengthen possibl develop feasibl cost-effect strategi prevent hiv transmiss human',\n",
       "  'rna favour analys egfr mutat malign pleural effus lung cancer malign pleural effus mpe use specimen allow evalu egfr statu nonsmal cell lung cancer nsclc howev direct sequenc genom dna mpe sampl found sensit egfr mutat detect test whether egfr analysi rna less prone interfer nontumour cell lower egfr express compar three method sequenc cell-deriv rna versu sequenc mass-spectrometr analysi genom dna parallel egfr mutat detect mpe sampl 150 lung adenocarcinoma patient receiv first-lin tyrosin kinas inhibitor tki among mpe sampl egfr mutat much frequent identifi sequenc use rna sequenc mass-spectrometr analysi genom dna mutat 67.3 versu 44.7 46.7 l858r exon 19 delet 61.3 versu 41.3 46.7 respect better mutat detect yield sequenc rna coupl superior predict clinic efficaci first-lin tki patient acquir resist egfr sequenc rna provid satisfactori detect t790m 54.2 result demonstr egfr sequenc use rna templat greatli improv sensit egfr mutat detect sampl mpe highlight rna favour sourc analys egfr mutat heterogen mpe specimen nsclc',\n",
       "  'pharmacolog correct defect pparγ signal amelior diseas sever cftr-defici mice cystic fibrosi caus mutat cystic fibrosi transmembran conduct regul encod cftr impair role apic chlorid channel support bicarbon transport individu cystic fibrosi show retain thicken mucu plug airway obstruct lumin organ well numer abnorm includ inflamm affect organ alter lipid metabol insulin resist show colon epitheli cell whole lung tissu cftr-defici mice show defect peroxisom proliferator-activ receptor-gamma ppar-gamma encod pparg function contribut patholog program gene express lipidom analysi colon epitheli cell suggest defect result part reduc amount endogen ppar-gamma ligand 15-keto-prostaglandin e 2 15-keto-pg 2 treatment cftr-defici mice synthet ppar-gamma ligand rosiglitazon partial normal alter gene express pattern associ cftr defici reduc diseas sever rosiglitazon effect chlorid secret colon increas express gene encod carbon anhydras 4 2 car4 car2 increas bicarbon secret reduc mucu retent studi reveal revers defect ppar-gamma signal cftr-defici cell pharmacolog correct amelior sever cystic fibrosi phenotyp mice',\n",
       "  'visual volatil substanc differ organel atmospheric-pressur mass microscop develop mass microscop mass spectrometri imag spatial resolut higher nake eye equip atmospher pressur ion-sourc chamber laser desorption/ion ap-ldi quadrupol ion trap time-of-flight qit-tof analyz optic microscop combin mass spectromet permit us precis determin relev tissu region prior perform imag mass spectrometri im ultraviolet laser tightli focus triplet len use achiev high spatial resolut atmospher pressur ion-sourc chamber enabl us analyz fresh sampl minim loss intrins water volatil compound mass-microscop ap-ldi imag freshli cut ginger rhizom section reveal 6-gingerol k m/z 333.15 posit mode h m/z 293.17 neg mode monoterpen k m/z 191.09 compound relat pungenc flavor respect local oil drop-contain organel ap-ldi-tandem ms/m analys appli compar authent signal freshli cut ginger directli standard reagent thu atmosphere-imag mass spectromet enabl us monitor qualiti plant organel level',\n",
       "  'code sweet bitter umami tast differ receptor cell share similar signal pathway mammal tast wide repertoir chemosensori stimuli two unrel famili receptor t1r t2r mediat respons sweet amino acid bitter compound demonstr knockout trpm5 tast trp ion channel plcbeta2 phospholipas c select express tast tissu abolish sweet amino acid bitter tast recept impact sour salti tast therefor despit reli differ receptor sweet amino acid bitter transduct converg common signal molecul use plcbeta2 taste-blind anim examin fundament question tast percept tast modal encod cellular level mice engin rescu plcbeta2 function exclus bitter-receptor express cell respond normal bitter tastant tast sweet amino acid stimuli thu bitter encod independ sweet amino acid tast receptor cell broadli tune across modal',\n",
       "  'green synthesi silver nanoparticl character inhibitori effect age format use biophys techniqu advanc glycat end-product age result non-enzymat glycat one major factor implic secondari complic diabet scientist focus discov new compound may use potenti age inhibitor without affect normal structur function biomolecul number natur synthet compound propos age inhibitor studi investig inhibitori effect agnp silver nanoparticl age format agnp ~30.5 nm synthes alo vera leaf extract character use uv-vi spectroscopi energy-dispers x-ray spectroscopi edx high resolution-transmiss electron microscopi x-ray diffract dynam light scatter dl techniqu inhibitori effect agnp age format evalu investig degre reactiv free amino group lysin arginin residu protein-bound carbonyl carboxymethyl lysin cml content effect protein structur use variou physicochem techniqu result show agnp significantli inhibit age format concentr depend manner agnp posit effect protein structur find strongli suggest agnp may play therapeut role diabetes-rel complic',\n",
       "  'myosin light chain–activ phosphoryl site requir oogenesi drosophila drosophila spaghetti squash sqh gene encod regulatori myosin light chain rmlc nonmuscl myosin ii biochem analysi vertebr nonmuscl smooth muscl myosin ii establish phosphoryl certain amino acid rmlc greatli increas actin-depend myosin atpas motor activ myosin vitro assess vivo import site drosophila correspond serine-21 threonine-20 creat seri transgen specif amino acid alter phenotyp transgen examin otherwis null mutant background oocyt develop drosophila femal germ line cystoblast entir lack function sqh gene show sever defect prolifer cytokinesi ring canal cytoplasm bridg link oocyt nurs cell egg chamber abnorm suggest role myosin ii establish mainten addit numer aggreg myosin heavi chain accumul sqh null cell mutant sqh transgen sqh -a20 a21 serine-21 threonine-20 replac alanin behav respect ident null allel system except heavi chain aggreg found contrast express sqh -a21 primari phosphoryl target serine-21 site alter partial restor function germ line myosin ii allow cystoblast divis oocyt develop albeit cytokinesi failur defect rapid cytoplasm transport nurs cell cytoplasm characterist late stage oogenesi damag ring canal substitut glutam serine-21 mutant sqh -e21 allow oogenesi complet minim defect produc egg develop normal produc fertil adult fli express sqh -a20 secondari phosphoryl site absent appear entir wild type taken togeth genet evid argu phosphoryl serine-21 critic rmlc function activ myosin ii vivo function partial provid phosphoryl threonine-20',\n",
       "  'stage patholog process alzheim diseas age categori 1 100 year two thousand three hundr thirti two nonselect brain 1- 100-year-old individu examin use immunocytochemistri at8 gallya silver stain abnorm tau immunocytochemistri 4g8 campbell-switz stain use detect ofβ-amyloid total 342 case neg gallya stain restag at8 10 immunoneg fifty-eight case subcort tau predominantli locu coeruleu abnorm cortic tau subcort stage a-c cortic involv abnorm tau neurit identifi first transentorhin region stage 1a 38 case transentorhin pyramid cell display pretangl materi stage 1b 236 case pretangl gradual becam argyrophil neurofibrillari tangl nft progress parallel nft stage vi pretangl restrict subcort site seen chiefli younger age total case 1,031 44.2 β-amyloid plaqu first plaqu occur neocortex onset tauopathi brainstem plaqu gener develop 40 4 case culmin tenth decad 75 β-amyloid plaqu nft significantli correl p 0.0001 data suggest tauopathi associ sporad alzheim diseas may begin earlier previous thought possibl lower brainstem rather transentorhin region',\n",
       "  'coronari bypass graft patenc patient diabet bypass angioplasti revascular investig bari background studi compar long-term statu bypass graft patient without diabet uncertainti exist whether diabet independ predict poor clinic outcom cabg method result among 1526 patient bari underw cabg initi revascular 99 292 34 treat diabet mellitu tdm insulin oral hypoglycem agent 469 1234 38 without tdm follow-up angiographi angiogram longest interv initi surgeri percutan graft intervent mean 3.9 year review averag 3.0 graft place initi cabg patient tdm n=297 intern mammari arteri ima 33 2.9 graft patient without tdm n=1347 ima 34 patient tdm like without small 1.5 mm graft distal vessel 29 versu 22 vessel poor qualiti 9 versu 6 follow-up angiographi 89 ima graft free stenos =50 among patient tdm versu 85 among patient without tdm p=0.23 vein graft correspond percentag 71 versu 75 p=0.40 statist adjust tdm unrel graft stenosi =50 adjust odd ratio 0.87 95 ci 0.58 1.32 conclus despit diabet patient smaller distal vessel vessel judg poorer qualiti diabet appear advers affect patenc ima vein graft averag 4-year follow-up previous observ differ surviv cabg-treat patient without diabet may larg result differenti risk mortal noncardiac caus',\n",
       "  \"novel atac-seq approach reveal lineage-specif reinforc open chromatin landscap via cooper baf p63 background open chromatin region correl activ regulatori element develop dysregul diseas baf swi/snf complex essenti develop demonstr remodel reconstitut chromatin vitro control access individu region vivo howev remain unclear baf control open chromatin landscap regul development process human epiderm differenti result use novel `` on-plat '' atac-sequenc approach profil open chromatin landscap low number adher cell demonstr baf complex essenti maintain 11.6 open chromatin region epiderm differenti baf-depend open chromatin region highli cell-type-specif strongli enrich bind site p63 master epiderm transcript factor dna sequenc p63 bind site intrins favor nucleosom format inaccess cell type without p63 prevent ectop activ epiderm cell baf p63 mutual recruit maintain 14,853 open chromatin region demonstr baf p63 cooper posit nucleosom away p63 bind site recruit transcript machineri control tissu differenti conclus baf display high specif control open chromatin landscap epiderm differenti cooper master transcript factor p63 maintain lineage-specif open chromatin region\",\n",
       "  'age habitu exercis dynam arteri complianc background reduct complianc large-s cardiothorac central arteri independ risk factor develop cardiovascular diseas advanc age method result determin role habitu exercis age-rel decreas central arteri complianc use cross-sect intervent approach first studi 151 healthi men age 18 77 year 54 sedentari 45 recreat activ 53 endur exercise-train central arteri complianc simultan b-mode ultrasound arteri applan tonometri common carotid arteri lower p 0.05 middle-ag older men young men 3 group signific differ sedentari recreat activ men age howev arteri complianc endurance-train middle-ag older men 20 35 higher 2 less activ group p 0.01 age-rel differ central arteri complianc smaller endurance-train men sedentari recreat activ men second studi 20 middle-ag older 53+/-2 year sedentari healthi men 3-month aerob exercis intervent primarili walk regular exercis increas central arteri complianc p 0.01 level similar middle-ag older endurance-train men effect independ chang bodi mass adipos arteri blood pressur maxim oxygen consumpt conclus regular aerobic-endur exercis attenu age-rel reduct central arteri complianc restor level previous sedentari healthi middle-ag older men may one mechan habitu exercis lower risk cardiovascular diseas popul',\n",
       "  'comparison cancer screen practic cancer survivor gener popul korean nation health nutrit examin survey knhane 2001–2007 studi aim describ cancer screen rate second primari cancer among cancer survivor korea compar rate two control group individu without histori cancer chronic diseas individu without histori cancer without chronic diseas studi cross-sect analysi 15,556 adult ≥30 year old particip 2001 2005 2007 korean nation health nutrit examin survey knhane preval breast cervic gastric colorect cancer screen examin accord nation guidelin assess compar two control group screen rate among cancer survivor 48.5 54.7 34.7 28.6 breast cervic gastric colorect cancer screen respect cancer survivor show higher screen rate four cancer site compar control group breast cancer screen statist signific adjust gender age marit statu educ incom work statu health insur smoke drink statu self-report health statu cancer survivor like individu without cancer histori obtain screen examin accord recommend guidelin still screen rate even among survivor suboptim emphas need systemat approach second primari cancer screen prevent',\n",
       "  'neg effect transcript activ gal4 yeast transcript activ gal4 bind specif site dna activ transcript adjac genes1–5 distinct activ region gal4 rich acid residu suggest region interact anoth protein compon transcript machineri tata-bind protein rna polymeras ii dna-bind region serv posit activ region near gene6,7,8 show variou gal4 deriv express high level yeast inhibit transcript certain gene lack gal4 bind site effici activ inhibit strongli inhibit depend dna-bind domain suggest inhibit call squelch reflect titrat transcript factor activ region gal4',\n",
       "  'bayh–dol act univers research develop paper examin relationship univers research develop r activ bayh-dol act act made much easier univers obtain patent research fund feder govern may provid univers incent alter r activ act may provid incent reduc basic research gener licens fee increas appli research gener patent licens fee addit industri might will fund univers r project sinc result would easier patent paper differ exist literatur use patent data measur research output use research develop data measur invent input examin effect act',\n",
       "  'relat past exposur fine particul air pollut preval anxieti observ cohort studi object determin whether higher past exposur particul air pollut associ preval high symptom anxieti design observ cohort studi set nurs health studi particip 71,271 women enrol nurs health studi resid throughout contigu unit state valid estim exposur particul matter least one exposur period interest data anxieti symptom main outcom measur meaning high symptom anxieti defin score 6 point greater phobic anxieti subscal crown-crisp index administ 2004. result 71,271 elig women age 57 85 year mean 70 year time assess anxieti symptom preval high anxieti symptom 15 exposur particul matter character use estim averag exposur particul matter 2.5 μm diamet pm2.5 2.5 10 μm diamet pm2.5-10 one month three month six month one year 15 year prior assess anxieti symptom residenti distanc nearest major road two year prior assess significantli increas odd high anxieti symptom observ higher exposur pm2.5 multipl averag period exampl odd ratio per 10 µg/m 3 increas prior one month averag pm2.5 1.12 95 confid interv 1.06 1.19 prior 12 month averag pm2.5 1.15 1.06 1.26 model includ multipl exposur window suggest short term averag period relev long term averag period associ anxieti exposur pm2.5-10 residenti proxim major road relat anxieti symptom dose depend manner conclus exposur fine particul matter pm2.5 associ high symptom anxieti recent exposur potenti relev distant exposur research evalu whether reduct exposur ambient pm2.5 would reduc popul level burden clinic relev symptom anxieti warrant',\n",
       "  'mitochondri target compound delay age yeast mechan link mitochondri membran lipid metabol mitochondri redox biology☆ recent studi reveal mechan delay age yeast natur compound specif impact mitochondri redox process mechan exogen ad lithochol bile acid enter yeast cell accumul mainli inner mitochondri membran elicit age-rel remodel phospholipid synthesi movement within mitochondri membran remodel mitochondri phospholipid dynam progress chronolog age yeast cell ultim caus signific chang mitochondri membran lipidom chang composit membran phospholipid alter mitochondri abund morpholog therebi trigger chang age-rel chronolog longevity-defin redox process mitochondri respir mainten mitochondri membran potenti preserv cellular homeostasi mitochondri produc reactiv oxygen speci coupl electron transport atp synthesi',\n",
       "  'isol african syke monkey cercopithecu miti lentiviru relat human simian immunodefici virus analysi serum sampl 100 wild-caught colony-born syke monkey cercopithecu miti kenya reveal 59 anim antibodi cross-react human immunodefici viru type 2 hiv-2 simian immunodefici virus siv lentiviru design sivsyk isol five six seroposit asymptomat syke monkey four case isol possibl deplet cd8+ lymphocyt cocultiv cd4 -enrich cell popul peripher blood mononuclear cell seroneg syke monkey sivsyk resembl siv hiv morpholog mg2 -depend revers transcriptas enzym replic cytopath cemx174 sup-t1 cell sivsyk differ substanti siv howev fail replic normal human mangabey macaqu peripher blood mononuclear cell serum seroposit syke monkey immunoprecipit env antigen hiv-1 well hiv-2 sivsmm sivagm data demonstr high preval natur infect syke monkey kenya lentiviru appear uniqu respect host rang antigen cross-react',\n",
       "  \"role single-strand dna–bind protein ssbb pneumococc transform mainten reservoir genet plastic bacteria encod single-strand dna ssdna bind protein ssb crucial genom mainten bacillu subtili streptococcu pneumonia altern ssb ssbb express uniqu compet genet transform precis role disappointingli obscur report investig involv comparison null mutant ssbb c-ter truncat ssbbδ7 ssbb s. pneumonia latter construct ssb acid tail emerg key site interact partner protein provid evid ssbb directli protect intern ssdna show ssbb highli abund potenti allow bind ~1.15 mb ssdna half genom equival particip process ssdna recombin high dna concentr crucial import chromosom transform whilst antagon plasmid transform latter observ explain long-stand observ plasmid transform ineffici s. pneumonia compar chromosom transform former support previou suggest ssbb creat reservoir ssdna allow success recombin cycl ssbbδ7 fulfil reservoir function suggest ssbb c-ter necessari process protein access store ssdna propos evolutionari raison d'être ssbb abund mainten reservoir contribut genet plastic s. pneumonia increas likelihood multipl transform event cell\",\n",
       "  'cerebr organoid model human brain develop microcephali complex human brain made difficult studi mani brain disord model organ highlight need vitro model human brain develop develop human pluripot stem cell-deriv three-dimension organoid cultur system term cerebr organoid develop variou discret although interdepend brain region includ cerebr cortex contain progenitor popul organ produc matur cortic neuron subtyp furthermor cerebr organoid shown recapitul featur human cortic develop name characterist progenitor zone organ abund outer radial glial stem cell final use rna interfer patient-specif induc pluripot stem cell model microcephali disord difficult recapitul mice demonstr prematur neuron differenti patient organoid defect could help explain diseas phenotyp togeth data show three-dimension organoid recapitul develop diseas even complex human tissu',\n",
       "  'local gene partial epilepsi chromosom 10q strong evid genet contribut epilepsi commonli assum genet contribut limit ‘ gener ’ epilepsi form ‘ partial ’ epilepsi nongenet linkag analysi singl famili contain 11 affect individu obtain strong evid local gene partial epilepsi suscept gene map chromosom 10q maximum two–point lod score d10s192 3.99 θ=0.0 affect individu share singl haplotyp seven tightli link contigu marker maximum lod score haplotyp 4.83 θ=0.0 key recombin place suscept locu within 10 centimorgan interv',\n",
       "  'metastat colon requir repress epithelial-mesenchym transit induc prrx1 epithelial-mesenchym transit emt requir embryo format tissu cell origin far final destin carcinoma cell hijack program tumor dissemin relev emt cancer still debat unclear migratori cell colon distant tissu form macrometastas show homeobox factor prrx1 emt induc confer migratori invas properti loss prrx1 requir cancer cell metastas vivo revert epitheli phenotyp concomit acquisit stem cell properti thu unlik classic emt transcript factor prrx1 uncoupl emt stem biomark associ patient surviv lack metastasi',\n",
       "  'cohort studi risk cervic intraepitheli neoplasia grade 2 3 relat papillomaviru infect background human papillomaviru hpv associ cervic intraepitheli neoplasia tempor relat infect neoplasia remain unclear rel import specif type hpv sexual transmit diseas risk factor method studi prospect cohort 241 women present evalu sexual transmit diseas neg cervic cytolog test women follow everi four month cytolog colposcop examin uterin cervix test hpv dna sexual transmit diseas result cervic intraepitheli neoplasia grade 2 3 confirm biopsi 28 women basi surviv analysi cumul incid cervic intraepitheli neoplasia two year 28 percent among women posit test hpv 3 percent among without detect hpv dna risk highest among hpv type 16 18 infect adjust rel risk compar women without hpv infect 11 95 percent confid interv 4.6 26 attribut risk 52 percent 24 case cervic intraepitheli neoplasia grade 2 3 among hpv-posit women detect within 24 month first posit test hpv adjust presenc hpv infect develop cervic intraepitheli neoplasia also associ younger age first intercours presenc serum antibodi chlamydia trachomati presenc serum antibodi cytomegaloviru cervic infect neisseria gonorrhoea conclus cervic intraepitheli neoplasia common appar earli manifest cervic infect hpv particularli type 16 18',\n",
       "  'investig surviv prognosi glioblastoma use evolut properti gene network recent year widespread interest larg number public applic graph theori techniqu construct analyz biologically-inform gene network cancer cell line data set current research effort predominantli look overal static topolog represent network investig applic graph theoret techniqu evolutionari investig cancer number studi use graph theori metric degre between close central identifi import hub gene network howev fulli investig import gene across differ stage diseas previou human glioblastoma public identifi four subtyp glioblastoma adult base signatur gene one public verhaak et al found subtyp correspond narrow median surviv rang 11.3 month aggress subtyp 13.1 month least aggress one work present evolutionari graph theori studi glioblastoma base surviv data categor confirm gene associ differ surviv time identifi use establish graph theori metric work extend applic graph theori approach evolutionari studi cancer cell line data',\n",
       "  'compound heterozyg zmpste24 mutat reduc prelamin process result sever progeroid phenotyp hutchinson–gilford progeria syndrom hgp omim 176670 extrem rare devast disord mimic prematur aging.1–3 affect children appear normal birth typic develop failur thrive first two year featur includ alopecia micrognathia loss subcutan fat promin vein abnorm dentit sclerodermat skin chang osteolysi clavicl distal phalang mean age death age 13 year commonli due atherosclerosi hgp mainli sporad occurr genet caus implic follow identif de novo heterozyg mutat lmna gene major hgp patients.4,5 singl famili show autosom recess inherit homozyg lmna mutat also reported.6 lmna encod lamin c compon nuclear lamina meshwork underli nuclear envelop serv structur support also thought contribut chromatin organis regul gene expression.7,8 interestingli mutat lmna recent associ least eight inherit disord known laminopathi differenti dystroph effect varieti tissu includ muscl neuron skin bone adipos tissu review mounk et al 9 howev realis disord share common genet defect led clinic re-evalu emerg evid signific phenotyp overlap.10 henc laminopathi might reason consid spectrum relat diseas hgp phenotyp similar sever laminopathi particular atyp werner ’ syndrome11 mandibuloacr dysplasia mad omim 248370 608612 .12 diseas associ lipodystrophy,3,13 promin featur anoth laminopathi famili partial lipodystrophi dunnigan varieti omim 151660 .14 mad classifi two …',\n",
       "  'reliabl patient respons pay perform scheme analysi nation gener practition patient survey data england object assess robust patient respons new nation survey patient experi basi provid financi incent doctor design analysi repres respond gp patient survey compar sampl 5.5 million patient regist 8273 gener practic england januari 2009 gener popul analysi non-respons bia look relat practic respons rate score survey analysi reliabl survey estim proport varianc practic score attribut true differ practic result overal respons rate 38.2 2.2 million respons compar survey use similar methodolog uk men young adult peopl live depriv area under-repres among respond howev question relat pay perform systemat associ respons rate questionnair score two question trigger payment gener practition reliabl measur practic perform averag practice-level reliabl coeffici 93.2 95.0 less 3 0.5 practic fewer number respons requir achiev convent reliabl level 90 70 chang payment formula 2009 result increas averag impact random variat patient score payment gener practition compar payment made 2007 2008. conclus littl evid support concern gener practition low respons rate select non-respons bia led systemat unfair payment attach questionnair score studi rais issu relat valid reliabl payment base patient survey provid lesson uk countri consid use patient experi part pay perform scheme',\n",
       "  \"impact low alcohol verbal descriptor perceiv strength experiment studi object low alcohol label set label carri descriptor 'low 'lighter denot alcohol content beverag grow interest policymak produc lower strength alcohol product howev lack evid gener popul perceiv verbal descriptor strength present research examin consum percept strength abv appeal alcohol product use low high alcohol verbal descriptor design within-subject experiment studi particip rate strength appeal 18 term denot low nine term high eight term regular one term strength either 1 wine 2 beer accord drink prefer method thousand six hundr adult 796 wine 804 beer drinker sampl nation repres uk panel result low lower light lighter reduc form cluster rate denot lower strength product regular higher strength cluster intensifi consist extra low super low extra light super light similar cluster perceiv strength observ amongst high verbal descriptor regular appeal strength descriptor low high verbal descriptor use intensifi rate least appeal conclus perceiv strength appeal alcohol product diminish verbal descriptor impli deviat regular implic find discuss term polici implic lower strength alcohol label associ public health outcom statement contribut alreadi known subject current uk eu legisl limit number low strength verbal descriptor associ alcohol volum abv 1.2 abv lower grow interest policymak produc extend rang lower strength alcohol product current cap 1.2 abv set nation legisl lack evid gener popul perceiv verbal descriptor alcohol product strength low high studi add verbal descriptor lower strength wine beer form two cluster effect commun reduc alcohol content low lower light lighter reduc consid lower strength regular averag abv descriptor use intensifi extra low super low extra light super light consid lowest strength similar cluster perceiv strength observ amongst high verbal descriptor appeal alcohol product reduc verbal descriptor impli deviat regular\",\n",
       "  'transgen interleukin 10 prevent induct experiment autoimmun encephalomyel effect interleukin 10 il-10 treatment autoimmune-medi central nervou system inflamm controversi studi model system experiment autoimmun encephalomyel eae use variou rout regimen deliveri method il-10 suggest variabl may affect immunoregulatori function studi influenc factor il-10 regul eae pathogenesi analyz transgen mice express human il-10 hil-10 transgen control class ii major histocompat complex mhc promot hil-10 transgen mice highli resist eae induc activ immun resist appear mediat suppress autoreact cell function myelin-react helper 1 cell induc nonpathogen il-10 transgen mice antibodi deplet confirm eae resist depend presenc transgen il-10 mice express hil-10 transgen endogen murin il-10 gene demonstr transgen il-10 mhc class ii–express cell suffici block induct eae studi demonstr il-10 prevent eae complet present appropri level time diseas induct',\n",
       "  'autosom domin immun dysregul syndrom human ctla4 mutat protein cytotox lymphocyt antigen-4 ctla-4 essenti neg regul immun respons loss caus fatal autoimmun mice studi larg famili five individu present complex autosom domin immun dysregul syndrom character hypogammaglobulinemia recurr infect multipl autoimmun clinic featur identifi heterozyg nonsens mutat exon 1 ctla4 screen 71 unrel patient compar clinic phenotyp identifi five addit famili nine individu previous undescrib splice site missens mutat ctla4 clinic penetr incomplet eight adult total 19 genet proven ctla4 mutat carrier consid unaffect howev ctla-4 protein express decreas regulatori cell treg cell patient carrier ctla4 mutat wherea treg cell gener present elev number individu suppress function ctla-4 ligand bind transendocytosi cd80 impair mutat ctla4 also associ decreas circul b cell number taken togeth mutat ctla4 result ctla-4 haploinsuffici impair ligand bind result disrupt b cell homeostasi complex immun dysregul syndrom',\n",
       "  'specif inhibit cyclin-depend kinas 4/6 pd 0332991 associ antitumor activ human tumor xenograft pd 0332991 highli specif inhibitor cyclin-depend kinas 4 cdk4 ic50 0.011 micromol/l cdk6 ic50 0.016 micromol/l activ panel 36 addit protein kinas potent antiprolif agent retinoblastoma rb -posit tumor cell vitro induc exclus g1 arrest concomit reduct phospho-ser780/ser795 rb protein oral administr pd 0332991 mice bear colo-205 human colon carcinoma produc mark tumor regress therapeut dose pd 0332991 caus elimin phospho-rb prolif marker ki-67 tumor tissu down-regul gene transcript control e2f result indic inhibit cdk4/6 alon suffici caus tumor regress net reduct tumor burden tumor',\n",
       "  'neutrophil support lung colon metastasis-initi breast cancer cell despit progress develop drug effici target cancer cell treatment metastat tumour often ineffect well-establish depend cancer cell microenviron suggest target non-cancer-cel compon tumour might form basi develop novel therapeut approach howev as-yet poorli character contribut host respons tumour growth metastat progress repres limit exploit approach identifi neutrophil main compon driver metastat establish within pre- metastat lung microenviron mous breast cancer model neutrophil fundament role inflammatori respons contribut tumorigenesi still controversi use variou strategi block neutrophil recruit pre-metastat site demonstr neutrophil specif support metastat initi importantli find neutrophil-deriv leukotrien aid colon distant tissu select expand sub-pool cancer cell retain high tumorigen potenti genet pharmacolog inhibit leukotriene-gener enzym arachidon 5-lipoxygenas alox5 abrog neutrophil pro-metastat activ consequ reduc metastasi result reveal efficaci use target therapi specif tumour microenviron compon indic neutrophil alox5 inhibit may limit metastat progress',\n",
       "  'effect previou miscarriag depress symptom subsequ pregnanc postpartum first babi studi object test hypothesi nullipar women histori miscarriag increas risk depress late pregnanc 1 6 12 month postpartum compar women without histori miscarriag conduct secondari analysi longitudin cohort studi first babi studi compar 448 pregnant women histori miscarriag 2,343 pregnant women without histori miscarriag risk probabl depress score 12 edinburgh postnat depress scale logist regress model use estim odd ratio time point gener estim equat use obtain estim longitudin analysi women histori miscarriag like woman without histori miscarriag score probabl depress rang third trimest 6 12 month postpartum like 1 month postpartum adjust sociodemograph factor 1.66 95 ci 1.03–2.69 women histori miscarriag may vulner depress first month postpartum women without prior miscarriag effect appear persist beyond time period support promot awar surround issu recommend research plan identifi risk factor may posit woman histori miscarriag higher risk depress',\n",
       "  'il-1β il-4 il-12 control fate group 2 innat lymphoid cell human airway inflamm lung group 2 innat lymphoid cell ilc2 secret type 2 cytokin protect parasit also contribut varieti inflammatori airway diseas report interleukin 1β il-1β directli activ human ilc2 il-12 induc convers activ ilc2 interferon-γ ifn-γ -produc ilc1 revers il-4 plastic ilc manifest diseas tissu patient sever chronic obstruct pulmonari diseas copd chronic rhinosinus nasal polyp crswnp display il-12 il-4 signatur accumul ilc1 ilc2 respect eosinophil major cellular sourc il-4 reveal cross-talk il-5-produc ilc2 il-4-produc eosinophil propos il-12 il-4 govern ilc2 function ident imbal result perpetu type 1 type 2 inflamm',\n",
       "  'summari steroid receptor rna activ sra known rna coactiv augment transactiv nuclear receptor nr identifi slirp sra stem-loop interact rna bind protein bind function substructur sra str7 slirp express normal tumor tissu contain rna recognit motif rrm repress nr transactiv sra- rrm-depend manner augment effect tamoxifen modul associ src-1 sra sharp rrm-contain corepressor also bind str7 augment repress slirp slirp coloc skip chr14q24.3 anoth nr coregul reduc skip-potenti nr signal slirp recruit endogen promot ps2 metallothionein latter sra-depend manner ncor promot recruit depend slirp major endogen slirp resid mitochondria data demonstr slirp modul nr transactiv suggest may regul mitochondri function provid mechanist insight interact sra slirp src-1 ncor',\n",
       "  'naringenin inhibit allergen-induc airway inflamm airway respons inhibit nf-kappab activ murin model asthma naringenin flavonoid antiinflammatori immunomodulatori properti investig whether naringenin could attenu allergen-induc airway inflamm possibl mechan murin model asthma mice sensit challeng ovalbumin mice administ naringenin ovalbumin challeng evalu develop airway inflamm airway reactiv interleukin il 4 il13 chemokin c-c motif ligand ccl 5 ccl11 bronchoalveolar lavag fluid serum total ige detect elisa ikappabalpha degrad induc nitric oxid synthas ino lung measur western blot also test nf-kappab bind activ electrophoret mobil shift assay mrna level ino ccl5 ccl11 detect real-tim pcr naringenin attenu ovalbumin-induc airway inflamm airway reactiv experiment mice naringenin-tr mice lower level il4 il13 bronchoalveolar lavag fluid lower serum total ige furthermor naringenin inhibit pulmonari ikappabalpha degrad nf-kappab dna-bind activ level ccl5 ccl11 ino also significantli reduc result indic naringenin may play protect role asthma process inhibit nf-kappab decreas express target gene may account phenomenon',\n",
       "  'evolut fox gene role develop diseas forkhead box fox famili transcript factor origin unicellular eukaryot expand time multipl duplic event sometim gene loss 40 member mammal fox gene evolv acquir special function mani key biolog process mutat fox gene profound effect human diseas caus phenotyp vari cancer glaucoma languag disord summar salient featur evolut fox gene famili highlight divers contribut variou fox subfamili development process organogenesi speech acquisit',\n",
       "  'emerg structur dynam cell coloni contact inhibit locomot cell tissu organ broad spectrum structur accord function drastic chang organ epithelial-mesenchym transit format spheroid aggreg often associ either tissu morphogenesi cancer progress studi organ cell coloni mean simul self-propel particl gener cell-lik interact interplay cell soft cell-cel adhes contact inhibit locomot cil yield structur collect dynam observ sever exist tissu phenotyp includ regular distribut cell dynam cell cluster gel-lik network collect migrat monolay 3d aggreg give analyt predict transit noncohes cohes 3d cell arrang explicitli show cil yield effect repuls promot cell dispers therebi hinder format cohes tissu yet continu monolay cil lead collect cell motion ensur tensil intercellular stress oppos cell extrus thu work highlight promin role cil determin emerg structur dynam cell coloni',\n",
       "  'failur cell cleavag induc senesc tetraploid primari cell tetraploidi aris variou mitot cleavag defect mammalian cell inherit multipl centrosom induc aneuploidi tetraploid cell continu cycl arrest tetraploid cell cycl therefor potenti critic cellular control report primari rat embryo fibroblast ref52 human foreskin fibroblast becom senesc tetraploid g1 drug- small interf rna sirna -induc failur cell cleavag contrast t-antigen-transform ref52 p53+/+ hct116 tumor cell rapidli becom aneuploid continu cycl cleavag failur tetraploid primari cell quickli becom quiescent determin loss ki-67 prolifer marker fluoresc ubiquitination-bas cell cycl indicator/l cell cycl marker geminin arrest due dna damag γ-h2ax dna damag marker remain control level tetraploidi induct arrest tetraploid cell final becom senesc determin sa-β-galactosidas activ tetraploid arrest depend p16ink4a express sirna suppress p16ink4a bypass tetraploid arrest permit primari cell becom aneuploid conclud tetraploid primari cell becom senesc without dna damag induct senesc critic tetraploidi arrest',\n",
       "  'cell death signific apoptosi publish summari classif cell death base morpholog biochem criteria circumst occurr current irrevers structur alter provid unequivoc evid death biochem indic cell death univers applic precis defin studi cell function reproduct capac necessarili differenti death dormant state recoveri may possibl also prove feasibl categor die cell one two discret distinct pattern morpholog chang gener found occur dispar individu characterist circumst one pattern swell proceed ruptur plasma organel membran dissolut organ structure—term “ coagul necrosi ” result injuri agent toxin ischemia affect cell group rather singli evok exud inflamm develop vivo morpholog pattern character condens cell mainten organel integr format surfac protuber separ membrane-bound globul tissu phagocytos digest resid cell associ inflamm',\n",
       "  'mitochondri rna-bind protein grsf1 local rna granul requir posttranscript mitochondri gene express rna-bind protein heart posttranscript gene regul coordin process storag handl cellular rna show grsf1 previous implic bind select translat influenza mrna target mitochondria form granul coloc foci newli synthes mtrna next mitochondri nucleoid grsf1 preferenti bind rna transcrib three contigu gene light strand mtdna nd6 mrna long noncod rna cytb nd5 contain multipl consensu bind sequenc rnai-medi knockdown grsf1 lead alter mitochondri rna stabil abnorm load mrna lncrna mitochondri ribosom impair ribosom assembl result specif protein synthesi defect failur assembl normal amount oxid phosphoryl complex data implic grsf1 key regul posttranscript mitochondri gene express',\n",
       "  'identif purif 62,000-dalton protein bind specif polypyrimidin tract intron protein molecular size 62,000 dalton p62 detect hela cell nuclear extract uv cross-link mrna precursor p62 bind specif polypyrimidin tract 3 splice site region intron p62 purifi homogen bind polypyrimidin tract pre-mrna bind requir ag dinucleotid 3 splice site alter polypyrimidin tract reduc bind p62 yield correspond reduct effici format u2 snrnp/pre-mrna complex splice p62 protein retain spliceosom remain bound pre-mrna polypyrimidin tract bind protein pptb propos critic compon recognit 3 splice site splice',\n",
       "  'capsul endoscopi acut upper gastrointestin hemorrhag prospect cohort studi background studi aim capsul endoscopi may play role evalu patient present acut upper gastrointestin hemorrhag emerg depart patient method evalu adult acut upper gastrointestin hemorrhag present emerg depart two academ center patient ingest wireless video capsul follow immedi nasogastr tube aspir later esophagogastroduodenoscopi egd compar capsul endoscopi nasogastr tube aspir determin presenc blood egd discrimin sourc bleed identif peptic/inflammatori lesion safeti patient satisfact result studi enrol 49 patient 32 men 17 women mean age 58.3 ± 19 year three patient complet capsul endoscopi five intoler nasogastr tube blood detect upper gastrointestin tract significantli often capsul endoscopi 15 /18 83.3 nasogastr tube aspir 6 /18 33.3 p 0.035 signific differ identif peptic/inflammatori lesion capsul endoscopi 27 /40 67.5 egd 35 /40 87.5 p 0.10 0.39 95 ci 0.11 1.15 capsul endoscopi reach duodenum 45 /46 patient 98 one patient 2.2 self-limit short breath one 2.2 cough capsul ingest conclus emerg depart set capsul endoscopi appear feasibl safe peopl present acut upper gastrointestin hemorrhag capsul endoscopi identifi gross blood upper gastrointestin tract includ duodenum significantli often nasogastr tube aspir identifi inflammatori lesion well egd capsul endoscopi may facilit patient triag earlier endoscopi consid substitut egd',\n",
       "  'electropor cas9 protein/sgrna earli pronuclear zygot gener non-mosa mutant mous crispr/cas9 system power tool elucid role gene wide varieti organ includ mice obtain genet modifi embryo mice method cas9 mrna sgrna usual introduc zygot microinject electropor howev mutant gener method genet mosaic compos sever type cell carri differ mutat complic phenotyp analysi founder embryo mice simplifi analysi elucid role gene involv development process method produc non-mosa mutant need establish method gener non-mosa mous mutant embryo introduc cas9 protein sgrna vitro fertil ivf zygot electropor enabl genom edit occur first replic mous genom result cell mutant carri set mutat method solv problem mosaicism/allel complex founder mutant embryo mice gener cripsr/cas9 system',\n",
       "  'molecular basi target rna recognit cleavag human risc rna-induc silenc complex risc ribonucleoprotein particl compos single-strand short interf rna sirna endonucleolyt activ argonaut protein capabl cleav mrna complementari sirna mechan risc cleav target rna well understood howev remain enigmat risc find target rna show vitro vivo access target site correl directli effici cleavag demonstr risc unabl unfold structur rna cours target recognit risc transient contact single-strand rna nonspecif promot sirna-target rna anneal furthermor 5 part sirna within risc creat thermodynam threshold determin stabl associ risc target rna therefor provid mechanist insight reveal featur risc target rna crucial achiev effici specif rna interfer',\n",
       "  'cancer associ fibroblast caf tumor microenviron cancer associ fibroblast caf one crucial compon tumor microenviron promot growth invas cancer cell variou mechan caf demonstr high degre heterogen due variou origin howev mani distinct morpholog featur physiolog function caf identifi becom clear crosstalk cancer cell caf play key role progress cancer understand mutual relationship would eventu enabl us treat cancer patient target caf review discuss latest find role caf tumorigenesi metastasi well potenti therapeut implic caf',\n",
       "  'cold exposur promot atherosclerot plaqu growth instabl via ucp1-depend lipolysi molecular mechan underli cold-associ high cardiovascular risk remain unknown show cold-trigg food-intake-independ lipolysi significantli increas plasma level small low-dens lipoprotein ldl remnant lead acceler develop atherosclerot lesion mice two genet mous knockout model apolipoprotein e -/- apo -/- ldl receptor -/- ldlr -/- mice persist cold exposur stimul atherosclerot plaqu growth increas lipid deposit furthermor mark increas inflammatori cell plaque-associ microvessel detect cold-acclim apo -/- ldlr -/- mice lead plaqu instabl delet uncoupl protein 1 ucp1 key mitochondri protein involv thermogenesi brown adipos tissu bat apo -/- strain complet protect mice cold-induc atherosclerot lesion cold acclim markedli reduc plasma level adiponectin system deliveri adiponectin protect apo -/- mice plaqu develop find provid mechanist insight low-temperature-associ cardiovascular risk',\n",
       "  'mild overexpress mecp2 caus progress neurolog disord mice mutat x-link methyl-cpg-bind protein 2 mecp2 encod transcript repressor caus rett syndrom varieti relat neurodevelopment disord vast major mutat associ human diseas loss-of-funct mutat precis aspect mecp2 function respons phenotyp remain unknown overexpress wild-typ human protein transgen mice use larg genom clone contain entir human mecp2 locu detail neurobehavior electrophysiolog studi transgen line mecp2 tg1 express mecp2 approxim 2-fold wild-typ level demonstr onset phenotyp around 10 week age surprisingli mice display enhanc motor contextu learn enhanc synapt plastic hippocampu 20 week age howev mice develop seizur becam hypoact approxim 30 die 1 year age data demonstr mecp2 level must tightli regul vivo even mild overexpress protein detriment furthermor result support possibl duplic gain-of-funct mutat mecp2 might underli case x-link delayed-onset neurobehavior disord',\n",
       "  \"alcohol sale risk seriou assault background alcohol contribut caus unintent injuri motor vehicl crash prior research associ alcohol use violent injuri limit survey-bas data inclus case singl trauma centr without adequ control beyond limit inabl prior research comprehens captur alcohol sale ontario alcohol sold retail outlet run provinci govern hospit financ provinci health care system assess risk hospit due assault associ retail alcohol sale across ontario method find perform population-bas case-crossov analysi person age 13 year older hospit assault ontario 1 april 2002 1 decemb 2004. day prior assault case 's hospit volum alcohol sold store closest proxim victim 's home compar volum alcohol sold store 7 earlier condit logist regress analysi use determin associ rel risk rr assault per 1,000 l higher daili sale alcohol 3,212 person admit hospit assault nearli 25 age 13 20 83 male total 1,150 assault 36 involv use sharp blunt weapon 1,532 48 aros unarm brawl fight everi 1,000 l alcohol sold per store per day rel risk hospit assault 1.13 95 confid interv ci 1.02-1.26 risk accentu male 1.18 95 ci 1.05-1.33 youth age 13 20 1.21 95 ci 0.99-1.46 urban area 1.19 95 ci 1.06-1.35 conclus risk victim seriou assault increas alcohol sale especi among young urban men akin reduc risk drive impair consider given novel method prevent alcohol-rel violenc\",\n",
       "  \"mir-375 inhibit autophagi reduc viabil hepatocellular carcinoma cell hypox condit background aim tumor cell surviv hypox condit induc autophagi investig role microrna mirna regul autophagi hepatocellular carcinoma hcc cell hypox condit method use gain- loss-of-funct method evalu effect mirna autophagi human hcc cell line huh7 hep3b hypox condit autophagi quantifi immunoblot immunofluores transmiss electron microscopi analys incub cell bafilomycin a1 use luciferas report assay confirm associ mirna target analyz growth hcc xenograft tumor nude mice result mir-375 down-regul hcc cell tissu inhibit autophagi hypox condit suppress convers lc3i lc3ii therebi autophag flux abil mir-375 inhibit autophagi independ abil regul 3'-phosphoinositide-depend protein kinase-1-akt-mammalian target rapamycin signal instead involv suppress atg7 autophagy-associ gene mir-375 bound directli predict site 3 untransl region atg7 up-regul mir-375 down-regul atg7 inhibit mitochondri autophagi hcc cell reduc elimin damag mitochondria hypoxia increas releas mitochondri apoptot protein reduc viabil hcc cell mice xenograft tumor express mir-375 fewer autophag cell larger area necrosi grew slowli tumor hcc cell express lower level mir-375 conclus mir-375 inhibit autophagi reduc express atg7 impair viabil hcc cell hypox condit cultur mice mirna inhibit autophagi cancer cell might develop therapeut\",\n",
       "  'pseudouridin profil reveal regul mrna pseudouridyl yeast human cell post-transcript modif rna nucleosid occur live organ pseudouridin abund modifi nucleosid non-cod rna enhanc function transfer rna ribosom rna stabil rna structur messeng rna known contain pseudouridin artifici pseudouridyl dramat affect mrna function -- chang genet code facilit non-canon base pair ribosom decod centr howev without evid natur occur mrna pseudouridyl physiolog relev unclear present comprehens analysi pseudouridyl saccharomyc cerevisia human rna use pseudo-seq genome-wid single-nucleotide-resolut method pseudouridin identif pseudo-seq accur identifi known modif site well mani novel site non-cod rna reveal hundr pseudouridyl site mrna genet analysi allow us assign new modif site one seven conserv pseudouridin synthas pus1-4 6 7 9. notabl major pseudouridin mrna regul respons environment signal nutrient depriv yeast serum starvat human cell result suggest mechan rapid regul rewir genet code induc mrna modif find reveal unanticip role pseudouridyl provid resourc identifi target pseudouridin synthas implic human diseas',\n",
       "  'descent memori t-cell subset immun system evolv continu increas complex provid host advantag infecti agent develop immunolog memori engend long-last protect lengthen lifespan host gener subset memori cell distinct home function properti increas defens capabl howev development relationship memori t-cell subset matter debat opinion articl light recent develop suggest probabl two distinct lineag compris memori cd8+ t-cell popul gener respons infect',\n",
       "  'differenti distribut il28b.rs12979860 single-nucleotid polymorph among egyptian healthcar worker without hepat c virus-specif cellular immun respons cc genotyp interleukin il -28b.rs12979860 gene associ spontan hepat c viru hcv clearanc treatment respons distribut correl il28b.rs12979860 single-nucleotid polymorph snp hcv-specif cell-medi immun cmi respons among egyptian healthcar worker hcw known determin relationship 402 hcw serv patient cohort ~85 hcv preval enrol 402 hcw four group group 1 n 258 seroneg avirem subject group 2 n 25 seroneg virem subject group 3 n 41 subject spontan resolv hcv infect group 4 n 78 chronic hcv patient subject test hcv-specif cmi respons use ex-vivo interferon-gamma ifnγ elispot assay nine hcv genotype-4a overlap 15-mer peptid pool correspond hcv protein subject test il28b.rs12979860 snp real-tim pcr hcv-specif cmi demonstr ~27 seroneg avirem hcw group 1 suggest clearanc infect low-level exposur hcv frequenc il28b.rs12979860 c allel homozygos four group 49 48 49 23 allel 14 16 12 19 respect suggest differenti distribut among subject differ hcv statu report il28b.rs12979860 predict outcom hcv infect p 0.05 find relationship il28b genotyp outcom hcv-specif cmi respons four group p 0.05 data show differenti il28b.rs12979860 genotyp distribut among egyptian hcw differ hcv statu could predict outcom hcv-specif cmi respons',\n",
       "  'tcr ligand densiti affin determin peripher induct foxp3 vivo cell receptor tcr ligat requir extrathym differenti forkhead box p3 foxp3 regulatori cell sever line evid indic weak tcr stimul favor induct foxp3 peripheri howev remain determin tcr ligand potenc influenc process character densiti affin tcr ligand favor foxp3 induct found low dose strong agonist result maxim induct foxp3 vivo initi foxp3 induct weak agonist peptid could enhanc disrupt tcr-peptid major histocompat complex pmhc interact alter peptid dose howev time cours experi reveal foxp3-posit cell induc weak agonist stimul delet along foxp3-neg counterpart wherea foxp3-posit cell induc low dose strong agonist persist result suggest togeth pmhc ligand potenc densiti durat tcr interact defin cumul quantiti tcr stimul determin initi peripher foxp3 induct howev persist induc foxp3 cell tcr ligand potenc densiti noninterchang factor influenc rout peripher toler',\n",
       "  'electromagnet interfer radio frequenc identif induc potenti hazard incid critic care medic equip context health care applic autoidentif technolog radio frequenc identif rfid propos improv patient safeti also track trace medic equip howev electromagnet interfer emi rfid medic devic never report object assess classifi incid emi rfid critic care equip design set without patient connect emi 2 rfid system activ 125 khz passiv 868 mhz assess control condit may 2006 proxim 41 medic devic 17 categori 22 differ manufactur academ medic centr univers amsterdam amsterdam netherland assess took place accord intern test protocol incid emi classifi accord critic care advers event scale hazard signific light result 123 emi test 3 per medic devic rfid induc 34 emi incid 22 classifi hazard 2 signific 10 light passiv 868-mhz rfid signal induc higher number incid 26 incid 41 emi test 63 compar activ 125-khz rfid signal 8 incid 41 emi test 20 differ 44 95 confid interv 27 -53 p .001 passiv 868-mhz rfid signal induc emi 26 medic devic includ 8 also affect activ 125-khz rfid signal 26 41 devic 63 median distanc rfid reader medic devic emi incid 30 cm rang 0.1-600 cm conclus control nonclin set rfid induc potenti hazard incid medic devic implement rfid critic care environ requir on-sit emi test updat intern standard',\n",
       "  \"potent rnai short rna trigger rna interfer rnai gene-silenc mechan ribonucleoprotein complex rna-induc silenc complex risc double-strand ds short-interf rna sirna target complementari mrna site-specif cleavag subsequ degrad longer dsrna endogen process 21- 24-nucleotid nt sirna mirna induc gene silenc rnai studi human cell typic use synthet 19- 20-nt sirna duplex 2-nt overhang 3'-end strand report systemat synthesi analysi sirna delet passeng and/or guid strand reveal short rnai trigger 16-nt sirna induc potent rnai human cell result indic minim requir dsrna trigger rnai approxim 42 a-form helix approxim 1.5 helic turn 16-nt sirna effect knock mrna protein level 19-nt sirna target endogen cdk9 gene suggest 16-nt sirna potent rnai trigger vitro kinet analysi rna-induc silenc complex risc program hela cell indic 16-nt sirna higher risc-load capac 19-nt sirna result suggest risc assembl activ rnai necessarili requir 19-nt duplex sirna 16-nt duplex design potent trigger induc rnai\",\n",
       "  \"il-23–respons innat lymphoid cell increas inflammatori bowel diseas result experiment genet studi highlight role il-23/il-17 axi pathogenesi inflammatori bowel diseas ibd il-23-driven inflamm primarili link th17 cell howev recent identifi novel popul innat lymphoid cell ilc mice produc il-17 il-22 ifn-γ respons il-23 mediat innat coliti relev ilc popul human health diseas current poorli understood studi analyz role il-23-respons ilc human intestin control ibd patient result show increas express th17-associ cytokin gene il17a il17f among intestin cd3⁻ cell ibd il17a il17f express restrict cd56⁻ ilc wherea il-23 induc il22 il26 cd56⁺ ilc compart furthermor observ signific select increas cd127⁺cd56⁻ ilc inflam intestin crohn 's diseas cd patient ulcer coliti patient result indic il-23-respons ilc present human intestin intestin inflamm cd associ select accumul phenotyp distinct ilc popul character inflammatori cytokin express ilc may contribut intestin inflamm cytokin product lymphocyt recruit organ inflammatori tissu may repres novel tissue-specif target subtyp ibd\",\n",
       "  \"scale dorsal-ventr pattern embryo size-depend degrad spemann ’ organ signal spemann 's organ play key role dorsal-ventr dv pattern amphibian embryo secret diffus protein chordin antagonist ventral bone morphogenet protein bmp dv pattern robust amphibian embryo ventral half surgic remov develop smaller proport pattern larva show robust pattern depend facilit chordin degrad requir express chordin-proteinas inhibitor sizzl opposit side sizzl stabl diffus wide along dv axi stabil chordin expand distribut ventral direct expand chordin distribut turn limit bmp-depend sizzl product form axis-wid feedback loop shape chordin 's activ use bisect assay demonstr chordin degrad dynam control embryo-size-coupl sizzl accumul propos scale model enabl dv pattern adjust proport embryon axi size\",\n",
       "  'augment antitumor immun respons epigenet modifi agent epigenet silenc immune-rel gene strike featur cancer genom occur process tumorigenesi phenomena impact antigen process antigen present tumor cell facilit evas immunosurveil modul tumor microenviron alter express immunosuppress cytokin impair antigen-pres cell cytolyt t-cell function potenti revers immunosuppress epigenet modul therefor promis versatil therapeut approach reinstat endogen immun recognit tumor lysi pre-clin studi identifi multipl element immun system modul epigenet mechan result improv antigen present effector t-cell function breakdown suppressor mechan recent clinic studi util epigenet therapi prior combin immun therapi improv clinic outcom',\n",
       "  'activ proteinase-activ receptor 2 human osteoarthrit cartilag upregul catabol proinflammatori pathway capabl induc cartilag degrad basic scienc studi proteinase-activ receptor par belong famili g protein-coupl receptor par activ serine-depend cleavag gener tether activ ligand par-2 shown involv inflammatori pathway investig situ level modul par-2 human normal osteoarthr oa cartilage/chondrocyt furthermor evalu role par-2 synthesi major catabol factor oa cartilag includ metalloproteinas mmp -1 mmp-13 inflammatori mediat cyclooxygenas 2 cox-2 well par-2-activ signal pathway oa chondrocyt par-2 express determin use real-tim revers transcription-polymeras chain reaction protein level immunohistochemistri normal oa cartilag protein modul investig oa cartilag explant treat specif par-2-activ peptid par-2-ap sligkv-nh2 1 400 μm interleukin 1 beta il-1β 100 pg/ml tumor necrosi factor-alpha tnf-α 5 ng/ml transform growth factor-beta-1 tgf-β1 10 ng/ml signal pathway inhibitor p38 sb202190 mek1/2 mitogen-activ protein kinas kinas pd98059 nuclear factor-kappa b nf-κb sn50 par-2 level determin immunohistochemistri signal pathway analyz oa chondrocyt western blot use specif phospho-antibodi extracellular signal-regul kinas 1/2 erk1/2 p38 jnk c-jun n-termin kinas nf-κb presenc absenc par-2-ap and/or il-1β par-2-induc mmp cox-2 level cartilag determin immunohistochemistri par-2 produc human chondrocyt significantli upregul oa compar normal chondrocyt p 0.04 p 0.03 respect receptor level significantli upregul il-1β p 0.006 tnf-α p 0.002 well par-2-ap 10 100 400 μm p 0.02 downregul inhibit p38 48 hour incub par-2 activ significantli induc mmp-1 cox-2 start 10 μm p 0.005 mmp-13 100 μm p 0.02 well phosphoryl erk1/2 p38 within 5 minut incub p 0.03 though statist signific il-1β produc addit effect activ erk1/2 p38 studi document first time function consequ par-2 activ human oa cartilag identifi p38 major signal pathway regul synthesi demonstr specif par-2 activ induc erk1/2 p38 oa chondrocyt result suggest par-2 potenti new therapeut target treatment oa',\n",
       "  'neutrophil extracellular trap enrich oxid mitochondri dna interferogen contribut lupus-lik diseas neutrophil extracellular trap net implic autoimmun gener role steril inflamm remain unclear ribonucleoprotein immun complex rnp ic induc netosi requir mitochondri reactiv oxygen speci ro maxim net stimul rnp ic stimul neutrophil mitochondria becom hypopolar transloc cell surfac extracellular releas oxid mitochondri dna proinflammatori vitro dna inject mice stimul type interferon ifn signal pathway depend dna sensor sting mitochondri ro also necessari spontan netosi low-dens granulocyt individu system lupu erythematosu also observ individu chronic granulomat diseas lack nadph oxidas activ still develop autoimmun type ifn signatur mitochondri ro inhibit vivo reduc diseas sever type ifn respons mous model lupu togeth find highlight role mitochondria gener net also pro-inflammatori oxid mitochondri dna autoimmun diseas',\n",
       "  'microenviron rigid modul respons her2 receptor tyrosin kinas inhibitor lapatinib via yap taz transcript factor stiff biophys properti extracellular matrix modul cellular function includ prolifer invas differenti also may affect therapeut respons therapeut durabl cancer treatment remain problem chemotherapi pathway-target drug reason well understood tumor progress accompani chang biophys properti tissu ask whether matrix rigid modul sensit versu resist state her2-amplifi breast cancer cell respons her2-target kinas inhibitor lapatinib antiprolif effect lapatinib invers proport elast modulu adhes substrata down-regul mechanosensit transcript coactiv yap taz either sirna small-molecul yap/tead inhibitor verteporfin elimin modulus-depend lapatinib resist reduct yap vivo mice also slow growth implant her2-amplifi tumor show trend increas sensit lapatinib yap decreas thu address role stiff resist efficaci her2 pathway-target therapeut via mechanotransduct arm hippo pathway',\n",
       "  'effect popul size pattern molecular evolut variat effect size popul ne determin rate chang composit popul caus genet drift random sampl genet variant finit popul ne crucial determin level variabl popul effect select rel drift articl review properti ne varieti differ situat biolog interest factor influenc particular action select mean ne vari across genom advanc genom techniqu give new insight select shape ne',\n",
       "  'emot dysregul part psychopatholog adhd adult attention-deficit hyperact disord common condit adulthood disord character symptom inattent hyperact impuls alongsid symptom discuss whether symptom emot dysregul could add addit better descript psychopatholog adhd neither current icd-10 dsm-iv upcom dsm-5 includ symptom emot dysregul core aspect adhd sever author e.g. wender 1995 describ adult adhd differenti way propos concept disord consid subject experi adult patient introduc symptomatolog emot symptom empir studi attest dimens suffici reliabl valid symptom emot dysregul defin seem distinct factor psychopatholog adult adhd pharmacolog psychotherapeut intervent help allevi type symptom review attest decis role emot symptom adhd symptomatolog taken seriou consider futur research',\n",
       "  'neural basi melanocortin-4 receptor regul appetit pro-opiomelanocortin pomc agouti-rel peptid agrp -express neuron arcuat nucleu hypothalamu arc opposit regul calor deplet coordin stimul inhibit homeostat satieti respect bimod princip underscor antagonist action ligand downstream melanocortin-4 receptor mc4r paraventricular nucleu hypothalamu pvh although popul critic energi balanc underli neural circuitri remain unknown use mice express cre recombinas mc4r neuron demonstr bidirect control feed follow real-tim activ inhibit pvh mc4r neuron identifi cell function expon arc agrp neuron-driven hunger moreov reveal function mediat pvh mc4r →later parabrachi nucleu lpbn pathway activ circuit encod posit valenc calor deplet mice thu satiat appetit natur pvh mc4r →lpbn neuron support principl drive reduct highlight circuit promis target antiobes drug develop',\n",
       "  'lymph node cell respons predict efficaci live attenu siv vaccin live attenu simian immunodefici viru siv vaccin lav remain efficaci vaccin nonhuman primat model hiv aid yet basi robust protect remain poorli understood show degre lav-medi protect intraven wild-typ sivmac239 challeng strongli correl magnitud function siv-specif effector-differenti cell lymph node respons cell blood cellular humor innat immun paramet found mainten protect cell respons associ persist lav replic lymph node occur almost exclus follicular helper cell thu effect lav maintain lymphoid tissue-bas effector-differenti siv-specif cell intercept suppress earli wild-typ siv amplif present suffici frequenc complet control perhap clear infect observ provid rational develop safe persist vector elicit maintain respons',\n",
       "  'activ serotonin 2c receptor dopamin neuron inhibit binge-lik eat mice background neural network regul bing eat remain identifi effect treatment bing eat limit method combin neuroanatom pharmacolog electrophysiolog cre-lox chemogenet approach investig function 5-hydroxytryptamin 5-ht 2c receptor 5-ht2cr express dopamin da neuron regul binge-lik eat behavior mice result show 5-ht stimul da neural activ 5-ht2cr-mediat mechan activ midbrain 5-ht→da neural circuit effect inhibit binge-lik eat behavior mice notabl 5-ht medic includ fluoxetin d-fenfluramin lorcaserin select 5-ht2cr agonist act 5-ht2cr express da neuron inhibit binge-lik eat mice conclus identifi 5-ht2cr popul da neuron one potenti target antibing therapi provid preclin evid 5-ht2cr agonist could use treat bing eat',\n",
       "  'restor chaperone-medi autophagi age liver improv cellular mainten hepat function chaperone-medi autophagi cma select mechan degrad cytosol protein lysosom contribut remov alter protein part cellular quality-control system previous found cma activ declin age organ propos failur cellular clearanc could contribut accumul alter protein abnorm cellular homeostasi eventu function loss characterist age organ determin whether neg featur age prevent maintain effici autophag activ late life work correct cma defect age rodent gener doubl transgen mous model amount lysosom receptor cma previous shown decreas abund age modul analyz model consequ prevent age-depend decreas receptor abund age rodent cellular organ level show cma activ maintain advanc age decreas receptor abund prevent preserv autophag activ associ lower intracellular accumul damag protein better abil handl protein damag improv organ function',\n",
       "  \"incid repetit hospital-tr deliber self harm find world 's first nation registri background suicid signific public health issu almost one million peopl die suicid year worldwid deliber self harm dsh singl import risk factor suicid yet countri reliabl data dsh develop nation dsh registri republ ireland establish incid hospital-tr dsh nation level spectrum pattern present dsh repetit method find 2003 2009 irish nation registri deliber self harm collect data dsh present 40 hospit emerg depart countri data collect train data registr offic use standard method case ascertain definit registri record 75,119 dsh present involv 48,206 individu total incid rate fell 209 95 ci 205-213 per 100,000 2003 184 95 ci 180-189 per 100,000 2006 increas 209 95 ci 204-213 per 100,000 2009. notabl annual chang success 10 increas male rate 2008 2009. signific variat age peak rate women 15-19 year age group 620 95 ci 605-636 per 100,000 men 20-24 age group 427 95 ci 416-439 per 100,000 repetit rate vari significantli age method self harm number previou episod conclus population-bas data hospital-tr dsh repres import index burden mental ill suicid risk commun increas dsh rate irish men 2008 2009 coincid advent econom recess ireland find underlin need develop effect intervent reduc dsh repetit rate key prioriti health system\",\n",
       "  'common mechan cellular death induc bactericid antibiot antibiot mode-of-act classif base upon drug-target interact whether result inhibit cellular function lethal bacteria show three major class bactericid antibiot regardless drug-target interact stimul product highli deleteri hydroxyl radic gram-neg gram-posit bacteria ultim contribut cell death also show contrast bacteriostat drug produc hydroxyl radic demonstr mechan hydroxyl radic format induc bactericid antibiot end product oxid damag cellular death pathway involv tricarboxyl acid cycl transient deplet nadh destabil iron-sulfur cluster stimul fenton reaction result suggest three major class bactericid drug potenti target bacteri system remedi hydroxyl radic damag includ protein involv trigger dna damag respons e.g. reca',\n",
       "  'increas atherosclerosi mice reconstitut apolipoprotein e null macrophag macrophage-deriv foam cell express apolipoprotein e apo abundantli atherosclerot lesion examin physiolog role apo secret macrophag atherogenesi bone marrow transplant use reconstitut c57bl/6 mice macrophag either null wild type apo gene 13 week atherogen diet c57bl/6 mice reconstitut apo null marrow develop 10-fold atherosclerosi control absenc signific differ serum cholesterol level lipoprotein profil apo express absent macrophage-deriv foam cell c57bl/6 mice reconstitut apo null marrow thu lack apo express macrophag promot foam cell format data support protect role apo express macrophag earli atherogenesi',\n",
       "  'endothelium-medi relax porcin collateral-depend arteriol improv exercis train background endothelium-depend modul coronari tone impair collateral-depend coronari microcircul use porcin model chronic coronari occlus collater develop evalu hypothesi exercis train enhanc endothelium-medi relax increas endotheli nitric oxid synthas ecno mrna level collateral-depend microvasculatur method result adult femal miniatur swine subject chronic progress ameroid occlus proxim left circumflex coronari arteri lcx 2 month anim randomli expos 16-week exercise-train ex group treadmil run sedentari sed group cage confin protocol complet ex sed program coronari arteriol approxim 100 microm diamet isol collateral-depend lcx distal occlus nonocclud left anterior descend coronari arteri lad region heart arteriol studi vitro videomicroscopi frozen ecno mrna analysi rt-pcr techniqu relax endothelium-depend vasodil bradykinin decreas p 0.05 arteriol isol collateral-depend lcx versu nonocclud lad region sed anim bradykinin-medi relax howev differ lcx versu lad arteriol isol ex anim nitroprusside-induc relax unaffect either chronic occlus exercis importantli ecno mrna express significantli decreas arteriol isol lcx versu lad region sed anim train ecno mrna express differ lad lcx arteriol conclus data indic exercis train enhanc bradykinin-medi relax collateral-depend lcx arteriol isol chronic coronari occlus like effect ecno mrna express increas product',\n",
       "  'loss rhogap srgp-1 promot clearanc dead injur cell caenorhabd elegan multicellular anim rapidli clear die cell bodi mani pathway mediat cell remov conserv evolut identifi srgp-1 neg regul cell clearanc caenorhabd elegan mammalian cell loss srgp-1 function result improv engulf apoptot cell wherea srgp-1 overexpress inhibit apoptot cell corps remov show srgp-1 function engulf cell function gtpase activ protein gap ced-10 rac1 interestingli loss srgp-1 function promot clearanc alreadi dead cell also remov cell brought verg death subleth apoptot necrot cytotox insult contrast impair engulf allow damag cell escap clearanc result increas long-term surviv propos c. elegan use engulf machineri part primit evolutionarili conserv survey mechan identifi remov unfit cell within tissu',\n",
       "  'abnorm myeloid progenitor compart syndrom fetal liver preced acquisit gata1 mutat syndrom ds children high frequenc acut megakaryoblast leukemia amkl earli childhood least 2 utero genet event requir although suffici ds-amkl trisomi 21 t21 n-terminal-trunc gata1 mutat investig role t21 ds-amkl compar second trimest hemopoiesi ds without gata1 mutat gestation-match normal control ds fetal liver fl marrow megakaryocyte-erythroid progenitor frequenc increas 55.9 +/- 4 vs 17.1 +/- 3 cd34 cd38 cell p .001 common myeloid progenitor 19.6 +/- 2 vs 44.0 +/- 7 granulocyte-monocyt gm progenitor 15.8 +/- 4 vs 34.5 +/- 9 commensur reduc clonogen ds-fl versu normal fl cd34 cell markedli increas 78 +/- 7 vs 15 +/- 3 affect megakaryocyte-erythroid approxim 7-fold higher gm colony-form unit-granulocyt erythrocyt macrophag megakaryocyt cfu-gemm progenitor replat effici cfu-gemm also markedli increas data indic t21 profoundli disturb fl hemopoiesi provid testabl hypothesi explain increas suscept gata1 mutat ds-amkl ds-associ transient myeloprolif disord',\n",
       "  'regulatori metabol rewir laboratori evolut ethanol toler e. coli understand genet basi adapt central problem biolog howev reveal underli molecular mechan challeng chang fit may result perturb mani pathway may contribut rel littl develop combin experimental/comput framework address problem use understand genet basi ethanol toler escherichia coli use fit profil measur consequ single-locu perturb context ethanol exposur module-level comput analysi use reveal organ contribut loci cellular process regulatori pathway e.g osmoregul cell-wal biogenesi whose modif significantli affect ethanol toler strikingli discov domin compon adapt involv metabol rewir boost intracellular ethanol degrad assimil phenotyp metabolom analysi laboratory-evolv ethanol-toler strain investig natur access pathway ethanol toler remark laboratory-evolv strain larg follow adapt path infer coarse-grain search fit landscap',\n",
       "  \"famili risk lymphoprolif tumor famili patient chronic lymphocyt leukemia result swedish family-canc databas import genet factor etiolog chronic lymphocyt leukemia cll suggest famili popul studi howev spectrum malign share common genet factor cll effect sex age famili risk unknown use swedish family-canc databas test increas famili risk cll lymphoprolif tumor cancer diagnos 1958 1998 assess 14 336 first-degre rel 5918 cll case 28 876 first-degre rel 11 778 control cancer risk rel case compar rel control use margin surviv model rel case significantli increas risk cll rel risk rr 7.52 95 confid interv ci 3.63-15.56 non-hodgkin lymphoma rr 1.45 95 ci 0.98-2.16 hodgkin lymphoma rr 2.35 95 ci 1.08-5.08 cll risk similar parent sibl offspr case male femal rel affect case 's age diagnosi anticip signific analyz use life tabl method conclud famili compon cll share lymphoprolif malign suggest common genet pathway howev clinic diagnos cll uncommon absolut excess risk rel small\",\n",
       "  'collagen/polypropylen composit mesh biocompat abdomin wall reconstruct background intraperiton placement polypropylen mesh lead extens viscer adhes contraind differ coat use improv polypropylen mesh properti collagen protein uniqu biocompat cell ingrowth enhanc potenti novel acet acid extract collagen coat develop allow placement polypropylen mesh direct contact viscera author aim evalu long-term influenc acet acid extract collagen coat surgic aspect biomechan properti polypropylen mesh implant direct contact viscera includ complic adhes viscera strength incorpor microscop inflammatori reaction method forti adult wistar rat divid two group experiment polypropylen mesh/acet acid extract collagen coat control polypropylen mesh astandard procedur mesh implant perform anim kill 3 month surgeri analyz complic mesh area cover adhes type adhes strength incorpor intens inflammatori respons result mean adhes area lower polypropylen mesh/acet acid extract collagen coat 14.5 percent versu 69.9 percent p 0.001 adhes sever decreas experiment group grade 0 1 frequent p 0.04 p 0.002 respect grade 3 less frequent p 0.0001 associ adhes area sever found p 0.0001 complic strength incorpor intens inflammatori respons mesh similar conclus viscer adhes polypropylen mesh significantli reduc acet acid extract collagen coat collagen coat increas complic induc alter polypropylen mesh incorpor',\n",
       "  'microvessel densiti statu p53 protein potenti prognost factor adjuv anthracyclin chemotherapi retrospect analysi earli breast cancer patient group consider subgroup patient earli breast cancer address benefit anthracyclin base chemotherapi aim retrospect studi investig effect microvessel densiti mvd statu p53 protein 5-year diseas free surviv df group breast cancer patient treat anthracyclin adjuv set correl mvd p53 statu clinicopatholog paramet also assess mvd p53 statu analyz immunohistochem group 172 women breast cancer clinic stage t1-2 n1-n2 m0 123 tumor 71.5 lower mvd ≤ 214.8 microvesells/mm 2 49 28.5 higher mvd 214.8 microvesells/mm 2 proport higher mvd tumor significantli increas n2 p 0.000 estrogen p 0.046 progesteron receptor p 0.029 neg tumor p53 posit indic 50 cancer 29.1 significantli associ higher grade p 0.000 steroid receptor neg p 0.000 cytokeratin5/6 posit p 0.026 topoisomeras iiα overexpress p 0.005 higher prolifer rate p 0.001 univari analysi higher mvd p 0.016 p53 neg p 0.023 significantli relat longer df median follow-up 36 month multivari cox regress analysi mvd independ associ df data suggest higher mvd favour prognost factor earli advanc breast cancer patient adjuv anthracyclin base chemotherapi',\n",
       "  'rank elimin feasibl malaria-endem countri experi gain global malaria erad program 1955-72 identifi set share technic oper factor enabl countri success elimin malaria spatial data factor assembl malaria-endem countri combin provid object rel rank countri technic oper combin elimin feasibl analysi done separ plasmodium falciparum plasmodium vivax limit approach discuss rel rank suggest malaria elimin would feasibl countri america asia least feasibl countri central west africa result differ feasibl measur technic oper factor highlight differ type challeng face countri result intend prescript predict provid absolut assess feasibl show spatial inform avail facilit evidence-bas assess rel feasibl malaria elimin countri rapidli updat',\n",
       "  'genet obes adult adopte biolog sibl adopt studi genet effect obes adulthood carri adopte separ natur parent earli life compar biolog full half sibl rear natur parent adopte repres four group sampl larger popul categoris either thin medium weight overweight obes weight height obtain 115 full sibl 57 adopte 850 half sibl 341 adopte full sibl bodi mass index kg/m2 significantli increas weight adopte bodi mass index half sibl show steadi weaker increas across four weight group adopte signific interact sex adopte sex sibl half sibl sex common parent contrast find half sibl previous natur parent strike signific increas bodi mass index full sibl overweight obes adopte degre fat adult live environ appear influenc genet factor independ sex may includ polygen well major gene effect obes',\n",
       "  \"2010 rheumatoid arthriti classif criteria american colleg rheumatology/european leagu rheumat collabor initi object 1987 american colleg rheumatolog acr formerli american rheumat associ classif criteria rheumatoid arthriti ra criticis lack sensit earli diseas work undertaken develop new classif criteria ra method joint work group acr european leagu rheumat develop three phase new approach classifi ra work focus identifi among patient newli present undifferenti inflammatori synov factor best discrimin high risk persist and/or eros diseas -- appropri current paradigm underli diseas construct 'ra result new criteria set classif 'definit ra base confirm presenc synov least one joint absenc altern diagnosi better explain synov achiev total score 6 greater possibl 10 individu score four domain number site involv joint rang 0-5 serolog abnorm rang 0-3 elev acute-phas respons rang 0-1 symptom durat two level rang 0-1 conclus new classif system redefin current paradigm ra focus featur earlier stage diseas associ persist and/or eros diseas rather defin diseas late-stag featur refocu attent import need earlier diagnosi institut effect disease-suppress therapi prevent minimis occurr undesir sequela current compris paradigm underli diseas construct 'ra\",\n",
       "  'role fibroblast mediat effect tobacco-induc epitheli cell growth invas cigarett smoke smokeless tobacco extract contain multipl carcinogen compound littl known mechan tumor develop progress upon chronic exposur carcinogen present tobacco product examin effect smokeless tobacco extract human oral fibroblast show smokeless tobacco extract elev level intracellular reactiv oxygen oxid dna damag dna double-strand break dose-depend manner extend exposur extract induc fibroblast undergo senescence-lik growth arrest strike accompani chang secretori phenotyp use cocultur smokeless tobacco extracts-expos fibroblast immort nontumorigen keratinocyt show factor secret extracts-modifi fibroblast increas prolifer invas partial transform epitheli cell normal counterpart addit smokeless tobacco extracts-expos fibroblast caus partial transform keratinocyt lose express e-cadherin zo-1 well involucrin chang indic compromis epitheli function commonli associ malign progress togeth result suggest fibroblast may contribut tumorigenesi indirectli increas epitheli cell aggress thu tobacco may initi mutagen chang epitheli cell also promot growth invas mutant cell creat procarcinogen stromal environ',\n",
       "  'immtac-redirect tumour cell kill induc potenti antigen cross-present dendrit cell antigen cross-present dendrit cell dc thought play critic role drive polyclon durabl cell respons cancer follow therefor capac emerg immunotherapeut agent orchestr tumour erad may depend abil induc antigen cross-present immtac immune-mobilis monoclon tcr cell receptor cancer new class solubl bi-specif anti-canc agent combin pico-molar affin tcr-base antigen recognit cell activ via cd3-specif antibodi fragment immtac specif recognis human leucocyt antigen hla -restrict tumour-associ antigen present cancer cell lead cell redirect potent anti-tumour respons use immtac specif hla-a 02-restrict peptid deriv melanoma antigen gp100 term imcgp100 observ immtac-driven melanoma-cel death lead cross-present melanoma antigen dc turn activ melanoma-specif cell polyclon cell redirect imcgp100 moreov activ melanoma-specif cell cross-pres dc enhanc presenc imcgp100 featur serv increas prospect break toler tumour microenviron mechan dc cross-present occur via ‘ cross-dress ’ involv rapid direct captur dc membran fragment die tumour cell dc cross-present gp100-peptide-hla complex visualis quantifi use fluoresc label solubl tcr data demonstr immtac engag innat adapt compon immun system enhanc prospect mediat effect durabl anti-tumour respons patient',\n",
       "  'basal keratinocyt tetrasomi low-grad squamou intra-epitheli lesion cervix restrict high intermedi risk hpv infect type-specif human papillomaviru hpv infect appear earli event cervic carcinogenesi addit abnorm requir biolog transform analys 179 low-grad cervic squamou intra-epitheli lesion sil 15 normal cervic presenc hpv use situ hybrid polymeras chain reaction pcr pcr perform gp5+/gp6+ primer follow hybrid use probe low hpv 6 11 40 42 43 44 intermedi hpv 31 33 35 39 51 52 58 59 66 68 high-risk hpv hpv 16 18 45 56 interphas cytogenet analysi use pericentromer probe chromosom 1 3 4 6 10 11 17 18 x also perform identifi numer chromosom abnorm tetrasomi nine chromosom identifi within basal keratinocyt restrict epithelia infect high risk 17 46 intermedi risk 23 83 hpv hpv type-specif tetrasomi identifi epithelia infect low risk hpv n 62 number includ multipl infect find indic induct tetrasomi properti restrict high intermediate-risk hpv type type-specif factor govern lesion develop abnorm yet unclear © 2000 cancer research campaign',\n",
       "  \"“ rapid-impact intervent ” polici integr control africa 's neglect tropic diseas could benefit poor past two decad signific achiev control hand import human tropic infect 1 achiev includ substant reduct preval incid so-cal neglect diseas lymphat filariasi onchocerciasi guinea worm leprosi trachoma box 1 2 neglect diseas poverty-promot often stigmat condit occur primarili rural area low-incom countri box 2 3 ancient afflict describ bibl ancient text burden human millennia 3 result aggress region vertic intervent possibl neglect tropic infect could eventu control point elimin area endem 2–8 case guinea worm infect diseas erad might also soon possibl 9 box 2. common featur neglect tropic diseas ancient afflict burden human centuri poverty-promot condit associ stigma rural area low-incom countri fragil state commerci market product target diseas intervent appli histori success\",\n",
       "  'fty720 fingolimod neuroprotect disease-modifi agent cellular mous model huntington diseas huntington diseas hd genet neurodegen disord current cure way stop even slow brain chang caus present studi aim investig whether fty720 first approv oral therapi multipl sclerosi may effect hd model eventu constitut altern therapeut approach treatment diseas util preclin target valid paradigm examin vivo efficaci chronic administr fty720 r6/2 hd mous model find indic fty720 improv motor function prolong surviv reduc brain atrophi r6/2 mice benefici effect fty720 administr associ signific strengthen neuron activ connect reduct mutant huntingtin aggreg also parallel increas phosphoryl mutant huntingtin serin 13/16 residu predict attenu protein toxic',\n",
       "  'specif residu determin bind affin two-compon signal transduct system unlabel two-compon system tc compris histidin kinas cognat respons regul allow bacteria sens respond wide varieti signal histidin kinas hk phosphoryl dephosphoryl cognat respons regul rr respons stimuli gener reaction appear highli specif requir appropri associ hk rr protein myxococcu xanthu genom encod one largest repertoir signal protein bacteria 685 open read frame orf includ least 127 hk least 143 rr 27 bona fide ntrc-famili respons regul 21 encod adjac predict cognat kinas use system-wid profil method determin hk-ntrc rr pair display kinet prefer phosphotransf phosphatas function therebi defin cognat signal system m. xanthu isotherm titrat calorimetri measur indic cognat hk-rr pair interact dissoci constant kd approxim 1 µm noncogn pair measur bind lastli chimera gener histidin kinas crd hk1190 reveal residu confer phosphotransf phosphatas specif dictat bind affin therebi establish discret protein-protein interact prevent cross talk data indic bind affin critic paramet govern system-wid signal fidel bacteri signal transduct protein import use vitro phosphotransf phosphatas profil assay isotherm titrat calorimetri taken system-wid approach demonstr specif famili two-compon signal protein myxococcu xanthu result demonstr previous identifi specif residu dictat bind affin phosphatas specif follow phosphotransf specif cognat hk-rr pair data indic preferenti bind affin basi signal fidel bacteri two-compon system',\n",
       "  \"hnrnp a1 associ telomer end stimul telomeras activ telomeras ribonucleoprotein enzym complex reverse-transcrib integr rna templat add short dna repeat 3'-end telomer g-quadruplex structur dna substrat block extens telomeras found hnrnp a1 -- previous implic telomer length regul -- bind single-strand structur human telomer repeat latter case disrupt higher-ord structur use vitro telomeras assay observ deplet hnrnp a/b protein 293 human embryon kidney cell extract dramat reduc telomeras activ fulli recov upon addit purifi recombin hnrnp a1 find suggest hnrnp a1 function auxiliari essenti factor telomeras holoenzym show use chromatin immunoprecipit hnrnp a1 associ human telomer vivo propos hnrnp a1 stimul telomer elong unwind g-quadruplex g-g hairpin structur form transloc step\",\n",
       "  'rapamycin pass torch new gener mtor inhibitor mammalian target rapamycin mtor atyp protein kinas control growth metabol respons nutrient growth factor cellular energi level frequent dysregul cancer metabol disord rapamycin alloster inhibitor mtor approv immuno-suppress 1999. recent year interest focus potenti anticanc drug howev perform rapamycin analogu rapalogu undistinguish despit isol success subset cancer suggest full therapeut potenti target mtor yet exploit new gener atp-competit inhibitor directli target mtor catalyt site display potent comprehens mtor inhibit earli clinic trial',\n",
       "  'dynam capsul restructur main pneumococc autolysin lyta respons epithelium bacteri pathogen produc complex carbohydr capsul protect bactericid immun molecul paradox pneumococc capsul sensit bacterium antimicrobi peptid found epitheli surfac show upon interact antimicrobi peptid encapsul pneumococci surviv remov capsul cell surfac within minut process depend suicid amidas autolysin lyta contrast classic bacteri autolysi capsul shed lyta promot bacteri surviv dispers circumferenti around cell howev autolysi capsul shed depend cell wall hydrolyt activ lyta capsul shed drastic increas invas epitheli cell main pathway pneumococci reduc surfac bound capsul earli acut lung infect mice previous unrecogn role lyta remov capsul combat antimicrobi peptid may explain nearli clinic isol pneumococci conserv enzym despit lethal select pressur antibiot',\n",
       "  'mammalian scribbl polar protein regul epitheli cell adhes migrat e-cadherin scribbl scrib conserv polar protein requir drosophila melanogast synapt function neuroblast differenti epitheli polar also tumor suppressor rodent scrib implic receptor recycl planar polar apical/bas polar show knockdown scrib disrupt adhes madin–darbi canin kidney epitheli cell consequ cell acquir mesenchym appear migrat rapidli lose direction although tight junction assembl delay confluent monolay remain polar effect independ rac activ scrib bind βpix rather scrib deplet disrupt e-cadherin–medi cell–cel adhes chang morpholog migrat phenocopi e-cadherin knockdown adhes partial rescu express e-cadherin–α-catenin fusion protein e-cadherin–green fluoresc protein result suggest scrib stabil coupl e-cadherin catenin consist idea mammalian scrib could behav tumor suppressor regul epitheli cell adhes migrat',\n",
       "  'histon acetyl dna demethyl cell result anaplast larg cell lymphoma-lik phenotyp characterist featur anaplast larg cell lymphoma signific repress t-cell express program despit t-cell origin reason down-regul t-cell phenotyp still unknown elucid whether epigenet mechan respons loss t-cell phenotyp treat anaplast larg cell lymphoma t-cell lymphoma/leukemia cell line n=4 epigenet modifi evok dna demethyl histon acetyl global gene express data treat untreat cell line gener select differenti express gene evalu real-tim revers transcriptas polymeras chain reaction western blot analysi addit histon h3 lysin 27 trimethyl analyz chromatin immunoprecipit combin dna demethyl histon acetyl anaplast larg cell lymphoma cell abl reconstitut t-cell phenotyp instead treatment induc cell up-regul anaplast larg cell lymphoma-characterist gene e.g id2 lgals1 c-jun ii almost complet extinct t-cell phenotyp includ cd3 lck zap70 addit suppress trimethyl histon h3 lysin 27 import t-cell transcript factor gene gata3 lef1 tcf1 present anaplast larg cell lymphoma cell line absenc primari tumor specimen demonstr immunohistochemistri data suggest epigenet activ suppressor e.g id2 contribut down-regul t-cell express program anaplast larg cell lymphoma maintain trimethyl histon h3 lysin 27',\n",
       "  'yeastract provid programmat access curat transcript regulatori associ saccharomyc cerevisia web servic interfac yeast search transcript regul consensu track yeastract inform system http //www.yeastract.com develop support analysi transcript regulatori associ saccharomyc cerevisia last updat june 2010 databas contain 48,200 regulatori associ transcript factor tf target gene includ 298 specif dna-bind site 110 character tf regulatori associ store databas revisit detail inform experiment evid sustain associ ad classifi direct indirect evid inclus new data gather respons request yeastract user allow user restrict queri subset data base exist experiment evid direct action tf promot region target gene anoth new featur releas avail data machin readabl web-servic interfac user longer restrict set avail queri made avail exist web interfac use web servic interfac queri retriev exploit yeastract data use implement addit function yeastract inform system complement sever comput tool facilit use curat data answer number import biolog question sinc first releas 2006 yeastract extens use hundr research world expect make new data servic avail system continu instrument yeast biologist system biolog research',\n",
       "  'mechan specifi promot nucleosom locat ident chromatin architectur eukaryot gene promot gener character nucleosome-fre region nfr flank least one h2a.z variant nucleosom comput predict nucleosom posit base thermodynam properti dna-histon interact met limit success show action essenti rsc remodel complex s. cerevisia help explain discrep theori experi rsc-deplet cell nfr shrink averag posit flank nucleosom move toward predict site nucleosom posit distinct subset promot addit requir essenti myb famili protein abf1 reb1 whose bind site enrich nfr contrast h2a.z deposit dispens nucleosom posit regul h2a.z deposit use steroid-induc protein splice strategi show nfr establish necessari h2a.z deposit studi suggest order pathway assembl promot chromatin architectur',\n",
       "  'hiv seroposit tuberculosi larg gener hospit malawi incid acquir immunodefici syndrom aid malawi one highest central africa sinc tuberculosi import initi manifest diseas consecut patient admit tuberculosi tb ward zomba gener hospit malawi ask permiss undergo human immunodefici viru hiv -antibodi test addit two studi done septemb 1986 medic in-pati clinic suspect immun defici april 1988 blood donor test hiv seroposit seventy-f percent tb patient volunt 32 125 26 seroposit high-risk age group 20-40 year percentag rose 32. among medic in-pati suspect immun defici seroposit rose sharpli april 1987 octob 1988. among blood donor test 20 seroposit',\n",
       "  \"determin neonat mortal indonesia background neonat mortal account almost 40 per cent under-f child mortal global understand factor relat neonat mortal import guid develop focus evidence-bas health intervent prevent neonat death studi aim identifi determin neonat mortal indonesia nation repres sampl birth 1997 2002. method data sourc analysi 2002-2003 indonesia demograph health survey surviv inform 15,952 singleton live-born infant born 1997 2002 examin multilevel logist regress use hierarch approach perform analyz factor associ neonat death use commun socio-econom statu proxim determin result commun level odd neonat death significantli higher infant east java 5.01 p 0.00 north central southeast sulawesi gorontalo combin 3.17 p 0.03 compar lowest neonat mortal region bali south sulawesi jambi provinc progress reduct odd found percentag deliveri assist train deliveri attend cluster increas odd neonat death higher infant born mother father employ 1.84 p 0.00 infant born father unemploy 2.99 p 0.02 odd also higher higher rank infant short birth interv 2.82 p 0.00 male infant 1.49 p 0.01 smaller average-s infant 2.80 p 0.00 infant 's whose mother histori deliveri complic 1.81 p 0.00 infant receiv postnat care significantli protect neonat death 0.63 p 0.03 conclus public health intervent direct reduc neonat death address commun household individu level factor significantli influenc neonat mortal indonesia low birth weight short birth interv infant well perinat health servic factor avail skill birth attend postnat care util taken account plan intervent reduc neonat mortal indonesia\",\n",
       "  \"high densiti map mhc identifi share role hla-drb1 01:03 inflammatori bowel diseas heterozyg advantag ulcer coliti genome-wid associ studi relat chronic inflammatori bowel diseas ibd known crohn 's diseas ulcer coliti shown strong evid associ major histocompat complex mhc region encod larg number immunolog candid includ antigen-pres classic human leukocyt antigen hla molecul studi ibd indic multipl independ associ exist hla non-hla gene lack statist power defin architectur associ causal allel address perform high-dens snp type mhc 32,000 individu ibd implic multipl hla allel primari role hla-drb1 01:03 crohn 's diseas ulcer coliti noteworthi differ observ diseas includ predomin role class ii hla variant heterozyg advantag observ ulcer coliti suggest import role adapt immun respons colon environ pathogenesi ibd\",\n",
       "  'high-threshold mechanosensit ion channel block novel conopeptid mediat pressure-evok pain littl known molecular basi somatosensori mechanotransduct mammal screen librari peptid toxin effect mechan activ current cultur dorsal root ganglion neuron one conopeptid analogu term nmb-1 noxiou mechanosens blocker 1 select inhibit ic50 1 µm sustain mechan activ current subset sensori neuron biotinyl nmb-1 retain activ bind select peripherin-posit nocicept sensori neuron select nmb-1 confirm fact inhibitori effect voltage-g sodium calcium channel ligand-g channel acid-sens ion channel trpa1 channel convers tarantula toxin gsmtx-4 inhibit stretch-activ ion channel effect mechan activ current sensori neuron behavior assay nmb-1 inhibit respons high intens pain mechan stimul effect low intens mechan stimul thermosens unexpectedli nmb-1 found also inhibitor rapid fm1-43 load measur mechanotransduct cochlear hair cell data demonstr pharmacolog distinct channel respond distinct type mechan stimuli suggest mechan activ sustain current underli noxiou mechanosens nmb-1 thu provid novel diagnost tool molecular definit channel involv hear pressure-evok pain',\n",
       "  'hyperact neuroendocrin secret caus size feed metabol defect c. elegan bardet-biedl syndrom mutant bardet-biedl syndrom bb rare autosom recess disord clinic present includ polydactyli retinopathi hyperphagia obes short statur cognit impair development delay disrupt bb protein varieti organ impair cilia format function multi-organ defect bb attribut defici variou cilia-associ signal pathway c. elegan bb gene express exclus sixti ciliat sensori neuron anim bb mutant exhibit sensori defect well bodi size feed metabol abnorm show contrast mani cilia-defect mutant c. elegan bb mutant exhibit increas releas dense-cor vesicl organism-wid phenotyp associ enhanc activ insulin neuropeptid biogen amin signal pathway show alter bodi size feed metabol abnorm bb mutant correct wild-typ level abrog enhanc secret dense-cor vesicl without concomit correct ciliari defect find expand role bb protein regul dense-core-vesicl exocytosi suggest featur bardet-biedl syndrom may caus excess neuroendocrin secret',\n",
       "  'fiji open-sourc platform biological-imag analysi fiji distribut popular open-sourc softwar imagej focus biological-imag analysi fiji use modern softwar engin practic combin power softwar librari broad rang script languag enabl rapid prototyp image-process algorithm fiji facilit transform new algorithm imagej plugin share end user integr updat system propos fiji platform product collabor comput scienc biolog research commun',\n",
       "  'pharmacolog character potent inhibitor class phosphatidylinositid 3-kinas extens evid implic activ lipid phosphatidylinositid 3-kinas pi3k pathway genesi progress variou human cancer pi3k inhibitor thu consider potenti molecular cancer therapeut detail pharmacolog properti prototyp new seri inhibitor class pi3k pi103 potent inhibitor low ic50 valu recombin pi3k isoform p110alpha 2 nmol/l p110beta 3 nmol/l p110delta 3 nmol/l p110gamma 15 nmol/l pi103 also inhibit torc1 83.9 0.5 micromol/l exhibit ic50 14 nmol/l dna-pk high degre select pi3k famili shown lack activ pi103 panel 70 protein kinas pi103 potent inhibit prolifer invas wide varieti human cancer cell vitro show biomark modul consist inhibit pi3k signal pi103 extens metabol distribut rapidli tissu tumor result tumor growth delay eight differ human cancer xenograft model variou pi3k pathway abnorm decreas phosphoryl akt observ u87mg glioma consist drug level achiev also show inhibit invas orthotop breast ovarian cancer xenograft model obtain evid pi103 antiangiogen potenti despit rapid vivo metabol pi103 valuabl tool compound explor biolog function class pi3k importantli repres lead optim novel class target molecular cancer therapeut',\n",
       "  'optim crispr/ca tool effici germlin somat genom engin drosophila type ii cluster regularli interspac short palindrom repeat crispr /crispr-associ ca system emerg recent power method manipul genom variou organ report toolbox high-effici genom engin drosophila melanogast consist transgen cas9 line versatil guid rna grna express plasmid systemat evalu reveal cas9 line ubiquit germ-line-restrict pattern activ also demonstr differenti activ grna express differ u6 snrna promot previous untest u6:3 promot give potent effect appropri combin cas9 grna allow target essenti nonessenti gene transmiss rate rang 25-100 also demonstr optim crispr/ca tool use offset nicking-bas mutagenesi furthermor combin oligonucleotid long double-strand donor templat reagent allow precis genom edit homology-direct repair rate make select marker unnecessari last demonstr novel applic crispr/cas-medi technolog reveal loss-of-funct phenotyp somat cell follow effici biallel target cas9 express ubiquit tissue-restrict manner crispr/ca tool facilit rapid evalu mutant phenotyp specif gene precis modif genom single-nucleotid precis result also pave way high-throughput genet screen crispr/ca',\n",
       "  'cost-effect 10-year risk threshold initi statin therapi primari prevent cardiovascular diseas import american colleg cardiolog american heart associ acc/aha cholesterol treatment guidelin wide-scal implic treat adult without histori atherosclerot cardiovascular diseas ascvd statin object estim cost-effect variou 10-year ascvd risk threshold could use acc/aha cholesterol treatment guidelin design set particip microsimul model includ lifetim time horizon us societ perspect 3 discount rate cost health outcom model hypothet individu repres us popul age 40 75 year receiv statin treatment experienc ascvd event die ascvd-rel non-ascvd-rel caus base ascvd natur histori statin treatment paramet data sourc model paramet includ nation health nutrit examin survey larg clinic trial meta-analys statin benefit treatment publish sourc main outcom measur estim ascvd event prevent increment cost per quality-adjust life-year qali gain result base-cas scenario current ascvd threshold 7.5 higher estim associ 48 adult treat statin increment cost-effect ratio icer 37,000/qali compar 10 higher threshold lenient ascvd threshold 4.0 higher 61 adult treat 3.0 higher 67 adult treat icer 81,000/qali 140,000/qali respect shift 7.5 higher ascvd risk threshold 3.0 higher ascvd risk threshold estim associ addit 161,560 cardiovascular diseas event avert cost-effect result sensit chang disutil associ take pill daili statin price risk statin-induc diabet probabilist sensit analysi higher 93 chanc optim ascvd threshold 5.0 lower use cost-effect threshold 100,000/qali conclus relev microsimul model us adult age 45 75 year correct current 10-year ascvd risk threshold ≥7.5 risk threshold use acc/aha cholesterol treatment guidelin accept cost-effect profil icer 37,000/qali lenient ascvd threshold would optim use cost-effect threshold 100,000/qali ≥4.0 risk threshold 150,000/qali ≥3.0 risk threshold optim ascvd threshold sensit patient prefer take pill daili chang statin price risk statin-induc diabet',\n",
       "  'biochem properti highli neuroinvas prion strain infecti prion propag peripher entri site central nervou system cn caus progress neurodegener ultim lead death yet pathogenesi prion diseas vari dramat depend strain conform variant aberrantli fold aggreg protein prp sc although prion strain invad cn prion strain gain entri caus clinic sign diseas conform basi remark variat pathogenesi among strain unclear use mouse-adapt prion strain show highli neuroinvas prion strain primarili form diffus aggreg brain noncongophil conform unstabl denatur condit lead rapidli lethal diseas neuroinvas strain effici gener prp sc short incub period contrast weakli neuroinvas prion strain form larg fibrillari plaqu stabl congophil ineffici gener prp sc long incub period overal result indic neuroinvas prion strain also least stabl support concept effici replic unstabl natur rapidli convert prion may featur link effici spread cn',\n",
       "  'twin-arginin transloc tat protein export pathway twin-arginin transloc tat protein export system present cytoplasm membran bacteria archaea highli unusu properti transport fulli fold protein system must therefor provid transmembran pathway larg enough allow passag structur macromolecular substrat differ size maintain imperm membran ion gram-neg bacterium escherichia coli complex task achiev use three small membran protein tata tatb tatc review summar recent advanc understand remark machin oper',\n",
       "  'new develop atsa program packag small-angl scatter data analysi new develop program packag atsa version 2.4 process analysi isotrop small-angl x-ray neutron scatter data describ includ multiplatform data manipul display tool ii program autom data process calcul overal paramet iii improv usag high- low-resolut model structur method iv new algorithm build three-dimension model weakli interact oligomer system complex v enhanc tool analys data mixtur flexibl system new atsa releas includ instal current major platform window linux mac osx provid improv index user document web-rel develop includ user discuss forum widen onlin access run atsa program also present',\n",
       "  'first myriapod genom sequenc reveal conserv arthropod gene content genom organis centiped strigamia maritima myriapod e.g. centiped milliped display simpl homonom bodi plan rel arthropod member class terrestri attain terrestri independ insect myriapoda arthropod class repres sequenc genom present analysi genom centiped strigamia maritima retain compact genom undergon less gene loss shuffl previous sequenc arthropod mani orthologu gene conserv bilaterian ancestor lost insect analysi locat mani gene conserv macro-synteni context mani small-scal exampl gene cluster describ sever exampl s. maritima show differ solut insect similar problem insect olfactori receptor gene famili absent s. maritima olfact air like effect expans receptor gene famili gene s. maritima evolv paralogu gener code sequenc divers insect use altern splice strike dscam gene drosophila gener 100,000 altern splice form s. maritima encod 100 paralogu see intrigu linkag absenc known photosensori protein blind organ addit absenc canon circadian clock gene phylogenet posit myriapod allow us identifi arthropod phylogeni sever particular molecular mechan trait emerg exampl conclud juvenil hormon signal evolv emerg exoskeleton arthropod rr-1 contain cuticl protein evolv lineag lead mandibulata also identifi variou gene expans loss occur genom s. maritima offer us uniqu glimps ancestr arthropod genom also display mani adapt specif life histori',\n",
       "  'genet function diversif small rna pathway plant multicellular eukaryot produc small rna molecul approxim 21–24 nucleotid two gener type microrna mirna short interf rna sirna collect function sequence-specif guid silenc regul gene transposon virus modifi chromatin genom structur format activ small rna requir factor belong gene famili encod dicer dicer-lik dcl argonaut protein case sirna rna-depend rna polymeras rdr protein unlik mani anim plant encod multipl dcl rdr protein use seri insert mutant arabidopsi thaliana uniqu function three dcl protein mirna dcl1 endogen sirna dcl3 viral sirna dcl2 biogenesi identifi one rdr protein rdr2 requir endogen sirna analyz loss endogen sirna dcl3 rdr2 mutant associ loss heterochromat mark increas transcript accumul loci defect sirna-gener activ respons turnip crinkl viru dcl2 mutant plant correl increas viru suscept conclud prolifer diversif dcl rdr gene evolut plant contribut special small rna-direct pathway develop chromatin structur defens',\n",
       "  'immunosuppress fty720 inhibit thymocyt emigr one major role thymu provid peripher immun system matur cell mechan involv cellular export fulli understood studi examin abil novel immunosuppress reagent fty720 inhibit cell export thymu daili administr fty720 dose 1 mg kg result mark decreas number peripher blood lymphocyt thymu long-term daili administr fty720 caus three- fourfold increas proport matur medullari thymocyt cd4 cd8 cd4 cd8 well slight decreas double-posit cell cd4 cd8 ratio phenotyp analysi tcralpha beta h-2k cd44 cd69 cd24 reveal increas subset repres possibl peripher recent thymic emigr high level express l-selectin subset suggest prevent leav thymu intrathym label fluorescein isothiocyan one fourth label cell could detect lymph node spleen fty720-treat mice compar saline-tr control mice taken togeth result suggest immunosuppress action fty720 least part could due inhibitori effect cell emigr thymu peripheri',\n",
       "  \"valid conceptu model inter-profession approach share decis make mix method studi rational aim object follow increas interest inter-profession ip health care team engag patient decis make develop conceptu model ip approach share decis make sdm primari care assess valid model stakehold canada method 15 individu interview 7 group interview 79 stakehold ask 1 propos chang ip-sdm model 2 identifi barrier facilit model 's implement clinic practic 3 assess model use theori apprais questionnair perform themat analysi transcript descript analysi questionnair result stakehold suggest place patient centr extend concept famili includ signific other clarifi outcom highlight concept time merg micro meso macro level one figur recogn influenc environ emot common barrier identifi time constraint insuffici resourc imbal power among health profession common facilit educ train inter-profession sdm motiv achiev ip approach sdm mutual knowledg understand disciplinari role stakehold consid concept relationship concept clear rate model logic testabl clear schemat represent relev inter-profession collabor sdm primari care conclus stakehold valid new ip-sdm model primari care set propos modif futur research assess model help implement sdm ip clinic practic\",\n",
       "  'glutaminolysi activ rag-mtorc1 signal amino acid control cell growth via activ highli conserv kinas torc1 glutamin particularli import amino acid cell growth control metabol howev role glutamin torc1 activ remain poorli defin glutamin metabol glutaminolysi produc α-ketoglutar demonstr glutamin combin leucin activ mammalian torc1 mtorc1 enhanc glutaminolysi α-ketoglutar product inhibit glutaminolysi prevent gtp load ragb lysosom transloc subsequ activ mtorc1 constitut activ rag heterodim activ mtorc1 absenc glutaminolysi convers enhanc glutaminolysi cell-perm α-ketoglutar analog stimul lysosom transloc activ mtorc1 final cell growth autophagi two process control mtorc1 regul glutaminolysi thu mtorc1 sens activ glutamin leucin via glutaminolysi α-ketoglutar product upstream rag may provid explan glutamin addict cancer cell',\n",
       "  \"microrna-31/factor-inhibit hypoxia-induc factor 1 nexu regul keratinocyt differenti notch play critic role transit prolifer differenti epidermi corneal epithelium furthermor aberr notch signal featur diseas like psoriasi eczema nonmelanoma skin cancer melanoma differenti prolifer impair wherea much known downstream event follow notch signal factor respons neg regul notch receptor signal ligand activ incomplet understood notch undergo hydroxyl factor-inhibit hypoxia-induc factor 1 fih-1 howev biolog signific phenomenon unclear show fih-1 express up-regul diseas epidermi corneal epithelium elev fih-1 level primari human epiderm keratinocyt hek human corneal epitheli keratinocyt hcek impair differenti submerg cultur `` three-dimension '' organotyp raft model human epidermi part via coordin decreas notch signal knockdown fih-1 enhanc keratinocyt differenti loss fih-1 vivo increas notch activ limbal epithelium result differenti phenotyp microrna-31 mir-31 endogen neg regul fih-1 express result keratinocyt differenti mediat notch activ ectop express mir-31 undifferenti corneal epitheli cell line promot differenti recapitul corneal epithelium three-dimension raft cultur model result defin previous unknown mechan keratinocyt fate decis notch signal potenti part control mir-31/fih-1 nexu\",\n",
       "  'advantag larval control african malaria vector low mobil behaviour respons immatur mosquito stage allow high effect coverag base sensit analysi macdonald-ross model long argu best way reduc malaria transmiss target adult femal mosquito insecticid reduc longev human-feed frequenc vector howev analys ignor fundament biolog differ mosquito adult immatur stage preced adult highli mobil fli insect readili detect avoid mani intervent measur wherea mosquito egg larva pupa confin within rel small aquat habitat readili escap control measur hypothes control adult immatur mosquito compromis abil avoid intervent excito-repel insecticid appli simpl model intervent avoid mosquito demonstr substanti reduc effect coverag term proport vector popul cover overal impact malaria transmiss review histor evid larval control african malaria vector effect conclud limit effect coverag larval control practic rather fundament larval control strategi vector malaria sub-saharan africa could highli effect complementari adult control intervent priorit develop evalu implement integr part roll back malaria',\n",
       "  'arabidopsi chromatin-modifi nuclear sirna pathway involv nucleolar rna process center arabidopsi thaliana small interf rna sirna direct cytosin methyl endogen dna repeat pathway involv two form nuclear rna polymeras iv pol iva pol ivb rna-depend rna polymeras 2 rdr2 dicer-lik 3 dcl3 argonaute4 ago4 chromatin remodel drd1 de novo cytosin methyltransferas drm2 show rdr2 dcl3 ago4 nrpd1b largest subunit pol ivb coloc sirna within nucleolu contrast pol iva drd1 extern nucleolu coloc endogen repeat loci mutation-induc loss pathway protein caus downstream protein misloc reveal order action pol iva act first local rna depend suggest rna templat hypothes mainten heterochromat state involv locus-specif pol iva transcript follow sirna product assembl ago4- nrpd1b-contain silenc complex within nucleolar process center',\n",
       "  'peripher arteri diseas elderli rotterdam studi assess age- sex-specif preval peripher arteri diseas pad intermitt claudic ic elderli popul perform population-bas studi 7715 subject 40 men 60 women age 55 year presenc pad ic determin measur ankle-arm systol blood pressur index aai mean world health organization/ros questionnair respect pad consid present aai 0.90 either leg preval pad 19.1 95 confid interv 18.1 20.0 16.9 men 20.5 women symptom ic report 1.6 95 confid interv 1.3 1.9 studi popul 2.2 men 1.2 women pad 6.3 report symptom ic 8.7 men 4.9 women wherea 68.9 ic aai 0.90 found subject aai 0.90 like smoker hypertens symptomat asymptomat cardiovascular diseas compar subject aai 0.90 higher author conclud preval pad elderli high wherea preval ic rather low although preval clearli increas advanc age vast major pad patient report symptom ic',\n",
       "  'antioxid attenu plasma cytokin respons exercis human exercis increas plasma tnf-alpha il-1beta il-6 yet stimuli sourc tnf-alpha il-1beta remain larg unknown test role oxid stress potenti contribut monocyt cytokin especi il-1beta respons previous untrain individu six healthi nonathlet perform two 45-min bicycl exercis session 70 vo 2 max combin antioxid vitamin e c 60 day allopurinol 15 day n-acetylcystein 3 day blood drawn baselin end-exercis 30 120 min postexercis plasma cytokin determin elisa monocyt intracellular cytokin level flow cytometri antioxid tnf-alpha increas 60 il-1beta threefold il-6 sixfold secondari exercis p 0.05 antioxid plasma il-1beta becam undetect tnf-alpha respons exercis abolish il-6 respons significantli blunt p 0.05 exercis increas percentag monocyt produc cytokin mean fluoresc intens conclud untrain human oxid stress major stimulu exercise-induc cytokin product monocyt play role process',\n",
       "  'relat colon proglucagon express metabol respons oligofructos high fat diet-f mice sever data suggest ferment dietari fiber could play role control obes associ metabol disord aim studi investig put role short chain fructo-oligosaccharid of non-digest oligosaccharid mice fed standard diet mice fed two distinct high fat diet induc metabol disord associ obes confirm mice sever effect previous shown rat fed standard diet enrich of name increas total empti caecum weight signific decreas epididym fat mass increas colon portal plasma glucagon-lik peptide-1 glp-1 phenomenon posit correl higher colon proglucagon mrna level curious 4-week treatment of ad dose induc differ effect ad two differ high fat diet of decreas energi intak bodi weight gain glycemia epididym fat mass ad togeth high fat-carbohydr free diet of promot colon proglucagon express insulin secret result support associ increas proglucagon express proxim colon of effect glycemia fat mass develop and/or bodi weight gain conclus dietari oligosaccharid would constitut interest class dietari fiber promot certain condit endogen glp-1 product benefici physiolog consequ remain proven human studi',\n",
       "  'aurora b phosphoryl spatial distinct target differenti regul kinetochore-microtubul interfac accur chromosom segreg requir care regul interact kinetochor microtubul plastic achiev correct divers attach defect remain unclear demonstr aurora b kinas phosphoryl three spatial distinct target within conserv outer kinetochor knl1/mis12 complex/ndc80 complex kmn network key player kinetochore-microtubul attach combinatori phosphoryl kmn network gener grade level microtubule-bind activ full phosphoryl sever compromis microtubul bind alter phosphoryl state protein caus correspond chromosom segreg defect importantli spatial distribut target along kinetochor axi lead differenti phosphoryl respons chang tension attach state total rather gener exclus binari chang microtubul bind result suggest mechan tension-depend fine-tun kinetochore-microtubul interact',\n",
       "  'prognost import 6-mercaptopurin dose intens acut lymphoblast leukemia 6-mercaptopurin 6mp methotrex backbon continu therapi childhood acut lymphoblast leukemia studi oral 6mp methotrex indic chronic system exposur activ metabolit agent name red blood cell rbc concentr methotrex polyglutam mtxpg thioguanin nucleotid tgn posit correl event-fre surviv ef object evalu whether mtxpg tgn dose intens administ methotrex 6mp prognost set treatment protocol treatment coordin singl center weekli dose methotrex given parenter protocol total xii 182 children achiev remiss receiv weekli methotrex 40 mg/m2 parenter daili oral 6mp interrupt everi 6 week first year puls chemotherapi total 709 tgn 418 mtx-pg 267 thiopurin methyltransferas tpmt measur along complet dose intens inform dose receiv divid protocol dose per week 19,046 week 6mp methotrex analyz univari analys higher dose intens 6mp weekli methotrex signific predictor overal ef p =.006 039 respect occurr neutropenia associ wors outcom p =.040 multivari analysi higher dose intens 6mp p =.020 signific predictor ef lower tpmt activ p =.096 tend associ better outcom 6mp dose intens also associ p =.007 ef among patient homozyg wild-typ tpmt phenotyp lower 6mp dose intens primarili due miss week therapi reduct daili dose conclud increas dose-intens oral 6mp import determin ef particularli among children homozyg wild-typ tpmt phenotyp howev increas intens therapi neutropenia preclud chemotherapi administr may counterproduct',\n",
       "  'orai1 stim1 critic breast tumor cell migrat metastasi tumor metastasi primari caus death cancer patient understand molecular mechan underli tumor metastasi provid potenti drug target report orai1 stim1 involv store-oper calcium entri essenti breast tumor cell migrat vitro tumor metastasi mice reduct orai1 stim1 rna interfer highli metastat human breast cancer cell treatment pharmacolog inhibitor store-oper calcium channel decreas tumor metastasi anim model data demonstr role orai1 stim1 tumor metastasi suggest store-oper calcium entri channel potenti cancer therapeut target',\n",
       "  \"mous spermatogen stem cell continu interconvert equipot singli isol syncyti state ident behavior mous spermatogen stem cell long-stand focu interest prevail `` model '' stem cell function restrict singli isol spermatogonia examin single-cel dynam gfrα1+ stem cell vivo evalu altern hypothesi fragment syncyti spermatogonia also contribut stem cell function homeostasi use live imag puls label quantit determin fate individu gfrα1+ cell find steady-st spermatogenesi entir gfrα1+ popul compris singl stem cell pool cell continu interconvert syncyti state minim biophys model reli rate incomplet cell divis syncyti fragment precis predict stochast fate gfrα1+ cell steadi state postinsult regener thu result defin altern dynam model spermatogen stem cell function mous testi\",\n",
       "  'pseudoknot rna structur divers function rna molecul fulfil divers set biolog function within cell transfer genet inform dna protein enzymat catalysi reflect rang role simpl linear string rna—mad uracil guanin cytosin adenine—form varieti complex three-dimension structur protein form distinct structur motif zinc finger beta barrel certain structur also commonli adopt rna molecul among preval rna structur motif known pseudoknot first recogn turnip yellow mosaic viru 1 pseudoknot rna structur minim compos two helic segment connect single-strand region loop figur 1 although sever distinct fold topolog pseudoknot exist best character h type h-type fold base loop hairpin form intramolecular pair base outsid stem figur 1a \\u200band1b .1b caus format second stem loop result pseudoknot two stem two loop figur 1c two stem abl stack top form quasi-continu helix one continu one discontinu strand single-strand loop region often interact adjac stem loop 1–stem 2 loop 2–stem 1 form hydrogen bond particip overal structur molecul henc rel simpl fold yield complex stabl rna structur due variat length loop stem well type interact pseudoknot repres structur divers group fit play varieti divers role biolog role includ form catalyt core variou ribozym 2,3 self-splic intron 4 telomeras 5 addit pseudoknot play critic role alter gene express induc ribosom frameshift mani virus 6–9',\n",
       "  'essenti role interferon gamma resist mycobacterium tuberculosi infect tuberculosi major health problem develop countri reemerg recent year mani industri countri increas suscept immunocompromis individu tuberculosi mani experiment studi indic cell-medi immun play import role resist lymphokin interferon gamma ifn-gamma thought princip mediat macrophag activ resist intracellular pathogen mice develop fail produc ifn-gamma gko target disrupt gene ifn-gamma upon infect mycobacterium tuberculosi although develop granuloma gko mice fail produc reactiv nitrogen intermedi unabl restrict growth bacilli contrast control mice gko mice exhibit heighten tissu necrosi succumb rapid fatal cours tuberculosi could delay prevent treatment exogen recombin ifn-gamma',\n",
       "  'malign prothrombot mutat risk venou thrombosi context venou thrombosi common complic patient cancer lead addit morbid compromis qualiti life object identifi individu cancer increas thrombot risk evalu differ tumor site presenc distant metastas carrier statu prothrombot mutat design set patient larg population-bas case-control multipl environment genet assess mega risk factor venou thrombosi studi 3220 consecut patient age 18 70 year first deep venou thrombosi leg pulmonari embol march 1 1999 may 31 2002 6 anticoagul clinic netherland separ 2131 control particip partner patient report via questionnair acquir risk factor venou thrombosi three month discontinu anticoagul therapi patient control interview blood sampl taken dna isol ascertain factor v leiden prothrombin 20210a mutat main outcom measur risk venou thrombosi result overal risk venou thrombosi increas 7-fold patient malign odd ratio 6.7 95 confid interv ci 5.2-8.6 vs person without malign patient hematolog malign highest risk venou thrombosi adjust age sex adjust 28.0 95 ci 4.0-199.7 follow lung cancer gastrointestin cancer risk venou thrombosi highest first month diagnosi malign adjust 53.5 95 ci 8.6-334.3 patient cancer distant metastas higher risk vs patient without distant metastas adjust 19.8 95 ci 2.6-149.1 carrier factor v leiden mutat also cancer 12-fold increas risk vs individu without cancer factor v leiden adjust 12.1 95 ci 1.6-88.1 similar result indirectli calcul prothrombin 20210a mutat patient cancer conclus patient cancer highli increas risk venou thrombosi especi first month diagnosi presenc distant metastas carrier factor v leiden prothrombin 20210a mutat appear even higher risk',\n",
       "  'hippo signal pathway restrict oncogen potenti intestin regener program although development role hippo signal organ size control well appreci pathway function tissu regener larg unknown address issu use dextran sodium sulfat dss -induc colon regener model find regener crypt express elev yes-associ protein yap level inactiv yap caus obviou intestin defect normal homeostasi sever impair dss-induc intestin regener convers hyperactiv yap result widespread early-onset polyp format follow dss treatment thu yap oncoprotein must exquisit control tissu regener allow compensatori prolifer prevent intrins oncogen potenti tissu regener program',\n",
       "  'essenc snp singl nucleotid polymorph snp abund form genom variat distinguish rare variat requir least abund allel frequenc 1 wide rang genet disciplin stand benefit greatli studi use snp recent surg interest snp stem continu depend upon merg coincid matur sever research area i.e large-scal genom analysi relat technolog ii bio-informat comput iii genet analysi simpl complex diseas state iv global human popul genet field propel forward often unchart territori ongo discoveri effort promis yield hundr thousand human snp next year major question ask experiment theoret ethic effect way unlock full potenti upcom snp revolut',\n",
       "  'combin inhibit pi3k mtorc1 yield durabl remiss orthotop patient-deriv xenograft her2-posit breast cancer brain metastas brain metastas repres greatest clinic challeng treat her2-posit breast cancer report develop orthotop patient-deriv xenograft pdx her2-express breast cancer brain metastas bcbm use identif target combin therapi combin inhibit pi3k mtor result durabl tumor regress three five pdx therapeut respons correl reduct phosphoryl 4ebp1 mtorc1 effector two nonrespond pdx show hypermut genom enrich mutat dna-repair gene suggest associ genom instabl therapeut resist find suggest biomarker-driven clinic trial pi3k inhibitor combin mtor inhibitor conduct patient her2-posit bcbm',\n",
       "  \"activ frontal neocort area vocal product marmoset primat often reli vocal commun mediat social interact although much known acoust structur primat vocal social context usual utter knowledg neocort control audio-voc interact primat still incipi mostli deriv lesion studi squirrel monkey macaqu map neocort area relat vocal control new world primat speci common marmoset employ method previous use success vertebr speci analysi express immedi earli gene egr-1 freeli behav anim neocort distribut egr-1 immunoreact cell three marmoset expos playback conspecif vocal vocal spontan h/v group compar data three marmoset also heard playback vocal h/n group anterior cingul cortex dorsomedi prefront cortex ventrolater prefront cortex present higher number egr-1 immunoreact cell h/v group h/n anim result provid direct evid ventrolater prefront cortex region compris broca 's area human associ auditori process species-specif vocal orofaci control macaqu engag vocal output marmoset altogeth result support notion network neocort area relat vocal commun marmoset quit similar old world primat vocal product role play area import evolut speech primat discuss\",\n",
       "  'famili hiatal hernia larg five gener famili confirm true autosom domin inherit background famili hiatal hernia rare document aim describ pattern inherit famili hiatal hernia within affect famili subject thirti eight member famili pedigre across five gener method famili member interview investig barium meal evid hiatal hernia result twenti three 38 famili member radiolog evid hiatal hernia individu hiatal hernia born unaffect parent one case direct male male transmiss shown conclus famili inherit hiatal hernia occur evid direct male male transmiss point autosom domin mode inherit',\n",
       "  'excitatori loop astrocyt contribut drive neuron seizur threshold seizur focal epilepsi sustain highli synchron neuron discharg aris restrict brain site subsequ spread larg portion brain despit intens experiment research field earlier cellular event initi sustain focal seizur still well defin identif central understand pathophysiolog focal epilepsi develop new pharmacolog therapi drug-resist form epilepsi promin involv astrocyt ictogenesi recent propos test whether cooper astrocyt neuron prerequisit support ictal seizure-lik interict epileptiform event simultan patch-clamp record ca2+ imag techniqu perform new vitro model focal seizur induc local applic n-methyl-d-aspart acid nmda rat entorhin cortex slice found ca2+ elev astrocyt correl initi develop mainten focal seizure-lik discharg delay astrocyt activ ictal discharg also observ model includ whole vitro isol guinea pig brain site gener seizur activ precis monitor contrast interict discharg associ ca2+ chang astrocyt select inhibit stimul astrocyt ca2+ signal block enhanc respect ictal discharg affect interict discharg gener data reveal neuron engag astrocyt recurr excitatori loop possibl involv gliotransmiss promot seizur ignit sustain ictal discharg neuron-astrocyt interact may repres novel target develop effect therapeut strategi control seizur',\n",
       "  'diminish perform neuropsycholog test late life depress correl microstructur white matter abnorm background tradit t2 weight mr imag result non-specif extent underli white matter structur abnorm present late life depress lld diffus tensor imag provid uniqu opportun investig extent natur structur injuri limit examin subset region interest roi confound common studi elderli popul includ comorbid vascular patholog furthermor comprehens correl diffus tensor imag dti measur includ axial radial diffus measur demonstr late life depress popul method 51 depress 16 non-depress age- cerebrovascular risk factor-match elderli subject underw tradit anatom t1 t2 weight imag well dti dti data skeleton use tract base spatial statist tbss region global analys perform result widespread structur abnorm within white matter detect lld group account age gender educ match cerebrovascular risk factor global t2 white matter hyperintens t2wmh region differ promin uncin cingul white matter gener character increas radial diffus age-rel chang particularli cingul bundl advanc individu lld rel control regress analysi demonstr signific correl region fraction anisotropi radial diffus five differ neuropsycholog factor score tbss analysi demonstr greater extent white matter abnorm lld respons treatment compar control conclus white matter integr compromis late life depress larg manifest increas radial diffus specif region suggest underli myelin injuri possibl mechan underli myelin injuri chronic white matter ischemia relat intrins cerebrovascular diseas region cingul bundl white matter injuri relat late life depress appear independ compound age-rel chang correl neuropsycholog test indic essenti effect white matter injuri function statu lastli respons treatment may depend extent white matter injuri suggest need intact function network',\n",
       "  'atyp antipsychot olanzapin caus weight gain target serotonin receptor 2c atyp antipsychot olanzapin often induc excess weight gain type 2 diabet howev mechan underli drug-induc metabol perturb remain poorli understood use experiment model reproduc olanzapine-induc hyperphagia obes femal c57bl/6 mice found olanzapin treatment acut increas food intak impair glucos toler alter physic activ energi expenditur mice furthermor olanzapine-induc hyperphagia weight gain blunt mice lack serotonin 2c receptor htr2c final show treatment htr2c-specif agonist lorcaserin suppress olanzapine-induc hyperphagia weight gain lorcaserin treatment also improv glucos toler olanzapine-f mice collect studi suggest olanzapin exert untoward metabol effect via antagon htr2c',\n",
       "  'case-control studi endogen steroid hormon endometri cancer background suggest identifi risk factor endometri cancer oper singl etiolog pathway i.e. exposur rel high level unoppos estrogen estrogen absenc progestin studi howev address issu directli purpos assess risk develop endometri cancer among premenopaus postmenopaus women relat circul level steroid hormon sex hormone-bind globulin shbg independ effect hormon assess adjust known risk factor method data use analysi case-control studi conduct five geograph region unit state incid case newli diagnos period june 1 1987 may 15 1990. case patient age 20-74 year match control subject age race geograph region commun control subject obtain random-digit-di procedur subject 20-64 year old file health care financ administr subject 65 year old addit control subject hysterectomi perform benign condit obtain particip center women report use exogen estrogen oral contracept within 6 month interview exclud result 68 case patient 107 control subject among premenopaus women 208 case patient 209 control subject among postmenopaus women hormon analys perform blood sampl obtain case patient hysterectomi control subject surgeri odd ratio or 95 confid interv ci estim use uncondit logist regress analysi control match variabl potenti confound p valu two-sid result high circul level androstenedion associ 3.6-fold 2.8-fold increas risk among premenopaus postmenopaus women respect adjust factor p trend .01 .001 respect risk relat hormon fraction vari menopaus statu among postmenopaus women reduc risk associ high shbg level persist adjust made obes factor 0.51 95 ci 0.27-0.95 high estron level associ increas risk 3.8 95 ci 2.2-6.6 although adjust risk factor particularli bodi mass index diminish effect 2.2 95 ci 1.2-4.4 albumin-bound estradiol e2 marker bioavail fraction also remain import risk factor adjust made factor 2.0 95 ci 1.0-3.9 contrast high concentr total free albumin-bound e2 unrel increas risk premenopaus women premenopaus postmenopaus group risk associ obes fat distribut affect adjust hormon conclus high endogen level unoppos estrogen relat increas risk endometri cancer independ risk factor inconsist common underli biolog pathway risk factor endometri cancer oper implic research focu altern endocrinolog mechan risk associ obes bodi fat distribut biolog relev increas risk associ androstenedion premenopaus postmenopaus diseas',\n",
       "  'foxo4 necessari neural differenti human embryon stem cell proteostasi critic maintain cell function proteom stabil may play import role human embryon stem cell hesc immort notabl hesc popul exhibit high assembl activ proteasom key node proteostasi network foxo4 insulin/igf-1 respons transcript factor regul proteasom activ hesc find loss foxo4 reduc potenti hesc differenti neural lineag therefor foxo4 cross evolutionari boundari link hesc function invertebr longev modul',\n",
       "  'gestat protein restrict affect trophoblast differenti whether gestat protein restrict pr affect placent develop function remain unknown test hypothesi pr affect trophoblast differenti mid-and late pregnanc rat fed 20 isocalor 6 protein diet day 1 14 18 pregnanc effect pr trophoblast differenti determin chang express marker gene trophoblast lineag day 18 pregnanc pr increas express esrrb id1 andid2 trophoblast stem cell marker decreas express ascl2 spongiotrophblast cell marker prl2c1 trophoblast giant cell marker alter express gjb3 pcdh12 glycogen cell marker junction zone jz labyrinth zone lz pr chang express prl2b1 trophoblast giant cell marker gcm1 syna syncytiotrophoblast cell marker decreas express ctsq sinusoid trophoblast giant cell marker result indic pr impair differenti trophoblast stem cell spongiotrophoblast trophoblast giant cell jz format sinusoid trophoblast giant cell lz',\n",
       "  'vitro character anti-pd-1 antibodi nivolumab bms-936558 vivo toxicolog non-human primat program death-1 pd-1 receptor serv immunolog checkpoint limit bystand tissu damag prevent develop autoimmun inflammatori respons pd-1 express activ cell downmodul t-cell effector function upon bind ligand pd-l1 pd-l2 antigen-pres cell patient cancer express pd-1 tumor-infiltr lymphocyt interact ligand tumor immun cell tumor microenviron undermin antitumor immun support rational pd-1 blockad cancer immunotherapi report detail develop character nivolumab fulli human igg4 s228p anti-pd-1 receptor-block monoclon antibodi nivolumab bind pd-1 high affin specif effect inhibit interact pd-1 ligand vitro assay demonstr abil nivolumab potent enhanc t-cell respons cytokin product mix lymphocyt reaction superantigen cytomegaloviru stimul assay vitro antibody-depend cell-medi complement-depend cytotox observ use nivolumab activ cell target nivolumab treatment induc advers immune-rel event given cynomolgu macaqu high concentr independ circul anti-nivolumab antibodi observ data provid comprehens preclin character nivolumab antitumor activ safeti demonstr human clinic trial variou solid tumor',\n",
       "  \"combin impact lifestyle-rel factor total cause-specif mortal among chines women prospect cohort studi background although cigarett smoke excess alcohol drink obes sever well-studi unhealthi lifestyle-rel factor link risk multipl chronic diseas prematur death littl known combin impact mortal outcom particular among chines non-western popul object studi quantifi overal impact lifestyle-rel factor beyond activ cigarett smoke alcohol consumpt all-caus cause-specif mortal chines women method find use data shanghai women 's health studi ongo population-bas prospect cohort studi china particip includ 71,243 women age 40 70 year enrol 1996-2000 never smoke drank alcohol regularli healthi lifestyl score creat basi five lifestyle-rel factor shown independ associ mortal outcom normal weight lower waist-hip ratio daili exercis never expos spous 's smoke higher daili fruit veget intak score rang zero least healthi five healthi point averag follow-up 9 year 2,860 death occur includ 775 cardiovascular diseas cvd 1,351 cancer adjust hazard ratio mortal decreas progress increas number healthi lifestyl factor compar women score zero hazard ratio 95 confid interv women four five factor 0.57 0.44-0.74 total mortal 0.29 0.16-0.54 cvd mortal 0.76 0.54-1.06 cancer mortal invers associ healthi lifestyl score mortal seen consist regardless chronic diseas statu baselin popul attribut risk 4-5 healthi lifestyl factor 33 total death 59 cvd death 19 cancer death conclus first studi knowledg quantifi combin impact lifestyle-rel factor mortal outcom chines women healthier lifestyl pattern-includ normal weight lower central adipos particip physic activ nonexposur spousal smoke higher fruit veget intake-wa associ reduct total cause-specif mortal among lifetim nonsmok nondrink women support import overal lifestyl modif diseas prevent pleas see later articl editor summari\",\n",
       "  'aptamer-function lipid nanoparticl target osteoblast novel rna interference–bas bone anabol strategi current major concern safeti efficaci rna interfer rnai -base bone anabol strategi still exist lack direct osteoblast-specif deliveri system osteogen sirna screen aptam ch6 cell-selex specif target rat human osteoblast develop ch6 aptamer–function lipid nanoparticl lnp encapsul osteogen pleckstrin homolog domain-contain famili member 1 plekho1 sirna ch6-lnps-sirna result show ch6 facilit vitro osteoblast-select uptak plekho1 sirna mainli via macropinocytosi boost vivo osteoblast-specif plekho1 gene silenc promot bone format improv bone microarchitectur increas bone mass enhanc mechan properti osteopen healthi rodent result indic osteoblast-specif aptamer-function lnp could act new rnai-bas bone anabol strategi advanc target deliveri select osteogen sirna tissu level cellular level',\n",
       "  'high abund plasma cell secret transglutaminas 2–specif iga autoantibodi limit somat hypermut celiac diseas intestin lesion celiac diseas immune-medi disord mucos autoantibodi enzym transglutaminas 2 tg2 gener respons exogen antigen gluten individu express human leukocyt antigen hla-dq2 hla-dq8 ref 3 assess comprehens nonbias manner iga anti-tg2 respons express clone antibodi repertoir ex vivo–isol intestin antibody-secret cell asc found tg2-specif plasma cell markedli expand within duoden mucosa individu activ celiac diseas tg2-specif antibodi high affin yet show littl adapt somat mutat unlik infection-induc peripher blood plasmablast tg2-specif asc recent prolifer short-liv ex vivo altogeth observ demonstr germlin repertoir high affin tg2 may favor massiv gener autoreact b cell tg2-specif antibodi block enzymat activ serv substrat tg2-mediat crosslink express igd igm iga1 igg1 could result preferenti recruit plasma cell naiv igd- igm-express b cell thu possibl explain antibodi respons tg2 bear sign primari immun respons despit diseas chronic',\n",
       "  'alter white matter integr adult major depress disord magnet reson imag studi object purpos studi investig alter white matter integr adult major depress disord mdd use magnet reson imag mri method perform diffus tensor imag 3t mri scanner 45 patient major depress 45 healthi control match age sex educ use voxel-bas analysi measur fraction anisotropi fa investig differ patient control group examin correl microstructur abnorm white matter symptom sever age ill onset cumul ill durat respect result found signific decreas fa left hemispher includ anterior limb intern capsul inferior pariet portion superior longitudin fasciculu patient mdd compar healthi control diffus tensor imag measur left anterior limb intern capsul neg relat sever depress symptom even control age sex conclus find provid new evid microstructur chang white matter non-late-onset adult depress result complement observ late-lif depress support hypothesi disrupt cortical- subcort circuit integr may involv etiolog major depress disord',\n",
       "  \"clinic studi therapeut effect acupunctur treatment post-strok depress object observ therapeut effect `` xingnao kaiqiao zhenfa '' acupunctur techniqu restor conscious treatment post-strok depress method total 256 stroke patient divid acupunctur group n 180 male 138 femal 42 medic group n 76 male 57 femal 19 accord visit sequenc hospit acupoint use neiguan pc 6 renzhong gv 26 baihui gv 20 yintang ex-hn 3 sanyinjiao sp 6 affect side needl retain 20 min everi time patient medic group ask take amitriptylin 50 mg/d first 200 mg/d acupunctur treatment conduct twice daili one month 's treatment therapeut effect evalu self-rat depress scale sd hamilton rate scale depress hrsd use assess patient 's state depress result treatment 180 76 case acupunctur medic group 31 17.2 13 17.1 cure 73 40.6 18 23.7 mark improv depress state 27 15.0 12 15.8 improv 49 27.2 33 43.4 fail effect rate 72.8 56.6 respect markedli effect rate total effect rate acupunctur group significantli higher medic group p 0.05 treatment total score sd hrsd sever index two group decreas pronouncedli comparison individu pre-treat therapeut effect acupunctur group significantli better medic group reduc sd hrsd sever index p 0 .05 addit decreas valu depress pessimist mood irrit acupunctur group bigger medic group p 0.05 signific differ found two group decreas valu insomnia p 0.05 conclus `` acupunctur techniqu restor conscious '' effect improv depress patient symptom therapeut effect acupunctur markedli superior medic post-strok patient\",\n",
       "  '30 year nf-κb blossom relev human pathobiolog nf-κb discov 30 year ago rapidli induc transcript factor sinc time found broad role gene induct divers cellular respons particularli throughout immun system summar elabor regulatori pathway involv transcript factor use recent discoveri human genet diseas place specif protein within relev medic biolog context',\n",
       "  'increas gene express brown fat uncoupl protein ucp 1 skelet muscl ucp2 ucp3 mac16-induc cancer cachexia weight loss cancer cachexia attribut decreas food intak and/or enhanc energi expenditur investig role uncoupl protein ucp ucpi -2 -3 murin model cachexia mac16 adenocarcinoma weight fell 24 non-tumor-bear control p 0.01 18 day mac16 inocul signific reduct fat-pad mass -67 p 0.01 muscl mass -20 p 0.01 food intak 26-60 lower p 0.01 control day 17-18. non-tumor-bear mice pair-f match mac16-induc hypophagia show less weight loss 10 control p 0.01 16 mac-16 p 0.01 smaller decreas fat-pad mass 21 control p 0.01 core temperatur mac16 mice significantli lower -2.4 degre c p 0.01 control pair-feed effect mac16 mice show significantli higher ucp1 mrna level brown adipos tissu bat control +63 p 0.01 pair-feed effect ucp2 -3 express bat differ significantli group contrast ucp2 mrna level skelet muscl compar increas mac16 pair-f group respect 183 163 control p 0.05 signific differ two group similarli ucp3 mrna significantli higher control mac16 +163 p 0.05 pair-f +253 p 0.01 group signific differ two experiment group overexpress ucp1 bat mac16-bear mice may adapt respons hypothermia appar induc tumor product increas thermogenesi bat could increas total energi expenditur thu contribut tissu wast increas ucp2 -3 express muscl attribut reduc food intak may involv lipid util lipolysi mac16-induc cachexia',\n",
       "  'vitro anti-tumor effect statin head neck squamou cell carcinoma systemat review background statin commonli use arteriosclerot diseas recent retrospect analys suggest statin also prevent cancer aim systemat review verifi vitro anti-tumor effect statin head neck squamou cell carcinoma method studi gather search cochran medlin embas lilac pubm may 9 2015 time languag restrict vitro studi discuss effect statin head neck carcinoma select result 153 identifi paper 14 studi met inclus criteria studi demonstr statin signific effect head neck squamou cell carcinoma cell line influenc cell viabil cell cycl cell death protein express level involv pathway carcinogenesi corrobor potenti vitro anti-tumor effect provid highlight biolog mechan statin use alon associ tradit therapi cancer conclus though studi topic current avail evid suggest statin show preclin experi support potenti statin adjuv agent chemotherapi and/or radiotherapi approach routin use manag hnscc undergo clinic assess',\n",
       "  \"circul mitochondri dna patient icu marker mortal deriv valid background mitochondri dna mtdna critic activ inflamm innat immun system howev mtdna level test role biomark intens care unit icu hypothes circul cell-fre mtdna level would associ mortal improv risk predict icu patient method find analys mtdna level perform blood sampl obtain two prospect observ cohort studi icu patient brigham women 's hospit registri critic ill bwh roci n 200 molecular epidemiolog acut respiratori distress syndrom ard n 243 mtdna level plasma assess measur copi number nadh dehydrogenas 1 gene use quantit real-tim pcr medic icu patient elev mtdna level ≥3,200 copies/µl plasma increas odd die within 28 icu admiss bwh roci odd ratio 7.5 95 ci 3.6-15.8 p 1×10 -7 ard 8.4 95 ci 2.9-24.2 p 9×10 -5 cohort evid associ note non-med icu patient addit elev mtdna level improv net reclassif index nri 28-d mortal among medic icu patient ad clinic model bwh roci nri 79 standard error 14 p 1×10 -4 ard nri 55 standard error 20 p 0.007 cohort bwh roci cohort elev mtdna level increas risk death even analys limit patient sepsi acut respiratori distress syndrom studi limit includ lack data elucid concis patholog role mtdna patient limit number measur biomark conclus increas mtdna level associ icu mortal inclus mtdna level improv risk predict medic icu patient data suggest mtdna could serv viabl plasma biomark medic icu patient\",\n",
       "  'fructosamin use indic hyperglycaemia glucos control clinic epidemiolog studi – cross-sect longitudin experi amori cohort context fructosamin glycem biomark may use indic control diabet respect object object studi evalu fructosamin indic hyperglycaemia glucos control subject diabet design set patient amori cohort subject serum glucos fructosamin hba1c examin studi cross-sect longitudin n 10,987 5,590 overnight-fast guidelin american diabet associ follow classif prediabet diabet separ analys perform patient newli detect known diagnosi type 1 type 2 diabet respect result three biomark strongli correl regard associ fructosamin hba1c pearson linear correl coeffici rang 0.67-0.75 observ fast non-fast subject type 1 type 2 diabet analys glucos control fast patient type 2 diabet three biomark measur three separ occas within averag 290 day index examin show similar trend time glucos fructosamin hba1c discrimin subject without diabet across rang fructosamin level good area curv auc 0.91-0.95 fructosamin level 2.5 mmol/l classifi subject diabet sensit 61 specif 97 conclus fructosamin close associ hba1c glucos respect may use biomark hyperglycaemia glucos control clinic epidemiolog studi',\n",
       "  'lifeact versatil marker visual f-actin live imag actin cytoskeleton crucial studi mani fundament biolog process current approach visual actin sever limit describ lifeact 17-amino-acid peptid stain filament actin f-actin structur eukaryot cell tissu lifeact interfer actin dynam vitro vivo chemic modifi peptid form allow visual actin dynam nontransfect cell',\n",
       "  \"robust random forest-bas gene select method gene select import part microarray data analysi provid inform lead better mechanist understand investig phenomenon time gene select difficult noisi natur microarray data consequ gene select often perform machin learn method random forest method particularli well suit purpos work four state-of-the-art random forest-bas featur select method compar gene select context analysi focus stabil select although necessari determin signific result often ignor similar studi comparison post-select accuraci valid random forest classifi reveal investig method equival context howev method substanti differ respect number select gene stabil select analys method boruta algorithm predict gene potenti import post-select classifi error rate frequent use measur found potenti decept measur gene select qualiti number consist select gene consid boruta algorithm clearli best although also comput intens method boruta algorithm 's comput demand could reduc level compar algorithm replac random forest import compar measur random fern similar simplifi classifi despit design assumpt minim optim select method found select high fraction fals posit\",\n",
       "  'improv variant discoveri local re-align short-read next-gener sequenc data use srma primari compon next-gener sequenc analysi align short read refer genom read align independ howev read observ non-refer dna sequenc highli correl use better model true variat target genom novel short-read micro realign srma leverag correl better resolv consensu underli dna sequenc target genom describ',\n",
       "  'function element within dynein microtubule-bind domain dynein interact microtubul atp-sensit linkag map structur complex region heavi chain follow fourth p-loop motif virtual noth known regard bind affin achiev modul atp hydrolysi perform detail dissect microtubul contact site use fragment express alanin substitut peptid competit work identifi three cluster amino acid import physic contact microtubul two fall within region share sequenc homolog map1b third region downstream amino acid substitut within one region elimin weaken microtubul bind kk3379 80 e3385 k3387 k3397 kk3410,11 w3414 rkk3418-20 f3426 r3464 s3466 k3467 suggest activ highli coordin peptid activ displac map1b microtubul perturb dynein bind support previou evid similar site interact also identifi four amino acid whose substitut affect releas motor microtubul e3413 r3444 e3460 c3469 suggest nucleotide-sensit affin may local control site contact work first detail descript dynein-tubulin interact provid framework understand affin achiev modul',\n",
       "  'transcript factor egr2 egr3 essenti control inflamm antigen-induc prolifer b cell lymphocyt provid optim respons pathogen minim inflammatori patholog howev intrins mechan regul respons unknown report delet transcript factor egr2 egr3 lymphocyt result lethal autoimmun syndrom excess serum proinflammatori cytokin also impair antigen receptor-induc prolifer b cell egr2- egr3-defect b cell hyperact signal transduc activ transcription-1 stat1 stat3 antigen receptor-induc activ transcript factor ap-1 sever impair discov egr2 and/or egr3 directli induc express suppressor cytokin signaling-1 socs1 socs3 inhibitor stat1 stat3 also block function batf ap-1 inhibitor b cell thu egr2 egr3 regul b cell function adapt immun respons homeostasi promot antigen receptor signal control inflamm',\n",
       "  'effect hyperosmol alkalin phosphatas stress-respons protein 27 mcf-7 breast cancer cell mcf-7 continu cell line deriv human breast carcinoma exhibit low alkalin phosphatas alp activ enzym heat-stabl inhibit l-phenylalanin l-phenylalanylgly-cylglycin l-homoarginin 1-bromotetramisol levamisol data indic mcf-7 produc term-placent alp oncodevelopment enzym form inappropri express varieti human tumor contrast human cancer cell produc enzym monophenotyp alp activ mcf-7 cell significantli increas glucocorticoid sodium butyr comparison exposur hyperosmol caus strike increas enzym activ cycloheximid block effect result obtain cell-fre assay confirm cytochem immunocytochem assay whole cell agent test enzym modul experi affect cell prolifer possibl effect two stress-respons protein srp 27 srp 72 also examin specif immunocytochem assay use test reveal neither protein affect glucocorticoid sodium butyr effect srp 27 alter intracellular distribut srp 72 hyperosmol significantli affect srp 72 caus increas srp 27',\n",
       "  'bile acid chenodeoxychol acid increas human brown adipos tissu activ interest brown adipos tissu bat target combat metabol diseas recent renew discoveri function bat human rodent bat activ bile acid activ type 2 iodothyronin deiodinas d2 bat via g-coupl protein receptor tgr5 result increas oxygen consumpt energi expenditur examin effect oral supplement bile acid chenodeoxychol acid cdca human bat activ treatment 12 healthi femal subject cdca 2 day result increas bat activ whole-bodi energi expenditur also increas upon cdca treatment vitro treatment primari human brown adipocyt deriv cdca specif tgr5 agonist increas mitochondri uncoupl d2 express effect absent human primari white adipocyt find identifi bile acid target activ bat human',\n",
       "  'rnase h postrepl repair protect cell ribonucleotid incorpor dna chemic ident integr genom challeng incorpor ribonucleosid triphosph rntp place deoxyribonucleosid triphosph dntp replic misincorpor limit select dna replicas show accumul ribonucleosid monophosph rnmp genom caus replic stress toxic consequ particularli absenc rnase h1 rnase h2 remov rnmp demonstr postrepl repair prr pathways-mms2-depend templat switch pol ζ-depend bypass-ar crucial toler presenc rnmp chromosom inde show pol ζ effici replic 1-4 rnmp moreov cell lack rnase h accumul mono- polyubiquityl pcna constitut activ prr find describ crucial function rnase h1 rnase h2 templat switch transles dna synthesi overcom rntp misincorpor dna replic may relev pathogenesi aicardi-goutièr syndrom',\n",
       "  \"select elimin high constitut activ chemokin bind human herpesviru 8 encod seven transmembran oncogen orf74 open read frame 74 orf74 encod human herpesviru 8 highli constitut activ seven transmembran 7tm receptor stimul angiogen chemokin e.g growth-rel oncogene-alpha inhibit angiostat chemokin e.g interferon-gamma-induc protein transgen mice express orf74 control cd2 promot develop highli vascular kaposi 's sarcoma-lik tumor target mutagenesi creat three distinct phenotyp orf74 receptor normal high constitut signal phospholipas c pathway depriv bind action chemokin obtain delet 22 amino acid n-termin extens orf74 high constitut activ select elimin stimulatori regul angiogen chemokin obtain substitut basic residu extracellular end tm-v tm-vi orf74 lack constitut activ preserv abil stimul agonist chemokin obtain introduct asp residu hydrophob presum membrane-expos face tm-ii conclud care molecular dissect select elimin either agonist invers agonist modul well high constitut activ viral encod oncogen orf74 mutant form presum use transgen anim identifi molecular mechan transform activ\",\n",
       "  'insulin-lik signal pathway affect longev reproduct caenorhabd elegan mutat daf-2 age-1 caus dramat increas longev well development arrest dauer diapaus stage caenorhabd elegan daf-2 age-1 encod compon insulin-lik signal pathway daf-2 age-1 act similar point genet epistasi pathway dauer arrest longev regul activ daf-16 gene mutat daf-16 caus dauer-defect phenotyp epistat diapaus arrest life span extens phenotyp daf-2 age-1 mutant show mutat pathway also affect fertil embryon develop weak daf-2 allel matern rescu age-1 allel caus life span extens arrest dauer stage also reduc fertil viabil find age-1 hx546 reduc matern zygot age-1 activ daf-16 mutat suppress daf-2 age-1 phenotyp includ dauer arrest life span extens reduc fertil viabil defect data show insulin signal mediat daf-2 age-1 phosphatidylinositol-3-oh kinas regul reproduct embryon develop well dauer diapaus life span daf-16 transduc signal regul fertil life span metabol insulin-lik signal pathway similar endocrin regul metabol fertil mammalian insulin signal',\n",
       "  'estim prion concentr fluid tissu quantit pmca prion proteinac infecti agent respons prion diseas detect high sensit protein misfold cyclic amplif pmca technolog describ quantit pmca procedur calcul concentr low level prion biolog sampl use procedur determin quantiti misfold prion protein prpsc brain spleen blood urin scrapie-affect hamster',\n",
       "  'posit clone apec gene autoimmun polyglandular syndrom type ap 1 also call apec autosomal-recess disord map human chromosom 21q22.3 marker d21s49 d21s171 linkag studi isol novel gene region air autoimmun regul encod protein contain motif suggest transcript factor includ two zinc-fing phd-finger motif proline-rich region three lxxll motif two mutat c→t substitut chang arg 257 cga stop codon tga a→g substitut chang ly 83 aag glu codon gag found novel gene swiss finnish apec patient arg257stop r257x predomin mutat finnish apec patient account 10/12 allel studi result indic gene respons pathogenesi apec identif gene defect apec facilit genet diagnosi potenti treatment diseas enhanc gener understand mechan underli autoimmun diseas',\n",
       "  'amp-activ protein kinas ubiquit signal pathway key role cardiovascular system amp-activ protein kinas ampk key regul cellular whole-bodi energi homeostasi act restor energi homoeostasi whenev cellular energi charg deplet last 2 decad becom appar ampk regul sever cellular function specif role cardiovascular tissu act regul cardiac metabol contractil function well promot anticontractil anti-inflammatori antiatherogen action blood vessel review discuss role ampk cardiovascular system includ molecular basi mutat ampk alter cardiac physiolog propos mechan ampk regul vascular function physiolog pathophysiolog condit',\n",
       "  'differenti trophoblast stem cell giant cell trigger p57/kip2 inhibit cdk1 activ genom endoredupl mammalian develop rare event mechan unknown first appear fibroblast growth factor 4 fgf4 depriv induc differenti trophoblast stem ts cell nonprolifer trophoblast giant tg cell requir embryo implant show ro3306 inhibit cyclin-depend protein kinas 1 cdk1 enzym requir enter mitosi induc differenti ts cell tg cell contrast ro3306 induc abort endoredupl apoptosi embryon stem cell reveal inactiv cdk1 trigger endoredupl cell program differenti polyploid cell similarli fgf4 depriv result cdk1 inhibit overexpress two cdk-specif inhibitor p57/kip2 p21/cip1 ts cell mutant reveal p57 requir trigger endoredupl inhibit cdk1 p21 suppress express checkpoint protein kinas chk1 therebi prevent induct apoptosi furthermor cdk2 -/- ts cell reveal cdk2 requir endoredupl cdk1 inhibit express p57 tg cell restrict g-phase nuclei allow cdk activ phase thu endoredupl ts cell trigger p57 inhibit cdk1 concomit suppress dna damag respons p21',\n",
       "  'atg5-independ autophagi regul mitochondri clearanc essenti ipsc reprogram success gener induc pluripot stem cell entail major metabol switch mitochondri oxid phosphoryl glycolysi reprogram process mechan metabol reprogram howev remain elus result suggest atg5-independ autophag process mediat mitochondri clearanc characterist event involv metabol switch found block autophagi canon autophagi inhibit mitochondri clearanc turn prevent ipsc induct furthermor ampk seem upstream autophag pathway target small molecul modul mitochondri clearanc metabol reprogram work reveal atg5-independ autophagi crucial establish pluripot also suggest ipsc gener tumorigenesi share similar metabol switch',\n",
       "  'mutat orai1 caus immun defici abrog crac channel function antigen stimul immun cell trigger ca2+ entri ca2+ release-activ ca2+ crac channel promot immun respons pathogen activ transcript factor nfat previous shown cell patient one form hereditari sever combin immun defici scid syndrom defect store-oper ca2+ entri crac channel function identifi genet defect patient use combin two unbias genome-wid approach modifi linkag analysi single-nucleotid polymorph array drosophila rna interfer screen design identifi regul store-oper ca2+ entri nfat nuclear import approach converg novel protein call orai1 contain four put transmembran segment scid patient homozyg singl missens mutat orai1 express wild-typ orai1 scid cell restor store-oper ca2+ influx crac current icrac propos orai1 essenti compon regul crac channel complex',\n",
       "  'estim global preval childhood underweight 1990 2015. context one key target unit nation millennium develop goal reduc preval underweight among children younger 5 year half 1990 2015. object estim trend childhood underweight geograph region world design set particip time seri studi preval underweight defin weight 2 sd mean weight age nation center health statist world health organ refer popul nation preval rate deriv global databas child growth malnutrit includ data approxim 31 million children younger 5 year particip 419 nation nutrit survey 139 countri 1965 2002. main outcom measur linear mixed-effect model use estim preval rate number underweight children region 1990 2015 calcul chang ie increas decreas valu 1990 2015. result worldwid underweight preval project declin 26.5 1990 17.6 2015 chang -34 95 confid interv ci -43 -23 develop countri preval estim decreas 1.6 0.9 chang -41 95 ci -92 343 develop region preval forecast declin 30.2 19.3 chang -36 95 ci -45 -26 africa preval underweight forecast increas 24.0 26.8 chang 12 95 ci 8 -16 asia preval estim decreas 35.1 18.5 chang -47 95 ci -58 -34 worldwid number underweight children project declin 163.8 million 1990 113.4 million 2015 chang -31 95 ci -40 -20 number project decreas subregion except subregion sub-saharan eastern middl western africa expect experi substanti increas number underweight children conclus overal improv global situat anticip howev neither world whole develop region expect achiev millennium develop goal larg due deterior situat africa subregion except northern africa expect fail meet goal',\n",
       "  \"canon wnt signal regul organ-specif assembl differenti cn vasculatur everi organ depend blood vessel oxygen nutrient vasculatur associ individu organ structur molecularli divers central nervou system cn vasculatur consist tightli seal endothelium form blood-brain barrier wherea blood vessel organ porou wnt7a wnt7b encod two wnt ligand produc neuroepithelium develop cn coincid vascular invas use genet mous model found ligand directli target vascular endothelium cn use canon wnt signal pathway promot format cns-specif differenti organ 's vasculatur\",\n",
       "  \"bone progenitor dysfunct induc myelodysplasia secondari leukemia mesenchym cell contribut 'stroma normal malign tissu specif mesenchym cell particip regulatori nich stem cell examin mesenchym osteolineag cell modul haematopoiesi show delet dicer1 specif mous osteoprogenitor matur osteoblast disrupt integr haematopoiesi myelodysplasia result acut myelogen leukaemia emerg acquir sever genet abnorm intact dicer1 examin gene express alter osteoprogenitor result dicer1 delet show reduc express sbd gene mutat schwachman-bodian-diamond syndrome-a human bone marrow failur leukaemia pre-disposit condit delet sbd mous osteoprogenitor induc bone marrow dysfunct myelodysplasia therefor perturb specif mesenchym subset stromal cell disord differenti prolifer apoptosi heterolog cell disrupt tissu homeostasi furthermor primari stromal dysfunct result secondari neoplast diseas support concept niche-induc oncogenesi\",\n",
       "  'gener diploid embryo xenopu tropicali spectacular advantag xenopu tropicali eas diploid embryo gener year round simpl administr human chorion gonadotropin investig gener mani hundr synchron embryo vitro fertil thousand embryo mate pair abil induc ovul desir facilit mani differ experi experiment embryolog molecular manipul gene product genet',\n",
       "  'oct4-induc pluripot adult neural stem cell four transcript factor oct4 sox2 klf4 c-myc induc pluripot mous human fibroblast previous describ direct reprogram adult mous neural stem cell nsc oct4 either klf4 c-myc nsc endogen express sox2 c-myc klf4 well sever intermedi reprogram marker report exogen express germline-specif transcript factor oct4 suffici gener pluripot stem cell adult mous nsc one-factor induc pluripot stem cell 1f ip similar embryon stem cell vitro vivo cell effici differenti nsc cardiomyocyt germ cell vitro also capabl teratoma format germlin transmiss vivo result demonstr oct4 requir suffici directli reprogram nsc pluripot',\n",
       "  \"get start yeast publish summari yeast saccharomyc cerevisia recogn model system repres simpl eukaryot whose genom easili manipul yeast slightli greater genet complex bacteria share mani technic advantag permit rapid progress molecular genet prokaryot virus properti make yeast particularli suitabl biolog studi includ rapid growth dispers cell eas replica plate mutant isol well-defin genet system import highli versatil dna transform system nonpathogen yeast handl littl precaut larg quantiti normal baker 's yeast commerci avail provid cheap sourc biochem studi develop dna transform made yeast particularli access gene clone genet engin techniqu structur gene correspond virtual genet trait identifi complement plasmid librari plasmid introduc yeast cell either replic molecul integr genom contrast organ integr recombin transform dna yeast proce exclus via homolog recombin clone yeast sequenc accompani foreign sequenc plasmid therefor direct specif locat genom\",\n",
       "  'pcna function molecular platform trigger cdt1 destruct prevent re-repl ubiquitin-medi proteolysi replic licens factor cdt1 cdc10-depend transcript 1 phase key mechan limit dna replic singl round per cell cycl metazoan xenopu egg extract cdt1 destroy chromatin dna replic report replication-depend proteolysi cdt1 requir interact prolifer cell nuclear antigen pcna homotrimer process factor dna polymeras cdt1 bind pcna consensu pcna-interact motif conserv cdt1 metazoan remov pcna egg extract inhibit replication-depend cdt1 destruct mutat pcna-interact motif yield stabil cdt1 protein induc re-repl ddb1 compon cul4 e3 ubiquitin ligas mediat human cdt1 proteolysi respons dna damag also requir replication-depend cdt1 destruct cdt1 ddb1 interact extract ddb1 chromatin load depend bind cdt1 pcna indic pcna dock activ pre-form cdt1–cul4ddb1 ligas complex thu pcna function platform cdt1 destruct ensur effici tempor restrict inactiv key cell-cycl regul',\n",
       "  'meiosi drosophila see believ recent mani excit advanc achiev understand drosophila meiosi due combin cytolog genet approach new techniqu permit character chromosom posit spindl format femal meiosi i. protein encod nod ncd gene two gene known need proper partit chromosom lack exchang event identifi found kinesin-lik motor effect mutat gene spindl chromosom togeth local protein yield model mechan femal meiosi i. male meiosi chromosom region respons homolog pair resolv level specif dna sequenc provid foundat elucid molecular basi meiotic pair cytolog techniqu avail drosophila also permit inroad regul sister-chromatid segreg product two gene mei-s332 ord essenti sister-chromatid cohes identifi recent addit advanc understand drosophila meiosi delin function centromer use minichromosom deriv identif sever regulatori gene meiotic cell cycl',\n",
       "  'effect physic activ cognit function older adult risk alzheim diseas random trial context mani observ studi shown physic activ reduc risk cognit declin howev evid random trial lack object determin whether physic activ reduc rate cognit declin among older adult risk design set random control trial 24-week physic activ intervent conduct 2004 2007 metropolitan perth western australia assessor cognit function blind group membership particip recruit volunt report memori problem meet criteria dementia three hundr eleven individu age 50 year older screen elig 89 elig 52 refus particip total 170 particip random 138 particip complet 18-month assess intervent particip randomli alloc educ usual care group 24-week home-bas program physic activ main outcom measur chang alzheim diseas assess scale-cognit subscal adas-cog score possibl rang 0-70 18 month result intent-to-treat analysi particip intervent group improv 0.26 point 95 confid interv -0.89 0.54 usual care group deterior 1.04 point 95 confid interv 0.32 1.82 adas-cog end intervent absolut differ outcom measur intervent control group -1.3 point 95 confid interv -2.38 -0.22 end intervent 18 month particip intervent group improv 0.73 point 95 confid interv -1.27 0.03 adas-cog usual care group improv 0.04 point 95 confid interv -0.46 0.88 word list delay recal clinic dementia rate sum box improv modestli well wherea word list total immedi recal digit symbol code verbal fluenci beck depress score medic outcom 36-item short-form physic mental compon summari chang significantli conclus studi adult subject memori impair 6-month program physic activ provid modest improv cognit 18-month follow-up period trial registr anzctr.org.au identifi actrn12605000136606',\n",
       "  \"variant 6q21 implic prdm1 etiolog therapy-induc second malign hodgkin 's lymphoma survivor pediatr hodgkin 's lymphoma risk radiat therapy–induc second malign neoplasm smn identifi two variant chromosom 6q21 associ smn survivor hodgkin 's lymphoma treat radiat therapi children adult variant compris risk locu associ decreas basal express prdm1 encod pr domain contain 1 znf domain impair induct prdm1 protein radiat exposur data suggest new gene-exposur interact may implic prdm1 etiolog radiat therapy-induc smn\",\n",
       "  \"long non-cod rna profil human lymphoid progenitor cell reveal transcript diverg b cell cell lineag elucid transcript 'landscap regul human lymphoid commit postnat life use rna sequenc assembl long non-cod transcriptom across human bone marrow thymic progenitor cell span earliest stage b lymphoid lymphoid specif 3,000 gene encod previous unknown long non-cod rna lncrna reveal analysi rare popul lymphoid commit character lncrna express pattern highli stage specif lineag specif protein-cod gene protein-cod gene co-express neighbor lncrna gene show enrich ontolog relat lymphoid differenti exquisit cell-typ specif global lncrna express pattern independ reveal new development relationship among earliest progenitor cell human bone marrow thymu\",\n",
       "  'vti famili snare protein necessari plant viabil mediat differ protein transport pathway arabidopsi genom contain famili v-snare vti11 vti12 vti13 vti11 vti12 express appreci level although two protein 60 ident complement differ transport pathway express yeast vti1 mutant vti11 identifi recent mutat gene shoot gravitrop mutant zig show vti11 zig mutant defect vascular pattern auxin transport arabidopsi t-dna insert mutant vti12 normal phenotyp nutrient-rich growth condit howev nutrient-poor condit vti12 show acceler senesc phenotyp suggest vti12 may play role plant autophagi pathway vti11 vti12 also abl substitut respect snare complex double-mut cross zig vti12 embryo lethal result suggest vti1 protein necessari plant viabil two protein partial function redund',\n",
       "  'clasp link focal adhesion-associ microtubul captur local exocytosi adhes site turnov turnov integrin-bas focal adhes fa extracellular matrix ecm essenti coordin cell movement collect migrat human keratinocyt fa assembl near lead edg grow matur result contractil forc disassembl underneath advanc cell bodi report cluster microtubule-associ clasp1 clasp2 protein around fa tempor correl fa turnov clasp ll5β also known phldb2 recruit clasp fa facilit fa disassembl clasp requir fa-associ ecm degrad matrix metalloproteas inhibit slow fa disassembl similarli clasp phldb2 ll5β deplet final clasp-medi microtubul tether fa establish fa-direct transport pathway deliveri dock local fusion exocyt vesicl near fa propos clasp coupl microtubul organ vesicl transport cell interact ecm establish local secret pathway facilit fa turnov sever cell-matrix connect',\n",
       "  'chd4 rangtp-depend map stabil microtubul regul bipolar spindl format background product gtp-bound form ran gtpase rangtp around chromosom induc spindl assembl activ nuclear local signal nl -contain protein sever nl protein identifi spindl assembl factor complex process led us search addit protein distinct role spindl assembl result identifi chromatin-remodel atpas chd4 rangtp-depend microtubul mt -associ protein map mt bind occur via region contain nl chromatin-bind domain xenopu egg extract cultur cell chd4 larg dissoci mitot chromosom partial local spindl immunodeplet chd4 egg extract significantli reduc quantiti mt produc around chromatin prevent spindl assembl chd4 rnai hela drosophila s2 cell induc defect spindl assembl chromosom align earli mitosi lead chromosom missegreg analysi egg extract hela cell reveal chd4 rangtp-depend mt stabil moreov chd4-contain nurd complex promot organ mt bipolar spindl egg extract importantli function chd4 independ chromatin remodel conclus result uncov new role chd4 map requir mt stabil involv gener spindl bipolar',\n",
       "  'myocardi muscarin receptor upregul normal respons isoproterenol denerv heart famili amyloid polyneuropathi background patient famili amyloid polyneuropathi rare hereditari form amyloidosi progress autonom neuropathi diseas usual induc heart failur associ sudden death conduct disturb increas risk complic anesthesia although cardiac sympathet denerv clearli demonstr postsynapt statu cardiac autonom nervou system remain unelucid method result twenty-on patient studi age 39+/-11 year normal coronari arteri left ventricular eject fraction 68+/-9 evalu densiti affin constant myocardi muscarin receptor pet 11 c-mqnb methylquinuclidinyl benzil specif hydrophil antagonist use cardiac beta-receptor function effici studi heart rate hr respons intraven infus isoproterenol 5 minut 2 mg atropin 5 10 15 ng/kg per minut 5 minut per step mean muscarin receptor densiti higher patient control subject b max 35.5+/-8.9 versu 26.1+/-6.7 pmol/ml p=0.003 without chang receptor affin increas hr inject atropin well mqnb lower patient compar control subject despit similar basal hr deltahr atropin 11+/-21 versu 62+/-17 p 0.001 consist parasympathet denerv increment infus isoproterenol induc similar increas hr patient control subject conclus cardiac autonom denerv famili amyloid polyneuropathi result upregul myocardi muscarin receptor without chang cardiac beta-receptor respons catecholamin',\n",
       "  '6-phosphoglucon dehydrogenas link oxid ppp lipogenesi tumor growth inhibit lkb1-ampk signal oxid pentos phosphat pathway ppp contribut tumour growth precis contribut 6-phosphoglucon dehydrogenas 6pgd third enzym pathway tumorigenesi remain unclear found suppress 6pgd decreas lipogenesi rna biosynthesi elev ro level cancer cell attenu cell prolifer tumour growth 6pgd-mediat product ribulose-5-phosph ru-5-p inhibit ampk activ disrupt activ lkb1 complex therebi activ acetyl-coa carboxylas 1 lipogenesi ru-5-p nadph thought precursor rna biosynthesi lipogenesi respect thu find provid addit link oxid ppp lipogenesi ru-5-p-depend inhibit lkb1-ampk signal moreov identifi develop 6pgd inhibitor physcion deriv s3 effect inhibit 6pgd cancer cell prolifer tumour growth nude mice xenograft without obviou toxic suggest 6pgd could anticanc target',\n",
       "  'plant nuclear rna polymeras iv mediat sirna dna methylation-depend heterochromatin format eukaryot three nuclear dna-depend rna polymeras name pol ii iii interestingli plant catalyt subunit fourth nuclear polymeras pol iv genet biochem evid indic pol iv function overlap pol ii iii nonessenti viabil howev disrupt pol iv catalyt subunit gene nrpd1 nrpd2 inhibit heterochromatin associ chromocent coincid loss cytosin methyl pericentromer 5s gene cluster atsn1 retroel loss cg cng cnn methyl pol iv mutant implic partnership pol iv methyltransferas respons rna-direct de novo methyl consist hypothesi 5s gene atsn1 sirna essenti elimin pol iv mutant data suggest pol iv help produc sirna target de novo cytosin methyl event requir facult heterochromatin format higher-ord heterochromatin associ',\n",
       "  'sema3a regul bone-mass accrual sensori innerv semaphorin 3a sema3a diffus axon chemorepel import role axon guidanc previou studi demonstr sema3a−/− mice multipl development defect due abnorm neuron innerv show mice sema3a abundantli express bone cell-bas assay show sema3a affect osteoblast differenti cell-autonom fashion accordingli sema3a−/− mice low bone mass due decreas bone format howev osteoblast-specif sema3a-defici mice sema3acol1−/− sema3aosx−/− mice normal bone mass even though express sema3a bone substanti decreas contrast mice lack sema3a neuron sema3asynapsin−/− sema3anestin−/− mice low bone mass similar sema3a−/− mice indic neuron-deriv sema3a respons observ bone abnorm independ local effect sema3a bone inde number sensori innerv trabecular bone significantli decreas sema3asynapsin−/− mice wherea sympathet innerv trabecular bone unchang moreov ablat sensori nerv decreas bone mass wild-typ mice wherea reduc low bone mass sema3anestin−/− mice support essenti role sensori nervou system normal bone homeostasi final neuron abnorm sema3a−/− mice olfactori develop identifi sema3asynasin−/− mice demonstr neuron-deriv sema3a contribut abnorm neural develop seen sema3a−/− mice indic sema3a produc neuron regul neural develop autocrin manner studi demonstr sema3a regul bone remodel indirectli modul sensori nerv develop directli act osteoblast',\n",
       "  'direct lineag reprogram strategi mechan applic direct lineag reprogram one special cell type anoth use defin factor fundament re-shap tradit concept regard epigenet stabil differenti cell rapid increas cell type gener direct convers recent year strategi becom promis approach produc function cell review recent advanc lineag reprogram includ identif novel reprogram factor underli molecular mechan strategi gener function matur cell assay character induc cell also discuss progress toward applic lineag reprogram major futur challeng strategi',\n",
       "  'converg intracrani marker consciou access compar consciou nonconsci process briefli flash word use visual mask procedur record intracrani electroencephalogram ieeg ten patient nonconsci process mask word observ multipl cortic area mostli within earli time window 300 ms accompani induc gamma-band activ without coher long-dist neural activ suggest quickli dissip feedforward wave contrast consciou process unmask word character converg four distinct neurophysiolog marker sustain voltag chang particularli prefront cortex larg increas spectral power gamma band increas long-dist phase synchroni beta rang increas long-rang granger causal argu measur provid distinct window distribut state consciou process result direct impact current theoret discuss concern neural correl consciou access',\n",
       "  'hyperglycemia associ increas bone miner densiti decreas trabecular bone score elderli japanes men fujiwara-kyo osteoporosi risk men formen studi purpos patient type 2 diabet mellitu t2dm increas fractur risk despit higher areal bone miner densiti abmd studi aim clarifi associ glycem insulin resist statu bone microarchitectur whether pentosidin bone turnov marker play role associ method total 2012 community-dwel men age ≥65year complet baselin measur spine abmd fast plasma glucos fpg serum insulin hemoglobin a1c hba1c osteocalcin type procollagen n-termin propeptid type collagen c-termin crosslink telopeptid tartrate-resist acid phosphatas isoenzym 5b pentosidin height weight interview regard past diseas histori homeostasi model assessment-insulin resist homa-ir also calcul t2dm defin physician-diagnos middl age elderly-onset diabet mellitu accord biochem test result evalu bone microarchitectur trabecular bone score tb calcul vertebra use abmd measur result exclud particip diseas histori and/or take medic affect bone metabol 1683 men age 72.9±5.2year analyz men t2dm significantli higher abmd compar without t2dm signific differ tb howev fpg hba1c homa-ir level significantli invers correl tb adjust age bmi abmd multivari linear regress analys reveal glycem indic fpg hba1c significantli associ increas abmd decreas tb homa-ir associ tb associ chang adjust bone turnov maker pentosidin level conclus hyperglycemia elev insulin-resist associ low tb independ bone turnov pentosidin level',\n",
       "  'matrix remodel promot pulmonari hypertens feedback mechanoactiv yap/taz-mir-130/301 circuit pulmonari hypertens ph deadli vascular diseas enigmat molecular origin found vascular extracellular matrix ecm remodel stiffen earli pervas process promot ph multipl pulmonari vascular cell type ecm stiffen induc microrna-130/301 famili via activ co-transcript factor yap taz microrna-130/301 control ppar -apoe-lrp8 axi promot collagen deposit lox-depend remodel upregul yap/taz via mechanoact feedback loop turn ecm remodel control pulmonari vascular cell crosstalk via mechanotransduct modul secret vasoact effector regul associ microrna pathway vivo pharmacolog inhibit microrna-130/301 apo lox activ amelior ecm remodel ph thu ecm remodel control yap/taz-mir-130/301 feedback circuit earli ph trigger offer combinatori therapeut target devast diseas',\n",
       "  'exosom transfer stroma-deriv mir21 confer paclitaxel resist ovarian cancer cell target apaf1 advanc ovarian cancer usual spread viscer adipos tissu omentum howev oment stromal cell-deriv molecular determin modul ovarian cancer growth character use next-gener sequenc technolog identifi significantli higher level microrna-21 mir21 isomirna exosom tissu lysat isol cancer-associ adipocyt caa fibroblast caf ovarian cancer cell function studi reveal mir21 transfer caa caf cancer cell suppress ovarian cancer apoptosi confer chemoresist bind direct novel target apaf1 data suggest malign phenotyp metastat ovarian cancer cell alter mir21 deliv exosom deriv neighbour stromal cell oment tumour microenviron inhibit transfer stromal-deriv mir21 altern modal treatment metastat recurr ovarian cancer',\n",
       "  \"age-rel chang kynuren acid product rat brain two separ vitro assay use examin biosynthesi broad spectrum excitatori amino acid receptor antagonist kynuren acid kyna life span adult rat assess kyna 's anabol enzym kynurenin aminotransferas reveal steadi increas 3 24 month age five brain region examin chang observ liver chang particularli pronounc cortex striatum enzym activ increas three-fold period studi kyna product bioprecursor l-kynurenin also investig tissu slice found significantli enhanc cortex hippocampu old anim effect depolar agent sodium replac virtual ident tissu young old rat data excel agreement report age-depend increas kyna concentr brain tissu suggest enhanc kyna tone age brain togeth report declin cerebr excitatori amino acid receptor densiti age increas product kyna may play role cognit memori dysfunct old anim\",\n",
       "  'polycomb group protein suz12 requir embryon stem cell differenti polycomb group pcg protein form multiprotein complex call polycomb repress complex prc prc2 contain pcg protein ezh2 suz12 eed repress transcript methyl lysin k 27 histon h3 h3 suz12 essenti prc2 activ inactiv result earli lethal mous embryo demonstr suz12 -/- mous embryon stem es cell establish expand tissu cultur suz12 -/- es cell character global loss h3k27 trimethyl h3k27me3 higher express level differentiation-specif gene moreov suz12 -/- es cell impair proper differenti result lack repress es cell marker well activ differentiation-specif gene final demonstr pcg activ recruit sever gene es cell differenti despit increas h3k27me3 level alway suffici prevent transcript activ summari demonstr suz12 requir establish specif express program requir es cell differenti furthermor provid evid pcg differ mechan regul transcript cellular differenti',\n",
       "  '1.9 structur proteasome-11 activ complex implic proteasome-pan/pa700 interact proteasom cylindr structur function multipl cellular process degrad wide varieti cytosol nuclear protein substrat access product releas enclos catalyt chamber occur axial pore open activ complex report high-resolut structur wild-typ mutant archaeal proteasom bound activ pa26 structur support propos order open conform requir proteolysi format trigger outward displac surround residu structur associ biochem assay reveal mechan bind involv interact pa26 c terminu conserv lysin surprisingli biochem observ implic equival interact unrel atp-depend activ pan pa700',\n",
       "  'innat immun chemic trigger oxid stress modifi translat fidel translat fidel essenti protein cell function requir accur transfer rna trna aminoacyl purifi aminoacyl-trna synthetas exhibit fidel one error per 10,000 100,000 coupl accuraci trna aminoacyl vivo uncertain howev might consider lower show mammalian cell approxim 1 methionin met residu use protein synthesi aminoacyl non-methionyl-trna remark met-misacyl increas tenfold upon expos cell live non-infecti virus toll-lik receptor ligand chemic induc oxid stress met misacyl specif non-methionyl-trna famili met-misacyl trna use translat met-misacyl block inhibitor cellular oxidas implic reactiv oxygen speci ro misacyl trigger among six amino acid test trna misacyl occur exclus met met residu known protect protein ros-medi damag propos met-misacyl function adapt increas met incorpor protein protect cell oxid stress demonstr unexpect condit aspect decod mrna find illustr import consid altern iter genet code',\n",
       "  'yeast sirtuin regul age sirtuin phylogenet conserv famili nad -depend protein deacetylas consum one molecul nad everi deacetyl lysin side chain requir nad potenti make prone regul fluctuat nad biosynthesi intermedi thu link cellular metabol sir2 protein saccharomyc cerevisia found sirtuin famili member well character histon deacetylas function transcript silenc heterochromatin domain pro-longev factor replic life span rl defin number time mother cell divid bud senesc delet sir2 shorten rl increas gene dosag caus extens furthermor sir2 implic mediat benefici effect calor restrict cr life span yeast also higher eukaryot paradigm share disagr debat also help rapidli drive age research field forward s. cerevisia four addit sirtuin hst1 hst2 hst3 hst4 review discuss function sir2 hst homolog replic age chronolog age also address sirtuin regul respons environment stress cr',\n",
       "  'effect combin treatment aliskiren blocker renin-angiotensin system hyperkalaemia acut kidney injuri systemat review meta-analysi object examin safeti use aliskiren combin agent use block renin-angiotensin system design systemat review meta-analysi randomis control trial data sourc medlin embas cochran librari two trial registri publish 7 may 2011. studi select publish unpublish randomis control trial compar combin treatment use aliskiren angiotensin convert enzym inhibitor angiotensin receptor blocker monotherapi use agent least four week provid numer data advers event outcom hyperkalaemia acut kidney injuri random effect model use calcul pool risk ratio 95 confid interv outcom result 10 randomis control studi 4814 particip includ analysi combin therapi aliskiren angiotensin convert enzym inhibitor angiotensin receptor blocker significantli increas risk hyperkalaemia compar monotherapi use angiotensin convert enzym angiotensin receptor blocker rel risk 1.58 95 confid interv 1.24 2.02 aliskiren alon 1.67 1.01 2.79 risk acut kidney injuri differ significantli combin therapi monotherapi group 1.14 0.68 1.89 conclus use aliskerin combin angiotensin convert enzym inhibitor angiotensin receptor blocker associ increas risk hyperkalaemia combin use agent warrant care monitor serum potassium level',\n",
       "  'in out dna transfer bacteria transform conjug permit passag dna bacteri membran repres domin mode transfer genet inform bacteri cell bacteri eukaryot cell respons spread fitness-enhanc trait includ antibiot resist process usual involv recognit double-strand dna follow transfer singl strand elabor molecular machin respons negoti passag macromolecular dna layer cell surfac nearli machin compon involv transform conjug identifi present model role dna transport',\n",
       "  'synapt island defin territori singl astrocyt mammalian brain astrocyt modul neuron function part synchron neuron fire coordin synapt network littl howev known accomplish structur standpoint investig structur basi astrocyte-medi neuron synchroni synapt coordin three-dimension relationship cortic astrocyt neuron investig use transgen viral approach label astrocyt enhanc green fluoresc protein perform three-dimension reconstruct astrocyt tissu section live anim vivo found cortic astrocyt occupi nonoverlap territori similar describ hippocampu use immunofluoresc label neuron somata singl astrocyt enwrap averag four neuron somata upper limit eight single-neuron dye-fil allow us estim one astrocyt contact 300-600 neuron dendrit togeth recent find show glial ca2+ signal restrict individu astrocyt vivo ca2+ signal lead gliotransmiss propos concept function island synaps group synaps confin within boundari individu astrocyt modul gliotransmitt environ control astrocyt descript offer new structur base conceptu framework evalu function data involv interact neuron astrocyt mammalian brain',\n",
       "  'role dna methyl epigenet silenc hand2 endometri cancer develop background endometri cancer incid continu rise wake current age obes epidem much risk endometri cancer develop influenc environ lifestyl accumul evid suggest epigenom serv interfac genom environ hypermethyl stem cell polycomb group target gene epigenet hallmark cancer object studi determin function role epigenet factor endometri cancer develop method find epigenome-wid methyl analysi 27,000 cpg site endometri cancer tissu sampl n 64 control sampl n 23 reveal hand2 gene encod transcript factor express endometri stroma one commonli hypermethyl silenc gene endometri cancer novel integr epigenome-transcriptome-interactom analysi reveal hand2 hub highli rank differenti methyl hotspot endometri cancer find valid use candid gene methyl analysi multipl clinic sampl set tissu sampl total 272 addit women increas hand2 methyl featur premalign endometri lesion seen parallel decreas rna protein level furthermor women high endometri hand2 methyl premalign lesion less like respond progesteron treatment hand2 methyl analysi endometri secret collect use high vagin swab taken women postmenopaus bleed specif identifi patient earli stage endometri cancer high sensit high specif receiv oper characterist area curv 0.91 stage 1a 0.97 higher stage 1a final mice harbour hand2 knock-out specif endometrium shown develop precancer endometri lesion increas age lesion also demonstr lack pten express conclus hand2 methyl common crucial molecular alter endometri cancer could potenti employ biomark earli detect endometri cancer predictor treatment respons true clinic util hand2 dna methyl howev requir valid prospect studi pleas see later articl editor summari',\n",
       "  'socioeconom factor materi inequ perceiv control self-rat health cross-sect data seven post-communist countri studi examin associ perceiv control sever socioeconom variabl self-rat health seven post-communist countri russia estonia lithuania latvia hungari poland czech republ questionnair interview use collect data self-rat health last 12 month educ marit statu perceiv control base nine question materi depriv base avail food cloth heat popul two ecolog measur materi inequ avail inequ score estim survey data distanc 90th 10th percentil materi depriv gini coeffici publish sourc data 5330 men women age 20-60 analys preval poor health wors averag vari 8 czech 19 hungarian age-sex-adjust odd ratio univers vs primari educ 0.36 0.26-0.49 odd ratio per 1 standard deviat increas perceiv control materi depriv 0.58 95 ci 0.48-0.69 1.51 1.40-1.63 respect odd ratio increas inequ equival differ least unequ popul 1.49 0.88-2.52 use materi inequ score 1.41 0.91-2.20 use gini coeffici indic effect either inequ measur seen adjust individu depriv perceiv control result suggest western popul educ materi depriv strongli relat self-rat health perceiv control appear statist mediat effect materi depriv non-signific effect ecolog measur inequ elimin control individu characterist',\n",
       "  'integrin αvβ3/c-src “ oncogen unit ” promot anchorage-independ tumor progress integrin regul adhesion-depend growth surviv invas tumor cell particular express integrin alpha v beta 3 associ progress varieti human tumor reveal previous undescrib adhesion-independ role integrin alpha v beta 3 pancreat cancer carcinoma specif alpha v beta 3 express carcinoma cell enhanc anchorage-independ tumor growth vitro increas lymph node metastas vivo effect requir recruit c-src beta 3 integrin cytoplasm tail lead c-src activ crk-associ substrat ca phosphoryl tumor cell surviv unexpectedli independ cell adhes focal adhes kinas fak activ pharmacolog blockad c-src kinas activ decreas express endogen alpha v beta 3 integrin c-src inhibit anchorage-independ growth also suppress metastasi vivo yet manipul affect tumor cell migrat invas data defin unexpect role integrin mediat anchorag independ suggest alpha v beta 3 -c-src signal modul may account aggress behavior integrin alpha v beta 3 -express tumor human',\n",
       "  'genomewid analysi prc1 prc2 occup identifi two class bival domain embryon stem es cell bival chromatin domain overlap repress h3 lysin 27 tri-methyl activ h3 lysin 4 tri-methyl histon modif mark promot 2,000 gene gain insight structur function bival domain map key histon modif subunit polycomb-repress complex 1 2 prc1 prc2 genomewid human mous es cell chromatin immunoprecipit follow ultra high-throughput sequenc find bival domain segreg two class -- first occupi prc2 prc1 prc1-posit second specif bound prc2 prc2-onli prc1-posit bival domain appear function distinct effici retain lysin 27 tri-methyl upon differenti show stringent conserv chromatin state associ overwhelm number development regul gene promot also use comput genom search sequenc determin polycomb bind analysi reveal genomewid locat prc2 prc1 larg predict locat size underli motif content cpg island propos larg cpg island deplet activ motif confer epigenet memori recruit full repertoir polycomb complex pluripot cell',\n",
       "  \"spatiotempor regul epithelial-mesenchym transit essenti squamou cell carcinoma metastasi epithelial-mesenchym transit emt implic convert stationari epitheli tumor cell motil mesenchym cell metastasi howev involv emt metastasi still controversi due lack mesenchym phenotyp human carcinoma metastas use spontan squamou cell carcinoma mous model show activ emt-induc transcript factor twist1 suffici promot carcinoma cell undergo emt dissemin blood circul importantli distant site turn twist1 allow revers emt essenti dissemin tumor cell prolifer form metastas studi demonstr vivo requir `` revers emt '' tumor metastasi may resolv controversi import emt carcinoma metastasi\",\n",
       "  'control apoptosi asymmetr cell divis asymmetr cell divis apoptosi program cell death two fundament process import develop function multicellular organ found process asymmetr cell divis apoptosi function link specif show asymmetr cell divis nematod caenorhabd elegan mediat pathway involv three gene dnj-11 mida1 ces-2 hlf ces-1 snail directli control enzymat machineri respons apoptosi interestingli mida1-lik protein glsa alga volvox carteri well snail-rel protein snail escargot worniu drosophila melanogast previous implic asymmetr cell divis therefor c. elegan dnj-11 mida1 ces-2 hlf ces-1 snail may compon pathway involv asymmetr cell divis conserv throughout plant anim kingdom furthermor base result propos pathway directli control apoptot fate c. elegan possibl anim well',\n",
       "  'cxcr2 mediat nadph oxidase–independ neutrophil extracellular trap format cystic fibrosi airway inflamm upon activ neutrophil releas dna fiber decor antimicrobi protein form neutrophil extracellular trap net although net bactericid contribut innat host defens excess net format link pathogenesi autoinflammatori diseas howev mechan regul net format particularli chronic inflamm poorli understood show g protein–coupl receptor gpcr cxcr2 mediat net format downstream analys show cxcr2-mediat net format independ nadph oxidas involv src famili kinas show pathophysiolog relev mechan cystic fibrosi lung diseas character chronic neutrophil inflamm found abund net airway fluid individu cystic fibrosi mous cystic fibrosi lung diseas net amount correl impair obstruct lung function pulmonari blockad cxcr2 intra-airway deliveri small-molecul antagonist inhibit net format improv lung function vivo without affect neutrophil recruit proteolyt activ antibacteri host defens studi establish cxcr2 receptor mediat nadph oxidase–independ net format provid evid gpcr pathway oper druggabl cystic fibrosi lung diseas',\n",
       "  'model impact artemisinin combin therapi long-act treatment malaria transmiss intens background artemisinin deriv use recent introduc combin therapi act plasmodium falciparum malaria significantli lower patient infecti potenti reduc population-level transmiss parasit increas interest malaria elimin understand impact transmiss act antimalari drug differ pharmacodynam becom key issu studi estim reduct transmiss may achiev introduc differ type treatment symptomat p. falciparum malaria endem area method find develop mathemat model predict potenti impact transmiss outcom introduc act first-lin treatment uncompl malaria six area vari transmiss intens tanzania also estim impact could achiev antimalari differ efficaci prophylact time gametocytocid effect rate treatment asymptomat infect symptomat infect six studi area estim use model togeth data cross-sect survey 5,667 individu conduct prior polici chang sulfadoxine-pyrimethamin act effect act drug type gametocytaemia infecti mosquito independ estim clinic trial data predict percentag reduct preval infect incid clinic episod achiev act highest area low initi transmiss 53 reduct preval infect seen 100 current treatment switch act area baselin slide-preval parasitaemia lowest 3.7 compar 11 reduct highest-transmiss set baselin slide preval 57.1 estim percentag reduct incid clinic episod similar absolut size public health impact howev greater highest-transmiss area 54 clinic episod per 100 person per year avert compar five per 100 person per year lowest-transmiss area high coverag import reduc presumpt treatment improv diagnosi substanti reduc number treatment cours requir per clinic episod avert lower-transmiss set although loss overal impact transmiss efficaci antimalari regimen specif gametocytocid properti long prophylact time estim effect reduc transmiss short-act act highest-transmiss set conclus result suggest act potenti transmiss reduct approach achiev insecticide-tr net lower-transmiss set act partner drug nonartemisinin regimen longer prophylact time could result larger impact higher-transmiss set although long term benefit must evalu relat risk develop parasit resist',\n",
       "  'system metabol engin escherichia coli l-threonin product amino-acid produc tradit develop repeat random mutagenesi owe difficulti ration engin complex highli regul metabol network report develop genet defin l-threonin overproduc escherichia coli strain system metabol engin feedback inhibit aspartokinas iii encod thra lysc respect transcript attenu regul locat thrl remov pathway thr degrad remov delet tdh mutat ilva meta lysa gene delet make precursor avail thr biosynthesi target gene engin identifi transcriptom profil combin silico flux respons analysi express level manipul accordingli final engin e. coli strain abl produc thr high yield 0.393 g per gram glucos 82.4 g/l thr fed-batch cultur system metabol engin strategi report may broadli employ develop genet defin organ effici product variou bioproduct',\n",
       "  'associ adhd obes systemat review meta-analysi object impuls inattent relat attent deficit hyperact disord adhd may increas food intak consequ weight gain howev find associ obesity/overweight adhd mix author conduct meta-analysi estim associ method broad rang databas search aug. 31 2014. unpublish studi also obtain studi qualiti rate newcastle-ottawa scale random-effect model use result forty-two studi includ total 728,136 individu 48,161 adhd subject 679,975 comparison subject retain signific associ obes adhd found children odd ratio=1.20 95 ci=1.05-1.37 adult odd ratio=1.55 95 ci=1.32-1.81 pool preval obes increas 70 adult adhd 28.2 95 ci=22.8-34.4 compar without adhd 16.4 95 ci=13.4-19.9 40 children adhd 10.3 95 ci=7.9-13.3 compar without adhd 7.4 95 ci=5.4-10.1 signific associ adhd obes remain limit studi 1 report odd ratio adjust possibl confound factor 2 diagnos adhd direct interview 3 use directli measur height weight gender studi set studi countri studi qualiti moder associ obes adhd adhd also significantli associ overweight individu medic adhd higher risk obes conclus studi provid meta-analyt evid signific associ adhd obesity/overweight research address possibl underli mechan long-term effect adhd treatment weight individu adhd obes',\n",
       "  'amyloid-dna composit bacteri biofilm stimul autoimmun research human microbiom establish commens pathogen bacteria influenc obes cancer autoimmun mechan mostli unknown found compon bacteri biofilm amyloid protein curli irrevers form fiber bacteri dna biofilm format interact acceler amyloid polymer creat potent immunogen complex activ immun cell includ dendrit cell produc cytokin type interferon pathogen system lupu erythematosu sle given system curli-dna composit trigger immun activ product autoantibodi lupus-pron wild-typ mice also found infect lupus-pron mice curli-produc bacteria trigger higher autoantibodi titer compar curli-defici bacteria data provid mechan microbiom biofilm-produc enter infect may contribut progress sle point potenti molecular target treatment autoimmun',\n",
       "  'comprehens genom character defin human glioblastoma gene core pathway human cancer cell typic harbour multipl chromosom aberr nucleotid substitut epigenet modif drive malign transform cancer genom atla tcga pilot project aim assess valu large- scale multi- dimension analysi molecular characterist human cancer provid data rapidli research commun report interim integr analysi dna copi number gene express dna methyl aberr 206 glioblastoma common type primari adult brain cancer nucleotid sequenc aberr 91 206 glioblastoma analysi provid new insight role erbb2 nf1 tp53 uncov frequent mutat phosphatidylinositol- 3- oh kinas regulatori subunit gene pik3r1 provid network view pathway alter develop glioblastoma furthermor integr mutat dna methyl clinic treatment data reveal link mgmt promot methyl hypermut phenotyp consequ mismatch repair defici treat glioblastoma observ potenti clinic implic togeth find establish feasibl power tcga demonstr rapidli expand knowledg molecular basi cancer',\n",
       "  'ly2405319 engin fgf21 variant improv metabol statu diabet monkey fibroblast growth factor 21 fgf21 novel metabol regul repres promis target treatment sever metabol diseas administr recombin wild type fgf21 diabet anim lead dramat improv glycaemia amelior system measur metabol health report pharmacolog outcom observ non-human primat upon administr recent describ fgf21 analogu ly2405319 ly diabet rhesu monkey treat subcutan ly daili period seven week dose ly use 3 9 50 mg/kg deliv escal fashion washout measur taken 2 4 6 8 week follow final ly dose ly therapi led dramat rapid lower sever import metabol paramet includ glucos bodi weight insulin cholesterol triglycerid level dose test addit observ favor chang circul profil adipokin increas adiponectin reduc leptin indic direct fgf21 action adipos tissu importantli first time show fgf21 base therapi metabol efficaci anim late stage diabet glycem efficaci ly anim partial attenu lipid lower effect fulli preserv suggest fgf21 may viabl treatment option even patient advanc diseas progress find support continu explor fgf21 pathway treatment metabol diseas',\n",
       "  'epigenet control stem cell potenti homeostasi age diseas stem cell declin import cellular driver aging-associ pathophysiolog multipl tissu epigenet regul central establish maintain stem cell function emerg evid indic epigenet dysregul contribut alter potenti stem cell age unlik termin differenti cell impact epigenet dysregul stem cell propag beyond self alter herit transmit differenti progeni addit perpetu amplifi within stem cell pool self-renew divis review focus recent studi examin epigenet regul tissue-specif stem cell homeostasi age aging-rel diseas',\n",
       "  'host–parasit interact evolut gene express interact host parasit provid ongo sourc select promot evolut varieti featur interact speci use genet explicit mathemat model explor pattern gene express evolv genet loci respons host resist parasit infect result reveal strike yet intuit conclus gene express evolv along differ trajectori two interact speci specif host resist loci frequent evolv co-express allel wherea parasit infect loci evolv express singl allel result aris host co-express resist allel abl recogn clear greater divers parasit genotyp token parasit co-express antigen elicitor allel like recogn clear host favour express singl allel model provid testabl predict help interpret accumul data express level gene relev host−parasit interact',\n",
       "  'crucial role interleukin il -1 induct il-17–produc cell mediat autoimmun encephalomyel recent demonstr interleukin il -23–driven il-17–produc thil-17 cell mediat inflammatori patholog certain autoimmun diseas show induct antigen-specif thil-17 cell helper th 1 th2 cell immun antigen adjuv abrog il-1 receptor type i–defici il-1ri−/− mice furthermor incid experiment autoimmun encephalomyel eae significantli lower il-1ri−/− compar wild-typ mice correl failur induc autoantigen-specif thil-17 cell wherea induct th1 th2 respons substanti differ howev eae induc il-1ri−/− mice adopt transfer autoantigen-specif cell wild-typ mice eae il-23 alon induc il-17 product cell il-1ri−/− mice il-23–induc il-17 product substanti enhanc il-1α il-1β even absenc cell receptor stimul demonstr essenti role phosphatidylinositol 3-kinas nuclear factor κb novel protein kinas c isoform il-1– il-23–medi il-17 product tumor necrosi factor α also synerg il-23 enhanc il-17 product il-1 depend find demonstr il-1 function upstream il-17 promot pathogen thil-17 cell eae',\n",
       "  'aberr lumin progenitor candid target popul basal tumor develop brca1 mutat carrier basal-lik breast cancer aris women carri mutat brca1 gene encod tumor suppressor protein brca1 thought develop mammari stem cell explor earli cellular chang occur brca1 mutat carrier prospect isol distinct epitheli subpopul normal mammari tissu preneoplast specimen individu heterozyg brca1 mutat describ three epitheli subset includ basal stem/progenitor lumin progenitor matur lumin cell unexpectedli found breast tissu brca1 mutat carrier harbor expand lumin progenitor popul show factor-independ growth vitro moreov gene express profil reveal breast tissu heterozyg brca1 mutat basal breast tumor similar normal lumin progenitor cell subset includ stem cell–enrich popul c-kit tyrosin kinas receptor encod kit emerg key marker lumin progenitor cell highli express brca1-associ preneoplast tissu tumor find suggest aberr lumin progenitor popul target transform brca1-associ basal tumor',\n",
       "  'get site inflamm leukocyt adhes cascad updat neutrophil recruit lymphocyt recircul monocyt traffick requir adhes transmigr blood-vessel wall tradit three step roll activ firm adhes recent augment refin slow roll adhes strengthen intralumin crawl paracellular transcellular migrat recogn separ addit step neutrophil second activ pathway discov requir signal g-protein-coupl receptor signal step lead integrin activ begin emerg review focus new aspect one central paradigm inflamm immun — leukocyt adhes cascad',\n",
       "  \"genome-wid loss 5-hmc novel epigenet featur huntington 's diseas 5-hydroxymethylcytosin 5-hmc may repres new epigenet modif cytosin dynam 5-hmc neurodevelop recent report littl known genom distribut function neurodegen diseas huntington 's diseas hd observ mark reduct 5-hmc signal yac128 yeast artifici chromosom transgen 128 cag repeat hd mous brain tissu compar age-match wild-typ wt mice suggest defici 5-hmc reconstruct hd brain postnat develop genome-wid distribut analysi 5-hmc confirm diminish 5-hmc signal striatum cortex yac128 hd mice gener genom featur 5-hmc highli conserv affect either diseas brain region intriguingli identiﬁ disease-specif yac128 versu wt differenti hydroxymethyl region dhmr found acquisit dhmr gene bodi posit epigenet regul gene express ingenu pathway analysi ipa genotype-specif dhmr-annot gene reveal altern number canon pathway involv neuron development/differenti wnt/β-catenin/sox pathway axon guidanc signal pathway neuron function/surviv glutam receptor/calcium/creb gaba receptor signal dopamine-darpp32 feedback pathway etc could import onset hd result indic loss 5-hmc marker novel epigenet featur hd aberr epigenet regul may impair neurogenesi neuron function surviv hd brain studi also open new avenu hd treatment re-establish nativ 5-hmc landscap may potenti slow/halt progress hd\",\n",
       "  'plan postdisast resili focu articl plan resili aftermath catastroph first author offer concept plan resili goal recov commun benefit plan effort creat resili place next discuss major issu associ plan postdisast recoveri includ barrier pose feder state govern plan resili promis risk compact urban form model guid rebuild failur involv citizen plan disast final discuss lesson prior research address issu polici recommend foster predisast recoveri plan resili commun',\n",
       "  'increas stress-induc inflammatori respons male patient major depress increas earli life stress object author sought determin innat immun system activ follow psychosoci stress patient major depress increas earli life stress method plasma interleukin il -6 lymphocyt subset dna bind nuclear factor nf -kb peripher blood mononuclear cell compar medic healthi male subject current major depress increas earli life stress n=14 versu nondepress male comparison subject n=14 complet trier social stress test result trier social stress test-induc increas il-6 nf-kappab dna-bind greater major depress patient increas earli life stress independ correl depress sever earli life stress natur killer nk cell percentag also increas follow stress howev differ group correl nk cell percentag stress-induc nf-kappab dna-bind il-6 conclus male major depress patient increas earli life stress exhibit enhanc inflammatori respons psychosoci stress provid preliminari indic link major depress earli life stress advers health outcom diseas associ inflamm',\n",
       "  'kif3a/b heterodimer kinesin superfamili protein work microtubul plu end-direct motor membran organel transport clone new member murin brain kinesin superfamili kif3b found amino acid sequenc highli homolog ident kif3a previous clone name kif3 47 ident kif3b local variou organ tissu develop neuron mice accumul anterograd move membran organel ligat nerv axon immunoprecipit assay brain reveal kif3b form complex kif3a three high molecular weight approxim 100 kd -associ polypeptid call kinesin superfamily-associ protein 3 kap3 vitro reconstruct use baculoviru express system show kif3a kif3b directli bind absenc kap3 recombin kif3a/b complex approxim 50-nm rod two globular head singl globular tail demonstr plu end-direct microtubul slide activ vitro addit show kif3b motor activ vitro make complex wild-typ kif3b chimer motor protein kif3b head kif3a rod tail subcellular fraction mous brain homogen show consider amount nativ kif3 complex associ membran fraction synapt vesicl immunoprecipit anti-kif3b antibody-conjug bead electron microscop studi also reveal kif3 associ membran organel moreov found composit kap3 differ brain testi find suggest kif3b form heterodim kif3a function new microtubule-bas anterograd transloc membran organel kap3 may determin function divers kif3 complex variou kind cell vivo',\n",
       "  'genet screen identifi lkb1–mark signal axi control hippo–yap pathway hippo–yap pathway emerg signal cascad involv regul stem cell activ organ size identifi compon pathway perform rnai-bas kinom screen human cell screen identifi sever kinas previous associ hippo signal control multipl cellular process one hit lkb1 common tumour suppressor whose mechan action partial understood demonstr lkb1 act substrat microtubul affinity-regul kinas famili regul local polar determin scribbl activ core hippo kinas data also indic yap function import tumour suppress effect lkb1 result identifi signal axi link yap activ lkb1 mutat implic treatment lkb1-mutant human malign addit find provid insight upstream signal hippo–yap signal cascad',\n",
       "  'beyond melanoma inhibit pd-1/pd-l1 pathway solid tumor immun checkpoint inhibitor identifi breakthrough treatment melanoma given dramat respons pd-1/pd-l1 blockad like extend mani cancer hundr clinic trial conduct propos use excit modal therapi varieti malign immun checkpoint inhibitor extens studi melanoma recent lung cancer littl known regard immun checkpoint blockad cancer review focu tumor immun microenviron express pd-1/pd-l1 effect immun modul use pd-1 pd-l1 inhibitor patient head neck prostat urotheli renal breast gastrointestin lung cancer',\n",
       "  'partit symptom hypoglycaemia use multi-sampl confirmatori factor analysi alloc hypoglycaem symptom autonomi neuroglycopen group tend occur priori basi view practic need clear symptom marker hypoglycaemia scientif approach must pursu substanti evid present two larg scale studi perform support three factor model hypoglycaem symptomatolog base statist associ discov among symptom report diabet patient studi 1 involv 295 insulin-tr outpati found 11 key hypoglycaem symptom segreg three clear factor autonomi sweat palpit shake hunger neuroglycopen confus drowsi odd behaviour speech difficulti incoordin malais nausea headach three factor valid separ group 303 insulin-tr diabet out-pati confirmatori factor analys show three factor model optim model explain symptom covari group multi-sampl confirmatori factor analysi test rigor assumpt rel load symptom factor across group equal residu varianc symptom ident across group assumpt success indic three factor model replic detail across two larg sampl suggest result indic valid group symptom may use futur research clinic practic',\n",
       "  'extracellular vesicl human cardiac progenitor cell inhibit cardiomyocyt apoptosi improv cardiac function myocardi infarct aim recent evid suggest cardiac progenitor cell cpc may improv cardiac function injuri underli mechan indirect mediat remain unidentifi exosom secret membran vesicl hereaft collect refer extracellular vesicl ev act paracrin signal mediat report ev secret human cpc crucial cardioprotect agent method result cpc deriv atrial appendag explant patient underw heart valv surgeri cpc-condit medium cm inhibit apoptosi mous hl-1 cardiomyocyt cell enhanc tube format human umbil vein endotheli cell effect abrog deplet cm ev reproduc ev secret cpc secret human dermal fibroblast transmiss electron microscopi nanoparticl track analysi show ev 30-90 nm diamet size exosom although smaller larger vesicl also present microrna highli enrich ev secret cpc compar fibroblast includ mir-210 mir-132 mir-146a-3p mir-210 down-regul known target ephrin a3 ptp1b inhibit apoptosi cardiomyocyt cell mir-132 down-regul target rasgap-p120 enhanc tube format endotheli cell infarct heart inject ev cpc fibroblast exhibit less cardiomyocyt apoptosi enhanc angiogenesi improv lv eject fraction 0.8 ± 6.8 vs. -21.3 ± 4.5 p 0.05 compar inject control medium conclus ev activ compon paracrin secret human cpc cell-fre approach ev could circumv mani limit cell transplant',\n",
       "  'increas adipocyt o2 consumpt trigger hif-1α caus inflamm insulin resist obes adipos tissu hypoxia inflamm causal implic obesity-induc insulin resist report earli cours high-fat diet hfd feed obes adipocyt respir becom uncoupl lead increas oxygen consumpt state rel adipocyt hypoxia event suffici trigger hif-1α induct set chronic adipos tissu inflammatori respons characterist obes molecular level event involv satur fatti acid stimul adenin nucleotid translocas 2 ant2 inner mitochondri membran protein lead uncoupl respiratori state genet pharmacolog inhibit either ant2 hif-1α prevent revers pathophysiolog event restor state insulin sensit glucos toler result reveal sequenti seri event obesity-induc inflamm insulin resist',\n",
       "  'lpcat3-depend product arachidonoyl phospholipid key determin triglycerid secret role specif phospholipid pl lipid transport difficult assess due inabl select manipul membran composit vivo show phospholipid remodel enzym lysophosphatidylcholin acyltransferas 3 lpcat3 critic determin triglycerid tg secret due uniqu abil catalyz incorpor arachidon membran mice lack lpcat3 intestin fail thrive wean exhibit enterocyt lipid accumul reduc plasma tg mice lack lpcat3 liver show reduc plasma tg hepatosteatosi secret lipid-poor low-dens lipoprotein vldl lack arachidonoyl pl mechanist studi indic lpcat3 activ impact membran lipid mobil live cell suggest biophys basi requir arachidonoyl pl lipid lipoprotein particl data identifi lpcat3 key factor lipoprotein product illustr manipul membran composit use regulatori mechan control metabol pathway',\n",
       "  'character single-strand dna-bind protein pseudomona aeruginosa pao1 single-strand dna-bind protein ssb play import role dna metabol dna replic repair recombin essenti cell surviv character single-strand dna ssdna -bind properti pseudomona aeruginosa pao1 ssb passb use fluoresc quench measur electrophoret mobil shift analysi emsa analysi purifi passb gel filtrat chromatographi reveal stabl tetram solut fluoresc titrat passb bound 22-32 nucleotid nt per tetram depend salt concentr use emsa character stoichiometri passb complex seri ssdna homopolym size bind site determin 29 ± 1 nt furthermor emsa result indic dissoci constant passb first tetram less second tetram basi biophys analys ssdna bind mode passb expect noncoop',\n",
       "  'primari cilia coordin receptor tyrosin kinas rtk signal primari cilia microtubule-bas sensori organel coordin signal pathway cell-cycl control migrat differenti cellular process critic develop tissu homeostasi accordingli defect assembl function primari cilia lead plethora development disord patholog condit known ciliopathi review summar current statu role primari cilia coordin receptor tyrosin kinas rtk signal pathway present potenti mechan signal crosstalk network primari cilium discuss defect ciliari rtk signal link human diseas disord',\n",
       "  'detect target tumor relaps resist innat effector earli recurr tumor recurr repres major clinic challeng data show emerg recurr tumor acquir phenotyp radic differ origin primari tumor phenotyp allow evad host-deriv innat immun respons elicit progress minim residu diseas mrd activ grow recurr screen innat respons predict accur mice recurr would occur prematur induct recurr resensit mrd primari therapi suggest possibl paradigm shift clinic treatment dormant diseas current expect approach replac activ attempt uncov mrd evolut escap phenotyp complet combin screen second-lin treatment target innat insensit 100 mice would otherwis relaps cure data may open new avenu earli detect appropri time highli target treatment tumor recurr irrespect tumor type frontlin treatment',\n",
       "  'forc tissu morphogenesi pattern develop mechan forc caus chang size shape number posit gene express cell therefor integr morphogenet process forc gener actin-myosin network forc transmiss adhes complex two self-organ phenomena drive tissu morphogenesi coordin integr forc long-rang forc transmiss mechanosens cell within tissu produc large-scal tissu shape chang extrins mechan forc also control tissu pattern modul cell fate specif differenti thu interplay tissu mechan biochem signal orchestr tissu morphogenesi pattern develop',\n",
       "  'cd169+ macrophag present lipid antigen mediat earli activ invari nkt cell lymph node invari natur killer cell inkt cell involv host defens microbi infect although known inkt cell recogn glycolipid present cd1d encount antigen vivo remain unclear use multiphoton microscopi visual dynam activ inkt cell lymph node antigen administr inkt cell becam confin cd1d-depend manner close proxim subcapsular sinu cd169 macrophag macrophag retain intern present lipid antigen requir inkt cell activ cytokin product popul expans thu cd169 macrophag act true antigen-pres cell control earli inkt cell activ favor fast initi immun respons',\n",
       "  'oxygen metabol caus chromosom break associ neuron apoptosi observ dna double-strand break repair mutant cell defici major dna double-strand break repair pathway nonhomolog dna end join nhej increas spontan chromosom break howev sourc chromosom break remain undefin show observ spontan chromosom break partial suppress reduc cellular oxygen tension convers elev level reactiv oxygen speci overexpress antioxid enzym superoxid dismutas 1 sod1 transgen mous increas chromosom breakag effect sod1 also modul cellular oxygen tension elev chromosom breakag correl histolog signific increas amount neuron cell death ku86 -/- sod1 transgen embryo seen ku86 -/- embryo therefor oxygen metabol major sourc genom instabl observ nhej-defici cell presum cell',\n",
       "  'insert mutagenesi gene therapi stem cell biolog purpos review recent preclin clinic studi reveal semirandom insert transgen chromosom dna hematopoiet cell may induc clonal competit potenti may even trigger leukemia sarcoma insert mutagenesi caus gene vector thu led major uncertainti among develop advanc hematopoiet cell therapi review summar novel studi underli mechan studi demonstr possibl improv gene vector biosafeti gener new insight stem cell biolog recent find characterist insert pattern variou retrovir gene vector system may explain properti viral integras associ cellular cofactor cell cultur assay anim model includ disease-specif cancer-pron mous model emerg reveal contribut vector featur system factor induct clonal imbal databas summar vector insert site domin hematopoiet clone evolv new tool identifi gene regul clonal homeostasi summari mechanist studi insert mutagenesi random gene vector insert lead improv tool advanc hematopoiet cell therapi simultan fascin insight gene network regul cell fit gener import consequ field hematolog oncolog regen medicin',\n",
       "  'market voucher subsidi free net combin achiev high bed net coverag rural tanzania background tanzania well-develop network commerci itn retail 2004 govern introduc voucher subsidi pregnant women mid 2005 help distribut free net under-f small number district includ rufiji southern coast child health campaign contribut multipl insecticide-tr net deliveri strategi exist time place coverag poor rural commun assess method cross-sect household survey 6,331 member randomli select 1,752 household 31 rural villag demograph surveil system rufiji district southern tanzania conduct 2006. questionnair administ everi consent respond net use treatment statu deliveri mechan find net use 62.7 overal 87.2 amongst infant 0 1 year 81.8 amongst young children 1 5 year 54.5 amongst older children 6 15 year 59.6 amongst adult 15 year 30.2 net treat six month prior interview biggest sourc net use infant purchas privat sector voucher subsidi 41.8 half net use young children 50.0 third use older children 37.2 obtain free charg vaccin campaign largest sourc net amongst popul overal commerci purchas 45.1 use primari mean protect adult 60.2 use deliveri mechan especi sale net full market price under-serv poorest differ equiti observ voucher-subsid freeli distribut net conclus three deliveri strategi enabl poor rural commun achiev net coverag high enough yield person commun level protect entir popul reach relev target group free net temporarili suppress net market illustr set complementari rather mutual exclus approach',\n",
       "  'human chorion gonadotropin level matern blood late pregnanc relat birthweight sex condit infant birth total 527 blood sampl obtain unselect popul women 36 40 week gestat serum human chorion gonadotropin hcg level measur use specif radioimmunoassay beta 1-subunit hcg serum hcg level higher primigravida women carri femal fetus also relat birthweight child occurr fetal distress',\n",
       "  'brain-specif phosphoryl mecp2 regul activity-depend bdnf transcript dendrit growth spine matur mutat duplic mecp2 caus rett rett-lik syndrom neurodevelopment disord character mental retard motor dysfunct autist behavior mecp2 express mani mammalian tissu function global repressor transcript howev molecular mechan mecp2 dysfunct lead neural-specif phenotyp rtt remain poorli understood show neuron activ subsequ calcium influx trigger de novo phosphoryl mecp2 serin 421 s421 camkii-depend mechan mecp2 s421 phosphoryl induc select brain respons physiolog stimuli significantli find s421 phosphoryl control abil mecp2 regul dendrit pattern spine morphogenesi activity-depend induct bdnf transcript find suggest trigger mecp2 phosphoryl neuron activ regul program gene express mediat nervou system matur disrupt process individu mutat mecp2 may underli neural-specif patholog rtt',\n",
       "  'candid gene approach identifi traf1/c5 region risk factor rheumatoid arthriti correct kurreeman fa padyukov l marqu rb schrodi sj seddighzadeh et al 2007 candid gene approach identifi traf1/c5 region risk factor rheumatoid arthriti plo med 4 9 e278 doi:10.1371/journal.pmed.0040278 tabl 1 allel ratio column eight allel ratiosb case control refer allel allel b allele1 allele2 describ footnot b allel suscept allel denot column seven footnot read bnumber allel compar case versu control allel allel b case allel allel b control allel refer suscept allel given column seven',\n",
       "  'potenti use γ-secretas modul treatment alzheim diseas although signific progress occur past 20 year regard understand alzheim diseas pathogenesi yet identifi disease-modifi therapeut capabl substanti alter clinic cours preval neurodegen diseas short review discuss 2 approach current test clinic γ-secretas inhibit γ-secretas modul emphas signific differ 2 therapeut approach also discuss certain genetic- biomarker-bas translat clinic trial paradigm may assist develop use therapeut agent',\n",
       "  \"ration design flaviviru vaccin abolish viral rna 2'-o methyl virus replic cytoplasm access host nuclear cap machineri virus evolv viral methyltransferas methyl n-7 2'-o cap rna altern `` snatch '' host mrna cap form 5 end viral rna function 2'-o methyl viral rna cap mimic cellular mrna evad host innat immun restrict cytoplasm viru defect 2'-o methyl replic viral rna lack 2'-o methyl recogn elimin host immun respons mutant viru could ration design live attenu vaccin use japanes enceph viru jev import mosquito-born flaviviru prove novel vaccin concept show jev methyltransferas respons n-7 2'-o cap methyl well evas host innat immun respons recombin viru complet defect 2'-o methyl stabl cell cultur passag 30 day mutant viru attenu mice elicit robust humor cellular immun respons retain engin mutat vivo singl dose immun induc full protect lethal challeng jev strain mice mechanist attenu phenotyp attribut enhanc sensit mutant viru antivir effect interferon ifit protein collect result demonstr feasibl use 2'-o methylation-defect viru vaccin approach vaccin approach applic flavivirus nonflavivirus encod viral 2'-o methyltransferas\",\n",
       "  'fruit consumpt risk type 2 diabet result three prospect longitudin cohort studi object determin whether individu fruit differenti associ risk type 2 diabet design prospect longitudin cohort studi set health profession unit state particip 66,105 women nurs health studi 1984-2008 85,104 women nurs health studi ii 1991-2009 36,173 men health profession follow-up studi 1986-2008 free major chronic diseas baselin studi main outcom measur incid case type 2 diabet identifi self report confirm supplementari questionnair result 3,464,641 person year follow-up 12,198 particip develop type 2 diabet adjust person lifestyl dietari risk factor diabet pool hazard ratio type 2 diabet everi three servings/week total whole fruit consumpt 0.98 95 confid interv 0.97 correct 0.99 mutual adjust individu fruit pool hazard ratio type 2 diabet everi three servings/week 0.74 0.66 0.83 blueberri 0.88 0.83 0.93 grape raisin 0.89 0.79 1.01 prune 0.93 0.90 0.96 appl pear 0.95 0.91 0.98 banana 0.95 0.91 0.99 grapefruit 0.97 0.92 1.02 peach plum apricot 0.99 0.95 1.03 orang 1.03 0.96 1.10 strawberri 1.10 1.02 1.18 cantaloup pool hazard ratio increment fruit juic consumpt 1.08 1.05 1.11 associ risk type 2 diabet differ significantli among individu fruit p 0.001 cohort conclus find suggest presenc heterogen associ individu fruit consumpt risk type 2 diabet greater consumpt specif whole fruit particularli blueberri grape appl significantli associ lower risk type 2 diabet wherea greater consumpt fruit juic associ higher risk',\n",
       "  \"oncomir-196 promot invas phenotyp oral cancer nme4-jnk-timp1-mmp signal pathway background microrna-196 mir-196 highli up-regul oral cancer cell report aberrantli express sever cancer howev signific mir-196 oral cancer yet address method cellular function respons mir-196 modul examin includ cell growth migrat invas radio/chemosensit algorithm-bas studi use identifi regulatori target mir-196 mir-196 target gene downstream molecular mechan confirm rt-qpcr western blot luciferas report confoc microscopi analys mir-196 express determin pair cancer adjac normal tissu oral cancer patient result mir-196a mir-196b highli over-express cancer tissu correl lymph node metastasi p 0.001 p 0.006 respect function mir-196 activ promot cell migrat invas without affect cell growth mechanist mir-196 perform 's function inhibit nme4 express activ p-jnk suppress timp1 augment mmp1/9 conclus mir-196 contribut oral cancer promot cell migrat invas clinic mir-196a/b significantli over-express cancer tissu correl lymph node metastasi thu find provid new knowledg underli mechan cancer metastasi mir-196 may serv promis marker better oral cancer manag\",\n",
       "  'revers engin tlx oncogen transcript network identifi runx1 tumor suppressor t-all tlx1 tlx3 transcript factor oncogen key role pathogenesi cell acut lymphoblast leukemia t-all use revers engin global transcript network deciph oncogen regulatori circuit control tlx1 tlx3 system biolog analysi defin cell leukemia homeobox 1 tlx1 tlx3 master regul oncogen transcript circuit govern t-all notabl network structur analysi hierarch network identifi runx1 key mediat t-all induc tlx1 tlx3 predict tumor-suppressor role runx1 cell transform consist result identifi recurr somat loss-of-funct mutat runx1 human t-all overal result place tlx1 tlx3 top oncogen transcript network control leukemia develop show power network analys identifi key element regulatori circuit govern human cancer identifi runx1 tumor-suppressor gene t-all',\n",
       "  'impact new antiretrovir treatment guidelin hiv epidem dynam cost south africa background sinc novemb 2009 recommend adult infect hiv initi antiretrovir therapi art cd4+ cell count ≤350 cells/µl rather ≤200 cells/µl south africa decid adopt strategi pregnant tb co-infect patient estim impact fulli adopt new guidelin hiv epidem dynam associ cost method find use establish model transmiss control hiv specifi sexual network healthcar set quantifi model repres hlabisa subdistrict kwazulu-nat south africa predict hiv epidem dynam number art program cost new guidelin rel treat patient ≤200 cells/µl next 30 year first five year new treatment guidelin requir 7 extra annual invest wherea 28 patient receiv treatment furthermor profound impact hiv incid lead rel less annual cost seven year result cumul net cost reach break-even point averag 16 year conclus studi strengthen recommend start art ≤350 cells/µl hiv-infect patient apart benefit associ mani life-year save modest frontload appear lead net save within limit time-horizon find robust altern assumpt forese chang art price effect therefor south africa aim rapidli expand healthcar infrastructur fulli embrac new guidelin',\n",
       "  'er-associ mitochondri divis link distribut mitochondria mitochondri dna yeast mitochondri divis import mitochondri distribut function recent data demonstr er-mitochondria contact mark mitochondri divis site molecular basi function contact understood show yeast er-mitochondria tether complex erm highli conserv miro gtpase gem1 spatial function link er-associ mitochondri divis gem1 act neg regul er-mitochondria contact activ requir spatial resolut distribut newli gener mitochondri tip follow divis previou data demonstr erm local subset activ replic mitochondri nucleoid show mitochondri divis spatial link nucleoid major nucleoid segreg prior divis result distribut newli gener tip mitochondri network thu postul er-associ divis serv link distribut mitochondria mitochondri nucleoid cell doi http //dx.doi.org/10.7554/elife.00422.001',\n",
       "  \"bmi-1 autoantibodi new potenti biomark cervic carcinoma bmi-1 overexpress varieti cancer elicit immun respons lead induct autoantibodi howev bmi-1 autoantibodi biomark seldom studi except nasopharyng carcinoma whether bmi-1 autoantibodi use biomark cervic carcinoma unclear studi bmi-1 protein isol screen t7 phage cdna librari mix cervic carcinoma tissu analyz bmi-1 autoantibodi level serum sampl 67 patient cervic carcinoma 65 control use elisa immunoblot bmi-1 mrna protein level over-express cervic carcinoma cell line immunoblot result exhibit increas bmi-1 autoantibodi level patient sera compar normal sera addit result antibodi affin assay show differ cervic polyp normal sera bmi-1 autoantibodi level significantli greater patient sera normal control patient 0.827±0.043 normal 0.445±0.023 p 0.001 's level bmi-1 autoantibodi increas significantli stage 0.672±0.019 compar normal sera p 0.001 level bmi-1 autoantibodi increas gradual tumor progress stage 0.672±0.019 stage ii 0.775 ±0.019 stage iii 0.890 ±0.027 stage iv 1.043±0.041 significantli correl diseas progress cervic cancer p 0.001 statist analys use logist regress receiv oper characterist roc curv indic bmi-1 autoantibodi level use biomark cervic carcinoma sensit 0.78 specif 0.76 auc 0.922 conclus measur bmi-1 autoantibodi level patient cervic cancer could clinic prognost valu well non-tissu specif biomark neoplasm express bmi-1\",\n",
       "  \"microrna gener threshold target gene express microrna mirna short highli conserv noncod rna molecul repress gene express sequence-depend manner perform single-cel measur use quantit fluoresc microscopi flow cytometri monitor target gene 's protein express presenc absenc regul mirna find although averag level repress modest agreement previou population-bas measur repress among individu cell vari dramat particular show regul mirna establish threshold level target mrna protein product highli repress near threshold protein express respond sensit target mrna input consist mathemat model molecular titrat result show mirna act switch fine-tun gene express\",\n",
       "  \"oncogen mtor signal recruit myeloid-deriv suppressor cell promot tumor initi myeloid-deriv suppressor cell mdsc play critic role primari metastat cancer progress mdsc regul wide variabl even among patient harbour type malign mechan govern heterogen larg unknown integr human tumour genom syngen mammari tumour model demonstr mtor signal cancer cell dictat mammari tumour 's abil stimul mdsc accumul regul g-csf inhibit pathway activ exampl fgfr impair tumour progress partial rescu restor mdsc g-csf tumour-initi cell tic exhibit elev g-csf mdsc reciproc increas tic frequenc activ notch tumour cell form feedforward loop analys primari breast cancer patient-deriv xenograft corrobor mechan patient find establish non-canon oncogen role mtor signal recruit pro-tumorigen mdsc show defin cancer subset may evolv promot depend distinct immun microenviron\",\n",
       "  'manag women genet predisposit breast cancer manag women genet predisposit breast cancer requir care plan women brca 1 brca 2 mutat increas risk breast cancer cancer well particularli ovarian cancer screen prophlyact surgeri chemoprevent commonli util strategi manag patient women may choos one strategi random prospect trial assess impact strategi specif mutat carrier patient inform screen prophylact surgeri chemoprevent potenti harm well benefit',\n",
       "  'astrocyt famili sporad al patient toxic motor neuron amyotroph later sclerosi al fatal motor neuron diseas astrocyt implic contribut substanti motor neuron death famili f al howev propos role astrocyt patholog al deriv part rodent model fal base upon domin mutat within superoxid dismutas 1 sod1 gene account 2 al case role sporad al affect 90 al patient remain establish use astrocyt gener postmortem tissu fal sal patient show astrocyt deriv patient group similarli toxic motor neuron also demonstr sod1 viabl target sal knockdown significantli attenu astrocyte-medi toxic toward motor neuron data highlight astrocyt non-cel autonom compon sal provid vitro model system investig common diseas mechan evalu potenti therapi sal fal',\n",
       "  'high-intens function exercis program protein-enrich energi supplement older person depend activ daili live randomis control trial aim randomis control trial determin high-intens function exercis program improv balanc gait abil lower-limb strength older person depend activ daili live intak protein-enrich energi supplement immedi exercis increas effect train one hundr ninety-on older person depend activ daili live live residenti care facil mini-ment state examin mmse score 10 particip randomis high-intens function exercis program control activ includ 29 session 3 month well protein-enrich energi supplement placebo berg balanc scale self-pac maximum gait speed one-repetit maximum lower-limb strength followed-up three six month analys 2 x 2 factori ancova use intention-to-treat principl three month exercis group improv significantli self-pac gait speed compar control group mean differ 0.04 m/ p 0.02 six month signific improv favour exercis group berg balanc scale 1.9 point p 0.05 self-pac gait speed 0.05 m/ p 0.009 lower-limb strength 10.8 kg p 0.03 interact effect seen exercis nutrit intervent conclus high-intens function exercis program posit long-term effect balanc gait abil lower-limb strength older person depend activ daili live intak protein-enrich energi supplement immedi exercis appear increas effect train',\n",
       "  'inhibit fatti acid oxid modul immunosuppress function myeloid-deriv suppressor cell enhanc cancer therapi myeloid-deriv suppressor cell mdsc promot tumor growth inhibit t-cell immun promot malign cell prolifer migrat therapeut potenti block mdsc tumor limit heterogen plastic resist variou chemotherapi agent recent studi highlight role energi metabol pathway differenti function immun cell howev metabol characterist regul mdsc remain unclear aim determin energi metabol pathway use mdsc establish impact immunosuppress function test whether inhibit block mdsc enhanc antitumor therapi use sever murin tumor model found tumor-infiltr mdsc t-mdsc increas fatti acid uptak activ fatti acid oxid fao accompani increas mitochondri mass upregul key fao enzym increas oxygen consumpt rate pharmacolog inhibit fao block immun inhibitori pathway function t-mdsc decreas product inhibitori cytokin fao inhibit alon significantli delay tumor growth t-cell-depend manner enhanc antitumor effect adopt t-cell therapi furthermor fao inhibit combin low-dos chemotherapi complet inhibit t-mdsc immunosuppress effect induc signific antitumor effect interestingli similar increas fatti acid uptak express fao-rel enzym found human mdsc peripher blood tumor result support possibl test fao inhibit novel approach block mdsc enhanc variou cancer therapi',\n",
       "  \"predict mortal patient hospit acut exacerb chronic obstruct pulmonari diseas purpos identifi factor affect short-term prognosi patient acut exacerb chronic obstruct pulmonari diseas copd patient method 590 patient copd primari diseas hospit pneumolog unit univers hospit 1981 1990 studi standard protocol treatment acut exacerb copd adopt patient patient record retrospect analyz two observ 23 clinic laboratori variabl defin patient statu admiss collect age arteri ga data also taken account outcom mortal record interobserv reproduc test comput kappa coeffici spearman 's rho dichotom continu variabl respect relationship clinic laboratori factor outcom assess first univari analysi logist regress analysi assess independ predict role variabl previous shown univari correl mortal result mortal rate 14.4 logist regress analysi identifi four independ predictor death age odd ratio 1.07 95 confid interv ci 1.04 1.11 alveolar-arteri oxygen gradient greater 41 mm hg 2.33 95 ci 1.39 3.90 ventricular arrhythmia 1.91 95 ci 1.10 3.31 atrial fibril 2.27 95 ci 1.14 4.51 conclus patient acut exacerb copd high risk death identifi time admiss variabl reflect heart dysfunct import determin risk among pulmonari function data alveolar-arteri oxygen gradient contribut predict model\",\n",
       "  'clathrin requir function mitot spindl clathrin establish function gener vesicl transfer membran protein around cell format clathrin-co vesicl occur continu non-divid cell shut mitosi clathrin concentr spindl apparatu show clathrin stabil fibr mitot spindl aid congress chromosom clathrin bound spindl directli amino-termin domain clathrin heavi chain deplet clathrin heavi chain use rna interfer prolong mitosi kinetochor fibr destabil lead defect congress chromosom metaphas plate persist activ spindl checkpoint normal mitosi rescu clathrin triskelia n-termin domain clathrin heavi chain indic stabil kinetochor fibr depend uniqu structur clathrin import clathrin normal mitosi may relev understand human cancer involv gene fusion clathrin heavi chain',\n",
       "  'origin neuron function vivo nonsynapt glutam basal extracellular glutam sampl vivo present micromolar concentr extracellular space outsid synapt cleft neither origin function glutam known report reveal blockad glutam releas cystine-glutam antiport produc signific decreas 60 extrasynapt glutam level rat striatum wherea blockad voltage-depend na+ ca2+ channel produc rel minim chang 0-30 indic primari origin vivo extrasynapt glutam striatum aris nonvesicular glutam releas cystine-glutam antiport measur 35 cystin uptak shown similar vesicular releas activ cystine-glutam antiport neg regul group ii metabotrop glutam receptor mglur2/3 via camp-depend protein kinas mechan extracellular glutam deriv antiport shown regul extracellular level glutam dopamin infus mglur2/3 antagonist rs -1-amino-5-phosphonoindan-1-carboxyl acid apica increas extracellular glutam level previou blockad antiport prevent apica-induc rise extracellular glutam suggest glutam releas antiport sourc endogen tone mglur2/3 blockad antiport also produc increas extracellular dopamin revers infus mglur2/3 agonist 2r,4r -4-aminopyrrolidine-2,4-dicarboxlyl indic antiporter-deriv glutam modul dopamin transmiss via mglur2/3 heteroreceptor result suggest nonvesicular releas cystine-glutam antiport primari sourc vivo extracellular glutam glutam modul glutam dopamin transmiss',\n",
       "  'disease-associ function il-33 new kid il-1 famili interleukin-33 il-33 newli describ member il-1 famili express mani cell type follow pro-inflammatori stimul thought releas cell lysi il-33 receptor consist st2 il-1 receptor accessori protein also wide express particularli helper 2 th2 cell mast cell il-33 host-protect helminth infect reduc atherosclerosi promot th2-type immun respons howev il-33 also promot pathogenesi asthma expand th2 cell mediat joint inflamm atop dermat anaphylaxi mast cell activ thu il-33 could new target therapeut intervent across rang diseas',\n",
       "  'interferon alpha therapi hepat c treatment complet respons rate among patient substanc use disord backgroundindividu substanc use disord sud increas risk hepat c viral infect hcv studi explor treatment respons empir object studi assess interferon alpha therapi ifn complet respons rate among patient hcv histori comorbid sud data need inform treatment strategi guidelin patient use medic record databas inform retrospect collect 307,437 veteran seen veteran integr servic network 20 visn 20 veteran healthcar administr vha 1998 2003. patient treat type ifn includ regular pegyl ifn combin therapi ifn ribavirin known hcv genotyp ifn complet respons rate compar among patient histori sud sud+ group patient without histori sud sud- group .resultsodd ratio analys reveal compar sud- group sud+ group equal like complet ifn therapi genotyp 2 3 73.1 vs. 68.0 genotyp 1 4 39.5 vs. 39.9 within sampl patient began ifn therapi sud- sud+ group similarli like achiev end treatment respons genotyp 2 3 52.8 vs. 54.3 genotyp 1 4 24.5 vs. 24.8 sustain viral respons genotyp 2 3 42.6 vs. 41.1 genotyp 1 4 16.0 vs. 22.3 .conclusionindividu without histori sud respond antivir therapi hcv similar rate collect find suggest patient co-morbid sud hcv diagnos success complet cours antivir therapi',\n",
       "  'associ infect helicobact pylori risk gastric cancer evid prospect investig object investig associ gastric cancer prior infect helicobact pylori design case-control comparison preval igg antibodi h pylori blood sampl collect prospect diagnosi gastric cancer case presenc h pylori antibodi greater 10 microgram igg/ml determin enzym link immunosorb assay elisa subject 29 men subsequ diagnosi gastric cancer 116 age match control select 22,000 middl age men particip two ongo cohort studi british unit provid associ studi caerphilli collabor heart diseas studi provid blood sampl 1975-1982. result 20 29 case 69 54 116 control 47 posit h pylori specif antibodi median specif igg concentr significantli higher case control 90 micrograms/ml v 3.6 micrograms/ml p less 0.01 estim odd ratio risk gastric cancer histori infect h pylori 2.77 95 confid interv 1.04 7.97 2p 0.039 conclus h pylori infect may import caus gastric cancer 35 55 case may associ infect',\n",
       "  'oncostatin leukemia inhibitori factor use function receptor mice oncostatin osm leukemia inhibitori factor lif member interleukin-6 il-6 subfamili cytokin use common signal transduc gp130 human osm hosm lif share function high-affin receptor compos gp130 lif receptor beta subunit lifrbeta second high-affin receptor hosm recent found form gp130 hosm receptor beta subunit howev natur murin osm mosm receptor remain unknown use recent clone mosm cdna produc recombin mosm studi biolog activ receptor structur murin hematopoiet cell line m1 da1.a embryon stem cell line cce ba/f3 transfect express gp130 lifrbeta respond murin lif mlif hosm equal well cell respond mosm 30-fold 100-fold higher concentr mlif hosm contrast nih3t3 cell respond mosm mlif hosm scatchard plot analys show mosm bound gp130 low-affin kd 2.8 4.2 nmol/l bind affin increas presenc lifrbeta howev mosm bound nih3t3 cell high-affin kd 660 pmol/l wherea mlif bind nih3t3 cell result indic unlik hosm mosm mlif share function receptor mosm deliv signal specif receptor complex studi mice defin physiolog role osm',\n",
       "  'multifunct vivo vascular imag use near-infrar ii fluoresc vivo real-tim epifluoresc imag mous hind limb vasculatur second near-infrar region nir-ii perform use single-wal carbon nanotub fluorophor high spatial ∼30 μm tempor 200 ms per frame resolut small-vessel imag achiev 1–3 mm deep hind limb owe benefici nir-ii optic window afford deep anatom penetr low scatter spatial resolut unattain tradit nir imag nir-i microscop comput tomographi tempor resolut far exce scan microscop imag techniqu arteri venou vessel unambigu differenti use dynam contrast-enhanc nir-ii imag techniqu basi distinct hemodynam deep tissu penetr high spatial tempor resolut nir-ii imag allow precis quantif blood veloc normal ischem femor arteri beyond capabl ultrasonographi lower blood veloc',\n",
       "  'colorect cancer surviv socioeconom group england variat mainli short term diagnosi unlabel object studi examin differ cancer surviv socioeconom group england particular attent surviv short term follow-up patient method individu diagnos colorect cancer 1996 2004 england identifi cancer registri record five-year cumul rel surviv excess death rate comput result colon cancer high excess death rate first month follow-up excess death rate highest socioeconom depriv group subsequ period excess mortal rate much lower less socioeconom variat pattern variat excess death rate gener similar rectal cancer socioeconom differ death rate persist sever year longer excess death rate entir colorect cancer patient popul observ affluent socioeconom quintil annual reduct would 360 death colon cancer 336 death rectal cancer patient death occur almost entir first month first year diagnosi conclus recent develop nation cancer control agenda includ increas emphasi outcom measur short-term cancer surviv oper measur variat progress cancer control provid clue natur surviv differ socioeconom group result present give strong support strategi',\n",
       "  'cardiac myocyt remodel mediat n-cadherin-depend mechanosens cell-to-cel adhes crucial maintain structur function integr cardiac cell littl known mechanosensit mechanotransduct cell-to-cel interact studi cardiac mechanotransduct myofibrillogenesi focus cell-extracellular matrix ecm -specif interact studi assess direct role intercellular adhes specif n-cadherin-medi mechanotransduct morpholog intern organ neonat ventricular cardiac myocyt result show cadherin-medi cell attach capabl elicit cytoskelet network respons similar integrin-medi forc respons transmiss affect myofibrillar organ myocyt shape cortic stiff traction forc mediat n-cadherin shown compar sustain ecm direct chang predict traction forc function impos load gel stiff provid ad evid n-cadherin mechanorespons adhes receptor strikingli mechan sensit respons gain term measur cell-spread area function impos load adhes substrat rigid consist higher n-cadherin-co surfac compar ecm protein-co surfac addit cytoskelet architectur myocyt n-cadherin adhes microenviron characterist differ ecm environ suggest two mechanotransduct cell adhes system may play independ complementari role myocyt cytoskelet spatial organ result indic cell-to-cell-medi forc percept transmiss involv organ develop cardiac structur function',\n",
       "  'neat1 novel cancer‐rel long non‐cod rna aberr overexpress long non-cod rna neat1 nuclear paraspeckl assembl transcript 1 document differ type solid tumour lung cancer oesophag cancer colorect cancer hepatocellular carcinoma high level associ poor prognosi contrast neat1 downregul acut promyelocyt leukaemia promot leucocyt differenti review provid overview current evid concern oncogen role potenti clinic util neat1 investig warrant elucid upstream downstream mechan neat1 overexpress',\n",
       "  'function therapeut potenti long non-cod rna cardiovascular develop diseas popular genome-wid analys rna sequenc led discoveri larg part human genom effect transcrib encod protein long non-cod rna emerg critic regul gene express normal diseas state studi long non-cod rna express heart combin gene associ studi reveal molecul regul cardiovascular develop diseas long non-cod rna function implic cardiac pathophysiolog constitut potenti therapeut target review current knowledg function long non-cod rna cardiovascular system emphasi cardiovascular develop biolog focus hypertens coronari arteri diseas myocardi infarct ischemia heart failur discuss potenti therapeut implic challeng long non-cod rna research direct futur research translat focu',\n",
       "  \"oct4 link multipl epigenet pathway pluripot network oct4 well-known transcript factor play fundament role stem cell self-renew pluripot somat cell reprogram howev limit inform avail oct4-associ protein complex intrins protein-protein interact dictat oct4 's critic regulatori activ employ improv affin purif approach combin mass spectrometri purifi oct4 protein complex mous embryon stem cell mesc discov mani novel oct4 partner import self-renew pluripot mesc notabl found oct4 associ multipl chromatin-modifi complex document well newli prove function signific stem cell mainten somat cell reprogram studi establish solid biochem basi genet epigenet regul stem cell pluripot provid framework explor altern factor-bas reprogram strategi\",\n",
       "  'tet1 dispens maintain pluripot loss compat embryon postnat develop tet famili enzym tet1/2/3 convert 5-methylcytosin 5mc 5-hydroxymethylcytosin 5hmc mous embryon stem cell mesc highli express tet1 elev level 5hmc tet1 implic esc mainten lineag specif vitro precis function develop well defin establish role tet1 pluripot develop gener tet1 mutant mesc mice tet1 -/- esc reduc level 5hmc subtl chang global gene express pluripot support develop live-born mice tetraploid complement assay display skew differenti toward trophectoderm vitro tet1 mutant mice viabl fertil grossli normal though mutant mice slightli smaller bodi size birth data suggest tet1 loss lead partial reduct 5hmc level affect pluripot esc compat embryon postnat develop',\n",
       "  'ldl-cholesterol concentr genome-wid associ studi background ldl cholesterol causal role develop cardiovascular diseas improv understand biolog mechan underli metabol regul ldl cholesterol might help identifi novel therapeut target therefor genome-wid associ studi ldl-cholesterol concentr method use genome-wid associ data 11,685 particip measur circul ldl-cholesterol concentr across five studi includ data 293 461 autosom singl nucleotid polymorph snp minor allel frequenc 5 pass qualiti control criteria also use data second genome-wid array 4337 particip three five studi data 290,140 snp replic studi two independ popul consist 4979 particip statist approach includ meta-analysi linkag disequilibrium plot use refin associ signal analys pool data seven popul determin effect snp variat circul ldl-cholesterol concentr find initi scan found two snp rs599839 p=1.7x10 -15 rs4970834 p=3.0x10 -11 show genome-wid statist associ ldl cholesterol chromosom locu 1p13.3 second genom screen found third statist associ snp locu rs646776 p=4.3x10 -9 meta-analysi data studi show associ snp rs599839 combin p=1.2x10 -33 rs646776 p=4.8x10 -20 ldl-cholesterol concentr snp rs599839 rs646776 explain around 1 variat circul ldl-cholesterol concentr associ 15 sd chang ldl cholesterol per allel assum sd 1 mmol/l interpret found evid novel locu ldl cholesterol chromosom 1p13.3 result potenti provid insight biolog mechan underli regul ldl cholesterol might help discoveri novel therapeut target cardiovascular diseas',\n",
       "  'popul densiti water suppli risk dengu fever vietnam cohort studi spatial analysi background aed aegypti major vector dengu virus often breed water storag contain use household without tap water suppli occur high number even dens urban area analys interact human popul densiti lack tap water caus dengu fever outbreak aim identifi geograph area highest risk method find conduct individual-level cohort studi popul 75,000 geo-referenc household vietnam cours two epidem basi dengu hospit admiss n 3,013 appli space-tim scan statist mathemat model confirm find identifi surprisingli narrow rang critic human popul densiti around 3,000 7,000 people/km² prone dengu outbreak studi area popul densiti typic villag peri-urban area scan statist show area high popul densiti adequ water suppli experi sever outbreak risk dengu higher rural urban area larg explain lack pipe water suppli human popul densiti often fall within critic rang mathemat model suggest simpl assumpt regard area-level vector/host ratio may explain occurr outbreak conclus rural area may contribut least much dissemin dengu fever citi improv water suppli vector control area human popul densiti critic dengu transmiss could increas effici control effort pleas see later articl editor summari',\n",
       "  'helicobact pylori induc ag cell motil elong via independ signal pathway helicobact pylori induc motogen cytoskelet respons gastric epitheli cell demonstr respons induc via independ signal pathway often occur parallel cag pathogen island appear nonessenti induct motil wherea elong phenotyp depend transloc phosphoryl caga',\n",
       "  'sequenc alignment/map format samtool summari sequenc alignment/map sam format gener align format store read align refer sequenc support short long read 128 mbp produc differ sequenc platform flexibl style compact size effici random access format align 1000 genom project releas samtool implement variou util post-process align sam format index variant caller align viewer thu provid univers tool process read align avail http //samtools.sourceforge.net',\n",
       "  'character two class small molecul inhibitor arp2/3 complex polymer actin filament direct actin-rel protein arp 2/3 complex support mani type cellular movement howev question remain regard rel contribut arp2/3 complex versu mechan actin filament nucleat process path find neuron growth cone lack simpl method inhibit arp2/3 complex revers live cell describ two class small molecul bind differ site arp2/3 complex inhibit abil nucleat actin filament ck-0944636 bind arp2 arp3 appear block movement arp2 arp3 activ conform ck-0993548 insert hydrophob core arp3 alter conform class compound inhibit format actin filament comet tail listeria podosom monocyt two inhibitor differ mechan action provid power approach studi arp2/3 complex live cell',\n",
       "  'stress cell-to-substr interfac locomot fibroblast recent technolog improv elast substrat method make possibl produc spatial resolv measur traction exert singl motil cell studi appli develop produc map traction exert 3t3 fibroblast steadi locomot result imag spatial resolut approxim 5 micromet maximum intens approxim 10 2 kdyn/cm2 10 4 pn/micrometers2 find propuls thrust fibroblast locomot approxim 0.2 dyn impart substratum within 15 micromet lead edg observ demonstr lamellipodium fibroblast abl gener intens traction stress cell bodi posterior seem mechan passiv structur pull forward entir action',\n",
       "  'cancer-associ adipocyt exhibit activ phenotyp contribut breast cancer invas earli local tumor invas breast cancer result like encount cancer cell matur adipocyt role fat cell tumor progress remain unclear show murin human tumor cell cocultiv matur adipocyt exhibit increas invas capac vitro vivo use origin two-dimension cocultur system likewis adipocyt cultiv cancer cell also exhibit alter phenotyp term delipid decreas adipocyt marker associ occurr activ state character overexpress proteas includ matrix metalloproteinase-11 proinflammatori cytokin interleukin il -6 il-1β case il-6 show play key role acquir proinvas effect tumor cell equal import confirm presenc modifi adipocyt human breast tumor immunohistochemistri quantit pcr interestingli tumor larger size and/or lymph node involv exhibit higher level il-6 tumor surround adipocyt collect data provid vitro vivo evid invas cancer cell dramat impact surround adipocyt ii peritumor adipocyt exhibit modifi phenotyp specif biolog featur suffici name cancer-associ adipocyt caa iii caa modifi cancer cell characteristics/phenotyp lead aggress behavior result strongli support innov concept adipocyt particip highli complex viciou cycl orchestr cancer cell promot tumor progress might amplifi obes patient',\n",
       "  'preval cardiovascular diseas risk factor chines popul 2007-2008 china nation diabet metabol disord studi aim cardiovascular diseas cvd preval debilit diseas affect chines popul goal present manuscript analys cardiovascular risk factor preval non-fat cvd data gather 2007-2008 china nation diabet metabol disord studi method result nation repres sampl 46 239 adult 20 year age older randomli recruit use multistag stratifi design method lifestyl factor diagnosi cvd stroke diabet famili histori subject collect oral glucos toler test standard meal test perform variou non-fat cvd report subject sudaan softwar use perform weight statist analys p 0.05 consid statist signific preval coronari heart diseas stroke cvd 0.74 1.07 1.78 male 0.51 0.60 1.10 femal respect presenc cvd increas age male femal preval overweight obes hypertens dyslipidaemia hyperglycaemia 36.67 30.09 67.43 26.69 male 29.77 24.79 63.98 23.62 femal respect total sampl 46 239 patient preval one subject 1 2 3 ≥4 5 defin risk factor i.e smoke overweight obes hypertens dyslipidaemia hyperglycaemia 31.17 27.38 17.76 10.19 respect follow adjust gender age odd ratio cvd 1 2 3 ≥4 risk factor 2.36 4.24 4.88 7.22 respect compar patient risk factor conclus morbid attribut five defin cardiovascular risk factor high chines popul multipl risk factor present individu therefor reason prevent strategi design attenu rapid rise cardiovascular morbid',\n",
       "  'microvascular macrovascular complic diabet diabet group chronic diseas character hyperglycemia modern medic care use vast array lifestyl pharmaceut intervent aim prevent control hyperglycemia addit ensur adequ deliveri glucos tissu bodi treatment diabet attempt decreas likelihood tissu bodi harm hyperglycemia import protect bodi hyperglycemia overst direct indirect effect human vascular tree major sourc morbid mortal type 1 type 2 diabet gener injuri effect hyperglycemia separ macrovascular complic coronari arteri diseas peripher arteri diseas stroke microvascular complic diabet nephropathi neuropathi retinopathi import physician understand relationship diabet vascular diseas preval diabet continu increas unit state clinic armamentarium primari secondari prevent complic also expand diabet retinopathi diabet retinopathi may common microvascular complic diabet respons ∼ 10,000 new case blind everi year unit state alone.1 risk develop diabet retinopathi microvascular complic diabet depend durat sever hyperglycemia develop diabet retinopathi patient type 2 diabet found relat sever hyperglycemia presenc hypertens u.k. prospect diabet studi ukpd patient type 1 diabet develop evid retinopathi within 20 year diagnosis.2,3 retinopathi may begin develop earli 7 year diagnosi diabet patient type 2 diabetes.1 sever propos patholog mechan diabet may lead …',\n",
       "  \"involv s-nitrosyl actin inhibit neurotransmitt releas nitric oxid background role diffus messeng nitric oxid regul pain transmiss still debat matter pro-nocicept and/or anti-nocicept s-nitrosyl revers post-transl modif select cystein residu protein emerg import mechan act signal molecul occurr s-nitrosyl spinal cord target may modul pain transmiss remain unclarifi `` biotin-switch '' method matrix-assist laser desorption/ion time-of-flight mass spectrometri employ identifi s-nitrosyl protein result show actin major protein s-nitrosyl spinal cord donor s-nitroso-n-acetyl-dl-penicillamin snap interestingli actin s-nitrosyl s2 fraction p2 fraction spinal homogen treatment pc12 cell snap caus rapid s-nitrosyl actin inhibit dopamin releas cell like cytochalasin b depolymer actin snap decreas amount filament actin cytoskeleton beneath membran inhibit dopamin releas attenu inhibitor solubl guanylyl cyclas cgmp-depend protein kinas conclus present studi demonstr actin major s-nitrosyl protein spinal cord suggest directli regul neurotransmitt releas s-nitrosyl addit well-known phosphoryl cgmp-depend protein kinas\",\n",
       "  'independ associ lobular involut mammograph breast densiti breast cancer risk background lobular involut age-rel atrophi breast lobul invers associ breast cancer risk mammograph breast densiti mbd posit associ breast cancer risk method evalu whether lobular involut mbd independ associ breast cancer risk women benign breast diseas perform nest cohort studi among women n 2666 benign breast diseas diagnos mayo clinic januari 1 1985 decemb 31 1991 mammogram avail within 6 month diagnosi women follow averag 13.3 year document breast cancer incid lobular involut categor none partial complet parenchym pattern classifi use wolf classif n1 nondens p1 p2 ductal promin occupi 25 25 breast respect dy extrem dens hazard ratio hr 95 confid interv ci assess associ lobular involut mbd breast cancer risk estim use adjust cox proport hazard model test statist signific two-sid result adjust mbd partial lobular involut associ higher risk breast cancer complet involut none hr breast cancer incid 2.62 95 ci 1.39 4.94 partial hr breast cancer incid 1.61 95 ci 1.03 2.53 p trend .002 similarli adjust involut dens breast associ higher risk breast cancer nondens breast dy hr breast cancer incid 1.67 95 ci 1.03 2.73 p2 hr breast cancer incid 1.96 95 ci 1.20 3.21 p1 hr breast cancer incid 1.23 95 ci 0.67 2.26 p trend .02 combin involut dens breast associ higher risk breast cancer complet involut nondens breast hr breast cancer incid 4.08 95 ci 1.72 9.68 p .006 conclus lobular involut mbd independ associ breast cancer incid combin associ even greater risk breast cancer',\n",
       "  'pleiotropi mechan stabil cooper gene affect mani trait phenomenon known pleiotropi major constraint evolut adapt chang one trait may prevent would compromis trait affect gene show pleiotropi unexpect effect benefit one enigmat adaptations—cooper spectacular act cooper occur social amoeba dictyostelium discoideum cell die form stalk hold cell aloft reproduct spore identifi gene dima d. discoideum two contrast effect requir receiv signal molecul dif-1 caus differenti prestalk cell ignor dif-1 becom prestalk allow cell cheat avoid stalk howev find aggreg contain wild-typ cell lack dima gene result exclus spore pleiotrop linkag stalk spore format limit potenti cheat d. discoideum defect prestalk cell product result even greater reduct spore propos evolut pleiotrop link cheat person cost stabil cooper adapt',\n",
       "  \"homeobox gene goosecoid control cell migrat xenopu embryo goosecoid gsc homeobox gene express specif dorsal blastopor lip xenopu gastrula consid play import role spemann 's organ phenomenon lineag trace time-laps microscopi use follow fate embryon cell microinject gsc mrna microinject gsc non-cel autonom effect recruit neighbor uninject cell twin dorsal axi ectop express gsc mrna ventral blastomer well overexpress gsc dorsal blastomer lead cell movement toward anterior embryo result suggest function gsc control gastrul movement group cell dissoci cell demonstr vertebr homeobox gene regul region-specif cell migrat\",\n",
       "  'epigenet switch involv activ pioneer factor foxa1-depend enhanc transcript factor tf bind specif discret region mammalian genom call cis-regulatori element among enhanc play key role regul gene express develop differenti despit recogn central regulatori role exert chromatin control tf function much remain learn regard chromatin structur enhanc establish analyz genomic-scal enhanc recruit foxa1 pioneer transcript factor trigger transcript compet cis-regulatori site importantli found foxa1 bind genom region show local dna hypomethyl cell-type-specif recruit chromatin link differenti dna methyl level bind site use neural differenti model show induct foxa1 express subsequ recruit enhanc associ dna demethyl concomitantli histon h3 lysin 4 methyl induc enhanc epigenet chang may stabil foxa1 bind allow subsequ recruit transcript regulatori effector interestingli clone report construct foxa1-depend enhanc abl recapitul cell type specif howev activ inhibit dna methyl henc enhanc intrins cell-type-specif regulatori region activ potenti foxa1 induct epigenet switch includ notabl dna demethyl',\n",
       "  'leptin treatment amelior anxieti ob/ob obes mice investig whether administ leptin influenc anxiety-lik behavior ob/ob mice repeat intraperiton administr leptin continu 5 day anxieti assess standard elev plu maze bodi weight measur daili repeat administr leptin significantli increas percentag total number entri open arm number total entri bodi weight significantli reduc 13.2 treatment leptin treatment amelior obes also anxieti ob/ob mice result indic treatment obes may lead solut psycholog problem',\n",
       "  'predict new molecular target known drug although drug intend select least bind sever physiolog target explain side effect efficaci mani drug-target combin exist would use explor possibl interact comput compar 3,665 us food drug administr fda -approv investig drug hundr target defin target ligand chemic similar drug ligand set predict thousand unanticip associ thirti test experiment includ antagon beta 1 receptor transport inhibitor prozac inhibit 5-hydroxytryptamin 5-ht transport ion channel drug vadilex antagon histamin h 4 receptor enzym inhibitor rescriptor overal 23 new drug-target associ confirm five potent 100 nm physiolog relev one drug n n-dimethyltryptamin dmt serotonerg receptor confirm knockout mous chemic similar approach systemat comprehens may suggest side-effect new indic mani drug',\n",
       "  'bone loss vascular calcif bi-direct interplay vascular calcif vc repres recogn advers predictor cardiovascular morbid mortal previous consid passiv degen vc recogn activ process resembl bone format share number histopatholog featur miner composit initi mechan bone develop metabol oxid stress inflamm key factor vc osteoporosi op biochem factor known primarili involv healthi bone metabol also regul vc biomark includ vitamin osteoprotegerin osteopontin matrix gla protein cathepsin k fibroblast growth factor-23 fetuin-a better understand highli control regulatori network multipl nest feedback loop cross talk organ may help decreas grow preval calcif vasculopathi well op age popul advanc common prevent therapeut intervent target condit',\n",
       "  'immobil chemokin field solubl chemokin gradient cooper shape migrat pattern dendrit cell chemokin orchestr immun cell traffick elicit either direct random migrat activ integrin order induc cell adhes analyz dendrit cell dc migrat show distinct cellular respons depend mode chemokin present within tissu surface-immobil form chemokin ccl21 heparan sulfate-anchor ligand cc-chemokin receptor 7 ccr7 caus random movement dc confin chemokine-pres surfac trigger integrin-medi adhes upon direct contact ccl21 dc truncat anchor residu ccl21 therebi releas solid phase solubl ccl21 function resembl second ccr7 ligand ccl19 lack anchor residu form solubl gradient solubl ccr7 ligand trigger chemotact movement surfac adhes adhes random migrat direct steer cooper produc dynam spatial restrict locomot pattern close resembl cellular dynam observ secondari lymphoid organ',\n",
       "  'local prolifer domin lesion macrophag accumul atherosclerosi inflammatori respons drive atherogenesi macrophag accumul progress expand arteri wall observ circul monocyt give rise lesion macrophag reinforc concept monocyt infiltr dictat macrophag buildup recent work indic howev macrophag accumul depend monocyt recruit inflammatori context therefor revisit mechan underli macrophag accumul atherosclerosi murin atherosclerot lesion found macrophag turn rapidli 4 week replenish macrophag experiment atheromata depend predominantli local macrophag prolifer rather monocyt influx microenviron orchestr macrophag prolifer involv scaveng receptor sr-a studi reveal macrophag prolifer key event atherosclerosi identifi macrophag self-renew therapeut target cardiovascular diseas',\n",
       "  'enzymat activ lysosom proteas associ amyloid deposit alzheim brain format beta-amyloid brain individu alzheim diseas requir proteolyt cleavag membrane-associ precursor protein proteas may involv process yet identifi cathepsin normal intracellular proteolyt enzym associ lysosom howev section alzheim brain stain antisera cathepsin cathepsin b high level immunoreact also detect senil plaqu extracellular site cathepsin immunoreact seen control brain age-match individu without neurolog diseas patient huntington diseas parkinson diseas situ enzym histochemistri cathepsin cathepsin b section neocortex use synthet peptid protein substrat show senil plaqu contain highest level enzymat activ cathepsin ultrastructur level cathepsin immunoreact senil plaqu local princip lysosom dens bodi lipofuscin granul extracellular similar structur abund degener neuron alzheim neocortex cathepsin-laden neuron perikarya variou stage disintegr could seen within senil plaqu high level enzymat compet lysosom proteas abnorm local senil plaqu repres evid candid enzym may mediat proteolyt format amyloid propos amyloid precursor protein within senil plaqu process lysosom proteas princip deriv degener neuron escap cathepsin stringent regul intracellular milieu provid basi abnorm sequenc proteolyt cleavag accumul amyloid precursor protein',\n",
       "  'gastric juic mir-129 potenti biomark screen gastric cancer microrna mirna play crucial role occurr develop gastric cancer convent serolog test screen gastric cancer limit sensit specif sever mirna peripher blood use biomark gastric cancer howev mirna share sever type cancer thank tissu specif gastric juic examin feasibl use gastric juic mir-129-1/2 aberrantli express gastric cancer screen gastric cancer total 141 gastric juic sampl gastric cancer gastric ulcer atroph gastriti minim gastriti patient subject normal mucosa collect gastroscopi gastric juic mir-129-1/2 level detect quantit revers transcription-polymeras chain reaction receiv oper characterist roc curv construct differenti patient gastric cancer patient benign gastric diseas show compar patient benign gastric diseas patient gastric cancer significantli lower level gastric juic mir-129-1-3p mir-129-2-3p area roc curv auc 0.639 0.651 mir-129-1-3p mir-129-2-3p respect use parallel combin test auc 0.656. summari result suggest gastric juic mir-129-1-3p mir-129-2-3p potenti biomark screen gastric cancer detect gastric juic mirna conveni non-invas method diagnosi gastric cancer',\n",
       "  'epidemiolog expans structur studi clinic challeng new β-lactamas gram-neg bacteria β-lactamas evolut present infecti diseas commun major challeng treatment infect caus multidrug-resist gram-neg bacteria 1,000 natur occur β-lactamas exist attempt correl structur function becom daunt although new enzym extended-spectrum β-lactamas esbl famili frequent identifi older ctx-m-14 ctx-m-15 enzym becom preval esbl global surveil carbapenemas either serine-bas zinc-facilit hydrolysi mechan pose critic problem geograph region report kpc serin carbapenemas metallo-β-lactamas vim imp ndm-1 even though ndm-1 recent identifi rapid emerg newer enzym multipl β-lactamas appear singl organ make design new β-lactamas inactiv β-lactamase-st β-lactam difficult combin therapi like requir counteract continu evolut insidi enzym multidrug-resist pathogen',\n",
       "  'robust synchron coupl circadian cell cycl oscil singl mammalian cell circadian cycl cell cycl two fundament period process period rang 1 day consequ coupl cycl lead synchron estim mutual interact two oscil time-laps imag singl mammalian nih3t3 fibroblast sever day analysi thousand circadian cycl divid cell clearli indic oscil tick 1:1 mode-lock state cell divis occur tightli 5 h peak circadian rev-erbα-yfp report express principl synchroni may caus either unidirect bidirect coupl gate cell divis circadian cycl studi data combin stochast model unambigu show revers coupl predomin nih3t3 cell moreov temperatur genet pharmacolog perturb show two interact cellular oscil adopt synchron state highli robust wide rang paramet find implic circadian function prolif tissu includ epidermi immun cell cancer',\n",
       "  'identif brainstem circuit control feed hunger driven neg energi balanc elicit search consumpt food respons part mediat neuron hypothalamu role specif cell type brain region less well defin show neuron dorsal raph nucleu express vesicular transport gaba glutam hereaft drnvgat drnvglut3 neuron reciproc activ chang energi balanc modul activ opposit effect feeding-drnvgat neuron increas wherea drnvglut3 neuron suppress food intak furthermor modul neuron obes ob/ob mice suppress food intak bodi weight normal locomotor activ final use molecular profil identifi druggabl target neuron show local infus agonist specif receptor neuron potent effect feed data establish drn import node control energi balanc paperclip',\n",
       "  'infection-induc netosi dynam process involv neutrophil multitask vivo neutrophil extracellular trap net releas neutrophil die vitro process requir hour leav tempor gap invas microb may exploit neutrophil capabl migrat phagocytosi undergo netosi document gram-posit skin infect directli visual live polymorphonuclear cell pmn vivo rapidli releas net prevent system bacteri dissemin netosi occur crawl therebi cast larg area net net-releas pmn develop diffus decondens nuclei ultim becom devoid dna cell abnorm nuclei show unusu crawl behavior highlight errat pseudopod hyperpolar consist nucleu fulcrum crawl requir toll-lik receptor 2 complement-medi opson tightli regul net releas addit live human pmn inject mous skin develop decondens nuclei form net vivo intact anuclear neutrophil abund gram-posit human abscess therefor earli infect netosi involv neutrophil undergo lysi retain abil multitask',\n",
       "  'swim train suppress tumor growth mice present studi design determin effect physic train develop cancer induc inject ehrlich tumor cell mice male swiss mice subject swim train protocol 5 days/wk 6 wk 1 h 50 maxim capacity-train group remain sedentari cage sedentari group inocul ehrlich tumor cell perform end fourth week anim kill 6 wk train heart solid tumor weight record tumor volum calcul portion tumor use evalu macrophag neutrophil accumul fix neutral 10 buffer formalin histolog analysi tumor volum weight respect approxim 270 280 greater sedentari mice train mice macrophag infiltr tumor tissu significantli lower train mice 0.65 +/- 0.16 vs. 1.78 +/- 0.43 macrophag x 10 3 sedentari group moreov neutrophil accumul tumor slightli reduc exercis train amount tumor cell reduc train mice exercis capac substanti increas train mice determin 440 increas exercis time 50 maxim capac summari swim train retard develop ehrlich tumor mice accompani reduct macrophag infiltr neutrophil accumul find provid conceptu support clinic observ control physic activ may therapeut import approach prevent cancer progress may improv outcom cancer treatment',\n",
       "  'lung dendrit cell imprint cell lung home promot lung immun chemokin receptor ccr4 cell traffick lung critic lung immun mechan mediat cell lung home well understood show lung dendrit cell dc imprint cell lung home lung dc-activ cell traffic effici lung respons inhal antigen homeostasi compar cell activ dc tissu consequ lung dc-imprint cell protect influenza effect gut skin dc-imprint cell lung dc imprint express ccr4 cell ccr4 contribut cell lung imprint lung dc-activ ccr4-defici cell fail traffic lung effici protect influenza effect lung dc-activ ccr4-suffici cell thu lung dc imprint cell lung home promot lung immun part ccr4',\n",
       "  'microrna safeguard turmoil emerg data suggest microrna mirna instrument varieti stress respons addit recogn role develop surprisingli mirna normal suppress express target transcript may becom activ express stress might partial explain new interact mirna/argonaut complex rna-bind protein reloc differ subcellular compart stress',\n",
       "  'vascular smooth muscl cell calcif mediat regul exosom secret rational matrix vesicl mv secret vascular smooth muscl cell vsmc form first nidu miner fetuin-a potent circul inhibitor calcif specif load mv howev process fetuin-a intracellular traffick mv biogenesi poorli understood object object studi investig regul role mv biogenesi vsmc calcif method result alexa488-label fetuin-a intern human vsmc traffick via endosom system exocytos multivesicular bodi via exosom releas vsmc-deriv exosom enrich tetraspanin cd9 cd63 cd81 releas regul sphingomyelin phosphodiesteras 3. compar proteom show vsmc-deriv exosom composit similar exosom cell sourc also share compon osteoblast-deriv mv includ calcium-bind extracellular matrix protein elev extracellular calcium found induc sphingomyelin phosphodiesteras 3 express secret calcifi exosom vsmc vitro chemic inhibit sphingomyelin phosphodiesteras 3 prevent vsmc calcif vivo multivesicular bodi contain exosom observ vessel chronic kidney diseas patient dialysi cd63 found coloc calcif importantli factor tumor necrosi factor-α platelet deriv growth factor-bb also found increas exosom product lead increas calcif vsmc respons calcifi condit conclus studi identifi mv exosom show factor increas exosom releas promot vascular calcif respons environment calcium stress modul exosom releas pathway may novel therapeut target prevent',\n",
       "  \"vaccin malaria licenc vaccin human parasit diseas plasmodium falciparum malaria major caus infecti mortal present great challeng vaccin develop led assess wide varieti approach malaria vaccin design develop assist avail safe challeng model small-scal efficaci test vaccin candid malaria vaccin develop forefront assess mani new vaccin technolog includ novel adjuv vector prime-boost regim concept commun vaccin block malaria transmiss current vaccin candid target singl stage parasit 's life cycl vaccin earli pre-erythrocyt stage shown success protein adjuv vaccin work antibodi sporozoit viral vector vaccin target intracellular liver-stag parasit cellular immun show partial efficaci human anti-sporozoit vaccin current phase iii trial howev effect malaria vaccin suitabl widespread cost-effect deploy like requir multi-compon vaccin target one life cycl stage attract near-term approach develop product combin exist partial effect pre-erythrocyt vaccin candid\",\n",
       "  'microrna-21 induc rapamycin model tuber sclerosi tsc lymphangioleiomyomatosi lam lymphangioleiomyomatosi lam multisystem diseas women manifest prolifer smooth muscle-lik cell lung result cystic lung destruct women lam also develop renal angiomyolipoma lam caus mutat tuber sclerosi complex gene tsc1 tsc2 result hyperact mammalian target rapamycin mtor signal mtor inhibitor rapamycin stabil lung function lam decreas volum renal angiomyolipoma lung function declin angiomyolipoma regrow treatment discontinu suggest factor induc mtorc1 inhibit may promot surviv tsc2-defici cell whether microrna mirna mir signal involv respons lam mtorc1 inhibit unknown identifi rapamycin-depend mirna lam patient angiomyolipoma-deriv cell use two separ screen first assay 132 mirna known signific tumor biolog use cut-off 1.5-fold chang 48 microrna rapamycin-induc 4 mir downregul second screen encompass 946 mirna 18 mir upregul rapamycin eight downregul dysregul mir 29b 21 24 221 106a 199a common platform classifi candid `` rapamirs. `` valid qrt-pcr confirm microrna increas mir-21 pro-surviv mir significantli increas mtor-inhibit p 0.01 regul mir-21 rapamycin cell type independ mtor inhibit promot process mir-21 transcript pri-mir-21 prematur form pre-mir-21 conclus find demonstr rapamycin upregul multipl mir includ pro-surviv mir tsc2-defici patient-deriv cell induct mir may contribut respons lam tsc patient rapamycin therapi',\n",
       "  'reduc nf1 express confer resist egfr inhibit lung cancer activ mutat egf receptor egfr associ clinic respons egfr tyrosin kinas inhibitor tki erlotinib gefitinib howev resist eventu aris often due second egfr mutat commonli t790m genome-wid sirna screen human lung cancer cell line analys murin mutant egfr-driven lung adenocarcinoma found erlotinib resist associ reduc express neurofibromin ra gtpase-activ protein encod nf1 gene erlotinib fail fulli inhibit ras-erk signal neurofibromin level reduc treatment neurofibromin-defici lung cancer map-erk kinas mek inhibitor restor sensit erlotinib low level nf1 express associ primari acquir resist lung adenocarcinoma egfr tki patient find identifi subgroup patient egfr-mut lung adenocarcinoma might benefit combin therapi egfr mek inhibitor',\n",
       "  'human irgm induc autophagi elimin intracellular mycobacteria immunity-rel p47 guanosin triphosphatas irg play role defens intracellular pathogen found murin irgm1 lrg-47 guanosin triphosphatas induc autophagi gener larg autolysosom organel mechan elimin intracellular mycobacterium tuberculosi also identifi function human irg protein control intracellular pathogen report human irgm1 ortholog irgm play role autophagi reduct intracellular bacillari load',\n",
       "  'implement clinic pharmaci educ program teach hospit resid orient document intervent aim studi provid clinic pharmaci educ program masih daneshvari hospit univers affili hospit locat tehran iran purpos common pharmacist involv intervent aspect potenti field pharmaci student resid educ firstli identifi clinic pharmaci intervent drug inform form fill studi period januari 2006 till januari 2007. base result studi total number 772 intervent conduct studi year drug inform highest rate 22.30 among intervent follow dose adjust therapeut reduct addit mean number medic per patient 8.62 ± 7.54. conclus could said although countri challeng pharmaci profess initi stage compar develop countri result studi reveal high demand servic among health care provid',\n",
       "  'surgic anatomi conduct tissu basi collect experi review disposit cardiac conduct tissu might observ surgeon normal abnorm heart sinu node lie subepicardi termin sulcu variabl blood suppli entir superior cavoatri junction potenti danger area morpholog discret tract extend atrial tissu sinu atrioventricular node atrioventricular node atrial extent atrioventricular conduct axi contain exclus within triangl koch axi penetr central fibrou bodi branch muscular ventricular septum immedi beneath interventricular compon membran septum landmark structur describ might seen right atrium left atrium aorta consider given surgic anatomi abnorm muscular atrioventricular connect underscor ventricular pre-excit syndrom final rule develop wherebi disposit conduct tissu predict accuraci congenit malform heart set normal abnorm chamber connect import variabl respect align atrial ventricular septal structur pattern ventricular architectur present',\n",
       "  'agreement onlin dietari assess tool myfood24 interviewer-administ 24-h dietari recal british adolesc age 11-18 year myfood24 onlin 24-h dietari assess tool develop use among british adolesc adult limit inform avail regard valid use new technolog assess nutrit intak among adolesc thu rel valid myfood24 face-to-fac interviewer-administ 24-h multiple-pass recal mpr conduct among seventy-f british adolesc age 11-18 year particip ask complet myfood24 interviewer-administ mpr day 2 non-consecut day school total energi intak ei nutrient record two method compar use intraclass correl coeffici icc bland-altman plot use within-individu inform weight κ assess agreement energi macronutri report nutrient myfood24 demonstr strong agreement interview mpr data icc rang 0·46 na 0·88 ei signific bia two method ei macronutri report nutrient mean differ myfood24 interviewer-administ mpr ei -230 kj -55 kcal 95 ci -490 30 kj -117 7 kcal p=0·4 limit agreement rang 39 3336 kj -797 kcal lower 34 2874 kj 687 kcal higher interviewer-administ mpr good agreement term classifi adolesc tertil ei κ w =0·64 agreement day 1 day 2 good myfood24 interviewer-administ mpr reflect reliabl myfood24 myfood24 potenti collect dietari data compar qualiti interviewer-administ mpr',\n",
       "  'modul cancer chemotherapi green tea biochem modul play import role develop cancer chemotherapi direct attent intak common beverag investig effect green tea tea compon antitumor activ doxorubicin carri combin treatment toxorubicin green tea ehrlich ascit carcinoma tumor-bear mice oral administr green tea enhanc 2.5-fold inhibitori effect doxorubicin tumor growth doxorubicin concentr tumor increas combin green tea doxorubicin contrast increas doxorubicin concentr observ normal tissu green tea combin furthermor enhanc antitumor activ doxorubicin induc green tea observ m5076 ovarian sarcoma low sensit doxorubicin result suggest drink green tea encourag cancer chemotherapi may improv qualiti life clinic patient',\n",
       "  'histon deacetylas 5 interact krüppel-lik factor 2 inhibit transcript activ endothelium aim vascular endotheli dysfunct inflamm hallmark atherosclerosi krüppel-lik factor 2 klf2 key mediat anti-inflammatori anti-atherosclerot properti endothelium howev littl known molecular mechan regul klf2 transcript activ method result found histon deacetylas 5 hdac5 associ klf2 repress klf2 transcript activ hdac5 resid klf2 nuclei human umbil cord vein endotheli cell huvec steadi laminar flow attenu associ hdac5 klf2 via stimul hdac5 phosphorylation-depend nuclear export huvec also map klf2-hdac5-interact domain found n-termin region hdac5 interact c-termin domain klf2 chromatin immunoprecipit luciferas report assay show hdac5 direct associ klf2 suppress klf2 transcript activ hdac5 overexpress inhibit klf2-depend endotheli nitric oxid synthesi eno promot activ cos7 cell gene express huvec bovin aortic endotheli cell baec convers hdac5 silenc enhanc klf2 transcript henc eno express huvec moreov observ level eno protein thorac aorta isol hdac5 knockout mice higher wherea express pro-inflammatori vascular cell adhes molecul 1 lower compar hdac5 wild-typ mice conclus reveal novel role hdac5 modul klf2 transcript activ eno express find suggest hdac5 bind partner modul klf2 could new therapeut target prevent vascular endotheli dysfunct associ cardiovascular diseas',\n",
       "  'n348i hiv-1 revers transcriptas counteract nevirapine-medi bia toward rnase h cleavag plus-strand initi drug resistance-associ mutat hiv-1 revers transcriptas rt affect balanc polymeras ribonucleas h rnase h activ enzym recent demonstr n348i mutat connect domain caus select dissoci rnase h-compet complex wherea function integr polymerase-compet complex remain larg unaffect n348i associ resist non-nucleosid rt inhibitor nnrti nevirapin howev possibl mechan link chang rnase h activ chang nnrti suscept remain establish address problem consid recent find suggest nnrti may affect orient rt nucleic acid substrat increas rnase h activ demonstr rnase h-mediat primer remov inde effici presenc nnrti howev n348i mutant enzym abl counteract effect efavirenz tight bind inhibitor restrict influenc mutat find provid strong evid suggest n348i thwart inhibitori effect nevirapin initi -strand dna synthesi provid novel mechan resist data agreement clinic data demonstr stronger effect n348i suscept nevirapin compar efavirenz',\n",
       "  'cancer survivorship research challeng recruit adult long term cancer survivor cooper clinic trial group introduct grow number adult cancer survivor increas need inform link potenti late long term effect specif treatment regimen adult cancer patient treat clinic trial howev patient previous enrol trial import sourc inform treatment-rel late effect method focus colorect cancer survivor use databas five phase iii random clinic trial nation surgic adjuv breast bowel project nsabp recruit enrol long term survivor studi late health outcom qualiti life describ challeng recruit patient 5 -20 year treatment result sixty-f nsabp treatment site invit enrol patient studi sixti particip potenti recruit 2,408 patient receiv registr form 976 patient 41 744 76 express interest particip 708 complet interview 95 express interest 29 total potenti sampl multipl barrier recruit difficulti locat patient lack institut commit lack patient interest conclus patient treat clinic trial import potenti sourc examin late effect cancer treatment retrospect recruit substanti limit futur mechan establish prospect long-term follow-up identifi understand frequenc type late effect associ cancer treatment implic cancer survivor cancer patient live longer import learn particip clinic trial whether specif treatment regimen associ seriou late effect',\n",
       "  'arylsulfatas b improv locomotor function mous spinal cord injuri bacteri chondroitinas abc chaseabc use remov inhibitori chondroitin sulfat chain chondroitin sulfat proteoglycan improv regener rodent spinal cord injuri hypothes mammalian enzym arylsulfatas b arsb would also enhanc recoveri mous spinal cord injuri applic mammalian enzym would attract altern chaseabc robust chemic stabil reduc immunogen one-tim inject human arsb injur mous spinal cord elimin immunoreact chondroitin sulfat within five day 9 week injuri moder spinal cord injuri observ improv locomotor recoveri assess basso mous scale bm arsb treat mice compar buffer-tr control group 6 week inject sever spinal cord injuri mice inject equival unit arsb chaseabc improv similarli group achiev significantli locomotor recoveri buffer-tr control mice serotonin tyrosin hydroxylas immunoreact axon extens present mous spinal cord treat arsb chaseabc immunoreact axon penetr beyond injuri site arsb chaseabc treat mice control mice result indic mammalian arsb improv function recoveri cn injuri structural/molecular mechan underli observ function improv remain elucid',\n",
       "  \"world health organ adult adhd self-report scale asr short screen scale use gener popul background self-report screen scale adult attention-deficit/hyperact disord adhd world health organ adult adhd self-report scale asr develop conjunct revis composit intern diagnost interview cidi current report present data concord asr short-form asr screener blind clinic diagnos commun sampl method asr includ 18 question frequenc recent dsm-iv criterion symptom adult adhd asr screener consist six 18 question select base stepwis logist regress optim concord clinic classif asr respons compar blind clinic rate dsm-iv adult adhd sampl 154 respond previous particip us nation comorbid survey replic ncs-r oversampl report childhood adhd adult persist result asr symptom measur significantli relat compar clinic symptom rate vari substanti concord cohen 's kappa rang 0.16-0.81 optim score predict clinic syndrom classif sum unweight dichotom respons across 18 asr question howev wide variat symptom-level concord unweight six-quest asr screener outperform unweight 18-question asr sensit 68.7 v. 56.3 specif 99.5 v. 98.3 total classif accuraci 97.9 v. 96.2 kappa 0.76 v. 0.58 conclus clinic calibr larger sampl might show weight version 18-question asr outperform six-quest asr screener time howev unweight screener prefer full asr commun survey clinic outreach case-find initi\",\n",
       "  'human milk proresolv mediat stimul resolut acut inflamm human milk contain nutrient bioactiv product relev infant develop immunolog protect investig proresolv properti milk use human milk lipid mediat isol hlmi determin impact resolut program vivo human macrophag hlmi reduc maximum neutrophil number 14.6±1.2 × 106–11.0±1.0 × 106 cell per exud shorten resolut interv ri 50 neutrophil reduct 54 compar periton use rigor liquid-chromatographi tandem-mass spectrometri lc-ms-m -base lipid mediat lm metabololipidom demonstr human milk possess proresolv lm-special proresolv mediat lm-spm signatur profil contain spm e.g resolvin rv protectin pd maresin mar lipoxin lx bioactiv level pico-nanomolar concentr enhanc human macrophag efferocytosi bacteri contain spm identifi human milk includ d-seri rv e.g. rvd1 rvd2 rvd3 at-rvd3 rvd4 pd1 mar1 e-seri rv e.g rve1 rve2 rve3 lx lxa4 lxb4 spm identifi human milk rvd2 mar1 50 ng per mous individu shorten ri ∼75 milk mastiti gave higher leukotrien b4 prostanoid lower spm level taken togeth find provid evid human milk proresolv action via comprehens lm-spm profil describ potenti novel mechan maternal–inf biochem imprint',\n",
       "  'cerebr perfus stroke stroke heterogen syndrom caus multipl diseas mechan result disrupt cerebr blood flow subsequ tissu damag review cover mechan respons regul normal cerebr circul disrupt diseas state central concept treat patient acut ischaem stroke exist ischaem penumbra potenti salvag tissu evid exist human review',\n",
       "  \"epigenet regul mir-184 mbd1 govern neural stem cell prolifer differenti methyl-cpg bind protein 1 mbd1 regul gene express via dna methylation-medi epigenet mechan previous demonstr mbd1 defici impair adult neural stem/progenitor cell ansc differenti neurogenesi underli mechan unclear show mbd1 regul express sever microrna ansc specif mir-184 directli repress mbd1 high level mir-184 promot prolifer inhibit differenti ansc wherea inhibit mir-184 rescu phenotyp associ mbd1 defici found mir-184 regul express numblik numbl known regul brain develop bind 3'-utr numbl mrna affect translat express exogen numbl could rescu ansc defect result either mir-184 overexpress mbd1 defici therefor mbd1 mir-184 numbl form regulatori network help control balanc prolifer differenti ansc\",\n",
       "  \"landscap genet lesion 944 patient myelodysplast syndrom high-throughput dna sequenc significantli contribut diagnosi prognost patient myelodysplast syndrom md determin biolog prognost signific genet aberr md total 944 patient variou md subtyp screen known/put mutations/delet 104 gene use target deep sequenc array-bas genom hybrid total 845/944 patient 89.5 harbor least one mutat median 3 per patient rang 0-12 forty-seven gene significantli mutat tet2 sf3b1 asxl1 srsf2 dnmt3a runx1 mutat 10 case mani mutat associ higher risk group and/or blast elev surviv investig 875 patient univari analysi 25/48 gene result 47 gene test significantli plu prpf8 affect surviv p 0.05 statu 14 gene combin convent factor reveal novel prognost model 'model-1 separ patient four risk group 'low 'intermedi 'high 'veri high risk 3-year surviv 95.2 69.3 32.8 5.3 p 0.001 subsequ 'gene-onli model 'model-2 construct base 14 gene also yield four signific risk group p 0.001 model reproduc valid cohort n=175 patient p 0.001 thu large-scal genet molecular profil multipl target gene invalu subclassif prognost md patient\",\n",
       "  'integr molecular genet profil pediatr high-grad glioma reveal key differ adult diseas purpos defin copi number alter gene express signatur underli pediatr high-grad glioma hgg patient method conduct high-resolut analysi genom imbal 78 de novo pediatr hgg includ seven diffus intrins pontin glioma 10 hgg aris children receiv cranial irradi previou cancer use singl nucleotid polymorph microarray analysi gene express analyz gene express microarray 53 tumor result compar publicli avail data adult tumor result signific differ copi number alter distinguish childhood adult glioblastoma pdgfra predomin target focal amplif childhood hgg includ diffus intrins pontin glioma gene express analys support import role deregul pdgfralpha signal pediatr hgg idh1 hotspot mutat found pediatr tumor highlight molecular differ adult secondari glioblastoma pediatr adult glioblastoma clearli distinguish frequent gain chromosom 1q 30 v 9 respect lower frequenc chromosom 7 gain 13 v 74 respect 10q loss 35 v 80 respect pdgfra amplif 1q gain occur significantli higher frequenc irradiation-induc tumor suggest initi event childhood gliomagenesi subset pediatr hgg show minim copi number chang conclus integr molecular profil show substanti differ molecular featur underli pediatr adult hgg indic find adult tumor simpli extrapol younger patient pdgfralpha may use target pediatr hgg includ diffus pontin glioma',\n",
       "  'gene set enrich analysi knowledge-bas approach interpret genome-wid express profil although genomewid rna express analysi becom routin tool biomed research extract biolog insight inform remain major challeng describ power analyt method call gene set enrich analysi gsea interpret gene express data method deriv power focus gene set group gene share common biolog function chromosom locat regul demonstr gsea yield insight sever cancer-rel data set includ leukemia lung cancer notabl single-gen analysi find littl similar two independ studi patient surviv lung cancer gsea reveal mani biolog pathway common gsea method embodi freeli avail softwar packag togeth initi databas 1,325 biolog defin gene set',\n",
       "  'evolut rna multipl function increas number transcript report transmit protein-cod regulatori inform apart challeng concept gene observ rais question extent phenomenon occur across genom dual encod function evolv eukaryot genom address question consid evolutionari path gene earliest form life earth gener regard protein evolv cellular machineri base entir within rna led domin protein-cod gene genom microorgan although like rna never lost capac function evidenc cis-act riboswitch utr basi subsequ evolut sophist regulatori architectur provid higher level epigenet control accur spatiotempor express development complex organ complic task hypothes mrna remain subject secondari select provid trans-act regulatori capabl parallel protein-cod function ii perhap mani protein-cod loci possibl consequ gene duplic lost protein-cod function en rout acquir sophist trans-regulatori function iii mani transcript becom subject secondari process releas differ product iv novel protein emerg within loci previous evolv function regulatori rna support idea dynam flux differ type inform rna evolutionari real time review recent observ arisen transcriptom survey complex eukaryot reconsid observ impact notion appar discret loci may express transcript one function conclus posit mani eukaryot loci evolv capac transact multitud overlap potenti independ function regulatori protein-cod rna',\n",
       "  'vitro–expand antigen-specif regulatori cell suppress autoimmun diabet low number cd4+ cd25+ regulatori cell treg anerg phenotyp divers antigen specif present major challeng har potent tolerogen popul treat autoimmun transplant reject studi describ robust method expand antigen-specif treg autoimmune-pron nonobes diabet mice purifi cd4+ cd25+ treg expand 200-fold less 2 wk vitro use combin anti-cd3 anti-cd28 interleukin 2. expand treg express classic cell surfac phenotyp function vitro vivo suppress effector cell function significantli small number antigen-specif treg revers diabet diseas onset suggest novel approach cellular immunotherapi autoimmun',\n",
       "  'stathmin overexpress identifi high-risk patient lymph node metastasi endometri cancer purpos overexpress oncogen stathmin link aggress endometri carcinoma potenti pi3kinas inhibitor diseas want valid prognost valu stathmin express larg prospect multicent set lymph node sampl part current surgic stage also aim test stathmin express endometri curettag specimen could predict lymph node metastasi experiment design total 1,076 endometri cancer patient recruit 10 center investig biolog tumor marker stathmin relat clinicopatholog variabl includ lymph node statu surviv stathmin immunohistochem stain carri 477 hysterectomi 818 curettag specimen result seventy-on percent patient n 763 subject lymph node sampl 12 metastat node n 94 overexpress stathmin detect 37 302 818 curettag 18 84 477 hysterectomi specimen investig stathmin overexpress curettag hysterectomi specimen highli correl significantli associ nonendometrioid histolog high grade aneuploidi stathmin analysi preoper curettag sampl significantli correl independ predictor lymph node metastas high stathmin express associ poor disease-specif surviv p ≤ 0.002 curettag hysterectomi specimen conclus stathmin immunohistochem stain identifi endometri carcinoma lymph node metastas poor surviv valu predict marker respons pi3kinas inhibit tool stratifi patient lymph node sampl endometri carcinoma remain determin',\n",
       "  'statin prophylaxi inflammatori mediat follow cardiopulmonari bypass systemat review introduct induct inflammatori respons thought signific role complic follow cardiopulmonari bypass cpb statin drug increasingli recogn potent anti-inflammatori effect henc potenti influenc import mechan injuri cpb although current confirm inde case object systemat review pre-op prophylact statin therapi compar placebo standard care decreas inflammatori respons peopl undergo heart surgeri cpb method perform systemat comprehens literatur search random control trial rct open heart surgeri cpb adult children receiv prophylact statin treatment prior cpb report outcom includ marker inflamm two author independ identifi elig studi extract data assess studi qualiti use standard instrument weight mean differ wmd primari summari statist data pool use random effect model descript analysi use data could pool result eight rct includ review number trial inflammatori outcom even limit pool data demonstr benefit use statin attenu post-cpb increas interleukin 6 8 il-6 il-8 peak high sensit c-reactiv protein hscrp tumor necrosi factor-alpha tnf-alpha post-cpb wmd 95 confid interv ci -23.5 pg/ml -36.6 -10.5 -23.4 pg/ml -35.8 -11.0 -15.3 mg/l ci -26.9 -3.7 -2.10 pg/ml -3.83 -0.37 respect limit rct evid suggest prophylact statin therapi may also decreas adhes molecul follow cpb includ neutrophil cd11b solubl p sp -selectin conclus although rct evid may suggest reduct post-cpb inflamm statin therapi evid definit due signific limit sever trial methodolog rigor statin intervent highli variabl small number studi systemat review demonstr signific gap exist current literatur regard potenti anti-inflammatori effect statin therapi prior cpb',\n",
       "  'array-bas compar genom hybrid genome-wid screen dna copi number bladder tumor genome-wid copi number profil character 41 primari bladder tumor use array-bas compar genom hybrid array cgh addit previous identifi alter larg chromosom region alter identifi mani small genom region high-level amplif homozyg delet high-level amplif detect 192 genom clone frequent 6p22.3 e2f3 8p12 fgfr1 8q22.2 cmyc 11q13 ccnd1 ems1 int2 19q13.1 ccne homozyg delet detect 51 genom clone four show delet one case two clone map 9p21.3 cdkn2a/p16 nine case one 8p23.1 three case one 11p13 two case signific correl observ copi number gain clone contain ccne1 gain erbb2 gain ccnd1 delet tp53 addit signific complementari associ gain ccnd1 gain e2f3 although signific relationship copi number chang tumor stage grade link behavior among genom loci suggest array cgh increasingli import understand pathway critic bladder tumor biolog',\n",
       "  'tet2 requir resolv inflamm recruit hdac2 specif repress il-6 epigenet modifi fundament role defin uniqu cellular ident establish mainten lineage-specif chromatin methyl statu sever dna modif 5-hydroxymethylcytosin 5hmc catalys ten eleven transloc tet methylcytosin dioxygenas famili member role tet protein regul chromatin architectur gene transcript independ dna methyl gradual uncov howev regul immun inflamm tet protein independ role modul dna methyl remain larg unknown show tet2 select mediat activ repress interleukin-6 il-6 transcript inflamm resolut innat myeloid cell includ dendrit cell macrophag loss tet2 result upregul sever inflammatori mediat includ il-6 late phase respons lipopolysaccharid challeng tet2-defici mice suscept endotoxin shock dextran-sulfate-sodium-induc coliti display sever inflammatori phenotyp increas il-6 product compar wild-typ mice iκbζ il-6-specif transcript factor mediat specif target tet2 il6 promot indic opposit regulatori role iκbζ initi resolut phase inflamm repress mechan independ dna methyl hydroxymethyl tet2 recruit hdac2 repress transcript il6 via histon deacetyl provid mechanist evid gene-specif transcript repress activ tet2 via histon deacetyl prevent constant transcript activ chromatin level resolv inflamm',\n",
       "  'control immun tnfr-relat molecul ox40 cd134 tnfr/tnf superfamili member control divers aspect immun function research past 10 year shown one import promin interact famili ox40 cd134 partner ox40l cd252 molecul strongli regul convent cd4 cd8 cell recent data highlight abil modul nkt cell nk cell function well mediat cross-talk profession antigen-pres cell divers cell type mast cell smooth muscl cell endotheli cell addit ox40-ox40l interact alter differenti activ regulatori cell block ox40l produc strong therapeut effect multipl anim model autoimmun inflammatori diseas line prospect clinic futur reagent stimul ox40 signal show promis adjuv vaccin well treatment cancer',\n",
       "  'drosophila dhr96 nuclear receptor bind cholesterol regul cholesterol homeostasi cholesterol homeostasi requir maintain normal cellular function avoid deleteri effect hypercholesterolemia show drosophila dhr96 nuclear receptor bind cholesterol requir coordin transcript respons gene regul cholesterol involv cholesterol uptak traffick storag dhr96 mutant die grown low level cholesterol accumul excess cholesterol maintain high-cholesterol diet cholesterol accumul phenotyp attribut misregul npc1b ortholog mammalian niemann-pick c1-like 1 gene npc1l1 essenti dietari cholesterol uptak studi defin dhr96 central regul cholesterol homeostasi',\n",
       "  'neuroimag investig associ aerob fit hippocamp volum memori perform preadolesc children children becom overweight unhealthi unfit understand neurocognit benefit activ lifestyl childhood import public health educ implic anim research indic aerob exercis relat increas cell prolifer surviv hippocampu well enhanc hippocampal-depend learn memori recent evid extend relationship elderli human suggest high aerob fit level older adult associ increas hippocamp volum superior memori perform present studi aim extend link fit hippocamp volum memori sampl preadolesc children end magnet reson imag employ investig whether higher- lower-fit 9- 10-year-old children show differ hippocamp volum differ relat perform item relat memori task relat item memori primarili support hippocampu consist predict higher-fit children show greater bilater hippocamp volum superior relat memori task perform compar lower-fit children hippocamp volum also posit associ perform relat item memori task furthermor bilater hippocamp volum found mediat relationship fit level vo 2 max relat memori relationship aerob fit nucleu accumben volum memori report strengthen hypothes specif effect fit hippocampu find first indic aerob fit may relat structur function preadolesc human brain',\n",
       "  'associ matern serum 25-hydroxyvitamin level pregnanc neonat outcom systemat review meta-analysi observ studi object assess effect 25-hydroxyvitamin 25-ohd level pregnanc outcom birth variabl design systemat review meta-analysi data sourc medlin 1966 august 2012 pubm 2008 august 2012 embas 1980 august 2012 cinahl 1981 august 2012 cochran databas systemat review cochran databas regist clinic trial studi select studi report associ serum 25-ohd level pregnanc outcom interest pre-eclampsia gestat diabet bacteri vaginosi caesarean section small gestat age infant birth weight birth length head circumfer data extract two author independ extract data origin research articl includ key indic studi qualiti pool adjust odd ratio weight mean differ associ test subgroup repres differ patient characterist studi qualiti result 3357 studi identifi review elig 31 elig studi includ final analysi insuffici serum level 25-ohd associ gestat diabet pool odd ratio 1.49 95 confid interv 1.18 1.89 pre-eclampsia 1.79 1.25 2.58 small gestat age infant 1.85 1.52 2.26 pregnant women low serum 25-ohd level increas risk bacteri vaginosi low birthweight infant deliveri caesarean section conclus vitamin insuffici associ increas risk gestat diabet pre-eclampsia small gestat age infant pregnant women low 25-ohd level increas risk bacteri vaginosi lower birth weight infant deliveri caesarean section',\n",
       "  'β-adrenerg receptor antagon prevent anxiety-lik behavior microgli reactiv induc repeat social defeat psychosoci stress associ alter immun function develop psycholog disord includ anxieti depress show repeat social defeat mice increas c-fo stain brain region associ fear threat apprais promot anxiety-lik behavior β-adrenerg receptor-depend manner repeat social defeat also significantli increas number cd11b /cd45 high /ly6c high macrophag traffick brain addit sever inflammatori marker increas surfac microglia cd14 cd86 tlr4 macrophag cd14 cd86 social defeat repeat social defeat also increas presenc deramifi microglia medial amygdala prefront cortex hippocampu moreov mrna analysi microglia indic repeat social defeat increas level interleukin il -1β reduc level glucocorticoid respons gene glucocorticoid-induc leucin zipper gilz fk506 bind protein-51 fkbp51 stress-depend chang microglia macrophag prevent propranolol β-adrenerg receptor antagonist microglia isol social defeat mice cultur ex vivo produc markedli higher level il-6 tumor necrosi factor-α monocyt chemoattract protein-1 stimul lipopolysaccharid compar microglia control mice last repeat social defeat increas c-fo activ il-1 receptor type-1-defici mice promot anxiety-lik behavior microglia activ absenc function il-1 receptor type-1 find indic repeat social defeat-induc anxiety-lik behavior enhanc reactiv microglia depend activ β-adrenerg il-1 receptor',\n",
       "  'vitro differenti transplant neural precursor human embryon stem cell remark development potenti replic capac human embryon stem es cell promis almost unlimit suppli specif cell type transplant therapi describ vitro differenti enrich transplant neural precursor cell human es cell upon aggreg embryoid bodi differenti es cell form larg number neural tube–lik structur presenc fibroblast growth factor 2 fgf-2 neural precursor within format isol select enzymat digest purifi basi differenti adhes follow withdraw fgf-2 differenti neuron astrocyt oligodendrocyt transplant neonat mous brain human es cell–deriv neural precursor incorpor varieti brain region differenti neuron astrocyt teratoma format observ transplant recipi result depict human es cell sourc transplant neural precursor possibl nervou system repair',\n",
       "  'character prostaglandin e2 product candida albican candida albican produc lipid metabolit function similar host prostaglandin studi use mass spectrometri demonstr c. albican produc authent prostaglandin e 2 pge 2 arachidon acid maxim pge 2 product achiev 37 degre c stationary-phas cultur supernat cell-fre lysat gener stationary-phas cell interestingli pge 2 product inhibit nonspecif cyclooxygenas lipoxygenas inhibitor inhibitor specif cyclooxygenas 2 isoenzym c. albican genom possess cyclooxygenas homolog howev sever gene may play role prostaglandin product c. albican investig found c. albican fatti acid desaturas homolog ole2 multicopp oxidas homolog fet3 play role prostaglandin product ole2/ole2 fet3/fet3 mutant strain exhibit reduc pge 2 level compar parent strain work demonstr synthesi pge 2 c. albican proce via novel pathway',\n",
       "  'global role klf1 erythropoiesi reveal chip-seq primari erythroid cell klf1 regul divers suit gene direct erythroid cell differenti bipot progenitor determin local cis-regulatori context transcript factor network klf1 oper perform klf1 chip-seq mous found least 945 site genom e14.5 fetal liver erythroid cell occupi endogen klf1 mani recov site resid erythroid gene promot hbb-b1 major distant known gene data suggest klf1 directli regul aspect termin erythroid differenti includ product alpha- beta-globin protein chain heme biosynthesi coordin prolifer anti-apoptot pathway construct red cell membran cytoskeleton function primarili transcript activ addit suggest new mechan klf1 cooper transcript factor particular erythroid transcript factor gata1 maintain homeostasi erythroid compart',\n",
       "  'koba 2.0 web server annot identif enrich pathway diseas high-throughput experiment technolog often identifi dozen hundr gene relat chang biolog patholog process gene one want identifi biolog pathway may involv diseas may implic report web server koba 2.0 annot input set gene put pathway diseas relationship base map gene known annot allow id map cross-speci sequenc similar map perform statist test identifi statist significantli enrich pathway diseas koba 2.0 incorpor knowledg across 1327 speci 5 pathway databas kegg pathway pid biocyc reactom panther 5 human diseas databas omim kegg diseas fundo gad nhgri gwa catalog koba 2.0 access http //kobas.cbi.pku.edu.cn',\n",
       "  'transloc sickl cell erythrocyt microrna plasmodium falciparum inhibit parasit translat contribut malaria resist erythrocyt carri variant hemoglobin allel hb caus sickl cell diseas resist infect malaria parasit plasmodium falciparum molecular basi resist long recogn multifactori remain incomplet understood show dysregul microrna mirna composit either heterozyg hba homozyg hbss erythrocyt contribut resist p. falciparum intraerythrocyt life cycl p. falciparum subset erythrocyt mirna transloc parasit two mirna mir-451 let-7i highli enrich hba hbss erythrocyt mirna along mir-223 neg regul parasit growth surprisingli found mir-451 let-7i integr essenti parasit messeng rna via impair ribosom load result translat inhibit henc sickl cell erythrocyt exhibit cell-intrins resist malaria part atyp mirna activ may repres uniqu host defens strategi complex eukaryot pathogen',\n",
       "  'cd28 itk signal regul autoreact cell traffick activ self-react cell traffick target tissu lead autoimmun organ destruct mice lack co-inhibitori receptor cytotox lymphocyt antigen-4 ctla-4 develop fatal autoimmun character lymphocyt infiltr nonlymphoid tissu demonstr cd28 co-stimulatori pathway regul traffick self-react ctla4 -/- cell tissu concurr ablat cd28-activ tec famili kinas itk block spontan cell activ instead caus self-react ctla4 -/- cell accumul secondari lymphoid organ despit excess spontan cell activ prolifer lymphoid organ itk -/- ctla4 -/- mice otherwis healthi mount antivir immun respons exhibit long lifespan propos itk specif licens autoreact cell enter tissu mount destruct immun respons notabl itk inhibitor mimic null mutant phenotyp also prevent pancreat islet infiltr diabetogen cell mous model type 1 diabet highlight potenti util treatment human autoimmun disord',\n",
       "  \"delay acceler age share common longev assur mechan mutant dwarf calorie-restrict mice benefit healthi age unusu long lifespan contrast mous model dna repair-defici progeroid syndrom age die prematur identifi mechan regul mammalian longev quantifi parallel genome-wid liver express profil mice two extrem lifespan contrari expect find signific genome-wid express associ progeroid long-liv mice subsequ analysi significantli over-repres biolog process reveal suppress endocrin energi pathway increas stress respons delay prematur age test relev process natur age compar transcriptom liver lung kidney spleen entir murin adult lifespan subsequ confirm find independ age cohort major gene show similar express chang four organ indic system transcript respons age system respons includ biolog process trigger progeroid long-liv mice howev genome-wid scale transcriptom natur age mice show strong associ progeroid long-liv mice thu endocrin metabol chang indic `` surviv '' respons genotox stress starvat wherea genome-wid associ gene express natur age indic biolog age may thu delin pro- anti-ag effect treatment aim health-span extens\",\n",
       "  'arginin deplet mechan immun privileg corneal allograft cornea immun privileg tissu sinc arginas found modul t-cell function deplet arginin investig express arginas cornea possibl role immun privileg use murin transplant model found endothelium epithelium murin cornea express function arginas capabl down-regul t-cell prolifer vitro cultur system administr specif arginas inhibitor n-hydroxy-nor-l-arg recipi mice result acceler reject allogen c57bl/6 b6 corneal graft contrast vivo blockad arginas activ effect alter cours reject primari skin graft express littl arginas addit inhibit arginas alter system t-cell prolifer data show arginas function cornea contribut immun privileg eye modul arginas contribut graft surviv',\n",
       "  \"once-a-day concerta methylphenid versu three-times-daili methylphenid laboratori natur set object methylphenid mph commonli prescrib drug attention-deficit/hyperact disord adhd short half-lif necessit multipl daili dose need multipl dose produc problem medic administr school after-school hour therefor complianc previou long-act stimul prepar shown effect equival twice-daili dose mph studi test efficaci durat action natur laboratori set extended-releas mph prepar design last 12 hour therefor equival 3-times-daili dose method sixty-eight children adhd 6 12 year old particip within-subject double-blind comparison placebo immediate-releas ir mph 3 time day tid concerta once-daili mph formul three dose level medic use 5 mg ir mph tid/18 mg concerta day qd 10 mg ir mph tid/36 mg concerta qd 15 mg ir mph tid/54 mg concerta qd children current medic mph enrol child 's dose level base child 's mph dose studi dose concerta select compar daili dose mph child receiv achiev ascend rate mph deliveri determin initi investig provid necessari continu coverag concerta dose 20 higher daili basi compar tid regimen ir mph children receiv medic condit 7 day investig conduct context background clinic behavior intervent natur environ laboratori set parent receiv behavior parent train teacher taught establish school-hom daili report card drc drc list individu target behavior repres child 's salient area impair teacher set daili goal child 's impair target parent provid reward home goal attain weekday teacher complet drc use depend measur individu medic respons teacher parent also complet weekli standard rate behavior treatment effect evalu time cours medic effect children spent 12 hour laboratori set saturday medic effect measur use procedur method adapt summer treatment program measur classroom behavior academ productivity/accuraci taken laboratori classroom set children complet independ math read worksheet measur social behavior taken structur small-group board game set unstructur recess set measur includ behavior frequenc count academ problem complet accuraci independ observ teacher counselor rate individu behavior target goal report advers event sleep qualiti appetit collect result virtual measur set drug condit significantli differ placebo 2 drug differ children 's regular school set medic improv behavior measur teacher rate individu target behavior drc effect seen even measur parent rate laboratori set effect concerta equival tid mph last least 12 hour dose concerta significantli superior tid mph 2 parent rate score ask parent prefer concerta prefer tid ir mph placebo side effect children 's sleep appetit similar 2 prepar lab set medic improv product accuraci arithmet seatwork assign disrupt on-task behavior classroom rule follow medic improv children 's rule follow neg behavior small group board game well unstructur recess set individu target behavior also show signific improv medic across domain laboratori set children 's behavior across set deterior across laboratori day primari effect medic prevent deterior day wore result support use background behavior treatment clinic trial stimul medic illustr util measur individu daili target goal ie drc object measur medic respons laboratori natur school set conclus investig clearli support efficaci concerta long-act formul mph parent desir medic benefit child throughout day earli even abstract truncat\",\n",
       "  \"leaderless gene bacteria clue evolut translat initi mechan prokaryot background shine-dalgarno sd signal long view domin translat initi signal prokaryot recent leaderless gene lack 5'-untransl region 5'-utr mrna shown abund archaea howev current large-scal silico analys initi mechan bacteria mainli base sd-led initi way leaderless one studi leaderless gene bacteria remain open caus uncertain understand translat initi mechan prokaryot result studi signal translat initi region gene 953 bacteri 72 archaeal genom make effort construct evolutionari scenario view leaderless gene bacteria algorithm design identifi multi-sign upstream region gene genom classifi gene sd-led ta-l atyp gene accord categori probabl signal upstream sequenc particularli occurr ta-lik signal 10 bp upstream translat initi site ti bacteria probabl mean leaderless gene conclus analysi reveal leaderless gene total widespread although domin varieti bacteria especi actinobacteria deinococcus-thermu twenti percent gene leaderless analyz close relat bacteri genom result impli chang translat initi mechan happen gene deriv common ancestor linearli depend phylogenet relationship analysi macroevolut leaderless gene show proport leaderless gene bacteria decreas trend evolut\",\n",
       "  'neuron sirt1 defici increas insulin sensit brain peripher tissu sirt1 nad -depend class iii deacetylas function cellular energi sensor addit well-character effect peripher tissu emerg evid suggest neuron sirt1 activ play role central regul energi balanc glucos metabol assess idea gener sirt1 neuron-specif knockout sinko mice standard chow hfd sinko mice insulin sensit sirt1 f/f mice thu sinko mice lower fast insulin level improv glucos toler insulin toler enhanc system insulin sensit hyperinsulinem euglycem clamp studi hypothalam insulin sensit sinko mice also increas control assess hypothalam activ pi3k phosphoryl akt foxo1 follow system insulin inject intracerebroventricular inject insulin led greater system effect improv glucos toler insulin sensit sinko mice compar control line vivo result insulin-induc akt foxo1 phosphoryl potenti inhibit sirt1 cultur hypothalam cell line mechanist effect trace reduc effect sirt1 directli deacetyl repress irs-1 function enhanc central insulin signal sinko mice accompani increas insulin receptor signal transduct liver muscl adipos tissu summari conclud neuron sirt1 neg regul hypothalam insulin signal lead system insulin resist intervent reduc neuron sirt1 activ potenti improv system insulin action limit weight gain obesigen diet',\n",
       "  'candid causal regulatori effect integr express qtl complex trait genet associ recent success genome-wid associ studi gwa follow challeng determin report suscept variant mediat complex trait diseas express quantit trait loci eqtl implic diseas associ overlap eqtl gwa signal howev abund eqtl strong correl structur ld genom make like overlap coincident driven function variant present studi propos empir methodolog call regulatori trait concord rtc account local ld structur integr eqtl gwa result order reveal subset associ signal due ci eqtl simul genom region variou ld pattern singl two causal variant show score outperform snp correl metric statist r 2 histor follow observ signific abund regulatori signal among current publish gwa loci appli method goal priorit relev gene respect complex trait detect sever potenti disease-caus regulatori effect strong enrich immunity-rel condit consist natur cell line test lcl furthermor present extens method tran interrog whole genom downstream effect diseas variant inform regard unknown primari biolog effect conclud integr cellular phenotyp associ organism complex trait facilit biolog interpret genet effect trait',\n",
       "  'gender-depend differ outcom treatment infect hospit patient context establish manag strategi outcom differ gender mani diseas effect infect adequ studi object investig role gender among hospit patient treat infect design observ cohort studi conduct 26-month period decemb 1996 januari 1999. set university-affili hospit particip total 892 patient surgic unit hospit 1470 consecut infecti episod 782 men 688 women main outcom measur mortal hospit gender infect episod overal specif infecti site includ lung peritoneum bloodstream cathet urin surgic site skin/soft tissu result among infect signific differ mortal base gender men 11.1 vs women 14.2 p .07 logist regress analysi factor independ associ mortal includ higher apach acut physiolog chronic health evalu ii score older age malign blood transfus diagnosi infect 7 day admiss gender femal odd ratio death 1.32 95 confid interv ci 0.90-1.94 p .16 mortal higher women lung men 18 vs women 34 p .002 soft tissu men 2 vs women 10 p .05 infect infecti site mortal differ gender factor associ mortal due pneumonia logist regress includ higher apach ii score malign diabet mellitu diagnosi infect 7 day admiss older age transplant femal gender death 2.25 95 ci 1.17-4.32 p .02 conclus although gender may predict mortal among infect women appear increas risk death hospital-acquir pneumonia even control comorbid',\n",
       "  'compar safeti target therapi metastat colorect cancer elderli younger patient studi use intern pharmacovigil databas metastat colorect cancer mcrc increasingli treat use target therapi post-market safeti agent understudi especi elderli studi aim compar accord age advers drug reaction adr target therapi use mcrc real life extract vigibas contain world health organ individu case safeti report icsr perform adr report aflibercept bevacizumab cetuximab panitumumab regorafenib use crc consid drug chi-squar test use compar frequenc seriou adr patient age ≥75 75 year select adr drug drug-adr associ compar anticanc drug estim proport report ratio prr age group 21,565 icsr includ among 74 seriou 11 fatal median age 64 year inter quartil rang 56–71 15 patient age ≥75 57 male seriou icsr account 47,292 adr neutropenia report elderli drug diarrhea report elderli panitumumab cardiac disord report elderli patient particular heart failur especi bevacizumab cetuximab regorafenib respiratori thorac mediastin disord prr differ two group except encephalopathi significantli associ bevacizumab elderli adr relat target therapi use mcrc treatment differ across age group yet systemat report wors elderli patient select elderli patient could therefor treat target therapi',\n",
       "  'cpg island methyl premalign stage gastric carcinoma limit report methyl analysi premalign lesion gastric carcinoma thu far despit fact gastric carcinoma one tumor high frequenc cpg island hypermethyl determin frequenc time hypermethyl multistep gastric carcinogenesi non-neoplast gastric mucosa n 118 adenoma n 61 carcinoma n 64 analyz p16 human mut l homologu 1 hmlh1 death-associ protein dap -kinas thromobospondin-1 thbs1 tissu inhibitor metalloproteinas 3 timp-3 methyl statu use methylation-specif pcr three differ class methyl behavior found five test gene dap-kinas methyl similar frequenc four stage wherea hmlh1 p16 methyl cancer sampl 20.3 42.2 respect frequent intestin metaplasia 6.3 2.1 respect adenoma 9.8 11.5 respect howev hmlh1 p16 methyl chronic gastriti thbs-1 timp-3 methyl stage show mark increas hypermethyl frequenc chronic gastriti 10.1 14.5 respect intestin metaplasia 34.7 36.7 respect p 0.05 adenoma 28.3 26.7 respect carcinoma 48.4 57.4 respect p 0.05 hmlh1 thbs1 timp-3 hypermethyl frequenc similar intestin metaplasia adenoma p16 hypermethyl frequenc tend higher adenoma 11.5 intestin metaplasia 2.1 p 0.073 averag number methyl gene 0.6 1.1 1.1 2.0 per five gene per sampl chronic gastriti intestin metaplasia adenoma carcinoma respect show mark increas methyl gene non-metaplast mucosa intestin metaplasia p 0.001 well premalign lesion carcinoma p 0.002 result suggest cpg island hypermethyl occur earli multistep gastric carcinogenesi tend accumul along multistep carcinogenesi',\n",
       "  'famili amyloidot polyneuropathi current emerg treatment option transthyretin-medi amyloidosi transthyretin famili amyloid polyneuropathi ttr-fap fatal clinic disord character extracellular deposit abnorm fibril deriv misfold normal solubl transthyretin ttr molecul diseas commonli caus point mutat within ttr gene inherit autosom domin fashion 100 mutat identifi lead destabil physiolog ttr tetram result mani monom origin tendenc spontan conform chang self-aggreg main clinic featur ttr-fap progress sensorimotor autonom neuropathi begin polyneuropathi predominantli involv small unmyelin nerv fiber result dissoci sensori loss disproportion affect sensat pain temperatur autonom neuropathi typic accompani sensori deficit earli diseas cours symptom includ orthostat hypotens constip altern diarrhea erectil dysfunct anhydrosi urinari retent incontin later involv motor fiber caus rapidli progress weak gait disturb addit peripher nervou system heart gut frequent affect onset symptom bimod one peak age 33 year earli onset anoth distinct peak sixth decad life late onset cours ttr-fap uniformli progress fatal death occur averag 10.8 year onset symptom portugues patient 7.3 year late-onset japanes patient common caus includ cachexia cardiac failur arrhythmia secondari infect liver transplant standard therapi patient clinic condit good enough toler intervent stop progress neuropathi remov main sourc mutant ttr recent oral administ tafamidi meglumin approv european author treatment fap substanc shown stabil ttr tetram therebi improv outcom patient ttr-fap variou strategi studi vitro prevent ttr amyloidosi includ gene therapi immun dissolut ttr aggreg free radic scaveng none readi clinic use far',\n",
       "  'invari natur killer cell bridg innat adapt immun cell innat immun system interact pathogen via conserv pattern-recognit receptor wherea cell adapt immun system recogn pathogen divers antigen-specif receptor gener somat dna rearrang invari natur killer inkt cell subset lymphocyt bridg innat adapt immun system although inkt cell express cell receptor gener somat dna rearrang receptor semi-invari interact limit set lipid glycolipid antigen thu resembl pattern-recognit receptor innat immun system function inkt cell close resembl cell innat immun system rapidli elicit effector function follow activ fail develop immunolog memori inkt cell becom activ respons varieti stimuli particip regul variou immun respons activ inkt cell produc sever cytokin capac jump-start modul adapt immun respons varieti glycolipid antigen differenti elicit distinct effector function inkt cell identifi reagent employ test hypothesi inkt cell har therapeut purpos human diseas review innate-lik properti function inkt cell discuss interact cell type immun system',\n",
       "  'olmesartan-bas therapi effect way improv blood pressur control cardiovascular protect main purpos hypertens treatment reduct cardiovascular diseas burden among differ first-lin antihypertens drug class angiotensin-receptor blocker character good effect toler furthermor interrupt renin-angiotensin cascad relat sever benefit target organ protect cardiovascular prevent among differ angiotensin-receptor blocker olmesartan examin sever trial organ protect show improv sever diseas marker microinflamm regress plaqu volum vascular hypertrophi well microalbuminuria prevent olmesartan also wide examin combin either hydrochlorothiazid amlodipin well drug single-pil tripl combin show improv antihypertens efficaci without signific effect toler treatment strategi base drug characterist avail differ type combin first-lin drug class may repres effect way achiev blood pressur control major hypertens patient could also relat better cardiovascular diseas prevent',\n",
       "  'manslaught fake artesun asia—wil africa next falciparum malaria kill particularli kill rural poor artemisinin deriv artesun vital compon plasmodium falciparum malaria treatment control face global increas antimalari drug resist sinc 1998 worsen epidem sophist counterfeit “ artesun ” tablet contain artesun plagu mainland southeast asia see figur s1 countri avail artesun fake 1–5 artemisinin deriv remark rapid antimalari effect well toler medicin avail sought rel expens demand creat cheaper version amongst poorest vulner peopl upon counterfeit preyed–with fatal result',\n",
       "  'workshop endotheli cell dysfunct lead diabet nephropathi focu nitric oxid clinic manifest diabet nephropathi express diabet microangiopathi review revisit previous propos steno hypothesi advanc hypothesi develop endotheli cell dysfunct repres common pathophysiolog pathway diabet complic specif abil glucos scaveng nitric oxid propos initi phase endotheli dysfunct gradual accumul advanc glycat end product induct plasminogen activ inhibitor-1 result decreas express endotheli nitric oxid synthas reduc gener nitric oxid propos pathophysiolog critic mainten phase endotheli dysfunct propos conceptu shift toward role endotheli dysfunct diabet complic may provid new strategi prevent',\n",
       "  'nuclear argonaut promot multi-gener epigenet inherit germlin immort epigenet inform frequent eras near start new gener case howev epigenet inform transmit parent progeni multigener epigenet inherit particularli notabl exampl type epigenet inherit double-strand rna-medi gene silenc caenorhabd elegan rna-medi interfer rnai inherit five gener understand process conduct genet screen nematod defect transmit rnai silenc signal futur gener screen identifi herit rnai defect 1 hrde-1 gene hrde-1 encod argonaut protein associ small interf rna germ cell progeni anim expos double-strand rna nuclei germ cell hrde-1 engag nuclear rnai defect pathway direct trimethyl histon h3 ly 9 h3k9me3 rnai-target genom loci promot rnai inherit normal growth condit hrde-1 associ endogen express short interf rna direct nuclear gene silenc germ cell hrde-1- nuclear rnai-defici anim germlin silenc lost gener time concurr anim exhibit steadili worsen defect gamet format function ultim lead steril result establish argonaut protein hrde-1 direct gene-silenc event germ-cel nuclei drive multigener rnai inherit promot immort germ-cel lineag propos c. elegan use rnai inherit machineri transmit epigenet inform accru past gener futur gener regul import biolog process',\n",
       "  'autophag program cell death select catalas degrad autophagi play central role regul import cellular function cell surviv starvat control infecti pathogen recent shown autophagi induc cell die howev mechan autophag cell death program unclear show caspas inhibit lead cell death mean autophagi involv reactiv oxygen speci ro accumul membran lipid oxid loss plasma membran integr inhibit autophagi chemic compound knock express key autophagi protein atg7 atg8 receptor interact protein rip block ro accumul cell death caus abnorm ro accumul select autophag degrad major enzymat ro scaveng catalas caspas inhibit directli induc catalas degrad ro accumul block autophagi inhibitor find unveil molecular mechan role autophagi cell death provid insight complex relationship ro nonapoptot program cell death',\n",
       "  'human epiderm stem cell function regul circadian oscil human skin cope harm environment factor circadian natur yet circadian rhythm modul function human epiderm stem cell mostli unknown show human epiderm stem cell differenti counterpart core clock gene peak success phase manner establish distinct tempor interv 24 hr day period success clock wave associ peak express subset transcript tempor segreg predisposit epiderm stem cell respond cue regul prolifer differenti tgfβ calcium accordingli circadian arrhythmia profoundli affect stem cell function cultur vivo hypothes intric mechan ensur homeostasi provid epiderm stem cell environment relev tempor function cue cours day perturb may contribut age carcinogenesi',\n",
       "  'engraft engin es cell–deriv cardiomyocyt bm cell restor contractil function infarct myocardium cellular cardiomyoplasti attract option treatment sever heart failur howev still unclear controversi promis cell sourc therefor investig examin fate function impact bone marrow bm cell embryon stem cell es cell –deriv cardiomyocyt transplant infarct mous heart prove particularli challeng es cell enrich cardiomyocyt long-term engraft tumorigen still poorli understood gener transgen es cell express puromycin resist enhanc green fluoresc protein cassett control cardiac-specif promot puromycin select result highli purifi 99 cardiomyocyt popul yield cardiomyocyt increas 6–10-fold induct prolifer purif long-term engraft 4–5 month observ co-transpl select es cell–deriv cardiomyocyt fibroblast injur heart syngen mice teratoma format found n 60 although transplant es cell–deriv cardiomyocyt improv heart function bm cell posit effect furthermor contribut bm cell cardiac endotheli smooth muscl neogenesi detect henc result demonstr es-bas cell therapi promis approach treatment impair myocardi function provid better result bm-deriv cell',\n",
       "  'hyaluronan impair vascular function drug deliveri mous model pancreat cancer object pancreat ductal adenocarcinoma pda characteris stromal desmoplasia vascular dysfunct critic impair drug deliveri studi examin role abund extracellular matrix compon megadalton glycosaminoglycan hyaluronan ha novel therapeut target pda method use genet engin mous model pda author enzymat deplet ha clinic formul pegyl human recombin ph20 hyaluronidas pegph20 examin tumour perfus vascular permeabl drug deliveri preclin util pegph20 combin gemcitabin assess short-term surviv studi result pegph20 rapidli sustain deplet ha induc re-expans pda blood vessel increas intratumor deliveri two chemotherapeut agent doxorubicin gemcitabin moreov pegph20 trigger fenestr interendotheli junction gap pda tumour endothelia promot tumour-specif increas macromolecular permeabl final combin therapi pegph20 gemcitabin led inhibit pda tumour growth prolong surviv gemcitabin monotherapi suggest immedi clinic util conclus author demonstr ha imped intratumor vasculatur pda propos enzymat deplet explor mean improv drug deliveri respons patient pancreat cancer',\n",
       "  'ribos 2′-o-methyl provid molecular signatur distinct self non-self mrna depend rna sensor mda5 5′ cap structur higher eukaryot mrna ribos 2′-o-methyl likewis mani virus replic cytoplasm eukaryot evolv 2′-o-methyltransferas autonom modifi mrna howev defin biolog role 2′-o-methyl mrna remain elus show 2′-o-methyl viral mrna critic involv subvert induct type interferon demonstr human mous coronaviru mutant lack 2′-o-methyltransferas activ induc higher express type interferon highli sensit type interferon notabl induct type interferon virus defici 2′-o-methyltransferas depend cytoplasm rna sensor mda5 link mda5-medi sens viral rna 2′-o-methyl mrna suggest rna modif 2′-o-methyl provid molecular signatur discrimin self non-self mrna',\n",
       "  \"relationship activ level aerob fit bodi fat 8- 10-yr-old children relationship children 's activ aerob fit fat unclear indirect estim activ e.g. heart rate hr recal may mask associ purpos studi assess relationship use tritrac-r3d pedomet heart rate thirty-four children age 8-10 yr particip studi tritrac pedomet worn 6 day hr measur 1 day activ measur tritrac pedomet correl posit fit whole group tritrac r 0.66 pedomet r 0.59 p 0.01 boy girl separ p 0.05 correl neg fat whole group r -0.42 p 0.05 contrast hr correl significantli fit hr 139 beats/min correl posit fat girl r 0.64 p 0.05 suggest hr mislead measur activ studi support posit relationship activ fit suggest neg relationship fat activ\",\n",
       "  'junction actin assembl mediat formin-lik 2 downstream rac1 epitheli integr vital import deregul caus earli stage cancer de novo format adheren junction aj singl epitheli cell requir coordin spatial actin dynam mechan steer nascent actin polymer cell-cel adhes initi well understood investig real-tim actin assembl daughter cell-cel adhes format human breast epitheli cell 3d environ identifi formin-lik 2 fmnl2 specif requir actin assembl turnov newli form cell-cel contact well human epitheli lumen format fmnl2 associ compon aj complex involv rac1 activ fmnl2 c terminu optogenet control rac1 live cell rapidli drove fmnl2 epitheli cell-cel contact zone furthermor rac1-induc actin assembl subsequ aj format critic depend fmnl2 data uncov fmnl2 driver human epitheli aj format downstream rac1',\n",
       "  'inhibit hdm2 activ p53 ribosom protein l23 import coordin cell growth prolifer recogn long time molecular basi relationship howev poorli understood show ribosom protein l23 interact hdm2 interact involv central acid domain hdm2 n-termin domain l23 l23 l11 anoth hdm2-interact ribosom protein simultan yet distinctli interact hdm2 togeth form ternari complex show overexpress l23 inhibit hdm2-induc p53 polyubiquitin degrad caus p53-depend cell cycl arrest hand knock l23 caus nucleolar stress trigger transloc b23 nucleolu nucleoplasm lead stabil activ p53 data suggest cell may maintain steady-st level l23 normal growth altern level l23 respons chang growth condit could imping hdm2-p53 pathway interrupt integr nucleolu',\n",
       "  'associ blood monocyt platelet marker carotid arteri characterist atherosclerosi risk commun carotid mri studi background atherosclerosi character infiltr inflammatori cell circul blood blood cell activ could play import role plaqu format method analyz relationship blood cellular marker quantit measur carotid wall compon 1,546 particip aric atherosclerosi risk commun carotid mri studi carotid imag perform use gadolinium contrast-enhanc mri cellular phenotyp flow cytometri result monocyt toll-lik receptor tlr -2 associ larger plaqu cd14 myeloperoxidas tlr-4 associ smaller platelet cd40l associ smaller plaqu thinner cap p-selectin associ smaller core size conclus blood cell activ significantli associ atherosclerot chang carotid wall',\n",
       "  'vascular endotheli cadherin control vegfr-2 intern signal intracellular compart receptor endocytosi fundament step control magnitud durat natur cell signal event confluent endotheli cell contact inhibit growth respond poorli prolif signal vascular endotheli growth factor vegf previou studi found associ vascular endotheli cadherin vec vegf receptor vegfr type 2 contribut density-depend growth inhibit lampugnani g.m. a. zanetti m. corada t. takahashi g. balconi f. breviario f. orsenigo a. cattelino r. kemler t.o daniel e. dejana 2003. j. cell biol 161:793–804 present studi describ mechan vec reduc vegfr-2 signal found vegf induc clathrin-depend intern vegfr-2 vec absent engag junction vegfr-2 intern rapidli remain endosom compart longer time intern termin signal instead intern receptor phosphoryl codistribut activ phospholipas c–γ activ p44/42 mitogen-activ protein kinas phosphoryl cell prolifer inhibit vegfr-2 intern reestablish contact inhibit cell growth wherea silenc junction-associ density-enhanc phosphatase-1/cd148 phosphatas restor vegfr-2 intern signal thu vec limit cell prolifer retain vegfr-2 membran prevent intern signal compart',\n",
       "  'diversif hiv-1 envelop hyper-vari domain v2 v4 v5 higher probabl transmitted/found envelop glycosyl favor develop heterolog neutral breadth recent studi plasma neutral breadth hiv-1 infect individu nine intern aid vaccin initi iavi site report viral load hla-a 03 genotyp subtyp c infect strongli associ develop neutral breadth refin find studi analyz impact transmitted/found t/f envelop env earli env diversif autolog neutral develop plasma neutral breadth 21 particip identifi recent infect two site kigali rwanda n 9 lusaka zambia n 12 single-genom analysi full-length t/f env sequenc reveal 21 individu infect highli homogen popul viral variant categor subtyp c n 12 a1 n 7 recombin ac n 2 extens amino acid sequence-bas analysi variabl loop length glycosyl pattern t/f env reveal lower ratio nx nxt-encod glycan motif correl neutral breadth analysi compar amino acid sequenc chang insertions/delet glycan motif alter t/f env autolog earli env variant reveal extens diversif focus v2 v4 v5 region gp120 accompani contemporan viral escap significantli favor develop breadth result suggest effici glycosyl subtyp c t/f env fewer nxs-encod glycan site like elicit antibodi transit autolog heterolog neutral activ follow exposur gp120 diversif initi env-antibodi co-evolut cycl increas neutral breadth augment time addit viral host factor find suggest understand variat effici site-specif glycosyl influenc neutral antibodi elicit target could advanc design immunogen aim induc antibodi transit autolog heterolog neutral activ',\n",
       "  'glycolyt oligodendrocyt maintain myelin long-term axon integr oligodendrocyt myelin-form glial cell central nervou system maintain long-term axon integr howev underli support mechan understood identifi metabol compon axon–glia interact gener condit cox10 protohem ix farnesyltransferas mutant mice oligodendrocyt schwann cell fail assembl stabl mitochondri cytochrom c oxidas cox also known mitochondri complex iv peripher nervou system cox10 condit mutant exhibit sever neuropathi dysmyelin abnorm remak bundl muscl atrophi paralysi notabl perturb mitochondri respir caus glial cell death adult central nervou system found sign demyelin axon degener secondari inflamm unlik cultur oligodendrocyt sensit cox inhibitor post-myelin oligodendrocyt surviv well absenc cox activ importantli vivo magnet reson spectroscopi brain lactat concentr mutant increas compar control detect mice expos volatil anaesthet indic aerob glycolysi product deriv oligodendrocyt rapidli metabol within white matter tract myelin axon use lactat energy-depriv find suggest model axon–glia metabol coupl serv physiolog function',\n",
       "  'siglec-1 novel dendrit cell receptor mediat hiv-1 trans-infect recognit viral membran gangliosid dendrit cell dc essenti antigen-pres cell induct immun pathogen howev hiv-1 spread strongli enhanc cluster dc cd4 cell uninfect dc captur hiv-1 mediat viral transfer bystand cd4 cell process term trans-infect initi studi identifi c-type lectin dc-sign hiv-1 bind factor dc interact viral envelop glycoprotein upon dc matur howev dc-sign down-regul hiv-1 captur trans-infect strongli enhanc via glycoprotein-independ captur pathway recogn sialyllactose-contain membran gangliosid show sialic acid-bind ig-lik lectin 1 siglec-1 cd169 highli express matur dc specif bind hiv-1 vesicl carri sialyllactos furthermor siglec-1 essenti trans-infect matur dc find identifi siglec-1 key factor hiv-1 spread via infecti dc/t-cell synaps highlight novel mechan mediat hiv-1 dissemin activ tissu',\n",
       "  'composit gut microbiota throughout life emphasi earli life intestin microbiota becom relev aspect human health microbi colon run parallel immun system matur play role intestin physiolog regul increas evid earli microbi contact suggest human intestin microbiota seed birth matern microbiota form first microbi inoculum birth microbi divers increas converg toward adult-lik microbiota end first 3-5 year life perinat factor mode deliveri diet genet intestin mucin glycosyl contribut influenc microbi colon establish composit gut microbiota rel stabl throughout adult life alter result bacteri infect antibiot treatment lifestyl surgic long-term chang diet shift complex microbi system report increas risk diseas therefor adequ establish microbiota mainten throughout life would reduc risk diseas earli late life review discuss recent studi earli colon factor influenc process impact health',\n",
       "  'intrauterin protein restrict combin earli postnat overfeed associ adult-onset obes produc glucos intoler pancreat dysfunct investig whether intrauterin protein restrict combin overfeed lactat would caus adult-onset obes metabol disord birth litter dam fed control 17 protein low protein 6 protein diet adjust size four co lo group respect eight cc lc group respect pup offspr fed diet contain 12 protein time wean 90 old compar cc lc group co lo group higher rel absolut food intak oxygen consumpt carbon dioxid product lower brown adipos tissu weight lipid content greater weight gain absolut rel white adipos tissu weight absolut lipid content compar co cc rat lc lo rat exhibit higher rel food intak brown adipos tissu weight lipid content reduc oxygen consumpt carbon dioxid product spontan activ increas rel retroperiton adipos tissu weight unalt absolut white adipos tissu weight lipid content fast serum glucos similar among group area glucos curv higher lo co rat lc cc rat basal insulinemia homeostasi model assess insulin resist homa-ir lower lo group group total area insulin curv lo rat similar cc rat lower co lc rat kitt higher lo lc co group cc group thu intrauterin protein restrict follow overfeed lactat induc obes produc glucos intoler impair pancreat function adulthood',\n",
       "  'somat code mutat human induc pluripot stem cell defin transcript factor induc epigenet reprogram adult mammalian cell induc pluripot stem cell although dna factor integr reprogram method unknown whether genom remain unchang singl nucleotid level show 22 human induc pluripot stem hip cell line reprogram use five differ method contain averag five protein-cod point mutat region sampl estim six protein-cod point mutat per exom major mutat non-synonym nonsens splice variant enrich gene mutat caus effect cancer least half reprogramming-associ mutat pre-exist fibroblast progenitor low frequenc wherea rest occur reprogram thu hip cell acquir genet modif addit epigenet modif extens genet screen becom standard procedur ensur hip cell safeti clinic use',\n",
       "  'cell cycl cdk cancer chang paradigm tumour-associ cell cycl defect often mediat alter cyclin-depend kinas cdk activ misregul cdk induc unschedul prolifer well genom chromosom instabl accord current model mammalian cdk essenti drive cell cycl phase therapeut strategi block cdk activ unlik select target tumour cell howev recent genet evid reveal wherea cdk1 requir cell cycl interphas cdk essenti prolifer special cell emerg evid suggest tumour cell may also requir specif interphas cdk prolifer thu select cdk inhibit may provid therapeut benefit certain human neoplasia',\n",
       "  'sudden infant death syndrom despit declin preval past two decad sudden infant death syndrom sid continu lead caus death infant age 1 month 1 year develop countri behaviour risk factor identifi epidemiolog studi includ prone side posit infant sleep smoke exposur soft bed sleep surfac overh evid also suggest pacifi use sleep time room share without bed share associ decreas risk sid although caus sid unknown immatur cardiorespiratori autonom control failur arous respons sleep import factor gene polymorph relat serotonin transport autonom nervou system develop might make affect infant vulner sid campaign risk reduct help reduc sid incid 50-90 howev reduc incid even greater stride must made reduc prenat smoke exposur implement recommend infant care practic continu research need identifi pathophysiolog basi sid',\n",
       "  'regul heterochromat silenc histon h3 lysine-9 methyl rnai eukaryot heterochromatin character high densiti repeat transposon well modifi histon influenc gene express chromosom segreg fission yeast schizosaccharomyc pomb delet argonaut dicer rna-depend rna polymeras gene homolog encod part machineri respons rna interfer rnai delet result aberr accumul complementari transcript centromer heterochromat repeat accompani transcript de-repress transgen integr centromer loss histon h3 lysine-9 methyl impair centromer function propos double-strand rna aris centromer repeat target format mainten heterochromatin rnai',\n",
       "  'conform chang pore format perforin-rel protein pleurotolysin membran attack complex/perforin-lik macpf protein compris largest superfamili pore-form protein play crucial role immun pathogenesi solubl monom assembl larg transmembran pore via conform transit remain structur mechanist characteris present 11 å resolut cryo-electron microscopi cryo-em structur two-part fungal toxin pleurotolysin pli togeth crystal structur compon lipid bind plya protein pore-form macpf compon plyb data reveal 13-fold pore 80 å diamet 100 å height subunit compris plyb molecul atop membran bound dimer plya resolut em map togeth biophys comput experi allow confid assign subdomain macpf pore assembl major conform chang plyb ∼70° open bent distort central β-sheet macpf domain accompani extrus refold two α-helic region transmembran β-hairpin tmh1 tmh2 determin structur three differ disulphid bond-trap prepor intermedi analysi data molecular model flexibl fit allow us gener potenti trajectori β-sheet unbend result suggest macpf conform chang trigger disrupt interfac conserv helix-turn-helix motif top tmh2 follow releas propos transmembran region assembl β-hairpin via top zipper backbon hydrogen bond form membrane-insert β-barrel intermedi structur macpf domain refold β-barrel pore establish structur paradigm transit solubl monom pore may conserv across whole superfamili tmh2 region critic releas tmh cluster suggest region target endogen inhibitor macpf function',\n",
       "  'widespread regul microrna biogenesi function decay microrna mirna larg famili post-transcript regul gene express ∼21 nucleotid length control mani development cellular process eukaryot organ research past decad identifi major factor particip mirna biogenesi establish basic principl mirna function recent becom appar mirna regul subject sophist control mani report past year report regul mirna metabol function rang mechan involv numer protein–protein protein–rna interact regul import role context-specif function mirna',\n",
       "  'cytidin deaminas cem15 induc hypermut newli synthes hiv-1 dna high mutat frequenc revers transcript princip role genet variat primat lentivir popul main drive forc gener drug resist escap immun surveil g hypermut one characterist primat lentivirus well retrovirus replic vivo cell cultur molecular mechan process howev remain clarifi demonstr cem15 also known apolipoprotein b mrna edit enzym catalyt polypeptide-lik 3g apobec3g endogen inhibitor human immunodefici viru type 1 hiv-1 replic cytidin deaminas abl induc g hypermut newli synthes viral dna effect counteract hiv-1 virion infect factor vif seem viral dna mutat viral defenc mechan host cell may induc either lethal hypermut instabl incom nascent viral revers transcript could account vif-defect phenotyp importantli accumul cem15-medi non-leth hypermut replic viral genom could potent contribut genet variat primat lentivir popul',\n",
       "  'variant toll-interact protein gene associ suscept sepsi chines han popul introduct deregul excess host immun respons contribut pathogenesi sepsi toll-lik receptor tlr signal pathway neg regul play pivot role modul host immun respons develop sepsi object studi investig associ variant tlr signal pathway gene neg regul gene suscept sepsi chines han popul method patient sever sepsi n 378 healthi control subject n 390 enrol five gene name tlr2 tlr4 tlr9 myd88 tollip investig associ sepsi suscept tag singl nucleotid polymorph snp strategi twelv tag snp select base data chines han beij hapmap project genotyp direct sequenc mrna express level tollip determin use real-tim quantit polymeras chain reaction pcr assay concentr tumor necrosi factor alpha tnf-α interleukin-6 il-6 measur enzyme-link immunosorb assay elisa result result show minor c-allel rs5743867 tollip significantli associ decreas risk sepsi padj 0.00062 odd ratio adj 0.71 95 confid interv ci 0.59 0.86 adjust covari multipl logist regress analysi 3-snp haplotyp block harbor associ snp rs5743867 also display strong associ omnibu test p valu 0.00049. haplotyp gtc show protect role sepsi padj 0.0012 haplotyp gct show increas risk sepsi padj 0.00092 exposur lipopolysaccharid lp tollip mrna express level peripher blood mononuclear cell pbmc homozygot rs5743867c allel significantli higher heterozygot homozygot rs5743867t allel p 0.013 p 0.01 respect moreov concentr tnf-α il-6 cultur supernat significantli lower subject rs5743867cc genotyp ct tt genotyp subject p 0.016 p 0.003 tnf-α p 0.01 p 0.002 il-6 respect conclus find indic variant tollip significantli associ sepsi suscept chines han popul',\n",
       "  \"children 's estim food portion size develop evalu three portion size assess tool use children number method develop assist subject provid estim portion size applic improv portion size estim children investig systemat aim develop portion size assess tool use children assess accuraci children 's estim portion size use tool tool food photograph food model interact portion size assess system ipsa children n 201 age 4-16 year suppli known quantiti food eat school food leftov weigh children estim amount food use tool 24 h consum food age-specif portion size repres base portion size consum children nation survey signific differ found accuraci estim use three tool children age perform well use ipsa food photograph accuraci precis estim made use food model poor tool estim amount food serv accur estim amount consum issu relat report food left impact estim amount food actual consum requir studi ipsa shown potenti assess dietari intak children practic applic assess dietari intak children tool would need expand cover wider rang food valid 'real-lif situat\",\n",
       "  '3d map yeast kinetochor reveal presenc core accessori centromere-specif histon bud yeast kinetochor ~68 nm length diamet slightli larger 25 nm microtubul kinetochor 16 chromosom organ stereotyp cluster encircl central spindl microtubul quantit analysi inner kinetochor cluster cse4 coma reveal structur featur appar singli attach kinetochor cluster cse4-contain kinetochor physic larger perpendicular spindl axi rel cluster ndc80 molecul singl cse4 molecul nucleosom kinetochor attach microtubul plu end cluster cse4 would appear geometr ident ndc80 thu structur inner kinetochor surfac chromosom remain unsolv use point fluoresc microscopi statist probabl map deduc two-dimension mean posit repres compon yeast kinetochor rel mitot spindl metaphas comparison experiment imag three-dimension architectur convolut mathemat model reveal pool cse4 radial displac cse4 kinetochor kinetochor microtubul plu end pool displac cse4 experiment deplet mrna process pat1δ xrn1δ mutant peripher cse4 molecul templat outer kinetochor compon studi suggest inner kinetochor plate centromere-microtubul interfac bud yeast yield inform number ndc80 molecul microtubul attach site',\n",
       "  \"american societi clinic oncolog polici statement role oncologist cancer prevent risk assess oncologist critic opportun util risk assess cancer prevent strategi interrupt initi progress cancer cancer survivor individu high risk develop cancer expand knowledg natur histori prognosi cancer posit oncologist advis patient regard risk second malign treatment-rel cancer addit recogn expert full spectrum cancer care oncologist afford opportun involv community-bas cancer prevent activ although oncologist current provid mani cancer prevent risk assess servic patient econom barrier exist includ inadequ lack insur may compromis uniform patient access servic addit insuffici reimburs exist develop intervent may discourag patient access servic american societi clinic oncolog asco medic societi repres cancer specialist involv patient care clinic research commit support oncologist wide-rang involv cancer prevent statement risk assess prevent counsel although intend comprehens overview cancer prevent describ current role oncologist risk assess prevent provid exampl risk assess prevent activ offer oncologist identifi potenti opportun coordin oncologist primari care physician prevent educ coordin care cancer survivor describ asco 's involv educ train oncologist regard prevent propos improv payment environ encourag patient access servic\",\n",
       "  \"blm helicas contribut telomer mainten process late-repl intermedi structur werner 's syndrom ws bloom 's syndrom bs cancer predisposit disord caus loss function recq helicas wrn blm respect bs ws character replic defect hyperrecombin event chromosom aberr hallmark cancer ineffici replic g-rich telomer strand contribut chromosom aberr ws cell demonstr link wrn telomer genom stabil herein provid evid blm also contribut chromosome-end mainten telomer defect td observ blm-defici cell elev frequenc similar cell lack function wrn helicas loss helicas exacerb td chromosom aberr indic blm wrn function independ telomer mainten blm local particularli recruit telomer chang respons replic dysfunct wrn-defici cell aphidicolin treatment exposur replic challeng caus increas decaten deoxyribonucl acid dna structur late-repl intermedi lri visibl blm-cover ultra-fin bridg ufb anaphas subset ufb origin telomer dna frequenc correl telomer replic defect propos blm complex contribut telomer mainten activ resolv lri\",\n",
       "  'format thymu rat es cell xenogen nude mouse↔rat es chimera variou condit differenti embryon stem es cell induc pluripot stem ip cell specif kind cell line intens investig howev product function organ three-dimension structur es ip cell difficult achiev vitro present paper describ establish green fluoresc protein-express rat es cell line product mouse↔rat es chimera inject rat es cell mous blastocyst rat es cell contribut variou organ chimera includ germ cell inject es cell blastocyst nu/nu mice lack thymu result chimera produc thymu deriv rat es cell bodi chimer anim may provid method deriv variou organ es ip cell',\n",
       "  'wnt/beta-catenin signal requir cn non-cn angiogenesi despit import cn blood vessel molecular mechan regul cn angiogenesi blood-brain barrier bbb format larg unknown analyz role wnt/beta-catenin signal regul format cn blood vessel first analysi top-gal wnt report mice identifi canon wnt/beta-catenin signal specif activ cn non-cn blood vessel develop activ correl express differ wnt ligand neural progenitor cell distinct locat throughout cn includ wnt7a wnt7b ventral region wnt1 wnt3 wnt3a wnt4 dorsal region blockad wnt/beta-catenin signal vivo specif disrupt cn non-cn angiogenesi defect includ reduct vessel number loss capillari bed format hemorrhag vascular malform remain adher mening furthermor demonstr wnt/beta-catenin signal regul express bbb-specif glucos transport glut-1 taken togeth experi reveal essenti role wnt/beta-catenin signal drive cns-specif angiogenesi provid molecular evid angiogenesi bbb format part link',\n",
       "  'cyanidin-3-rutinosid natur polyphenol antioxid select kill leukem cell induct oxid stress anthocyanin group natur occur phenol compound wide avail fruit veget human diet broad biolog activ includ anti-mutagenesi anticarcinogenesi gener attribut antioxid activ studi effect mechan common type anthocyanin cyanidin-3-rutinosid sever leukemia lymphoma cell line found cyanidin-3-rutinosid extract purifi black raspberri cultivar jewel induc apoptosi hl-60 cell dose- time-depend manner paradox compound induc accumul peroxid involv induct apoptosi hl-60 cell addit cyanidin-3-rutinosid treatment result reactiv oxygen speci ro -depend activ p38 mapk jnk contribut cell death activ mitochondri pathway mediat bim down-regul bim overexpress bcl-2 bcl-x l consider block apoptosi notabl cyanidin-3-rutinosid treatment lead increas ro accumul normal human peripher blood mononuclear cell cytotox effect cell result indic cyanidin-3-rutinosid potenti use leukemia therapi advantag wide avail select tumor',\n",
       "  'gout-associ uric acid crystal activ nalp3 inflammasom develop acut chronic inflammatori respons known gout pseudogout associ deposit monosodium urat msu calcium pyrophosph dihydr cppd crystal respect joint periarticular tissu although msu crystal first identifi aetiolog agent gout eighteenth centuri recent ‘ danger signal ’ releas die cell littl known molecular mechan underli msu- cppd-induc inflamm show msu cppd engag caspase-1-activ nalp3 also call cryopyrin inflammasom result product activ interleukin il -1β il-18 macrophag mice defici variou compon inflammasom caspase-1 asc nalp3 defect crystal-induc il-1β activ moreov impair neutrophil influx found vivo model crystal-induc periton inflammasome-defici mice mice defici il-1β receptor il-1r find provid insight molecular process underli inflammatori condit gout pseudogout support pivot role inflammasom sever autoinflammatori diseas',\n",
       "  'hematopoiet stem cell quiescenc promot error-pron dna repair mutagenesi adult stem cell includ hematopoiet stem cell hsc maintain quiescent rest state vivo quiescenc wide consid essenti protect mechan stem cell minim endogen stress caus cellular respir dna replic demonstr hsc quiescenc also detriment effect found hsc uniqu cell-intrins mechan ensur surviv respons ioniz irradi ir includ enhanc prosurviv gene express strong activ p53-mediat dna damag respons show quiescent prolifer hsc equal radioprotect use differ type dna repair mechan describ nonhomolog end join nhej -mediat dna repair quiescent hsc associ acquisit genom rearrang persist vivo contribut hematopoiet abnorm result demonstr quiescenc double-edg sword render hsc intrins vulner mutagenesi follow dna damag',\n",
       "  'recruit nck cd3ϵ reveal ligand-induc conform chang essenti cell receptor signal synaps format membran receptor initi signal transduct upon ligand bind matter intens scrutini cell receptor complex tcr-cd3 compos tcr alpha/beta ligand bind subunit bound cd3 subunit respons signal transduct although long specul tcr-cd3 may undergo conform chang confirm still lack present strong evid ligand engag tcr-cd3 induc conform chang expos proline-rich sequenc cd3 epsilon result recruit adaptor protein nck occur earlier independ tyrosin kinas activ final interf nck-cd3 epsilon associ vivo demonstr tcr-cd3 recruit nck critic matur immun synaps cell activ',\n",
       "  'pseudo-seq genome-wid detect pseudouridin modif rna rna molecul contain varieti chemic divers posttranscript modifi base abund modifi base found cellular rna pseudouridin ψ recent map hundr site mrna mani dynam regul though pseudouridin landscap determin cell type growth condit enzym respons mrna pseudouridyl univers conserv suggest mani novel pseudouridyl site remain discov present pseudo-seq techniqu allow identif site pseudouridyl genome-wid single-nucleotid resolut chapter provid detail descript pseudo-seq includ protocol rna isol saccharomyc cerevisia pseudo-seq librari prepar data analysi includ descript process map sequenc read comput identif site pseudouridyl assign site specif pseudouridin synthas approach present readili adapt cell tissu type high-qual mrna isol identif novel pseudouridyl site import first step elucid regul function modif',\n",
       "  'mammalian epigenom chemic modif dna histon protein form complex regulatori network modul chromatin structur genom function epigenom refer complet descript potenti herit chang across genom composit epigenom within given cell function genet determin lineag environ sequenc human genom complet investig seek comprehens view epigenet chang determin genet inform made manifest across incred vari background development stage tissu type diseas state review current research effort emphasi large-scal studi emerg technolog challeng ahead',\n",
       "  'microtubule-associ histon deacetylas 6 support calcium store sensor stim1 mediat malign cell behavior stromal-interact molecul 1 stim1 endoplasm reticulum ca 2+ storag sensor promot cell growth migrat angiogenesi breast cervic cancer report microtubule-associ histon deacetylas 6 hdac6 differenti regul activ stim1-medi store-oper ca 2+ entri soce cervic cancer cell normal cervic epitheli cell confoc microscopi live cell indic microtubul integr necessari stim1 traffick plasma membran interact orai1 essenti pore subunit soce cancer cell overexpress stim1 orai1 compar normal cervic epitheli cell hdac6 upregul cancer cell accompani hypoacetyl α-tubulin tubastatin-a specif hdac6 inhibitor inhibit stim1 transloc plasma membran block soce activ cancer cell normal epitheli cell genet pharmacolog inhibit hdac6 block stim1 membran traffick downstream ca 2+ influx evidenc total intern reflect fluoresc imag intracellular ca 2+ determin contrast hdac6 inhibit affect interact stim1 microtubul plu end-bind protein eb1 analysi surgic specimen confirm cervic cancer tissu overexpress stim1 orai1 accompani hypoacetyl α-tubulin togeth result identifi hdac6 candid target disrupt stim1-medi soce gener strategi block malign cell behavior',\n",
       "  'tumor necrosi factor famili receptor rank cd40 cooper establish thymic medullari microenviron self-toler medullari thymic epitheli cell mtec establish cell self-toler express autoimmun regul air peripher tissue-specif self-antigen howev signal underli mtec develop remain larg unclear demonstr crucial regul mtec develop receptor activ nf-kappab rank cd40 signal wherea rank signal essenti mtec develop embryogenesi postnat mice cooper cd40 rank signal requir mtec develop success establish medullari microenviron ligat rank cd40 fetal thymic stroma vitro induc mtec develop tumor necrosi factor-associ factor 6 traf6 nf-kappab induc kinas nik ikappab kinas beta ikkbeta -depend manner result show developmental-stage-depend cooper rank cd40 promot mtec develop therebi establish self-toler',\n",
       "  'rare common variant twenti argument genome-wid associ studi greatli improv understand genet basi diseas risk fact tend identifi fraction specif causal loci led diverg opinion whether varianc hidden numer rare variant larg effect common variant small effect review 20 argument model genet basi complex trait conclud class effect readili reconcil',\n",
       "  'dna methyl statu predict cell type-specif enhanc activ cell-select glucocorticoid receptor gr bind distal regulatori element associ cell type-specif region local access chromatin region either pre-exist chromatin pre-program induc receptor de novo mechan creat maintain site well understood observ global enrich cpg densiti pre-program element implic demethyl state mainten open chromatin tissue-specif manner contrast site activ open gr de novo character low cpg densiti form uniqu class enhanc devoid suppress effect agglomer methyl-cytosin furthermor treatment glucocorticoid induc rapid chang methyl level select cpg within de novo site final identifi gr-bind element cpg critic posit show methyl affect gr-dna interact vitro find present uniqu link tissue-specif chromatin access dna methyl transcript factor bind show dna methyl integr compon gene regul nuclear receptor',\n",
       "  'blm helicas facilit telomer replic lead strand synthesi telomer base vitro unwind activ g-quadruplex g4 dna bloom syndrome-associ helicas blm propos particip telomer replic aid fork progress g-rich telomer dna singl molecul analysi replic dna smard use determin contribut blm helicas telomer replic blm-defici cell replic fork initi origin within telomer copi g-rich strand lead strand synthesi move slower telomer compar adjac subtelomer fork progress telomer slow presenc g4 stabil use g4-specif antibodi found defici blm anoth g4-unwind helicas werner syndrome-associ helicas wrn result increas g4 structur cell importantli defici either helicas led greater increas g4 dna detect telomer compar g4 seen genome-wid collect find consist blm helicas facilit telomer replic resolv g4 structur form copi g-rich strand lead strand synthesi',\n",
       "  'reflect 25 year myc 25 year ago myc human homologu retrovir oncogen identifi sinc time myc research intens advanc impress reflect astonish increment insight myc regul function also impact numer biolog disciplin includ understand molecular oncogenesi gener chronicl major advanc understand myc biolog peer futur myc research',\n",
       "  \"protect effect exercis phosphoinositid 3-kinas p110alpha signal dilat hypertroph cardiomyopathi physic activ protect cardiovascular diseas physiolog cardiac hypertrophi associ regular exercis usual benefici mark contrast patholog hypertrophi associ diseas p110alpha isoform phosphoinositid 3-kinas pi3k play critic role induct exercise-induc hypertrophi whether gene activ athlet 's heart might impact cardiac function surviv set heart failur unknown examin whether progress exercis train pi3k p110alpha activ affect surviv and/or cardiac function two model heart diseas subject transgen mous model dilat cardiomyopathi dcm swim train genet cross cardiac-specif transgen mice increas decreas pi3k p110alpha activ dcm model subject pi3k p110alpha transgen acut pressur overload ascend aortic constrict life-span cardiac function molecular marker patholog hypertrophi examin exercis train increas cardiac pi3k p110alpha activ prolong surviv dcm model 15-20 contrast reduc pi3k p110alpha activ drastic shorten lifespan approxim 50 increas pi3k p110alpha activ favor effect cardiac function fibrosi pressure-overload model attenu patholog growth pi3k p110alpha signal neg regul g protein-coupl receptor stimul extracellular respons kinas akt via pi3k p110gamma activ isol cardiomyocyt find suggest exercis enhanc pi3k p110alpha activ delay prevent progress heart diseas supraphysiolog activ benefici identif gene import hypertrophi athlet 's heart could offer new strategi treat heart failur\",\n",
       "  'effect cigarett smoke alcohol consumpt fruit veget consumpt ivf outcom review present origin data background lifestyl factor includ cigarett smoke alcohol consumpt nutrit habit impact health well risk chronic diseas area in-vitro fertil ivf pregnanc lifestyl factor influenc oocyt product fertil rate pregnanc pregnanc loss chronic low-grad oxid stress may underli poor outcom ivf case method review current literatur present origin previous unpublish data obtain coupl attend pivet medic centr western australia result studi 80 femal 70 male partner complet 1-week diari document smoke alcohol fruit veget intak subsequ clinic outcom ivf treatment quantiti oocyt collect fertil rate pregnanc pregnanc loss submit multipl regress analysi order investig relationship patient treatment record lifestyl factor signific found male smoke caus increas risk pregnanc loss p 0.029 femal smoke caus advers effect ovarian reserv alcohol consumpt β 0.074 p 0.001 fruit veget consumpt β 0.034 p 0.001 posit effect fertil conclus base result current literatur import impact lifestyl factor ivf clinic outcom current conflict result regard lifestyl factor nutrit habit alcohol consumpt appar chronic oxid stress induc lifestyl factor poor nutrit habit associ lower rate ivf success',\n",
       "  'effici mitochondri genom edit crispr/cas9 cluster regularli interspac short palindrom repeat crispr /cas9 system wide use nuclear dna edit gener mutat correct specif diseas allel despit flexibl applic determin crispr/cas9 origin identifi bacteri defens system viru target mitochondria mtdna edit show regular flag-cas9 local mitochondria edit mitochondri dna sgrna target specif loci mitochondri genom express flag-cas9 togeth grna target cox1 cox3 lead cleavag specif mtdna loci addit observ disrupt mitochondri protein homeostasi follow mtdna truncat cleavag crispr/cas9 overcom nonspecif distribut flag-cas9 also creat mitochondria-target cas9 mitocas9 new version cas9 local mitochondria togeth express grna target mtdna specif cleavag mtdna mitocas9-induc reduct mtdna transcript lead mitochondri membran potenti disrupt cell growth inhibit mitocas9 could appli edit mtdna togeth grna express vector without affect genom dna brief studi demonstr mtdna edit possibl use crispr/cas9 moreov develop mitocas9 specif local mitochondria facilit applic mitochondri genom edit',\n",
       "  'histon variant h2a.z mark 5′ end activ inact gene euchromatin s. cerevisia histon variant h2a.z deposit euchromatin flank silent heterochromatin prevent ectop spread show h2a.z nucleosom found promot region nearli gene euchromatin gener occur two posit nucleosom flank nucleosome-fre region nfr contain transcript start site astonishingli enrich 5 end observ activ transcrib gene also inact loci mutagenesi typic promot reveal 22 bp segment dna suffici program format nfr flank two h2a.z nucleosom segment contain bind site myb-rel protein reb1 adjac dt da tract effici deposit h2a.z promot specif pattern histon h3 h4 tail acetyl bromodomain protein bdf1 compon swr1 remodel complex deposit h2a.z',\n",
       "  'exercis respiratori train improv exercis capac qualiti life patient sever chronic pulmonari hypertens background pulmonari hypertens ph associ restrict physic capac limit qualiti life poor prognosi right heart failur present studi first prospect random studi evalu effect exercis respiratori train patient sever symptomat ph method result thirti patient ph 21 women mean age 50+/-13 year mean pulmonari arteri pressur 50+/-15 mm hg mean world health organ class 2.9+/-0.5 pulmonari arteri hypertens n=23 chronic thromboembol ph n=7 stabl disease-target medic randomli assign control n=15 primari train n=15 group medic remain unchang studi period primari end point chang baselin week 15 distanc walk 6 minut score short form health survey quality-of-lif questionnair chang function class borg scale paramet echocardiographi ga exchang also assess week 15 patient primari secondari train group improv 6-minut walk distanc mean differ control primari train group 111 95 confid interv 65 139 p 0.001 exercis train well toler improv score qualiti life function class peak oxygen consumpt oxygen consumpt anaerob threshold achiev workload systol pulmonari arteri pressur valu rest chang significantli 15 week exercis respiratori train 61+/-18 54+/-18 mm hg within train group conclus studi indic respiratori physic train could promis adjunct medic treatment sever ph effect add benefici result modern medic treatment',\n",
       "  'hiv-1 regul latenc monocyte-macrophag lineag cd4+ lymphocyt introduct 1996 haart rais hope erad hiv-1 unfortun discoveri latent hiv-1 reservoir cd4+ cell monocyte-macrophag lineag prove optim prematur long-liv hiv-1 reservoir constitut major obstacl erad hiv-1 review focu establish mainten hiv-1 latenc two major target hiv-1 cd4+ cell monocyte-macrophag lineag understand cell-typ molecular mechan establish mainten reactiv hiv-1 latenc reservoir crucial effici therapeut intervent complet viral erad holi graal clinician might achiev strateg intervent target latent product infect cell suggest new approach combin differ kind provir activ may help reduc dramat size latent hiv-1 reservoir patient haart',\n",
       "  'effect electro-acupunctur therapi post-strok depress patient differ degre motor function impair pilot studi purpos present studi examin whether electro-acupunctur therapi reduc post-strok depress psd whether motor function impair interact effect therapi subject twenty-eight psd patient assess assign either good poor motor function group depend motor grade method beck depress inventori bdi hamilton depress rate scale hdr manual muscl test mmt administ screen initi phase studi 4th 8th 12th 16th week daili electro-acupunctur treatment result electro-acupunctur treatment reduc psd assess bdi hdr patient particular depress good motor function group significantli reduc poor motor function group degre motor function impair chang throughout studi either group conclus result present studi demonstr electro-acupunctur therapi improv psd treatment effect vari depend degre motor function impair',\n",
       "  'cell receptor ligat induc format dynam regul signal assembl tcell antigen receptor tcr ligat initi tyrosin kinas activ signal complex assembl immun synaps format studi kinet mechan signal complex format live jurkat leukem cell use signal protein fluoresc tag variant enhanc gfp egfp within second contact coverslip coat stimulatori antibodi cell develop small dynam regul cluster enrich tcr phosphotyrosin zap-70 lat grb2 gad slp-76 exclud lipid raft marker enhanc yellow fluoresc protein–gpi compet induc calcium elev lat grb2 gad transient associ tcr although zap-70–contain cluster persist 20 min photobleach studi reveal zap-70 continu dissoci return complex strikingli slp-76 transloc perinuclear structur cluster tcr result emphas dynam chang composit signal complex indic complex form within second tcr engag absenc either lipid raft aggreg format central tcr-rich cluster',\n",
       "  'development heterogen cardiac fibroblast predict patholog prolifer activ rational fibrosi mediat partli extracellular matrix-deposit fibroblast heart although mesenchym cell report multipl embryon origin function consequ heterogen unknown object sought valid panel surfac marker prospect identifi cardiac fibroblast elucid development origin cardiac fibroblast character correspond phenotyp also determin prolifer rate development subset fibroblast pressur overload injuri method result show thy1 cd45 cd31 cd11b ter119 cell constitut major cardiac fibroblast character cell use flow cytometri epifluoresc confoc microscopi transcript profil use revers transcript polymeras chain reaction rna-seq use lineag trace transplant studi parabiosi show adult cardiac fibroblast deriv epicardium minor aris endotheli cell small fraction pax3-express cell detect gener cardiac fibroblast bone marrow circul cell interestingli prolifer rate fibroblast subset injuri ident rel abund lineag remain injuri anatom distribut fibroblast lineag also remain unchang pressur overload furthermor rna-seq analysi demonstr tie2-deriv tbx18-deriv fibroblast within oper group exhibit similar gene express profil conclus cellular expans cardiac fibroblast transaort constrict surgeri restrict singl development subset parallel prolifer activ heterogen popul fibroblast pressur overload could suggest common signal mechan stimul patholog respons',\n",
       "  \"pre-eclampsia connect angiogen metabol pathway pre-eclampsia hypertens diseas pregnanc worldwid incid 5-8 review focus recent develop pre-eclampsia research relat angiogenesi metabol first address 'angiogen imbal theori hypothes pre-eclampsia result imbal factor promot antagon angiogenesi solubl fms-like tyrosin kinas sflt1 2-methoxyestradiol 2-me catechol-o-methyltransferas comt next analyz associ pre-eclampsia dysfunct metabol homocystein placent glycogen hope illumin variou connect exist angiogenesi metabol pre-eclampsia facilit updat reconsider old model pathogenesi\",\n",
       "  'protein lysin acetylated/deacetyl enzym metabolism-rel diseas lysin acetyl revers posttransl modifc epigenet phenomenon refer transfer acetyl group acetyl coa lysin e- amino group target protein modul acetyltransferas histone/ lysin k acetyltransferas hats/kat deacetylas histone/lysin k deacetylas hdacs/kdac lysin acetyl regul variou metabol process fatti acid oxid kreb cycl oxid phosphoryl angiogenesi thu disord lysin acetyl may correl obes diabet cardiovascular diseas term metabol complic accumul studi proteom acetyl lysin acetyl also involv cell immun statu degen diseas exampl alzheim ’ diseas huntington ’ diseas review primarili summar current studi lysin acetyl metabol modul metabolism-rel diseas cardiovascular diseas fat metabol disord',\n",
       "  'differenti specif endocrin fgf19 fgf21 fgfr1 fgfr4 complex klb background recent studi suggest betaklotho klb endocrin fgf19 fgf21 redirect fgfr signal regul metabol homeostasi suppress obes diabet howev ident predomin metabol tissu major fgfr-klb resid critic mediat differenti action metabol effect fgf19 fgf21 remain unclear methodology/princip find determin receptor tissu specif fgf21 comparison fgf19 use direct sensit quantit bind kinet downstream signal transduct express earli respons gene upon administr fgf19 fgf21 mice found fgf21 bind fgfr1 much higher affin fgfr4 presenc klb fgf19 bind fgfr1 fgfr4 presenc klb compar affin interact fgf21 fgfr4-klb weak even high concentr could neglig physiolog concentr fgf19 fgf21 fgf1 exhibit bind affin klb bind fgf1 depend fgfr present fgf19 fgf21 unabl displac fgf1 bind convers fgf1 displac fgf19 fgf21 bind result indic klb indispens mediat bind fgf19 fgf21 fgfr requir fgf1 although fgf19 predominantli activ respons liver less extent adipos tissu fgf21 significantli adipos tissu adipocyt among sever metabol endocrin tissu respons adipos tissu fgf21 predomin blunt ablat klb fgfr1 conclus result indic unlik fgf19 fgf21 unabl bind fgfr4-klb complex affin compar fgfr1-klb therefor physiolog concentr less like directli significantli target liver fgfr4-klb predominantli resid howev fgf21 fgf19 potenti activ respons primarili adipos tissu fgfr1-klb resid',\n",
       "  'therapeut efficaci multi-epitop vaccin helicobact pylori infect balb/c mice model epitop vaccin promis option therapeut vaccin helicobact pylori h. pylori infect studi construct multi-epitop vaccin five epitop mucos adjuv e. coli heat-labil enterotoxin b subunit ltb name huepi-ltb evalu therapeut effect h. pylori infect balb/c mice model huepi-ltb contain three th epitop ureb two b cell epitop ureb hpaa construct express e. coli oral therapeut immun huepi-ltb significantli decreas h. pylori colon compar oral immun pb protect correl antigen-specif cd4+ cell igg mucos iga antibodi respons multi-epitop vaccin may promis vaccin candid may help control h. pylori infect',\n",
       "  'dna fragment blood plasma cancer patient quantit evid origin apoptot necrot cell increas level dna fragment frequent found blood plasma cancer patient publish data suggest fraction dna blood plasma deriv cancer cell howev known much circul dna cancer noncanc cell quantit methylation-specif pcr promot region cdkn2a tumor suppressor gene abl quantifi fraction plasma dna deriv tumor cell plasma sampl 30 unselect cancer patient detect quantiti tumor dna 3 much 93 total circul dna investig possibl origin nontumor dna plasma demonstr contribut t-cell dna case investig possibl plasma dna origin apoptot necrot cell perform studi apoptot staurosporin necrot staurosporin plu oligomycin cell vitro mice induct apoptot anti-cd95 necrot acetaminophen liver injuri increas amount dna found releas supernat cell blood plasma sampl treat anim clear discrimin apoptot necrot plasma dna possibl gel electrophoresi characterist pattern dna fragment could identifi plasma deriv differ cancer patient data consist possibl apoptot necrot cell major sourc plasma dna cancer patient',\n",
       "  'pharmacodynam pharmacokinet eptifibatid patient acut coronari syndrom prospect analysi pursuit background platelet deposit aggreg central pathogenesi ischem complic acut coronari syndrom ac pharmacodynam effect platelet glycoprotein iib/iiia antagonist eptifibatid delin healthi subject patient ac assess effect eptifibatid ex vivo platelet aggreg patient enrol platelet glycoprotein iib/iiia unstabl angina receptor suppress use integrilin eptifibatid therapi pursuit trial ac method result patient randomli assign intraven bolu 180 microgram/kg 72-hour infus eptifibatid 2.0 microgram/kg per minut n=48 placebo n=50 assess correl plasma eptifibatid level receptor occup inhibit ex vivo platelet aggreg 5 minut 1 4 24 48 72 hour treatment 4 8 hour termin infus blood collect buffer citrat d-phenylalanyl-l-prolyl-l-arginin chloromethylketon anticoagul although eptifibatid produc profound prolong inhibit platelet aggreg therapi aggreg appear recov partial 4 hour bolu aggreg respons greater thrombin receptor agonist peptid versu adp stimul inhibit platelet aggreg greater blood sampl anticoagul citrat versu d-phenylalanyl-l-prolyl-l-arginin chloromethylketon ppack plasma eptifibatid level correl significantli receptor occup inhibit platelet aggreg conclus bolu infus eptifibatid inhibit platelet aggreg profoundli patient ac follow brief partial recoveri result enhanc understand relat pharmacodynam clinic effect eptifibatid patient may import implic use percutan intervent',\n",
       "  \"proinflammatori cytokin underli inflamm crohn 's diseas purpos review encapsul current understand proinflammatori cytokin respons inflamm underli crohn 's diseas prospect use inform devis therapi condit base inhibit cytokin recent find current research shed new light role helper cell th 1 th17 respons pathogenesi crohn 's diseas initi studi conduct decad ago highlight view crohn 's diseas inflamm caus interleukin-12-driven th1 respons result gener interferon-gamma serv main inflammatori mediat recent year howev view larg eclips studi conduct mainli murin model show th17 respons main caus crohn 's diseas inflamm product interleukin-17 somewhat balanc view emerg hold interferon-gamma still major proinflammatori cytokin crohn 's diseas although may aris th1 th17-mediat respons differ phase inflammatori process summari new find continu support idea anti-interleukin-12p40 antibodi inhibit th1 th17 respons logic potent anticytokin treatment crohn 's diseas\",\n",
       "  'statist method assess agreement two method clinic measur clinic measur comparison new measur techniqu establish one often need see whether agre suffici new replac old investig often analys inappropri notabl use correl coeffici use correl mislead altern approach base graphic techniqu simpl calcul describ togeth relat analysi assess repeat',\n",
       "  'multidrug abc transport bmrc/bmrd bacillu subtili regul via ribosome-medi transcript attenu mechan express particular drug transport respons antibiot pressur critic element develop bacteri multidrug resist repres seriou concern human health obtain better understand underli regulatori mechan dissect transcript activ atp-bind cassett abc transport bmrc/bmrd gram-posit model bacterium bacillu subtili use promoter-gfp fusion live cell array technolog demonstr tempor control transcript activ bmrcd gene respons antibiot target protein synthesi intriguingli bmrcd express occur late-exponenti stationari growth stage irrespect time antibiot challeng show due tight transcript control transit state regul abrb moreov result show bmrcd gene co-transcrib bmrb yhej small open read frame immedi upstream bmrc harbor three altern stem-loop structur stem-loop appar crucial antibiotic-induc bmrcd transcript importantli antibiotic-induc bmrcd express requir translat bmrb impli bmrb serv regulatori leader peptid altogeth demonstr first time ribosome-medi transcript attenu mechan control express multidrug abc transport',\n",
       "  'neural crest sourc mesenchym stem cell special hematopoiet stem cell nich function mesenchym stem cell msc osteolineag cell contribut hematopoiet stem cell hsc nich bone marrow long bone howev development relationship remain unclear studi demonstr differ msc popul develop marrow long bone distinct function prolif mesoderm-deriv nestin msc particip fetal skeletogenesi lose msc activ soon birth contrast quiescent neural crest-deriv nestin cell preserv msc activ gener fetal chondrocyt instead differenti hsc niche-form msc help establish hsc nich secret cxcl12 perineur migrat cell bone marrow requir erbb3 receptor neonat nestin-gfp pdgfrα cell popul also contain schwann cell precursor compris matur schwann cell thu develop bone marrow hsc niche-form msc share common origin sympathet peripher neuron glial cell ontogen distinct msc non-overlap function endochondrogenesi hsc nich format',\n",
       "  'hotspot aberr epigenom reprogram human induc pluripot stem cell induc pluripot stem cell ipsc offer immens potenti regen medicin studi diseas develop somat cell reprogram involv epigenom reconfigur confer ipsc characterist similar embryon stem es cell howev remain unknown complet reestablish es-cell-lik dna methyl pattern throughout genom report first whole-genom profil dna methyl single-bas resolut five human ipsc line along methylom es cell somat cell differenti ipsc es cell ipsc show signific reprogram variabl includ somat memori aberr reprogram dna methyl ipsc share megabase-scal differenti methyl region proxim centromer telomer display incomplet reprogram non-cg methyl differ cg methyl histon modif lastli differenti ipsc trophoblast cell reveal error reprogram cg methyl transmit high frequenc provid ipsc reprogram signatur maintain differenti',\n",
       "  'inherit coronari arteri diseas men analysi role chromosom background sexual dimorph exist incid preval coronari arteri diseas -- men commonli affect age-match women explor role chromosom coronari arteri diseas context sexual inequ method genotyp 11 marker male-specif region chromosom 3233 biolog unrel british men three cohort british heart foundat famili heart studi bhf-fh west scotland coronari prevent studi woscop cardiogen studi basi inform chromosom track back one 13 ancient lineag defin haplogroup examin associ common chromosom haplogroup risk coronari arteri diseas cross-sect bhf-fh prospect woscop final undertook function analysi chromosom effect monocyt macrophag transcriptom british men cardiogen studi find nine haplogroup identifi two r1b1b2 account roughli 90 chromosom variant among british men carrier haplogroup 50 higher age-adjust risk coronari arteri diseas men chromosom lineag bhf-fh odd ratio 1·75 95 ci 1·20-2·54 p=0·004 woscop 1·45 1·08-1·95 p=0·012 joint analysi popul 1·56 1·24-1·97 p=0·0002 associ haplogroup increas risk coronari arteri diseas independ tradit cardiovascular socioeconom risk factor analysi macrophag transcriptom cardiogen studi reveal 19 molecular pathway show strong differenti express men haplogroup lineag chromosom interconnect common gene relat inflamm immun strong relev atherosclerosi interpret human chromosom associ risk coronari arteri diseas men european ancestri possibl interact immun inflamm fund british heart foundat uk nation institut health research lew carti charit fund nation health medic research council australia european union 6th framework programm wellcom trust',\n",
       "  \"cytoscap 2.8 new featur data integr network visual unlabel cytoscap popular bioinformat packag biolog network visual data integr version 2.8 introduc two power new featur -- custom node graphic attribut equat -- use jointli greatli enhanc cytoscap 's data integr visual capabl custom node graphic allow imag project onto node includ imag gener dynam remot locat attribut equat provid cytoscap spreadsheet-lik function valu attribut comput dynam function attribut network properti avail implement cytoscap desktop java applic releas librari gnu public licens lgpl binari instal bundl sourc code cytoscap 2.8 avail download http //cytoscape.org\",\n",
       "  'detect histon modif specif gene loci singl cell histolog section chromatin immunoprecipit assay contribut greatli understand role histon modif gene regul howev permit analysi single-cel resolut thu confound analys heterogen cell popul present method permit visual histon modif singl genom loci single-cel resolut formaldehyde-fix paraffin-embed tissu section base combin use situ hybrid proxim ligat assay show dimethyl lysin 4 histon h3 h3k4me2 myh11 locu restrict smooth muscl cell smc lineag human mous tissu section mark persist even phenotyp modul smc atherosclerot lesion show detect express smc marker gene methodolog promis broad applic studi epigenet mechan complex multicellular tissu develop diseas',\n",
       "  \"mechanist character sulfur-relay system eukaryot 2-thiouridin biogenesi trna wobbl posit wobbl modif trna 5-methoxycarbonylmethyl-2-thiouridin mcm 5 2 u requir proper decod nnr codon eukaryot 2-thio group confer conform rigid mcm 5 2 u larg fix c3'-endo ribos pucker ensur stabl accur codon-anticodon pair identifi five gene saccharomyc cerevisia yil008w urm1 yhr111w uba4 yor251c tum1 ynl119w ncs2 ygl211w ncs6 requir 2-thiolat mcm 5 2 u. vitro sulfur transfer experi reveal tum1p stimul cystein desulfuras nfs1p accept persulfid sulfur nfs1p urm1 ubiquitin-rel modifi uba4 e1-lik enzym involv protein urmyl carboxy-terminu urm1p activ acyl-adenyl -coamp thiocarboxyl -cosh uba4p activ thiocarboxyl util subsequ reaction 2-thiouridin format mediat ncs2p/ncs6p could success reconstitut 2-thiouridin format vitro use recombin protein studi reveal 2-thiouridin format share pathway chemic reaction protein urmyl sulfur-flow eukaryot 2-thiouridin format distinct mechan bacteri sulfur-relay system base persulfid chemistri\",\n",
       "  'high preval asthma cross countri skier object studi preval asthma asthma symptom bronchial hyperrespons swedish cross countri skier compar non-skier monitor chang symptom bronchial hyperrespons year design cross section studi winter ski season summer set six ski club élite skier total 47 two differ area sweden subject 42 élite cross countri skier 29 non-ski refer main outcom measur bronchial respons asthma symptom lung function result bronchial respons significantli greater asthma symptom preval skier refer differ bronchial respons within either group winter summer 15 42 skier use antiasthmat drug regularli 23 combin asthma symptom hyperrespons airway physician diagnos asthma altogeth 33 skier symptom asthma bronchial hyperrespons one refer symptom asthma bronchial hyperrespons none use antiasthmat drug regularli conclus asthma asthma-lik symptom bronchial hyperrespons much common cross countri skier gener popul non-skier strenuou exercis low temperatur entail breath larg volum cold air probabl explan persist asthma skier',\n",
       "  \"character biochem properti bacillu subtili recq helicas recq famili helicas function safeguard genom unlik escherichia coli gram-posit bacillu subtili bacterium possess two recq-lik homologu recq bs rec requir repair dna double-strand break recq bs also bind fork dna ensur smooth progress cell cycl present first biochem analysi recombin recq bs recq bs bind weakli single-strand dna ssdna blunt-end double-strand dna dsdna strongli fork dsdna protein exhibit dna-stimul atpas activ atp- mg 2+ -depend dna helicas activ 3 → 5 polar molecular model show recq bs share high sequenc structur similar e. coli recq surprisingli recq bs resembl truncat saccharomyc cerevisia sgs1 human recq helicas recq ec regard enzymat activ specif recq bs unwind fork dsdna dna duplex 3'-overhang inact blunt-end dsdna 5'-overhung duplex interestingli recq bs unwind blunt-end dna structur featur includ nick gap 5'-flap kappa joint synthet replic fork holliday junction discuss find context recq bs 's possibl function preserv genom stabil\",\n",
       "  'sod1 integr signal oxygen glucos repress respir cu/zn superoxid dismutas sod1 abund enzym best studi regul antioxid defens use yeast saccharomyc cerevisia report sod1 transmit signal oxygen glucos repress respir mechan involv sod1-medi stabil two casein kinas 1-gamma ck1γ homolog yck1p yck2p requir respiratori repress sod1 bind c-termin degron identifi yck1p/yck2p promot kinas stabil catalyz superoxid convers peroxid effect sod1 ck1γ stabil also observ mammalian sod1 ck1γ human cell line therefor singl circuit oxygen glucos reactiv oxygen repress respir sod1/ck1γ signal data therefor may provid mechanist insight rapidli prolifer cell mani cancer accomplish glucose-medi repress respir favor aerob glycolysi',\n",
       "  'prognost impact platelet distribut width-to-platelet count ratio patient breast cancer activ platelet promot tumor cell growth angiogenesi invas platelet activ infer platelet volum indic pvi includ platelet distribut width pdw mean platelet volum mpv platelet distribut width-to-platelet count ratio pdw/p mean platelet volume-to-platelet count ratio platelet platelet-rel marker platelet-to-lymphocyt ratio found signific prognost factor patient breast cancer howev role pvi predict surviv breast cancer remain unknown henc perform retrospect analysi 275 patient breast cancer pvi compar clinicopatholog variabl assess identifi independ indic associ disease-fre surviv df use cox proport hazard model elev pdw/p significantli correl age her2 statu univari analysi reveal elev pdw mpv pdw/p well tumor size nuclear grade lymph node involv significantli associ inferior df rate tumor size p 0.01 nuclear grade lymph node involv pdw mpv pdw/p p 0.05 multivari analysi larg tumor size elev pdw/p signific prognost factor df hazard ratio 3.24 95 confid interv ci 1.24-8.47 2.99 95 ci 1.18-7.57 respect p 0.05 studi first reveal elev pdw/p significantli reduc df patient breast carcinoma measur pdw/p simpl rel inexpens almost univers avail use routin blood count make attract biomark improv risk assess',\n",
       "  'persist lcmv infect control blockad type interferon signal persist viral infect chronic immun activ neg immun regul express elev interferon signatur lymphoid tissu destruct correl diseas progress demonstr blockad type interferon ifn-i signal use ifn-i receptor neutral antibodi reduc immun system activ decreas express neg immun regulatori molecul restor lymphoid architectur mice persist infect lymphocyt choriomening viru ifn-i blockad establish persist viru infect result enhanc viru clearanc cd4 cell-depend henc demonstr direct causal link ifn-i signal immun activ neg immun regul express lymphoid tissu disorgan viru persist result suggest therapi target ifn-i may help control persist viru infect',\n",
       "  'lam6 regul extent contact organel commun organel crucial eukaryot cell function one coher unit import mean commun membran contact site two organel come close proxim allow transport lipid small solut contact site dynam size chang respons environment cellular stimuli howev regul unclear show saccharomyc cerevisia lam6 resid sever central contact site erm er/mitochondria encount structur vclamp vacuol mitochondria patch nvj nuclear vacuolar junction show lam6 suffici expans contact site physiolog condit necessari coordin contact site size given lam6 part larg protein famili conserv vertebr work open avenu investig underli principl organel commun',\n",
       "  'endocrin regul human fetal growth role mother placenta fetu environ fetu develop critic surviv long-term health regul normal human fetal growth involv mani multidirect interact mother placenta fetu mother suppli nutrient oxygen fetu via placenta fetu influenc provis matern nutrient via placent product hormon regul matern metabol placenta site exchang mother fetu regul fetal growth via product metabol growth-regul hormon igf glucocorticoid adequ trophoblast invas earli pregnanc increas uteroplacent blood flow ensur suffici growth uteru placenta fetu placenta may respond fetal endocrin signal increas transport matern nutrient growth placenta activ transport system product placent hormon influenc matern physiolog even behavior consequ poor fetal growth short term long term form increas mortal morbid endocrin regul fetal growth involv interact mother placenta fetu effect may program long-term physiolog',\n",
       "  'endothelial-to-mesenchym transit contribut cardiac fibrosi cardiac fibrosi associ decreas extent microvasculatur disrupt normal myocardi structur result excess deposit extracellular matrix mediat recruit fibroblast sourc fibroblast unclear specif anti-fibrot therapi current avail show cardiac fibrosi associ emerg fibroblast origin endotheli cell suggest endothelial-mesenchym transit endmt similar event occur format atrioventricular cushion embryon heart transform growth factor-β1 tgf-β1 induc endotheli cell undergo endmt wherea bone morphogen protein 7 bmp-7 preserv endotheli phenotyp system administr recombin human bmp-7 rhbmp-7 significantli inhibit endmt progress cardiac fibrosi mous model pressur overload chronic allograft reject find show endmt contribut progress cardiac fibrosi rhbmp-7 use inhibit endmt interven progress chronic heart diseas associ fibrosi',\n",
       "  'coupl local translat degrad regul growth cone collaps local translat mediat axon respons semaphorin3a sema3a guidanc cue howev subset axon proteom local synthes wherea protein traffick soma reason specif protein local synthes unknown show local protein synthesi degrad link event growth cone find growth cone exhibit high level ubiquitin local signal pathway trigger ubiquitin degrad rhoa mediat sema3a-induc growth cone collaps inhibit rhoa degrad suffici remov protein-synthesi requir sema3a-induc growth cone collaps addit rhoa find local translat protein main target ubiquitin-proteasom system growth cone thu local protein degrad major featur growth cone creat requir local translat replenish protein need maintain growth cone respons',\n",
       "  'cdk11 rangtp-depend microtubul stabil factor regul spindl assembl rate product ran-guanosin triphosph gtp around chromosom induc local nucleat plu end stabil microtubul mt nuclear protein tpx2 requir rangtp-depend mt nucleat find mt stabil affin purifi nuclear local signal nl -contain protein xenopu laevi egg extract nl protein fraction contain mt stabil activ purif use mass spectrometri identifi protein activ fraction includ cyclin-depend kinas 11 cdk11 cdk11 local spindl pole mt xenopu cultur cell egg extract recombin cdk11 demonstr rangtp-depend mt stabil activ wherea kinase-dead mutant inactiv cdk11 egg extract block rangtp-depend mt stabil dramat decreas spindl assembl rate simultan deplet tpx2 complet inhibit centrosome-depend spindl assembl result indic cdk11 respons rangtp-depend mt stabil around chromosom local stabil essenti normal rate spindl assembl spindl function',\n",
       "  'popul dynam pathogen conundrum vivax malaria build mathemat model popul dynam pathogen within host involv consider factor similar ecolog pathogen prey cell host within multicellular host attack cell type integr cellular system turn interven infect exampl immun respons attempt sens elimin contain pathogen homeostat mechan tri compens cell loss review focus model appli malaria diseas caus single-cel eukaryot parasit infect red blood cell special concern given vivax malaria diseas often thought benign sometim incapacit parasit attack small proport red blood cell youngest one howev use mathemat model argu deplet pool red blood cell disastr host growth parasit vigor check host immun respons also model elucid aspect new field observ indic vivax malaria danger previous thought electron supplementari materi onlin version articl doi:10.1007/s12551-010-0034-3 contain supplementari materi avail author user',\n",
       "  'identif analysi ribonucleas p mrp rna broad rang eukaryot rnase p mrp ribonucleoprotein complex involv trna rrna process respect rna subunit two enzym structur relat play essenti role enzymat reaction rna highli conserv helic region p4 import catalyt reaction use bioinformat approach base conserv element comput analyz avail genom sequenc eukaryot organ identifi larg number novel nuclear rnase p mrp rna gene mrp rna instanc investig increas number known sequenc factor three present secondari structur model mani predict rna although sequenc abl fold consensu secondari structur p mrp rna strike variat size observ rang nosema locusta mrp rna 160 nt much larger rna e.g plasmodium knowlesi p rna 696 nt p mrp rna gene appear tandem protist emphas close evolutionari relationship rna',\n",
       "  'calcium absorpt vari within refer rang serum 25-hydroxyvitamin d. background calcium absorpt gener consid impair condit vitamin defici vitamin statu fulli normal absorpt known human object quantifi calcium absorpt two level vitamin replet use pharmacokinet method commerci market calcium supplement design two experi perform spring year one year apart first particip pretreat 25-hydroxyvitamin 25ohd mean serum 25ohd concentr 86.5 nmol/l pretreat mean serum concentr 50.2 nmol/l particip receiv 500 mg oral calcium load part standard low calcium breakfast low calcium lunch provid mid-day blood obtain fast frequent interv 10 12 hour thereaft method rel calcium absorpt two 25ohd concentr estim area curv auc load-induc increment serum total calcium result auc 9 +/- sem 3.63 mg hr/dl +/- 0.234 particip pretreat 25ohd 2.20 +/- 0.240 pretreat p 0.001 brief absorpt 65 higher serum 25ohd level averag 86.5 nmol/l level averag 50 nmol/l valu within nomin refer rang analyt conclus despit fact mean serum 25ohd level experi without supplement within current refer rang calcium absorpt perform 50 nmol/l significantli reduc rel mean 25ohd level 86 nmol/l thu individu serum 25-hydroxyvitamin level low end current refer rang may get full benefit calcium intak conclud lower end current refer rang set low',\n",
       "  'evolut virul opportunist pathogen gener plastic control standard virul evolut theori assum virul factor maintain aid parasit exploit increas growth within and/or transmiss host increas number studi demonstr mani opportunist pathogen op conform assumpt virul factor maintain instead advantag non-parasit context review virul evolut theori context op highlight import incorpor environ outsid focal virul site illustr virul select constrain correl extern focal set pinpoint driver key environment correl focu generalist strategi phenotyp plastic end summari key theoret empir challeng met fuller understand op',\n",
       "  'genome-wid profil h3k56 acetyl transcript factor bind site human adipocyt grow epidem obes metabol diseas call better understand adipocyt biolog regul transcript adipocyt particularli import target sever therapeut approach transcript outcom influenc histon modif transcript factor bind although epigenet state bind site sever import transcript factor profil mous 3t3-l1 cell line data lack human adipocyt studi identifi h3k56 acetyl site human adipocyt deriv mesenchym stem cell h3k56 acetyl cbp p300 deacetyl sirt1 protein import role diabet insulin signal found almost half genom show sign h3k56 acetyl highest level h3k56 acetyl associ transcript factor protein adipokin signal type ii diabet pathway order discov transcript factor recruit acetyltransferas deacetylas site h3k56 acetyl analyz dna sequenc near h3k56 acetyl region found e2f recognit sequenc enrich use chromatin immunoprecipit follow high-throughput sequenc confirm gene bound e2f4 well hsf-1 c/ebpα higher expect level h3k56 acetyl transcript factor bind site acetyl site often adjac rare overlap also discov signific differ bound target c/ebpα 3t3-l1 human adipocyt highlight need construct species-specif epigenet transcript factor bind site map first genome-wid profil h3k56 acetyl e2f4 c/ebpα hsf-1 bind human adipocyt serv import resourc better understand adipocyt transcript regul',\n",
       "  'detect character circular rna circular rna transcript first identifi earli 1990 knowledg speci remain limit studi tradit method rna analysi difficult novel bioinformat approach coupl biochem enrich strategi deep sequenc allow comprehens studi circular rna speci recent studi reveal thousand endogen circular rna mammalian cell highli abund evolutionarili conserv evid emerg circrna might regul microrna mirna function role transcript control also suggest therefor studi class noncod rna potenti implic therapeut research applic believ key futur challeng field understand regul function unusu molecul',\n",
       "  'classif unstabl angina revisit unstabl angina critic phase coronari heart diseas wide variabl symptom prognosi decad ago classif unstabl angina base clinic symptom introduc system valid prospect clinic studi correl prognosi link angiograph histolog find use categor patient mani larg clinic trial recent year pathophysiolog role platelet activ inflamm unstabl angina elucid subsequ improv marker myocardi injuri acute-phas protein hemostat marker may associ clinic outcom identifi particularli cardiac-specif troponin troponin shown repres best predictor earli risk patient angina rest accordingli suggest origin classif extend subclassifi one larg group unstabl angina patient ie angina rest within past 48 hour class iiib troponin-posit po troponin-neg neg patient 30-day risk death myocardi infarct consid 20 class iiib-t po 2 class iiib-t neg patient initi result suggest troponin may function surrog marker thrombu format effect guid therapi glycoprotein iib/iiia antagonist low-molecular-weight heparin observ provid addit impetu ad measur marker clinic classif repres novel concept treat high-risk patient',\n",
       "  'alcohol intak blood pressur systemat review implement mendelian random approach background alcohol report common modifi risk factor hypertens howev observ studi subject confound behaviour sociodemograph factor clinic trial difficult implement limit follow-up time mendelian random provid robust evid natur associ use common polymorph aldehyd dehydrogenas 2 aldh2 surrog measur alcohol consumpt aldh2 encod major enzym involv alcohol metabol individu homozyg null variant 2 2 experi advers symptom drink alcohol consequ drink consider less alcohol wild-typ homozygot 1 1 heterozygot hypothesis polymorph may influenc risk hypertens affect alcohol drink behaviour method find carri fix effect meta-analys aldh2 genotyp blood pressur five studi n 7,658 hypertens three studi n 4,219 use studi identifi via systemat review male obtain overal odd ratio 2.42 95 confid interv ci 1.66-3.55 p 4.8 x 10 -6 hypertens compar 1 1 2 2 homozygot odd ratio 1.72 95 ci 1.17-2.52 p 0.006 compar heterozygot surrog moder drinker 2 2 homozygot systol blood pressur 7.44 mmhg 95 ci 5.39-9.49 p 1.1 x 10 -12 greater among 1 1 among 2 2 homozygot 4.24 mmhg 95 ci 2.18-6.31 p 0.00005 greater among heterozygot among 2 2 homozygot conclus find support hypothesi alcohol intak mark effect blood pressur risk hypertens',\n",
       "  \"rapid sensit rt-quic detect human creutzfeldt-jakob diseas use cerebrospin fluid unlabel fast definit diagnosi creutzfeldt-jakob diseas cjd import assess patient care option transmiss risk real-tim quaking-induc convers rt-quic assay cerebrospin fluid csf nasal-brush specimen valuabl distinguish cjd non-cjd condit requir 2.5 5 day improv rt-quic assay describ identifi posit csf sampl within 4 14 h better analyt sensit moreov analysi 11 cjd patient demonstr 7 rt-quic posit use previou condit 10 posit use new assay analys total 46 48 csf sampl sporad cjd patient posit 39 non-cjd patient neg give 95.8 diagnost sensit 100 specif second-gener rt-quic assay markedli improv speed sensit detect prion seed csf specimen cjd patient enhanc prospect rapid accur ant mortem cjd diagnosi import long-stand problem deal variou neurodegen protein misfold diseas earli accur diagnosi issu particularli import human prion diseas cjd prion deadli transmiss unusu resist decontamin recent develop rt-quic test allow highli sensit specif detect cjd human cerebrospin fluid broadli implement key diagnost tool howev current appli rt-quic take 2.5 5 day miss 11 23 cjd case markedli improv rt-quic analysi human csf cjd non-cjd patient discrimin matter hour rather day enhanc sensit improv allow much faster accur practic test cjd broader term studi provid prototyp test misfold protein aggreg caus mani import amyloid diseas alzheim 's parkinson 's tauopathi\",\n",
       "  'wortmannin phosphoinositid 3-kinas inhibitor select enhanc cytotox receptor-directed-toxin chimera vitro vivo background gener resist neoplast cell line treatment ligand-toxin chimera attribut increas rate lysosom uptak degrad follow endocytosi chimera-receptor complex phosphoinositid 3-kinas pl 3-kinas activ known play role intracellular traffick particularli endosom lysosom hypothes co-expos cell pl 3-kinas inhibitor wortmannin might enhanc cytotox ligand-toxin chimera method vitro cytotox five receptor directed-toxin chimera bfgf-sap bfgf-pe afgf-p hbegf-sap bfgf-gelonin immunotoxin 11a8-sap examin presenc absenc pl 3-kinas inhibitor panel human neoplast cell line sk-mel-5 melanoma pa-1 ovarian teratocarcinoma du145 prostat carcinoma mcf-7 breast carcinoma vivo antitumor activ treatment regimen combin wortmannin 1 2 mg/kg i.p bfgf-sap 10 micrograms/kg i.v week 4 week evalu compar administr agent alon c3h/hen mice implant fsallc murin fibrosarcoma result concentr greater report ki pl 3-kinas inhibit 1-10 microm wortmannin enhanc cytotox combin saporin gelonin chimera produc subaddit cytotox combin pseudomona exotoxin chimera low nanomolar concentr select pl 3-kinas inhibit 5-100 nm examin effect one receptor directed-toxin chimera wortmannin dramat enhanc bfgf-sap cytotox three four cell line differ pl 3-kinas inhibitor ly294002 ki approxim 1 microm howev fail potenti bfgf-sap administ mice wortmannin combin bfgf-sap result signific decreas tumor volum compar vehicle-tr control observ mice treat either agent alon conclus taken togeth result suggest although wortmannin increas cytotox efficaci receptor-direct chimera potenti may occur altern pathway involv pl 3-kinas inhibit',\n",
       "  'chronic stress glucocorticoid receptor resist inflamm diseas risk propos model wherein chronic stress result glucocorticoid receptor resist gcr turn result failur down-regul inflammatori respons test model two viral-challeng studi studi 1 assess stress life event gcr control variabl includ baselin antibodi challeng viru age bodi mass index bmi season race sex educ viru type 276 healthi adult volunt volunt subsequ quarantin expos one two rhinovirus follow 5 nasal wash viral isol assess signs/symptom common cold studi 2 assess control variabl gcr 79 subject subsequ expos rhinoviru monitor baselin 5 viral challeng product local nasal secret proinflammatori cytokin il-1β tnf-α il-6 studi 1 covari control variabl recent exposur long-term threaten stress experi demonstr gcr gcr higher risk subsequ develop cold studi 2 control use studi 1 greater gcr predict product local proinflammatori cytokin among infect subject data provid support model suggest prolong stressor result gcr turn interfer appropri regul inflamm inflamm play import role onset progress wide rang diseas model may broad implic understand role stress health',\n",
       "  'pituitari adenyl cyclase-activ polypeptid pacap neuron-deriv peptid regul glial glutam transport metabol brain glutamaterg neurotransmiss termin predominantli rapid uptak synapt releas glutam astrocyt na -depend glutam transport glt-1 glast subsequ convers glutamin enzym glutamin synthetas gs date sever factor identifi rapidli alter glial glutam uptak post-transl modif glutam transport condit known affect express glial glutam transport gs cocultur glia neuron demonstr neuron regul glial glutam turnov via pituitari adenyl cyclase-activ polypeptid pacap cerebr cortex pacap synthes neuron act subpopul astroglia involv glutam turnov exposur astroglia pacap increas maxim veloc 3 h glutam uptak promot express glt-1 glast gs moreov stimulatori effect neuron-condit medium glial glutam transport express attenu presenc pacap-inactiv antibodi pacap receptor antagonist pacap 6-38. contrast pacap vasoact intestin peptid promot glutam transport express distinctli higher concentr suggest pacap exert effect glial glutam turnov via pac1 receptor although pac1 receptor-depend activ protein kinas pka suffici promot express glast activ pka protein kinas c pkc requir promot glt-1 express optim given exist variou pac1 receptor isoform activ pka pkc differ level find point complex mechan pacap regul glial glutam transport metabol disturb regulatori mechan could repres major caus glutamate-associ neurolog psychiatr disord',\n",
       "  'factor influenc b lymphopoiesi allogen hematopoiet cell transplant 93 allograft recipi number marrow b-cell precursor day 80 365 correl count circul b cell suggest posttransplant b-cell defici least part due insuffici b lymphopoiesi factor could affect b lymphopoiesi evalu number marrow b-cell precursor day 30 80 least 4-fold lower patient grade 2 4 acut graft-versus-host diseas gvhd compar patient grade 0 1 acut gvhd number b-cell precursor day 365 18-fold lower patient extens chronic gvhd compar patient limit chronic gvhd number b-cell precursor relat cd34 cell dose type transplant marrow versu blood stem cell donor age patient age conclud posttransplant b-cell defici result part inhibit b lymphopoiesi gvhd and/or treatment',\n",
       "  'genet variant rs1994016 rs3825807 adamts7 affect mrna express atherosclerot occlus peripher arteri diseas aim peripher arteri diseas pad vascular diseas affect peripher circul recent genome-wid associ studi reveal relationship singl nucleotid polymorph snp adamts7 disintegrin metalloproteas thrombospondin motif 7 atherosclerosi studi aim determin adamts7 express peripher blood mononuclear cell pbmc frequenc adamts7 rs1994016 rs3825807 polymorph sampl turkish patient pad evalu associ matrix metalloproteinas mmp level pad develop method case-control studi adamts7mrna protein express determin use revers transcript quantit real-tim polymeras chain reaction rt-qpcr western blot respect rs1994016 rs3825807 variant adamts7 determin real-tim pcr 115 pad patient 116 healthi control plasma level nine mmp determin use multiplex immunoassay system result adamts7mrna level significantli higher pad patient control t=-2.75 p=.007 signific differ frequenc rs1994016 rs3825807 pad patient control p .05 pad patient adamts7mrna level significantli increas cc genotyp rs1994016 t=-2.31 p=.026 tt genotyp rs3825807 t=-2.23 p=.032 furthermor plasma level mmp-1 mmp-3 mmp-7 mmp-10 mmp-12 mmp-13 significantli higher pad patient control p .05 conclus first report relationship pad adamts7 express effect rs1994016 rs3825807 variant pad develop adamts7 may associ pad develop',\n",
       "  \"distinct pariet tempor pathway homologu broca 's area monkey homologu two distinct architecton area 44 45 constitut anterior languag zone broca 's region human ventrolater frontal lobe recent establish macaqu monkey although know inferior pariet lobul later tempor cortic region project ventrolater frontal cortex know sever cortic area found region project homologu broca 's region macaqu monkey mean white matter pathway use autoradiograph method permit establish cortic area axon origin i.e. site inject precis cours axon white matter termin within particular cortic area examin pariet tempor connect area 44 two subdivis area 45 i.e. area 45a 45b result demonstr ventral temporo-front stream fiber origin variou auditori multisensori visual associ cortic area intermedi superolater tempor region axon cours via extrem capsul target strongli area 45 modest termin area 44. contrast dorsal stream axon origin variou cortic area inferior pariet lobul adjac caudal superior tempor sulcu found target area 44 45. axon cours superior longitudin fasciculu axon origin ventral inferior pariet lobul adjac superior tempor sulcu arch form simpl arcuat fasciculu cortex rostral part inferior pariet lobul preferenti link ventral premotor cortex ventral area 6 control orofaci musculatur cortex intermedi part inferior pariet lobul link area 44 45. find demonstr posterior pariet tempor connect ventrolater frontal area left hemispher human brain adapt variou aspect languag product precursor circuit found nonlinguist nonhuman primat brain also exist human brain possibl reason area adapt languag use human brain discuss result throw new light prelinguist precursor circuitri broca 's region help understand function interact broca 's ventrolater frontal region posterior pariet tempor associ area\",\n",
       "  'mira-seq dna methyl analysi cpg island aim develop reliabl method whole genom analysi dna methyl materi method genome-scal analysi dna methyl includ affinity-bas approach enrich use methyl-cpg-bind protein one method methylated-cpg island recoveri assay mira base high affin mbd2b-mbd3l1 complex cpg-methyl dna provid detail descript mira combin next gener sequenc platform mira-seq result assess perform mira-seq compar data whole genom bisulfit sequenc conclus mira-seq reliabl genome-scal dna methyl analysi platform score dna methyl differ cpg-rich genom region method limit primer probe design cost effect',\n",
       "  'mani imag auditori scene auditori scene consist mani spatial separ sound sourc mani sound sourc process auditori system experi determin mani speech sourc could local simultan azimuth plane differ word play multipl loudspeak listen report total number sound sourc individu locat experi ii accuraci local one speech sourc mixtur multipl speech sourc determin extra sound sourc ad exist set sound sourc task local extra sourc experi iii setup task experi except sound tone result show maximum number sound sourc listen could perceiv limit approxim four spatial separ speech signal three tonal signal local error increas along increas total number sound sourc four speech sourc alreadi exist accuraci local addit sourc near chanc',\n",
       "  'mobil intracellular copper store ctr2 vacuolar copper transport copper play essenti role process includ signal transcript protein traffick machineri oxid phosphoryl iron mobil neuropeptid matur normal develop wherea much known intracellular mobil ion calcium littl inform avail eukaryot cell mobil intracellular copper store describ mechan saccharomyc cerevisia ctr2 protein provid bioavail copper via mobil intracellular copper store wherea ctr2 exhibit structur similar ctr1 plasma membran copper import microscop biochem fraction studi local ctr2 vacuol membran demonstr ctr2 mobil vacuolar copper store manner depend amino acid residu conserv ctr1 ctr2 copper transport famili ctr2 delta mutant hyper-accumul vacuolar copper furthermor ctr2 mutant misloc plasma membran stimul extracellular copper uptak support direct role ctr2 copper transport across membran studi identifi novel mechan copper mobil suggest organ cope copper depriv via use intracellular vesicular store',\n",
       "  'peroxisom signal platform antivir innat immun peroxisom long establish play central role regul variou metabol activ mammalian cell organel act concert mitochondria control metabol lipid reactiv oxygen speci howev mitochondria emerg import site antivir signal transduct role peroxisom immun defens unknown report rig-i-lik receptor rlr adaptor protein mav locat peroxisom mitochondria find peroxisom mitochondri mav act sequenti creat antivir cellular state upon viral infect peroxisom mav induc rapid interferon-independ express defens factor provid short-term protect wherea mitochondri mav activ interferon-depend signal pathway delay kinet amplifi stabil antivir respons interferon regulatori factor irf1 play crucial role regul mavs-depend signal peroxisom result establish peroxisom import site antivir signal transduct',\n",
       "  'two-sid confid interv singl proport comparison seven method stat med simpl interv estim method proport exhibit poor coverag produc evid inappropri interv criteria appropri evalu variou propos method includ close achiev coverag probabl nomin valu whether interv locat close distant middl scale expect interv width avoid aberr limit outsid 0,1 zero width interv eas use whether tabl softwar formula seven method singl proport evalu 96,000 paramet space point interv base tail area simpler score method recommend use case method avail aim align either minimum mean coverag nomin 1 -alpha',\n",
       "  'nuclear accumul hdac4 atm defici promot neurodegener ataxia-telangiectasia ataxia telangiectasia neurodegen diseas caus mutat atm gene report ataxia telangiectasia mutat atm defici caus nuclear accumul histon deacetylas 4 hdac4 neuron promot neurodegener nuclear hdac4 bind chromatin well myocyt enhanc factor 2a mef2a camp-respons element bind protein creb lead histon deacetyl alter neuron gene express block either hdac4 activ nuclear accumul blunt neurodegen chang rescu sever behavior abnorm atm-defici mice full rescu neurodegener howev also requir presenc hdac4 cytoplasm suggest ataxia telangiectasia phenotyp result loss cytoplasm hdac4 well nuclear accumul remain cytoplasm hdac4 must phosphoryl activ hdac4 phosphatas protein phosphatas 2a pp2a downregul atm-medi phosphoryl atm defici enhanc pp2a activ lead hdac4 dephosphoryl nuclear accumul hdac4 result defin crucial role cellular local hdac4 event lead ataxia telangiectasia neurodegener',\n",
       "  'regul function e-cadherin/catenin complex cell monocyte-macrophag lineag dc e-cadherin best character adheren junction protein homotyp interact contribut mainten epitheli barrier function epitheli cell cytoplasm tail e-cadherin form dynam complex catenin regul sever intracellular signal transduct pathway includ wnt/β-catenin pi3k/akt rho gtpase nf-κb signal recent progress uncov novel critic role adhes molecul mononuclear phagocyt function e-cadherin regul matur migrat langerhan cell ligat prevent induct tolerogen state bone marrow-deriv dendrit cell dc respect function β-catenin could instrument determin balanc immunogen tolerogen dc vitro vivo fusion altern activ macrophag osteoclast also e-cadherin-depend addit e-cadherin ligand cd103 klrg1 express dc- t- nk-cell subset contribut interact e-cadherin-express dc macrophag discuss regul function implic e-cadherin express central orchestr immun system',\n",
       "  'polymorph ligand depend chang human glucagon-lik peptide-1 receptor glp-1r function alloster rescu loss function mutat glucagon-lik peptide-1 receptor glp-1r key physiolog regul insulin secret major therapeut target treatment type ii diabet howev regul glp-1r function complex multipl endogen peptid interact receptor includ full-length 1-37 truncat 7-37 form glp-1 exist amid form glp-1 1-36 nh₂ glp-1 7-36 nh₂ relat peptid oxyntomodulin addit glp-1r possess exogen agonist includ exendin-4 alloster modul compound 2 6,7-dichloro-2-methylsulfonyl-3-tert-butylaminoquinoxalin complex ligand-receptor system increas presenc sever singl nucleotid polymorph snp distribut across receptor investig 10 glp-1r snp character three physiolog relev signal pathway camp accumul extracellular signal-regul kinas 1/2 phosphoryl intracellular ca²⁺ mobil ligand bind cell surfac receptor express also determin demonstr ligand- pathway-specif effect multipl snp dramat effect observ met¹⁴⁹ receptor variant met¹⁴⁹ variant select loss peptide-induc respons across pathway examin preserv respons small molecul compound 2. contrast cys³³³ variant peptid respons preserv attenu respons compound 2. strikingli loss peptid function met¹⁴⁹ receptor variant could alloster rescu compound 2 provid proof-of-principl evid alloster drug could use treat patient loss function variant',\n",
       "  'neuron circuitri mechan regul adult quiescent neural stem cell fate decis adult neurogenesi aris neural stem cell within special nich neuron activ experi presum act local nich regul multipl stage adult neurogenesi neural progenitor prolifer new neuron matur synapt integr surviv unknown whether local neuron circuitri direct impact adult neural stem cell show adult mous hippocampu nestin-express radial glia-lik quiescent neural stem cell rgl respond tonic neurotransmitt γ-aminobutyr acid gaba mean γ2-subunit-contain gabaa receptor clonal analysi individu rgl reveal rapid exit quiescenc enhanc symmetr self-renew condit delet γ2 rgl close proxim termin express 67-kda glutam acid decarboxylas gad67 parvalbumin-express pv+ interneuron respond tonic gaba releas neuron function optogenet control activ dentat pv+ interneuron somatostatin-express vasoact intestin polypeptid vip -express interneuron dictat rgl choic quiescenc activ furthermor pv+ interneuron activ restor rgl quiescenc social isol experi induc rgl activ symmetr divis studi identifi nich cell–signal–receptor trio local circuitri mechan control activ self-renew mode quiescent adult neural stem cell respons neuron activ experi',\n",
       "  'global vitamin level relat age gender skin pigment latitud ecolog meta-regress analysi perform meta-analysi cross-sect studi serum 25 oh statu global serum 25 oh level averag 54 nmol/l higher women men higher caucasian non-caucasian trend serum 25 oh level latitud vitamin defici widespread studi vitamin statu express serum 25-hydroxy-vitamin 25 oh nativ subject worldwid meta-analysi meta-regress studi report 25 oh healthi subject retriev pubm embas web scienc use term “ serum ” “ 25-hydroxy-vitamin ” “ cholecalciferol ” “ human ” total 394 studi includ mean 25 oh level 54 nmol/l 95 ci 52–57 nmol/l women borderlin significantli higher 25 oh level men caucasian higher level non-caucasian 25 oh level higher subject age 15 year younger subject unadjust signific decreas 25 oh latitud slope curv −0.03 ± 0.12 nmol/l per degre latitud north south equat p 0.8 signific declin latitud caucasian −0.69 ± 0.30 nmol/l per degre p 0.02 non-caucasian 0.03 ± 0.39 nmol/l per degre p 0.14 adjust age gender ethnic overal correl present 25 oh latitud −0.29 ± 0.24 nmol/l per degre p 0.23 overal influenc latitud 25 oh d. howev separ analys 25 oh decreas latitud caucasian non-caucasian widespread global vitamin insuffici present compar propos threshold level',\n",
       "  'identif character novel monocyte/macrophag differentiation-depend gene respons lipopolysaccharid ceramid lysophosphatidylcholin novel differentiation-depend cdna dif-2 isol human mononuclear phagocyt differenti display full-length cdna clone sequenc dif-2 consist 156 amino acid predict isoelectr point 8.84. mrna express freshli isol monocyt downregul significantli monocyt subject differenti similar differentiation-depend downregul observ normal hepatocyt compar undifferenti hepg2 cell mrna express monocyt sensit lipopolysaccharid ceramid strongli increas dif-2 transcript lysophosphatidylcholin result weaker upregul dif-2 express dif-2 homolog gene previous isol mous fibroblast shown serum growth factor-induc immedi earli gene result indic dif-2 repres gene regul differenti process strongli respons lipopolysaccharid ceramid lysophosphatidylcholin',\n",
       "  'novel 3-hydroxysteroid dehydrogenas regul reproduct develop longev endogen small molecul metabolit regul anim longev emerg novel mean influenc health life span c. elegan bile acid-lik steroid call dafachron acid da regul development time longev conserv nuclear hormon receptor daf-12 homolog mammalian sterol-regul receptor lxr fxr use metabol genet mass spectrometri biochem approach identifi new activ da biosynthesi character evolutionarili conserv short chain dehydrogenas dhs-16 novel 3-hydroxysteroid dehydrogenas regul da product dhs-16 control daf-12 activ govern longev respons signal gonad elucid c. elegan bile acid biosynthet pathway reveal possibl novel ligand well strike biochem conserv anim could illumin new target manipul longev metazoan',\n",
       "  'argonaut transport sirna cytoplasm nucleu ribonucleoprotein complex consist argonaute-lik protein small regulatori rna function wide rang biolog process mani small regulatori rna predict act least part within nucleu conduct genet screen identifi factor essenti rna interfer rnai nuclei caenorhabd elegan identifi argonaut protein nrde-3 absenc small interf rna sirna nrde-3 resid cytoplasm nrde-3 bind sirna gener rna-depend rna polymeras act messeng rna templat cytoplasm redistribut nucleu nuclear redistribut nrde-3 requir function nuclear local signal requir nuclear rnai result nrde-3 associ nuclear-loc nascent transcript thu specif argonaut protein transport specif class small regulatori rna distinct cellular compart regul gene express',\n",
       "  \"phosphatidylinositol 4,5-bisphosph function second messeng regul cytoskeleton–plasma membran adhes bind interact plasma membran cytoskeleton defin cell function cell shape format cell process cell movement endocytosi use optic tweezer tether forc measur show plasma membran phosphatidylinositol 4,5-bisphosph pip2 act second messeng regul adhes energi cytoskeleton plasma membran receptor stimuli hydrolyz pip2 lower adhes energi process could mimick express ph domain sequest pip2 target 5'-pip2-phosphatas plasma membran select lower plasma membran pip2 concentr studi suggest plasma membran pip2 control dynam membran function cell shape local increas decreas adhes actin-bas cortic cytoskeleton plasma membran\",\n",
       "  'tissue-resid memori cell local specialist immun defenc cell crucial role protect infect cancer although traffick memori cell around bodi integr capac provid immun protect studi shown special memori cell uniqu tissue-resid subset give host enhanc region immun recent year consider progress understand tissue-resid cell develop function reveal mechan enhanc protect immun potenti influenc ration vaccin design review discuss major advanc emerg concept field summar known differenti protect function tissue-resid memori cell differ tissu bodi highlight key unansw question',\n",
       "  'defect replic stress respons inhibit lymphomagenesi impair lymphocyt reconstitut dna replic stress promot genom instabl cancer howev contribut replic stress respons develop malign remain unresolv dna replic stress respons protein smarcal1 stabil dna replic fork prevent replic fork collaps caus dna break apoptosi fork regression/remodel function smarcal1 investig vivo function replic stress cancer unclear use gamma radiat ir -induc replic stress t-cell lymphoma mous model observ signific inhibit lymphomagenesi mice lack one allel smarcal1 notabl quarter smarcal1-defici mice develop tumor moreov hematopoiet stem/progenitor cell hspc develop thymocyt smarcal1-defici mice show increas dna damag apoptosi prolifer burst follow ir impair abil repopul thymu ir addit mice lack smarcal1 show signific hspc defect challeng respond replic stress stimuli thu data reveal critic function dna replic stress respons specif smarcal1 hematopoiet cell surviv tumor develop result also provid import insight immunodefici observ individu mutat smarcal1 suggest hspc defect',\n",
       "  'human dna methylom base resolut show widespread epigenom differ dna cytosin methyl central epigenet modif essenti role cellular process includ genom regul develop diseas present first genome-wid single-base-resolut map methyl cytosin mammalian genom human embryon stem cell fetal fibroblast along compar analysi messeng rna small rna compon transcriptom sever histon modif site dna–protein interact sever key regulatori factor widespread differ identifi composit pattern cytosin methyl two genom nearli one-quart methyl identifi embryon stem cell non-cg context suggest embryon stem cell may use differ methyl mechan affect gene regul methyl non-cg context show enrich gene bodi deplet protein bind site enhanc non-cg methyl disappear upon induc differenti embryon stem cell restor induc pluripot stem cell identifi hundr differenti methyl region proxim gene involv pluripot differenti widespread reduc methyl level fibroblast associ lower transcript activ refer epigenom provid foundat futur studi explor key epigenet modif human diseas develop',\n",
       "  'laparoscop adhesiolysi patient chronic abdomin pain blind randomis control multi-centr trial background laparoscop adhesiolysi chronic abdomin pain controversi evid base aim test hypothesi laparoscop adhesiolysi lead substanti pain relief improv qualiti life patient adhes chronic abdomin pain method patient diagnost laparoscopi chronic abdomin pain attribut adhes caus pain exclud adhes confirm diagnost laparoscopi patient randomli assign either laparoscop adhesiolysi treatment treatment alloc conceal patient assessor unawar patient treatment outcom pain assess 1 year visual analogu score va score scale 0-100 pain chang score use analges qualiti life score analysi intent treat find 116 patient enrol diagnost laparoscopi 100 randomli alloc either laparoscop adhesiolysi 52 treatment 48 group report substanti pain relief significantli improv qualiti life differ group mean chang baselin va score 12 month differ 3 point p=0.53 95 ci -7 13 interpret although laparoscop adhesiolysi reliev chronic abdomin pain benefici diagnost laparoscopi alon therefor laparoscop adhesiolysi recommend treatment adhes patient chronic abdomin pain',\n",
       "  'insulin signal dietari restrict differenti influenc declin learn memori age age-rel declin memori loss one devast condit increas longev identifi effect longevity-promot factor learn memori unknown show c. elegan insulin/igf-1 receptor mutant daf-2 improv memori perform earli adulthood maintain learn abil better age surprisingli demonstr extens long-term memori age contrast eat-2 mutant model dietari restrict dr exhibit impair long-term memori young adulthood maintain level memori longer age find crh-1 c. elegan homolog creb transcript factor requir long-term associ memori learn short-term memori express crh-1 declin age differ longev mutant creb express activ correl memori perform result suggest specif longev treatment acut long-term effect cognit function declin age regul rate-limit gene requir learn memori',\n",
       "  'uniqu respons pathway establish alloster interact among nuclear hormon receptor heterodimer common paradigm among eukaryot transcript factor 9-ci retino acid receptor rxr serv common heterodimer partner sever nuclear receptor includ thyroid hormon receptor t3r retino acid receptor rar rais question whether complex possess dual hormon respons devis strategi examin transcript properti receptor individu tether heterodimer partner find intrins bind properti rxr mask t3r-rxr rar-rxr heterodim contrast rxr activ non-dna-bind cofactor ngfi-b/nurr1 orphan receptor heterodimer rxr constitut activ ngfi-b/nurr1 creat novel hormone-depend complex find suggest alloster interact among heterodim creat complex uniqu properti suggest allosteri critic featur underli gener divers hormon respons network',\n",
       "  'midlif late‐lif vascular risk factor white matter microstructur integr atherosclerosi risk commun neurocognit studi background diffus tensor imag measur white matter wm microstructur integr appear provid earlier indic wm injuri wm hyperintens howev risk factor poor wm microstructur integr establish studi quantifi associ vascular risk factor midlif late life measur late-lif wm microstructur integr method result use data 1851 particip aric atherosclerosi risk commun studi complet 3-t magnet reson imag includ diffus tensor imag part aric neurocognit studi aric-nc quantifi associ among lipid glucos blood pressur baselin aric visit 1987-1989 age 44-65 midlif visit 5 aric 2011-2013 age 67-90 late life concurr aric-nc region overal wm mean diffus fraction anisotropi obtain aric visit 5 aric particip also consid whether associ independ modifi wm hyperintens volum found elev blood pressur midlif late life elev glucos midlif late life associ wors late-lif wm microstructur integr associ independ degre wm hyperintens associ glucos wm microstructur integr appear stronger least wm hyperintens littl support advers associ lipid wm microstructur integr conclus hypertens midlif late life elev glucos midlif relat wors wm microstructur integr late life',\n",
       "  'kra gene amplif overexpress mutat associ aggress metastat endometri cancer background three quarter endometri carcinoma treat earli stage still 15 20 patient experi recurr littl effect system therapi homo sapien v-ki-ras2 kirsten rat sarcoma viral oncogen homologu kra mutat report import role tumorigenesi human cancer limit knowledg regard clinic relev kra statu endometri carcinoma method perform comprehens integr characteris genome-wid express relat kra mutat copy-numb alter primary- metastat endometri carcinoma lesion relat clinic histopatholog data primari investig set clinic valid set appli consist 414 primari tumour 61 metastat lesion total result amplif gain kra present 3 primari lesion 18 metastat lesion correl significantli poor outcom high intern feder gynaecolog obstetr stage non-endometrioid subtyp high grade aneuploidi receptor loss high kra mrna level also found associ aggress phenotyp contrast kra mutat present 14.7 primari lesion increas metastat lesion influenc outcom significantli associ endometrioid subtyp low grade obes conclus result support kra amplif kra mrna express increas primari metastat lesion relev endometri carcinoma diseas progress',\n",
       "  'hyperhomocysteinemia atherosclerot vascular diseas pathophysiolog screen treatment hyperhomocysteinemia recent identifi import risk factor atherosclerot vascular diseas articl review homocystein metabol caus hyperhomocysteinemia pathophysiolog find disord epidemiolog studi homocystein vascular diseas screen hyperhomocysteinemia consid patient high risk vascular diseas abnorm homocystein metabol primari prevent vascular diseas treatment patient homocystein level 14 micromol/l higher consid secondari prevent treatment patient homocystein level 11 micromol/l higher consid treatment conveni administ folic acid supplement 400-1000 microg high-pot multivitamin contain least 400 microg folat higher dose folic acid cyanocobalamin supplement may requir patient prospect clinic trial data becom avail conserv recommend provid safe effect evidence-bas approach diagnosi evalu manag patient hyperhomocysteinemia',\n",
       "  \"best -- worst scale health care research statement like `` qualiti care highli valu wait time '' neither support refut comparison util paramet tradit discret choic experi dce best -- worst scale overcom problem ask respond perform differ choic task howev whilst natur best -- worst task gener understood number issu relat design analysi best -- worst choic experi requir exposit paper illustr aggreg analys data use qualiti life pilot studi demonstr richer insight drawn use best -- worst task\",\n",
       "  'genet variant non-genet factor predict circul vitamin level hispan non-hispan white women breast cancer health dispar studi genome-wid associ studi gwa identifi common polymorph near gc cyp2r1 cyp24a1 nadsyn1/dhcr7 gene associ circul level 25-hydroxyvitamin 25 oh european popul replic gwa find examin six select polymorph region relat circul 25 oh level 1,605 hispan women 629 u.s. hispan 976 mexican 354 non-hispan white nhw women also assess potenti interact variant known non-genet predictor 25 oh level includ bodi mass index bmi sunlight exposur vitamin intak diet supplement minor allel two gc polymorph rs7041 rs2282679 significantli associ lower 25 oh level hispan nhw women cyp2r1 polymorph rs2060793 also significantli associ 25 oh level group found signific associ polymorph cyp24a1 hispan control 25 oh level significantli associ rs12785878t rs1790349g haplotyp nadsyn1/dhcr7 region signific interact gc rs2282679 bmi rs12785878 time spent outdoor activ observ result provid support contribut common genet variant individu variabl circul 25 oh level observ interact snp non-genet factor warrant confirm',\n",
       "  'gener character methyl-lysin histon antibodi publish summari chapter summar develop character rabbit polyclon antibodi name histon direct methyl h3-k9 posit provid protocol peptid design rabbit immun qualiti control methyl-lysin histon antibodi follow vivo character use indirect inter-and metaphas chromatin wild-typ wt mutant mous cell defici suv39h histon methyltransferas hmtase histon amino-termini tail protrud nucleosom core subject varieti post-transl modif includ acetyl lysin residu phosphoryl serin threonin residu methyl lysin arginin residu ubiquitin lysin residu adp-ribosyl glutam acid residu addit structur role histon play import function control gene express regul access underli nucleosom templat without doubt develop high-qual position-specif methyl-lysin histon antibodi provid import tool decod epigenet inform part index distinct methyl state select lysin residu histon amino-termini compar analysi indic signific discrep specif avid avail methyl-lysin histon antibodi highlight need extens qualiti control experiment data correctli interpret despit exquisit complex histon lysin methyl',\n",
       "  'hallmark age age character progress loss physiolog integr lead impair function increas vulner death deterior primari risk factor major human patholog includ cancer diabet cardiovascular disord neurodegen diseas age research experienc unpreced advanc recent year particularli discoveri rate age control least extent genet pathway biochem process conserv evolut review enumer nine tent hallmark repres common denomin age differ organ special emphasi mammalian age hallmark genom instabl telomer attrit epigenet alter loss proteostasi deregul nutrient sens mitochondri dysfunct cellular senesc stem cell exhaust alter intercellular commun major challeng dissect interconnected candid hallmark rel contribut age final goal identifi pharmaceut target improv human health age minim side effect',\n",
       "  'sensit mass spectrometri platform identifi metabol chang life histori trait c. elegan abnorm nutrient metabol hallmark age underli genet nutrit framework rapidli uncov particularli use c. elegan model howev direct metabol consequ perturb life histori c. elegan remain clarifi base recent advanc metabolom field optim valid sensit mass spectrometri ms platform identif major metabolit class worm appli studi age diet relat chang use platform allow detect 600 metabolit sampl 2500 worm observ mark chang fatti acid amino acid phospholipid worm life histori independ germ-lin worm underw strike shift lipid metabol earli adulthood least partli control metabol regul aak-2/ampk amino acid peak develop except aspart acid glycin accumul age worm dietari intervent also influenc worm metabolit profil regul highli specif depend metabolit class altogeth ms-base method power tool perform worm metabolom age metabolism-ori studi',\n",
       "  \"characteris antibiot prescript acut respiratori tract infect danish gener practic retrospect registri base cohort studi inappropri use antibiot contribut increas rate antimicrobi resist sever danish guidelin antibiot prescrib acut respiratori tract infect gener practic issu promot ration prescrib antibiot howev unclear recommend follow aim characteris pattern antibiot prescript patient diagnos acut respiratori tract infect mean electron prescript label clinic indic danish gener practic acut respiratori tract infect account 456,532 antibiot prescript issu juli 2012 june 2013. pneumonia common indic 178,354 prescript 39 follow acut tonsil 21 acut otiti media 19 total penicillin v account 58 prescript follow macrolid 18 amoxicillin 15 use second-lin agent increas age indic compris 40 prescript patient age 75 year women often prescrib antibiot regardless clinic indic first danish studi characteris antibiot prescript pattern acut respiratori tract infect data linkag clinic indic find confirm penicillin v commonli prescrib antibiot agent treatment patient acut respiratori tract infect danish gener practic howev second-lin agent like macrolid amoxicillin without clavulan acid overus strategi improv qualiti antibiot prescrib especi pneumonia acut otiti media acut rhinosinus warrant respiratori tract infect track overus antibiot better adher guidelin prescrib antibiot differ respiratori tract infect warrant danish gener practic over-us antibiot particularli so-cal 'second-lin agent amoxicillin increas resist may lead potenti catastroph scenario antibiot longer effect exactli widespread over-us antibiot differ infect howev clear rune aabenhu univers copenhagen co-work analyz primari care data regard antibiot prescript acut respiratori tract infect includ pneumonia ear infect denmark found penicillin v-the current recommend first-lin drug scandinavian countries-account 58 per cent prescript figur improv amoxicillin macrolid over-prescrib particularli elderli patient team also call analysi prescript given out-of-hour clinic\",\n",
       "  'lack skelet muscl il-6 affect pyruv dehydrogenas activ rest prolong exercis pyruv dehydrogenas pdh play key role regul skelet muscl substrat util il-6 produc skelet muscl exercis durat depend manner report increas whole bodi fatti acid oxid muscl glucos uptak decreas pdha activ skelet muscl fed mice aim present studi examin whether muscl il-6 contribut exercise-induc pdh regul skelet muscl skelet muscle-specif il-6 knockout il-6 mko mice flox litterm control control complet singl bout treadmil exercis 10 60 120 min rest mice genotyp serv basal control respiratori exchang ratio rer overal higher p 0.05 il-6 mko control mice 120 min treadmil exercis rer decreas exercis independ genotyp ampk acc phosphoryl also increas exercis independ genotyp pdha activ control mice higher p 0.05 10 60 min exercis rest remain unchang il-6 mko mice addit pdha activ higher p 0.05 il-6 mko control mice rest 60 min exercis neither pdh phosphoryl acetyl could explain genotyp differ pdha activ togeth provid evid skelet muscl il-6 contribut regul pdh rest prolong exercis suggest muscl il-6 normal dampen carbohydr util prolong exercis via effect pdh',\n",
       "  'clinic patholog characterist patient brca-posit brca-neg breast cancer purpos mutat brca1 brca2 gene confer greater risk develop breast cancer determin whether tumor patholog featur clinic featur differ patient without brca mutat patient method tumor patholog featur clinic characterist examin 491 women breast cancer underw genet test brca mutat 1997 2006. retrospect review medic record conduct determin clinic characterist includ ethnic age clinic stage diagnosi age pariti number full-term pregnanc use oral contracept hormon replac therapi brca mutat statu tumor patholog review determin histolog type tumor grade estrogen receptor progesteron receptor her-2/neu statu result 491 patient identifi breast cancer 391 patient brca neg 86 patient brca posit triple-neg breast cancer ie neg estrogen receptor progesteron receptor her-2/neu statu diagnos 57.1 brca1-posit patient 23.3 brca2-posit patient 13.8 brca-neg patient brca1 mutat carrier higher nuclear grade tumor two group p .001 triple-neg cancer patient brca2 mutat carrier older diagnos brca1 mutat carrier noncarri p .01 conclus result suggest tumor associ brca1 mutat may divid two distinct group triple-neg non-triple-neg group futur studi seek determin whether patient brca1 mutat triple-neg breast cancer respond treatment better brca-neg patient similar tumor patholog',\n",
       "  \"interferon success anti-vir immunotherapi interferon ifn glycoprotein strong antivir activ repres one first line host defens invad pathogen protein classifi three group type ii iii ifn base structur receptor cell surfac due abil modul immun respons becom attract therapeut option control chronic viru infect combin drug type ifn consid `` standard care '' suppress hepat c hcv hepat b hbv infect type iii ifn gener encourag result treatment hcv infect phase iii clinic trial howev though effect use ifn treatment without need caution ifn power cytokin affect wide array cell type result patient usual experi unpleas symptom percentag patient suffer system wide effect thu constant monitor requir patient treat ifn order reach treatment goal suppress viru infect maintain qualiti life\",\n",
       "  'genet analysi human obes italian sampl analysi genet factor obes carri sampl nuclear famili aosta n. itali famili consist parent sib elementari school children consid obes preliminari screen similar sampl non-obes children nuclear famili number famili 67 112 respect sever test appli order examin genet contribut obes particular investig presenc domin major gene conclus genet factor certainli present sever analys suggest presenc domin major gene weak effect',\n",
       "  'non-cod rna landscap human hematopoiesi leukemia non-cod rna emerg crucial regul gene express cell fate decis howev express pattern regulatori function normal malign human hematopoiesi incomplet understood present comprehens resourc defin non-cod rna landscap human hematopoiet system base highli specif non-cod rna express portrait per blood cell popul identifi uniqu fingerprint non-cod rnas-such linc00173 granulocytes-and assign critic regulatori circuit involv blood homeostasi follow incorpor acut myeloid leukemia sampl landscap uncov prognost relev non-cod rna stem cell signatur share acut myeloid leukemia blast healthi hematopoiet stem cell find highlight import non-cod transcriptom format mainten human blood hierarchi micro-rna known regul haematopoiesi leukemogenesi role long non-cod rna less clear author provid non-cod rna express landscap human hematopoiet system highlight role format mainten human blood hierarchi',\n",
       "  'incid risk central nervou system metastas site first recurr patient her2-posit breast cancer treat adjuv trastuzumab background central nervou system cn diseas site first relaps exposur adjuv trastuzumab report carri comprehens meta-analysi determin risk cn metastas first site recurr patient her2-posit breast cancer receiv adjuv trastuzumab method elig studi includ random trial adjuv trastuzumab administ 1 year patient her2-posit breast cancer report cn metastas first site diseas recurr statist analys conduct calcul incid rel risk rr 95 confid interv ci use fixed-effect invers varianc random-effect model result total 9020 patient includ incid cn metastas first site diseas recurr her2-posit patient receiv adjuv trastuzumab 2.56 95 ci 2.07 3.01 compar 1.94 95 ci 1.54 2.38 her2-posit patient receiv adjuv trastuzumab rr cn first site relaps trastuzumab-tr patient 1.35 95 ci 1.02-1.78 p 0.038 compar control arm without trastuzumab therapi ratio cn metastas total number recurr event 16.94 95 ci 10.85 24.07 8.33 95 ci 6.49 10.86 trastuzumab-tr control group respect statist signific differ found base trastuzumab schedul median follow-up time evid public bia observ conclus adjuv trastuzumab associ signific increas risk cn metastas site first recurr her2-posit breast cancer patient',\n",
       "  'neutrophil activ regul innat adapt immun neutrophil long view final effector cell acut inflammatori respons primari role clearanc extracellular pathogen howev recent evid extend function cell newli discov repertoir effector molecul neutrophil armamentarium includ broad array cytokin extracellular trap effector molecul humor arm innat immun system addit neutrophil involv activ regul effector function innat adapt immun cell accordingli neutrophil crucial role pathogenesi broad rang diseas includ infect caus intracellular pathogen autoimmun chronic inflamm cancer',\n",
       "  \"function dna methyl island start site gene bodi beyond dna methyl frequent describ 'silenc epigenet mark inde function 5-methylcytosin origin propos 1970 thank improv genome-scal map methyl evalu dna methyl differ genom context transcript start site without cpg island gene bodi regulatori element repeat sequenc emerg pictur function dna methyl seem vari context relationship dna methyl transcript nuanc realiz first improv understand function dna methyl necessari interpret chang mark observ diseas cancer\",\n",
       "  'metaplasia transdifferenti pure biolog clinic transform one tissu type anoth make well establish set phenomena explain principl development biolog although phenomena might rare natur imagin possibl deliber reprogram cell one tissu type anoth manipul express transcript factor approach could gener new therapi mani human diseas',\n",
       "  'pioglitazon use risk bladder cancer common cancer person diabet import studi suggest pioglitazon use may increas risk cancer object examin whether pioglitazon use diabet associ risk bladder 10 addit cancer design set particip cohort nest case-control analys among person diabet bladder cancer cohort follow 193,099 person age 40 year older 1997-2002 decemb 2012 464 case patient 464 match control survey addit confound cohort analysi 10 addit cancer includ 236,507 person age 40 year older 1997-2005 follow june 2012. cohort kaiser permanent northern california exposur ever use durat cumul dose time sinc initi pioglitazon time depend main outcom measur incid cancer includ bladder prostat femal breast lung/bronchu endometri colon non-hodgkin lymphoma pancrea kidney/ren pelvi rectum melanoma result among 193,099 person bladder cancer cohort 34,181 18 receiv pioglitazon median durat 2.8 year rang 0.2-13.2 year 1261 incid bladder cancer crude incid bladder cancer pioglitazon user nonus 89.8 75.9 per 100,000 person-year respect ever use pioglitazon associ bladder cancer risk adjust hazard ratio hr 1.06 95 ci 0.89-1.26 result similar case-control analys pioglitazon use 19.6 among case patient 17.5 among control adjust odd ratio 1.18 95 ci 0.78-1.80 adjust analys associ 8 10 addit cancer ever use pioglitazon associ increas risk prostat cancer hr 1.13 95 ci 1.02-1.26 pancreat cancer hr 1.41 95 ci 1.16-1.71 crude incid prostat pancreat cancer pioglitazon user vs nonus 453.3 vs 449.3 81.1 vs 48.4 per 100,000 person-year respect clear pattern risk cancer observ time sinc initi durat dose conclus relev pioglitazon use associ statist signific increas risk bladder cancer although increas risk previous observ could exclud increas prostat pancreat cancer risk associ ever use pioglitazon merit investig assess whether causal due chanc residu confound revers causal',\n",
       "  'embryon stem cell line human blastocyst somat differenti vitro describ deriv pluripot embryon stem es cell human blastocyst two diploid es cell line cultiv vitro extend period maintain express marker characterist pluripot primat cell human es cell express transcript factor oct-4 essenti develop pluripotenti cell mous graft scid mice line give rise teratoma contain deriv three embryon germ layer cell line differenti vitro extraembryon somat cell lineag neural progenitor cell may isol differenti es cell cultur induc form matur neuron embryon stem cell provid model studi earli human embryolog investig tool discoveri novel growth factor medicin potenti sourc cell use transplant therapi',\n",
       "  'multipoint kra oncogen mutat potenti indic mucin carcinoma entir spectrum mucin ovarian neoplasm kra mutat common phenomenon mani human neoplasm aim assess kra mutat statu along histolog continuum normal ovari develop benign borderlin malign ovarian mucin neoplasm analyz 41 case malign 10 case borderlin 7 case benign mucin ovarian tumor 7 case normal ovarian tissu preval kra mutat normal ovari 0.00 n=0/7 preval benign borderlin malign mucin neoplasm 57.14 n=4/7 90.00 n=9/10 75.61 n=31/41 respect multipl kra mutat detect 6 case mucin carcinoma includ 5 doubl mutat g13d/v14i n=1 g12v/g13 n=1 g12d/g13 n=3 one tripl mutat a11v/g13n/v14i n=1 identifi six case 3 novel kra mutat previous describ cosmic databas includ a11v n=3 v14i n=2 mucin carcinoma a11t n=1 mucin borderlin tumor conclus kra mutat appear one imper event ovarian mucin adenoma-borderlin tumor-carcinoma sequenc increas number kra mutat shown strongest predictor unequivoc malign ovarian mucin neoplasm',\n",
       "  'identif distinct regul yeast tata box-contain gene despit one first eukaryot transcript regulatori element identifi sequenc nativ tata box signific remain elus appli criteria associ tata box queri sever saccharomyc genom arriv consensu tata a/t a/t a/g approxim 20 yeast gene contain tata box strikingli tata box-contain gene associ respons stress highli regul preferenti util saga rather tfiid compar tata-less promot transcript regul yeast appear mechanist bipolar possibl reflect need balanc induc stress-rel respons constitut housekeep function',\n",
       "  'il6 deriv cancer-associ fibroblast promot chemoresist via cxcr7 esophag squamou cell carcinoma variou factor cellular compon tumor microenviron key driver associ drug resist mani cancer analyz factor molecular mechan involv chemoresist patient esophag squamou cell carcinoma escc found interleukin 6 il6 deriv mainli cancer-associ fibroblast play import role chemoresist upregul c-x-c motif chemokin receptor 7 cxcr7 express signal transduc activ transcript 3/nuclear factor-κb pathway cxcr7 knockdown result inhibit il6-induc prolifer chemoresist addit cxcr7 silenc significantli decreas gene express associ stem chemoresist epithelial–mesenchym transit suppress prolifer abil escc cell three-dimension cultur system angiogenesi assay clinic sampl escc patient high express cxcr7 il6 present significantli wors overal surviv progression-fre surviv upon receiv cisplatin oper result suggest il6–cxcr7 axi may provid promis target treatment escc',\n",
       "  'myelodysplast syndrom revisit role bone marrow microenviron diseas pathogenesi myelodysplast syndrom heterogen group diseas character ineffect hematopoiesi propens leukem transform pathogenesi complex like depend interplay aberr hematopoiet cell microenviron nich cell play role diseas evolut poorli defin delin hematopoiet stem cell nich abil interrog role hematopoiet diseas anim model further insight recent year data support view microenviron play activ role evolut myelodysplasia myeloprolif disord thu provid rational explor therapeut target mesenchymal–hematopoiet interact diseas',\n",
       "  'smc complex differenti compact mitot chromosom accord genom context structur mainten chromosom smc protein complex key determin chromosom conform use hi-c polym model studi cohesin condensin two deepli conserv smc complex organ chromosom bud yeast saccharomyc cerevisia canon role cohesin co-align sister chromatid condensin gener compact mitot chromosom find strikingli differ role two complex bud yeast mitosi first cohesin respons compact mitot chromosom arm independ sister chromatid cohes polym simul demonstr role fulli account cis-loop chromatin second condensin gener dispens compact along chromosom arm instead play target role compact rdna proxim region promot resolut peri-centromer region result argu conserv mechan smc complex form chromatin loop distinct smc-depend loop activ select deploy appropri compact chromosom',\n",
       "  \"pattern chlamydia test differ set implic wider sti diagnosi care probabl sampl survey british popul background follow widespread rollout chlamydia test non-specialist commun set uk mani individu receiv chlamydia test without offer comprehens sti hiv test assess sexual behaviour among tester differ set view understand need sti diagnost servic method probabl sampl survey british popul undertaken 2010-2012 third nation survey sexual attitud lifestyl analys weight data chlamydia test past year includ locat recent test diagnos past 5 year individu age 16-44 year report least one sexual partner past year 4992 women 3406 men result 26.8 95 ci 25.4 28.2 women 16.7 15.5 18.1 men report chlamydia test past year 28.4 women 41.2 men test genitourinari medicin gum 41.1 20.7 women men respect test gener practic gp remaind test non-gum set women test outsid gum like older relationship live rural area individu test outsid gum report fewer risk behaviour nevertheless 11.0 8.6 14.1 women 6.8 3.9 11.6 men test gp 13.2 10.2 16.8 9.6 6.5 13.8 women men test non-gum set report 'unsaf sex defin two partner condom use partner past year individu treat chlamydia outsid gum past 5 year less like report hiv test time frame women 54.5 42.7 65.7 vs 74.1 65.9 80.9 gum men 23.9 12.7 40.5 vs 65.8 56.2 74.3 conclus chlamydia test occur non-gum set among popul report fewer risk behaviour howev need provid pathway comprehens sti care sizeabl minor higher risk\",\n",
       "  'treatment nonalcohol fatti liver diseas role ampk nonalcohol fatti liver diseas nafld grow worldwid epidem import risk factor develop insulin resist type 2 diabet nonalcohol steatohepat nash hepat cellular carcinoma hcc despit preval nafld lifestyl intervent involv exercis weight loss accept treatment diseas last decad numer experiment compound shown improv nafld preclin anim model mani therapeut shown increas activ cellular energi sensor amp-activ protein kinas ampk ampk activ reduc inflamm obes diabet increas ampk activ view viabl therapeut strategi improv nafld review propos three primari mechan ampk activ may improv nafld addit examin mechan ampk activ final identifi 27 studi use ampk activ reduc nafld futur consider studi examin relationship ampk nafld highlight',\n",
       "  'microenvironment-depend growth pre-neoplast malign plasma cell human mice human cancer includ myeloma preced precursor state unmet need vivo model studi interact human preneoplast cell bone marrow microenviron non-malign cell genet human mice permit growth primari human preneoplast malign plasma cell togeth non-malign cell vivo growth larg restrict bone marrow mirror pattern patient myeloma xenograft captur genom complex parent tumor reveal addit somat chang moreov xenograft patient preneoplast gammopathi show progress growth suggest clinic stabil lesion may part due growth control extrins tumor cell data demonstr new approach investig entir spectrum human plasma cell neoplasia illustr util human model understand function divers human tumor',\n",
       "  'effect activ charcoal hemoperfus renal function patient paraquat poison present studi retrospect analyz 19 patient diagnos paraquat pq poison aim investig effect activ charcoal hemoperfus renal function pq elimin result indic 7 patient die 12 surviv non-oligur renal failur occur 7 patient die among 12 surviv patient 10 normal renal function 2 develop non-oligur renal failur linear correl plasma urin paraquat concentr prior activ charcoal hemoperfus equat paramet togeth correl coeffici admiss follow y=0.5820+1.7348x r2=0.678 f=35.768 p 0.0001 equat paramet togeth correl coeffici follow activ charcoal hemoperfus y=0.6827+1.2649x r2=0.626 f=50.308 p 0.0001 therefor conclud patient normal renal function elimin kinet pq kidney associ plasma pq concentr activ charcoal hemoperfus littl effect avoid acut kidney injuri patient sever pq poison',\n",
       "  'diabetes-induc effect cardiomyocyt chick embryon heart micromass mous embryon d3 differenti stem cell diabet mellitu pregnanc consider medic challeng sinc relat \\u200eaugment morbid mortal concern fetu \\u200eand pregnant woman record show etiolog diabet \\u200eembryopathi complic mani teratolog factor might involv \\u200ein mechan diabet mellitus-induc congenit malform \\u200ein studi potenti cardiotox effect hyperglycemia hyperketonemia investig use two vitro model primari chick embryon cardiomyocyt stem cell deriv cardiomyocyt advers effect record system cell evalu chang beat activ cell activ protein content ro product dna damag differenti stem cell migrat diabet formula use produc increas dna damag declin cell migrat mous embryon stem cell result provid addit insight advers effect gestat diabet mellitu recommend expect mother matern staff monitor glycaem level month ahead concept studi also support recommend use antioxid pregnanc prevent dna damag product ro might result heart defect well development anomali',\n",
       "  \"motion magnif present motion magnif techniqu act like microscop visual motion amplifi subtl motion video sequenc allow visual deform would otherwis invis achiev motion magnif need accur measur visual motion group pixel modifi initi imag registr step measur motion robust analysi featur point trajectori segment pixel base similar posit color motion novel measur motion similar group even small motion accord correl time often relat physic caus outlier mask mark observ explain layer motion model pixel simpli reproduc output origin regist observ motion select layer may magnifi user-specifi amount textur synthesi fills-in unseen `` hole '' reveal amplifi motion result motion-magnifi imag reveal emphas small motion origin sequenc demonstr deform load-bear structur subtl motion balanc correct peopl `` rigid '' structur bend hand pressur\",\n",
       "  'human trpml1 channel structur open close conform transient receptor potenti mucolipin 1 trpml1 ca2+-releas cation channel mediat calcium signal homeostasi lysosom mutat trpml1 lead mucolipidosi type iv sever lysosom storag disord report two electron cryo-microscopi structur full-length human trpml1 3.72-å apo structur ph 7.0 close state 3.49-å agonist-bound structur ph 6.0 open state sever aromat hydrophob residu pore helix 1 helic s5 s6 helix s6 neighbour subunit form hydrophob caviti hous agonist suggest distinct agonist-bind site found trpv1 trp channel differ subfamili open trpml1 associ distinct dilat lower gate togeth slight structur movement pore helix 1. work reveal regulatori mechan trpml channel facilit better understand trp channel activ provid insight molecular basi mucolipidosi type iv pathogenesi',\n",
       "  \"integr genom viewer igv high-perform genom data visual explor data visual essenti compon genom data analysi howev size divers data set produc today 's sequenc array-bas profil method present major challeng visual tool integr genom viewer igv high-perform viewer effici handl larg heterogen data set provid smooth intuit user experi level genom resolut key characterist igv focu integr natur genom studi support array-bas next-gener sequenc data integr clinic phenotyp data although igv often use view genom data public sourc primari emphasi support research wish visual explor data set colleagu end igv support flexibl load local remot data set optim provid high-perform data visual explor standard desktop system igv freeli avail download http //www.broadinstitute.org/igv gnu lgpl open-sourc licens\",\n",
       "  'genom engin use target cancer-associ enhanc transcript misregul involv develop mani diseas especi neoplast transform distal regulatori element enhanc play major role specifi cell-specif transcript pattern normal diseas tissu suggest enhanc may prime target therapeut intervent focus modul gene regul mediat cell type-specif enhanc hope normal epigenet pattern affect tissu could restor fewer side effect observ treatment employ rel nonspecif inhibitor epigenet drug new method employ genom nucleas site-specif epigenet regul target specif genom region use either artifici dna-bind protein rna-dna interact may allow precis genom engin enhanc howev field still infanc refin increas specif effici clearli requir',\n",
       "  'long‐term follow‐up cd19 car therapi acut lymphoblast leukemia background cd19‐specif chimer antigen receptor car cell induc high rate initi respons among patient relaps b‐cell acut lymphoblast leukemia long‐term remiss subgroup patient method conduct phase 1 trial involv adult relaps b‐cell receiv infus autolog cell express 19‐28z car memori sloan ketter cancer center mskcc safeti long‐term outcom assess associ demograph clinic diseas characterist result total 53 adult receiv 19‐28z car cell manufactur mskcc infus sever cytokin releas syndrom occur 14 53 patient 26 95 confid interv ci 15 40 1 patient die complet remiss observ 83 patient median follow‐up 29 month rang 1 65 median event‐fre surviv 6.1 month 95 ci 5.0 11.5 median overal surviv 12.9 month 95 ci 8.7 23.4 patient low diseas burden 5 bone marrow blast treatment markedli enhanc remiss durat surviv median event‐fre surviv 10.6 month 95 ci 5.9 reach median overal surviv 20.1 month 95 ci 8.7 reach patient higher burden diseas ≥5 bone marrow blast extramedullari diseas greater incid cytokin releas syndrom neurotox event shorter long‐term surviv patient low diseas burden conclus entir cohort median overal surviv 12.9 month among patient low diseas burden median overal surviv 20.1 month accompani markedli lower incid cytokin releas syndrom neurotox event 19‐28z car t‐cell infus observ among patient higher diseas burden fund commonwealth foundat cancer research other clinicaltrials.gov number nct01044069',\n",
       "  'periosteum contain skelet stem cell high bone regen potenti control periostin bone regener reli activ skelet stem cell ssc still remain poorli character show periosteum contain ssc high bone regen potenti compar bone marrow stromal cells/skelet stem cell bmsc mice although periost cell pc bmsc deriv common embryon mesenchym lineag postnat pc exhibit greater clonogen growth differenti capac bmsc bone repair pc effici contribut cartilag bone integr long-term transplant molecular profil uncov gene encod periostin extracellular matrix molecul associ enhanc respons injuri pc periostin gene delet impair pc function fractur consolid periostin-defici periosteum reconstitut pool pc injuri demonstr presenc ssc within periosteum requir periostin maintain pool overal result highlight import analyz periosteum pc understand bone phenotyp',\n",
       "  'metabol strike back metabol flux regul cell signal mammalian cell depend growth factor signal take nutrient howev coordin glucos glutamin uptak mysteri issu gene develop wellen colleagu pp 2784-2799 show glucos flux hexosamin biosynthesi pathway regul growth factor receptor glycosyl enabl glutamin consumpt mechan ensur cell engag anabol metabol nutrient limit highlight substrat avail protein modif modul cell signal',\n",
       "  'associ pembrolizumab tumor respons surviv among patient advanc melanoma import program death 1 pd-1 pathway limit immun respons melanoma block human anti-pd-1 monoclon antibodi pembrolizumab object character associ pembrolizumab tumor respons overal surviv among patient advanc melanoma design set particip open-label multicohort phase 1b clinic trial enrol decemb 2011-septemb 2013 median durat follow-up 21 month studi perform academ medic center australia canada franc unit state elig patient age 18 year older advanc metastat melanoma data pool 655 enrol patient 135 nonrandom cohort n 87 ipilimumab naiv n 48 ipilimumab treat 520 random cohort n 226 ipilimumab naiv n 294 ipilimumab treat cutoff date april 18 2014 safeti analys octob 18 2014 efficaci analys exposur pembrolizumab 10 mg/kg everi 2 week 10 mg/kg everi 3 week 2 mg/kg everi 3 week continu diseas progress intoler toxic investig decis main outcom measur primari end point confirm object respons rate best overal respons complet respons partial respons patient measur diseas baselin per independ central review secondari end point includ toxic durat respons progression-fre surviv overal surviv result among 655 patient median rang age 61 18-94 year 405 62 men 581 measur diseas baselin object respons report 194 581 patient 33 95 ci 30 -37 60 133 treatment-na patient 45 95 ci 36 54 overal 74 152/205 respons ongo time data cutoff 44 90/205 patient respons durat least 1 year 79 162/205 respons durat least 6 month twelve-month progression-fre surviv rate 35 95 ci 31 -39 total popul 52 95 ci 43 -60 among treatment-na patient median overal surviv total popul 23 month 95 ci 20-29 12-month surviv rate 66 95 ci 62 -69 24-month surviv rate 49 95 ci 44 -53 treatment-na patient median overal surviv 31 month 95 ci 24 reach 12-month surviv rate 73 95 ci 65 -79 24-month surviv rate 60 95 ci 51 -68 ninety-two 655 patient 14 experienc least 1 treatment-rel grade 3 4 advers event ae 27 655 4 patient discontinu treatment treatment-rel ae treatment-rel seriou ae report 59 patient 9 drug-rel death conclus relev among patient advanc melanoma pembrolizumab administr associ overal object respons rate 33 12-month progression-fre surviv rate 35 median overal surviv 23 month grade 3 4 treatment-rel ae occur 14 trial registr clinicaltrials.gov identifi nct01295827',\n",
       "  'inflammatori signal human tuberculosi granuloma spatial organ granuloma patholog hallmark tuberculosi tb howev function mechan format remain poorli understood understand role granuloma tb analyz proteom granuloma subject tuberculosi unbias manner use laser-captur microdissect mass spectrometri confoc microscopi gener detail molecular map human granuloma found center granuloma pro-inflammatori environ character presenc antimicrobi peptid reactiv oxygen speci pro-inflammatori eicosanoid convers tissu surround caseum compar anti-inflammatori signatur find consist across set six human subject rabbit although balanc system pro- anti-inflammatori signal crucial tb diseas outcom find signal physic segreg within granuloma protein lipid snapshot human rabbit lesion analyz hypothes patholog respons tb shape precis anatom local inflammatori pathway develop granuloma',\n",
       "  'suppress interferon-medi anti-hbv respons singl cpg methyl 5′-utr trim22 object interferon ifn mediat direct antivir activ play crucial role earli host immun respons viral infect howev ifn therapi hbv infect less effect viral infect design explor cellular target hbv respons ifn use proteome-wid screen result use lc-ms/m identifi protein downregul upregul ifn treatment hbv x protein hbx -stabl control cell found sever ifn-stimul gene downregul hbx includ trim22 known antiretrovir protein demonstr hbx suppress transcript trim22 singl cpg methyl 5′-utr reduc ifn regulatori factor-1 bind affin therebi suppress ifn-stimul induct trim22 conclus verifi find use mous model primari human hepatocyt human liver tissu data elucid mechan hbv evad host innat immun system',\n",
       "  'development analysi bone marrow neutrophil reveal popul special expans traffick effector function summari neutrophil special innat cell requir constant replenish prolif bone marrow bm precursor result short half‐lif although establish neutrophil deriv granulocyte‐macrophag progenitor gmp differenti pathway gmp function matur neutrophil poorli defin use mass cytometri cytof cell‐cycle‐bas analysi identifi three neutrophil subset within bm commit prolif neutrophil precursor preneu differenti non‐prolifer immatur neutrophil matur neutrophil transcriptom profil function analysi reveal preneu requir c/ebp egr transcript factor gener gmp prolif program substitut gain migratori effector function matur preneu expand microbi tumor stress immatur neutrophil recruit peripheri tumor‐bear mice summari studi identifi special bm granulocyt popul ensur suppli homeostasi stress respons graphic abstract figur caption avail highlightsprolifer activ identifi commit neutrophil precursor mice humansneutrophil subset possess distinct transcriptom function signaturesdefect neutrophil develop lead impair neutrophil‐medi responsesincreas circul immatur neutrophil associ cancer progress na neutrophil differenti pathway poorli defin evrard et al demonstr workflow character bone marrow neutrophil subset basi prolif capac molecular signatur therebi defin development trajectori function properti neutrophil',\n",
       "  'tak1-medi autophagi fatti acid oxid prevent hepatosteatosi tumorigenesi map kinas kinas kinas tgfβ-activ kinas 1 tak1 activ tlr il-1 tnf tgfβ turn activ ikk-nf-κb jnk regul cell surviv growth tumorigenesi metabol tak1 signal also upregul ampk activ autophagi investig tak1-depend regul autophagi lipid metabol tumorigenesi liver fast mice hepatocyte-specif delet tak1 exhibit sever hepatosteatosi increas mtorc1 activ suppress autophagi compar wt counterpart tak1-defici hepatocyt exhibit suppress ampk activ autophagi respons starvat metformin treatment howev ectop activ ampk restor autophagi cell peroxisom proliferator-activ receptor α pparα target gene β-oxid regul hepat lipid degrad also suppress hepatocyt lack tak1 due suppress autophagi β-oxid high-fat diet challeng aggrav steatohepat mice hepatocyte-specif delet tak1 notabl inhibit mtorc1 restor autophagi pparα target gene express tak1-defici liver indic tak1 act upstream mtorc1 mtorc1 inhibit also suppress spontan liver fibrosi hepatocarcinogenesi anim hepatocyte-specif delet tak1 data indic tak1 regul hepat lipid metabol tumorigenesi via ampk/mtorc1 axi affect autophagi pparα activ',\n",
       "  'formin junction actin cytoskeleton adhes junction physic function coupl cell-cel interfac epitheli cell actin regulatori complex arp2/3 establish role turnov junction actin howev role formin largest group actin regul less clear formin dynam shape actin cytoskeleton variou function within cell review describ recent progress formin regul actin dynam cell-cel contact highlight formin function polar protein traffic necessari epitheli',\n",
       "  \"crispr adapt bias explain prefer acquisit foreign dna crispr-ca cluster regularli interspac short palindrom repeat coupl crispr-associ protein bacteri immun system protect invad phage plasmid process crispr adapt short piec dna 'spacer acquir foreign element integr crispr array far remain mysteri spacer preferenti acquir foreign dna self chromosom avoid show spacer acquisit replication-depend dna break form stall replic fork promot spacer acquisit chromosom hotspot spacer acquisit confin chi site sequenc octam highli enrich bacteri chromosom suggest site limit spacer acquisit self dna show avoid self mediat recbcd double-strand dna break repair complex result suggest escherichia coli acquisit new spacer larg depend recbcd-medi process double-strand dna break occur primarili replic fork prefer foreign dna achiev higher densiti chi site self chromosom combin higher number fork foreign dna model explain strong prefer acquir spacer high copi plasmid phage\",\n",
       "  'high-resolut map open chromatin rice genom gene express control complex interact transcript factor bind promot regulatori dna element one common characterist genom region associ regulatori protein pronounc sensit dnase digest gener genome-wid high-resolut map dnase hypersensit dh site seedl callu tissu rice oryza sativa approxim 25 dh site tissu found put promot indic vast major gene regulatori element rice locat promot region found 58 dh site callu seedl dh site detect seedl callu 31 display significantli differ level dnase sensit within two tissu gene differenti express seedl callu frequent associ dh site tissu dna sequenc contain within dh site hypomethyl consist known activ gene regulatori element interestingli tissue-specif dh site locat promot show higher level dna methyl averag dna methyl level dh site locat promot distinct elev h3k27me3 associ intergen dh site result suggest epigenet modif play role dynam chang number dnase sensit dh site develop',\n",
       "  'prospect studi bodi fat distribut risk endometri cancer background epidemiolog studi found overal obes posit relat endometri cancer ec risk howev data assess associ bodi fat distribut risk ec still limit method follow 51,948 women first report waist circumfer wc hip circumfer 1986 nurs health studi waist-to-hip ratio whr calcul result 24 year follow-up 449 incid invas ec case diagnos multivari analysi without adjust bodi mass index bmi rel risk rr ec compar extrem categori 2.44 95 confid interv ci 1.72-3.45 wc 1.69 95 ci=1.20-2.40 whr howev adjust bmi posit associ substanti attenu longer signific rr=1.08 95 ci=0.69-1.67 wc 1.15 95 ci=0.81-1.64 whr respect conclus prospect cohort studi found independ associ bodi fat distribut risk ec adjust bmi',\n",
       "  'breast cancer cluster northeast unit state geograph analysi high breast cancer mortal rate report northeastern part unit state recent attent focus long island new york studi author investig whether high breast cancer mortal evenli spread northeast sens observ cluster death explain chanc alon whether cluster statist signific demograph data age-specif breast cancer mortal rate women obtain 244 counti 11 northeastern state district columbia 1988-1992. recent develop spatial scan statist use search cluster case without specifi size locat ahead time test statist signific adjust multipl test inher procedur basic analysi adjust age analys examin result affect incorpor race urban pariti confound variabl statist signific geograph broad cluster breast cancer death new york city-philadelphia pennsylvania metropolitan area p 0.0001 7.4 higher mortal rate rest northeast cluster remain signific race urban and/or pariti includ confound variabl four smaller subclust within area also signific strength philadelphia suburb p 0.0001 long island p 0.0001 central new jersey p 0.0001 northeastern new jersey p 0.0001 elev breast cancer mortal long island might view less uniqu local phenomenon part gener situat involv larg part new york city-philadelphia metropolitan area sever known hypothes risk factor could adjust may explain detect cluster notabl age first birth age menarch age menopaus breastfeed genet mutat environment factor',\n",
       "  'cd200r/cd200 inhibit osteoclastogenesi new mechan osteoclast control mesenchym stem cell human bone homeostasi maintain balanc bone-form osteoblast bone-degrad osteoclast osteoblast mesenchym origin wherea osteoclast belong myeloid lineag osteoclast osteoblast commun occur solubl factor secret cell-bon interact cell-cel contact modul activ cd200 immunoglobulin superfamilli member express variou type cell includ mesenchym stem cell msc cd200 receptor cd200r express myeloid cell monocytes/macrophag assum cd200 could new molecul involv control osteoclastogenesi could play role msc-osteoclast commun human studi demonstr solubl cd200 inhibit differenti osteoclast precursor well matur bone-resorb cell vitro solubl cd200 modifi monocyt phenotyp inhibit receptor activ nuclear factor kappa-b ligand rankl signal pathway well gene express osteoclast marker osteoclast-associ receptor oscar nuclear factor activ cell cytoplasm 1 nfatc1 moreov msc inhibit osteoclast format depend cell-cel contact associ cd200 express msc surfac result clearli demonstr msc express cd200 play major role regul bone resorpt bone physiolog cd200-cd200r coupl could new target control bone diseas',\n",
       "  'tumor-specif th17-polar cell erad larg establish melanoma cd4+ cell differenti multipl effector subset potenti role subset anti-tumor immun fulli explor seek studi impact cd4+ cell polar tumor reject model mimick human diseas gener new mhc class ii-restrict t-cell receptor tcr transgen mous model cd4+ cell recogn novel epitop tyrosinase-rel protein 1 trp-1 antigen express normal melanocyt b16 murin melanoma cell could robustli polar th0 th1 th17 subtyp vitro evidenc cytokin chemokin adhes molecul profil surfac marker suggest potenti differenti effector function vivo contrari current view th1 cell import tumor reject found th17-polar cell better mediat destruct advanc b16 melanoma therapeut effect critic depend interferon-gamma ifn-gamma product wherea deplet interleukin il -17a il-23 littl impact taken togeth data indic appropri vitro polar effector cd4+ cell decis success tumor erad principl consid design clinic trial involv adopt transfer-bas immunotherapi human malign',\n",
       "  'defin commun acquir pneumonia sever present hospit intern deriv valid studi background assess sever commun acquir pneumonia cap modifi british thorac societi mbt rule identifi patient sever pneumonia patient might suitabl home manag multicentr studi conduct deriv valid practic sever assess model stratifi adult hospitalis cap differ manag group method data three prospect studi cap conduct uk new zealand netherland combin deriv cohort compris 80 data use develop model prognost variabl identifi use multipl logist regress 30 day mortal outcom measur final model test valid cohort result 1068 patient studi mean age 64 year 51.5 male 30 day mortal 9 age /=65 year 3.5 95 ci 1.6 8.0 albumin 30 g/dl 4.7 95 ci 2.5 8.7 independ associ mortal mbt rule 5.2 95 ci 2.7 10 six point score one point confus urea 7 mmol/l respiratori rate /=30/min low systol 90 mm hg diastol /=60 mm hg blood pressur age /=65 year curb-65 score base inform avail initi hospit assess enabl patient stratifi accord increas risk mortal score 0 0.7 score 1 3.2 score 2 3 score 3 17 score 4 41.5 score 5 57 valid cohort confirm similar pattern conclus simpl six point score base confus urea respiratori rate blood pressur age use stratifi patient cap differ manag group',\n",
       "  'mitochondri iron chelat amelior cigarette-smok induc bronchiti emphysema mice chronic obstruct pulmonari diseas copd link cigarett smoke genet determin previous identifi iron-respons element-bind protein 2 irp2 import copd suscept gene shown irp2 protein increas lung individu copd demonstr mice defici irp2 protect cigarett smoke cs -induc experiment copd integr rna immunoprecipit follow sequenc rip-seq rna sequenc rna-seq gene express function enrich cluster analysi identifi irp2 regul mitochondri function lung mice irp2 increas mitochondri iron load level cytochrom c oxidas cox led mitochondri dysfunct subsequ experiment copd frataxin-defici mice higher mitochondri iron load show impair airway mucociliari clearanc mcc higher pulmonari inflamm baselin wherea mice defici synthesi cytochrom c oxidas reduc cox protect cs-induc pulmonari inflamm impair mcc mice treat mitochondri iron chelat mice fed low-iron diet protect cs-induc copd mitochondri iron chelat also allevi cs-induc impair mcc cs-induc pulmonari inflamm cs-associ lung injuri mice establish copd suggest critic function role potenti therapeut intervent mitochondrial-iron axi copd',\n",
       "  'cancer-associ fibroblast neutral anti-tumor effect csf1 receptor blockad induc pmn-mdsc infiltr tumor tumor-associ macrophag tam contribut aspect tumor progress use csf1r inhibitor target tam therapeut appeal limit anti-tumor effect identifi mechan limit effect csf1r target therapi demonstr carcinoma-associ fibroblast caf major sourc chemokin recruit granulocyt tumor csf1 produc tumor cell caus hdac2-medi downregul granulocyte-specif chemokin express caf limit migrat cell tumor treatment csf1r inhibitor disrupt crosstalk trigger profound increas granulocyt recruit tumor combin csf1r inhibitor cxcr2 antagonist block granulocyt infiltr tumor show strong anti-tumor effect',\n",
       "  'phenotyp deficit hiv-1 envelop associ matur v2-direct broadli neutral antibodi lineag broadli neutral antibodi bnab hiv-1 evolv year iter process viru escap antibodi adapt hiv-1 vaccin design seek mimic enabl properti render hiv-1 envelop env capabl elicit bnab respons need defin follow evolut v2 apex direct bnab lineag vrc26 hiv-1 subtyp c superinfect donor cap256 investig phenotyp chang viru popul circul earli phase bnab induct longitudin virus evolv vrc26-resist primari infect pi viru vrc26-sensit superinfect su viru ensu pi-su recombin reveal substanti phenotyp chang env switch env properti coincid earli resist vrc26 decreas sensit su-lik virus vrc26 link reduc infect alter entri kinet lower sensit neutral cd4 attach vrc26 maintain neutral activ cell-associ cap256 viru indic escap cell-cel transmiss rout domin escap pathway reduc fit earli escap variant sustain sensit cell-cel transmiss featur limit viru replic therebi imped rapid escap support scenario vrc26 allow partial viral escap prolong period possibl increas time window bnab matur collect data highlight phenotyp plastic hiv-1 env evad bnab pressur need consid phenotyp trait select design env immunogen combin env variant differenti phenotyp pattern bnab sensit describ cap256 may maxim potenti induc bnab respons vaccin',\n",
       "  'high somat mutat neoantigen burden correl decreas progression-fre surviv multipl myeloma tumor-specif mutat result immunogen neoantigen correl respons immun checkpoint inhibitor highli mutagen cancer howev earli result single-ag checkpoint inhibitor multipl myeloma mm underwhelm therefor sought understand relationship mutat neoantigen landscap mm patient respons therapi somat mutat burden neoantigen load respons therapi determin use interim data mmrf commpass studi nct01454297 664 mm patient popul mean somat missens mutat load 405.84 s=608.55 63.90 s=95.88 mutat per patient respect posit linear relationship mutat neoantigen burden r2=0.862 averag predict neoantigen load 23.52 s=52.14 neoantigen averag 9.40 s=26.97 express neoantigen surviv analysi reveal significantli shorter progression-fre surviv pf patient greater averag somat missens mutat load n=163 0.493 vs 0.726 2-year pf p=0.0023 predict express neoantigen load n=214 0.555 vs 0.729 2-year pf p=0.0028 pattern maintain stratifi diseas stage cytogenet abnorm therefor high mutat neoantigen load clinic relev risk factor neg impact surviv mm patient current standard care',\n",
       "  'postmarket safeti event among novel therapeut approv us food drug administr 2001 2010 import postmarket safeti event novel pharmaceut biolog occur new safeti risk identifi initi regulatori approv therapeut safeti event chang novel therapeut use clinic practic inform patient clinician decis make object character frequenc postmarket safeti event among novel therapeut approv us food drug administr fda examin whether novel therapeut characterist known time fda approv associ increas risk design set cohort studi novel therapeut approv fda januari 1 2001 decemb 31 2010 follow februari 28 2017. exposur novel therapeut characterist known time fda approv includ drug class therapeut area prioriti review acceler approv orphan statu near–regulatori deadlin approv regulatori review time main outcom measur composit 1 withdraw due safeti concern 2 fda issuanc increment box warn ad postmarket period 3 fda issuanc safeti commun result 2001 2010 fda approv 222 novel therapeut 183 pharmaceut 39 biolog 123 new postmarket safeti event 3 withdraw 61 box warn 59 safeti commun median follow-up period 11.7 year interquartil rang iqr 8.7-13.8 year affect 71 32.0 novel therapeut median time approv first postmarket safeti event 4.2 year iqr 2.5-6.0 year proport novel therapeut affect postmarket safeti event 10 year 30.8 95 ci 25.1 -37.5 multivari analysi postmarket safeti event statist significantli frequent among biolog incid rate ratio irr 1.93 95 ci 1.06-3.52 p .03 therapeut indic treatment psychiatr diseas irr 3.78 95 ci 1.77-8.06 p .001 receiv acceler approv irr 2.20 95 ci 1.15-4.21 p .02 near–regulatori deadlin approv irr 1.90 95 ci 1.19-3.05 p .008 event statist significantli less frequent among regulatori review time less 200 day irr 0.46 95 ci 0.24-0.87 p .02 conclus relev among 222 novel therapeut approv fda 2001 2010 32 affect postmarket safeti event biolog psychiatr therapeut acceler near–regulatori deadlin approv statist significantli associ higher rate event highlight need continu monitor safeti novel therapeut throughout life cycl',\n",
       "  'risk chronic obstruct pulmonari diseas spatial epidemiolog analysi health insur claim copd northeastern germani background chronic obstruct pulmonari diseas copd high preval rate germani increas expect within next year although risk factor individu level wide understood littl known spatial heterogen population-bas risk factor copd background knowledg broader population-bas process could help plan futur provis healthcar prevent strategi align expect demand aim studi analyz preval copd vari across northeastern germani smallest spatial-scal possibl identifi location-specif population-bas risk factor use health insur claim aok nordost method visual spatial distribut copd preval level municip urban district use condit autoregress besag-york-mollié bym model geograph weight regress model gwr appli analyz location-specif ecolog risk factor copd result sex- age-adjust preval copd 6.5 2012 vari wide across northeastern germani population-bas risk factor consist proport insur age 65 older insur migrat background household size area depriv result gwr model reveal popul risk copd vari consider across northeastern germani conclus area depriv direct indirect influenc preval copd person age social disadvantag area higher chanc develop copd even necessarili directli affect depriv individu level underlin import consid impact area depriv health plan healthcar addit result reveal part studi area insur migrat background person live multi-person household elev risk copd',\n",
       "  'larg intergen non-cod rna-ror modul reprogram human induc pluripot stem cell convers lineage-commit cell induc pluripot stem cell ipsc reprogram accompani global remodel epigenom result alter pattern gene express character transcript reorgan larg intergen non-cod rna lincrna occur upon deriv human ipsc identifi numer lincrna whose express link pluripot among defin ten lincrna whose express elev ipsc compar embryon stem cell suggest activ may promot emerg ipsc support result indic lincrna direct target key pluripot transcript factor use loss-of-funct gain-of-funct approach found one lincrna lincrna-ror modul reprogram thu provid first demonstr critic function lincrna deriv pluripot stem cell',\n",
       "  'extracellular vesicl isol character toward clinic applic two broad categori extracellular vesicl ev exosom shed microvesicl smv differ size distribut well protein rna profil describ ev known play key role cell-cel commun act proxim well system review discuss natur ev subtyp strategi isol ev cell-cultur media bodi fluid procedur quantifi ev also discuss protein select enrich exosom smv potenti use marker discrimin ev subtyp well variou applic ev clinic diagnosi',\n",
       "  'up-regul nrip2 colorect cancer initi cell modul wnt pathway target rorβ background colorect cancer remain one common malign tumor worldwid colorect cancer initi cell ccic small subpopul respons malign behavior colorect cancer aberr activ wnt pathway regul self-renew ccic howev underli mechan remain poorli understood method via retrovir librari screen identifi nuclear receptor-interact protein 2 nrip2 novel interactor wnt pathway enrich colorect cancer colospher cell express level nrip2 retino acid-rel orphan receptor β rorβ examin fish qrt-pcr ihc western blot nrip2 overexpress knockdown colorect cancer cell produc studi role nrip2 wnt pathway also verifi bind nrip2 rorβ investig effect rorβ ccic vitro vivo genechip-scan specul downstream target hbp1 western blot chip luciferas report carri investig interact nrip2 rorβ hbp1 result nrip2 significantli up-regul ccic cell line primari colorect cancer tissu reinforc express nrip2 increas wnt activ silenc nrip2 attenu wnt activ transcript factor rorβ key target nrip2 regul wnt pathway activ rorβ transcript enhanc inhibitor hbp1 wnt pathway nrip2 prevent rorβ bind downstream hbp1 promot region reduc transcript hbp1 turn attenu hbp1-depend inhibit tcf4-mediat transcript conclus nrip2 novel interactor wnt pathway colorect cancer initi cell interact nrip2 rorβ hbp1 mediat new mechan ccic self-renew via wnt activ',\n",
       "  'speed limit nonvesicular intracellular sterol transport sterol transport endoplasm reticulum er plasma membran pm occur nonvesicular mechan requir sterol transport protein stp examin idea transport enhanc membran contact site er close appos pm conclud sterol desorpt membran rather stp-mediat diffus rate limit cellular context appar kinet benefit stp-mediat sterol transfer occur contact site contact site may instead compartment lipid synthesi transport machineri provid opportun regul',\n",
       "  \"misunderstand prescrib decis gener practic qualit studi object identifi describ misunderstand patient doctor associ prescrib decis gener practic design qualit studi set 20 gener practic west midland south east england particip 20 gener practition 35 consult patient main outcom measur misunderstand patient doctor potenti actual advers consequ take medicin result 14 categori misunderstand identifi relat patient inform unknown doctor doctor inform unknown patient conflict inform disagr attribut side effect failur commun doctor 's decis relationship factor misunderstand associ lack patient particip consult term voic expect prefer voic respons doctor decis action associ potenti actual advers outcom non-adher treatment mani base inaccur guess assumpt particular doctor seem unawar relev patient idea medicin success prescrib conclus patient particip consult advers consequ lack particip import author develop educ intervent build find\",\n",
       "  'phase-pl cryo-em structur bias agonist-bound human glp-1 receptor–g complex class b glucagon-lik peptide-1 glp-1 g protein-coupl receptor major target treatment type 2 diabet obes endogen mimet glp-1 peptid exhibit bias agonism—a differ function selectivity—that may provid improv therapeut outcom describ structur human glp-1 receptor complex g protein-bias peptid exendin-p5 gα heterotrim determin global resolut 3.3 å. extracellular surfac organ extracellular loop 3 proxim transmembran segment differ exendin-p5-bound structur previou glp-1-bound glp-1 receptor structur intracellular face six-degre differ angl gαs–α5 helix engag structur propag across g protein heterotrim addit structur differ rate extent conform reorgan gα protein structur provid insight molecular basi bias agon',\n",
       "  'therapeut equival alendron 70 mg once-weekli alendron 10 mg daili treatment osteoporosi alendron once-weekli studi group dose conveni key element effect manag chronic diseas particularli import long-term manag osteoporosi less frequent dose medic may enhanc complianc therebi maxim effect therapi anim data support rational once-weekli dose alendron 70 mg 7 time daili oral treatment dose could provid similar efficaci daili dose alendron 10 mg due long durat effect bone addit dog studi suggest potenti esophag irrit observ daili oral bisphosphon may substanti reduc once-weekli dose dose regimen would provid patient increas conveni would like enhanc patient complianc compar efficaci safeti treatment oral once-weekli alendron 70 mg n=519 twice-weekli alendron 35 mg n=369 daili alendron 10 mg n=370 one-year double-blind multicent studi postmenopaus women age 42 95 osteoporosi bone miner densiti bmd either lumbar spine femor neck least 2.5 sd peak premenopaus mean prior vertebr hip fractur primari efficaci endpoint compar increas lumbar spine bmd use strict pre-defin equival criteria secondari endpoint includ chang bmd hip total bodi rate bone turnov assess biochem marker new regimen fulli satisfi equival criteria rel daili therapi mean increas lumbar spine bmd 12 month 5.1 95 ci 4.8 5.4 70 mg once-weekli group 5.2 4.9 5.6 35 mg twice-weekli group 5.4 5.0 5.8 10 mg daili treatment group increas bmd total hip femor neck trochant total bodi similar three dose regimen three treatment group similarli reduc biochem marker bone resorpt urinari n-telopeptid type collagen bone format serum bone-specif alkalin phosphatas middl premenopaus refer rang treatment regimen well toler similar incid upper gi advers experi fewer seriou upper gi advers experi trend toward lower incid esophag event once-weekli dose group compar daili dose group data consist preclin anim model suggest once-weekli dose potenti improv upper gi toler clinic fractur captur advers experi similar among group conclud alendron 70 mg once-weekli dose regimen provid patient conveni therapeut equival altern daili dose may enhanc complianc long-term persist therapi',\n",
       "  'associ toll-lik receptor 4 human monocyt subset vulner characterist coronari plaqu assess 64-slice multidetector comput tomographi background although toll-lik receptor 4 tlr-4 involv monocyt activ patient acceler form atherosclerosi relationship express tlr-4 circul monocyt coronari plaqu vulner previous evalu investig relationship use 64-slice multidetector comput tomographi mdct patient stabl angina pectori sap .method result enrol 65 patient sap underw mdct three monocyt subset cd14++cd16- cd14++cd16+ cd14+cd16+ express tlr-4 measur flow cytometri intracoronari plaqu assess 64-slice mdct defin vulner intracoronari plaqu accord presenc posit remodel remodel index 1.05 and/or low ct attenu 35 hu circul cd14++cd16+monocyt frequent express tlr-4 cd14++cd16-and cd14+cd16+monocyt p 0.001 rel proport express tlr-4 cd14++cd16+monocyt significantli greater patient vulner plaqu compar without 10.4 4.1-14.5 vs. 4.5 2.8-7.8 p=0.012 addit rel proport tlr-4 express cd14++cd16+monocyt posit correl remodel index r=0.28 p=0.025 neg correl ct attenu valu r=-0.31 p=0.013 conclus upregul tlr-4 cd14++cd16+monocyt might associ coronari plaqu vulner patient sap',\n",
       "  'expand cardiovascular progenitor cell reprogram fibroblast stem cell-bas approach cardiac regener increasingli viabl strategi treat heart failur gener abund function autolog cell transplant set howev remain signific challeng isol cell popul extens prolifer capac restrict cardiovascular differenti potenti cardiac transdifferenti mous fibroblast induc expand cardiovascular progenitor cell iecpc prolifer extens 18 passag chemic defin condit 10 5 start fibroblast robustli produc 10 16 iecpc iecpc express cardiac signatur gene readili differenti function cardiomyocyt cm endotheli cell ec smooth muscl cell smc vitro even long-term expans transplant mous heart follow myocardi infarct iecpc spontan differenti cm ec smc improv cardiac function 12 week transplant thu iecpc power system studi cardiovascular specif provid strategi regen medicin heart',\n",
       "  'thyroid hormon inhibit lung fibrosi mice improv epitheli mitochondri function thyroid hormon th critic mainten cellular homeostasi stress respons role lung fibrosi unknown found activ express iodothyronin deiodinas 2 dio2 enzym activ th higher lung patient idiopath pulmonari fibrosi control individu correl diseas sever also found dio2-knockout mice exhibit enhanc bleomycin-induc lung fibrosi aerosol th deliveri increas surviv resolv fibrosi two model pulmonari fibrosi mice intratrach bleomycin induc tgf-β1 sobetirom th mimet also blunt bleomycin-induc lung fibrosi bleomycin-induc injuri th promot mitochondri biogenesi improv mitochondri bioenerget attenu mitochondria-regul apoptosi alveolar epitheli cell vivo vitro th blunt fibrosi ppargc1a- pink1-knockout mice suggest depend pathway conclud antifibrot properti th associ protect alveolar epitheli cell restor mitochondri function th may thu repres potenti therapi pulmonari fibrosi',\n",
       "  'tenomodulin promot human adipocyt differenti benefici viscer adipos tissu expans proper regul energi storag adipos tissu crucial maintain insulin sensit molecul contribut process fulli reveal show type ii transmembran protein tenomodulin tnmd upregul adipos tissu insulin-resist versu insulin-sensit individu match bodi mass index bmi tnmd express increas human preadipocyt differenti wherea silenc tnmd block adipogenesi upon high-fat diet feed transgen mice overexpress tnmd develop increas epididym white adipos tissu ewat mass preadipocyt deriv tnmd transgen mice display greater prolifer consist elev adipogenesi tnmd transgen mice lipogen gene upregul ewat ucp1 brown fat liver triglycerid accumul attenu despit expand ewat transgen anim display improv system insulin sensit decreas collagen deposit inflamm ewat increas insulin stimul akt phosphoryl data suggest tnmd act protect factor viscer adipos tissu allevi insulin resist obes',\n",
       "  'evid limit human lifespan driven technolog progress human life expect increas greatli sinc nineteenth centuri demograph evid reveal ongo reduct old-ag mortal rise maximum age death may gradual extend human longev togeth observ lifespan variou anim speci flexibl increas genet pharmaceut intervent result led suggest longev may subject strict species-specif genet constraint analys global demograph data show improv surviv age tend declin age 100 age death world ’ oldest person increas sinc 1990 result strongli suggest maximum lifespan human fix subject natur constraint',\n",
       "  'effect oral semaglutid compar placebo subcutan semaglutid glycem control patient type 2 diabet random clinic trial import glucagon-lik peptide-1 glp-1 receptor agonist effect therapi treatment type 2 diabet current avail inject object compar effect oral semaglutid placebo primari open-label subcutan semaglutid secondari glycem control patient type 2 diabet design set patient phase 2 random parallel-group dosage-find 26-week trial 5-week follow-up 100 site hospit clinic gener practic clinic research center 14 countri conduct decemb 2013 decemb 2014. 1106 particip assess 632 type 2 diabet insuffici glycem control use diet exercis alon stabl dose metformin random random stratifi metformin use intervent once-daili oral semaglutid 2.5 mg n 70 5 mg n 70 10 mg n 70 20 mg n 70 40-mg 4-week dose escal standard escal n 71 40-mg 8-week dose escal slow escal n 70 40-mg 2-week dose escal fast escal n 70 oral placebo n 71 double-blind once-weekli subcutan semaglutid 1.0 mg n 70 26 week main outcom measur primari end point chang hemoglob a1c hba1c baselin week 26. secondari end point includ chang baselin bodi weight advers event result baselin characterist compar across treatment group 632 random patient mean age 57.1 year sd 10.6 men 395 62.7 diabet durat 6.3 year sd 5.2 bodi weight 92.3 kg sd 16.8 bmi 31.7 sd 4.3 583 92 complet trial mean chang hba1c level baselin week 26 decreas oral semaglutid dosage-depend rang −0.7 −1.9 subcutan semaglutid −1.9 placebo −0.3 oral semaglutid reduct signific vs placebo dosage-depend estim treatment differ etd rang oral semaglutid vs placebo –0.4 –1.6 p .01 2.5 mg .001 dosag reduct bodi weight greater oral semaglutid dosage-depend rang −2.1 kg −6.9 kg subcutan semaglutid −6.4 kg vs placebo −1.2 kg signific oral semaglutid dosag 10 mg vs placebo dosage-depend etd rang –0.9 –5.7 kg p .001 advers event report 63 86 371 490 patient oral semaglutid group 81 56 69 patient subcutan semaglutid group 68 48 71 patient placebo group mild moder gastrointestin event common conclus relev among patient type 2 diabet oral semaglutid result better glycem control placebo 26 week find support phase 3 studi assess longer-term clinic outcom well safeti trial registr clinicaltrials.gov identifi nct01923181',\n",
       "  'fast accur short read align burrows–wheel transform motiv enorm amount short read gener new dna sequenc technolog call develop fast accur read align program first gener hash table-bas method develop includ maq accur featur rich fast enough align short read singl individu howev maq support gap align single-end read make unsuit align longer read indel may occur frequent speed maq also concern align scale resequenc hundr individu result implement burrows-wheel align tool bwa new read align packag base backward search burrows-wheel transform bwt effici align short sequenc read larg refer sequenc human genom allow mismatch gap bwa support base space read e.g illumina sequenc machin color space read ab solid machin evalu simul real data suggest bwa approxim 10-20x faster maq achiev similar accuraci addit bwa output align new standard sam sequenc alignment/map format variant call downstream analys align achiev open sourc samtool softwar packag avail http //maq.sourceforge.net',\n",
       "  \"financi cost doctor emigr sub-saharan africa human capit analysi object estim lost invest domest educ doctor migrat sub-saharan african countri australia canada unit kingdom unit state design human capit cost analysi use publicli access data set sub-saharan african countri particip nine sub-saharan african countri hiv preval 5 greater one million peopl hiv/aid least one medic school ethiopia kenya malawi nigeria south africa tanzania uganda zambia zimbabw data avail number doctor practis destin countri main outcom measur financi cost educ doctor primari secondari medic school assum migrat occur graduat use current countri specif interest rate save convert us dollar cost accord number sourc countri doctor current work destin countri save destin countri receiv train doctor result nine sourc countri estim govern subsidis cost doctor 's educ rang 21,000 £13,000 €15,000 uganda 58,700 south africa overal estim loss return invest doctor current work destin countri 2.17bn 95 confid interv 2.13bn 2.21bn cost countri rang 2.16m 1.55m 2.78m malawi 1.41bn 1.38bn 1.44bn south africa ratio estim compound lost invest gross domest product show zimbabw south africa largest loss benefit destin countri recruit train doctor largest unit kingdom 2.7bn unit state 846m conclus among sub-saharan african countri affect hiv/aid lost invest emigr doctor consider destin countri consid invest measur train sourc countri strengthen health system\",\n",
       "  'chromatin modifi enzym modul reprogram gener induc pluripot stem cell ipsc somat cell reprogram involv global epigenet remodel wherea sever protein known regul chromatin mark associ distinct epigenet state cell reprogram role specif chromatin-modifi enzym reprogram remain determin address chromatin-modifi protein influenc reprogram use short hairpin rna shrna target gene dna histon methyl pathway identifi posit neg modul ipsc gener wherea inhibit core compon polycomb repress complex 1 2 includ histon 3 lysin 27 methyltransferas ezh2 reduc reprogram effici suppress suv39h1 yy1 dot1l enhanc reprogram specif inhibit h3k79 histon methyltransferas dot1l shrna small molecul acceler reprogram significantli increas yield ipsc coloni substitut klf4 c-myc also known myc inhibit dot1l earli reprogram process associ mark increas two altern factor nanog lin28 play essenti function role enhanc reprogram genome-wid analysi h3k79me2 distribut reveal fibroblast-specif gene associ epitheli mesenchym transit lose h3k79me2 initi phase reprogram dot1l inhibit facilit loss mark gene fate repress pluripot state find implic specif chromatin-modifi enzym barrier facilit reprogram demonstr modul chromatin-modifi enzym exploit effici gener ipsc fewer exogen transcript factor',\n",
       "  'natur variat paramet innat immun cell preferenti driven genet factor quantif character circul immun cell provid key indic human health diseas identifi rel effect environment genet factor variat paramet innat adapt immun cell homeostat condit combin standard flow cytometri blood leukocyt genome-wid dna genotyp 1,000 healthi unrel peopl western european ancestri found smoke togeth age sex latent infect cytomegaloviru main non-genet factor affect variat paramet human immun cell genome-wid associ studi 166 immunophenotyp identifi 15 loci show enrich disease-associ variant final demonstr paramet innat cell strongli control genet variat adapt cell driven mainli environment exposur data establish resourc gener new hypothes immunolog highlight role innat immun suscept common autoimmun diseas environment factor genet factor influenc human immun albert colleagu leverag data milieu intérieur consortium comprehens describ effect lifestyl environ genet human innat adapt immun',\n",
       "  'transcript program function heterogen clinic target mast cell mast cell uniqu tissue-resid immun cell express array receptor activ sever extracellular cue includ antigen-immunoglobulin e ige complex bacteria virus cytokin hormon peptid drug mast cell constitut small popul tissu extraordinari abil respond rapidli releas granule-stor newli made mediat underpin import health diseas review document biolog mast cell introduc new concept opinion regard role human diseas beyond ige-medi allerg respons antiparasit function bring light recent discoveri develop mast cell research includ regul mast cell function differenti surviv novel mous model final highlight current futur opportun therapeut intervent mast cell function inflammatori diseas',\n",
       "  'lin28b enhanc tumorigenesi autochthon krasg12v-driven lung carcinoma mous model lin28b rna-bind protein regul predominantli let-7 microrna essenti function inflamm wound heal embryon stem cell cancer lin28b express associ tumor initi progress resist poor outcom sever solid cancer includ lung cancer howev function role lin28b especi non-smal cell lung adenocarcinoma remain elus investig effect lin28b express lung tumorigenesi use lin28b transgen overexpress autochthon krasg12v-driven mous model found lin28b overexpress significantli increas number cd44+/cd326+ tumor cell upregul vegf-a mir-21 promot tumor angiogenesi epithelial-to-mesenchym transit emt accompani enhanc akt phosphoryl nuclear transloc c-myc moreov lin28b acceler tumor initi enhanc prolifer led shorten overal surviv addit analyz lung adenocarcinoma cancer genom atla tcga found lin28b express 24 kras-mut case underscor relev model',\n",
       "  'cost-effect comparison topic silver sulfadiazin enclos silver dress partial-thick burn treatment standard treatment partial-thick burn includ topic silver product silver sulfadiazin ssd cream enclos dress includ silver-impregn foam mepilex ag molnlyck health care gothenburg sweden silver-laden sheet aquacel ag convatec skillman nj current state health care limit resourc emphasi evidence-bas outcom cost-effect treatment studi includ decis analysi increment cost-util ratio compar enclos silver dress ssd partial-thick burn patient tbsa less 20 comprehens literatur review conduct identifi clinic relev health state partial-thick burn patient health state includ success heal infect noninfect delay heal requir either surgeri conserv manag probabl health state combin medicar cpt reimburs code cost patient-deriv util fit decis model util obtain use visual analog scale patient interview expect cost quality-adjust life year qali calcul use roll-back method increment cost-util ratio enclos silver dress rel ssd 40,167.99/qali one-way sensit analysi complic rate confirm robust model assum maximum willing pay 50,000/qali complic rate ssd must 22 higher enclos silver dress cost effect vari complic rate ssd enclos silver dress two-way sensit analysi demonstr cost effect use enclos silver dress major complic rate treatment modal enclos silver dress cost-effect mean treat partial thick burn',\n",
       "  'random clinic studi hydrofib dress silver silver sulfadiazin manag partial-thick burn prospect random studi compar protocol care use either aquacel ag hydrofib convatec bristol-my squibb compani skillman nj dress silver n 42 silver sulfadiazin n 42 21 day manag partial-thick burn cover 5 40 bodi surfac area bsa aquacel ag dress associ less pain anxieti dress chang less burn sting wear fewer dress chang less nurs time fewer procedur medic silver sulfadiazin associ greater flexibl eas movement advers event includ infect compar treatment group aquacel ag dress protocol tend lower total treatment cost dollar 1040 vs. dollar 1180 greater rate re-epitheli 73.8 vs 60.0 result cost-effect per burn heal dollar 1,409.06 aquacel ag dress dollar 1,967.95 silver sulfadiazin protocol care aquacel r ag provid clinic econom benefit compar silver sulfadiazin patient partial-thick burn',\n",
       "  \"hepat c viru blood transfus past present risk risk hcv transmiss blood blood product greatli reduc sinc earli 1980 's select non-remuner donor donor select prevent hiv transmiss initi surrog test region introduct anti-hcv test contribut alt surrog test becom obsolet sinc introduct anti-hcv test residu risk hcv transmiss due donat anti-hcv window period present 1 100 000 transfus cellular product transmiss hcv plasma product treat modern inactiv method solvent-deterg treatment report hemovigil programm present instal provid data safeti blood transfus introduct hcv nucleic amplif technolog nat qualiti control manufactur pool plasma product form blood donor screen minipool anticip mani european countri come year given industri develop nat test individu blood donat may becom avail within next 2 year hcv nat test annihil residu risk cost-effect becom rel low comparison public health measur\",\n",
       "  'p62/sqstm1 bind vitamin receptor inhibit hepat stellat cell activ fibrosi liver cancer hepat stellat cell hsc play critic role liver fibrosi hepatocellular carcinoma hcc vitamin receptor vdr activ hsc inhibit liver inflamm fibrosi found p62/sqstm1 protein upregul liver parenchym cell downregul hcc-associ hsc neg control hsc activ total bodi hsc-specif p62 ablat potenti hsc enhanc inflamm fibrosi hcc progress p62 directli interact vdr rxr promot heterodimer critic vdr rxr target gene recruit loss p62 hsc impair repress fibrosi inflamm vdr agonist demonstr p62 neg regul liver inflamm fibrosi abil promot vdr signal hsc whose activ support hcc',\n",
       "  \"develop criteria evalu geroprotector key stage toward translat clinic come decad massiv shift age segment popul major social econom consequ around world one way offset increas expedit develop geroprotector substanc slow age repair age-associ damag extend healthi lifespan healthspan 200 geroprotector report model organ human use specif diseas indic path toward determin whether affect age human remain obscur translat clinic hamper multipl issu includ absenc common set criteria defin select classifi substanc given complex age process enorm divers mechan action translat research effort would benefit format scientif consensu follow definit 'geroprotector select criteria geroprotector comprehens classif system analyt model review current approach select put forth suggest select criteria standard select geroprotector streamlin discoveri analysi new candid save time cost involv translat clinic\",\n",
       "  'β-catenin signal role liver homeostasi injuri tumorigenesi β-catenin encod ctnnb1 subunit cell surfac cadherin protein complex act intracellular signal transduc wnt signal pathway alter activ associ develop hepatocellular carcinoma liver diseas wnt addit signal pathway also converg β-catenin β-catenin also interact transcript factor t-cell factor forkhead box protein hypoxia induc factor 1α regul express target gene discuss role β-catenin metabol zonat adult liver β-catenin also regul express gene control metabol glucos nutrient xenobiot alter activ may contribut pathogenesi nonalcohol steatohepat alter β-catenin signal may lead activ hepat stellat cell requir fibrosi mani hepat tumor hepatocellular adenoma hepatocellular cancer hepatoblastoma mutat ctnnb1 result constitut activ β-catenin molecul could therapeut target discuss alter β-catenin activ contribut liver diseas might use diagnosi prognosi well develop therapeut',\n",
       "  'global burden dengu analysi global burden diseas studi 2013. background dengu common arboviru infect global burden poorli quantifi estim dengu mortal incid burden global burden diseas studi 2013. method model mortal vital registr verbal autopsi surveil data use caus death ensembl model tool model incid offici report case adjust raw estim under-report base publish estim expans factor total 1780 country-year mortal data 130 countri 1636 country-year dengu case report 76 countri expans factor estim 14 countri find estim averag 9221 dengu death per year 1990 2013 increas low 8277 95 uncertainti estim 5353-10 649 1992 peak 11 302 6790-13 722 2010. yield total 576 900 330 000-701 200 year life lost prematur mortal attribut dengu 2013. incid dengu increas greatli 1990 2013 number case doubl everi decad 8·3 million 3·3 million-17·2 million appar case 1990 58·4 million 23·6 million-121·9 million appar case 2013. account disabl moder sever acut dengu post-dengu chronic fatigu 566 000 186 000-1 415 000 year live disabl attribut dengu 2013. consid fatal non-fat outcom togeth dengu respons 1·14 million 0·73 million-1·98 million disability-adjust life-year 2013. interpret although lower estim result offer evid true symptomat incid dengu probabl fall within commonli cite rang 50 million 100 million case per year mortal estim lower present elsewher consid light total evid suggest dengu mortal might fact substanti higher fund bill melinda gate foundat',\n",
       "  'formin-medi actin polymer cell–cel junction stabil e-cadherin maintain monolay integr wound repair cadherin-medi cell-cel adhes requir epitheli tissu integr homeostasi develop tissu repair e-cadherin stabil depend f-actin mechan regul actin polymer cell-cel junction remain poorli understood investig role formin-medi actin polymer cell-cel junction identifi mdia1 fmnl3 major factor enhanc actin polymer stabil e-cadherin epitheli junction fmnl3 local adheren junction downstream src cdc42 deplet lead reduct f-actin e-cadherin junction weaken cell-cel adhes import fmnl3 express up-regul junction local increas collect cell migrat deplet fmnl3 mdia1 migrat monolay result dissoci leader cell impair wound repair summari result show formin activ epitheli cell-cel junction import adhes mainten epitheli cohes dynam process wound repair',\n",
       "  'mechan activ heterotyp e-cadherin/n-cadherin adhes enabl fibroblast drive cancer cell invas cancer-associ fibroblast caf promot tumour invas metastasi show caf exert physic forc cancer cell enabl collect invas forc transmiss mediat heterophil adhes involv n-cadherin caf membran e-cadherin cancer cell membran adhes mechan activ subject forc trigger β-catenin recruit adhes reinforc depend α-catenin/vinculin interact impair e-cadherin/n-cadherin adhes abrog abil caf guid collect cell migrat block cancer cell invas n-cadherin also mediat repolar caf away cancer cell parallel nectin afadin recruit cancer cell/caf interfac caf repolar afadin depend heterotyp junction caf cancer cell observ patient-deriv materi togeth find show mechan activ heterophil adhes caf cancer cell enabl cooper tumour invas',\n",
       "  'long non-cod rna hottip promot bcl-2 express induc chemoresist small cell lung cancer spong mir-216a despit progress treatment small cell lung cancer sclc multidrug chemoresist poor prognosi still remain recent global assess long non-cod rna lncrna contribut sclc chemoresist use microarray data vitro vivo assay report hottip encod lncrna frequent amplifi sclc associ sclc cell chemosensit prolifer poor prognosi sclc patient moreov mechanist investig show hottip function oncogen sclc progress bind mir-216a abrog tumor-suppress function set hand hottip increas express anti-apoptot factor bcl-2 anoth import target gene mir-216a jointli enhanc chemoresist sclc regul bcl-2 taken togeth studi establish role hottip sclc progress chemoresist suggest candidaci new diagnost prognost biomark clinic manag sclc',\n",
       "  'gsd 2.0 upgrad gene featur visual server unlabel visual gene structur annot featur help biologist investig function evolut intuit gene structur display server gsd wide use 60 000 user sinc first public 2007. report upgrad gsd 2.0 newli design interfac support type annot featur format well integr visual editor edit gener figur moreov user-specifi phylogenet tree ad facilit evolutionari analysi full sourc code also avail download avail implement web server sourc code freeli avail http //gsds.cbi.pku.edu.cn contact gaog mail.cbi.pku.edu.cn gsd mail.cbi.pku.edu.cn supplementari inform supplementari data avail bioinformat onlin',\n",
       "  'slp-65 regul immunoglobulin light chain gene recombin pi 3 k-pkb-foxo pathway although essenti role adaptor protein slp-65 pre-b cell differenti establish molecular mechan underli function poorli understood studi uncov link slp-65–depend signal phosphoinositide-3-oh kinas pi 3 k –protein kinas b pkb –foxo pathway show forkhead box transcript factor foxo3a promot light chain rearrang pre-b cell data suggest pkb suppress light chain recombin phosphoryl foxo protein wherea reconstitut slp-65 function counteract pkb activ promot foxo3a foxo1 activ pre-b cell togeth data illumin molecular function slp-65 identifi key role foxo protein regul light chain recombin receptor edit b cell select',\n",
       "  'case-mix classif system explain healthcar cost use administr data itali background italian nation health servic nh provid univers coverag citizen grant primari hospit care copay system outpati drug servic financ local health trust lht base capit system adjust age gender area resid appli risk-adjust system john hopkin adjust clinic group system acg® system order explain health care cost use routin collect administr data veneto region north-eastern itali method resid veneto region includ studi acg system appli classifi region popul base follow inform sourc year 2015 hospit discharg emerg room visit chronic diseas registri copay exempt ambulatori visit medic home care databas drug prescript simpl linear regress use contrast age-gend model model incorpor comprehens risk measur aim predict health care cost result simpl age-gend model explain 8 varianc 2015 total cost ad diagnoses-rel variabl provid 23 increas pharmaci base variabl provid addit 17 increas explain varianc adjust r-squar comprehens model 6 time simpl age-gend model conclus acg system provid substanti improv predict health care cost compar simpl age-gend adjust age main determin increas health care cost better explain accumul chronic condit result multimorbid',\n",
       "  'epcam-regul intramembran proteolysi induc cancer stem cell-lik gene signatur hepat b virus-infect hepatocyt background aim hepatocyt hepat b viru hbv replic exhibit loss chromatin modifi polycomb repress complex 2 prc2 result re-express specif cellular prc2-repress gene epitheli cell adhes molecul epcam prc2-repress gene normal express hepat progenitor re-express hepat cancer stem cell hcsc herein investig function signific epcam re-express hbv-mediat hepatocarcinogenesi method employ molecular approach transfect fluorescence-activ cell sort immunoblot qrt-pcr investig role epcam-regul intramembran proteolysi rip hbv replic cell vitro liver tumor hbv x/c-myc mice chronic hbv infect patient result epcam undergo rip hbv replic cell activ canon wnt signal transfect wnt-respons plasmid express green fluoresc protein gfp identifi gfp popul hbv replic cell gfp+/wnt+ cell exhibit cisplatin- sorafenib-resist growth resembl hcsc increas express pluripot gene nanog oct4 sox2 hcsc marker bambi cd44 cd133 gene refer epcam rip wnt-induc hcsc-like gene signatur interestingli gene signatur also overexpress liver tumor x/c-myc bitransgen mice clinic group hbv-associ hepatocellular carcinoma identifi exhibit elev express hcsc-like gene signatur associ reduc overal surviv post-surg resect conclus hcsc-like gene signatur offer promis prognost tool classifi subtyp hbv-induc hcc sinc epcam rip wnt signal drive express hcsc-like signatur inhibit pathway explor therapeut strategi subtyp hbv-associ hcc lay summari studi provid evid molecular mechan chronic infect hepat b viru result develop poor prognosi liver cancer base mechan result suggest possibl therapeut intervent',\n",
       "  \"parathyroid hormon direct bone marrow mesenchym cell fate intermitt pth administr build bone mass prevent fractur mechan action unclear genet delet pth/pthrp receptor pth1r mesenchym stem cell use prx1cre found low bone format increas bone resorpt high bone marrow adipos tissu bmat bone marrow adipocyt trace prx1 express classic adipogen marker high receptor activ nuclear factor kappa b ligand rankl express rankl level also elev bone marrow supernat serum undetect adipos depot cell sort pref1+rankl+ marrow progenitor twice great mutant versu control marrow intermitt pth administr control mice reduc bmat significantli similar find note male osteoporot patient thu marrow adipocyt exhibit osteogen adipogen characterist uniqu respons pth secret rankl studi reveal import mechan pth 's therapeut action abil direct mesenchym cell fate\",\n",
       "  'metformin attenu blood-brain barrier disrupt mice follow middl cerebr arteri occlus background metformin wide use hypoglycem drug reduc stroke incid allevi chronic inflamm clinic trial howev effect metformin ischem stroke unclear investig effect metformin ischem stroke mice explor possibl underli mechan method ninety-eight adult male cd-1 mice underw 90-minut transient middl cerebr arteri occlus tmcao metformin 200 mg/kg administr 14 day neurobehavior outcom brain infarct volum inflammatori factor blood-brain barrier bbb permeabl ampk signal pathway evalu follow tmcao oxygen glucos depriv perform bend.3 cell explor mechan metformin inhibit inflammatori signal pathway result infarct volum reduc metformin-tr mice compar control group follow tmcao p 0.05 neurobehavior outcom greatli improv metformin-tr mice p 0.05 mpo+ cell gr1+ cell mpo activ bbb permeabl decreas metformin administr p 0.05 addit metformin activ ampk phosphoryl inhibit nf-κb activ down-regul cytokin il-1β il-6 tnf-α icam-1 express follow tmcao p 0.05 furthermor metformin activ ampk signal pathway allevi oxygen-glucos deprivation-induc icam-1 express bend.3 cell p 0.05 compound c select ampk inhibitor elimin promot effect conclus metformin down-regul icam-1 ampk-depend manner could effect prevent ischemia-induc brain injuri allevi neutrophil infiltr suggest metformin promis therapeut agent stroke therapi',\n",
       "  'epstein-barr viru nuclear antigen 1 ebna1 confer resist apoptosi ebv-posit b-lymphoma cell up-regul survivin resist apoptosi import compon overal mechan drive tumorigen process ebv ubiquit human gamma-herpesviru preferenti establish latent infect viral infect b-lymphocyt ebna1 typic express form ebv-posit malign import replic latent episom concert replic host cell investig effect ebna1 survivin up-regul ebv-infect human b-lymphoma cell present evid demonstr ebna1 form complex sp1 sp1-like protein bound cis-el survivin promot enhanc activ complex up-regul survivin knockdown survivin ebna1 show enhanc apoptosi infect cell thu support role ebna1 suppress apoptosi ebv-infect cell suggest ebv encod ebna1 contribut oncogen process up-regul apoptosi suppressor protein survivin ebv-associ b-lymphoma cell',\n",
       "  \"microfluid platform evalu migrat cell patient dyt1 dystonia background microfluid platform quantit evalu cell biolog process allow low cost time effici research studi biolog patholog event monitor cell migrat real-tim imag healthi diseas state cell migrat crucial develop wound heal well maintain bodi 's homeostasi new method microfluid chamber allow precis measur investig whether fibroblast carri mutat tor1a gene underli hereditari neurolog diseas -- dyt1 dystonia decreas migrat properti compar control cell result observ fibroblast dyt1 patient show abnorm basic featur cell migrat reduc veloc persist movement comparison exist method microfluid method enabl us demonstr reduc polar nucleu abnorm orient nuclei golgi insid move dyt1 patient cell compar control cell well vectori movement singl cell conclus report differ assay use determin variou paramet cell migrat dyt1 patient cell consequ tor1a gene mutat includ microfluid platform provid mean evalu real-tim vectori movement singl cell resolut three-dimension environ\",\n",
       "  'sugar-sweeten beverag weight gain children adult systemat review meta-analysi background relat sugar-sweeten beverag ssb bodi weight remain controversi object conduct systemat review meta-analysi summar evid children adult design search pubm embas cochran databas march 2013 prospect cohort studi random control trial rct evalu ssb-weight relat separ meta-analys conduct children adult cohort rct use random- fixed-effect model result thirty-two origin articl includ meta-analys 20 children 15 cohort studi n 25,745 5 trial n 2772 12 adult 7 cohort studi n 174,252 5 trial n 292 cohort studi one daili serv increment ssb associ 0.06 95 ci 0.02 0.10 0.05 95 ci 0.03 0.07 -unit increas bmi children 0.22 kg 95 ci 0.09 0.34 kg 0.12 kg 95 ci 0.10 0.14 kg weight gain adult 1 random- fixed-effect model respect rct children show reduct bmi gain ssb reduc random fix effect -0.17 95 ci -0.39 0.05 -0.12 95 ci -0.22 -0.2 wherea rct adult show increas bodi weight ssb ad random fix effect 0.85 kg 95 ci 0.50 1.20 kg sensit analys rct children show pronounc benefit prevent weight gain ssb substitut trial compar school-bas educ program among overweight children compar normal-weight children conclus systemat review meta-analysi prospect cohort studi rct provid evid ssb consumpt promot weight gain children adult',\n",
       "  'tumorigen potenti pluripot stem cell minim human pluripot stem cell hpsc potenti fundament chang way go treat understand human diseas despit extraordinari potenti cell also innat capabl form tumor immunocompromis individu introduc pluripot state although current therapeut strategi involv transplant differenti hpsc deriv still concern transplant cell popul could contain small percentag cell fulli differenti addit cell frequent report acquir genet alter case associ certain type human cancer tri separ panic realiti ration evalu true tumorigen potenti cell also discuss recent studi examin effect cultur condit genet integr hpsc final present set sensibl guidelin minim tumorigen potenti hpsc-deriv cell © 2016 author insid cell publish wiley period inc',\n",
       "  'epidemiolog sepsi septic shock critic care unit comparison sepsis-2 sepsis-3 popul use nation critic care databas background new sepsi septic shock definit could chang epidemiolog sepsi differ criteria therefor compar sepsi popul identifi old new definit method use high-qual nation intens care unit icu databas 654 918 consecut admiss 189 adult icu england januari 2011 decemb 2015. primari outcom acut hospit mortal compar old sepsis-2 new sepsis-3 incid outcom trend outcom predict valid sepsi septic shock popul result among 197 724 sepsis-2 sever sepsi 197 142 sepsis-3 sepsi case identifi 153 257 sepsis-2 septic shock 39 262 sepsis-3 septic shock case extrapol popul incid sepsis-3 sepsi sepsis-3 septic shock 101.8 19.3 per 100 000 person-year respect 2015. sepsis-2 sever sepsi sepsis-3 sepsi similar incid similar mortal show signific risk-adjust improv mortal time sepsis-3 septic shock much higher acut physiolog chronic health evalu ii apach ii score greater mortal risk-adjust trend mortal improv compar sepsis-2 septic shock icu admiss identifi either sepsis-3 sepsi septic shock sepsis-2 sever sepsi septic shock significantli greater risk-adjust odd death compar non-sepsi admiss p 0.001 predict valid greatest sepsis-3 septic shock conclus icu databas compar sepsis-2 sepsis-3 identifi similar sepsi popul 92 overlap much smaller septic shock popul improv predict valid',\n",
       "  'thymic express golli-myelin basic protein gene sjl/j mous cell antigen-specif repertoir thought shape thymic express self molecul sinc myelin basic protein mbp -like gene golli-mbp report express cell immun system present studi undertaken determin whether golli-mbp gene express mous thymu character transcript gene organ use exon-specif primer mbp golli-mbp cdna thymu tissu amplifi amplifi product analyz southern blot exon-specif oligonucleotid probe amplifi product subclon insert character dna sequenc thymic transcript found contain golli-mbp exon 1 2 3 5a 5b 5c 6 7 8 11',\n",
       "  'urin microrna biomark bladder cancer diagnost meta-analysi background diagnost valu microrna mirna detect patient bladder cancer bca controversi perform diagnost meta-analysi evalu current evid use mirna assay diagnos bca method systemat search pubm embas web scienc studi publish march 31 2015. pool sensit specif posit neg likelihood ratio diagnost odd ratio area curv auc calcul evalu overal test perform subgroup analys use explor between-studi heterogen deek funnel plot asymmetri test use test public bia appli softwar revman 5.2 stata 11.0 meta-analysi result total 23 studi nine articl includ meta-analysi total 719 patient 494 control pool sensit specif 0.75 95 confid interv ci 0.68-0.80 0.75 95 ci 0.70-0.80 respect pool posit likelihood ratio 3.03 95 ci 2.50-3.67 neg likelihood ratio 0.33 95 ci 0.27-0.42 diagnost odd ratio 9.07 95 ci 6.35-12.95 pool auc 0.81 95 ci 0.78-0.85 subgroup analys indic multipl mirna assay urin supernat assay show high accuraci diagnos bca conclus mirna assay may serv potenti noninvas diagnost tool detect bca howev clinic applic mirna assay bca diagnosi still need valid larg prospect studi',\n",
       "  'elev plasma transform growth factor bgr 1 level predict develop hypertens normotens 14-year follow-up studi background transform growth factor β1 tgf-β1 multifunct cytokin grow evid tgf-β1 involv pathogenesi hypertens develop target organ damag hypertens although sever studi shown tgf-β1 induc vascular hypertrophi remodel variou vascular diseas longitudin data hypertens epidemiolog studi present studi test hypothesi whether elev tgf-β1 level predict develop hypertens method 2002-2004 528 subject receiv health examin uku town southwestern japan examin blood pressur bp bodi mass index blood test data fast plasma tgf-β1 obtain 528 individu 149 normotens bp 140/90 mm hg without antihypertens medic baselin followed-up 14 year result receiver-oper characterist curv use calcul cutoff valu 8.9 ng/ml 149 normotens baselin 59 subject develop hypertens plasma tgf-β1 level significantli associ develop hypertens adjust confound factor examin associ perform logist regress analysi divid baselin plasma tgf-β1 level 2 group use cutoff valu signific high odd ratio 3.582 95 confid interv 1.025-12.525 develop hypertens found highest group tgf-β1 level vs. lowest group adjust confound conclus first report demonstr causal relationship elev plasma tgf-β1 level predict develop hypertens normotens popul community-dwel japanes',\n",
       "  \"myc disrupt circadian clock metabol cancer cell myc oncogen encod myc transcript factor bind genom site term e-box 5'-cacgtg-3 ident bind site heterodimer clock-bmal1 master circadian transcript factor henc hypothes ectop myc express perturb clock deregul e-box-driven compon circadian network cancer cell report deregul express myc n-myc disrupt molecular clock vitro directli induc rev-erbα dampen express oscil bmal1 could rescu knockdown rev-erb rev-erbα express predict poor clinic outcom n-myc-driven human neuroblastoma diminish bmal1 express re-express ectop bmal1 neuroblastoma cell line suppress clonogen ectop myc profoundli alter oscil glucos metabol perturb glutaminolysi result demonstr unsuspect link oncogen transform circadian metabol dysrhythmia surmis advantag cancer\",\n",
       "  'integr map quail coturnix japonica confirm high degre synteni conserv chicken gallu gallu despit 35 million year diverg backgroundbi compar quail genom chicken chromosom rearrang occur two galliform speci 35 million year evolut detect practic point view definit conserv synteni help predict posit gene quail base inform taken chicken sequenc thu enhanc util speci biolog studi better knowledg genom structur microsatellit amplifi fragment length polymorph aflp genet map previous publish quail well compar cytogenet data chicken macrochromosom quail genom benefit extens integr map resultsth integr linkag map present base segreg analysi anonym marker function gene loci 1,050 quail three independ f2 popul ninety-two loci resolv 14 autosom linkag group z chromosome-specif linkag group align quail aflp map size linkag group rang 7.8 cm 274.8 cm total map distanc cover 904.3 cm averag space 9.7 cm loci coverag complet macrochromosom cja08 gonosom cjaw 23 microchromosom marker assign yet signific sequenc ident quail marker chicken enabl align quail linkag group chicken genom sequenc assembl togeth interspecif fluoresc situ hybrid fish reveal high similar marker order two speci eight macrochromosom 14 microchromosom studi conclusionintegr two microsatellit aflp quail genet map greatli enhanc qualiti result inform thu facilit identif quantit trait loci qtl align chicken chromosom confirm high conserv gene order expect two speci macrochromosom extend compar studi microchromosom suggest wealth inform mine chicken use genom analys quail',\n",
       "  'cadherin activ requir activity-induc spine remodel neural activ induc remodel pre- postsynapt membran maintain apposit cell adhes molecul among n-cadherin redistribut undergo activity-depend conform chang requir synapt plastic show depolar induc enlarg width spine head cadherin activ essenti synapt rearrang dendrit spine visual green fluoresc protein hippocamp neuron show expans activ ampa receptor synapt apposit zone may expand n-cadherin-venu fusion protein later dispers along expand spine head overexpress dominant-neg form n-cadherin result abrog spine expans inhibit actin polymer cytochalasin abolish spine expans togeth data suggest cadherin-bas adhes machineri coupl actin-cytoskeleton critic remodel synapt apposit zone',\n",
       "  'aliskiren combin losartan type 2 diabet nephropathi background diabet nephropathi lead caus end-stag renal diseas develop countri evalu renoprotect effect dual blockad renin-angiotensin-aldosteron system ad treatment aliskiren oral direct renin inhibitor treatment maxim recommend dose losartan 100 mg daili optim antihypertens therapi patient hypertens type 2 diabet nephropathi method enrol 599 patient multin random double-blind studi 3-month open-label run-in period patient receiv 100 mg losartan daili patient randomli assign receiv 6 month treatment aliskiren 150 mg daili 3 month follow increas dosag 300 mg daili anoth 3 month placebo addit losartan primari outcom reduct ratio albumin creatinin measur early-morn urin sampl 6 month result baselin characterist two group similar treatment 300 mg aliskiren daili compar placebo reduc mean urinari albumin-to-creatinin ratio 20 95 confid interv 9 30 p 0.001 reduct 50 24.7 patient receiv aliskiren compar 12.5 receiv placebo p 0.001 small differ blood pressur seen treatment group end studi period systol 2 mm hg lower p=0.07 diastol 1 mm hg lower p=0.08 aliskiren group total number advers seriou advers event similar group conclus aliskiren may renoprotect effect independ blood-pressure-low effect patient hypertens type 2 diabet nephropathi receiv recommend renoprotect treatment clinicaltrials.gov number nct00097955 clinicaltrials.gov',\n",
       "  'overweight celiac diseas preval clinic characterist effect gluten-fre diet background well establish minor celiac patient present “ classic ” symptom due malabsorpt howev studi focuss distribut bodi mass index bmi celiac popul relationship clinic characterist respons treatment method review bmi measur clinic patholog characterist databas 371 celiac patient diagnos 10-yr period seen singl gastroenterologist assess respons gluten exclus compar bmi diagnosi 2 yr treatment patient serolog support dietari complianc result mean bmi 24.6 kg/m2 rang 16.3–43.5 seventeen patient 5 underweight bmi 18.5 211 57 normal 143 39 overweight bmi ≥25 includ 48 13 patient obes rang bmi ≥30.0 signific associ low bmi femal gender histori diarrhea reduc hemoglobin concentr reduc bone miner densiti bmd osteoporosi higher grade subtotal/tot villou atrophi patient compliant gluten-fre diet 81 gain weight 2 yr includ 82 initi overweight patient conclus celiac patient underweight diagnosi larg minor overweight less like present classic featur diarrhea reduc hemoglobin fail delay diagnosi celiac diseas may reflect lack awar larg subgroup increas weight alreadi overweight patient dietari gluten exclus potenti caus morbid gluten-fre diet convent prescrib need modifi accordingli',\n",
       "  \"structur studi four-mbt repeat protein mbtd1 background polycomb group pcg protein famili import development regul respect member function larg protein complex involv establish mainten transcript repress development control gene mbtd1 malign brain tumor domain-contain protein 1 one pcg protein mbtd1 contain four mbt repeat methodology/princip find determin crystal structur mbtd1 residu 130-566aa cover 4 mbt repeat 2.5 resolut x-ray crystallographi crystal structur mbtd1 reveal similar anoth four-mbt-repeat protein l3mbtl2 bind lower methyl lysin histon fluoresc polar experi confirm mbtd1 preferenti bind mono- di-methyllysin histon peptid like l3mbtl1 l3mbtl2 known mbt-peptid complex structur character date exhibit strong histon peptid sequenc select use `` caviti insert recognit mode '' recogn methyl lysin deepli buri methyl-lysin form extens interact protein peptid residu flank methyl-lysin form contact 1 nevertheless mutagenesi data base l3mbtl1 suggest histon peptid could bind mbt repeat orient conclus four mbt repeat mbtd1 exhibit asymmetr rhomboid architectur like mbt repeat protein character far mbtd1 bind mono- dimethyl lysin histon one four mbt repeat util semi-aromat cage enhanc version articl also view enhanc version text articl integr interact 3d represent anim transit pleas note web plugin requir access enhanc function instruct instal use web plugin avail text s1\",\n",
       "  'glutamin support pancreat cancer growth kras-regul metabol pathway cancer cell metabol depend distinguish normal counterpart among depend increas use amino acid glutamin fuel anabol process inde spectrum glutamine-depend tumour mechan wherebi glutamin support cancer metabol remain area activ investig report identif non-canon pathway glutamin use human pancreat ductal adenocarcinoma pdac cell requir tumour growth wherea cell use glutam dehydrogenas glud1 convert glutamine-deriv glutam α-ketoglutar mitochondria fuel tricarboxyl acid cycl pdac reli distinct pathway glutamine-deriv aspart transport cytoplasm convert oxaloacet aspart transaminas got1 subsequ oxaloacet convert malat pyruv ostens increas nadph/nadp ratio potenti maintain cellular redox state importantli pdac cell strongli depend seri reaction glutamin depriv genet inhibit enzym pathway lead increas reactiv oxygen speci reduct reduc glutathion moreov knockdown compon enzym seri reaction also result pronounc suppress pdac growth vitro vivo furthermor establish reprogram glutamin metabol mediat oncogen kra signatur genet alter pdac transcript upregul repress key metabol enzym pathway essenti pathway pdac fact dispens normal cell may provid novel therapeut approach treat refractori tumour',\n",
       "  \"cd4+ cell help guid format cd103+ lung-resid memori cd8+ cell influenza viral infect tissue-resid memori trm cell provid enhanc protect infect mucos site found cd4 cell import format function lung-resid cd8 cell influenza viru infect absenc cd4 cell cd8 cell display reduc express cd103 itga misloc away airway epithelia demonstr impair abil recruit cd8 cell lung airway upon heterosubtyp challeng cd4 cell-deriv interferon-γ necessari gener lung-resid cd103 cd8 trm cell furthermor express transcript factor t-bet increas `` unhelp '' lung trm cell reduct t-bet rescu cd103 express absenc cd4 cell help thu cd4 cell-depend signal import limit express t-bet allow develop cd103 cd8 trm cell lung airway follow respiratori infect\",\n",
       "  'inhibit apoptosi overcom stage-rel compat barrier chimera format mous embryo cell type advanc develop embryon stem cell episc fail contribut chimera inject pre-implantation-stag blastocyst appar inject cell undergo apoptosi show transient promot cell surviv express anti-apoptot gene bcl2 enabl episc sox17+ endoderm progenitor integr blastocyst contribut chimer embryo upon inject blastocyst bcl2-express episc contribut bodili tissu chimer anim sox17+ endoderm progenitor specif contribut region-specif fashion endoderm tissu addit bcl2 express enabl rat episc contribut mous embryon chimera therebi form interspeci chimera could surviv adulthood system therefor provid method overcom cellular compat issu typic restrict chimera format applic type approach could broaden use embryon chimera includ region-specif chimera basic development biolog research regen medicin',\n",
       "  'comput statist analys amino acid usag physico-chem properti twelv late embryogenesi abund protein class late embryogenesi abund protein leap ubiquit protein expect play major role desicc toler littl known structur function relationship scarciti 3-d structur leap previou build leapdb databas dedic leap plant organ led classif 710 leap 12 non-overlap class distinct properti use resourc numer physico-chem properti leap amino acid usag leap comput statist analyz reveal distinct featur class unpreced analysi allow rigor character 12 leap class differ also multipl structur physico-chem featur although leap predict intrins disord protein analysi indic leap class 7 pf03168 probabl leap class 11 pf04927 nativ fold protein studi thu provid detail descript structur properti protein famili open path toward leap structur function analysi final sinc leap class clearli character uniqu set physico-chem properti allow develop softwar predict protein leap',\n",
       "  'direct reprogram hepat myofibroblast hepatocyt vivo attenu liver fibrosi direct induct induc hepatocyt ihep fibroblast hold potenti strategi regen medicin shown cultur set describ vivo ihep format use transcript factor induct genet fate trace mous model chronic liver diseas show ectop express transcript factor foxa3 gata4 hnf1a hnf4a polycistron lentivir vector convert mous myofibroblast cell hepatocyt phenotyp vivo express set transcript factor p75 neurotrophin receptor peptid p75ntrp -tag adenoviru enabl gener hepatocyte-lik cell myofibroblast fibrot mous liver reduc liver fibrosi therefor abl convert pro-fibrogen myofibroblast liver hepatocyte-lik cell posit function benefit direct vivo reprogram approach may open new avenu treatment chronic liver diseas',\n",
       "  'epitheli mesenchym transit tgfβ-1 induct increas stem characterist primari non small cell lung cancer cell line background cancer stem cell csc hypothesi assert small subset cell within tumour capabl tumour initi sustain epithelial-mesenchym transit emt embryon development program often activ cancer invas metastasi aim studi shed light relationship emt csc use lc31 lung cancer primari cell line materi method a549 lc31 cell line treat 2 ng/ml tgfβ-1 30 day 80 day respect evalu emt morpholog chang assess light microscopi immunofluoresc cytometri follow marker cytokeratin e-cadherin cd326 epitheli marker cd90 vimentin mesenchym marker moreov rt-pcr slug twist β-catenin gene perform tgfβ-1 treat untreat lc31 cell line perform stem test pneumospher growth stem marker express oct4 nanog sox2 c-kit cd133 western blot cd133 tumorigen assay use nod/scid mice perform result tgfβ-1 treat lc31 cell line lost epitheli morpholog assum fibroblast-lik appear result obtain a549 cell line control immunofluoresc cytometri show up-regul vimentin cd90 down-regul cytocheratin e-cadherin cd326 tgfβ-1 treat lc31 a549 cell line slug twist β-catenin m-rna transcript up-regul tgfβ-1 treat lc31 cell line confirm emt cell line show also over-express oct4 nanog sox2 cd133 gene stem addit tgfβ-1 treat lc31 cell line increas pneumosphere-form capac tumours-form abil nod/scid mice detect conclus induct emt tgfβ-1 exposur primari lung cancer cell line result acquisit mesenchym profil express stem cell marker',\n",
       "  'dnmt3a dnmt3b associ enhanc regul human epiderm stem cell homeostasi genome-wid local function endogen dnmt3a dnmt3b adult stem cell unknown show human epiderm stem cell two protein bind histon h3k36me3-depend manner activ enhanc requir produc associ enhanc rna protein prefer super-enhanc associ gene either defin ectoderm lineag establish stem cell differenti state howev dnmt3a dnmt3b differ mechan enhanc regul dnmt3a associ p63 maintain high level dna hydroxymethyl center enhanc tet2-depend manner wherea dnmt3b promot dna methyl along bodi enhanc deplet either protein inactiv target enhanc profoundli affect epiderm stem cell function altogeth reveal novel function dnmt3a dnmt3b enhanc could contribut role diseas tumorigenesi',\n",
       "  'cdk inhibitor cancer therapi next pursuit drug inhibit cyclin-depend kinas cdk intens area research 15 year first-gener inhibitor flavopiridol cy-202 late-stag clinic trial far demonstr modest activ sever second-gener inhibitor clinic trial futur approach determin clinic benefit need incorpor lesson learn earli compound inform recent obtain genet analysi cdk preclin model discuss key concept consid valid clinic util cdk inhibitor cancer therapi',\n",
       "  'lipid desatur metabol marker therapeut target ovarian cancer stem cell lack sensit single-cel analysi tool limit character metabol activ cancer stem cell hyperspectral-stimul raman scatter imag singl live cell mass spectrometri analysi extract lipid report significantli increas level unsatur lipid ovarian cancer stem cell csc compar non-csc higher lipid unsatur level also detect csc-enrich spheroid compar monolay cultur ovarian cancer cell line primari cell inhibit lipid desaturas effect elimin csc suppress sphere format vitro block tumor initi capac vivo mechanist demonstr nuclear factor κb nf-κb directli regul express level lipid desaturas inhibit desaturas block nf-κb signal collect find reveal increas lipid unsatur metabol marker ovarian csc target csc-specif therapi',\n",
       "  'mesenchym inflamm drive genotox stress hematopoiet stem cell predict diseas evolut human pre-leukemia mesenchym nich cell may drive tissu failur malign transform hematopoiet system underli molecular mechan relev human diseas remain poorli defin show perturb mesenchym cell mous model pre-leukem disord shwachman-diamond syndrom sd induc mitochondri dysfunct oxid stress activ dna damag respons hematopoiet stem progenitor cell massiv parallel rna sequenc highli purifi mesenchym cell sd mous model rang human pre-leukem syndrom identifi p53-s100a8/9-tlr inflammatori signal common drive mechan genotox stress transcript activ signal axi mesenchym nich predict leukem evolut progression-fre surviv myelodysplast syndrom md princip leukemia predisposit syndrom collect find identifi mesenchym niche-induc genotox stress heterotyp stem progenitor cell inflammatori signal target determin diseas outcom human pre-leukemia',\n",
       "  'novel function set lipid-deriv mediat antiinflammatori action gener omega-3 fatti acid via cyclooxygenas 2–nonsteroid antiinflammatori drug transcellular process aspirin therapi inhibit prostaglandin biosynthesi without directli act lipoxygenas yet via acetyl cyclooxygenas 2 cox-2 lead bioactiv lipoxin lx epimer carbon 15 15-epi-lx also term aspirin-trigg lx atl report inflammatori exud mice treat ω-3 polyunsatur fatti acid aspirin asa gener novel array bioactiv lipid signal human endotheli cell upregul cox-2 treat asa convert c20:5 ω-3 18r-hydroxyeicosapentaeno acid hepe 15r-hepe use polymorphonuclear leukocyt gener separ class novel trihydroxy-contain mediat includ 5-seri 15r-lx5 5,12,18r-trihep new compound prove potent inhibitor human polymorphonuclear leukocyt transendotheli migrat infiltr vivo atl analogu 5,12,18r-trihep 18r-hepe acetaminophen indomethacin also permit 18r-hepe 15r-hepe gener recombin cox-2 well ω-5 ω-9 oxygen fatti acid act hematolog cell find establish new transcellular rout produc array bioactiv lipid mediat via cox-2–nonsteroid antiinflammatori drug–depend oxygen cell–cel interact impact microinflamm gener relat compound provid novel mechan therapeut benefit ω-3 dietari supplement may import inflamm neoplasia vascular diseas',\n",
       "  'cholesteryl ester transfer protein cetp polymorph affect mrna splice hdl level sex-depend cardiovascular risk polymorph around cholesteryl ester transfer protein cetp gene associ hdl level risk coronari arteri diseas cad respons therapi mechan action polymorph yet defin use mrna allel express splice isoform measur human liver tissu identifi genet variant affect cetp level allel cetp mrna express ratio 56 human liver strongli associ sever variant 2.5-7 kb upstream transcript start site e.g. rs247616 p 6.4 × 10 -5 allel frequenc 33 addit common altern splice cetp isoform lack exon 9 δ9 shown prevent cetp secret dominant-neg manner δ 9 express rang 10 48 total cetp mrna 94 liver increas format isoform exclus associ exon 9 polymorph rs5883-c p 6.8 × 10 -10 intron 8 polymorph rs9930761-t c 5.6 × 10 -8 high linkag disequilibrium allel frequenc 6-7 rs9930761 chang key splice branch point nucleotid intron 8 rs5883 alter exon splice enhanc sequenc exon 9.the effect polymorph evalu two clinic studi whitehal ii studi 4745 subject rs247616 rs5883t/rs9930761c independ associ increas hdl-c level male similar effect size rs247616 p 9.6 × 10 -28 rs5883 p 8.6 × 10 -10 adjust rs247616 independ multiethn us cohort hypertens subject cad invest-gen rs5883t/rs9930761c alon significantli associ increas incid mi stroke all-caus mortal male rs5883 2.36 ci 1.29-4.30 p 0.005 n 866 variant reach signific femal either studi similar earlier result link low cetp activ poor outcom male result suggest genet sex-depend cetp splice effect cardiovascular risk mechan independ circul hdl-c level',\n",
       "  '6-sulphat chondroitin posit influenc axon regener chondroitin sulphat proteoglycan cspg upregul glial scar inhibit axon regener via sulphat glycosaminoglycan gag chondroitin 6-sulphotransferase-1 c6st-1 upregul injuri lead increas 6-sulphat gag studi ask increas 6-sulphat gag respons increas inhibit within glial scar whether repres partial revers permiss embryon state domin 6-sulphat glycosaminoglycan gag use c6st-1 knockout mice ko studi post-injuri chang chondroitin sulphotransferas csst express effect chondroitin 6-sulphat central peripher axon regener cn injuri wild-typ anim wt show increas mrna c6st-1 c6st-2 c4st-1 ko upregul csst pn injuri wt upregul c6st-1 ko show upregul c6st-2 examin regener nigrostriat axon demonstr mild spontan axon regener wt ko show mani fewer regener axon axon retract wt howev pn repair median ulnar nerv led similar normal level axon regener wt ko function test plastic repair also show evid enhanc plastic ko result suggest upregul 6-sulphat gag injuri make extracellular matrix permiss axon regener balanc differ css microenviron around lesion site import factor determin outcom nervou system injuri',\n",
       "  'tissu mechan orchestr wnt-depend human embryon stem cell differenti regen medicin predic understand mechan regul develop appli condit direct stem cell fate embryogenesi guid cell-cel cell-matrix interact unclear physic cue influenc stem cell cultur use human embryon stem cell hesc examin whether mechan featur extracellular microenviron could differenti modul mesoderm specif found hydrogel-bas compliant matrix hesc accumul β-catenin cell-cel adhes show enhanc wnt-depend mesoderm differenti mechanist src-driven ubiquitin e-cadherin cbl-like ubiquitin ligas releas p120-catenin facilit transcript activ β-catenin initi reinforc mesoderm differenti contrast stiff hydrogel matrix hesc show elev integrin-depend gsk3 src activ promot β-catenin degrad inhibit differenti thu found mechan featur microenvironment matrix influenc tissue-specif differenti hesc alter cellular respons morphogen',\n",
       "  'predict perform quick sequenti organ failur assess score screen tool sepsi mortal intens care unit admiss patient febril neutropenia sepsis-3 quick sequenti organ failur assess qsofa score develop criteria use recogn patient may poor outcom studi perform evalu predict perform qsofa score screen tool sepsi mortal intens care unit icu admiss patient febril neutropenia fn also tri compar perform system inflammatori respons syndrom sir criteria multin associ support care cancer mascc score fn use prospect collect adult fn data registri qsofa sir score calcul retrospect use preexist data primari outcom develop sepsi secondari outcom icu admiss 28-day mortal 615 patient 100 develop sepsi 20 die 38 admit icu multivari analysi qsofa independ factor predict sepsi icu admiss howev compar mascc score area receiv oper curv qsofa lower qsofa show low sensit 0.14 0.2 0.23 high specif 0.98 0.97 0.97 predict sepsi 28-day mortal icu admiss perform qsofa score inferior mascc score preexist risk stratif tool use predict outcom patient fn',\n",
       "  'lin28 regul stem cell metabol convers prime pluripot rna-bind protein lin28a lin28b play critic role embryon develop tumorigenesi pluripot exact function poorli understood show like lin28a lin28b function effect nanog oct4 sox2 reprogram pluripot reactiv endogen lin28a lin28b loci requir maxim reprogram effici human fibroblast lin28b activ earli reprogram lin28a activ later transit bona fide induc pluripot stem cell ipsc murin cell lin28a lin28b facilit convers naiv prime pluripot proteom metabolom analysi highlight role lin28 maintain low mitochondri function associ prime pluripot regul one-carbon metabol nucleotid metabol histon methyl lin28 bind mrna protein import oxid phosphoryl modul protein abund thu lin28a lin28b play cooper role regul reprogram naive/prim pluripot stem cell metabol',\n",
       "  'genet drift compromis mitochondri replac nuclear transfer human oocyt replac mitochondria nuclear transfer oocyt two differ women emerg recent strategi prevent inherit mtdna diseas although experi human oocyt shown effect replac consequ small amount mtdna carryov studi suffici use human mitochondri replac stem cell line show even though low level heteroplasmi introduc human oocyt mitochondri carryov nuclear transfer often vanish sometim instead result mtdna genotyp drift revers origin genotyp comparison cell ident oocyte-deriv nuclear dna differ mtdna show either mtdna genotyp compat nucleu drift independ mitochondri function thu although function replac mitochondri genom possibl even low level heteroplasmi affect stabil mtdna genotyp compromis efficaci mitochondri replac',\n",
       "  'tal effector remot control gene activ tal transcript activator-lik effector constitut novel class dna-bind protein predict specif employ gram-neg plant-pathogen bacteria genu xanthomona transloc cocktail differ effector protein via type iii secret system t3ss plant cell serv virul determin insid plant cell tal local nucleu bind target promot induc express plant gene dna-bind specif tal determin central domain tandem repeat repeat confer recognit one base pair bp dna rearrang repeat modul allow design protein desir dna-bind specif summar tal specif encod first structur data first data site-specif tal nucleas',\n",
       "  'vascular heterogen special develop diseas blood lymphat vessel pervad almost bodi tissu numer essenti role physiolog diseas inner line network form singl layer endotheli cell special accord need tissu suppli wherea gener mechan blood lymphat vessel develop defin increas molecular precis studi process endotheli special remain mostli descript recent insight genet anim model illumin endotheli cell interact tissu environ provid paradigm vessel type- organ-specif endotheli differenti delin govern principl crucial understand tissu develop maintain function becom abnorm diseas',\n",
       "  'associ intracerebr hemorrhag among patient take non–vitamin k antagonist vs vitamin k antagonist oral anticoagul in-hospit mortal import although non–vitamin k antagonist oral anticoagul noac increasingli use prevent thromboembol diseas limit data noac-rel intracerebr hemorrhag ich object assess associ preced oral anticoagul use warfarin noac oral anticoagul oac in-hospit mortal among patient ich design set particip retrospect cohort studi 141 311 patient ich admit octob 2013 decemb 2016 1662 get guidelines–strok hospit exposur anticoagul therapi ich defin use oac within 7 day prior hospit arriv main outcom measur in-hospit mortal result among 141 311 patient ich mean sd age 68.3 15.3 year 48.1 women 15 036 10.6 take warfarin 4918 3.5 take noac preced ich 39 585 28.0 5783 4.1 take concomit singl dual antiplatelet agent respect patient prior use warfarin noac older higher preval atrial fibril prior stroke acut ich stroke sever measur nation institut health stroke scale significantli differ across 3 group median 9 interquartil rang 2-21 warfarin 8 2-20 noac 8 2-19 oac unadjust in-hospit mortal rate 32.6 warfarin 26.5 noac 22.5 oac compar patient without prior use oac risk in-hospit mortal higher among patient prior use warfarin adjust risk differ ard 9.0 97.5 ci 7.9 10.1 adjust odd ratio aor 1.62 97.5 ci 1.53 1.71 higher among patient prior use noac ard 3.3 97.5 ci 1.7 4.8 aor 1.21 97.5 ci 1.11-1.32 compar patient prior use warfarin patient prior use noac lower risk in-hospit mortal ard −5.7 97.5 ci −7.3 −4.2 aor 0.75 97.5 ci 0.69 0.81 differ mortal noac-treat patient warfarin-tr patient numer greater among patient prior use dual antiplatelet agent 32.7 vs 47.1 ard −15.0 95.5 ci −26.3 −3.8 aor 0.50 97.5 ci 0.29 0.86 among take agent without prior antiplatelet therapi 26.4 vs 31.7 ard −5.0 97.5 ci −6.8 −3.2 aor 0.77 97.5 ci 0.70 0.85 although interact p valu .07 statist signific conclus relev among patient ich prior use noac warfarin associ higher in-hospit mortal compar oac prior use noac compar prior use warfarin associ lower risk in-hospit mortal',\n",
       "  'elev red blood cell distribut width contribut poor prognosi patient undergo resect nonmetastat rectal cancer sever studi report elev red blood cell distribut width rdw associ poor prognosi differ kind cancer aim studi investig prognost role rdw patient undergo resect nonmetastat rectal cancer retrospect review databas 625 consecut patient underw cur resect nonmetastat rectal cancer institut januari 2009 decemb 2014. cutoff valu rdw calcul receiver-oper characterist curv result demonstr patient high rdw-cv group lower overal surviv os p .018 disease-fre surviv p .004 also observ patient high rdw-sd group associ significantli lower os p .033 wherea disease-fre surviv df significantli differ p .179 .in multivari analysi found elev rdw-cv associ poor df hazard ratio hr 1.56 p .010 rdw-sd predict wors os hr 1.70 p .009 .we confirm elev rdw independ prognost factor patient undergo resect nonmetastat rectal cancer intervent surveil might paid patient nonmetastat rectal cancer elev rdw valu futur',\n",
       "  'health worker cohort studi method studi design object examin differ health outcom associ specif lifestyl genet factor materi method march 2004 april 2006 sampl employe three differ health academ institut well famili member enrol studi provid inform consent baselin follow-up 2010-2013 particip complet self-administ questionnair physic examin provid blood sampl result total 10 729 particip age 6 94 year recruit baselin 70 femal 50 mexican social secur institut nearli 42 adult sampl overweight 20 obes conclus studi offer new insight diseas mechan prevent analysi risk factor inform larg sampl mexican',\n",
       "  'aberr pro-atri natriuret peptide/corin/natriuret peptid receptor signal present matern vascular endothelium preeclampsia object corin serin proteas convert pro-atri natriuret peptid pro-anp atrial natriuret peptid anp cardiac hormon regul salt-wat balanc blood pressur anp degrad natriuret peptid receptor npr studi determin aberr pro-anp/corin/npr signal present matern vascular system preeclampsia studi design matern venou blood obtain 197 pregnant women 84 normotens 16 complic chronic hypertens cht 11 mild 86 sever preeclampsia plasma corin pro-anp concentr measur enzyme-link immunosorb assay matern subcutan fat tissu obtain 12 pregnant women cesarean section deliveri 6 normotens 6 preeclampsia vascular anp receptor npr-a npr-b npr-c express examin immunostain paraffin embed subcutan fat tissu section result corin concentr significantli higher mild 2.78 ± 0.67 ng/ml p .05 sever 2.53 ± 0.18 ng/ml p .01 preeclampsia normotens 1.58 ± 0.08 ng/ml cht 1.55 ± 0.20 ng/ml group pro-anp concentr significantli higher cht 1.59 ± 0.53 ng/ml p .05 sever preeclampsia 1.42 ± 0.24 ng/ml p .01 normotens 0.48 ± 0.06 ng/ml mild preeclampsia 0.52 ± 0.09 ng/ml group anp npr-b express undetect matern vessel normotens preeclampt pregnanc reduc npr-a express increas npr-c express found matern vessel endothelium preeclampsia conclus anp vasodil npr-c clearanc receptor anp find upregul npr-c express suggest circul anp clearanc degrad increas preeclampsia result also suggest pro-anp/corin/npr signal domin vascular system preeclampsia',\n",
       "  'optimis strategi plasmodium falciparum malaria elimin cambodia primaquin mass drug administr artemisinin resist background malaria elimin requir varieti approach individu optim differ transmiss set recent field studi area low season transmiss south west cambodia demonstr dramat reduct malaria parasit preval follow mass drug administr mda high treatment coverag symptomat patient artemisinin-piperaquin plu primaquin studi employ multipl combin strategi unclear contribut made reduct malaria method find mathemat model fit trial result use assess effect variou compon intervent design optim elimin strategi explor interact artemisinin resist recent discov western cambodia model indic initi reduct p. falciparum malaria result mda artemisinin-piperaquin subsequ continu declin near elimin result mainli high coverag artemisinin-piperaquin treatment strategi effect addit primaquin mda artemisinin combin therapi act increas proport artemisinin resist infect although much less treatment symptomat case act increas slow ad primaquin artemisinin resist reduc effect intervent use act preval resist high main result robust assumpt primaquin action immun conclus key messag model result polici maker high coverag act treatment produc long-term reduct malaria wherea impact mda gener short-term primaquin enhanc effect act elimin malaria reduc increas proport artemisinin resist infect parasit preval better surveil measur elimin programm number symptomat case combin intervent effect sustain effort crucial success elimin',\n",
       "  'role parasite-deriv prostaglandin d2 inhibit epiderm langerhan cell migrat schistosomiasi infect epiderm langerhan cell lc play key role immun defens mechan numer immunolog disord report show percutan infect c57bl/6 mice helminth parasit schistosoma mansoni lead activ lc surprisingli retent epidermi moreov use experiment model lc migrat induc tumor necrosi factor tnf -α show parasit transient impair departur lc epidermi subsequ accumul dendrit cell drain lymph node inhibitori effect mediat solubl lipophil factor releas parasit host-deriv antiinflammatori cytokin interleukin-10 find prostaglandin pg d2 major eicosanoid produc parasit specif imped tnf-α–trigger migrat lc adenyl cyclase–coupl pgd2 receptor dp receptor moreov potent dp receptor antagonist bw a868c restor lc migrat infect mice final model contact allergen-induc lc migrat show activ dp receptor inhibit lc emigr also dramat reduc contact hypersensit respons challeng taken togeth propos inhibit lc migrat could repres addit stratagem schistosom escap host immun system pgd2 may play key role control cutan immun respons',\n",
       "  'axicabtagen ciloleucel car t‐cell therapi refractori larg b‐cell lymphoma background phase 1 trial axicabtagen ciloleucel axi‐cel autolog anti‐cd19 chimer antigen receptor car t‐cell therapi show efficaci patient refractori larg b‐cell lymphoma failur convent therapi method multicent phase 2 trial enrol 111 patient diffus larg b‐cell lymphoma primari mediastin b‐cell lymphoma transform follicular lymphoma refractori diseas despit undergo recommend prior therapi patient receiv target dose 2×106 anti‐cd19 car cell per kilogram bodi weight receiv condit regimen low‐dos cyclophosphamid fludarabin primari end point rate object respons calcul combin rate complet respons partial respons secondari end point includ overal surviv safeti biomark assess result among 111 patient enrol axi‐cel success manufactur 110 99 administ 101 91 object respons rate 82 complet respons rate 54 .with median follow‐up 15.4 month 42 patient continu respons 40 continu complet respons overal rate surviv 18 month 52 common advers event grade 3 higher treatment neutropenia 78 patient anemia 43 thrombocytopenia 38 grade 3 higher cytokin releas syndrom neurolog event occur 13 28 patient respect three patient die treatment higher car t‐cell level blood associ respons conclus multicent studi patient refractori larg b‐cell lymphoma receiv car t‐cell therapi axi‐cel high level durabl respons safeti profil includ myelosuppress cytokin releas syndrom neurolog event fund kite pharma leukemia lymphoma societi therapi acceler program zuma‐1 clinicaltrials.gov number nct02348216',\n",
       "  'beta adrenerg blockad decreas immunomodulatori effect social disrupt stress physiolog psycholog stress catecholamin produc sympathet nervou system sn regul immun system previou studi report activ β-adrenerg receptor βar mediat action catecholamin increas pro-inflammatori cytokin product number differ cell type impact sn immun modul social defeat examin follow studi design determin whether sn activ social disrupt stress sdr influenc anxiety-lik behavior well activ prime glucocorticoid resist splenocyt social stress cd-1 mice expos one three six cycl sdr hplc analysi plasma spleen reveal increas catecholamin six cycl sdr open field test use measur behavior characterist anxieti indic social defeat induc increas anxiety-lik behavior block pre-treat β-adrenerg antagonist propranolol pre-treat β-adrenerg antagonist propranolol significantli alter corticosteron level indic differ activ hypothalamic-pituitary-adren axi addit anxiety-lik behavior sdr induc splenomegali increas plasma il-6 tnfα mcp-1 revers pre-treat propranolol furthermor flow cytometr analysi cell propranolol pretreat mice reduc sdr-induc increas percentag cd11b splenic macrophag significantli decreas express tlr2 tlr4 cd86 surfac cell addit supernat 18h lps-stimul ex vivo cultur splenocyt propranolol-tr sdr mice contain less il-6 likewis propranolol pre-treat abrog glucocorticoid insensit cd11b cell ex vivo compar splenocyt sdr vehicle-tr mice togeth studi demonstr immun activ prime effect sdr result part consequ sn activ',\n",
       "  'stereotact radiosurgeri plu whole-brain radiat therapi vs stereotact radiosurgeri alon treatment brain metastas random control trial context patient brain metastas unclear whether ad up-front whole-brain radiat therapi wbrt stereotact radiosurgeri sr benefici effect mortal neurolog function compar sr alon object determin wbrt combin sr result improv surviv brain tumor control function preserv rate frequenc neurolog death design set patient random control trial 132 patient 1 4 brain metastas less 3 cm diamet enrol 11 hospit japan octob 1999 decemb 2003. intervent patient randomli assign receiv wbrt plu sr 65 patient sr alon 67 patient main outcom measur primari end point overal surviv secondari end point brain tumor recurr salvag brain treatment function preserv toxic effect radiat caus death result median surviv time 1-year actuari surviv rate 7.5 month 38.5 95 confid interv 26.7 -50.3 wbrt sr group 8.0 month 28.4 95 confid interv 17.6 -39.2 sr alon p .42 12-month brain tumor recurr rate 46.8 wbrt sr group 76.4 sr alon group p .001 salvag brain treatment less frequent requir wbrt sr group n 10 sr alon n 29 p .001 death attribut neurolog caus 22.8 patient wbrt sr group 19.3 treat sr alon p .64 signific differ system neurolog function preserv toxic effect radiat conclus compar sr alon use wbrt plu sr improv surviv patient 1 4 brain metastas intracrani relaps occur consider frequent receiv wbrt consequ salvag treatment frequent requir up-front wbrt use trial registr umin.ac.jp/ctr identifi c000000412',\n",
       "  'rank signal cd4+3− induc cell regul develop aire-express epitheli cell thymic medulla aire-express medullari thymic epitheli cell mtec play key role prevent autoimmun express tissue-restrict antigen help purg emerg cell receptor repertoir self-react specif demonstr novel role cd4+3− induc cell popul previous link develop organ secondari lymphoid structur mainten cell memori function regul aire-medi promiscu gene express thymu cd4+3− cell close associ mtec adult thymu fetal thymu appear tempor link appear aire+ mtec show rankl signal cell promot matur rank-express cd80−aire− mtec progenitor cd80+aire+ mtec transplant rank-defici thymic stroma immunodefici host induc autoimmun collect data reveal cellular molecular mechan lead gener aire+ mtec highlight previous unrecogn role cd4+3−rankl+ induc cell intrathym self-toler',\n",
       "  'proteom approach character biochemistri meat qualiti defect proteom use character qualiti defect includ pale soft exud pse meat pork poultri woodi broiler breast meat reddish catfish fillet meat tough beef myoglobin oxid pse broiler meat character 15 protein differ abund comparison normal broiler breast meat eight protein differenti express woodi breast meat comparison normal breast meat hemoglobin protein differenti express red normal catfish fillet howev induc low oxygen and/or heat stress condit catfish fillet lead product red fillet proteom data provid inform pertain protein differ exist meat qualiti defect howev data need evalu conjunct inform pertain genet nutrit environ live anim muscl meat convers meat qualiti analys sensori attribut understand causal protein biomark ultim prevent qualiti defect',\n",
       "  'phosphoryl janu kinas 1 jak1 amp-activ protein kinas ampk link energi sens anti-inflammatori signal adenosin 5′-monophosphate–activ protein kinas ampk pivot regul metabol cellular organism level ampk also suppress inflamm found pharmacolog activ ampk rapidli inhibit janu kinas jak –signal transduc activ transcript stat pathway variou cell vitro kinas assay reveal ampk directli phosphoryl two residu ser515 ser518 within src homolog 2 domain jak1 activ ampk enhanc interact jak1 14-3-3 protein cultur vascular endotheli cell fibroblast effect requir presenc ser515 ser518 abolish cell lack ampk catalyt subunit mutat ser515 ser518 abolish ampk-medi inhibit jak-stat signal stimul either sil-6rα/il-6 complex express constitut activ v658f-mutant jak1 human fibrosarcoma cell clinic use ampk activ metformin salicyl enhanc inhibitori phosphoryl endogen jak1 inhibit stat3 phosphoryl primari vascular endotheli cell therefor find reveal mechan jak1 function inflammatori signal may suppress respons metabol stress provid mechanist rational investig ampk activ rang diseas associ enhanc activ jak-stat pathway',\n",
       "  'iap antagonist induc anti-tumor immun multipl myeloma cellular inhibitor apoptosi ciap 1 2 amplifi 3 cancer identifi multipl malign potenti therapeut target result role evas apoptosi consequ small-molecul iap antagonist lcl161 enter clinic trial abil induc tumor necrosi factor tnf -mediat apoptosi cancer cell howev ciap1 ciap2 recurr homozyg delet multipl myeloma mm result constitut activ noncanon nuclear factor nf -κb pathway surpris observ robust vivo anti-myeloma activ lcl161 transgen myeloma mous model patient relapsed-refractori mm addit cyclophosphamid result median progression-free-surviv 10 month effect result direct induct tumor cell death rather upregul tumor-cell-autonom type interferon ifn signal strong inflammatori respons result activ macrophag dendrit cell lead phagocytosi tumor cell treatment mm mous model lcl161 establish long-term anti-tumor protect induc regress fraction mice notabl combin lcl161 immune-checkpoint inhibitor anti-pd1 cur treat mice',\n",
       "  'psychobiolog protect factor modifi associ age sexual health men find men ’ health 40+ studi sexual health sever decreas age male older 40 year erectil dysfunct ed common sexual disord although physic psycholog risk factor ed identifi protect factor yet determin date studi examin endocrin psychosoci factor parallel regard modifi effect age-rel increas ed two hundr seventy-on self-report healthi men age 40 75 year provid psychometr data sexual function set potenti psychosoci protect factor saliva sampl analysi steroid hormon proinflammatori cytokin around 35 particip report least mild form ed direct associ ed identifi perceiv gener health emot support relationship qualiti intimaci motiv steroid hormon proinflammatori marker moder analys associ age ed reveal posit effect testosteron dehydroepiandrosteron dhea perceiv gener health emot support intimaci motiv neg effect interleukin-6 p .05 f2 .17 group differ older men without ed emerg dhea psychometr measur perceiv gener health emot support satisfact life intimaci motiv p .05 .3 psychosoci endocrin paramet moder associ age sexual health perceiv gener health emot support intimaci motiv relationship qualiti emerg psychosoci protect factor ed higher dhea lower interleukin-6 level also buffer age-rel increas ed',\n",
       "  'patient-deriv induc pluripot stem cell cancer research precis oncolog togeth recent advanc process cultur human tissu bioengin xenotransplant genom edit induc pluripot stem cell ipsc present rang new opportun studi human cancer discuss main advantag limit ipsc model method intersect patient-deriv model cancer organoid organs-on-chip patient-deriv xenograft pdx highlight opportun ipsc model provid beyond offer exist system anim model present current challeng crucial area futur improv toward wider adopt technolog',\n",
       "  'structur basi sequence-specif recognit dna tal effector tal transcript activator-lik effector secret phytopathogen bacteria recogn host dna sequenc central domain tandem repeat repeat compris 33 35 conserv amino acid target specif base pair use two hypervari residu known repeat variabl diresidu rvd posit 12 13. report crystal structur 11.5-repeat tal effector dna-fre dna-bound state tal repeat compris two helic connect short rvd-contain loop 11.5 repeat form right-hand superhel structur track along sens strand dna duplex rvd contact major groov 12th residu stabil rvd loop wherea 13th residu make base-specif contact understand dna recognit tal effector may facilit ration design dna-bind protein biotechnolog applic',\n",
       "  'caveolin-1 delet exacerb cardiac interstiti fibrosi promot m2 macrophag activ mice myocardi infarct advers remodel follow myocardi infarct mi lead heart failur driven imbalanc resolut inflamm macrophag cell import control post-mi inflamm macrophag subtyp secret mediat either promot inflamm extend injuri m1 phenotyp suppress inflamm promot scar format m2 phenotyp previous shown absenc caveolin-1 cav1 membran scaffold protein associ advers cardiac remodel mice mechan respons remain elucid explor role cav1 activ macrophag use wild type c57bl6/j wt cav1 tm1mls/j cav1 -/- mice echocardiographi cardiac function compar wt cav1 -/- mice 3day post-mi absenc cav1 surprisingli higher percentag m2 macrophag arginase-1 posit detect infarct zone convers restor cav1 function mi wt mice ad back cav1 scaffold domain reduc m2 activ profil adopt transfer cav1 null macrophag wt mice d3 post-mi exacerb advers cardiac remodel d14 post-mi vitro studi reveal cav1 null macrophag pronounc m2 profil activ respons il-4 stimul conclus cav1 delet promot array maladapt repair process mi includ increas tgf-β signal increas m2 macrophag infiltr dysregul m1/m2 balanc data also suggest cardiac remodel improv therapeut intervent regul cav1 function inflammatori respons phase',\n",
       "  'lipid hydroperoxid measur oxid fe2+ presenc xylenol orang comparison tba assay iodometr method studi role hydroperoxid lipid peroxid diseas requir simpl sensit method direct hydroperoxid measur report techniqu measur hydroperoxid reli upon rapid hydroperoxide-medi oxid fe2+ acid condit fe3+ form chromophor xylenol orang absorb strongli 560 nm yield appar e560 h2o2 butyl hydroperoxid cumen hydroperoxid 4.3×104 m−1 cm−1 assay valid studi liposom lipid peroxid shown give result compar obtain iodometr method measur conjug dien assay involv thiobarbitur acid comparison underestim lipid peroxid measur hydroperoxidep se',\n",
       "  'role exosom cardioprotect exosom extracellular vesicl endosom origin emerg key mediat intercellular commun major cardiac cell types-includ cardiomyocyt endotheli cell fibroblasts-releas exosom modul cellular function exosom releas human cardiac progenitor cell cpc cardioprotect improv cardiac function myocardi infarct extent compar achiev parent cell cardiac progenitor cell-deriv exosom enrich cardioprotect microrna particularli mir-146a-3p circul exosom mediat remot ischaem precondit moreov current investig diagnost marker discoveri cell-deriv extracellular signal organel mediat paracrin effect stem cell suggest cell-fre strategi could supplant cell transplant review discuss emerg role exosom cardiovascular physiolog focu cardioprotect activ cpc-deriv exosom',\n",
       "  'rate chang declin steroid hormon new paramet healthi age men research healthi age men increasingli focus age-rel hormon chang testosteron declin primarili investig age-rel chang sex steroid dehydroepiandrosteron dhea estradiol e2 progesteron p mostli neglect integr hormon paramet reflect age process men yet identifi 271 self-report healthi men 40 75 provid psychometr data saliva sampl hormon analysi correl analysi age sex steroid reveal neg associ four sex steroid dhea e2 p princip compon analysi includ ten salivari analyt identifi princip compon mainli unifi varianc four sex steroid hormon subsequ princip compon analysi includ four sex steroid extract princip compon declin steroid hormon dsh moder analysi associ age dsh reveal signific moder effect psychosoci factor depress chronic stress perceiv gener health conclus result provid evid sex steroid declin age men integr hormon paramet dsh rate chang use biomark healthi age men furthermor neg associ age dsh moder psychosoci factor',\n",
       "  'develop novel helper-depend adenovirus-epstein-barr viru hybrid system stabl transform mammalian cell epstein-barr viru ebv episom stabli maintain permiss prolifer cell line due ebv nuclear antigen 1 ebna-1 protein-medi replic segreg previou studi show abil ebv episom confer long-term transgen express correct genet defect defici cell achiev quantit deliveri ebv episom vitro vivo develop binari helper-depend adenoviru hda -ebv hybrid system consist one hda vector express cre recombinas second hda vector contain sequenc ebv episom flank loxp site upon coinfect cell cre express first vector recombin loxp site second vector result circular ebv episom express transgen contain ebv-deriv famili repeat ebna-1 express cassett 19 kb human dna function replic origin mammalian cell hda-ebv hybrid system transform 40 cultur cell transgen express prolifer cell observ 20 week condit select express transgen absenc select ebv episom lost rate 8 10 per cell divis success deliveri ebv episom vivo demonstr liver transgen mice express cre albumin promot novel gene transfer system potenti confer long-term episom transgen express therefor correct genet defect reduc vector-rel toxic without insert mutagenesi',\n",
       "  'spliceosom assembl pathway differ type altern splice converg commit splice site pair complex differenti splice site pair establish altern splice pattern result gener multipl mrna isoform process carri spliceosom activ seri sequenti structur rearrang five core snrnp determin splice site becom function pair carri seri kinet trap experi use pre-mrna undergo altern 5 splice site select altern exon inclus show commit splice site pair case occur complex character atp-depend associ u2 snrnp branch point interestingli time splice site pair independ intron exon definit mode splice site recognit use atp analog atpgamma show atp hydrolysi requir splice site pair independ u2 snrnp bind pre-mrna result identifi complex spliceosom assembl step dedic splice site pair suggest atp hydrolysi lock splice site splice pattern stabl u2 snrnp associ branch point',\n",
       "  'transcript mhm region chicken z chromosom accumul non-cod rna nucleu femal cell adjac dmrt1 locu male hypermethyl mhm region locat near middl short arm z chromosom chicken consist approxim 210 tandem repeat bamhi 2.2-kb sequenc unit cytosin cpg dinucleotid region extens methyl two z chromosom male much less methyl singl z chromosom femal state methyl mhm region establish fertil 1-day embryon stage mhm region transcrib femal particular strand heterogen high molecular-mass non-cod rna accumul site transcript adjac dmrt1 locu nucleu transcript silenc mhm region male like caus cpg methyl sinc treatment male embryon fibroblast 5-azacytidin result hypo-methyl activ transcript region zzw triploid chicken mhm region hypomethyl transcrib two z chromosom wherea mhm region hypermethyl transcript inact three z chromosom zzz triploid chicken suggest possibl role w chromosom state mhm region',\n",
       "  'macropinocytosi protein amino acid suppli rout ras-transform cell macropinocytosi highli conserv endocyt process extracellular fluid content intern cell larg heterogen vesicl known macropinosom oncogen ra protein shown stimul macropinocytosi function contribut uptak mechan transform phenotyp remain unknown show ras-transform cell use macropinocytosi transport extracellular protein cell intern protein undergo proteolyt degrad yield amino acid includ glutamin enter central carbon metabol accordingli depend ras-transform cell free extracellular glutamin growth suppress macropinocyt uptak protein consist macropinocytosi repres import rout nutrient uptak tumour pharmacolog inhibit compromis growth ras-transform pancreat tumour xenograft result identifi macropinocytosi mechan cancer cell support uniqu metabol need point possibl exploit process design anticanc therapi',\n",
       "  'link splice pol ii transcript stabil pre-mrna influenc splice pattern rna process carri close proxim site transcript suggest regulatori link transcript pre-mrna splice use vitro transcription/spl assay demonstr associ rna polymeras ii pol ii transcript pre-mrna splice requir effici gene express pol ii-synthes rna contain function splice site protect nuclear degrad presum local concentr splice machineri suffici high ensur associ interact nucleas furthermor process transcript influenc altern splice newli synthes pre-mrna rna polymeras provid similar protect nucleas rna product display alter splice pattern link transcript rna process rna pol ii-specif propos connect transcript pol ii pre-mrna splice guarante extend half-lif proper process nascent pre-mrna',\n",
       "  'emerg role skelet muscl extracellular matrix remodel obes exercis skelet muscl extracellular matrix remodel propos new featur associ obes metabol dysfunct exercis train improv muscl function obes may mediat regulatori effect muscl extracellular matrix review examin avail literatur skelet muscl extracellular matrix remodel obes effect exercis non-systemat literatur review perform pubm public 1970 2015. total 37 studi human anim retain studi report overal increas gene protein express differ type collagen growth factor enzymat regul skelet muscl extracellular matrix obes two studi investig effect exercis skelet muscl extracellular matrix obes suggest regulatori effect exercis effect exercis muscl extracellular matrix seem influenc durat type exercis train variabl effect singl session compar longer durat exercis studi need elucid mechan behind skelet muscl extracellular matrix remodel obes effect exercis',\n",
       "  'effect specif exercis strategi need surgeri patient subacromi imping syndrom randomis control studi object evalu specif exercis strategi target rotat cuff scapula stabilis improv shoulder function pain unspecif exercis patient subacromi imping syndrom therebi decreas need arthroscop subacromi decompress design randomis particip singl assessor blind control studi set depart orthopaed swedish univers hospit particip 102 patient long stand six month persist subacromi imping syndrom earlier conserv treatment fail recruit orthopaed specialist intervent specif exercis strategi consist strengthen eccentr exercis rotat cuff concentric/eccentr exercis scapula stabilis combin manual mobilis control exercis programm consist unspecif movement exercis neck shoulder patient group receiv five six individu guid treatment session 12 week supervis session particip perform home exercis twice day 12 week main outcom measur primari outcom constant-murley shoulder assess score evalu shoulder function pain secondari outcom patient global impress chang treatment decis regard surgeri result 97 95 particip complet 12 week studi significantli greater improv constant-murley score specif exercis group control exercis group 24 point 95 confid interv 19 28.0 v 9 point 5 13 mean differ group 15 point 8.5 20.6 significantli patient specif exercis group report success outcom defin larg improv recov patient global assess chang treatment 69 35/51 v 24 11/46 odd ratio 7.6 3.1 18.9 p 0.001 significantli lower proport patient specif exercis group subsequ chose undergo surgeri 20 10/51 v 63 29/46 odd ratio 7.7 3.1 19.4 p 0.001 conclus specif exercis strategi focus strengthen eccentr exercis rotat cuff concentric/eccentr exercis scapula stabilis effect reduc pain improv shoulder function patient persist subacromi imping syndrom extens exercis strategi reduc need arthroscop subacromi decompress within three month timefram use studi trial registr clinic trial nct01037673',\n",
       "  'nucleotid sequenc avian sarcoma viru oncogen src propos amino acid sequenc gene product transform gene src avian sarcoma viru asv adjac region viral genom isol molecular clone viral dna nucleotid sequenc encompass whole src portion gene env encod gp 37 one two glycoprotein found viral envelop src encod singl hydrophob protein structur featur conform previou descript gene product pp60src appear singl viral protein respons initi mainten neoplast transform avian sarcoma viru neither src product bear obviou structur relationship sever viral oncogen encod protein src flank repeat nucleotid sequenc may facilit frequent delet gene viral genom',\n",
       "  'issu design interpret mdr-tb clinic trial report first global mdr-tb clinic trial landscap meet recogn current mdr-tb regimen suboptim base low-qual evid global mdr-tb clinic trial landscap meet held decemb 2014 strateg coordin research develop new treatment regimen diseas affect million peopl worldwid everi year sixti intern expert multidrug-resist tuberculosi mdr-tb met washington d.c. cape town south africa consid key mdr-tb trial-rel issu includ standard definit clinic trial capac build regimen optim foster complianc avoid emerg resist clinic relev special popul includ children co-infect hiv underpin gener suffici evid base facilit regulatori approv improv norm guidanc particip discuss treatment combin current studi phase 2b phase 3 trial well promis new regimen combin may evalu near futur includ regimen design specif enabl shorter durat all-or treatment mean maxim treatment complet hope clear definit challeng facilit process identifi solut acceler progress toward effect non-tox treatment programmat implement',\n",
       "  'para-aort splanchnopleura earli mous embryo contain b1a cell progenitor definit erythropoiesi bird origin stem cell emerg splanchnopleur mesoderm near embryon aorta1–4 yolk sac still gener held uniqu provid haematopoiet stem cell mammalian ontogeny5 although may altern intraembryon sourc stem cell mous fetus6,7 search possibl non-yolk-sac sourc stem cell graft intraembryon splanchnopleura 10- 18-somit mous embryo adult immunodefici scid mice find signific amount donor-deriv serum igm normal number igm-secret plasma cell bla igma brightb220dullcd5+ cell subset fulli reconstitut donor progenitor 3 6 month engraft haematogen capac reveal experi present previous unrecogn site earliest describ embryo 12 hour fetal liver colon',\n",
       "  'establish cultur pluripotenti cell mous embryo pluripotenti cell present mous embryo least earli post-implant stage shown abil take part hi format chimaer animals1 form teratocarcinomas2 possibl establish progress grow cultur cell vitro cell line obtain teratocarcinoma format vivo report establish tissu cultur pluripot cell line isol directli vitro cultur mous blastocyst cell abl differenti either vitro innocul mous tumour vivo normal karyotyp',\n",
       "  'mhc class ii interact cd4 mediat region analog mhc class bind site cd8 interact major histocompat complex mhc molecul cd4 cd coreceptor major role intrathym t-cell selection1 matur cell two glycoprotein associ class-specif bia mhc molecul recognit t-cell receptor cd4+ cell respond antigen associ mhc class ii molecul cd8+ cell respond antigen associ mhc class molecul physic interact cd4/mhc class ii molecul cd8/mhc class molecul demonstr cell adhes assay2–5 bind site cd class identified6,7 demonstr region mhc class iiβ-chain β2 domain structur analog cds-bind loop mhc class α3 domain critic function mous human cd4',\n",
       "  'instabl decay primari structur dna although dna carrier genet inform limit chemic stabil hydrolysi oxid nonenzymat methyl dna occur signific ratesin vivo counteract specif dna repair process spontan decay dna like major factor mutagenesi carcinogenesi age also set limit recoveri dna fragment fossil',\n",
       "  \"single-cel proteom analysi s. cerevisia reveal architectur biolog nois major goal biolog provid quantit descript cellular behaviour task howev hamper difficulti measur protein abund variat present strategi pair high-throughput flow cytometri librari gfp-tag yeast strain monitor rapidli precis protein level single-cel resolut bulk protein abund measur 2,500 protein rich minim media provid detail view cellular respons condit captur mani chang observ dna microarray analys single-cel data argu nois protein express domin stochast production/destruct messeng rna beyond global trend dramat protein-specif differ nois strongli correl protein 's mode transcript function exampl protein respond environment chang noisi wherea involv protein synthesi quiet thu studi reveal remark structur biolog nois suggest protein nois level select reflect cost potenti benefit variat\",\n",
       "  'direct convers fibroblast function neuron defin factor cellular differenti lineag commit consid robust irrevers process develop recent work shown mous human fibroblast reprogram pluripot state combin four transcript factor rais question whether transcript factor could directli induc defin somat cell fate undifferenti state hypothes combinatori express neural-lineage-specif transcript factor could directli convert fibroblast neuron start pool nineteen candid gene identifi combin three factor ascl1 brn2 also call pou3f2 myt1l suffic rapidli effici convert mous embryon postnat fibroblast function neuron vitro induc neuron cell express multipl neuron-specif protein gener action potenti form function synaps gener cell non-neur lineag could import implic studi neural develop neurolog diseas model regen medicin',\n",
       "  'inflammasome-medi dysbiosi regul progress nafld obes non-alcohol fatti liver diseas nafld hepat manifest metabol syndrom lead caus chronic liver diseas western world twenti per cent nafld individu develop chronic hepat inflamm non-alcohol steatohepat nash associ cirrhosi portal hypertens hepatocellular carcinoma yet caus progress nafld nash remain obscur show nlrp6 nlrp3 inflammasom effector protein il-18 neg regul nafld/nash progress well multipl aspect metabol syndrom via modul gut microbiota differ mous model reveal inflammasome-deficiency-associ chang configur gut microbiota associ exacerb hepat steatosi inflamm influx tlr4 tlr9 agonist portal circul lead enhanc hepat tumour-necrosi factor tnf -α express drive nash progress furthermor co-hous inflammasome-defici mice wild-typ mice result exacerb hepat steatosi obes thu alter interact gut microbiota host produc defect nlrp3 nlrp6 inflammasom sens may govern rate progress multipl metabol syndrome-associ abnorm highlight central role microbiota pathogenesi heretofor seemingli unrel system auto-inflammatori metabol disord',\n",
       "  'chromatin remodel promot suppress antisens transcript chromatin allow eukaryot cell packag dna effici understand chromatin structur control across saccharomyc cerevisia genom investig role atp-depend chromatin remodel complex isw2 posit nucleosom find isw2 function adjac promot region reposit nucleosom interfac genic intergen sequenc nucleosom reposit isw2 direct result increas nucleosom occup intergen region loss isw2 activ lead inappropri transcript result gener code noncod transcript show isw2 reposit nucleosom enforc direction transcript prevent transcript initi cryptic site analys reveal chromatin organ global scale advanc understand transcript regul',\n",
       "  'human mitochondri dead-box protein ddx28 resid rna granul function mitoribosom assembl human mitochondri ribosom special synthesi 13 protein fundament compon oxid phosphoryl system pathway mitoribosom biogenesi compartment process factor involv remain larg unknown identifi dead-box protein ddx28 rna granul compon essenti biogenesi mitoribosom larg subunit mt-lsu ddx28 interact 16 rrna mt-lsu rnai-medi ddx28 silenc hek293t cell affect mitochondri mrna stabil 16 rrna process modif howev lead reduc level 16 rrna mt-lsu protein impair mt-lsu assembl deepli attenu mitochondri protein synthesi consequ failur assembl oxid phosphoryl complex find identifi ddx28 essenti earli stage mitoribosom mt-lsu biogenesi process take place mainli near mitochondri nucleoid compart defin rna granul',\n",
       "  'convers adult pancreat α-cell β-cell extrem β-cell loss pancreat insulin-produc beta-cel long lifespan healthi condit replic littl lifetim nevertheless show increas self-dupl increas metabol demand injuri beta-cel loss known whether adult mammal differenti regener new beta-cel extrem total beta-cel loss diabet would indic differenti precursor anoth heterolog non-beta-cel sourc show beta-cel regener transgen model diphtheria-toxin-induc acut select near-tot beta-cel ablat given insulin mice surviv show beta-cel mass augment time lineage-trac label glucagon-produc alpha-cel beta-cel ablat track larg fraction regener beta-cel deriv alpha-cel reveal previous disregard degre pancreat cell plastic inter-endocrin spontan adult cell convers could har toward method produc beta-cel diabet therapi either differenti set vitro induc regener',\n",
       "  'driver mutat histon h3.3 chromatin remodel gene paediatr glioblastoma glioblastoma multiform gbm lethal brain tumour adult children howev dna copi number gene express signatur indic differ adult paediatr case explor genet event underli distinct sequenc exom 48 paediatr gbm sampl somat mutat h3.3-atrx-daxx chromatin remodel pathway identifi 44 tumour 21/48 recurr mutat h3f3a encod replication-independ histon 3 variant h3.3 observ 31 tumour led amino acid substitut two critic posit within histon tail k27m g34r/g34v involv key regulatori post-transl modif mutat atrx α-thalassaemia/ment retard syndrom x-link daxx death-domain associ protein encod two subunit chromatin remodel complex requir h3.3 incorpor pericentr heterochromatin telomer identifi 31 sampl overal 100 tumour harbour g34r g34v h3.3 mutat somat tp53 mutat identifi 54 case 86 sampl h3f3a and/or atrx mutat screen larg cohort glioma variou grade histolog n 784 show h3f3a mutat specif gbm highli preval children young adult furthermor presenc h3f3a/atrx-daxx/tp53 mutat strongli associ altern lengthen telomer specif gene express profil knowledg first report highlight recurr mutat regulatori histon human data suggest defect chromatin architectur underli paediatr young adult gbm pathogenesi',\n",
       "  'translat control intron splice eukaryot eukaryot gene interrupt non-cod intron must accur remov pre-messeng rna produc translat mrna splice guid local short conserv sequenc gene typic contain mani potenti splice site mechan specifi correct site remain poorli understood organ short intron recogn intron definit mechan effici predict sole basi sequenc motif multicellular eukaryot long intron recogn exon definit gene produc multipl mrna variant altern splice nonsense-medi mrna decay nmd pathway may shape observ set variant select degrad contain prematur termin codon frequent produc mammal show tini intron ciliat paramecium tetraurelia strong select pressur caus prematur termin mrna translat event intron retent bia observ among short intron plant fungi anim knock two p. tetraurelia gene encod upf1 protein crucial nmd show intrins effici splice vari wide among intron nmd activ significantli reduc fraction unsplic mrna result suggest independ altern splice speci larg intron number univers reli nmd compens suboptim splice effici accuraci',\n",
       "  'altern activ macrophag produc catecholamin sustain adapt thermogenesi homeotherm use thermogenesi maintain core bodi temperatur ensur cellular function physiolog process continu cold environ prevail model thermogenesi hypothalamu sens cold temperatur trigger sympathet discharg result releas noradrenalin brown adipos tissu white adipos tissu act via β 3 -adrenerg receptor noradrenalin induc lipolysi white adipocyt wherea stimul express thermogen gene ppar-γ coactiv 1a ppargc1a uncoupl protein 1 ucp1 acyl-coa synthetas long-chain famili member 1 acsl1 brown adipocyt howev precis natur cell type involv effer loop well establish report mice unexpect requir interleukin-4 il-4 -stimul program altern macrophag activ adapt thermogenesi exposur cold temperatur rapidli promot altern activ adipos tissu macrophag secret catecholamin induc thermogen gene express brown adipos tissu lipolysi white adipos tissu absenc altern activ macrophag impair metabol adapt cold wherea administr il-4 increas thermogen gene express fatti acid mobil energi expenditur macrophage-depend manner thu discov role altern activ macrophag orchestr import mammalian stress respons respons cold',\n",
       "  'altern lengthen telomer mediat mitot dna synthesi engag break-induc replic process altern lengthen telomer alt telomerase-independ telomer mainten mechan occur subset cancer analyz telomerase-posit cell human terc knockout-deriv alt human cell line show alt cell harbor fragil telomer repres telomer replic problem alt-associ replic defect trigger mitot dna synthesi mida telomer rad52-depend rad51-independ manner telomer mida conserv dna synthesi process potenti mediat break-induc replic similar type ii alt survivor saccharomyc cerevisia replic stress induc ectop oncogen express cyclin e g-quadruplex r-loop format facilit alt pathway lead telomer cluster hallmark alt cancer timeless/tipin complex suppress telomer cluster telomer mida wherea smc5/6 complex promot summari alt cell exhibit telomer replic defect result persist dna damag respons telomer lead engag telomer mida spontan mitot telomer synthesi trigger dna replic stress potenti driver genom duplic cancer',\n",
       "  'light act directli organ cell cultur set vertebr circadian clock express clock gene vertebr widespread restrict classic clock structur express clock gene zebrafish show strong circadian oscil mani tissu vivo cultur show endogen oscil exist peripher organ defin featur circadian clock set entrain local time usual environment light-dark cycl import question whether peripher oscil entrain local time signal central pacemak eye directli light-respons show peripher organ clock zebrafish set light-dark cycl cultur also show zebrafish-deriv cell line contain circadian oscil also directli light entrain',\n",
       "  'small molecul inhibit kras–pdeδ interact impair oncogen kra signal kra oncogen product consid major target anticanc drug discoveri howev direct interfer kra signal yet led clinic use drug correct local signal farnesyl kra regul prenyl-bind protein pdeδ sustain spatial organ kra facilit diffus cytoplasm report interf bind mammalian pdeδ kra mean small molecul provid novel opportun suppress oncogen ra signal alter local endomembran biochem screen subsequ structure-bas hit optim yield inhibitor kras–pdeδ interact select bind prenyl-bind pocket pdeδ nanomolar affin inhibit oncogen ra signal suppress vitro vivo prolifer human pancreat ductal adenocarcinoma cell depend oncogen kra find may inspir novel drug discoveri effort aim develop drug target oncogen ra',\n",
       "  'evolut novel cooper swarm bacterium myxococcu xanthu cooper among individu necessari evolutionari transit higher level biolog organ transit group individu one level singl cell cooper form select unit higher level multicellular organ though evolut cooper difficult observ directli higher eukaryot microorgan offer opportun report evolut novel cooper behaviour experiment lineag bacterium myxococcu xanthu wild-typ strain m. xanthu exhibit social depend swarm across soft surfac mechan known ‘ s-motil ’ requir presenc extracellular type iv pili lineag m. xanthu unabl make pili new mechanist basi cooper swarm evolv evolv swarm mediat least part enhanc product extracellular fibril matrix bind cells—and evolutionari interests—togeth though costli individu fibril product greatli enhanc popul expans group interconnect cell result show fundament transit primit cooper readili occur bacteria',\n",
       "  'exon duplic diverg human preproglucagon gene glucagon 29-amino acid pancreat hormon counteract blood glucose-low action insulin stimul hepat glycogenolysi gluconeogenesis1 structur hamster pancreat glucagon precursor recent determin sequenc clone cdna2 hamster preproglucagon 180-amino acid protein contain five function region signal pre-peptid nh2-termin peptid also call glicentin-rel pancreat peptid grpp glucagon two carboxy-termin glucagon-lik peptid glp-1 glp-2 sequenc two non-allel anglerfish pancreat glucagon precursors3–5 also determin organ similar ident hamster protein lack polypeptid segment correspond hamster glp-2 presenc three region possess intern homolog glucagon glp-1 glp-2 within proglucagon absenc glp-2 anglerfish precursor suggest structur preproglucagon gene might provid insight evolut polyprotein isol sequenc human preproglucagon gene report organ human precursor deduc sequenc ident hamster protein gene contain least three interven sequenc divid protein-cod portion gene four region correspond signal peptid part nh2-termin peptid remaind nh2-termin peptid glucagon glp-1 glp-2 data suggest triplic subsequ sequenc diverg exon encod glucagon glucagon-lik peptid produc polyprotein precursor',\n",
       "  \"bh1 bh2 domain bcl-2 requir inhibit apoptosi heterodimer bax bcl-2 isol 14 18 chromosom breakpoint follicular b-cell lymphoma1–3 bcl-2 uniqu oncogen role extend cell surviv inhibit varieti apoptot deaths4–13 emerg famili bcl-2 -relat protein share two highli conserv regions14–20 refer bcl-2 homolog 1 2 bh1 bh2 domain fig 1 includ bax heterodimer bcl-2 overexpress counteract bcl-214 report site-specif mutagenesi bcl-2 establish two domain novel dimer motif substitu-t gli 145 bhl domain trp 188 bh2 domain complet abrog bcl-2 's death-repressor activ inter-leukin-3 depriv γ-irradi glucocorticoid-induc apoptosi mutat affect bcl-2 's function also disrupt heterodimer bax yet still permit bcl-2 homo-dimer result establish function role bh1 bh2 domain suggest bcl-2 exert action heterodimer bax\",\n",
       "  'kap1 control endogen retrovirus embryon stem cell forti per cent mammalian genom deriv retroel one-quart endogen retrovirus erv still activ notabl mice highli polymorph earli transposon etn /musd intracistern a-typ particl iap erv transcript silenc earli embryogenesi histon dna methyl review ref 7 although initi process essenti protect genom integr remain larg unknown kap1 krab-associ protein 1 also known tripartit motif-contain protein 28 trim28 repress gene recruit histon methyltransferas setdb1 heterochromatin protein 1 hp1 nurd histon deacetylas complex physiolog target known two line evid suggest kap1-medi repress could contribut control erv first kap1 trigger perman gene silenc earli embryogenesi second kap1 complex silenc retroviru murin leukaemia viru embryon cell consist hypothesi show kap1 delet lead mark upregul rang erv particular iap element mous embryon stem es cell earli embryo demonstr kap1 act synergist dna methyl silenc iap element enrich 5′ untransl region 5′utr iap genom kap1 delet lead loss histon 3 lysin 9 trimethyl h3k9me3 hallmark kap1-medi repress correspondingli iap 5′utr sequenc impos ci kap1-depend repress heterolog promot es cell result establish kap1 control endogen retroel earli embryon develop',\n",
       "  'tor signal pathway control nuclear local nutrient-regul transcript factor rapamycin-sensit tor signal pathway saccharomyc cerevisia activ cell-growth program respons nutrient nitrogen carbon tor1 tor2 kinas tor control cytoplasm protein synthesi degrad conserv tap42 protein upon phosphoryl tor tap42 bind possibl inhibit type 2a type-2a-rel phosphatas howev mechan tor control nuclear event global repress starvation-specif transcript unknown show tor prevent transcript gene express upon nitrogen limit promot associ gata transcript factor gln3 cytoplasm protein ure2 bind gln3 ure2 requir tor-depend phosphoryl gln3 phosphoryl cytoplasm retent gln3 also depend tor effector tap42 antagon type-2a-rel phosphatas sit4 tor inhibit express carbon-source-regul gene stimul bind transcript activ msn2 msn4 cytoplasm 14-3-3 protein bmh2 thu tor signal pathway broadli control nutrient metabol sequest sever transcript factor cytoplasm',\n",
       "  'inhibit pluripotenti embryon stem cell differenti purifi polypeptid murin embryon stem es cell pluripot cell line establish directli earli embryo1,2 contribut differenti progeni adult tissu includ germ-cel lineage3 re-incorpor normal embryo provid cellular vector gener transgen animals4 use system identif polypeptid factor control differenti process earli development5 particular medium condit buffalo rat liver cell contain polypeptid factor es cell differenti inhibitori activ dia specif suppress spontan differenti es cell vitro therebi permit growth homogen stem cell popul absenc heterolog feeder cells6 es cell pluripotenti includ abil give rise function gamet preserv prolong cultur buffalo rat liver media sourc dia7 report purifi dia relat structur function recent identifi haemopoet regulatori factor human interleukin da cells8,9 leukaemia inhibitori factor10 dia human interleukin da/leukaemia inhibitori factor thu identifi relat multifunct regulatori factor distinct biolog activ earli embryon haemopoet stem cell system',\n",
       "  'pancreat cancer genom reveal aberr axon guidanc pathway gene pancreat cancer highli lethal malign effect therapi perform exom sequenc copi number analysi defin genom aberr prospect accru clinic cohort n 142 earli stage ii sporad pancreat ductal adenocarcinoma detail analysi 99 inform tumour identifi substanti heterogen 2,016 non-sil mutat 1,628 copy-numb variat defin 16 significantli mutat gene reaffirm known mutat kra tp53 cdkn2a smad4 mll3 tgfbr2 arid1a sf3b1 uncov novel mutat gene includ addit gene involv chromatin modif epc1 arid2 dna damag repair atm mechan zim2 map2k4 nalcn slc16a4 magea6 integr analysi vitro function data anim model provid support evid potenti role genet aberr carcinogenesi pathway-bas analysi recurr mutat gene recapitul cluster core signal pathway pancreat ductal adenocarcinoma identifi new mutat gene pathway also identifi frequent divers somat aberr gene describ tradit embryon regul axon guidanc particularli slit/robo signal also evid murin sleep beauti transposon-medi somat mutagenesi model pancreat cancer provid support evid potenti involv axon guidanc gene pancreat carcinogenesi',\n",
       "  'rejuven age progenitor cell exposur young system environ declin tissu regen potenti hallmark age may due age-rel chang tissue-specif stem cell declin skelet muscl stem cell satellit cell activ due loss notch signal result impair regener age muscl declin hepat progenitor cell prolifer owe format complex involv cebp-α chromatin remodel factor brahma brm inhibit regen capac age liver examin influenc system factor age progenitor cell tissu establish parabiot pair share circulatori system young old mice heterochron parabios expos old mice factor present young serum notabl heterochron parabiosi restor activ notch signal well prolifer regen capac age satellit cell exposur satellit cell old mice young serum enhanc express notch ligand delta increas notch activ enhanc prolifer vitro furthermor heterochron parabiosi increas age hepatocyt prolifer restor cebp-α complex level seen young anim result suggest age-rel declin progenitor cell activ modul system factor chang age',\n",
       "  'continu single-cel imag blood gener haemogen endothelium despit decad research ident cell gener first haematopoiet cell mammalian embryo unknown inde whether blood cell aris mesoderm cell mesenchym progenitor bipot endothelial–haematopoiet precursor haemogen endotheli cell remain controversi proxim endotheli blood cell site embryon haematopoiesi well similar gene express led hypothesi endothelium gener blood howev owe lack technolog imposs observ blood cell emerg continu single-cel level postul exist haemogen endotheli cell remain disput use new imag cell-track method show embryon endotheli cell haemogen continu long-term single-cel observ mous mesoderm cell gener endotheli cell blood coloni possibl detect haemogen endotheli cell give rise blood cell live endotheli haematopoiet cell identifi simultan detect morpholog multipl molecular function marker detach nascent blood cell endothelium directli link asymmetr cell divis haemogen endotheli cell specifi cell alreadi express endotheli marker result improv understand development origin mammalian blood potenti gener haematopoiet stem cell embryon stem cell',\n",
       "  'format germ-lin chimaera embryo-deriv teratocarcinoma cell line recent avail cultur embryo-deriv pluripotenti cell exhibit normal karyotyp high differenti ability1–3 encourag us assess potenti cell form function germ cell follow incorpor chimaer mice report result blastocyst inject studi use three independ isol xy embryo-deriv cell line ek.cp1 ek.cc1.1 ekcc1.2 produc high proport 50 live-born anim overtli chimaer seven chimaer male mice deriv three line far prove function germ-lin chimaera',\n",
       "  'chloroquin resist link mdr-like gene plasmodium falciparum cross chloroquin thought act falciparum malaria accumul acid vesicl parasit interf function1\\x964 parasit resist chloroquin expel drug rapidli unalt form therebi reduc level accumul vesicles5 discoveri verapamil partial revers chloroquin resist vitro 6 led propos efflux may involv atp-driven p-glycoprotein pump similar mammalian multidrug-resist mdr tumor cell line inde plasmodium falciparum contain least two mdr-like genes7,8 one suggest confer chloroquin resist cqr phenotype7,9,10 determin either gene link chloroquin resist perform genet cross cqr chloroquine-suscept cq clone p. falciparum examin 16 independ recombin progeni indic rapid efflux phenotyp control singl gene close link group gene linkag rapid efflux cqr phenotyp either mdr-like p. falciparum gene amplif gene data indic genet locu govern chloroquin efflux resist independ known mdr-like gene',\n",
       "  'identif cold receptor reveal gener role trp channel thermosens cellular molecular mechan enabl us sens cold well understood insight process come use pharmacolog agent menthol elicit cool sensat character clone menthol receptor trigemin sensori neuron also activ thermal stimuli cool cold rang cold- menthol-sensit receptor cmr1 member trp famili excitatori ion channel propos function transduc cold stimuli somatosensori system find togeth previou identif heat-sensit channel vr1 vrl-1 demonstr trp channel detect temperatur wide rang princip sensor thermal stimuli mammalian peripher nervou system',\n",
       "  'surfac mechan mediat pattern format develop retina pattern format biolog structur involv organ differ type cell spatial configur studi investig physic basi biolog pattern drosophila retina vivo demonstr e- n-cadherin mediat apic adhes retina epitheli cell differenti express n-cadherin within sub-group retin cell cone cell caus form overal shape minim surfac contact surround cell cell within group normal experiment manipul condit pack togeth way soap bubbl shape cone cell group pack compon precis imit physic tendenc surfac minim thu simpl pattern express n-cadherin result complex spatial pattern cell owe cellular surfac mechan',\n",
       "  'role inscut orient asymmetr cell divis drosophila drosophila neuroblast epitheli cell procephal neurogen region divid perpendicular surfac segreg protein numb prospero basal daughter cell demonstr orient mitot spindl correct local numb prospero cell requir inscut gene moreov ectop express inscut epitheli cell lead spindl reorient inscut protein local apic cell cortex mitosi suggest inscut function establish polar asymmetr cell divis',\n",
       "  'specif interfer ingest dsrna genet interfer phenomenon nematod caenorhabd elegan describ express individu gene specif reduc microinject correspond fragment double-strand ds rna one strike featur process spread effect interfer broad region anim observ follow inject dsrna extracellular bodi caviti show c. elegan respond gene-specif manner dsrna encount environ c. elegan normal feed bacteria ingest grind pharynx subsequ absorb bacteri content gut find escherichia coli bacteria express dsrna confer specif interfer effect nematod larva feed',\n",
       "  'bacteri rna small antivir compound activ caspase-1 cryopyrin/nalp3 missens mutat cias1 gene caus three autoinflammatori disord famili cold autoinflammatori syndrom muckle–wel syndrom neonatal-onset multiple-system inflammatori diseas cryopyrin also call nalp3 product cias1 member nod-lrr protein famili link activ intracellular host defenc signal pathway cryopyrin form multi-protein complex term ‘ inflammasom ’ contain apoptosis-associ speck-lik protein asc caspase-1 promot caspase-1 activ process pro-interleukin il -1β ref 4 show effect cryopyrin defici inflammasom function immun respons cryopyrin asc essenti caspase-1 activ il-1β il-18 product respons bacteri rna imidazoquinolin compound r837 r848 contrast secret tumour-necrosi factor-α il-6 well activ nf-κb mitogen-activ protein kinas mapk unaffect cryopyrin defici furthermor show toll-lik receptor cryopyrin control secret il-1β il-18 differ intracellular pathway result reveal critic role cryopyrin host defenc bacteri rna-medi activ caspase-1 provid insight regard pathogenesi autoinflammatori syndrom',\n",
       "  'control cortic gaba circuitri develop nrg1 erbb4 signal schizophrenia complex disord interfer function sever brain system requir cognit normal social behaviour although notabl clinic aspect diseas becom appar late adolesc earli adulthood mani line evid suggest schizophrenia neurodevelopment disord strong genet compon sever independ studi identifi neuregulin 1 nrg1 receptor erbb4 import risk gene schizophrenia although precis role diseas process remain unknown show nrg1 erbb4 signal control develop inhibitori circuitri mammalian cerebr cortex cell-autonom regul connect specif gaba γ-aminobutyr acid -contain interneuron contrast preval view support role gene format function excitatori synaps pyramid cell found erbb4 express mous neocortex hippocampu larg confin certain class interneuron particular erbb4 express mani parvalbumin-express chandeli basket cell local axon termin postsynapt densiti receiv glutamaterg input gain- loss-of-funct experi vitro vivo demonstr erbb4 cell-autonom promot format axo-axon inhibitori synaps pyramid cell function probabl mediat nrg1 addit erbb4 express gaba-contain interneuron regul format excitatori synaps onto dendrit cell contrast erbb4 dispens excitatori transmiss pyramid neuron altogeth result indic nrg1 erbb4 signal requir wire gaba-medi circuit postnat cortex provid new perspect involv gene aetiolog schizophrenia',\n",
       "  \"obes medic problem obes common within world 's popul begin replac undernutrit infecti diseas signific contributor ill health particular obes associ diabet mellitu coronari heart diseas certain form cancer sleep-breath disord obes defin body-mass index weight divid squar height 30 kg -2 greater take account morbid mortal associ modest degre overweight detriment effect intra-abdomin fat global epidem obes result combin genet suscept increas avail high-energi food decreas requir physic activ modern societi obes longer regard simpli cosmet problem affect certain individu epidem threaten global well\",\n",
       "  'nonlinear elast biolog gel unlik synthet materi biolog materi often stiffen deform nonlinear elast respons critic physiolog function tissu document sinc least 19th centuri molecular structur design principl respons unknown current model respons requir geometr complex order structur uniqu materi articl show much simpler molecular theori account strain stiffen wide rang molecularli distinct biopolym gel form purifi cytoskelet extracellular protein theori show system semi-flex chain filament protein arrang open crosslink meshwork invari stiffen low strain without need specif architectur multipl element differ intrins stiff',\n",
       "  'live-cel delamin counterbal epitheli growth limit tissu overcrowd develop mainten epithelium requir fine balanc rate growth cell death howev mechan biochem mechan ensur proper feedback control tissu growth deregul contribut tumorigenesi poorli understood use fli notum model system identifi novel process crowding-induc cell delamin balanc growth ensur develop well-ord cell pack crowd region tissu proport cell undergo serial loss cell–cel junction progress loss apic area squeez neighbour path delamin recapitul simpl comput model epitheli mechan stochast cell loss reliev overcrowd system tend toward equilibrium show process delamin mechanist distinct apoptosis-medi cell extrus preced first sign cell death overal analysi reveal simpl mechan buffer epithelia variat growth live-cel delamin constitut mechanist link epitheli hyperplasia cell invas like import implic understand earli stage cancer develop',\n",
       "  'broad antiretrovir defenc human apobec3g lethal edit nascent revers transcript viral replic usual requir innat intracellular line defenc overcom task usual accomplish special viral gene product virion infect factor vif protein human immunodefici viru hiv requir late stage viral product counter antivir activ apobec3g apolipoprotein b mrna-edit enzym catalyt polypeptide-lik 3g also known cem15 protein express notabl human lymphocyt produc presenc apobec3g vif-defect viru non-infecti apobec3g close relat apobec1 central compon rna-edit complex deamin cytosin residu apob messeng rna apobec famili member also potent dna mutat activ dc deamin howev whether edit potenti apobec3g relev hiv inhibit unknown demonstr apobec3g exert antivir effect revers transcript trigger g-to-a hypermut nascent retrovir dna also find apobec3g act broad rang retrovirus addit hiv suggest hypermut edit gener innat defenc mechan import group pathogen',\n",
       "  'gener cell polar plant link endocytosi auxin distribut cell fate decis dynam polar membran protein defin differ cell boundari import role intercellular communication—a vital featur multicellular develop efflux carrier signal molecul auxin pin famili landmark cell polar plant crucial involv auxin distribution-depend develop includ embryo pattern organogenesi tropism polar pin local determin direct intercellular auxin flow yet mechan gener pin polar remain unclear identifi endocytosis-depend mechan pin polar gener analys development implic real-tim pin track show synthesi pin initi deliv plasma membran non-polar manner polar establish subsequ endocyt recycl interfer pin endocytosi either auxin manipul arabidopsi rab5 gtpase pathway prevent pin polar failur pin polar transient alter asymmetr auxin distribut embryogenesi increas local auxin respons apic embryo region result ectop express auxin pathway-associ root-form master regul embryon leav promot homeot transform leav root result indic two-step mechan gener pin polar local essenti role endocytosi process also highlight link endocytosis-depend polar individu cell auxin distribution-depend cell fate establish multicellular pattern',\n",
       "  \"congenit leptin defici associ sever early-onset obes human extrem obes obes ob/ob mous attribut mutat gene encod leptin adipocyte-specif secret protein profound effect appetit energi expenditur know equival evid regard leptin 's role control fat mass human examin two sever obes children member highli consanguin pedigre serum leptin level low despit markedli elev fat mass homozyg frame-shift mutat involv delet singl guanin nucleotid codon 133 gene leptin found sever obes found congenit leptin-defici subject provid first genet evid leptin import regul energi balanc human\",\n",
       "  \"target cell-surfac β-amyloid precursor protein lysosom altern process amyloid-bear fragment progress cerebr deposit amyloid β-peptid earli invari featur alzheim 's diseas β-peptid releas proteolyt cleavag β-amyloid precursor protein βapp 1 membrane-span glycoprotein express mammalian cell normal secret βapp involv cleavag β-peptid region2-3 releas solubl extramembran portion4,5 retain 10k c-termin fragment membrane6 secretori pathway preclud β-amyloid format search altern proteolyt process pathway gener β-peptide-bear fragment full-length β app incub live human endotheli cell βapp antibodi reveal reintern matur βapp cell surfac target endosomes/lysosom cell-surfac biotinyl full-length biotinyl βapp recov insid cell purif lysosom directli demonstr presenc matur βapp extens array β-peptide-contain proteolyt product result defin second process pathway βapp suggest may respons gener amyloid-bear fragment alzheim 's diseas\",\n",
       "  'keratin cytoskelet protein regul protein synthesi epitheli cell growth cell growth increas mass size highli regul cellular event akt/mtor mammalian target rapamycin signal pathway central role control protein synthesi thu growth cell tissu organ strike exampl physiolog context requir rapid cell growth tissu repair respons injuri show keratin 17 intermedi filament protein rapidli induc wound stratifi epithelia regul cell growth bind adaptor protein 14-3-3σ mous skin keratinocyt lack keratin 17 ref 4 show depress protein translat smaller size correl decreas akt/mtor signal activ signal kinas normal activ point specif defect two amino acid residu locat amino-termin head domain keratin 17 requir serum-depend reloc 14-3-3σ nucleu cytoplasm concomit stimul mtor activ cell growth find reveal new unexpect role intermedi filament cytoskeleton influenc cell growth size regul protein synthesi',\n",
       "  'co-cryst structur hnf-3/fork head dna-recognit motif resembl histon h5 three-dimension structur hnf-3/fork head dna-recognit motif complex dna determin x-ray crystallographi 2.5 å resolut α/β protein bind b-dna monom interact dna backbon direct water-medi major minor groov base contact induc 13° bend transcript factor fold similar structur histon h5 amino-termin half three α-helic adopt compact structur present third helix major groov remaind protein includ twist antiparallel β-structur random coil interact minor groov',\n",
       "  \"mechan link extra centrosom chromosom instabl chromosom instabl cin hallmark mani tumour correl presenc extra centrosom howev direct mechanist link extra centrosom cin establish propos extra centrosom gener cin promot multipolar anaphas highli abnorm divis produc three aneuploid daughter cell use long-term live-cel imag demonstr cell multipl centrosom rare undergo multipolar cell divis progeni divis typic inviabl thu multipolar divis explain observ rate cin contrast observ cin cell extra centrosom routin undergo bipolar cell divis display significantli increas frequenc lag chromosom anaphas defin mechan underli mitot defect gener cell differ centrosom number demonstr extra centrosom alon suffici promot chromosom missegreg bipolar cell divis segreg error consequ cell pass transient 'multipolar spindl intermedi merotel kinetochore-microtubul attach error accumul centrosom cluster anaphas find provid direct mechanist link extra centrosom cin two common characterist solid tumour propos mechan may common underli caus cin human cancer\",\n",
       "  'haematopoiet stem cell earli lymphoid progenitor occupi distinct bone marrow nich although haematopoiet stem cell hsc commonli assum resid within special microenviron nich publish experiment manipul hsc nich affect function divers restrict progenitor rais fundament question whether hsc restrict progenitor resid within distinct special nich whether share common nich assess physiolog sourc chemokin cxcl12 hsc restrict progenitor mainten cxcl12 dsred knock-in mice dsred-express2 recombin cxcl12 locu show cxcl12 primarili express perivascular stromal cell lower level endotheli cell osteoblast haematopoiet cell condit delet cxcl12 haematopoiet cell nestin-cre-express cell littl effect hsc restrict progenitor delet cxcl12 endotheli cell deplet hsc myeloerythroid lymphoid progenitor delet cxcl12 perivascular stromal cell deplet hsc certain restrict progenitor mobil cell circul delet cxcl12 osteoblast deplet certain earli lymphoid progenitor hsc myeloerythroid progenitor mobil cell circul differ stem progenitor cell thu resid distinct cellular nich bone marrow hsc occupi perivascular nich earli lymphoid progenitor occupi endost nich',\n",
       "  'broad neutral coverag hiv multipl highli potent antibodi broadli neutral antibodi highli variabl viral pathogen much sought treat protect global circul virus probe neutral antibodi repertoir four human immunodefici viru hiv -infect donor remark broad potent neutral respons rescu 17 new monoclon antibodi neutral broadli across clade mani new monoclon antibodi almost tenfold potent recent describ pg9 pg16 vrc01 broadli neutral monoclon antibodi 100-fold potent origin prototyp hiv broadli neutral monoclon antibodi monoclon antibodi larg recapitul neutral breadth found correspond donor serum mani recogn novel epitop envelop env glycoprotein gp120 illumin new target vaccin design analysi neutral full complement anti-hiv broadli neutral monoclon antibodi avail reveal certain combin antibodi offer markedli favour coverag enorm divers global circul virus other combin might sought activ passiv immun regim overal isol multipl hiv broadli neutral monoclon antibodi sever donor aggreg provid broad coverag low concentr highli posit indic eventu design effect antibody-bas hiv vaccin',\n",
       "  \"coordin rho gtpase activ cell protrus gtpase rac1 rhoa cdc42 act togeth control cytoskeleton dynam recent biosensor studi shown three gtpase activ front migrat cell biochem evid suggest may regul one anoth cdc42 activ rac1 ref 8 rac1 rhoa mutual inhibitori howev spatiotempor coordin second single-micrometr dimens typic individu protrus event remain unknown examin gtpase coordin mous embryon fibroblast simultan visual two gtpase biosensor use 'comput multiplex approach capabl defin relationship multipl protein activ visual separ experi found rhoa activ cell edg synchron edg advanc wherea cdc42 rac1 activ 2 micro-m behind edg delay 40 s. indic rac1 rhoa oper antagonist spatial separ precis time rhoa role initi event protrus wherea rac1 cdc42 activ pathway implic reinforc stabil newli expand protrus\",\n",
       "  'understand mechan underli human gene express variat rna sequenc understand genet mechan underli natur variat gene express central goal medic evolutionari genet studi express quantit trait loci eqtl becom import tool achiev goal although eqtl studi far assay messeng rna level use express microarray recent advanc rna sequenc enabl analysi transcript variat unpreced resolut sequenc rna 69 lymphoblastoid cell line deriv unrel nigerian individu extens genotyp intern hapmap project pool data individu gener map transcript landscap cell identifi extens use unannot untransl region 100 new put protein-cod exon use genotyp hapmap project identifi thousand gene genet variat influenc overal express level splice demonstr eqtl near gene gener act mechan involv allele-specif express variat influenc inclus exon enrich within near consensu splice site result illustr power high-throughput sequenc joint analysi variat transcript splice allele-specif express across individu',\n",
       "  'mesenchym haematopoiet stem cell form uniqu bone marrow nich cellular constitu form haematopoiet stem cell hsc nich bone marrow unclear studi implic osteoblast endotheli perivascular cell demonstr mesenchym stem cell msc identifi use nestin express constitut essenti hsc nich compon nestin+ msc contain bone-marrow colony-forming-unit fibroblast activ propag non-adher ‘ mesenspher ’ self-renew expand serial transplant nestin+ msc spatial associ hsc adrenerg nerv fibr highli express hsc mainten gene gene other trigger osteoblast differenti select downregul enforc hsc mobil β3 adrenoreceptor activ wherea parathormon administr doubl number bone marrow nestin+ cell favour osteoblast differenti vivo nestin+ cell deplet rapidli reduc hsc content bone marrow purifi hsc home near nestin+ msc bone marrow lethal irradi mice wherea vivo nestin+ cell deplet significantli reduc bone marrow home haematopoiet progenitor result uncov unpreced partnership two distinct somat stem-cel type indic uniqu nich bone marrow made heterotyp stem-cel pair',\n",
       "  'respons self antigen imprint regulatori memori tissu immun homeostasi tissu achiev delic balanc pathogen t-cell respons direct tissue-specif antigen abil tissu inhibit respons mechan tissu immun system commun establish maintain immun homeostasi current unknown clinic evid suggest chronic repeat exposur self antigen within tissu lead attenu patholog autoimmun respons possibl mean mitig inflammatori damag preserv function mani human organ-specif autoimmun diseas character initi present diseas sever subsequ flare lesser sever durat fact diseas often spontan resolv despit persist tissu autoantigen express practic antigen-specif immunotherapi allergen self antigen repeatedli inject skin diminut inflammatori respons occur success exposur although find indic tissu acquir abil attenu autoimmun reaction upon repeat respons antigen mechan occur unknown show upon express self antigen peripher tissu thymus-deriv regulatori cell treg cell becom activ prolifer differenti potent suppressor mediat resolut organ-specif autoimmun mice resolut inflammatori respons activ treg cell maintain target tissu prime attenu subsequ autoimmun reaction antigen re-express thu treg cell function confer ‘ regulatori memori ’ target tissu find provid framework understand treg cell respond expos self antigen peripher tissu offer mechanist insight tissu regul autoimmun',\n",
       "  'reprogram human somat cell pluripot defin factor pluripot pertain cell earli embryo gener tissu organ embryon stem cell embryo-deriv cell line retain pluripot repres invalu tool research mechan tissu format recent murin fibroblast reprogram directli pluripot ectop express four transcript factor oct4 sox2 klf4 myc yield induc pluripot stem ip cell use factor deriv ip cell fetal neonat adult human primari cell includ dermal fibroblast isol skin biopsi healthi research subject human ip cell resembl embryon stem cell morpholog gene express capac form teratoma immune-defici mice data demonstr defin factor reprogramm human cell pluripot establish method wherebi patient-specif cell might establish cultur',\n",
       "  'haematopoiet stem cell asymmetr segreg chromosom retain brdu stem cell propos segreg chromosom asymmetr self-renew divis older ‘ immort ’ dna strand retain daughter stem cell wherea newli synthes strand segreg differenti cell stem cell also propos retain dna label 5-bromo-2-deoxyuridin brdu either segreg chromosom asymmetr divid slowli howev puriti stem cell among brdu-label-retain cell document tissu ‘ immort strand hypothesi ’ test system definit stem cell marker test hypothes haematopoiet stem cell hsc highli purifi use well character marker administ brdu newborn mice mice treat cyclophosphamid granulocyt colony-stimul factor normal adult mice 4 10 day follow 70 day without brdu case less 6 hsc retain brdu less 0.5 brdu-retain haematopoiet cell hsc reveal brdu poor specif poor sensit hsc marker sequenti administr 5-chloro-2-deoxyuridin 5-iodo-2-deoxyuridin indic hsc segreg chromosom randomli divis individu hsc cultur reveal asymmetr segreg label thu hsc identifi basi brdu-label retent retain older dna strand divis indic gener properti stem cell',\n",
       "  'circadian clock human red blood cell circadian ∼24 hour clock fundament import coordin physiolog organ divers cyanobacteria human current model molecular circadian clockwork eukaryot cell base transcription-transl feedback loop non-transcript mechan clockwork difficult studi mammalian system circumv problem develop novel assay use human red blood cell nucleu dna therefor perform transcript result show transcript requir circadian oscil human non-transcript event seem suffici sustain cellular circadian rhythm use red blood cell found peroxiredoxin highli conserv antioxid protein undergo ∼24-hour redox cycl persist mani day constant condit absenc extern cue moreov rhythm entrain tunabl environment stimuli temperature-compens key featur circadian rhythm anticip find facilit sophist cellular clock model highlight interdepend transcript non-transcript oscil potenti eukaryot cell',\n",
       "  \"g-protein-coupl receptor kaposi 's sarcoma-associ herpesviru viral oncogen angiogenesi activ kaposi 's sarcoma-associ herpesviru kshv/hhv8 gamma-2 herpesviru implic pathogenesi kaposi 's sarcoma primari effus b-cell lymphoma pel kshv infect malign progenitor cell kaposi 's sarcoma pel encod put oncogen gene may caus kaposi 's sarcoma pathogenesi stimul angiogenesi g-protein-coupl receptor encod open read frame orf 74 kshv express kaposi 's sarcoma lesion pel stimul signal pathway link cell prolifer constitut agonist-independ way show signal kshv g-protein-coupl receptor lead cell transform tumorigen induc switch angiogen phenotyp mediat vascular endotheli growth factor angiogenesi kaposi's-spindle-cel growth factor find receptor activ two protein kinas jnk/sapk p38mapk trigger signal cascad like induc inflammatori cytokin angiogenesi activ mitogen kaposi 's sarcoma cell b cell conclud kshv g-protein-coupl receptor viral oncogen exploit cell signal pathway induc transform angiogenesi kshv-mediat oncogenesi\",\n",
       "  'therapeut potenti gsk-j4 histon demethylas kdm6b/jmjd3 inhibitor acut myeloid leukemia purpos acut myeloid leukemia aml heterogen diseas poor outcom despit increas evid show dysregul histon modif contribut aml specif drug target key histon modul appli clinic treatment aml investig whether target kdm6b demethylas tri-methyl histon h3 lysin 27 h3k27me3 therapeut potenti aml method kdm6b-specif inhibitor gsk-j4 appli treat primari cell aml patient aml cell line vitro vivo rna-sequenc perform reveal underli mechan inhibit kdm6b treatment aml result observ mrna express kdm6b up-regul aml posit correl poor surviv treatment gsk-j4 increas global level h3k27me3 reduc prolifer colony-form abil primari aml cell aml cell line gsk-j4 treatment significantli induc cell apoptosi cell-cycl arrest kasumi-1 cell display synergist effect cytosin arabinosid notabl inject gsk-j4 attenu diseas progress human aml xenograft mous model vivo treatment gsk-j4 predominantli result down-regul dna replic cell-cycle-rel pathway well abrog express critic cancer-promot hox gene chip-qpcr valid increas enrich h3k27me3 transcript start site hox gene conclus summari find suggest target kdm6b gsk-j4 therapeut potenti treatment aml',\n",
       "  \"structur proton-g urea channel gastric pathogen helicobact pylori half world 's popul chronic infect helicobact pylori caus gastriti gastric ulcer increas incid gastric adenocarcinoma proton-g inner-membran urea channel hpurei essenti surviv acid environ stomach channel close neutral ph open acid ph allow rapid access urea cytoplasm ureas ureas produc nh 3 co 2 neutral enter proton thu buffer periplasm ph roughli 6.1 even gastric juic ph 2.0. report structur hpurei reveal six protom assembl hexamer ring surround central bilay plug order lipid protom enclos channel form twist bundl six transmembran helic bundl defin previous unobserv fold compris two-helix hairpin motif repeat three time around central axi channel without invert repeat mammalian-typ urea transport channel protom interfac contain residu conserv amis/urei superfamili suggest preserv channel architectur oligomer state superfamili predominantli aromat aliphat side chain line entir channel defin two consecut constrict site middl channel mutat trp 153 cytoplasm constrict site ala phe decreas select urea comparison thiourea suggest solut interact trp 153 contribut specif previous unobserv hexamer channel structur describ provid new model permeat urea small amid solut prokaryot archaea\",\n",
       "  'drosophila oocyt local mediat differenti cadherin-bas adhes drosophila follicl oocyt alway occupi posterior posit among group sixteen germlin cell although import cell arrang subsequ format anterior-posterior axi embryo well document molecular mechan respons posterior local oocyt unknown show homophil adhes molecul de-cadherin mediat oocyt posit follicl biogenesi de-cadherin express germlin includ oocyt surround follicl cell highest concentr de-cadherin found interfac oocyt posterior follicl cell mosaic analysi show de-cadherin requir germlin follicl cell correct oocyt local indic germline-soma interact may involv process analys behaviour oocyt follicl chimaer follicular epithelium find posit oocyt determin posit de-cadherin-express follicl cell oocyt attach select among de-cadherin posit follicl cell oocyt preferenti contact cell express higher level de-cadherin basi data propos wild-typ follicl oocyt compet success sister germlin cell contact posterior follicl cell sort process driven differ concentr de-cadherin knowledg first vivo exampl cell-sort process depend differenti adhes mediat cadherin',\n",
       "  'somat sex ident cell-autonom chicken mammalian model sex determin embryo consid sexual indiffer transient action sex-determin gene initi gonad differenti although model thought appli vertebr yet establish examin three later gynandromorph chicken rare natur occur phenomenon one side anim appear male femal investig sex-determin mechan bird studi demonstr gynandromorph bird genuin male femal chimaera indic male femal avian somat cell may inher sex ident test hypothesi transplant presumpt mesoderm embryo reciproc sex gener embryo contain male femal chimaer gonad contrast outcom mammalian mixed-sex chimaera chicken mixed-sex chimaera donor cell exclud function structur host gonad exampl femal tissu transplant male host donor cell contribut develop testi retain femal ident express marker femal function studi demonstr avian somat cell possess inher sex ident bird sexual differenti substant cell autonom',\n",
       "  'centrosom polar deliv secretori granul immunolog synaps cytotox lymphocyt ctl destroy viral infect tumorigen cell releas content special secretori lysosomes—term ‘ lytic granul ’ —at immunolog synaps form ctl target contact target cell microtubul organ centr ctl polar toward target granul move along microtubul minus-end direct toward polar microtubul organ centr howev final step secret remain unclear show ctl requir actin plus-end microtubul motor secret instead centrosom move contact plasma membran central supramolecular activ cluster immunolog synaps actin iqgap1 clear away synaps granul deliv directli plasma membran data show ctl use previous unreport mechan deliv secretori granul immunolog synaps granul secret control centrosom deliveri plasma membran',\n",
       "  'deubiquitin p53 hausp import pathway p53 stabil p53 tumour suppressor short-liv protein maintain low level normal cell mdm2-mediat ubiquitin subsequ proteolysi stabil p53 crucial tumour suppressor function howev precis mechan ubiquitin p53 level regul vivo complet understood mass spectrometri affinity-purifi p53-associ factor identifi herpesvirus-associ ubiquitin-specif proteas hausp novel p53-interact protein hausp strongli stabil p53 even presenc excess mdm2 also induc p53-depend cell growth repress apoptosi significantli hausp intrins enzymat activ specif deubiquitin p53 vitro vivo contrast express catalyt inact point mutant hausp cell increas level p53 ubiquitin destabil p53 find reveal import mechan p53 stabil direct deubiquitin also impli hausp might function tumour suppressor vivo stabil p53',\n",
       "  'defect tryptophan catabol underli inflamm mous chronic granulomat diseas half centuri ago chronic granulomat diseas cgd first describ diseas fatal affect abil children surviv infect variou mileston discoveri sinc made insuffici abil patient ’ leucocyt kill microb underli genet abnorm inherit disord phagocyt lack nadph oxidas activ gener reactiv oxygen speci notabl superoxid anion caus recurr bacteri fungal infect patient cgd also suffer chronic inflammatori condit promin granuloma format hollow viscera precis mechan increas microbi pathogen unclear reason exagger inflammatori respons show superoxide-depend step tryptophan metabol along kynurenin pathway block cgd mice lethal pulmonari aspergillosi lead unrestrain vγ1+ γδ t-cell reactiv domin product interleukin il -17 defect regulatori t-cell activ acut inflammatori lung injuri although benefici effect induc il-17 neutral γδ t-cell contract complet cure revers hyperinflammatori phenotyp achiev replac therapi natur kynurenin distal blockad pathway effect therapi includ co-administr recombin interferon-γ ifn-γ restor product downstream immunoact metabolit enabl emerg regulatori vγ4+ γδ foxp3+ αβ cell therefor paradox lack reactiv oxygen speci contribut hyperinflammatori phenotyp associ nadph oxidas defici dysfunct kynurenin pathway tryptophan catabol yet condit revert reactiv pathway downstream superoxide-depend step',\n",
       "  'experiment theoret studi mitot spindl orient architectur adhes cell microenviron critic factor regul spindl orient vivo use combin theori experi investig spindl orient hela human cell show spindl orient understood result action cortic forc gener interact spindl microtubul activ cortic cue develop simpl physic descript spindl mechan allow us calcul angular profil torqu act spindl well angular distribut spindl orient model account prefer spindl orient shape full angular distribut spindl orient observ larg varieti differ cellular microenviron geometri also correctli describ asymmetr spindl orient observ certain distribut cortic cue conclud basi simpl assumpt provid quantit descript spindl orient adher cell',\n",
       "  'chromothripsi dna damag micronuclei genom sequenc uncov new mutat phenomenon cancer congenit disord call chromothripsi chromothripsi character extens genom rearrang oscil pattern dna copi number level curious restrict one chromosom mechan chromothripsi unknown previous propos could occur physic isol chromosom aberr nuclear structur call micronuclei use combin live cell imag single-cel genom sequenc demonstr micronucleu format inde gener spectrum genom rearrang recapitul known featur chromothripsi event restrict mis-segreg chromosom occur within one cell divis demonstr mechan chromothripsi involv fragment subsequ reassembl singl chromatid micronucleu collect experi establish new mutat process chromothripsi one extrem outcom',\n",
       "  'dna-bind factor shape mous methylom distal regulatori region methyl cytosin essenti epigenet modif mammalian genom yet rule govern methyl pattern remain larg elus gain insight process gener base-pair-resolut mous methylom stem cell neuron progenitor advanc quantit analysi identifi low-methyl region lmr averag methyl 30 repres cpg-poor distal regulatori region evidenc locat dnase hypersensit presenc enhanc chromatin mark enhanc activ report assay lmr occupi dna-bind factor bind necessari suffici creat lmr comparison neuron stem-cel methylom confirm depend cell-type-specif lmr occupi cell-type-specif transcript factor studi provid methylom refer mous show dna-bind factor local influenc dna methyl enabl identif activ regulatori region',\n",
       "  'molecular basi rna-depend rna polymeras ii activ rna polymeras pol ii catalys dna-depend rna synthesi gene transcript howev evid pol ii also possess rna-depend rna polymeras rdrp activ pol ii use homopolymer rna templat extend rna sever nucleotid absenc dna implic replic rna genom hepat delta viru hdv plant viroid show intrins rdrp activ pol ii pure polymeras rna template–product scaffold nucleosid triphosph ntp crystallographi reveal template–product duplex site occupi dna–rna hybrid transcript rdrp activ resid activ site use transcript slower less process dna-depend activ rdrp activ also obtain part hdv antigenom complex transcript factor ii tfii pol ii cleav one hdv strand creat reactiv stem-loop hybrid site extend new rna 3′ end short rna stem-loop 5′ extens suffic activ growth critic length appar impair process rdrp activ pol ii provid miss link molecular evolut suggest pol ii evolv ancient replicas duplic rna genom',\n",
       "  'bacteria activ sensori neuron modul pain inflamm nociceptor sensori neuron special detect potenti damag stimuli protect organ initi sensat pain elicit defens behaviour bacteri infect produc pain unknown molecular mechan although presum secondari immun activ demonstr bacteria directli activ nociceptor immun respons mediat tlr2 myd88 cell b cell neutrophil monocyt necessari staphylococcu aureus-induc pain mice mechan thermal hyperalgesia mice correl live bacteri load rather tissu swell immun activ bacteria induc calcium flux action potenti nociceptor neuron part via bacteri n-formyl peptid pore-form toxin α-haemolysin distinct mechan specif ablat nav1.8-lineag neuron includ nociceptor abrog pain bacteri infect concurr increas local immun infiltr lymphadenopathi drain lymph node thu bacteri pathogen produc pain directli activ sensori neuron modul inflamm unsuspect role nervou system host-pathogen interact',\n",
       "  'e2f1-3 switch activ progenitor cell repressor differenti cell establish model mammalian cell cycl control retinoblastoma protein rb function restrict cell enter phase bind sequest e2f activ e2f1 e2f2 e2f3 invari portray ultim effector transcript program commit cell enter progress phase use panel tissue-specif cre-transgen mice condit e2f allel examin effect e2f1 e2f2 e2f3 tripl defici murin embryon stem cell embryo small intestin show normal divid progenitor cell e2f1-3 function transcript activ contrari current view dispens cell divis instead necessari cell surviv differenti cell e2f1-3 function complex rb repressor silenc e2f target facilit exit cell cycl inactiv rb differenti cell result switch e2f1-3 repressor activ lead superactiv e2f respons target ectop cell divis loss e2f1-3 complet suppress phenotyp caus rb defici work contextu activ versu repressor function e2f1-3 vivo reveal distinct role divid versu differenti cell normal versu cancer-lik cell cycl',\n",
       "  'k-ra g12c inhibitor alloster control gtp affin effector interact somat mutat small gtpase k-ra common activ lesion found human cancer gener associ poor respons standard therapi effort target oncogen directli face difficulti owe picomolar affin gtp/gdp absenc known alloster regulatori site oncogen mutat result function activ ra famili protein impair gtp hydrolysi diminish regul gtpase activ nucleotid state ra becom depend rel nucleotid affin concentr give gtp advantag gdp increas proport activ gtp-bound ra report develop small molecul irrevers bind common oncogen mutant k-ra g12c compound reli mutant cystein bind therefor affect wild-typ protein crystallograph studi reveal format new pocket appar previou structur ra beneath effector bind switch-ii region bind inhibitor k-ra g12c disrupt switch-i switch-ii subvert nativ nucleotid prefer favour gdp gtp impair bind raf data provid structure-bas valid new alloster regulatori site ra target mutant-specif manner',\n",
       "  'cyclin regul kinetochore-microtubul promot faith chromosom segreg conspicu event cell cycl align chromosom metaphas chromosom align foster faith segreg format bi-ori attach kinetochor spindl microtubul notabl numer kinetochore-microtubul k-mt attach error present earli mitosi prometaphas persist error lead caus chromosom mis-segreg aneuploid human tumour cell continu mis-segreg whole chromosom display chromosom instabl robust error correct achiev prometaphas ensur error-fre mitosi remain unknown show k-mt attach prometaphas cell consider less stabl metaphas cell switch stabl k-mt attach metaphas requir proteasome-depend destruct cyclin prometaphas persist cyclin express prevent k-mt stabil even cell align chromosom contrast k-mt prematur stabil cyclin-a-defici cell consequ cell lack cyclin display higher rate chromosom mis-segreg thu stabil k-mt attach increas decis coordin fashion among chromosom cell transit prometaphas metaphas cyclin creat cellular environ promot microtubul detach kinetochor prometaphas ensur effici error correct faith chromosom segreg',\n",
       "  'induc pluripot stem cell spinal muscular atrophi patient spinal muscular atrophi one common inherit form neurolog diseas lead infant mortal patient select loss lower motor neuron result muscl weak paralysi often death although patient fibroblast use extens studi spinal muscular atrophi motor neuron uniqu anatomi physiolog may underli vulner diseas process report gener induc pluripot stem cell skin fibroblast sampl taken child spinal muscular atrophi cell expand robustli cultur maintain diseas genotyp gener motor neuron show select deficit compar deriv child ’ unaffect mother first studi show human induc pluripot stem cell use model specif patholog seen genet inherit diseas repres promis resourc studi diseas mechan screen new drug compound develop new therapi',\n",
       "  'role mitochondria nlrp3 inflammasom activ inflammatori respons initi nlrp3 inflammasom trigger varieti situat host ‘ danger ’ includ infect metabol dysregul previou studi suggest nlrp3 inflammasom activ neg regul autophagi posit regul reactiv oxygen speci ro deriv uncharacter organel show mitophagy/autophagi blockad lead accumul damag ros-gener mitochondria turn activ nlrp3 inflammasom rest nlrp3 local endoplasm reticulum structur wherea inflammasom activ nlrp3 adaptor asc redistribut perinuclear space co-loc endoplasm reticulum mitochondria organel cluster notabl ro gener inflammasom activ suppress mitochondri activ dysregul inhibit voltage-depend anion channel indic nlrp3 inflammasom sens mitochondri dysfunct may explain frequent associ mitochondri damag inflammatori diseas',\n",
       "  'break-induc telomer synthesi underli altern telomer mainten homology-direct dna repair essenti genom mainten templat dna synthesi altern lengthen telomer alt necessit homology-direct dna repair maintain telomer 10–15 human cancer dna damag induc assembl execut dna replic complex break-induc replisom telomer elsewher mammalian genom poorli understood defin break-induc telomer synthesi demonstr util special replisom underli alt telomer mainten dna double-strand break enact nascent telomer synthesi long-tract unidirect replic prolifer cell nuclear antigen pcna load replic factor c rfc act initi sensor telomer damag establish predomin dna polymeras δ pol δ pold3 subunit break-induc telomer synthesi requir rfc–pcna–pol δ axi independ canon replisom compon atm atr homolog recombin protein rad51 thu incept telomer damag recognit break-induc replisom orchestr homology-direct telomer mainten',\n",
       "  'innat immun induc composition-depend rig-i recognit hepat c viru rna innat immun defenc essenti control viru infect trigger host recognit viral macromolecular motif known pathogen-associ molecular pattern pamp hepat c viru hcv rna viru replic liver infect 200 million peopl worldwid infect regul hepat immun defenc trigger cellular rig-i helicas rig-i bind pamp rna signal interferon regulatori factor 3 activ induc express interferon-α/β antiviral/interferon-stimul gene isg limit infect identifi polyuridin motif hcv genom 3′ non-transl region replic intermedi pamp substrat rig-i show similar homopolyuridin homopolyriboadenin motif present genom rna virus chief featur rig-i recognit immun trigger human murin cell 5′ termin triphosph pamp rna necessari suffici rig-i bind primarili depend homopolymer ribonucleotid composit linear structur length hcv pamp rna stimul rig-i-depend signal induc hepat innat immun respons vivo trigger interferon isg express suppress hcv infect vitro result provid conceptu advanc defin specif homopolymer rna motif within genom hcv rna virus pamp substrat rig-i demonstr immunogen featur pamp–rig-i interact could use immun adjuv vaccin immunotherapi approach',\n",
       "  'gener transgen non-human primat germlin transmiss common marmoset callithrix jacchu increasingli attract use non-human primat anim model biomed research rel high reproduct rate primat make potenti suitabl transgen modif although sever attempt made produc non-human transgen primat transgen express somat tissu live infant demonstr object analys polymeras chain reaction revers transcript western blot show inject self-inactiv lentivir vector sucros solut marmoset embryo result transgen common marmoset express transgen sever organ notabl achiev germlin transmiss transgen transgen offspr develop normal success creation transgen marmoset provid new anim model human diseas great advantag close genet relationship human model valuabl mani field biomed research',\n",
       "  'induct human neuron cell defin transcript factor somat cell nuclear transfer cell fusion express lineage-specif factor shown induc cell-fat chang divers somat cell type recent observ forc express combin three transcript factor brn2 also known pou3f2 ascl1 myt1l effici convert mous fibroblast function induc neuron cell show three factor gener function neuron human pluripot stem cell earli 6 day transgen activ combin basic helix-loop-helix transcript factor neurod1 factor could also convert fetal postnat human fibroblast cell show typic neuron morpholog express multipl neuron marker even downregul exogen transcript factor importantli vast major human cell abl gener action potenti mani matur receiv synapt contact co-cultur primari mous cortic neuron data demonstr non-neur human somat cell well pluripot stem cell convert directli neuron lineage-determin transcript factor method may facilit robust gener patient-specif human neuron vitro diseas model futur applic regen medicin',\n",
       "  'paar-repeat protein sharpen diversifi type vi secret system spike bacteri type vi secret system t6ss larg multicompon dynam macromolecular machin import role ecolog mani gram-neg bacteria t6ss respons transloc wide rang toxic effector molecul allow predatori cell kill prokaryot well eukaryot prey cell t6ss organel function analog contractil tail bacteriophag thought attack cell initi penetr trimer protein complex call vgrg spike neither exact protein composit t6ss organel mechan effector select deliveri known report protein paar proline-alanine-alanine-arginin repeat superfamili form sharp conic extens vgrg spike involv attach effector domain spike crystal structur two paar-repeat protein bound vgrg-like partner show protein sharpen tip t6ss spike complex demonstr paar protein essenti t6ss-mediat secret target cell kill vibrio cholera acinetobact baylyi result indic new model t6ss organel vgrg-paar spike complex decor multipl effector deliv simultan target cell singl contraction-driven transloc event',\n",
       "  'replic stress activ dna repair synthesi mitosi oncogene-induc dna replic stress implic driver tumorigenesi mani chromosom rearrang characterist human cancer origin specif region genom call common fragil site cfss cfss difficult-to-repl loci manifest gap break metaphas chromosom term cf ‘ express ’ particularli cell expos replic stress mus81–eme1 structure-specif endonucleas promot appear chromosom gap break cfss follow replic stress show entri cell mitot prophas trigger recruit mus81 cfss nucleas activ mus81 promot pold3-depend dna synthesi cfss serv minim chromosom mis-segreg non-disjunct propos attempt condens incomplet duplic loci earli mitosi serv trigger complet dna replic cf loci human cell given pold3-depend mitot dna synthesi enhanc aneuploid cancer cell exhibit intrins high level chromosom instabl cin+ replic stress suggest target pathway could repres new therapeut approach',\n",
       "  \"specif amyloid-β protein assembl brain impair memori memori function often declin age believ deterior initi chang synapt function rather loss neuron individu go develop alzheim 's diseas neurodegener use tg2576 mice express human amyloid-β precursor protein app variant link alzheim 's diseas investig caus memori declin absenc neurodegener amyloid-β protein amyloidosi young tg2576 mice 6 month old normal memori lack neuropatholog middle-ag mice 6–14 month old develop memori deficit without neuron loss old mice 14 month old form abund neurit plaqu contain amyloid-β ref 3–6 found memori deficit middle-ag tg2576 mice caus extracellular accumul 56-kda solubl amyloid-β assembl term aβ 56 aβ star 56 aβ 56 purifi brain impair tg2576 mice disrupt memori administ young rat propos aβ 56 impair memori independ plaqu neuron loss may contribut cognit deficit associ alzheim 's diseas\",\n",
       "  'cleavag gsdmd inflammatori caspas determin pyroptot cell death inflammatori caspas caspase-1 -4 -5 -11 critic innat defenc caspase-1 activ ligand variou canon inflammasom caspase-4 -5 -11 directli recogn bacteri lipopolysaccharid trigger pyroptosi despit crucial role immun endotox shock mechan pyroptosi induct inflammatori caspas unknown identifi gasdermin gsdmd genome-wid cluster regularli interspac palindrom repeat crispr -cas9 nucleas screen caspase-11- caspase-1-medi pyroptosi mous bone marrow macrophag gsdmd-defici cell resist induct pyroptosi cytosol lipopolysaccharid known canon inflammasom ligand interleukin-1β releas also diminish gsdmd−/− cell despit intact process caspase-1 caspase-1 caspase-4/5/11 specif cleav linker amino-termin gasdermin-n carboxy-termin gasdermin-c domain gsdmd requir suffici pyroptosi cleavag releas intramolecular inhibit gasdermin-n domain show intrins pyroptosis-induc activ gasdermin famili member cleav inflammatori caspas share autoinhibit gain-of-funct mutat gsdma3 caus alopecia skin defect disrupt autoinhibit allow gasdermin-n domain trigger pyroptosi find offer insight inflammasome-medi immunity/diseas also chang understand pyroptosi program necrosi',\n",
       "  'role corin trophoblast invas uterin spiral arteri remodel pregnanc pregnanc trophoblast invas uterin spiral arteri remodel import lower matern vascular resist increas uteroplacent blood flow impair spiral arteri remodel implic pre-eclampsia major complic pregnanc long time underli mechan remain unclear corin also known atrial natriuret peptide-convert enzym cardiac proteas activ atrial natriuret peptid anp cardiac hormon import regul blood pressur unexpectedli corin express detect pregnant uteru identifi new function corin anp promot trophoblast invas spiral arteri remodel show pregnant corin- anp-defici mice develop high blood pressur proteinuria characterist pre-eclampsia mice trophoblast invas uterin spiral arteri remodel markedli impair consist anp potent stimul human trophoblast invad matrigel patient pre-eclampsia uterin corin messeng rna protein level significantli lower normal pregnanc moreov identifi corin gene mutat pre-eclampt patient decreas corin activ process pro-anp result indic corin anp essenti physiolog chang maternal–fet interfac suggest defect corin anp function may contribut pre-eclampsia',\n",
       "  'metabol rescu pluripot cell patient mtdna diseas mitochondria major role energi product via oxid phosphoryl depend express critic gene encod mitochondri mt dna mutat mtdna caus fatal sever debilit disord limit treatment option clinic manifest vari base mutat type heteroplasmi rel level mutant wild-typ mtdna within cell gener genet correct pluripot stem cell psc patient mtdna diseas multipl induc pluripot stem ip cell line deriv patient common heteroplasm mutat includ 3243a g caus mitochondri encephalomyopathi stroke-lik episod mela 8993t g 13513g implic leigh syndrom isogen mela leigh syndrom ip cell line gener contain exclus wild-typ mutant mtdna spontan segreg heteroplasm mtdna prolifer fibroblast furthermor somat cell nuclear transfer scnt enabl replac mutant mtdna homoplasm 8993t g fibroblast gener correct leigh-nt1 psc although leigh-nt1 psc contain donor oocyt wild-typ mtdna human haplotyp d4a differ leigh syndrom patient haplotyp f1a total 47 nucleotid site leigh-nt1 cell display transcriptom profil similar embryo-deriv psc carri wild-typ mtdna indic normal nuclear-to-mitochondri interact moreov genet rescu patient psc display normal metabol function compar impair oxygen consumpt atp product observ mutant cell conclud reprogram approach offer complementari strategi deriv psc contain exclus wild-typ mtdna spontan segreg heteroplasm mtdna individu ip cell line mitochondri replac scnt homoplasm mtdna-bas diseas',\n",
       "  \"yeast pif1p helicas remov telomeras telomer dna telomer physic end eukaryot chromosom genet studi establish baker 's yeast pif1p dna helicas neg regul telomeras special revers transcriptas maintain telomer dna biochem basi inhibit unknown show vitro pif1p reduc process telomeras releas telomeras telomer oligonucleotid releas telomeras enzymat activ abl lengthen challeng oligonucleotid vivo overexpress pif1p reduc telomeras associ telomer wherea deplet cell pif1p increas level telomere-bound est1p telomeras subunit present telomer telomeras activ propos pif1p helicas activ limit telomeras action vivo vitro displac activ telomeras dna end\",\n",
       "  'small regulatori rna inhibit rna polymeras ii elong phase transcript eukaryot cell express wide varieti endogen small regulatori rna regul heterochromatin format development time defenc parasit nucleic acid genom rearrang mani small regulatori rna thought function nuclei instanc plant fungi short interf rna sirna associ nascent transcript direct chromatin and/or dna modif understand biolog role small regulatori rna conduct genet screen identifi factor requir rna interfer rnai caenorhabd elegan nuclei show gene nuclear rnai defective-2 nrde-2 encod evolutionarili conserv protein requir sirna-medi silenc nuclei nrde-2 associ argonaut protein nrde-3 within nuclei recruit nrde-3/sirna complex nascent transcript target rnai find nuclear-loc sirna direct nrde-2-depend silenc pre-messeng rna pre-mrna 3 site rnai nrde-2-depend accumul rna polymeras rnap ii genom loci target rnai nrde-2-depend decreas rnap ii occup rnap ii transcript activ 3 site rnai result defin nrde-2 compon nuclear rnai machineri demonstr metazoan sirna silenc nuclear-loc rna co-transcript addit result establish novel mode rnap ii regul sirna-direct recruit nrde factor inhibit rnap ii elong phase transcript',\n",
       "  'cdk1 suffici drive mammalian cell cycl unicellular organ yeast requir singl cyclin-depend kinas cdk1 drive cell divis contrast mammalian cell thought requir sequenti activ least four differ cyclin-depend kinas cdk2 cdk3 cdk4 cdk6 drive cell interphas well cdk1 proceed mitosi model challeng recent genet evid mice surviv absenc individu interphas cdk moreov mous cell type prolifer absenc two even three interphas cdk similar result obtain ablat activ subunit cdk d-type e-typ cyclin show mous embryo lack interphas cdk cdk2 cdk3 cdk4 cdk6 undergo organogenesi develop midgest embryo cdk1 bind cyclin result phosphoryl retinoblastoma protein prb express gene regul e2f transcript factor mous embryon fibroblast deriv embryo prolifer vitro albeit extend cell cycl due ineffici inactiv rb protein howev becom immort continu passag also report embryo fail develop morula blastocyst stage absenc cdk1 result indic cdk1 essenti cell cycl cdk moreov show absenc interphas cdk cdk1 execut event requir drive cell divis',\n",
       "  'calori restrict extend saccharomyc cerevisia lifespan increas respir calori restrict cr extend lifespan wide spectrum organ regimen known lengthen lifespan mammal establish model cr bud yeast saccharomyc cerevisia system lifespan extend limit glucos reduc activ glucose-sens cyclic-amp-depend kinas pka lifespan extens mutant reduc pka activ requir sir2 nad nicotinamid adenin dinucleotid studi explor cr activ sir2 extend lifespan show shunt carbon metabol toward mitochondri tricarboxyl acid cycl concomit increas respir play central part process discuss metabol strategi may appli cr anim',\n",
       "  'mosaic ppm1d mutat associ predisposit breast ovarian cancer improv sequenc technolog offer unpreced opportun investig role rare genet variat common diseas howev consider challeng respect studi design data analysi replic use pool next-gener sequenc 507 gene implic repair dna 1,150 sampl analyt strategi focus protein-trunc variant ptv large-scal sequenc case–control replic experi 13,642 individu show rare ptv p53-induc protein phosphatas ppm1d associ predisposit breast cancer ovarian cancer ppm1d ptv mutat present 25 7,781 case versu 1 5,861 control p 1.12 × 10−5 includ 18 mutat 6,912 individu breast cancer p 2.42 × 10−4 12 mutat 1,121 individu ovarian cancer p 3.10 × 10−9 notabl identifi ppm1d ptv mosaic lymphocyt dna cluster within 370-base-pair region final exon gene carboxy-termin phosphatas catalyt domain function studi demonstr mutat result enhanc suppress p53 respons ioniz radiat exposur suggest mutant allel encod hyperact ppm1d isoform thu although mutat caus prematur protein truncat result simpl loss-of-funct effect typic associ class variant instead probabl gain-of-funct effect result implic detect manag breast ovarian cancer risk gener data provid new insight role rare mosaic genet variant common condit use sequenc identif',\n",
       "  'immunogen induc pluripot stem cell induc pluripot stem cell ipsc reprogram somat cell defin factor hold great promis regen medicin renew sourc autolog cell wherea gener assum autolog cell immune-toler recipi ipsc deriv immunogen vigor examin show wherea embryon stem cell esc deriv inbr c57bl/6 b6 mice effici form teratoma b6 mice without evid immun reject allogen esc 129/svj mice fail form teratoma b6 mice due rapid reject recipi b6 mous embryon fibroblast mef reprogram ipsc either retrovir approach vipsc novel episom approach eipsc caus genom integr contrast b6 esc teratoma form b6 vipsc mostli immune-reject b6 recipi addit major teratoma form b6 eipsc immunogen b6 mice cell infiltr appar tissu damag regress observ small fraction teratoma global gene express analysi teratoma form b6 esc eipsc reveal number gene frequent overexpress teratoma deriv eipsc sever gene product shown contribut directli immunogen b6 eipsc-deriv cell b6 mice find indic contrast deriv esc abnorm gene express cell differenti ipsc induc t-cell-depend immun respons syngen recipi therefor immunogen therapeut valuabl cell deriv patient-specif ipsc evalu clinic applic autolog cell patient',\n",
       "  'direct convers human fibroblast multilineag blood progenitor case embryo-deriv stem cell applic reprogram human induc pluripot stem cell limit understand lineag specif demonstr abil gener progenitor matur cell haematopoiet fate directli human dermal fibroblast without establish pluripot ectop express oct4 also call pou5f1 -activ haematopoiet transcript factor togeth specif cytokin treatment allow gener cell express pan-leukocyt marker cd45 uniqu fibroblast-deriv cell gave rise granulocyt monocyt megakaryocyt erythroid lineag demonstr vivo engraft capac note adult haematopoiet program activ consist bypass pluripot state gener blood fate distinct haematopoiesi involv pluripot stem cell embryon program activ find demonstr restor multipot human fibroblast suggest altern approach cellular reprogram autolog cell-replac therapi avoid complic associ use human pluripot stem cell',\n",
       "  'mical link semaphorin f-actin disassembl instruct cue present cell surfac precis effect actin cytoskeleton poorli understood semaphorin one largest famili instruct cue wide studi effect cell movement navig angiogenesi immunolog cancer semaphorins/collapsin character part basi abil drastic alter actin cytoskelet dynam neuron process despit consider progress identif semaphorin receptor signal pathway molecul link precis control cytoskelet element remain unknown recent highli unusu protein mical famili enzym found associ cytoplasm portion plexin larg cell-surfac semaphorin receptor mediat axon guidanc synaptogenesi dendrit prune cell morpholog chang mical enzym perform reduction–oxid redox enzymat reaction also contain domain found protein regul cell morpholog howev noth known role mical redox activ mediat morpholog chang report mical directli link semaphorin plexin receptor precis control actin filament f-actin dynam found mical necessari suffici semaphorin–plexin-medi f-actin reorgan vivo likewis purifi mical protein found directli bind f-actin disassembl individu bundl actin filament also found mical util redox activ alter f-actin dynam vivo vitro indic previous unknown role specif redox signal event actin cytoskelet regul mical therefor novel f-actin-disassembl factor provid molecular conduit actin reorganization—a hallmark cell morpholog chang includ axon navigation—can precis achiev spatiotempor respons semaphorin',\n",
       "  'novel foxo1-depend transcript program control treg cell function regulatori treg cell character express transcript factor forkhead box p3 foxp3 maintain immun homeostasi suppress self-destruct immun respons foxp3 oper late-act differenti factor control treg cell homeostasi function wherea earli treg-cell-lineag commit regul akt kinas forkhead box foxo famili transcript factor howev whether foxo protein act beyond treg-cell-commit stage control treg cell homeostasi function remain larg unexplor show foxo1 pivot regul treg cell function treg cell express high amount foxo1 display reduc t-cell-receptor-induc akt activ foxo1 phosphoryl foxo1 nuclear exclus mice treg-cell-specif delet foxo1 develop fatal inflammatori disord similar sever seen foxp3-defici mice without loss treg cell genome-wid analysi foxo1 bind site reveal ∼300 foxo1-bound target gene includ pro-inflammatori cytokin ifng seem directli regul foxp3 find show evolutionarili ancient akt–foxo1 signal modul control novel genet program indispens treg cell function',\n",
       "  'function screen identifi mirna induc cardiac regener mammal enlarg heart embryon develop primarili depend increas cardiomyocyt number shortli birth howev cardiomyocyt stop prolifer growth myocardium occur hypertroph enlarg exist myocyt consequ minim renew cardiomyocyt adult life repair cardiac damag myocardi regener limit show exogen administr select microrna mirna markedli stimul cardiomyocyt prolifer promot cardiac repair perform high-cont microscopi high-throughput function screen human mirna promot neonat cardiomyocyt prolifer use whole-genom mirna librari forti mirna strongli increas dna synthesi cytokinesi neonat mous rat cardiomyocyt two mirna hsa-mir-590 hsa-mir-199a select test shown promot cell cycl re-entri adult cardiomyocyt ex vivo promot cardiomyocyt prolifer neonat adult anim myocardi infarct mice mirna stimul mark cardiac regener almost complet recoveri cardiac function paramet mirna identifi hold great promis treatment cardiac patholog consequ cardiomyocyt loss',\n",
       "  'specif sensory–motor connect encod sema3e–plxnd1 recognit spinal reflex mediat synapt connect sensori affer motor neuron organ circuit show sever level specif certain class propriocept sensori neuron make direct monosynapt connect motor neuron bound rule motor pool specif form strong connect motor neuron suppli muscl avoid motor pool suppli antagonist muscl pattern connect initi accur maintain absenc activ impli wire specif reli match recognit molecul surfac sensori motor neuron howev determin fine synapt specif region central nervou system yet defin address origin synapt specif reflex circuit use molecular genet method manipul recognit protein express subset sensori motor neuron show recognit system involv express class 3 semaphorin sema3 select motor neuron pool high-affin receptor plexin d1 plxnd1 propriocept sensori neuron critic determin synapt specif sensory–motor circuit mice chang profil sema3e–plxnd1 signal sensori motor neuron result function anatom rewir monosynapt connect alter motor pool specif find indic pattern monosynapt connect prototyp central nervou system circuit construct recognit program base repel signal',\n",
       "  'chromatin remodel complex involv transcript dna process packag eukaryot genom chromatin present barrier restrict access enzym process dna overcom barrier cell possess number multi-protein atp-depend chromatin remodel complex contain atpas subunit snf2/swi2 superfamili chromatin remodel complex function increas nucleosom mobil clearli implic transcript analys snf2/swi2- iswi-rel protein identifi remodel complex potenti assist dna transact purifi complex saccharomyc cerevisia contain ino80 atpas ino80 complex contain 12 polypeptid includ two protein relat bacteri ruvb dna helicas catalys branch migrat holliday junction purifi complex remodel chromatin facilit transcript vitro display 3 5 dna helicas activ mutant ino80 show hypersensit agent caus dna damag addit defect transcript result indic chromatin remodel driven ino80 atpas may connect transcript well dna damag repair',\n",
       "  'oncogen pathway signatur human cancer guid target therapi develop oncogen state complex process involv accumul multipl independ mutat lead deregul cell signal pathway central control cell growth cell fate abil defin cancer subtyp recurr diseas respons specif therapi use dna microarray-bas gene express signatur demonstr multipl studi variou studi also demonstr potenti use gene express profil analysi oncogen pathway show gene express signatur identifi reflect activ statu sever oncogen pathway evalu sever larg collect human cancer gene express signatur identifi pattern pathway deregul tumour clinic relev associ diseas outcom combin signature-bas predict across sever pathway identifi coordin pattern pathway deregul distinguish specif cancer tumour subtyp cluster tumour base pathway signatur defin prognosi respect patient subset demonstr pattern oncogen pathway deregul underli develop oncogen phenotyp reflect biolog outcom specif cancer predict pathway deregul cancer cell line also shown predict sensit therapeut agent target compon pathway link pathway deregul sensit therapeut target compon pathway provid opportun make use oncogen pathway signatur guid use target therapeut',\n",
       "  'ctcf mediat methylation-sensit enhancer-block activ h19/igf2 locu insulin-lik growth factor 2 igf2 h19 gene imprint result silenc matern patern allel respect event depend upon imprinted-control region two kilobas upstream h19 ref 1 2 patern chromosom element methyl requir silenc h19 ref 2-4 matern chromosom region unmethyl requir silenc igf2 gene 90 kilobas upstream propos unmethyl imprinted-control region act chromatin boundari block interact igf2 enhanc lie 3 h19 ref 5 6 enhancer-block activ would lost region methyl therebi allow express igf2 patern show use transgen mice tissu cultur unmethyl imprinted-control region mous human h19 exhibit enhancer-block activ furthermor show ctcf zinc finger protein implic vertebr boundari function bind sever site unmethyl imprinted-control region essenti enhanc block consist model ctcf bind abolish dna methyl first exampl knowledg regul chromatin boundari vertebr',\n",
       "  'broad potent neutral hiv-1 gp41-specif human antibodi character human monoclon antibodi provid consider insight mechan broad hiv-1 neutral report hiv-1 gp41 membrane-proxim extern region mper -specif antibodi name 10e8 neutral ∼98 test virus analysi sera 78 healthi hiv-1-infect donor demonstr 27 contain mper-specif antibodi 8 contain 10e8-lik specif contrast neutral mper antibodi 10e8 bind phospholipid autoreact bound cell-surfac envelop structur 10e8 complex complet mper reveal site vulner compris narrow stretch highli conserv gp41-hydrophob residu critic arginin lysin transmembran region analysi resist hiv-1 variant confirm import residu neutral highli conserv mper target potent non-self-react neutral antibodi suggest hiv-1 vaccin aim induc antibodi region hiv-1 envelop glycoprotein',\n",
       "  'disrupt hepcidin/ferroportin regulatori system caus pulmonari iron overload restrict lung diseas emerg evid suggest pulmonari iron accumul implic spectrum chronic lung diseas howev mechan involv pulmonari iron deposit role vivo pathogenesi lung diseas remain unknown show point mutat murin ferroportin gene caus hereditari hemochromatosi type 4 slc40a1c326 increas iron level alveolar macrophag epitheli cell line conduct airway lung parenchyma vascular smooth muscl cell pulmonari iron overload associ oxid stress restrict lung diseas decreas total lung capac reduc blood oxygen satur homozyg slc40a1c326s/c326 mice compar wild-typ control find implic iron lung patholog far consid classic iron-rel disord',\n",
       "  'genome-wid genet analysi polyploidi yeast polyploidi increas set chromosom occur develop cellular stress diseas evolut despit preval littl known physiolog alter accompani polyploidi previous describ ‘ ploidy-specif lethal ’ gene delet lethal haploid diploid bud yeast caus lethal triploid tetraploid report genome-wid screen identifi ploidy-specif lethal function 39 3,740 mutat screen exhibit ploidy-specif lethal almost mutat affect genom stabil impair homolog recombin sister chromatid cohes mitot spindl function uncov defect wild-typ tetraploid predict screen identifi mechan tetraploid affect genom stabil show tetraploid high incid syntelic/monopolar kinetochor attach spindl pole suggest defect explain mismatch abil scale size spindl pole bodi spindl kinetochor thu geometr constraint may profound effect genom stabil phenomenon describ may relev varieti biolog context includ diseas state cancer',\n",
       "  'divers herit lineag imprint earli haematopoiet progenitor haematopoiet stem cell hsc subsequ progenitor produc blood cell precis natur kinet product contenti issu one model lymphoid myeloid product branch lymphoid-prim multipot progenitor lmpp branch subsequ produc dendrit cell howev model base mainli vitro clonal assay population-bas track vivo could miss vivo single-cel complex avoid issu use new quantit version ‘ cellular barcod ’ trace vivo fate hundr lmpp hsc single-cel level data demonstr lmpp highli heterogen cell type produc separ combin lymphoid- myeloid- dendritic-cell-bias produc convers although observ known lineag bia hsc cellular output deriv small number hsc gener cell type crucial vivo analysi output sibl cell deriv singl lmpp show often share similar fate suggest fate progenitor imprint furthermor imprint also observ dendritic-cell-bias lmpp dendrit cell may consid distinct lineag basi separ ancestri data suggest ‘ grade commit ’ model haematopoiesi herit divers lineag imprint occur earlier previous thought',\n",
       "  'crowd induc live cell extrus maintain homeostat cell number epithelia epithelium provid protect barrier must maintain homeostat cell number match number divid cell number die cell although compensatori cell divis trigger die cell unknown cell death might reliev overcrowd due prolifer trigger apoptosi epithelia die cell extrud preserv function barrier extrus occur cell destin die signal surround epitheli cell contract actomyosin ring squeez die cell howev clear drive cell death normal homeostasi show human canin zebrafish cell overcrowd due prolifer migrat induc extrus live cell control epitheli cell number extrus live cell occur site highest crowd occur vivo induc experiment overcrowd monolay vitro like apoptot cell extrus live cell extrus result overcrowd also requir sphingosin 1-phosphat signal rho-kinase-depend myosin contract distinguish signal stretch-activ channel moreov disrupt stretch-activ channel piezo1 zebrafish prevent extrus lead format epitheli cell mass find reveal homeostat turnov growth divis epitheli cell confin substratum caus overcrowd lead extrus consequ death owe loss surviv factor result suggest live cell extrus could tumour-suppress mechan prevent accumul excess epitheli cell',\n",
       "  'direct observ ligand recognit cell activ cell interact t-cell receptor antigen peptid bound major histocompat complex mhc surfac antigen present cell apc crucial step adapt immun use three-dimension fluoresc microscopi visual individu peptide–i-ek class ii mhc complex label phycobiliprotein phycoerythrin effort character t-cell sensit requir form immunolog synaps singl cell show cell express cd4 antigen respond transient calcium signal even singl agonist peptide–mhc ligand organ molecul contact zone cell apc take characterist immunolog synaps ten agonist present sensit highli depend cd4 block molecul antibodi render cell unabl detect less 30 ligand',\n",
       "  'crypt stem cell cells-of-origin intestin cancer intestin cancer initi wnt-pathway-activ mutat gene adenomat polyposi coli apc cancer cell origin remain elus previous establish lgr5 leucine-rich-repeat contain g-protein-coupl receptor 5 knockin mous model tamoxifen-induc cre recombinas express long-liv intestin stem cell show delet apc stem cell lead transform within day transform stem cell remain locat crypt bottom fuell grow microadenoma microadenoma show unimped growth develop macroscop adenoma within 3-5week distribut lgr5+ cell within stem-cell-deriv adenoma indic stem cell/progenitor cell hierarchi maintain earli neoplast lesion apc delet short-liv transit-amplifi cell use differ cre mous growth induc microadenoma rapidli stall even 30week larg adenoma rare mice conclud stem-cell-specif loss apc result progress grow neoplasia',\n",
       "  \"microbi engin product advanc biofuel advanc biofuel produc microorgan similar properti petroleum-bas fuel 'drop exist transport infrastructur howev produc biofuel yield high enough use requir engin microorgan 's metabol engin base one specif feedstock host organ data-driven synthetic-biolog approach use optim host pathway maxim fuel product despit success challeng still need met move advanc biofuel toward commerci compet convent fuel\",\n",
       "  'sperm chromatin proteom identifi evolutionarili conserv fertil factor male infertil long-stand enigma signific medic concern integr sperm chromatin clinic indic male fertil vitro fertil potenti chromosom aneuploidi dna decondens damag correl reproduct failur identifi conserv protein import sperm chromatin structur packag reveal univers caus infertil combin proteom cytolog function analysi caenorhabd elegan identifi spermatogen chromatin-associ protein import fertil strategi employ multipl step purif chromatin compar meiotic cell type name undergo spermatogenesi oogenesi proteom analysi multidimension protein identif technolog mudpit factor co-purifi chromatin priorit sperm protein base abund subtract common protein elimin gener chromatin meiotic factor approach reduc 1,099 protein co-purifi spermatogen chromatin current extens catalogu 132 protein function analysi reduct gene function rna interfer coupl protein local studi reveal conserv spermatogenesis-specif protein vital dna compact chromosom segreg fertil unexpect role spermatogenesi also detect factor involv process strategi find fertil factor conserv c. elegan mammal achiev goal mous gene knockout correspond nematod protein 37 7/19 caus male steril list therefor provid signific opportun identifi caus male infertil target male contracept',\n",
       "  'nanog safeguard pluripot mediat germlin develop nanog diverg homeodomain protein found mammalian pluripot cell develop germ cell delet nanog caus earli embryon lethal wherea constitut express enabl autonom self-renew embryon stem cell nanog accordingli consid core element pluripot transcript network howev report nanog fluctuat mous embryon stem cell transient downregul nanog appear predispos cell toward differenti mark commit genet delet show although prone differenti embryon stem cell self-renew indefinit perman absenc nanog expand nanog null cell colon embryon germ layer exhibit multilineag differenti fetal adult chimaera although also recruit germ line primordi germ cell lack nanog fail matur reach genit ridg defect rescu repair mutant allel thu nanog dispens express somat pluripot specif requir format germ cell nanog therefor act primarili construct inner cell mass germ cell state rather housekeep machineri pluripot surmis nanog stabil embryon stem cell cultur resist revers altern gene express state',\n",
       "  'succin inflammatori signal induc il-1β hif-1α macrophag activ gram-neg bacteri product lipopolysaccharid switch core metabol oxid phosphoryl glycolysi show inhibit glycolysi 2-deoxyglucos suppress lipopolysaccharide-induc interleukin-1β tumour-necrosi factor-α mous macrophag comprehens metabol map lipopolysaccharide-activ macrophag show upregul glycolyt downregul mitochondri gene correl directli express profil alter metabolit lipopolysaccharid strongli increas level tricarboxylic-acid cycl intermedi succin glutamine-depend anerplerosi princip sourc succin although ‘ gaba γ-aminobutyr acid shunt ’ pathway also role lipopolysaccharide-induc succin stabil hypoxia-induc factor-1α effect inhibit 2-deoxyglucos interleukin-1β import target lipopolysaccharid also increas succinyl sever protein therefor identifi succin metabolit innat immun signal enhanc interleukin-1β product inflamm',\n",
       "  'planar cell polar signal coupl cell divis morphogenesi neurul environment genet aberr lead neural tube closur defect ntd 1 everi 1,000 birth mous frog model birth defect indic van gogh-lik 2 vangl2 also known strabismu compon planar cell polar pcp signal might control neurul promot converg neural progenitor midlin show novel role pcp signal neurul zebrafish demonstr non-canon wnt/pcp signal polar neural progenitor along anteroposterior axi polar transient lost cell divis neural keel re-establish daughter cell reintegr neuroepithelium loss zebrafish vangl2 trilobit mutant abolish polar neural keel cell disrupt re-intercal daughter cell neuroepithelium result ectop neural progenitor accumul ntd remark block cell divis lead rescu trilobit neural tube morphogenesi despit persist defect converg extens result reveal function pcp signal coupl cell divis morphogenesi neurul indic previous unrecogn mechan might underli ntd',\n",
       "  'challeng new drug discoveri tuberculosi tuberculosi tb preval world today time human histori mycobacterium tuberculosi pathogen respons tb use divers strategi surviv varieti host lesion evad immun surveil key question robust approach discov new tb drug measur could taken reduc long protract clinic develop new drug emerg multi-drug-resist strain m. tuberculosi make discoveri new molecular scaffold prioriti current situat even necessit re-engin reposit old drug famili achiev effect control whatev strategi use success depend larg proper understand complex interact pathogen human host review discuss innov tb drug discoveri evolv strategi bring newer agent quickli patient',\n",
       "  \"subunit arrang phenylethanolamin bind glun1/glun2b nmda receptor sinc discov anti-hypertens agent ifenprodil neuroprotect activ effect nmda n-methyl-d-aspart receptor determin effort made understand mechan action develop improv therapeut compound basi knowledg neurotransmiss mediat nmda receptor essenti basic brain develop function receptor form heteromer ion channel becom activ concurr bind glycin glutam glun1 glun2 subunit respect function hallmark nmda receptor ion-channel activ alloster regul bind small compound amino-termin domain atd subtype-specif manner ifenprodil relat phenylethanolamin compound specif inhibit glun1 glun2b nmda receptor intens studi potenti use treatment variou neurolog disord diseas includ depress alzheim 's diseas parkinson 's diseas despit consider enthusiasm mechan underli recognit phenylethanolamin atd-medi alloster inhibit remain limit owe lack structur inform report glun1 glun2b atd form heterodim phenylethanolamin bind interfac glun1 glun2b rather within glun2b cleft crystal structur heterodim form glun1b atd xenopu laevi glun2b atd rattu norvegicu show highli distinct pattern subunit arrang differ arrang observ homodimer non-nmda receptor reveal molecular determin phenylethanolamin bind restrict domain movement bi-lob structur glun2b atd engin inter-subunit disulphid bond markedli decreas sensit ifenprodil indic conform freedom glun2b atd essenti ifenprodil-medi alloster inhibit nmda receptor find pave way improv design subtype-specif compound therapeut valu neurolog disord diseas\",\n",
       "  \"associ nod2 leucine-rich repeat variant suscept crohn 's diseas crohn 's diseas ulcer coliti two main type chronic inflammatori bowel diseas multifactori condit unknown aetiolog suscept locu crohn 's diseas map chromosom 16. use positional-clon strategi base linkag analysi follow linkag disequilibrium map identifi three independ associ crohn 's diseas frameshift variant two missens variant nod2 encod member apaf-1/ced-4 superfamili apoptosi regul express monocyt nod2 variant alter structur either leucine-rich repeat domain protein adjac region nod2 activ nuclear factor nf-kb activ function regul carboxy-termin leucine-rich repeat domain inhibitori role also act intracellular receptor compon microbi pathogen observ suggest nod2 gene product confer suscept crohn 's diseas alter recognit compon and/or over-activ nf-kb monocyt thu document molecular model pathogen mechan crohn 's diseas investig\",\n",
       "  'human cardiovascular progenitor cell develop kdr+ embryonic-stem-cell-deriv popul function heart compris distinct mesoderm-deriv lineag includ cardiomyocyt endotheli cell vascular smooth muscl cell studi mous embryo mous embryon stem cell differenti model provid evid indic three lineag develop common flk-1+ kinas insert domain protein receptor also known kdr cardiovascular progenitor repres one earliest stage mesoderm specif cardiovascular lineag determin whether compar progenitor present human cardiogenesi analys develop cardiovascular lineag human embryon stem cell differenti cultur show induct combin activin bone morphogenet protein 4 bmp4 basic fibroblast growth factor bfgf also known fgf2 vascular endotheli growth factor vegf also known vegfa dickkopf homolog 1 dkk1 serum-fre media human embryonic-stem-cell-deriv embryoid bodi gener kdrlow/c-kit cd117 neg popul display cardiac endotheli vascular smooth muscl potenti vitro transplant vivo plate monolay cultur kdrlow/c-kitneg cell differenti gener popul consist greater 50 contract cardiomyocyt popul deriv kdrlow/c-kitneg fraction give rise coloni contain three lineag plate methylcellulos cultur result limit dilut studi cell-mix experi support interpret coloni clone indic develop cardiovascular colony-form cell togeth find identifi human cardiovascular progenitor defin one earliest stage human cardiac develop',\n",
       "  \"cancer-rel inflamm mediat cellular effector inflamm import constitu local environ tumour type cancer inflammatori condit present malign chang occur convers type cancer oncogen chang induc inflammatori microenviron promot develop tumour regardless origin 'smoulder inflamm tumour microenviron mani tumour-promot effect aid prolifer surviv malign cell promot angiogenesi metastasi subvert adapt immun respons alter respons hormon chemotherapeut agent molecular pathway cancer-rel inflamm unravel result identif new target molecul could lead improv diagnosi treatment\",\n",
       "  'escrt-iii recognit vps4 atpas escrt endosom sort complex requir transport pathway requir termin membran fission event sever import biolog process includ endosom intralumin vesicl format hiv bud cytokinesi vps4 atpas perform key function pathway recogn membrane-associ escrt-iii assembl catalys disassembl possibl conjunct membran fission show microtubul interact transport mit domain human vps4a vps4b bind conserv sequenc motif locat carboxi termini chmp1–3 class escrt-iii protein structur vps4a mit–chmp1a vps4b mit–chmp2b complex reveal c-termin chmp motif form amphipath helix bind groov last two helic tetratricopeptide-lik repeat tpr vps4 mit domain opposit orient canon tpr interact distinct pocket mit domain bind three conserv leucin residu chmp motif mutat inhibit interact block vps4 recruit impair endosom protein sort reliev dominant-neg vps4 inhibit hiv bud thu studi reveal vps4 atpas recogn chmp substrat facilit membran fission event requir releas virus endosom vesicl daughter cell',\n",
       "  'pif1 famili helicas suppress genom instabl g-quadruplex motif saccharomyc cerevisia pif1 helicas prototyp member pif1 dna helicas famili conserv bacteria human show except potent g-quadruplex unwind conserv among pif1 helicas moreov pif1 helicas organ separ 3 billion year evolut suppress dna damag g-quadruplex motif yeast g-quadruplex-induc damag gener absenc pif1 helicas led new genet epigenet chang furthermor express yeast human pif1 suppress g-quadruplex-associ dna damag telomer lengthen',\n",
       "  'lysyl oxidas essenti hypoxia-induc metastasi metastasi multistep process respons cancer death influenc immedi microenviron cell–cel cell–matrix interact extend tumour microenviron exampl vascular hypoxia low oxygen clinic associ metastasi poor patient outcom although underli process remain unclear microarray studi shown express lysyl oxidas lox elev hypox human tumour cell paradox lox express associ tumour suppress tumour progress role tumorigenesi seem depend cellular locat cell type transform statu show lox express regul hypoxia-induc factor hif associ hypoxia human breast head neck tumour patient high lox-express tumour poor distant metastasis-fre overal surviv inhibit lox elimin metastasi mice orthotop grown breast cancer tumour mechanist secret lox respons invas properti hypox human cancer cell focal adhes kinas activ cell matrix adhes furthermor lox may requir creat nich permiss metastat growth find indic lox essenti hypoxia-induc metastasi good therapeut target prevent treat metastas',\n",
       "  \"identif human brain tumour initi cell cancer stem cell csc hypothesi suggest neoplast clone maintain exclus rare fraction cell stem cell properti although exist csc human leukaemia establish littl evid exist csc solid tumour except breast cancer recent prospect isol cd133+ cell subpopul human brain tumour exhibit stem cell properti vitro howev true measur csc capac self renew exact recapitul origin tumour report develop xenograft assay identifi human brain tumour initi cell initi tumour vivo cd133+ brain tumour fraction contain cell capabl tumour initi nod-scid non-obes diabet sever combin immunodefici mous brain inject 100 cd133+ cell produc tumour could serial transplant phenocopi patient 's origin tumour wherea inject 105 cd133- cell engraft caus tumour thu identif brain tumour initi cell provid insight human brain tumour pathogenesi give strong support csc hypothesi basi mani solid tumour establish previous unidentifi cellular target effect cancer therapi\",\n",
       "  \"anthropometr refer data intern use recommend world health organ expert committe world health organ conven expert committe reevalu use anthropometri differ age assess health nutrit social wellb committe 's task includ identifi refer data anthropometr index appropri provid guidelin data use fetal growth committe recommend exist sex-specif multiraci refer view signific technic drawback current nation center health statist nch /who refer inadequaci assess growth breast-f infant committe recommend develop new refer concern weight length/height infant children complex costli undertak proper interpret midupp arm circumfer preschool requir age-specif refer data evalu adolesc height-for-ag committe recommend current nchs/who refer use nch bodi mass index bmi data upper percentil elev skew undesir set health goal howev data provision recommend defin obes base combin elev bmi high subcutan fat nch valu provision recommend refer data subscapular tricep skinfold thick guidelin also provid adjust adolesc anthropometr comparison matur statu current need adult refer data bmi interpret base pragmat bmi cutoff final committe note norm anthropometr data exist elderli especi 80 age proper definit health statu function biolog age remain develop group\",\n",
       "  \"divers intervent extend mous lifespan suppress share age-associ epigenet chang critic gene regulatori region background age-associ epigenet chang implic age notabl age-associ dna methyl chang compris so-cal age `` clock '' robust biomark age howev genet dietari drug intervent extend lifespan impact epigenom uncharacteris fill knowledg gap defin age-associ dna methyl chang whole-genom single-nucleotid level mous liver test impact longevity-promot intervent specif ame dwarf prop1 df/df mutat calori restrict rapamycin result wild-typ mice fed unsuppl ad libitum diet age-associ hypomethyl enrich super-enhanc highli express gene critic liver function gene harbour hypomethyl enhanc enrich gene chang express age hypermethyl enrich cpg island mark bival activ repress histon modif resembl hypermethyl liver cancer age-associ methyl chang suppress ame dwarf calori restrict mice select less specif rapamycin treat mice conclus age-associ hypo- hypermethyl event occur distinct regulatori featur genom distinct longevity-promot intervent specif genet dietari drug intervent suppress age-associ methyl chang consist idea intervent exert benefici effect part modul epigenom studi foundat understand epigenet contribut healthi age longev molecular basi dna methyl clock\",\n",
       "  'extracellular vesicl drug deliveri extracellular vesicl ev cell-deriv membran vesicl repres endogen mechan intercellular commun sinc discoveri ev capabl function transfer biolog inform potenti use ev drug deliveri vehicl gain consider scientif interest ev may multipl advantag current avail drug deliveri vehicl abil overcom natur barrier intrins cell target properti stabil circul howev therapeut applic ev drug deliveri system limit due lack method scalabl ev isol effici drug load furthermor order achiev target drug deliveri intrins cell target properti tune ev engin review discuss recent progress remain challeng develop ev drug deliveri vehicl',\n",
       "  'effect soy isoflavon phytat homocystein c-reactiv protein iron statu postmenopaus women background soy protein compon may protect atherosclerot cardiovascular diseas cvd risk factor total homocystein thci c-reactiv protein crp excess bodi iron gener increas menopaus object primari object studi determin independ effect soy protein compon isoflavon phytat cvd risk factor postmenopaus women secondari object identifi factor blood lipid oxid stress index serum ferritin plasma folat plasma vitamin b-12 bodi mass index bmi contribut thci crp concentr design double-blind 6-wk studi 55 postmenopaus women age 47-72 randomli assign 1 4 soy protein 40 g/d isol treatment nativ phytat nativ isoflavon n 14 nativ phytat low isoflavon n 13 low phytat nativ isoflavon n 14 low phytat low isoflavon n 14 measur iron index thci crp bmi result soy protein nativ phytat significantli reduc thci p 0.017 transferrin satur p 0.027 ferritin p 0.029 wherea soy protein nativ isoflavon effect variabl baselin bmi highli correl thci r 0.39 p 0.003 crp r 0.55 p 0.0001 wherea hdl cholesterol correl crp r -0.30 p 0.02 multipl regress analysi show ldl cholesterol bmi contribut significantli r2= 19.9 p 0.003 overal varianc thci conclus consum phytate-rich food maintain healthi weight may reduc atherosclerot cvd risk factor postmenopaus women',\n",
       "  'replic fork stabil confer chemoresist brca-defici cell cell defici brca1 brca2 gene reduc capac repair dna double-strand break homolog recombin consequ hypersensit dna-damag agent includ cisplatin poli adp-ribos polymeras parp inhibitor show loss mll3/4 complex protein ptip protect brca1/2-defici cell dna damag rescu lethal brca2-defici embryon stem cell howev ptip defici restor homolog recombin activ double-strand break instead absenc inhibit recruit mre11 nucleas stall replic fork turn protect nascent dna strand extens degrad gener acquisit parp inhibitor cisplatin resist associ replic fork protect brca2-defici tumour cell develop brca2 revers mutat disrupt multipl protein includ parp1 chd4 lead end point replic fork protect highlight complex tumour cell evad chemotherapeut intervent acquir drug resist',\n",
       "  'plasma corin predictor cardiovascular event patient chronic heart failur object aim studi determin prognost valu plasma corin patient chronic heart failur chf background recent year accumul evid indic corin play critic role regul blood pressur cardiac function method enrol 1,148 consecut chf patient prospect cohort studi explor associ plasma corin level clinic prognosi use multivari cox regress analysi result patient low corin level 458 pg/ml like women hypertens low corin found associ increas new york heart associ nyha function class n-termin pro-b-typ natriuret peptid nt-probnp level decreas left ventricular eject fraction lvef estim glomerular filtrat rate egfr multivari cox regress analysi suggest log corin independ predictor major advers cardiac event mace hazard ratio 0.62 95 confid interv 0.39 0.95 togeth age diabet nyha function class lvef egfr log nt-probnp addit log corin also signific predictor cardiovascular death p 0.041 heart failur rehospit p 0.015 adjust clinic variabl establish biomark advers prognosi kaplan-mei surviv curv show low corin signific predictor mace patient nt-probnp level median conclus studi demonstr plasma corin valuabl prognost marker mace patient chf independ establish convent risk factor',\n",
       "  \"cryo-em structur tau filament alzheim ’ diseas brain alzheim 's diseas common neurodegen diseas mechanism-bas therapi diseas defin presenc abund neurofibrillari lesion neurit plaqu cerebr cortex neurofibrillari lesion compris pair helic straight tau filament wherea tau filament differ morpholog character neurodegen diseas high-resolut structur tau filament avail present cryo-electron microscopi cryo-em map 3.4-3.5 å resolut correspond atom model pair helic straight filament brain individu alzheim 's diseas filament core made two ident protofila compris residu 306-378 tau protein adopt combin cross-β/β-helix structur defin seed tau aggreg pair helic straight filament differ inter-protofila pack show ultrastructur polymorph find demonstr cryo-em allow atom character amyloid filament patient-deriv materi pave way investig rang neurodegen diseas\",\n",
       "  'modul proteoglycan receptor ptpσ promot recoveri spinal cord injuri contus spinal cord injuri lead varieti disabl owe limit neuron regener function plastic well establish upregul glial-deriv chondroitin sulphat proteoglycan cspg within glial scar perineuron net creat barrier axon regrowth sprout protein tyrosin phosphatas σ ptpσ along sister phosphatas leukocyt common antigen-rel lar nogo receptor 1 3 ngr recent identifi receptor inhibitori glycosyl side chain cspg find rat ptpσ critic role convert growth cone dystroph state tightli stabil within cspg-rich substrat gener membrane-perm peptid mimet ptpσ wedg domain bind ptpσ reliev cspg-mediat inhibit system deliveri peptid week restor substanti serotonerg innerv spinal cord level injuri facilit function recoveri locomotor urinari system result add new layer understand critic role ptpσ mediat growth-inhibit state neuron due cspg within injur adult spinal cord',\n",
       "  'gp130–src–yap modul link inflamm epitheli regener inflamm promot regener injur tissu poorli understood mechan involv interleukin il -6 famili member express elev mani diseas includ inflammatori bowel diseas colorect cancer show mice human cell gp130 co-receptor il-6 cytokin trigger activ yap notch transcript regul control tissu growth regener independ gp130 effector stat3 yap notch intestin gp130 signal stimul epitheli cell prolifer caus aberr differenti confer resist mucos eros gp130 associ relat tyrosin kinas src ye activ receptor engag phosphoryl yap induc stabil nuclear transloc signal modul strongli activ upon mucos injuri promot heal maintain barrier function',\n",
       "  'hemoglobin concentr white black orient children need separ criteria screen anemia concentr hemoglobin black found 0.5 1.0 g/dl lower income-match white sever larg survey differ could racial characterist black might due higher frequenc genet trait thalassemia minor hemoglobinopathi environment factor iron defici help make distinct analyz data multiphas examin 1973 1975 1718 white 741 black 315 orient healthi nonindig children 5 14 year age entir popul median hemoglobin concentr averag 0.5 g/dl lower black white sex test p less 0.001 differ still averag 0.5 g/dl p less 0.001 exclus abnorm hemoglobin electrophoresi hgb c whose mean corpuscular volum 5 normal mean age exclud iron defici thalassemia minor data strengthen impress black normal concentr hemoglobin averag 0.5 g/dl less white case 10 normal black mistakenli design anem norm appli',\n",
       "  'diverg reprogram rout lead altern stem-cel state pluripot defin abil cell differenti deriv three embryon germ layer ectoderm mesoderm endoderm pluripot cell captur via archetyp deriv embryon stem cell via somat cell reprogram somat cell induc acquir pluripot stem cell ipsc state forc express key transcript factor mous cell fulfil strictest development assay pluripot cell gener complet ipsc-deriv embryo mice howev known whether addit class pluripot cell spectrum reprogram phenotyp encompass explor altern outcom somat reprogram fulli character reprogram cell independ preconceiv definit ipsc state demonstr maintain elev reprogram factor express level mous embryon fibroblast go uniqu epigenet modif arriv stabl nanog-posit altern pluripot state prove pluripot spectrum encompass multipl uniqu cell state',\n",
       "  'autophagi mediat degrad nuclear lamina macroautophagi hereaft refer autophagi catabol membran traffick process degrad varieti cellular constitu associ human diseas although extens studi focus autophag turnov cytoplasm materi littl known role autophagi degrad nuclear compon report autophagi machineri mediat degrad nuclear lamina compon mammal autophagi protein lc3/atg8 involv autophagi membran traffick substrat deliveri present nucleu directli interact nuclear lamina protein lamin b1 bind lamin-associ domain chromatin lc3-lamin b1 interact downregul lamin b1 starvat mediat degrad upon oncogen insult activ ra lamin b1 degrad achiev nucleus-to-cytoplasm transport deliv lamin b1 lysosom inhibit autophagi lc3-lamin b1 interact prevent activ ras-induc lamin b1 loss attenu oncogene-induc senesc primari human cell studi suggest new function autophagi act guard mechan protect cell tumorigenesi',\n",
       "  'pro-resolv lipid mediat lead resolut physiolog advanc understand mechan bring resolut acut inflamm uncov new genu pro-resolv lipid mediat includ lipoxin resolvin protectin maresin famili collect call special pro-resolv mediat synthet version mediat potent bioaction administ vivo anim experi mediat evok anti-inflammatori novel pro-resolv mechan enhanc microbi clearanc although identifi inflamm resolut special pro-resolv mediat conserv structur also function host defenc pain organ protect tissu remodel review cover mechan special pro-resolv mediat omega-3 essenti fatti acid pathway could help us understand physiolog function',\n",
       "  'zmynd11 link histon h3.3k36me3 transcript elong tumour suppress recognit modifi histon ‘ reader ’ protein play critic role regul chromatin h3k36 trimethyl h3k36me3 deposit onto nucleosom transcrib region rna polymeras ii elong yeast mark turn recruit epigenet regul reset chromatin rel repress state thu suppress cryptic transcript howev much less known role h3k36me3 transcript regul mammal complic transcription-coupl incorpor histon variant h3.3 gene bodi show candid tumour suppressor zmynd11 specif recogn h3k36me3 h3.3 h3.3k36me3 regul rna polymeras ii elong structur studi show addit trimethyl-lysin bind aromat cage within pwwp domain h3.3-depend recognit mediat encapsul h3.3-specif ‘ ser 31 ’ residu composit pocket form tandem bromo–pwwp domain zmynd11 chromatin immunoprecipit follow sequenc show genome-wid co-loc zmynd11 h3k36me3 h3.3 gene bodi occup requir pre-deposit h3.3k36me3 although zmynd11 associ highli express gene function unconvent transcript co-repressor modul rna polymeras ii elong stage zmynd11 critic repress transcript program essenti tumour cell growth low express level zmynd11 breast cancer patient correl wors prognosi consist overexpress zmynd11 suppress cancer cell growth vitro tumour format mice togeth studi identifi zmynd11 h3.3-specif reader h3k36me3 link histone-variant-medi transcript elong control tumour suppress',\n",
       "  'autocrin bdnf–trkb signal within singl dendrit spine brain-deriv neurotroph factor bdnf receptor trkb crucial mani form neuron plastic includ structur long-term potenti sltp correl anim ’ learn howev unknown whether bdnf releas trkb activ occur sltp use fluoresc reson energi transfer-bas sensor trkb two-photon fluoresc lifetim imag microscopi monitor trkb activ singl dendrit spine ca1 pyramid neuron cultur murin hippocamp slice respons sltp induct find fast onset 1 min sustain 20 min activ trkb stimul spine depend nmdar n-methyl-d-aspart receptor camkii signal postsynapt synthes bdnf confirm presenc postsynapt bdnf use electron microscopi local endogen bdnf dendrit spine hippocamp ca1 pyramid neuron consist find also show rapid glutamate-uncaging-evok time-lock bdnf releas singl dendrit spine use bdnf fuse supereclipt phluorin demonstr postsynapt bdnf–trkb signal pathway necessari structur function ltp togeth find reveal spine-autonom autocrin signal mechan involv nmdar–camkii-depend bdnf releas stimul dendrit spine subsequ trkb activ spine crucial structur function plastic',\n",
       "  'whole genom redefin mutat landscap pancreat cancer pancreat cancer remain one lethal malign major health burden perform whole-genom sequenc copi number variat cnv analysi 100 pancreat ductal adenocarcinoma pdac chromosom rearrang lead gene disrupt preval affect gene known import pancreat cancer tp53 smad4 cdkn2a arid1a robo2 new candid driver pancreat carcinogenesi kdm6a prex2 pattern structur variat variat chromosom structur classifi pdac 4 subtyp potenti clinic util subtyp term stabl local rearrang scatter unstabl signific proport harbour focal amplif mani contain druggabl oncogen erbb2 met fgfr1 cdk6 pik3r3 pik3ca low individu patient preval genom instabl co-segreg inactiv dna mainten gene brca1 brca2 palb2 mutat signatur dna damag repair defici 8 patient receiv platinum therapi 4 5 individu measur defect dna mainten respond',\n",
       "  'human oocyt reprogram adult somat nuclei type 1 diabet diploid pluripot stem cell transfer somat cell nuclei oocyt give rise pluripot stem cell consist equival embryon stem cell hold promis autolog cell replac therapi although method induc pluripot stem cell somat cell transcript factor wide use basic research numer differ induc pluripot stem cell embryon stem cell report potenti affect clinic use therapeut potenti diploid embryon stem-cel line deriv adult cell diseas human subject systemat investig paramet affect effici blastocyst develop stem-cel deriv show improv oocyt activ protocol includ use kinas translat inhibitor cell cultur presenc histon deacetylas inhibitor promot develop blastocyst stage development effici vari oocyt donor invers relat number day hormon stimul requir oocyt matur wherea daili dose gonadotropin total number metaphas ii oocyt retriev affect development outcom use concentr sendai viru cell fusion induc increas intracellular calcium concentr caus prematur oocyt activ use dilut sendai viru calcium-fre medium use modifi nuclear transfer protocol deriv diploid pluripot stem-cel line somat cell newborn first time adult femal type 1 diabet',\n",
       "  'three-dimension human neural cell cultur model alzheim ’ diseas alzheim ’ diseas common form dementia character two patholog hallmark amyloid-β plaqu neurofibrillari tangl amyloid hypothesi alzheim ’ diseas posit excess accumul amyloid-β peptid lead neurofibrillari tangl compos aggreg hyperphosphoryl tau howev date singl diseas model serial link two patholog event use human neuron cell mous model famili alzheim ’ diseas fad mutat exhibit amyloid-β-induc synapt memori deficit fulli recapitul key patholog event alzheim ’ diseas includ distinct neurofibrillari tangl patholog human neuron deriv alzheim ’ diseas patient shown elev level toxic amyloid-β speci phosphoryl tau demonstr amyloid-β plaqu neurofibrillari tangl report fad mutat β-amyloid precursor protein presenilin 1 abl induc robust extracellular deposit amyloid-β includ amyloid-β plaqu human neural stem-cell-deriv three-dimension 3d cultur system importantli 3d-differenti neuron cell express fad mutat exhibit high level detergent-resist silver-posit aggreg phosphoryl tau soma neurit well filament tau detect immunoelectron microscopi inhibit amyloid-β gener β- γ-secretas inhibitor decreas amyloid-β patholog also attenu tauopathi also found glycogen synthas kinas 3 gsk3 regul amyloid-β-medi tau phosphoryl success recapitul amyloid-β tau patholog singl 3d human neural cell cultur system uniqu strategi recapitul alzheim ’ diseas patholog 3d neural cell cultur model also serv facilit develop precis human neural cell model neurodegen disord',\n",
       "  'mesenchymal-endothelial-transit contribut cardiac neovascular endotheli cell contribut subset cardiac fibroblast undergo endothelial-to-mesenchym transit whether cardiac fibroblast adopt endotheli cell fate directli contribut neovascular cardiac injuri known use genet fate map techniqu demonstr cardiac fibroblast rapidli adopt endothelial-cell-lik phenotyp acut ischaem cardiac injuri fibroblast-deriv endotheli cell exhibit anatom function characterist nativ endotheli cell show transcript factor p53 regul switch cardiac fibroblast fate loss p53 cardiac fibroblast sever decreas format fibroblast-deriv endotheli cell reduc post-infarct vascular densiti worsen cardiac function convers stimul p53 pathway cardiac fibroblast augment mesenchymal-to-endotheli transit enhanc vascular improv cardiac function observ demonstr mesenchymal-to-endotheli transit contribut neovascular injur heart repres potenti therapeut target enhanc cardiac repair',\n",
       "  'estim optim serum concentr 25-hydroxyvitamin multipl health outcom recent evid suggest vitamin intak current recommend may associ better health outcom howev optim serum concentr 25-hydroxyvitamin 25 oh defin review summar evid studi evalu threshold serum 25 oh concentr relat bone miner densiti bmd lower-extrem function dental health risk fall fractur colorect cancer endpoint advantag serum concentr 25 oh begin 75 nmol/l 30 ng/ml best 90 100 nmol/l 36-40 ng/ml person concentr could reach current recommend intak 200 600 iu vitamin d/d younger older adult respect comparison vitamin intak achiev serum concentr 25 oh purpos estim optim intak led us suggest bone health younger adult studi outcom older adult increas current recommend intak vitamin warrant intak adult =1000 iu 25 microg dosag error correct vitamin cholecalciferol /d need bring vitamin concentr less 50 popul 75 nmol/l implic higher dose entir adult popul address futur studi',\n",
       "  \"cohesin-depend globul heterochromatin shape 3d genom architectur s. pomb eukaryot genom fold three-dimension structur self-associ topolog domain border enrich cohesin ccctc-bind factor ctcf requir long-rang interact local chromatin interact govern higher-ord fold chromatin fibr function cohesin process remain poorli understood perform genome-wid chromatin conform captur hi-c analysi explor high-resolut organ schizosaccharomyc pomb genom despit small size exhibit fundament featur found eukaryot analys wild-typ mutant strain reveal key element chromosom architectur genom organ chromosom arm small region chromatin local interact form 'globul featur requir function cohesin distinct role sister chromatid cohes cohesin enrich globul boundari loss caus disrupt local globul structur global chromosom territori contrast heterochromatin load cohesin specif site includ pericentromer subtelomer domain dispens globul format nevertheless affect genom organ show heterochromatin mediat chromatin fibr compact centromer promot promin inter-arm interact within centromere-proxim region provid structur constraint crucial proper genom organ loss heterochromatin relax constraint chromosom caus increas intra- inter-chromosom interact togeth analys uncov fundament genom fold principl drive higher-ord chromosom organ crucial coordin nuclear function\",\n",
       "  'tempor shift circuit mediat retriev fear memori fear memori allow anim avoid danger therebi increas chanc surviv fear memori retriev long learn littl known retriev circuit chang time show dorsal midlin thalamu rat requir retriev auditori condit fear late 24 hour 7 day 28 day earli 0.5 hour 6 hour time point learn consist paraventricular nucleu thalamu pvt subregion dorsal midlin thalamu show increas c-fo express late time point indic pvt gradual recruit fear retriev accordingli condit tone respons pvt neuron increas time train prelimb pl prefront cortex necessari fear retriev send dens project pvt retriev late time point activ pl neuron project pvt optogenet silenc project impair retriev late earli time point contrast silenc pl input basolater amygdala impair retriev earli late time point indic time-depend shift retriev circuit retriev late time point also activ pvt neuron project central nucleu amygdala silenc project late earli time point induc persist attenu fear thu pvt may act crucial thalam node recruit cortico-amygdalar network retriev mainten long-term fear memori',\n",
       "  'deriv novel human ground state naiv pluripot stem cell mous embryon stem es cell isol inner cell mass blastocyst preserv vitro naiv inner-cell-mass-lik configur provid exogen stimul leukaemia inhibitori factor lif small molecul inhibit erk1/erk2 gsk3β signal term 2i/lif condit hallmark naiv pluripot includ drive oct4 also known pou5f1 transcript distal enhanc retain pre-inactiv x chromosom state global reduct dna methyl h3k27me3 repress chromatin mark deposit development regulatori gene promot upon withdraw 2i/lif naiv mous es cell drift toward prime pluripot state resembl post-implant epiblast although human es cell share sever molecular featur naiv mous es cell also share varieti epigenet properti prime murin epiblast stem cell episc includ predomin use proxim enhanc element maintain oct4 express pronounc tendenc x chromosom inactiv femal human es cell increas dna methyl promin deposit h3k27me3 bival domain acquisit lineag regulatori gene feasibl establish human ground state naiv pluripot vitro equival molecular function featur character mous es cell remain defin establish defin condit facilit deriv genet unmodifi human naiv pluripot stem cell alreadi establish prime human es cell somat cell induc pluripot stem ip cell reprogram directli blastocyst novel naiv pluripot cell valid herein retain molecular characterist function properti highli similar mous naiv es cell distinct convent prime human pluripot cell includ compet gener cross-speci chimaer mous embryo underw organogenesi follow microinject human naiv ip cell mous morula collect find establish new avenu regen medicin patient-specif ip cell diseas model studi earli human develop vitro vivo',\n",
       "  'predict immunogen tumour mutat combin mass spectrometri exom sequenc human tumour typic harbour remark number somat mutat present major histocompat complex class molecul mhci peptid contain mutat could potenti immunogen recogn ‘ non-self ’ neo-antigen adapt immun system recent work confirm mutant peptid serv t-cell epitop howev mutant epitop describ discoveri requir labori screen patient tumour-infiltr lymphocyt abil recogn antigen librari construct follow tumour exom sequenc sought simplifi discoveri immunogen mutant peptid character gener properti develop approach combin whole-exom transcriptom sequenc analysi mass spectrometri identifi neo-epitop two wide use murin tumour model 1,300 amino acid chang identifi ∼13 predict bind mhci small fraction confirm mass spectrometri peptid structur model bound mhci mutat solvent-expos therefor access t-cell antigen receptor predict immunogen vaccin mice confirm approach predict immunogen peptid yield therapeut activ t-cell respons predict also enabl gener peptide–mhci dextram could use monitor kinet distribut anti-tumour t-cell respons vaccin find indic suitabl predict algorithm may provid approach pharmacodynam monitor t-cell respons well develop person vaccin cancer patient',\n",
       "  'vivo genom edit use staphylococcu aureu cas9 rna-guid endonucleas cas9 emerg versatil genome-edit platform howev size commonli use cas9 streptococcu pyogen spcas9 limit util basic research therapeut applic use highli versatil adeno-associ viru aav deliveri vehicl character six smaller cas9 orthologu show cas9 staphylococcu aureu sacas9 edit genom effici similar spcas9 1 kilobas shorter packag sacas9 singl guid rna express cassett singl aav vector target cholesterol regulatori gene pcsk9 mous liver within one week inject observ 40 gene modif accompani signific reduct serum pcsk9 total cholesterol level assess genome-wid target specif sacas9 spcas9 use bless demonstr sacas9-medi vivo genom edit potenti effici specif',\n",
       "  'effect exercis intens cardiovascular fit total bodi composit viscer adipos obes adolesc background littl known intens exercis influenc cardiovascular fit bodi composit especi obes adolesc object goal determin effect physic train intens cardiovascular fit percentag bodi fat bf viscer adipos tissu vat obes adolesc design obes 13-16-y-old n 80 assign 1 biweekli lifestyl educ lse 2 lse moderate-intens physic train 3 lse high-intens physic train intervent last 8 mo physic train offer 5 d/wk target energi expenditur subject physic train group 1047 kj 250 kcal /session cardiovascular fit measur multistag treadmil test bf dual-energi x-ray absorptiometri vat magnet reson imag result increas cardiovascular fit high-intens physic train group moderate-intens group significantli greater lse alon group p 0.009 comparison 3 group signific compar lse alon group group compos subject physic train group combin attend train session or=2 d/wk show favor chang cardiovascular fit p 0.001 bf p 0.001 vat p 0.029 found evid high-intens physic train effect moderate-intens physic train enhanc bodi composit conclus cardiovascular fit obes adolesc significantli improv physic train especi high-intens physic train physic train also reduc viscer total-bodi adipos clear effect intens physic train',\n",
       "  'low methionin ingest rat extend life span dietari energi restrict wide use mean experiment extend mammalian life span report lifelong reduct concentr singl dietari compon essenti amino acid l-methionin 0.86 0.17 diet result 30 longer life span male fischer 344 rat methionin restrict complet abolish growth although food intak actual greater bodi weight basi studi energi consumpt earli life indic energi intak 0.17 methionine-f anim near normal anim size although consumpt per anim much larger 0.86 methionine-f rat increas energi intak rat fed 0.17 methionin fail increas rate growth wherea restrict 0.85 methionine-f rat food intak 0.17 methionine-f anim materi reduc growth indic food restrict factor life span extens experi biochem well-defin pathway methionin metabol util offer potenti uncov precis mechan underli specif dietari restriction-rel extens life span',\n",
       "  'epicatechin cocoa polyphenol extract modul gene express human caco-2 cell perform function genom analysi studi effect epicatechin polyphenol cocoa extract human colon adenocarcinoma cell line caco-2 specif human hematology/immunolog cdna array clontech contain 406 gene duplic use differenti express gene classifi accord level express calcul ratio valu obtain treatment rel control cell statist signific p 0.05 upregul ratio 1.5 downregul ratio 0.6 treatment epicatechin decreas express 21 gene upregul 24 gene upon incub cocoa polyphenol extract 24 gene underexpress 28 overexpress chang express ferritin heavi polypeptid 1 fth1 mitogen-activ protein kinas kinas 1 mapkk1 signal transduc activ transcript 1 stat1 topoisomeras 1 upon incub epicatechin myeloid leukemia factor 2 mlf2 ccaat/enhanc bind protein gamma c/ebpg mapkk1 atp-bind cassett subfamili c member 1 mrp1 stat1 topoisomeras 1 x-ray repair complement defect repair 1 xrcc1 upon incub cocoa polyphenol extract valid rt-pcr chang messeng rna level mapkk1 stat1 mrp1 topoisomeras 1 upon incub either epicatechin cocoa extract confirm protein level western blot chang express stat1 mapkk1 mrp1 fth1 gene involv cellular respons oxid stress agreement antioxid properti cocoa flavonoid addit chang express c/ebpg topoisomeras 1 mlf2 xrcc1 suggest novel mechan action flavonoid molecular level',\n",
       "  'atla activ enhanc across human cell type tissu enhanc control correct tempor cell-type-specif activ gene express multicellular eukaryot know properti regulatori activ target crucial understand regul differenti homeostasi use fantom5 panel sampl cover major human tissu cell type produc atla activ vivo-transcrib enhanc show enhanc share properti cpg-poor messeng rna promot produc bidirect exosome-sensit rel short unsplic rna gener strongli relat enhanc activ atla use compar regulatori program differ cell unpreced depth identifi disease-associ regulatori singl nucleotid polymorph classifi cell-type-specif ubiquit enhanc explor util enhanc redund explain gene express strength rather express pattern onlin fantom5 enhanc atla repres uniqu resourc studi cell-type-specif enhanc gene regul',\n",
       "  'precis microbiom reconstitut restor bile acid mediat resist clostridium difficil gastrointestin tract mammal colon hundr microbi speci contribut health includ colon resist intestin pathogen mani antibiot destroy intestin microbi commun increas suscept intestin pathogen among clostridium difficil major caus antibiotic-induc diarrhoea greatli increas morbid mortal hospit patient intestin bacteria provid resist c. difficil infect vivo inhibitori mechan remain unclear correl loss specif bacteri taxa develop infect treat mice differ antibiot result distinct microbiota chang lead vari suscept c. difficil mathemat model augment analys microbiota hospit patient identifi resistance-associ bacteria common mice human use platform determin clostridium scinden bile acid 7α-dehydroxyl intestin bacterium associ resist c. difficil infect upon administr enhanc resist infect secondari bile acid depend fashion use workflow involv mous model clinic studi metagenom analys mathemat model identifi probiot candid correct clinic relev microbiom defici find implic ration design target antimicrobi well microbiome-bas diagnost therapeut individu risk c. difficil infect',\n",
       "  'transcript initi complex structur elucid dna open transcript eukaryot protein-cod gene begin assembl rna polymeras pol ii initi complex promot dna open report cryo-electron microscopi cryo-em structur yeast initi complex contain close open dna resolut 8.8 å 3.6 å respect dna posit retain pol ii cleft network interact tata-box-bind protein tbp transcript factor tfiia tfiib tfiie tfiif dna open occur around tip pol ii clamp tfiie ‘ extend wing helix ’ domain occur absenc tfiih load dna templat strand activ centr may facilit movement obstruct protein element trigger alloster bind tfiie ‘ e-ribbon ’ domain result suggest unifi model transcript initi key event trap open promot dna extend protein–protein protein–dna contact',\n",
       "  'multipl mechan disrupt let-7 microrna famili neuroblastoma poor prognosi neuroblastoma associ genet amplif mycn mycn target let-7 tumour suppressor famili microrna implic numer cancer lin28b inhibitor let-7 biogenesi overexpress neuroblastoma report regul mycn show howev lin28b dispens mycn-amplifi neuroblastoma cell line despit de-repress let-7 demonstr mycn messeng rna level amplifi diseas except high suffici spong let-7 reconcil dispens lin28b found genet loss let-7 common neuroblastoma invers associ mycn amplif independ associ poor outcom provid rational chromosom loss pattern neuroblastoma propos let-7 disrupt lin28b mycn spong genet loss unifi mechan neuroblastoma develop broad implic cancer pathogenesi',\n",
       "  'radiat dual checkpoint blockad activ non-redund immun mechan cancer immun checkpoint inhibitor result impress clinic respons optim result requir combin therapi rais fundament question mechan non-redund resist report major tumour regress subset patient metastat melanoma treat anti-ctla4 antibodi anti-ctla4 radiat reproduc effect mous model although combin treatment improv respons irradi unirradi tumour resist common unbias analys mice reveal resist due upregul pd-l1 melanoma cell associ t-cell exhaust accordingli optim respons melanoma cancer type requir radiat anti-ctla4 anti-pd-l1/pd-1 anti-ctla4 predominantli inhibit t-regulatori cell treg cell therebi increas cd8 t-cell treg cd8/treg ratio radiat enhanc divers t-cell receptor tcr repertoir intratumor cell togeth anti-ctla4 promot expans cell radiat shape tcr repertoir expand peripher clone addit pd-l1 blockad revers t-cell exhaust mitig depress cd8/treg ratio encourag oligoclon t-cell expans similarli result mice patient clinic trial melanoma show high pd-l1 respond radiat plu anti-ctla4 demonstr persist t-cell exhaust rapidli progress thu pd-l1 melanoma cell allow tumour escap anti-ctla4-bas therapi combin radiat anti-ctla4 anti-pd-l1 promot respons immun distinct mechan',\n",
       "  'g-protein-independ coupl mc4r kir7.1 hypothalam neuron regul releas anorexigen α-melanocyt stimul hormon α-msh orexigen agouti-rel protein agrp discret hypothalam arcuat neuron onto common target site central nervou system fundament role regul energi homeostasi peptid bind high affin melanocortin-4 receptor mc4r exist data show α-msh agonist coupl receptor gα signal pathway agrp bind competit block α-msh bind block constitut activ mediat ligand-mimet amino-termin domain receptor show mice regul fire activ neuron paraventricular nucleu hypothalamu pvn α-msh agrp mediat independ gα signal ligand-induc coupl mc4r closur inwardli rectifi potassium channel kir7.1 furthermor agrp bias agonist hyperpolar neuron bind mc4r open kir7.1 independ inhibit α-msh bind consequ kir7.1 signal appear central melanocortin-medi regul energi homeostasi within pvn coupl mc4r kir7.1 may explain unusu aspect control energi homeostasi melanocortin signal includ gene dosag effect mc4r sustain effect agrp food intak',\n",
       "  'role ghrelin relationship hyperphagia acceler gastric empti diabet mice background aim ghrelin orexigen peptid gastroprokinet effect mice streptozotocin stz -induc diabet exhibit hyperphagia alter gastric empti increas plasma ghrelin level investig caus role ghrelin herein compar chang ghrelin receptor knockout growth hormon secretagogu receptor ghs-r -/- wild-typ ghs-r +/+ mice stz-induc diabet method gastric empti measur 13 c octano acid breath test messeng rna mrna express neuropeptid npi agouti-rel peptid agrp proopiomelanocortin quantifi real-tim reverse-transcript polymeras chain reaction neural contract elicit electr field stimul fundic smooth muscl strip result diabet increas plasma ghrelin level similar extent genotyp hyperphagia pronounc ghs-r +/+ ghs-r -/- mice day 12 21. increas npi agrp mrna express less pronounc diabet ghs-r -/- ghs-r +/+ mice day 15 wherea decreas proopiomelanocortin mrna level similar genotyp gastric empti acceler similar extent genotyp start day 16. fundic smooth muscl strip diabet ghs-r +/+ ghs-r -/- mice neuron relax reduc wherea contract increas increas relat increas affin muscarin tachykinerg receptor conclus diabet hyperphagia regul central mechan ghrelin-sign pathway affect express npi agrp hypothalamu acceler gastric empti affect ghrelin signal caus diabet hyperphagia probabl involv local contractil chang fundu',\n",
       "  'human serum 25-hydroxycholecalciferol respons extend oral dose cholecalciferol background cholecalciferol input requir achiev maintain given serum 25-hydroxycholecalciferol concentr known particularli within rang compar probabl physiolog suppli vitamin object object establish quantit relat steadi state cholecalciferol input result serum 25-hydroxycholecalciferol concentr estim proport daili requir winter met cholecalciferol reserv bodi tissu store design cholecalciferol administ daili control oral dose label 0 25 125 250 micro g cholecalciferol approxim 20 wk winter 67 men live omaha 41.2 degre n latitud time cours serum 25-hydroxycholecalciferol concentr measur interv cours treatment result mean baselin valu 70.3 nmol/l equilibrium concentr serum 25-hydroxycholecalciferol chang winter month direct proport dose slope approxim 0.70 nmol/l addit 1 micro g cholecalciferol input calcul oral input requir sustain serum 25-hydroxycholecalciferol concentr present studi ie autumn 12.5 micro g 500 iu /d wherea total amount sourc supplement food tissu store need sustain start 25-hydroxycholecalciferol concentr estim approxim 96 micro g approxim 3800 iu /d differ tissu store provid approxim 78-82 micro g/d conclus healthi men seem use 3000-5000 iu cholecalciferol/d appar meet 80 winter cholecalciferol need cutan synthes accumul solar sourc preced summer month current recommend vitamin input inadequ maintain serum 25-hydroxycholecalciferol concentr absenc substanti cutan product vitamin',\n",
       "  'intratumor heterogen branch evolut reveal multiregion sequenc background intratumor heterogen may foster tumor evolut adapt hinder personalized-medicin strategi depend result singl tumor-biopsi sampl method examin intratumor heterogen perform exom sequenc chromosom aberr analysi ploidi profil multipl spatial separ sampl obtain primari renal carcinoma associ metastat site character consequ intratumor heterogen use immunohistochem analysi mutat function analysi profil messeng rna express result phylogenet reconstruct reveal branch evolutionari tumor growth 63 69 somat mutat detect across everi tumor region intratumor heterogen observ mutat within autoinhibitori domain mammalian target rapamycin mtor kinas correl s6 4ebp phosphoryl vivo constitut activ mtor kinas activ vitro mutat intratumor heterogen seen multipl tumor-suppressor gene converg loss function setd2 pten kdm5c underw multipl distinct spatial separ inactiv mutat within singl tumor suggest converg phenotyp evolut gene-express signatur good poor prognosi detect differ region tumor allel composit ploidi profil analysi reveal extens intratumor heterogen 26 30 tumor sampl four tumor harbor diverg allelic-imbal profil ploidi heterogen two four tumor conclus intratumor heterogen lead underestim tumor genom landscap portray singl tumor-biopsi sampl may present major challeng personalized-medicin biomark develop intratumor heterogen associ heterogen protein function may foster tumor adapt therapeut failur darwinian select fund medic research council other',\n",
       "  'success microbi consortia develop infant gut microbiom colon process infant gut microbiom call chaotic view could reflect insuffici document factor affect microbiom perform 2.5-i case studi assembl human infant gut microbiom relat life event microbiom composit function sixti fecal sampl collect healthi infant along diari diet health statu analysi 300,000 16 rrna gene indic phylogenet divers microbiom increas gradual time chang commun composit conform smooth tempor gradient contrast major taxonom group show abrupt shift abund correspond chang diet health commun assembl nonrandom observ discret step bacteri success punctuat life event furthermor analysi ≈ 500,000 dna metagenom read 12 fecal sampl reveal earliest microbiom enrich gene facilit lactat util function gene involv plant polysaccharid metabol present introduct solid food prime infant gut adult diet howev ingest tabl food caus sustain increas abund bacteroidet elev fecal short chain fatti acid level enrich gene associ carbohydr util vitamin biosynthesi xenobiot degrad stabl commun composit characterist adult microbiom studi reveal seemingli chaotic shift microbiom associ life event howev addit experi ought conduct assess differ infant respond similar life event',\n",
       "  'gamma-tocopherol major form vitamin e us diet deserv attent gamma-tocopherol major form vitamin e mani plant seed us diet drawn littl attent compar alpha-tocopherol predomin form vitamin e tissu primari form supplement howev recent studi indic gamma-tocopherol may import human health possess uniqu featur distinguish alpha-tocopherol gamma-tocopherol appear effect trap lipophil electrophil alpha-tocopherol gamma-tocopherol well absorb accumul signific degre human tissu metabol howev larg 2,7,8-trimethyl-2- beta-carboxyethyl -6-hydroxychroman gamma-cehc mainli excret urin gamma-cehc correspond metabolit deriv alpha-tocopherol natriuret activ may physiolog import gamma-tocopherol gamma-cehc alpha-tocopherol inhibit cyclooxygenas activ thu possess antiinflammatori properti human anim studi indic plasma concentr gamma-tocopherol invers associ incid cardiovascular diseas prostat cancer distinguish featur gamma-tocopherol metabolit suggest gamma-tocopherol may contribut significantli human health way recogn previous possibl evalu especi consid high dose alpha-tocopherol deplet plasma tissu gamma-tocopherol contrast supplement gamma-tocopherol increas review current inform bioavail metabol chemistri nonantioxid activ gamma-tocopherol epidemiolog data concern relat gamma-tocopherol cardiovascular diseas cancer',\n",
       "  \"disclosur apo genotyp risk alzheim 's diseas background apolipoprotein e apo genotyp provid inform risk alzheim 's diseas genotyp patient famili member discourag examin effect genotyp disclosur prospect random control trial method randomli assign 162 asymptomat adult parent alzheim 's diseas receiv result apo genotyp disclosur group receiv result nondisclosur group measur symptom anxieti depress test-rel distress 6 week 6 month 1 year disclosur nondisclosur result signific differ two group chang time-averag measur anxieti 4.5 disclosur group 4.4 nondisclosur group p=0.84 depress 8.8 8.7 respect p=0.98 test-rel distress 6.9 7.5 respect p=0.61 secondari comparison nondisclosur group disclosur subgroup subject carri apo epsilon4 allel associ increas risk also reveal signific differ howev epsilon4-neg subgroup significantli lower level test-rel distress epsilon4-posit subgroup p=0.01 subject clinic meaning chang psycholog outcom distribut evenli among nondisclosur group epsilon4-posit epsilon4-neg subgroup baselin score anxieti depress strongli associ post-disclosur score measur p 0.001 comparison conclus disclosur apo genotyp result adult children patient alzheim 's diseas result signific short-term psycholog risk test-rel distress reduc among learn apo epsilon4-neg person high level emot distress undergo genet test like emot difficulti disclosur clinicaltrials.gov number nct00571025\",\n",
       "  'blood pressur incid twelv cardiovascular diseas lifetim risk healthi life-year lost age-specif associ 1·25 million peopl background associ blood pressur differ manifest incid cardiovascular diseas contemporari popul compar studi aim analys associ blood pressur 12 differ present cardiovascular diseas method use link electron health record 1997 2010 calib cardiovascular research use link bespok studi electron health record programm assembl cohort 1·25 million patient 30 year age older initi free cardiovascular diseas fifth receiv blood pressure-low treatment studi heterogen age-specif associ clinic measur blood pressur 12 acut chronic cardiovascular diseas estim lifetim risk 95 year age cardiovascular disease-fre life-year lost adjust risk factor index age 30 60 80 year studi regist clinicaltrials.gov number nct01164371 find 5·2 year median follow-up record 83,098 initi cardiovascular diseas present age group lowest risk cardiovascular diseas peopl systol blood pressur 90-114 mm hg diastol blood pressur 60-74 mm hg evid j-shape increas risk lower blood pressur effect high blood pressur vari cardiovascular diseas endpoint strongli posit effect associ high systol blood pressur strongest intracerebr haemorrhag hazard ratio 1·44 95 ci 1·32-1·58 subarachnoid haemorrhag 1·43 1·25-1·63 stabl angina 1·41 1·36-1·46 weakest abdomin aortic aneurysm 1·08 1·00-1·17 compar diastol blood pressur rais systol blood pressur greater effect angina myocardi infarct peripher arteri diseas wherea rais diastol blood pressur greater effect abdomin aortic aneurysm rais systol pressur puls pressur associ invers abdomin aortic aneurysm hr per 10 mm hg 0·91 95 ci 0·86-0·98 strongest peripher arteri diseas 1·23 1·20-1·27 peopl hypertens blood pressur ≥140/90 mm hg receiv blood pressure-low drug lifetim risk overal cardiovascular diseas 30 year age 63·3 95 ci 62·9-63·8 compar 46·1 45·5-46·8 normal blood pressur develop cardiovascular diseas 5·0 year earlier 95 ci 4·8-5·2 stabl unstabl angina account 43 cardiovascular disease-fre year life lost associ hypertens index age 30 year wherea heart failur stabl angina account largest proport 19 year life lost index age 80 year interpret wide held assumpt blood pressur strong associ occurr cardiovascular diseas across wide age rang diastol systol associ concord support find high-resolut studi despit modern treatment lifetim burden hypertens substanti find emphasis need new blood pressure-low strategi help inform design randomis trial assess fund medic research council nation institut health research wellcom trust',\n",
       "  'onlin consum contribut drug knowledg mixed-method comparison consumer-gener profession control psychotrop medic inform internet background ongo initi filter onlin health search exclud consumer-gener content search return though inferior compar profession control content demonstr antidepress escitalopram antipsychot quetiapin rank last 5 year top-sel agent respect drug class drug variou off-label mental health non-ment health use rang relief insomnia migrain treatment sever development disord object object describ frequent report effect escitalopram quetiapin onlin consum review compar effect describ profession control commerci health websit gaug usabl onlin consum medic review method stratifi simpl random sampl 960 consum review select 6998 consum review two drug 2 consumer-gener www.askapatient.com www.crazymeds.u 2 profession control www.webmd.com www.revolutionhealth.com health websit profession medic descript includ standard inform medic latter 2 websit textual data induct code medic effect intercod agreement assess chi-squar use test associ consumer-report effect websit origin result consum take either escitalopram n 480 quetiapin n 480 frequent report symptom improv 30.4 146/480 24.8 119/480 symptom worsen 15.8 76/480 10.2 49/480 chang sleep 36 173/480 60.6 291/480 chang weight appetit 22.5 108/480 30.8 148/480 consum post review consumer-gener rather profession control websit report symptom worsen quetiapin 17.3 38/220 versu 5 11/220 p .001 consum post profession control websit report symptom improv 32.7 72/220 versu 21.4 47/220 p .008 profession descript frequent list physic advers effect warn suicid ideat consum review emphas effect disrupt daili routin provid richer descript effect context recent 20 consum review drug websit n 80 compar full sampl review frequenc commonli report effect conclus consum review profession medic descript gener report similar effect two psychotrop medic differ descript frequenc report profession medic descript offer advantag concis yet comprehens list drug effect consum review offer greater context situat exampl effect may manifest variou combin vari degre dispers consum review across websit limit integr brief brows strategi two target medic nonetheless retriev repres consum content current strategi filter onlin health search return trust approv websit may inappropri address challeng identifi qualiti health sourc internet strategi unduli limit access entir complementari sourc health inform',\n",
       "  \"effect supplement zinc growth serum zinc concentr prepubert children meta-analysi random control trial background multipl studi carri assess effect zinc supplement children 's growth result studi inconsist factor respons vari outcom unknown object meta-analys random control intervent trial therefor complet assess effect zinc supplement physic growth serum zinc concentr prepubert children design total 33 accept studi appropri data identifi medlin nation librari medicin bethesda md search method weight mean effect size express sd unit calcul chang height weight weight-for-height serum zinc concentr use random-effect model factor associ effect size explor meta-regress techniqu result zinc supplement produc highli signific posit respons height weight increment effect size 0.350 95 ci 0.189 0.511 0.309 0.178 0.439 respect signific effect zinc weight-for-height index weight mean effect size -0.018 -0.132 0.097 zinc supplement caus larg increas children 's serum zinc concentr effect size 0.820 0.499 1.14 growth respons greater children low initi weight-for-ag z score age 6 mo low initi height-for-ag z score conclus intervent improv children 's zinc nutritur consid popul risk zinc defici especi elev rate underweight stunt popul mean serum zinc concentr use indic success deliveri absorpt zinc supplement children\",\n",
       "  'mechan age-rel macular degener age-rel macular degener amd progress condit untreat 90 patient lead caus blind elderli worldwid two form amd wet dri classifi base presenc absenc blood vessel disrupt invad retina respect detail understand molecular mechan underli wet amd led sever robust fda-approv therapi contrast approv treatment dri amd review provid insight critic effector pathway mediat form diseas recur theme span aspect amd pathogenesi defect immun modul classic immune-privileg ocular interestingli latest advanc amd research also highlight common molecular diseas pathway neurodegen disord final therapeut potenti interven known mechanist step amd pathogenesi discuss',\n",
       "  'n-end rule pathway regul pathogen respons plant effici counteract pathogen plant reli complex set immun respons tightli regul allow time activ appropri durat adequ amplitud defens program coordin plant immun respons known requir activ ubiquitin/proteasom system control stabil protein eukaryot demonstr n-end rule pathway subset ubiquitin/proteasom system regul defens wide rang bacteri fungal pathogen model plant arabidopsi thaliana show pathway posit regul biosynthesi plant-defens metabolit glucosinol well biosynthesi respons phytohormon jasmon acid play key role plant immun result also suggest arginyl branch n-end rule pathway regul time amplitud defens program model pathogen pseudomona syringa avrrpm1',\n",
       "  'h3k9 demethylas kdm4e epigenet regul bovin embryon develop defect factor nuclear reprogram aberr epigenet reprogram often result development defect somat cell nuclear transfer scnt embryo embryon genom activ ega bovin eight-cel scnt embryo exhibit global hypermethyl histon h3 lysin 9 tri- di-methyl h3k9me3/2 intrins reason remain elus provid evid two h3k9 demethylas gene lysine-specif demethylas 4d kdm4d 4e kdm4e relat activ h3k9me3/2 demethyl vitro fertil ivf embryo defici express clone embryo time ega moreov kdm4e play crucial role ivf scnt embryon develop overexpress kdm4e restor global transcriptom improv blastocyst format increas clone effici scnt embryo result therebi indic kdm4e function crucial epigenet regul ega intern defect factor respons persist h3k9me3/2 barrier scnt-mediat reprogram furthermor show interact rna kdm4e essenti h3k9 demethyl ega observ advanc understand incomplet nuclear reprogram great import transgen cattl procreat',\n",
       "  'risk gestat hypertens relat folic acid supplement pregnanc author investig associ folic acid supplement gestat hypertens studi popul includ women nonmalform infant unit state canada particip slone epidemiolog center birth defect studi 1993 2000. women interview within 6 month deliveri sociodemograph medic factor occurr hypertens without preeclampsia multivitamin use pregnanc rel risk adjust weight pariti twin pregnanc diabet smoke educ famili incom estim use cox regress model 2,100 women 204 9.7 report gestat hypertens onset 20th week gestat multivariate-adjust rel risk develop gestat hypertens month folic acid supplement compar use folic acid month 0.55 95 confid interv 0.39 0.79 find suggest folic acid-contain multivitamin may reduc risk gestat hypertens',\n",
       "  'air regul neg select organ-specif cell autoimmun polyendocrinopathi syndrom type 1 recess mendelian disord result mutat novel gene air character spectrum organ-specif autoimmun diseas known toler mechan defect result air mutat trace fate autoreact cd4+ cell high affin pancreat antigen transgen mice air mutat show air defici caus almost complet failur delet organ-specif cell thymu result indic autoimmun polyendocrinopathi syndrom 1 caus failur special mechan delet forbidden cell clone establish central role toler mechan',\n",
       "  'extracellular acid ph activ sterol regulatori element-bind protein 2 promot tumor progress condit tumor microenviron hypoxia nutrient starvat play critic role cancer progress howev role acid extracellular ph cancer progress studi extens hypoxia show extracellular acid ph ph 6.8 trigger activ sterol regulatori element-bind protein 2 srebp2 stimul nuclear transloc promot bind target along intracellular acidif interestingli inhibit srebp2 srebp1 suppress upregul low ph-induc cholesterol biosynthesis-rel gene moreov acyl-coa synthetas short-chain famili member 2 acss2 direct srebp2 target provid growth advantag cancer cell acid ph furthermor acid ph-respons srebp2 target gene associ reduc overal surviv cancer patient thu find show srebp2 key transcript regul metabol gene progress cancer cell partli respons extracellular acidif',\n",
       "  'mutat human circadian clock gene cry1 famili delay sleep phase disord pattern daili human activ control intrins circadian clock promot ∼24 hr rhythm mani behavior physiolog process system alter delay sleep phase disord dspd common form insomnia sleep episod shift later time misalign societ norm report hereditari form dspd associ domin code variat core circadian clock gene cry1 creat transcript inhibitor enhanc affin circadian activ protein clock bmal1 gain-of-funct cry1 variant caus reduc express key transcript target lengthen period circadian molecular rhythm provid mechanist link dspd symptom allel frequenc 0.6 revers phenotyp unrel famili corrobor late and/or fragment sleep pattern carrier suggest affect sleep behavior sizeabl portion human popul',\n",
       "  'later hypothalam signal mechan underli feed stimul differenti contribut src famili tyrosin kinas feed trigger either nmda inject food depriv rat feed trigger experiment use mani approach includ among 1 food depriv 2 acut microinject neurotransmitt l-glutam glu receptor agonist nmda later hypothalam area lha paradigm nmda receptor nmda-r within lha appear critic involv transfer signal encod glu stimul feed howev intracellular mechan underli signal transfer unknown protein-tyrosin kinas ptk particip nmda-r signal mechan determin ptk involv lha mechan underli type feed stimul food intak biochem measur lha inject ptk inhibitor significantli suppress feed elicit lha nmda inject 69 mildli suppress depriv feed 24 suggest ptk may less critic signal underli feed behavior convers food depriv nmda inject produc mark increas appar activ src ptk express pyk2 src-activ ptk consid togeth behavior biochem result demonstr although easier suppress nmda-elicit feed ptk inhibitor food depriv readili drive ptk activ vivo latter result may reflect greater ptk recruit neurotransmitt receptor distinct nmda-r activ deprivation-elicit nmda-elicit feed result also demonstr use one feed stimul paradigm may fail reveal true contribut signal molecul pathway underli feed behavior vivo',\n",
       "  \"relationship advanc glycat end‐product accumul low skelet muscl mass japanes men women aim present studi aim investig relationship advanc glycat end-product accumul skelet muscl mass among middle-ag older japanes men women method total 132 particip enrol cross-sect studi skin autofluoresc assess measur advanc glycation-end product appendicular skelet muscl mass measur use dual-energi x-ray absorptiometri skelet muscl index calcul divid appendicular skelet muscl mass height squar particip divid two group low skelet muscl index normal skelet muscl index use asian work group sarcopenia 's skelet muscl index criteria diagnos sarcopenia multivari logist regress analysi area receiv oper characterist curv use determin signific factor associ low skelet muscl index result particip consist 70 men mean age 57 ± 10 year 62 women mean age 60 ± 11 year 31 101 particip low normal skelet muscl index group respect skin autofluoresc significantli higher low skelet muscl index group compar normal skelet muscl index group p 0.01 skin autofluoresc signific independ factor associ low skelet muscl index base multivari logist regress analysi odd ratio 15.7 95 confid interv 1.85-133.01 p 0.012 cut-off skin autofluoresc 2.45 arbitrari unit sensit 0.75 specif 0.91. conclus skin autofluoresc independ factor associ low skelet muscl index among middle-ag older japanes men women geriatr gerontol int 2017 17 785-790\",\n",
       "  'large-scal profil reveal influenc genet variat gene express human induc pluripot stem cell studi use whole-genom sequenc gene express profil 215 human induc pluripot stem cell ipsc line differ donor identifi genet variant associ rna express 5,746 gene abl predict causal variant express quantit trait loci eqtl disrupt transcript factor bind valid subset experiment also identifi copy-numb variant cnv eqtl includ appear affect gene express alter copi number intergen regulatori region addit abl identifi effect gene express rare genic cnv regulatori single-nucleotid variant found reactiv gene express x chromosom depend gene chromosom posit work highlight valu ipsc genet associ analys provid uniqu resourc investig genet regul gene express pluripot cell',\n",
       "  'ethanol extract allium fistulosum inhibit develop non-alcohol fatti liver diseas background/object non-alcohol fatti liver diseas nafld lead caus chronic liver diseas close associ metabol syndrom present studi observ effect ethanol extract allium fistulosum eaf nafld suggest possibl use eaf natur product applic develop treatment nafld materials/method prevent effect hepat lipid accumul estim use oleic acid oa -induc nafld model vitro western diet high-fat high-sucros wd -induc obes mous model anim divid three group n 7 normal diet group nd wd group wd plu 1 eaf group result eaf reduc oa-stimul lipid accumul hepg2 cell absenc cellular cytotox significantli block transcript activ sterol regulatori element-bind protein 1 fatti acid synthas gene subsequ investig effect vivo mice fed either nd wd presenc absenc eaf supplement comparison nd control wd-fed mice exhibit increas bodi weight liver weight epididym fat weight accumul fat hepatocyt effect significantli attenu eaf supplement conclus allium fistulosum attenu develop nafld eaf elicit anti-lipogen activ liver therefor eaf repres promis candid use develop novel therapeut drug drug combin prevent treatment nafld',\n",
       "  'cardiovascular risk factor childhood carotid arteri intima-media thick adulthood cardiovascular risk young finn studi context exposur cardiovascular risk factor childhood adolesc may associ develop atherosclerosi later life object studi relationship cardiovascular risk factor measur childhood adolesc common carotid arteri intima-media thick imt marker preclin atherosclerosi measur adulthood design set particip population-bas prospect cohort studi conduct 5 center finland among 2229 white adult age 24 39 year examin childhood adolesc age 3 18 year 1980 reexamin 21 year later septemb 2001 januari 2002. main outcom measur associ cardiovascular risk variabl level low-dens lipoprotein cholesterol ldl-c high-dens lipoprotein cholesterol hdl-c triglycerid ldl-c/hdl-c ratio systol diastol blood pressur bodi mass index smoke measur childhood adulthood common carotid arteri imt measur adulthood result multivari model adjust age sex imt adulthood significantli associ childhood ldl-c level p =.001 systol blood pressur p .001 bodi mass index p =.007 smoke p =.02 adult systol blood pressur p .001 bodi mass index p .001 smoke p =.004 number risk factor measur 12- 18-year-old adolesc includ high level ie extrem age- sex-specif 80th percentil ldl-c systol blood pressur bodi mass index cigarett smoke directli relat carotid imt measur young adult age 33 39 year p .001 men women remain signific adjust contemporan risk variabl number risk factor measur age 3 9 year demonstr weak direct relationship carotid imt age 24 30 year men p =.02 women p =.63 conclus risk factor profil assess 12- 18-year-old adolesc predict adult common carotid arteri imt independ contemporan risk factor find suggest exposur cardiovascular risk factor earli life may induc chang arteri contribut develop atherosclerosi',\n",
       "  \"microrna-29 induc cellular senesc age muscl multipl signal pathway mechan underli develop aging-induc muscl atrophi unclear microrna array individu qpcr analys found signific up-regul mir-29 muscl age rodent vs. result young age p85α igf-1 b-myb muscl level lower express certain cell arrest protein p53 p16 prb increas mir-29 express muscl progenitor cell mpc prolifer impair sa-βgal express increas signifi develop senesc impair mpc prolifer result interact mir-29 3'-utr p85a igf-1 b-myb suppress translat mediat myoblast prolifer vivo electropor mir-29 muscl young mice suppress prolifer increas level cellular arrest protein recapitul aging-induc respons muscl potenti stimulu mir-29 express wnt-3a sinc found exogen wnt-3a stimul mir-29 express 2.7-fold primari cultur mpc thu aging-induc muscl senesc result activ mir-29 wnt-3a lead suppress express sever signal protein p85α igf-1 b-myb act coordin impair prolifer mpc contribut muscl atrophi increas mir-29 provid potenti mechan aging-induc sarcopenia\",\n",
       "  'rictor novel bind partner mtor defin rapamycin-insensit raptor-independ pathway regul cytoskeleton mammalian tor mtor pathway integr nutrient- growth factor-deriv signal regul growth process wherebi cell accumul mass increas size mtor larg protein kinas target rapamycin immunosuppress also block vessel restenosi potenti anticanc applic mtor interact raptor gbetal protein form complex target rapamycin demonstr mtor also part distinct complex defin novel protein rictor rapamycin-insensit companion mtor rictor share homolog previous describ pianissimo d. discoidieum ste20p s. pomb avo3p s. cerevisia interestingli avo3p part rapamycin-insensit tor complex contain yeast homolog raptor signal actin cytoskeleton pkc1 consist find rictor-contain mtor complex contain gbetal raptor neither regul mtor effector s6k1 bound fkbp12-rapamycin find rictor-mtor complex modul phosphoryl protein kinas c alpha pkcalpha actin cytoskeleton suggest aspect tor signal conserv yeast mammal',\n",
       "  'activ estrogen receptor phosphoryl mitogen-activ protein kinas phosphoryl human estrogen receptor er serin residu posit 118 requir full activ er activ function 1 af-1 ser118 phosphoryl mitogen-activ protein kinas mapk vitro cell treat epiderm growth factor egf insulin-lik growth factor igf vivo overexpress mapk kinas mapkk guanin nucleotid bind protein ra activ mapk enhanc estrogen-induc antiestrogen tamoxifen -induc transcript activ wild-typ er mutant er alanin place ser118 thu activ amino-termin af-1 er modul phosphoryl ser118 ras-mapk cascad growth factor signal pathway',\n",
       "  'regul antimicrobi respons nlr protein nucleotide-bind oligomer domain nod -like receptor nlr protein famili innat immun receptor play pivot role microbi sens lead initi antimicrobi immun respons dysregul function multipl nlr famili member link mice human propens infect autoinflammatori diseas despit increas understand nlr function interact mani aspect relat mechan sens downstream signal vivo function remain elus review focu key member nlr famili describ activ divers microb downstream effector function interact innat sensor protein famili also discuss role microbi sens nlr receptor lead activ adapt immun arm collabor antimicrobi defens',\n",
       "  'acetylcystein prevent acut deterior renal function follow elect coronari angiographi intervent random control trial context antioxid acetylcystein prevent acut contrast nephrotox patient impair renal function undergo comput tomographi scan howev role coronari angiographi unclear object determin whether oral acetylcystein prevent acut deterior renal function patient moder renal insuffici undergo elect coronari angiographi design set prospect random double-blind placebo-control trial conduct may 2000 decemb 2001 grantham hospit univers hong kong particip two hundr chines patient age mean sd 68 6.5 year stabl moder renal insuffici creatinin clearanc 60 ml/min 1.00 ml/ undergo elect coronari angiographi without intervent intervent particip randomli assign receiv oral acetylcystein 600 mg twice per day n 102 match placebo tablet n 98 day day angiographi patient receiv low-osmol contrast agent main outcom measur occurr 25 increas serum creatinin level within 48 hour contrast administr chang creatinin clearanc serum creatinin level result twelv control patient 12 4 acetylcystein patient 4 develop 25 increas serum creatinin level within 48 hour contrast administr rel risk 0.32 95 confid interv ci 0.10-0.96 p =.03 serum creatinin lower acetylcystein group 1.22 mg/dl 107.8 micromol/l 95 ci 1.11-1.33 mg/dl vs 1.38 mg/dl 122.9 micromol/l 95 ci 1.27-1.49 mg/dl p =.006 first 48 hour angiographi acetylcystein treatment significantli increas creatinin clearanc 44.8 ml/min 0.75 ml/ 95 ci 42.7-47.6 ml/min 58.9 ml/min 0.98 ml/ 95 ci 55.6-62.3 ml/min 2 day contrast administr p .001 increas signific control group 42.1 44.1 ml/min 0.70 0.74 ml/ p =.15 benefit acetylcystein consist among variou patient subgroup persist least 7 day major treatment-rel advers event conclus acetylcystein protect patient moder chronic renal insuffici contrast-induc deterior renal function coronari angiograph procedur minim advers effect low cost',\n",
       "  \"dna methyl human cerebr cortex dynam regul throughout life span involv differenti neuron role dna cytosin methyl epigenet regul chromatin structur function normal patholog brain develop age remain unclear examin methylight pcr dna methyl statu 50 loci encompass primarili 5′ cpg island gene relat cn growth develop tempor neocortex 125 subject rang age 17 week gestat 104 year old two psychiatr diseas cohorts—defin chronic neurodegener alzheim 's lack thereof schizophrenia —were includ robust progress rise dna methyl level across lifespan observ 8/50 loci gabra2 gad1 hoxa1 neurod1 neurod2 pgr stk11 syk typic conjunct declin level correspond mrna anoth 16 loci defin sharp rise dna methyl level within first month year birth disease-associ chang limit 2/50 loci alzheim 's cohort appear reflect acceler age-rel chang normal brain addit methyl studi sort nuclei provid evid bidirect methyl event cortic neuron transit childhood advanc age reflect signific increas 3 decreas 1 10 loci furthermor dnmt3a de novo dna methyl-transferas express across age includ subset neuron resid layer iii v matur cortex therefor dna methyl dynam regul human cerebr cortex throughout lifespan involv differenti neuron affect substanti portion gene predominantli age-rel increas\",\n",
       "  'mulberri leav moru alba l. amelior obesity-induc hepat lipogenesi fibrosi oxid stress high-fat diet-f mice obes associ chronic diseas fatti liver type 2 diabet cardiovascular diseas sever metabol syndrom obes caus metabol impair includ excess lipid accumul fibrosi hepat tissu well increas oxid stress order investig effect mulberri leaf moru alba l. extract mle obesity-induc oxid stress lipogenesi fibrosi liver mle gavag 12 week high-fat diet hfd -induc obes mice mle treatment significantli amelior lxrα-mediat lipogenesi hepat fibrosi marker α-smooth muscl actin mle up-regul lipolysis-associ marker lipoprotein lipas hfd-fed mice moreov mle normal activ antioxid enzym includ heme oxygenase-1 glutathion peroxidas accord protein level 4-hydroxynonen hfd-fed mice mle benefici effect obesity-rel fatti liver diseas regul hepat lipid metabol fibrosi antioxid defens system mle supplement might potenti therapeut approach obesity-rel diseas includ non-alcohol fatti liver diseas',\n",
       "  'hmg-coa reductas inhibitor risk hip fractur elderli patient context recent anim studi found 3-hydroxy-3-methylglutaryl coenzym hmg-coa lipid-low drug statin substanti increas bone format whether statin use human result clinic meaning bone format reduct risk osteoporot fractur known object determin whether use statin associ reduc hip fractur risk design case-control studi set patient total 6110 new jersey resid age 65 year older enrol medicar either medicaid pharmaci assist age disabl program case patient n=1222 underw surgic repair hip fractur 1994. control patient n=4888 identifi ratio 4:1 frequency-match case patient age sex main outcom measur adjust odd ratio hip fractur statin use 180 day 3 year prior index date earliest date admiss surgeri adjust demograph clinic characterist health care util result use statin either prior 180 day adjust 0.50 95 confid interv ci 0.33-0.76 prior 3 year adjust 0.57 95 ci 0.40-0.82 associ signific reduct risk hip fractur even control variabl race insur statu psychoact medic estrogen thiazid use ischem heart diseas cancer diabet mellitu signific relationship observ use nonstatin lipid-low agent hip fractur risk clear relationship observ degre reduct hip fractur risk extent statin use evid relationship nonstatin lipid-low agent adjust extent statin use prior 3 year current use index date associ 71 reduct risk adjust 0.29 95 ci 0.10-0.81 relationship statin use hip fractur risk persist control variabl number medic charlson comorbid index score hospit nurs home stay last 180 day well exclud patient nurs home prior index date die year index date use nonstatin lipid-low agent observ associ reduct hip fractur risk altern model analys conclus find support associ statin use elderli patient reduct risk hip fractur control trial need exclud possibl unmeasur confound jama 2000 283:3211-3216',\n",
       "  'qualiti modern cross-sect ecolog studi bibliometr review ecolog studi design routin use epidemiologist spite limit present unknown well challeng design dealt epidemiolog research purpos bibliometr review critic evalu characterist statist method report result modern cross-sect ecolog paper search 6 major epidemiolog journal identifi cross-sect ecolog studi publish sinc januari 1 2000. total 125 articl met inclus requir assess via common evalu criteria found consider number cross-sect ecolog studi use unreli method contain statist oversight investig adjust outcom age sex improperli 64 statist valid potenti issu 20 regress model simpl linear regress common analyt approach 31 mani author omit import inform discuss ecolog natur studi 31 choic studi design 58 suscept research ecolog fallaci 49 result suggest need intern set guidelin standard report ecolog studi addit greater attent given relev biostatist literatur',\n",
       "  'efficaci beta1 integrin egfr target sphere-form human head neck cancer cell background resist radiotherapi continu limit factor treatment cancer includ head neck squamou cell carcinoma hnscc simultan target β1 integrin egfr shown higher radiosensit potenti mono-target major test hnscc cancer model tumor-initi cell tic thought play key role therapi resist recurr enrich sphere form condit studi investig efficaci β1 integrin/egfr target without combin x-ray irradi behavior sphere-form cell sfc method hnscc cell line utscc15 utscc5 cal33 sa inject subcutan nude mice tumor up-tak plate primari secondari sphere format non-adhes condit thought reflect enrich sfc self-renew capac respect treatment accomplish inhibitori antibodi β1 integrin aiib2 egfr cetuximab well x-ray irradi 2 6 gy singl dose flow cytometri tic marker express cell cycl well western blot dna repair protein express phosphoryl employ result found higher primari secondari sphere form capac sa cell rel hnscc cell line line tumor up-tak rate sa versu utscc15 cell aiib2 cetuximab administr minor cytotox radiosensit effect sfc intriguingli secondari sa sphere repres fraction surviv sfc upon passag show greatli enhanc radiosensit compar primari sphere intriguingli neither aiib2 cetuximab significantli alter basal sphere form capac radiosensit increas accumul g0/g1 phase cell observ secondari sa sphere dna doubl strand break repair indic differ basi significantli enhanc atm chk2 dephosphoryl upon irradi conclus hnscc model sphere-form condit select cell unsuscept anti-β1 integrin anti-egfr inhibitori antibodi regard primari secondari sphere format data suggest sfc fraction express distinct surviv strategi independ β1 integrin egfr futur work warrant better understand sfc surviv enrich treatment untangl underli mechan identifi novel druggabl cancer target sfc',\n",
       "  'anxieti object examin effect routin administ psychiatr questionnair recognit manag outcom psychiatr disord non-psychiatr set data sourc embas medlin psyclit cinahl cochran control trial regist hand search key journal method systemat review randomis control trial administr routin feedback psychiatr screen outcom questionnair clinician non-psychiatr set narr overview key design featur end point togeth random effect quantit synthesi compar studi main outcom measur recognit psychiatr disord feedback questionnair result intervent psychiatr disord outcom psychiatr disord result nine randomis studi identifi examin use common psychiatr instrument primari care gener hospit set studi compar effect administr instrument follow feedback result clinician administr feedback meta-analyt pool possibl four studi 2457 particip measur effect feedback recognit depress disord routin administr feedback score patient irrespect score increas overal rate recognit mental disord anxieti depress rel risk detect depress clinician feedback 0.95 95 confid interv 0.83 1.09 two studi show routin administr follow select feedback high scorer increas rate recognit depress rel risk detect depress feedback 2.64 1.62 4.31 increas recognit howev translat increas rate intervent overal studi routin administr psychiatr measur show effect patient outcom conclus routin measur outcom costli exercis littl evid show benefit improv psychosoci outcom psychiatr disord manag non-psychiatr set',\n",
       "  'challeng overcom antibiot resist plant extract potenti sourc antimicrobi resist modifi agent problem antibiot resist limit use cheap old antibiot necessit need continu search new antimicrobi compound understand mechan resist import develop strategi solv problem activ efflux drug alter target site enzymat degrad strategi pathogen bacteria acquir develop intrins resist antibiot multi-drug resist mdr pump capabl recogn expel varieti structur unrel compound bacteri cell confer resist wide rang antibiot sinc character mani gram posit gram neg pathogen like staphylococcu aureu pseudomona aeruginosa escherichia coli recent mycobacteria abil chemic compound call mdr inhibitor resist modifi agent modifi resist phenotyp bacteria work synergist antibiot vitro sinc observ search compound combin antibiot treatment drug resist infect may altern overcom problem resist bacteria crude extract medicin plant stand verit sourc potenti resist modifi agent african biospher promis potenti sourc compound owe rich plant speci divers',\n",
       "  'effect n-acetylcystein nucleu accumben neurotransmiss relaps cocain background relaps cocain seek link low glutam nucleu accumben core nacor caus potenti synapt glutam transmiss prefront cortex pfc affer system n-acetylcystein nac shown restor glutam homeostasi reduc relaps cocain seek depotenti pfc-nacor synaps examin effect nac appli directli nacor relaps neurotransmiss pfc-nacor synaps well involv metabotrop glutam receptor 2/3 mglur2/3 5 mglur5 method rat train self-administ cocain 2 week follow extinct receiv either intra-accumben nac system nac 30 120 minut respect induc reinstat condit cue combin cue cocain inject also record postsynapt current use vitro whole cell record acut slice measur cystin glutam uptak primari glial cultur result nac microinject nacor inhibit reinstat cocain seek slice low concentr nac reduc amplitud evok glutamaterg synapt current nacor mglur2/3-depend manner high dose nac increas amplitud mglur5-depend manner effect depend nac uptak cystein transport activ cysteine/glutam exchang final show block mglur5 inhibit cocain seek nac potenti conclus effect nac relaps cocain seek depend balanc stimul mglur2/3 mglur5 nacor efficaci nac improv simultan inhibit mglur5',\n",
       "  'phospholipid transfer function er-mitochondria encount structur reveal vitro phospholipid synthes mainli endoplasm reticulum er mitochondri inner membran cell properli distribut specif phospholipid divers cellular membran crucial problem mainten organelle-specif phospholipid composit although er-mitochondria encount structur erm propos facilit phospholipid transfer er mitochondria role erm still controversi await experiment demonstr develop novel vitro assay system isol yeast membran fraction monitor phospholipid exchang er mitochondria system found phospholipid transport er mitochondria reli membran intact energi sourc atp gtp membran potenti across mitochondri inner membran found lack erm compon impair phosphatidylserin transport er mitochondria phosphatidylethanolamin transport mitochondria er vitro assay system thu offer power tool analyz non-vesicular phospholipid transport er mitochondria',\n",
       "  'integrin β3–kras–ralb complex drive tumour stem resist egfr inhibit tumour cell stem-lik properti highli aggress often show drug resist reveal integrin αvβ3 serv marker breast lung pancreat carcinoma stem-lik properti highli resist receptor tyrosin kinas inhibitor erlotinib observ vitro mice bear patient-deriv tumour xenograft clinic specimen lung cancer patient progress erlotinib mechanist αvβ3 unligand state recruit kra ralb tumour cell plasma membran lead activ tbk1 nf-κb fact αvβ3 express result kras–ralb–nf-κb pathway necessari suffici tumour initi anchorag independ self-renew erlotinib resist pharmacolog target pathway bortezomib revers tumour stem erlotinib resist find identifi αvβ3 marker/driv carcinoma stem also reveal therapeut strategi sensit tumour rtk inhibit',\n",
       "  \"gain toxic apolipoprotein e4 effect human ipsc-deriv neuron amelior small-molecul structur corrector effort develop drug alzheim 's diseas ad shown promis anim studi fail human trial suggest press need studi ad human model system use human neuron deriv induc pluripot stem cell express apolipoprotein e4 apoe4 variant apo gene product major genet risk factor ad demonstr apoe4-express neuron higher level tau phosphoryl unrel increas product amyloid-β aβ peptid display gabaerg neuron degener apoe4 increas aβ product human mous neuron convert apoe4 apoe3 gene edit rescu phenotyp indic specif effect apoe4 neuron lack apo behav similarli express apoe3 introduct apoe4 express recapitul patholog phenotyp suggest gain toxic effect apoe4 treatment apoe4-express neuron small-molecul structur corrector amelior detriment effect thu show correct pathogen conform apoe4 viabl therapeut approach apoe4-rel ad\",\n",
       "  'lncrna neat1/let-7a-5p axi regul cisplatin resist nasopharyng carcinoma target rsf-1 modul ras-mapk pathway long non-cod rna nuclear paraspeckl assembl transcript 1 neat1 report upregul involv oncogen growth drug resist nasopharyng carcinoma npc howev exact role neat1 underli mechan drug resist npc remain larg unclear studi express neat1 let-72-5p rsf-1 mrna detect revers transcription-quantit polymeras chain reaction rt-qpcr effect neat1 let-72-5p cell prolifer cisplatin resist npc cell investig 3- 4,5-dimethylthiazol-2-yl -2,5-diphenyl tetrazolium bromid mtt assay 5-ethynyl-20-deoxyuridin edu assay western blot analysi perform detect protein level rsf-1 ra p-raf1 raf1 p-mek1 mek1 p-erk1/2 erk1/2 xenograft tumor assay done elucid role neat1 involv npc tumor growth vivo found neat1 upregul let-7a-5p downregul npc tissu well npc cell line inhibit neat1 markedli repress cisplatin resist npc cell neat1 demonstr interact let-7a-5p besid neg correl neat1 let-7a-5p express observ npc tissu rsf-1 confirm target let-7a-5p neat1 remark revers inhibitori effect let-7q-5p cisplatin resist npc cell vitro addit neat1 knockdown inhibit ras-mapk pathway npc cell neat1 knockdown suppress tumor growth presenc cisplatin vivo overal find suggest neat1/let-7a-5p axi regul cisplatin resist npc target rsf-1 modul ras-mapk signal pathway',\n",
       "  \"antibacteri peptid microcin j25 inhibit transcript bind within obstruct rna polymeras secondari channel antibacteri peptid microcin j25 mccj25 inhibit transcript bacteri rna polymeras rnap biochem result indic inhibit transcript occur level ntp uptak ntp bind rnap genet result indic inhibit transcript requir extens determin compris 50 amino acid residu within rnap secondari channel also known `` ntp-uptak channel '' `` pore '' biophys result indic inhibit transcript involv bind mccj25 within rnap secondari channel molecular model indic bind mccj25 within rnap secondari channel obstruct rnap secondari channel conclud mccj25 inhibit transcript bind within obstruct rnap secondari channel -- act essenti `` cork bottle. `` obstruct rnap secondari channel repres attract target drug discoveri\",\n",
       "  'explor exploit system effect deregul replic licens mainten accur propag genet materi key featur physiolog develop wellb replic licens machineri crucial replic precis ensur replic take place per cell cycl thu express statu compon compris replic licens apparatu tightli regul avoid re-repl form replic stress lead genom instabl hallmark cancer present review discuss mechanist basi replic licens deregul lead system effect exemplifi role carcinogenesi varieti genet syndrom addit new insight demonstr particular threshold replic licens factor cdc6 act global transcript regul outlin new line explor role put replic licens factor chlr1/ddx11 mutat warsaw breakag syndrom cancer also consid final futur perspect focus potenti therapeut advantag target replic licens factor particularli cdc6 discuss',\n",
       "  \"regulatori principl pluripot ground state pluripot remark capac singl cell engend special cell type adult organ properti captur indefinit deriv self-renew embryon stem cell esc repres invalu platform investig cell fate decis diseas recent advanc reveal manipul distinct signal cue render esc uniform `` ground state '' pluripot close recapitul pluripot naiv epiblast discuss extrins intrins regulatori principl underpin natur pluripot consid emerg spectrum pluripot state\",\n",
       "  \"neonat mortal level 193 countri 2009 trend sinc 1990 systemat analysi progress project prioriti background histor main focu studi childhood mortal infant under-f mortal rate neonat mortal death 28 day age receiv limit attent although death account 41 child death better assess progress develop annual estim neonat mortal rate nmr neonat death 193 countri period 1990-2009 forecast futur method find compil databas mortal neonat children 5 year compris 3,551 country-year inform reliabl civil registr data 1990 2009 avail 38 countri statist model develop estim nmr remain 155 countri 17 nation data countri consult undertaken identifi data input review estim 2009 estim 3.3 million babi die first month life-compar 4.6 million neonat death 1990-and half neonat death occur five countri world 44 global livebirth india 27.8 19.6 global livebirth nigeria 7.2 4.5 pakistan 6.9 4.0 china 6.4 13.4 democrat republ congo 4.6 2.1 1990 2009 global nmr declin 28 33.2 death per 1,000 livebirth 23.9. proport child death neonat period increas region world global 41 nmr halv region world africa 's nmr drop 17.6 43.6 35.9 conclus neonat mortal declin world region progress slowest region high nmr global health program need address neonat death effect millennium develop goal 4 two-third reduct child mortal achiev\",\n",
       "  'neuroprotect effect four phenylethanoid glycosid h2o2-induc apoptosi pc12 cell via nrf2/are pathway nuclear factor erythroid 2-relat factor 2 nrf2 key transcript factor oxid stress neurodegen disord phenylethanoid glycosid phg salidrosid acteosid isoacteosid echinacosid exhibit antioxid neuroprotect bioactiv studi perform investig neuroprotect effect molecular mechan phg phg pretreat significantli suppress h₂o₂-induc cytotox pc12 cell trigger nuclear transloc nrf2 revers downregul protein express heme oxygenas 1 ho-1 nad p h quinon oxidoreductas 1 nqo1 glutam cystein ligase-catalyt subunit gclc glutamate-cystein ligas modifi subunit gclm nrf2 sirna ho-1 inhibitor zinc protoporphyrin znpp reduc neuroprotect effect phg show potenti interact nrf2 bind site kelch-lik ech-associ protein 1 keap1 result may support hypothesi phg activ nrf2 demonstr potenti bind phg keap1-activ nrf2/are pathway phg glycosid enhanc effect',\n",
       "  'mortal risk attribut high low ambient temperatur multicountri observ studi background although studi provid estim prematur death attribut either heat cold select countri none far offer systemat assess across whole temperatur rang popul expos differ climat aim quantifi total mortal burden attribut non-optimum ambient temperatur rel contribut heat cold moder extrem temperatur method collect data 384 locat australia brazil canada china itali japan south korea spain sweden taiwan thailand uk usa fit standard time-seri poisson model locat control trend day week estim temperature-mort associ distribut lag non-linear model 21 day lag pool multivari metaregress includ countri indic temperatur averag rang calcul attribut death heat cold defin temperatur optimum temperatur correspond point minimum mortal moder extrem temperatur defin use cutoff 2·5th 97·5th temperatur percentil find analys 74,225,200 death variou period 1985 2012. total 7·71 95 empir ci 7·43-7·91 mortal attribut non-optimum temperatur select countri within studi period substanti differ countri rang 3·37 3·06 3·63 thailand 11·00 9·29 12·47 china temperatur percentil minimum mortal vari roughli 60th percentil tropic area 80-90th percentil temper region temperature-attribut death caus cold 7·29 7·02-7·49 heat 0·42 0·39-0·44 extrem cold hot temperatur respons 0·86 0·84-0·87 total mortal interpret temperature-rel mortal burden attribut contribut cold effect day extrem temperatur substanti less attribut milder non-optimum weather evid import implic plan public-health intervent minimis health consequ advers temperatur predict futur effect climate-chang scenario fund uk medic research council',\n",
       "  'survivin requir endomitot cell cycl megakaryocyt survivin member chromosom passeng complex play import role chromosom align separ cytokinesi although survivin requir prolifer surviv hematopoiet stem progenitor cell extent necessari endomitosi megakaryocyt remain controversi determin whether survivin requir polyploid analyz mice megakaryocyte-specif delet pf4-cre/survivin fl/fl mice harbor normal platelet count megakaryocyt reach ploidi state compar control litterm cd41 cell within anim show littl excis increas annexin v stain impli survivin requir surviv megakaryocyt progenitor vivo contrast megakaryocyt survivin excis ex vivo show robust excis increas degre polyploid result demonstr survivin necessari surviv megakaryocyt progenitor requir polyploid commit megakaryocyt',\n",
       "  'β1 integrin mediat altern surviv pathway breast cancer cell resist lapatinib introduct overexpress human epiderm growth factor receptor -2 20 human breast cancer associ aggress growth led widespread use her2-target therapi trastuzumab lapatinib l despit success drug efficaci limit patient whose tumor demonstr de novo acquir resist treatment β1 integrin resid membran breast cancer cell activ sever element breast tumor progress includ prolifer surviv method develop panel her2-overexpress cell line resist l potent lt combin long-term exposur valid model 3d cultur parent l/t/lt-resist cell subject her2 β1 integrin inhibitor 3d monitor 12 day follow quantif coloni number parallel experi conduct cell either stain ki-67 termin deoxynucleotidyl transferas dutp nick end label tunel harvest protein analyz immunoblot result subject statist test use analysi varianc linear contrast follow adjust sidak method result use multipl cell line includ bt474 hcc1954 reveal l lt resist phosphoryl egfr/her1 her2 her3 strongli inhibit kinas downstream β1 integrin -- includ focal adhes kinas fak src -- up-regul blockad β1 antibodi aiib2 abrog up-regul function achiev signific growth inhibit l lt resist cell 3d without dramat affect parent cell sirna β1 well pharmacolog inhibit fak achiev growth inhibitori effect contrast trastuzumab-resist cell retain high level phosphoryl egfr/her1 her2 her3 modestli growth-inhibit aiib2 conclus data suggest her2 activ suppress resist involv l alon dictat whether β1 mediat altern pathway drive resist find justifi clinic studi investig inhibit β1 downstream signal moieti strategi overcom acquir l lt resist',\n",
       "  'incid trend sepsi us hospit use clinic vs claim data 2009-2014 import estim claims-bas analys suggest incid sepsi increas mortal rate sepsi decreas howev estim claim data may lack clinic fidel affect chang diagnosi code practic time object estim us nation incid sepsi trend use detail clinic data electron health record ehr system divers hospit design set popul retrospect cohort studi adult patient admit 409 academ commun feder hospit 2009-2014. exposur sepsi identifi use clinic indic presum infect concurr acut organ dysfunct adapt third intern consensu definit sepsi septic shock sepsis-3 criteria object consist ehr-bas surveil main outcom measur sepsi incid outcom trend 2009-2014 calcul use regress model compar claims-bas estim use intern classif diseas ninth revis clinic modif code sever sepsi septic shock case-find criteria valid sepsis-3 criteria use medic record review result total 173 690 sepsi case mean age 66.5 sd 15.5 77 660 42.4 women identifi use clinic criteria among 2 901 019 adult admit studi hospit 2014 6.0 incid 26 061 15.0 die hospit 10 731 6.2 discharg hospic 2009-2014 sepsi incid use clinic criteria stabl +0.6 rel change/i 95 ci −2.3 3.5 p .67 wherea incid per claim increas +10.3 /y 95 ci 7.2 13.3 p .001 in-hospit mortal use clinic criteria declin −3.3 /y 95 ci −5.6 −1.0 p .004 signific chang combin outcom death discharg hospic −1.3 /y 95 ci −3.2 0.6 p .19 contrast mortal use claim declin significantli −7.0 /y 95 ci −8.8 −5.2 p .001 death discharg hospic −4.5 /y 95 ci −6.1 −2.8 p .001 clinic criteria sensit identifi sepsi claim 69.7 95 ci 52.9 92.0 vs 32.3 95 ci 24.4 43.0 p .001 compar posit predict valu 70.4 95 ci 64.0 76.8 vs 75.2 95 ci 69.8 80.6 p .23 conclus relev clinic data 409 hospit sepsi present 6 adult hospit contrast claims-bas analys neither incid sepsi combin outcom death discharg hospic chang significantli 2009-2014. find also suggest ehr-bas clinic data provid object estim claims-bas data sepsi surveil',\n",
       "  'body-mass index risk 22 specif cancer population-bas cohort studi 5·24 million uk adult background high body-mass index bmi predispos sever site-specif cancer large-scal systemat detail characteris pattern risk across common cancer adjust potenti confound previous undertaken aim investig link bmi common site-specif cancer method primari care data individu clinic practic research datalink bmi data fit cox model investig associ bmi 22 common cancer adjust potenti confound fit linear non-linear spline model investig effect modif sex menopaus statu smoke age calcul popul effect find 5·24 million individu includ 166,955 develop cancer interest bmi associ 17 22 cancer effect vari substanti site 5 kg/m 2 increas bmi roughli linearli associ cancer uteru hazard ratio hr 1·62 99 ci 1·56-1·69 p 0·0001 gallbladd 1·31 1·12-1·52 p 0·0001 kidney 1·25 1·17-1·33 p 0·0001 cervix 1·10 1·03-1·17 p=0·00035 thyroid 1·09 1·00-1·19 p=0·0088 leukaemia 1·09 1·05-1·13 p≤0·0001 bmi posit associ liver 1·19 1·12-1·27 colon 1·10 1·07-1·13 ovarian 1·09 1.04-1.14 postmenopaus breast cancer 1·05 1·03-1·07 overal p 0·0001 effect vari underli bmi individual-level characterist estim invers associ prostat premenopaus breast cancer risk overal prostat 0·98 0·95-1·00 premenopaus breast cancer 0·89 0·86-0·92 never-smok prostat 0·96 0·93-0·99 premenopaus breast cancer 0·89 0·85-0·94 contrast lung oral caviti cancer observ associ never smoker lung 0·99 0·93-1·05 oral caviti 1·07 0·91-1·26 invers associ overal driven current smoker ex-smok probabl residu confound smoke amount assum causal 41 uterin 10 gallbladd kidney liver colon cancer could attribut excess weight estim 1 kg/m 2 population-wid increas bmi would result 3790 addit annual uk patient develop one ten cancer posit associ bmi interpret bmi associ cancer risk substanti population-level effect heterogen effect suggest differ mechan associ differ cancer site differ patient subgroup fund nation institut health research wellcom trust medic research council',\n",
       "  'cryo-em structur herpesviru capsid 3.1 å structur genet human herpesvirus among largest complex virus use cryo–electron microscopi cryo-em optim imag reconstruct strategi report herp simplex viru type 2 hsv-2 capsid structur 3.1 angstrom built 3000 protein organ three type hexon central peripenton edg penton triplex hexon penton contain major capsid protein vp5 hexon also contain small capsid protein vp26 triplex compris vp23 vp19c act core organ vp5 protein form extens intermolecular network involv multipl disulfid bond 1500 total noncoval interact vp26 protein triplex underpin capsid stabil assembl conform adapt protein induc microenviron lead 46 differ conform assembl massiv quasisymmetr shell exemplifi structur function complex hsv',\n",
       "  'asymptot resampl strategi assess compar indirect effect multipl mediat model hypothes involv mediat common behavior scienc mediat exist predictor affect depend variabl indirectli least one interven variabl mediat method assess mediat involv multipl simultan mediat receiv littl attent methodolog literatur despit clear need provid overview simpl multipl mediat explor three approach use investig indirect process well method contrast two mediat within singl model present illustr exampl assess contrast potenti mediat relationship help social agent job satisfact also provid sa spss macro well mplu lisrel syntax facilit use method applic',\n",
       "  'distinct metabolom signatur associ longev human alter metabol influenc lifespan experiment model data human lack use liquid chromatography/mass spectrometri quantifi 217 plasma metabolit examin relat longev larg cohort men women follow 20 year find higher concentr citric acid cycl intermedi isocitr bile acid taurochol associ lower odd longev defin attain 80 year age higher concentr isocitr taurochol also associ wors cardiovascular health baselin well risk futur cardiovascular diseas death none metabolit identifi associ cancer risk find suggest metabol pathway relat human longev link risk common caus death',\n",
       "  'expand problem adipos depot remodel postnat adipocyt progenitor recruit rise incid obes associ metabol diseas increas urgenc understand aspect adipos tissu biolog includ function adipocyt adipos tissu expand obes expand adipos tissu adult impact physiolog highlight grow appreci import de novo adipocyt differenti adipos tissu expans adult human anim detail recent effort identifi adipos precursor popul contribut physiolog postnat recruit white brown beig adipocyt mice summar new data reveal complex adipos tissu develop vivo',\n",
       "  'clonal competit bcrabl-driven leukemia transplant acceler clonal convers background clonal competit cancer describ process progeni cell clone supersed succumb compet clone due differ function characterist mostli base subsequ acquir mutat even though pattern mutat well explor mani tumor dynam process clonal select underexpos method studi dynam clonal competit bcrabl-induc leukemia use γ-retrovir vector librari encod oncogen conjunct genet barcod end studi growth dynam transduc cell clonal level vitro vivo transplant mice result detect moder chang clonal abund vitro observ monoclon leukemia 6/30 mice transplant intriguingli caus two differ bcrabl clone analyz success clone appli mathemat model hematopoiet tissu mainten indic differenti engraft capac two domin clone provid possibl explan observ find support addit transplant experi increas bcrabl transcript level clone conclus find show clonal competit absolut process base mutat highli depend select mechan given environment context',\n",
       "  'open babel open chemic toolbox background frequent problem comput model interconvers chemic structur differ format standard interchang format exist exampl chemic markup languag de facto standard arisen exampl smile format need interconvert format continu problem due multitud differ applic area chemistri data differ data store differ format 0d versu 3d exampl competit softwar along lack vendor-neutr format result discuss first time open babel open-sourc chemic toolbox speak mani languag chemic data open babel version 2.3 interconvert 110 format need repres wide varieti chemic molecular data requir librari implement wide rang cheminformat algorithm partial charg assign aromat detect bond order percept canonic detail implement open babel describ key advanc 2.3 releas outlin varieti use term softwar product scientif research includ applic far beyond simpl format interconvers conclus open babel present solut prolifer multipl chemic file format addit provid varieti use util conform search 2d depict filter batch convers substructur similar search develop use program librari handl chemic data area organ chemistri drug design materi scienc comput chemistri freeli avail open-sourc licens http //openbabel.org',\n",
       "  \"young adolesc nutrit assess comput yana-c object assess rel valid accept computeris 24-h recal ‘ young adolesc 's nutrit assess comput yana-c ’ .design food nutrient intak assess yana-c compar food record studi 1 24-h dietari recal interview studi 2 .main outcom measur intak food group fruit fruit juic veget potato bread cereal milk chees milk product soft drink diet soft drink sugar/sweet pastry/cooki savouri snack butter/sauc egg fish meat nutrient energi carbohydr protein fat fiber calcium vitamin c iron .subject set total 237 pupil 11–14 two primari four secondari school studi 1 n=136 studi 2 n=101 belgium-fland result yana-c prove agre well standard method categor subject consum nonconsum κstudi 1=0.48–0.92 κstudi 2=0.38–0.90 spearman 's correl energi nutrient intak rang 0.44 0.79 studi 1 0.44 0.86 studi 2. nutrient energi intak gener exclud calcium significantli higher yana-c comparison food record comparison interview fiber statist use investig whether yana-c agre method rank portions/amount consum fair moder food group weight κ studi 1=0.11–0.55 studi 2=0.04–0.73 amount consum significantli lower yana-c standard cereal amount significantli higher yana-c food record milk soft drink sugar/sweet savouri snack interview potato pupil evalu program neg conclus yana-c promis method collect detail dietari inform young adolesc rel low staff resourc use mani nutrit research applic\",\n",
       "  'antiretrovir therapi prevent tuberculosi adult hiv systemat review meta-analysi background human immunodefici viru hiv infect strongest risk factor develop tuberculosi fuell resurg especi sub-saharan africa 2010 estim 1.1 million incid case tuberculosi among 34 million peopl live hiv worldwid antiretrovir therapi substanti potenti prevent hiv-associ tuberculosi conduct systemat review studi analys impact antiretrovir therapi incid tuberculosi adult hiv infect method find pubm embas african index medicu lilac clinic trial registri systemat search randomis control trial prospect cohort studi retrospect cohort studi includ compar tuberculosi incid antiretrovir therapi statu hiv-infect adult median 6 mo develop countri meta-analys four categori base cd4 count antiretrovir therapi initi 1 less 200 cells/µl 2 200 350 cells/µl 3 greater 350 cells/µl 4 cd4 count eleven studi met inclus criteria antiretrovir therapi strongli associ reduct incid tuberculosi baselin cd4 count categori 1 less 200 cells/µl hazard ratio hr 0.16 95 confid interv ci 0.07 0.36 2 200 350 cells/µl hr 0.34 95 ci 0.19 0.60 3 greater 350 cells/µl hr 0.43 95 ci 0.30 0.63 4 cd4 count hr 0.35 95 ci 0.28 0.44 evid hazard ratio modif respect baselin cd4 count categori p 0.20 conclus antiretrovir therapi strongli associ reduct incid tuberculosi across cd4 count strata earlier initi antiretrovir therapi may key compon global nation strategi control hiv-associ tuberculosi syndem review registr intern prospect regist systemat review crd42011001209 pleas see later articl editor summari',\n",
       "  'diabet metabol syndrom breast cancer review current evid incid breast cancer type 2 diabet metabol syndrom increas past decad obes epidem especi industri countri insulin resist hyperinsulinemia chang signal growth hormon steroid hormon associ diabet may affect risk breast cancer review epidemiolog studi associ type 2 diabet risk breast cancer avail evid role hormon mediat associ diabet breast cancer combin evid support modest associ type 2 diabet risk breast cancer appear consist among postmenopaus among premenopaus women despit mani propos potenti pathway mechan underli associ diabet breast cancer risk remain unclear particularli 2 diseas share sever risk factor includ obes sedentari lifestyl possibl intak satur fat refin carbohydr may confound associ although metabol syndrom close relat diabet embrac addit compon might influenc breast cancer risk role metabol syndrom breast carcinogenesi studi thu remain unknown',\n",
       "  'loss tdp43 inhibit progress triple-neg breast cancer coordin srsf3 aberr altern splice highlight potenti hallmark cancer identifi tdp43 tar dna-bind protein 43 import splice regul respons uniqu splice profil triple-neg breast cancer tnbc clinic data demonstr tdp43 highli express tnbc poor prognosi knockdown tdp43 inhibit tumor progress includ prolifer metastasi overexpress tdp43 promot prolifer malign mammari epitheli cell deep sequenc analysi function experi indic tdp43 alter splice event splice factor srsf3 serine/arginine-rich splice factor 3 regul tnbc progress tdp43/srsf3 complex control specif splice event includ downstream gene par3 numb effect reduc metastasi prolifer upon knockdown tdp43 srsf3 mediat splice regul par3 numb exon 12 respect tdp43/srsf3 complex downstream par3 isoform potenti therapeut target tnbc',\n",
       "  'atherosclerot plaqu ruptur -- patholog basi plaqu stabil instabl time primari reveiw 27 day atherosclerosi continu one main subject patholog research intrigu complex pathogenesi well import clinic sequela provid rational 1 larg number diseas total differ clinic present basic atherosclerosi relat among myocardi infarct stroke abdomin aneurysm lower limb ischemia determin larg extent morbid mortal western style popul despit broad spectrum clinic diseas acut manifest atherosclerosi share common pathogenet featur ruptur atherosclerot plaqu 2–4 plaqu disrupt may vari greatli extent tini fissur eros plaqu surfac deep intim tear extend soft lipid core lesion instanc least degre thrombu format occur 5 6 abdomin aorta arteri site promin involv process plaqu format also plaqu complic larg diamet vessel process plaqu disrupt thrombosi end lumin occlus may lead extens surfac ulcer compris larg area aortic wall observ mani autopsi case older age apart undisput role atherosclerosi abdomin aneurysm format 7 mural thrombosi lead surprisingli low rate clinic signific complic patient although cholesterol emboli regularli found kidney skin autopsi still present unclear impact variou biolog activ mediat releas erod aortic surfac may human bodi contrast small diamet vessel coronari arteri occlus thrombosi frequent often fatal complic plaqu … correspond author tel +31-20-5665-633 fax +31-20-914-738 e-mail a.c.vanderw amc.uva.nl',\n",
       "  'pioneer factor pax7 deploy stabl enhanc repertoir specif cell fate pioneer transcript factor establish new cell-fat compet trigger chromatin remodel howev mani featur pioneer action kinet stabil remain poorli defin show pax7 open uniqu repertoir enhanc necessari suffici specif one pituitari lineag pax7 bind target enhanc rapidli chromatin remodel gene activ slower enhanc open pax7 show loss dna methyl acquir stabl epigenet memori evidenc bind nonpion factor pax7 withdraw work show transient pax7 express suffici stabl specif cell ident analysi pax7 dynam pituitari lineag specif show pax7 bind rapidli uniqu mark heterochromatin pioneer site initi chromatin open remain stabl pax7 withdraw loss dna hypermethyl pioneer enhanc',\n",
       "  'human cancer cell util mitot dna synthesi resist replic stress telomer regardless telomer mainten mechan telomer resembl common fragil site cfss difficult-to-repl exhibit fragil mitosi respons dna replic stress cfss fragil associ delay complet dna replic earli mitosi whereupon cell propos switch rad52-depend form break-induc replic show mitot dna synthesi mida also featur human telomer telomer mida restrict telomer display overt fragil featur wide rang cell line irrespect whether telomer maintain telomeras altern lengthen telomer alt mechan mida telomer requir rad52 mechanist similar cfs-associ mida notabl except telomer mida requir mus81-eme1 endonucleas propos model wherebi replic stress initi rad52-depend form break-induc replic bypass requir mus81-eme1 complet dna synthesi mitosi',\n",
       "  'low drug level thrombot complic high‐risk atrial fibril patient treat direct oral anticoagul essenti direct oral anticoagul doac requir laboratori monitor current doac specif measur perform trough patient atrial fibril patient develop thromboembol event show lower doac plasma level studi support concept measur doac level steadi state summari background direct oral anticoagul doac administ fix dose without need dose adjust accord laboratori test high interindividu variabl drug blood level shown doac evalu possibl relationship doac c-trough anticoagul level thromboembol event 565 consecut naiv patient atrial fibril af enrol studi perform within start laboratori registri method doac-specif measur dilut thrombin time anti-activ factor ii calibr dabigatran anti-activ fx calibr rivaroxaban apixaban c-trough perform local steadi state within 15-25 day start treatment doac interv c-trough level limit quantif highest valu subdivid four equal class result attribut class median valu result also calcul thromboembol complic occur 1 year follow-up record result thromboembol event 1.8 occur 10 patient baselin c-trough level lowest class drug level incid thromboembol event among patient doac c-trough level lowest level class 2.4 remain group 0 patient thrombot complic also higher mean cha2 ds2 -vasc score total patient popul 5.3 95 confid interv ci 4.3-6.3 versu 3.0 95 ci 2.9-3.1 conclus studi cohort thrombot complic occur doac-treat af patient low c-trough level rel high cha2 ds2 -vasc score larger studi warrant confirm preliminari observ',\n",
       "  \"consensu guidelin detect immunogen cell death apoptot cell long consid intrins tolerogen unabl elicit immun respons specif dead cell-associ antigen howev multipl stimuli trigger function peculiar type apoptot demis go unnot adapt arm immun system name `` immunogen cell death '' icd icd preced accompani emiss seri immunostimulatori damage-associ molecular pattern damp precis spatiotempor configur sever anticanc agent success employ clinic decad includ variou chemotherapeut radiotherapi elicit icd moreov defect compon underli capac immun system perceiv cell death immunogen neg influenc diseas outcom among cancer patient treat icd induc thu icd profound clinic therapeut implic unfortun gold-standard approach detect icd reli vaccin experi involv immunocompet murin model syngen cancer cell approach incompat larg screen campaign outlin strategi conceiv detect surrog marker icd vitro screen larg chemic librari put icd induc base high-cont high-throughput platform recent develop platform allow detect multipl damp like cell surface-expos calreticulin extracellular atp high mobil group box 1 hmgb1 and/or process underli emiss endoplasm reticulum stress autophagi necrot plasma membran permeabil surmis technolog facilit develop next-gener anticanc regimen kill malign cell simultan convert cancer-specif therapeut vaccin\",\n",
       "  'long-term erk inhibit kras-mut pancreat cancer associ myc degrad senescence-lik growth suppress induct compensatori mechan erk reactiv limit effect raf mek inhibitor ras-mut cancer determin direct pharmacolog inhibit erk suppress growth subset kras-mut pancreat cancer cell line concurr phosphatidylinositol 3-kinas pi3k inhibit caus synergist cell death addit combin enhanc erk inhibitor action also identifi unexpectedli long-term treatment sensit cell line caus senesc mediat part myc degrad p16 reactiv enhanc basal pi3k-akt-mtor signal associ de novo resist erk inhibitor protein kinas identifi kinome-wid sirna screen genet gain-of-funct screen find reveal distinct consequ inhibit kinas cascad level erk',\n",
       "  'trf2 recruit rtel1 telomer phase promot t-loop unwind helicas rtel1 promot t-loop unwind suppress telomer fragil maintain integr vertebr telomer interact rtel1 pcna import prevent telomer fragil rtel1 engag telomer promot t-loop unwind unclear establish shelterin protein trf2 recruit rtel1 telomer phase requir prevent catastroph t-loop process structure-specif nucleas show trf2-rtel1 interact mediat metal-coordin c4c4 motif rtel1 compromis hoyeraal-hreidarsson syndrom hh mutat rtel1 r1264h convers defin trf2 i124d substitut mutat within trfh domain trf2 elimin rtel1 bind phenocopi rtel1 r1264h mutat give rise aberr t-loop excis telomer length heterogen loss telomer circl result implic trf2 recruit rtel1 facilit t-loop disassembl telomer phase',\n",
       "  'macrophag facilit electr conduct heart organ-specif function tissue-resid macrophag steady-st heart unknown show cardiac macrophag facilit electr conduct distal atrioventricular node conduct cell dens interspers elong macrophag express connexin 43. coupl spontan beat cardiomyocyt via connexin-43-contain gap junction cardiac macrophag neg rest membran potenti depolar synchroni cardiomyocyt convers macrophag render rest membran potenti cardiomyocyt posit accord comput model acceler repolar photostimul channelrhodopsin-2-express macrophag improv atrioventricular conduct wherea condit delet connexin 43 macrophag congenit lack macrophag delay atrioventricular conduct cd11bdtr mous macrophag ablat induc progress atrioventricular block observ implic macrophag normal aberr cardiac conduct',\n",
       "  'tunabl diffusion‐consumpt mechan cytokin propag enabl plastic cell‐to‐cel commun immun system na immun cell commun exchang cytokin achiev context‐appropri respons distanc commun happen known use theoret consider experiment model immun respons vitro vivo quantifi spatial extent cytokin commun dens tissu establish competit cytokin diffus consumpt gener spatial nich high cytokin concentr sharp boundari size self‐assembl nich scale densiti cytokine‐consum cell paramet get tune immun respons vivo measur interact length scale 80–120 mgr result high degre cell‐to‐cel varianc cytokin exposur heterogen distribut cytokin sourc non‐genet cell‐to‐cel variabl often overlook single‐cel studi find thu provid basi understand variabl pattern immun respons diffus factor graphic abstract figur caption avail highlightscytokin penetr tissu govern diffusion‐consumpt mechanismspher cytokin nich gener around cytokine‐produc cellsth characterist nich size depend densiti cytokin consumerscytokin nich sourc variabl otherwis ident cell na cytokine‐medi commun allow immun cell achiev context‐appropri respons distanc commun happen unclear oyler‐yaniv et al 2017 show simpl diffusion‐consumpt mechan quantit describ spatial spread cytokin vivo result local nich high cytokin concentr contribut cell‐to‐cel variabl',\n",
       "  'cardiac neural crest contribut cardiomyogenesi zebrafish bird mammal cardiac neural crest essenti heart develop contribut conotrunc cushion format outflow tract septat zebrafish prototyp heart lack outflow tract septat rais question whether cardiac neural crest exist zebrafish result three distinct lineage-label approach identifi zebrafish cardiac neural crest cell indic cell abil gener mf20-posit muscl cell myocardium major chamber develop fate-map demonstr cardiac neural crest cell origin neural tube region analog found bird well novel region rostral otic vesicl contrast vertebr cardiac neural crest invad myocardium segment heart includ outflow tract atrium atrioventricular junction ventricl zebrafish three distinct group premigratori neural crest along rostrocaud axi differ propens contribut differ segment heart correspondingli mark uniqu combin gene express pattern zebrafish serv model understand interact cardiac neural crest cardiovascular develop',\n",
       "  'sodium hydroxid product seawat desalin brine process design energi effici abil increas ph crucial need desalin pretreat especi revers osmosi industri process use rais ph often incur signific emiss nonrenew resourc use altern wast brine desalin use creat sodium hydroxid via appropri concentr purif pretreat step input chlor-alkali process work effici process train variat develop model sodium hydroxid product seawat desalin brine use membran chlor-alkali electrolysi integr system includ nanofiltr concentr via evapor mechan vapor compress chemic soften ion-exchang soften dechlorin membran electrolysi system product compon perform energi consumpt naoh product process highlight depend electrolyz outlet condit brine recircul investig analysi process also includ assess energi effici major compon estim system oper expens comparison similar process brine-to-caust process shown technic feasibl offer sever advantag reduc environment impact desalin lessen brine discharg increas overal water recoveri ratio revers osmosi facil addit best-us condit given produc caustic use within plant also excess amount potenti revenu',\n",
       "  'high-throughput genet screen identifi larg divers collect new sporul gene bacillu subtili differenti bacterium bacillu subtili dormant spore among well-character development pathway biolog classic genet screen perform past half centuri identifi score factor involv everi step morpholog process recent transcript profil uncov addit sporulation-induc gene requir success spore develop use transposon-sequenc tn-seq assess whether sporul gene left discov screen identifi 133 148 gene known sporul defect surprisingli discov 24 addit gene previous implic spore format investig function use fluoresc microscopi survey earli middl late stage differenti null mutant b. subtili order knockout collect analysi identifi mutant delay initi sporul defect membran remodel impair spore matur sever mutant novel sporul phenotyp perform in-depth character two new factor particip cell-cel signal pathway sporul one spoiit function activ σe mother cell spoiiil requir σg activ forespor analysi also reveal mani 36 sporulation-induc gene previous report mutant phenotyp requir time spore matur final discov larg set transposon insert trigger prematur initi sporul result highlight power tn-seq discoveri new gene novel pathway sporul combin recent complet null mutant collect open door similar screen less well-character process',\n",
       "  'psychobiolog mechan underli social buffer hypothalamic-pituitary-adrenocort axi review anim model human studi across develop discov stress-buff effect social relationship one major find psychobiolog last centuri howev understand underli neurobiolog psycholog mechan buffer begin emerg import avenu research concern neurocircuitri regul activ hypothalamic-pituitary-adrenocort hpa axi present review translat effort aim integr anim model human studi social regul hpa axi infanc adulthood specif focus process name social buffer process note across speci consist dampen hpa axi stress respons threat challeng occur presenc assist conspecif describ aspect relev underli neurobiolog enough inform exist expos major gap understand across domain literatur aim integr provid work conceptu model focus role oxytocinerg system prefront neural network 2 put biolog mediat process propos role earli experi critic shape later social buffer effect synthesi point gener futur direct specif experi need conduct build comprehens model hpa social buffer effect across life span incorpor multipl level analysi neuroendocrin behavior social',\n",
       "  'elev circul branched-chain amino acid earli event human pancreat adenocarcinoma develop patient pancreat ductal adenocarcinoma pdac diagnos advanc diseas surviv less 12 month pdac link obes glucos intoler whether chang circul metabolit associ earli cancer progress unknown better understand metabol derang associ earli diseas profil metabolit prediagnost plasma individu pancreat cancer case match control four prospect cohort studi find elev plasma level branched-chain amino acid bcaa associ greater twofold increas risk futur pancreat cancer diagnosi elev risk independ known predispos factor strongest associ observ among subject sampl collect 2 5 year diagnosi occult diseas probabl present show plasma bcaa also elev mice early-stag pancreat cancer driven mutant kra express mice kras-driven tumor tissu breakdown tissu protein account increas plasma bcaa accompani early-stag diseas togeth find suggest increas whole-bodi protein breakdown earli event develop pdac',\n",
       "  'effect use pi3k mek inhibitor treat mutant k-ra g12d pik3ca h1047r murin lung cancer somat mutat activ phosphoinositid 3-kinas pi3k identifi p110-alpha catalyt subunit encod pik3ca frequent observ two hotspot helic domain e545k e542k kinas domain h1047r although p110-alpha mutant transform vitro oncogen potenti assess genet engin mous model furthermor clinic trial pi3k inhibitor recent initi unknown efficaci restrict specif genet defin malign studi engin mous model lung adenocarcinoma initi maintain express p110-alpha h1047r treatment tumor nvp-bez235 dual pan-pi3k mammalian target rapamycin mtor inhibitor clinic develop led mark tumor regress shown positron emiss tomography-comput tomographi magnet reson imag microscop examin contrast mous lung cancer driven mutant kra substanti respond single-ag nvp-bez235 howev nvp-bez235 combin mitogen-activ protein kinas kinas mek inhibitor arry-142886 mark synergi shrink kras-mut cancer vivo studi suggest inhibitor pi3k-mtor pathway may activ cancer pik3ca mutat combin mek inhibitor may effect treat kra mutat lung cancer',\n",
       "  'transdifferenti glioblastoma cell vascular endotheli cell glioblastoma gbm malign brain tumor highli resist intens combin therapi anti-vegf therapi assess resist mechan anti-vegf therapi examin vessel gbm tumor induc transduct p53 +/- heterozyg mice lentivir vector contain oncogen marker gfp hippocampu gfap-cr recombinas cre mice surpris observ gfp vascular endotheli cell ec transplant mous gbm cell reveal tumor-deriv endotheli cell tdec origin tumor-initi cell result cell fusion ec tumor cell vitro differenti assay suggest hypoxia import factor differenti tumor cell ec independ vegf tdec format resist anti-vegf receptor inhibitor mous gbm led increas frequenc xenograft model human gbm sphere clinic specimen direct clinic sampl patient gbm also show presenc tdec suggest tdec import player resist anti-vegf therapi henc potenti target gbm therapi',\n",
       "  'ribosom dna copi loss repeat instabl atrx-mut cancer atrx alpha thalassemia/ment retard x-link complex daxx deposit histon variant h3.3 repetit heterochromatin recent genom sequenc studi cancer reveal mutat atrx associ alt altern lengthen telomer activ report deplet atrx mous es cell lead select loss ribosom rna gene rdna copi number support atrx-mut human alt-posit tumor also show substanti lower rdna copi alt-neg tumor investig show rdna copi loss repeat instabl caus disrupt h3.3 deposit thu failur heterochromatin format rdna repeat absenc atrx also find atrx-deplet cell reduc ribosom rna transcript output show increas sensit rna polymeras pol transcript inhibitor cx5461 addit human alt-posit cancer cell line also sensit cx5461 treatment studi provid insight contribut atrx loss function tumorigenesi loss rdna stabil suggest therapeut potenti target pol transcript alt cancer',\n",
       "  'combin indoor residu spray insecticide-tr net malaria control africa review possibl outcom outlin suggest futur insecticide-tr net itn indoor residu spray ir current prefer method malaria vector control mani case method use togeth household especi suppress transmiss holoendem hyperendem scenario though widespread limit evid suggest co-appl confer greater protect benefit either itn ir use alon sinc method insecticide-bas intradomicilliari articl hypothesis outcom combin would depend effect candid activ ingredi mosquito enter attempt enter hous suggest enhanc household level protect achiev itn ir diverg yet complementari properti e.g highli deterr ir compound coupl highli toxic itn ensur problem insecticid resist avoid itn ir product prefer differ insecticid class e.g pyrethroid-bas net combin organophosph carbam base ir overal commun benefit would howev depend also factor proport peopl cover intervent behaviour vector speci articl conclud emphas need basic oper research includ mathemat model evalu irs/itn combin comparison ir alon itn alon',\n",
       "  'membran estrogen receptor-α level mcf-7 breast cancer cell predict camp prolifer respons 17β-estradiol e2 rapidli induc camp product condit camp level best measur signal pathway respons consequ prolif effect breast cancer cell fulli understood help resolv issu compar camp mechanist respons mcf-7 cell line select low merlow high merhigh express membran form estrogen receptor mer -α thu address receptor subform involv camp signal mcf-7 cell immunopan subsequ separ fluoresc activ cell sort merhigh mer-α-enrich merlow mer-α-deplet popul uniqu compar previous report incub condit 4°c found optim demonstr e2-induc camp product time-depend dose-depend effect e2 camp product determin cell subpopul effect forskolin 8-cpt camp protein kinas inhibitor h-89 adenylyl cyclas inhibitor sq 22,536 e2-induc cell prolifer assess use crystal violet assay demonstr rapid transient camp increas 1 pmol/l e2 stimul merhigh cell 4°c respons much reliabl robust 37°c condit often use loss camp 37°c due export 3-isobutyl-1-methylxanthin ibmx 1 mmol/l partial preserv camp suggest multipl phosphodiesteras modul level accumul camp consist much higher merhigh cell merlow cell implic mer-α level process ici172,780 block e2-induc respons 17α-estradiol elicit respons also suggest activ estrogen receptor e2 dose-depend camp product although biphas cell type respons 50-fold higher e2 concentr merhigh cell prolifer merlow cell stimul whole rang e2concentr wherea number merhigh cell greatli decreas concentr 1 nmol/l suggest estrogen over-stimul lead cell death previous report mer-α particip e2-medi activ adenylyl cyclas downstream particip protein kinas shown involv respons rapid mer-α-medi nongenom signal cascad gener camp downstream signal event contribut regul breast cancer cell number',\n",
       "  'embryon cell lineag nematod caenorhabd elegan embryon cell lineag caenorhabd elegan trace zygot newli hatch larva result entir cell lineag organ known embryogenesi 671 cell gener hermaphrodit 113 male 111 undergo program death remaind either differenti termin becom postembryon blast cell embryon lineag highli invari fate cell give rise spite fix relationship cell ancestri cell fate correl lack much obviou pattern thu although neuron aris embryon ectoderm produc mesoderm sister muscl lineal boundari necessarili coincid function boundari nevertheless cell ablat experi well previou cell isol experi demonstr substanti cell autonomi least section embryogenesi conclud cell lineag complex play import role determin cell fate discuss origin repeat unit partial segment bodi wall gener variou order symmetri analysi lineag term sublineag evolutionari implic',\n",
       "  'self-react b cell germin center reaction mainten immunolog self-toler requir lymphocyt carri self-react antigen receptor select prevent mount destruct inflammatori effector respons classic self-toler view term remov edit silenc b cell form self-react antigen receptor earli develop howev b cell activ foreign antigen enter germin center gc modifi antigen receptor somat hypermut shm immunoglobulin gene inevit emerg activ self-react gc b cell present uniqu challeng mainten self-toler must rapidli counter avoid autoantibodi product discuss current knowledg mechan enforc b cell self-toler particular focu control self-react gc b cell also consid self-react gc b cell escap self-toler initi autoantibodi product instead redeem via shm use product antibodi respons',\n",
       "  'chronic inflamm inflammag potenti contribut age-associ diseas human age character chronic low-grad inflamm phenomenon term `` inflammaging. `` inflammag highli signific risk factor morbid mortal elderli peopl age-rel diseas share inflammatori pathogenesi nevertheless precis etiolog inflammag potenti causal role contribut advers health outcom remain larg unknown identif pathway control age-rel inflamm across multipl system therefor import order understand whether treatment modul inflammag may benefici old peopl session inflamm advanc gerosci meet held nation institut health/nat institut age bethesda octob 30 31 2013 aim defin import unansw question inflammag articl report main outcom session',\n",
       "  'cryptochrom enabl plant anim determin circadian time cryptochrom flavin-contain blue light photoreceptor relat photolyases-they found plant anim recent describ bacteria plant cryptochrom perform varieti function includ entrain circadian rhythm serv similar role drosophila mammal cryptochrom also perform addit function essenti compon circadian clock',\n",
       "  'neural crest-deriv stem cell migrat differenti cardiomyocyt myocardi infarct object recent demonstr primit neural crest-deriv nc cell migrat cardiac neural crest embryon develop remain heart dormant stem cell capac differenti variou cell type includ cardiomyocyt examin migrat differenti potenti cell myocardi infarct mi method result obtain double-transgen mice cross protein-0 promoter-cr mice floxed-enhanc green fluoresc protein mice nc cell express enhanc green fluoresc protein neonat heart nc stem cell ncsc local predominantli outflow tract also distribut gradient base apex throughout ventricular myocardium time-laps video analysi reveal ncsc migratori ncsc persist adult heart mi ncsc accumul ischem border zone area bza express monocyt chemoattract protein-1 mcp-1 ex vivo cell migrat assay demonstr mcp-1 induc ncsc migrat chemotact effect significantli depress anti-mcp-1 antibodi small nc cardiomyocyt first appear bza 2 week post-mi gradual increas number thereaft conclus result suggest ncsc migrat bza via mcp-1/ccr2 signal contribut provis cardiomyocyt cardiac regener mi',\n",
       "  'mitochondria sensor regul calcium signal past two decad calcium ca2+ accumul energ mitochondria emerg biolog process utmost physiolog relev mitochondri ca2+ uptak shown control intracellular ca2+ signal cell metabol cell surviv cell-typ specif function buffer cytosol ca2+ level regul mitochondri effector recent ident mitochondri ca2+ transport reveal open new perspect investig molecular intervent',\n",
       "  'caspase-11 promot fusion phagosom harbor pathogen bacteria lysosom modul actin polymer inflammasom multiprotein complex includ member nlr nucleotide-bind domain leucine-rich repeat contain famili caspase-1 bacteri molecul sens within macrophag inflammasom assembl mediat activ caspase-1 caspase-11 mediat caspase-1 activ respons lipopolysaccharid bacteri toxin yet role bacteri infect unknown demonstr caspase-11 dispens caspase-1 activ respons legionella salmonella francisella listeria also determin activ mous caspase-11 requir restrict l. pneumophila infect similarli human caspase-4 caspase-5 homolog mous caspase-11 cooper restrict l. pneumophila infect human macrophag caspase-11 promot fusion l. pneumophila vacuol lysosom modul actin polymer cofilin howev caspase-11 dispens fusion lysosom phagosom contain nonpathogen bacteria uncov fundament differ traffick phagosom accord cargo',\n",
       "  'adipocyt inflamm essenti healthi adipos tissu expans remodel chronic inflamm constitut import link obes pathophysiolog sequela contrast belief inflammatori signal exert fundament neg impact metabol show proinflammatori signal adipocyt fact requir proper adipos tissu remodel expans three mous model adipos tissue-specif reduct proinflammatori potenti gener display reduc capac adipogenesi vivo differenti potenti unalt vitro upon high-fat-diet exposur expans viscer adipos tissu promin affect associ decreas intestin barrier function increas hepat steatosi metabol dysfunct impair local proinflammatori respons adipocyt lead increas ectop lipid accumul glucos intoler system inflamm adipos tissu inflamm therefor adapt respons enabl safe storag excess nutrient contribut viscer depot barrier effect filter gut-deriv endotoxin',\n",
       "  'chronic variabl stress activ hematopoiet stem cell exposur psychosoci stress risk factor mani diseas includ atherosclerosi although incomplet understood interact psych immun system provid one potenti mechan link stress diseas incept progress known cross-talk brain immun system includ hypothalamic-pituitary-adren axi central drive glucocorticoid product adren cortex sympathetic-adrenal-medullari axi control stress-induc catecholamin releas support fight-or-flight reflex remain unknown howev whether chronic stress chang hematopoiet stem cell activ show stress increas prolifer primit hematopoiet progenitor give rise higher level disease-promot inflammatori leukocyt found chronic stress induc monocytosi neutrophilia human investig sourc leukocytosi mice discov stress activ upstream hematopoiet stem cell condit chronic variabl stress mice sympathet nerv fiber releas surplu noradrenalin signal bone marrow nich cell decreas cxcl12 level β3-adrenerg receptor consequ hematopoiet stem cell prolifer elev lead increas output neutrophil inflammatori monocyt atherosclerosis-pron apo -/- mice subject chronic stress acceler hematopoiesi promot plaqu featur associ vulner lesion caus myocardi infarct stroke human',\n",
       "  'cntf revers obesity-induc insulin resist activ skelet muscl ampk ciliari neurotroph factor cntf induc weight loss improv glucos toler human rodent cntf thought act central induc hypothalam neurogenesi modul food intak peripher alter hepat gene express manner similar leptin show cntf signal cntfrα–il-6r–gp130β receptor complex increas fatty-acid oxid reduc insulin resist skelet muscl activ amp-activ protein kinas ampk independ signal brain thu find show antiobesogen effect cntf peripheri result direct effect skelet muscl peripher effect suppress diet-induc genet model obes essenti requir therapeut treatment obesity-rel diseas',\n",
       "  \"global spread hepat c viru 1a 1b phylodynam phylogeograph analysi background hepat c viru hcv estim affect 130-180 million peopl worldwid although origin unknown pattern viral divers suggest hcv genotyp 1 probabl origin west africa previou attempt estim spatiotempor paramet viru global region suggest epidem hcv transmiss began 1900 grew steadili late 1980 howev epidemiolog data suggest expans hcv may occur second world war aim studi elucid timescal rout global spread hcv method find show rare sequenc hcv region e2p7ns2 inform molecular epidemiolog studi commonli use ns5b region appli phylodynam method substanti set new e2p7ns2 ns5b sequenc togeth avail global hcv sequenc inform genom region order estim timescal natur global expans preval hcv subtyp 1a 1b show transmiss subtyp 1a 1b `` explod '' 1940 1980 spread 1b preced 1a least 16 95 confid interv 15-17 phylogeograph analysi avail ns5b sequenc suggest hcv subtyp 1a 1b dissemin develop world develop countri conclus evolutionari rate hcv appear faster previous suggest global spread hcv coincid widespread use transfus blood blood product expans intraven drug use slow prior wide implement anti-hcv screen differ transmiss rout associ subtyp 1a 1b provid explan rel earlier expans 1b data show plausibl rout hcv dispers develop countri develop world pleas see later articl editor summari\",\n",
       "  \"pharmacolog intervent smoke cessat overview network meta-analysi background smoke lead prevent caus ill prematur death worldwid medic proven help peopl quit three licens purpos europ usa nicotin replac therapi nrt bupropion vareniclin cytisin treatment pharmacolog similar vareniclin also licens use russia former socialist economi countri therapi includ nortriptylin also test effect object nrt bupropion vareniclin compar placebo achiev long-term abstin six month longer remain treatment compar placebo achiev long-term abstin risk advers seriou advers event sae compar treatment instanc harm may outweigh benefit method overview restrict cochran review includ randomis trial particip usual adult smoker exclud review smoke cessat pregnant women particular diseas group specif set cover nicotin replac therapi nrt antidepress bupropion nortriptylin nicotin receptor partial agonist vareniclin cytisin anxiolyt select type 1 cannabinoid receptor antagonist rimonab clonidin lobelin dianiclin mecamylamin nicobrevin opioid antagonist nicotin vaccin silver acet outcom benefit continu prolong abstin least six month start treatment outcom harm incid seriou advers event associ treatment search cochran databas systemat review cdsr cochran librari review 'smoke titl abstract keyword field last search conduct novemb 2012. assess methodolog qualiti use revis version amstar scale nrt bupropion vareniclin conduct network meta-analys compar other placebo benefit vareniclin bupropion risk seriou advers event main result identifi 12 treatment-specif review analys cover 267 studi involv 101,804 particip nrt bupropion superior placebo odd ratio 1.84 95 credibl interv credi 1.71 1.99 1.82 95 credi 1.60 2.06 respect vareniclin increas odd quit compar placebo 2.88 95 credi 2.40 3.47 head-to-head comparison bupropion nrt show equal efficaci 0.99 95 credi 0.86 1.13 vareniclin superior singl form nrt 1.57 95 credi 1.29 1.91 bupropion 1.59 95 credi 1.29 1.96 vareniclin effect nicotin patch 1.51 95 credi 1.22 1.87 nicotin gum 1.72 95 credi 1.38 2.13 'other nrt inhal spray tablet lozeng 1.42 95 credi 1.12 1.79 effect combin nrt 1.06 95 credi 0.75 1.48 combin nrt also outperform singl formul four categori nrt perform similarli apart 'other nrt margin effect nrt gum 1.21 95 credi 1.01 1.46 cytisin nicotin receptor partial agonist return posit find risk ratio rr 3.98 95 ci 2.01 7.87 without signific advers event sae across 82 includ exclud bupropion trial estim six seizur bupropion arm versu none placebo arm lower expect rate 1:1000 1:1500. sae meta-analysi bupropion studi demonstr excess neuropsychiatr rr 0.88 95 ci 0.31 2.50 cardiovascular event rr 0.77 95 ci 0.37 1.59 sae meta-analysi 14 vareniclin trial found differ vareniclin placebo arm rr 1.06 95 ci 0.72 1.55 subgroup analys detect signific excess neuropsychiatr event rr 0.53 95 ci 0.17 1.67 cardiac event rr 1.26 95 ci 0.62 2.56 nortriptylin increas chanc quit rr 2.03 95 ci 1.48 2.78 neither nortriptylin bupropion shown enhanc effect nrt compar nrt alon clonidin increas chanc quit rr 1.63 95 ci 1.22 2.18 offset dose-depend rise advers event mecamylamin combin nrt may increas chanc quit current evid inconclus treatment fail demonstr benefit compar placebo nicotin vaccin yet licens use aid smoke cessat relaps prevent nicobrevin 's uk licens revok manufactur rimonab taranab dianiclin longer support develop test treatment author conclus nrt bupropion vareniclin cytisin shown improv chanc quit combin nrt vareniclin equal effect quit aid nortriptylin also improv chanc quit current evid none treatment appear incid advers event would mitig use research warrant safeti vareniclin cytisin 's potenti effect afford treatment efficaci safeti nrt\",\n",
       "  'librari yeast transcript factor motif reveal widespread function rsc3 target nucleosom exclus promot sequenc specif dna-bind protein primari mechan cell recogn genom featur describ systemat determin yeast transcript factor dna-bind specif obtain bind specif 112 dna-bind protein repres 19 distinct structur class one-third bind specif previous report sever bind sequenc strike genom distribut rel transcript start site support biolog relev suggest role promot architectur among rsc3 bind sequenc contain core cgcg found preferenti approxim 100 bp upstream transcript start site mutat rsc3 result dramat increas nucleosom occup hundr proxim promot contain rsc3 bind element littl impact promot lack rsc3 bind sequenc indic rsc3 play broad role target nucleosom exclus yeast promot',\n",
       "  'epha3 maintain tumorigen therapeut target glioblastoma multiform signific endeavor appli identifi function therapeut target glioblastoma gbm halt growth aggress cancer show receptor tyrosin kinas epha3 frequent overexpress gbm particular aggress mesenchym subtyp importantli epha3 highli express tumor-initi cell popul glioma appear critic involv maintain tumor cell less differenti state modul mitogen-activ protein kinas signal epha3 knockdown deplet epha3-posit tumor cell reduc tumorigen potenti degre compar treatment therapeut radiolabel epha3-specif monoclon antibodi result identifi epha3 function target receptor gbm',\n",
       "  'chimer antigen receptor-modifi cell acut lymphoid leukemia chimer antigen receptor-modifi cell specif cd19 shown promis treatment chronic lymphocyt leukemia cll remain establish whether chimer antigen receptor cell clinic activ acut lymphoblast leukemia two children relaps refractori pre-b-cel receiv infus cell transduc anti-cd19 antibodi t-cell signal molecul ctl019 chimer antigen receptor cell dose 1.4×10 6 1.2×10 7 ctl019 cell per kilogram bodi weight patient ctl019 cell expand level 1000 time high initi engraft level cell identifi bone marrow addit chimer antigen receptor cell observ cerebrospin fluid csf persist high level least 6 month eight grade 3 4 advers event note cytokine-releas syndrom b-cell aplasia develop patient one child cytokine-releas syndrom sever cytokin blockad etanercept tocilizumab effect revers syndrom prevent expans chimer antigen receptor cell reduc antileukem efficaci complet remiss observ patient ongo one patient 11 month treatment patient relaps blast cell longer express cd19 approxim 2 month treatment chimer antigen receptor-modifi cell capabl kill even aggress treatment-refractori acut leukemia cell vivo emerg tumor cell longer express target indic need target molecul addit cd19 patient',\n",
       "  'extended-connect fingerprint extended-connect fingerprint ecfp novel class topolog fingerprint molecular character histor topolog fingerprint develop substructur similar search ecfp develop specif structure-act model ecfp circular fingerprint number use qualiti rapidli calcul predefin repres essenti infinit number differ molecular featur includ stereochem inform featur repres presenc particular substructur allow easier interpret analysi result ecfp algorithm tailor gener differ type circular fingerprint optim differ use use ecfp wide adopt valid descript implement previous present literatur',\n",
       "  'suppressor cytokin signal 3 inhibit antivir ifn-beta signal enhanc hiv-1 replic macrophag hiv-1 replic within macrophag cn often result cognit motor impair known hiv-associ dementia sever form ifn-beta suppress viral replic within cell earli cn infect effect transient hiv-1 eventu overcom protect innat immun respons resum replic unknown mechan initi progress toward articl show suppressor cytokin signal soc 3 molecular inhibitor ifn signal may allow hiv-1 evad innat immun within cn found socs3 elev vivo siv/macaqu model pattern express correl recurr viral replic onset cn diseas vitro hiv-1 regulatori protein transactiv transcript induc socs3 human murin macrophag nf-kappab-depend manner socs3 express attenu respons macrophag ifn-beta proxim level pathway activ downstream antivir gene express consequ overcom inhibitori effect ifn-beta hiv-1 replic studi indic socs3 express induc stimuli present hiv-1-infect brain transactiv transcript inhibit antivir ifn-beta signal enhanc hiv-1 replic macrophag consequ socs3 express vitro support correl increas viral load onset cn diseas vivo suggest socs3 may allow hiv-1 evad protect innat immun respons within cn allow recurr viral replic ultim promot progress toward',\n",
       "  'molecular model human 26 proteasom 26 proteasom play fundament role eukaryot homeostasi undertak highli control degrad wide rang protein includ key cellular regul control cell-cycl progress apoptosi report structur human 26 proteasom determin cryo-electron microscopi single-particl analysi secondari structur element identifi 20 proteolyt core region 19 regulatori particl use inform togeth crystal structur homolog model biochem inform construct molecular model complet 26 proteasom model allow detail descript 20 core within 26 proteasom redefin overal assign subunit within 19 regulatori particl inform present provid strong basi mechanist understand 26 proteasom',\n",
       "  'urinari bisphenol concentr earli reproduct health outcom among women undergo ivf studi question women undergo ivf urinari bisphenol bpa concentr associ ovarian respons earli reproduct outcom includ oocyt matur fertil day 3 embryo qualiti blastocyst format summari answer higher urinari bpa concentr found associ decreas ovarian respons number fertil oocyt decreas blastocyst format known alreadi experiment anim vitro studi report associ bpa exposur advers reproduct outcom previous report associ urinari bpa decreas ovarian respons peak serum estradiol e 2 oocyt count time retriev women undergo ivf howev limit human data reproduct health outcom fertil embryo develop studi design size durat prospect preconcept cohort studi one hundr seventy-four women age 18-45 year undergo 237 ivf cycl recruit massachusett gener hospit fertil center boston usa novemb 2004 august 2010. women follow either live birth discontinu treatment cryothaw donor egg cycl includ analysi participants/materi set method urinari bpa concentr measur onlin solid-phas extraction-high-perform liquid chromatography-isotop dilution-tandem mass spectrometri mix effect model poisson regress multivari logist regress model use wherev appropri evalu associ cycle-specif urinari bpa concentr measur ovarian respons oocyt matur metaphas ii fertil embryo qualiti cleavag rate account correl among multipl ivf cycl woman use gener estim equat main result role chanc geometr mean sd urinari bpa concentr 1.50 2.22 µg/l adjust age potenti confound day 3 serum fsh smoke bmi signific linear dose-respons associ increas urinari bpa concentr decreas number oocyt overal matur decreas number normal fertil oocyt decreas e 2 level mean decreas 40 253 471 pg/ml urinari bpa quartil 2 3 4 compar lowest quartil respect p-valu trend 0.001 mean number oocyt normal fertil oocyt decreas 24 27 respect highest versu lowest quartil urinari bpa trend test p 0.001 0.002 respect women urinari bpa lowest quartil decreas blastocyst format trend test p-valu 0.08 limit reason caution potenti limit includ exposur misclassif due short half-lif bpa high variabl time uncertainti generaliz result gener popul women conceiv natur limit sampl wider implic find result extend studi use ivf model studi earli reproduct health outcom human indic neg dose-respons associ urinari bpa concentr serum peak e 2 oocyt yield confirm previou find addit found significantli decreas metaphas ii oocyt count number normal fertil oocyt suggest associ bpa urinari concentr decreas blastocyst format thu indic bpa may alter reproduct function suscept women undergo ivf studi funding/compet interest work support grant es009718 es000002 nation institut environment health scienc grant oh008578 nation institut occup safeti health none author actual potenti compet financi interest disclaim find conclus report author necessarili repres view center diseas control prevent',\n",
       "  'cost-effect option diagnosi high blood pressur primari care model studi background diagnosi hypertens tradit base blood-pressur measur clinic home ambulatori measur better correl cardiovascular outcom ambulatori monitor accur clinic home monitor diagnos hypertens aim compar cost-effect differ diagnost strategi hypertens method markov model-bas probabilist cost-effect analysi use hypothet primary-car popul age 40 year older screen blood-pressur measur greater 140/90 mm hg risk-factor preval equival gener popul compar three diagnost strategies-furth blood pressur measur clinic home ambulatori monitor-in term lifetim cost quality-adjust life year cost-effect find ambulatori monitor cost-effect strategi diagnosi hypertens men women age cost-sav group -£56 95 ci -105 -10 men age 75 year -£323 -389 -222 women age 40 year result quality-adjust life year men women older 50 year 0·006 0·000 0·015 women age 60 year 0·022 0·012 0·035 men age 70 year find robust assess wide rang determinist sensit analys around base case sensit home monitor judg equal test perform ambulatori monitor treatment judg effect irrespect whether individu hypertens interpret ambulatori monitor diagnost strategi hypertens initi rais read clinic would reduc misdiagnosi save cost addit cost ambulatori monitor counterbalanc cost save better target treatment ambulatori monitor recommend patient start antihypertens drug fund nation institut health research nation institut health clinic excel',\n",
       "  'folic acid improv endotheli function coronari arteri diseas via mechan larg independ homocystein lower background homocystein risk factor coronari arteri diseas cad although causal relat remain proven import determin direct causal rest fact plasma homocystein safe inexpens reduc 25 folic acid reduct maxim achiev dose 0.4 mg/d high-dos folic acid 5 mg/d improv endotheli function cad although mechan controversi propos improv occur reduct total thci free non-protein bound homocystein fhci investig effect folic acid endotheli function chang homocystein patient cad method result random placebo-control studi folic acid 5 mg/d 6 week undertaken 33 patient endotheli function assess flow-medi dilat fmd measur 2 4 hour first dose folic acid 6 week treatment plasma folat increas markedli 1 hour 200 compar 25.8 nmol/l p 0.001 fmd improv 2 hour 83 compar 47 microm p 0.001 larg complet 4 hour 101 compar 51 microm p 0.001 thci significantli differ acut 4-hour thci 9.56 compar 9.79 micromol/l p=n fhci differ 3 hour slightli reduc 4 hour 1.55 compar 1.78 micromol/l p=0.02 fmd improv correl reduct either fhci thci time conclus data suggest folic acid improv endotheli function cad acut mechan larg independ homocystein',\n",
       "  'focal adhes kinas link mechan forc skin fibrosi via inflammatori signal exuber fibroprolifer common complic injuri reason well understood one key compon wound repair often overlook mechan forc regul cell-matrix interact intracellular focal adhes compon includ focal adhes kinas fak report fak activ cutan injuri process potenti mechan load fibroblast-specif fak knockout mice substanti less inflamm fibrosi control mice model hypertroph scar format show fak act extracellular-rel kinas erk mechan trigger secret monocyt chemoattract protein-1 mcp-1 also known ccl2 potent chemokin link human fibrot disord similarli mcp-1 knockout mice form minim scar indic inflammatori chemokin pathway major mechan fak mechanotransduct induc fibrosi small-molecul inhibit fak block effect human cell reduc scar format vivo attenu mcp-1 signal inflammatori cell recruit find collect indic physic forc regul fibrosi inflammatori fak–erk–mcp-1 pathway molecular strategi target fak effect uncoupl mechan forc patholog scar format',\n",
       "  'prognost accuraci sofa score sir criteria qsofa score in-hospit mortal among adult suspect infect admit intens care unit import sepsis-3 criteria emphas valu chang 2 point sequenti sepsis-rel organ failur assess sofa score introduc quick sofa qsofa remov system inflammatori respons syndrom sir criteria sepsi definit object extern valid assess discriminatori capac increas sofa score 2 point 2 sir criteria qsofa score 2 point outcom among patient critic ill suspect infect design set particip retrospect cohort analysi 184 875 patient infection-rel primari admiss diagnosi 182 australian new zealand intens care unit icu 2000 2015. exposur sofa qsofa sir criteria appli data collect within 24 hour icu admiss main outcom measur primari outcom in-hospit mortal in-hospit mortal icu length stay lo 3 day composit secondari outcom discrimin assess use area receiv oper characterist curv auroc adjust analys perform use model baselin risk determin use variabl independ score system result among 184 875 patient mean age 62.9 year sd 17.4 women 82 540 44.6 common diagnosi bacteri pneumonia 32 634 17.7 total 34 578 patient 18.7 die hospit 102 976 patient 55.7 die experienc icu lo 3 day sofa score increas 2 point 90.1 86.7 manifest 2 sir criteria 54.4 qsofa score 2 point sofa demonstr significantli greater discrimin in-hospit mortal crude auroc 0.753 99 ci 0.750-0.757 sir criteria crude auroc 0.589 99 ci 0.585-0.593 qsofa crude auroc 0.607 99 ci 0.603-0.611 increment improv 0.164 99 ci 0.159-0.169 sofa vs sir criteria 0.146 99 ci 0.142-0.151 sofa vs qsofa p .001 sofa auroc 0.736 99 ci 0.733-0.739 outperform score secondari end point sir criteria auroc 0.609 99 ci 0.606-0.612 qsofa auroc 0.606 99 ci 0.602-0.609 increment improv 0.127 99 ci 0.123-0.131 sofa vs sir criteria 0.131 99 ci 0.127-0.134 sofa vs qsofa p .001 find consist outcom multipl sensit analys conclus relev among adult suspect infect admit icu increas sofa score 2 greater prognost accuraci in-hospit mortal sir criteria qsofa score find suggest sir criteria qsofa may limit util predict mortal icu set',\n",
       "  \"predictor mammograph densiti insight gain novel regress analysi twin studi understand factor influenc mammograph dens nondens area import percent mammograph densiti adjust age strong continu distribut risk factor breast cancer especi adjust weight bodi mass index use computer-assist method measur mammograph dens area 571 monozygot 380 dizygot australian north american twin pair age 40 70 year use novel regress model approach twin 's measur dens nondens area regress one twin 's co-twin 's covari natur chang regress estim inclus twin and/or co-twin 's covari evalu consist causal and/or model causal mean possibl vari covari experiment expect valu outcom measur would chang adjust individu 's weight co-twin associ weight attenu consist causal effect weight mammograph measur absolut log cm 2 /kg thrice stronger nondens dens area adjust weight later age menarch greater height associ greater dens lesser nondens area manner inconsist causal associ dens nondens area pariti consist causal effect and/or within-person confound associ mammograph densiti measur height consist share earli life environment factor predispos height percent mammograph densiti possibl breast cancer risk\",\n",
       "  'shape landscap escherichia coli chromosom replication-transcript encount cell ectop replic origin cell divis requir unwind million dna base pair allow chromosom duplic gene transcript dna replic transcript share templat conflict process unavoid head-on collis thought particularli problemat surprisingli recent studi report unperturb cell cycl progress escherichia coli cell ectop replic origin highli transcrib rrn operon forc replic opposit normal studi re-gener similar strain found doubl time twice normal cell replic profil background reveal signific deviat comparison wild-typ profil particularli highli transcrib region termin area deviat allevi mutat either inactiv termin area destabilis rna polymeras complex allow easier displac replic fork data demonstr head-on replication-transcript conflict highli problemat inde analysi replic profil previous publish e. coli construct reveal chromosom rearrang allevi replication-transcript conflict intriguingli simpl way data support idea avoid head-on collis significantli contribut shape distinct architectur bacteri chromosom',\n",
       "  'epithelial–mesenchym transit tumour progress without epithelial–mesenchym transit polar epitheli cell convert motil cell multicellular organ would incap get past blastula stage embryon develop howev import development programm sinist role tumour progress epithelial–mesenchym transit provid new basi understand progress carcinoma toward dedifferenti malign state',\n",
       "  \"platelet interfac thrombosi inflamm cancer although primarili recogn role hemostasi thrombosi platelet increasingli recogn multipurpos cell inde circul platelet abil influenc wide rang seemingli unrel pathophysiolog event highlight notabl observ link platelet inflamm reinforc platelet 's origin lower vertebr cell type hemostat immunolog role addit consid relev platelet cancer biolog focus hallmark cancer way platelet influenc multistep develop tumor beyond tradit role hemostasi thrombosi platelet 's involv interplay hemostasi thrombosi inflamm cancer like complex yet extrem import diseas process exist anim model platelet dysfunct current use antiplatelet therapi provid framework understand mechanist insight wide rang pathophysiolog event thu basic scientist studi platelet function think beyond tradit hemostasi thrombosi paradigm practic hematologist must appreci platelet relev wide rang diseas process\",\n",
       "  'cellular role dna topoisomeras molecular perspect dna topoisomeras magician dna world — allow dna strand doubl helic pass solv topolog problem dna replic transcript cellular transact extens biochem structur studi past three decad provid molecular model variou subfamili dna topoisomeras manipul dna review cellular role enzym examin molecular point view',\n",
       "  \"microrna spong progress possibl microrna mirna `` spong '' method introduc three year ago mean creat continu mirna loss function cell line transgen organ spong rna contain complementari bind site mirna interest produc transgen within cell mirna target gene spong 's bind site specif mirna seed region allow block whole famili relat mirna transgen approach proven use tool probe mirna function varieti experiment system discuss way spong relat construct optim review recent applic method particular emphasi stabl express cancer studi transgen anim\",\n",
       "  'wip1 phosphatas regul p53-depend apoptosi stem cell tumorigenesi mous intestin colorect cancer one major caus cancer-rel death gain insight mechan underli develop investig role wip1 phosphatas highli express intestin stem cell mous model apc min -driven polyposi found wip1 remov increas life span apc min mice signific suppress polyp format protect depend p53 tumor suppressor play put role regul apoptosi intestin stem cell activ apoptosi stem cell wip1-defici mice wild-typ apc min mice increas wnt pathway constitut activ propos therefor wip1 phosphatas regul homeostasi intestin stem cell turn wip1 loss suppress apc min -driven polyposi lower threshold p53-depend apoptosi stem cell thu prevent convers tumor-initi stem cell',\n",
       "  'shunt problem control function shunt normal tumour vasculatur network blood vessel normal tumour tissu heterogen structur wide vari blood flow pathway length achiev effici blood flow distribut mechan structur adapt vessel diamet must abl inhibit format function shunt wherebi short pathway becom enlarg flow bypass long pathway adapt requir inform tissu metabol statu commun upstream feed vessel conduct respons propos impair vascular commun tumour microvascular network lead function shunt primari caus dysfunct microcircul local hypoxia cancer suggest anti-angiogen treatment tumour may restor vascular commun therebi improv normal flow distribut tumour vasculatur',\n",
       "  'pharmacolog blockad asct2-depend glutamin transport lead anti-tumor efficaci preclin model uniqu metabol demand cancer cell underscor potenti fruit opportun drug discoveri era precis medicin howev therapeut target cancer metabol led surprisingli new drug date neutral amino acid glutamin serv key intermedi numer metabol process leverag cancer cell includ biosynthesi cell signal oxid protect herein report preclin develop v-9302 competit small molecul antagonist transmembran glutamin flux select potent target amino acid transport asct2 pharmacolog blockad asct2 v-9302 result attenu cancer cell growth prolifer increas cell death increas oxid stress collect contribut antitumor respons vitro vivo first studi knowledg demonstr util pharmacolog inhibitor glutamin transport oncolog repres new class target therapi lay framework paradigm-shift therapi target cancer cell metabol',\n",
       "  'antidepress decreas csf aβ product healthi individu transgen ad mice serotonin signal suppress gener amyloid-β aβ vitro anim model alzheim ’ diseas ad show age transgen ad mous model app/ps1 plaque-bear mice antidepress citalopram select serotonin reuptak inhibitor decreas aβ brain interstiti fluid dose-depend manner growth individu amyloid plaqu assess plaque-bear mice chronic administ citalopram citalopram arrest growth preexist plaqu reduc appear new plaqu 78 healthi human volunt citalopram ’ effect aβ product aβ concentr cerebrospin fluid csf measur prospect use stabl isotop label kinet csf sampl acut dose citalopram aβ product csf slow 37 citalopram group compar placebo chang associ 38 decreas total csf aβ concentr drug-treat group abil safe decreas aβ concentr potenti import prevent strategi ad studi demonstr key target engag futur ad prevent trial',\n",
       "  \"variat qualiti sustain long-term glycaem control continu subcutan insulin infus aim investig pattern chang hba1c peopl type 1 diabet manag long-term continu subcutan insulin infus method studi hba1c chang use computer clinic record 35 adult peopl type 1 diabet elev hba1c ≥ 64 mmol/mol 8.0 multipl daili insulin inject switch continu subcutan insulin infus least 5 year result identifi three subgroup similar baselin hba1c differ long-term respons pump therapi group -- improv follow deterior 57 group b -- improv sustain throughout 5 year 31 group c-those hba1c chang significantli baselin 12 patient group c higher bmi 31.0 ± 5.2 vs. 25.9 ± 3.3 vs. 25.2 ± 3.1 kg/m² group c vs. group group b p 0.02 conclus improv glycaem control continu subcutan insulin infus maintain 5 year 88 peopl type 1 diabet studi variat long-term efficaci peopl improv worsen other maintain strict control subcutan insulin infus 'non-respond\",\n",
       "  \"histor review megakaryopoiesi thrombopoiesi studi thrombopoiesi evolv greatli sinc era platelet term `` dust blood '' 100 year ago time megakaryocyt identifi origin blood platelet marrow-deriv megakaryocyt progenitor cell function defin purifi primari regul process thrombopoietin clone character therapeut thrombopoiet agent develop journey continu learn physiolog mechan drive proplatelet format recapitul cell-fre system biochemistri evalu molecular underpin endomitosi increasingli understood intracellular signal sent engag larg number megakaryocyt surfac receptor defin mani transcript factor drive megakaryocyt fate determin identifi experiment manipul biolog process mimic seen cell type megakaryocyt platelet possess enough uniqu development featur virtual assur continu studi thrombopoiesi yield innumer clinic scientif insight mani decad come\",\n",
       "  'obes metabol complic role adipokin relationship obes inflamm insulin resist dyslipidemia nonalcohol fatti liver diseas accumul evid indic obes close associ increas risk metabol diseas insulin resist type 2 diabet dyslipidemia nonalcohol fatti liver diseas obes result imbal food intak energi expenditur lead excess accumul adipos tissu adipos tissu recogn main site storag excess energi deriv food intak also endocrin organ expans adipos tissu produc number bioactiv substanc known adipocytokin adipokin trigger chronic low-grad inflamm interact rang process mani differ organ although precis mechan still unclear dysregul product secret adipokin caus excess adipos tissu adipos tissu dysfunct contribut develop obesity-rel metabol diseas review focu role sever adipokin associ obes potenti impact obesity-rel metabol diseas multipl line evid provid valuabl insight role adipokin develop obes metabol complic research still requir fulli understand mechan underli metabol action newli identifi adipokin',\n",
       "  'combat trastuzumab resist target src common node downstream multipl resist pathway trastuzumab success ration design erbb2-target therapi howev half individu erbb2-overexpress breast cancer respond trastuzumab-bas therapi owe variou resist mechan clinic applic regimen overcom trastuzumab resist differ mechan yet avail show nonreceptor tyrosin kinas c-src src key modul trastuzumab respons common node downstream multipl trastuzumab resist pathway find src activ acquir de novo trastuzumab-resist cell uncov novel mechan src regul involv dephosphoryl pten increas src activ confer consider trastuzumab resist breast cancer cell correl trastuzumab resist patient target src combin trastuzumab sensit multipl line trastuzumab-resist cell trastuzumab elimin trastuzumab-resist tumor vivo suggest potenti clinic applic strategi overcom trastuzumab resist',\n",
       "  'microrna new tool diagnosi prognosi therapi hepatocellular carcinoma microrna mirna evolutionarili conserv small noncod rna involv regul gene express protein translat mani studi shown play crucial role drive organ tissu differenti embryogenesi fine-tun fundament biolog process prolifer apoptosi grow evid indic deregul play import role cancer onset progress well act oncogen oncosuppressor review highlight recent find regard role mirna hepatocellular carcinoma hcc analyz possibl mechan contribut neoplasm moreov discuss possibl role circul mirna biomark field need urgent improv clinic surveil hcc fascin possibl use therapeut target drug',\n",
       "  \"vertebr gene ticrr essenti checkpoint replic regul eukaryot numer checkpoint pathway protect genom fidel normal cell divis respons dna damag screen g2/m checkpoint regul zebrafish identifi ticrr topbp1-interact checkpoint replic regul previous uncharacter gene requir prevent mitot entri treatment ioniz radiat ticrr defici embryonic-leth absenc exogen dna damag essenti normal cell cycl progress specif loss ticrr impair dna replic disrupt s/m checkpoint lead prematur mitot entri mitot catastroph show human ticrr ortholog associ topbp1 known checkpoint protein core compon dna replic preiniti complex pre-ic ticrr-topbp1 interact stabl without chromatin requir brct motif essenti topbp1 's replic checkpoint function importantli find ticrr defici disrupt chromatin bind pre-ic prerepl complex compon taken togeth data show ticrr act associ topbp1 play essenti role pre-ic format remain determin whether ticrr repres vertebr ortholog yeast pre-ic compon sld3 hitherto unknown metazoan replic checkpoint regul\",\n",
       "  'matern methyl cpg island kvlqt1 associ antisens patern transcript loss imprint beckwith-wiedemann syndrom loss imprint igf2 gener h19-independ mechan associ larg percentag patient overgrowth cancer predisposit condit beckwith-wiedemann syndrom bw imprint control element propos exist within kvlqt1 locu multipl bws-associ chromosom rearrang disrupt gene identifi evolutionarili conserv matern methyl cpg island kvdmr1 intron kvlqt1 gene among 12 case bw normal h19 methyl 5 show demethyl kvdmr1 fibroblast lymphocyt dna wherea 4 case bw h19 hypermethyl methyl kvdmrl normal thu inactiv h19 hypomethyl kvdmr1 associ phenomenon repres distinct epigenet anomali associ biallel express igf2 revers transcription-pcr analysi human synten mous loci identifi presenc kvdmr1-associ rna transcrib exclus patern allel opposit orient respect matern express kvlqt1 gene propos kvdmr1 and/or associ antisens rna kvlqt1-a repres addit imprint control element center human 11p15.5 mous distal 7 imprint domain',\n",
       "  'alarm level drug-resist tuberculosi belaru result survey minsk resist anti-tuberculosi tb medicin major public health threat countri former soviet union repres quality-assur inform magnitud problem exist belaru survey conduct capit citi minsk novemb 2009 decemb 2010 156 consecut diagnos new 68 previous treat culture-posit tb patient resid minsk enrol survey mycobacterium tuberculosi isol obtain patient test suscept first- second-lin anti-tb drug multidrug-resist mdr -tb found 35.3 95 ci 27.7-42.8 new patient 76.5 95 ci 66.1-86.8 previous treat overal nearli one two patient enrol mdr-tb extens drug-resist tb report 15 107 mdr-tb patient 14.0 95 ci 7.3-20.7 patient 35 yr age shown two time higher odd ratio multidrug-resist tb age 35 yr find survey minsk citi alarm repres highest proport mdr-tb ever record world studi greatli contribut understand burden drug-resist tb urban area belaru',\n",
       "  'partit regulatori mechan within-host malaria dynam use effect propag number immun clearanc resourc limit via red blood cell deplet shape peak trough malaria parasitemia turn affect diseas sever transmiss quantit partit rel role effect time challeng use data rodent malaria estim effect propag number reflect rel import contrast within-host control mechan time sensit inocul parasit dose analysi show capac innat respons restrict initi parasit growth satur parasit dose experiment enhanc innat immun affect parasit densiti indirectli via resourc deplet statist approach offer tool improv target drug vaccin human therapi reveal dynam interact within-host regulatori mechan',\n",
       "  ...])"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# TODO\n",
    "\n",
    "claims_preprocessed_joined = []\n",
    "titles_preprocessed_joined = []\n",
    "abstract_preprocessed_joined = []\n",
    "texts_preprocessed_joined = []\n",
    "\n",
    "\n",
    "for text in claims_preprocessed:\n",
    "    temp_tokens = []\n",
    "    for token in text:\n",
    "        if token in vocab_dict:\n",
    "            temp_tokens.append(token)\n",
    "    claims_preprocessed_joined.append(temp_tokens)\n",
    "    \n",
    "claims_preprocessed_joined = [' '.join(tokens) for tokens in claims_preprocessed_joined]\n",
    "    \n",
    "for text in titles_preprocessed:\n",
    "    temp_tokens = []\n",
    "    for token in text:\n",
    "        if token in vocab_dict:\n",
    "            temp_tokens.append(token)\n",
    "    titles_preprocessed_joined.append(temp_tokens)\n",
    "    \n",
    "titles_preprocessed_joined = [' '.join(tokens) for tokens in titles_preprocessed_joined]\n",
    "    \n",
    "for text in abstracts_preprocessed:\n",
    "    temp_tokens = []\n",
    "    for token in text:\n",
    "        if token in vocab_dict:\n",
    "            temp_tokens.append(token)\n",
    "    abstract_preprocessed_joined.append(temp_tokens)\n",
    "    \n",
    "abstract_preprocessed_joined = [' '.join(tokens) for tokens in abstract_preprocessed_joined]\n",
    "    \n",
    "for text in texts_preprocessed:\n",
    "    temp_tokens = []\n",
    "    for token in text:\n",
    "        if token in vocab_dict:\n",
    "            temp_tokens.append(token)\n",
    "    texts_preprocessed_joined.append(temp_tokens)\n",
    "    \n",
    "texts_preprocessed_joined = [' '.join(tokens) for tokens in texts_preprocessed_joined]\n",
    "    \n",
    "\n",
    "claims_preprocessed_joined, titles_preprocessed_joined, abstract_preprocessed_joined, texts_preprocessed_joined \n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 2.2.2 Pondération (4 points)\n",
    "\n",
    "En utilisant un modèle sac de mots basé sur des unigrammes et des bigrammes, créez une représentation vectorielle de vos documents (titles, abstracts, texts) et de vos affirmations (claims) avec TF-IDF en utilisant le TfidfVectorizer de sklearn. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [],
   "source": [
    "# TODO\n",
    "corpus = claims_preprocessed_joined + texts_preprocessed_joined\n",
    "vectorizer = TfidfVectorizer(ngram_range=(1,2))\n",
    "tfidf = vectorizer.fit(corpus)\n",
    "\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 2.2.3 Affichage (1 point)\n",
    "\n",
    "Affichez les dimensions (shape) de vos corpus (claims, text, title, abstract) après vectorisation"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(809, 473643)"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# TODO\n",
    "claims_vector = tfidf.transform(claims_preprocessed_joined)\n",
    "claims_vector.shape\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Sortie attendue pour \"_claims_\"\n",
    "```\n",
    "(809, 473643)\n",
    "```"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(5183, 473643)"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# TODO\n",
    "texts_vector = tfidf.transform(texts_preprocessed_joined)\n",
    "texts_vector.shape\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Sortie attendue pour \"_texts_\"\n",
    "```\n",
    "(5183, 473643)\n",
    "```"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(5183, 473643)"
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# TODO\n",
    "titles_vector = tfidf.transform(titles_preprocessed_joined)\n",
    "titles_vector.shape\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Sortie attendue pour \"_titles_\"\n",
    "```\n",
    "(5183, 473643)\n",
    "```"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(5183, 473643)"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# TODO\n",
    "abstracts_vector = tfidf.transform(abstract_preprocessed_joined)\n",
    "abstracts_vector.shape\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Sortie attendue pour abstracts\n",
    "```\n",
    "(5183, 473643)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "sMrNWcxL9QNF"
   },
   "source": [
    "#### 2.3 Pertinence d'un document (20 points)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Maintenant que vous avez une représentation de vos affirmations \"_claims_\" et documents (\"_texts_\", \"_titles_\", \"_abstracts_\"), il faut être capable de déterminer quel document sera le plus pertinent pour une affirmation donnée."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "3AsiWH2O9XKD"
   },
   "source": [
    "##### 2.3.1 Implémentation de \"_eval_similarity_\" (3 points)\n",
    "\n",
    "Implémentez la fonction \"_eval_similarity_\" pour évaluer la similarité cosinus entre la représentation de l'affirmation et celle de chaque document. La fonction prend une liste d'affirmations et une liste de documents et retourne une matrice où chaque ligne représente une affirmation et chaque colonne représente un document (\"title\", \"abstract\" ou \"text\") et les valeurs sont les similarités cosinus entre une affirmation et un document."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(array([[0.00617696, 0.00537931, 0.        , ..., 0.        , 0.        ,\n",
       "         0.        ],\n",
       "        [0.        , 0.        , 0.        , ..., 0.        , 0.        ,\n",
       "         0.01116709],\n",
       "        [0.        , 0.00488052, 0.00319313, ..., 0.        , 0.        ,\n",
       "         0.        ],\n",
       "        ...,\n",
       "        [0.        , 0.        , 0.00337391, ..., 0.        , 0.        ,\n",
       "         0.        ],\n",
       "        [0.        , 0.        , 0.        , ..., 0.        , 0.        ,\n",
       "         0.        ],\n",
       "        [0.        , 0.        , 0.01176279, ..., 0.        , 0.        ,\n",
       "         0.        ]]),\n",
       " (809, 5183))"
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# TODO\n",
    "from numpy.linalg import norm\n",
    "def eval_similarity(claims_tfidf, doc_tfidf):\n",
    "    \n",
    "    cosine_matrix = cosine_similarity(claims_tfidf, doc_tfidf)\n",
    "    return cosine_matrix\n",
    "\n",
    "\n",
    "eval_claims_texts = eval_similarity(claims_vector, texts_vector)\n",
    "eval_claims_titles = eval_similarity(claims_vector, titles_vector)\n",
    "eval_claims_abstracts = eval_similarity(claims_vector, abstracts_vector)\n",
    "\n",
    "#eval_claims = eval_similarity(claims_vector, texts_vector+titles_vector+abstracts_vector)\n",
    "\n",
    "eval_claims_texts, eval_claims_texts.shape\n",
    "    \n",
    "#END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "5_gDSgTv9fCu"
   },
   "source": [
    "##### 2.3.2 Implémentation de la fonction \"_rank_texts_\" (2 points)\n",
    "\n",
    "Implémentez la fonction \"_rank_texts_\", qui, au moyen de la précédente (_eval_similarity_), retourne le top-N (N=1,3,5) des documents pertinents pour une affirmation donnée (N est un paramètre). Ces documents devront être ordonnés du plus pertinent au moins pertinent. Idéalement, le document à la position 1 sera celui qui contient la preuve (ou justification) de l'affirmation. Il faudra retourner non pas les indices des documents dans le dataframe mais plutôt leur identifiants au niveau de la colonne \"_doc_id_\"."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[13734012, 17333231, 13770184]"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# TODO\n",
    "#assuming claim is the index row of df_claims\n",
    "def rank_texts(N, claim, cosine_sim):\n",
    "    cosine_row = cosine_sim[claim]\n",
    "    max_indexes = np.argsort(cosine_row)[::-1][:N]\n",
    "    \n",
    "    doc_list = []\n",
    "    \n",
    "    for id in max_indexes:\n",
    "        doc_list.append(df_corpus.iloc[id][\"doc_id\"])\n",
    "        \n",
    "    return doc_list\n",
    "    \n",
    "    \n",
    "rank_docs = rank_texts(3, 1, eval_claims_texts)\n",
    "rank_docs\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>doc_id</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "      <th>structured</th>\n",
       "      <th>text</th>\n",
       "      <th>title_length</th>\n",
       "      <th>abstract_length</th>\n",
       "      <th>text_length</th>\n",
       "      <th>titles_preprocessed</th>\n",
       "      <th>abstracts_preprocessed</th>\n",
       "      <th>texts_preprocessed</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2232</th>\n",
       "      <td>13734012</td>\n",
       "      <td>Prevalent abnormal prion protein in human appe...</td>\n",
       "      <td>OBJECTIVES To carry out a further survey of ar...</td>\n",
       "      <td>True</td>\n",
       "      <td>Prevalent abnormal prion protein in human appe...</td>\n",
       "      <td>15</td>\n",
       "      <td>305</td>\n",
       "      <td>320</td>\n",
       "      <td>[preval, abnorm, prion, protein, human, append...</td>\n",
       "      <td>[object, carri, survey, archiv, appendix, samp...</td>\n",
       "      <td>[preval, abnorm, prion, protein, human, append...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        doc_id                                              title  \\\n",
       "2232  13734012  Prevalent abnormal prion protein in human appe...   \n",
       "\n",
       "                                               abstract  structured  \\\n",
       "2232  OBJECTIVES To carry out a further survey of ar...        True   \n",
       "\n",
       "                                                   text  title_length  \\\n",
       "2232  Prevalent abnormal prion protein in human appe...            15   \n",
       "\n",
       "      abstract_length  text_length  \\\n",
       "2232              305          320   \n",
       "\n",
       "                                    titles_preprocessed  \\\n",
       "2232  [preval, abnorm, prion, protein, human, append...   \n",
       "\n",
       "                                 abstracts_preprocessed  \\\n",
       "2232  [object, carri, survey, archiv, appendix, samp...   \n",
       "\n",
       "                                     texts_preprocessed  \n",
       "2232  [preval, abnorm, prion, protein, human, append...  "
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_corpus[df_corpus[\"doc_id\"] == 13734012]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "809"
      ]
     },
     "execution_count": 41,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(eval_claims_texts)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 2.3.3 Préparation des dataframes de réponses (1 point) \n",
    "\n",
    "Vous allez écrire la fonction \"prepare_results_df\" qui crée les dataframes qui vont contenir les résultats de la recherche de documents pertinents pour les affirmations.\n",
    "\n",
    "La fonction \"prepare_results_df\" prend les arguments suivants:\n",
    "\n",
    "- '_df_': le dataframe original nommé '_df_claims_' à partir duquel on crée les autres, \n",
    "- '_columns_to_drop_': les colonnes à supprimer \n",
    "- '_column_to_rename_': le nom de la colonne de référence dans le dataframe original qui sera renommée \"gold standard passage\"\n",
    "\n",
    "et effectue les opérations suivantes:\n",
    "\n",
    "1. Créer un nouveau dataframe à partir de \"_df_claims_\" en supprimant toutes les colonnes sauf \"cited_doc_ids\".\n",
    "2. Renommer la colonne \"cited_doc_ids\" en \"gold standard passage\".\n",
    "3. Ajouter les colonnes \"top_1\", \"top_3\", et \"top_5\" au dataframe, \n",
    "en les initialisant avec des chaînes de zéros séparés par des points-\n",
    "virgules, correspondant respectivement à des configurations de 1, 3, et \n",
    "5 zéros pour toutes les lignes.\n",
    "\n",
    "Vous utiliserez ensuite cette fonction pour créer les dataframes \"results_titles_df\", \"results_abstracts_df\" et \"results_texts_df\", qui seront destinés à contenir les résultats de recherche de documents pour \"title\", \"abstract\" et \"text\" respectivement."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>gold standard passage</th>\n",
       "      <th>top_1</th>\n",
       "      <th>top_3</th>\n",
       "      <th>top_5</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>[31715818]</td>\n",
       "      <td>0</td>\n",
       "      <td>0;0;0</td>\n",
       "      <td>0;0;0;0;0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>[13734012]</td>\n",
       "      <td>0</td>\n",
       "      <td>0;0;0</td>\n",
       "      <td>0;0;0;0;0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>4</td>\n",
       "      <td>[22942787]</td>\n",
       "      <td>0</td>\n",
       "      <td>0;0;0</td>\n",
       "      <td>0;0;0;0;0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>6</td>\n",
       "      <td>[2613775]</td>\n",
       "      <td>0</td>\n",
       "      <td>0;0;0</td>\n",
       "      <td>0;0;0;0;0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>9</td>\n",
       "      <td>[44265107]</td>\n",
       "      <td>0</td>\n",
       "      <td>0;0;0</td>\n",
       "      <td>0;0;0;0;0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>804</th>\n",
       "      <td>1403</td>\n",
       "      <td>[33370, 38355793]</td>\n",
       "      <td>0</td>\n",
       "      <td>0;0;0</td>\n",
       "      <td>0;0;0;0;0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805</th>\n",
       "      <td>1404</td>\n",
       "      <td>[33370, 38355793]</td>\n",
       "      <td>0</td>\n",
       "      <td>0;0;0</td>\n",
       "      <td>0;0;0;0;0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>806</th>\n",
       "      <td>1405</td>\n",
       "      <td>[10504681]</td>\n",
       "      <td>0</td>\n",
       "      <td>0;0;0</td>\n",
       "      <td>0;0;0;0;0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>807</th>\n",
       "      <td>1406</td>\n",
       "      <td>[2617858]</td>\n",
       "      <td>0</td>\n",
       "      <td>0;0;0</td>\n",
       "      <td>0;0;0;0;0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>808</th>\n",
       "      <td>1407</td>\n",
       "      <td>[8087082, 29863668]</td>\n",
       "      <td>0</td>\n",
       "      <td>0;0;0</td>\n",
       "      <td>0;0;0;0;0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>809 rows × 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       id gold standard passage top_1  top_3      top_5\n",
       "0       0            [31715818]     0  0;0;0  0;0;0;0;0\n",
       "1       2            [13734012]     0  0;0;0  0;0;0;0;0\n",
       "2       4            [22942787]     0  0;0;0  0;0;0;0;0\n",
       "3       6             [2613775]     0  0;0;0  0;0;0;0;0\n",
       "4       9            [44265107]     0  0;0;0  0;0;0;0;0\n",
       "..    ...                   ...   ...    ...        ...\n",
       "804  1403     [33370, 38355793]     0  0;0;0  0;0;0;0;0\n",
       "805  1404     [33370, 38355793]     0  0;0;0  0;0;0;0;0\n",
       "806  1405            [10504681]     0  0;0;0  0;0;0;0;0\n",
       "807  1406             [2617858]     0  0;0;0  0;0;0;0;0\n",
       "808  1407   [8087082, 29863668]     0  0;0;0  0;0;0;0;0\n",
       "\n",
       "[809 rows x 5 columns]"
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# TODO\n",
    "def prepare_results_df(df, columns_to_drop, column_to_rename):\n",
    "    new_df = df.drop(columns_to_drop, axis=1)\n",
    "    new_df = new_df.rename(columns={\"cited_doc_ids\": column_to_rename})\n",
    "    \n",
    "    \n",
    "    \n",
    "    new_df = new_df.assign(top_1='0')\n",
    "    new_df = new_df.assign(top_3='0;0;0')\n",
    "    new_df = new_df.assign(top_5='0;0;0;0;0')\n",
    "    \n",
    "    return new_df\n",
    "\n",
    "columns_to_drop = list(df_claims)\n",
    "columns_to_keep = [\"id\", \"cited_doc_ids\"]\n",
    "for column in columns_to_keep:\n",
    "    columns_to_drop.remove(column)\n",
    "\n",
    "results_abstracts_df = prepare_results_df(df_claims, columns_to_drop, \"gold standard passage\")\n",
    "results_titles_df = prepare_results_df(df_claims, columns_to_drop, \"gold standard passage\")\n",
    "results_texts_df = prepare_results_df(df_claims, columns_to_drop, \"gold standard passage\")\n",
    "\n",
    "results_abstracts_df\n",
    "\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'0'"
      ]
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "results_texts_df.iloc[1][\"top_1\"]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "> Sortie attendue pour chaque dataframe préparé\n",
    "<div>\n",
    "<style scoped>\n",
    "    .dataframe tbody tr th:only-of-type {\n",
    "        vertical-align: middle;\n",
    "    }\n",
    "\n",
    "    .dataframe tbody tr th {\n",
    "        vertical-align: top;\n",
    "    }\n",
    "\n",
    "    .dataframe thead th {\n",
    "        text-align: right;\n",
    "    }\n",
    "</style>\n",
    "<table border=\"1\" class=\"dataframe\">\n",
    "  <thead>\n",
    "    <tr style=\"text-align: right;\">\n",
    "      <th></th>\n",
    "      <th>id</th>\n",
    "      <th>gold standard passage</th>\n",
    "      <th>top_1</th>\n",
    "      <th>top_3</th>\n",
    "      <th>top_5</th>\n",
    "    </tr>\n",
    "  </thead>\n",
    "  <tbody>\n",
    "    <tr>\n",
    "      <th>0</th>\n",
    "      <td>0</td>\n",
    "      <td>[31715818]</td>\n",
    "      <td>0</td>\n",
    "      <td>0;0;0</td>\n",
    "      <td>0;0;0;0;0</td>\n",
    "    </tr>\n",
    "    <tr>\n",
    "      <th>1</th>\n",
    "      <td>2</td>\n",
    "      <td>[13734012]</td>\n",
    "      <td>0</td>\n",
    "      <td>0;0;0</td>\n",
    "      <td>0;0;0;0;0</td>\n",
    "    </tr>\n",
    "    <tr>\n",
    "      <th>2</th>\n",
    "      <td>4</td>\n",
    "      <td>[22942787]</td>\n",
    "      <td>0</td>\n",
    "      <td>0;0;0</td>\n",
    "      <td>0;0;0;0;0</td>\n",
    "    </tr>\n",
    "  </tbody>\n",
    "</table>\n",
    "</div>"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 2.3.4 Implémentation de la fonction \"_fill_results_\" (2 points)\n",
    "\n",
    "Vous devez maintenant implémenter la fonction \"_fill_results_\" qui remplit les dataframes préparés dans l'étape précédente en utilisant les resultats de recherche de document.\n",
    "Cette fonction prend les arguments suivant: \n",
    "- \"_results_\" : matrice contenant les valeurs de similarite des affirmations et des documents\n",
    "- \"_results_texts_df_\" : Dataframe contenant les affirmations ainsi que les colonnes \"top_1\", \"top_3\", \"top_5\" où doivent être mis les top-n documents les plus pertinents.\n",
    "\n",
    "Les deux arguments contiennent le même nombre d'éléments et pour le même indice, font référence à la même affirmation."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [],
   "source": [
    "# TODO\n",
    "pd.options.mode.chained_assignment = None \n",
    "def fill_results(results, results_texts_df):\n",
    "    for i in range(len(results)):\n",
    "            top_1_values = rank_texts(1, i, results)\n",
    "            top_3_values = rank_texts(3, i, results)\n",
    "            top_5_values = rank_texts(5, i, results)\n",
    "            \n",
    "            top_1_values = ';'.join([str(j) for j in top_1_values])\n",
    "            top_3_values = ';'.join([str(j) for j in top_3_values])\n",
    "            top_5_values = ';'.join([str(j) for j in top_5_values])\n",
    "            \n",
    "            results_texts_df.at[i, \"top_1\"] = top_1_values\n",
    "            results_texts_df.at[i, \"top_3\"] = top_3_values\n",
    "            results_texts_df.at[i, \"top_5\"] = top_5_values\n",
    "            \n",
    "    return results_texts_df\n",
    "        \n",
    "\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "EqRUGA9D9xoI"
   },
   "source": [
    "##### 2.3.5 Exécution des fonctions \"_rank_texts_\" et fill_results(2 points)\n",
    "\n",
    "Exécutez maintenant votre fonction \"_rank_texts_\" sur toutes les affirmations (claims) et toutes les représentations de documents (title, abstract, text) en mettant les résultats dans les variables \"results_texts\", \"results_titles\" et \"results_abstracts\". Ensuite appelez la fonction \"_fill_results_\" qui remplit les dataframes \"_results_titles_df_\", \"_results_abstracts_df_\", et \"_results_texts_df_\" contenant les résultats de recheche de documents."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>gold standard passage</th>\n",
       "      <th>top_1</th>\n",
       "      <th>top_3</th>\n",
       "      <th>top_5</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>[31715818]</td>\n",
       "      <td>10608397</td>\n",
       "      <td>10608397;42421723;10607877</td>\n",
       "      <td>10608397;42421723;10607877;21257564;35008773</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>[13734012]</td>\n",
       "      <td>13734012</td>\n",
       "      <td>13734012;17333231;13770184</td>\n",
       "      <td>13734012;17333231;13770184;42240424;3716075</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>4</td>\n",
       "      <td>[22942787]</td>\n",
       "      <td>7165938</td>\n",
       "      <td>7165938;1387104;520579</td>\n",
       "      <td>7165938;1387104;520579;10958594;52188256</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>6</td>\n",
       "      <td>[2613775]</td>\n",
       "      <td>23117378</td>\n",
       "      <td>23117378;2613775;21050357</td>\n",
       "      <td>23117378;2613775;21050357;20240998;35521287</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>9</td>\n",
       "      <td>[44265107]</td>\n",
       "      <td>44265107</td>\n",
       "      <td>44265107;24700152;14647747</td>\n",
       "      <td>44265107;24700152;14647747;26105746;25182647</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>804</th>\n",
       "      <td>1403</td>\n",
       "      <td>[33370, 38355793]</td>\n",
       "      <td>33370</td>\n",
       "      <td>33370;38355793;45764440</td>\n",
       "      <td>33370;38355793;45764440;40412980;7986878</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>805</th>\n",
       "      <td>1404</td>\n",
       "      <td>[33370, 38355793]</td>\n",
       "      <td>38355793</td>\n",
       "      <td>38355793;33370;45764440</td>\n",
       "      <td>38355793;33370;45764440;40412980;7986878</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>806</th>\n",
       "      <td>1405</td>\n",
       "      <td>[10504681]</td>\n",
       "      <td>20402596</td>\n",
       "      <td>20402596;10504681;38675228</td>\n",
       "      <td>20402596;10504681;38675228;5849439;14926162</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>807</th>\n",
       "      <td>1406</td>\n",
       "      <td>[2617858]</td>\n",
       "      <td>2617858</td>\n",
       "      <td>2617858;4465762;4857085</td>\n",
       "      <td>2617858;4465762;4857085;10577574;13963620</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>808</th>\n",
       "      <td>1407</td>\n",
       "      <td>[8087082, 29863668]</td>\n",
       "      <td>3801693</td>\n",
       "      <td>3801693;16090672;4820792</td>\n",
       "      <td>3801693;16090672;4820792;30224907;7549811</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>809 rows × 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       id gold standard passage     top_1                       top_3  \\\n",
       "0       0            [31715818]  10608397  10608397;42421723;10607877   \n",
       "1       2            [13734012]  13734012  13734012;17333231;13770184   \n",
       "2       4            [22942787]   7165938      7165938;1387104;520579   \n",
       "3       6             [2613775]  23117378   23117378;2613775;21050357   \n",
       "4       9            [44265107]  44265107  44265107;24700152;14647747   \n",
       "..    ...                   ...       ...                         ...   \n",
       "804  1403     [33370, 38355793]     33370     33370;38355793;45764440   \n",
       "805  1404     [33370, 38355793]  38355793     38355793;33370;45764440   \n",
       "806  1405            [10504681]  20402596  20402596;10504681;38675228   \n",
       "807  1406             [2617858]   2617858     2617858;4465762;4857085   \n",
       "808  1407   [8087082, 29863668]   3801693    3801693;16090672;4820792   \n",
       "\n",
       "                                            top_5  \n",
       "0    10608397;42421723;10607877;21257564;35008773  \n",
       "1     13734012;17333231;13770184;42240424;3716075  \n",
       "2        7165938;1387104;520579;10958594;52188256  \n",
       "3     23117378;2613775;21050357;20240998;35521287  \n",
       "4    44265107;24700152;14647747;26105746;25182647  \n",
       "..                                            ...  \n",
       "804      33370;38355793;45764440;40412980;7986878  \n",
       "805      38355793;33370;45764440;40412980;7986878  \n",
       "806   20402596;10504681;38675228;5849439;14926162  \n",
       "807     2617858;4465762;4857085;10577574;13963620  \n",
       "808     3801693;16090672;4820792;30224907;7549811  \n",
       "\n",
       "[809 rows x 5 columns]"
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# TODO\n",
    "\n",
    "#JE NE COMPRENDS PAS COMMENT CETTE QUESTION EST FORMULE, POURQUOI ON VEUT RESULTS_TEXTS\n",
    "\n",
    "results_abstracts_df = fill_results(eval_claims_abstracts, results_abstracts_df)\n",
    "results_titles_df = fill_results(eval_claims_titles, results_titles_df)\n",
    "results_texts_df = fill_results(eval_claims_texts, results_texts_df)\n",
    "\n",
    "results_texts_df\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 2.3.6 Enregistrement des dataframes \n",
    "\n",
    "On enregistre les dataframes dans des fichiers .csv."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [],
   "source": [
    "# TODO\n",
    "\n",
    "results_abstracts_df.to_csv(\"abstracts.csv\")\n",
    "results_titles_df.to_csv(\"titles.csv\")\n",
    "results_texts_df.to_csv(\"texts.csv\")\n",
    "\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "4qWHRy8oZvOt"
   },
   "source": [
    "##### 2.3.7 Implémentation de la fonction \"_show_top_n_passages_\" (3 points)\n",
    "\n",
    "Vous devez maintenant implémenter une fonction \"_show_top_n_passages_\" qui affiche le top-n ainsi que le texte (document) attendu pour une affirmation donnée. Ici on considère que document est representé par \"_text_\" donc la fusion du titre (\"_title_\") et du résumé (\"_abstract_\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {
    "id": "-l9sKrgC-Sq7"
   },
   "outputs": [],
   "source": [
    "# TODO\n",
    "def show_top_n_passages(claim_id, N, results_texts_df, df_corpus):\n",
    "    \n",
    "    top_text = results_texts_df.at[claim_id, f'top_{str(N)}']\n",
    "    top_text = top_text.split(';')\n",
    "    top_text = [eval(i) for i in top_text]\n",
    "    \n",
    "    all_text = []\n",
    "    \n",
    "    for doc_id in top_text:\n",
    "        all_text.append(df_corpus[df_corpus[\"doc_id\"]==doc_id]['text'].iloc[0])\n",
    "        \n",
    "    return all_text\n",
    "\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 2.3.8 Affichage (1 point)\n",
    "\n",
    "Appliquez cette fonction sur l'affirmation ayant pour identifiant 211 et affichez le top-5 des documents les plus pertinents retrouvés."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity Oligodendrocytes, the myelin-forming glial cells of the central nervous system, maintain long-term axonal integrity. However, the underlying support mechanisms are not understood. Here we identify a metabolic component of axon–glia interactions by generating conditional Cox10 (protoheme IX farnesyltransferase) mutant mice, in which oligodendrocytes and Schwann cells fail to assemble stable mitochondrial cytochrome c oxidase (COX, also known as mitochondrial complex IV). In the peripheral nervous system, Cox10 conditional mutants exhibit severe neuropathy with dysmyelination, abnormal Remak bundles, muscle atrophy and paralysis. Notably, perturbing mitochondrial respiration did not cause glial cell death. In the adult central nervous system, we found no signs of demyelination, axonal degeneration or secondary inflammation. Unlike cultured oligodendrocytes, which are sensitive to COX inhibitors, post-myelination oligodendrocytes survive well in the absence of COX activity. More importantly, by in vivo magnetic resonance spectroscopy, brain lactate concentrations in mutants were increased compared with controls, but were detectable only in mice exposed to volatile anaesthetics. This indicates that aerobic glycolysis products derived from oligodendrocytes are rapidly metabolized within white matter tracts. Because myelinated axons can use lactate when energy-deprived, our findings suggest a model in which axon–glia metabolic coupling serves a physiological function.',\n",
       " 'The Transcription Factors Egr2 and Egr3 Are Essential for the Control of Inflammation and Antigen-Induced Proliferation of B and T Cells Lymphocytes provide optimal responses against pathogens with minimal inflammatory pathology. However, the intrinsic mechanisms regulating these responses are unknown. Here, we report that deletion of both transcription factors Egr2 and Egr3 in lymphocytes resulted in a lethal autoimmune syndrome with excessive serum proinflammatory cytokines but also impaired antigen receptor-induced proliferation of B and T cells. Egr2- and Egr3-defective B and T cells had hyperactive signal transducer and activator of transcription-1 (STAT1) and STAT3 while antigen receptor-induced activation of transcription factor AP-1 was severely impaired. We discovered that Egr2 and/or Egr3 directly induced expression of suppressor of cytokine signaling-1 (SOCS1) and SOCS3, inhibitors of STAT1 and STAT3, and also blocked the function of Batf, an AP-1 inhibitor, in B and T cells. Thus, Egr2 and Egr3 regulate B and T cell function in adaptive immune responses and homeostasis by promoting antigen receptor signaling and controlling inflammation.',\n",
       " 'Label-free in vivo imaging of myelinated axons in health and disease with spectral confocal reflectance microscopy We report a newly developed technique for high-resolution in vivo imaging of myelinated axons in the brain, spinal cord and peripheral nerve that requires no fluorescent labeling. This method, based on spectral confocal reflectance microscopy (SCoRe), uses a conventional laser-scanning confocal system to generate images by merging the simultaneously reflected signals from multiple lasers of different wavelengths. Striking color patterns unique to individual myelinated fibers are generated that facilitate their tracing in dense axonal areas. These patterns highlight nodes of Ranvier and Schmidt-Lanterman incisures and can be used to detect various myelin pathologies. Using SCoRe we carried out chronic brain imaging up to 400 μm deep, capturing de novo myelination of mouse cortical axons in vivo. We also established the feasibility of imaging myelinated axons in the human cerebral cortex. SCoRe adds a powerful component to the evolving toolbox for imaging myelination in living animals and potentially in humans.',\n",
       " 'In vivo electroporation in the embryonic mouse central nervous system This protocol describes a basic method for in vivo electroporation in the nervous system of embryonic mice. Delivery of electric pulses following microinjection of DNA into the brain ventricle or the spinal cord central canal enables efficient transfection of genes into the nervous system. Transfection is facilitated by forceps-type electrodes, which hold the uterus and/or the yolk sac containing the embryo. More than ten embryos in a single pregnant mouse can be operated on within 30 min. More than 90% of operated embryos survive and more than 90% of these survivors express the transfected genes appropriately. Gene expression in neurons persists for a long time, even at postnatal stages, after electroporation. Thus, this method could be used to analyze roles of genes not only in embryonic development but also in higher order function of the nervous system, such as learning.',\n",
       " 'Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Both axon and myelin degeneration have significant impact on the long-term disability of patients with white matter disorder. However, the clinical manifestations of the neurological dysfunction caused by white matter disorders are not sufficient to determine the origin of neurological deficits. A noninvasive biological marker capable of detecting and differentiating axon and myelin degeneration would be a significant addition to currently available tools. Directional diffusivities derived from diffusion tensor imaging (DTI) have been previously proposed by this group as potential biological markers to detect and differentiate axon and myelin degeneration. To further test the hypothesis that axial (lambdaparallel) and radial (lambdaperpendicular) diffusivities reflect axon and myelin pathologies, respectively, the optic nerve was examined serially using DTI in a mouse model of retinal ischemia. A significant decrease of lambdaparallel, the putative DTI axonal marker, was observed 3 days after ischemia without concurrently detectable changes in lambdaperpendicular, the putative myelin marker. This result is consistent with histological findings of significant axonal degeneration with no detectable demyelination at 3 days after ischemia. The elevation of lambdaperpendicular observed 5 days after ischemia is consistent with histological findings of myelin degeneration at this time. These results support the hypothesis that lambdaparallel and lambdaperpendicular hold promise as specific markers of axonal and myelin injury, respectively, and, further, that the coexistence of axonal and myelin degeneration does not confound this utility.']"
      ]
     },
     "execution_count": 48,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# TODO\n",
    "all_text = show_top_n_passages(211, 5, results_texts_df, df_corpus)\n",
    "all_text\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 2.3.9 Évaluation (3 points)\n",
    "\n",
    "Vous devez maintenant implémenter la fonction \"_evaluate_\" qui, à partir des colonnes *Gold standard passage* et de vos top-N respectifs, calcule la précision top-N (N=1,3,5) sur l’ensemble de données en paramètre et l’affiche. \n",
    "\n",
    "Cette précision connue sous le nom \"precision at k (precision@k)\" se calcule de la manière suivante:\n",
    "\n",
    "\n",
    "$$\n",
    "\\text{precision@k} = \\frac{\\text{nombre d'éléments corrects}}{\\text{nombre total d'éléments k retrouvés}}\n",
    "$$\n",
    "\n",
    "\n",
    "Veillez à ce que la fonction soit générique. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [],
   "source": [
    "# TODO\n",
    "def evaluate(results_df):\n",
    "    correct_element = 0\n",
    "    total = 0\n",
    "    N = [1,3,5]\n",
    "    all_precisions=[]\n",
    "    \n",
    "    for n in N:\n",
    "        if n == 1:\n",
    "            for i in range(len(results_df)):\n",
    "                id_1 = int(results_df.iloc[i][\"top_1\"])\n",
    "                if id_1 in results_df.iloc[i][\"gold standard passage\"]:\n",
    "                    correct_element +=1\n",
    "                total += 1\n",
    "            precision = correct_element/total\n",
    "            all_precisions.append(precision)\n",
    "        \n",
    "        else:\n",
    "            for i in range(len(results_df)):\n",
    "                all_ids = results_df.iloc[i][f\"top_{str(n)}\"]\n",
    "                all_ids = all_ids.split(';')\n",
    "                all_ids = [eval(z) for z in all_ids]\n",
    "                \n",
    "                for index in all_ids:\n",
    "                    if index in results_df.iloc[i][\"gold standard passage\"]:\n",
    "                        correct_element +=1\n",
    "                    total+=1\n",
    "                    \n",
    "            precision = correct_element/total\n",
    "            all_precisions.append(precision)\n",
    "                   \n",
    "    return all_precisions\n",
    "\n",
    "    \n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 2.3.10 Affichage (1 point)\n",
    "\n",
    "Appliquez cette fonction pour calculer la précision des documents retrouvés en utilisant les titres (\"_title_\"), les résumés (\"_abstract_\") et la fusion des deux (\"_text_\")."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "([0.48702101359703337, 0.29079110012360937, 0.21370690839170445],\n",
       " [0.3226205191594561, 0.20333745364647712, 0.15245158632056036],\n",
       " [0.46600741656365885, 0.27904820766378247, 0.20395550061804696])"
      ]
     },
     "execution_count": 50,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# TODO\n",
    "all_precisions_texts = evaluate(results_texts_df)\n",
    "all_precisions_titles = evaluate(results_titles_df)\n",
    "all_precisions_abstracts = evaluate(results_abstracts_df)\n",
    "\n",
    "all_precisions_texts, all_precisions_titles, all_precisions_abstracts\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 2.3.11 Graphique (2 points)\n",
    "\n",
    "Tracez un graphique des valeurs de précisions des documents retrouvés (\"__title__\", \"__abstract__\", \"__text__\") pour différents N (1,3,5)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# TODO\n",
    "\n",
    "N = 3\n",
    "ind = np.arange(N)  \n",
    "width = 0.25\n",
    "  \n",
    "\n",
    "bar1 = plt.bar(ind, all_precisions_texts, width, color = 'r') \n",
    "  \n",
    "\n",
    "bar2 = plt.bar(ind+width, all_precisions_titles, width, color='g') \n",
    "  \n",
    "bar3 = plt.bar(ind+width*2, all_precisions_abstracts, width, color = 'b') \n",
    "  \n",
    "plt.xlabel(\"N\") \n",
    "plt.ylabel('Precision@k') \n",
    "plt.title(\"Precision@k for different values of N and document\") \n",
    "  \n",
    "plt.xticks(ind+width,['1', '3', '5']) \n",
    "plt.legend( (bar1, bar2, bar3), ('Texts', 'Titles', 'Abstract') ) \n",
    "plt.show() \n",
    "\n",
    "\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "vI_2JXRxAygz"
   },
   "source": [
    "### 3 Amélioration avec BM25 (20 points)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "BM25 (Best Matching 25) est un algorithme de recherche utilisé pour évaluer la pertinence des documents par rapport à une requête. Basé sur le modèle de récupération d'informations probabilistes, BM25 calcule un score de pertinence en tenant compte de la fréquence des termes de la requête dans chaque document et dans le corpus global mais aussi de la longueur des documents. \n",
    "\n",
    "BM25 est pertinent pour la recherche d'information car il offre un bon équilibre entre précision et rappel, il gère efficacement de grandes collections de documents et permet des ajustements pour différents types de corpus. Il est largement utilisé dans les moteurs de recherche et les systèmes de recommandation.\n",
    "\n",
    "Dans cette partie on vous demande de la tester au moyen de la librairie rank_bm25 pour cette tâche de recherche de texte qui justifie ou contredit une affirmation donnée. Vous allez utiliser le corpus et les affirmations et procéder comme indiqué dans la suite."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 3.1 Initialisation du modèle BM25 (3 points)\n",
    "Réutilisez les variables \"claims_preprocessed_joined\", \"texts_preprocessed_joined\", \"titles_preprocessed_joined\" et \"abstract_preprocessed_joined\" définies à la question `2.2.1` pour initialiser les modèles BM25 pour les documents (\"__titles__\", \"__abstracts__\" et \"__text__\"). Il faudra transformer chaque séquence (dont les jetons étaient joints pour former une seule chaîne) en une liste de jetons. Vous utiliserez la classe \"_BM250kapi_\" à ce niveau. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<rank_bm25.BM25Okapi at 0x1de568d9850>"
      ]
     },
     "execution_count": 62,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# TODO\n",
    "from rank_bm25 import BM25Okapi\n",
    "\n",
    "texts_split = [doc.split(\" \") for doc in texts_preprocessed_joined]\n",
    "titles_split = [doc.split(\" \") for doc in titles_preprocessed_joined]\n",
    "abstract_split = [doc.split(\" \") for doc in abstract_preprocessed_joined]\n",
    "\n",
    "texts_bm = BM25Okapi(texts_split)\n",
    "titles_bm = BM25Okapi(titles_split)\n",
    "abstract_split = BM25Okapi(abstract_split)\n",
    "\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 3.2 Utilisation du modèle BM25 (5 points)\n",
    "\n",
    "Retrouvez les identifiants des documents pour les cinq meilleures correspondances de \"_title_\", de \"_abstract_\" et de \"_text_\" en utilisant le score BM25 pour chaque affirmation (claim) traitée, et mettez à jour les résultats avec les identifiants de documents correspondants."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "metadata": {},
   "outputs": [],
   "source": [
    "# TODO\n",
    "\n",
    "def top_bm25_scores(claims_preprocessed_joined, bm25, df_corpus, n):\n",
    "    top_doc_ids = []\n",
    "    for claim in claims_preprocessed_joined:\n",
    "        temp_doc_ids = []\n",
    "        claim = claim.split(\" \")\n",
    "        bm25_scores = bm25.get_scores(claim)\n",
    "\n",
    "        top_n_idx = np.argsort(bm25_scores)[-n:]\n",
    "\n",
    "        for index in top_n_idx:\n",
    "            temp_doc_ids.append(df_corpus.iloc[index][\"doc_id\"])\n",
    "\n",
    "        top_doc_ids.append(temp_doc_ids)\n",
    "        \n",
    "    return top_doc_ids\n",
    "\n",
    "\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 3.3 Affichage des performances (4 points)\n",
    "\n",
    "Affichez les résultats des performances BM25 pour les configurations Top1, Top3 et Top5 avec \"_title_\", \"_asbtract_\" et \"_text_\"."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'top_1': [[26071782],\n",
       "  [13734012],\n",
       "  [10958594],\n",
       "  [23117378],\n",
       "  [44265107],\n",
       "  [25510546],\n",
       "  [25510546],\n",
       "  [33409100],\n",
       "  [1373287],\n",
       "  [25238950],\n",
       "  [7662395],\n",
       "  [10958594],\n",
       "  [7042304],\n",
       "  [7042304],\n",
       "  [13843341],\n",
       "  [6490571],\n",
       "  [1900152],\n",
       "  [23117378],\n",
       "  [79696454],\n",
       "  [79696454],\n",
       "  [12670680],\n",
       "  [13069283],\n",
       "  [12428497],\n",
       "  [42441846],\n",
       "  [42441846],\n",
       "  [16252863],\n",
       "  [13497630],\n",
       "  [13497630],\n",
       "  [18174210],\n",
       "  [5398179],\n",
       "  [56893404],\n",
       "  [56893404],\n",
       "  [380526],\n",
       "  [26996935],\n",
       "  [45638119],\n",
       "  [9899292],\n",
       "  [4709641],\n",
       "  [39984099],\n",
       "  [39984099],\n",
       "  [25510546],\n",
       "  [12909503],\n",
       "  [12909503],\n",
       "  [39443128],\n",
       "  [21295300],\n",
       "  [21295300],\n",
       "  [5956380],\n",
       "  [1127562],\n",
       "  [6076903],\n",
       "  [13965483],\n",
       "  [5531479],\n",
       "  [5531479],\n",
       "  [5099266],\n",
       "  [5099266],\n",
       "  [4320424],\n",
       "  [38919140],\n",
       "  [21387297],\n",
       "  [12827098],\n",
       "  [12827098],\n",
       "  [12827098],\n",
       "  [4254064],\n",
       "  [4254064],\n",
       "  [45276789],\n",
       "  [33733520],\n",
       "  [4399311],\n",
       "  [13966946],\n",
       "  [14500725],\n",
       "  [6540064],\n",
       "  [32159283],\n",
       "  [36606083],\n",
       "  [25515907],\n",
       "  [22995579],\n",
       "  [4319174],\n",
       "  [13513790],\n",
       "  [6157837],\n",
       "  [33872649],\n",
       "  [33872649],\n",
       "  [14606752],\n",
       "  [14606752],\n",
       "  [24157077],\n",
       "  [24157077],\n",
       "  [4883040],\n",
       "  [28738741],\n",
       "  [21884449],\n",
       "  [26016929],\n",
       "  [6807122],\n",
       "  [10582939],\n",
       "  [6227220],\n",
       "  [15488881],\n",
       "  [2272614],\n",
       "  [2272614],\n",
       "  [37549932],\n",
       "  [37549932],\n",
       "  [13439128],\n",
       "  [2015126],\n",
       "  [52874170],\n",
       "  [6903077],\n",
       "  [5824985],\n",
       "  [5824985],\n",
       "  [18872233],\n",
       "  [18872233],\n",
       "  [5824985],\n",
       "  [5824985],\n",
       "  [12670680],\n",
       "  [8411251],\n",
       "  [2947540],\n",
       "  [79336156],\n",
       "  [25510546],\n",
       "  [9669099],\n",
       "  [13831558],\n",
       "  [16966326],\n",
       "  [19510470],\n",
       "  [12827098],\n",
       "  [17374970],\n",
       "  [17374970],\n",
       "  [3566945],\n",
       "  [19313533],\n",
       "  [2177022],\n",
       "  [2177022],\n",
       "  [18231807],\n",
       "  [2462673],\n",
       "  [9558539],\n",
       "  [7898952],\n",
       "  [470625],\n",
       "  [25510546],\n",
       "  [13794374],\n",
       "  [25606339],\n",
       "  [27054878],\n",
       "  [19205437],\n",
       "  [19205437],\n",
       "  [19205437],\n",
       "  [2014909],\n",
       "  [32742683],\n",
       "  [32742683],\n",
       "  [3727986],\n",
       "  [26973393],\n",
       "  [4928057],\n",
       "  [56893404],\n",
       "  [4388470],\n",
       "  [11557602],\n",
       "  [11557602],\n",
       "  [8148122],\n",
       "  [21498497],\n",
       "  [3430789],\n",
       "  [3430789],\n",
       "  [10474873],\n",
       "  [1568684],\n",
       "  [1568684],\n",
       "  [42441846],\n",
       "  [42441846],\n",
       "  [5850219],\n",
       "  [5850219],\n",
       "  [6397191],\n",
       "  [20261352],\n",
       "  [18924534],\n",
       "  [11328820],\n",
       "  [11328820],\n",
       "  [2033917],\n",
       "  [22405338],\n",
       "  [5912283],\n",
       "  [11614737],\n",
       "  [14376683],\n",
       "  [14376683],\n",
       "  [25001628],\n",
       "  [3514072],\n",
       "  [1974176],\n",
       "  [5548081],\n",
       "  [4709641],\n",
       "  [4709641],\n",
       "  [15048300],\n",
       "  [15048300],\n",
       "  [21170174],\n",
       "  [4398832],\n",
       "  [39381118],\n",
       "  [8496132],\n",
       "  [14797520],\n",
       "  [14797520],\n",
       "  [7821634],\n",
       "  [7821634],\n",
       "  [7821634],\n",
       "  [14464451],\n",
       "  [14464451],\n",
       "  [26735905],\n",
       "  [20732789],\n",
       "  [4506414],\n",
       "  [22174015],\n",
       "  [12909503],\n",
       "  [12909503],\n",
       "  [9505448],\n",
       "  [9505448],\n",
       "  [29023309],\n",
       "  [29023309],\n",
       "  [25079962],\n",
       "  [1780819],\n",
       "  [18816720],\n",
       "  [18816720],\n",
       "  [23349986],\n",
       "  [7098463],\n",
       "  [7098463],\n",
       "  [19308127],\n",
       "  [9641846],\n",
       "  [11902109],\n",
       "  [11902109],\n",
       "  [13497630],\n",
       "  [21622715],\n",
       "  [18855191],\n",
       "  [9646449],\n",
       "  [2506153],\n",
       "  [20821402],\n",
       "  [20821402],\n",
       "  [38587347],\n",
       "  [20646904],\n",
       "  [2601324],\n",
       "  [600437],\n",
       "  [13956305],\n",
       "  [27099731],\n",
       "  [27099731],\n",
       "  [6826100],\n",
       "  [1550937],\n",
       "  [1550937],\n",
       "  [24922825],\n",
       "  [1522647],\n",
       "  [5710820],\n",
       "  [18810195],\n",
       "  [17150648],\n",
       "  [19005293],\n",
       "  [18340282],\n",
       "  [24652030],\n",
       "  [51972698],\n",
       "  [21602220],\n",
       "  [21602220],\n",
       "  [21602220],\n",
       "  [21602220],\n",
       "  [21602220],\n",
       "  [11360768],\n",
       "  [1456068],\n",
       "  [1456068],\n",
       "  [20261352],\n",
       "  [791050],\n",
       "  [5633876],\n",
       "  [29459383],\n",
       "  [27437459],\n",
       "  [38899659],\n",
       "  [9451052],\n",
       "  [12443371],\n",
       "  [4709641],\n",
       "  [6309659],\n",
       "  [12443371],\n",
       "  [16494316],\n",
       "  [9315213],\n",
       "  [21598000],\n",
       "  [42441846],\n",
       "  [33257464],\n",
       "  [16728949],\n",
       "  [4418070],\n",
       "  [36540079],\n",
       "  [10993232],\n",
       "  [8002887],\n",
       "  [41877386],\n",
       "  [10359591],\n",
       "  [2014909],\n",
       "  [10526279],\n",
       "  [7583161],\n",
       "  [22703082],\n",
       "  [22703082],\n",
       "  [33203108],\n",
       "  [4200695],\n",
       "  [4200695],\n",
       "  [4162857],\n",
       "  [30507607],\n",
       "  [597790],\n",
       "  [40096222],\n",
       "  [1389264],\n",
       "  [22544171],\n",
       "  [15889329],\n",
       "  [12685434],\n",
       "  [1754001],\n",
       "  [7177329],\n",
       "  [37182501],\n",
       "  [6325527],\n",
       "  [6325527],\n",
       "  [14706752],\n",
       "  [10991183],\n",
       "  [24705390],\n",
       "  [12588500],\n",
       "  [30041340],\n",
       "  [12588500],\n",
       "  [25606339],\n",
       "  [1780819],\n",
       "  [1320137],\n",
       "  [56893404],\n",
       "  [92499],\n",
       "  [515489],\n",
       "  [13223957],\n",
       "  [22227889],\n",
       "  [22227889],\n",
       "  [26064662],\n",
       "  [17930286],\n",
       "  [10883736],\n",
       "  [22703082],\n",
       "  [45401535],\n",
       "  [25516011],\n",
       "  [29564505],\n",
       "  [6793674],\n",
       "  [6793674],\n",
       "  [1617327],\n",
       "  [3360421],\n",
       "  [3360421],\n",
       "  [3360421],\n",
       "  [16056514],\n",
       "  [17150648],\n",
       "  [19688024],\n",
       "  [6820680],\n",
       "  [10648422],\n",
       "  [6070278],\n",
       "  [8903143],\n",
       "  [1471041],\n",
       "  [14853989],\n",
       "  [1049501],\n",
       "  [30034334],\n",
       "  [20101846],\n",
       "  [2867345],\n",
       "  [2867345],\n",
       "  [16120395],\n",
       "  [16120395],\n",
       "  [23418635],\n",
       "  [20333864],\n",
       "  [20333864],\n",
       "  [8596357],\n",
       "  [10300888],\n",
       "  [10300888],\n",
       "  [4468861],\n",
       "  [37029185],\n",
       "  [23460562],\n",
       "  [14260013],\n",
       "  [14260013],\n",
       "  [8428935],\n",
       "  [7142113],\n",
       "  [10984005],\n",
       "  [14682243],\n",
       "  [14682243],\n",
       "  [19675911],\n",
       "  [4824840],\n",
       "  [12258338],\n",
       "  [12258338],\n",
       "  [26735905],\n",
       "  [6540064],\n",
       "  [20732789],\n",
       "  [4506414],\n",
       "  [21439293],\n",
       "  [14644164],\n",
       "  [32408470],\n",
       "  [9638032],\n",
       "  [9638032],\n",
       "  [9638032],\n",
       "  [17911973],\n",
       "  [17911973],\n",
       "  [24541180],\n",
       "  [20888849],\n",
       "  [1642727],\n",
       "  [25599283],\n",
       "  [20033112],\n",
       "  [20033112],\n",
       "  [16355392],\n",
       "  [5468807],\n",
       "  [5172048],\n",
       "  [5172048],\n",
       "  [1686997],\n",
       "  [25649714],\n",
       "  [6503185],\n",
       "  [13619127],\n",
       "  [32611468],\n",
       "  [21636085],\n",
       "  [33409100],\n",
       "  [15041758],\n",
       "  [15041758],\n",
       "  [3202143],\n",
       "  [9433958],\n",
       "  [9433958],\n",
       "  [21372171],\n",
       "  [57574395],\n",
       "  [57574395],\n",
       "  [8533245],\n",
       "  [5293024],\n",
       "  [37204802],\n",
       "  [37204802],\n",
       "  [22080671],\n",
       "  [12580014],\n",
       "  [4469125],\n",
       "  [6493422],\n",
       "  [25148216],\n",
       "  [25148216],\n",
       "  [5573975],\n",
       "  [5573975],\n",
       "  [15635366],\n",
       "  [2095573],\n",
       "  [11250124],\n",
       "  [11250124],\n",
       "  [23269537],\n",
       "  [6227220],\n",
       "  [9315213],\n",
       "  [9315213],\n",
       "  [9315213],\n",
       "  [4452659],\n",
       "  [797114],\n",
       "  [4452659],\n",
       "  [4452659],\n",
       "  [25238950],\n",
       "  [1071991],\n",
       "  [16355392],\n",
       "  [22544171],\n",
       "  [16557565],\n",
       "  [18924534],\n",
       "  [22442133],\n",
       "  [22442133],\n",
       "  [33912748],\n",
       "  [15635366],\n",
       "  [15635366],\n",
       "  [17587795],\n",
       "  [5531479],\n",
       "  [22406695],\n",
       "  [8548635],\n",
       "  [33634749],\n",
       "  [33634749],\n",
       "  [4961038],\n",
       "  [5389095],\n",
       "  [4417558],\n",
       "  [4417558],\n",
       "  [1684489],\n",
       "  [23078022],\n",
       "  [11291348],\n",
       "  [11291348],\n",
       "  [11291348],\n",
       "  [11291348],\n",
       "  [40608679],\n",
       "  [19800147],\n",
       "  [19800147],\n",
       "  [40900567],\n",
       "  [31933981],\n",
       "  [33499189],\n",
       "  [3095620],\n",
       "  [1805641],\n",
       "  [41644178],\n",
       "  [21884449],\n",
       "  [11481946],\n",
       "  [11481946],\n",
       "  [22057077],\n",
       "  [2488880],\n",
       "  [15476777],\n",
       "  [24922825],\n",
       "  [11569583],\n",
       "  [11569583],\n",
       "  [11569583],\n",
       "  [13001323],\n",
       "  [13001323],\n",
       "  [40632104],\n",
       "  [8246922],\n",
       "  [4740447],\n",
       "  [4740447],\n",
       "  [15889329],\n",
       "  [17438862],\n",
       "  [23785605],\n",
       "  [3610080],\n",
       "  [27693891],\n",
       "  [18678095],\n",
       "  [14767844],\n",
       "  [5293024],\n",
       "  [22180793],\n",
       "  [22180793],\n",
       "  [22180793],\n",
       "  [22180793],\n",
       "  [36606083],\n",
       "  [22186938],\n",
       "  [19799455],\n",
       "  [33387953],\n",
       "  [8148304],\n",
       "  [8148304],\n",
       "  [35467590],\n",
       "  [45487164],\n",
       "  [2319305],\n",
       "  [15319019],\n",
       "  [26025370],\n",
       "  [4700428],\n",
       "  [15928989],\n",
       "  [45166582],\n",
       "  [3912660],\n",
       "  [3912660],\n",
       "  [17741440],\n",
       "  [22696649],\n",
       "  [14500725],\n",
       "  [24922825],\n",
       "  [12206390],\n",
       "  [8190282],\n",
       "  [6407356],\n",
       "  [6219790],\n",
       "  [12315072],\n",
       "  [16066726],\n",
       "  [16066726],\n",
       "  [16361581],\n",
       "  [4457834],\n",
       "  [14340571],\n",
       "  [43220289],\n",
       "  [43220289],\n",
       "  [3095620],\n",
       "  [14803797],\n",
       "  [14803797],\n",
       "  [14803797],\n",
       "  [6477536],\n",
       "  [6477536],\n",
       "  [15670968],\n",
       "  [15670968],\n",
       "  [13509809],\n",
       "  [37562370],\n",
       "  [18750453],\n",
       "  [16686383],\n",
       "  [16686383],\n",
       "  [41337677],\n",
       "  [1049501],\n",
       "  [14496749],\n",
       "  [6540064],\n",
       "  [10648422],\n",
       "  [6923961],\n",
       "  [11254556],\n",
       "  [11254556],\n",
       "  [11254556],\n",
       "  [463309],\n",
       "  [34071621],\n",
       "  [16422880],\n",
       "  [17077004],\n",
       "  [17077004],\n",
       "  [16390264],\n",
       "  [16390264],\n",
       "  [18174210],\n",
       "  [18174210],\n",
       "  [16056514],\n",
       "  [14711483],\n",
       "  [8563659],\n",
       "  [5483793],\n",
       "  [6421792],\n",
       "  [9929089],\n",
       "  [12258338],\n",
       "  [12258338],\n",
       "  [7034001],\n",
       "  [1642727],\n",
       "  [18537148],\n",
       "  [18537148],\n",
       "  [16905344],\n",
       "  [21414718],\n",
       "  [3355397],\n",
       "  [3355397],\n",
       "  [3355397],\n",
       "  [4896726],\n",
       "  [8780599],\n",
       "  [935538],\n",
       "  [21330280],\n",
       "  [21330280],\n",
       "  [2820454],\n",
       "  [15077696],\n",
       "  [15077696],\n",
       "  [27446873],\n",
       "  [27446873],\n",
       "  [34378726],\n",
       "  [8702697],\n",
       "  [8702697],\n",
       "  [11659421],\n",
       "  [20128547],\n",
       "  [6828370],\n",
       "  [1383826],\n",
       "  [9988425],\n",
       "  [16472469],\n",
       "  [16472469],\n",
       "  [16472469],\n",
       "  [16472469],\n",
       "  [16472469],\n",
       "  [16472469],\n",
       "  [16472469],\n",
       "  [26607366],\n",
       "  [5702790],\n",
       "  [24624992],\n",
       "  [14332945],\n",
       "  [3952288],\n",
       "  [3952288],\n",
       "  [4926049],\n",
       "  [14105446],\n",
       "  [1982286],\n",
       "  [9745001],\n",
       "  [6277638],\n",
       "  [6277638],\n",
       "  [1225513],\n",
       "  [16927286],\n",
       "  [32408470],\n",
       "  [3113630],\n",
       "  [3113630],\n",
       "  [13923140],\n",
       "  [6441369],\n",
       "  [12486491],\n",
       "  [24541180],\n",
       "  [24541180],\n",
       "  [15803282],\n",
       "  [15803282],\n",
       "  [15803282],\n",
       "  [16287725],\n",
       "  [16287725],\n",
       "  [9451052],\n",
       "  [17421851],\n",
       "  [17671145],\n",
       "  [22500262],\n",
       "  [22500262],\n",
       "  [12486491],\n",
       "  [368506],\n",
       "  [24737389],\n",
       "  [26000593],\n",
       "  [2097256],\n",
       "  [2097256],\n",
       "  [10072941],\n",
       "  [13906581],\n",
       "  [4200695],\n",
       "  [13027590],\n",
       "  [20418809],\n",
       "  [15659108],\n",
       "  [15659108],\n",
       "  [4200695],\n",
       "  [6129301],\n",
       "  [4824840],\n",
       "  [4824840],\n",
       "  [14658685],\n",
       "  [14658685],\n",
       "  [5691302],\n",
       "  [5691302],\n",
       "  [32159283],\n",
       "  [39281140],\n",
       "  [17628888],\n",
       "  [18237384],\n",
       "  [4784069],\n",
       "  [18038250],\n",
       "  [410286],\n",
       "  [3874000],\n",
       "  [3874000],\n",
       "  [3898784],\n",
       "  [6710713],\n",
       "  [6710713],\n",
       "  [4313478],\n",
       "  [23117378],\n",
       "  [1686881],\n",
       "  [12824568],\n",
       "  [44048701],\n",
       "  [20829129],\n",
       "  [5323845],\n",
       "  [5323845],\n",
       "  [21009874],\n",
       "  [21009874],\n",
       "  [28149602],\n",
       "  [6936141],\n",
       "  [24142891],\n",
       "  [33370],\n",
       "  [33370],\n",
       "  [33370],\n",
       "  [3531388],\n",
       "  [12009265],\n",
       "  [12009265],\n",
       "  [5260382],\n",
       "  [10071552],\n",
       "  [4828631],\n",
       "  [7370282],\n",
       "  [7098463],\n",
       "  [40127292],\n",
       "  [12584053],\n",
       "  [43220289],\n",
       "  [11902109],\n",
       "  [15305881],\n",
       "  [28614776],\n",
       "  [28614776],\n",
       "  [9889151],\n",
       "  [8563659],\n",
       "  [4319174],\n",
       "  [18956141],\n",
       "  [18956141],\n",
       "  [7370282],\n",
       "  [15419873],\n",
       "  [13910150],\n",
       "  [13910150],\n",
       "  [6144337],\n",
       "  [3952288],\n",
       "  [13613916],\n",
       "  [1967017],\n",
       "  [16737210],\n",
       "  [30844602],\n",
       "  [41710132],\n",
       "  [86704258],\n",
       "  [39187170],\n",
       "  [23938319],\n",
       "  [5558754],\n",
       "  [18909530],\n",
       "  [2291922],\n",
       "  [2638387],\n",
       "  [4928282],\n",
       "  [4928282],\n",
       "  [17934603],\n",
       "  [13905670],\n",
       "  [16355392],\n",
       "  [3829232],\n",
       "  [29429111],\n",
       "  [13023410],\n",
       "  [5289038],\n",
       "  [26873988],\n",
       "  [25641414],\n",
       "  [25641414],\n",
       "  [1676568],\n",
       "  [13905670],\n",
       "  [13905670],\n",
       "  [13905670],\n",
       "  [14865329],\n",
       "  [14865329],\n",
       "  [3654468],\n",
       "  [3654468],\n",
       "  [6148876],\n",
       "  [36178047],\n",
       "  [70455704],\n",
       "  [36606083],\n",
       "  [7209559],\n",
       "  [7209559],\n",
       "  [12827098],\n",
       "  [39465575],\n",
       "  [3495456],\n",
       "  [25451374],\n",
       "  [12040627],\n",
       "  [13069283],\n",
       "  [13023410],\n",
       "  [46816158],\n",
       "  [37480103],\n",
       "  [52072815],\n",
       "  [13900610],\n",
       "  [4406819],\n",
       "  [34615397],\n",
       "  [3578380],\n",
       "  [4687948],\n",
       "  [21239672],\n",
       "  [56893404],\n",
       "  [43329366],\n",
       "  [4896726],\n",
       "  [21239672],\n",
       "  [9167230],\n",
       "  [1373287],\n",
       "  [106301],\n",
       "  [106301],\n",
       "  [37438296],\n",
       "  [17023584],\n",
       "  [18231807],\n",
       "  [18231807],\n",
       "  [37549932],\n",
       "  [12956194],\n",
       "  [26378103],\n",
       "  [24177706],\n",
       "  [14408200],\n",
       "  [16120395],\n",
       "  [16284655],\n",
       "  [19912367],\n",
       "  [19912367],\n",
       "  [23260700],\n",
       "  [24241932],\n",
       "  [3475317],\n",
       "  [21382907],\n",
       "  [17844478],\n",
       "  [1649738],\n",
       "  [266641],\n",
       "  [15482274],\n",
       "  [15482274],\n",
       "  [4037034],\n",
       "  [28249680],\n",
       "  [9505402],\n",
       "  [19005293],\n",
       "  [19005293],\n",
       "  [5377642],\n",
       "  [5377642],\n",
       "  [28369117],\n",
       "  [2097256],\n",
       "  [5256564],\n",
       "  [13764090],\n",
       "  [11614737],\n",
       "  [38587347],\n",
       "  [1122279],\n",
       "  [4406819],\n",
       "  [2425364],\n",
       "  [16256507],\n",
       "  [21003930],\n",
       "  [21003930],\n",
       "  [21623140],\n",
       "  [21623140],\n",
       "  [19408393],\n",
       "  [2488880],\n",
       "  [37480103],\n",
       "  [42782688],\n",
       "  [3831884],\n",
       "  [306006],\n",
       "  [15521377],\n",
       "  [2890952],\n",
       "  [6766459],\n",
       "  [6766459],\n",
       "  [5253987],\n",
       "  [12582729],\n",
       "  [5492542],\n",
       "  [19343151],\n",
       "  [368506],\n",
       "  [5185871],\n",
       "  [29877890],\n",
       "  [38355793],\n",
       "  [38355793],\n",
       "  [10504681],\n",
       "  [2617858],\n",
       "  [29863668]],\n",
       " 'top_3': [[18953920, 21257564, 26071782],\n",
       "  [4828631, 18617259, 13734012],\n",
       "  [1387104, 24980622, 10958594],\n",
       "  [35521287, 2613775, 23117378],\n",
       "  [24700152, 25182647, 44265107],\n",
       "  [13780287, 29459383, 25510546],\n",
       "  [13780287, 29459383, 25510546],\n",
       "  [43557480, 11705328, 33409100],\n",
       "  [393001, 6421792, 1373287],\n",
       "  [18953920, 3848469, 25238950],\n",
       "  [17450673, 1263446, 7662395],\n",
       "  [1387104, 24980622, 10958594],\n",
       "  [21232018, 13072113, 7042304],\n",
       "  [21232018, 13072113, 7042304],\n",
       "  [1259359, 45341480, 13843341],\n",
       "  [14682243, 21274919, 6490571],\n",
       "  [4468861, 15128866, 1900152],\n",
       "  [35521287, 2613775, 23117378],\n",
       "  [14260013, 437924, 79696454],\n",
       "  [14260013, 437924, 79696454],\n",
       "  [28015516, 14938990, 12670680],\n",
       "  [20454006, 24341590, 13069283],\n",
       "  [27527854, 33723822, 12428497],\n",
       "  [8595678, 11705328, 42441846],\n",
       "  [18557974, 33409100, 42441846],\n",
       "  [42441846, 33409100, 16252863],\n",
       "  [9997636, 11109043, 13497630],\n",
       "  [9997636, 11109043, 13497630],\n",
       "  [4449524, 40913091, 18174210],\n",
       "  [4816339, 8563659, 5398179],\n",
       "  [2138843, 24704139, 56893404],\n",
       "  [24704139, 41264017, 56893404],\n",
       "  [13519661, 43329366, 380526],\n",
       "  [11336632, 3512154, 26996935],\n",
       "  [10024681, 7821634, 45638119],\n",
       "  [1590744, 49556906, 9899292],\n",
       "  [4459491, 22116439, 4709641],\n",
       "  [28806780, 374902, 39984099],\n",
       "  [374902, 13899137, 39984099],\n",
       "  [13780287, 29459383, 25510546],\n",
       "  [30122260, 21295300, 12909503],\n",
       "  [21295300, 30122260, 12909503],\n",
       "  [20399078, 10326242, 39443128],\n",
       "  [213017, 12909503, 21295300],\n",
       "  [21219071, 29422484, 21295300],\n",
       "  [21307488, 4414547, 5956380],\n",
       "  [16267205, 24864273, 1127562],\n",
       "  [1031534, 17119869, 6076903],\n",
       "  [20330519, 2837758, 13965483],\n",
       "  [14407673, 52925737, 5531479],\n",
       "  [14407673, 52925737, 5531479],\n",
       "  [8551160, 37608303, 5099266],\n",
       "  [6000423, 4407455, 5099266],\n",
       "  [7317051, 24190159, 4320424],\n",
       "  [18038250, 16964262, 38919140],\n",
       "  [3619372, 4427392, 21387297],\n",
       "  [12966719, 7521113, 12827098],\n",
       "  [12966719, 7521113, 12827098],\n",
       "  [13116880, 3155731, 12827098],\n",
       "  [24594624, 22973574, 4254064],\n",
       "  [24594624, 22973574, 4254064],\n",
       "  [30553457, 33733520, 45276789],\n",
       "  [41493639, 30553457, 33733520],\n",
       "  [34469966, 15435343, 4399311],\n",
       "  [25878014, 7433668, 13966946],\n",
       "  [3662510, 6085365, 14500725],\n",
       "  [27264454, 37205759, 6540064],\n",
       "  [40164383, 24097933, 32159283],\n",
       "  [164189, 25787749, 36606083],\n",
       "  [45447613, 5151024, 25515907],\n",
       "  [6191684, 23865182, 22995579],\n",
       "  [14865329, 29381091, 4319174],\n",
       "  [23418635, 7581911, 13513790],\n",
       "  [26199970, 1759213, 6157837],\n",
       "  [2140513, 15194125, 33872649],\n",
       "  [4942718, 2140513, 33872649],\n",
       "  [14566771, 5691302, 14606752],\n",
       "  [5691302, 22995579, 14606752],\n",
       "  [1234098, 12801438, 24157077],\n",
       "  [1234098, 12801438, 24157077],\n",
       "  [13899137, 31363207, 4883040],\n",
       "  [5867846, 27063470, 28738741],\n",
       "  [35087728, 39059143, 21884449],\n",
       "  [21914176, 457630, 26016929],\n",
       "  [31293581, 15678772, 6807122],\n",
       "  [7583161, 40164383, 10582939],\n",
       "  [56528795, 31001322, 6227220],\n",
       "  [1471041, 38587347, 15488881],\n",
       "  [25895285, 9929089, 2272614],\n",
       "  [25895285, 9929089, 2272614],\n",
       "  [34436231, 22890091, 37549932],\n",
       "  [34436231, 22890091, 37549932],\n",
       "  [2758012, 39637840, 13439128],\n",
       "  [3285322, 9394119, 2015126],\n",
       "  [3078080, 23816832, 52874170],\n",
       "  [28931537, 20187433, 6903077],\n",
       "  [29022271, 18872233, 5824985],\n",
       "  [15559582, 18872233, 5824985],\n",
       "  [43220289, 19071857, 18872233],\n",
       "  [43220289, 19071857, 18872233],\n",
       "  [29022271, 7627167, 5824985],\n",
       "  [15559582, 7627167, 5824985],\n",
       "  [28015516, 14938990, 12670680],\n",
       "  [29877890, 20781656, 8411251],\n",
       "  [79336156, 6985854, 2947540],\n",
       "  [6985854, 2947540, 79336156],\n",
       "  [13780287, 29459383, 25510546],\n",
       "  [37204802, 21557055, 9669099],\n",
       "  [3285322, 1171121, 13831558],\n",
       "  [13380011, 9217800, 16966326],\n",
       "  [10795340, 6374918, 19510470],\n",
       "  [17271462, 8137081, 12827098],\n",
       "  [84580585, 12789595, 17374970],\n",
       "  [84580585, 12789595, 17374970],\n",
       "  [4421578, 5560962, 3566945],\n",
       "  [3419709, 26025820, 19313533],\n",
       "  [13778710, 40590358, 2177022],\n",
       "  [40590358, 13778710, 2177022],\n",
       "  [13868795, 35651106, 18231807],\n",
       "  [28006126, 35651106, 2462673],\n",
       "  [41548287, 25513319, 9558539],\n",
       "  [4412772, 470625, 7898952],\n",
       "  [4412772, 7898952, 470625],\n",
       "  [13780287, 29459383, 25510546],\n",
       "  [8458567, 31154082, 13794374],\n",
       "  [2758012, 6903077, 25606339],\n",
       "  [40156901, 9846940, 27054878],\n",
       "  [15535511, 14865329, 19205437],\n",
       "  [37964706, 29362104, 19205437],\n",
       "  [37964706, 29362104, 19205437],\n",
       "  [5483793, 42465769, 2014909],\n",
       "  [35993767, 10812605, 32742683],\n",
       "  [9648896, 3727986, 32742683],\n",
       "  [9648896, 32742683, 3727986],\n",
       "  [5406411, 22980205, 26973393],\n",
       "  [7521113, 12827098, 4928057],\n",
       "  [8892905, 9394119, 56893404],\n",
       "  [36708463, 5597586, 4388470],\n",
       "  [14471161, 4320111, 11557602],\n",
       "  [14471161, 4320111, 11557602],\n",
       "  [14225271, 24766509, 8148122],\n",
       "  [24707550, 14644164, 21498497],\n",
       "  [22547508, 25104843, 3430789],\n",
       "  [22547508, 25104843, 3430789],\n",
       "  [26008462, 13578199, 10474873],\n",
       "  [52865789, 4319174, 1568684],\n",
       "  [4319174, 14865329, 1568684],\n",
       "  [37424881, 8595678, 42441846],\n",
       "  [37424881, 8595678, 42441846],\n",
       "  [829646, 3413083, 5850219],\n",
       "  [3413083, 829646, 5850219],\n",
       "  [2260571, 29509926, 6397191],\n",
       "  [14806256, 14657344, 20261352],\n",
       "  [1667063, 14050257, 18924534],\n",
       "  [17967608, 30041340, 11328820],\n",
       "  [30041340, 14853989, 11328820],\n",
       "  [14205246, 38127792, 2033917],\n",
       "  [18374364, 7878807, 22405338],\n",
       "  [7627167, 24346598, 5912283],\n",
       "  [24019260, 5114940, 11614737],\n",
       "  [83667891, 37677954, 14376683],\n",
       "  [37677954, 83667891, 14376683],\n",
       "  [14075252, 2931832, 25001628],\n",
       "  [4632921, 6401675, 3514072],\n",
       "  [10071552, 9822397, 1974176],\n",
       "  [21859699, 21216726, 5548081],\n",
       "  [47018050, 15347087, 4709641],\n",
       "  [4405194, 15347087, 4709641],\n",
       "  [13625993, 95102458, 15048300],\n",
       "  [16705338, 13843341, 15048300],\n",
       "  [42267740, 10874408, 21170174],\n",
       "  [600808, 45875990, 4398832],\n",
       "  [9588931, 23403754, 39381118],\n",
       "  [40721190, 6828370, 8496132],\n",
       "  [34559336, 32275758, 14797520],\n",
       "  [32275758, 1354567, 14797520],\n",
       "  [15248287, 24190159, 7821634],\n",
       "  [29073751, 24190159, 7821634],\n",
       "  [23403754, 24190159, 7821634],\n",
       "  [32770503, 14185503, 14464451],\n",
       "  [32770503, 14185503, 14464451],\n",
       "  [10463997, 25576204, 26735905],\n",
       "  [2443495, 9159125, 20732789],\n",
       "  [12549585, 30058568, 4506414],\n",
       "  [2014909, 4658268, 22174015],\n",
       "  [43192375, 40349336, 12909503],\n",
       "  [3113630, 40349336, 12909503],\n",
       "  [9669099, 13794374, 9505448],\n",
       "  [9669099, 13794374, 9505448],\n",
       "  [798152, 8300657, 29023309],\n",
       "  [798152, 8300657, 29023309],\n",
       "  [46743299, 24338780, 25079962],\n",
       "  [6121668, 4767806, 1780819],\n",
       "  [17454301, 8665891, 18816720],\n",
       "  [17454301, 8665891, 18816720],\n",
       "  [24211561, 36288526, 23349986],\n",
       "  [16390264, 5824985, 7098463],\n",
       "  [32850528, 5824985, 7098463],\n",
       "  [5884524, 23783727, 19308127],\n",
       "  [23577867, 30580263, 9641846],\n",
       "  [30714190, 26873988, 11902109],\n",
       "  [37699461, 26873988, 11902109],\n",
       "  [9997636, 11109043, 13497630],\n",
       "  [25263810, 39048693, 21622715],\n",
       "  [39048693, 16167746, 18855191],\n",
       "  [38380061, 13936152, 9646449],\n",
       "  [52095986, 6144337, 2506153],\n",
       "  [12552297, 12207340, 20821402],\n",
       "  [12552297, 12207340, 20821402],\n",
       "  [34615397, 15488881, 38587347],\n",
       "  [2389574, 37444589, 20646904],\n",
       "  [19238, 17814815, 2601324],\n",
       "  [9304312, 26019505, 600437],\n",
       "  [97884, 1265945, 13956305],\n",
       "  [14831629, 25612629, 27099731],\n",
       "  [14831629, 25612629, 27099731],\n",
       "  [30507607, 3882374, 6826100],\n",
       "  [9787715, 7399084, 1550937],\n",
       "  [9787715, 7399084, 1550937],\n",
       "  [3566945, 8883846, 24922825],\n",
       "  [21048969, 20459964, 1522647],\n",
       "  [27580223, 17433284, 5710820],\n",
       "  [14180565, 12225214, 18810195],\n",
       "  [14782049, 4700428, 17150648],\n",
       "  [17223891, 21651116, 19005293],\n",
       "  [16098747, 27123743, 18340282],\n",
       "  [17412260, 41710132, 24652030],\n",
       "  [7285256, 40666943, 51972698],\n",
       "  [1148122, 24019260, 21602220],\n",
       "  [1148122, 24019260, 21602220],\n",
       "  [1148122, 24019260, 21602220],\n",
       "  [1148122, 24019260, 21602220],\n",
       "  [1148122, 24019260, 21602220],\n",
       "  [2425364, 70455704, 11360768],\n",
       "  [24918110, 10209731, 1456068],\n",
       "  [24918110, 10209731, 1456068],\n",
       "  [14657344, 40473317, 20261352],\n",
       "  [42387637, 471921, 791050],\n",
       "  [13242763, 57783564, 5633876],\n",
       "  [21150010, 27437459, 29459383],\n",
       "  [21150010, 5132358, 27437459],\n",
       "  [3118719, 32170702, 38899659],\n",
       "  [20781656, 8411251, 9451052],\n",
       "  [18852643, 4709641, 12443371],\n",
       "  [6947286, 12443371, 4709641],\n",
       "  [12443371, 4709641, 6309659],\n",
       "  [6309659, 4709641, 12443371],\n",
       "  [2714623, 17188921, 16494316],\n",
       "  [7150238, 4583180, 9315213],\n",
       "  [15983148, 15327601, 21598000],\n",
       "  [18557974, 37424881, 42441846],\n",
       "  [20645335, 13791044, 33257464],\n",
       "  [29429111, 28937856, 16728949],\n",
       "  [28937856, 29429111, 4418070],\n",
       "  [3468459, 22191759, 36540079],\n",
       "  [2543135, 19922508, 10993232],\n",
       "  [33507866, 31882215, 8002887],\n",
       "  [18546584, 4418070, 41877386],\n",
       "  [4418070, 41877386, 10359591],\n",
       "  [2030623, 25726838, 2014909],\n",
       "  [10165258, 7583161, 10526279],\n",
       "  [10526279, 9911547, 7583161],\n",
       "  [24705390, 2052720, 22703082],\n",
       "  [24705390, 2052720, 22703082],\n",
       "  [22547508, 8447873, 33203108],\n",
       "  [44586415, 38493521, 4200695],\n",
       "  [40631095, 53779698, 4200695],\n",
       "  [7860396, 10423989, 4162857],\n",
       "  [42565477, 6826100, 30507607],\n",
       "  [6227220, 52865789, 597790],\n",
       "  [52805891, 15578265, 40096222],\n",
       "  [13030852, 4325398, 1389264],\n",
       "  [15692098, 34747208, 22544171],\n",
       "  [14924526, 17150648, 15889329],\n",
       "  [7028976, 13235609, 12685434],\n",
       "  [11527822, 6106004, 1754001],\n",
       "  [10562341, 2601135, 7177329],\n",
       "  [42377686, 34254203, 37182501],\n",
       "  [23627419, 3761017, 6325527],\n",
       "  [23627419, 3761017, 6325527],\n",
       "  [14119470, 368506, 14706752],\n",
       "  [24881307, 8093935, 10991183],\n",
       "  [26488879, 22703082, 24705390],\n",
       "  [19485243, 7137057, 12588500],\n",
       "  [502591, 25606339, 30041340],\n",
       "  [7137057, 19485243, 12588500],\n",
       "  [22522432, 30041340, 25606339],\n",
       "  [6121668, 11359243, 1780819],\n",
       "  [22561064, 5473074, 1320137],\n",
       "  [15678772, 24269361, 56893404],\n",
       "  [9911547, 19583924, 92499],\n",
       "  [25830701, 6718824, 515489],\n",
       "  [34873974, 34054472, 13223957],\n",
       "  [17077004, 5548081, 22227889],\n",
       "  [34139429, 5548081, 22227889],\n",
       "  [23206239, 12662435, 26064662],\n",
       "  [21274919, 6191684, 17930286],\n",
       "  [53211308, 38401028, 10883736],\n",
       "  [7465900, 2638387, 22703082],\n",
       "  [40323148, 14853989, 45401535],\n",
       "  [18374364, 104143831, 25516011],\n",
       "  [2032877, 20109325, 29564505],\n",
       "  [14803797, 33684572, 6793674],\n",
       "  [14803797, 33684572, 6793674],\n",
       "  [4653837, 3863543, 1617327],\n",
       "  [26374799, 11335860, 3360421],\n",
       "  [25413327, 11335860, 3360421],\n",
       "  [11335860, 25413327, 3360421],\n",
       "  [4447055, 21046889, 16056514],\n",
       "  [14782049, 4700428, 17150648],\n",
       "  [7968532, 41337677, 19688024],\n",
       "  [1970884, 5137019, 6820680],\n",
       "  [8639034, 37762357, 10648422],\n",
       "  [164985, 24998637, 6070278],\n",
       "  [34905328, 5914739, 8903143],\n",
       "  [27772649, 21060008, 1471041],\n",
       "  [9878167, 43054703, 14853989],\n",
       "  [42873134, 20456030, 1049501],\n",
       "  [2506153, 5377059, 30034334],\n",
       "  [57121667, 5152028, 20101846],\n",
       "  [752423, 25355575, 2867345],\n",
       "  [29253460, 8780599, 2867345],\n",
       "  [26596106, 15551129, 16120395],\n",
       "  [15551129, 26596106, 16120395],\n",
       "  [4462419, 6441369, 23418635],\n",
       "  [22975806, 24249915, 20333864],\n",
       "  [22975806, 24249915, 20333864],\n",
       "  [13231899, 72159, 8596357],\n",
       "  [9704467, 7643848, 10300888],\n",
       "  [32638085, 7643848, 10300888],\n",
       "  [15128866, 8994465, 4468861],\n",
       "  [34139429, 9622258, 37029185],\n",
       "  [17463549, 1336292, 23460562],\n",
       "  [29023309, 708425, 14260013],\n",
       "  [43378932, 708425, 14260013],\n",
       "  [42291761, 2575938, 8428935],\n",
       "  [42855554, 40558887, 7142113],\n",
       "  [752423, 1068106, 10984005],\n",
       "  [32463364, 6309659, 14682243],\n",
       "  [32463364, 6309659, 14682243],\n",
       "  [31889025, 20945963, 19675911],\n",
       "  [17023584, 3776162, 4824840],\n",
       "  [583260, 42404093, 12258338],\n",
       "  [583260, 42404093, 12258338],\n",
       "  [10463997, 25576204, 26735905],\n",
       "  [7757997, 33118292, 6540064],\n",
       "  [2443495, 9159125, 20732789],\n",
       "  [12549585, 30058568, 4506414],\n",
       "  [4664540, 17023584, 21439293],\n",
       "  [5785219, 21439293, 14644164],\n",
       "  [970012, 4319174, 32408470],\n",
       "  [21598000, 16056410, 9638032],\n",
       "  [7549811, 33911859, 9638032],\n",
       "  [7549811, 33911859, 9638032],\n",
       "  [8892905, 22317868, 17911973],\n",
       "  [11255504, 22317868, 17911973],\n",
       "  [5914739, 87986426, 24541180],\n",
       "  [21258863, 6673421, 20888849],\n",
       "  [4407385, 15041758, 1642727],\n",
       "  [22843838, 4462079, 25599283],\n",
       "  [6082738, 21676556, 20033112],\n",
       "  [3756384, 3847200, 20033112],\n",
       "  [10574949, 22241778, 16355392],\n",
       "  [2727303, 9211173, 5468807],\n",
       "  [16280642, 9507605, 5172048],\n",
       "  [1800734, 9507605, 5172048],\n",
       "  [14198646, 25513319, 1686997],\n",
       "  [73473433, 6129301, 25649714],\n",
       "  [2460304, 8373753, 6503185],\n",
       "  [120626, 24921368, 13619127],\n",
       "  [2481032, 17150648, 32611468],\n",
       "  [11705328, 33409100, 21636085],\n",
       "  [11705328, 21636085, 33409100],\n",
       "  [6334188, 19945096, 15041758],\n",
       "  [19945096, 44409062, 15041758],\n",
       "  [12789595, 13771184, 3202143],\n",
       "  [30437264, 10559501, 9433958],\n",
       "  [30437264, 10559501, 9433958],\n",
       "  [28149602, 17421851, 21372171],\n",
       "  [6961811, 4407385, 57574395],\n",
       "  [6961811, 4407385, 57574395],\n",
       "  [37643601, 15716328, 8533245],\n",
       "  [13230773, 7454794, 5293024],\n",
       "  [29788648, 27134931, 37204802],\n",
       "  [1103795, 29788648, 37204802],\n",
       "  [7711685, 15879931, 22080671],\n",
       "  [25738896, 13989491, 12580014],\n",
       "  [45154987, 1070920, 4469125],\n",
       "  [44724517, 22153455, 6493422],\n",
       "  [26873988, 18489989, 25148216],\n",
       "  [1630949, 22150633, 25148216],\n",
       "  [40349336, 25928548, 5573975],\n",
       "  [40349336, 25928548, 5573975],\n",
       "  [19572798, 1791637, 15635366],\n",
       "  [5612738, 9814332, 2095573],\n",
       "  [14893425, 9796495, 11250124],\n",
       "  [8006440, 9796495, 11250124],\n",
       "  [4162857, 4393153, 23269537],\n",
       "  [9315213, 23397658, 6227220],\n",
       "  [4890578, 970012, 9315213],\n",
       "  [23397658, 6227220, 9315213],\n",
       "  [4890578, 970012, 9315213],\n",
       "  [25036988, 34747208, 4452659],\n",
       "  [7643848, 4701662, 797114],\n",
       "  [34747208, 10518721, 4452659],\n",
       "  [34747208, 25036988, 4452659],\n",
       "  [24101431, 3848469, 25238950],\n",
       "  [10190778, 8182950, 1071991],\n",
       "  [2405259, 27545868, 16355392],\n",
       "  [34747208, 15692098, 22544171],\n",
       "  [19950357, 38675228, 16557565],\n",
       "  [43711341, 18276599, 18924534],\n",
       "  [33912748, 24269361, 22442133],\n",
       "  [33912748, 24269361, 22442133],\n",
       "  [24269361, 22442133, 33912748],\n",
       "  [42314147, 6828370, 15635366],\n",
       "  [2000038, 6828370, 15635366],\n",
       "  [22038539, 175735, 17587795],\n",
       "  [8396189, 4389252, 5531479],\n",
       "  [14492339, 7521113, 22406695],\n",
       "  [13400643, 4387494, 8548635],\n",
       "  [25148216, 15551129, 33634749],\n",
       "  [25148216, 15551129, 33634749],\n",
       "  [4920376, 2272614, 4961038],\n",
       "  [24554740, 13573143, 5389095],\n",
       "  [16562534, 6609935, 4417558],\n",
       "  [16562534, 6609935, 4417558],\n",
       "  [35531883, 29863668, 1684489],\n",
       "  [39424916, 83308790, 23078022],\n",
       "  [9680193, 21307488, 11291348],\n",
       "  [14637235, 21307488, 11291348],\n",
       "  [12225214, 21562657, 11291348],\n",
       "  [29557235, 12225214, 11291348],\n",
       "  [1550937, 28006126, 40608679],\n",
       "  [3588621, 14768471, 19800147],\n",
       "  [3588621, 14768471, 19800147],\n",
       "  [5289038, 8593263, 40900567],\n",
       "  [7451018, 10494012, 31933981],\n",
       "  [2617858, 17123657, 33499189],\n",
       "  [27815697, 1391126, 3095620],\n",
       "  [13899137, 3929361, 1805641],\n",
       "  [1964163, 33986200, 41644178],\n",
       "  [35087728, 39059143, 21884449],\n",
       "  [4353857, 4345757, 11481946],\n",
       "  [4345757, 23397658, 11481946],\n",
       "  [23397658, 11481946, 22057077],\n",
       "  [29253460, 20526907, 2488880],\n",
       "  [20606520, 2492146, 15476777],\n",
       "  [21150010, 152245, 24922825],\n",
       "  [12552297, 27635177, 11569583],\n",
       "  [12552297, 27635177, 11569583],\n",
       "  [12552297, 27635177, 11569583],\n",
       "  [6227220, 2481032, 13001323],\n",
       "  [6227220, 2481032, 13001323],\n",
       "  [24338780, 8246922, 40632104],\n",
       "  [39084565, 7155555, 8246922],\n",
       "  [21186109, 4393153, 4740447],\n",
       "  [21186109, 4393153, 4740447],\n",
       "  [17991818, 15493354, 15889329],\n",
       "  [16863359, 15889329, 17438862],\n",
       "  [14566771, 15984735, 23785605],\n",
       "  [72580164, 17779800, 3610080],\n",
       "  [3107733, 8425533, 27693891],\n",
       "  [20456030, 4701662, 18678095],\n",
       "  [12058271, 5094468, 14767844],\n",
       "  [13230773, 7454794, 5293024],\n",
       "  [7177329, 4373433, 22180793],\n",
       "  [7986878, 4373433, 22180793],\n",
       "  [7177329, 4373433, 22180793],\n",
       "  [6550579, 4373433, 22180793],\n",
       "  [19974105, 25787749, 36606083],\n",
       "  [60515890, 25041967, 22186938],\n",
       "  [5409325, 17081238, 19799455],\n",
       "  [14241418, 21307488, 33387953],\n",
       "  [19255949, 23604601, 8148304],\n",
       "  [19255949, 23604601, 8148304],\n",
       "  [27731651, 45487164, 35467590],\n",
       "  [35467590, 14767844, 45487164],\n",
       "  [6426919, 15319019, 2319305],\n",
       "  [6426919, 2319305, 15319019],\n",
       "  [4700428, 140098548, 26025370],\n",
       "  [26025370, 14584755, 4700428],\n",
       "  [6121668, 1780819, 15928989],\n",
       "  [11557602, 23286603, 45166582],\n",
       "  [15663829, 34054472, 3912660],\n",
       "  [68317730, 15663829, 3912660],\n",
       "  [30041340, 11328820, 17741440],\n",
       "  [28015516, 2692522, 22696649],\n",
       "  [3662510, 6085365, 14500725],\n",
       "  [152245, 10494012, 24922825],\n",
       "  [25562234, 4506414, 12206390],\n",
       "  [14361849, 40867854, 8190282],\n",
       "  [28419824, 878526, 6407356],\n",
       "  [40127292, 6407356, 6219790],\n",
       "  [1982286, 22049489, 12315072],\n",
       "  [3475317, 8698857, 16066726],\n",
       "  [21258863, 3475317, 16066726],\n",
       "  [20568364, 16086778, 16361581],\n",
       "  [10546779, 15803282, 4457834],\n",
       "  [26735018, 10675756, 14340571],\n",
       "  [32421068, 37029185, 43220289],\n",
       "  [32421068, 37029185, 43220289],\n",
       "  [6431384, 313394, 3095620],\n",
       "  [33684572, 6327940, 14803797],\n",
       "  [33684572, 6327940, 14803797],\n",
       "  [12709184, 33684572, 14803797],\n",
       "  [7098463, 7613033, 6477536],\n",
       "  [7098463, 9754530, 6477536],\n",
       "  [8665891, 10300888, 15670968],\n",
       "  [8665891, 10300888, 15670968],\n",
       "  [23727313, 38899659, 13509809],\n",
       "  [58050905, 22505710, 37562370],\n",
       "  [19487477, 24269361, 18750453],\n",
       "  [21425864, 14338915, 16686383],\n",
       "  [21425864, 14338915, 16686383],\n",
       "  [19688024, 1049501, 41337677],\n",
       "  [41337677, 7968532, 1049501],\n",
       "  [33912020, 7005276, 14496749],\n",
       "  [7757997, 33118292, 6540064],\n",
       "  [5372773, 37762357, 10648422],\n",
       "  [6945691, 11915280, 6923961],\n",
       "  [6625693, 10666475, 11254556],\n",
       "  [14188138, 22800314, 11254556],\n",
       "  [17967608, 14188138, 11254556],\n",
       "  [24541180, 10786948, 463309],\n",
       "  [469066, 15176526, 34071621],\n",
       "  [12145359, 26067999, 16422880],\n",
       "  [1259359, 24596228, 17077004],\n",
       "  [36202354, 22414304, 17077004],\n",
       "  [42404093, 5641851, 16390264],\n",
       "  [42404093, 5641851, 16390264],\n",
       "  [25420421, 2460304, 18174210],\n",
       "  [25420421, 2460304, 18174210],\n",
       "  [52874170, 44830890, 16056514],\n",
       "  [2360905, 29947146, 14711483],\n",
       "  [3512154, 28821565, 8563659],\n",
       "  [994800, 42693833, 5483793],\n",
       "  [25895285, 18682109, 6421792],\n",
       "  [2272614, 25895285, 9929089],\n",
       "  [16495649, 21260231, 12258338],\n",
       "  [16495649, 21260231, 12258338],\n",
       "  [5597586, 16737210, 7034001],\n",
       "  [45336190, 10190462, 1642727],\n",
       "  [13230773, 11201004, 18537148],\n",
       "  [13230773, 11201004, 18537148],\n",
       "  [37204802, 41493639, 16905344],\n",
       "  [4422723, 26047921, 21414718],\n",
       "  [24581365, 31229233, 3355397],\n",
       "  [4959368, 31229233, 3355397],\n",
       "  [24581365, 31229233, 3355397],\n",
       "  [11011905, 23208167, 4896726],\n",
       "  [6525844, 75636923, 8780599],\n",
       "  [20018321, 13931771, 935538],\n",
       "  [7860396, 4067274, 21330280],\n",
       "  [7860396, 4067274, 21330280],\n",
       "  [40631095, 40817021, 2820454],\n",
       "  [17368516, 11401602, 15077696],\n",
       "  [41314611, 11401602, 15077696],\n",
       "  [829646, 46695481, 27446873],\n",
       "  [27873158, 6561200, 27446873],\n",
       "  [29509926, 3475317, 34378726],\n",
       "  [21382907, 29509926, 8702697],\n",
       "  [21382907, 29509926, 8702697],\n",
       "  [40349336, 16630060, 11659421],\n",
       "  [2335873, 4447055, 20128547],\n",
       "  [16364639, 34071621, 6828370],\n",
       "  [16686383, 27900414, 1383826],\n",
       "  [23262027, 12742164, 9988425],\n",
       "  [4926049, 4899981, 16472469],\n",
       "  [9038803, 38131471, 16472469],\n",
       "  [13791206, 6710699, 16472469],\n",
       "  [28697248, 38131471, 16472469],\n",
       "  [21793890, 20420780, 16472469],\n",
       "  [20420780, 21793890, 16472469],\n",
       "  [13791206, 6710699, 16472469],\n",
       "  [16472469, 25842866, 26607366],\n",
       "  [4418112, 23913146, 5702790],\n",
       "  [43419566, 11328820, 24624992],\n",
       "  [4899981, 8577229, 14332945],\n",
       "  [20155713, 2734421, 3952288],\n",
       "  [301838, 2734421, 3952288],\n",
       "  [40721190, 7848113, 4926049],\n",
       "  [4380451, 19343151, 14105446],\n",
       "  [22049489, 12315072, 1982286],\n",
       "  [43122426, 26026009, 9745001],\n",
       "  [18662787, 6690087, 6277638],\n",
       "  [15615957, 10557471, 6277638],\n",
       "  [39859981, 11603066, 1225513],\n",
       "  [22482024, 23342686, 16927286],\n",
       "  [36838958, 970012, 32408470],\n",
       "  [22500262, 22185730, 3113630],\n",
       "  [16686383, 22185730, 3113630],\n",
       "  [36642096, 11899391, 13923140],\n",
       "  [23418635, 4462419, 6441369],\n",
       "  [15590539, 22358449, 12486491],\n",
       "  [87986426, 5914739, 24541180],\n",
       "  [87986426, 5914739, 24541180],\n",
       "  [18998807, 4547102, 15803282],\n",
       "  [18998807, 4547102, 15803282],\n",
       "  [4457834, 22490293, 15803282],\n",
       "  [8290760, 1630949, 16287725],\n",
       "  [8290760, 1630949, 16287725],\n",
       "  [11844791, 5966635, 9451052],\n",
       "  [7373453, 7711685, 17421851],\n",
       "  [14116046, 22180793, 17671145],\n",
       "  [4587978, 11565780, 22500262],\n",
       "  [13277039, 11565780, 22500262],\n",
       "  [12240507, 22482024, 12486491],\n",
       "  [9315213, 14706752, 368506],\n",
       "  [8925851, 7487927, 24737389],\n",
       "  [11246427, 19878070, 26000593],\n",
       "  [3716075, 129199129, 2097256],\n",
       "  [129199129, 3716075, 2097256],\n",
       "  [40790033, 2522977, 10072941],\n",
       "  [16495649, 3776162, 13906581],\n",
       "  [44586415, 38493521, 4200695],\n",
       "  [12561083, 32462603, 13027590],\n",
       "  [25419778, 16660256, 20418809],\n",
       "  [16217855, 15305881, 15659108],\n",
       "  [15305881, 799586, 15659108],\n",
       "  [40631095, 53779698, 4200695],\n",
       "  [154243324, 33135135, 6129301],\n",
       "  [22153455, 3776162, 4824840],\n",
       "  [3878434, 3776162, 4824840],\n",
       "  [19572798, 16167746, 14658685],\n",
       "  [19572798, 16167746, 14658685],\n",
       "  [25973484, 13831842, 5691302],\n",
       "  [23627419, 8595678, 5691302],\n",
       "  [43629704, 5691302, 32159283],\n",
       "  [6112053, 3981244, 39281140],\n",
       "  [7645565, 7915836, 17628888],\n",
       "  [8144920, 40365566, 18237384],\n",
       "  [3583084, 4457834, 4784069],\n",
       "  [18489989, 26851674, 18038250],\n",
       "  [12922760, 41928290, 410286],\n",
       "  [31311495, 43661837, 3874000],\n",
       "  [43661837, 30884033, 3874000],\n",
       "  [16760369, 32328114, 3898784],\n",
       "  [28017005, 17374970, 6710713],\n",
       "  [28017005, 17374970, 6710713],\n",
       "  [22544171, 40349336, 4313478],\n",
       "  [2032877, 21050357, 23117378],\n",
       "  [23117378, 35521287, 1686881],\n",
       "  [16541762, 27138601, 12824568],\n",
       "  [19529370, 19182166, 44048701],\n",
       "  [23351136, 718601, 20829129],\n",
       "  [18997216, 26710772, 5323845],\n",
       "  [13907928, 26710772, 5323845],\n",
       "  [9056874, 11481946, 21009874],\n",
       "  [9056874, 11481946, 21009874],\n",
       "  [28015516, 5448119, 28149602],\n",
       "  [41982985, 15972906, 6936141],\n",
       "  [27588420, 19756935, 24142891],\n",
       "  [7898952, 22901758, 33370],\n",
       "  [470625, 18600579, 33370],\n",
       "  [7898952, 22901758, 33370],\n",
       "  [10795340, 24356383, 3531388],\n",
       "  [8512633, 24581365, 12009265],\n",
       "  [38551172, 30720103, 12009265],\n",
       "  [15347087, 9194077, 5260382],\n",
       "  [12224536, 9822397, 10071552],\n",
       "  [19205326, 18340282, 4828631],\n",
       "  [2603304, 5700349, 7370282],\n",
       "  [22922353, 40949706, 7098463],\n",
       "  [44265107, 12584053, 40127292],\n",
       "  [1456068, 2787558, 12584053],\n",
       "  [39264456, 40949706, 43220289],\n",
       "  [4366738, 4417177, 11902109],\n",
       "  [38300781, 29877890, 15305881],\n",
       "  [23269537, 9791313, 28614776],\n",
       "  [23269537, 9791313, 28614776],\n",
       "  [9451052, 8411251, 9889151],\n",
       "  [18574146, 40584205, 8563659],\n",
       "  [52865789, 14865329, 4319174],\n",
       "  [83308790, 4447785, 18956141],\n",
       "  [83308790, 4447785, 18956141],\n",
       "  [2603304, 12885341, 7370282],\n",
       "  [10627801, 38899659, 15419873],\n",
       "  [4423327, 13955536, 13910150],\n",
       "  [4423327, 13955536, 13910150],\n",
       "  [16058322, 10627801, 6144337],\n",
       "  [301838, 39128592, 3952288],\n",
       "  [14541844, 8909176, 13613916],\n",
       "  [27408104, 36242796, 1967017],\n",
       "  [41774099, 21859699, 16737210],\n",
       "  [4432763, 2338488, 30844602],\n",
       "  [4394817, 7688110, 41710132],\n",
       "  [275294, 32421068, 86704258],\n",
       "  [19205437, 79447, 39187170],\n",
       "  [12149169, 26283293, 23938319],\n",
       "  [27054878, 23983289, 5558754],\n",
       "  [46277811, 27061085, 18909530],\n",
       "  [15425958, 1933281, 2291922],\n",
       "  [4347374, 544971, 2638387],\n",
       "  [13636631, 35764259, 4928282],\n",
       "  [13636631, 35764259, 4928282],\n",
       "  [21498497, 23901235, 17934603],\n",
       "  [17934603, 36444198, 13905670],\n",
       "  [4423401, 27545868, 16355392],\n",
       "  [6268106, 2423940, 3829232],\n",
       "  [9393969, 17055665, 29429111],\n",
       "  [1941721, 5765455, 13023410],\n",
       "  [6144337, 26474812, 5289038],\n",
       "  [30933307, 21932050, 26873988],\n",
       "  [881332, 7662395, 25641414],\n",
       "  [13097856, 7662395, 25641414],\n",
       "  [22505710, 20943272, 1676568],\n",
       "  [28937856, 6144969, 13905670],\n",
       "  [1265945, 5922085, 13905670],\n",
       "  [12443371, 28937856, 13905670],\n",
       "  [1568684, 29381091, 14865329],\n",
       "  [1568684, 29381091, 14865329],\n",
       "  [46277811, 38630735, 3654468],\n",
       "  [11254040, 37628989, 3654468],\n",
       "  [39164524, 4020950, 6148876],\n",
       "  [18949516, 16267205, 36178047],\n",
       "  [27099731, 108886332, 70455704],\n",
       "  [37592824, 34105878, 36606083],\n",
       "  [18537148, 44572913, 7209559],\n",
       "  [108886332, 19878070, 7209559],\n",
       "  [7230315, 7521113, 12827098],\n",
       "  [16999023, 3495456, 39465575],\n",
       "  [16284655, 23036207, 3495456],\n",
       "  [24273592, 14319754, 25451374],\n",
       "  [5389523, 14191255, 12040627],\n",
       "  [20454006, 24341590, 13069283],\n",
       "  [1941721, 5765455, 13023410],\n",
       "  [3893473, 3981729, 46816158],\n",
       "  [13831842, 13765757, 37480103],\n",
       "  [71625969, 46437558, 52072815],\n",
       "  [20491205, 14843502, 13900610],\n",
       "  [7481159, 27731651, 4406819],\n",
       "  [24707550, 3475317, 34615397],\n",
       "  [34481589, 8069939, 3578380],\n",
       "  [19529370, 16812091, 4687948],\n",
       "  [27550580, 28264919, 21239672],\n",
       "  [4886637, 17656445, 56893404],\n",
       "  [17625068, 380526, 43329366],\n",
       "  [11011905, 23208167, 4896726],\n",
       "  [27550580, 28264919, 21239672],\n",
       "  [1606628, 20999249, 9167230],\n",
       "  [19497526, 38401028, 1373287],\n",
       "  [4932668, 37673301, 106301],\n",
       "  [4932668, 37673301, 106301],\n",
       "  [37673301, 18747744, 37438296],\n",
       "  [31313782, 23273454, 17023584],\n",
       "  [4387484, 37549932, 18231807],\n",
       "  [37549932, 25842866, 18231807],\n",
       "  [18231807, 13639330, 37549932],\n",
       "  [3610282, 16461149, 12956194],\n",
       "  [13763195, 45143088, 26378103],\n",
       "  [10443642, 49208216, 24177706],\n",
       "  [26083387, 16120395, 14408200],\n",
       "  [35861290, 26083387, 16120395],\n",
       "  [803312, 14192687, 16284655],\n",
       "  [4326318, 20418809, 19912367],\n",
       "  [20418809, 4326318, 19912367],\n",
       "  [9197092, 10207180, 23260700],\n",
       "  [20610390, 7111021, 24241932],\n",
       "  [24707550, 34615397, 3475317],\n",
       "  [29509926, 8702697, 21382907],\n",
       "  [29509926, 8702697, 17844478],\n",
       "  [15081770, 6559701, 1649738],\n",
       "  [25571386, 11899391, 266641],\n",
       "  [52874170, 84580585, 15482274],\n",
       "  [4325398, 52874170, 15482274],\n",
       "  [18037805, 7137057, 4037034],\n",
       "  [42489926, 46617075, 28249680],\n",
       "  [26973393, 9929089, 9505402],\n",
       "  [8300657, 3835423, 19005293],\n",
       "  [8300657, 3835423, 19005293],\n",
       "  [1454773, 5752492, 5377642],\n",
       "  [19047331, 3870062, 5377642],\n",
       "  [21598000, 36111909, 28369117],\n",
       "  [17454301, 18816720, 2097256],\n",
       "  [28937856, 24185667, 5256564],\n",
       "  [708425, 12966719, 13764090],\n",
       "  [24019260, 5114940, 11614737],\n",
       "  [15058155, 15488881, 38587347],\n",
       "  [23513718, 8290953, 1122279],\n",
       "  [34735369, 27731651, 4406819],\n",
       "  [23267371, 13312471, 2425364],\n",
       "  [8856690, 23267371, 16256507],\n",
       "  [28738741, 53779698, 21003930],\n",
       "  [28738741, 53779698, 21003930],\n",
       "  [21993510, 23245050, 21623140],\n",
       "  [16322674, 21993510, 21623140],\n",
       "  [31616203, 23639838, 19408393],\n",
       "  [29253460, 20526907, 2488880],\n",
       "  [17450673, 5487448, 37480103],\n",
       "  [20310709, 13481880, 42782688],\n",
       "  [9483851, 4138659, 3831884],\n",
       "  [994800, 9283422, 306006],\n",
       "  [6896063, 9669099, 15521377],\n",
       "  [13552682, 34498325, 2890952],\n",
       "  [129199129, 22800314, 6766459],\n",
       "  [5253987, 2619579, 6766459],\n",
       "  [16086778, 6913227, 5253987],\n",
       "  [15590539, 32556431, 12582729],\n",
       "  [22309946, 36831892, 5492542],\n",
       "  [7506409, 18218379, 19343151],\n",
       "  [3847200, 14706752, 368506],\n",
       "  [26314743, 3878434, 5185871],\n",
       "  [13907427, 37164306, 29877890],\n",
       "  [33638477, 33370, 38355793],\n",
       "  [33638477, 33370, 38355793],\n",
       "  [19950357, 20402596, 10504681],\n",
       "  [3441524, 1744752, 2617858],\n",
       "  [24555417, 7549811, 29863668]],\n",
       " 'top_5': [[825728, 26731863, 18953920, 21257564, 26071782],\n",
       "  [17333231, 42240424, 4828631, 18617259, 13734012],\n",
       "  [13030852, 5641851, 1387104, 24980622, 10958594],\n",
       "  [21050357, 20240998, 35521287, 2613775, 23117378],\n",
       "  [14647747, 21186109, 24700152, 25182647, 44265107],\n",
       "  [20904154, 4399311, 13780287, 29459383, 25510546],\n",
       "  [20904154, 4399311, 13780287, 29459383, 25510546],\n",
       "  [23377475, 26025820, 43557480, 11705328, 33409100],\n",
       "  [22712546, 641786, 393001, 6421792, 1373287],\n",
       "  [3758260, 15337254, 18953920, 3848469, 25238950],\n",
       "  [5487448, 25182647, 17450673, 1263446, 7662395],\n",
       "  [13030852, 5641851, 1387104, 24980622, 10958594],\n",
       "  [3202143, 16267205, 21232018, 13072113, 7042304],\n",
       "  [3202143, 16267205, 21232018, 13072113, 7042304],\n",
       "  [23862975, 41493639, 1259359, 45341480, 13843341],\n",
       "  [13934676, 73473433, 14682243, 21274919, 6490571],\n",
       "  [8963413, 3471191, 4468861, 15128866, 1900152],\n",
       "  [21050357, 20240998, 35521287, 2613775, 23117378],\n",
       "  [38410121, 1373287, 14260013, 437924, 79696454],\n",
       "  [38410121, 1373287, 14260013, 437924, 79696454],\n",
       "  [5448119, 28149602, 28015516, 14938990, 12670680],\n",
       "  [15721252, 12438901, 20454006, 24341590, 13069283],\n",
       "  [2264455, 44629665, 27527854, 33723822, 12428497],\n",
       "  [21636085, 37424881, 8595678, 11705328, 42441846],\n",
       "  [37424881, 16252863, 18557974, 33409100, 42441846],\n",
       "  [11705328, 12810152, 42441846, 33409100, 16252863],\n",
       "  [17088791, 34198460, 9997636, 11109043, 13497630],\n",
       "  [34198460, 17088791, 9997636, 11109043, 13497630],\n",
       "  [45218443, 27162821, 4449524, 40913091, 18174210],\n",
       "  [40234452, 9433958, 4816339, 8563659, 5398179],\n",
       "  [3230557, 41264017, 2138843, 24704139, 56893404],\n",
       "  [13282296, 3230557, 24704139, 41264017, 56893404],\n",
       "  [3868322, 17625068, 13519661, 43329366, 380526],\n",
       "  [28707489, 23117928, 11336632, 3512154, 26996935],\n",
       "  [22401720, 25973484, 10024681, 7821634, 45638119],\n",
       "  [9752604, 3419709, 1590744, 49556906, 9899292],\n",
       "  [11659421, 22185730, 4459491, 22116439, 4709641],\n",
       "  [25134146, 13071728, 28806780, 374902, 39984099],\n",
       "  [25134146, 46353045, 374902, 13899137, 39984099],\n",
       "  [20904154, 4399311, 13780287, 29459383, 25510546],\n",
       "  [16644043, 5572127, 30122260, 21295300, 12909503],\n",
       "  [16644043, 5572127, 21295300, 30122260, 12909503],\n",
       "  [8925851, 25388309, 20399078, 10326242, 39443128],\n",
       "  [29422484, 5572127, 213017, 12909503, 21295300],\n",
       "  [29429111, 28697248, 21219071, 29422484, 21295300],\n",
       "  [23985464, 9669099, 21307488, 4414547, 5956380],\n",
       "  [7036529, 22362025, 16267205, 24864273, 1127562],\n",
       "  [14333540, 15953181, 1031534, 17119869, 6076903],\n",
       "  [22703082, 26488879, 20330519, 2837758, 13965483],\n",
       "  [8774475, 195683603, 14407673, 52925737, 5531479],\n",
       "  [15248287, 45770026, 14407673, 52925737, 5531479],\n",
       "  [10494012, 6082738, 8551160, 37608303, 5099266],\n",
       "  [15414628, 34469966, 6000423, 4407455, 5099266],\n",
       "  [36310858, 33507866, 7317051, 24190159, 4320424],\n",
       "  [15833835, 33796570, 18038250, 16964262, 38919140],\n",
       "  [1905095, 20033112, 3619372, 4427392, 21387297],\n",
       "  [2604063, 4928057, 12966719, 7521113, 12827098],\n",
       "  [2604063, 4928057, 12966719, 7521113, 12827098],\n",
       "  [12966719, 10015292, 13116880, 3155731, 12827098],\n",
       "  [25994317, 25068298, 24594624, 22973574, 4254064],\n",
       "  [25994317, 25068298, 24594624, 22973574, 4254064],\n",
       "  [24906548, 41493639, 30553457, 33733520, 45276789],\n",
       "  [5922085, 42950029, 41493639, 30553457, 33733520],\n",
       "  [6000423, 32533299, 34469966, 15435343, 4399311],\n",
       "  [18025240, 23801039, 25878014, 7433668, 13966946],\n",
       "  [409280, 9274291, 3662510, 6085365, 14500725],\n",
       "  [30351165, 18852643, 27264454, 37205759, 6540064],\n",
       "  [14823313, 17897801, 40164383, 24097933, 32159283],\n",
       "  [24307695, 15685921, 164189, 25787749, 36606083],\n",
       "  [8318922, 54490092, 45447613, 5151024, 25515907],\n",
       "  [14606752, 24865781, 6191684, 23865182, 22995579],\n",
       "  [32955023, 970012, 14865329, 29381091, 4319174],\n",
       "  [4784069, 13777138, 23418635, 7581911, 13513790],\n",
       "  [14584755, 25816994, 26199970, 1759213, 6157837],\n",
       "  [21789744, 4942718, 2140513, 15194125, 33872649],\n",
       "  [40005757, 3078080, 4942718, 2140513, 33872649],\n",
       "  [17930286, 22995579, 14566771, 5691302, 14606752],\n",
       "  [14566771, 39390206, 5691302, 22995579, 14606752],\n",
       "  [43165768, 36497180, 1234098, 12801438, 24157077],\n",
       "  [43165768, 36497180, 1234098, 12801438, 24157077],\n",
       "  [17077004, 7111021, 13899137, 31363207, 4883040],\n",
       "  [23985464, 46202852, 5867846, 27063470, 28738741],\n",
       "  [5824985, 14395738, 35087728, 39059143, 21884449],\n",
       "  [10893238, 1358909, 21914176, 457630, 26016929],\n",
       "  [3847200, 49556906, 31293581, 15678772, 6807122],\n",
       "  [24766509, 14192687, 7583161, 40164383, 10582939],\n",
       "  [39558597, 10463997, 56528795, 31001322, 6227220],\n",
       "  [38899659, 15058155, 1471041, 38587347, 15488881],\n",
       "  [711256, 9505402, 25895285, 9929089, 2272614],\n",
       "  [711256, 9505402, 25895285, 9929089, 2272614],\n",
       "  [10218447, 4323425, 34436231, 22890091, 37549932],\n",
       "  [10218447, 4323425, 34436231, 22890091, 37549932],\n",
       "  [2679511, 16217855, 2758012, 39637840, 13439128],\n",
       "  [4414547, 22975806, 3285322, 9394119, 2015126],\n",
       "  [654735, 5260382, 3078080, 23816832, 52874170],\n",
       "  [13868795, 1398021, 28931537, 20187433, 6903077],\n",
       "  [43220289, 7627167, 29022271, 18872233, 5824985],\n",
       "  [7627167, 29022271, 15559582, 18872233, 5824985],\n",
       "  [5824985, 29022271, 43220289, 19071857, 18872233],\n",
       "  [5824985, 29022271, 43220289, 19071857, 18872233],\n",
       "  [43220289, 18872233, 29022271, 7627167, 5824985],\n",
       "  [29022271, 13831842, 15559582, 7627167, 5824985],\n",
       "  [5448119, 28149602, 28015516, 14938990, 12670680],\n",
       "  [20524091, 13907427, 29877890, 20781656, 8411251],\n",
       "  [4340358, 25597580, 79336156, 6985854, 2947540],\n",
       "  [4340358, 25597580, 6985854, 2947540, 79336156],\n",
       "  [20904154, 4399311, 13780287, 29459383, 25510546],\n",
       "  [7225911, 43880096, 37204802, 21557055, 9669099],\n",
       "  [12762485, 2140497, 3285322, 1171121, 13831558],\n",
       "  [2543135, 6722522, 13380011, 9217800, 16966326],\n",
       "  [13205096, 8385277, 10795340, 6374918, 19510470],\n",
       "  [46193388, 10078024, 17271462, 8137081, 12827098],\n",
       "  [24159217, 2867345, 84580585, 12789595, 17374970],\n",
       "  [24159217, 2867345, 84580585, 12789595, 17374970],\n",
       "  [7177329, 4373433, 4421578, 5560962, 3566945],\n",
       "  [3973445, 9899292, 3419709, 26025820, 19313533],\n",
       "  [25942757, 6123924, 13778710, 40590358, 2177022],\n",
       "  [8494570, 23634484, 40590358, 13778710, 2177022],\n",
       "  [2462673, 28006126, 13868795, 35651106, 18231807],\n",
       "  [18231807, 13868795, 28006126, 35651106, 2462673],\n",
       "  [7583725, 15946643, 41548287, 25513319, 9558539],\n",
       "  [4414547, 25479072, 4412772, 470625, 7898952],\n",
       "  [29125354, 4414547, 4412772, 7898952, 470625],\n",
       "  [35760786, 4399311, 13780287, 29459383, 25510546],\n",
       "  [21547032, 35760786, 8458567, 31154082, 13794374],\n",
       "  [44737533, 6290112, 2758012, 6903077, 25606339],\n",
       "  [20887554, 750781, 40156901, 9846940, 27054878],\n",
       "  [11742219, 1590744, 15535511, 14865329, 19205437],\n",
       "  [10562341, 17231273, 37964706, 29362104, 19205437],\n",
       "  [10562341, 17231273, 37964706, 29362104, 19205437],\n",
       "  [25726838, 2030623, 5483793, 42465769, 2014909],\n",
       "  [9648896, 952111, 35993767, 10812605, 32742683],\n",
       "  [35993767, 10812605, 9648896, 3727986, 32742683],\n",
       "  [35993767, 10812605, 9648896, 32742683, 3727986],\n",
       "  [6550579, 34066665, 5406411, 22980205, 26973393],\n",
       "  [12966719, 4460880, 7521113, 12827098, 4928057],\n",
       "  [3285322, 1387104, 8892905, 9394119, 56893404],\n",
       "  [7011850, 9047718, 36708463, 5597586, 4388470],\n",
       "  [8816869, 19979816, 14471161, 4320111, 11557602],\n",
       "  [8816869, 19979816, 14471161, 4320111, 11557602],\n",
       "  [3874000, 22428640, 14225271, 24766509, 8148122],\n",
       "  [5798227, 8596357, 24707550, 14644164, 21498497],\n",
       "  [33203108, 19132741, 22547508, 25104843, 3430789],\n",
       "  [24097933, 19132741, 22547508, 25104843, 3430789],\n",
       "  [44420873, 10669582, 26008462, 13578199, 10474873],\n",
       "  [29381091, 14865329, 52865789, 4319174, 1568684],\n",
       "  [29691654, 29381091, 4319174, 14865329, 1568684],\n",
       "  [10557471, 12810152, 37424881, 8595678, 42441846],\n",
       "  [10557471, 12810152, 37424881, 8595678, 42441846],\n",
       "  [8298120, 75636923, 829646, 3413083, 5850219],\n",
       "  [8298120, 33257464, 3413083, 829646, 5850219],\n",
       "  [6144969, 8446259, 2260571, 29509926, 6397191],\n",
       "  [9904546, 24596228, 14806256, 14657344, 20261352],\n",
       "  [16806763, 5519177, 1667063, 14050257, 18924534],\n",
       "  [36089763, 14853989, 17967608, 30041340, 11328820],\n",
       "  [17741440, 17967608, 30041340, 14853989, 11328820],\n",
       "  [1684489, 600808, 14205246, 38127792, 2033917],\n",
       "  [7560876, 12232678, 18374364, 7878807, 22405338],\n",
       "  [7239105, 31554917, 7627167, 24346598, 5912283],\n",
       "  [1759213, 5551138, 24019260, 5114940, 11614737],\n",
       "  [29107180, 21230110, 83667891, 37677954, 14376683],\n",
       "  [87986426, 46193478, 37677954, 83667891, 14376683],\n",
       "  [5238341, 24670522, 14075252, 2931832, 25001628],\n",
       "  [5116145, 2151983, 4632921, 6401675, 3514072],\n",
       "  [6207111, 32534305, 10071552, 9822397, 1974176],\n",
       "  [708425, 9539248, 21859699, 21216726, 5548081],\n",
       "  [5953485, 4405194, 47018050, 15347087, 4709641],\n",
       "  [13717103, 5953485, 4405194, 15347087, 4709641],\n",
       "  [23206239, 3610080, 13625993, 95102458, 15048300],\n",
       "  [583260, 13625993, 16705338, 13843341, 15048300],\n",
       "  [9704467, 32638085, 42267740, 10874408, 21170174],\n",
       "  [23356816, 17805221, 600808, 45875990, 4398832],\n",
       "  [15836115, 10698739, 9588931, 23403754, 39381118],\n",
       "  [30297355, 24221369, 40721190, 6828370, 8496132],\n",
       "  [29788648, 13072112, 34559336, 32275758, 14797520],\n",
       "  [13072112, 34559336, 32275758, 1354567, 14797520],\n",
       "  [20738970, 23403754, 15248287, 24190159, 7821634],\n",
       "  [18938992, 6121555, 29073751, 24190159, 7821634],\n",
       "  [41646286, 37444589, 23403754, 24190159, 7821634],\n",
       "  [25041967, 13123189, 32770503, 14185503, 14464451],\n",
       "  [17447653, 13123189, 32770503, 14185503, 14464451],\n",
       "  [10024681, 31882215, 10463997, 25576204, 26735905],\n",
       "  [24828165, 6923961, 2443495, 9159125, 20732789],\n",
       "  [4890578, 30639847, 12549585, 30058568, 4506414],\n",
       "  [19510470, 24612804, 2014909, 4658268, 22174015],\n",
       "  [39225849, 3113630, 43192375, 40349336, 12909503],\n",
       "  [30353437, 43192375, 3113630, 40349336, 12909503],\n",
       "  [23423230, 40145839, 9669099, 13794374, 9505448],\n",
       "  [7878807, 14461101, 9669099, 13794374, 9505448],\n",
       "  [20357868, 44737533, 798152, 8300657, 29023309],\n",
       "  [20357868, 44737533, 798152, 8300657, 29023309],\n",
       "  [2533768, 21297708, 46743299, 24338780, 25079962],\n",
       "  [42279414, 9634465, 6121668, 4767806, 1780819],\n",
       "  [2097256, 42387637, 17454301, 8665891, 18816720],\n",
       "  [2097256, 42387637, 17454301, 8665891, 18816720],\n",
       "  [14973286, 15948830, 24211561, 36288526, 23349986],\n",
       "  [32850528, 25816994, 16390264, 5824985, 7098463],\n",
       "  [43122426, 5262240, 32850528, 5824985, 7098463],\n",
       "  [7873737, 44827480, 5884524, 23783727, 19308127],\n",
       "  [1507222, 5254463, 23577867, 30580263, 9641846],\n",
       "  [37699461, 6673421, 30714190, 26873988, 11902109],\n",
       "  [27588420, 8610932, 37699461, 26873988, 11902109],\n",
       "  [17088791, 34198460, 9997636, 11109043, 13497630],\n",
       "  [2452989, 1791714, 25263810, 39048693, 21622715],\n",
       "  [13277118, 22561064, 39048693, 16167746, 18855191],\n",
       "  [12800122, 15816729, 38380061, 13936152, 9646449],\n",
       "  [19099739, 37256966, 52095986, 6144337, 2506153],\n",
       "  [15472716, 18111172, 12552297, 12207340, 20821402],\n",
       "  [15472716, 18111172, 12552297, 12207340, 20821402],\n",
       "  [10354110, 15058155, 34615397, 15488881, 38587347],\n",
       "  [18834078, 20610557, 2389574, 37444589, 20646904],\n",
       "  [34854444, 1550937, 19238, 17814815, 2601324],\n",
       "  [418246, 38919140, 9304312, 26019505, 600437],\n",
       "  [8428837, 34481589, 97884, 1265945, 13956305],\n",
       "  [9967265, 25691541, 14831629, 25612629, 27099731],\n",
       "  [9967265, 25691541, 14831629, 25612629, 27099731],\n",
       "  [12152977, 9675944, 30507607, 3882374, 6826100],\n",
       "  [31107919, 857189, 9787715, 7399084, 1550937],\n",
       "  [31107919, 857189, 9787715, 7399084, 1550937],\n",
       "  [1071991, 7177329, 3566945, 8883846, 24922825],\n",
       "  [44693226, 28249680, 21048969, 20459964, 1522647],\n",
       "  [3929361, 14337960, 27580223, 17433284, 5710820],\n",
       "  [6788835, 36855703, 14180565, 12225214, 18810195],\n",
       "  [16398827, 11886686, 14782049, 4700428, 17150648],\n",
       "  [11328820, 26068103, 17223891, 21651116, 19005293],\n",
       "  [3524352, 15512462, 16098747, 27123743, 18340282],\n",
       "  [15521377, 13814480, 17412260, 41710132, 24652030],\n",
       "  [32357890, 8582337, 7285256, 40666943, 51972698],\n",
       "  [22908536, 28025754, 1148122, 24019260, 21602220],\n",
       "  [22908536, 28025754, 1148122, 24019260, 21602220],\n",
       "  [22908536, 28025754, 1148122, 24019260, 21602220],\n",
       "  [22908536, 28025754, 1148122, 24019260, 21602220],\n",
       "  [22908536, 28025754, 1148122, 24019260, 21602220],\n",
       "  [4550036, 8842332, 2425364, 70455704, 11360768],\n",
       "  [12438901, 27240667, 24918110, 10209731, 1456068],\n",
       "  [27240667, 12438901, 24918110, 10209731, 1456068],\n",
       "  [5752492, 20646904, 14657344, 40473317, 20261352],\n",
       "  [7285256, 21003930, 42387637, 471921, 791050],\n",
       "  [14492964, 28071965, 13242763, 57783564, 5633876],\n",
       "  [26108767, 18938992, 21150010, 27437459, 29459383],\n",
       "  [9278263, 18938992, 21150010, 5132358, 27437459],\n",
       "  [24356383, 43619625, 3118719, 32170702, 38899659],\n",
       "  [9889151, 29877890, 20781656, 8411251, 9451052],\n",
       "  [51386222, 24906548, 18852643, 4709641, 12443371],\n",
       "  [18852643, 20937018, 6947286, 12443371, 4709641],\n",
       "  [15669393, 34228604, 12443371, 4709641, 6309659],\n",
       "  [15669393, 37205759, 6309659, 4709641, 12443371],\n",
       "  [12785130, 19752008, 2714623, 17188921, 16494316],\n",
       "  [1840993, 970012, 7150238, 4583180, 9315213],\n",
       "  [28086354, 35004872, 15983148, 15327601, 21598000],\n",
       "  [8595678, 19278208, 18557974, 37424881, 42441846],\n",
       "  [23073816, 27129115, 20645335, 13791044, 33257464],\n",
       "  [4418070, 83707680, 29429111, 28937856, 16728949],\n",
       "  [16728949, 83707680, 28937856, 29429111, 4418070],\n",
       "  [5702790, 14464451, 3468459, 22191759, 36540079],\n",
       "  [24746892, 36838958, 2543135, 19922508, 10993232],\n",
       "  [3504761, 6227220, 33507866, 31882215, 8002887],\n",
       "  [10359591, 13398997, 18546584, 4418070, 41877386],\n",
       "  [18546584, 15635366, 4418070, 41877386, 10359591],\n",
       "  [15435343, 5836, 2030623, 25726838, 2014909],\n",
       "  [17271462, 9911547, 10165258, 7583161, 10526279],\n",
       "  [2853291, 17271462, 10526279, 9911547, 7583161],\n",
       "  [39550665, 26488879, 24705390, 2052720, 22703082],\n",
       "  [39550665, 26488879, 24705390, 2052720, 22703082],\n",
       "  [24097933, 19132741, 22547508, 8447873, 33203108],\n",
       "  [11933721, 42950029, 44586415, 38493521, 4200695],\n",
       "  [4164929, 2028532, 40631095, 53779698, 4200695],\n",
       "  [20585600, 13384318, 7860396, 10423989, 4162857],\n",
       "  [26596106, 8290760, 42565477, 6826100, 30507607],\n",
       "  [14116046, 10463997, 6227220, 52865789, 597790],\n",
       "  [2604063, 6372244, 52805891, 15578265, 40096222],\n",
       "  [14717213, 25504006, 13030852, 4325398, 1389264],\n",
       "  [834336, 14178995, 15692098, 34747208, 22544171],\n",
       "  [37592824, 21767325, 14924526, 17150648, 15889329],\n",
       "  [15570691, 5123516, 7028976, 13235609, 12685434],\n",
       "  [4463811, 7185591, 11527822, 6106004, 1754001],\n",
       "  [3330111, 35521287, 10562341, 2601135, 7177329],\n",
       "  [11359243, 7177329, 42377686, 34254203, 37182501],\n",
       "  [37065914, 18256197, 23627419, 3761017, 6325527],\n",
       "  [37065914, 18256197, 23627419, 3761017, 6325527],\n",
       "  [25251625, 8093935, 14119470, 368506, 14706752],\n",
       "  [10530014, 32532238, 24881307, 8093935, 10991183],\n",
       "  [34258065, 29367554, 26488879, 22703082, 24705390],\n",
       "  [29877890, 502591, 19485243, 7137057, 12588500],\n",
       "  [7137057, 22522432, 502591, 25606339, 30041340],\n",
       "  [502591, 29877890, 7137057, 19485243, 12588500],\n",
       "  [29788648, 8460275, 22522432, 30041340, 25606339],\n",
       "  [24249915, 2494748, 6121668, 11359243, 1780819],\n",
       "  [25606339, 24706198, 22561064, 5473074, 1320137],\n",
       "  [8529693, 24521894, 15678772, 24269361, 56893404],\n",
       "  [17271462, 18374364, 9911547, 19583924, 92499],\n",
       "  [19583924, 14550841, 25830701, 6718824, 515489],\n",
       "  [13350374, 17897801, 34873974, 34054472, 13223957],\n",
       "  [45461275, 5835149, 17077004, 5548081, 22227889],\n",
       "  [5835149, 17077004, 34139429, 5548081, 22227889],\n",
       "  [1538080, 30983338, 23206239, 12662435, 26064662],\n",
       "  [24285403, 12667988, 21274919, 6191684, 17930286],\n",
       "  [21003930, 12691537, 53211308, 38401028, 10883736],\n",
       "  [39550665, 24705390, 7465900, 2638387, 22703082],\n",
       "  [21439293, 23117928, 40323148, 14853989, 45401535],\n",
       "  [11900630, 14550841, 18374364, 104143831, 25516011],\n",
       "  [21287352, 18988265, 2032877, 20109325, 29564505],\n",
       "  [25822299, 13714201, 14803797, 33684572, 6793674],\n",
       "  [54490092, 46277811, 14803797, 33684572, 6793674],\n",
       "  [18489989, 4421742, 4653837, 3863543, 1617327],\n",
       "  [36651210, 25413327, 26374799, 11335860, 3360421],\n",
       "  [36651210, 26374799, 25413327, 11335860, 3360421],\n",
       "  [36651210, 26374799, 11335860, 25413327, 3360421],\n",
       "  [36637129, 9288638, 4447055, 21046889, 16056514],\n",
       "  [2481032, 2225918, 14782049, 4700428, 17150648],\n",
       "  [40044800, 1049501, 7968532, 41337677, 19688024],\n",
       "  [15419873, 44366096, 1970884, 5137019, 6820680],\n",
       "  [9334631, 26068103, 8639034, 37762357, 10648422],\n",
       "  [11630388, 33118292, 164985, 24998637, 6070278],\n",
       "  [9283422, 41982985, 34905328, 5914739, 8903143],\n",
       "  [14340571, 10675756, 27772649, 21060008, 1471041],\n",
       "  [29399239, 42873134, 9878167, 43054703, 14853989],\n",
       "  [13106686, 44693226, 42873134, 20456030, 1049501],\n",
       "  [9977329, 18275697, 2506153, 5377059, 30034334],\n",
       "  [56391045, 33203108, 57121667, 5152028, 20101846],\n",
       "  [11630388, 27466734, 752423, 25355575, 2867345],\n",
       "  [25355575, 12770738, 29253460, 8780599, 2867345],\n",
       "  [12922760, 46346525, 26596106, 15551129, 16120395],\n",
       "  [12922760, 46346525, 15551129, 26596106, 16120395],\n",
       "  [4423327, 20524091, 4462419, 6441369, 23418635],\n",
       "  [20839751, 15832146, 22975806, 24249915, 20333864],\n",
       "  [20839751, 15832146, 22975806, 24249915, 20333864],\n",
       "  [7224723, 11784947, 13231899, 72159, 8596357],\n",
       "  [4414481, 13613916, 9704467, 7643848, 10300888],\n",
       "  [9704467, 39462488, 32638085, 7643848, 10300888],\n",
       "  [14657344, 14863011, 15128866, 8994465, 4468861],\n",
       "  [24408040, 19675911, 34139429, 9622258, 37029185],\n",
       "  [3788528, 14500725, 17463549, 1336292, 23460562],\n",
       "  [31560225, 20864487, 29023309, 708425, 14260013],\n",
       "  [20864487, 29023309, 43378932, 708425, 14260013],\n",
       "  [21459247, 41233511, 42291761, 2575938, 8428935],\n",
       "  [25516011, 2296264, 42855554, 40558887, 7142113],\n",
       "  [5698494, 1831916, 752423, 1068106, 10984005],\n",
       "  [21274919, 45457778, 32463364, 6309659, 14682243],\n",
       "  [13934676, 45457778, 32463364, 6309659, 14682243],\n",
       "  [33533307, 36355784, 31889025, 20945963, 19675911],\n",
       "  [5596332, 52827184, 17023584, 3776162, 4824840],\n",
       "  [29845974, 11254040, 583260, 42404093, 12258338],\n",
       "  [29845974, 11254040, 583260, 42404093, 12258338],\n",
       "  [27647593, 31882215, 10463997, 25576204, 26735905],\n",
       "  [11868606, 9814332, 7757997, 33118292, 6540064],\n",
       "  [24828165, 6923961, 2443495, 9159125, 20732789],\n",
       "  [4890578, 30639847, 12549585, 30058568, 4506414],\n",
       "  [14853989, 35651106, 4664540, 17023584, 21439293],\n",
       "  [4664540, 17023584, 5785219, 21439293, 14644164],\n",
       "  [36838958, 17933691, 970012, 4319174, 32408470],\n",
       "  [34498093, 11983390, 21598000, 16056410, 9638032],\n",
       "  [36830715, 28369117, 7549811, 33911859, 9638032],\n",
       "  [23702805, 28369117, 7549811, 33911859, 9638032],\n",
       "  [13072112, 24896957, 8892905, 22317868, 17911973],\n",
       "  [25576204, 8892905, 11255504, 22317868, 17911973],\n",
       "  [8903143, 623486, 5914739, 87986426, 24541180],\n",
       "  [9122283, 9929089, 21258863, 6673421, 20888849],\n",
       "  [2028532, 37156349, 4407385, 15041758, 1642727],\n",
       "  [3034412, 12074066, 22843838, 4462079, 25599283],\n",
       "  [8790729, 54561384, 6082738, 21676556, 20033112],\n",
       "  [21676556, 14198646, 3756384, 3847200, 20033112],\n",
       "  [41599676, 21369472, 10574949, 22241778, 16355392],\n",
       "  [9638032, 33370, 2727303, 9211173, 5468807],\n",
       "  [14591894, 28195565, 16280642, 9507605, 5172048],\n",
       "  [28195565, 16280642, 1800734, 9507605, 5172048],\n",
       "  [4680262, 19205437, 14198646, 25513319, 1686997],\n",
       "  [31612088, 31019903, 73473433, 6129301, 25649714],\n",
       "  [25499612, 40900567, 2460304, 8373753, 6503185],\n",
       "  [41298619, 36799998, 120626, 24921368, 13619127],\n",
       "  [6076903, 1070920, 2481032, 17150648, 32611468],\n",
       "  [16252863, 37424881, 11705328, 33409100, 21636085],\n",
       "  [16252863, 37424881, 11705328, 21636085, 33409100],\n",
       "  [44409062, 6767133, 6334188, 19945096, 15041758],\n",
       "  [6334188, 32012666, 19945096, 44409062, 15041758],\n",
       "  [15041758, 9278263, 12789595, 13771184, 3202143],\n",
       "  [38376189, 4402497, 30437264, 10559501, 9433958],\n",
       "  [38376189, 4402497, 30437264, 10559501, 9433958],\n",
       "  [24384587, 6853699, 28149602, 17421851, 21372171],\n",
       "  [8305686, 4459491, 6961811, 4407385, 57574395],\n",
       "  [8305686, 4459491, 6961811, 4407385, 57574395],\n",
       "  [35612665, 26108767, 37643601, 15716328, 8533245],\n",
       "  [2138767, 14803797, 13230773, 7454794, 5293024],\n",
       "  [16217855, 12225214, 29788648, 27134931, 37204802],\n",
       "  [350542, 40901687, 1103795, 29788648, 37204802],\n",
       "  [5979056, 8446259, 7711685, 15879931, 22080671],\n",
       "  [39559521, 29785642, 25738896, 13989491, 12580014],\n",
       "  [15488881, 32250572, 45154987, 1070920, 4469125],\n",
       "  [33068577, 14407673, 44724517, 22153455, 6493422],\n",
       "  [1630949, 22150633, 26873988, 18489989, 25148216],\n",
       "  [6446747, 18489989, 1630949, 22150633, 25148216],\n",
       "  [12130690, 22800314, 40349336, 25928548, 5573975],\n",
       "  [39291138, 22800314, 40349336, 25928548, 5573975],\n",
       "  [23244529, 13777706, 19572798, 1791637, 15635366],\n",
       "  [7662206, 15360986, 5612738, 9814332, 2095573],\n",
       "  [22190276, 4350400, 14893425, 9796495, 11250124],\n",
       "  [22190276, 14893425, 8006440, 9796495, 11250124],\n",
       "  [1695604, 4411760, 4162857, 4393153, 23269537],\n",
       "  [2832403, 21232018, 9315213, 23397658, 6227220],\n",
       "  [7373453, 17421851, 4890578, 970012, 9315213],\n",
       "  [2832403, 1840993, 23397658, 6227220, 9315213],\n",
       "  [13923069, 7373453, 4890578, 970012, 9315213],\n",
       "  [37362689, 22544171, 25036988, 34747208, 4452659],\n",
       "  [10518721, 37608303, 7643848, 4701662, 797114],\n",
       "  [4701662, 22544171, 34747208, 10518721, 4452659],\n",
       "  [37362689, 22544171, 34747208, 25036988, 4452659],\n",
       "  [4381486, 35811036, 24101431, 3848469, 25238950],\n",
       "  [17327939, 27567994, 10190778, 8182950, 1071991],\n",
       "  [4423401, 5106691, 2405259, 27545868, 16355392],\n",
       "  [834336, 14178995, 34747208, 15692098, 22544171],\n",
       "  [20402596, 4350400, 19950357, 38675228, 16557565],\n",
       "  [5519177, 9655347, 43711341, 18276599, 18924534],\n",
       "  [3866315, 21636085, 33912748, 24269361, 22442133],\n",
       "  [25974070, 3866315, 33912748, 24269361, 22442133],\n",
       "  [20148808, 3866315, 24269361, 22442133, 33912748],\n",
       "  [16550075, 2000038, 42314147, 6828370, 15635366],\n",
       "  [10024681, 16550075, 2000038, 6828370, 15635366],\n",
       "  [7808055, 4305576, 22038539, 175735, 17587795],\n",
       "  [17934082, 52925737, 8396189, 4389252, 5531479],\n",
       "  [36444198, 12370881, 14492339, 7521113, 22406695],\n",
       "  [15215393, 18841257, 13400643, 4387494, 8548635],\n",
       "  [34469966, 37768883, 25148216, 15551129, 33634749],\n",
       "  [34469966, 37768883, 25148216, 15551129, 33634749],\n",
       "  [28334217, 85665741, 4920376, 2272614, 4961038],\n",
       "  [24335068, 19482914, 24554740, 13573143, 5389095],\n",
       "  [3506723, 1539159, 16562534, 6609935, 4417558],\n",
       "  [29073751, 3506723, 16562534, 6609935, 4417558],\n",
       "  [16242975, 14205246, 35531883, 29863668, 1684489],\n",
       "  [9956893, 27093166, 39424916, 83308790, 23078022],\n",
       "  [21562657, 14637235, 9680193, 21307488, 11291348],\n",
       "  [12225214, 33068577, 14637235, 21307488, 11291348],\n",
       "  [29557235, 23513818, 12225214, 21562657, 11291348],\n",
       "  [25817686, 6422576, 29557235, 12225214, 11291348],\n",
       "  [18231807, 35651106, 1550937, 28006126, 40608679],\n",
       "  [17209919, 4435369, 3588621, 14768471, 19800147],\n",
       "  [4435369, 17209919, 3588621, 14768471, 19800147],\n",
       "  [3770726, 3929361, 5289038, 8593263, 40900567],\n",
       "  [25315295, 23122306, 7451018, 10494012, 31933981],\n",
       "  [8246090, 2714623, 2617858, 17123657, 33499189],\n",
       "  [14195528, 41239107, 27815697, 1391126, 3095620],\n",
       "  [10617916, 13948920, 13899137, 3929361, 1805641],\n",
       "  [980008, 7997337, 1964163, 33986200, 41644178],\n",
       "  [5824985, 14395738, 35087728, 39059143, 21884449],\n",
       "  [1831916, 13441037, 4353857, 4345757, 11481946],\n",
       "  [32777637, 22635278, 4345757, 23397658, 11481946],\n",
       "  [22635278, 4345757, 23397658, 11481946, 22057077],\n",
       "  [15984735, 33835579, 29253460, 20526907, 2488880],\n",
       "  [13256155, 9929089, 20606520, 2492146, 15476777],\n",
       "  [8883846, 23915841, 21150010, 152245, 24922825],\n",
       "  [31293581, 3173489, 12552297, 27635177, 11569583],\n",
       "  [31293581, 3173489, 12552297, 27635177, 11569583],\n",
       "  [31293581, 3173489, 12552297, 27635177, 11569583],\n",
       "  [10889845, 14116046, 6227220, 2481032, 13001323],\n",
       "  [10889845, 43192375, 6227220, 2481032, 13001323],\n",
       "  [39084565, 6270720, 24338780, 8246922, 40632104],\n",
       "  [19130782, 29015485, 39084565, 7155555, 8246922],\n",
       "  [25014337, 1569031, 21186109, 4393153, 4740447],\n",
       "  [1569031, 25543207, 21186109, 4393153, 4740447],\n",
       "  [17438862, 16863359, 17991818, 15493354, 15889329],\n",
       "  [15493354, 17991818, 16863359, 15889329, 17438862],\n",
       "  [38369817, 8672737, 14566771, 15984735, 23785605],\n",
       "  [3662510, 27711043, 72580164, 17779800, 3610080],\n",
       "  [5254463, 8551160, 3107733, 8425533, 27693891],\n",
       "  [8425533, 27693891, 20456030, 4701662, 18678095],\n",
       "  [8425533, 8551160, 12058271, 5094468, 14767844],\n",
       "  [5939172, 2138767, 13230773, 7454794, 5293024],\n",
       "  [36642096, 4421578, 7177329, 4373433, 22180793],\n",
       "  [26038789, 36642096, 7986878, 4373433, 22180793],\n",
       "  [25543207, 4421578, 7177329, 4373433, 22180793],\n",
       "  [17188921, 27772649, 6550579, 4373433, 22180793],\n",
       "  [14180217, 31514338, 19974105, 25787749, 36606083],\n",
       "  [19951373, 14337960, 60515890, 25041967, 22186938],\n",
       "  [5107861, 8698208, 5409325, 17081238, 19799455],\n",
       "  [15322518, 13329980, 14241418, 21307488, 33387953],\n",
       "  [711256, 33370, 19255949, 23604601, 8148304],\n",
       "  [11887584, 7662206, 19255949, 23604601, 8148304],\n",
       "  [17814815, 25789730, 27731651, 45487164, 35467590],\n",
       "  [17814815, 7840442, 35467590, 14767844, 45487164],\n",
       "  [9505402, 25014337, 6426919, 15319019, 2319305],\n",
       "  [2272614, 25014337, 6426919, 2319305, 15319019],\n",
       "  [7821634, 4678846, 4700428, 140098548, 26025370],\n",
       "  [3669694, 7821634, 26025370, 14584755, 4700428],\n",
       "  [30369606, 25263942, 6121668, 1780819, 15928989],\n",
       "  [18852643, 15928989, 11557602, 23286603, 45166582],\n",
       "  [5567005, 24150328, 15663829, 34054472, 3912660],\n",
       "  [24150328, 34054472, 68317730, 15663829, 3912660],\n",
       "  [14853989, 9878167, 30041340, 11328820, 17741440],\n",
       "  [16962732, 23122306, 28015516, 2692522, 22696649],\n",
       "  [409280, 9274291, 3662510, 6085365, 14500725],\n",
       "  [8883846, 23915841, 152245, 10494012, 24922825],\n",
       "  [54490092, 31889025, 25562234, 4506414, 12206390],\n",
       "  [19464037, 38735355, 14361849, 40867854, 8190282],\n",
       "  [5836, 22482820, 28419824, 878526, 6407356],\n",
       "  [17438862, 1227277, 40127292, 6407356, 6219790],\n",
       "  [13048272, 9076196, 1982286, 22049489, 12315072],\n",
       "  [34615397, 21258863, 3475317, 8698857, 16066726],\n",
       "  [38830961, 34615397, 21258863, 3475317, 16066726],\n",
       "  [26735905, 17917408, 20568364, 16086778, 16361581],\n",
       "  [37822406, 3360421, 10546779, 15803282, 4457834],\n",
       "  [11415809, 21956124, 26735018, 10675756, 14340571],\n",
       "  [24347647, 11414664, 32421068, 37029185, 43220289],\n",
       "  [1831916, 26199970, 32421068, 37029185, 43220289],\n",
       "  [3099497, 14437255, 6431384, 313394, 3095620],\n",
       "  [6793674, 12709184, 33684572, 6327940, 14803797],\n",
       "  [6793674, 12709184, 33684572, 6327940, 14803797],\n",
       "  [44624045, 6793674, 12709184, 33684572, 14803797],\n",
       "  [9754530, 9967265, 7098463, 7613033, 6477536],\n",
       "  [6112053, 9967265, 7098463, 9754530, 6477536],\n",
       "  [18816720, 457630, 8665891, 10300888, 15670968],\n",
       "  [39984099, 18816720, 8665891, 10300888, 15670968],\n",
       "  [3105781, 25419778, 23727313, 38899659, 13509809],\n",
       "  [1044552, 33912748, 58050905, 22505710, 37562370],\n",
       "  [41915616, 25938221, 19487477, 24269361, 18750453],\n",
       "  [10189634, 26625002, 21425864, 14338915, 16686383],\n",
       "  [30675656, 57574395, 21425864, 14338915, 16686383],\n",
       "  [13106686, 7968532, 19688024, 1049501, 41337677],\n",
       "  [40044800, 19688024, 41337677, 7968532, 1049501],\n",
       "  [4306711, 19957813, 33912020, 7005276, 14496749],\n",
       "  [8997410, 46277811, 7757997, 33118292, 6540064],\n",
       "  [34469966, 22406695, 5372773, 37762357, 10648422],\n",
       "  [39758684, 14332945, 6945691, 11915280, 6923961],\n",
       "  [8536018, 22800314, 6625693, 10666475, 11254556],\n",
       "  [30553457, 20128547, 14188138, 22800314, 11254556],\n",
       "  [37205759, 20128547, 17967608, 14188138, 11254556],\n",
       "  [25462689, 1631583, 24541180, 10786948, 463309],\n",
       "  [6828370, 16364639, 469066, 15176526, 34071621],\n",
       "  [34369306, 7639744, 12145359, 26067999, 16422880],\n",
       "  [28821565, 2758012, 1259359, 24596228, 17077004],\n",
       "  [2058909, 25134146, 36202354, 22414304, 17077004],\n",
       "  [10374686, 5372432, 42404093, 5641851, 16390264],\n",
       "  [10374686, 5372432, 42404093, 5641851, 16390264],\n",
       "  [13959707, 25938221, 25420421, 2460304, 18174210],\n",
       "  [13959707, 25938221, 25420421, 2460304, 18174210],\n",
       "  [24770122, 5260382, 52874170, 44830890, 16056514],\n",
       "  [23349986, 10761515, 2360905, 29947146, 14711483],\n",
       "  [11238951, 24082820, 3512154, 28821565, 8563659],\n",
       "  [23122306, 18237384, 994800, 42693833, 5483793],\n",
       "  [18062308, 6491532, 25895285, 18682109, 6421792],\n",
       "  [9505402, 17462437, 2272614, 25895285, 9929089],\n",
       "  [42404093, 13843341, 16495649, 21260231, 12258338],\n",
       "  [42404093, 13843341, 16495649, 21260231, 12258338],\n",
       "  [21859699, 11527199, 5597586, 16737210, 7034001],\n",
       "  [21274919, 4407385, 45336190, 10190462, 1642727],\n",
       "  [4449524, 12224536, 13230773, 11201004, 18537148],\n",
       "  [4449524, 12224536, 13230773, 11201004, 18537148],\n",
       "  [13083189, 5172048, 37204802, 41493639, 16905344],\n",
       "  [4340358, 2727303, 4422723, 26047921, 21414718],\n",
       "  [4828631, 12009265, 24581365, 31229233, 3355397],\n",
       "  [16630996, 9831859, 4959368, 31229233, 3355397],\n",
       "  [12009265, 10024681, 24581365, 31229233, 3355397],\n",
       "  [9732010, 13242763, 11011905, 23208167, 4896726],\n",
       "  [5698494, 202259, 6525844, 75636923, 8780599],\n",
       "  [16242975, 4306711, 20018321, 13931771, 935538],\n",
       "  [13384318, 946756, 7860396, 4067274, 21330280],\n",
       "  [13384318, 946756, 7860396, 4067274, 21330280],\n",
       "  [32322418, 25822299, 40631095, 40817021, 2820454],\n",
       "  [41314611, 28904104, 17368516, 11401602, 15077696],\n",
       "  [28904104, 17368516, 41314611, 11401602, 15077696],\n",
       "  [6561200, 27873158, 829646, 46695481, 27446873],\n",
       "  [28617573, 829646, 27873158, 6561200, 27446873],\n",
       "  [20722510, 343052, 29509926, 3475317, 34378726],\n",
       "  [120626, 6397191, 21382907, 29509926, 8702697],\n",
       "  [6144969, 120626, 21382907, 29509926, 8702697],\n",
       "  [7506409, 4457834, 40349336, 16630060, 11659421],\n",
       "  [39532074, 6153754, 2335873, 4447055, 20128547],\n",
       "  [16346504, 15113221, 16364639, 34071621, 6828370],\n",
       "  [4411760, 3153673, 16686383, 27900414, 1383826],\n",
       "  [9675944, 19756935, 23262027, 12742164, 9988425],\n",
       "  [4444861, 4319844, 4926049, 4899981, 16472469],\n",
       "  [4418878, 8774475, 9038803, 38131471, 16472469],\n",
       "  [12086599, 19522248, 13791206, 6710699, 16472469],\n",
       "  [11568270, 21439293, 28697248, 38131471, 16472469],\n",
       "  [27635177, 10874408, 21793890, 20420780, 16472469],\n",
       "  [27635177, 10874408, 20420780, 21793890, 16472469],\n",
       "  [38252314, 19522248, 13791206, 6710699, 16472469],\n",
       "  [18639989, 7468449, 16472469, 25842866, 26607366],\n",
       "  [29107180, 22623275, 4418112, 23913146, 5702790],\n",
       "  [30041340, 13011249, 43419566, 11328820, 24624992],\n",
       "  [5389523, 4401289, 4899981, 8577229, 14332945],\n",
       "  [39128592, 39559521, 20155713, 2734421, 3952288],\n",
       "  [39559521, 20155713, 301838, 2734421, 3952288],\n",
       "  [35231675, 10247314, 40721190, 7848113, 4926049],\n",
       "  [24155601, 4380287, 4380451, 19343151, 14105446],\n",
       "  [16364639, 13048272, 22049489, 12315072, 1982286],\n",
       "  [37912677, 6751418, 43122426, 26026009, 9745001],\n",
       "  [34760396, 24632480, 18662787, 6690087, 6277638],\n",
       "  [34760396, 2266471, 15615957, 10557471, 6277638],\n",
       "  [4362729, 36962270, 39859981, 11603066, 1225513],\n",
       "  [30261663, 39729277, 22482024, 23342686, 16927286],\n",
       "  [4319174, 17933691, 36838958, 970012, 32408470],\n",
       "  [21307488, 6157371, 22500262, 22185730, 3113630],\n",
       "  [24721866, 12640810, 16686383, 22185730, 3113630],\n",
       "  [7115651, 15578265, 36642096, 11899391, 13923140],\n",
       "  [3882374, 14923462, 23418635, 4462419, 6441369],\n",
       "  [935538, 24863571, 15590539, 22358449, 12486491],\n",
       "  [623486, 34905328, 87986426, 5914739, 24541180],\n",
       "  [623486, 34905328, 87986426, 5914739, 24541180],\n",
       "  [12100854, 14225271, 18998807, 4547102, 15803282],\n",
       "  [14225271, 8185080, 18998807, 4547102, 15803282],\n",
       "  [8185080, 4547102, 4457834, 22490293, 15803282],\n",
       "  [11011905, 31882215, 8290760, 1630949, 16287725],\n",
       "  [19384430, 31882215, 8290760, 1630949, 16287725],\n",
       "  [15778034, 25254425, 11844791, 5966635, 9451052],\n",
       "  [2192419, 13923069, 7373453, 7711685, 17421851],\n",
       "  [3203590, 27167110, 14116046, 22180793, 17671145],\n",
       "  [11968641, 26099680, 4587978, 11565780, 22500262],\n",
       "  [3805841, 4587978, 13277039, 11565780, 22500262],\n",
       "  [16712164, 24737389, 12240507, 22482024, 12486491],\n",
       "  [11721676, 207972, 9315213, 14706752, 368506],\n",
       "  [11935250, 24450344, 8925851, 7487927, 24737389],\n",
       "  [17482507, 16812091, 11246427, 19878070, 26000593],\n",
       "  [18816720, 6766459, 3716075, 129199129, 2097256],\n",
       "  [18816720, 6766459, 129199129, 3716075, 2097256],\n",
       "  [39368721, 45447613, 40790033, 2522977, 10072941],\n",
       "  [39059143, 21323587, 16495649, 3776162, 13906581],\n",
       "  [11933721, 42950029, 44586415, 38493521, 4200695],\n",
       "  [42185082, 3190689, 12561083, 32462603, 13027590],\n",
       "  [20186814, 4326318, 25419778, 16660256, 20418809],\n",
       "  [29098525, 799586, 16217855, 15305881, 15659108],\n",
       "  [16217855, 29098525, 15305881, 799586, 15659108],\n",
       "  [4164929, 2028532, 40631095, 53779698, 4200695],\n",
       "  [25822299, 31019903, 154243324, 33135135, 6129301],\n",
       "  [5596332, 3878434, 22153455, 3776162, 4824840],\n",
       "  [22153455, 5596332, 3878434, 3776162, 4824840],\n",
       "  [5373138, 23244529, 19572798, 16167746, 14658685],\n",
       "  [5373138, 23244529, 19572798, 16167746, 14658685],\n",
       "  [16701509, 1428840, 25973484, 13831842, 5691302],\n",
       "  [14566771, 37424881, 23627419, 8595678, 5691302],\n",
       "  [15984735, 20526907, 43629704, 5691302, 32159283],\n",
       "  [27466734, 5850219, 6112053, 3981244, 39281140],\n",
       "  [143251, 23577014, 7645565, 7915836, 17628888],\n",
       "  [46594244, 15425958, 8144920, 40365566, 18237384],\n",
       "  [14128314, 86129154, 3583084, 4457834, 4784069],\n",
       "  [364522, 4662264, 18489989, 26851674, 18038250],\n",
       "  [39729277, 42373087, 12922760, 41928290, 410286],\n",
       "  [30884033, 5633876, 31311495, 43661837, 3874000],\n",
       "  [5633876, 31311495, 43661837, 30884033, 3874000],\n",
       "  [20544428, 5884524, 16760369, 32328114, 3898784],\n",
       "  [38784540, 24159217, 28017005, 17374970, 6710713],\n",
       "  [11624482, 12789595, 28017005, 17374970, 6710713],\n",
       "  [31324978, 756887, 22544171, 40349336, 4313478],\n",
       "  [21789744, 26341063, 2032877, 21050357, 23117378],\n",
       "  [21050357, 2496002, 23117378, 35521287, 1686881],\n",
       "  [27647593, 11943989, 16541762, 27138601, 12824568],\n",
       "  [11246427, 23704559, 19529370, 19182166, 44048701],\n",
       "  [12943966, 5293024, 23351136, 718601, 20829129],\n",
       "  [13907928, 8596837, 18997216, 26710772, 5323845],\n",
       "  [58006489, 18997216, 13907928, 26710772, 5323845],\n",
       "  [11156883, 2030623, 9056874, 11481946, 21009874],\n",
       "  [1032372, 36480032, 9056874, 11481946, 21009874],\n",
       "  [27466734, 12670680, 28015516, 5448119, 28149602],\n",
       "  [7869794, 4389252, 41982985, 15972906, 6936141],\n",
       "  [25510546, 10086360, 27588420, 19756935, 24142891],\n",
       "  [13235609, 18600579, 7898952, 22901758, 33370],\n",
       "  [22901758, 7898952, 470625, 18600579, 33370],\n",
       "  [13235609, 18600579, 7898952, 22901758, 33370],\n",
       "  [11716783, 12130067, 10795340, 24356383, 3531388],\n",
       "  [25513319, 25915873, 8512633, 24581365, 12009265],\n",
       "  [10699587, 39174007, 38551172, 30720103, 12009265],\n",
       "  [7221410, 4407385, 15347087, 9194077, 5260382],\n",
       "  [3770750, 33960383, 12224536, 9822397, 10071552],\n",
       "  [103007, 21547032, 19205326, 18340282, 4828631],\n",
       "  [8563659, 8596357, 2603304, 5700349, 7370282],\n",
       "  [35495268, 24917562, 22922353, 40949706, 7098463],\n",
       "  [31612088, 13083189, 44265107, 12584053, 40127292],\n",
       "  [11360768, 36033696, 1456068, 2787558, 12584053],\n",
       "  [38752049, 12584053, 39264456, 40949706, 43220289],\n",
       "  [38919140, 23269537, 4366738, 4417177, 11902109],\n",
       "  [8646760, 11844826, 38300781, 29877890, 15305881],\n",
       "  [7426741, 12887068, 23269537, 9791313, 28614776],\n",
       "  [7426741, 12887068, 23269537, 9791313, 28614776],\n",
       "  [20781656, 406733, 9451052, 8411251, 9889151],\n",
       "  [12966719, 5735492, 18574146, 40584205, 8563659],\n",
       "  [4854076, 29381091, 52865789, 14865329, 4319174],\n",
       "  [22210434, 23078022, 83308790, 4447785, 18956141],\n",
       "  [22210434, 7735859, 83308790, 4447785, 18956141],\n",
       "  [6767271, 8563659, 2603304, 12885341, 7370282],\n",
       "  [9169645, 16058322, 10627801, 38899659, 15419873],\n",
       "  [5448119, 1649738, 4423327, 13955536, 13910150],\n",
       "  [1649738, 22428640, 4423327, 13955536, 13910150],\n",
       "  [22191759, 23342686, 16058322, 10627801, 6144337],\n",
       "  [24828165, 2734421, 301838, 39128592, 3952288],\n",
       "  [4414481, 32712381, 14541844, 8909176, 13613916],\n",
       "  [13069283, 22505190, 27408104, 36242796, 1967017],\n",
       "  [7034001, 21203899, 41774099, 21859699, 16737210],\n",
       "  [45218443, 51972698, 4432763, 2338488, 30844602],\n",
       "  [28697248, 9641846, 4394817, 7688110, 41710132],\n",
       "  [36355784, 14482051, 275294, 32421068, 86704258],\n",
       "  [5687200, 41790911, 19205437, 79447, 39187170],\n",
       "  [22191759, 5473074, 12149169, 26283293, 23938319],\n",
       "  [18654430, 654735, 27054878, 23983289, 5558754],\n",
       "  [5403286, 40090058, 46277811, 27061085, 18909530],\n",
       "  [12489688, 37444589, 15425958, 1933281, 2291922],\n",
       "  [12552297, 14376683, 4347374, 544971, 2638387],\n",
       "  [9159125, 32665136, 13636631, 35764259, 4928282],\n",
       "  [9159125, 20460020, 13636631, 35764259, 4928282],\n",
       "  [22890091, 36444198, 21498497, 23901235, 17934603],\n",
       "  [10648422, 4418878, 17934603, 36444198, 13905670],\n",
       "  [21369472, 5106691, 4423401, 27545868, 16355392],\n",
       "  [18914652, 14581009, 6268106, 2423940, 3829232],\n",
       "  [3748310, 4418070, 9393969, 17055665, 29429111],\n",
       "  [22696649, 35543846, 1941721, 5765455, 13023410],\n",
       "  [3001685, 24157077, 6144337, 26474812, 5289038],\n",
       "  [10450300, 25141908, 30933307, 21932050, 26873988],\n",
       "  [25806385, 13097856, 881332, 7662395, 25641414],\n",
       "  [25806385, 881332, 13097856, 7662395, 25641414],\n",
       "  [36345185, 3093512, 22505710, 20943272, 1676568],\n",
       "  [36242796, 12443371, 28937856, 6144969, 13905670],\n",
       "  [6957332, 24906548, 1265945, 5922085, 13905670],\n",
       "  [26068103, 37762357, 12443371, 28937856, 13905670],\n",
       "  [4854076, 4319174, 1568684, 29381091, 14865329],\n",
       "  [4854076, 4319174, 1568684, 29381091, 14865329],\n",
       "  [6070278, 11939159, 46277811, 38630735, 3654468],\n",
       "  [583260, 15968271, 11254040, 37628989, 3654468],\n",
       "  [4427392, 2828460, 39164524, 4020950, 6148876],\n",
       "  [4457834, 5145974, 18949516, 16267205, 36178047],\n",
       "  [49429882, 29107210, 27099731, 108886332, 70455704],\n",
       "  [14145440, 406733, 37592824, 34105878, 36606083],\n",
       "  [11716783, 19878070, 18537148, 44572913, 7209559],\n",
       "  [11246427, 3613041, 108886332, 19878070, 7209559],\n",
       "  [2192419, 15081770, 7230315, 7521113, 12827098],\n",
       "  [9420732, 6148876, 16999023, 3495456, 39465575],\n",
       "  [8771704, 12240507, 16284655, 23036207, 3495456],\n",
       "  [12428497, 14682243, 24273592, 14319754, 25451374],\n",
       "  [4407318, 36547290, 5389523, 14191255, 12040627],\n",
       "  [17163294, 12438901, 20454006, 24341590, 13069283],\n",
       "  [4391121, 35543846, 1941721, 5765455, 13023410],\n",
       "  [25830701, 19099739, 3893473, 3981729, 46816158],\n",
       "  [5487448, 25973484, 13831842, 13765757, 37480103],\n",
       "  [5939172, 11742219, 71625969, 46437558, 52072815],\n",
       "  [43855756, 34227917, 20491205, 14843502, 13900610],\n",
       "  [22632303, 7145763, 7481159, 27731651, 4406819],\n",
       "  [21258863, 9977329, 24707550, 3475317, 34615397],\n",
       "  [3935126, 2492146, 34481589, 8069939, 3578380],\n",
       "  [9555784, 3613041, 19529370, 16812091, 4687948],\n",
       "  [15925931, 16511863, 27550580, 28264919, 21239672],\n",
       "  [1974176, 41264017, 4886637, 17656445, 56893404],\n",
       "  [22534357, 24323369, 17625068, 380526, 43329366],\n",
       "  [9732010, 13242763, 11011905, 23208167, 4896726],\n",
       "  [15925931, 16511863, 27550580, 28264919, 21239672],\n",
       "  [52188256, 8298120, 1606628, 20999249, 9167230],\n",
       "  [6157371, 4391121, 19497526, 38401028, 1373287],\n",
       "  [3619372, 9122283, 4932668, 37673301, 106301],\n",
       "  [4460880, 3619372, 4932668, 37673301, 106301],\n",
       "  [43566999, 4627816, 37673301, 18747744, 37438296],\n",
       "  [51952430, 21498497, 31313782, 23273454, 17023584],\n",
       "  [1574014, 23078022, 4387484, 37549932, 18231807],\n",
       "  [3140772, 16790253, 37549932, 25842866, 18231807],\n",
       "  [25842866, 1574014, 18231807, 13639330, 37549932],\n",
       "  [32909242, 11288846, 3610282, 16461149, 12956194],\n",
       "  [8698857, 18924534, 13763195, 45143088, 26378103],\n",
       "  [26751583, 45401535, 10443642, 49208216, 24177706],\n",
       "  [516867, 35861290, 26083387, 16120395, 14408200],\n",
       "  [9704467, 516867, 35861290, 26083387, 16120395],\n",
       "  [21232018, 3952288, 803312, 14192687, 16284655],\n",
       "  [4653837, 8771704, 4326318, 20418809, 19912367],\n",
       "  [6334188, 15955172, 20418809, 4326318, 19912367],\n",
       "  [40476126, 30041895, 9197092, 10207180, 23260700],\n",
       "  [10365749, 22414304, 20610390, 7111021, 24241932],\n",
       "  [2947124, 9977329, 24707550, 34615397, 3475317],\n",
       "  [343052, 41877386, 29509926, 8702697, 21382907],\n",
       "  [13329980, 21382907, 29509926, 8702697, 17844478],\n",
       "  [1153655, 11238951, 15081770, 6559701, 1649738],\n",
       "  [13448422, 9822397, 25571386, 11899391, 266641],\n",
       "  [6847208, 13497630, 52874170, 84580585, 15482274],\n",
       "  [13497630, 24906548, 4325398, 52874170, 15482274],\n",
       "  [13790144, 5273056, 18037805, 7137057, 4037034],\n",
       "  [31902335, 37204802, 42489926, 46617075, 28249680],\n",
       "  [34066665, 18682109, 26973393, 9929089, 9505402],\n",
       "  [24879055, 10648422, 8300657, 3835423, 19005293],\n",
       "  [10648422, 24879055, 8300657, 3835423, 19005293],\n",
       "  [3870062, 9178310, 1454773, 5752492, 5377642],\n",
       "  [17844478, 10648422, 19047331, 3870062, 5377642],\n",
       "  [7925817, 35231675, 21598000, 36111909, 28369117],\n",
       "  [27527854, 25069745, 17454301, 18816720, 2097256],\n",
       "  [2030623, 9588931, 28937856, 24185667, 5256564],\n",
       "  [11415809, 24190159, 708425, 12966719, 13764090],\n",
       "  [1759213, 5551138, 24019260, 5114940, 11614737],\n",
       "  [3580005, 28644298, 15058155, 15488881, 38587347],\n",
       "  [25175997, 79447, 23513718, 8290953, 1122279],\n",
       "  [16736883, 38675228, 34735369, 27731651, 4406819],\n",
       "  [19799455, 17450673, 23267371, 13312471, 2425364],\n",
       "  [13312471, 9555784, 8856690, 23267371, 16256507],\n",
       "  [42387637, 2248870, 28738741, 53779698, 21003930],\n",
       "  [42387637, 2248870, 28738741, 53779698, 21003930],\n",
       "  [16322674, 36558211, 21993510, 23245050, 21623140],\n",
       "  [23245050, 2659805, 16322674, 21993510, 21623140],\n",
       "  [9629682, 22509015, 31616203, 23639838, 19408393],\n",
       "  [15984735, 33835579, 29253460, 20526907, 2488880],\n",
       "  [16322674, 38784540, 17450673, 5487448, 37480103],\n",
       "  [1265945, 1022115, 20310709, 13481880, 42782688],\n",
       "  [5256564, 1344498, 9483851, 4138659, 3831884],\n",
       "  [17539488, 12265561, 994800, 9283422, 306006],\n",
       "  [9559146, 25419778, 6896063, 9669099, 15521377],\n",
       "  [16242975, 30261663, 13552682, 34498325, 2890952],\n",
       "  [4319174, 34121231, 129199129, 22800314, 6766459],\n",
       "  [9159495, 8006440, 5253987, 2619579, 6766459],\n",
       "  [4740447, 4305576, 16086778, 6913227, 5253987],\n",
       "  [2000038, 2452989, 15590539, 32556431, 12582729],\n",
       "  [7506409, 7711685, 22309946, 36831892, 5492542],\n",
       "  [23746313, 928281, 7506409, 18218379, 19343151],\n",
       "  [25251625, 207972, 3847200, 14706752, 368506],\n",
       "  [20746604, 34208005, 26314743, 3878434, 5185871],\n",
       "  [20781656, 30184745, 13907427, 37164306, 29877890],\n",
       "  [19644821, 3419802, 33638477, 33370, 38355793],\n",
       "  [22180793, 3419802, 33638477, 33370, 38355793],\n",
       "  [4350400, 38675228, 19950357, 20402596, 10504681],\n",
       "  [10577574, 14362678, 3441524, 1744752, 2617858],\n",
       "  [21598000, 35231675, 24555417, 7549811, 29863668]]}"
      ]
     },
     "execution_count": 77,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# TODO\n",
    "N = [1,3,5]\n",
    "top_text_ids = {}\n",
    "top_titles_ids = {}\n",
    "top_abstract_ids = {}\n",
    "for n in N:\n",
    "    top_text_ids[f'top_{str(n)}'] = top_bm25_scores(claims_preprocessed_joined, texts_bm, df_corpus, n)\n",
    "    top_titles_ids[f'top_{str(n)}'] = top_bm25_scores(claims_preprocessed_joined, titles_bm, df_corpus, n)\n",
    "    top_abstract_ids[f'top_{str(n)}'] = top_bm25_scores(claims_preprocessed_joined, abstract_split, df_corpus, n)\n",
    "\n",
    "top_text_ids\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 3.4 Graphique (4 points)\n",
    "\n",
    "Dans un même graphique, affichez les performances pour les deux modèles (TF-IDF et BM25) dans la recherche des documents (text, title et abstract) pour les affirmations."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {},
   "outputs": [],
   "source": [
    "# TODO\n",
    "# END TODO"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### 3.5 Observation (4 points)\n",
    "\n",
    "Par rapport à vos résultats avec TF-IDF, observez-vous une amélioration ou une détérioration des performances, qu'est ce qui explique cela ? (Donnez au moins trois justifications)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "DVYiuH8aeB8x"
   },
   "source": [
    "## Livrables\n",
    "Vous devez remettre votre notebook sur Moodle et Gradescope en ipynb et pdf. Pour Gradescope vous devez associer les numéros de questions avec vos réponses dans le pdf grâce à l'outil que fournit Gradescope.\n",
    "\n",
    "\n",
    "## Évaluation \n",
    "Votre TP sera évalué selon les critères suivants :\n",
    "1. Exécution correcte du code et obtention des sorties attendues\n",
    "2. Réponses correctes aux questions d'analyse\n",
    "3. Qualité du code (noms significatifs, structure, performance, gestion d’exception, etc.)\n",
    "4. Commentaires clairs et informatifs\n"
   ]
  }
 ],
 "metadata": {
  "colab": {
   "collapsed_sections": [
    "1tMX8go24rB_",
    "4ItqD8yL-utW",
    "0kzLIzqD-vp7",
    "VIRjMFlY-wHL",
    "R41oj9nI-wwi",
    "3FibZKYkHi06"
   ],
   "name": "TP2 solution.ipynb",
   "provenance": []
  },
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
